<SEC-DOCUMENT>0000790526-21-000009.txt : 20210316
<SEC-HEADER>0000790526-21-000009.hdr.sgml : 20210316
<ACCEPTANCE-DATETIME>20210316154101
ACCESSION NUMBER:		0000790526-21-000009
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		86
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210316
DATE AS OF CHANGE:		20210316

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RadNet, Inc.
		CENTRAL INDEX KEY:			0000790526
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				133326724
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33307
		FILM NUMBER:		21745489

	BUSINESS ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025
		BUSINESS PHONE:		3104787808

	MAIL ADDRESS:	
		STREET 1:		1510 COTNER AVE
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMEDEX HEALTH SYSTEMS INC
		DATE OF NAME CHANGE:	19930518

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CCC FRANCHISING CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>rdnt-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:cd605a11-4611-4df1-b35a-84491793f997,g:2afe2a05-cf4e-4f48-9c2a-eb0c739eec8b,d:5a2935eeac0a4d05a10ff02c7b77fcb4--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:rdnt="http://www.radnet.com/20201231" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rdnt-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF80L2ZyYWc6ZTgxYWIyZjU4YTllNDhmYmFlYmY5MWY1ZDM5ZmY2NzAvdGFibGU6ZTdhMjVlMTllN2U2NDhkNzkzYzEwOTZjNzY1NGNjMDMvdGFibGVyYW5nZTplN2EyNWUxOWU3ZTY0OGQ3OTNjMTA5NmM3NjU0Y2MwM18zLTEtMS0xLTA_e8e730f1-58a3-4070-867f-6a31bf41df1d">0000790526</ix:nonNumeric><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF80L2ZyYWc6ZTgxYWIyZjU4YTllNDhmYmFlYmY5MWY1ZDM5ZmY2NzAvdGFibGU6ZTdhMjVlMTllN2U2NDhkNzkzYzEwOTZjNzY1NGNjMDMvdGFibGVyYW5nZTplN2EyNWUxOWU3ZTY0OGQ3OTNjMTA5NmM3NjU0Y2MwM180LTEtMS0xLTA_17fc1705-311f-458d-8855-9003ff98f8c4">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF80L2ZyYWc6ZTgxYWIyZjU4YTllNDhmYmFlYmY5MWY1ZDM5ZmY2NzAvdGFibGU6ZTdhMjVlMTllN2U2NDhkNzkzYzEwOTZjNzY1NGNjMDMvdGFibGVyYW5nZTplN2EyNWUxOWU3ZTY0OGQ3OTNjMTA5NmM3NjU0Y2MwM182LTEtMS0xLTA_2b7f07cb-e338-47f4-be71-a2339b0a5bab">FY</ix:nonNumeric><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF80L2ZyYWc6ZTgxYWIyZjU4YTllNDhmYmFlYmY5MWY1ZDM5ZmY2NzAvdGFibGU6ZTdhMjVlMTllN2U2NDhkNzkzYzEwOTZjNzY1NGNjMDMvdGFibGVyYW5nZTplN2EyNWUxOWU3ZTY0OGQ3OTNjMTA5NmM3NjU0Y2MwM183LTEtMS0xLTA_41f9e787-4c59-4f77-8666-7c84278777c7">2020</ix:nonNumeric><ix:nonNumeric contextRef="i9aa53910584d4308b3a9af105783ce91_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE1Ng_34d0b0f5-d4d7-4f53-b8d4-f97aa42926e1">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i9aa53910584d4308b3a9af105783ce91_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE2OQ_cb2940f3-3de2-419f-b70c-92ae0342fb0b">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i38c4184cf981409f99903c799615fc7c_D20200101-20201231" format="ixt-sec:duryear" name="rdnt:WeightedAverageAmortizationPeriodRemainingInYears" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85NC9mcmFnOjE2MjIwMGJlY2E3ZDRhMWViNDExNWQ3ZGZiN2RmMDBkL3RleHRyZWdpb246MTYyMjAwYmVjYTdkNGExZWI0MTE1ZDdkZmI3ZGYwMGRfODk_a1822f62-5368-4c90-94c1-b2ca0df8fc0c">0</ix:nonNumeric><ix:nonNumeric contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" name="us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xNDkzL2ZyYWc6NmEyYTRlNzBjYzhiNDA4MjhjODgxZmY2ZWM2NzVlY2QvdGV4dHJlZ2lvbjo2YTJhNGU3MGNjOGI0MDgyOGM4ODFmZjZlYzY3NWVjZF8zMjk4NTM0ODgzNDQy_d897b2f3-cbc9-419f-9b14-f9c4ce8df9f7">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="i80da3a0cfbcd4daabbb76961c2faeb86_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc2OA_936612e8-22fa-4ff0-b720-c4675549c40d">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i80da3a0cfbcd4daabbb76961c2faeb86_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc4OA_046091b3-dd3f-4a0f-84b9-3f6b7a937f8c">P5Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rdnt-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i3f632fde5d0946eaae6fa48e47fe915a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ibaa2464885764c41ae09dcb977e30937_I20210305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36f65120df6f499e96c85073c30fef44_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bc65197cb4a4267a98b35b45d061e65_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i91cab1d2676f4c75984b340531fdb510_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibeb4b5f80227407994e895e9fdf49c2c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i234d43f26e4d4788b2228afca82d6341_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0cb6103e98c484a80f4c648cf9a807a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf8d37678bac4561b537c7457bdd558b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife6ce5fe36734a9a814d0f68137a31b0_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb4c0755ae114d328c14dac7820d1e90_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dc4ab6f79444662b0f8c57ff6fbf123_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5e6c5ca93f94736bb1c3bfc63efbccf_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i023faad94c6344268f372203aa84692b_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf6a4235673d476da3ca1a82e301b586_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8189d3507f114e55b1eb07765a0f8fdb_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4642cbc638c646e88712849889f662b5_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b406d963f1849e7bc859162bb04f9c4_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ided679c17b004e37bf6e8caf9a77bfb8_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if58d2cdaa8dc40528b9291019c26a4d5_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3b1f19594f8442296a0ad23c159cb2f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86f3f1e4adc845aa8ff6eecc119258e8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d7d69f790144635b6dfa34118ab2074_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e34bb1f702e49a0b37e15b35cc7d11e_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1a562ce319b492e8ddb3e7f62714b25_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09006b479cba4028a203556db5818971_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibae6485d220c4366bf04745e679dee34_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56a7504cf2d24b3c95f46157e23014d6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74beb185d82c45bb93d9dce1efe2e18e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica4a33e11a3249c8ad15dd466a5a1d51_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaface0b8920a4f0488a80ec15c2e0796_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7d78ac548ab47a6892df2497561bd63_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86411c359d1a4e08bd83fa3becd2af69_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8cb870c78c7468b82991b63a957577f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fe1e680ce184c668d237cef4fa45980_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia696c9fb613641ca908b22d1a1b6fda4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cc5dbf72ca544cd8fdd6e81e4269864_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99f93a3af86d4cf18e3b0b79c87477e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac2767be8a5846ac88dc5a19d3c5cdd0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia89915e83e8f47d7b74a40ecdf68fe96_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd9fc193c5854fdc93bcf728fb8b4b34_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4830b5a7c0d4df5923a89542ecd633a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1cd86610d3e409eb7e61fdffe0b0402_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i416ef7c3fc3f4c4c990703d137b448b8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19057998bb654587aa0fe2496a826358_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3baa465341b441d8ae234bdc7ac7a2c0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id829ecfe8db8402f80f8ee378ed8854e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89e9405f6f814d8a9a3df0257feaca2a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i314621482e04419e975d6e27278101d0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac06a801037b41eea48e4721682546dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief57d143117e41c48907a4d78682dee8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d288cd107d84361b2e08ab554ae5ed7_D20190801-20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i46ed970e221a4949933067bb7c822615_I20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a886167e5d546978b5a20d615e9fc78_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida4995e095e84733a7a3db2b2c529f94_D20190801-20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b935882b4d8429a874b97a0270ab625_I20190301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6d052daae794a8fac16e845d601f61e_D20190227-20190227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-27</xbrli:startDate><xbrli:endDate>2019-02-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a9e5ef103564deb822d473edf70473d_I20190227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i107a79c6ba52476ebe7de9b31052579f_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:NewJerseyImagingNetworkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff1137ebe584b6e9251f4be6a157e86_I20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:NewJerseyImagingNetworkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0394c754617f470ca05634e5df485f1f_D20181001-20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MedicalArtsRadiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadcbd5b4c90e437fae076570fd592eab_I20181001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MedicalArtsRadiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id037acfdb2974904b3b0606b4fe20b4d_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MedicalArtsRadiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia978d78cb33c49d0b2db28864fec1dce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MedicalArtsRadiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5527d962127c4f0890eb1bf05ca35aac_D20180901-20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife75574fa4f34d78b8d99e90205c9f7b_D20180901-20180930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-01</xbrli:startDate><xbrli:endDate>2018-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c749423cff34945b7292f9e192be48f_I20180101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="center"><xbrli:measure>rdnt:Center</xbrli:measure></xbrli:unit><xbrli:context id="i9bcc7eba5c6e48c898708be79cf90c04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:BeverlyRadiologyMedicalGroupIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58b03b73c60d49f3939e2ad703919efe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:BeverlyRadiologyMedicalGroupIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">rdnt:BoardMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d60bb5091324738b842894a8d612608_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80ff729336ff43a7b8f70a9e53ad3932_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e0c5a3c996d40d6b9a18855f3170e9f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:ScriptSenderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9aa53910584d4308b3a9af105783ce91_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59d8b9f6e0ef49d4a4d3fe5016d69357_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a6ccbfae5264333868c009a4c975e8d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i891c10b64f17493bb11c320547b8151e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if13c433b6a59448e80ed8ed7eba74c84_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia42b0a40b551449aa8cf5aab61557ad1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55ae38103bc54357bc2d68bf08c2da7f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1d4292049a343c6bc7508d9b0441dfa_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i624a2cd5a57c45c195d9eea635adda77_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic586562cfaa14df5b15da5de1aa5bd11_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44ff6aefd98947aea4638300eb0bc851_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7d1f53911394e648410f42738dfedaa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfb18a43c61343ecb86bc5802bdfcb00_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i066fe4ef9d6f479db95ce1cf95386477_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i614755c7eae243538ab15e0aa1c51f04_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a20030cccbd4aa184a599982173e41c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b5081b915b84065ab6982f64bd2cdc2_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie97dd2adff264063a2311999801b83cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6faacec13adc4cfaa3714f042eb08eca_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b4058b6aea4480f93436186354111d6_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib673d95e637f4dcdb5dc1061d5a63735_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8efa81ad11b426eb95ebed781413689_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i411513ce21ff409cb97e6b96a1937d9b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e3cd3d7d43342508d2f3e021c52f178_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia05b082668734b48affdda6293f59c04_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f11681d86e440a8a138ad9a36324ab1_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i378af55f9d9f47e98887a9393d7f737d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id29d143ec6924d1587f745bf76712764_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1db908b8572402e87b53c44f73c46c9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c6d94c52f45408a9a65cb42ed24c2d7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff9c306f9afc4473a51abdf18b8b4dee_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id626261985f3405eb1ffba0c34b5000f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d4beeb600334777869da4212f754cd3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i924340cebec24f3d98853f0b12bf9470_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i235a1122e4214ab5937abc9704a2165a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife26e87c47284440b905cc0d64ac26ec_I20201001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie584d839922d4a17968542922cbe6707_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0aee577b90c4f58aa31701ba3a01b9b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReinsurancePolicyTypeAxis">rdnt:HealthInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic130af0a16044225945a7112208da137_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReinsurancePolicyTypeAxis">rdnt:HealthInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifce3d08cb6c9413a851bd3ff47c40964_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf9ac2491d4342e0b58df2c8c84ae62b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd66928c30e1473b9c9c069d01b5bdbb_I20061130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RadiologixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2006-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i964d58a775bd4fa199e750e6ee03db8e_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:PrimedexHealthSystemsInc.andRadiologixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i40918c356ba546019d9cf3855b255d7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b4b71ee39b549678fe63c62bb7e85e5_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">rdnt:USAttorneysOfficeForTheWesternDistrictofNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50d9608d8beb4655b129134c49d35159_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">rdnt:USAttorneysOfficeForTheWesternDistrictofNewYorkMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="numberofagreement"><xbrli:measure>rdnt:numberOfAgreement</xbrli:measure></xbrli:unit><xbrli:context id="i4d8112539b844f619adaf708f61bd146_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67ac9c2904dc49e2ac4bc506d54d17e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:September2020CapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id90a9127362e454283d08c7e3fd0c691_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2020CapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34ed4d9f350d499789b3e42719f10a5b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">rdnt:Caps2016Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i654a8e8ed7bb4f3bbb5cd9c288d0b69d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ee370d9a22543fb9f2dab8cc9aa4803_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79371fc04e834bfcaea740fd6bc52153_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if60e961bba2a4bbfae302a70f01ee39d_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib856840ca6324eeba1a6b1494e0c38f1_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61555f9eb90b46f688385e53cb2d0b54_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b6ec598f73740f98940d9eb5201b90a_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4f79b8708a34406aeaa4254bff7bf57_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9921f768cd544944875eaeacb5eb5af9_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab09020dae044987a27d5a27395d9975_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb0a905a8db84850b58584bad8c4af86_D20200701-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccd401f36a0c470ea4320cd33aebeea3_D20231101-20251031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2025-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc5d103d5dec4837a37b5436811017d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46e5bfcb59a44381930228cdbedb0c73_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fefeb1f7013464bbd2ec16f399ab7af_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee473bf952d14518a4aa17edb183780b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic23c6521ea5a4ca0beeee403496fb2b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3f8d60d96a441aba20d06c47362b2b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i565b0d00fc96454389f20aa5dbe8bf55_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9421b4c3defc4cf7b17e066a06b1caa7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ad49d0deed647c0a498c2366fc5efb5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d6a973db2ba408383529fed3405f008_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i311a05ca14ed4565b8093ad84dc6c1f8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a0f55d2766d408490715ca7893da207_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50b5d4270b9a405a974ddd1764a0c39e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75a252a681e34b079a5a7f189f4bf384_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48064a0601f7427da1f6463f58e86cf6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc527a4818a643d49fe09cfa85c4c780_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fe005478a77480f8ca9f42839c796df_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5bf62651ffd4565b1634ab1e49d1658_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic953d4eafcbf4d7cb0bf03e5e5a554d1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c602f38cb744dff881ca06c457467bc_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc5f93ef9014432796ae78b5a5f1277a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie29a29bde2bc4177a697491ea4430974_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie15c1fc805524eb3949f0526154afb88_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1092fa5159474e67b00fbddb2636707c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f52dc1b8df24f608f50e003a77157f1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95972ba545c2413db9a96bb8f5a78f19_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id37d5b32618d4989a2d4ae3321a56a10_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if56b240e264240e4b120a420105c6f77_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e91f8345bde4d118909d99c801fab52_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee2fd20ee7b4470a880084f9e273f9a5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie40d3a8fbcef47b19505b8259baa9c2d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:SunTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a358573454349cf8e2a7aa01f671b00_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:SunTrustMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bceea0558df4aa7a7b357ca906e3844_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1c392fb7a5b4f1bb1f098f0d9a1675e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if76464750e804b1b92602d1d98c066fa_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i473019f6980c4551a0817c8df1b09e13_I20170324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ded1c2d91fb4066b0d52f289dbc6bf1_D20170324-20170324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-03-24</xbrli:startDate><xbrli:endDate>2017-03-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dbe4948ad594309b6b27c4836c67b68_D20180301-20180301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4843fa912a25453896424af36c06d915_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8e2a3314e2147c8878b4abe3dfe0373_D20180201-20180201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-02-01</xbrli:startDate><xbrli:endDate>2018-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5596086792694e92ace9a030c37a797a_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5c53a008eee4b64b7e27857cbb84f0d_I20191011"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7a0400670894eb7a7e0b89fd33e8d63_D20191105-20191105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-05</xbrli:startDate><xbrli:endDate>2019-11-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="joint_venture"><xbrli:measure>rdnt:joint_venture</xbrli:measure></xbrli:unit><xbrli:context id="i39bb82566bf248d0b0fd688dde04dbe9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice6bd37091d347f3832020ccc4810992_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84c20c51ca704a07878759c0f075f79e_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticRadiologyGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieef3f7dbd23c40ba8dec17264c4c7404_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticRadiologyGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CHINationalServicesIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice510c28777843f7908e514b19c6921c_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03c69569d3d64c1ca16e558b4cf75bee_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd3a6d6c4d174d43891d0ceddc82c6fa_I20170401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacffbad6df7e4b20a00f3fce533dc4dc_I20170401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied3dcc77eee243f38eab75f3a00f0e81_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b637d843dc04b2db741ddae2d1a65cd_D20190101-20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie59b21d255d147928f8d589fb25170fa_D20141006-20141106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-10-06</xbrli:startDate><xbrli:endDate>2014-11-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c644318cb64465f94242234734b4336_I20180412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92c0f7af41664881930d4f739dc6b4cb_D20180412-20180412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-12</xbrli:startDate><xbrli:endDate>2018-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2554f6fee6574c18aa40868ebe1c695b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7055474fff84385849f9083f2f9de03_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia5ea44f74d23424abb3bafc1c81918e2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabdd0283752a4382b0580526189689c1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2197fe5a97c5429da1cc14762c73c186_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:ZPAtlanticLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d6cef46192147a3a9e8eb7ca0715056_I20201101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:ZPElmhurstLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaeade28b6efd4a5892b49eea2eb7af2c_D20200831-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:AZTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-31</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:AZTechMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89d9310e311f4127811afce11cd60c48_I20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i465e71fce78e4f91b93ebe3aac52f888_D20200302-20200302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-02</xbrli:startDate><xbrli:endDate>2020-03-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15cd63800a8f437f9409f248d1e8148d_I20200302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b97202f8ab7436596da79bcd433c721_D20200102-20200102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-02</xbrli:startDate><xbrli:endDate>2020-01-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb22327f2e344552abfc54aa4c8a3bff_I20200102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1ca963b4ec644fb9fafe95a4d9cb74f_I20190731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia72ddff7bc5d4634b0956b82982d346c_D20190401-20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:KernRadiologyImagingSystemsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fb7800d73114cc8a0a897cae7906feb_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:KernRadiologyImagingSystemsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6013424b82d141dba94b68360286b828_D20190401-20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZilkhaRadiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZilkhaRadiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e74f1c4a6d74c37aa2e96e236ce886f_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia312590d9b814f1386f70c721698d7d1_D20190228-20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-28</xbrli:startDate><xbrli:endDate>2019-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4337c29255b447709dce2086107be291_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4874f4e250774b1fbb5b0f4c47efae14_I20190228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i456f5191d4dd4b73882fca5d3f1ad088_D20190201-20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a60c6284cf54e1ca418b050d90465a0_I20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf7fe2658d284b5cb2907e0de5419820_D20190201-20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-01</xbrli:startDate><xbrli:endDate>2019-02-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b95c89ccfed4e1fb901493260558cab_I20190201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-02-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieac963b9dd7b42a5bc5034ac64e4e8ee_D20190301-20190301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLC.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i612c3bc5981e4ff8bd89f7fc44a3a3fe_I20190301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealth.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLC.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i091d9ede79dd4469affa6d73b62fd16c_I20190301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLC.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i029867b23b704961b44fc1543f234b9f_D20190301-20190301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealth.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLC.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-01</xbrli:startDate><xbrli:endDate>2019-03-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e571ad52d964e1389114033d8e4b89c_D20200601-20200601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5528883c400f402890b0b9e360fa9757_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MedicalArtsRadiologicalGroupPCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd9c48ca86d84fb980d466453795b682_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DignityHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b0b910fae6b4ba090ec1c469a5c973a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa266170ed154d5198ecd30150de0a0d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e225ee197db4962846379c1f756351b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:KernRadiologyImagingSystemsInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i774974bb637346659642b95eb18c0d88_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZilkhaRadiologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b7b602ee54a433b9e40d150fe55fbb3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RamicMahwahLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e8e0ca3243444e7970426cdcd410ff4_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e940ec7fd4d4b28bb5546113a619040_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4351f86bc864495c813b7164d4002e89_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i037ebcff3f474b6a85350f30a450750f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41f3fcd0c1b7458b8c2b5611fd14cbe3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AZTechRadiologyOpenMRILLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffd13c35af724f7495f80a4ffd36d14a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPOzoneParkLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff9d9ba698244f9295f632171332ff38_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPElmhurstLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9bf401f259054b239c444a7ba3779a78_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id05c02a9c24c46eb8f9844d8050a58a4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5df3beb96ec040a792ee0fc37556ccd6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3126da00ef154364bff57a0c60402471_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id061ad1af2d248bfb7f45397fa7e8c96_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedtechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf3163cdc65c43c2bb456cfbfe498c0e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedtechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61448a8add4f4771a367c78ff3a9877b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:TradeNamesAmortizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i830cf944df0341d7a34972034686fd2b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:TradeNamesAmortizedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:TradeNamesIndefiniteLifeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1af3ae0e5caa47a7a61c06002e11c661_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38c4184cf981409f99903c799615fc7c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90897045b27b47d3851512df495fb317_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4ba3f78a0f049ebbe6bbd419db532c1_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3ebc23af28648849d72a86f89b15a59_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4215872a7995444cb1ddcef9705d75d5_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdea4c2c6a394718bbe4f06a3a8dc179_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f79bab3685041179f8a090705f8145d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e015b6f1727458c8d7a3e194aee3c2d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b6f7873910a406998fcb4834647b21b_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab72392226114b9c9189e2d1cfb7fe7c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i285fdbc8c707469b8e163fb3a3e1934f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbc658ed6a3a4a78a3c5bf60feff2cd1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78316bdeb53c42e49f72d68723354ca6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f7c6c92238d4993b8ecc28a6fac055a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c47a542e8864e56810edc15688328c9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05a8cf1c3f364c8385b06277f3785c9f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4293895b42684cfab6b3bb70114b012f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10c7eb7f995c42fd9e9471533755d56c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if541ba545c6849c9b80ae7c8f6901cfc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib81178c4dfa84fc9bdd6fffca1947078_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienTermLoansAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibdfce80209e24d048368e13932f4df63_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ba89948df004b25bb090cc21c311d86_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i393ed2858c1548b6b82e961dc7975352_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82d3729db9c24aed80f38ee4cff8b9e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ffc456155284a328dd24dd400e38ed4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie76ddddf094d4fa9a36625b0a91bb963_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f3bcd1c38c94c46890195526ab00dc7_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03d496ffc98f4cbea3c2e52184411ed8_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fd684fe4e424d05a9e16bcf1667b1d8_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c94cda8e234414db8eeb093634ddc93_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id542a67b5a124e768231f2834084c93e_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i565421d3700145cc93c48dbb3d1a4773_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d53766b85e942388c2185f85329d9fe_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6a7dcb8d79a4eb49b6cbd0775ce1798_D20160701-20160701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8288ed7887c48afb55992d498cc71a8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i995ae7f592fb4fefb0bb03523e52883b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae3bdf0809064518b238f69ea108dcd7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80b7b2a03f3941348f06c63609e7c6cb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1263f290830a4060aed96f7ad872c48a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibacf3bc799af4bb38a866940c2a2c3bb_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750fa1f8302a426fb9a669a5704e685e_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81c400dac51f406a9711305492c3b4c2_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c266838663e4aa9bd0e5ea532d2b79c_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaa9f7ca79134dada648ef42e6c6db50_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43b7dfec154e47c7ae3282f11f953037_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a3f1fe7a6fb45e28d7055b802128ddd_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77430f8ce1d24d29b21836836ac4c9f5_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddf06388c8db452292fd4be8fac89b3d_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66e971e62a534f359ea61e7860897264_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i726b0bebd34a4e46a057d38e4f1ba269_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i219c247a7c464cf9815c4651e1be0884_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie388174914b1418aaa031d162e279aa9_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f4b411c521e4514876b71fb6b7b4ad2_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65e5beb9352246028536bb875e13ba71_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63f437b3e9a640edad9d5b48f6ada9eb_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie69f018701ff451c852994840d5678f4_I20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3142f65c94ae47beb9a1aff303e0d018_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f40b418b6d84fc884519577e1396a36_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6ed187b6ae14da3a3469e3302627e8c_D20180831-20180831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-08-31</xbrli:startDate><xbrli:endDate>2018-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54f63ff21ef3452fba37a70277f1b7dd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic509aa6e20d8451e869c6c1adc35cb1b_D20180101-20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-01-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48cfb04da83545e39b2c1c70193a8083_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56bc70ab4f98412fb60048a93886fb28_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a1fe13162294ec8b4af081e02f06560_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35416759782a4ffcae881c1975663437_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8545538a2ef54e1b9d395b7b7743a4a3_I20170822"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i296abca1ec384478903ec34e3f7c3244_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a18b41ec6e94cbbbda45664ee69a4e0_I20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66691542788640c6b83e170f22e99fd2_D20190418-20190418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-18</xbrli:startDate><xbrli:endDate>2019-04-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ec14573b907475cbd068c8d85492abd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e615f475e34430ead7ea3449fb67aa1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="loan"><xbrli:measure>rdnt:loan</xbrli:measure></xbrli:unit><xbrli:context id="i7393b27f4af1422f97fa04785bd0e65e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6dad76471cb45619fba56de651a701e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b790074af0343b2807bdb47a7b6fc97_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i443f461b18dc4cbc8d9de4443701c2c5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2018Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9828ffc96914aafb4d9efce6667921c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e81d491c9834d05aaea374ea32dd36c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RavenHoldingsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80da3a0cfbcd4daabbb76961c2faeb86_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38edc38946a14643a72d3091d803e56d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaeedfaefcdd24073a7791f2cf8216e31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e82aebaacf64a089fdc7fe9fdc1e466_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if04aa1ab93ce4b9a8e416308089ebf97_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7aaf101d3fad496781ceeb004ddadb94_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82674e78aaef409482561fb16833fed8_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7924f95e7254282bcfd904f5e8c2a33_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a16c03189374ecc8b0cfdb8f468e8f7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2855760db5544e182b346d57d04d55d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf9d07d86bdb4bdf9c4770c8c4998e95_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d7b881e14e742dcb65f5f1ced340221_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7d23330ea44497788f06f832afc7e77_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdc31c4ffa00452f9f099766b10087be_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i109a113f281d4536a92aad55cbd4446b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic762f9e446734268b2ec4cc6053e0784_I20210316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f85f9b11184e229c14b88e0c866f9a_D20210301-20210316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7780ac5dfb3420c990d47876f42a92d_D20210301-20210316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d7ba65a559c49258e9c430b845e4b63_I20210316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5392aaed1912447ab767bc58444d59ac_D20210301-20210316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd5cb14789334c5ba54f208a8b80147c_D20210101-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000790526</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPCompaniesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDky_14fa1730-774f-4c92-8b89-0013a82c8ec7">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDg4_797432f2-f8b1-42ef-a4a3-406bf21ae017">&#9746;</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8yMTk5MDIzMjU5MDM0_6159f374-8465-4b7d-ac99-d11e077218dc"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8yMTk5MDIzMjU5MDM0_91cb0d8d-f3c9-44d7-a7ab-59b29e4a785b">December&#160;31</ix:nonNumeric>, 2020</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDg2_be64219e-5397-40ae-b91a-cc49307b2c26">&#9744;</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF     </span></div><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">     1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDkz_48b6628d-2bf2-4e2f-bde1-592d869d6453">001-33307</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDk1_33f4b91b-3d50-4847-b276-303cb1ebfe0c">RadNet, Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.865%"><tr><td style="width:1.0%"></td><td style="width:26.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.322%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl8wLTAtMS0xLTA_ba98a73d-55cc-4c87-819e-11140edf60d7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl8wLTItMS0xLTA_866d3ee8-e4e8-4c07-a781-35b1e2e8b930">13-3326724</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl8zLTAtMS0xLTA_f8ff3346-fa98-4f47-824d-9c36039829dd">1510 Cotner Avenue</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl80LTAtMS0xLTA_cf35d786-31ea-4230-acd9-7b55f50a44cd">Los Angeles,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl80LTEtMS0xLTA_028e72e2-8c81-448e-8b74-5d7704766953">California</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl80LTItMS0xLTA_55c664d4-8791-4df7-b667-2b280239b824">90025</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDk2_183bd283-4717-44a7-a384-c6bc37a16ac6">310</ix:nonNumeric>) <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDg5_45ff9f1c-859c-44f9-a824-06cc8bc741d2">478-7808</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:36.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.822%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Title of Each Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6MTMxMjY2N2M0MjIwNDgxZjkzNWEyMDZiODY4MzEwNmQvdGFibGVyYW5nZToxMzEyNjY3YzQyMjA0ODFmOTM1YTIwNmI4NjgzMTA2ZF8xLTAtMS0xLTA_f9b57a1a-44be-4ba4-bce1-ce6296008041">Common Stock, $.0001 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6MTMxMjY2N2M0MjIwNDgxZjkzNWEyMDZiODY4MzEwNmQvdGFibGVyYW5nZToxMzEyNjY3YzQyMjA0ODFmOTM1YTIwNmI4NjgzMTA2ZF8xLTEtMS0xLTA_f4913953-5ea2-4c15-8c08-8d965ed19196">RDNT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6MTMxMjY2N2M0MjIwNDgxZjkzNWEyMDZiODY4MzEwNmQvdGFibGVyYW5nZToxMzEyNjY3YzQyMjA0ODFmOTM1YTIwNmI4NjgzMTA2ZF8xLTItMS0xLTA_e054f121-1665-41dc-a275-f147cb69e7d0">NASDAQ Global Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes&#160; &#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDkw_5a3dcfcb-0bc6-4485-b77a-17d5037fe1ff">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDk3_3dbca137-473d-4220-9370-82db91f71191">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#160;<ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDkx_2bf0a266-e29f-4e92-ae65-60f218d63723">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDk4_b44ca52d-54fc-4f71-b38c-c1c7db038f19">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.695%"><tr><td style="width:1.0%"></td><td style="width:34.819%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.321%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6ZGFlMzc1ZTg1MDRmNDNmZmIwYzE4OWZjZWExMjU2MjAvdGFibGVyYW5nZTpkYWUzNzVlODUwNGY0M2ZmYjBjMTg5ZmNlYTEyNTYyMF8wLTItMS0xLTA_519ecec1-5291-451c-b7c9-9a34047f82c9">Accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6ZGFlMzc1ZTg1MDRmNDNmZmIwYzE4OWZjZWExMjU2MjAvdGFibGVyYW5nZTpkYWUzNzVlODUwNGY0M2ZmYjBjMTg5ZmNlYTEyNTYyMF8xLTMtMS0xLTA_86c4dac8-f74b-4e3f-ad9e-cc6a5e6f7efb">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6ZGFlMzc1ZTg1MDRmNDNmZmIwYzE4OWZjZWExMjU2MjAvdGFibGVyYW5nZTpkYWUzNzVlODUwNGY0M2ZmYjBjMTg5ZmNlYTEyNTYyMF8yLTEtMS0xLTA_edf14735-f481-4c34-8ab1-a57839a5de26">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMjk4NTM0ODg2Nzg5_55829180-2688-421c-87f0-7eb8f70a678e">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act) Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDk0_f6b594e2-39b6-4340-8e8e-9e96f40f2bc1">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="i3f632fde5d0946eaae6fa48e47fe915a_I20200630" decimals="-5" format="ixt:numdotdecimal" name="dei:EntityPublicFloat" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8yNDAx_a358749e-b25b-4131-9a50-a6672eda786c">691.2</ix:nonFraction> million on June&#160;30, 2020 (the last business day of the registrant&#8217;s most recently completed second quarter) based on the closing price for the common stock on the NASDAQ Global Market on June&#160;30, 2020.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares of the registrant&#8217;s common stock outstanding on March&#160;5, 2021, was <ix:nonFraction unitRef="shares" contextRef="ibaa2464885764c41ae09dcb977e30937_I20210305" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8yNjUz_5bd799c9-1f85-400a-b3a4-8d8393a3fa07">52,272,092</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDg3_e3fb5af2-e8f9-417c-a7b0-77f5cce7874d" escape="true">Portions of the registrant&#8217;s definitive proxy statement for the 2021 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#8217;s fiscal year.</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.027%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.514%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">FORM 10-K ITEM</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PAGE</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_13">PART I.</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_16">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_19">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_19">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_22">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_22">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_25">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_25">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_28">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_28">30</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_31">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_31">31</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_34">PART II.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_37">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_37">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_40">Selected Consolidated Financial Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_40">34</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_43">Management&#8217;s Discussion and Analysis of Financial Condition&#160;and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_43">36</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_46">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_46">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_49">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_49">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_136">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_136">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_139">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_139">93</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_145">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_145">95</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_148">PART III.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_151">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_151">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_154">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_154">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_157">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_157">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_160">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_160">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_163">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_163">95</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_169">PART IV.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_169">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_169">97</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_175">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_178">102</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This annual report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements reflect current views about future events and are based on our currently available financial, economic and competitive data and on current business plans. Actual events or results may differ materially depending on risks and uncertainties that may affect our operations, markets, services, prices and other factors.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Statements in this annual report concerning our ability to successfully acquire and integrate new operations, to grow our contract management business, our financial guidance, our future cost saving efforts, our increased business from new equipment or operations, inclusive of their anticipated benefits, our ability to finance our operations and the ongoing impact on our business, suppliers, payors, customers, referral sources, partners, patients and employees of the COVID-19 pandemic, related public health measures and the measures we are taking to respond to the COVID-19 pandemic are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;assumption&#8221; or the negative of these terms or other comparable terminology.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. These risks include those factors listed in Item 1 &#8212; &#8220;Business,&#8221; Item 1A&#8212; &#8220;Risk Factors,&#8221; Item 3&#8212; &#8220;Legal Proceedings,&#8221; Item 7 &#8212; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in this annual report and in other reports that we file with the Securities and Exchange Commission.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not undertake any responsibility to release publicly any revisions to these forward-looking statements to take into account events or circumstances that occur after the date of this annual report or any unanticipated events which may cause actual results to differ from those expressed or implied by the forward-looking statements contained in this annual report, except to the extent required by law.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_16"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.190%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.610%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Business</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States based on number of locations and annual imaging revenue and have been in business since 1985.  At December 31, 2020, we operated directly or indirectly through joint ventures with hospitals, 331 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.&#160;Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services, a key point of differentiation from our competitors. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to develop leading positions in regional markets in order to leverage operational efficiencies. We develop our medical imaging business through a combination of organic growth and acquisitions. Our scale and density within selected geographies provide close, long-term relationships with key payors, radiology groups and referring physicians. Each of our center-level and regional operations teams is responsible for managing relationships with local physicians and payors, meeting our standards of patient service, and maintaining profitability. We provide training programs, standardized policies and procedures, and sharing of best practices among the physicians in our regional networks.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have a software division which complements our imaging business.  Through our subsidiary eRAD, Inc., we sell computerized systems that distribute, display, store and retrieve digital images. We have a focus on Artificial Intelligence (AI), with the contributions from our acquisitions of Nulogix and DeepHealth plus our investment in Whiterabbit.ai, to develop and deploy AI suites to enhance radiologist interpretation of images.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All reports we file with the Securities and Exchange Commission are available free of charge via EDGAR through the SEC website at www.sec.gov. We also maintain a website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.radnet.com </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">where we make available, free of charge, our annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and all amendments to those reports as soon as is reasonably practicable after the material is electronically filed with the Securities and Exchange Commission. References to our website in this report are provided as a convenience and the information contained on, or otherwise accessible through, the website is not incorporated by reference into, nor does it form a part of this annual report on Form 10-K or any other document that we file with the Securities and Exchange Commission.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Overview</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging involves the use of non-invasive procedures to generate representations of internal anatomy and function that can be recorded on film or digitized for display on a video monitor. Diagnostic imaging procedures facilitate the early diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often minimizing the cost and amount of care for patients. Diagnostic imaging procedures include MRI, CT, PET, nuclear medicine, ultrasound, mammography, X-ray and fluoroscopy.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While X-ray remains the most commonly performed diagnostic imaging procedure, the fastest growing and higher margin procedures are MRI, CT and PET. The rapid growth in PET scans is attributable to the increasing recognition of the efficacy of PET scans in the diagnosis and monitoring of cancer. The number of MRI and CT scans performed annually in the United States continues to grow due to their wider acceptance by physicians and payors, an increasing number of applications for their use and a general increase in demand due to the aging population.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although currently small in scope, Artificial Intelligence (AI) methods are now being employed to aid radiologists in   scan interpretation by quickly allowing comparison to large imaging databases to enable pinpoint diagnosis in shorter time frames.  In addition, AI methods can keep track of individuals needing procedures on a regular basis (i.e. mammograms, follow ups, etc.) and alert our staff to contact the patient and schedule appointments.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Settings</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging services are typically provided in one of the following settings:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fixed-site, freestanding outpatient diagnostic facilities</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These facilities range from single-modality to multi-modality facilities and are generally not owned by hospitals or clinics. These facilities depend upon physician referrals for their patients and generally do not maintain dedicated, contractual relationships with hospitals or clinics. In fact, these facilities may compete with hospitals or clinics that have their own imaging systems to provide services to these patients. These facilities bill third-party payors, such as managed care organizations, insurance companies, Medicare or Medicaid. All of our wholly owned facilities  are in this category.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hospitals</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many hospitals provide both inpatient and outpatient diagnostic imaging services, typically on site or at a dedicated center located on or nearby the hospital campus.  These can be owned and operated by the hospital and provide imaging services to inpatients as ordered or outpatients through physician referrals. The hospital normally bills third-party payors such as managed care organizations, insurance companies, Medicare or Medicaid. We have entered into joint ventures with certain hospitals both provide and manage their diagnostic imaging services, allowing them to leverage our industry expertise.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mobile Imaging</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While many hospitals own or lease their own equipment, certain hospitals provide diagnostic imaging services by contracting with providers of mobile imaging services. Using specially designed trailers, mobile imaging service providers transport imaging equipment and provide services to hospitals and clinics on a part-time or full-time basis, thus allowing small to mid-size hospitals and clinics that do not have the patient demand to justify fixed on-site access to advanced diagnostic imaging technology. Diagnostic imaging providers contract directly with the hospital or clinic and are typically reimbursed directly by them. We do not provide mobile imaging services.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Modalities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal diagnostic imaging modalities we use at our facilities are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MRI</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MRI has become widely accepted as the standard diagnostic tool for a wide and fast-growing variety of clinical applications for soft tissue anatomy, such as those found in the brain, spinal cord, abdomen, heart and interior ligaments of body joints such as the knee. MRI uses a strong magnetic field in conjunction with low energy electromagnetic waves that are processed by a computer to produce high-resolution, three-dimensional, cross-sectional images of body tissue. A typical MRI examination takes from 20 to 45 minutes. MRI systems are designed as either open or closed and have magnetic field strength of 0.2 Tesla to 3.0 Tesla.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CT</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CT provides higher resolution images than conventional X-rays, but generally not as well defined as those produced by MRI. CT uses a computer to direct the movement of an X-ray tube to produce multiple cross-sectional images of a particular organ or area of the body. CT is used to detect tumors and other conditions affecting bones and internal organs. It is also used to detect the occurrence of strokes, hemorrhages and infections. A typical CT examination takes from 15 to 45 minutes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PET</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PET scanning involves the administration of a radiopharmaceutical agent with a positron-emitting isotope and the measurement of the distribution of that isotope to create images for diagnostic purposes. PET scans provide the capability to determine how metabolic activity impacts other aspects of physiology in the disease process by correlating the reading for the PET with other tools such as CT or MRI. PET technology has been found highly effective and appropriate in certain clinical circumstances for the detection and assessment of tumors throughout the body, the evaluation of some cardiac conditions and the assessment of epilepsy seizure sites. The information provided by PET technology often obviates the need to perform further highly invasive or diagnostic surgical procedures.  In addition, we employ combined PET/CT systems that blend the PET and CT imaging modalities into one scanner. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nuclear Medicine</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nuclear medicine uses short-lived radioactive isotopes that release small amounts of radiation that can be recorded by a gamma camera and processed by a computer to produce an image of various anatomical structures or to assess the function of various organs such as the heart, kidneys, thyroid and bones. Nuclear medicine is used primarily to study anatomic and metabolic functions. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">X-ray</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X-rays use roentgen rays to penetrate the body and record images of organs and structures on film. Digital X-ray systems add computer image processing capability to traditional X-ray images, which provides faster transmission of images with a higher resolution and the capability to store images more cost-effectively. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ultrasound</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ultrasound imaging uses sound waves and their echoes to visualize and locate internal organs. It is particularly useful in viewing soft tissues that do not X-ray well. Ultrasound is used in pregnancy to avoid X-ray exposure as well as in gynecological, urologic, vascular, cardiac and breast applications. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mammography</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mammography is a specialized form of radiology using low dosage X-rays to visualize breast tissue and is the primary screening tool for breast cancer. Mammography procedures and related services assist in the diagnosis of and treatment planning for breast cancer. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fluoroscopy</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluoroscopy uses ionizing radiation combined with a video viewing system for real time monitoring of organs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Trends</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the diagnostic imaging services industry will continue to grow as a result of a number of factors, including the following:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Escalating Demand for Healthcare Services from an Aging Population</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the United States Census Bureau estimates released in June 2020, the number of US residents age 65 or over increased from 35.0 million in 2000 to an estimated 73 million in 2020, and the median age for the United States is also expected to continue to increase.  Because diagnostic imaging use tends to increase as a person ages, we believe the aging population will generate more demand for diagnostic imaging procedures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Greater Consumer Awareness of and Demand for Preventive Diagnostic Screening</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostic imaging, such as elective full-body scans, is increasingly being used as a screening tool for preventive care procedures. Consumer awareness of diagnostic imaging as a less invasive and preventive screening method has added to the growth in diagnostic imaging procedures. We believe that further technological advancements allowing for early diagnosis of diseases and disorders using less invasive procedures will create additional demand for diagnostic imaging.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Effective Applications for Diagnostic Imaging Technology</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New technological developments are expected to extend the clinical uses of diagnostic imaging technology and increase the number of scans performed. Recent technological advancements include:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">MRI spectroscopy, which can differentiate malignant from benign lesions;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">MRI angiography, which can produce three-dimensional images of body parts and assess the status of blood vessels;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">enhancements in teleradiology systems, which permit the digital transmission of radiological images from one location to another for interpretation by radiologists at remote locations,</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the development of combined PET/CT and PET/MRI scanners, which combine technologies to create a powerful diagnostic imaging system; and</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">use of augmented reality technologies make it possible to create three dimensional images that physicians can examine through virtual reality headsets or print using a three dimensional printer.</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional improvements in imaging technologies, contrast agents and scan capabilities are leading to new non-invasive diagnostic imaging application, including methods of diagnosing blockages in the heart&#8217;s vital coronary arteries, liver metastases, pelvic diseases and vascular abnormalities without exploratory surgery. We believe that the use of the diagnostic capabilities of MRI and other imaging services will continue to increase because they are cost-effective, time-efficient and non-invasive, as compared to alternative procedures, including surgery, and that newer technologies and future technological advancements will further increase the use of imaging services. At the same time, the industry has increasingly used upgrades to existing equipment to expand applications, extend the useful life of existing equipment, improve image quality, reduce image acquisition time and increase the volume of scans that can be performed. We believe the use of equipment upgrades rather than equipment replacements will continue, as we do not foresee new imaging technologies on the near-term horizon that will displace MRI, CT or PET as the principal advanced diagnostic imaging modalities.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Utilization of Artificial Intelligence</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AI has the potential to significantly change the medical imaging industry.  Current AI applications are focused on comparing images against large databases and flagging areas of concern for the radiologist.  This is expected to result in improved quality, particularly with diseases, injuries, or conditions that are difficult to detect without supplemental technology.  AI can also improve business processes to better effectively serve customers and improve reimbursement and collections accuracy.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Competitive Strengths</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Scale and Position as the Largest Provider of Freestanding, Fixed-site Outpatient Diagnostic Imaging Services in the United States, Based on Number of Centers and Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we operated 331 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.&#160;Our size and scale allow us to achieve operating, sourcing and administrative efficiencies, including equipment and medical supply sourcing savings and favorable maintenance contracts from equipment manufacturers and other suppliers. Our specific knowledge of our geographic markets drives strong relationships with key payors, radiology groups and referring physicians within our markets.&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Comprehensive "Multi-Modality" Diagnostic Imaging Offering</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vast majority of our centers offer multiple types of imaging procedures, driving strong relationships with referring physicians and payors in our markets and a diversified revenue base. At each of our multi-modality facilities, we offer patients and referring physicians one location to serve their needs for multiple procedures. This prevents multiple patient visits or unnecessary travel between facilities, thereby increasing patient throughput and decreasing costs and time delays. Our revenue is generated by a broad mix of modalities. We believe our multi-modality strategy lessens our exposure to reimbursement changes in any specific modality.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Competitive Pricing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business focus, scale, resources and access to technology afford us with certain operating efficiencies.  As such, we believe our fees are generally lower than hospital fees for the services we provide.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Facility Density in Many Highly Populated Areas of the United States</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The strategic organization of our diagnostic imaging facilities into regional networks concentrated in major population centers in seven states offers unique benefits to our patients, our referring physicians, our payors and us. We are able to increase the convenience of our services to patients by implementing scheduling systems within geographic regions, where practical. For example, many of our diagnostic imaging facilities within a particular region can access the patient appointment calendars of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other facilities within the same regional network to efficiently allocate time available and to meet a patient's appointment, date, time, or location preferences. The grouping of our facilities within regional networks enables us to easily move technologists and other personnel, as well as equipment, from over-utilized to under-utilized facilities on an as-needed basis, and drive referrals. Our organization of referral networks results in increased patient throughput, greater operating efficiencies, better equipment utilization rates and improved response time for our patients. We believe our networks of facilities and tailored service offerings for geographic areas drive local physician referrals, make us an attractive candidate for selection as a preferred provider by third-party payors and create economies of scale.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Strong Relationships with Payors and Diversified Payor Mix</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is derived from a diverse mix of payors, including private payors, managed care capitated payors and government payors, which should mitigate our exposure to possible unfavorable reimbursement trends within any one payor class. In addition, our experience with capitation arrangements has provided us with the expertise to manage utilization and pricing effectively, resulting in a predictable and recurring stream of revenue. We believe that third-party payors representing large groups of patients often prefer to enter into managed care contracts with providers that offer a broad array of diagnostic imaging services at convenient locations throughout a geographic area. In 2020, we received approximately 54% of our net service revenue from commercial insurance payors, 13% from managed care capitated payors, 20% from Medicare and 2% from Medicaid.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Strong Relationships with Experienced and Highly Regarded Radiologists</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracted radiologists have outstanding credentials, strong relationships with referring physicians, and a broad mix of sub-specialties. The collective experience and expertise of these radiologists translates into more accurate and efficient service to patients. Our close relationship with Howard G. Berger, M.D., our President and Chief Executive Officer, and Beverly Radiology Medical Group (&#8220;BRMG&#8221;) in California and our long-term arrangements with radiologists outside of California enable us to better ensure that the medical service provided at our facilities is consistent with the needs and expectations of our referring physicians, patients and payors.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Experienced and Committed Management Team</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior management group has more than 100 years of combined healthcare management experience. Our executive management team has created our differentiated approach based on their comprehensive understanding of the diagnostic imaging industry and the dynamics of our regional markets. We have a track record of successful acquisitions and integration of acquired businesses into RadNet, and have managed the business through a variety of economic and reimbursement cycles.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Technologically Advanced Operations</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, we created an Artificial Intelligence (AI) division that now hosts the combined efforts of our acquisitions of DeepHealth, Nulogix, and an equity investment in WhiteRabbit.ai.  The division is currently focused on developing both improved medical interpretation of scans and patient management within the field of mammography.  Combined with our established eRad subsidiary, which develops and sells computerized imaging systems for the industry, we have assembled an industry leading team of software developers to create radiology workflow solutions that improve patient care.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Strategy</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Maximize Performance at Our Existing Facilities</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to enhance our operations and increase scan volume and revenue at our existing facilities by expanding physician relationships and increasing the procedure offerings.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Focus on Profitable Contracting</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly evaluate our contracts with third-party payors, industry vendors and radiology groups, as well as our equipment and real property leases, to determine how we may improve the terms to increase our revenues and reduce our expenses. Because many of our contracts with third party payors are short-term in nature, we can regularly renegotiate these contracts, if necessary. We believe our position as a leading provider of diagnostic imaging services and our long-term relationships with physician groups in our markets enable us to obtain more favorable contract terms than would be available to smaller or less experienced imaging services providers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Optimize Operating Efficiencies</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We try to maximize our equipment utilization by adding, upgrading and re-deploying equipment where we experience excess demand. We will continue to trim excess operating and general and administrative costs where it is feasible to do so. We may also continue to use, where appropriate, highly trained radiology physician assistants to perform, under appropriate supervision of radiologists, basic services traditionally performed by radiologists. We will continue to upgrade our advanced information technology system to create cost reductions for our facilities in areas such as image storage, support personnel and financial management.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expand Our Networks</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to expand the number of our facilities both organically and through targeted acquisitions, using a disciplined approach for evaluating and entering new areas, including consideration of whether we have adequate financial resources to expand. Our current plans are to strengthen our market presence in geographic areas where we currently have existing operations and to expand into neighboring and other areas where we believe we can compete effectively. We perform extensive due diligence before developing a new facility or acquiring an existing facility or entering into a joint venture with a hospital to manage a facility, including surveying local referral sources and radiologists, as well as examining the demographics, reimbursement environment, competitive landscape and intrinsic demand of the geographic market. We generally will only enter new markets where:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there is sufficient patient demand for outpatient diagnostic imaging services;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we believe we can gain significant market share;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we can build key referral relationships or we have already established such relationships; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">payors are receptive to our entry into the market.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This was exemplified by our recent expansion into the Phoenix, Arizona marketplace which not only met our qualifications, but also strengthened our relationship with Dignity Health, forming our third outpatient radiology venture to manage the acquired imaging centers.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expand Our Joint Ventures</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our growth strategy we have entered into joint ventures with hospitals, health systems or radiology practices that were formed for the purpose of owning and operating diagnostic imaging centers. We have created a number of joint ventures in key markets with well-established hospital systems to manage additional facilities. We intend to continue to expand in established markets through additional joint ventures, particularly with hospital systems. We believe that such joint ventures strengthen and expand our strength in markets where we are already established.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Services</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer a comprehensive set of imaging services including MRI, CT, PET, nuclear medicine, X-ray, ultrasound, mammography, fluoroscopy and other related procedures. We focus on providing standardized high quality imaging services, regardless of location, to ensure patients, physicians and payors consistency in service and quality. To ensure the high quality of our services, we monitor patient satisfaction, timeliness of services to patients and reports to physicians.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key features of our services include:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">patient-friendly, non-clinical environments;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">a 24-hour turnaround on routine examinations;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">interpretations within one to two hours, if needed;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">flexible patient scheduling, including same-day appointments;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">extended operating hours, including weekends;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">reports delivered by courier, facsimile or email;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">availability of second opinions and consultations;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">availability of sub-specialty interpretations at no additional charge; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">standardized fee schedules by region.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Radiology Professionals</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the states in which we provide services (except Florida), a lay person or any entity other than a professional corporation or similar professional organization is not allowed to practice medicine, including by employing professional persons or by having any ownership interest or profit participation in or control over any medical professional practice. This doctrine is commonly referred to as the prohibition on the &#8220;corporate practice&#8221; of medicine. In order to comply with this prohibition, we contract with radiologists to provide professional medical services in our facilities, including the supervision and interpretation of diagnostic imaging procedures. The radiology practice maintains full control over the physicians it employs. Pursuant to each management contract, we make available the imaging facility and all of the furniture and medical equipment at the facility for use by the radiology practice, and the practice is responsible for staffing the facility with qualified professional medical personnel. In addition, we provide management services and administration of the non-medical functions relating to the professional medical practice at the facility, including among other functions, provision of clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities. As compensation for the services furnished under contracts with radiologists, we generally receive an agreed percentage of the medical practice billings for, or collections from, services provided at the facility, typically 79% of global net service fee revenue or collections after deduction of the professional component of the medical practice billings.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many states have also enacted laws prohibiting a licensed professional from splitting fees derived from the practice of medicine with an unlicensed person or business entity. We do not believe that the management, administrative, technical and other non-medical services we provide to each of our contracted radiology groups violate the corporate practice of medicine prohibition or that the fees we charge for such services violate the fee splitting prohibition. However, the enforcement and interpretation of these laws by regulatory authorities and state courts vary from state to state. If our arrangements with our independent contractor radiology groups are found to violate state laws prohibiting the practice of medicine by general business corporations or fee splitting, our business, financial condition and ability to operate in those states could be adversely affected.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Consolidated Medical Group</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated medical group ("the Group") consists of professional corporations owned or controlled by individuals within our senior management, namely Howard G. Berger, M.D., our President and Chief Executive Officer, and John V. Crues, III, M.D., RadNet's Medical Director, both of whom are members of our Board of Directors.  The Group provides professional medical services in California, Delaware, Maryland, New Jersey and New York, and includes Beverly Radiology Medical Group (BRMG).  BRMG is responsible for the professional medical services at nearly all of our facilities located in California.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that physicians are drawn to the Group, and the other external radiologist groups with whom we contract, by the opportunity to work with the state-of-the-art equipment we make available to them, as well as the opportunity to receive specialized training through our fellowship programs, and engage in clinical research programs, which generally are available only in university settings and major hospitals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our management agreement with BRMG, we are paid a percentage of the amounts collected for the professional services BRMG physicians render as compensation for our services and for the use of our facilities and equipment. For the year ended December 31, 2020, this percentage was 79%. The percentage may be adjusted, if necessary, to ensure that the parties receive fair value for the services they render. The following are the other principal terms of our management agreement with BRMG:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The agreement expires on January 1, 2024. The agreement automatically renews for consecutive 10-year periods, unless either party delivers a notice of non-renewal to the other party no later than six months prior to the scheduled expiration date. Either party may terminate the agreement if the other party defaults under its obligations, after notice and an opportunity to cure. We may terminate the agreement if Dr. Berger no longer owns </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:54pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at least 60% of the equity of BRMG; as of December 31, 2020, he owned indirectly 99% of the equity interests of BRMG.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">At its expense, BRMG employs or contracts with an adequate number of physicians necessary to provide all professional medical services at almost all of our California facilities.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">At our expense, we provide all furniture, furnishings and medical equipment located at the facilities and we manage and administer all non-medical functions at, and provide all nurses and other non-physician personnel required for the operation of, the facilities.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If BRMG wants to open a new facility, we have the right of first refusal to provide the space and services for the facility under the same terms and conditions set forth in the management agreement.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we want to open a new facility in California, BRMG must use its best efforts to provide medical personnel under the same terms and conditions set forth in the management agreement. If BRMG cannot provide such personnel, we have the right to contract with other physicians to provide services at the facility.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">BRMG must maintain medical malpractice insurance for each of its physicians with coverage limits not less than $1 million per incident and $3 million in the aggregate per year. BRMG also has agreed to indemnify us for any losses we suffer that arise out of the acts or omissions of BRMG and its employees, contractors and agents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The management contracts with the remaining professional medical corporations within the Group are on a basis similar to our contract with BRMG.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Professional Radiology Groups</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At locations where the Group does not provide professional medical services, we have entered into long-term contracts with prominent third-party radiology groups in the area to provide physician services at those facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These third-party radiology practice groups provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. The contracted radiology practices have outstanding physician and practice credentials and reputations; strong competitive market positions; a broad sub-specialty mix of physicians; a history of growth and potential for continued growth. In these facilities we have entered into long-term agreements (typically 10-40 years in length) under which, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee based on the practice group&#8217;s professional revenue. We typically receive 100% of the technical reimbursements associated with imaging procedures plus certain fees paid to us for providing additional management services. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we perform certain management services for a portion of the professional groups with whom we contract who provide professional radiology services at local hospitals. For performing these management services, which include billing, collecting, transcription and medical coding, we receive management fees.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payors</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fees charged for diagnostic imaging services performed at our facilities are paid by a diverse mix of payors, as illustrated for the following periods presented in the table below:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Net Service Fee Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>December&#160;31,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>December&#160;31,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended<br/>December&#160;31,<br/>2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Insurance </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Care Capitated Payors</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Includes co-payments, direct patient payments and payments through contracts with physician groups and other non-insurance company payors.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have described below the types of reimbursement arrangements we have with third-party payors.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Insurance</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, insurance companies reimburse us, directly or indirectly, including through the group or through the contracted radiology groups elsewhere, on the basis of agreed upon rates. These rates are negotiated and may differ materially with rates set forth in the Medicare Physician Fee Schedule for the particular service. The patients may be responsible for certain co-payments or deductibles.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed Care Capitation Agreements</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these agreements, which are generally between BRMG in California and outside of California between the contracted radiology group (typically an independent physician group or other medical group) and the payor (which in most cases are large medical groups or Independent Practice Associations), the payor pays a pre-determined amount per-member per-month in exchange for the radiology group providing all necessary covered services to the managed care members included in the agreement. These contracts pass much of the financial risk of providing outpatient diagnostic imaging services, including the risk of over-use, from the payor to the radiology group and, as a result of our management agreement with the radiology group, to us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that through our comprehensive utilization management, or UM, program we have become highly skilled at assessing and moderating the risks associated with the capitation agreements, so that these agreements are profitable for us. Our UM program is managed by our UM department, which consists of administrative and nursing staff as well as BRMG medical staff who are actively involved with the referring physicians and payor management in both prospective and retrospective review programs. Our UM program includes features such as physician education combined with peer review procedures which are designed to manage our costs while ensuring that patients receive appropriate care.</span></div><div style="text-align:justify;text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare/Medicaid</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare is the federal health insurance program for people age 65 or older and people under age 65 with certain disabilities. Medicaid, funded by both the federal government and states, is a state-administered health insurance program for qualifying low-income and medically needy persons. For services for which we bill Medicare directly or indirectly, including through contracted radiologists, we are paid under the Medicare Physician Fee Schedule. Under the Protecting Access to Medicare Act of 2014, Congress introduced a new quality incentive program that, effective January 1, 2016, reduces Medicare payments for certain CT services reimbursed through the Medicare Physician Fee Schedule that are furnished using equipment that does not meet certain dose optimization and management standards. Medicare patients usually pay a 20% co-payment unless they have secondary insurance. Medicaid rates are set by the individual states for each state program and Medicaid patients may be responsible for a modest co-payment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contracts with Physician Groups and Other Non-Insurance Company Payors</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For some of our contracts with physician groups and other providers, we do not bill payors, but instead accept agreed upon rates for our radiology services. These rates are typically at or below the rates set forth in the current Medicare Fee Schedule for the particular service. However, we often agree to a specified rate for MRI and CT procedures that is not tied to the Medicare Fee Schedule.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facilities</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our facilities are primarily located in geographic networks that we refer to as regions. The majority of our facilities are multi-modality sites, offering various combinations of MRI, CT, PET, nuclear medicine, ultrasound, X-ray, fluoroscopy services and other related procedures. A portion of our facilities are single-modality sites, offering either X-ray or MRI services. Consistent with our regional network strategy, we locate our single-modality facilities near multi-modality facilities, to help accommodate overflow in targeted demographic areas.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the number of our facilities operated directly or managed through joint ventures for each year during the five-year period ended December 31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total facilities owned or managed (at beginning of the year)</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facilities added by:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facilities closed or sold</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total facilities owned or managed (at year end)</span></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Diagnostic Imaging Equipment</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table indicates, as of December 31, 2020, the quantity of principal diagnostic equipment available at our facilities operated directly or through joint venture investments:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.543%"><tr><td style="width:1.0%"></td><td style="width:58.931%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.696%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment Count</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CT</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PET/CT</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mammography</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ultrasound</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X-ray</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuclear Medicine</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fluoroscopy</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equipment</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,089</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,893</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average age of our MRI and CT units is less than five years, and the average age of our PET units is less than four years. The useful life of our MRI, CT and PET units is typically ten years.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facility Acquisitions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding our facility acquisitions can be found within Item 7 - &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;, as well as Note 4 to our consolidated financial statements included in this annual report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Technology</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters and many of our facilities are interconnected through a state-of-the-art information technology system. This system, which is compliant with the Health Insurance Portability and Accountability Act of 1996, is comprised of a number of integrated applications and provides a single operating platform for billing and collections, electronic medical records, practice management and image management.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This technology has created cost reductions for our facilities in areas such as image storage, support personnel and financial management and has further allowed us to optimize the productivity of all aspects of our business by enabling us to:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">capture patient demographic, history and billing information at point-of-service;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">automatically generate bills and electronically file claims with third-party payors;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">record and store diagnostic report images in digital format;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">digitally transmit in real-time diagnostic images from one location to another, thus enabling networked radiologists to cover larger geographic markets by using the specialized training of other networked radiologists;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perform claims, rejection and collection analysis; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perform sophisticated financial analysis, such as analyzing cost and profitability, volume, charges, current activity and patient case mix, with respect to each of our managed care contracts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed our own Radiology Information System through our team of software development engineers, which is used as our front desk patient tracing system, and began running this internally developed system in the first quarter of 2015.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the strength of our workforce is critical to the success of our mission to provide comprehensive radiology solutions and change the future of healthcare.  We are focused on attracting, retaining, and developing the talent we need to deliver on our commitment to our patients and partners.  We invest in our employees to ensure their confidence and competence in their roles, as well as to provide a path for professional career development.  We are keenly aware of the value of a diverse workforce and are proud of our track record.  We further our objectives of inclusion by providing training and growth opportunities, market-competitive compensation and a responsive benefits plan to support the needs of our human capital.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ imaging center  managers who are responsible for overseeing day-to-day and routine operations at each of our facilities, including staffing, modality and schedule coordination, referring physician and patient relations and purchasing of materials to effectively manage their location(s). These imaging center managers report to regional managers and/or directors, who are responsible for oversight of the operations of all facilities within their region, including sales, marketing and contracting. The regional managers and directors, along with our directors of contracting, marketing, facilities, management/purchasing and senior human resources leadership all report to our chief operating officers. These officers, our chief financial officer, our director of information services and our medical director report to our chief executive officer. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, we had a total of 6,157 full-time, 525 part-time and 1,645 per diem employees, including those employed by the Group. These numbers include 130 full-time and 51 part-time physicians and 2,033 full-time, 358 part-time and 1,089 per-diem technologists.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Diversity and Inclusion.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Our culture of diversity and inclusion continues to enable us to exceed the expectations of our patients and meet our growth strategy.  Our success in inclusion and diversity objectives are the result of  strong leadership, transparency and accountability. While our workforce demographics clearly indicate our success in achieving a highly diverse team, in order to foster even stronger understanding of diversity, equity and inclusion, we have developed an internal education program to ensure all of our team are aware of our closely held values.  Our initiatives include: :</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">Building a Harmonious Workforce &#8211; a three part training series aimed at education, awareness and sensitivity training for senior management, center level management and our team at large</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">RadRecruit &#8211; training on best in class recruiting practices to ensure equity in the interview/hiring process and education regarding unconscious bias for our management team </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">Corporate support and sponsorship of community outreach/enrichment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">programs for underserved population such as our ongoing and flourishing relationship with JVS SoCal.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">High School, Vocational School and Collegiate outreach</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt">The 2020 second quarter launch of RadNet Voices, an internal DE &amp; I committee, sponsored by senior leadership, and comprised of a core members and rotating group of team members to capture and respond to team member experience.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 80% of the Company&#8217;s workforce at December 31, 2020 was female and 49% were from under-represented groups.   During the year ended December 31, 2020, our total attrition rate was less than 2%.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Development.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  We continue to emphasize employee development and education.  We provide a range of internal education and development programs and opportunities to support the advancement of our employees. RadNet offers Leadership Development and Operations Rotation Program, Management Training, Technical Scholarship, and various modality education and training support programs We offer both formal and informal programs to identify, foster and retain top talent.  Aside from our Tuition Reimbursement program which encourages professional development for our incumbent team, we also sponsor undergraduate and graduate education and advanced technical training (RPA) for various incumbent team members.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pay.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our primary compensation strategy is to promote a pay-for-performance culture. Our guiding principles are anchored on the goals of being able to attract, incentivize, and retain talented employees.  We provide compensation that is competitive and consistent with employee positions, skill levels, and experience.  We align our executives&#8217; and eligible non-executive employees long-term equity compensation with our stockholders&#8217; interests.  Our employees are eligible for benefits that are industry-leading, including PPO and HDHP medical plans with a company sponsored HSA, wellness plans that include financial incentives, free radiology procedures for team and family, paid life insurance and AD&amp;D, dental, vision. Employee Assistance Plan (EAP) with enhanced mental health benefits, group paid long and short term disability plans, 401(k), tuition reimbursement, access to instant earned wages through DailyPay, paid and unpaid leave, flexible working schedule,and a variety of voluntary benefits including Colonial, Supplemental Life, Dependent Life and Commuter benefits and free flu vaccinations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health and Wellness.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Beyond the fundamental needs of health, welfare and retirement programs, we are focused on the specific needs of our individual employees. In 2020, our employees adapted to an unprecedented amount of change and uncertainty driven by the COVID-19 pandemic, including  rescheduled work priorities, and closure of schools and daycare facilities for families. We have continued to provide resources and ongoing support to employees facing these challenges throughout the year, such as a wellness incentives, , home office setup allowance, expanded health coverage, and flexible work schedules.  Additionally and as a result of many of our hospital and managed care partners we were able to provide access to COVID vaccinations for our patient facing healthcare workers first, then our lower risk but essential infrastructure team.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales and marketing team employs a multi-pronged approach to marketing, including physician, payor and sports marketing programs, each of which are described below:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Physician Marketing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each customer service representative on our physician marketing team is responsible for marketing activity on behalf of one or more facilities. The representatives act as a liaison between the facility and referring physicians, holding meetings periodically and on an as-needed basis with them and their staff to present educational programs on new applications and uses of our systems and to address particular patient service issues that have arisen. In our experience, consistent hands-on contact with a referring physician and his or her staff generates goodwill and increases referrals to our facilities. The representatives also continually seek to establish referral relationships with new physicians and physician groups. In addition to a base salary, each representative receives a bonus based upon success.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payor Marketing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing team regularly meets with managed care organizations and insurance companies to solicit contracts and meet with existing contracting payors to solidify those relationships. The comprehensiveness of our services, the geographic location of our facilities and the reputation of the physicians with whom we contract all serve as tools for obtaining new or repeat business from payors.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sports Marketing Program</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our west coast operations provide diagnostic digital X-ray services for the following organizations at their respective stadiums: Los Angeles Clippers, Dodgers, Lakers, Kings and Sparks and the USC Trojans football team. In exchange for these services the teams provide us with season tickets and parking.  Contract lengths vary from yearly up to five years.  We also provide radiology services at select imaging centers for the Anaheim Ducks, Los Angeles Angels, Los Angeles Rams, Oakland Athletics and San Francisco 49ers organizations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our east coast operations, we have entered into sponsorship agreements with the Baltimore Ravens of the National Football League and the Baltimore Orioles of Major League Baseball which permits us to state we are the imaging partner to each organization. The sponsorship agreement with the Ravens lasts through 2022 and the Orioles through 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Suppliers</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquire our major diagnostic imaging equipment directly from original equipment manufacturers or through third party financing companies and purchase medical supplies from various national vendors.  We have excellent working relationships with our providers who are of comparable stature in the event one becomes unavailable.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our diagnostic imaging equipment represents a cornerstone investment of the company as it provides our customers the latest in imaging technology.  We employ direct purchase or finance arrangements to accomplish our needs with such firms as GE, Hologic, Key Equipment, Philips, Siemens and Spectrum.  At December 31, 2020, our liabilities for financing arrangements for radiology equipment, inclusive of operating and finance leases, amounted to approximately $58.9 million.  If we open or acquire additional imaging facilities, we may incur material lease obligations.  See Note 9, Leases,  to our consolidated financial statements included in this annual report on Form 10-K for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timely and effective maintenance is essential for achieving high utilization rates of our imaging equipment.  In order to ensure operational efficiency, we have maintenance arrangements with&#160;the various service arms of the original equipment manufacturers.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors include independent imaging operators and smaller regional operators, as well as hospitals and hospital groups that operate their own imaging services.  In addition, some physician practices have established their own diagnostic imaging facilities within their group practices. We experience additional competition as a result of those activities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete principally on the basis of our reputation, our ability to provide multiple modalities at many of our facilities, the location of our facilities, the quality of our diagnostic imaging services and technologists and our ability to establish and maintain relationships with healthcare providers and referring physicians. See &#8220;Competitive Strengths&#8221; above. Some of our competitors may now or in the future have access to greater financial resources than we do, which could allow them to establish more facilities and provide access to newer, more advanced equipment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the third party contracted radiology practices has entered into agreements with its physician shareholders and full-time employed radiologists that generally prohibit those shareholders and radiologists from competing for a period of two to five years within defined geographic regions after they cease to be owners or employees, as applicable. In certain states, like California, a covenant not to compete is enforced in limited circumstances involving the sale of a business. In other states, a covenant not to compete will be enforced only:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">to the extent it is necessary to protect a legitimate business interest of the party seeking enforcement;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if it does not unreasonably restrain the party against whom enforcement is sought; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if it is not contrary to public interest.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enforceability of a non-compete covenant is determined by a court based on all of the facts and circumstances of the specific case at the time enforcement is sought. For this reason, it is not possible to predict whether or to what extent a court will enforce the contracted radiology practices&#8217; covenants. The inability of the contracted radiology practices or us to enforce a radiologist&#8217;s non-compete covenants could result in increased competition from individuals who are knowledgeable about our business strategies and operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liability Insurance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain insurance policies with coverage we believe is appropriate in light of the risks attendant to our business and consistent with industry practice. We maintain general liability insurance and professional liability insurance in commercially reasonable amounts. Additionally, we maintain workers&#8217; compensation insurance on all of our employees. Coverage is placed on a statutory basis and corresponds to individual state&#8217;s requirements. However, adequate liability insurance may not be available to us in the future at acceptable costs or at all. In addition, insurers from which we purchase such insurance may experience financial hardship which would impact their ability to pay covered policyholder claims.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our agreements with physician groups with whom we contract, including the Group, each must maintain medical malpractice insurance for each physician in the group, having coverage limits of not less than $1.0 million per incident and $3.0 million in the aggregate per year.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California&#8217;s medical malpractice cap further reduces our exposure. California places a $250,000 limit on non-economic damages for medical malpractice cases. Non-economic damages are defined as compensation for pain, suffering, inconvenience, physical impairment, disfigurement and other non-pecuniary injury. The cap applies whether the case is for injury or death, and it allows only one $250,000 recovery in a wrongful death case. No cap applies to economic damages. Other states in which we now operate do not have similar limitations and in those states we believe our insurance coverage to be sufficient.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is highly regulated, and changes in the regulatory environment could significantly affect our operations in the future. Our ability to operate profitably will depend in part upon us, and the contracted radiology practices and their affiliated physicians, obtaining and maintaining all necessary licenses and other approvals, and operating in compliance with applicable healthcare regulations. We believe that healthcare regulations will continue to change. Therefore, we monitor developments in healthcare law and modify our operations from time to time as the business and regulatory environment changes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing and Certification Laws</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ownership, construction, operation, expansion and acquisition of diagnostic imaging facilities are subject to various federal and state laws, regulations and approvals concerning licensing of facilities and personnel. In addition, free-standing diagnostic imaging facilities that provide services not performed as part of a physician's office must meet Medicare requirements to be certified as an independent diagnostic testing facility before it can be authorized to bill the Medicare program. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Practice of Medicine</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the states in which we operate, other than Florida, a lay person or any entity other than a professional corporation or other similar professional organization is not allowed to practice medicine, including by employing professional persons or by having any ownership interest or profit participation in or control over any medical professional practice. The laws of such states also prohibit a lay person or a non-professional entity from exercising control over the medical judgments or decisions of physicians and from engaging in certain financial arrangements, such as splitting professional fees with physicians. We structure our relationships with the radiology practices, including the purchase of diagnostic imaging facilities, in a manner that we believe keeps us from engaging in the practice of medicine, exercising control over the medical judgments or decisions of the radiology practices or their physicians, or violating the prohibitions against fee-splitting.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; Federal Anti-kickback Statute</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, approximately 20% of our net service revenue generated at our diagnostic imaging centers was derived from federal government sponsored healthcare programs (Medicare) and 2% from state sponsored programs (Medicaid).</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal law known as the Anti-kickback Statute prohibits the knowing and willful offer, payment, solicitation or receipt of any form of remuneration in return for, or to induce, (i) the referral of a person, (ii) the furnishing or arranging for the furnishing of items or services reimbursable under the Medicare, Medicaid or other governmental programs or (iii) the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">purchase, lease or order or arranging or recommending purchasing, leasing or ordering of any item or service reimbursable under the Medicare, Medicaid or other governmental programs. Noncompliance with the federal Anti-kickback Statute can result in exclusion from the Medicare, Medicaid or other governmental programs and civil and criminal penalties.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Anti-kickback Statute is broad, and it prohibits many arrangements and practices that are lawful in businesses outside of the healthcare industry. To create better clarity, the Office of the Inspector General of the U.S. Department of Health and Human Services (OIG) has issued regulations as "safe harbor" guidelines which if met in form and substance, will assure healthcare providers that they will not be prosecuted for violation of the Anti&#8211;kickback Statute.  The OIG issued a final rule on November 20, 2020, as part of the Regulatory Sprint to Coordinated Care initiative by the U.S. Department of Health and Human Services that, among other things, established new "safe harbors" under the Anti-kickback Statute for certain value-based compensation arrangements.  Although full compliance with these provisions ensures against prosecution under the federal Anti-kickback Statute, the failure of a transaction or arrangement to fit within a specific safe harbor does not necessarily mean that the transaction or arrangement is illegal or that prosecution under the federal Anti-kickback Statute will be pursued.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although some of our arrangements may not fall within a safe harbor, we believe that such business arrangements do not violate the Anti-kickback Statute because we are careful to structure them to reflect fair value and ensure that the reasons underlying our decision to enter into a business arrangement comport with reasonable interpretations of the Anti-kickback Statute. However, even though we continuously strive to comply with the requirements of the Anti-kickback Statute, liability under the Anti-kickback Statute may still arise because of the intentions or actions of the parties with whom we do business. While we are not aware of any such intentions or actions, we have only limited knowledge regarding the intentions or actions underlying those arrangements. Conduct and business arrangements that do not fully satisfy one of these safe harbor provisions may result in increased scrutiny by government enforcement authorities such as the Office of the Inspector General.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; Stark Law</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ethics in Patient Referral Act of 1989, commonly known as the Stark Law, prohibits a physician from referring Medicare patients to an entity providing designated health services in which the physician (or immediate family member) has an ownership or investment interest or with which the physician (or immediate family member) has entered into a compensation arrangement. The Stark Law also prohibits the entity from billing for any such prohibited referral. The penalties for violating the Stark Law include a prohibition on payment by these governmental programs and civil penalties of as much as $15,000 for each violation referral and $100,000 for participation in a circumvention scheme. The regulations governing the Stark Law were also recently amended as part of the Regulatory Sprint to Coordinated Care initiative.  These new regulations, which among other things establish new exceptions for value-based arrangements, were published by the Centers for Medicare &amp; Medicaid Services (CMS) on November 20, 2020.  We believe that, although we receive fees under our service agreements for management and administrative services, we are not in a position to make or influence referrals of patients.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Stark Law, radiology and certain other imaging services and radiation therapy services and supplies are services included in the designated health services subject to the self-referral prohibition. Such services include the professional and technical components of any diagnostic test or procedure using X-rays, ultrasound or other imaging services, CT, MRI, radiation therapy and diagnostic mammography services (but not screening mammography services). PET and nuclear medicine procedures are also included as designated health services under the Stark Law. The Stark Law, however, excludes from designated health services: (i) X-ray, fluoroscopy or ultrasound procedures that require the insertion of a needle, catheter, tube or probe through the skin or into a body orifice; (ii) radiology procedures that are integral to the performance of, and performed during, non-radiological medical procedures; and (iii) invasive or interventional radiology, because the radiology services in these procedures are merely incidental or secondary to another procedure that the physician has ordered.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Stark Law provides that a request by a radiologist for diagnostic radiology services or a request by a radiation oncologist for radiation therapy, if such services are furnished by or under the supervision of such radiologist or radiation oncologist pursuant to a consultation requested by another physician, does not constitute a referral by a referring physician. If such requirements are met, the Stark Law self-referral prohibition would not apply to such services. The effect of the Stark Law on the radiology practices, therefore, will depend on the precise scope of services furnished by each such practice&#8217;s radiologists and whether such services derive from consultations or are self-generated.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that, other than self-referred patients, all of the services covered by the Stark Law provided by the contracted radiology practices derive from requests for consultation by non-affiliated physicians. Therefore, we believe that the Stark Law is not implicated by the financial relationships between our operations and the contracted radiology practices. In addition, we believe that we have structured our acquisitions of the assets of existing practices, and we intend to structure any future acquisitions, so as not to violate the Anti-kickback Statute, Stark Law and the regulations related to these laws. Specifically, we believe the consideration paid by us to physicians to acquire the tangible and intangible assets associated with </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">their practices is consistent with fair value in arms&#8217; length transactions and is not intended to induce the referral of patients or other business generated by such physicians. Should any such practice be deemed to constitute an arrangement designed to induce the referral of Medicare or Medicaid patients, then our acquisitions could be viewed as possibly violating anti-kickback and anti-referral laws and regulations. A determination of liability under any such laws could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare and Medicaid Fraud and Abuse &#8211; General</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal government embarked on an initiative to audit all Medicare carriers, which are the companies that adjudicate and pay Medicare claims. These audits are expected to intensify governmental scrutiny of individual providers. An unsatisfactory audit of any of our diagnostic imaging facilities or contracted radiology practices could result in any or all of the following: significant repayment obligations, exclusion from Medicare, Medicaid or other governmental programs, and civil and criminal penalties.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal regulatory and law enforcement authorities have increased enforcement activities with respect to Medicare and Medicaid fraud and abuse regulations and other reimbursement laws and rules, including laws and regulations that govern our activities and the activities of the radiology practices. The federal government also has increased funding to fight healthcare fraud and is coordinating its enforcement efforts among various agencies, such as the U.S. Department of Justice, the U.S. Department of Health and Human Services Office of Inspector General, and state Medicaid fraud control units. The government may investigate our or the radiology practices&#8217; activities, claims may be made against us or the radiology practices and these increased enforcement activities may directly or indirectly have an adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Anti-kickback and Physician Self-referral Laws</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many states have adopted laws similar to the federal Anti-kickback Statute and the Stark Law. Some of these state prohibitions apply to services and the referral of patients for healthcare services reimbursed by any source, not only the Medicare and Medicaid programs. Although we believe that we comply with both federal and state anti-kickback laws and self-referral laws, any finding of a violation of these laws could subject us to criminal and civil penalties or possible exclusion from federal or state healthcare programs. Such penalties would adversely affect our financial performance and our ability to operate our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal False Claims Act</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal False Claims Act provides, in part, that the federal government may bring a lawsuit against any person who it believes has knowingly presented, or caused to be presented, a false or fraudulent request for payment from the federal government, or who has made a false statement or used a false record to get a claim approved. The federal False Claims Act further provides that a lawsuit thereunder may be initiated in the name of the United States by an individual, a &#8220;whistleblower,&#8221; who is an original source of the allegations. The government has taken the position that claims presented in violation of the federal Anti-kickback Statute or Stark Law may be considered a violation of the federal False Claims Act. Penalties include civil penalties of not less than $5,500 and not more than $11,000 for each false claim, plus three times the amount of damages that the federal government sustained because of the act of that person.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, states are being encouraged to adopt false claims acts similar to the federal False Claims Act, which establish liability for submission of fraudulent claims to the State Medicaid program and contain whistleblower provisions. Even in instances when a whistleblower action is dismissed with no judgment or settlement, we may incur substantial legal fees and other costs relating to an investigation. Future actions under the False Claims Act may result in significant fines and legal fees, which would adversely affect our financial performance and our ability to operate our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are in compliance with the rules and regulations that apply to the federal False Claims Act as well as its state counterparts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Healthcare Reform Legislation</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare reform legislation enacted in the first quarter of 2010 by the Patient Protection and Affordable Care Act or PPACA, specifically requires the U.S. Department of Health and Human Services, in computing physician practice expense relative value units, to increase the equipment utilization factor for advanced diagnostic imaging services (such as MRI, CT and PET) from a presumed utilization rate of 50% to 65% for 2010 through 2012, 70% in 2013, and 75% thereafter. Excluded from the adjustment is low-technology imaging modalities such as ultrasound, X-ray and fluoroscopy. The Health Care and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Education Reconciliation Act of 2010 (H.R. 4872), or Reconciliation Act, which was passed by the Senate and approved by the President on March 30, 2010, amends the provision for higher presumed utilization of advanced diagnostic imaging services to a presumed rate of 75%. The higher utilization rate was fully implemented in the beginning of 2011 and replaced the phase-in approach provided in the PPACA. This utilization rate was further increased to 90% by the American Taxpayer Relief Act of 2012 (&#8220;ATRA&#8221;), effective as of January 1, 2014.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aim of increased utilization of diagnostic imaging services is to spread the cost of the equipment and services over a greater number of scans, resulting in a lower cost per scan. These changes have precipitated reductions in federal reimbursement for medical imaging and have resulted in decreased revenue for the scans we perform for Medicare beneficiaries. Other changes in reimbursement for services rendered by Medicare Advantage plans may also reduce the revenues we receive for services rendered to Medicare Advantage enrollees.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2017, President Trump signed into law the Tax Cuts and Jobs Act (the &#8220;Tax Act&#8221;)). Among numerous changes to the tax code, the Tax Act repealed the individual mandate tax penalty (the &#8220;Individual Mandate&#8221;), a PPACA provision that required individuals to pay additional taxes if he or she was uninsured during the year.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repeal of the Individual Mandate may lead to more people being uninsured, and could raise premium rates for insured persons. Such a development could affect reimbursement, coverage, and utilization of diagnostic imaging services in ways that are currently unpredictable.  Other changes to the PPACA (whether through legislation or judicial action), including further rollbacks or full repeal of the PPACA being sought by congressional and state members of the Republican Party, or expansion of the PPACA (including, but not limited to, the development of a "public option" that would compete with private insurers to offer coverage to both individuals and those with employer sponsored insurance) being sought by the Biden Administration, could have similarly unpredictable effects.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Insurance Portability and Accountability Act of 1996</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress enacted the Health Insurance Portability and Accountability Act of 1996, or HIPAA, in part, to combat healthcare fraud and to protect the privacy and security of patients&#8217; individually identifiable healthcare information. &#160;HIPAA, among other things, amends existing crimes and criminal penalties for Medicare fraud and enacts new federal healthcare fraud crimes, including actions affecting non-government healthcare benefit programs. Under HIPAA, a healthcare benefit program includes any private plan or contract affecting interstate commerce under which any medical benefit, item or service is provided. A person or entity that knowingly and willfully obtains the money or property of any healthcare benefit program by means of false or fraudulent representations in connection with the delivery of healthcare services is subject to a fine or imprisonment, or potentially both. In addition, HIPAA authorizes the imposition of civil money penalties against entities that employ or enter into contracts with excluded Medicare or Medicaid program participants if such entities provide services to federal health program beneficiaries. A finding of liability under HIPAA could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, HIPAA requires healthcare providers and their business associates to maintain the privacy and security of individually identifiable protected health information (&#8220;PHI&#8221;). HIPAA imposes federal standards for electronic transactions, for the security of electronic health information and for protecting the privacy of PHI. The Health Information Technology for Economic and Clinical Health Act of 2009 (&#8220;HITECH&#8221;), signed into law on February 17, 2009, dramatically expanded, among other things, (1) the scope of HIPAA to now apply directly to &#8220;business associates,&#8221; or independent contractors who receive or obtain PHI in connection with providing a service to a covered entity, (2) substantive security and privacy obligations, including new federal security breach notification requirements to affected individuals, DHHS and prominent media outlets, of certain breaches of unsecured PHI, (3) restrictions on marketing communications and a prohibition on covered entities or business associates from receiving remuneration in exchange for PHI, and (4) the civil and criminal penalties that may be imposed for HIPAA violations, increasing the annual cap in penalties from $25,000 to $1.5 million per year.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, many states have enacted comparable privacy and security statutes or regulations that, in some cases, are more stringent than HIPAA requirements. In those cases it may be necessary to modify our operations and procedures to comply with the more stringent state laws, which may entail significant and costly changes for us. We believe that we are in compliance with such state laws and regulations. However, if we fail to comply with applicable state laws and regulations, we could be subject to additional sanctions.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are in compliance with the current HIPAA requirements, as amended by HITECH, and comparable state laws, but we anticipate that we may encounter certain costs associated with future compliance. Moreover, we cannot guarantee that enforcement agencies or courts will not make interpretations of the HIPAA standards that are inconsistent with ours, or the interpretations of our contracted radiology practices or their affiliated physicians. A finding of liability under the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA standards may result in significant criminal and civil penalties. Noncompliance also may result in exclusion from participation in government programs, including Medicare and Medicaid. These actions could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Food and Drug Administration or FDA</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA has issued the requisite pre-market approval for all of the MRI and CT systems we use.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mammography systems are regulated by the FDA pursuant to the Mammography Quality Standards Act of 1992, as amended by the Mammography Quality Standards Reauthorization Acts of 1998 and 2004 (collectively, the &#8220;MQSA&#8221;). All mammography facilities are required to meet the applicable MQSA requirements, including quality standards, be accredited by an approved accreditation body or state agency and certified by the FDA or an FDA-approved certifying state agency. Pursuant to the accreditation process, each facility providing mammography services must comply with certain standards that include, among other things, annual inspection of the facility's equipment, personnel (interpreting physicians, technologists and medical physicists) and practices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with these MQSA requirements and standards is required to obtain Medicare payment for services provided to beneficiaries and to avoid various sanctions, including monetary penalties, or suspension of certification. Although the Mammography Accreditation Program of the American College of Radiology is an approved accreditation body and currently accredits all of our facilities which provide mammography services, and although we anticipate continuing to meet the requirements for accreditation, if we lose such accreditation, the FDA could revoke our certification. Congress has extended Medicare benefits to include coverage of screening mammography but coverage is subject to the facility performing the mammography meeting prescribed quality standards described above. The Medicare requirements to meet the standards apply to diagnostic mammography and image quality examination as well as screening mammography.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Radiologist Licensing</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The radiologists providing professional medical services at our facilities are subject to licensing and related regulations by the states in which they provide services. As a result, we require the radiology groups with which we contract to require those radiologists to have and maintain appropriate licensure. We do not believe that such laws and regulations will either prohibit or require licensure approval of our business operations, although no assurances can be made that such laws and regulations will not be interpreted to extend such prohibitions or requirements to our operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Laws and Regulation</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States in which we operate have adopted certain laws and regulations affecting risk assumption in the healthcare industry, including those that subject any physician or physician network engaged in risk-based managed care to comply with applicable insurance laws and regulations. These laws and regulations may require physicians and physician networks to meet minimum capital requirements and other safety and soundness requirements. Implementing additional regulations or compliance requirements could result in substantial costs to the contracted radiology practices, limiting their ability to enter into capitated or other risk-sharing managed care arrangements and indirectly affecting our revenue from the contracted practices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Federal Budget</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a substantial portion of our revenue from direct billings to governmental healthcare programs, such as Medicare and Medicaid, and private health insurance companies and/or health plans, including but not limited to those participating in the Medicare Advantage program. As a result, any negative changes in governmental capitation or fee-for-service rates or methods of reimbursement for the services we provide could have a significant adverse impact on our revenue and financial results.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because governmental healthcare programs generally reimburse on a fee schedule basis rather than on a charge-related basis, we generally cannot increase our revenues from these programs by increasing the amount of charges for services. Moreover, if our costs increase, we may not be able to recover our increased costs from these programs. Government and private payors have taken and may continue to take steps to control the cost, eligibility for, use, and delivery of healthcare services as a result of budgetary constraints, cost containment pressures and other reasons. We believe that these trends in cost containment will continue. These cost containment measures, and other market changes in non-governmental insurance plans have generally restricted our ability to recover, or shift to non-governmental payors, any increased costs that we experience. Our integrated care business and financial operations may be materially affected by these developments.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental Matters</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The facilities we operate or manage generate hazardous and medical waste subject to federal and state requirements regarding handling and disposal. We believe that the facilities that we operate and manage are currently in compliance in all material respects with applicable federal, state and local statutes and ordinances regulating the handling and disposal of such materials. We do not believe that we will be required to expend any material additional amounts in order to remain in compliance with these laws and regulations or that compliance will materially affect our capital expenditures, earnings or competitive position.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance Program</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a program to monitor compliance with federal and state laws and regulations applicable to healthcare entities. We have a compliance officer who is charged with implementing and supervising our compliance program, which includes the adoption of (i) Standards of Conduct for our employees and affiliates and (ii) a process that specifies how employees, affiliates and others may report regulatory or ethical concerns to our compliance officer. We believe that our compliance program meets the relevant standards provided by the Office of Inspector General of the Department of Health and Human Services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An important part of our compliance program consists of conducting periodic audits of various aspects of our operations and that of the contracted radiology practices. We also conduct mandatory educational programs designed to familiarize our employees with the regulatory requirements and specific elements of our compliance program.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_19"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Risk Factors</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Operations and Third-Party Relationships</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our contracted radiology practices terminate their agreements with us, our business could substantially diminish.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our relationship with professional corporations contracted to provide medical services is an integral part of our business. These professional corporations must use their best efforts to provide medical services at any new facilities that we open or acquire in their areas of operation. In addition, these professional corporation's strong relationships with referring physicians are largely responsible for the revenue generated at the facilities they service. Although our management agreements are for multiple years, the radiology groups have the right to terminate the agreements if we default on our obligations and fail to cure the default. Also, the various radiology groups&#8217; ability to continue performing under the management agreements may be curtailed or eliminated due to the groups&#8217; financial difficulties, loss of physicians or other circumstances. If the radiology groups cannot perform their obligations to us, we would need to contract with one or more other radiology groups to provide the professional medical services at the facilities serviced by the group. We may not be able to locate radiology groups willing to provide those services on terms acceptable to us, if at all. Even if we were able to do so, any replacement radiology group&#8217;s relationships with referring physicians may not be as extensive as those of the terminated group. In any such event, our business could be seriously harmed. In addition, the radiology groups are party to substantially all of the managed care contracts from which we derive revenue. If we were unable to readily replace these contracts, our revenue would be negatively affected.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to generate revenue depends in large part on referrals from physicians.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive substantially all of our net revenue, directly or indirectly, from fees charged for the diagnostic imaging services performed at our facilities. We depend on referrals of patients from unaffiliated physicians and other third parties who have no contractual obligations to refer patients to us for a substantial portion of the services we perform. If a sufficiently large number of these physicians and other third parties were to discontinue referring patients to us, our scan volume could decrease, which would reduce our net revenue and operating margins. Further, commercial third-party payors have implemented programs that could limit the ability of physicians to refer patients to us. For example, prepaid healthcare plans, such as health maintenance organizations, sometimes contract directly with providers and require their enrollees to obtain these services exclusively from those providers. Some insurance companies and self-insured employers also limit these services to contracted providers. These &#8220;closed panel&#8221; systems are now common in the managed care environment. Other systems create an economic disincentive for referrals to providers outside the system&#8217;s designated panel of providers. If we are unable to compete successfully for these managed care contracts, our results and prospects for growth could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our contracted radiology practices, including the Group, lose a significant number of their radiologists, our financial results could be adversely affected.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At times, there has been a shortage of qualified radiologists in some of the regional markets we serve. In addition, competition in recruiting radiologists may make it difficult for our contracted radiology practices to maintain adequate levels of radiologists. If a significant number of radiologists terminate their relationships with our contracted radiology practices and those radiology practices cannot recruit sufficient qualified radiologists to fulfill their obligations under our agreements with them, our ability to maximize the use of our diagnostic imaging facilities and our financial results could be adversely affected. Increased expenses for the Group will impact our financial results because the management fee we receive from them, which is based on a percentage of their collections, is adjusted annually to take into account their expenses as applicable. Neither we, nor our contracted radiology practices, maintain insurance on the lives of any affiliated physicians.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become subject to professional malpractice liability, which could be costly and negatively impact our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The physicians&#160;employed by&#160;our contracted radiology practices are from time to time subject to malpractice claims. We structure our relationships with the practices under our management agreements in a manner that we believe does not constitute the practice of medicine by us or subject us to professional malpractice claims for acts or omissions of physicians employed by the contracted radiology practices. Nevertheless, claims, suits or complaints relating to services provided by the contracted radiology practices have been asserted against us in the past and may be asserted against us in the future. In addition, we may be subject to professional liability claims, including, without limitation, for improper use or malfunction of our diagnostic imaging equipment or for accidental contamination or injury from exposure to radiation. We may not be able to maintain adequate liability insurance to protect us against those claims at acceptable costs or at all.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have sought to manage this risk of loss by, among other things, purchasing professional liability insurance. However, the insurer from which we purchased such insurance for the period ending July 15, 2017, Fairway Physicians Insurance Company, A Risk Retention Group (&#8220;Fairway&#8221;), experienced financial hardship.&#160; As a result, on August 29, 2017, the District of Columbia Department of Insurance, Securities and Banking (&#8220;DISB&#8221;) found that Fairway was statutorily insolvent and that its continued operation would be hazardous to its policyholders, creditors and the general public.&#160; On October 25, 2017, the Superior Court for the District of Columbia issued an order authorizing the DISB Commissioner to liquidate Fairway.&#160; Fairway&#8217;s liquidation is currently pending, and it is presently unknown whether the Fairway liquidation estate will be able to pay covered policyholder claims, including claims asserted against us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any claim made against us that is not fully covered by insurance could be costly to defend, result in a substantial damage award against us and divert the attention of our management from our operations, all of which could have an adverse effect on our financial performance. In addition, successful claims against us may adversely affect our business or reputation. Although California places a $250,000 limit on non-economic damages for medical malpractice cases, no limit applies to economic damages and no such limits exist in the other states in which we provide services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not receive payment from some of our healthcare provider customers because of their financial circumstances.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our healthcare provider customers do not have significant financial resources, liquidity or access to capital. If these customers experience financial difficulties they may be unable to pay us for the equipment and services that we provide. A significant deterioration in general or local economic conditions could have a material adverse effect on the financial health of certain of our healthcare provider customers. As a result, we may have to increase the amounts of accounts receivables that we write-off, which would adversely affect our financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitation fee arrangements could reduce our operating margins.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2020, we derived approximately 13% of our total net revenue from capitation arrangements, and we intend to increase the revenue we derive from capitation arrangements in the future. Under capitation arrangements, the payor pays a pre-determined amount per-patient per-month in exchange for us providing all necessary covered services to the patients covered under the arrangement. These contracts pass much of the financial risk of providing diagnostic imaging services, including the risk of over-use, from the payor to the provider. Our success depends in part on our ability to negotiate effectively, on behalf of the contracted radiology practices and our diagnostic imaging facilities, contracts with health maintenance organizations, employer groups and other third-party payors for services to be provided on a capitated basis and to efficiently manage the utilization of those services. If we are not successful in managing the utilization of services under these capitation arrangements or if patients or enrollees covered by these contracts require more frequent or extensive care than anticipated, we would incur unanticipated costs not offset by additional revenue, which would reduce operating margins.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the method or rates of third-party reimbursement could have a negative impact on our results</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, changes designed to contain healthcare costs have been implemented, some of which have resulted in decreased reimbursement rates for diagnostic imaging services that impact our business. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 4, 2020, CMS released the 2021 Medicare Physician Fee Schedule proposed rules, which proposed significant payment reductions effective January 1, 2021 for radiology services as a result of a proposed new coding structure for the office/outpatient evaluation and management (E/M) and statutorily mandated budget neutrality rules.  While the Consolidated Appropriations Acct, 2021 (H.R. 133), enacted on December 27, 2020, mitigated the reimbursement cuts for 2021, H.R. 133 does not completely eliminate the cuts and only reduces their impact for 2021.  Moreover, absent further and more permanent intervention from Congress, CMS could propose and impose similar or more significant reimbursement cuts in the years ahead, thus negatively impacting our revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disruption or malfunction in our information systems could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information technology systems to process, transmit and store electronic information. A significant portion of the communication between personnel, customers, business partners, and suppliers depends on information technology. We rely on our information systems to perform functions critical to our ability to operate, including patient scheduling, billing, collections, image storage and image transmission. We also use information technology systems and networks in our operations and supporting departments such as marketing, accounting, finance, and human resources. The future success and growth of our business depends on streamlined processes made available through information systems, global communications, internet activity and other network processes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our information technology systems, and those of our third-party service providers, have been and may again in the future be vulnerable to information security breaches, acts of vandalism, computer viruses and interruption or loss of valuable business data. Our information technology system is vulnerable to damage or interruption from:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">earthquakes, fires, floods and other natural disasters;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">power losses, computer systems failures, internet and telecommunications or data network failures, operator negligence, improper operation by or supervision of employees, physical and electronic losses of data and similar events; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">computer viruses, penetration by hackers seeking to disrupt operations or misappropriate information and other breaches of security.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have technology security initiatives and disaster recovery plans in place to mitigate our risk to these vulnerabilities, but these measures may not be adequate or implemented properly to ensure that our operations are not disrupted or that data security breaches do not occur.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#373739;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We suffered an unauthorized access to our network and could again face attempts by others to gain unauthorized access through the Internet or to introduce malicious software to our information technology systems. If a malicious hacker gained unauthorized access to our systems and network, it could have a material adverse impact on our business or operations. Such incidents, whether or not successful, could result in our incurring significant costs related to, for example, rebuilding internal systems, defending against litigation, responding to regulatory inquiries or actions, paying damages, or taking other remedial steps with respect to third parties. In addition, these threats are constantly changing, thereby increasing the difficulty of successfully defending against them or implementing adequate preventive measures. Accordingly, an extended interruption in our information technology system&#8217;s function could significantly curtail, directly and indirectly, our ability to conduct our business and generate revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our network was compromised, it could give rise to unwanted media attention, materially damage our payor and physician relationships, harm our business, reputation, results of operations, cash flows and financial condition, result in fines or lawsuits, and may increase the costs we incur to protect against such information security breaches, such as increased investment in technology, the costs of compliance with consumer protection laws and costs resulting from consumer fraud. While we maintain cyber liability insurance, our insurance may not be sufficient to protect against all losses we may incur if we suffer significant or multiple attacks.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Technological change in our industry could reduce the demand for our services and require us to incur significant costs to upgrade our equipment.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development of new technologies or refinements of existing modalities may require us to upgrade and enhance our existing equipment before we may otherwise intend. Many companies currently manufacture diagnostic imaging equipment. Competition among manufacturers for a greater share of the diagnostic imaging equipment market may result in technological advances in the speed and imaging capacity of new equipment. This may accelerate the obsolescence of our equipment, and we may not have the financial ability to acquire the new or improved equipment and may not be able to maintain a competitive equipment base. In addition, advances in technology may enable physicians and others to perform diagnostic imaging procedures without us. If we are unable to deliver our services in the efficient and effective manner that payors, physicians and patients expect our revenue could substantially decrease.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Ability to Grow Our Business</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face various risks related to health epidemics and other outbreaks, which may have a material adverse effect on our business, financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face various risks related to health epidemics and other outbreaks, including the global outbreak of COVID-19.  the COVID-19 pandemic, changes in patient behavior related to illness, pandemic fears and market downturns, and restrictions intended to slow the spread of COVID-19, including quarantines, government-mandated actions, stay-at-home orders and other restrictions, have led to disruption of our business and volatility in the global capital markets.  The United States government has taken steps to attempt to mitigate some of the more severe anticipated effects of the COVID-19 pandemic, including the passage of the Coronavirus Aid, Relief, and Economic Security Act (CARES Act).  Additionally, we have received some funding from the U.S. Department of Health &amp; Human Services under the CARES Act's Public Health and Social Services Emergency Fund (PHSSEF), which is geared towards supporting healthcare related expenses or lost revenue attributable to COVID-19.  Nonetheless, no assurance that such types of measures and funding whether already enacted or to be enacted, including H.R. 133, will be effective or achieve their desired results in a timely fashion, including as it relates to our business operations.  Moreover, while we believe we are in compliance with the applicable terms and conditions of funding under PHSSEF, compliance-related guidance for the program remains in process, and we may face enforcement risk if we are found to have failed to comply with such terms and conditions.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If significant portions of our workforce are unable to work effectively as a result of the COVID-19 pandemic, including because of illness, quarantines, facility closures, ineffective remote work arrangements or technology failures or limitations, our operations would be adversely impacted.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently believe our results of operations will continue to be negatively impacted by these developments.  In addition, changes to statutes, regulations or regulatory policies or practices as a result of, or in response to COVID-19, could affect us in substantial and unpredictable ways.  Given the many uncertainties and far-reaching consequences of potential developments, we cannot assure that the COVID-19 outbreak and the many related impacts will not require extended or additional diagnostic center closures and other disruptions to our business or will not materially and adversely affect our business, results of operations and financial condition for significant periods of time moving forward.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pressure to control healthcare costs could have a negative impact on our results.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the principal objectives of health maintenance organizations and preferred provider organizations is to control the cost of healthcare services. Healthcare providers participating in managed care plans may be required to refer diagnostic imaging tests to certain providers depending on the plan in which a covered patient is enrolled. In addition, managed care contracting has become very competitive, and reimbursement schedules are at or below Medicare reimbursement levels. The expansion of health maintenance organizations, preferred provider organizations and other managed care organizations within the geographic areas covered by our network could have a negative impact on the utilization and pricing of our services, because these organizations will exert greater control over patients&#8217; access to diagnostic imaging services, the selections of the provider of such services and reimbursement rates for those services.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We experience competition from other diagnostic imaging companies and hospitals, and this competition could adversely affect our revenue and business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for diagnostic imaging services is highly competitive. We compete for patients principally on the basis of our reputation, our ability to provide multiple modalities at many of our facilities, the location of our facilities and the quality of our diagnostic imaging services. We compete locally with groups of radiologists, established hospitals, clinics and other independent organizations that own and operate imaging equipment. Our competitors include independent imaging operators, such as Alliance Healthcare and smaller regional operators, as well as hospitals and hospital groups that operate their own imaging services. Some of our competitors may now or in the future have access to greater financial resources than we do and may have access to newer, more advanced equipment. In addition, some physician practices have established their own diagnostic imaging facilities within their group practices and compete with us. We are experiencing increased competition as a result of such activities, and if we are unable to successfully compete, our business and financial condition would be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends in part on our key personnel and loss of key executives could adversely affect our operations. In addition, former employees and radiology practices we have previously contracted with could use the experience and relationships developed while employed or under contract with us to compete with us.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in part on our ability to attract and retain qualified senior and executive management, and managerial and technical personnel. Competition in recruiting these personnel may make it difficult for us to continue our growth and success. The loss of their services or our inability in the future to attract and retain management and other key personnel could hinder the implementation of our business strategy. The loss of the services of Dr. Howard G. Berger, our President and Chief Executive Officer, and Norman R. Hames or Stephen M. Forthuber, our Chief Operating Officers, West Coast and East Coast, respectively, could have a significant negative impact on our operations. We believe that they could not easily be replaced with executives of equal experience and capabilities.  Additionally, if we lose the services of Dr. Berger, our relationship with BRMG could deteriorate, which would materially adversely affect our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the states in which we operate do not enforce agreements that prohibit a former employee from competing with a former employer. As a result, many of our employees whose employment is terminated are free to compete with us, subject to prohibitions on the use of trade secret information and, depending on the terms of the employee&#8217;s employment agreement, on solicitation of existing employees and customers (if enforceable). A former executive, manager or other key employee who joins one of our competitors could use the relationships he or she established with third party payors, radiologists or referring physicians while our employee and the industry knowledge he or she acquired during that tenure to enhance the new employer&#8217;s ability to compete with us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements with most of our radiology practices contain non-compete provisions; however the enforceability of these provisions is determined by a court based on all the facts and circumstances of the specific case at the time enforcement is sought. Our inability to enforce radiologists&#8217; non-compete provisions could result in increased competition from individuals who are knowledgeable about our business strategies and operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to successfully, and in a timely manner, integrate acquired businesses and/or new lines of businesses could reduce our profitability.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may never realize expected synergies, business opportunities and growth prospects in connection with our acquisitions and joint ventures. We may not be able to capitalize on expected business opportunities, assumptions underlying estimates of expected cost savings may be inaccurate, or general industry and business conditions may deteriorate. In addition, integrating operations will require significant efforts and expense on our part. Personnel may leave or be terminated because of an acquisition. Our management may have its attention diverted while trying to integrate an acquisition. If these factors limit our ability to integrate the operations of an acquisition successfully or on a timely basis, our expectations of future results of operations, including certain cost savings and synergies as a result of the acquisition, may not be met.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past we have acquired, and may again in the future acquire, companies that create a new line of business. The process of integrating the acquired business, technology, service and research and development component into our business and operations and entry into a new line of business in which we are inexperienced may result in unforeseen operating difficulties and expenditures. In developing a new line of business, we may invest significant time and resources that take away the attention of management that would otherwise be available for ongoing development of our business. In addition, there can be no assurance that our new lines of business will ultimately be successful. The failure to successfully manage these risks in the development and implementation of new lines of business could have a material, adverse effect on the Company&#8217;s business, financial condition, and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to successfully grow our business, which would adversely affect our financial condition and results of operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have experienced substantial growth through acquisitions that have increased our size, scope and geographic distribution. During the past two fiscal years, we have completed 9 acquisitions. These acquisitions have added 22 centers to our fixed-site outpatient diagnostic imaging services. Our ability to successfully expand through acquiring facilities, developing new facilities, adding equipment at existing facilities, and directly or indirectly entering into contractual relationships with high-quality radiology practices depends upon many factors, including our ability to:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identify attractive and willing candidates for acquisitions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identify locations in existing or new markets for development of new facilities;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">comply with legal requirements affecting our arrangements with contracted radiology practices;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain regulatory approvals where necessary and comply with licensing and certification requirements applicable to our diagnostic imaging facilities, the contracted radiology practices and their associated physicians;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recruit a sufficient number of qualified radiology technologists and other non-medical personnel;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expand our infrastructure and management; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compete for opportunities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to compete effectively for the acquisition of diagnostic imaging facilities. Our competitors may have more established operating histories and greater resources than we do. Competition may also make any acquisitions more expensive.  If we are unable to successfully grow our business through acquisitions it could have an adverse effect on our financial condition and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A restriction in our ability to make capital expenditures would restrict our growth and could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations, particularly the initial start-up and development expenses of new diagnostic imaging facilities and the acquisition of additional facilities and new diagnostic imaging equipment. We incur capital expenditures to, among other things, upgrade and replace equipment for existing facilities and expand within our existing markets and enter new markets. If we open or acquire additional imaging facilities, we may have to incur material capital lease obligations. To the extent we are unable to generate sufficient cash from our operations, funds are not available from our lenders or we are unable to structure or obtain financing through operating leases, finance leases or long-term installment notes, we may be unable to meet our capital expenditure requirements to support the maintenance and continued growth of our operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Healthcare Laws and Regulations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The regulatory framework in which we operate is uncertain and evolving.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that we are operating in compliance with applicable federal and state laws, neither our current or anticipated business operations nor the operations of the contracted radiology practices have been the subject of judicial or regulatory interpretation. We cannot assure you that a review of our business by courts or regulatory authorities will not result in a determination that could adversely affect our operations or that the healthcare regulatory environment will not change in a way that restricts our operations. In addition, healthcare laws and regulations may change significantly in the future. We continuously monitor these developments and modify our operations from time to time as the regulatory environment changes. We cannot assure you however, that we will be able to adapt our operations to address new regulations or that new regulations will not adversely affect our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have enacted statutes or adopted regulations affecting risk assumption in the healthcare industry, including statutes and regulations that subject any physician or physician network engaged in risk-based managed care contracting to comply with applicable insurance laws. These laws, if adopted in the states in which we operate, may require physicians and physician networks to meet minimum capital requirements and other safety and soundness requirements. Implementing additional regulations or compliance requirements could result in substantial costs to us and the contracted radiology practices and limit our ability to enter into capitation or other risk-sharing managed care arrangements.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be impacted by eligibility changes to government and private insurance programs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to potential decreased availability of healthcare through private employers, the number of patients who are uninsured or participate in governmental programs may increase. Healthcare reform legislation will increase the participation of individuals in the Medicaid program in states that elect to participate in the expanded Medicaid coverage. A shift in payor mix from managed care and other private payors to government payors as well as an increase in the number of uninsured patients may result in a reduction in the rates of reimbursement or an increase in uncollectible receivables or uncompensated care, with a corresponding decrease in net revenue. Changes in the eligibility requirements for governmental programs and state decisions on whether to participate in the expansion of such programs also could increase the number of patients who participate in such programs and the number of uninsured patients. Even for those patients who remain in private insurance plans, changes to those plans could increase patient financial responsibility, resulting in a greater risk of uncollectible receivables. Furthermore, additional changes to, or repeal of, the PPACA, whether through legislation or judicial action, may also affect reimbursement and coverage in ways that are currently unpredictable. These factors and events could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State and federal anti-kickback and anti-self-referral laws may adversely affect income.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various federal and state laws govern financial arrangements among healthcare providers. The federal Anti-Kickback Statute prohibits the knowing and willful offer, payment, solicitation or receipt of any form of remuneration in return for, or to induce, the referral of Medicare, Medicaid, or other federal healthcare program patients, or in return for, or to induce, the purchase, lease or order of items or services that are covered by Medicare, Medicaid, or other federal healthcare programs. Similarly, many state laws prohibit the solicitation, payment or receipt of remuneration in return for, or to induce the referral of patients in private as well as government programs. Violation of these anti-kickback laws may result in substantial civil or criminal penalties for individuals or entities and/or exclusion from federal or state healthcare programs. We believe we are operating in compliance with applicable law and believe that our arrangements with providers would not be found to violate the anti-kickback laws. However, these laws could be interpreted in a manner inconsistent with our operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal law prohibiting certain physician self-referrals, known as the Stark Law, prohibits a physician from referring Medicare or Medicaid patients to an entity for certain &#8220;designated health services&#8221; if the physician has a prohibited financial relationship with that entity, unless an exception applies. Certain radiology services are considered &#8220;designated health services&#8221; under the Stark Law. Although we believe our operations do not violate the Stark Law, our activities may be challenged. If a challenge is successful, it could have an adverse effect on our operations. In addition, legislation may be enacted in the future that further addresses Medicare and Medicaid fraud and abuse or imposes additional regulatory burdens on us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, under the DRA, states enacting false claims statutes similar to the federal False Claims Act, which establish liability for submission of fraudulent claims to the State Medicaid program and contain qui tam or whistleblower provisions, receive an increased percentage of any recovery from a State Medicaid judgment or settlement. Adoption of new false claims statutes in states where we operate may impose additional burdens on us.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal and state privacy and information security laws are complex, and if we fail to comply with applicable laws, regulations and standards, or if we fail to properly maintain the integrity of our data, protect our proprietary rights to our systems, or defend against cybersecurity attacks, we may be subject to government or private actions due to privacy and security breaches, and our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations rely on the secure processing, transmission and storage of confidential, proprietary and other information in our computer systems and networks.  We must comply with numerous federal and state laws and regulations governing the collection, dissemination, access, use, security and privacy of PHI, including HIPAA and its implementing privacy and security regulations, as amended by the federal HITECH Act and collectively referred to as HIPAA. Information security risks have significantly increased in recent years in part because of the proliferation of new technologies, the use of the internet and telecommunications technologies to conduct our operations, and the increased sophistication and activities of organized crime, hackers, terrorists and other external parties, including foreign state agents. If we fail to comply with applicable privacy and security laws, regulations and standards, properly maintain the integrity of our data, protect our proprietary rights to our systems, or defend against cybersecurity attacks, our business, reputation, results of operations, financial position and cash flows could be materially and adversely affected.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continuously implementing multiple layers of security measures. We utilize current security technologies and our defenses are monitored and routinely tested internally and by external parties. Despite these efforts, our facilities and systems may be vulnerable to privacy and security incidents; security attacks and breaches; acts of vandalism or theft; computer viruses; coordinated attacks by activist entities; emerging cybersecurity risks; misplaced or lost data; programming and/or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">human errors; or other similar events. Emerging and advanced security threats, including coordinated attacks, require additional layers of security which may disrupt or impact efficiency of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any security breach involving the misappropriation, loss or other unauthorized disclosure or use of confidential information, including protected health information, financial data, competitively sensitive information, or other proprietary data, whether by us or a third party, could have a material adverse effect on our business, reputation, financial condition, cash flows, or results of operations. The occurrence of any of these events could result in interruptions, delays, the loss or corruption of data, cessations in the availability of systems or liability under privacy and security laws, all of which could have a material adverse effect on our financial position and results of operations and harm our business reputation.&#160;If we are unable to protect the physical and electronic security and privacy of our databases and transactions, we could be subject to potential liability and regulatory action, our reputation and relationships with our patients and vendors would be harmed, and our business, operations, and financial results may be materially adversely affected. Failure to adequately protect and maintain the integrity of our information systems (including our networks) and data, or to defend against cybersecurity attacks, could subject us to monetary fines, civil suits, civil penalties or criminal sanctions and requirements to disclose the breach publicly, and may further result in a material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Complying with federal and state regulations is an expensive and time-consuming process, and any failure to comply could result in substantial penalties.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are directly or indirectly, through the radiology practices with which we contract, subject to extensive regulation by both the federal government and the state governments in which we provide services, including:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal False Claims Act;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Medicare and Medicaid Anti-Kickback Statute, and state anti-kickback prohibitions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state billing and claims submission laws and regulations;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by HITECH, and comparable state laws;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal physician self-referral prohibition commonly known as the Stark Law and state equivalents;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws that prohibit the corporate practice of medicine and prohibit similar fee-splitting arrangements;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">federal and state laws governing the diagnostic imaging and therapeutic equipment we use in our business concerning patient safety, equipment operating specifications and radiation exposure levels; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws governing reimbursement for diagnostic services related to services compensable under workers' compensation rules.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our operations are found to be in violation of any of the laws and regulations to which we or the radiology practices with which we contract are subject, we may be subject to penalties, including civil and criminal penalties, damages, fines and the curtailment of our operations. Any penalties, damages, fines or curtailment of our operations, individually or in the aggregate, could adversely affect our ability to operate our business and our financial results. The risks of our being found in violation of these laws and regulations is increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action brought against us for violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with various licensure, certification and accreditation standards, we may be subject to loss of licensure, certification or accreditation, which would adversely affect our operations.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ownership, construction, operation, expansion and acquisition of our diagnostic imaging facilities are subject to various federal and state laws, regulations and approvals concerning licensing of personnel, other required certificates for certain types of healthcare facilities and certain medical equipment. In addition, freestanding diagnostic imaging facilities that provide services independent of a physician&#8217;s office must be enrolled by Medicare as an independent diagnostic treatment facility, or IDTF, to bill the Medicare program. Medicare carriers have discretion in applying the IDTF requirements and therefore the application of these requirements may vary from jurisdiction to jurisdiction. In addition, federal legislation requires all suppliers that provide the technical component of diagnostic MRI, PET/CT, CT, and nuclear medicine to be accredited by an accreditation organization designated by CMS (which currently include the American College of Radiology (ACR), the Intersocietal Accreditation Commission (IAC) and the Joint Commission). Our MRI, CT, nuclear medicine, ultrasound and mammography facilities are currently accredited by the American College of Radiology. We may not be able to receive the required regulatory approvals or accreditation for any future acquisitions, expansions or replacements, and the failure to obtain these approvals could limit the opportunity to expand our services.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our facilities are subject to periodic inspection by governmental and other authorities to assure continued compliance with the various standards necessary for licensure and certification. If any facility loses its certification under the Medicare program, then the facility will be ineligible to receive reimbursement from the Medicare and Medicaid programs. For the year ended December 31, 2020, approximately 20% and 2% of our net service fee revenue came from Medicare and various state Medicaid programs, respectively. A change in the applicable certification status of one of our facilities could adversely affect our other facilities and in turn us as a whole. Credentialing of physicians is required by our payors prior to commencing payment. We have experienced a slowdown in the credentialing of our physicians over the last several years which has lengthened our billing and collection cycle, and could negatively impact our ability to collect revenue from patients covered by Medicare.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our agreements with the contracted radiology practices must be structured to avoid the corporate practice of medicine and fee-splitting.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of certain states prohibit us from exercising control over the medical judgments or decisions of physicians and from engaging in certain financial arrangements, such as splitting professional fees with physicians. These laws are enforced by state courts and regulatory authorities, each with broad discretion. A component of our business has been to enter into management agreements with radiology practices. We provide management, administrative, technical and other non-medical services to the radiology practices in exchange for a service fee typically based on a percentage of the practice&#8217;s revenue. We structure our relationships with the radiology practices, including the purchase of diagnostic imaging facilities, in a manner that we believe keeps us from engaging in the practice of medicine or exercising control over the medical judgments or decisions of the radiology practices or their physicians, or violating the prohibitions against fee-splitting. There can be no assurance that our present arrangements with the Group or the physicians providing medical services and medical supervision at our imaging facilities will not be challenged, and, if challenged, that they will not be found to violate the corporate practice of medicine or fee splitting prohibitions, thus subjecting us to potential damages, injunction and/or civil and criminal penalties or require us to restructure our arrangements in a way that would affect the control or quality of our services and/or change the amounts we receive under our management agreements. Any of these results could jeopardize our business.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Some of our imaging modalities use radioactive materials, which generate regulated waste and could subject us to liabilities for injuries or violations of environmental and health and safety laws.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our imaging procedures use radioactive materials, which generate medical and other regulated wastes. For example, patients are injected with a radioactive substance before undergoing a PET scan. Storage, use and disposal of these materials and waste products present the risk of accidental environmental contamination and physical injury. We are subject to federal, state and local regulations governing storage, handling and disposal of these materials. We could incur significant costs and the diversion of our management&#8217;s attention in order to comply with current or future environmental and health and safety laws and regulations. Also, we cannot completely eliminate the risk of accidental contamination or injury from these hazardous materials. Although we maintain professional liability insurance coverage in amounts we believe is consistent with industry practice in the event of an accident, we could be held liable for any resulting damages, and any liability could exceed the limits of or fall outside the coverage of our professional liability insurance.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Economic, Legal, Tax and Financial Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adverse changes in general domestic and worldwide economic conditions and instability and disruption of credit markets could adversely affect our operating results, financial condition, or liquidity.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to risk arising from adverse changes in general domestic and global economic conditions, including recession or economic slowdown and disruption of credit markets. Continued concerns about the systemic impact of potential long-term and wide-spread recession, inflation, energy costs, geopolitical issues, the availability and cost of credit have contributed to increased market volatility and diminished expectations for the United States economy. The United States and other western countries have responded to this economic situation by exercising monetary policy to keep interest rates low. Any significant change in economic conditions or change in fiscal monetary policy could result in material changes in interest rates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continued turbulence in domestic and international markets and economies may adversely affect our liquidity and financial condition, and the liquidity and financial condition of our patients. If these market conditions continue, they may increase expenses associated with borrowing, limit our ability to timely replace maturing liabilities and access the capital markets to meet liquidity needs, resulting in adverse effects on our financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business disruptions and interruptions due to external events beyond our control can adversely affect our business, financial condition or results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations can be subject to external events beyond our control, such as the effects of earthquakes, fires, floods, severe weather, public health issues, power failures, telecommunication loss, and other natural and man-made events, some of which may be intensified by the effects of climate change and changing weather patterns. Our corporate headquarters and over 100 of our radiology centers are located in California, which is subject to wildfires, blackouts, and potentially damaging earthquakes. In addition, several of our facilities located in parts of the east coast have suffered from weather events that caused us to temporarily close facilities.  More recently, the novel coronavirus outbreak has impacted our business.  This or such other events could cause disruption or interruption to our operations and significantly impact our employees.  Any disruption to our services may result in decreases in revenues or increased operating and capital expenses.  Historically, when we have experienced a reduction in business due to inclement weather or external events for a period of time, our operations have returned to a normalized level, but we have not experience a significant increase of procedures that would fully compensate for the revenues lost during the slower periods.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Possible volatility in our stock price could negatively affect us and our stockholders.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading price of our common stock on the NASDAQ Global Market has fluctuated significantly in the past. During the period from January 1, 2019 through December 31, 2020, the trading price of our common stock fluctuated from a high of $23.45 per share to a low of $5.81 per share. In the past, we have experienced a drop in stock price following an announcement of disappointing earnings or earnings guidance. Any such announcement in the future could lead to a similar drop in stock price. The price of our common stock could also be subject to wide fluctuations in the future as a result of a number of other factors, including the following:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in expectations as to future financial performance or buy/sell recommendations of securities analysts;</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our, or a competitor&#8217;s, announcement of new services, or significant acquisitions, strategic partnerships, joint ventures or capital commitments; and</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the operating and stock price performance of other comparable companies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the U.S. securities markets have experienced significant price and volume fluctuations. These fluctuations often have been unrelated to the operating performance of companies in these markets. Broad market and industry factors may lead to volatility in the price of our common stock, regardless of our operating performance. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, following periods of volatility in the market price of an individual company&#8217;s securities, securities class action litigation often has been instituted against that company. The institution of similar litigation against us could result in substantial costs and a diversion of management&#8217;s attention and resources, which could negatively affect our business, results of operations or financial condition.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our substantial debt could adversely affect our financial condition and prevent us from fulfilling our obligations under our outstanding indebtedness.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current substantial indebtedness and any future indebtedness we incur could adversely affect our financial condition. We are highly leveraged. As of December 31, 2020, our total combined indebtedness of term loans, capital leases and notes payable, excluding discount on term loan debt, was $662.4 million.  Term loan indebtedness, excluding related discount, was $662.4 million, of which the Barclays first lien term loans were $611.0 million and the SunTrust term loan was $51.4 million. Our substantial indebtedness could also:</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">make it difficult for us to satisfy our payment obligations with respect to our outstanding indebtedness;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">require us to dedicate a substantial portion of our cash flow from operations to payments on our debt, reducing the availability of our cash flow to fund working capital, capital expenditures, acquisitions and other general corporate purposes;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expose us to the risk of interest rate increases on our variable rate borrowings, including borrowings under our new senior secured credit facilities;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase our vulnerability to adverse general economic and industry conditions;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">place us at a competitive disadvantage compared to our competitors that have less debt; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limit our ability to borrow additional funds on terms that are satisfactory to us or at all.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to finance future needs or adapt our business plan to changes because of restrictions placed on us by our credit facilities and instruments governing our other indebtedness.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our credit facilities contain affirmative and negative covenants which restrict, among other things, our ability to:</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay dividends or make certain other restricted payments or investments;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">incur additional indebtedness and certain disqualified equity interests;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create liens (other than permitted liens) securing indebtedness or trade payables;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sell certain assets or merge with or into other companies or otherwise dispose of all or substantially all of our assets;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enter into certain transactions with affiliates;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create restrictions on dividends or other payments by our restricted subsidiaries; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">create guarantees of indebtedness by restricted subsidiaries.</span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of these restrictions could affect our ability to operate our business and may limit our ability to take advantage of potential business opportunities as they arise. A failure to comply with these covenants and restrictions would permit the relevant creditors to declare all amounts borrowed under the applicable agreement governing such indebtedness, together with accrued interest and fees, to be immediately due and payable. If the indebtedness under our credit facilities is accelerated, we may not have sufficient assets to repay amounts due under the credit facilities or on other indebtedness then outstanding.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be adversely impacted if there are deficiencies in our disclosure controls and procedures or internal control over financial reporting.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The design and effectiveness of our disclosure controls and procedures and internal control over financial reporting may not prevent all errors, misstatements or misrepresentations. While our management regularly reviews the effectiveness of our disclosure controls and procedures and internal control over financial reporting, there can be no guarantee that our disclosure controls and procedures or our internal control over financial reporting will be effective in accomplishing all control objectives all of the time. Deficiencies, including any material weakness, in our internal control over financial reporting that may occur in the future could result in misstatements of our results of operations, restatements of our financial statements, or otherwise adversely impact our financial condition, results of operations, cash flows, and our ability to satisfy our debt service obligations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to tax audits, challenges to our tax positions, or adverse changes or interpretations of tax laws.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to federal and applicable state income tax laws and regulations. Income tax laws and regulations are often complex and require significant judgment in determining our effective tax rate and in evaluating our tax positions. Our determination of our tax liability is subject to review by applicable tax authorities. Any audits or challenges of such determinations may adversely affect our effective tax rate, tax payments or financial condition. Recently enacted U.S. tax legislation, the most significant of which is the Tax Cuts and Jobs Act of 2017 (the "Tax Act") , made significant changes to federal tax law, including the taxation of corporations, by, among other things, reducing the corporate income tax rate, disallowing certain deductions that had previously been allowed, and altering the expensing of capital expenditures. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ultimate impact of the Tax Act may differ from our estimates due to changes in interpretations and assumptions made by us as well as potential amendments, technical corrections, and additional regulatory guidance that may be issued, and any such changes could have an adverse effect on our business, results of operations, financial condition and cash flow.  Furthermore, future related changes may occur at the state level that could result in unfavorable adjustments to our tax liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be required to recognize an impairment of our goodwill or other indefinite-lived intangible assets, which could have an adverse effect on our financial position and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognized an impairment of goodwill and trade name in our Imaging On Call reporting unit in the amount of $3.9 million for the year ended December 31, 2018.  During the current year of 2020 we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full.  We are required to perform impairment tests for goodwill and other indefinite-lived intangible assets annually and whenever events or circumstances indicate that it is more likely than not that impairment exists or that the carrying amounts of the assets may not be recoverable, we recognize an impairment. A decline in the Company's operating results, future estimated cash flows and other assumptions could impact our estimated fair values, potentially leading to a material impairment of goodwill or other indefinite-lived assets, which could adversely affect our financial position and results of operations. </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we have high fixed costs, lower scan volumes per system could adversely affect our business.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal components of our expenses, excluding depreciation, consist of debt service, capital lease payments, compensation paid to technologists, salaries, real estate lease expenses and equipment maintenance costs. Because a majority of these expenses are fixed, a relatively small change in our revenue could have a disproportionate effect on our operating and financial results depending on the source of our revenue. Thus, decreased revenue as a result of lower scan volumes per system could result in lower margins, which could materially adversely affect our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions of the Delaware General Corporation Law and our organizational documents may discourage an acquisition of us.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we could become the subject of an unsolicited attempted takeover of our company. Although an unsolicited takeover could be in the best interests of our stockholders, our organizational documents and the General Corporation Law of the State of Delaware both contain provisions that will impede the removal of directors and may discourage a third-party from making a proposal to acquire us. For example, the provisions:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">permit the board of directors to increase its own size, within the maximum limitations set forth in the bylaws, and fill the resulting vacancies;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorize the issuance of shares of preferred stock in one or more series without a stockholder vote;</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establish an advance notice procedure for stockholder proposals to be brought before an annual meeting of our stockholders, including proposed nominations of persons for election to the board of directors; and</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prohibit transfers and/or acquisitions of stock (without consent of the Board of Directors ) that would result in any stockholder owning greater than 5% of the currently outstanding stock resulting in a limitation on net operating loss carryovers, capital loss carryovers, general business credit carryovers, alternative minimum tax credit carryovers and foreign tax credit carryovers, as well as any loss or deduction attributable to a &#8220;net unrealized built-in loss&#8221; within the meaning of Section 382 of the internal revenue code of 1986, as amended.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to Section 203 of the Delaware General Corporation Law, which could have the effect of delaying or preventing a change in control.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_22"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Unresolved Staff Comments</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_25"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Properties</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters is located in adjoining premises at 1508, 1510 and 1516 Cotner Avenue, Los Angeles, California 90025, and approximately 21,500 square feet is occupied under these leases, which including options, expire June&#160;30, 2027. We also have a regional office of approximately 39,000 square feet in Baltimore, Maryland under a lease, which including options, expires September&#160;30, 2028. In addition, we lease approximately 52,000 square feet of warehouse space under leases nationwide, which expire at various dates, including options, through December&#160;31, 2028. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, we operated directly or indirectly through joint ventures with hospitals, 331 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York.  We lease the premises at which these facilities are located and do not have options to purchase the facilities we rent. Our most common initial term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at the facilities we lease. We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year. Rental increases can range from 1% to 10% on an annual basis, depending on the location and market conditions where we do business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, total square footage operated directly or indirectly under lease, including medical office, administrative and warehouse locations, was approximately 2.7 million square feet.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_28"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Legal Proceedings</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are engaged from time to time in the defense of lawsuits arising out of the ordinary course and conduct of our business. We believe that the outcome of our current litigation will not have a material adverse impact on our business, financial condition and results of operations. However, we could be subsequently named as a defendant in other lawsuits that could adversely affect us.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_31"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Mine Safety Disclosures</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_37"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Principal Trading Market</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is quoted on the NASDAQ Global Market under the symbol &#8220;RDNT&#8221;.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our capital stock and we do not expect to pay any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to finance the growth and development of our business. Our current credit facilities place restrictions on our ability to issue dividends. See discussion under &#8220;Liquidity and Capital Resources&#8221; regarding our current credit facilities. Payment of future dividends, if any, will be at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements and such other factors as the board of directors deems relevant.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plans Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item will be contained in our definitive proxy statement, to be filed with the SEC in connection with our 2021 annual meeting of stockholders, which is expected to be filed not later than 120 days after the end of our fiscal year ended December 31, 2020, and is incorporated in this report by reference.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares the yearly percentage change in cumulative total stockholder return of our common stock during the period from 2015 to 2020 with (i) the cumulative total return of the S&amp;P 500 index and (ii) the cumulative total return of the S&amp;P 500 &#8211; Healthcare Sector index. The comparison assumes $100 was invested on December&#160;31, 2015 in our common stock and in each of the foregoing indices and the reinvestment of dividends through December&#160;31, 2020. The stock price performance on the following graph is not necessarily indicative of future stock price performance.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This graph shall not be deemed incorporated by reference by any general statement incorporating by reference this Form 10-K into any filing under the Securities Act or under the Exchange Act, except to the extent that RadNet specifically incorporates this information by reference, and shall not otherwise be deemed filed under the Securities Act or the Exchange Act.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><img src="rdnt-20201231_g1.jpg" alt="rdnt-20201231_g1.jpg" style="height:480px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:41.462%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL RETURN PERCENTAGE<br/>Years Ending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company / Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/30/16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/29/17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/20</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RadNet, Inc.</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.37</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.59</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.69</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.61</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P 500 Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.96</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.83</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.49</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P Health Care Sector</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.69)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.08</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.47</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.82</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.45</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:29.975%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.651%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INDEXED RETURNS<br/>Years Ending</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Company / Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/30/16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/29/17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12/31/20</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RadNet, Inc.</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.37</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163.43</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164.56</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.48</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316.67</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P 500 Index</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111.96</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.42</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171.49</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.04</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">S&amp;P Health Care Sector</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.31</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.79</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.47</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.81</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.36</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Selected Consolidated Financial Data</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our selected historical consolidated financial data. The selected consolidated statements of operations data set forth below for the years ended December 31, 2020, 2019 and 2018, and the consolidated balance sheet data as of December 31, 2020 and 2019, are derived from our audited consolidated financial statements and notes thereto included in this annual report on Form 10-K. The selected historical consolidated statements of operations data set forth below for the years ended December 31, 2017 and 2016, and the consolidated balance sheet data set forth below as of&#160;December 31, 2018, 2017 and 2016, are derived from our audited consolidated financial statements not included herein. This data should be read in conjunction with and is qualified in its entirety by reference to the audited consolidated financial statements and the related notes included elsewhere in this annual report and Item 7 - &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial data set forth below and discussed in this annual report are derived from the consolidated financial statements of RadNet, its subsidiaries and certain affiliates. As a result of the contractual and operational relationship among Dr. Berger, Dr. Crues and the Company, we are considered to have a controlling financial interest in the Group pursuant to applicable accounting guidance. Due to the deemed controlling financial interest, we are required to include the Group as consolidated entities in our consolidated financial statements. This means, for example, that revenue generated by the Group from the provision of professional medical services to our patients, as well as the Group's costs of providing those services, are included as net revenue and cost of operations in our consolidated statement of operations, whereas the management fee that the Group pays to us under our management agreement with the Group is eliminated as a result of the consolidation of our results. Also, because the Group is consolidated in our financial statements, any borrowings or advances we have received from or made to the Group has been eliminated in our consolidated balance sheet. If the Group was not treated as consolidated entities in our consolidated financial statements, the presentation of certain items in our income statement, such as net service fee revenue and costs and expenses, would change but our net income would not, because in operation and historically, the annual revenue of the Group from all sources closely approximates its expenses, including Dr. Berger&#8217;s and Dr. Crues&#8217; compensation, fees payable to us and amounts payable to third parties.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:42.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands, except per share data)</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Statement of Operations Data:</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue and provider relief funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,098,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154,179&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975,146&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999,692&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802,377</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775,801</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,795&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,607&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,899&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,796</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,610</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on sale and disposal of equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,054)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,142</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of imaging center and medical practice</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,416)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on re-measurement of pre-existing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,539)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on return of common stock</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,032)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Meaningful use incentive</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(250)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,808)</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on extinguishment of debt</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,047)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to RadNet common stockholders</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,243&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,230</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic income per share attributable to RadNet common stockholders</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.18</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted income per share attributable to RadNet common stockholders</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,018&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,165&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,389&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,322&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,638&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786,657&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646,986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,109,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868,979</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">849,476</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,130,240&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,086,419&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669,560&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607,448</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642,082</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,413,847&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799,054</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">797,423</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital (exclusive of current operating lease liability)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,896)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,048)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,827)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,745</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,573</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,925</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,053</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations (&#8220;MD&amp;A&#8221;) is intended to help the reader understand the results of operations and financial condition of RadNet Inc. MD&amp;A is provided as a supplement to, and should be read in conjunction with, our consolidated financial statements and the accompanying notes included in this annual report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States based on number of locations and annual imaging revenue.  Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, often reducing the cost and amount of care for patients.  We have developed our medical imaging business through a combination of organic growth, acquisitions and joint venture formations, and derive substantially all of our revenue from fees charged for the diagnostic imaging services performed at our facilities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, facing the novel strain of the coronavirus ("COVID-19"), we began experiencing reduced procedure volumes at the end of the first quarter which intensified through mid year but did return to 90% of pre-COVID-19 pace in the third quarter and remained consistent throughout the fourth quarter.  To respond to the pandemic during the year we adjusted our business operations, inclusive of concentrating patient traffic to larger imaging centers, negotiating payment terms with vendors and landlords, initiating employee furloughs, compensation reductions, and telecommuting.  The arrival of the mRNA vaccine to protect against the virus is a welcome development.  As inoculations ramp up across the country and other mitigation procedures continue, we can begin to look forward to a return of normal business operations.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the impact of COVID, we continued to invest and position for future growth.  We continued to grow through acquisition, being a new entrant in Arizona marketplace and on the east coast adding to our presence in New Jersey and  the New York city area.  In our related businesses we increased our focus on Artificial Intelligence with our acquisition of DeepHealth Inc. while exiting our Imaging on Call teleradiology operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following table shows our facilities in operation at year end and revenues for the years ended December 31, 2020, 2019 and 2018:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facilities in operation</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue (millions)</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is derived from a diverse mix of payors, including private payors, managed care capitated payors and government payors. We believe our payor diversity mitigates our exposure to possible unfavorable reimbursement trends within any one payor class. In addition, our experience with capitation arrangements over the last several years has provided us with the expertise to manage utilization and pricing effectively, resulting in a predictable stream of revenue. Our service fee revenue, net of contractual allowances and discounts, implicit price concessions, and revenue under capitation arrangements for the years ended December 31, are summarized in the following table (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,035&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642,341&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,011&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,928&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,427&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,881&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,619&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,283&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,615&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,478&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,792&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,193&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,314&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,862&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,117&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,659&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,882&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging on call and software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,317&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,261&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,297&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,555&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,781&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ededed;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931,722&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028,236&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ededed;padding:0 1pt"></td><td colspan="2" style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868,741&#160;</span></td><td style="background-color:#ededed;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,118&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,943&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,405&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#e2e2e2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#e2e2e2;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e2e2e2;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#e2e2e2;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e2e2e2;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154,179&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e2e2e2;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975,146&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically experience some seasonality to our business. During the first quarter of each year we generally experience the lowest volumes of procedures and the lowest level of revenue for any quarter during the year. This is primarily the result of two factors. First, our volumes and revenue are typically impacted by winter weather conditions in our northeastern operations. It is common for snowstorms and other inclement weather to result in patient appointment cancellations and, in some cases, imaging center closures. Second, in recent years, we have observed greater participation in high deductible health plans by patients. As these high deductibles reset in January for most of these patients, we have observed that patients utilize medical services less during the first quarter, when&#160;securing medical care&#160;will result in significant out-of-pocket expenditures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The following table shows the number of systems that we had in operation as of the years ended December 31, 2020, 2019 and 2018:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">273&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CT</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PET/CT</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mammography</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ultrasound</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">689&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X-ray</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nuclear Medicine</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fluoroscopy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equipment</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,089</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,996</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,893</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Facility Acquisitions, Dispositions, Equity Investments and Formation of Joint Ventures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion summarizes certain details concerning our acquisition or disposition of facilities, our equity investment and our joint venture transaction.  See Note 4, Facility Acquisitions and Dispositions to our consolidated financial statements included in this annual report on Form 10-K for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facility acquisitions</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October and November 2020, we completed our acquisition of certain assets of ZP Atlantic LLC, and ZP Elmhurst LLC.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:54.970%"><tr><td style="width:1.0%"></td><td style="width:42.782%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.423%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Atlantic</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmhurst</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment</span></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,931&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,681&#160;</span></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of Use Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,181&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,571&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of Use Liabilities</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,181)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,571)</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</span></td><td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,871&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,269&#160;</span></td><td style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2020 we completed our acquisition of certain assets of AZ-Tech Radiology &amp; Open MRI, LLC, consisting of eight multi-modality imaging centers located in the Phoenix, Arizona area for purchase consideration of $5.5 million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $2.5 million in property and equipment, $7.6 million in right-of-use assets, $0.1 million in other assets, $7.6 million in operating lease liabilities, and $2.9 million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued 915,132 shares at $16.93 per share (823,615 issued at execution, with up to 91,517 shares to be issued 18 months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $34.6 million including i) 823,615 shares issued on the date of closing with fair value of $13.9 million, ii) a liability of 91,517 shares with a fair value of $1.5 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $2.0 million, iv) acquisition date fair value of contingent consideration of $17.0 million and v) $0.1 million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with 390,789, 586,184, and 195,393 shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We preliminarily recorded $0.1 million in current assets, $3.5 million in deferred tax liabilities, $14.8 million in intangible assets, primarily in-process research and development ("IPR&amp;D'), and $23.3 million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#8217;s assembled workforce and IPR&amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;D were determined by the income method and the assets will not be amortized until completion. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 2, 2020 our consolidated subsidiary New Jersey Imaging Networks ("NJIN") completed the acquisition of certain assets of MRI at Woodbridge, LLC consisting of a single multi-modality imaging center located in Avenel, New Jersey for cash consideration of $2.6 million.  NJIN made a fair value determination of the acquired assets and assumed liabilities and approximately $0.5 million in property and equipment, $1.1 million in right-of-use assets, $0.3 million in intangible assets, $1.1 million in operating lease liabilities, $0.1 million in finance lease liabilities, and $1.8 million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 2, 2020 we completed our acquisition of certain assets of Olney Open MRI, LLC, consisting of a single multi-modality imaging center located in Columbia, Maryland for cash consideration of $1.8 million.  We have made a fair value determination of the acquired assets and assumed liabilities and approximately $0.8 million in property and equipment, $1.3 million in right-of-use assets, $0.3 million in intangible assets, $1.3 million in operating lease liabilities and $0.6 million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019 we completed a step-up acquisition upon the dissolution of our former 49% owned joint venture, Garden State Radiology LLC ("GSRN").  GSRN consisted of two multi-modality centers operating in New Jersey.  GSRN became our wholly owned subsidiary with the withdrawal of the 51% majority partner for the full ownership of one center with no other consideration.  We made a fair value determination of our original 49% interest which resulted in a step-up gain of&#160; approximately $1.3 million. We determined a fair value of the remaining acquired imaging center of $3.1 million in assets and $0.4 million in liabilities were recognized.  We recorded $1.0&#160;thousand in other assets, $0.7 million in fixed assets, $0.4 million in right-of-use assets, $0.4 million in operating lease liabilities, and $2.0 million in goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019 we completed a step-up acquisition of our former 25% owned joint venture, Nulogix, via a stock issuance of RadNet common shares valued at $1.5 million to obtain the remaining 75% outstanding Nulogix shares. We made a fair value determination of the acquired assets and approximately $0.2 million in fixed assets, $0.7 million in intangible assets, $0.3 million in deferred tax liability and goodwill of $1.3 million were recorded.  We also made a fair value determination of our 25% pre-existing interest in the business and recognized a loss of $0.5 million which is included in operating expenses within the consolidated statements of operations. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019 we completed our acquisition of certain assets of Kern Radiology Imaging Systems Inc., consisting of four multi-modality imaging centers located in Bakersfield, California for purchase consideration of $19.3 million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $10.1 million in property and equipment, $9.7 million in right-of-use assets, $36.0&#160;thousand in other assets, $3.4 million in intangible assets, $14.5 million in operating lease liabilities, and $10.5 million in goodwill were recorded.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019 we completed our acquisition of certain assets of Zilkha Radiology Inc. consisting of two multi-modality centers located in Islip, New York for purchase consideration of $4.5 million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $2.2 million in property and equipment, $5.1 million in right-of-use assets, $0.1 million in intangible assets, $5.1 million in operating lease liabilities, $0.3 million  in finance lease liabilities and $2.6 million in goodwill were recorded.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2019, one of our Variable Interest Entities (VIEs), Lenox Hill Radiology and Medical Imaging Associates, P.C. ("LHR"), purchased the membership interest of Hudson Valley Radiology Associates, P.L.L.C. ("HVRA") for $6.0 million of RadNet common stock and contingent consideration valued at $0.7 million to guarantee the share value issued for a period of six months post acquisition date.  LHR has performed a fair value purchase price allocation and recorded equipment of $10.0&#160;thousand, a covenant not to compete of $50.0&#160;thousand, trade name of $0.4 million, other intangible assets of $0.3 million and goodwill of $3.1 million from the transaction. In connection with the acquisition, RadNet also settled against the purchase consideration, $2.8 million, net of taxes, of an unfavorable vendor contract with HVRA stemming from the previous acquisition of Radiologix, Inc. in November 2006. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2019, our majority owned subsidiary, West Valley Imaging Group, LLC ("WVIG") completed its acquisition of certain assets of West Valley Imaging Center, LLC ("West Valley"), consisting of a single multi-modality imaging center located in West Hills, CA for purchase consideration of $3.0 million all of which was initially funded by the Company.  We have made a fair value determination of the acquired assets and approximately $0.3 million in equipment and fixed assets, $7.0&#160;thousand in other assets, $0.2 million in intangible assets and $2.5 million in goodwill were recorded.  Subsequent to the transaction, our partner in WVIG, Cedars Sinai Medical Center, contributed $0.8 million in cash to maintain its 25% economic interest in the venture.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispositions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary for approximately $1.0&#160;thousand.  With this transaction, we have exited the teleradiology business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial 12.50% equity interest in Medic Vision - Imaging Solutions Ltd for $1.0 million. We also received an option to exercise warrants to acquire up to an additional 12.50% equity interest for $1.4 million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional 1.96% for $0.2 million. Our initial equity interest has been diluted to 12.25% and our total equity investment stands at 14.21%.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as we exercise no significant influence over Medic Vision&#8217;s operations, the investment is recorded at its cost of $1.2 million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was noted as of the year ended December 31, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million.  On January 1, 2019 we funded a convertible promissory note in the amount of $143,000 that converted to an additional 80,000 preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2020.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Formation of new joint ventures</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective November 1 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial oversight of our Arizona centers.  We hold a 49% economic interest and CHI holds 51% economic interest in ADRG and we account for the venture under the equity method.  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 13, 2019 we formed a wholly owned subsidiary, Ventura County Imaging Group, LLC ("VCIG").  On March 1, 2019, Dignity Health joined as a venture partner.  Total agreed contribution of both parties was $10.4 million of cash and assets with RadNet contributing net assets with a book value of $4.3 million for a 60% economic interest and Dignity Health contributing $6.1 million in cash and assets for a 40% economic interest.  For its contribution, RadNet transferred net assets of three wholly owned multi-modality imaging centers.  Dignity Health contributed approximately $0.8 million in assets to acquire 5% economic interest and paid RadNet $5.3 million for an additional 35% economic interest.  We maintain controlling economic interest in VCIG and fully consolidate the results into our financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of joint venture interest:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2017, we formed in conjunction with Cedars Sinai Medical Center (&#8220;CSMC&#8221;) the Santa Monica Imaging Group, LLC (&#8220;SMIG&#8221;), consisting of two multi-modality imaging centers located in Santa Monica, CA.  Upon formation, RadNet held a 40% economic interest and CSMC held a 60% economic interest.  RadNet accounts for our share of the venture under the equity method.  On January 1, 2019, CSMC purchased from us an additional 5% percent economic interest in SMIG valued at $0.1 million.  As a result of the transaction, our economic interest in SMIG has been reduced to 35%.  We recorded a loss of  $2.0&#160;thousand on the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in control of existing joint ventures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 6, 2014, we acquired a 49% equity interest in Garden State Radiology Network, LLC ("GSRN") for cash consideration of $2.2 million.  The venture consisted of two imaging centers located in New Jersey.  On August 1, 2019, the entity was dissolved by transferring ownership of the assets of the centers to the partners for no consideration, with each partner receiving full ownership of one center. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2018 we acquired&#160;25%&#160;share capital in Nulogix, Inc. for cash consideration of&#160;$2.0 million.  On August 1, 2019 we completed via the issuance of RadNet common stock valued at $1.5 million, the acquisition of the remaining 75% economic interest and we now consolidate the financial statements of Nulogix as a wholly owned subsidiary.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, for the periods indicated, the percentage that certain items in the statements of operations bears to net revenue for the years 2020, 2019 and 2018.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.0&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on re-measurement of pre-existing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on extinguishment of debt</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expenses (income)</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit from (provision for) income taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC.</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMMON STOCKHOLDERS</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.4)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December 31, 2020 Compared to the Year Ended December 31, 2019 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We grow through a combination of organic growth as well as acquisitions and joint ventures.  We have segregated some of our information to demonstrate which is attributable to centers that were in operation throughout the entirety of the comparison period, and which is attributable to centers that were acquired or disposed of during the period.  For the discussion below, same centers are those that were in continuous operation from January 1, 2019 through December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Revenue inclusive of Provider Relief Funding for 2020</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,098,104</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,154,179</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($56,075)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.9)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center Revenue</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,038,780</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,093,317</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($54,537)</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our procedure volumes for the year ended December 31, 2020 were affected by the COVID-19 pandemic, which precipitated an approximate 12.3% decrease in same center procedural volumes year over year. Mitigating the income decline is $26.3 million received in Provider Relief funding, which, per the official designation of the program, was used to offset lost revenues and incremental expenses.  This comparison excludes revenue contributions from centers that were acquired or divested subsequent to January 1, 2019. For the twelve months ended December 31, 2020, net service fee revenue from centers </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">that were acquired or divested subsequent to January 1, 2019 and excluded from the above comparison was $59.3 million. For the twelve months ended December 31, 2019, net service fee revenue from centers that were acquired or divested subsequent to January 1, 2019 and excluded from the above comparison was $60.9 million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses for the twelve months ended December 31, 2020 decreased approximately $21.9 million, or 2.0%, from $1.08 billion for the twelve months ended December 31, 2019 to $1.06 billion for the twelve months ended December 31, 2020.  The following table sets forth our cost of operations and total operating expenses for the twelve months ended December 31, 2020 and 2019 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and professional reading fees, excluding stock-based compensation</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591,338&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634,179&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and equipment rental</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,202&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,495&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical supplies</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">*</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,993&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,332&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">965,902&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">999,692&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,795&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,353&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062,420&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,084,301&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Includes billing fees, office supplies, repairs and maintenance, insurance, business tax and license, outside services, telecommunications, utilities, marketing, travel and other expenses.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;  Salaries and professional reading fees, excluding stock-based compensation and severance</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:31.5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Salaries and Professional Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$591,338</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$634,179</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($42,841)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$561,720</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$602,448</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($40,728)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)%</span></td></tr></table></div><div style="padding-left:31.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in salaries expense was a result of staff furloughs and payroll reductions initiated in response to the COVID-19 crisis and later sustained by the implementation of efficiencies garnered from a review of operational workflows.  This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2019.  For the twelve months ended December 31, 2020, salaries and professional reading fees from centers that were acquired or divested subsequent to January 1, 2019 and excluded from the above comparison was $29.6 million. For the twelve months ended December 31, 2019, salaries and professional reading fees from centers that were acquired or divested subsequent to January 1, 2019 and excluded from the above comparison was approximately $31.7 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stock-based compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation increased $3.7 million, or 42.1%, to approximately $12.4 million for the twelve months ended December 31, 2020 compared to $8.7 million for the twelve months ended December 31, 2019. This increase </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was driven by the higher fair value of RSA&#8217;s awarded and vested in the year ended December 31, 2020 as compared to RSA&#8217;s awarded and vested in the same period in 2019.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Building and equipment rental</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building &amp; Equipment Rental</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$108,202</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$106,495</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,707</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center </span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$99,483</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$98,482</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,001</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2019. For the twelve months ended December 31, 2020, building and equipment rental expenses from centers that were acquired or divested subsequent to January 1, 2019 and excluded from the above comparison was $8.7 million. For the twelve months ended December 31, 2019, building and equipment rental expenses from centers that were acquired or divested subsequent to January 1, 2019 and excluded from the above comparison was also $8.0 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Medical supplies</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.614%"><tr><td style="width:1.0%"></td><td style="width:39.272%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.806%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.810%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Supplies Expense</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$44,964</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$45,955</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($991)</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$40,894</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$42,384</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(1,490)</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.5)%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The drop in medical supplies expense was related to decreased use of contrast agents driven by volume reduction in our advanced imaging modalities of CT and PET, which were reduced a combined 10% year over year due to COVID-19.  This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2019. For the twelve months ended December 31, 2020, medical supplies expenses from centers that were acquired or divested subsequent to January 1, 2019 and excluded from the above comparison was $4.1 million. For the twelve months ended December 31, 2019, medical supplies expense from centers that were acquired or divested subsequent to January 1, 2019 and excluded from the above comparison was $3.6 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other operating expenses</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Operating Expenses</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$208,993</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$204,332</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,661</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$196,484</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$190,398</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,086</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in other operating expenses relates to higher billing fees and charges for outside services.  This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2019. For the twelve months ended December 31, 2020, other operating expense from centers that were acquired or divested subsequent to January 1, 2019 and excluded from the above comparison was $12.5 million. For the twelve months ended December 31, 2019, other operating expense from centers that were acquired or divested subsequent to January 1, 2019 was $13.9 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Depreciation and amortization</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%"><tr><td style="width:1.0%"></td><td style="width:39.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation &amp; Amortization</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$86,795</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$80,607</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,188</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Same Center</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$81,337</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$75,190</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,147</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2%</span></td></tr></table></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in same center depreciation and amortization is primarily due to additional equipment and leasehold improvements placed in service in the twelve months ending December 31, 2020 compared to the same period in 2019.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This comparison excludes expenses from centers that were acquired or divested subsequent to January 1, 2019. For the twelve months ended December 31, 2020, depreciation expense from centers that were acquired or divested subsequent to January 1, 2019 and excluded from the above comparison was $5.5 million. For the twelve months ended December 31, 2019, depreciation and amortization from centers that were acquired or divested subsequent to January 1, 2019 and excluded from the above comparison was $5.4 million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Loss on sale and disposal of equipment</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded a loss on the sale of equipment of approximately $1.2 million and $2.4 million for each of the twelve months ended December 31, 2020 and 2019, respectively.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Severance Costs</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incurred total severance expense of $4.4 million and $1.6 million for each of the twelve months ended December 31, 2020 and 2019, respectively, an increase of $2.7 million or 168.9%, which was related to payroll reduction charges.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Impairment Charges</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the current year of 2020, we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded impairment charges to our Imaging On Call reporting unit of $3.9 million for the twelve months ended December&#160;31, 2018, with goodwill representing $3.8 million of the total and the remainder being a write off the Imaging On Call trade name of approximately $100,000.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:36pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:73.684%"><tr><td style="width:1.0%"></td><td style="width:41.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">In Thousands</span></td><td colspan="12" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ Increase/(Decrease)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Interest Expense</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$45,882</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$48,044</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">($2,162)</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to derivatives*</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$6,206</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(1,125)</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest related to amortization**</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,413</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$4,184</span></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted Interest Expense***</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$35,263</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$44,985</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(9,722)</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)%</span></td></tr></table></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Includes interest on 2016 caps and 2019 swaps.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Includes combined noncash amortization of deferred loan coasts and discount on issuance of debt</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***Includes interest related to our term loans, revolving credit line,notes, finance leases and other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reduction in interest expense solely paid on our debt and lease obligations corresponds to lowered variable LIBOR and Prime interest rates paid on our term loan and revolving debt in reaction to market conditions surrounding COVID-19. See &#8220;Liquidity and Capital Resources&#8221; below for more details on our credit facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To mitigate our future interest expense exposure the Company has entered into a forward interest rate agreements. See the Derivative Instruments section of Note 2 to the consolidated financial statements included in this annual report on Form 10-K and ITEM 7a, Quantitative and Qualitative Disclosure About Market Risk below for more details on our derivative transactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in earnings from unconsolidated joint ventures</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December 31, 2020 we recognized equity in earnings from unconsolidated joint ventures of  $7.9 million versus $8.3 million for the twelve months ended December 31, 2019, a decrease of $0.4 million or 4.9%, related to market conditions stemming from the COVID-19 pandemic.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-cash change in fair value of interest rate hedge</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded expense of approximately $2.5 million for the ineffective portion of our 2019 swaps for the year ended December 31, 2020.  See the Derivative Instruments section of Note 2 to the consolidated financial statements included in this annual report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on re-measurement valuation of pre-existing interest</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August of 2019 we completed step-up acquisitions of two of our then equity method joint ventures, Garden State Radiology and Nulogix.  Upon the fair value determination of our interests in both ventures, we recognized a step-up gain of $0.8 million for the year ended December 31, 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gain on extinguishment of debt</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we met the eligibility requirements for forgiveness of loans received under The Paycheck Protection Program and recorded a gain on extinguishment of debt of approximately $4.0 million.  See Note 8 Credit Facilities and Notes Payable included in this annual report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other expenses </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended ended December 31, 2020 and December 31, 2019 we recorded approximately $0.1 million and $1.3 million of other expenses respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for income taxes</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had a provision for income tax for the twelve months ended December 31, 2020 of $0.9 million or 104.8% of income before income taxes, compared to a tax provision for the twelve months ended December 31, 2019 of $6.2 million or 21.0% of income before income taxes. Income tax decreased in 2020 primarily due to the economic effects of the COVID-19 pandemic on our operations. The income tax rates for the twelve months ended December 31, 2020 diverge from the federal statutory rate due to adjustments for leasehold improvements, equity method investments, and other liabilities. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December 31, 2019 Compared to the Year Ended December 31, 2018 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the comparison of results of operations for the year ended December 31, 2019 to the year ended December 31, 2018, please see Item 7, Management's Discussion and Analysis of Financial Condition and Operations in our Form 10-K for the year ended December 31, 2019, filed with the SEC on March 16, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use both GAAP and non-GAAP metrics to measure our financial results. We believe that, in addition to GAAP metrics, non-GAAP metrics such as Adjusted EBITDA and Free Cash Flow assist us in measuring our core operations from period to period as well as our cash generated from operations and ability to service our debt obligations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Adjusted EBITDA metric removes non-cash and non-recurring charges that occur in the affected period and provides a basis for measuring the Company&#8217;s core financial performance against other periods.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, as adjusted to exclude losses or gains on the disposal of equipment, other income or loss, loss on debt extinguishment, bargain purchase gains, loss on de-consolidation of joint ventures and non-cash equity compensation.&#160; Adjusted EBITDA includes equity earnings in unconsolidated operations and subtracts allocations of earnings to non-controlling interests in subsidiaries, and is adjusted for non-cash or one-time events that take place during the period.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a non-GAAP financial measure used as an analytical indicator by us and the healthcare industry to assess business performance, and is a measure of leverage capacity and ability to service debt. Adjusted EBITDA should not be considered a measure of financial performance under GAAP, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, cash flows generated by operating, investing or financing activities or other financial statement data presented in the consolidated financial statements as an indicator of financial performance or liquidity.  Adjusted EBITDA is not a measurement determined in accordance with GAAP and is therefore susceptible to varying methods of calculation and this metric, as presented, may not be comparable to other similarly titled measures of other companies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the nearest comparable GAAP financial measure, net income, to Adjusted EBITDA for the years ended December 31, 2020, 2019, and 2018, respectively (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to RadNet, Inc. common stockholders</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,243&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus interest expense</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,882&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,044&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,456&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus severance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,931&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,795&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,607&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,899&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus non-cash employee stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus loss on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,383&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus other expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus non-cash change in swap valuation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,528&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus legal settlement and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus gain on sale of equipment attributable to noncontroling interest</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus transaction costs EmblemHealth/ACP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus one time legal settlement</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">786&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus changes in the organization of east coast and international operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,101&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus loss on impairment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,170&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,937&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less gain on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,047)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less gain on sale and disposal of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,054)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less other income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less gain on re-measurement of pre-existing interest</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(768)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,539)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted EBITDA</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$139,461</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$164,131</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$141,756</span></td></tr></table></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Free Cash Flow</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another non-GAAP measure that we use is &#8220;Free Cash Flow&#8221;. We use free cash flow as an additional way of viewing our liquidity that, when viewed with our GAAP results, provides a more complete understanding of factors and trends affecting our cash flows, and consequently our ability to service debt and make capital expenditures. Free cash flow is used in addition to and in conjunction with results presented in accordance with GAAP and free cash flow should not be relied upon to the exclusion of GAAP financial measures.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define free cash flow as Adjusted EBITDA, less capital expenditures, and less the cash portion of our interest expense. We reconcile free cash flow to &#8220;net cash flows provided by operating activities&#8221;. We use free cash flow to conduct and evaluate our business because, although it is similar to cash flow from operations, we believe it is a more conservative measure of cash flows since purchases of fixed assets and the cash portion of our interest expense are a necessary component of our ongoing operations. In limited circumstances in which proceeds from sales of fixed assets exceed purchases, free cash flow could exceed cash flow from operations. However, since we do not anticipate being a net seller of fixed assets, we expect free cash flow to be less than operating cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow has limitations due to the fact that it does not represent the residual cash flow available for discretionary expenditures. For example, free cash flow does not incorporate payments made on capital lease obligations or cash payments for business acquisitions. Therefore, we believe it is important to view Free Cash Flow as a complement to our entire consolidated statements of cash flows.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of free cash flow to &#8220;net cash flows from operations&#8221; the most directly comparable amounts reported in accordance with GAAP for the years ended December 31, 2020, 2019 and 2018 (in thousands):</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,461&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,131&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,756&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less cash paid for interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,521)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,254)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,016)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less cash capital purchases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,758)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71,540)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72,180)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less new finance debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus proceeds from sale of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,575&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Free cash flow</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">13,990</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">47,446</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,135</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Free cash flow as a percent of</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">cash flow from operations</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6.0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">45.5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30.1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of Property Plant &amp; Equipment is adjusted for capital purchases of NJIN, which is excluded from our debt covenant calculation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key balance sheet data as of December 31, 2020 and December 31, 2019 and income statement data for the twelve months ended December 31, 2020, 2019 and 2018 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:61.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.340%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Data for the period ended December 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,018&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,165&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,585&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,763&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Working capital (exclusive of current operating lease liability)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,896)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25,048)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income Statement data for the twelve months ended December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154,179&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975,146&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to RadNet common stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,243&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a capital intensive, high fixed-cost industry that requires significant amounts of capital to fund operations. In addition to operations, we require a significant amount of capital for the initial start-up and development of new diagnostic imaging facilities, the acquisition of additional facilities and new diagnostic imaging equipment. Because our cash flows from operations have been insufficient to fund all of these capital requirements, we have depended on the availability of financing under credit arrangements with third parties.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID 19 pandemic has resulted in a reduction of procedure volumes and corresponding operating revenues for the year ended December 31, 2020.  We are uncertain of the duration and ultimate severity of its effects.  Although we took measures to reduce operating expenses and have received government stimulus funding, we may continue to experience decreased procedure volumes during the duration of the pandemic.  We have credit available from our current credit facilities and borrowing under those facilities is subject to continued compliance with lending covenants.  We currently meet those requirements, but substantial and sustained operating losses could impact our ability to borrow under those facilities.  If we are not able to meet such requirements, we may be required to seek additional financing and there can be no assurance that we will be able to obtain financing from other sources on terms acceptable to us, if at all.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a continuing basis, we also consider various transactions to increase shareholder value and enhance our business results, including acquisitions, divestitures and joint ventures. These types of transactions may result in future cash proceeds or payments but the general timing, size or success of any acquisition, divestiture or joint venture effort and the related potential capital commitments cannot be predicted. We expect to fund any future acquisitions primarily with cash flow from operations and borrowings, including borrowing from amounts available under our senior secured credit facilities or through new equity or debt issuances.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our subsidiaries or affiliates may from time to time, in our sole discretion, purchase, repay, redeem or retire any of our outstanding debt or equity securities in privately negotiated or open market transactions, by tender offer or otherwise.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Cash</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key components of our sources and uses of cash for the twelve  months ended December 31, 2020 and 2019:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.497%"><tr><td style="width:1.0%"></td><td style="width:66.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.092%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.411%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash Flow Data</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash provided by operating activities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,759&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,322&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(126,244)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,465)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,561)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,951&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For cash used in investing activities for the twelve months ended December 31, 2020, we purchased property and equipment for approximately $94.2 million, acquired imaging facilities for $31.3 million, made an equity contributions to joint venture of $1.6 million. We received proceeds from the sale of equipment of $0.8 million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash used in financing activities for the twelve months ended December 31, 2020 was mainly due to principal payments on our term loans.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018 and 2019 we entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. Payments on the associated notes receivables will be reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.  At December 31, 2020 we have&#160;$20.5 million, net of discount, remaining to be collected on these agreements.  We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Credit Facilities:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain secured credit facilities with Barclays Bank PLC and with SunTrust.  The Barclays credit facilities are comprised of first lien term loans and a revolving credit facility.  On August 28, 2020 we amended the Barclays credit facilities to increase the amount available under the revolving line of credit to $195.0 million.  The SunTrust credit facilities are comprised of a term loan and a revolving credit facility of $30.0 million. As of December 31, 2020, we were in compliance with all covenants under our credit facilities.  Deferred financing costs at December 31, 2020, net of accumulated amortization, was $1.8 million and is specifically related to our Barclays revolving credit facility.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our consolidated balance sheets at December 31, 2020 are $601.3 million of First Lien Term Loans and $51.4 million of SunTrust Term Loan Agreement debt for a combined total of $652.7 million (net of unamortized discounts of $9.7 million) in thousands:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barclays First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,028&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,699)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601,329&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,403&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,699)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,704&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at December 31, 2020 and had reserved an additional $7.3 million for certain letters of credit.  The remaining $187.7 million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2020.  We also had no balance under our $30.0 million SunTrust Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2020, and with no letters of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2020 we were in compliance with all covenants under our credit facilities. For more information on our secured credit facilities see Note 8 to our consolidated financial statements in this annual report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contractual Commitments</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future obligations for notes payable, equipment under finance leases, lines of credit, equipment and building operating leases and other contractual obligations for the next five years and thereafter include (dollars in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:29.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.913%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.037%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable (1)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,670&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,795&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573,938&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,403&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases (2)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,654&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,406&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases (3)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,307&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,479&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,648&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,686&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,469&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,112&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717,701&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143,631&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,993&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">657,600&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,699&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,473&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,114&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,383,510&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes variable rate debt for which the contractual obligation was estimated using the applicable rate at December 31, 2020.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes interest component of finance lease obligations.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Includes interest component of operating lease obligations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We have service agreements with various vendors under which they have agreed to be responsible for the maintenance and repair of a majority of our equipment for a fee that is based on the type and age of the equipment. Under these agreements, we are committed to minimum payments of approximately $34.0 million in 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Securities and Exchange Commission defines critical accounting estimates as those that are both most important to the portrayal of a company&#8217;s financial condition and results of operations and require management&#8217;s most difficult, subjective or complex judgment, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods.&#160;In Note 2 to our consolidated financial statements in this annual report on Form 10-K we discuss our significant accounting policies, including those that do not require management to make difficult, subjective or complex judgments or estimates. The critical areas involving management&#8217;s judgments and estimates are described below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF ESTIMATES - The financial statements were prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations, changes in business and economic conditions, and the frequent changes in managed care contractual terms resulting from contract re-negotiations and renewals.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROVIDER RELIEF FUND (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">COVID-19 STIMULUS FUNDING</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) - The Provider Relief Fund offers government assistance to eligible providers throughout the healthcare system in support of certain expenses or lost revenue attributable to the coronavirus pandemic. In the fourth quarter of 2020, we received approximately $0.6 million in funding and for twelve months ended December 31, 2020 we have received funding of $26.3 million. Generally, the department of Health and Human Services ("HHS") does not intend to recoup funds as long as a provider's lost revenue and increased expenses exceed the amount of provider relief funding one has received. HHS reserves the right to audit Relief Fund recipients in the future to ensure that this requirement is met and collect any Relief Fund amounts that were made in error or exceed lost revenue or increased expenses due to the pandemic. Failure to comply with the terms and conditions may be grounds for recoupment. During the year ended December 31, 2020, we continued to evaluate our operating results and gave consideration to the updated reporting guidelines issued in January 2021 by the U.S. Department of Health and Human Services that significantly changed the measurement of Provider Relief Fund distributions providers are able to retain. Based on our assessment recognition of the revenue previously recognized remained appropriate.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE - Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients.&#160;Services are generally provided pursuant to one-year contracts with healthcare providers. Receivables generally are collected within industry norms for third-party payors.&#160;We continuously monitor collections from our payors and maintain an allowance for bad debts based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATION &#8211; We evaluate all purchases under the framework in ASU No. 2017-01 (&#8220;ASU 2017-01&#8221;), Clarifying the Definition of a Business. Once the purchase has been determined to be the acquisition of a business, we are required to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES &#8211; Goodwill totaled $472.9 million and $442.0 million million at December 31, 2020 and December 31, 2019, respectively. Indefinite lived intangible assets at December 31, 2020 were $7.1 million and $11.3 million at December 31, 2019 and are associated with the value of certain trade name intangibles. Goodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of a reporting unit exceeds its fair value an impairment charge would be recognized and should not exceed the total amount of goodwill allocated to that reporting unit. We test for impairment annually and in addition to that test, we regularly assess if an event has occurred which would require interim impairment testing. We considered the current and expected future economic and market conditions surrounding the novel strain of coronavirus ("COVID-19") pandemic and during the year did not identify an indication of goodwill or trade name impairment due that event.  During the year we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full. Separate from this, our annual impairment </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">test as of October 1, 2020 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFERRED REVENUE - In April of 2020, we received approximately $39.4 million in advanced Medicare payments from the Centers for Medicare and Medicaid Services ("CMS") as part of the expanded Accelerated and Advance Payment Program under the Coronavirus Aid, Relief, and Economic Security (CARES) Act. As these payments are required to be repaid to CMS beginning 120 days after their receipt through offsets from new Medicare claims over a three month period, we have recorded amounts received to deferred revenue which will be amortized as Medicare reimbursements are earned. In addition, in May of 2020 we received $5.0 million in advance payments from an insurance carrier with similar repayment terms as the CMS.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES - Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income, including tax planning strategies, in determining whether our net deferred tax assets are more likely than not to be realized.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LONG-LIVED ASSETS - We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill and indefinite lived intangibles, for impairment whenever indicators of impairment exist. To evaluate the long-lived assets our management estimates the undiscounted future cash flows expected to be derived from the asset. The accounting standards require that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell. No indicators of impairment were identified with respect to our long-lived assets as of December 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEPRECIATION AND AMORTIZATION OF LONG-LIVED ASSETS - We depreciate our long-lived assets over their estimated economic useful lives with the exception of leasehold improvements where we use the shorter of the assets useful lives or the lease term of the facility for which these assets are associated. We estimate the economic useful lives of assets, other than leasehold improvements, to be between 3 and 15 years depending on the type of asset.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liabilities, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.  ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments. We use the implicit rate when readily determinable. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term. For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the ROU asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. Our ROU assets consist of facility and equipment assets on operating leases. No events have occurred such as fire, flood, or other acts which have impaired the integrity of our ROU assets in 2020. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the Restated Plan 14,000,000 shares of common stock. We can issue options, stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options and warrants generally vest over three to five years and expire five to ten years from date of grant.  The compensation expense associated with option grants is calculated based on a valuation model, typically the Black&#8211;Scholes model, which requires certain management assumptions with respect to volatility.  The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 11, Stock-Based Compensation, for more information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. We believe that the amount or any estimable range of reasonably possible or probable loss will not, either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Standards</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2020-04 on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ASU 2016-13 replaces the incurred loss methodology previously utilized for valuing financial instruments with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology.  We adopted the standard on January 1, 2020 using the modified retrospective approach.  See the Accounts Receivable section to Note 2 for further information on our allowances for credit losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15 (&#8220;ASU 2018-15&#8221;),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal-Use Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;ASU 2018-15 aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU was effective in the first quarter of 2020 with early adoption permitted and can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on our consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-03 ("ASU 2020-03"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this update represent changes to clarify or improve the codification and correct unintended application. ASU 2020-03 was effective immediately upon issuance and its adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13 ("ASU 2018-13"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard removes, modifies and adds certain disclosures related to recurring and nonrecurring fair value measurements. We adopted ASC 2018-13 effective January 1, 2020 and it had no effect on our disclosures.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 is effective beginning in the first quarter of 2021. Early adoption is permitted. Certain amendments in this update must be applied on a prospective basis, certain amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. We are currently evaluating the impact this ASU will have on our financial statements and related disclosures.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. We do not expect the adoption of this guidance will have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-01 provides clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2021-01 on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Subsequent Events</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $0.5&#160;million. RadNet contributed $0.3&#160;million in assets for a 60% economic interest and Simi Adventist contributed assets totaling $0.2&#160;million for a 40% economic interest.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over January and February 2021, we completed additional acquisitions of ZP companies in the New York City area for total purchase consideration of approximately $53.4&#160;million.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we received $6.2&#160;million in general distribution funds under the CARES Act.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information concerning RadNet, Inc., including our consolidated subsidiaries, for each of the years ended December 31, 2020, 2019 and 2018 is included in the consolidated financial statements and notes thereto in this annual report.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_46"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Quantitative and Qualitative Disclosures About Market Risk</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We receive payment for our services exclusively in United States dollars. As a result, our financial results are unlikely to be affected by factors such as changes in foreign currency, exchange rates or weak economic conditions in foreign markets.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain research and development facilities in Prince Edward Island, Canada and Budapest, Hungary for which expenses are paid in the local currency. Accordingly, we do have currency risk resulting from fluctuations between such local currency and the United States Dollar. At the present time, we do not have any foreign currency exchange contracts to mitigate this risk. At December 31, 2020, a hypothetical 1% decline in the currency exchange rates between the U.S. dollar against the Canadian dollar and the Hungarian Forint would have resulted in an annual increase of approximately $27&#160;thousand in operating expenses.&#160;</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Sensitivity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We pay interest on various types of debt instruments to our suppliers and lending institutions. The agreements entail either fixed or variable interest rates.&#160; Instruments which have fixed rates are mainly leases on radiology equipment. Variable rate interest obligations relate primarily to amounts borrowed under our outstanding credit facilities.&#160;Accordingly, our interest expense and consequently, our earnings, are affected by changes in short term interest rates. However due to our purchase of caps, described below, the effects of interest rate changes are limited.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, we had $611.0 million outstanding subject to an adjusted Eurodollar election on First Lien Term Loans. We can elect Eurodollar or Base Rate (Prime) interest rate options on amounts outstanding under the First Lien Term Loans.  At December 31, 2020, our effective 6 month LIBOR was 1.00%. A hypothetical 1% increase in the adjusted Eurodollar rates under the First Lien Credit Agreement over the current Eurodollar rate would result in an increase of $6.1 million in annual interest expense and a corresponding decrease in income before taxes. At December 31, 2020, we had an additional $9.7 million in debt instruments tied to the prime rate. A hypothetical 1% increase in the prime rate would result in an annual increase in interest expense of approximately $0.1 million and a corresponding decrease in income before taxes. These amounts are determined by considering the impact of the hypothetical interest rates on the borrowing costs and swap agreements. </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, we had $51.4 million outstanding subject to an adjusted Eurodollar election on the SunTrust Restated Credit Agreement. We can elect Eurodollar or Base Rate (Prime) interest rate options on amounts outstanding under the SunTrust Restated Credit Agreement.  At December 31, 2020 our effective LIBOR rate plus applicable margin was 2.22%. A hypothetical 1% increase in the adjusted Eurodollar rates under the SunTrust Restated Credit Agreement would result in an increase of approximately $0.5 million in annual interest expense and a corresponding decrease in income before taxes.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 Swaps"). The 2019 Swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of $200,000,000 each. The 2019 Swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the smaller notional and October 2025 for the larger notional. Under these arrangements, we arranged the 2019 Swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Financial Statements and Supplementary Data</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_52"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To the Stockholders and the Board of Directors of RadNet, Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Opinion on the Financial Statements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have audited the accompanying consolidated balance sheets of RadNet, Inc. and subsidiaries (the Company) as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive (loss) income, equity and cash flows for each of the three years in the period ended December 31, 2020, and the related notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with U.S. generally accepted accounting principles.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated March 16, 2021 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Adoption of ASU No. 2016-02</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 9 to the consolidated financial statements, the Company changed its method for accounting for leases in 2019 due to the adoption of Accounting Standards Update (ASU) No. 2016-02, Leases (Topic 842), and the related amendments.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Basis for Opinion</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Critical Audit Matters</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.081%"><tr><td style="width:1.0%"></td><td style="width:17.198%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Accounting for Revenue Recognition</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the year ended December 31, 2020, the Company&#8217;s service fee revenue was $931.7 million. As discussed in Note 2 to the consolidated financial statements, service fee revenue is based upon the estimated amounts the Company expects to be entitled to receive from patients and third-party payors (Medicare, Medicaid, managed care health plans and commercial insurance companies). Estimates of contractual allowances and implicit price concessions associated with third-party payors and any amounts due directly from patients, are based upon historical collection experience from such payors. The contractual estimation process is periodically reviewed to consider and incorporate updates to the laws and regulations, changes in business and economic conditions and contractual terms resulting from contract negotiations and renewals. The Company also records estimated implicit price concessions (based primarily on historical collection experience) related to amounts due directly from patients to record these revenues and accounts receivable at the estimated amounts the Company expects to collect.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing management&#8217;s estimates of contractual allowances and implicit price concessions was complex and judgmental due to the significant data inputs and subjective assumptions utilized in determining related amounts.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Addressed the Matter in Our</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Audit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls that address the risks of material misstatement relating to the measurement of service fee revenue. This included testing controls related to management&#8217;s review of the significant assumptions and inputs used in the determination of the estimated amount that would be collected for services rendered during the period. We also tested controls over the current and historical data used by management in determining this estimate, including the completeness and accuracy of the data.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test the estimated contractual allowances and implicit price concessions, we performed audit procedures that included, among others, assessing methodologies and evaluating the significant assumptions discussed above and testing the completeness and accuracy of the underlying data used by the Company in its estimates. We compared the significant assumptions used by management to current industry and economic trends and considered changes, if any, to the Company&#8217;s business and other relevant factors. We also assessed the historical accuracy of management&#8217;s estimates as a source of potential corroborative or contrary evidence.</span></div></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Acquisition of DeepHealth, Inc.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Description of</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">the Matter</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As discussed in Note 4 to the consolidated financial statements, the Company completed its acquisition of DeepHealth, Inc. for net consideration of $34.6 million on June 1, 2020. The transaction was accounted for as a business combination.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Auditing the Company&#8217;s accounting for its acquisition of DeepHealth, Inc. was complex due to the significant estimation required by management in determining the fair value of in-process research and development (&#8220;IPR&amp;D&#8221;) intangible assets of $14.5 million. The significant estimation was primarily due to the complexity of the valuation models used by management to measure the fair value of the IPR&amp;D intangible assets and the sensitivity of the fair value estimates to the significant underlying assumptions. The Company used an income approach to measure the fair value of the IPR&amp;D. The significant assumptions used to estimate the value of the IPR&amp;D intangible assets included discount rates and certain assumptions that form the basis of the forecasted results (e.g., revenue growth rates, EBITDA margin and obsolescence factors). These significant assumptions are forward looking and could be affected by future economic and market conditions.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.444%"><tr><td style="width:1.0%"></td><td style="width:16.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.253%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Acquisition of DeepHealth, Inc. continued</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">How We</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Addressed the Matter in Our</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Audit</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We obtained an understanding, evaluated the design, and tested the operating effectiveness of controls over the Company&#8217;s accounting for the acquisition. We tested controls over the recognition and measurement of consideration transferred and IPR&amp;D intangible assets, including the valuation model and underlying assumptions used to develop such estimates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To test the estimated fair value of the IPR&amp;D intangible assets, we performed audit procedures that included, among others, evaluating the completeness and accuracy of the underlying data and reasonableness of significant assumptions such as revenue growth rates, EBITDA margin and obsolescence factors. For example, we compared the forecasted results, derived based on the significant assumptions discussed above, to current industry, market and economic trends, to the assumptions used in other acquisitions and to other guidelines used by companies within the same industry. We involved our valuation specialists to assist in our evaluation of the methodology used and reasonableness of the significant assumptions.</span></div></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ Ernst &amp; Young LLP</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have served as the Company&#8217;s auditor since 2007. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Los Angeles, California</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March 16, 2021</span></div><div style="margin-top:1.1pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT ASSETS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNC0xLTEtMS0w_81a79e75-e8d0-40f4-822b-6a18684148dd">102,018</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNC0zLTEtMS0w_82728ad0-6469-4715-b4ba-52de9383e806">40,165</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNS0xLTEtMS0w_9ff6b6f9-94d4-444d-81b0-f60c4b6ddd76">129,585</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNS0zLTEtMS0w_4212a05f-99e7-4d20-b465-fda8ee9002e9">154,763</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due from affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueFromRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNi0xLTEtMS0w_b02f2749-39bf-4f24-8a9e-c780196f6ea3">5,836</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueFromRelatedPartiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNi0zLTEtMS0w_bddcf963-cb7b-4381-b01d-1e9fd64d971f">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNy0xLTEtMS0w_e223b7de-c00b-4de0-af06-100c4b54e9cb">32,985</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNy0zLTEtMS0w_9962060a-f412-446a-8037-90dd09eadff6">45,004</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfOS0xLTEtMS0w_b5d2d051-7c91-4256-931c-783ea3c76044">270,424</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfOS0zLTEtMS0w_5e8c5a50-dbb8-4062-ac06-a40232f8e9fd">241,174</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTEtMS0xLTEtMA_94602ec2-acb5-451f-95c8-4e6783802574">399,335</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTEtMy0xLTEtMA_bf8f6b59-c0d2-497a-8d93-81ab97f7c970">367,795</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use-assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTItMS0xLTEtMA_f656869f-2bbd-4da0-818c-da3017db58d0">483,661</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTItMy0xLTEtMA_fe227025-cc96-45df-9b96-7cd49caa32df">445,477</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property, equipment and right-of-use-assets</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTMtMS0xLTEtMA_953957d2-17d4-494b-a215-1ad55fc0c9fa">882,996</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTMtMy0xLTEtMA_79cd031a-cfce-4155-ad4c-7f11f0037fc9">813,272</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER ASSETS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTUtMS0xLTEtMA_335921e0-cd29-44bb-90fc-55abcac1c0f9">472,879</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTUtMy0xLTEtMA_7db9fdd8-8b98-49e2-b5e4-040d3331e41b">441,973</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTYtMS0xLTEtMA_ed056aca-7f30-4879-bdea-46088074e168">52,393</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTYtMy0xLTEtMA_ab7f84a9-4f8a-4467-ac01-3137cd11ce8c">42,994</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred financing costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTctMS0xLTEtMA_f9e93b04-471b-4a0b-8c62-5e55c7951138">1,767</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNoncurrentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTctMy0xLTEtMA_eb61bd90-bd22-438b-b683-f86a7c4dfd24">1,559</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTgtMS0xLTEtMA_2d07d7fa-fa37-4509-9ea6-adaf5239494b">34,528</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTgtMy0xLTEtMA_bdc6d0dc-1368-4e20-9ac2-5143dac9742a">34,470</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTktMS0xLTEtMA_f350e6c2-c7d7-4bab-aae0-cb15557431f2">34,687</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTktMy0xLTEtMA_500c7f77-b356-429b-a67f-18ddd760d5bb">34,548</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deposits and other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepositsAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjAtMS0xLTEtMA_cd1c28f9-aa47-499e-b0e5-9674aa84d555">36,983</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepositsAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjAtMy0xLTEtMA_9df41dfb-7b81-4dbb-af89-a587b37cbb73">36,996</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjEtMS0xLTEtMA_41f97540-953a-42b3-bff5-cbe3ea5186bf">1,786,657</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjEtMy0xLTEtMA_658bde59-a955-4415-a1a5-83ec1e221c61">1,646,986</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CURRENT LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjQtMS0xLTEtMA_51e3275c-3dc6-47b1-9eea-6fc9de533cac">236,684</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjQtMy0xLTEtMA_f310a5aa-4756-405a-b284-a92c58c19416">207,585</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to affiliates</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueToAffiliateCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjUtMS0xLTEtMA_eeaa7d8b-4062-44be-b67e-8024ff6555ba">14,010</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueToAffiliateCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjUtMy0xLTEtMA_8e2439dd-f229-46ed-9a26-84d71beb61d8">14,347</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjYtMS0xLTEtMA_445ccbcb-ba2b-49b2-a63d-83a1c5e85db6">39,257</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjYtMy0xLTEtMA_2e28b59a-557a-440d-98c6-860de3af1d03">1,316</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance lease liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjgtMS0xLTEtMA_1cc7a3ad-415c-4a29-8cd1-2751b514964e">2,578</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjgtMy0xLTEtMA_4f0bd617-04bf-4fb1-b06a-a85aeafcd776">3,283</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjktMS0xLTEtMA_d091b483-1ee4-4c41-b4be-68eee7195e60">65,794</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjktMy0xLTEtMA_dd95416c-0228-4a93-8583-c6ea1f652608">61,206</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzAtMS0xLTEtMA_fbfca8a9-c7a3-45de-822e-28ab943a72b1">39,791</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzAtMy0xLTEtMA_5659cefe-eada-475e-b3f7-7773ed875731">39,691</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzItMS0xLTEtMA_16df8354-162b-4b4f-9376-ddb03eff19f2">398,114</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzItMy0xLTEtMA_69f9a1f7-5e7a-4a11-9f4d-57578e47cead">327,428</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM LIABILITIES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term finance lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzUtMS0xLTEtMA_2bd10ce8-b8e3-4e76-98a9-0219e16f7356">743</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzUtMy0xLTEtMA_7b18a4fc-0dab-4e5f-97ec-1cba7cbd83b8">3,264</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liability</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzYtMS0xLTEtMA_007a7c16-df00-4942-8106-b54cd414fcc4">463,096</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzYtMy0xLTEtMA_309e4d1a-14c5-4030-9a74-93e3278acde2">420,922</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net of current portion</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzctMS0xLTEtMA_164eee0b-3a62-4e1c-8b93-35daca469d2d">612,913</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzctMy0xLTEtMA_0dc7815c-5163-4c1d-99bb-9cc568ff813b">652,704</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzktMS0xLTEtMA_f42dcce3-06f6-4819-936e-9f369f2d0740">53,488</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzktMy0xLTEtMA_da4cf9e0-af33-4adf-b664-8998163e6bb6">9,529</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDAtMS0xLTEtMA_9c51a4ae-02a7-4936-990f-8fcae6bbbb80">1,528,354</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDAtMy0xLTEtMA_7cd85802-f740-4075-bffb-b67bad033308">1,413,847</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RadNet, Inc. stockholders' equity:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock - $<ix:nonFraction unitRef="usdPerShare" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1MDA_97547f9d-bcfd-490a-8672-7877487932ca"><ix:nonFraction unitRef="usdPerShare" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1MDA_fc9f5980-a50f-4213-97df-dc7089846988">.0001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1MTU_511cf06b-8a48-4da1-ad47-a5caab8e0c25"><ix:nonFraction unitRef="shares" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1MTU_f52e9898-2c7c-4002-9519-f3489cd766bd">200,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1Mjg_1657fa9d-48cd-42b9-9815-b19ee4c1c01a"><ix:nonFraction unitRef="shares" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1Mjg_a96901e5-0708-4d0a-b7fc-fb00f24087f6">51,640,537</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1NDE_387dc9e4-d059-4f51-808e-4168a3a98ace"><ix:nonFraction unitRef="shares" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1NDE_613c5352-e7d5-4f08-bff6-da451220d5a2">50,314,328</ix:nonFraction></ix:nonFraction> shares issued and outstanding at December 31, 2020 and 2019 respectively</span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMS0xLTEtMA_a4e7ece8-906a-4096-a8d9-36f6a94315cd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMy0xLTEtMA_845a66d5-f231-4d4c-8282-108dcc93d9f6">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDQtMS0xLTEtMA_7a3ebe74-c7e1-4b5b-956c-8d097cd5bf9f">307,788</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDQtMy0xLTEtMA_f266ad31-1948-46bd-b78f-1d6ed9940ac1">262,865</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDUtMS0xLTEtMA_52d8c914-c1ac-4d4a-b273-76e439f842ef">24,051</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDUtMy0xLTEtMA_276df60a-80f2-42d5-9e47-11ced68cc02d">8,026</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDYtMS0xLTEtMA_41473ae8-9468-457b-b2ea-a2c5d55303f0">117,999</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDYtMy0xLTEtMA_48a9ca8e-5436-41f0-8985-79a81c0515de">103,159</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total RadNet, Inc.'s stockholders' equity</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDctMS0xLTEtMA_b852ee06-446e-4df8-b8fe-042affb0a8d9">165,743</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDctMy0xLTEtMA_392c281a-7290-4c6a-b4b0-ed4ad81c1b7a">151,685</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDgtMS0xLTEtMA_dd2a0c83-6203-4453-986e-e35d51e90816">92,560</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDgtMy0xLTEtMA_c24f2d97-cee9-4180-adb7-0b3714f267a1">81,454</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDktMS0xLTEtMA_5129661f-5998-4017-bf39-6bf582013845">258,303</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDktMy0xLTEtMA_93925b38-83ff-4da8-90d2-999e612997f9">233,139</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNTAtMS0xLTEtMA_2ed8e920-51b4-4e85-af7e-e888557a9bf1">1,786,657</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNTAtMy0xLTEtMA_592c79a9-724f-49d9-a571-026d58fc9cee">1,646,986</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE AND PER SHARE DATA)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91cab1d2676f4c75984b340531fdb510_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNS0xLTEtMS0w_6f07de40-d92d-43bb-a490-b23e8a0dac5f">931,722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb4b5f80227407994e895e9fdf49c2c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNS0zLTEtMS0w_9a42ac4e-e38a-49ba-97f4-d167d63a3d41">1,028,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d43f26e4d4788b2228afca82d6341_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNS01LTEtMS0w_7f9c82c3-08b8-48b8-93e8-a945e98c1a21">868,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cb6103e98c484a80f4c648cf9a807a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi0xLTEtMS0w_8c884659-6dcb-46e5-8db6-aac158797ae9">140,118</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8d37678bac4561b537c7457bdd558b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi0zLTEtMS0w_55b38fd8-9ad4-4261-990e-b1789ea6fc5a">125,943</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6ce5fe36734a9a814d0f68137a31b0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi01LTEtMS0w_8c3ff17a-2763-4e4d-934c-adabe6efa7de">106,405</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNy0xLTEtMS0w_f585c198-af12-4287-b169-bad4d58b6629">1,071,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNy0zLTEtMS0w_13d289dd-00f9-4c35-b0fc-8b0b3ea7108c">1,154,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNy01LTEtMS0w_1a10aaab-aac0-42dd-bfd2-9f6d1aed5eb1">975,146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider relief funding</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueNotFromContractWithCustomer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi0xLTEtMS0yNjg3_c75629b7-d6fa-4880-b7df-4d9288764e0e">26,264</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueNotFromContractWithCustomer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi0zLTEtMS04MTY5_bce8345f-1346-49a4-aac6-5f6df952f2d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueNotFromContractWithCustomer" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi01LTEtMS04MTY5_41746b53-767d-4696-a607-f5fbd4fdea1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OPERATING EXPENSES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of operations, excluding depreciation and amortization</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfOS0xLTEtMS0w_9d488863-df69-4469-8275-dd5833bb368f">965,902</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfOS0zLTEtMS0w_65014e28-8d07-48cc-bc08-1f497ef5ba3f">999,692</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingCostsAndExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfOS01LTEtMS0w_89077501-f90d-4319-a4b7-e93167813c57">867,547</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTAtMS0xLTEtMA_0fdea395-25ea-4f5e-b550-c46e54d472f7">86,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTAtMy0xLTEtMA_a261dc1c-eb4e-4e21-9755-ffae4e6a7827">80,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTAtNS0xLTEtMA_73f351e9-9e47-499d-baa5-fa6bbd7f3335">72,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTEtMS0xLTEtMA_4f642166-f69a-45d2-877d-06e2c4aabebf">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTEtMy0xLTEtMA_13f7fe19-f2bc-4ab4-8b63-a7fc488ee163">2,383</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTEtNS0xLTEtMA_3ae9171f-fdc1-47ec-a48f-e68dcc3e0527">2,054</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTItMS0xLTEtMA_3f141138-4b9f-48f4-a281-52272fa101fc">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTItMy0xLTEtMA_db726c03-50ce-4164-9661-61b3322e50a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTItNS0xLTEtMA_46d8dd3e-dff1-43b4-a196-e5a7a6bc5369">3,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Severance costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTMtMS0xLTEtMA_24617a36-0144-4982-ba3e-83e3201a10ee">4,353</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTMtMy0xLTEtMA_ca2a1c7f-a5cc-4924-bf05-ae696962cc0a">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SeveranceCosts1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTMtNS0xLTEtMA_e61e7420-5162-4bcb-a06d-a576516a3a01">1,931</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTQtMS0xLTEtMA_ae7f7770-d727-4ded-a6a1-82fed5715718">1,062,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTQtMy0xLTEtMA_40151a93-e5b3-494b-b4b3-603ae254bda5">1,084,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTQtNS0xLTEtMA_916128ab-bc23-42d6-a564-f2d086785001">944,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME FROM OPERATIONS</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTUtMS0xLTEtMA_a9b6109c-4d49-4938-8fe7-9745b868b323">35,684</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTUtMy0xLTEtMA_b4855ac6-0a32-4b8b-a360-6a6846b540ad">69,878</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTUtNS0xLTEtMA_162d7b0a-9ec0-4d66-99d5-ac478e90eac8">30,886</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME AND EXPENSES</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTgtMS0xLTEtMA_6baad78b-0a8a-41e7-83f1-b0951e89e529">45,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTgtMy0xLTEtMA_bd9df417-e333-42a6-80f5-d99473444406">48,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTgtNS0xLTEtMA_d4821252-21bf-4d69-954d-8de7855ecd66">43,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktMS0xLTEtMA_55c40e81-df3f-4ab4-8b69-9ba4cc92aaf1">7,945</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktMy0xLTEtMA_a5ba5ed9-c9d0-4ac4-979d-25780421b8ca">8,350</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktNS0xLTEtMA_93524dbe-77f9-4608-8070-729b603bad5c">11,377</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktMS0xLTEtMjY5Mg_56a05377-da5b-46bd-b5be-428149f70abb">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktMy0xLTEtMjY5Ng_1afe12e2-b4dc-4b4a-9207-b2ed2ff3233c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktNS0xLTEtMjY5Ng_a563437a-fb51-48bd-84c0-51707cff8c4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on re-measurement of pre-existing interest</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="rdnt:GainLossonStepUpValuation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjAtMS0xLTEtMA_684fd0fa-e455-4212-8cd3-890d4f064e19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="rdnt:GainLossonStepUpValuation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjAtMy0xLTEtMA_286276c0-b527-4819-8e0a-1f704835018e">768</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:GainLossonStepUpValuation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjAtNS0xLTEtMA_aca7c47a-679c-48db-90d4-6643059c979b">39,539</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjEtMS0xLTEtMA_e8a01097-a1b3-490a-941e-736dcb604492">4,047</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjEtMy0xLTEtMA_ee62ec58-c58c-493e-a5fc-96b08384ee09">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjEtNS0xLTEtMA_29a69d31-3cbe-4134-9a23-ee2eddd861a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expenses (income)</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjItMS0xLTEtMA_207286d9-d617-4f86-baa5-125e7188aa6d">120</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjItMy0xLTEtMA_1ee0dd0d-fd12-4ba4-975b-5c43e7f2a8fa">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjItNS0xLTEtMA_0fc484d0-e138-4d92-9218-3ca012c1e0e8">181</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other expenses (income)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjMtMS0xLTEtMA_5c6a3f8c-f1c1-4ac1-a92f-c8676909b8e0">36,538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjMtMy0xLTEtMA_008bf3e9-2cd3-4820-93b3-cc13519c18fc">40,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjMtNS0xLTEtMA_dd50dcef-14b0-41f4-8cf0-5b569c40aa82">7,641</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(LOSS) INCOME BEFORE INCOME TAXES</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjQtMS0xLTEtMA_96a859b1-eac9-494f-9b05-eff10d896c61">854</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjQtMy0xLTEtMA_01e3c4cb-f5be-4a92-ae04-0772d86ec926">29,669</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjQtNS0xLTEtMA_e6836949-683c-4ebc-92d3-9b62d7ce2371">38,527</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjUtMS0xLTEtMA_57dee9ee-43dc-4822-bf03-e4adc140f830">895</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjUtMy0xLTEtMA_fce0eeeb-682f-46f5-9e89-b9cfcc9c0332">6,229</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjUtNS0xLTEtMA_6e52e15d-af9a-45e6-9331-e1dcc97a00ab">394</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET (LOSS) INCOME</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjYtMS0xLTEtMA_8da033af-7b5a-4640-b9ae-58bb2efb0916">1,749</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjYtMy0xLTEtMA_acb40148-56ca-4d7a-b91d-a5001061ad4e">23,440</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjYtNS0xLTEtMA_10fef2b6-11f5-4c95-ba75-d757bf17ee51">38,133</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjctMS0xLTEtMA_7353eb7c-77ff-46c1-b1f1-491844e0a27d">13,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjctMy0xLTEtMA_214ce95d-ab6d-445f-abcb-8441d88f5a09">8,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjctNS0xLTEtMA_d14180e7-fd0f-4e59-bcfc-db51b8f86d87">5,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjktMS0xLTEtMA_fe91ba44-b4b8-439c-8b23-bbc8ba7c6b79">14,840</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjktMy0xLTEtMA_50255600-25b9-4153-abbd-8d2aa3ab078a">14,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjktNS0xLTEtMA_49bb9b4d-1d28-4284-92aa-79794edb0437">32,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzEtMS0xLTEtMA_2b79a7be-701c-4435-96dd-7548a7359afc">0.29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzEtMy0xLTEtMA_478d50bd-653f-48f4-9359-c18b35dc4aed">0.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzEtNS0xLTEtMA_9e81e679-534c-4329-a809-e27fe8d2a13c">0.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzMtMS0xLTEtMA_f52e53f0-2c6e-45c0-8e8a-d6dfe325bf16">0.29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzMtMy0xLTEtMA_ab90daec-9ffd-43e1-a009-45898079227d">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzMtNS0xLTEtMA_996d9afa-dca4-40cc-8b59-bd5667813bce">0.66</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WEIGHTED AVERAGE SHARES OUTSTANDING</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzYtMS0xLTEtMA_f7403caa-5d30-4bcd-9cf6-76a281aa0764">50,891,791</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzYtMy0xLTEtMA_81a1d2a3-e3ee-4981-875d-82f35373ff22">49,674,858</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzYtNS0xLTEtMA_cc5f5b03-65f6-4236-a60b-840b8c0782e8">48,114,275</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzctMS0xLTEtMA_0da89059-fa40-4252-af6d-bea63f549df4">50,891,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzctMy0xLTEtMA_d8e25b6c-f236-45f3-a566-6909d4ebba20">50,244,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzctNS0xLTEtMA_0624d49d-404d-43ba-9f72-af08dbbef2ab">48,678,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET (LOSS) INCOME</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMi0xLTEtMS0w_34a85374-abd2-4e1e-8f06-b58a0eb30bbd">1,749</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMi0zLTEtMS0w_5da04bcb-8716-4b67-b05b-f203a838be53">23,440</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMi01LTEtMS0w_5efed053-1709-42a3-b2e4-1c76ca46e6c9">38,133</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMy0xLTEtMS0w_cbf5f794-447c-4ddb-a956-a282dd41ca32">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMy0zLTEtMS0w_3acc5901-1b5b-41c9-bb02-9f4dd0952fdd">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMy01LTEtMS0w_00065286-5434-4b05-acb4-01f4cf4a15fa">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge, net of taxes</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNC0xLTEtMS0w_50e40fca-106b-4410-b67b-2dadb33288fe">19,372</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNC0zLTEtMS0w_6c46fe16-e525-4fdb-b5cd-47a21e0ae102">10,253</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNC01LTEtMS0w_9619d481-34b9-44f8-bc29-e9dc0d97b6b5">2,876</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS0xLTEtMS0yNjI0_27f6b73d-950a-498e-8012-e923c207b550">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS0zLTEtMS0yNjI0_7793fcf7-3e4a-41a2-af75-5d8bdefece81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS01LTEtMS0yNjI0_e5ba7e24-b194-4593-b79b-60ecb6099c62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#dbdbdb;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE (LOSS)  INCOME</span></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS0xLTEtMS0w_4fe1981f-4dfb-42e3-96d7-b6bcef9a88ba">17,774</ix:nonFraction>)</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS0zLTEtMS0w_91b58cb1-135b-4416-8cdc-58a7fbb71029">13,155</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="2" style="background-color:#dbdbdb;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS01LTEtMS0w_8c1b1700-e986-43af-9791-13c9252878a2">40,940</ix:nonFraction>&#160;</span></td><td style="background-color:#dbdbdb;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less comprehensive income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNi0xLTEtMS0w_e488acbc-ddd0-427a-af62-62d454e6133c">13,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNi0zLTEtMS0w_fcbd6438-bb3c-4aa8-a192-b76e99c6c8ca">8,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNi01LTEtMS0w_919bb3a5-2921-42b6-81c0-14ebac27884f">5,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td><td colspan="3" style="background-color:#dbdbdb;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COMPREHENSIVE (LOSS) INCOME  ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfOC0xLTEtMS0w_fc1acf7d-224e-4757-a636-94e8068826da">30,865</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfOC0zLTEtMS0w_f5ebbdcc-3ed8-45de-9601-509fc646f0c0">4,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfOC01LTEtMS0w_e0bbd59d-0420-4fb3-b494-4ced50750490">35,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENT OF EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS EXCEPT SHARE DATA)&#160;</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Additional</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Radnet, Inc.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Paid-in</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Comprehensive</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accumulated</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stockholders'</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Noncontrolling</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Loss) Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Equity</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - JANUARY 1, 2018</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibb4c0755ae114d328c14dac7820d1e90_I20171231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItMS0xLTEtMA_b800759e-87ff-447f-af97-37363f27a256">47,723,915</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb4c0755ae114d328c14dac7820d1e90_I20171231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItMy0xLTEtMA_5fa4ca6c-0d0a-4491-930a-2eff61315bf3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dc4ab6f79444662b0f8c57ff6fbf123_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItNS0xLTEtMA_8eb73383-698c-4a9e-b5b4-8f54daca4d41">212,261</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5e6c5ca93f94736bb1c3bfc63efbccf_I20171231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItNy0xLTEtMA_713a7e3a-0575-44e0-b495-9b33eed519bd">548</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i023faad94c6344268f372203aa84692b_I20171231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItOS0xLTEtMA_1c217ea8-1822-4149-aaff-7c00ebf5dfdc">150,158</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf6a4235673d476da3ca1a82e301b586_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItMTEtMS0xLTA_02c4a1ef-262a-46df-9dfe-8a829190fb11">61,560</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8189d3507f114e55b1eb07765a0f8fdb_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItMTMtMS0xLTA_4aa8d5c9-2288-45c8-9b14-74bae842a9b3">8,365</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4642cbc638c646e88712849889f662b5_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItMTUtMS0xLTA_bbd9ca4b-6dc6-4a5a-8ba9-9b344d17ace1">69,925</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b406d963f1849e7bc859162bb04f9c4_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTMtMS0xLTEtMA_cc007417-2953-494e-9313-078a8d44a898">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTMtNS0xLTEtMA_eaedcd4e-c324-4420-94c8-028a566f6234">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTMtMTEtMS0xLTA_61130ba6-98c9-4a86-926b-2bd84fbeb7ca">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTMtMTUtMS0xLTA_840f52cc-0749-4c35-ac30-c1076a0acef5">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b406d963f1849e7bc859162bb04f9c4_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTQtMS0xLTEtMA_fb73eff0-2f3a-43d4-bcda-848d3bdf1610">713,160</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTQtNS0xLTEtMA_00031024-968a-44bb-a19b-f787b8c4dfe4">7,719</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTQtMTEtMS0xLTA_a6526b5e-fba4-4816-8a75-050041a4023b">7,719</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTQtMTUtMS0xLTA_bc7295b7-3f41-4650-b11a-15a157fb99ee">7,719</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeiture of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i6b406d963f1849e7bc859162bb04f9c4_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTUtMS0xLTEtMA_ef6b676d-2c3e-4b4c-b379-a637c0f0672a">1,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTUtNS0xLTEtMA_f87a7ca4-d819-4237-94b0-23fa621b9dff">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTUtMTEtMS0xLTA_d530c8a2-c390-4cfd-99b3-8093a5aa65c6">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTUtMTUtMS0xLTA_e2add45e-2dc6-4963-bab4-a66435b7ae31">7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock for acquisitions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6b406d963f1849e7bc859162bb04f9c4_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTYtMS0xLTEtMA_02d6ca22-1332-49b6-8976-99b00f81aaa9">531,560</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTYtNS0xLTEtMA_b43f6fcc-0d61-46e3-b121-0bb83ee9f62c">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTYtMTEtMS0xLTA_1a99b2ed-324a-4cc6-811d-eb70c4e99bee">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTYtMTUtMS0xLTA_4f886e94-de1a-472a-af2e-d90fcda5a28f">8,000</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sale to noncontrolling interests, net of taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTctNS0xLTEtMA_14afaa80-86fb-49cc-9f6a-521e2304c395">11,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTctMTEtMS0xLTA_ff3f3bea-77f3-4ae4-bfdf-73bae7a05d7e">11,991</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTctMTMtMS0xLTA_1fe06322-6052-4945-9632-70a91f3adcbb">22,666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTctMTUtMS0xLTA_b798882c-daa2-46e9-b81a-68f7b558d87e">34,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Special distribution from noncontrolling interest</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTgtNS0xLTEtMA_70b35377-0332-49a0-810d-dbdcc532a5f3">2,894</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTgtMTEtMS0xLTA_5b2c76cf-c009-423c-910e-e738afcda84f">2,894</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTgtMTMtMS0xLTA_31a94ced-e94c-4a66-ba85-a98d685204a9">9,175</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTgtMTUtMS0xLTA_24b0029b-3360-4fda-b4c1-c5ce6b929dca">6,281</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Purchase of noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTktNS0xLTEtMA_908a5cb1-d520-42b3-be4c-698aba04bd82">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTktMTEtMS0xLTA_cbec997e-255e-44d7-8fe7-4c411012d617">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTktMTMtMS0xLTA_3f9cd49e-7deb-45e0-9c56-fb96799035b7">157</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTktMTUtMS0xLTA_a9121790-1b4e-462d-a550-898593b83c82">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:ContributionsFromNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjAtMTMtMS0xLTA_67c8db07-aa2f-4848-a8d8-b92b279366e1">2,640</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:ContributionsFromNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjAtMTUtMS0xLTA_c9b7a556-d60b-4898-98a8-f90b0d738a23">2,640</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling&#160;interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjEtMTMtMS0xLTA_9560c5f8-77ef-40b9-9c30-76c8268fa991">1,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjEtMTUtMS0xLTA_fc6b702e-7a97-4171-b2ff-ef46f7cea1c8">1,427</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Re-measurement of noncontrolling interest upon change in control</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:IncreaseInNoncontrollingInterestDueToStepAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjItMTMtMS0xLTA_5220d4c3-9f49-4a9f-b781-8b7c9f9801d7">44,267</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:IncreaseInNoncontrollingInterestDueToStepAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjItMTUtMS0xLTA_cf03f716-da73-44f9-a4fd-7917a90c4765">44,267</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ided679c17b004e37bf6e8caf9a77bfb8_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjMtNy0xLTEtMA_5d867a78-468e-426b-9340-a60f917a3ba2">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjMtMTEtMS0xLTA_56f62a65-9928-458d-951c-855747c6f740">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjMtMTUtMS0xLTA_21e78537-5187-4032-999b-3be49fa15185">69</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value cash flow hedge,&#160;net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ided679c17b004e37bf6e8caf9a77bfb8_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjQtNy0xLTEtMA_f94c43bb-21a8-4ec7-9d23-74b7f6d90c28">2,876</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjQtMTEtMS0xLTA_a4927f8a-c258-4bbb-9e92-5fa4c9bff605">2,876</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjQtMTUtMS0xLTA_db44dea8-80c5-4833-819f-20bd25371b54">2,876</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if58d2cdaa8dc40528b9291019c26a4d5_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjUtOS0xLTEtMA_869324c3-804c-464e-b9ea-21542b832ccc">32,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjUtMTEtMS0xLTA_ffec13bf-c1ac-4662-8af3-b8eec161fb5b">32,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjUtMTMtMS0xLTA_33436f9f-b9b9-4f96-b0bc-fa6407664297">5,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjUtMTUtMS0xLTA_dd6c9237-5a6e-4138-bc48-657e10e78f78">38,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2018</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3b1f19594f8442296a0ad23c159cb2f_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtMS0xLTEtMA_59a4a4b4-51f3-4117-9359-b656ac36dbf1">48,977,485</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3b1f19594f8442296a0ad23c159cb2f_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtMy0xLTEtMA_47271fef-284a-4728-9d1f-90bf904f88de">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86f3f1e4adc845aa8ff6eecc119258e8_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtNS0xLTEtMA_717cd3c9-4ec7-4765-ab26-fc8bdea18353">242,835</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d7d69f790144635b6dfa34118ab2074_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtNy0xLTEtMA_515dce09-68db-4686-825a-1605fd812ce0">2,259</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e34bb1f702e49a0b37e15b35cc7d11e_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtOS0xLTEtMA_626ece2a-fa16-4b82-99df-607db1cfd666">117,915</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1a562ce319b492e8ddb3e7f62714b25_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtMTEtMS0xLTA_cecbacf6-e334-47e2-973f-67c8cfdf279d">127,184</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09006b479cba4028a203556db5818971_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtMTMtMS0xLTA_d5274b95-c33e-4939-a995-29828b2f67ef">73,069</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae6485d220c4366bf04745e679dee34_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtMTUtMS0xLTA_88797638-4dce-438c-8e75-d138ff4eca44">200,253</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock upon exercise of options</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjctMS0xLTEtMA_f77a3592-6c74-4f78-a944-af05c9cbe8a8">12,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjctNS0xLTEtMA_c159c338-4d51-4210-b323-802c6515a66f">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjctMTEtMS0xLTA_a65b7a4d-4ae7-4bcf-b2df-0cfbcc3c7fbd">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjctMTUtMS0xLTA_21231473-ae9e-45a1-a9c0-6c663fb6d5a3">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjgtMS0xLTEtMA_35bfaba6-23d3-458d-b103-beb299da075a">771,042</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjgtNS0xLTEtMA_0f5b147a-b557-4b2a-ba85-57b5ed0df0fe">8,735</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjgtMTEtMS0xLTA_9a909f2c-c103-40f7-b99f-580db8f7aeb4">8,735</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjgtMTUtMS0xLTA_7deb47c4-f9ee-49cc-ac11-6d8ac945474e">8,735</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Forfeiture of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjktMS0xLTEtMA_f297e70a-8254-43f0-96e1-b46ba63959df">1,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjktNS0xLTEtMA_5b81f1ea-1348-4721-88c3-f18dd40c5dde">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjktMTEtMS0xLTA_a95bb50e-cbeb-4073-a78b-14389e49fdc1">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjktMTUtMS0xLTA_f3b9e382-05e6-4898-a747-63e3d35664e0">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-cash severance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="rdnt:NonCashSeveranceShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtMS0xLTEtMA_0e21f6d5-332e-4b9b-a9c1-ce995f2a9b33">12,692</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231" decimals="-3" name="rdnt:NonCashSeverance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtNS0xLTEtMA_d7aea602-5d8c-44d5-a8fb-e3e8f2efd5e8">188</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231" decimals="-3" name="rdnt:NonCashSeverance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtMTEtMS0xLTA_27bc8661-b315-4d04-ae47-36dcd68c4674">188</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="rdnt:NonCashSeverance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtMTUtMS0xLTA_af30a186-4280-4d53-814f-80d9e9d40238">188</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of stock for acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtMS0xLTEtMA_e17a6fdd-81fb-473c-a6b4-a285af528f19">542,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtNS0xLTEtMA_546c61f0-5875-4ecb-9180-ca24e0560fa7">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtMTEtMS0xLTA_563475f4-4d0f-486d-b302-d9f6899fa114">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtMTUtMS0xLTA_c2459570-a9cf-47dd-b447-c3b926aad621">7,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Sale to noncontrolling interests, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItNS0xLTEtMA_eac134cb-b56d-4365-be67-43d81a0a4ceb">3,537</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItMTEtMS0xLTA_8fe42ca7-1d3e-41c0-95a4-b03c702e996e">3,537</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a7504cf2d24b3c95f46157e23014d6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItMTMtMS0xLTA_2691c10d-cd01-425d-baee-419f0e3eee7b">2,008</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItMTUtMS0xLTA_5bee75ac-e1f1-43a9-92a9-471dfc8e8618">5,545</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Contributions from noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a7504cf2d24b3c95f46157e23014d6_D20190101-20191231" decimals="-3" name="rdnt:ContributionsFromNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtMTMtMS0xLTA_7234280f-1272-46ea-b6b6-4a139f595064">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="rdnt:ContributionsFromNoncontrollingInterests" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtMTUtMS0xLTA_196983f5-e898-4951-bbe9-04284d0b0ec9">750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling&#160;interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56a7504cf2d24b3c95f46157e23014d6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTMtMS0xLTA_a880f519-b4a4-43a8-9122-9e25bb1bbbb4">3,057</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTUtMS0xLTA_50b86ff4-b966-4718-b1a7-15fc41c76b36">3,057</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency&#160;translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74beb185d82c45bb93d9dce1efe2e18e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtNy0xLTEtMA_327f1457-1422-414c-823c-9ecc406b8d8d">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtMTEtMS0xLTA_ad30c14e-dbc9-473b-925e-f2531a892dc2">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtMTUtMS0xLTA_545fe19c-bef5-47e7-84be-33ecc99a667b">32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value cash flow hedge,&#160;net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74beb185d82c45bb93d9dce1efe2e18e_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtNy0xLTEtMA_ed8bbe18-807c-43f3-91da-8a11e4f2edd7">10,253</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtMTEtMS0xLTA_217df6b9-b066-4749-ac2c-f321ee3dbb61">10,253</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtMTUtMS0xLTA_751ffbea-6b58-4d99-95d8-bff13b4e47ab">10,253</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica4a33e11a3249c8ad15dd466a5a1d51_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctOS0xLTEtMA_8033eeae-046f-4107-802d-a96b2b15576f">14,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctMTEtMS0xLTA_6b4058f4-eee4-4702-b170-171227ec2655">14,756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56a7504cf2d24b3c95f46157e23014d6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctMTMtMS0xLTA_34fe360d-a688-48c1-bce2-c017ee892946">8,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctMTUtMS0xLTA_99c1fcb9-7d6c-41f1-bffe-81b0bce88c09">23,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2019</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaface0b8920a4f0488a80ec15c2e0796_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMS0xLTEtMA_b5fc80a0-bc3e-4512-853b-c9c2224f1e1c">50,314,328</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaface0b8920a4f0488a80ec15c2e0796_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMy0xLTEtMA_fcf00887-8a4c-40b7-91b2-9f33d7604750">5</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7d78ac548ab47a6892df2497561bd63_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtNS0xLTEtMA_f618c692-dc22-43fd-b81a-aa0f5dc3fe91">262,865</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i86411c359d1a4e08bd83fa3becd2af69_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtNy0xLTEtMA_341b64dc-374f-4bc6-82ea-e41c3446d611">8,026</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id8cb870c78c7468b82991b63a957577f_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtOS0xLTEtMA_b59842d0-f0e9-4c86-a816-fbe9c19ed88d">103,159</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fe1e680ce184c668d237cef4fa45980_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTEtMS0xLTA_80577815-bf7c-4ef9-8391-0ff0c37f2af9">151,685</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia696c9fb613641ca908b22d1a1b6fda4_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTMtMS0xLTA_62119b44-b65f-4882-bffc-065e32ee2710">81,454</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTUtMS0xLTA_7afb80bb-4789-40d3-916e-05fd5d28663b">233,139</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Shares issued under the equity compensation plan</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6cc5dbf72ca544cd8fdd6e81e4269864_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtMS0xLTEtMjU1Nw_d33e21ca-221a-46e7-a62c-fe97484de1a6">491,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtMTUtMS0xLTI1NzM_747b4548-0d57-49df-a089-515a3c716f64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock under the DeepHealth equity compensation plan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99f93a3af86d4cf18e3b0b79c87477e8_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtMS0xLTEtMjU2MQ_a4b14915-dc24-472f-8faf-c1c5c52140dd">10,920</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac2767be8a5846ac88dc5a19d3c5cdd0_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtMTUtMS0xLTI1NzM_44c3438d-c530-439b-9278-662528f3cec5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia89915e83e8f47d7b74a40ecdf68fe96_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItNS0xLTEtMjU4OA_f6a26b76-5981-467a-9fb0-4f0e49aa2ef2">12,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItMTEtMS0xLTI1ODg_803b0d0b-426e-4a5a-ac47-3f78a998db82">12,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItMTUtMS0xLTI1ODg_5fcef480-46e2-46f0-8c97-ad844a07ddad">12,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Issuance of common stock for sale of unregistered securities for the DeepHealth acquisition</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99f93a3af86d4cf18e3b0b79c87477e8_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtMS0xLTEtMjU2NQ_96a44e00-59ff-49ac-b526-02d5bc8d4a45">823,615</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd9fc193c5854fdc93bcf728fb8b4b34_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtNS0xLTEtMjU5NA_0ad636ba-9184-4cb8-bbbd-78c1d6e567da">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4830b5a7c0d4df5923a89542ecd633a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtMTEtMS0xLTI1OTQ_0f6ff9b1-87e8-42a9-ace3-6564f2dad1b2">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac2767be8a5846ac88dc5a19d3c5cdd0_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtMTUtMS0xLTI1OTQ_49e7e097-b0b8-4c0d-b294-3076a19e6e0a">33,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Tax effect on gain on sale of noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia89915e83e8f47d7b74a40ecdf68fe96_D20200101-20201231" decimals="-3" name="rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtNS0xLTEtNzIxOA_0c6534aa-f439-44d2-8e04-17ed0861423c">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231" decimals="-3" name="rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTEtMS0xLTcyMTg_bd38820e-64bb-4805-b1d1-4e9bd8e6f010">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTUtMS0xLTcyMTg_59c2b7f8-11a3-4751-9336-9a084414e869">551</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1cd86610d3e409eb7e61fdffe0b0402_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTMtMS0xLTI2MDE_bbe1302e-3db3-4c1c-b74c-b2e83472dfba">1,985</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTUtMS0xLTI2MDE_bf8539a3-c6c5-4d99-8ec8-8f45abec6cc8">1,985</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in cumulative foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i416ef7c3fc3f4c4c990703d137b448b8_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtNy0xLTEtMjYwNg_27faad34-df62-4bfa-91e1-201f8b7e1b7e">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtMTEtMS0xLTI2MDY_02a24ec5-3f77-4a36-b091-5de4cd43b762">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtMTUtMS0xLTI2MDY_b6d09e81-89a1-4a7b-981a-1598d75b6b7e">101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value cash flow hedge, net of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i416ef7c3fc3f4c4c990703d137b448b8_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtNy0xLTEtMjYwNg_d03f724a-bae9-4fab-83bb-4a2a8cf79900">19,372</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtMTEtMS0xLTI2MDY_0b616f02-da33-4557-93b1-64e14fdd4ca0">19,372</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtMTUtMS0xLTI2MDY_ad60bcdd-0627-4372-a4e9-cb75b233ff73">19,372</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.685%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Change in fair value of cash flow hedge from prior periods reclassified to earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i416ef7c3fc3f4c4c990703d137b448b8_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctNy0xLTEtMjYwNg_357cf1e2-c6cc-46a8-b0a1-c5ea3942439b">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctMTEtMS0xLTI2MDY_c11b03f6-7e66-4a12-a639-84901bbed7db">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctMTUtMS0xLTI2MDY_dfd3f417-9beb-4915-a313-64a0ce775313">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19057998bb654587aa0fe2496a826358_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtOS0xLTEtMjYxMw_e21cb004-2c74-4e65-aeda-1ca0c44f34f4">14,840</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTEtMS0xLTI2MTM_78d27627-5940-4ec2-9e3d-9680926b39a8">14,840</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1cd86610d3e409eb7e61fdffe0b0402_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTMtMS0xLTI2MTM_4e73f71b-ff48-4ebc-9f2d-68a328f80374">13,091</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTUtMS0xLTI2MTM_95f9bb60-38ec-4f89-b775-c360c7a30155">1,749</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">BALANCE - DECEMBER 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3baa465341b441d8ae234bdc7ac7a2c0_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktMS0xLTEtMjU2OQ_bc3da239-827a-40a0-a2f8-4e9a5c1f67e5">51,640,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3baa465341b441d8ae234bdc7ac7a2c0_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktMy0xLTEtMjU2OQ_ab8a6250-fe01-4921-9192-1787243822b3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id829ecfe8db8402f80f8ee378ed8854e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktNS0xLTEtMjU2OQ_d11c637a-7179-4808-9a79-7b26c91efc04">307,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89e9405f6f814d8a9a3df0257feaca2a_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktNy0xLTEtMjU2OQ_3e2814b8-461d-4336-96bd-a3bc6b2d6ef6">24,051</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i314621482e04419e975d6e27278101d0_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktOS0xLTEtMjU2OQ_d5b1caac-b218-4748-b5f6-6833479f44b4">117,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac06a801037b41eea48e4721682546dc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktMTEtMS0xLTI1Njk_299e33fd-a69d-45be-8ecc-9e62f3052b1b">165,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief57d143117e41c48907a4d78682dee8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktMTMtMS0xLTI1Njk_a6327f59-347c-4df6-96d3-fdb1b41976f4">92,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktMTUtMS0xLTI1Njk_43fc0499-8b15-421f-a7bb-d0c4405f96a9">258,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_70"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(IN THOUSANDS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMy0xLTEtMS0w_a690f1f6-c0ac-42db-9ce0-3058e232b959">1,749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMy0zLTEtMS0w_4787fc70-fc12-44fb-bf4e-81dac791b4df">23,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMy01LTEtMS0w_85808450-6900-4e6b-9b4b-6eaa18fe841a">38,133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income&#160;to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNS0xLTEtMS0w_7bb7f3cc-1869-485b-a7ad-d8f6668dfd07">86,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNS0zLTEtMS0w_32c47142-ec41-4c78-8d4e-0e4f5d4e4eb9">80,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNS01LTEtMS0w_1b931e98-53a6-4708-81db-6d4c0b860d92">72,899</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:OperatingLeaseRightofUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNi0xLTEtMS0w_b28fb72f-3e8d-42c1-b2da-80d22c02426b">67,915</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:OperatingLeaseRightofUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNi0zLTEtMS0w_7a5c2bf1-1495-4c02-99ab-153b1efb69d2">66,842</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="rdnt:OperatingLeaseRightofUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNi01LTEtMS0w_aa305a04-bd98-4b15-bf45-66283241c817">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings of joint ventures, net of dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOC0xLTEtMS0w_97c3465c-070f-424e-b35c-8f8ba8566067">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOC0zLTEtMS0w_3a897a95-c178-4792-b7fd-fa58c7a5ad42">248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOC01LTEtMS0w_4830648d-3d33-44e9-8679-df931aa09402">13,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization and write off of deferred financing costs and loan discount</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOS0xLTEtMS0w_5e1c399b-a746-4b73-a059-602961b2de29">4,413</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOS0zLTEtMS0w_3b8d62b6-16bb-4fb1-ab3b-2fcb3f119b30">4,184</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOS01LTEtMS0w_f0b665f4-0043-43fb-9845-c15a53463077">3,898</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on sale and disposal of equipment and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTAtMS0xLTEtMA_0fafaa18-a9e3-43d8-b208-d435435f02ea">1,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTAtMy0xLTEtMA_b5c436d3-8993-4094-b529-eb93a5596494">2,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTAtNS0xLTEtMA_e0db9589-7673-44c7-b6fc-066f5cc1a667">2,054</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on extinguishment of debt</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTEtMS0xLTEtMA_15420bd4-df20-41e0-a087-0ab6d19a0f3d">4,047</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTEtMy0xLTEtMA_029a5480-b133-4ad5-b9fa-231070231468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTEtNS0xLTEtMA_3e732186-1538-4190-90d9-d311be4d2b33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on re-measurement of pre-existing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="rdnt:GainLossonStepUpValuation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTItMS0xLTEtMA_0f9c58dc-ab48-45a7-b32a-17992c4e0848">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="rdnt:GainLossonStepUpValuation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTItMy0xLTEtMA_6710b75e-dba3-4eb0-ab95-2db35e70fcd1">768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:GainLossonStepUpValuation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTItNS0xLTEtMA_44bb9b8a-ef9c-4299-a7bb-5732cf0e1082">39,539</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on impairment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtMS0xLTEtMA_c8935475-e400-48a2-a920-52be689b9160">4,170</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtMy0xLTEtMA_c2f2a732-6991-4866-b075-5221185b4eb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtNS0xLTEtMA_503d6c16-e69f-4759-86df-69a1a7f1d5fe">3,937</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of cash flow hedge</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtMS0xLTEtMjcyNQ_67cd0925-ffc9-49ce-9772-a8b717b6eb64">3,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtMy0xLTEtMjcyOQ_1d024de1-fd3f-46e9-a8c3-0e563c382986">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:AmortizationOfDeferredHedgeGains" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtNS0xLTEtMjcyOQ_cb615ba2-5721-4b65-b4b2-49fac2bdadd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash change in fair value of interest rate hedge</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtMS0xLTEtMjczMw_ce98cdbc-3201-4101-af83-2b4830a090dd">2,528</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtMy0xLTEtMjczMw_ebb183ad-30ca-4488-b251-bab92562d5f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtNS0xLTEtMjczMw_a2c1a646-d15a-4d54-a93e-5d6f2fc37a8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtMS0xLTEtMA_8cec152c-41a8-41ed-8a09-7e40b81a0eaf">12,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtMy0xLTEtMA_24c3d222-dd5b-45fa-8a27-a029d89e3553">8,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtNS0xLTEtMA_2f083040-79a2-42ef-9d1e-878f1d75645f">7,662</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non cash item in other expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" name="rdnt:IncreaseDecreaseInOtherNoncashItem" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTUtMS0xLTEtMA_c66f0a29-1c5b-40b1-9d3f-e4fa0a2d43fb">242</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="rdnt:IncreaseDecreaseInOtherNoncashItem" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTUtMy0xLTEtMA_e49c548c-be42-43ce-814a-3c3ca4c67fca">371</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="rdnt:IncreaseDecreaseInOtherNoncashItem" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTUtNS0xLTEtMA_c8ee35a1-c271-4d18-a4d5-5ea5df75bbe7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTctMS0xLTEtMA_f878b421-1291-4bb9-9a73-72de6acc27bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTctMy0xLTEtMA_60b79ef9-eab5-44f2-a379-3e452fd60d0e">3,123</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTctNS0xLTEtMA_39e46fb6-25b5-40a4-8ebe-b155240329e5">1,749</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTktMS0xLTEtMA_6326371c-98d3-4dcc-95b6-0b1d67379d7c">25,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTktMy0xLTEtMA_bf845ce8-6843-49d4-bebd-444e29d14cfc">17,482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTktNS0xLTEtMA_68f9ec5a-3bca-4c76-9eef-df105617bf8b">2,145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjAtMS0xLTEtMA_9809c9ba-0c7b-4edc-9d32-2918d2feb126">6,588</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjAtMy0xLTEtMA_f55a19b9-d953-4caa-9002-a0f6eb2e1c46">3,557</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherCurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjAtNS0xLTEtMA_ca0e55b6-0264-43da-9f12-1f614a458d10">9,248</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjEtMS0xLTEtMA_e2ea2ccb-0c83-4cfb-bc46-ab2e9e6083ed">5,425</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjEtMy0xLTEtMA_9201b247-1082-4ff9-ae2e-733fc75cf2fd">2,326</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjEtNS0xLTEtMA_4a5dc253-c9ed-43e6-ac0b-0f55131cf89c">1,687</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjItMS0xLTEtMA_96b69160-4200-41d9-9f22-44c8db462c4d">611</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjItMy0xLTEtMA_7769d1d4-5d23-401a-b6d7-bfa31e9c98df">3,888</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjItNS0xLTEtMA_3ab37790-d644-4ee9-89af-d84a26e43774">6,935</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:IncreaseDecreaseinOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjMtMS0xLTEtMA_1f3ff7ef-5787-491d-b39d-666d8bad883c">53,906</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:IncreaseDecreaseinOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjMtMy0xLTEtMA_5e7367d6-389e-49bc-be0b-e1ca598d852a">66,831</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="rdnt:IncreaseDecreaseinOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjMtNS0xLTEtMA_ffef190a-06f2-410b-9b0c-3317a5d70d6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred rent</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="rdnt:IncreaseDecreaseInDeferredRent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjQtMS0xLTEtMA_e5fb12a8-d198-4c12-92f0-5a89b0fb9820">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="rdnt:IncreaseDecreaseInDeferredRent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjQtMy0xLTEtMA_40631a84-352a-422f-9e38-109311048f47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:IncreaseDecreaseInDeferredRent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjQtNS0xLTEtMA_96e6f641-d630-454a-8dfc-6e86ad88b62c">6,312</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjUtMS0xLTEtMA_3e01ca54-879c-475b-b1ab-37206b455a90">37,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjUtMy0xLTEtMA_70709423-c96c-4cf8-8a02-83aeb8eec329">1,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjUtNS0xLTEtMA_4318c0cd-ab2e-4dec-b74d-f4eaf81d3a00">208</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjYtMS0xLTEtMA_0c64925c-7213-4442-ab44-a614198a9371">45,069</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjYtMy0xLTEtMA_99a18fdd-669d-4392-be3a-4a8de49e5d4e">17,316</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjYtNS0xLTEtMA_5467b233-13e9-4d36-94e4-b6a263c4ac2a">26,221</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjctMS0xLTEtMA_d06470ee-75a7-44cb-a083-d56f58a7bfc2">233,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjctMy0xLTEtMA_9c9d0628-1f1e-4bb8-90ac-15af6fcd4572">104,322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjctNS0xLTEtMA_1682b942-5249-4adc-9315-af1268900455">116,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of imaging facilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBuildings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjktMS0xLTEtMA_e92b4be3-fd25-4ef7-abc4-2c86fbfe0fd2">31,265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBuildings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjktMy0xLTEtMA_ce9523b4-0233-422f-9b0f-35e855ad2a64">27,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBuildings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjktNS0xLTEtMA_0cb3aa74-d2f1-4e5d-ae8b-87c1ee3845be">73,192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments at fair value</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzAtMS0xLTEtMA_e3d45c33-c518-41cc-9326-dba1d5300647">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzAtMy0xLTEtMA_1cb14599-7289-4a89-9d78-d943a7356bed">143</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzAtNS0xLTEtMA_496705e2-5318-4828-882f-6cc93d692c87">2,200</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzEtMS0xLTEtMA_72cef21d-8fdd-40eb-9e0b-0c49cbd9ad6c">94,172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzEtMy0xLTEtMA_11a67231-1333-44d6-bc30-701e5cceda08">74,153</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzEtNS0xLTEtMA_09785fd1-3602-472d-afbf-f6ee22fff544">72,180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of equipment</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzItMS0xLTEtMA_b3535805-a7ed-49a0-bffa-f1a081851e0e">828</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzItMy0xLTEtMA_8f9ff99f-bb7a-4a3a-85ec-72d5205761c0">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzItNS0xLTEtMA_f7a4a6c6-a574-4ece-ac63-9c0c5d3a9e06">2,575</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from the sale of equity interests in a joint venture</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzMtMS0xLTEtMA_98632047-93be-4ae5-8407-9382a284b3ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzMtMy0xLTEtMA_9fd693dc-d68e-4889-ab00-7ff71dacc9fd">132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzMtNS0xLTEtMA_80e96a60-c7ee-4993-9241-f3fa5ceb2de4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of internal use software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzUtMS0xLTEtMA_4fb12831-2ed1-40d2-a0e1-9af5ecc20cdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzUtMy0xLTEtMA_02fb88f1-4080-4e88-9969-6edb54a3cd78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:ProceedsFromSaleOfIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzUtNS0xLTEtMA_390d50ae-ad6b-4485-a08b-6d5fd4fd0b19">248</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix return of capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzYtMS0xLTEtMA_29fdcf0f-3330-44bf-ace0-e10f52cf134f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzYtMy0xLTEtMA_b41309a3-c630-42e6-96b6-04d86368ce58">792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzYtNS0xLTEtMA_c98d8397-25ca-4544-bb3f-f593ba810cd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzgtMS0xLTEtMA_11a6c022-6072-4e85-918c-0925b923be41">1,635</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzgtMy0xLTEtMA_6d699531-dd2b-4c84-9894-11c33b37f564">103</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzgtNS0xLTEtMA_cf5d9c75-bc6e-4168-b5ae-4984feb99bbb">2,000</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzktMS0xLTEtMA_4427851f-fb65-4490-bfe8-046963f6c95e">126,244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzktMy0xLTEtMA_dd2766dd-5a6e-464a-91dd-8072ddbfa311">99,465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzktNS0xLTEtMA_5639326c-3529-499f-99a2-50caa1ee9d33">146,749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH FLOWS FROM FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal payments on notes and leases payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDEtMS0xLTEtMA_19d2a393-e9cb-493a-9b9f-17c30c068f0b">3,562</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDEtMy0xLTEtMA_8f328457-667b-4f68-a17d-6b8b9fda5769">6,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDEtNS0xLTEtMA_9f824440-be49-46c0-a0f1-7bb1b91b1957">6,072</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on term loan debt</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDItMS0xLTEtMA_f481d6dd-86f7-4f10-90e8-93d753c617f3">43,296</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDItMy0xLTEtMA_6b2365e1-7e69-4ca1-8e40-26e0b5e56509">40,742</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDItNS0xLTEtMA_5c7c8f8a-b600-4103-914b-0b9762e0599d">33,830</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional deferred finance costs on revolving loan amendment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtMS0xLTEtNjE5OQ_1c81f725-59c0-44e7-af76-239352cc3591">741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtMy0xLTEtNjE5OQ_c519b0e4-6a04-4c16-91a9-ca2d064ef8f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtNS0xLTEtNjE5OQ_6f9802bd-f799-435c-96dd-a56ad4c2fbf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from debt issuance, net of issuance costs</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDMtMS0xLTEtMA_062039ab-c120-448e-b3f0-d6c422abf657">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDMtMy0xLTEtMA_87ad818f-1542-4751-82d2-83c8fcb2262c">97,144</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDMtNS0xLTEtMA_6c528607-6cc4-4446-9c3d-233054d598c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from paycheck protection program loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:ProceedsFromGovernmentAssistance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtMS0xLTEtNjIxMQ_10043e29-7021-4eed-ab09-98eb053d8e6d">4,023</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="rdnt:ProceedsFromGovernmentAssistance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtMy0xLTEtNjIxMQ_c0f2dafc-2791-4c9d-8faf-a8df71a29f1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="rdnt:ProceedsFromGovernmentAssistance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtNS0xLTEtNjIxMQ_f7fd6d30-7d0f-4d91-b79d-456032913072">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions paid to noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtMS0xLTEtMA_66f77811-f384-41b0-a7b3-3a76c9fc02cc">1,985</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtMy0xLTEtMA_b15d018d-910e-4633-b82f-076ae04a8661">3,057</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtNS0xLTEtMA_1d59c9b2-6701-4ebe-9891-735ff9b40c29">1,427</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of noncontrolling interest</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDUtMS0xLTEtMA_40efd8d9-accc-4e49-b5c8-0ac1a9945271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDUtMy0xLTEtMA_10de8fc1-f61b-47f4-8721-9883c4ca628d">5,275</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDUtNS0xLTEtMA_737aeffa-4115-41f0-a2bc-29473d8d5bf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contributions from noncontrolling partners</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromContributedCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtMS0xLTEtMA_d729c8aa-f733-42e4-ba11-26546380915e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromContributedCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtMy0xLTEtMA_d23a2b3f-9997-403e-b9dd-99674e93c2d1">750</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromContributedCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtNS0xLTEtMA_0e6bd985-4e75-4fb5-ab20-3c586268db16">2,640</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from revolving credit facility</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDctMS0xLTEtMA_286f88bb-c9d8-4d63-a29e-efd2504cceeb">250,900</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDctMy0xLTEtMA_27aab733-1f8d-40ce-ac62-b4a2a8030758">261,200</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDctNS0xLTEtMA_208f9bb3-3c99-4ac6-a5b5-5b79a6315332">204,300</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments on revolving credit facility</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDgtMS0xLTEtMA_f9b124f3-84ca-4444-8631-10d9f565bde9">250,900</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDgtMy0xLTEtMA_4967a75b-e81d-4a43-bbc9-40702bec4c5d">289,200</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLinesOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDgtNS0xLTEtMA_b146007e-a050-4529-a7ad-5a99c465b5e7">176,300</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of noncontrolling interests</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="rdnt:PaymentsToAcquireInterestInSubsidiaries" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDktMS0xLTEtMA_1529812f-7dce-4c3e-a0f5-d3eec0141c41">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="rdnt:PaymentsToAcquireInterestInSubsidiaries" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDktMy0xLTEtMA_440ec7a0-d191-43f3-a821-700c27ff7e63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="rdnt:PaymentsToAcquireInterestInSubsidiaries" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDktNS0xLTEtMA_d31a579f-04f9-4322-924e-a66e82729e9c">200</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock upon exercise of options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTAtMS0xLTEtMA_79415d70-4f3e-42b3-9627-bb4099c2e4b0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTAtMy0xLTEtMA_511307cf-5b12-4c64-a0d6-3002f28c0064">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTAtNS0xLTEtMA_57430c4e-1c4a-430d-a93a-44ce6add6034">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTEtMS0xLTEtMA_e565bf8a-99b7-4ef6-ad38-42a07126a760">45,561</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTEtMy0xLTEtMA_ecc913a3-236b-46e3-9203-3373abf8cf2e">24,951</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTEtNS0xLTEtMA_cce5960e-8825-4f6d-856e-c9eea9c708ff">10,869</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EFFECT OF EXCHANGE RATE CHANGES ON CASH</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTItMS0xLTEtMA_b1ed7879-07de-4e15-a138-64f9f7cd5f8f">101</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTItMy0xLTEtMA_2b11e1d6-a1cd-48c5-a13a-04d8db76771e">32</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTItNS0xLTEtMA_519020fe-9a3f-4b82-a8d6-68d02cc1c1e9">69</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCREASE (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTMtMS0xLTEtMA_4640b9d8-f4bd-4abd-a9fc-215428fde9d4">61,853</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTMtMy0xLTEtMA_5883d53d-e378-49cc-8e72-2be753985331">29,776</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTMtNS0xLTEtMA_8e3e94d5-8450-4472-86cc-aa87e3d07bd2">40,933</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTQtMS0xLTEtMA_34ebd1be-813f-484b-900f-2afa84199a46">40,165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae6485d220c4366bf04745e679dee34_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTQtMy0xLTEtMA_dbc62fb8-10c5-40ce-b373-7192da4e27fd">10,389</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4642cbc638c646e88712849889f662b5_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTQtNS0xLTEtMA_b7ad8467-140e-414d-814e-048e1c677e2a">51,322</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CASH AND CASH EQUIVALENTS, end of period</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTUtMS0xLTEtMA_a382d158-d2d3-49c5-89c0-baa3df8e10ab">102,018</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTUtMy0xLTEtMA_1f4f7deb-b0b4-4a9e-b9a3-712a76619117">40,165</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae6485d220c4366bf04745e679dee34_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTUtNS0xLTEtMA_59304e41-bcda-46ab-beeb-e9431eb86b70">10,389</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for interest</span></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTctMS0xLTEtMA_e8537a4b-4e1a-4d97-af70-fc0b4e72c6ec">39,521</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTctMy0xLTEtMA_ebf7e4d0-b2f0-406a-bebd-994d5f8f79a3">46,254</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTctNS0xLTEtMA_de8cac4f-bf64-4608-b9ca-ccc76d6d2f3b">37,016</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid during the period for income taxes</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTgtMS0xLTEtMA_8fefad57-8315-44ba-80ae-362095d3979a">5,069</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTgtMy0xLTEtMA_067c1cbb-9e31-4a6f-bb43-d19c40755912">5,884</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTgtNS0xLTEtMA_a1c44ee1-e9f0-4ef6-88f4-15321d0ec19f">4,933</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these financial statements.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supplemental Schedule of Non-Cash Investing and Financing Activities</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We acquired equipment and certain leasehold improvements for approximately $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfNDA1_298edbae-5ac9-4295-b3aa-9edb15595c36">52.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfNDA5_45dae2ad-234a-4f48-9e6a-3676d3a93f5d">51.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:EquipmentAcquiredAndLeaseholdImprovements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfNDE3_0ec3e1b9-bebf-43b4-a9ba-c9406de24130">47.8</ix:nonFraction> million during the years ended December 31, 2020, 2019 and 2018, respectively, that we had not paid for as of December 31, 2020, 2019 and 2018, respectively. The offsetting amount due was recorded in our consolidated balance sheets under &#8220;accounts payable, accrued expenses and other.&#8221;</span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We executed inclusive of all acquisitions, finance lease liability/capital lease debt of approximately $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:CapitalLeaseDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfODAz_20c50e58-993e-4a5c-bf0a-7dfdb4f4c054">20.0</ix:nonFraction> thousand, $<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:CapitalLeaseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfODA3_8a338a6c-9252-4d95-a201-3b24571a5e00">0.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:CapitalLeaseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfODE1_9f74b6e4-0fba-4d46-b20e-bafbf170ecda">6.7</ix:nonFraction> million during the twelve months ended December 31, 2020, 2019, and 2018.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our stock purchase of DeepHealth, Inc. by issuing <ix:nonFraction unitRef="shares" contextRef="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MzEzOQ_f4488766-f847-4c2f-be62-17b993d53730">823,615</ix:nonFraction> shares of our common stock to purchase all of DeepHealth's shares and share equivalents.  The shares were assigned a value of $<ix:nonFraction unitRef="usd" contextRef="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MzE0Mw_50329ef5-866d-4d89-8ee9-74cbe146f94e">13.9</ix:nonFraction> million.  See Note 4, Facility Acquisitions and Dispositions, to the consolidated financial statements contain herein for further information.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019 we issued RadNet common stock in the amount of $<ix:nonFraction unitRef="usd" contextRef="i0d288cd107d84361b2e08ab554ae5ed7_D20190801-20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MjA2Mg_e174b3ee-cd18-4cec-9e4f-ecbc3617d1ff">1.5</ix:nonFraction> million to acquire a <ix:nonFraction unitRef="number" contextRef="i46ed970e221a4949933067bb7c822615_I20190801" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MjA3OQ_e5cb3393-ec1c-4253-963a-14d33a1c1e38">75</ix:nonFraction>% controlling interest in our formerly owned joint venture Nulogix.  See Note 4, Facility Acquisitions and Dispositions, to the consolidated financial statements contain herein for further information.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019 we completed a step-up acquisition upon the dissolution of our former <ix:nonFraction unitRef="number" contextRef="i1a886167e5d546978b5a20d615e9fc78_I20190731" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2Mjg2Mw_9a13002a-15ec-483b-a454-c4fac8a06745">49</ix:nonFraction>% owned joint venture, Garden State Radiology LLC ("GSRN"). We made a fair value determination of our original <ix:nonFraction unitRef="number" contextRef="i1a886167e5d546978b5a20d615e9fc78_I20190731" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2Mjk3Ng_9a13002a-15ec-483b-a454-c4fac8a06745">49</ix:nonFraction>% interest which resulted in a step-up gain of&#160; approximately $<ix:nonFraction unitRef="usd" contextRef="ida4995e095e84733a7a3db2b2c529f94_D20190801-20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MzA0MA_40b3fe15-1bd6-454c-b6b1-5ffa7f2226be">1.3</ix:nonFraction> million.  See Note 4, Facility Acquisitions and Dispositions, for further information.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We transferred approximately $<ix:nonFraction unitRef="usd" contextRef="i3b935882b4d8429a874b97a0270ab625_I20190301" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjc0ODc3OTA3NTE3Mw_859a55fe-c957-4e1d-aa88-b945ea2b46bd">4.3</ix:nonFraction> million in net assets to our new joint venture, Ventura County Imaging Group. LLC in March 2019. See Note 4, Facility Acquisitions and Dispositions, for further information.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 27, 2019, we issued <ix:nonFraction unitRef="shares" contextRef="ib6d052daae794a8fac16e845d601f61e_D20190227-20190227" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjc0ODc3OTA3NTE4MA_e96f4b9f-a3f0-4121-9dc0-dbddf1a10976">440,207</ix:nonFraction> shares of our common stock to the sellers of Hudson Valley Radiology Associates, P.L.L.C. ("HVRA") which permitted our variable interest entity, Lenox Hill Radiology and Medical Imaging Associates, P.C., to complete its purchase of the membership interest of HVRA. The shares were ascribed a value of $<ix:nonFraction unitRef="usd" contextRef="i9a9e5ef103564deb822d473edf70473d_I20190227" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjc0ODc3OTA3NTE4NA_9c6803d0-84e2-4218-8938-61bd0e9f1d96">6.0</ix:nonFraction> million.  We also recorded contingent consideration valued at $<ix:nonFraction unitRef="usd" contextRef="i9a9e5ef103564deb822d473edf70473d_I20190227" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjc0ODc3OTA3NTE5MQ_b35c1b75-d30e-4263-850b-95804e6007dd">0.7</ix:nonFraction> million to guarantee the share value issued for a period of six months post acquisition date, which was taken to income upon the completion of the time period.  See Note 4, Facility Acquisitions and Dispositions, to the consolidated financial statements contain herein for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, we obtained control over the operations of New Jersey Imaging Network (NJIN) through an agreement with the other equity interest holder for no cash consideration. As such, we consolidated the financial statements of NJIN effective as of that date and recognized fair value of non controlling interest of $<ix:nonFraction unitRef="usd" contextRef="i107a79c6ba52476ebe7de9b31052579f_D20181001-20181001" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTI3MQ_a426b975-6e54-4d6e-be76-e4a8cbd7e1a1">44.3</ix:nonFraction> million on the date of the transaction. We remeasured our pre-existing <ix:nonFraction unitRef="number" contextRef="i4ff1137ebe584b6e9251f4be6a157e86_I20181001" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTI2Nw_2db3b96e-b210-42be-9724-d111bf73484a">49</ix:nonFraction>% equity interest in NJIN upon consolidation and recognized a non cash gain of $<ix:nonFraction unitRef="usd" contextRef="i107a79c6ba52476ebe7de9b31052579f_D20181001-20181001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTI2MA_27707fda-5a61-449a-a3d1-53c394533ce3">39.5</ix:nonFraction> million. We also obtained control of $<ix:nonFraction unitRef="usd" contextRef="i107a79c6ba52476ebe7de9b31052579f_D20181001-20181001" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationStepAcquisitionCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTI1Mw_b1136bdd-980d-40e4-87d2-2b623bcfc1da">5.4</ix:nonFraction> million cash in NJIN as a result of such consolidation. The economic interest of each party remained the same after consolidation. See Note 4, Facility Acquisitions and Dispositions, to the consolidated financial statements contain herein for further information.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018 we acquired Medical Arts Radiology for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i0394c754617f470ca05634e5df485f1f_D20181001-20181001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTI0Ng_682f2df2-c64d-486c-8cf7-88c5ccdd3d43">50.9</ix:nonFraction> million, the assumption of $<ix:nonFraction unitRef="usd" contextRef="i0394c754617f470ca05634e5df485f1f_D20181001-20181001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTIzOQ_8c7f8351-55d9-4c2d-b7aa-781ed909529b">2.7</ix:nonFraction> million in equipment debt, and $<ix:nonFraction unitRef="usd" contextRef="i0394c754617f470ca05634e5df485f1f_D20181001-20181001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTIzMw_a0ae072c-662b-4a35-86a1-a4f0379a88ab">8.0</ix:nonFraction> million in RadNet common stock.  As part of the transaction, we recorded a contingent liability of approximately $<ix:nonFraction unitRef="usd" contextRef="iadcbd5b4c90e437fae076570fd592eab_I20181001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTIyNg_c14bd9ae-d54b-4acc-b6b0-492da9eb7927">0.7</ix:nonFraction> million to guarantee the sellers stock price stability for a period of one year from the date of acquisition.  For the year ended December 31, 2018 we recorded a $<ix:nonFraction unitRef="usd" contextRef="id037acfdb2974904b3b0606b4fe20b4d_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTIxOQ_6bba612e-2720-43f7-9010-032ffa6e6a81">1.7</ix:nonFraction> million charge to record the contingent liability at fair market value.  For the year ended December 31, 2019, we recorded $<ix:nonFraction unitRef="usd" contextRef="ia978d78cb33c49d0b2db28864fec1dce_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjc0ODc3OTA3NTE5OA_ffa1a07c-355d-47a4-94f6-455df7c5d473">2.4</ix:nonFraction> million to income to resolve the fair market value charge recorded at December 31, 2019 and the original contingent liability at purchase. See Note 4, Facility Acquisitions and Dispositions, to the consolidated financial statements contain herein for further information.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a one-time special distribution from a controlled subsidiary which resulted in a $<ix:nonFraction unitRef="usd" contextRef="i5527d962127c4f0890eb1bf05ca35aac_D20180901-20180930" decimals="-5" format="ixt:numdotdecimal" name="rdnt:NoncontrollingInterestSpecialDistribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTE5NQ_5a1661f4-9bfa-472c-9ed6-fb080bf1adde">9.2</ix:nonFraction> million adjustment to noncontrolling interest and $<ix:nonFraction unitRef="usd" contextRef="ife75574fa4f34d78b8d99e90205c9f7b_D20180901-20180930" decimals="-5" format="ixt:numdotdecimal" name="rdnt:NoncontrollingInterestSpecialDistribution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTIwOA_7b085806-1d00-4066-bc3a-88ca7787051e">3.0</ix:nonFraction> million, net of taxes, to the Company&#8217;s additional paid in capital account in September 2018.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received $<ix:nonFraction unitRef="usd" contextRef="i7c749423cff34945b7292f9e192be48f_I20180101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTE1Nw_c4a8b119-eaa4-48d4-a016-9aaea99e711e">15.0</ix:nonFraction> million in fixed assets and assumed $<ix:nonFraction unitRef="usd" contextRef="i7c749423cff34945b7292f9e192be48f_I20180101" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTE4OA_60905546-4d69-4c94-a3dd-cccb6459afdb">4.0</ix:nonFraction> million in capital lease debt in January 2018 from the Company&#8217;s partner in Beach Imaging LLC. See Note 4, Facility Acquisitions and Dispositions contained herein for further information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RADNET, INC. AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> NOTE 1 &#8211; <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNzY3Mw_5bbc3bb6-f6ee-4d26-a2e1-a7add423fa3f" continuedAt="ia70a8d16ac194914927a92e1fb382046" escape="true">NATURE OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="ia70a8d16ac194914927a92e1fb382046" continuedAt="ifd5dbba94bcc4096a879d5e377d3dc83"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2020, we operated directly or indirectly through joint ventures with hospitals, <ix:nonFraction unitRef="center" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="INF" name="rdnt:NumberOfCenters" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfMjMz_8cf8ba6f-e5b6-40c3-81dc-46fa918f5ac7">331</ix:nonFraction> centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures. In addition to our imaging services, we have certain other software subsidiaries which design and sell computerized systems for the imaging industry and internally develop Artificial Intelligence suites to enhance interpretation of radiographic images. Our operations comprise a single segment for financial reporting purposes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management, namely Howard G. Berger, M.D., our President and Chief Executive Officer, and John V. Crues, III, M.D., RadNet's Medical Director; both of whom are members of our Board of Directors.  Dr. Berger owns, indirectly, <ix:nonFraction unitRef="number" contextRef="i9bcc7eba5c6e48c898708be79cf90c04_I20201231" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfMzU4NA_e874c50f-8208-452e-89e8-9f428e1b1f0c">99</ix:nonFraction>% of the equity interests in Beverly Radiology Medical Group III (BRMG) and a controlling interest in two professional corporations in New York City.  BRMG is responsible for the professional medical services at nearly all of our facilities located in California.  Dr. Crues owns six professional corporations which provide medical services in Delaware, Maryland, New Jersey and New York.  Additionally, Dr. Crues is a <ix:nonFraction unitRef="number" contextRef="i58b03b73c60d49f3939e2ad703919efe_I20201231" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDAwNA_decbcecc-d0b3-408d-9626-30260a8eb214">1</ix:nonFraction>% owner of BRMG.  These VIEs are collectively referred to as the consolidated medical group ("the Group").</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity. Through management agreements with us, substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDgxNQ_5a7b0555-3ca4-4759-a0ea-1ba100bdc1ec">147.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDgxOQ_1e8f6d58-e674-4973-965c-1c194e40a120">157.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDgyNw_de19d6df-0d02-426c-a535-5bc4e44050bb">132.9</ix:nonFraction> million of revenue, net of management services fees to RadNet, for the years ended December 31, 2020, 2019, and 2018, respectively and $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDkzOQ_bd46a425-45c5-4e5f-a132-b52d84dd28b4">147.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDk0Mw_25288aef-f13b-4498-a967-cc5bf588625f">157.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDk1MQ_3b8f28d5-0737-4ca7-8195-725512c80104">132.9</ix:nonFraction> million of operating expenses for the years ended December 31, 2020, 2019, and 2018, respectively. RadNet, Inc. recognized $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTA1MA_df4b48ca-5aab-4d2b-9c98-c594ffab11d6">600.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTA1NA_f513c65b-8fef-47b4-80d2-2bb2fe6ec92e">618.9</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTA2Mg_c86eb51c-e886-4923-b384-a754c973e961">505.2</ix:nonFraction> million of total billed net service fee revenue for the years ended December 31, 2020, 2019, and 2018, respectively, for management services provided to them relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifd5dbba94bcc4096a879d5e377d3dc83"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December 31, 2020 and December 31, 2019, we have included approximately $<ix:nonFraction unitRef="usd" contextRef="i7d60bb5091324738b842894a8d612608_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTUyMw_3b2803e7-58d1-42b6-8e8f-1b02d540a6e0">82.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i80ff729336ff43a7b8f70a9e53ad3932_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTUzMA_64c06885-3aa0-4e94-a432-94e169d27df1">100.3</ix:nonFraction> million, respectively, of accounts receivable and approximately $<ix:nonFraction unitRef="usd" contextRef="i7d60bb5091324738b842894a8d612608_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTU4OQ_5bd2b7a9-1449-404c-b11c-7a23621e84e4">15.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i80ff729336ff43a7b8f70a9e53ad3932_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTU5Ng_93088c58-9156-419f-a736-0cb0e91c1578">7.0</ix:nonFraction> million of accounts payable and accrued liabilities related to the Group, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of them. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also own a <ix:nonFraction unitRef="number" contextRef="i4e0c5a3c996d40d6b9a18855f3170e9f_I20201231" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTk3OA_9a22a3bd-d028-4aa6-b2b6-82f6459da23b">49</ix:nonFraction>% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender LLC is dependent on the Company to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts (typically <ix:nonNumeric contextRef="i9aa53910584d4308b3a9af105783ce91_D20200101-20201231" format="ixt-sec:duryear" name="rdnt:LongTermContractsTerm" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfMzI5ODUzNDg5MTI3NA_e9a45383-7eba-4bcd-869c-7241d734c6c7">10</ix:nonNumeric> to <ix:nonNumeric contextRef="i59d8b9f6e0ef49d4a4d3fe5016d69357_D20200101-20201231" format="ixt-sec:duryear" name="rdnt:LongTermContractsTerm" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfMzI5ODUzNDg5MTI4Ng_cde48027-da23-4d10-8269-1ea624b41735">40</ix:nonNumeric> years in length) with independent radiology groups to provide physician services at those centers. These radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee based on the value of the services we provide.  We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us and we have no economic controlling interest in these radiology practices. As such, the financial results of these practices are not consolidated in our financial statements.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2 - <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Mzc_89cf675a-610f-4e11-a735-e5da53f1e4b2" continuedAt="i717d09807c7045c8961d27fa781179c1" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i717d09807c7045c8961d27fa781179c1" continuedAt="ib6d806cf6d1740d0ba030a9041a2dd3f"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NjI_0fefba80-c42f-41f4-877f-105d6ee82223" escape="true">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.</ix:nonNumeric> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MTE_6290a8e1-2f92-4d0b-b264-771732be3ce2" escape="true">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NTI_95d60c45-e232-4a45-896a-bb96c3f4f4c6" escape="true">RECLASSIFICATION - For the year 2019, we have reclassified certain amounts previously classified as held for sale related to property and equipment and goodwill to conform to our 2020 presentation.</ix:nonNumeric></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Nzg_15909263-924e-422c-9123-6f9b0078df85" continuedAt="id48c023a71584ce7bada6d1a568e6715" escape="true">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib6d806cf6d1740d0ba030a9041a2dd3f" continuedAt="ib6f635d7b256432d925b4cbaa1ba107a"><ix:continuation id="id48c023a71584ce7bada6d1a568e6715"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;1, 2018, we adopted the new revenue recognition accounting standard issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) and codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding our revenue recognition policies and significant judgments employed in the determination of revenue.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NzQ_64e4d53c-71dc-47e6-961d-cbab5c08453a" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total net revenues for the years ended December 31, 2020, 2019, and 2018 are presented in the table below (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a6ccbfae5264333868c009a4c975e8d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMS0xLTEtMS0w_b08ed44b-fa3a-4d01-b333-4d6c5eaf6050">584,035</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i891c10b64f17493bb11c320547b8151e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMS0zLTEtMS0w_4f1dff3e-b192-47e4-be02-75e580c3a90f">642,341</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if13c433b6a59448e80ed8ed7eba74c84_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMS01LTEtMS0w_9ada6388-a04a-453d-9944-7f93e594b807">542,011</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42b0a40b551449aa8cf5aab61557ad1_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMi0xLTEtMS0w_bc703d9e-22e0-4a45-ae5e-60e839f8672a">217,928</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i55ae38103bc54357bc2d68bf08c2da7f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMi0zLTEtMS0w_7ff17749-d861-45d5-864d-a3262064ea75">237,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1d4292049a343c6bc7508d9b0441dfa_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMi01LTEtMS0w_1e4a45a3-024f-464f-b6ee-a2f1a09290e8">192,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i624a2cd5a57c45c195d9eea635adda77_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMy0xLTEtMS0w_6fe8a512-b245-4d8c-ac96-477d0e4c6ff7">25,619</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic586562cfaa14df5b15da5de1aa5bd11_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMy0zLTEtMS0w_2c7cc934-2232-4970-8de9-d1e046232861">28,283</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44ff6aefd98947aea4638300eb0bc851_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMy01LTEtMS0w_4865c39a-c83b-4277-8e25-d4f18c1da9bd">25,615</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d1f53911394e648410f42738dfedaa_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNC0xLTEtMS0w_2f5580b3-e808-4ce4-98cf-6375b1a0b3ad">33,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfb18a43c61343ecb86bc5802bdfcb00_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNC0zLTEtMS0w_a460b5a7-80f3-4b2e-aa8d-8358cdd80efc">42,792</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i066fe4ef9d6f479db95ce1cf95386477_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNC01LTEtMS0w_0a2c1de9-93d0-41ed-924f-314a14ae4756">34,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i614755c7eae243538ab15e0aa1c51f04_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNS0xLTEtMS0w_93a8d3d3-f0fd-4f8f-b0d5-ee2fc2428ab8">25,314</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a20030cccbd4aa184a599982173e41c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNS0zLTEtMS0w_15e432fa-f5d2-4336-832e-6be11268df95">23,862</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b5081b915b84065ab6982f64bd2cdc2_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNS01LTEtMS0w_6f07ccfd-746e-4952-9923-59040fa024be">25,117</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie97dd2adff264063a2311999801b83cb_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNi0xLTEtMS0w_9e145514-da97-489f-8270-179084a76e52">11,253</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6faacec13adc4cfaa3714f042eb08eca_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNi0zLTEtMS0w_22056673-3a12-41f6-bb38-dc08177e2d99">11,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b4058b6aea4480f93436186354111d6_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNi01LTEtMS0w_5e65017c-a5de-4b54-8cdd-b6c863cb3b5a">13,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging on call and software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib673d95e637f4dcdb5dc1061d5a63735_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNy0xLTEtMS0w_82545733-24cc-40ed-bc44-de2a3a048d86">10,798</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8efa81ad11b426eb95ebed781413689_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNy0zLTEtMS0w_dceb33fe-2eba-4840-8cf3-c7d118450813">17,317</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i411513ce21ff409cb97e6b96a1937d9b_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNy01LTEtMS0w_d3a9f54a-d96d-4b4d-8a36-746b79637341">16,261</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e3cd3d7d43342508d2f3e021c52f178_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOC0xLTEtMS0w_41020217-749f-414d-b26b-b448575ce8fd">23,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia05b082668734b48affdda6293f59c04_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOC0zLTEtMS0w_0a26fd35-c7cb-421e-a891-48c7dfc5c2c6">24,555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f11681d86e440a8a138ad9a36324ab1_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOC01LTEtMS0w_d49d7ca7-90be-4990-92cf-a1d159ad2486">18,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91cab1d2676f4c75984b340531fdb510_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOS0xLTEtMS0w_2c7ddc69-48d4-4d94-b1af-5667f2ffbd94">931,722</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb4b5f80227407994e895e9fdf49c2c_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOS0zLTEtMS0w_be555b70-b421-43b3-b9a0-adbb766839c0">1,028,236</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i234d43f26e4d4788b2228afca82d6341_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOS01LTEtMS0w_4feb08ec-a7bc-40f0-9cc9-eb80b24ed79a">868,741</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0cb6103e98c484a80f4c648cf9a807a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTItMS0xLTEtMA_bf4a7cb6-50b5-4491-ad0a-caa5f408fa42">140,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf8d37678bac4561b537c7457bdd558b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTItMy0xLTEtMA_f3f7b8b9-789e-453d-a76e-236c55b6da21">125,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife6ce5fe36734a9a814d0f68137a31b0_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTItNS0xLTEtMA_c8abbf63-944b-4a0e-88f3-8edc39ff36b6">106,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTMtMS0xLTEtMA_2f8db778-6aca-4784-86c4-869741f47059">1,071,840</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTMtMy0xLTEtMA_ef630487-8a45-405a-9244-900906ed5da5">1,154,179</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTMtNS0xLTEtMA_7404cb70-3682-4958-8bda-43fbc6b4cdf1">975,146</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="rdnt:CARESActDisclosurePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNjU5NzA2OTg3Njg2OA_a2990772-7294-4a07-8fc6-a84a40ffdc7d" continuedAt="i95c223b1fc2943509f5d862de98786a0" escape="true">COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  Patient volumes and the related revenues for our services were significantly impacted during the latter portion of the first quarter through the middle of the third quarter of 2020 as a result of federal, state and local government mandated restrictions requiring many people to remain at home and forced the closure of or limitations on certain businesses, as well as suspended elective procedures by health care facilities.  Many of these restrictions </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib6f635d7b256432d925b4cbaa1ba107a" continuedAt="ic6a011565bd5434c9127f23af3d899c4"><ix:continuation id="i95c223b1fc2943509f5d862de98786a0" continuedAt="ifb9463f817d145deacf1394a3ca30cdc"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">have been eased or completely lifted across the states the Company operates in however, we are unable to predict the future impact of the pandemic on our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the twelve months ended December 31, 2020, we received $<ix:nonFraction unitRef="usd" contextRef="i378af55f9d9f47e98887a9393d7f737d_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:AdvanceMedicarePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2NzM1Ng_f7dd4eba-0d74-4cd5-9c5b-d59b9606a62d">43.2</ix:nonFraction> million of accelerated Medicare payments, $<ix:nonFraction unitRef="usd" contextRef="i378af55f9d9f47e98887a9393d7f737d_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ProceedsReceivedFromInsurance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2NzM0OA_84bdc95b-b509-43ca-95fc-8d46f419834f">5.0</ix:nonFraction> million from Blue Shield, $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueNotFromContractWithCustomer" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2NzM0MA_4f53d2e7-4e1c-47e2-b8e0-501ca262b6de">26.3</ix:nonFraction> million from the general distribution and $<ix:nonFraction unitRef="usd" contextRef="id29d143ec6924d1587f745bf76712764_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2ODEwMA_9a62cb2d-0799-467a-8f39-6a2cb885bfb9">4.0</ix:nonFraction> million from the Paycheck Protection Program established through the Coronavirus Aid, Relief and Economic Security (&#8220;CARES&#8221;) Act.  The accelerated Medicare payments are recorded under the caption &#8220; Deferred Revenue&#8220;  in our consolidated balance sheet and will be withheld from reimbursements for services in 2021 and 2022.  The general distribution funds were accounted for as government grants and recognized as other revenue, once reasonable assurance that the applicable terms and conditions required to retain the funds were met, under the caption &#8220;Provider relief funding&#8221; in our Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The CARES Act also provides for a payment deferral of the employer portion of Social Security tax incurred during the pandemic, allowing half of such payroll taxes to be deferred until December 2021 and the remaining half until December 2022.  At December 31, 2020, the Company had deferred $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:SocialSecurityTaxEmployerDeferralCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2OTc3OQ_e243847d-eb0e-47b6-b317-d08b94c9b243">16.3</ix:nonFraction> million of Social Security taxes.  These payment deferrals are recorded as payroll tax liability under the caption &#8220;Accounts payable, accrued expenses and other&#8221; in our consolidated balance sheet.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="ifb9463f817d145deacf1394a3ca30cdc">We believe the extent of the COVID-19 pandemic&#8217;s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast.  Such factors include, but are not limited to, the scope and duration of stay-at-home practices, business closures  and restrictions, suspensions of elective procedures and continued decline in procedure volumes for an indeterminable length of time and incremental expenses required for supplies and personal protective equipment.  Because of these uncertainties, we cannot estimate the length or impact of the pandemic on our business.  If we incur declines in cash flows and results of operations, such declines could have an impact on the inputs and assumptions used in significant accounting estimates, including implicit prices concessions related to uninsured patient  accounts, and potential impairment of goodwill and long-lived assets.  During the fourth quarter of 2020, procedure volumes continued to increase and have had a positive impact on our patient revenue.  However, the impact of COVID-19 in future periods may vary and could adversely impact our results of operations.</ix:continuation>  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NjM_6c23ffab-e33a-4311-8384-01da6ada75a3" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections from our payors and record an estimated price concession based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. The aggregate amounts factored under these facilities, net of discounts recorded to reflect market interest rates is $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ContractsReceivableFactoredAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM3OTM5OA_dd9d41a7-e18b-44bf-9686-6a552643f860">29.5</ix:nonFraction> million.  Proceeds are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.  At December 31, 2020 we have $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ContractsReceivableFactoringReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjc0ODc3OTE2NjcwMw_3d4d39a3-2087-4c50-843e-552baac032f3">20.5</ix:nonFraction> million remaining to be collected on these agreements.  We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzI5ODUzNDk5MTQ1Nw_1d0c9a75-c96d-4e84-9917-d0703b85efb3" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; Our software division has developed and sells Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer. </span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, we recorded approximately $<ix:nonFraction unitRef="usd" contextRef="id1db908b8572402e87b53c44f73c46c9_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1OTI2NQ_1dba258d-94d4-42c1-8d03-dfc1236f059e">8.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i0c6d94c52f45408a9a65cb42ed24c2d7_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1OTI4MQ_d6602cc1-9cd4-4970-956f-cef64533825d">10.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="iff9c306f9afc4473a51abdf18b8b4dee_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1OTI4OQ_cc543052-ad69-437b-9000-3914261a6aa3">6.8</ix:nonFraction> million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statement of operations. At December 31, 2020 we had deferred revenue of approximately $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1OTI1Nw_32d26786-f5f0-410d-9f21-ff744e1802de">1.2</ix:nonFraction> million associated with these sales which we expect to recognize into revenue over the next 12 months.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MDQ_0ceef9b4-ccd9-48b7-af9c-03587693af73" escape="true">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ic6a011565bd5434c9127f23af3d899c4" continuedAt="i63b589d1e5ad4416bcd861c23868f0d4"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NTM_c198e97f-45dc-466d-a166-43622530b200" escape="true">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection, and to date have made all payments due to us in a timely manner.</ix:nonNumeric>  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3ODk_992934cb-fe8c-482a-a9bb-d00874f9b256" escape="true">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:DeferredChargesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NDk_2ef8e4b0-2282-45ed-82f3-411e96a14e16" escape="true">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are solely related to our Barclays Revolving Credit Facilities.  Deferred financing costs, net of accumulated amortization, were $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTM3NjE_d17f7609-5679-440b-a785-62977db94d92">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTM3Njg_fc8fd21b-434d-4a3e-96dd-fdee15c24925">1.6</ix:nonFraction> million for the twelve months ended December 31, 2020 and 2019, respectively.</ix:nonNumeric>  See Note 8, Revolving Credit Facility, Notes Payable, and Capital Leases for more information on our revolving lines of credit.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3ODE_4aef4b17-d85c-46ba-a551-df89e7cacea4" escape="true">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from <ix:nonNumeric contextRef="id626261985f3405eb1ffba0c34b5000f_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTQ0MDE_9174965a-db01-4374-8177-1641682e824b">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i0d4beeb600334777869da4212f754cd3_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTQ0MDc_5c878e03-1000-4729-a369-7ac0ced1e7d3">15</ix:nonNumeric> years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from <ix:nonNumeric contextRef="i924340cebec24f3d98853f0b12bf9470_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTQ1MjY_13f03a0d-3c0b-4b51-84f5-1d82fef9871f">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i235a1122e4214ab5937abc9704a2165a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTQ1MzI_946977aa-4f65-4d61-9c02-0b732e42ea00">15</ix:nonNumeric> years. Maintenance and repairs are charged to expense as incurred.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MzI_a9026243-40dc-44ff-a11f-05dd1efb23fa" escape="true">BUSINESS COMBINATION &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Nzc_21e03ab2-72f9-4d31-8f91-b4955a0311d0" escape="true">GOODWILL AND INDEFINITE LIVED INTANGIBLES &#8211; Goodwill totaled $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0ODcxNg_35f5a4a3-5346-4c76-97cf-01fd26b61da3">472.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0ODcwOA_0d2810a5-fdf2-465b-8ae3-9a7b9a0f4064">442.0</ix:nonFraction> million million at December 31, 2020 and December 31, 2019, respectively. Indefinite lived intangible assets at December 31, 2020 were $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0ODcyNA_4c1bccf5-6c54-4ba6-a024-0eb31cada69a">7.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0ODczMg_53b9d562-d702-4295-9017-a732b8a53a41">11.3</ix:nonFraction> million at December 31, 2019 and are associated with the value of certain trade name intangibles. Goodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.</ix:nonNumeric>  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We tested both goodwill and trade name intangibles for impairment&#160;on October 1, 2020.  However, during the year we ceased employing certain indefinite lived trade names with a total value of $<ix:nonFraction unitRef="usd" contextRef="ife26e87c47284440b905cc0d64ac26ec_I20201001" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjc0ODc3OTE5MTU4Mw_f8e833c3-c31b-44c3-a942-b3b40e7cf8d3">4.2</ix:nonFraction> million and they were written off in full. Separate from this, our annual impairment test as of October 1, 2020 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the testing of goodwill and trade name intangibles at October 1, 2018, our Teleradiology reporting unit, Imaging On Call, (IOC), experienced a reduction of professional medical group clients and a loss of a contract with a major local health provider during 2018.  This affected its estimated fair value and resulted in impairment charges to our reporting unit of $<ix:nonFraction unitRef="usd" contextRef="ie584d839922d4a17968542922cbe6707_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjc0ODc3OTE2Mzc1NA_ce1faed4-0efa-4c80-8489-9fd7f82d0824">3.9</ix:nonFraction> million for the twelve months ended December 31, 2018, with goodwill representing $<ix:nonFraction unitRef="usd" contextRef="ie584d839922d4a17968542922cbe6707_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTcyMjU_97c89579-429a-4d24-90e2-bac93ce7dc40">3.8</ix:nonFraction> million of the total and the remainder being its trade name of approximately $<ix:nonFraction unitRef="usd" contextRef="ie584d839922d4a17968542922cbe6707_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTczMDU_f9599b7c-5812-4f79-90d7-fd27424b7b6c">0.1</ix:nonFraction> million.  The estimated fair value of IOC reporting unit was determined by using the discounted cash flow method.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NDQ_68471206-6bee-43bc-af62-8424284df996" continuedAt="ib4d17e50633c4176ac527c18cbd813f6" escape="true">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived </ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i63b589d1e5ad4416bcd861c23868f0d4" continuedAt="id1ceb3ba97d94973a11d2b58826b831c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib4d17e50633c4176ac527c18cbd813f6">intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell. We determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MDM_b2e1a378-2853-4970-ab06-c9d68a130192" escape="true">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized.</ix:nonNumeric> Income taxes are further explained in Note 10, Income Taxes.&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Njc_5fafbf28-58fd-4a33-aa7c-1fb9565a779c" escape="true">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liability, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable.  As most of our leases do not provide an implicit rate, we use our incremental borrowing rate ("IBR") based on the information available at commencement date in determining the present value of lease payments.  Our IBR used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and is adjusted when those rates experience a substantial change. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. Our ROU assets consist of facility and equipment assets on operating leases. No events have occurred which have impaired the integrity of our ROU assets in 2020. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</ix:nonNumeric> See Note 9, Leases, for more information.  </span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="rdnt:UninsuredRisksPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3OTk_ee435df8-eb67-457d-bbb2-d84d36084154" continuedAt="i0230576efa7a4d36a2cad15226e4e78a" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNINSURED RISKS &#8211; On November&#160;1, 2008 we obtained a fully funded and insured workers&#8217; compensation policy, thereby eliminating any uninsured risks for employee injuries occurring on or after that date. This fully funded policy remained in effect through November 1, 2013 and continues to cover any claims incurred through this date.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2013 we entered into a high-deductible workers&#8217; compensation insurance policy. We have recorded liabilities of $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM3MDI2OA_6fc7b291-d82e-4477-b263-af865192953c">4.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WorkersCompensationLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2MzY3MQ_b04b27cc-82af-4b90-a5ca-77911c59a993">3.8</ix:nonFraction> million for each of the years ending December 31, 2020 and December 31, 2019, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits. The policy has a deductible which is $<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="INF" format="ixt:numdotdecimal" name="rdnt:MedicalMalpracticeDeductiblePerIncidence" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE3Njg_1e327127-3fe1-4e21-ae6e-9f6334591c36"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="INF" format="ixt:numdotdecimal" name="rdnt:MedicalMalpracticeDeductiblePerIncidence" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE3Njg_7dd542bc-74cf-4ee8-94c0-6d398fc8894c">10,000</ix:nonFraction></ix:nonFraction> per incidence for the years ended December 31, 2020 and December 31, 2019, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2020, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents. We have recorded liabilities as of December 31, 2020 and 2019 of $<ix:nonFraction unitRef="usd" contextRef="if0aee577b90c4f58aa31701ba3a01b9b_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SelfInsuranceReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2MjA4MA_4fc25466-3734-4fba-8a21-26e370053fb2">6.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic130af0a16044225945a7112208da137_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SelfInsuranceReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2MjA2MA_39fe8447-bd3e-4231-8ac9-42aa8e096af5">4.9</ix:nonFraction> million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="id1ceb3ba97d94973a11d2b58826b831c" continuedAt="i90730d09c8e84e3b964fdb2b8a57a479"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0230576efa7a4d36a2cad15226e4e78a">Shield for a stop loss policy that provides coverage for any claims that exceed $<ix:nonFraction unitRef="usd" contextRef="ifce3d08cb6c9413a851bd3ff47c40964_I20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:MedicalInsuranceStopLossPolicyClaimAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjI2OTc_e3748c07-82bb-4559-9a42-e20252b4f74a">250,000</ix:nonFraction> up to a maximum of $<ix:nonFraction unitRef="usd" contextRef="ibf9ac2491d4342e0b58df2c8c84ae62b_I20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:MedicalInsuranceStopLossPolicyClaimAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjI3MTk_e17f6aad-4332-4367-bced-2bedfb7b00af">1.0</ix:nonFraction> million in order for us to limit our exposure for unusual or catastrophic claims.</ix:continuation>&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:PostemploymentBenefitPlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3OTM_53250e6c-1f8e-4001-95a7-b2a5762e8c3f" escape="true">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.</ix:nonNumeric> We can elect to provide a matching contribution in the amount to a maximum of <ix:nonFraction unitRef="number" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="3" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjMyNDI_f1ff3039-9b51-4f75-8251-a4e5c5fc5f87">1.0</ix:nonFraction>% per <ix:nonFraction unitRef="number" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjMyNDk_04ba74e7-7e25-4e5c-adb6-088be440b2c5">4.0</ix:nonFraction>% of employee contribution, and have done so since 2017.  We contributed $<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjMyOTg_5798d978-2297-48ce-a907-ec8e4b442701">2.9</ix:nonFraction> million in matching for the year ended December 31, 2019 and have elected <ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DefinedContributionPlanCostRecognized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzI5ODUzNDk5MTQ2Mg_fe260aa1-5e96-4b96-9ec5-3694c3e4326e">no</ix:nonFraction>t to fund a matching contribution for the plan year ended December 31, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="rdnt:LossandOtherUnfavorableContractsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Mzk_7d3d447b-da49-47fd-8c9d-f423621da3f7" escape="true">LOSS AND OTHER UNFAVORABLE CONTRACTS &#8211; We assess the profitability of our contracts to provide management services to our contracted physician groups and identify those contracts where current operating results or forecasts indicate probable future losses. Anticipated future revenue is compared to anticipated costs and if the anticipated future cost exceeds the revenue, a loss contract accrual is recorded. In connection with the acquisition of Radiologix in November&#160;2006, we acquired certain management service agreements which met this criterion and recorded to other non-current liabilities an $<ix:nonFraction unitRef="usd" contextRef="icd66928c30e1473b9c9c069d01b5bdbb_I20061130" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ContractLossAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjQwMDE_b4a155ce-7be1-41ba-951b-f751894474bc">8.9</ix:nonFraction> million loss contract accrual.  Of the $<ix:nonFraction unitRef="usd" contextRef="ibae6485d220c4366bf04745e679dee34_I20181231" decimals="-5" name="rdnt:ContractLossAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjQwMzU_ff3f2b61-cf29-4b80-8cd1-46aa0d4c4f9e">4.6</ix:nonFraction> million ending balance at December 31, 2018, approximately $<ix:nonFraction unitRef="usd" contextRef="i964d58a775bd4fa199e750e6ee03db8e_I20190228" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjQwODI_f224ab2e-b39e-4dda-abf5-80897dc6449c">4.0</ix:nonFraction> million, ($<ix:nonFraction unitRef="usd" contextRef="i964d58a775bd4fa199e750e6ee03db8e_I20190228" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjQwODc_dc1bc7e6-8590-4e74-8e2a-a79ae8091a1f">2.8</ix:nonFraction> million net of taxes), was settled against the purchase consideration of Hudson Valley Radiology Associates, P.L.L.C. (HVRA) by our VIE entity Lenox Hill Radiology and Medical Associates, P.C. and the remaining balance of approximately $<ix:nonFraction unitRef="usd" contextRef="ibae6485d220c4366bf04745e679dee34_I20181231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:ContractLossAccrualWrittenOff" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjQzMTg_6c2fd2f7-945b-4603-a0a8-b111ea553764">558,000</ix:nonFraction> was written off upon ending a contract with a physician group.  See Note 4, Facility Acquisitions and Dispositions for further information on the purchase of HVRA.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MDg_408ee88a-8edc-4394-91ee-e6347a3488de" escape="true">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the Restated Plan <ix:nonFraction unitRef="shares" contextRef="i40918c356ba546019d9cf3855b255d7a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjU1OTE_c8a90d81-1a02-488d-b6db-9945fd75b006">14,000,000</ix:nonFraction> shares of common stock. We can issue options, stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options and warrants generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE1Ng_34d0b0f5-d4d7-4f53-b8d4-f97aa42926e1">three</span> to <ix:nonNumeric contextRef="i59d8b9f6e0ef49d4a4d3fe5016d69357_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjU5MzQ_3a100b69-6d8c-4195-85b7-5839270a938a">five years</ix:nonNumeric> and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE2OQ_cb2940f3-3de2-419f-b70c-92ae0342fb0b">five</span> to <ix:nonNumeric contextRef="i59d8b9f6e0ef49d4a4d3fe5016d69357_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjU5NTY_c7c5541e-8229-49b2-8899-960833c5bd47">ten years</ix:nonNumeric> from date of grant.  The compensation expense associated with option grants is calculated based on a valuation model, typically the Black&#8211;Scholes model, which requires certain management assumptions with respect to volatility.  The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 11, Stock-Based Compensation, for more information.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA4MDU_47cde96f-63be-44ab-b083-559f415374f7" escape="true">FOREIGN CURRENCY TRANSLATION &#8211; The functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NTU_8851e51d-5208-464f-bf67-84b885265576" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPREHENSIVE (LOSS) INCOME &#8211; Accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying comprehensive income (loss) and its components. Our unrealized gains or losses on foreign currency translation adjustments and our interest rate cap and swap agreements are included in comprehensive income (loss). The components of comprehensive income (loss) for the three years in the period ended December 31, 2020 are included in the consolidated statements of comprehensive income (loss).</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Mzg_046aa217-a3f2-4277-8e14-07cbe6af9115" escape="true">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i90730d09c8e84e3b964fdb2b8a57a479" continuedAt="i83c0ccf59fbd4e449eed4f07c07c05ec"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the second quarter of 2019, we accrued a liability of $<ix:nonFraction unitRef="usd" contextRef="i4b4b71ee39b549678fe63c62bb7e85e5_I20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyAccrualAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjg2MzE_10d2b941-43c8-4fc1-bd8d-3b62202ac414">2.3</ix:nonFraction> million related to allegations by the US Attorney's Office for the Western District of New York that RadNet submitted certain claims which incorrectly identified the physician who furnished the radiology services.&#160; The final settlement, which admits no wrong-doing on behalf of RadNet, was $<ix:nonFraction unitRef="usd" contextRef="i50d9608d8beb4655b129134c49d35159_D20190901-20190930" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjg5MTY_e25e79db-33ef-46a0-8c19-ff7536e8222c">2.2</ix:nonFraction> million&#160;and paid in September 2019.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA4MTI_09381dc0-d8c0-413d-94b6-e23beb022d06" continuedAt="ibceab909b1414f3b8f31e0be9e95bfaa" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 CAPS</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2016, we entered into <ix:nonFraction unitRef="numberofagreement" contextRef="i4d8112539b844f619adaf708f61bd146_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzI5ODUzNDkzMDYzNw_0b89ed67-fff8-4069-b74a-81afd5a15b23">two</ix:nonFraction> forward interest rate cap agreements ("2016 Caps"). The 2016 Caps matured in September and October 2020. The 2016 Caps had notional amounts of $<ix:nonFraction unitRef="usd" contextRef="i67ac9c2904dc49e2ac4bc506d54d17e5_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjkxODI_58f417b5-5393-4bc5-93c1-c72fa542ed51">150,000,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="id90a9127362e454283d08c7e3fd0c691_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjkxODk_b8d1e272-5ede-4418-9b60-45dd492ed5d0">350,000,000</ix:nonFraction>, respectively, which were designated at inception as cash flow hedges of future cash interest payments associated with portions of our variable rate bank debt. Under these arrangements, we purchased a cap on 3 month LIBOR at <ix:nonFraction unitRef="number" contextRef="i34ed4d9f350d499789b3e42719f10a5b_I20201231" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjk0MTc_ec15ab51-82c5-4e56-8b85-69009710e236">2.0</ix:nonFraction>%. We were liable for a $<ix:nonFraction unitRef="usd" contextRef="i4d8112539b844f619adaf708f61bd146_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjk0NDE_452adb06-d5b6-4fa8-a20f-3f21f57bf6dc">5.3</ix:nonFraction> million premium to enter into the caps which accrued to current liabilities on our balance sheet and paid over the life of the 2016 Caps.  The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MTM_0778aa7e-5829-4b0c-a21c-cd3a9724d074" continuedAt="i2cd21204b3f146c1af58b434570a1052" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:28.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.389%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i654a8e8ed7bb4f3bbb5cd9c288d0b69d_D20200101-20201231" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjgzZTQ0ZDJlODIyNzQ0YjQ4NTE2ZGQ5ZGIxZjQyYjU1L3RhYmxlcmFuZ2U6ODNlNDRkMmU4MjI3NDRiNDg1MTZkZDlkYjFmNDJiNTVfMy0xLTEtMS0w_77fb19aa-2a20-4641-9e84-6c1ef08bf0e4">788</ix:nonFraction></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ee370d9a22543fb9f2dab8cc9aa4803_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjgzZTQ0ZDJlODIyNzQ0YjQ4NTE2ZGQ5ZGIxZjQyYjU1L3RhYmxlcmFuZ2U6ODNlNDRkMmU4MjI3NDRiNDg1MTZkZDlkYjFmNDJiNTVfNC0xLTEtMS0w_c914d880-19a8-4fbe-851b-e6218a8a01e7">4,383</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79371fc04e834bfcaea740fd6bc52153_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjgzZTQ0ZDJlODIyNzQ0YjQ4NTE2ZGQ5ZGIxZjQyYjU1L3RhYmxlcmFuZ2U6ODNlNDRkMmU4MjI3NDRiNDg1MTZkZDlkYjFmNDJiNTVfNS0xLTEtMS0w_1dba6daf-6d4b-43b9-b334-2d2f5a4b6b7d">2,876</ix:nonFraction></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 SWAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into <ix:nonFraction unitRef="numberofagreement" contextRef="if60e961bba2a4bbfae302a70f01ee39d_I20190630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DerivativeAssetNumberOfInstrumentsHeld" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzMzOTYyMQ_2e04cff3-b03a-4553-b4b6-9d517154dbfd">four</ix:nonFraction> forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $<ix:nonFraction unitRef="usd" contextRef="if60e961bba2a4bbfae302a70f01ee39d_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzA0MTY_3be123ec-e3f5-4af6-b485-da78a0ff308a">500,000,000</ix:nonFraction>, consisting of two agreements of $<ix:nonFraction unitRef="usd" contextRef="ib856840ca6324eeba1a6b1494e0c38f1_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzA0NTI_66292264-73ff-4ace-8439-a1ae70b4a55c">50,000,000</ix:nonFraction> each and two agreements of  $<ix:nonFraction unitRef="usd" contextRef="i61555f9eb90b46f688385e53cb2d0b54_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzA0ODM_01446590-3ccf-4eea-987f-7d2badfa8b9d">200,000,000</ix:nonFraction> each.   The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional. Under these arrangements, we arranged the 2019 swaps with locked in 1 month LIBOR rates at <ix:nonFraction unitRef="number" contextRef="i0b6ec598f73740f98940d9eb5201b90a_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzA4NDk_9edb138e-5461-4a36-a084-b80b30fdb894">1.96</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="if4f79b8708a34406aeaa4254bff7bf57_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzMzOTYwNw_5e3688e9-e53d-4206-bfc5-2ad230d70fda">100,000,000</ix:nonFraction> notional and at <ix:nonFraction unitRef="number" contextRef="i9921f768cd544944875eaeacb5eb5af9_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzA4ODM_facc6d04-b147-4995-8686-b7731047fb6e">2.05</ix:nonFraction>% for the $<ix:nonFraction unitRef="usd" contextRef="iab09020dae044987a27d5a27395d9975_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzMzOTYxNA_74e1cdf0-c334-40a4-ac9a-b2fc796ed787">400,000,000</ix:nonFraction> notional. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $<ix:nonFraction unitRef="usd" contextRef="iab09020dae044987a27d5a27395d9975_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk1NA_74e1cdf0-c334-40a4-ac9a-b2fc796ed787">400,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="i9921f768cd544944875eaeacb5eb5af9_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk2MQ_facc6d04-b147-4995-8686-b7731047fb6e">2.05</ix:nonFraction>% due October 2025 and our $<ix:nonFraction unitRef="usd" contextRef="if4f79b8708a34406aeaa4254bff7bf57_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk2NQ_5e3688e9-e53d-4206-bfc5-2ad230d70fda">100,000,000</ix:nonFraction> notional interest rate swap contract locked in at <ix:nonFraction unitRef="number" contextRef="i0b6ec598f73740f98940d9eb5201b90a_I20190630" decimals="INF" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk3Mg_9edb138e-5461-4a36-a084-b80b30fdb894">1.96</ix:nonFraction>% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="iab09020dae044987a27d5a27395d9975_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk3Ng_74e1cdf0-c334-40a4-ac9a-b2fc796ed787">400,000,000</ix:nonFraction> notional and after July 1, 2020 for the $<ix:nonFraction unitRef="usd" contextRef="if4f79b8708a34406aeaa4254bff7bf57_I20190630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetNotionalAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk4MA_5e3688e9-e53d-4206-bfc5-2ad230d70fda">100,000,000</ix:nonFraction> notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $<ix:nonFraction unitRef="usd" contextRef="ifb0a905a8db84850b58584bad8c4af86_D20200701-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk5MA_b358f117-a13f-4f30-9c35-8d0fa1acbb64">24.4</ix:nonFraction> million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $<ix:nonFraction unitRef="usd" contextRef="ifb0a905a8db84850b58584bad8c4af86_D20200701-20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk5Nw_5348f221-5880-44bf-b1f0-e4352474237a">0.4</ix:nonFraction> million per month and continuing at approximately $<ix:nonFraction unitRef="usd" contextRef="iccd401f36a0c470ea4320cd33aebeea3_D20231101-20251031" decimals="-5" format="ixt:numdotdecimal" name="rdnt:MonthlyAmortizationOfDeferredHedgeGains" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjc0ODc3OTE4OTgxNA_1a2b1d72-c379-44f7-9baf-166e66eba75a">0.3</ix:nonFraction> million through October 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2cd21204b3f146c1af58b434570a1052" continuedAt="i70057cc8e66e4dc0b5ea50d67cad4148">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):</ix:continuation></span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i83c0ccf59fbd4e449eed4f07c07c05ec" continuedAt="i964c0978b4474aaa94632f6998ca502e"><ix:continuation id="i70057cc8e66e4dc0b5ea50d67cad4148"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ibceab909b1414f3b8f31e0be9e95bfaa"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:28.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.065%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Effective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Loss Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="icc5d103d5dec4837a37b5436811017d4_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjc5ZDZhZDYyNjkxNTQ1OWVhMGY4YzY4MjE4YzdlNDVjL3RhYmxlcmFuZ2U6NzlkNmFkNjI2OTE1NDU5ZWEwZjhjNjgyMThjN2U0NWNfMy0xLTEtMS0yNzY4_6197dc76-3f03-43c0-87a7-dae4a851125a">20,160</ix:nonFraction>)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i46e5bfcb59a44381930228cdbedb0c73_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjc5ZDZhZDYyNjkxNTQ1OWVhMGY4YzY4MjE4YzdlNDVjL3RhYmxlcmFuZ2U6NzlkNmFkNjI2OTE1NDU5ZWEwZjhjNjgyMThjN2U0NWNfMy0xLTEtMS0w_3da0a911-95fc-4c7d-8c3d-f37bf96f2bf4">5,870</ix:nonFraction>)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of  loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="i2fefeb1f7013464bbd2ec16f399ab7af_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjJhM2ZhZDY5ZjE2NTQ4MDA5YWM1ZmYxNWI5NjBjNjM2L3RhYmxlcmFuZ2U6MmEzZmFkNjlmMTY1NDgwMDlhYzVmZjE1Yjk2MGM2MzZfMy0xLTEtMS0yODAz_0caa4c81-6817-4912-8bcf-38c083001f23">2,528</ix:nonFraction>)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(<ix:nonFraction unitRef="usd" contextRef="iee473bf952d14518a4aa17edb183780b_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjJhM2ZhZDY5ZjE2NTQ4MDA5YWM1ZmYxNWI5NjBjNjM2L3RhYmxlcmFuZ2U6MmEzZmFkNjlmMTY1NDgwMDlhYzVmZjE1Yjk2MGM2MzZfMy0zLTEtMS0yODEw_0c726bee-ba27-427e-9ece-aeaabf65c9ca">3,448</ix:nonFraction>)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3OTA_33839724-4615-4a4d-8230-dbe5f68ae04b" continuedAt="ie0b9f1debdad4c088b95955ac7254194" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MTA_a1952d5a-5a53-4e22-aa3d-4cb48b4f3018" continuedAt="i6bde8544dc6c48b08ce4162b553a59d1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 CAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic23c6521ea5a4ca0beeee403496fb2b9_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfMy0xLTEtMS0w_20078fb6-81e9-46b2-b845-1440e3eaa2d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3f8d60d96a441aba20d06c47362b2b0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfMy0zLTEtMS0w_b00bc10c-eec9-4e73-8593-040a9789bf49">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i565b0d00fc96454389f20aa5dbe8bf55_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfMy01LTEtMS0w_7c7860d0-6ccb-429c-8b16-84b5604fc2ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9421b4c3defc4cf7b17e066a06b1caa7_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfMy03LTEtMS0w_38c569d1-e17c-4904-b71c-cce9d93b4023">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ad49d0deed647c0a498c2366fc5efb5_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfNC0xLTEtMS0w_037b456e-efb5-4452-b689-c8085e5b7b4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d6a973db2ba408383529fed3405f008_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfNC0zLTEtMS0w_90d7371d-ac9a-41a4-a875-007f45cd7c80">37,989</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i311a05ca14ed4565b8093ad84dc6c1f8_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfNC01LTEtMS0w_c9d4c8ea-f0dc-41cd-9d62-9d05582d5bdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a0f55d2766d408490715ca7893da207_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfNC03LTEtMS0w_b77c992b-f364-4acb-ac3d-ebbf922b6c2f">37,989</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 CAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50b5d4270b9a405a974ddd1764a0c39e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfMy0xLTEtMS0w_192794aa-aa2d-4798-afa9-75ce8ad0bbbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75a252a681e34b079a5a7f189f4bf384_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfMy0zLTEtMS0w_82bd990a-dbea-4550-8dc7-51da02e7190e">1,081</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48064a0601f7427da1f6463f58e86cf6_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfMy01LTEtMS0w_61598000-59c9-4347-b2d6-16d8f818228e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc527a4818a643d49fe09cfa85c4c780_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfMy03LTEtMS0w_868f1abb-4f7d-4764-aaa9-65e5066bb56c">1,081</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fe005478a77480f8ca9f42839c796df_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfNC0xLTEtMS0xNzU0_0e7e2779-3081-4c43-8058-70f58b3e52c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5bf62651ffd4565b1634ab1e49d1658_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfNC0zLTEtMS0xNzU0_ab0e7e54-5749-41b7-88db-db93ceb955c4">9,477</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic953d4eafcbf4d7cb0bf03e5e5a554d1_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfNC01LTEtMS0xNzU0_e3ba7b28-52a2-4b14-b9bc-6b1e3bc1a040">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c602f38cb744dff881ca06c457467bc_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfNC03LTEtMS0xNzU0_117933a2-4197-4a63-b6b9-8e697a027ef6">9,477</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i964c0978b4474aaa94632f6998ca502e" continuedAt="i592d2f5911614c3592957d6a88d12536"><ix:continuation id="ie0b9f1debdad4c088b95955ac7254194"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i6bde8544dc6c48b08ce4162b553a59d1"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc5f93ef9014432796ae78b5a5f1277a_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmVhMWIxM2E4NmY3MzRmMTc4ODQ2MDNlZjRkYTAwYmRhL3RhYmxlcmFuZ2U6ZWExYjEzYTg2ZjczNGYxNzg4NDYwM2VmNGRhMDBiZGFfMi0xLTEtMS0w_1a079a05-2582-4b95-9646-77ddb301d6cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie29a29bde2bc4177a697491ea4430974_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmVhMWIxM2E4NmY3MzRmMTc4ODQ2MDNlZjRkYTAwYmRhL3RhYmxlcmFuZ2U6ZWExYjEzYTg2ZjczNGYxNzg4NDYwM2VmNGRhMDBiZGFfMi0zLTEtMS0w_8c24258f-db90-4f27-8057-dd43ea0b68e4">661,640</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie15c1fc805524eb3949f0526154afb88_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmVhMWIxM2E4NmY3MzRmMTc4ODQ2MDNlZjRkYTAwYmRhL3RhYmxlcmFuZ2U6ZWExYjEzYTg2ZjczNGYxNzg4NDYwM2VmNGRhMDBiZGFfMi01LTEtMS0w_7624892e-4a60-40c8-9f54-eed0f590fde0">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1092fa5159474e67b00fbddb2636707c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmVhMWIxM2E4NmY3MzRmMTc4ODQ2MDNlZjRkYTAwYmRhL3RhYmxlcmFuZ2U6ZWExYjEzYTg2ZjczNGYxNzg4NDYwM2VmNGRhMDBiZGFfMi03LTEtMS0w_3e59f439-b316-4b95-a653-2d74cca4c21d">661,640</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmVhMWIxM2E4NmY3MzRmMTc4ODQ2MDNlZjRkYTAwYmRhL3RhYmxlcmFuZ2U6ZWExYjEzYTg2ZjczNGYxNzg4NDYwM2VmNGRhMDBiZGFfMi05LTEtMS0w_15c5439e-71f2-4de7-8396-bc4bd43489cb">662,403</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f52dc1b8df24f608f50e003a77157f1_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmI2MTkwZWViODQyYjRhYTc5MTlkZWU2YTU0NjRiYjk0L3RhYmxlcmFuZ2U6YjYxOTBlZWI4NDJiNGFhNzkxOWRlZTZhNTQ2NGJiOTRfMi0xLTEtMS0w_6957c13c-10e1-4b9e-a865-78bfa8e1488b">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95972ba545c2413db9a96bb8f5a78f19_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmI2MTkwZWViODQyYjRhYTc5MTlkZWU2YTU0NjRiYjk0L3RhYmxlcmFuZ2U6YjYxOTBlZWI4NDJiNGFhNzkxOWRlZTZhNTQ2NGJiOTRfMi0zLTEtMS0w_f0d64555-4fa4-4c1c-98d0-ea611fce93c6">708,948</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id37d5b32618d4989a2d4ae3321a56a10_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmI2MTkwZWViODQyYjRhYTc5MTlkZWU2YTU0NjRiYjk0L3RhYmxlcmFuZ2U6YjYxOTBlZWI4NDJiNGFhNzkxOWRlZTZhNTQ2NGJiOTRfMi01LTEtMS0w_9165e921-ef81-4ded-91f2-00de53bdde9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if56b240e264240e4b120a420105c6f77_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmI2MTkwZWViODQyYjRhYTc5MTlkZWU2YTU0NjRiYjk0L3RhYmxlcmFuZ2U6YjYxOTBlZWI4NDJiNGFhNzkxOWRlZTZhNTQ2NGJiOTRfMi03LTEtMS0w_df8c62bb-ef10-47bd-b7a3-9943bf6905bb">708,948</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmI2MTkwZWViODQyYjRhYTc5MTlkZWU2YTU0NjRiYjk0L3RhYmxlcmFuZ2U6YjYxOTBlZWI4NDJiNGFhNzkxOWRlZTZhNTQ2NGJiOTRfMi05LTEtMS0w_bfaafb2b-ec88-43ca-a500-100d37cdddfb">705,699</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays revolving credit facility had <ix:nonFraction unitRef="usd" contextRef="i8e91f8345bde4d118909d99c801fab52_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzM1OTc_58221b12-f162-4271-b56b-efbd81c74859"><ix:nonFraction unitRef="usd" contextRef="iee2fd20ee7b4470a880084f9e273f9a5_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzM1OTc_858e8509-06f9-4875-ad6c-20cbdec8cbd0">no</ix:nonFraction></ix:nonFraction> aggregate principal amount outstanding as of December 31, 2020 and December 31, 2019, respectively.  Our SunTrust revolving credit facility had <ix:nonFraction unitRef="usd" contextRef="ie40d3a8fbcef47b19505b8259baa9c2d_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzM3NDA_23cda816-02d2-4738-84cf-d266f681a2ac"><ix:nonFraction unitRef="usd" contextRef="i1a358573454349cf8e2a7aa01f671b00_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzM3NDA_f8d81cd3-87fe-4731-aff8-c167481f117e">no</ix:nonFraction></ix:nonFraction> aggregate principal amount outstanding as of December 31, 2020 and December 31, 2019, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and SunTrust term loans. Level 2 inputs primarily related to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i592d2f5911614c3592957d6a88d12536" continuedAt="i70b492feb20a4330818be8a1bd24d9b9"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Mjc_1b437c43-88fa-4f9d-b2bb-00c6436c8a4a" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EARNINGS PER SHARE - <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Nzk_2ce9118a-e926-4d9d-ba4d-a50d8d4fd1d7" continuedAt="i106b6d0234f545039601e29da0ca66bb" escape="true">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</ix:nonNumeric></span></div><ix:continuation id="i106b6d0234f545039601e29da0ca66bb"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:62.243%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.630%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.631%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMi0xLTEtMS0w_1371a80a-3849-404f-aca0-8ac2adb82d39">14,840</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMi0zLTEtMS0w_0abc2ada-9431-4bdf-84f6-b42ce67e9ba7">14,756</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMi01LTEtMS0w_8da59ef7-540a-40b7-9939-8e5753ae6768">32,243</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNS0xLTEtMS0w_9a40c5a9-02c3-4080-a162-aed52d356afd">50,891,791</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNS0zLTEtMS0w_3b2c88c5-57df-4ede-a3ad-3d94ee7a8d5e">49,674,858</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNS01LTEtMS0w_b8e484bc-2dde-4cc1-8bbb-7556f349d2b4">48,114,275</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net (loss) income per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNi0xLTEtMS0w_09443510-284a-4abb-9058-c3abe72b45e5">0.29</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNi0zLTEtMS0w_9ba57f85-fa2c-473e-90e8-77d28cec4435">0.30</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNi01LTEtMS0w_48e9e998-ac2f-49dc-83da-39fcce39d412">0.67</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOC0xLTEtMS0w_800e1935-7415-4b0c-bd4b-ac764a1159b5">50,891,791</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOC0zLTEtMS0w_a633b334-7383-4773-a408-2098a4bf2a47">49,674,858</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOC01LTEtMS0w_98b96434-3edc-44f9-9c93-f53f2f9c2dda">48,114,275</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="0" format="ixt:zerodash" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOS0xLTEtMS0w_903485a1-4677-4e86-af7d-e01cb2498215">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOS0zLTEtMS0w_a8ad4d10-ff7f-455b-943d-20eb1d69c6f3">208,963</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOS01LTEtMS0w_0b4a0c72-71f1-4080-b277-03ab09b45ee5">180,631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTAtMS0xLTEtMA_d266e57c-2fe9-46cc-9c33-05d555ae5d75">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTAtMy0xLTEtMA_bac5a474-d4ba-4d52-a1fd-59424b379e57">360,185</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTAtNS0xLTEtMA_06d29ba2-3c18-4ae0-9e61-6fd0970094ba">384,093</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTEtMS0xLTEtMA_5d8f26cf-92cc-4151-aefb-6924f98d2a51">50,891,791</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTEtMy0xLTEtMA_06f20840-b0e5-4b7b-86e4-cce1e828c89e">50,244,006</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTEtNS0xLTEtMA_8feb44ab-6137-4225-b0bf-b275d827f63a">48,678,999</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net (loss) income per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTItMS0xLTEtMA_21e5a0e9-437f-4cbf-bc94-26dbe9f349b2">0.29</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTItMy0xLTEtMA_9813f89d-2a4a-440c-9fee-38acf05c5000">0.29</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTItNS0xLTEtMA_9da0eb3b-fbca-4958-911e-0d645a839c5b">0.66</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bceea0558df4aa7a7b357ca906e3844_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtMS0xLTEtMzU3NQ_c6a7c3b2-a23e-4b17-ac27-865e7721c881">329,159</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if1c392fb7a5b4f1bb1f098f0d9a1675e_D20190101-20191231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtMy0xLTEtMzU4MQ_0ea10f8c-8dd1-410f-90b6-b0fa744b120f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if76464750e804b1b92602d1d98c066fa_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtNS0xLTEtMzU4NQ_039a5268-ed6b-4490-ba92-859e4c155b5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtMS0xLTEtMA_39baba8c-f73b-40ee-96e8-b720ab173db8">554,444</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtMy0xLTEtMA_b900cc14-db77-4492-85c6-4fbfb2327d95">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtNS0xLTEtMA_0c090f5c-6c18-4c2c-a13c-3a36fc7dfb95">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:continuation></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzI5ODUzNDk5MTQ1Ng_38d894d1-65d2-4945-a641-d32e40bbcc7d" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY INVESTMENTS AT FAIR VALUE- As of December 31, 2020, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.</span></ix:nonNumeric></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial <ix:nonFraction unitRef="number" contextRef="i473019f6980c4551a0817c8df1b09e13_I20170324" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU1NDg_31d7c40c-2088-44c1-8a45-b8bf131dfe12">12.50</ix:nonFraction>% equity interest in Medic Vision - Imaging Solutions Ltd for $<ix:nonFraction unitRef="usd" contextRef="i9ded1c2d91fb4066b0d52f289dbc6bf1_D20170324-20170324" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU2MTE_6609526a-921d-49f5-a599-9c514788d222">1.0</ix:nonFraction> million. We also received an option to exercise warrants to acquire up to an additional <ix:nonFraction unitRef="number" contextRef="i473019f6980c4551a0817c8df1b09e13_I20170324" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU3MDI_31d7c40c-2088-44c1-8a45-b8bf131dfe12">12.50</ix:nonFraction>% equity interest for $<ix:nonFraction unitRef="usd" contextRef="i473019f6980c4551a0817c8df1b09e13_I20170324" decimals="-5" name="rdnt:EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU3MjU_b2838e39-cc03-4944-abc4-01d291b85b0f">1.4</ix:nonFraction> million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional <ix:nonFraction unitRef="number" contextRef="i2dbe4948ad594309b6b27c4836c67b68_D20180301-20180301" decimals="INF" name="rdnt:EquityMethodInvestmentsOwnershipInterestPercentageAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU4ODk_a4e32cec-c249-4951-8f54-a119346febaa">1.96</ix:nonFraction>% for $<ix:nonFraction unitRef="usd" contextRef="i2dbe4948ad594309b6b27c4836c67b68_D20180301-20180301" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU4OTY_65a624af-62a2-4afc-a001-efe07dfd5e8d">200,000</ix:nonFraction>. Our initial equity interest has been diluted to <ix:nonFraction unitRef="number" contextRef="i2dbe4948ad594309b6b27c4836c67b68_D20180301-20180301" decimals="4" name="rdnt:EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU5NDg_39b195b6-b006-4cf8-a80b-5ea9a95c3e84">12.25</ix:nonFraction>% and our total equity investment stands at <ix:nonFraction unitRef="number" contextRef="i4843fa912a25453896424af36c06d915_I20201231" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU5OTM_4b3ab6ef-35fc-4f27-9048-b47793dd6d20">14.21</ix:nonFraction>%.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as we exercise no significant influence over Medic Vision&#8217;s operations, the investment is recorded at its cost of $<ix:nonFraction unitRef="usd" contextRef="i4843fa912a25453896424af36c06d915_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzYxNTM_002db41e-ef27-415e-84eb-08929589eaa3">1.2</ix:nonFraction> million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was noted as of the year ended December 31, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased <ix:nonFraction unitRef="shares" contextRef="id8e2a3314e2147c8878b4abe3dfe0373_D20180201-20180201" decimals="-5" name="rdnt:EquityMethodInvestmentSharesPurchased" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzY1MTk_91d46066-380a-46d3-8d9a-fd177b478fbb">2.1</ix:nonFraction> million preferred shares in Turner Imaging Systems for $<ix:nonFraction unitRef="usd" contextRef="id8e2a3314e2147c8878b4abe3dfe0373_D20180201-20180201" decimals="-5" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzY1Nzc_ae7af38a-3b7a-46ee-8700-c11a17ca8dcc">2.0</ix:nonFraction> million.  On January 1, 2019 we funded a convertible promissory note in the amount of $<ix:nonFraction unitRef="usd" contextRef="i5596086792694e92ace9a030c37a797a_I20190101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzY2NjY_89aa9278-3be6-47db-a6bc-a5de77df5c56">143,000</ix:nonFraction> that converted to an additional <ix:nonFraction unitRef="shares" contextRef="ie5c53a008eee4b64b7e27857cbb84f0d_I20191011" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzY3MDE_01df74f5-1267-402c-8d59-f42afdf77044">80,000</ix:nonFraction> preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2020.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i70b492feb20a4330818be8a1bd24d9b9" continuedAt="i9577b9c3b586456e9c13575fdbbbd496"><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $<ix:nonFraction unitRef="usd" contextRef="ie7a0400670894eb7a7e0b89fd33e8d63_D20191105-20191105" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzcxMDI_b6370806-a491-4a27-817d-87fb261e9f69">1.0</ix:nonFraction> million and also loaned the company $<ix:nonFraction unitRef="usd" contextRef="ie7a0400670894eb7a7e0b89fd33e8d63_D20191105-20191105" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToFundLongtermLoansToRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzcxMzM_ce3c3f5e-9520-4ebd-b8ed-9f5b67b6f8b4">2.5</ix:nonFraction> million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA4MDY_8e0d8712-2e85-4034-9131-7800673419be" continuedAt="i6795f5a47cba483bb11be308c59689b8" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have <ix:nonFraction unitRef="joint_venture" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="INF" name="rdnt:NumberofUnconsolidatedJointVentures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzcyNzM_35e5612b-8421-4d32-8e74-7c508e395771">13</ix:nonFraction> unconsolidated joint ventures with ownership interests ranging from <ix:nonFraction unitRef="number" contextRef="i39bb82566bf248d0b0fd688dde04dbe9_D20200101-20201231" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzczNDQ_6a603801-ff7c-4ff9-adb9-aa849d36ea30">35</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ice6bd37091d347f3832020ccc4810992_D20200101-20201231" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzczNTA_bb00da08-8d83-44ca-8649-4ec0446e52d7">55</ix:nonFraction>%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture formations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective November 1, 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial control of our Arizona centers.  We hold a <ix:nonFraction unitRef="number" contextRef="i84c20c51ca704a07878759c0f075f79e_I20201101" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1NjkwMg_02f60118-c4a4-44d6-af0f-6ceb9947676d">49</ix:nonFraction>% economic interest and CHI holds the majority <ix:nonFraction unitRef="number" contextRef="ieef3f7dbd23c40ba8dec17264c4c7404_I20201101" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1NjkwOA_6c5bc240-8533-478b-981a-8843ea206b65">51</ix:nonFraction>% economic interest, respectively in ADRG and account for the venture under the equity method .  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $<ix:nonFraction unitRef="usd" contextRef="ice510c28777843f7908e514b19c6921c_D20200801-20200831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInterestInJointVenture" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0NDU5OQ_36717efd-a02b-43fb-8925-07ac32e92e68">1.6</ix:nonFraction> million in support of its expanded operations.  We maintain our <ix:nonFraction unitRef="number" contextRef="i03c69569d3d64c1ca16e558b4cf75bee_I20190101" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0NDYwNg_da769b8a-021f-46db-b999-0613a96abfd2">35</ix:nonFraction>% economic interest in the partnership.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of joint venture interest:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2017, we formed in conjunction with Cedars Sinai Medical Center (&#8220;CSMC&#8221;) the Santa Monica Imaging Group, LLC (&#8220;SMIG&#8221;), consisting of two multi-modality imaging centers located in Santa Monica, CA with RadNet holding a <ix:nonFraction unitRef="number" contextRef="idd3a6d6c4d174d43891d0ceddc82c6fa_I20170401" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzgzNDY_e0bf5041-092d-4366-8314-15a1ecf72e99">40</ix:nonFraction>% economic interest and CSMC holding a <ix:nonFraction unitRef="number" contextRef="iacffbad6df7e4b20a00f3fce533dc4dc_I20170401" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzgzODY_5320ff6c-0608-491e-8e1a-fd421c42582c">60</ix:nonFraction>% economic interest.  RadNet accounts for our share of the venture under the equity method.  On January 1, 2019, CSMC purchased from the us an additional <ix:nonFraction unitRef="number" contextRef="ied3dcc77eee243f38eab75f3a00f0e81_I20190101" decimals="INF" name="rdnt:AdditionalEquityInterestAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2NjA2OQ_ce13212b-1e35-4d7a-a7d8-fc1cff05aa1d">5</ix:nonFraction>% economic interest in SMIG valued at $<ix:nonFraction unitRef="usd" contextRef="ied3dcc77eee243f38eab75f3a00f0e81_I20190101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentOwnedAtFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzg1ODA_9ede96a6-5b10-4c95-9df8-dd3ef859d798">134,000</ix:nonFraction>.  As a result of the transaction, our economic interest in SMIG has been reduced to <ix:nonFraction unitRef="number" contextRef="i03c69569d3d64c1ca16e558b4cf75bee_I20190101" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzg2Njc_da769b8a-021f-46db-b999-0613a96abfd2">35</ix:nonFraction>%.  We recorded a loss of $<ix:nonFraction unitRef="usd" contextRef="i7b637d843dc04b2db741ddae2d1a65cd_D20190101-20190101" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzg2OTQ_c2745603-e7e1-4560-abfa-33c1fd905257">2,000</ix:nonFraction> on the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in control of existing joint ventures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 6, 2014, we acquired a <ix:nonFraction unitRef="number" contextRef="i1a886167e5d546978b5a20d615e9fc78_I20190731" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzg3OTg_9a13002a-15ec-483b-a454-c4fac8a06745">49</ix:nonFraction>% equity interest in Garden State Radiology Network, LLC ("GSRN") for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="ie59b21d255d147928f8d589fb25170fa_D20141006-20141106" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzg4OTE_afc6988a-802b-404d-86af-3b539a39a1f4">2.2</ix:nonFraction> million.  The venture consisted of two imaging centers located in New Jersey.  On August 1, 2019, the entity was dissolved by transferring ownership of the assets of the centers with each partner receiving full ownership of one center. See Note 4, Facility Acquisitions and Dispositions, for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2018 we acquired&#160;<ix:nonFraction unitRef="number" contextRef="i4c644318cb64465f94242234734b4336_I20180412" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzkyMzA_bd16b156-3695-4a82-8d56-0eb8afb99fe5">25</ix:nonFraction>%&#160;share capital in Nulogix, Inc. for cash consideration of&#160;$<ix:nonFraction unitRef="usd" contextRef="i92c0f7af41664881930d4f739dc6b4cb_D20180412-20180412" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzkyOTA_0529417c-788e-423b-9e15-b123c58d1bfc">2.0</ix:nonFraction> million.  On August 1, 2019 we completed via the issuance of RadNet common stock valued at $<ix:nonFraction unitRef="usd" contextRef="i0d288cd107d84361b2e08ab554ae5ed7_D20190801-20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzkzNzY_1c0bcd0a-ad4a-4502-892b-10b48e164454">1.5</ix:nonFraction> million, the acquisition of the remaining <ix:nonFraction unitRef="number" contextRef="i46ed970e221a4949933067bb7c822615_I20190801" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzk0MTM_ff1bec31-09b8-4d52-8455-9c87efe010e6">75</ix:nonFraction>% economic interest and we now consolidate the financial statements of Nulogix.  &#160;See Note 4, Facility Acquisitions and Dispositions, for further information.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, we obtained control over the operations of NJIN through an agreement with the other equity interest holder for no cash consideration.  As such, we consolidated the financial statements of NJIN effective that date.  The economic interest of each party remained the same after consolidation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NDE_fd904850-911f-40e6-85bc-0694c12e3e12" continuedAt="idbb89202d97a48d7b9e1c2cbcd8e9fb1" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2020 and December 31, 2019 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i9577b9c3b586456e9c13575fdbbbd496"><ix:continuation id="i6795f5a47cba483bb11be308c59689b8"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><ix:continuation id="idbb89202d97a48d7b9e1c2cbcd8e9fb1"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae6485d220c4366bf04745e679dee34_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfNS0xLTEtMS0w_e5d86ee0-badf-4b4b-89d5-d720ad37aa3d">37,973</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="rdnt:EquityContributionsJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfNi0xLTEtMS0w_adcbe00b-b572-42e4-a2e6-7ea3536d8d77">103</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfNy0xLTEtMS0w_4a18553d-8f59-4d16-81ef-705d0f24dc30">8,350</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of ownership interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfOC0xLTEtMS0w_2599c8c3-80ab-4d1b-a110-4f59569c4802">134</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dissolution of GSRN</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfOS0xLTEtMS0w_b514d41f-ac53-4336-bcb7-3a292f3dddf3">1,428</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix return of capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTAtMS0xLTEtMA_7b31861c-cb50-439c-be38-071c2ed312b9">792</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix change in control</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTEtMS0xLTEtMA_b295009f-1564-4ae3-9cde-5eac0d8d38ca">1,004</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTItMS0xLTEtMA_848e9941-70f1-480f-8fb8-2a88dba0b118">8,598</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTMtMS0xLTEtMA_c6cf268f-8a0b-40f6-9ad6-c61305f2b497">34,470</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:EquityContributionsJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfOS0xLTEtMS0zMDEx_671bee68-5237-4f19-be27-ed27f418ae33">1,635</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTAtMS0xLTEtMzAxMQ_5e5de49b-a239-4a00-8fb5-d98ea71c15bc">7,945</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTEtMS0xLTEtMzAxMQ_811d1859-21b7-4358-a894-b06555a73f21">9,522</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTItMS0xLTEtMzAxMQ_f4cac74c-b129-42e4-bd68-f0ea4e911922">34,528</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately  $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ManagementServiceFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0NDI2Nw_e4e4273b-5bd2-4017-9b59-f4d7bf5e94f7">11.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ManagementServiceFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0NDI4Nw_ddf5fd9f-3e3e-471e-b127-027d885af8a5">11.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ManagementServiceFees" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0NDMwMw_3b3b5be1-d1de-4fd3-a312-6f9da162b366">13.8</ix:nonFraction> million for the years ended December 31, 2020, 2019 and 2018, respectively . We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzI5ODUzNDkzMDYyMg_7479fe82-dd6a-42d8-86f3-85817b493e69" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2020 and 2019, respectively, and for the years ended December 31, 2020, 2019 and 2018, respectively, (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2554f6fee6574c18aa40868ebe1c695b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfMi0xLTEtMS0w_62c1a606-bc51-4268-a2e5-1408dae19c6b">27,085</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7055474fff84385849f9083f2f9de03_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfMi0zLTEtMS0w_41f06991-1c66-40e2-b6c3-7a1415dbfa32">27,427</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2554f6fee6574c18aa40868ebe1c695b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfMy0xLTEtMS0w_989db149-31d3-4c7a-aa91-3608d47c3e65">68,686</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7055474fff84385849f9083f2f9de03_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfMy0zLTEtMS0w_aa8f1c40-b389-42a1-b43b-e0c42886736f">61,037</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2554f6fee6574c18aa40868ebe1c695b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNC0xLTEtMS0w_b8b992e6-5204-4baa-bd14-6568d0375df7">12,545</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7055474fff84385849f9083f2f9de03_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNC0zLTEtMS0w_e12e6b28-5a40-43fa-815a-788f6531f287">9,217</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2554f6fee6574c18aa40868ebe1c695b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNS0xLTEtMS0w_06d6908c-9479-4ae2-aa5c-958d6a6cf8a3">21,582</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7055474fff84385849f9083f2f9de03_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNS0zLTEtMS0w_7e70d902-605e-4e56-ada0-43bece44451d">18,872</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNi0xLTEtMS0w_d64745ee-f854-4d69-8bdb-23f0989fe532">61,644</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentAggregateCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNi0zLTEtMS0w_f38e5095-e14b-41c9-8a6a-741b1ece6d8b">60,375</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNy0xLTEtMS0w_3d46efe7-73b7-40e3-9895-a5855f2d2043">28,079</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNy0zLTEtMS0w_2ee7597b-6f93-4745-a265-812bdc3df773">28,001</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfOC0xLTEtMS0w_b7b5ee8f-9bc9-47c9-a9f2-d1f8fbecb68b">6,449</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfOC0zLTEtMS0w_6cbaca4e-4e9a-4d67-85f2-b76e27c21489">6,469</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfOS0xLTEtMS0w_f0b1ba7e-902d-4bd1-a4e6-8491e7c15479">34,528</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfOS0zLTEtMS0w_ad2ba1d8-d79b-4a63-b0d6-817d8ab896ff">34,470</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ea44f74d23424abb3bafc1c81918e2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMS0xLTEtMS0w_119f03f0-2f40-410c-b9e4-e128803d089f">101,921</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabdd0283752a4382b0580526189689c1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMS0zLTEtMS0w_2e01e542-35d5-460a-8863-939b641959c6">108,051</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2197fe5a97c5429da1cc14762c73c186_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMS01LTEtMS0w_4a13c534-f0fe-4d1a-8869-7ff8191aa543">155,820</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia5ea44f74d23424abb3bafc1c81918e2_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMi0xLTEtMS0w_51b8ebfa-76fc-4fb8-9f05-ad4ef1f2969d">16,850</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabdd0283752a4382b0580526189689c1_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMi0zLTEtMS0w_70cc5e77-f7b2-4cd8-9309-9850dc6d439a">18,624</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2197fe5a97c5429da1cc14762c73c186_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMi01LTEtMS0w_287863f2-c6c1-442b-9c9b-9be1195594be">24,596</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div><span><br/></span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_85"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3 - <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84NS9mcmFnOmU5MGFkMDUxYmQ3YTQ2NWU5YTA3M2JiN2IwNjVjNmI3L3RleHRyZWdpb246ZTkwYWQwNTFiZDdhNDY1ZTlhMDczYmI3YjA2NWM2YjdfNjc4MQ_88f51e15-dc9f-4255-84ae-b2405257cbc1" continuedAt="i0bcd3cb996474a289de01246461e0076" escape="true">RECENT ACCOUNTING STANDARDS</ix:nonNumeric></span></div><ix:continuation id="i0bcd3cb996474a289de01246461e0076" continuedAt="i6452190debc64b6fbee509e161cb0fb5"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84NS9mcmFnOmU5MGFkMDUxYmQ3YTQ2NWU5YTA3M2JiN2IwNjVjNmI3L3RleHRyZWdpb246ZTkwYWQwNTFiZDdhNDY1ZTlhMDczYmI3YjA2NWM2YjdfMTA0NDUzNjA0ODYwNTQ_aaaf7129-93da-4435-b53e-5a3467728f3a" continuedAt="ia749a9a8d3764f12803ed78371c73064" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2020-04 on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ASU 2016-13 replaces the incurred loss methodology previously utilized for valuing financial instruments with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology.  We adopted the standard on January </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i6452190debc64b6fbee509e161cb0fb5"><ix:continuation id="ia749a9a8d3764f12803ed78371c73064"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1, 2020 using the modified retrospective approach.  See the Accounts Receivable section to Note 2 for further information on our allowances for credit losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15 (&#8220;ASU 2018-15&#8221;),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal-Use Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;ASU 2018-15 aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU was effective in the first quarter of 2020 with early adoption permitted and can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on our consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-03 ("ASU 2020-03"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this update represent changes to clarify or improve the codification and correct unintended application. ASU 2020-03 was effective immediately upon issuance and its adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13 ("ASU 2018-13"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard removes, modifies and adds certain disclosures related to recurring and nonrecurring fair value measurements. We adopted ASC 2018-13 effective January 1, 2020 and it had no effect on our disclosures.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 is effective beginning in the first quarter of 2021. Early adoption is permitted. Certain amendments in this update must be applied on a prospective basis, certain amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. We are currently evaluating the impact this ASU will have on our financial statements and related disclosures.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. We do not expect the adoption of this guidance will have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-01 provides clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2021-01 on our financial statements.</span></div></ix:continuation></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4 &#8211; <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzg5OA_211ad05c-cb37-4d44-9a7e-fd7dffe2f1c1" continuedAt="i3af475e7e3a342bd8fa6cabc96c21396" escape="true">FACILITY ACQUISITIONS AND DISPOSITIONS</ix:nonNumeric></span></div><ix:continuation id="i3af475e7e3a342bd8fa6cabc96c21396" continuedAt="i5a57ce00f9a34905968e8c40f711af1f"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October and November 2020, we completed our acquisition of certain assets of ZP Atlantic LLC, and ZP Elmhurst LLC.  <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzg5OQ_f2b2d057-a286-401d-af44-835a7dc67692" continuedAt="i9ab46957c83c4d86a98969d216cf366a" escape="true">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i5a57ce00f9a34905968e8c40f711af1f" continuedAt="ia9c777fef01a470f8d3aeba172475661"><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><ix:continuation id="i9ab46957c83c4d86a98969d216cf366a"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.625%"><tr><td style="width:1.0%"></td><td style="width:40.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.837%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Atlantic</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmhurst</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment</span></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMS0yLTEtMS0xNzA0_65b045a7-d544-41b8-b896-2b72fd2ee676">7,931</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMS0zLTEtMS0xNzEw_c633190c-83ed-4492-b7e4-34a14d8aa610">10,681</ix:nonFraction>&#160;</span></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of Use Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101" decimals="-3" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMi0yLTEtMS0xNzA0_9ff98853-d125-414e-be5b-6b6d8e9668fa">6,181</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101" decimals="-3" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMi0zLTEtMS0xNzEw_c859ddae-f457-4707-bad8-bece40f0e3cd">12,571</ix:nonFraction>&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMy0yLTEtMS0xNzA0_e6b86be0-26a7-4cf3-9cb2-21a22b9998f0">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101" decimals="-3" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMy0zLTEtMS0xNzEw_f294cebb-9cca-4c7e-9f07-e376dd53d71e">75</ix:nonFraction>&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNC0yLTEtMS0xNzA0_a9174539-6550-4580-88a4-2c4c823d1ebe">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNC0zLTEtMS0xNzEw_f3d2d1b4-81a3-49cd-ad09-1b3b27a2273f">50</ix:nonFraction>&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of Use Liabilities</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101" decimals="-3" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNS0yLTEtMS0xNzA0_a182efc8-43d7-4749-ab5c-cdbf88fb78b4">6,181</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101" decimals="-3" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNS0zLTEtMS0xNzEw_8eed48b3-19f5-4ab1-a0cd-1a5a2169dd03">12,571</ix:nonFraction>)</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNi0yLTEtMS0xNzA0_e94a1970-edba-4bc3-b325-c8123e1e8cf1">828</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNi0zLTEtMS0xNzEw_52a00cfd-7bf3-4fd1-93bb-8fb94dc39f8d">1,463</ix:nonFraction>&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</span></td><td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNy0xLTEtMS01NzA1_74e310aa-edde-4ccb-98a3-42cbf71036e9">8,871</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNy0yLTEtMS01NzA3_8fe53e20-6688-4c01-8b7e-cac158050d86">12,269</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2020 we completed our acquisition of certain assets of AZ-Tech Radiology &amp; Open MRI, LLC, consisting of <ix:nonFraction unitRef="center" contextRef="iaeade28b6efd4a5892b49eea2eb7af2c_D20200831-20200831" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODE5Mw_2979e746-e8b7-4711-b36f-51b6e6857d8e">eight</ix:nonFraction> multi-modality imaging centers located in the Phoenix, Arizona area for purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="iaeade28b6efd4a5892b49eea2eb7af2c_D20200831-20200831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODE5Nw_bcfab398-7aea-458a-ac3b-ebd368438fba">5.5</ix:nonFraction> million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $<ix:nonFraction unitRef="usd" contextRef="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODIwNw_27d9feef-c80c-4d20-a8af-0f827c76005f">2.5</ix:nonFraction> million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODIxNQ_121803ef-8dea-442e-9ddd-8c173a0ed87e">7.6</ix:nonFraction> million in right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODIyMw_aa949e66-7273-4844-ba4e-5b8cb5748b5e">0.1</ix:nonFraction> million in other assets, $<ix:nonFraction unitRef="usd" contextRef="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODIzMw_d92476bb-dd49-4cb0-b1c9-6e74b2155a00">7.6</ix:nonFraction> million in operating lease liabilities, and $<ix:nonFraction unitRef="usd" contextRef="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODI0MQ_d35590ce-95d9-491e-8136-2a7159823a77">2.9</ix:nonFraction> million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued <ix:nonFraction unitRef="shares" contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDA4Mw_2340e759-44dd-4567-94df-7f104e292e5d">915,132</ix:nonFraction> shares at $<ix:nonFraction unitRef="usdPerShare" contextRef="i89d9310e311f4127811afce11cd60c48_I20200601" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDA4Nw_a158a4b4-6365-47a1-afd9-59aceb292b88">16.93</ix:nonFraction> per share (<ix:nonFraction unitRef="shares" contextRef="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDA5MQ_f4488766-f847-4c2f-be62-17b993d53730">823,615</ix:nonFraction> issued at execution, with up to <ix:nonFraction unitRef="shares" contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDA5NQ_e806a22b-bd6e-4048-afe9-2a32c47623d6">91,517</ix:nonFraction> shares to be issued <ix:nonNumeric contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601" format="ixt-sec:durmonth" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDA5OQ_2fed1836-aa33-4ade-aff0-b8f37c089230">18</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $<ix:nonFraction unitRef="usd" contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDEwNA_dec5ddb9-f685-4c49-abc4-b9dfd33d7be8">34.6</ix:nonFraction> million including i) <ix:nonFraction unitRef="shares" contextRef="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDExMg_f4488766-f847-4c2f-be62-17b993d53730">823,615</ix:nonFraction> shares issued on the date of closing with fair value of $<ix:nonFraction unitRef="usd" contextRef="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDExNg_50329ef5-866d-4d89-8ee9-74cbe146f94e">13.9</ix:nonFraction> million, ii) a liability of <ix:nonFraction unitRef="shares" contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDEyNA_e806a22b-bd6e-4048-afe9-2a32c47623d6">91,517</ix:nonFraction> shares with a fair value of $<ix:nonFraction unitRef="usd" contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDEyOA_b0684e66-8e09-4250-9187-2455ebdcc8e0">1.5</ix:nonFraction> million to be issued <ix:nonNumeric contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601" format="ixt-sec:durmonth" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDEzNg_2fed1836-aa33-4ade-aff0-b8f37c089230">18</ix:nonNumeric> months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $<ix:nonFraction unitRef="usd" contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE0MA_61bca10c-4c9b-4dab-b84c-e757d6f3fee1">2.0</ix:nonFraction> million, iv) acquisition date fair value of contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="i89d9310e311f4127811afce11cd60c48_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE0OA_2acb0d14-e9e1-4937-9c98-a9f2059e13c6">17.0</ix:nonFraction> million and v) $<ix:nonFraction unitRef="usd" contextRef="i89d9310e311f4127811afce11cd60c48_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE1Ng_65d1b644-e0b2-4c29-bf52-88a90c61a88c">0.1</ix:nonFraction> million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with <ix:nonFraction unitRef="shares" contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE2NA_258a5a89-2a87-43f5-8841-9f6c5d7ca639">390,789</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE2OA_1018121f-8dae-44a8-b0f7-097ac0d255dc">586,184</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601" decimals="INF" format="ixt:numdotdecimal" name="rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE3Mg_b2e44929-74f2-4bea-acb6-d1226406e680">195,393</ix:nonFraction> shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We preliminarily recorded $<ix:nonFraction unitRef="usd" contextRef="i89d9310e311f4127811afce11cd60c48_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE3Ng_6585ffab-5bc0-4810-bf3d-708321471e09">0.1</ix:nonFraction> million in current assets, $<ix:nonFraction unitRef="usd" contextRef="i89d9310e311f4127811afce11cd60c48_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE4NA_9165db22-0b0f-4c05-8529-801e9f116d6a">3.5</ix:nonFraction> million in deferred tax liabilities, $<ix:nonFraction unitRef="usd" contextRef="i89d9310e311f4127811afce11cd60c48_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE5Mg_86bff03e-0b79-42f5-90f6-e6d2d25043ca">14.8</ix:nonFraction> million in intangible assets, primarily in-process research and development ("IPR&amp;D'), and $<ix:nonFraction unitRef="usd" contextRef="i89d9310e311f4127811afce11cd60c48_I20200601" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDIwMA_2718ea42-d1c3-4f51-9284-0ea64965c353">23.3</ix:nonFraction> million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#8217;s assembled workforce and IPR&amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;D were determined by the income method and the assets will not be amortized until regulatory approval is obtained, but will be assessed for impairment annually, or more frequently if indicators of impairment become present</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 2, 2020 our consolidated subsidiary New Jersey Imaging Networks ("NJIN") completed the acquisition of certain assets of MRI at Woodbridge, LLC consisting of a single multi-modality imaging center located in Avenel, New Jersey for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i465e71fce78e4f91b93ebe3aac52f888_D20200302-20200302" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI0MA_ac2ca5d7-c2d9-4be2-ae17-f15bc00ec580">2.6</ix:nonFraction> million.  NJIN made a fair value determination of the acquired assets and assumed liabilities and approximately $<ix:nonFraction unitRef="usd" contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI0OA_7c0f197f-40ba-4dff-b693-9bf9d6c6a5ea">0.5</ix:nonFraction> million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI1Ng_fb57b821-33de-4af5-8c6f-f2761a597a2a">1.1</ix:nonFraction> million in right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI2NA_2e029a41-e6ed-49be-83a0-b1c5c13a00dc">0.3</ix:nonFraction> million in intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI3Mg_74c09d2b-f2e1-4b7d-8093-ffe7e28a0a97">1.1</ix:nonFraction> million in operating lease liabilities, $<ix:nonFraction unitRef="usd" contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI4MA_6605e8d4-893c-4629-8b48-435b44091087">0.1</ix:nonFraction> million in finance lease liabilities, and $<ix:nonFraction unitRef="usd" contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI5MA_b048114d-33c3-4c0f-b7d1-c75b1744a6de">1.8</ix:nonFraction> million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 2, 2020 we completed our acquisition of certain assets of Olney Open MRI, LLC, consisting of a single multi-modality imaging center located in Columbia, Maryland for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i6b97202f8ab7436596da79bcd433c721_D20200102-20200102" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODcyNA_e477880c-ce36-4b5f-87f8-09b2846d135e">1.8</ix:nonFraction> million.  We have made a fair value determination of the acquired assets and assumed liabilities and approximately $<ix:nonFraction unitRef="usd" contextRef="ibb22327f2e344552abfc54aa4c8a3bff_I20200102" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODczMg_9db7f6d9-55f0-4482-8de7-56cdb023b8f9">0.8</ix:nonFraction> million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="ibb22327f2e344552abfc54aa4c8a3bff_I20200102" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODc0MA_e0349b8d-7872-49a5-b39e-87b0c827e97c">1.3</ix:nonFraction> million in right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="ibb22327f2e344552abfc54aa4c8a3bff_I20200102" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODc1Ng_d18af8d6-8d98-45fa-b4dc-5fc61c893ecd">0.3</ix:nonFraction> million in intangible assets, $<ix:nonFraction unitRef="usd" contextRef="ibb22327f2e344552abfc54aa4c8a3bff_I20200102" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODc2OA_742981ab-c14d-4ef1-8b7d-ba33761564ff">1.3</ix:nonFraction> million in operating lease liabilities and $<ix:nonFraction unitRef="usd" contextRef="ibb22327f2e344552abfc54aa4c8a3bff_I20200102" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODgwNA_58594d1c-bd95-4628-9585-15401618b683">0.6</ix:nonFraction> million in goodwill were recorded.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019 we completed a step-up acquisition upon the dissolution of our former <ix:nonFraction unitRef="number" contextRef="i1a886167e5d546978b5a20d615e9fc78_I20190731" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTgx_9a13002a-15ec-483b-a454-c4fac8a06745">49</ix:nonFraction>% owned joint venture, Garden State Radiology LLC ("GSRN").  GSRN consisted of <ix:nonFraction unitRef="center" contextRef="ida4995e095e84733a7a3db2b2c529f94_D20190801-20190801" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzg5NQ_18937a93-613d-4d92-a5d2-ed67b23389f7">two</ix:nonFraction> multi-modality centers operating in New Jersey.  GSRN became our wholly owned subsidiary with the withdrawal of the <ix:nonFraction unitRef="number" contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzgx_a155ca09-9397-4c91-b4d6-a897a2f9e07b">51</ix:nonFraction>% majority partner for the full ownership of one center with no other consideration.  We made a fair value determination of our original <ix:nonFraction unitRef="number" contextRef="i1a886167e5d546978b5a20d615e9fc78_I20190731" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNTE5_9a13002a-15ec-483b-a454-c4fac8a06745">49</ix:nonFraction>% interest which resulted in a step-up gain of&#160; approximately $<ix:nonFraction unitRef="usd" contextRef="ida4995e095e84733a7a3db2b2c529f94_D20190801-20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNTgy_40b3fe15-1bd6-454c-b6b1-5ffa7f2226be">1.3</ix:nonFraction> million. We determined a fair value of  the remaining acquired imaging center of $<ix:nonFraction unitRef="usd" contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNjU4_719ca332-278b-470f-8e70-17d3121d9d5e">3.1</ix:nonFraction> million in assets and $<ix:nonFraction unitRef="usd" contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNjc1_86240d4f-c492-4fa4-878f-0b57a5aa156e">0.4</ix:nonFraction> million in liabilities were recognized.  We recorded $<ix:nonFraction unitRef="usd" contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801" decimals="-2" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNzIz_271ab4ef-1206-46f8-a800-f0d428445c3e">1.0</ix:nonFraction>&#160;thousand in other assets, $<ix:nonFraction unitRef="usd" contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNzQz_e9443433-ea17-4aed-a62a-93378d2a2e85">0.7</ix:nonFraction> million in fixed assets, $<ix:nonFraction unitRef="usd" contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNzYz_024c7823-5d1b-443f-b1b6-baf4e9c166c5">0.4</ix:nonFraction> million in right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNzkw_86240d4f-c492-4fa4-878f-0b57a5aa156e">0.4</ix:nonFraction> million in operating lease liabilities, and $<ix:nonFraction unitRef="usd" contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfODI5_617d0648-1572-4046-baa6-27ee869b3f44">2.0</ix:nonFraction> million in goodwill.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="ia9c777fef01a470f8d3aeba172475661"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019 we completed a step-up acquisition of our former <ix:nonFraction unitRef="number" contextRef="ic1ca963b4ec644fb9fafe95a4d9cb74f_I20190731" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfOTEz_628c19d1-c09d-4b6c-b036-3e58e9feea71">25</ix:nonFraction>% owned joint venture, Nulogix, via a stock issuance of RadNet common shares valued at $<ix:nonFraction unitRef="usd" contextRef="i0d288cd107d84361b2e08ab554ae5ed7_D20190801-20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTAwMQ_172ae7ba-97e5-4492-ad6a-f295abdb23a7">1.5</ix:nonFraction> million to obtain the remaining <ix:nonFraction unitRef="number" contextRef="i46ed970e221a4949933067bb7c822615_I20190801" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTAyOA_921ff1a7-9f3a-4255-8b22-fb4c153a5900">75</ix:nonFraction>% outstanding Nulogix shares. We made a fair value determination of the acquired assets and approximately $<ix:nonFraction unitRef="usd" contextRef="i46ed970e221a4949933067bb7c822615_I20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTEzNQ_e1bb45f8-4ee2-402e-9b0f-58bca4c82d60">0.2</ix:nonFraction> million in fixed assets, $<ix:nonFraction unitRef="usd" contextRef="i46ed970e221a4949933067bb7c822615_I20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTE1NQ_b2e58979-7dda-48a9-a755-bb941183f1a9">0.7</ix:nonFraction> million in intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i46ed970e221a4949933067bb7c822615_I20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTE4MA_a998055a-638c-4263-ba6e-6bdf4ada25e2">0.3</ix:nonFraction> million in deferred tax liability and goodwill of $<ix:nonFraction unitRef="usd" contextRef="i46ed970e221a4949933067bb7c822615_I20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTIyNQ_b579e86f-bbbe-42f7-b57e-1dea0d56de62">1.3</ix:nonFraction> million were recorded.  We also made a fair value determination of our <ix:nonFraction unitRef="number" contextRef="ic1ca963b4ec644fb9fafe95a4d9cb74f_I20190731" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTI5MQ_628c19d1-c09d-4b6c-b036-3e58e9feea71">25</ix:nonFraction>% pre-existing interest in the business and recognized a loss of $<ix:nonFraction unitRef="usd" contextRef="i0d288cd107d84361b2e08ab554ae5ed7_D20190801-20190801" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTM1Nw_2833185d-0f60-4fe5-8a77-12096fdc3bd2">0.5</ix:nonFraction> million which is included in operating expenses within the consolidated statements of operations. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019 we completed our acquisition of certain assets of Kern Radiology Imaging Systems Inc., consisting of <ix:nonFraction unitRef="center" contextRef="ia72ddff7bc5d4634b0956b82982d346c_D20190401-20190401" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzkwNw_5b4bfa3b-805f-454b-a19b-18dc8c4588d6">four</ix:nonFraction> multi-modality imaging centers located in Bakersfield, California for purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="ia72ddff7bc5d4634b0956b82982d346c_D20190401-20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTY3MA_6581a106-9048-46c1-b884-ab97cd092bc7">19.3</ix:nonFraction> million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $<ix:nonFraction unitRef="usd" contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTc3NQ_b61ea421-74d8-4df9-93da-ec396e870e7a">10.1</ix:nonFraction> million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTgwNQ_dc8583a1-0aff-4ccf-89aa-b0382cdcf608">9.7</ix:nonFraction> million in right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTgzMg_dbd99b7d-aeda-4b7f-a4c5-b2ea6d4c2f6f">36.0</ix:nonFraction>&#160;thousand in other assets, $<ix:nonFraction unitRef="usd" contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTg1Mg_a2668ad9-4b25-4018-92c6-3c2f0687dac6">3.4</ix:nonFraction> million in intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTg3Nw_7cefca38-fe1b-4cfe-b9dc-46b6299fa237">14.5</ix:nonFraction> million in operating lease liabilities, and $<ix:nonFraction unitRef="usd" contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTkxNg_b47d0d4b-8aaa-4310-bd6f-b401e35ecb99">10.5</ix:nonFraction> million in goodwill were recorded.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019 we completed our acquisition of certain assets of Zilkha Radiology Inc. consisting of <ix:nonFraction unitRef="center" contextRef="i6013424b82d141dba94b68360286b828_D20190401-20190401" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzkxNQ_d3eaaac6-9a8e-4b95-ba76-8f459833d334">two</ix:nonFraction> multi-modality centers located in Islip, New York for purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="i6013424b82d141dba94b68360286b828_D20190401-20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjEzMw_5f2ed3b0-1290-4eed-af30-708b1fdaec3f">4.5</ix:nonFraction> million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $<ix:nonFraction unitRef="usd" contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjIzOA_7cdf03f1-a573-446c-98d0-ca5c6856a8b0">2.2</ix:nonFraction> million in property and equipment, $<ix:nonFraction unitRef="usd" contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjI2OA_ed7070e7-29c1-4568-b2da-228467a7c49b">5.1</ix:nonFraction> million in right-of-use assets, $<ix:nonFraction unitRef="usd" contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjI5NQ_f489267b-369a-4950-81d8-829f4b84f46d">0.1</ix:nonFraction> million in intangible assets, $<ix:nonFraction unitRef="usd" contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjMyMA_9d40dcb2-86c1-4d21-8f94-f4be67fb6a1d">5.1</ix:nonFraction> million in operating lease liabilities, $<ix:nonFraction unitRef="usd" contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjM1NQ_d193deec-89b5-4174-ae00-1426ae8c4dd3">0.3</ix:nonFraction> million  in finance lease liabilities and $<ix:nonFraction unitRef="usd" contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjM5Mg_e60304fe-39e3-47c2-b813-fc08dbd79252">2.6</ix:nonFraction> million in goodwill were recorded.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2019, one of VIE entities, Lenox Hill Radiology and Medical Imaging Associates, P.C. ("LHR"), purchased the membership interest of Hudson Valley Radiology Associates, P.L.L.C. ("HVRA") for $<ix:nonFraction unitRef="usd" contextRef="i9e74f1c4a6d74c37aa2e96e236ce886f_I20190228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjYyNw_899528f3-46f4-42c6-af79-068d80d7a1fe">6.0</ix:nonFraction> million of RadNet common stock and contingent consideration valued at $<ix:nonFraction unitRef="usd" contextRef="ia312590d9b814f1386f70c721698d7d1_D20190228-20190228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjY5Mg_c7a524fe-7ee3-44cb-8dc6-5d7fde134d0b">0.7</ix:nonFraction> million to guarantee the share value issued for a period of six months post acquisition date.  LHR has performed a fair value purchase price allocation and recorded equipment of $<ix:nonFraction unitRef="usd" contextRef="i9e74f1c4a6d74c37aa2e96e236ce886f_I20190228" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjg2NQ_35f3ceec-2624-40fa-a871-2ee33f493b5e">10.0</ix:nonFraction>&#160;thousand, a covenant not to compete of $<ix:nonFraction unitRef="usd" contextRef="i4337c29255b447709dce2086107be291_I20190228" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjg5OA_9ba8e8ad-8208-4364-a986-dfbadfbc777b">50.0</ix:nonFraction>&#160;thousand, trade name of $<ix:nonFraction unitRef="usd" contextRef="i4874f4e250774b1fbb5b0f4c47efae14_I20190228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjkxNg_4b95084f-3fc9-4887-bad8-08f7c4b758d6">0.4</ix:nonFraction> million, other intangible assets of $<ix:nonFraction unitRef="usd" contextRef="i9e74f1c4a6d74c37aa2e96e236ce886f_I20190228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjk0Nw_77905dfa-bde0-4356-a241-945facafbf96">0.3</ix:nonFraction> million and goodwill of $<ix:nonFraction unitRef="usd" contextRef="i9e74f1c4a6d74c37aa2e96e236ce886f_I20190228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjk2Ng_aeffdcde-47a2-4687-8cf2-583fb74f9f03">3.1</ix:nonFraction> million from the transaction. In connection with the acquisition, RadNet also settled against the purchase consideration, $<ix:nonFraction unitRef="usd" contextRef="i964d58a775bd4fa199e750e6ee03db8e_I20190228" decimals="-5" format="ixt:numdotdecimal" name="rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzA4Mw_dc1bc7e6-8590-4e74-8e2a-a79ae8091a1f">2.8</ix:nonFraction> million, net of taxes, of an unfavorable vendor contract with HVRA stemming from the previous acquisition of Radiologix, Inc. in November 2006. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2019 our majority owned subsidiary, West Valley Imaging Group, LLC ("WVIG") completed its acquisition of certain assets of West Valley Imaging Center, LLC ("West Valley"), consisting of a single multi-modality imaging center located in West Hills, CA for purchase consideration of $<ix:nonFraction unitRef="usd" contextRef="i456f5191d4dd4b73882fca5d3f1ad088_D20190201-20190201" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzUxOQ_fea2ab8b-c34f-42ae-8d8e-22e9d83975de">3.0</ix:nonFraction> million all of which was initially funded by the Company.  We have made a fair value determination of the acquired assets and approximately $<ix:nonFraction unitRef="usd" contextRef="i6a60c6284cf54e1ca418b050d90465a0_I20190201" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzY1NA_9297365d-9f7f-4614-bf39-32127156197f">0.3</ix:nonFraction> million in equipment and fixed assets, $<ix:nonFraction unitRef="usd" contextRef="i6a60c6284cf54e1ca418b050d90465a0_I20190201" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzY4OA_6011fca5-920a-4513-a4ba-780113f2e079">7.0</ix:nonFraction>&#160;thousand in other assets, $<ix:nonFraction unitRef="usd" contextRef="i6a60c6284cf54e1ca418b050d90465a0_I20190201" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzcwOA_f4a934b1-2275-4481-ab59-643c4756a190">0.2</ix:nonFraction> million in intangible assets and $<ix:nonFraction unitRef="usd" contextRef="i6a60c6284cf54e1ca418b050d90465a0_I20190201" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzczNg_ea5a95e9-319d-4e78-b46e-4d9a49a273a5">2.5</ix:nonFraction> million in goodwill were recorded.  Subsequent to the transaction, our partner in WVIG, Cedars Sinai Medical Center, contributed $<ix:nonFraction unitRef="usd" contextRef="iaf7fe2658d284b5cb2907e0de5419820_D20190201-20190201" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzg2MA_b94c455e-e792-481f-add3-9cd122ca7871">0.8</ix:nonFraction> million in cash to maintain its <ix:nonFraction unitRef="number" contextRef="i8b95c89ccfed4e1fb901493260558cab_I20190201" decimals="INF" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzg4Nw_7defe955-cb26-4bae-9611-ede5bb64579a">25</ix:nonFraction>% economic interest in the venture.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture formations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 13, 2019 we formed a wholly owned subsidiary, Ventura County Imaging Group, LLC ("VCIG").  On March 1, 2019, Dignity Health joined as a venture partner.  Total agreed contribution of both parties was $<ix:nonFraction unitRef="usd" contextRef="ieac963b9dd7b42a5bc5034ac64e4e8ee_D20190301-20190301" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA0Njk_6cb5662a-68e5-4012-87e4-74be65340958">10.4</ix:nonFraction> million of cash and assets with RadNet contributing net assets with a book value of $<ix:nonFraction unitRef="usd" contextRef="i612c3bc5981e4ff8bd89f7fc44a3a3fe_I20190301" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA1NDg_9a52bad3-3e17-46b1-b7be-450eb922f323">4.3</ix:nonFraction> million for a <ix:nonFraction unitRef="number" contextRef="i091d9ede79dd4469affa6d73b62fd16c_I20190301" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA1NTc_d5d48172-8070-4d16-9b59-308357fa2137">60</ix:nonFraction>% economic interest and Dignity Health contributing $<ix:nonFraction unitRef="usd" contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA2MTA_1098b63f-1812-4f07-be28-eb1335a1cebc">6.1</ix:nonFraction> million in cash and assets for a <ix:nonFraction unitRef="number" contextRef="i612c3bc5981e4ff8bd89f7fc44a3a3fe_I20190301" decimals="INF" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA2Mzg_4d535a42-3e43-443a-984c-9ed731fe2e5b">40</ix:nonFraction>% economic interest.  For its contribution, RadNet transferred net assets of <ix:nonFraction unitRef="center" contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfBusinessesAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzkyNQ_dc7a82b0-0248-415e-9d79-8942aa879000">three</ix:nonFraction> wholly owned multi-modality imaging centers.  Dignity Health contributed approximately $<ix:nonFraction unitRef="usd" contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301" decimals="-5" format="ixt:numdotdecimal" name="rdnt:PaymentstoAcquireEquityMethodInvestmentsAssetsContributed" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA4MDk_a2a4cbb1-43e4-47cf-a142-e4d3541e756c">0.8</ix:nonFraction> million in assets to acquire <ix:nonFraction unitRef="number" contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301" decimals="INF" name="rdnt:EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA4MzM_8cd57d6f-912c-4e7a-ba9e-54d1fcf4e59c">5</ix:nonFraction>% economic interest and paid RadNet $<ix:nonFraction unitRef="usd" contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301" decimals="-5" format="ixt:numdotdecimal" name="rdnt:PaymentstoAcquireEquityMethodInvestmentsCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA4NzA_2b7ca0a4-7da6-4197-b48e-f006d3e73bb2">5.3</ix:nonFraction> million for an additional <ix:nonFraction unitRef="number" contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301" decimals="INF" name="rdnt:EquityMethodInvestmentOwnershipPercentageInExchangeforCash" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA4OTE_f9b4371c-af38-4d4a-ab3d-6acab50b52e2">35</ix:nonFraction>% economic interest.  We maintain controlling economic interest in VCIG and fully consolidate the results into our financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispositions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary to RadVantage P.C. (an unrelated corporation) for approximately $<ix:nonFraction unitRef="usd" contextRef="i3e571ad52d964e1389114033d8e4b89c_D20200601-20200601" decimals="-2" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTg0Mw_7e1686f6-75a3-4fb0-89f5-eb59150a641b">1.0</ix:nonFraction>&#160;thousand.  With this transaction, we have exited the teleradiology business.</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5 &#8211; <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfMTE3Mg_7d052876-0a63-4edd-918d-54d88cb86cff" continuedAt="idae1f51144654675a685188a7e01f496" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="idae1f51144654675a685188a7e01f496" continuedAt="ie48f4a3f99ad4a7c88712cee1b1548e9"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is recorded as a result of business combinations. <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfMTE3OA_328b2988-009d-462e-b6a0-8bf866fd815e" continuedAt="i69c798a38af1424b90f62259b88fbffc" escape="true">Activity in goodwill for the years ended December 31, 2019 and December 31, 2020 is provided below (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ie48f4a3f99ad4a7c88712cee1b1548e9"><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i69c798a38af1424b90f62259b88fbffc"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ibae6485d220c4366bf04745e679dee34_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTUtMS0xLTEtMA_1561f28b-f254-4850-a83c-e05fd98f2e57">418,093</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to our preliminary allocation of the purchase price of Medical Arts Radiological Group, P.C.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5528883c400f402890b0b9e360fa9757_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTYtMS0xLTEtMA_b381da8a-e176-451f-bca3-448101b4d366">722</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Dignity Health</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd9c48ca86d84fb980d466453795b682_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTctMS0xLTEtMA_1e576869-3744-4170-a253-433563fc90d5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of West Valley Imaging Center, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b0b910fae6b4ba090ec1c469a5c973a_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTgtMS0xLTEtMA_eabe3267-c696-4299-b884-63fcf174ea63">2,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill disposed through sale of assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTktMS0xLTEtMA_15ae2982-97c8-49d8-b946-40d29dcd9ad3">123</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired by Lenox Hill Radiology through the membership purchase of HVRA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa266170ed154d5198ecd30150de0a0d_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjAtMS0xLTEtMA_f4ae8292-dfe9-486d-a77f-94959721b620">3,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Kern Radiology, Inc.</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e225ee197db4962846379c1f756351b_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjEtMS0xLTEtMA_8bece3f8-8b31-40e5-b554-8b8caade0e9c">10,507</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Zilkha Radiology, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i774974bb637346659642b95eb18c0d88_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjItMS0xLTEtMA_4a72bcc8-f9d7-450d-9ff3-aed1b2805ce3">2,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Ramic Mahwah, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b7b602ee54a433b9e40d150fe55fbb3_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjMtMS0xLTEtMA_b7dcc263-f218-46c6-8809-e0a855903a63">231</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of GSRN</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e8e0ca3243444e7970426cdcd410ff4_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjQtMS0xLTEtMA_9dfd1f59-c9f7-4196-933e-2f86c0086cac">2,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of Nulogix</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e940ec7fd4d4b28bb5546113a619040_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjUtMS0xLTEtMA_aa787951-b496-47d8-abc9-3f481ca083c6">1,337</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill transferred from assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:GoodwillTransfers" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjYtMS0xLTEtMTUzMQ_b7976aa0-f4f5-4f4d-88ac-eb99fe98fa3e">992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMzAtMS0xLTEtMA_863959d0-8cb4-4b9a-8990-5a5829f3ff26">441,973</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of Olney Open MRI, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4351f86bc864495c813b7164d4002e89_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTMtMS0xLTEtMTU1OA_fb52e92d-3198-4264-a829-e62075273636">601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of MRI at Woodbridge, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i037ebcff3f474b6a85350f30a450750f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTQtMS0xLTEtMTU1OA_7093289c-2c36-4010-91c6-55ed6d03fc62">1,833</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of DeepHealth, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac2767be8a5846ac88dc5a19d3c5cdd0_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTUtMS0xLTEtMTU1OA_91172faf-6299-4ec6-84f7-fea9693f1a34">23,299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of AZ-Tech Radiology &amp; Open MRI, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41f3fcd0c1b7458b8c2b5611fd14cbe3_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTYtMS0xLTEtMTU1OA_8e686b3c-e3eb-4b69-9e56-77fd1c1e030f">2,882</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of ZP Ozone Park, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffd13c35af724f7495f80a4ffd36d14a_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTctMS0xLTEtMjM1Ng_a382e5b4-c322-4032-bf23-0a1adefc15a7">828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of ZP Elmhurst LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff9d9ba698244f9295f632171332ff38_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTgtMS0xLTEtMjM1Ng_302fa2fc-37af-4565-b4b9-34005e9035eb">1,463</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTktMS0xLTEtNTY3Ng_6f374742-3c7e-4f39-a7a4-6f0c02d4741b">472,879</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2020 is $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-5" name="rdnt:GoodwillDeductibleForTaxPurposes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfMjk2_c6b75cf3-4a52-4ae0-86a5-7657886c2ec6">148.3</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense was $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfNjAz_48611bd8-fe9f-4bb5-8238-0f51124a1175">3.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfNjA3_43e7d52f-a13e-4358-be8b-75ccfa7b8fae">3.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfNjE1_5267e11d-61cb-43b6-8db1-8f7fefc8dc57">2.7</ix:nonFraction> million for the years ended December 31, 2020, 2019 and 2018, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfODMw_4da849bc-d7ec-49cf-b150-3239468aae43">25</ix:nonNumeric> years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfMTE3NA_80fbb3fa-1004-4cff-ba28-3710957caaf0" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:22.464%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.736%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.536%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS0xLTEtMS0w_bb92b0ca-9f78-4e0e-a944-65d0d7a75d29">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS0zLTEtMS0w_04807d56-bf5d-4c2f-9d8e-c8ebe62ceea7">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS01LTEtMS0w_22df2f4a-59c7-415e-9b38-c4c2fcc3f7d8">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS03LTEtMS0w_cd154936-8079-4db0-a07d-de425dba222e">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS05LTEtMS0w_fcf6efca-225c-4e99-ac8e-ce4d5052db27">2,287</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS0xMS0xLTEtMA_33269783-bba0-4194-907f-73e16704489d">13,533</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS0xMy0xLTEtMA_9307e56b-b313-484a-a051-1f9276726def">24,968</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id05c02a9c24c46eb8f9844d8050a58a4_D20200101-20201231" format="ixt-sec:duryear" name="rdnt:WeightedAverageAmortizationPeriodRemainingInYears" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS0xNS0xLTEtMA_c6319fb0-1511-494f-917d-87ac967345d3">10.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi0xLTEtMS0w_771c4a70-a213-4b34-9a4b-d1630690d119">1,024</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi0zLTEtMS0w_0819bc6f-f8e7-4a09-abb4-8764c9805453">994</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi01LTEtMS0w_f2ebced3-04df-4cee-8767-9697561ee84d">883</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi03LTEtMS0w_795384a7-af0f-47cf-9b98-036671d30302">467</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi05LTEtMS0w_fecc89cc-54bd-43ad-8ce6-a6eda69c5d5e">233</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi0xMS0xLTEtMA_6291582a-8d8c-4945-a906-f8b98f9a44c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi0xMy0xLTEtMA_0c3fdc36-9866-47d2-bfd6-7938c8223109">3,601</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3126da00ef154364bff57a0c60402471_D20200101-20201231" format="ixt-sec:duryear" name="rdnt:WeightedAverageAmortizationPeriodRemainingInYears" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi0xNS0xLTEtMA_0a379905-a346-4c2e-a12b-0b6f92fa0425">3.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy0xLTEtMS0w_9c6fc668-eccd-4782-b354-b532840a729c">244</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy0zLTEtMS0w_22ceaaf7-4df1-453f-a2a0-1b7ed609f238">142</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy01LTEtMS0w_9c9d8527-6fbf-4a7e-8f89-bb63e43c6954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy03LTEtMS0w_7b4651cb-f9db-4010-99fd-85ed76ff1c11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy05LTEtMS0w_c38adbda-52ab-4e09-be18-12dce4b771c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy0xMS0xLTEtMA_b06fd673-4e29-4f52-ade5-77ff7a95c5ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy0xMy0xLTEtMA_2ab893f3-3b15-4325-9963-62936be03ab9">386</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibf3163cdc65c43c2bb456cfbfe498c0e_D20200101-20201231" format="ixt-sec:duryear" name="rdnt:WeightedAverageAmortizationPeriodRemainingInYears" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy0xNS0xLTEtMA_c24da227-4dd8-45ea-bd0e-9331ba355db3">1.6</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC0xLTEtMS0w_89510caf-8ac8-45d1-a075-1d0b788541a6">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC0zLTEtMS0w_69f013a8-c501-4881-b716-da1bdb707014">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC01LTEtMS0w_19baa591-ce10-4b03-a7e1-0e6c9d46acdd">66</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC03LTEtMS0w_2b8ceb54-7c4e-4d0d-a6f1-1e79a0670eae">64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC05LTEtMS0w_e032c13f-4992-49ea-ac49-6e00bf0dfe5a">64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC0xMS0xLTEtMA_aca02c82-2bf6-458c-9b64-18737a51d4ea">309</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC0xMy0xLTEtMA_bed1105b-2458-4c89-93ec-24c67d597f9f">653</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i830cf944df0341d7a34972034686fd2b_D20200101-20201231" format="ixt-sec:duryear" name="rdnt:WeightedAverageAmortizationPeriodRemainingInYears" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC0xNS0xLTEtMA_b09e0822-23aa-4bae-95a9-e36fc88ee678">5.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS0xLTEtMS0w_58491991-75e0-4181-957e-7460908b003b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS0zLTEtMS0w_c899ab80-0920-46e4-b402-c4b16de8d225">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS01LTEtMS0w_e7ec69cc-d578-495d-8545-084422b2684e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS03LTEtMS0w_6e5ccf64-1336-44ce-a2ae-bfba5498deca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS05LTEtMS0w_cfef856f-5a1c-4af0-88b3-2c01a7e6e5df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS0xMS0xLTEtMA_d51d2bb2-8a3b-4095-b023-3330d3f90f67">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS0xMy0xLTEtMA_288e3dd0-6ec3-410b-a1c1-77f099f59f62">7,100</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software in development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi0xLTEtMS0w_2dacd31b-3bae-4665-916f-b2eddc67e385">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi0zLTEtMS0w_aa1e74bc-cd5d-4197-b597-3780f8ec7244">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi01LTEtMS0w_a394b7b8-53d9-4a57-9742-81bf921b8236">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi03LTEtMS0w_acdb39e1-487b-44ef-a4cd-a765a0db3269">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi05LTEtMS0w_5709d7cd-36a8-4ca2-87b5-3b3e07c8da32">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi0xMS0xLTEtMA_37bc1093-eb7a-4a52-925b-97879b923cc0">15,685</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi0xMy0xLTEtMA_7711541d-83e9-4c5b-bdff-5d3068f496e2">15,685</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy0xLTEtMS0w_fa39842d-ec8d-461e-8857-13ef11a46ead">3,630</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy0zLTEtMS0w_870514df-3c26-480a-8aad-e4269a672c16">3,498</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy01LTEtMS0w_d148ad08-230c-4145-a06c-b9de014fc09f">3,236</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy03LTEtMS0w_76350d2b-8c17-46ad-9d16-9203478e9ce6">2,818</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy05LTEtMS0w_3b8fa96b-02d1-44b2-9c8c-c384d2bd79a7">2,584</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy0xMS0xLTEtMA_c4a8056d-6b45-4f8d-b5ff-4ecfcd24e2f0">36,627</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy0xMy0xLTEtMA_92f37da9-67cc-4407-9712-9917d894927b">52,393</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6 - <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfNTY1_2bbf935f-35a3-4df3-a9f2-cc513a7e40b2" continuedAt="ib0e7013b30d241159780bf20b13ed6a3" escape="true">PROPERTY AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="ib0e7013b30d241159780bf20b13ed6a3" continuedAt="ibac32906a19b487299ff5698bf743215"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfNTY4_c044954d-68ed-454d-b2f2-25b1d40ab42c" continuedAt="iefe31b91f254434992934e1a938150af" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ibac32906a19b487299ff5698bf743215" continuedAt="i806498f09e334bed853f881cf0893d09"><ix:continuation id="iefe31b91f254434992934e1a938150af"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90897045b27b47d3851512df495fb317_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMi0xLTEtMS0w_094706cc-7e53-4cea-9256-0fb8e7b16313">250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4ba3f78a0f049ebbe6bbd419db532c1_I20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMi0zLTEtMS0w_878c44b2-2bf6-45e2-8afd-5834eb8ebbdf">250</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3ebc23af28648849d72a86f89b15a59_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMy0xLTEtMS0w_088db926-b7c1-4da5-98f9-721ec88aca67">480,631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4215872a7995444cb1ddcef9705d75d5_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMy0zLTEtMS0w_e72e4755-b94e-4378-aa32-614365a29672">426,682</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibdea4c2c6a394718bbe4f06a3a8dc179_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNC0xLTEtMS0w_add08b4c-0f3c-4fe8-9359-d1939f514680">132,446</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f79bab3685041179f8a090705f8145d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNC0zLTEtMS0w_23837eaa-6a3d-4e63-a65e-0dbf575f23c5">120,490</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e015b6f1727458c8d7a3e194aee3c2d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNi0xLTEtMS0w_a3284106-d541-4ece-b6a1-698abd712759">399,253</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b6f7873910a406998fcb4834647b21b_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNi0zLTEtMS0w_563bc329-33f1-436f-9924-a78a78048591">377,676</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under financing/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab72392226114b9c9189e2d1cfb7fe7c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNy0xLTEtMS0w_358fef69-3ccc-42d5-9e7b-ca6a974ae678">13,984</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i285fdbc8c707469b8e163fb3a3e1934f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNy0zLTEtMS0w_510a029c-14a1-4fbd-9aa6-2a5eefa12123">14,105</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfOC0xLTEtMS0w_82709cc8-549c-4209-a326-d13debc7bb4c">1,026,564</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfOC0zLTEtMS0w_77450895-b8d2-4864-8329-82b3919a7a2e">939,203</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfOS0xLTEtMS0w_0af18829-99fe-4678-89a2-70de9593d556">627,229</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfOS0zLTEtMS0w_183d027f-0176-4a41-9bed-f60a9bb19996">571,408</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMTItMS0xLTEtMA_fd03daae-13ad-44f5-a180-79eca3a50a3b">399,335</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMTItMy0xLTEtMA_bfb3ff36-ca8d-413e-af13-c317c51879e0">367,795</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2020  is approximately $<ix:nonFraction unitRef="usd" contextRef="ifbc658ed6a3a4a78a3c5bf60feff2cd1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfMjEw_286542b4-c7f3-40c9-8edd-3211ab3c0738">57.5</ix:nonFraction> million total of construction in process amounts consisting of $<ix:nonFraction unitRef="usd" contextRef="i78316bdeb53c42e49f72d68723354ca6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfMjY4_db4159e1-ccf4-448c-af55-0cf883645373">26.0</ix:nonFraction> million in medical equipment, $<ix:nonFraction unitRef="usd" contextRef="i9f7c6c92238d4993b8ecc28a6fac055a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfMjkz_f6b21553-5ce5-467c-b73c-d782723e1d57">7.7</ix:nonFraction> million in computer and office equipment, and $<ix:nonFraction unitRef="usd" contextRef="i0e015b6f1727458c8d7a3e194aee3c2d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConstructionInProgressGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfMzM0_10bddc07-a696-4677-8a1c-d6c01c61ec94">23.8</ix:nonFraction> million in leasehold improvements.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i806498f09e334bed853f881cf0893d09">Depreciation and amortization expense of property and equipment, including amortization of equipment under finance/capital leases, for the years ended December 31, 2020, 2019 and 2018 was $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfNTM0_15c66ee5-4e0d-4393-9adf-f3751ecf32cf">83.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfNTM4_e0813eb0-6a01-4257-9d8b-f67d040eb03c">77.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfNTQ2_0f32b696-5c9b-415e-ae1b-dbd958827cc3">70.2</ix:nonFraction> million, respectively.</ix:continuation> </span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7 &#8211; <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90ZXh0cmVnaW9uOjUwYTIxYmE5MzdlYTQyZDVhMTYzMjJjZDQ5M2E3OTcxXzE0Ng_41849b1e-3688-4909-ad97-d0ab882eafcb" continuedAt="i67de506da7ea4a1aa633919353471b6d" escape="true">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</ix:nonNumeric></span></div><ix:continuation id="i67de506da7ea4a1aa633919353471b6d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90ZXh0cmVnaW9uOjUwYTIxYmE5MzdlYTQyZDVhMTYzMjJjZDQ5M2E3OTcxXzE0OQ_c5c860c9-149f-4615-8ae5-81df3ecc6577" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses were comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzItMS0xLTEtMA_825608af-2dce-4624-af98-9383597db501">70,071</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzItMy0xLTEtMA_7194df34-cc64-4568-bddb-d019c429cb12">64,300</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzMtMS0xLTEtMA_19ebe7b0-7231-4cce-b9d3-9b4d2cc23866">84,312</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzMtMy0xLTEtMA_9241c15c-2a48-4708-805d-731e19732267">83,853</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzQtMS0xLTEtMA_e0b1078d-a6cf-49d0-bfc7-3b4df0533d14">58,051</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzQtMy0xLTEtMA_f0e0bede-2223-4c9f-9013-61c66bc6b364">42,003</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzUtMS0xLTEtMA_a94fd17f-3350-47cc-ae4a-8b03c43924cf">24,250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzUtMy0xLTEtMA_fba5ecda-1e7c-41ad-9ed4-ee8af312800e">17,429</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzYtMS0xLTEtMA_78d7bf68-1b42-4ccc-be18-266aee58743d">236,684</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzYtMy0xLTEtMA_2f979ef1-7fd0-477c-b3d1-598cd4775d0a">207,585</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8 - <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzMyOTg1MzQ5MzI5NTI_a4d57ea4-011a-4103-af73-f5264cac7e3d" continuedAt="icae62424ed384e07bb2283e7b6e81665" escape="true">CREDIT FACILITIES AND NOTES PAYABLE</ix:nonNumeric></span></div><ix:continuation id="icae62424ed384e07bb2283e7b6e81665" continuedAt="i03c60be7acbb4608bebf02e0fd8d674b"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzU0OTc1NTgxNzE1Mzc_ea335c30-f216-4aac-bc9d-274993477288" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and December 31, 2019 our debt obligations consisted of the following (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzEtMS0xLTEtMA_a15f1b33-6baa-48d0-9670-9f9f10ddb4ef">611,028</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c47a542e8864e56810edc15688328c9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzEtMy0xLTEtMA_02a7a96e-8a71-46c9-9c40-b4e6110cbe80">649,824</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzItMS0xLTEtMA_33cfe0bd-0d7b-43b3-8fce-0697421ddb3b">9,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c47a542e8864e56810edc15688328c9_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzItMy0xLTEtMA_3134cedd-917b-42d0-9484-842d09092d36">13,579</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzMtMS0xLTEtMA_9a1fb91b-7749-4b19-a15d-964b1c3ccc2a">51,375</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05a8cf1c3f364c8385b06277f3785c9f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzMtMy0xLTEtMA_e41904c1-4452-4aa6-b729-550d08e2ba74">55,875</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment notes payable at interest rates ranging from <ix:nonFraction unitRef="number" contextRef="i4293895b42684cfab6b3bb70114b012f_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNhOTJhZGVmYjgzNDQxMmY4YmFjMzNiMjA3MjMyOGFjXzIxOTkwMjMyNTU2ODI_19e47a86-0830-4c1f-90f1-1163c549558d">4.4</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i10c7eb7f995c42fd9e9471533755d56c_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNhOTJhZGVmYjgzNDQxMmY4YmFjMzNiMjA3MjMyOGFjXzIxOTkwMjMyNTU2ODk_36754a4e-bcd5-4dce-bb06-afb6dcdbe4a3">5.6</ix:nonFraction>%, due through 2020, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LongTermLoansPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzYtMS0xLTEtMA_e476f94e-f531-4d56-a66b-66b6589b27d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" name="us-gaap:LongTermLoansPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzYtMy0xLTEtMA_cb5634f5-df7b-43f0-918f-3a70756c2ea0">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzgtMS0xLTEtMA_ffa48061-8b3a-43a4-a67b-61ba1711c2ac">652,704</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzgtMy0xLTEtMA_e917d03c-d972-4340-86bc-83560b91462e">692,395</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzktMS0xLTEtMA_28f2925c-4698-4c8d-bf5e-389579863820">39,791</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzktMy0xLTEtMA_6cd72ce4-17bd-4926-b702-7170ea5323e0">39,691</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion debt obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzEwLTEtMS0xLTA_0da7e71f-9f5d-4829-bc7a-3ec31aa032d4">612,913</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzEwLTMtMS0xLTA_5cd0cace-fbd7-4fcb-93bd-05eca994bf39">652,704</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzkwNjA_32dacb0c-39a1-4dcd-a3a3-7c382d22f43a" continuedAt="i1ca4f79f254643f3aae8551ad702e11c" escape="true">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i03c60be7acbb4608bebf02e0fd8d674b" continuedAt="i94d4d837a19848af8e6cb5bdde0cd283"><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i1ca4f79f254643f3aae8551ad702e11c"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.090%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.710%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMTgxZjdlNDcwNjI0YThhYTNjMGNkYjU2ZDEzNGYzMi90YWJsZXJhbmdlOmExODFmN2U0NzA2MjRhOGFhM2MwY2RiNTZkMTM0ZjMyXzAtMS0xLTEtMA_464ded19-1fbd-4ef5-bf8e-d8df8d577172">43,670</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMTgxZjdlNDcwNjI0YThhYTNjMGNkYjU2ZDEzNGYzMi90YWJsZXJhbmdlOmExODFmN2U0NzA2MjRhOGFhM2MwY2RiNTZkMTM0ZjMyXzEtMS0xLTEtMA_94fab6dc-b538-42d1-8568-4e184a7e7514">44,795</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMTgxZjdlNDcwNjI0YThhYTNjMGNkYjU2ZDEzNGYzMi90YWJsZXJhbmdlOmExODFmN2U0NzA2MjRhOGFhM2MwY2RiNTZkMTM0ZjMyXzItMS0xLTEtMA_9bc6fcca-237a-402e-8e7a-4554893788a0">573,938</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMTgxZjdlNDcwNjI0YThhYTNjMGNkYjU2ZDEzNGYzMi90YWJsZXJhbmdlOmExODFmN2U0NzA2MjRhOGFhM2MwY2RiNTZkMTM0ZjMyXzYtMS0xLTEtMA_4f048279-2142-40e8-8036-0dca8b39367f">662,403</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzkwNjE_e6829124-80eb-40dd-b9e3-8d0f4c6a0a06" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our consolidated balance sheets at December 31, 2020 are $<ix:nonFraction unitRef="usd" contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE1OTg_0195c96c-68a7-4d88-83ac-d9c28df29213">601.3</ix:nonFraction> million of First Lien Term Loans and $<ix:nonFraction unitRef="usd" contextRef="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE2MzA_ae7fcb0a-62ea-4ba1-a76e-141276caa37b">51.4</ix:nonFraction> million of SunTrust Term Loan debt for a combined total of $<ix:nonFraction unitRef="usd" contextRef="if541ba545c6849c9b80ae7c8f6901cfc_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE2ODQ_e0c8e099-4d70-479f-abec-0c0a42f5ab67">652.7</ix:nonFraction> million (net of unamortized discounts of $<ix:nonFraction unitRef="usd" contextRef="ib81178c4dfa84fc9bdd6fffca1947078_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE3MjA_32020314-377f-4f3d-8078-bab3db3b3ccb">9.7</ix:nonFraction> million) in thousands:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzEtMS0xLTEtMA_14d4e2a7-efa7-48f0-9d22-7670438703bb">611,028</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzEtMy0xLTEtMA_2aa3c18d-1d0e-4bdf-8e09-7b3117df0153">9,699</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzEtNS0xLTEtMA_fd24192a-c176-40f5-803a-524e1b2c7700">601,329</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzItMS0xLTEtMA_8cad6be3-f189-4783-afc2-780af3ad9654">51,375</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzItMy0xLTEtMA_341a2de0-193d-45b5-84b0-580ac1cc3517">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzItNS0xLTEtMA_39e026ff-63a3-446d-9258-469a74d3c9e2">51,375</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if541ba545c6849c9b80ae7c8f6901cfc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzMtMS0xLTEtMA_8bef48f9-eb02-4792-baba-0adc0a5f0984">662,403</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if541ba545c6849c9b80ae7c8f6901cfc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzMtMy0xLTEtMA_a65c2756-4053-4006-ba68-e3d23c354f88">9,699</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if541ba545c6849c9b80ae7c8f6901cfc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzMtNS0xLTEtMA_4fc66bf4-dd9f-4773-88d8-3ab14233b6f3">652,704</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had <ix:nonFraction unitRef="usd" contextRef="ibdfce80209e24d048368e13932f4df63_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE3NTA_d8444ebe-aa6b-47bd-b901-4100250b4ca7">no</ix:nonFraction> outstanding balance under our $<ix:nonFraction unitRef="usd" contextRef="ibdfce80209e24d048368e13932f4df63_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE3ODM_88d2c43f-01bd-4a66-b296-d681e63f752e">195.0</ix:nonFraction> million Barclays Revolving Credit Facility at December 31, 2020 and had reserved an additional $<ix:nonFraction unitRef="usd" contextRef="i4ba89948df004b25bb090cc21c311d86_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE4NTg_c564066d-a5c0-4db4-91cf-25802739f328">7.3</ix:nonFraction> million for certain letters of credit.  The remaining $<ix:nonFraction unitRef="usd" contextRef="i393ed2858c1548b6b82e961dc7975352_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE5MDc_2b20f84b-4228-47b1-89e3-1734de084c32">187.7</ix:nonFraction> million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2020.  We also had <ix:nonFraction unitRef="usd" contextRef="i82d3729db9c24aed80f38ee4cff8b9e5_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LineOfCredit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIwMDM_ba8407ac-1ac8-4f53-92c7-44524fab6e3a">no</ix:nonFraction> balance under our $<ix:nonFraction unitRef="usd" contextRef="i8ffc456155284a328dd24dd400e38ed4_I20201231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIwMjQ_5b7e815f-3f17-4f10-8bd5-05eec8d28f89">30.0</ix:nonFraction> million SunTrust Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2020, and with <ix:nonFraction unitRef="usd" contextRef="ie76ddddf094d4fa9a36625b0a91bb963_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LettersOfCreditOutstandingAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzMyOTg1MzQ5MzQ2MDA_46008970-f822-4e99-894c-f20a0c5e44b8">no</ix:nonFraction> letters of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2020 we were in compliance with all covenants under our credit facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Credit Facilities:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, our Barclays credit facilities were comprised of one tranche of term loans (&#8220;First Lien Term Loans&#8221;) and a revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="ibdfce80209e24d048368e13932f4df63_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyNjYzMzA_88d2c43f-01bd-4a66-b296-d681e63f752e">195.0</ix:nonFraction> million (the &#8220;Barclays Revolving Credit Facility&#8221;), both of which are provided pursuant to the Amended and Restated First Lien Credit and Guaranty Agreement dated July 1, 2016, among RadNet, Barclays Bank plc, as administrative agent, and the lenders identified therein (as amended, the "First Lien Credit Agreement").  Deferred financing costs at December 31, 2020, net of accumulated amortization, was $<ix:nonFraction unitRef="usd" contextRef="i4ba89948df004b25bb090cc21c311d86_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyNzE1ODU_c0629714-2cb5-4d73-9627-f6a97b710faa">1.8</ix:nonFraction> million and is specifically related to our Barclays Revolving Credit Facility.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="rdnt:ScheduleOfLeverageRatioTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzU0OTc1NTgxNzE1Mzg_37d78594-d67a-4734-a27c-c2adb00c6adb" continuedAt="i02c2738a07024d0bae730a4ba1d671e6" escape="true"><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our First Lien Term Loans bear interest at either an Adjusted Eurodollar Rate or a Base Rate (each as defined in the First Lien Credit Agreement) plus an applicable margin according to the following schedule:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"><tr><td style="width:1.0%"></td><td style="width:31.850%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.508%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 5.50x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f3bcd1c38c94c46890195526ab00dc7_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzEtMS0xLTEtMA_49da63fa-9df2-4a18-b9f3-a89051c406b7">4.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i03d496ffc98f4cbea3c2e52184411ed8_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzEtMi0xLTEtMA_9093b73e-a9c3-4a8e-a27c-bedbc807e70e">3.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 4.00x but &#8804; 5.50x</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9fd684fe4e424d05a9e16bcf1667b1d8_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzItMS0xLTEtMA_9eec2bd8-1dcf-4876-a754-a35cba55bc42">3.75</ix:nonFraction>%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6c94cda8e234414db8eeb093634ddc93_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzItMi0xLTEtMA_bba94d2c-28b7-454e-8b19-03ab85ce0c12">2.75</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;3.50x but &#8804; 4.00x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id542a67b5a124e768231f2834084c93e_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzMtMS0xLTEtMA_11729564-474e-4295-a9b0-5363c7e02647">3.50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i565421d3700145cc93c48dbb3d1a4773_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzMtMi0xLTEtMA_f4ca8e19-e0ab-44c8-b2ee-80632cc44600">2.50</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.50x</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2d53766b85e942388c2185f85329d9fe_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzQtMS0xLTEtMA_a51ca22a-11d4-4331-8edd-c1d5d27fb454">3.25</ix:nonFraction>%</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie6a7dcb8d79a4eb49b6cbd0775ce1798_D20160701-20160701" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzQtMi0xLTEtMA_577e7f94-5f89-4bb4-9628-55fc7b7dcc44">2.25</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020 the effective Adjusted Eurodollar Rate and the Base Rate for the First Lien Term Loans was <ix:nonFraction unitRef="number" contextRef="ie8288ed7887c48afb55992d498cc71a8_I20201231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODg2NTk_13337719-f1bb-483d-96a6-7627c3c909f0">1.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i995ae7f592fb4fefb0bb03523e52883b_I20201231" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODg2Njc_dff15b73-50cf-4313-a365-807eae572b58">3.25</ix:nonFraction>%, respectively and the applicable margin for Adjusted Eurodollar Rate and Base Rate borrowings was <ix:nonFraction unitRef="number" contextRef="iae3bdf0809064518b238f69ea108dcd7_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODg3Njk_d9914d17-9f4c-4458-97f8-4c0a31793333">3.75</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i80b7b2a03f3941348f06c63609e7c6cb_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODg3Nzc_30cdd39f-71b5-4c34-bbc4-14597c6f53fb">2.75</ix:nonFraction>%, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Lien Credit Agreement provides for quarterly payments of principal under the First Lien Term Loans in the amount of approximately $<ix:nonFraction unitRef="usd" contextRef="i1263f290830a4060aed96f7ad872c48a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODkxNDQ_3e839835-659e-422b-b333-07d91738758b">9.7</ix:nonFraction> million.  The  First Lien Term Loans will mature on July 1, 2023 unless otherwise accelerated under the terms of the First Lien Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, our SunTrust credit facilities, which relate to our consolidated subsidiary The New Jersey Imaging Network, L.L.C.("NJIN"), were comprised of one term loan (the "SunTrust Term Loan") and a revolving credit facility of $<ix:nonFraction unitRef="usd" contextRef="i8ffc456155284a328dd24dd400e38ed4_I20201231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyNjk2NjI_5b7e815f-3f17-4f10-8bd5-05eec8d28f89">30.0</ix:nonFraction> million (the "SunTrust Revolving Credit Facility") both of which are provided pursuant to the Amended and Restated revolving Credit and Term Loan Agreement dated August 31, 2018, among NJIN, as borrower, with SunTrust Bank, as </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i94d4d837a19848af8e6cb5bdde0cd283" continuedAt="ifa175107f70640128e9aa2bedc105ad8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">administrative agent, and the lenders identified therein (as amended, the "SunTrust Credit Agreement").  Our SunTrust Term Loan bears interest at either an Adjusted LIBOR Rate or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><ix:continuation id="i02c2738a07024d0bae730a4ba1d671e6"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.128%"><tr><td style="width:1.0%"></td><td style="width:8.790%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.226%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.700%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to <ix:nonFraction unitRef="number" contextRef="ibacf3bc799af4bb38a866940c2a2c3bb_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzEtMS0xLTEtNjkwL3RleHRyZWdpb246ZTEyMDAyYmJiNzI3NGEwMmExNzQ3ZTg5NmViNTg1NTBfMzI5ODUzNDg4MzM3MA_89b0e5f8-8503-4d00-ae12-d86129bcad4f">3.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i750fa1f8302a426fb9a669a5704e685e_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzEtMi0xLTEtNjc1L3RleHRyZWdpb246MDdkNmMwY2ZkZjg0NDY5YmE5MWNiMmI0OGQ4YTUwZTFfMzI5ODUzNDg4MzM1Mw_f56cbe43-6e2d-45d8-acaa-033025c5fc37">2.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i81c400dac51f406a9711305492c3b4c2_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzEtMy0xLTEtNjYwL3RleHRyZWdpb246MGZlZmJlMTYzYzU2NDliMWFlM2VmMjM4YzIzNzc0MDlfMzI5ODUzNDg4MzM1NQ_aa0ad2d1-f7e8-46c2-98ea-38c066a6d451">1.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c266838663e4aa9bd0e5ea532d2b79c_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzEtNC0xLTEtNjQ1L3RleHRyZWdpb246YmExMTE0ZjliNTJjNDQ5ODljOTVmYjYyMzBmNTgwNWRfMzI5ODUzNDg4MzM1Mw_16234487-50de-49d4-9e51-56f9b3de23c3">2.75</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c266838663e4aa9bd0e5ea532d2b79c_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzEtNS0xLTEtNjMwL3RleHRyZWdpb246OTc2MDUzMTY5OTQ4NGQ0ZDgxNjZlZDg0NTM0NzVkM2RfMzI5ODUzNDg4MzM1Mw_229a628f-48c0-420b-994a-9d78f957bc92">0.45</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="ibaa9f7ca79134dada648ef42e6c6db50_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItMS0xLTEtNjkzL3RleHRyZWdpb246NTU1N2U3YTI4NmIzNDVkNWE5YTFhYWU3MzY1MjM4ZDBfMzI5ODUzNDg4MzQwOA_88545767-2ba8-4420-b003-ecd7b92caeb8">3.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="ibaa9f7ca79134dada648ef42e6c6db50_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItMS0xLTEtNjkzL3RleHRyZWdpb246NTU1N2U3YTI4NmIzNDVkNWE5YTFhYWU3MzY1MjM4ZDBfMzI5ODUzNDg4MzM5NA_40e27e74-59cd-4e8f-afe9-868f4f1d9f1d">2.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i43b7dfec154e47c7ae3282f11f953037_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItMi0xLTEtNjg3L3RleHRyZWdpb246NTM3Y2YwY2Q5ZjY1NGI5Mzg1ZjA4YmUwOWVjMjgxMTJfMzI5ODUzNDg4MzM3Nw_2c419a27-8695-4bf9-afa2-4b866cfc6383">2.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9a3f1fe7a6fb45e28d7055b802128ddd_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItMy0xLTEtNjcyL3RleHRyZWdpb246ZGQzYTE1OWI5YmVhNDRiZTg0ZmUzNGM4MTRlMDUxODVfMzI5ODUzNDg4MzM2NQ_822327c5-f889-4cdc-8fbb-2fa78dd6cd1c">1.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i77430f8ce1d24d29b21836836ac4c9f5_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItNC0xLTEtNjUxL3RleHRyZWdpb246ZjNlODYxNGU3YTFhNDliMmFmODViMmUyNzA5MTM3ODdfMzI5ODUzNDg4MzM2MQ_3ba65f80-5dc7-4666-8f93-38213bf561e5">2.25</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i77430f8ce1d24d29b21836836ac4c9f5_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItNS0xLTEtNjM5L3RleHRyZWdpb246ZDc4MTQzNTA0OTRhNDY4OWI2ZGQ4NTE3MGMwYTBiYjBfMzI5ODUzNDg4MzM2MQ_050a485b-43c8-4e85-8cbc-ca3663e6c914">0.40</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="iddf06388c8db452292fd4be8fac89b3d_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtMS0xLTEtNjk5L3RleHRyZWdpb246YmMyOGQ2M2NlNDQ2NGQwN2FkOWY2YzNlNDU2NDg4MzFfMzI5ODUzNDg4MzQwMg_3abb5eef-bf82-4de7-811a-7a961c441bbb">2.50</ix:nonFraction>:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iddf06388c8db452292fd4be8fac89b3d_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtMS0xLTEtNjk5L3RleHRyZWdpb246YmMyOGQ2M2NlNDQ2NGQwN2FkOWY2YzNlNDU2NDg4MzFfMzI5ODUzNDg4MzQxMQ_4c11215b-dc93-44f6-ab64-275f718563be">2.00</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i66e971e62a534f359ea61e7860897264_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtMi0xLTEtNjc4L3RleHRyZWdpb246MmMwMDdjOTQxNzIxNDAxMGJjYTEyZTA5YjZhN2I4YThfMzI5ODUzNDg4MzM1Mw_a56ffe4c-7d84-47c8-8a7b-49df0d3d1173">2.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i726b0bebd34a4e46a057d38e4f1ba269_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtMy0xLTEtNjYzL3RleHRyZWdpb246ODI2YTUyOThiZGU5NGQ4ZTk0MTQ5MmRiNGViMmVmNzRfMzI5ODUzNDg4MzM1Mw_2b306b0f-c063-4ba2-ae57-909665c580f4">1.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i219c247a7c464cf9815c4651e1be0884_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtNC0xLTEtNjQ4L3RleHRyZWdpb246ZGY0YzlkYWIwODA5NGYzNmE0N2YzZjA5MjFiZWIyMjRfMzI5ODUzNDg4MzM1Mw_90da6057-b134-4c00-9249-ed2721b99685">2.00</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i219c247a7c464cf9815c4651e1be0884_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtNS0xLTEtNjMzL3RleHRyZWdpb246ZTczYjgyZjdhZTJhNGI0M2IwOTBmN2FmYzE0NDBiMjJfMzI5ODUzNDg4MzM1Mw_27fe537f-6bf8-4acc-9af7-cad7b817275d">0.35</ix:nonFraction>%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="ie388174914b1418aaa031d162e279aa9_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtMS0xLTEtNjk2L3RleHRyZWdpb246MjJlYTY3MjBmYjQ0NGE2Y2E0ZTc1MWIwMDQ3ZjlkMDFfMzI5ODUzNDg4MzQwOA_9598f1d2-8ace-4880-b770-00c6657802a7">2.00</ix:nonFraction>:1.00 but greater than or equal to <ix:nonFraction unitRef="number" contextRef="ie388174914b1418aaa031d162e279aa9_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtMS0xLTEtNjk2L3RleHRyZWdpb246MjJlYTY3MjBmYjQ0NGE2Y2E0ZTc1MWIwMDQ3ZjlkMDFfMzI5ODUzNDg4MzM5NA_bf65795a-1679-419b-b430-81e2511dc5c7">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f4b411c521e4514876b71fb6b7b4ad2_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtMi0xLTEtNjg0L3RleHRyZWdpb246ZWQ4MWRmMjkyMjQ2NGYxOGFkZDdiODY1ODIxMjgwZGZfMzI5ODUzNDg4MzM2MQ_d655f907-fccf-4360-971f-7b7bed3f063b">1.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i65e5beb9352246028536bb875e13ba71_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtMy0xLTEtNjY2L3RleHRyZWdpb246NTljMmQwYjhlMGUyNDYxNjljZDY1YTAyMGE0YWIwZWFfMzI5ODUzNDg4MzM1Mw_f3a6a0bc-ca0f-44d8-8271-87f0425eef19">0.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63f437b3e9a640edad9d5b48f6ada9eb_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtNC0xLTEtNjU0L3RleHRyZWdpb246MzI5NGE4ODQ1NTVjNDgyNGJlMTJiNGM1ZWRiODM4NTVfMzI5ODUzNDg4MzM1Mw_0ef276c2-d851-462e-a648-d11af93f48a7">1.75</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i63f437b3e9a640edad9d5b48f6ada9eb_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtNS0xLTEtNjQyL3RleHRyZWdpb246MzMzNGI2NTBlZjMwNGMyYmE2NjNlYTg1NTM4NzQ4MzlfMzI5ODUzNDg4MzM2MQ_8131f5b5-ad69-44c2-91b1-3c63a7214685">0.30</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than <ix:nonFraction unitRef="number" contextRef="ie69f018701ff451c852994840d5678f4_I20180831" decimals="INF" name="rdnt:DebtInstrumentCovenantLeverageRatioMaximum" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzUtMS0xLTEtNzA4L3RleHRyZWdpb246OGJmZmJiZWQ3MjgwNDE1NGFmZjExZGIzZThmOGZkYjhfMzI5ODUzNDg4MzM1NQ_b98c70b5-04b5-4500-a65e-7842e3c8b8cb">1.50</ix:nonFraction>:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3142f65c94ae47beb9a1aff303e0d018_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzUtMi0xLTEtNjgxL3RleHRyZWdpb246ZThlZWI2ZGI4ODgwNDYzZTk1MTcyOThjMjI2MTI4MjhfMzI5ODUzNDg4MzM1Mw_4801d74f-be08-409b-b100-47c5ace46115">1.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f40b418b6d84fc884519577e1396a36_D20180831-20180831" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzUtMy0xLTEtNjY5L3RleHRyZWdpb246NzNhZmQ4MzFmOTE1NDE3NmIyZjQ5MjlkNTQ4YTMyNGVfMzI5ODUzNDg4MzM1Mw_3a71fc7b-473d-4267-b545-6f6f69466dc2">0.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic6ed187b6ae14da3a3469e3302627e8c_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzUtNC0xLTEtNjU3L3RleHRyZWdpb246Nzc3Y2UwNmEwMTdhNGNjMzhmYWJmZjU0YTY3ZDY3M2NfMzI5ODUzNDg4MzM1Mw_10e9c106-2c36-48d1-a80f-b17814e7d313">1.50</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic6ed187b6ae14da3a3469e3302627e8c_D20180831-20180831" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzUtNS0xLTEtNjM2L3RleHRyZWdpb246N2EyYmQyYWM5ZDAzNDg3ZmFlNTg2YjJhMWRmMmIxZmNfMzI5ODUzNDg4MzM1Mw_f28264e1-b5ad-41d7-9b3e-b859b30a6aa2">0.30</ix:nonFraction>%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans and other obligations outstanding under the SunTrust Credit Agreement currently bear interest at a three month LIBOR election at <ix:nonFraction unitRef="number" contextRef="i54f63ff21ef3452fba37a70277f1b7dd_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDAxMjI_7c0cd832-f315-47e8-ac67-fcd5ffcbbcea">0.22</ix:nonFraction>% plus an applicable margin and fees based on Pricing Level III described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $<ix:nonFraction unitRef="usd" contextRef="ic509aa6e20d8451e869c6c1adc35cb1b_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzg4MjE_dd063329-c1cd-4580-b89b-0c1a85fb55c0">750,000</ix:nonFraction>, representing annual amortization equal to <ix:nonFraction unitRef="number" contextRef="ic509aa6e20d8451e869c6c1adc35cb1b_D20180101-20181231" decimals="INF" name="rdnt:DebtInstrumentPeriodicPaymentPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzg4Njc_f017f343-a486-4ee9-93a9-04217d1c9ab2">5.0</ix:nonFraction>% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $<ix:nonFraction unitRef="usd" contextRef="i48cfb04da83545e39b2c1c70193a8083_I20181231" decimals="INF" format="ixt:numdotdecimal" name="rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzg5OTQ_2c174fdf-4bc1-44fc-9d13-6208ffdc7e7d">375,000</ix:nonFraction>, with the remaining balance to be paid at maturity.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities:</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either an Adjusted Eurodollar Rate or a Base Rate (in each case, as more fully defined in the First Lien Credit Agreement) plus an applicable margin.  The applicable margin for borrowing under the Barclays Revolving Credit Facility varies based on our leverage ratio in accordance with the same schedule set forth above for First Lien Term Loans. As of December 31, 2020, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was <ix:nonFraction unitRef="number" contextRef="i4ba89948df004b25bb090cc21c311d86_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODIzOTA_d64c5907-ce5b-4964-8429-0b1b5881c5e7">6.00</ix:nonFraction>%.</span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Adjusted Eurodollar Rate revolving loans, currently <ix:nonFraction unitRef="number" contextRef="iae3bdf0809064518b238f69ea108dcd7_D20200101-20201231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODI1NzU_d9914d17-9f4c-4458-97f8-4c0a31793333">3.75</ix:nonFraction>%, and fronting fees accrue at <ix:nonFraction unitRef="number" contextRef="i56bc70ab4f98412fb60048a93886fb28_D20200101-20201231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODI2MDk_8c92a5af-91a5-46a0-9f48-2807fa069d32">0.25</ix:nonFraction>% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the First Lien Credit Agreement. In addition a commitment fee of <ix:nonFraction unitRef="number" contextRef="i56bc70ab4f98412fb60048a93886fb28_D20200101-20201231" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODI4MTE_39c69cb1-ce8d-4edf-8ba7-b619358b1d93">0.50</ix:nonFraction>% per annum accrues on the unused revolver commitments under the Barlcays Revolving Credit Facility. </span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on the earlier to occur of July 1, 2023 or termination due to specific events of default pursuant to the First Lien Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays Revolving Credit Facility was amended in August 2020 to add $<ix:nonFraction unitRef="usd" contextRef="i4a1fe13162294ec8b4af081e02f06560_I20201231" decimals="INF" format="ixt:numdotdecimal" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDExNzU_25379d52-eb81-4511-bdca-b39743d56f04">57.5</ix:nonFraction> million of revolving commitments, which additional commitments increased the maximum borrowing capacity to $<ix:nonFraction unitRef="usd" contextRef="ibdfce80209e24d048368e13932f4df63_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDEyMTE_88d2c43f-01bd-4a66-b296-d681e63f752e">195.0</ix:nonFraction> million.  Total issue costs added in relation to this amendment amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i4a1fe13162294ec8b4af081e02f06560_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDEyNDc_1e1a51f9-811c-467b-81a5-b0ddf2d7716f">0.7</ix:nonFraction> million and was capitalized as deferred financing costs and will be amortized over the remaining term of the First Lien Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Revolving Credit Facility:</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SunTrust Credit Agreement established a $<ix:nonFraction unitRef="usd" contextRef="i35416759782a4ffcae881c1975663437_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODQxMzY_a6b2a362-0091-421e-9999-a47d87a630e5">30.0</ix:nonFraction> million revolving credit facility available to NJIN for funding requirements. The SunTrust Revolving Credit Facility terminates on the earliest of (i) August 31, 2023, (ii) the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ifa175107f70640128e9aa2bedc105ad8"><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">voluntary termination thereof by NJIN pursuant to Section 2.8 of the SunTrust Credit Agreement, or (iii) the date on which all amounts outstanding under the SunTrust Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  As of December 31, 2020, NJIN had no borrowings under the SunTrust Revolving Credit Facility. </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Amendments to Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement ("the Eighth Amendment").  The Eighth Amendment amends the First Lien Credit Agreement to add $<ix:nonFraction unitRef="usd" contextRef="i4a1fe13162294ec8b4af081e02f06560_I20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQzODU_f87c8f6a-8cc1-4f4e-807c-3175e38b255a">57.5</ix:nonFraction> million of revolving commitments to the Barclays Revolving Credit Facility increasing the maximum borrowing capacity under the Barclays Revolving Credit Facility to $<ix:nonFraction unitRef="usd" contextRef="i4a1fe13162294ec8b4af081e02f06560_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQzOTM_90b92c10-941c-4cce-99cd-143da10dea2e">195.0</ix:nonFraction> million while leaving the maturity date of July 1, 2023 unchanged.  Total issue costs added in relation to the Eighth Amendment amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i4a1fe13162294ec8b4af081e02f06560_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0MDE_08221469-2135-4928-b882-2f3d90040bbb">0.7</ix:nonFraction> million and was capitalized as deferred financing costs and will be amortized over the remaining term of the First Lien Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019 we entered into the following two amendments to the First Lien Credit Agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#8220;Sixth Amendment&#8221;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#8220;Seventh Amendment&#8221;).  Among other things, the Sixth Amendment amended the First Lien Credit Agreement to issue $<ix:nonFraction unitRef="usd" contextRef="i8545538a2ef54e1b9d395b7b7743a4a3_I20170822" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0MDk_12602768-9251-42fe-90c4-ddc8e0134953">100.0</ix:nonFraction> million in incremental First Lien Term Loans and to add an additional $<ix:nonFraction unitRef="usd" contextRef="i296abca1ec384478903ec34e3f7c3244_I20190418" decimals="INF" format="ixt:numdotdecimal" name="rdnt:LineofCreditFacilityIncreaseBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0MTc_fc8d0630-b43c-412c-9bf4-29052889208c">20.0</ix:nonFraction> million of revolving commitments to the Barclay's Revolving Credit Facility.  The Seventh Amendment amended the First Lien Credit Agreement to extend the maturity date of the Barclays Revolving Credit Facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the First Lien Credit Agreement.  Total issue costs added in relation to the Sixth and Seventh amendments in 2019 amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i3a18b41ec6e94cbbbda45664ee69a4e0_I20190418" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0MjU_b5c05987-5faf-4956-843c-04ce3679ac9d">4.4</ix:nonFraction> million. Of this amount, $<ix:nonFraction unitRef="usd" contextRef="i3a18b41ec6e94cbbbda45664ee69a4e0_I20190418" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0MzM_a7d2956c-068f-4614-be88-ed4ca52e37de">2.1</ix:nonFraction> million was identified and capitalized as discount on debt, $<ix:nonFraction unitRef="usd" contextRef="i3a18b41ec6e94cbbbda45664ee69a4e0_I20190418" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0NDE_25c20ba8-e23b-4681-b87a-c48cf358e0af">0.7</ix:nonFraction> million was capitalized as deferred financing costs, and $<ix:nonFraction unitRef="usd" contextRef="i66691542788640c6b83e170f22e99fd2_D20190418-20190418" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfDeferredCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0NDk_81ac3679-bd9e-439f-b21d-ee277ed845e9">1.6</ix:nonFraction> million was expensed. Amounts capitalized will be amortized over the remaining term of the First Lien Credit Agreement.</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Paycheck Protection Program</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a <ix:nonFraction unitRef="number" contextRef="i9ec14573b907475cbd068c8d85492abd_I20201231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ1OTU_32bf309f-b1ef-4bf6-bb86-cc06638cfa12">1.0</ix:nonFraction>% fixed interest rate and are due in <ix:nonNumeric contextRef="i6e615f475e34430ead7ea3449fb67aa1_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ2MDA_37c091fb-c66a-4ed4-afc6-babe3b78e912">2</ix:nonNumeric> years.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received <ix:nonFraction unitRef="loan" contextRef="i6e615f475e34430ead7ea3449fb67aa1_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="rdnt:DebtInstrumentNumberofLoansReceived" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ2MDY_bc731f8d-53e9-47ca-b2e4-55e9f694ffb0">four</ix:nonFraction> loans totaling $<ix:nonFraction unitRef="usd" contextRef="id29d143ec6924d1587f745bf76712764_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ2MjI_0f1c3193-6bb2-4347-863f-d12a27fd48cc">4.0</ix:nonFraction> million.  We accounted for the funds received as debt and recorded a liability for the full amount of proceeds received and accrued interest over the term of the loans.  In December 2020 we met the eligibility requirements for forgiveness and the loans were written off to gain on debt extinguishment.</span></div></ix:continuation><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="text-indent:54pt"><span><br/></span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_109"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 9 &#8211; <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1ODU_0fd6c563-9ffd-4577-bd71-112555ff7bac" continuedAt="if34f77819aea4875ad152d900216a5cf" escape="true"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1OTI_3ad240ec-878e-4dfd-8511-e55b37e04331" continuedAt="id2e85e96069242e28a3509bb378895a1" escape="true">LEASES</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="if34f77819aea4875ad152d900216a5cf" continuedAt="iabde1a1994164d3cb981a218f34ed6a7"><ix:continuation id="id2e85e96069242e28a3509bb378895a1" continuedAt="i0b3a1d8af60e4e1e97d8fca9ff7ad502"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adoption of Standard</span></div><div style="margin-top:10pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued a new standard related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (&#8220;ROU&#8221;) assets and lease liabilities on the balance sheet for all leases with terms in excess of twelve months. Sufficient disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The standard was effective for us beginning January 1, 2019. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will not apply the standard to the comparative periods presented in the consolidated financial statements. We also elected the transition package of three practical expedients permitted within the standard, which eliminates the requirements to reassess prior conclusions about lease identification, lease classification, and initial direct costs.  The adoption of the standard had a material impact on our consolidated balance sheets, but did not have material impact on our consolidated income statements or cash flows.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="iabde1a1994164d3cb981a218f34ed6a7" continuedAt="ib8d235223fcf411182ecd9cbe8449b4b"><ix:continuation id="i0b3a1d8af60e4e1e97d8fca9ff7ad502" continuedAt="i346a2e82c7a04c83b51f1e6a38dc5993"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Liability</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating leases for medical facilities, administrative offices, warehouse space and major medical equipment.  We lease the premises at which these facilities are located and do not have options to purchase the facilities we rent. Our most common initial term varies in length from <ix:nonNumeric contextRef="i7393b27f4af1422f97fa04785bd0e65e_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzIwODg_bf3ade6c-f716-45df-b652-e9e58976f104">5</ix:nonNumeric> to <ix:nonNumeric contextRef="ie6dad76471cb45619fba56de651a701e_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzIwOTQ_e3f65566-d506-408d-a06f-5ec9c0ffb4a5">15</ix:nonNumeric> years. Including renewal options negotiated with the landlord, we can have a total span of <ix:nonNumeric contextRef="i7393b27f4af1422f97fa04785bd0e65e_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzIxODI_632e2db4-87e7-4612-9fa6-1ccb7c39c2bd">10</ix:nonNumeric> to <ix:nonNumeric contextRef="ie6dad76471cb45619fba56de651a701e_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzIxODg_dd0d7df3-848b-4081-ba31-9a9ffc2205dd">35</ix:nonNumeric> years at the facilities we lease. We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year. Additionally, we have operating and finance leases for certain medical and office equipment, with lease terms generally lasting from <ix:nonNumeric contextRef="i9aa53910584d4308b3a9af105783ce91_D20200101-20201231" format="ixt-sec:duryear" name="rdnt:LesseeLeaseTermofContract" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzI0NTU_58f3d60c-b712-4b4d-92a6-4174f4d73c47">5</ix:nonNumeric> to <ix:nonNumeric contextRef="i59d8b9f6e0ef49d4a4d3fe5016d69357_D20200101-20201231" format="ixt-sec:duryear" name="rdnt:LesseeLeaseTermofContract" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzI0NjE_bbc58111-3747-4154-ab67-ca2958e425d1">8</ix:nonNumeric> years.  Our Incremental Borrowing Rate ("IBR") used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and our IBR is adjusted when those rates experience a substantial change.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1OTM_60dc678b-73ea-4608-be94-9a6ff77df851" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:58.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.251%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.252%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzQtMS0xLTEtMjc4_a9bee75c-ac1b-4aff-8eb3-8e9a53266407">99,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzQtMS0xLTEtMA_9fee3b81-d0d1-4269-8d77-c4d92fa15725">95,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzctMS0xLTEtMjgy_02279927-c6b2-44e3-9c1f-edd15a700b31">3,122</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzctMS0xLTEtMA_db612a1f-bb5f-4f2b-8ae9-d391db126c31">3,135</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzgtMS0xLTEtMjgy_0fa7b899-2bf8-4cd1-83a0-6c32c4433b85">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzgtMS0xLTEtMA_f674b751-e867-4d53-b9e6-8c66b5ceddfd">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzktMS0xLTEtMjg2_524ab2ad-f6f1-4c19-ac02-b2828742b77e">3,332</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzktMS0xLTEtMA_a1e48932-0be2-48e8-91cf-a714024229e6">3,530</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzQtMS0xLTEtMzA3_144ac3db-5e33-467c-bfa0-9202f672e006">89,821</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzQtMS0xLTEtMA_cad7747c-702e-48b9-9aa3-8071fd37fa87">95,922</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzUtMS0xLTEtMzA3_9c27e1bf-8ca9-4040-97ac-0da5986f864e">210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzUtMS0xLTEtMA_4c234d46-1dc8-4e28-8632-8e3d6ffe1190">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzYtMS0xLTEtMzA3_9a6308a0-32e6-41bf-902d-9cfc22d65d34">3,304</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzYtMS0xLTEtMA_1809001e-41e8-4e17-add2-e152fcf71b9d">5,939</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzgtMS0xLTEtMzEx_52e1dada-28e8-43d0-822b-4339794ed1a9">106,099</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzgtMS0xLTEtMA_691ddf55-10db-49bf-8620-19130d22775d">482,399</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzktMS0xLTEtMzEx_50f63212-8004-494a-b97d-68c485d6a661">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzktMS0xLTEtMA_a924afb4-4609-4b8c-882e-a098cf89052c">14,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts for the twelve months ended December 31, 2019 include the transition adjustment for the adoption of Topic 842.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed in our 2018 Annual Report on Form 10-K and under the previous lease accounting, rental expense for the year ended December 31, 2018 was $<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesRentExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzIxOTkwMjMyNjc3MzE_a284bb90-80f9-4bbb-be93-3748352b3f54">83.0</ix:nonFraction> million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="rdnt:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1OTQ_86f0c917-61c3-45a4-b380-95d451cd7b7d" continuedAt="i44600a914a714ec9bce2af25d9d4985b" escape="true">Supplemental balance sheet information related to leases was as follows:</ix:nonNumeric></span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ib8d235223fcf411182ecd9cbe8449b4b"><ix:continuation id="i346a2e82c7a04c83b51f1e6a38dc5993"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i44600a914a714ec9bce2af25d9d4985b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzQtMS0xLTEtNDE3_0b3b7c83-058a-47db-b988-7df95ea299a8">483,661</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzQtMS0xLTEtMA_efab19ef-38f3-41e0-a4be-2c41f94e772c">445,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzUtMS0xLTEtNDE3_ac3e471e-3658-41a0-9edf-dd0b554d1ea9">65,794</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzUtMS0xLTEtMA_5647ef4a-e05e-43cb-8fa1-aeb6de6cd9f9">61,206</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzYtMS0xLTEtNDE3_a4402791-61f1-47c8-9c26-67dba7e47428">463,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzYtMS0xLTEtMA_25212ac2-72fc-42c1-90bc-d81d08c3a421">420,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzctMS0xLTEtNDE3_5a2f246e-14fd-411a-a31a-cc0432b87b94">528,890</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzctMS0xLTEtMA_1d707f33-5e3f-4937-99ae-d73c9da12afe">482,128</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEwLTEtMS0xLTM0MA_1491f1fe-bb7c-4a7f-8f2b-2162c265c553">13,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEwLTEtMS0xLTA_42636328-34a2-4975-ad1c-cb98b9b2498f">14,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzExLTEtMS0xLTM0MA_b36fda98-8f42-48af-a3ca-cf5b06e85dff">6,220</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzExLTEtMS0xLTA_1f68f355-e95f-4bef-bd0a-2bee43cf2486">3,135</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEyLTEtMS0xLTM0MA_c7dc4f07-d95b-4af1-80a4-e98ce970c033">7,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEyLTEtMS0xLTA_feb7e8a9-2ff3-4751-a491-85e6bf6371ae">10,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance lease</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEzLTEtMS0xLTM0MA_902a1b0c-9fb3-45e9-a6ac-b50abb94e81f">2,578</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEzLTEtMS0xLTA_d46d1604-479e-4665-84f6-8d472e1f89c8">3,283</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE0LTEtMS0xLTM0MA_4ef1f0c8-c2f5-4675-9e2e-4ed7951b987a">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE0LTEtMS0xLTA_ad97a6f2-9340-4273-ab0b-649860e24fca">3,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE1LTEtMS0xLTM0MA_49d8e31f-9d5f-49d0-abdb-dc6765bca735">3,321</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE1LTEtMS0xLTA_750885ab-0b5d-4bec-b856-c5f2cac204b4">6,547</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE4LTEtMS0xLTM5MQ_9c9768a1-d8a3-4470-b5cf-10ad62be9199">9.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE4LTEtMS0xLTA_6eaf861d-86e1-47f9-98d5-82085559bc9c">8.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE5LTEtMS0xLTM5MQ_16762176-0700-4f2a-b4b5-11c1f714571e">2.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE5LTEtMS0xLTA_e450705a-573b-4477-a7bb-77f551c5a169">3.3</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzIyLTEtMS0xLTM5NA_7abdd715-8e3e-43cc-ba15-be2e89aa29e9">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzIyLTEtMS0xLTA_1b3c9c79-a6ff-4a13-ba97-9745437ff526">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzIzLTEtMS0xLTM5NA_89bbc70d-ff3c-4927-b29c-4048405a281b">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzIzLTEtMS0xLTA_26c51646-5cb7-42ae-b6af-4bc9757a03a1">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1OTU_df40a80f-edc0-4fc6-acaf-4a8428050aa3" escape="true"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1OTY_39c2e4e6-4230-423a-b823-26b5fc9c638c" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:59.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.487%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.489%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzMtMS0xLTEtMA_a48dc49f-d6e7-49ff-b579-43812bf82ecb">97,307</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzMtMi0xLTEtMA_a690b40e-6abb-4dd4-b4e9-ec47878cf081">2,654</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzQtMS0xLTEtMA_2b3b238a-4ea0-4da4-bd8c-c1462efe3a58">91,479</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzQtMi0xLTEtMA_87fbdf86-f7f7-492d-9668-0b687a529313">719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzUtMS0xLTEtMA_39c067ec-1c99-4353-93c9-f30fc5160e54">83,648</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzUtMi0xLTEtMA_6a5eee94-5cef-42b6-98c2-3fec686fa03b">14</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzYtMS0xLTEtMA_4c7d64cc-117b-4d7b-b9ce-d4885997ab7d">69,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzYtMi0xLTEtMA_c5e0b654-9fa6-4190-82f7-2907144ede33">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzctMS0xLTEtMA_4626eefd-476b-44c3-ba89-eb9796d400d1">59,469</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzctMi0xLTEtMA_fc488daf-f072-4ed0-a457-2a93045187e0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzgtMS0xLTEtMA_141779ec-da37-4b87-aeac-295b3794cfb7">316,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzgtMi0xLTEtMA_ac556918-ef95-4715-8987-300f35411be0">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzktMS0xLTEtMA_43075df4-2884-4cbf-a48f-7e38329ddae3">717,701</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzktMi0xLTEtMA_e8f6b68c-eac5-4712-8921-aa3a8e169e0a">3,406</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzEwLTEtMS0xLTA_d22bafb3-b6a4-4184-b1f5-f454cdd4410d">188,811</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzEwLTItMS0xLTA_a85b3adf-ee68-4134-bacb-52ec4d4a8e99">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzExLTEtMS0xLTA_3d65fa63-8c93-45e0-a97c-ae5342d1d8e9">528,890</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzExLTItMS0xLTA_2a62bc28-ba93-4cd5-bbaf-58e367b8d26b">3,321</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzMyOTY_c2027151-5b0b-451b-a5ea-affeabc45074">8.8</ix:nonFraction> million.  These operating leases will commence in 2021 with lease terms of <ix:nonNumeric contextRef="i7393b27f4af1422f97fa04785bd0e65e_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzMzNjY_563a84e4-2f35-4270-be9b-c98c8a8325ab">3</ix:nonNumeric> to <ix:nonNumeric contextRef="ie6dad76471cb45619fba56de651a701e_I20201231" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzMzNzI_76d8fc66-231c-4ed8-9eb6-d313923e1f17">15</ix:nonNumeric> years.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 10 &#8211; <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ2MDI_6dcd7b0f-942c-4eed-b05d-bbda88019f49" continuedAt="i8401b378496a4ebf8a277e6cea947a03" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i8401b378496a4ebf8a277e6cea947a03" continuedAt="ia7d9d42effd5432e8e5b670763d2ec6c"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ2MTA_d27bbaad-e026-49e1-8b7a-dc1fb8b448f4" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzItMS0xLTEtMA_de8b5282-10f4-4527-82f4-cec5870fdaa0">256</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzItMy0xLTEtMA_75c6a173-9b9d-433d-ad99-50cbd5902783">161</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzItNS0xLTEtMA_5664381c-7cb2-413c-afb4-b8fe77254154">765</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzMtMS0xLTEtMA_6a7c1554-0462-46d0-9b10-be94ab853ac9">1,608</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzMtMy0xLTEtMA_25a663ae-54f1-4432-bfcc-56d4bf57d1c4">7,715</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzMtNS0xLTEtMA_2a2ce33f-6881-44a8-add2-53a436bde270">7,263</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:OtherTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzQtMS0xLTEtMA_7a708255-08b4-4ee3-9ad1-b896eaeb784e">27</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:OtherTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzQtMy0xLTEtMA_f33ca54e-3578-4ef2-88cf-2bad1676cacd">22</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:OtherTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzQtNS0xLTEtMA_1a0cf53f-af5f-4481-bfbb-5979fcec38f5">20</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzUtMS0xLTEtMA_c287a1fe-e96f-443a-80e6-0b59ea22ebc9">303</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzUtMy0xLTEtMA_7a71e04e-1f03-484f-a2d8-1c6ed052cda1">3,396</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzUtNS0xLTEtMA_47f77369-1ebe-4f3f-8b0a-06565b63c40b">2,020</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzYtMS0xLTEtMA_4afc6bed-51c4-49cf-9f63-66442a4674a1">3,035</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzYtMy0xLTEtMA_4a317da1-ae0e-4a02-8e34-441f7d36e937">4,743</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzYtNS0xLTEtMA_2b2129c9-7cb2-427e-94c5-91e46986a06b">4,104</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzgtMS0xLTEtMA_e5cf3099-13db-4235-a96a-bc21e59effa4">895</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzgtMy0xLTEtMA_5f061051-4b80-43d2-8cfb-93c8e50a3f60">6,229</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzgtNS0xLTEtMA_3c288503-13b0-46f5-971f-b9be1ae565d2">394</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ2MDc_82f382d8-d6b4-4db7-b257-8055f36b6f10" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:66.959%"><tr><td style="width:1.0%"></td><td style="width:44.314%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.891%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.891%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.891%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.275%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.897%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzItMS0xLTEtMA_24800f11-f001-4b2d-80b6-111687158f21">179</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzItNS0xLTEtMA_af408cca-680e-48de-9b24-a50de051568f">6,231</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzItOS0xLTEtMA_d97c3c7f-1d6c-4cc8-bac2-ec1f8bcf9c41">8,256</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzMtMS0xLTEtMA_c193db2a-fd2c-479a-ad4a-1c03bf548f48">779</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzMtNS0xLTEtMA_98c59f33-e003-467e-8a11-71df2f16c786">3,891</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzMtOS0xLTEtMA_5a5ece74-aa4b-41a7-8cef-a687c7067025">1,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzQtMS0xLTEtMA_61846817-85bc-4a7d-83e4-382c38855bd8">301</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzQtNS0xLTEtMA_54e17b92-12e4-44ad-b239-5f5d3be215ef">674</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzQtOS0xLTEtMA_b92ac05d-632f-46bb-89fa-59afcea1405e">471</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzUtMS0xLTEtMA_ca170ee0-f6f9-429a-87d0-9d0fdabf8d66">2,748</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzUtNS0xLTEtMA_4d955d0b-b46c-45f4-bb91-03152ed80635">1,824</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzUtOS0xLTEtMA_5dce9f9c-ff39-42ab-8f6e-e304407a47d1">1,237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzYtMS0xLTEtMA_52dee6e1-dbdb-4600-98b0-d62ebbbe8b10">33</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzYtNS0xLTEtMA_38059192-3a98-446a-8812-f87fd5d5d453">462</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzYtOS0xLTEtMA_efebfca3-cd2b-47c6-9663-3fb91b691f5a">1,760</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzctMS0xLTEtODcxNA_d5e1ad4a-70b1-4146-8506-0e60c7d2ba17">2,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzctNS0xLTEtODcxOA_62ef91d1-b6e3-4095-bb5e-0147eae3dd8b">1,324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzctOS0xLTEtODcyMg_0e8ad0a3-d453-4952-bce7-6e389f4d399a">1,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" sign="-" name="rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtMS0xLTEtODcxNA_0cc16ea7-c6f5-4ca9-9497-4006173c87ec">850</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtNS0xLTEtODcxOA_8ece2a07-7bcc-4d8e-8563-5c2546be2bf4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtOS0xLTEtODcyMg_aaca022c-05db-4546-90c2-15263e2e0932">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on change in control</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="rdnt:EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtMS0xLTEtMA_3e45b1ff-a91d-480a-a1b1-59576f43ae00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="rdnt:EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtNS0xLTEtMA_b03c71d2-c0a2-4252-b84d-f92e225aca9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="rdnt:EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtOS0xLTEtMA_7605ccce-3cb4-4d1c-a484-0c41b8182db6">8,303</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzktMS0xLTEtMA_8dab6733-2a82-42c0-bbce-7308c8c9ce1b">4,839</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzktNS0xLTEtMA_6c7eb436-5d2c-4ff1-bc03-4b7c91348915">761</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzktOS0xLTEtMA_8dbce254-14a0-4b4c-9a34-f950a255eb5f">4,254</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzExLTEtMS0xLTg3Mjc_58108c2c-7f99-4539-8d6e-48c501e98a1e">1,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="INF" sign="-" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzExLTUtMS0xLTg3MzE_a5aa3b76-0213-4027-bda4-361a41e3f672">217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationTaxContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzExLTktMS0xLTg3MzU_5e5082c2-974c-4579-b75a-e629d4e24653">1,046</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other reconciling items</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEwLTEtMS0xLTA_5bc75453-9272-402f-b3cf-9897266357e6">2</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEwLTUtMS0xLTA_16a32aa5-b235-4134-a36e-2742dc280ea9">21</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherReconcilingItems" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEwLTktMS0xLTA_f27e3ca5-ef19-434f-b1b4-a8c3a38f35bc">171</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEyLTEtMS0xLTA_1d51e1a7-6bfe-4c27-bbff-e481e54a6bc6">895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEyLTUtMS0xLTA_e31166e2-67e1-4dcd-85e2-0be85cee5323">6,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEyLTktMS0xLTA_a31f0acc-417c-4f60-a271-4787b93a23b5">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ2MDE_8db80698-6200-4bb1-bc99-dfbe0b36f5b1" continuedAt="i060e64504b7b4d09a2d75db58d7fad25" escape="true">Our deferred tax assets and liabilities comprise the following (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="ia7d9d42effd5432e8e5b670763d2ec6c" continuedAt="idad04b72d0eb46cf8cded51a0564f552"><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i060e64504b7b4d09a2d75db58d7fad25"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzItMS0xLTEtMA_d348c7e9-0880-49d3-947e-d311114d2205">59,154</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzItMy0xLTEtMA_c1815ccb-4be1-4ea1-ac85-b1fed418176c">34,490</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzMtMS0xLTEtMA_17debf04-e5f9-4d5b-bd63-413dde10958f">3,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzMtMy0xLTEtMA_dd3e5a43-1208-49d0-a099-0f9cf2be0d8e">4,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:DeferredTaxAssetsOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzQtMS0xLTEtMA_8fd13a06-a30e-4f74-bd31-c3406ee05b0c">124,139</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:DeferredTaxAssetsOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzQtMy0xLTEtMA_305bcaf2-bef7-4512-a391-e05b0f7803ea">126,546</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzctMS0xLTEtMA_63bebd83-d666-4340-9ef9-aa120ab675e0">1,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzctMy0xLTEtMA_71d54a40-0e89-4c86-9a54-c8f4b2586d14">1,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzgtMS0xLTEtMA_fb302282-f011-44e9-b53f-0ac13c8b99b1">21,284</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzgtMy0xLTEtMA_ff3a0986-554a-4700-817f-f74841d1593d">27,220</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzktMS0xLTEtMA_3c21e77a-c09e-4b9b-a529-a5383beb1b44">11,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzktMy0xLTEtMA_dc7346fb-e359-42db-915c-ea730300ffb1">4,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzEwLTEtMS0xLTA_9e338d42-693b-4f11-bc98-fe4ecd12ccc7">5,315</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzEwLTMtMS0xLTA_33e5bc0b-1cc7-4e00-8f1e-18d1733acc51">5,348</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzExLTEtMS0xLTA_5796f91d-b94d-4ae6-acaa-10016253d3cd">216,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzExLTMtMS0xLTA_06f0cb90-144d-427a-a233-a7174413c6a8">193,178</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzEzLTEtMS0xLTA_03ca8d50-e548-47e5-8cbd-dbc503827e3d">24,298</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzEzLTMtMS0xLTA_d5be626e-29c9-495f-8318-f4b1a5f66056">6,450</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE0LTEtMS0xLTA_9a119225-a2ea-492f-93a2-2b616fef36d3">28,457</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE0LTMtMS0xLTA_3029327e-87d4-4bac-a71e-435f5355ea0b">24,637</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE1LTEtMS0xLTA_cbcbb6d5-c7e5-4e01-ab54-aa1bb754b962">9,608</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE1LTMtMS0xLTA_4d0d9c31-4bfb-413a-be3a-354b53fcfc93">6,669</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE2LTEtMS0xLTA_08002384-b0c6-422f-b761-37b18ae1c82b">112,956</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE2LTMtMS0xLTA_ba35f96f-04f3-42cb-b2ca-a132f6f6252d">115,364</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE4LTEtMS0xLTA_a3e02f91-46ad-4152-99dc-0608ce884eb8">6,619</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE4LTMtMS0xLTA_8161419f-5049-43f8-aa2c-e6999f6037f2">5,510</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE5LTEtMS0xLTA_40c2bbd2-f035-401a-83e9-1be888bfdb5d">181,938</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE5LTMtMS0xLTA_419efc47-389c-45c4-b8e0-9e30bafa0421">158,630</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax Asset</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzIxLTEtMS0xLTA_ff0960e9-ff2a-45ac-aa84-98a6cdfbae75">34,687</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzIxLTMtMS0xLTA_1fb4fa97-84cd-42cf-a3c9-c7b6c4c9538f">34,548</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had federal net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i2b790074af0343b2807bdb47a7b6fc97_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzE0NjU_3dac6c1a-12b2-4d07-a555-efe669327f49">251.6</ix:nonFraction> million, which comprise of definite and indefinite net operating losses.  We had federal net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="i2b790074af0343b2807bdb47a7b6fc97_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzIxOTkwMjMyNjczODg_9d3deee7-d458-44be-9a58-c5a7fa980370">186.2</ix:nonFraction> million, which expire at various intervals from the years 2023 to 2037, and had carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i443f461b18dc4cbc8d9de4443701c2c5_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzE2OTE_6a1f2d08-87b1-4edc-a9ee-8d12f8e85f58">65.4</ix:nonFraction> million of net operating losses which do not expire.  Federal net operating losses generated following December 31, 2017 carryover indefinitely and may generally be used to offset up to 80% of future taxable net income.  The Company also had state net operating loss carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="ic9828ffc96914aafb4d9efce6667921c_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzE5OTY_721d40c6-4fdc-470d-b3b9-567a49ef7a6a">57.9</ix:nonFraction> million, which expire at various intervals from the years 2020 through 2039. As of December 31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i5e81d491c9834d05aaea374ea32dd36c_I20201231" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzIwNzg_5fcbf436-8ca7-45a6-818d-ebb5552d83d0">24.6</ix:nonFraction> million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code. Future ownership changes as determined under Section 382 of the Internal Revenue Code could further limit the utilization of net operating loss carryforwards.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2020, we have determined that deferred tax assets of $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" name="rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzMxODY_899481a1-72dd-40d6-ae85-b0eb4b45b2b7">216.6</ix:nonFraction> million are more likely-than-not to be realized. We have also taken into consideration deferred tax liabilities of $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzMzMDQ_689802ff-6aa8-4de5-af97-e447f93f1d73">28.5</ix:nonFraction> million are related to book basis in goodwill that has an indefinite life.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2015. We are currently under audit in the state of California for the tax years of 2016 and 2017.  It is too early to assess the impact such audits may have on the financial position of the Company, however we do not anticipate the results of any open examinations would result in a material change to our financial position.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, the Company has unrecognized tax benefits of $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzM5OTU_2e366547-12a0-4af2-9fe4-24a65a17af01">5.5</ix:nonFraction> million of which $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQwMDc_54004cb9-2f70-442e-8caf-61857214b655">4.4</ix:nonFraction> million  will affect the effective tax rate if recognized.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ1OTg_36117727-1839-420f-a86c-a8182ccfbb8b" continuedAt="i1686ab84b99b42e18b30c267708114bf" escape="true">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="idad04b72d0eb46cf8cded51a0564f552"><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i1686ab84b99b42e18b30c267708114bf"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzItMS0xLTEtMA_3d472c88-f3ba-41b5-9e5c-90839744f53d">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae6485d220c4366bf04745e679dee34_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzItMy0xLTEtMA_a29134b6-9ca8-4469-b3bf-b817400bfe29">4,629</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4642cbc638c646e88712849889f662b5_I20171231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzItNS0xLTEtMA_25d5b1f5-fef0-4c6f-bb1f-2b82cdd3e523">3,615</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzMtMS0xLTEtMA_3c1eb674-235b-4175-8b49-bd4c966b5a48">1,382</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzMtMy0xLTEtMA_e93684d1-1144-4a14-b2c8-d80185dcd34c">34</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzMtNS0xLTEtMA_7573a62b-4a8a-46a1-b0c5-1dce956fdac4">896</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzQtMS0xLTEtMA_853d4201-9953-4876-8c51-4e887bf38cdb">3</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzQtMy0xLTEtMA_b5892e5a-5f6f-4334-8834-d8c000954c0b">119</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzQtNS0xLTEtMA_1e75295f-93fd-45cd-8b63-cd77bd3f4a09">111</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzUtMS0xLTEtMA_4284f9ce-6df4-4292-adf0-eb9a614f56b2">221</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzUtMy0xLTEtMA_148605b1-3970-47e1-b5e1-d6830e1b969f">393</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzUtNS0xLTEtMA_2cc863d4-7b31-42da-afba-9dc947db578a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzYtMS0xLTEtMA_5a767189-2f0b-4a45-9e7c-303faf19756a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231" decimals="-3" sign="-" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzYtMy0xLTEtMA_7041dc84-1fe8-487f-ab57-8690cf96efb7">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231" decimals="-3" name="rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzYtNS0xLTEtMA_6fe8fe49-f65a-40e2-a049-98d9d3f0a0ac">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzctMS0xLTEtMA_68b4afc1-f13a-4440-8ef8-b3a6d0cbaed8">5,484</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzctMy0xLTEtMA_951288e1-8981-402f-9fe5-be31ce1aa6e1">4,320</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibae6485d220c4366bf04745e679dee34_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzctNS0xLTEtMA_06133d96-2873-4d3b-948b-0179af061e91">4,629</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2020 the Company accrued approximately $<ix:nonFraction unitRef="usd" contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ0OTQ_bc7be372-7a5e-4183-bcb3-689e00cd34bb">0.1</ix:nonFraction> million of interest and penalties. As of December 31, 2020, accrued interest and penalties amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ1OTE_1b4c101b-79c9-44c3-b04c-fc86f55c60a9">0.4</ix:nonFraction> million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic, some of the more significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. At December 31, 2020, the Company has taken advantage of the accelerated tax depreciation related to qualified improvement property and the Paycheck Protection Program loan allowed under the CARES Act.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the impact of the CAA and its impact on our financial statements in 2021 and beyond.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 29, 2020, the state of California passed Assembly Bill 85 which suspends the California net operating loss deduction for the 2020-2022 tax years and the R&amp;D credit usage for the same period (for credit usages in excess of $5M). These suspensions were considered in preparation of the 2020 financial statements.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_121"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 11 &#8211; <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI2Nzk_2297e74c-ad3a-4f8a-a69c-2bb89d7353b1" continuedAt="ie888e1ac297a4241ad1c7e35ecdbf846" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><ix:continuation id="ie888e1ac297a4241ad1c7e35ecdbf846" continuedAt="i38ca50efbf654eeaa64ab9978759677b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one long-term equity incentive plan which we refer to as the 2006 Equity Incentive Plan, which we first amended and restated as of April 20, 2015 and again on March 9, 2017 (&#8220;the Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the 2017 Restated Plan <ix:nonFraction unitRef="shares" contextRef="i40918c356ba546019d9cf3855b255d7a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIxOTkwMjMyNjA0MTE_c8a90d81-1a02-488d-b6db-9945fd75b006">14,000,000</ix:nonFraction> shares of common stock.  We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc2OA_936612e8-22fa-4ff0-b720-c4675549c40d">three</span> to <ix:nonNumeric contextRef="i38edc38946a14643a72d3091d803e56d_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc3NA_250c2b5b-f325-4232-aa3a-31b623419d82">five years</ix:nonNumeric> and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc4OA_046091b3-dd3f-4a0f-84b9-3f6b7a937f8c">five</span> to <ix:nonNumeric contextRef="i38edc38946a14643a72d3091d803e56d_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc5NA_54450bf4-0055-4222-82cc-4bac77d94267">ten years</ix:nonNumeric> from the date of grant.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i38ca50efbf654eeaa64ab9978759677b" continuedAt="i4f288b368da8429c9a01090ec73f8a3c"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had outstanding options to acquire <ix:nonFraction unitRef="shares" contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzg3Mg_8f062e1c-1d10-43b7-9ddd-3ffb8d79e8c4">527,899</ix:nonFraction> shares of our common stock, of which options to acquire <ix:nonFraction unitRef="shares" contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzkzMQ_dc76b1d0-dc86-40da-bbf7-b1f9730fe233">307,196</ix:nonFraction> shares were exercisable. <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI2ODE_ac5426eb-b16e-46f4-ac92-c1edd7f7aa88" continuedAt="iea08cf9401a746179539b79d445d673e" escape="true">The following summarizes all of our option transactions for the twelve months ended December 31, 2020:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><ix:continuation id="iea08cf9401a746179539b79d445d673e" continuedAt="iddb3d4a15d8549348ef099daad80db57"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:44.274%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.822%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e82aebaacf64a089fdc7fe9fdc1e466_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzEtMi0xLTEtMA_84ff246b-feb6-4db2-8f19-ccca2de49144">478,951</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1e82aebaacf64a089fdc7fe9fdc1e466_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzEtNC0xLTEtMA_1acc34f5-af8b-481d-ab42-43aeb1069f1b">8.21</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if04aa1ab93ce4b9a8e416308089ebf97_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzItMi0xLTEtMA_abba6ffb-ab99-41da-a399-d097016252fe">48,948</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if04aa1ab93ce4b9a8e416308089ebf97_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzItNC0xLTEtMA_9f8c3beb-229f-42cd-8ce0-f97e3f82a2b1">20.43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzUtMi0xLTEtMA_8f062e1c-1d10-43b7-9ddd-3ffb8d79e8c4">527,899</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzUtNC0xLTEtMA_65d98cb3-4e10-4725-8bda-670331607092">9.34</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if04aa1ab93ce4b9a8e416308089ebf97_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzUtNi0xLTEtMA_802befed-16ec-42a8-9924-457348feb9c7">6.34</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzUtOC0xLTEtMA_416b2bdf-7fcf-4b80-a8a8-8ecf00ac74bb">5,441,129</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzYtMi0xLTEtMA_dc76b1d0-dc86-40da-bbf7-b1f9730fe233">307,196</ix:nonFraction>&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzYtNC0xLTEtMA_3131385d-aa4d-4383-9790-44e49906a078">7.59</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if04aa1ab93ce4b9a8e416308089ebf97_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzYtNi0xLTEtMA_79854c82-f683-4aad-91d4-e028e95f8ebc">5.49</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzYtOC0xLTEtMA_743232a7-64da-4694-930c-9bdcf9e6cf79">3,679,803</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2020 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2020.  As of December 31, 2020, total unrecognized stock-based compensation expense related to non-vested employee awards was $<ix:nonFraction unitRef="usd" contextRef="i36f65120df6f499e96c85073c30fef44_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzE0Nzg_9cd0b0dc-4b64-469c-80ef-aea8be987308">0.6</ix:nonFraction> million which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzE1NjQ_e21b39b8-8a5b-40d2-a109-df157c36d503">1.50</ix:nonNumeric> years.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;<ix:nonFraction unitRef="shares" contextRef="i7aaf101d3fad496781ceeb004ddadb94_D20201001-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIxOTkwMjMyNTkzNTg_37efa57d-e1c2-42e3-8770-17e4f21ec4b6">412,434</ix:nonFraction>&#160;options at a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i82674e78aaef409482561fb16833fed8_D20201001-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIxOTkwMjMyNTkzMjk_69262bc1-aef9-4e53-9a42-f86ae19b4dc0">16.93</ix:nonFraction>&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2020, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $<ix:nonFraction unitRef="usd" contextRef="id7924f95e7254282bcfd904f5e8c2a33_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIxOTkwMjMyNTkzMzc_3f446a15-6c9b-4aa7-9d4a-ba6beb54759f">3.9</ix:nonFraction> million which is expected to be recognized over a weighted average period of approximately <ix:nonNumeric contextRef="i3a16c03189374ecc8b0cfdb8f468e8f7_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIxOTkwMjMyNTkzNjI_d5d25025-2e5c-4b6e-b9c8-5200c7eb53e8">2.29</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><ix:continuation id="iddb3d4a15d8549348ef099daad80db57"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"></td><td style="width:48.506%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.713%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib2855760db5544e182b346d57d04d55d_I20191231" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzEtMi0xLTEtMTg2Mw_accc9538-f3e0-4b2c-bf48-e4823bf396a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted, June 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf9d07d86bdb4bdf9c4770c8c4998e95_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzItMi0xLTEtMTg2Mw_03658ef7-1e43-4ec4-90ea-5e613e412c67">412,434</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idf9d07d86bdb4bdf9c4770c8c4998e95_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzMtMi0xLTEtMTg2Mw_7cdf54b6-0fd0-4ba5-8f0c-a7e47a59c360">11,895</ix:nonFraction>)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d7b881e14e742dcb65f5f1ced340221_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzQtMi0xLTEtMTg2Mw_d8d1b014-247e-45a1-89c7-eb53cd297e62">400,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf9d07d86bdb4bdf9c4770c8c4998e95_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzQtNi0xLTEtMTkwMw_b38cf684-d54c-41fd-b3a8-41208e50d6f7">8.40</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7b881e14e742dcb65f5f1ced340221_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzQtOC0xLTEtMTkxNA_b9bf8727-3adc-4a4e-8bc7-50ce2135b7c8">7,710,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4d7b881e14e742dcb65f5f1ced340221_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzUtMi0xLTEtMTg2Mw_0ba204b8-f67c-45b5-b682-80be8816a565">26,545</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="idf9d07d86bdb4bdf9c4770c8c4998e95_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzUtNi0xLTEtMTkwNw_7e8648de-2173-4ca7-a98e-f68e681677f9">8.40</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7b881e14e742dcb65f5f1ced340221_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzUtOC0xLTEtMTkxNA_16b945c6-eb4c-48d3-a441-898f646c8024">510,994</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards (&#8220;RSA&#8217;s&#8221;)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of December 31, 2020, we have issued a total of <ix:nonFraction unitRef="shares" contextRef="i3bceea0558df4aa7a7b357ca906e3844_I20201231" decimals="INF" format="ixt:numdotdecimal" name="rdnt:AwardsIssuedToDate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzE3MTc_a605e8ec-8c1f-4743-8c54-7d472b186e89">6,551,872</ix:nonFraction> RSA&#8217;s of which <ix:nonFraction unitRef="shares" contextRef="i3bceea0558df4aa7a7b357ca906e3844_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzE3MzU_fb501e03-b830-4d5f-ac65-fa88b636f074">329,159</ix:nonFraction> were unvested at December 31, 2020 . <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI2Nzc_86bf7d7e-1983-4c95-ad71-24574d65ae1c" continuedAt="i3cc1cecd3c3448d6b602a2bac896622f" escape="true">The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2020:</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3cc1cecd3c3448d6b602a2bac896622f" continuedAt="i87ccfde482884e58afeb0a1331293fae">&#160;</ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="i4f288b368da8429c9a01090ec73f8a3c"><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><ix:continuation id="i87ccfde482884e58afeb0a1331293fae"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:59.222%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.640%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2019</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib7d23330ea44497788f06f832afc7e77_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzEtMS0xLTEtMA_b3230c9d-2ead-4196-af8e-504da099b7ab">387,934</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib7d23330ea44497788f06f832afc7e77_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzEtNS0xLTEtMA_537d4f60-bd1b-4cac-b4a2-2075832769ec">11.61</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzMtMS0xLTEtMA_37f4d147-1b14-4842-ba4c-0544286c69af">457,596</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzMtNS0xLTEtMA_20da9958-4730-490b-8e75-607b6472cc0b">19.66</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzQtMS0xLTEtMA_43640f3c-cc1c-48af-9424-09a8a5ef4db8">516,371</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzQtNS0xLTEtMA_83057278-bd2a-42c8-9b4b-5bd584958a94">16.37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3bceea0558df4aa7a7b357ca906e3844_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzYtMS0xLTEtMA_c6a7c3b2-a23e-4b17-ac27-865e7721c881">329,159</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzYtMy0xLTEtMA_b07889ce-d98a-4567-af57-0b94d97dac50">0.87</ix:nonNumeric></span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3bceea0558df4aa7a7b357ca906e3844_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzYtNS0xLTEtMA_1388a3c7-0a4f-4619-92fe-53a9ab0070b8">16.69</ix:nonFraction>&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based of the closing price of our common stock on award date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2020 we issued <ix:nonFraction unitRef="shares" contextRef="ibdc31c4ffa00452f9f099766b10087be_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIyNDA_246d9732-1f72-4e0d-8f59-d98d760a87d9">66,078</ix:nonFraction> shares relating to these awards, approximately amounting to $<ix:nonFraction unitRef="usd" contextRef="ibdc31c4ffa00452f9f099766b10087be_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIyODk_f8b12dd5-0cba-4e1a-b842-a3371dc4f6b2">1.0</ix:nonFraction> million of compensation expense.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan summary</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the <ix:nonFraction unitRef="shares" contextRef="i40918c356ba546019d9cf3855b255d7a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIzNTM_c8a90d81-1a02-488d-b6db-9945fd75b006">14,000,000</ix:nonFraction> shares of common stock reserved for issuance under the Restated Plan, at December 31, 2020, we had issued <ix:nonFraction unitRef="shares" contextRef="i109a113f281d4536a92aad55cbd4446b_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI0NDc_ba93e5a5-f0e5-4bfb-8669-4dcc5cbc8d20">15,424,316</ix:nonFraction> total shares between options, RSA&#8217;s and other stock awards. With options cancelled and RSA&#8217;s forfeited amounting to <ix:nonFraction unitRef="shares" contextRef="i109a113f281d4536a92aad55cbd4446b_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI1NjY_98ded452-7c34-407b-ab25-3cf5654623f4">3,281,040</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i109a113f281d4536a92aad55cbd4446b_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI1NzM_3400ab3f-8b8a-4af1-9687-dc4c1f607bf4">61,703</ix:nonFraction> shares, respectively, there remain <ix:nonFraction unitRef="shares" contextRef="i40918c356ba546019d9cf3855b255d7a_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI2MTE_85f1e7d4-650b-4c5c-9f33-9e0b5495ca58">1,918,427</ix:nonFraction> shares available under the Restated Plan for future issuance.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_133"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 12 &#8211; <ix:nonNumeric contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzQyNA_629e7d88-3e8e-42c9-9ecb-c44a5ef0f4f9" continuedAt="id3052a941e7e4008aa570998319fa334" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><ix:continuation id="id3052a941e7e4008aa570998319fa334"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $<ix:nonFraction unitRef="usd" contextRef="ic762f9e446734268b2ec4cc6053e0784_I20210316" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5MTI_49198b43-f3d0-4ade-b3c9-31aea97d5d20">0.5</ix:nonFraction>&#160;million. RadNet contributed $<ix:nonFraction unitRef="usd" contextRef="i37f85f9b11184e229c14b88e0c866f9a_D20210301-20210316" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5MTk_5b130348-b0aa-4e85-b9da-35e7b110f9bb">0.3</ix:nonFraction>&#160;million in assets for a <ix:nonFraction unitRef="number" contextRef="ib7780ac5dfb3420c990d47876f42a92d_D20210301-20210316" decimals="INF" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5MjY_a3e0fb15-4082-4c62-b6ee-208e9a8c7b6a">60</ix:nonFraction>% economic interest and Simi Adventist contributed assets totaling $<ix:nonFraction unitRef="usd" contextRef="i3d7ba65a559c49258e9c430b845e4b63_I20210316" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5MzQ_cf063490-5723-4cf8-bb83-5f1b75788c42">0.2</ix:nonFraction>&#160;million for a <ix:nonFraction unitRef="number" contextRef="i5392aaed1912447ab767bc58444d59ac_D20210301-20210316" decimals="INF" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5MzA_48a6c43a-85b3-47c2-ac44-f3f8d2396916">40</ix:nonFraction>% economic interest.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over January and February 2021, we completed additional acquisitions of ZP companies in the New York City area for total purchase consideration of approximately $<ix:nonFraction unitRef="usd" contextRef="ibd5cb14789334c5ba54f208a8b80147c_D20210101-20210228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5NDE_35c9acd5-d931-42e9-b5df-15aab4d7720c">53.4</ix:nonFraction>&#160;million.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we received $<ix:nonFraction unitRef="usd" contextRef="i37f85f9b11184e229c14b88e0c866f9a_D20210301-20210316" decimals="-5" format="ixt:numdotdecimal" name="rdnt:ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5NDg_15bf62cd-b05f-4728-8c9a-9733ec688612">6.2</ix:nonFraction>&#160;million in general distribution funds under the CARES Act.</span></div></ix:continuation><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9.&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Changes In and Disagreements with Accountants on Accounting and Financial Disclosure</span></td></tr></table></div><div style="text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:36pt"><span><br/></span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_139"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 9A</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Controls and Procedures</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended, as of December 31, 2020. Based on this evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were effective as of December 31, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations on Effectiveness of Controls and Procedures</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with existing policies or procedures may deteriorate. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management's Report on Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). Internal control over financial reporting includes policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that receipts and expenditures of the Company are transacted in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, under the supervision of our Principal Executive Officer and Principal Financial Officer, conducted an assessment of the effectiveness of its internal control over financial reporting as of December 31, 2020 based on the criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (&#8220;COSO&#8221;). Based on this assessment, management concluded that our internal control over financial reporting was effective as of December 31, 2020.</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ernst &amp; Young LLP, the Company&#8217;s independent registered public accounting firm, has audited the Company&#8217;s internal control over financial reporting as of December 31, 2020, as stated in their report, which is included below in this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the&#160;quarter ended&#160;December&#160;31, 2020,&#160;that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of RadNet, Inc.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Opinion on Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We have audited RadNet, Inc. and subsidiaries&#8217; internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, RadNet, Inc. and subsidiaries&#8217; (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on the COSO criteria.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive (loss) income, equity and cash flows for each of the three years in the period ended December 31, 2020, and the related notes and our report dated March 16, 2021 expressed an unqualified opinion thereon.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Basis for Opinion</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">/s/ Ernst &amp; Young LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Los Angeles, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">March 16, 2021</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;9B.&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Other Information.</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_148"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_151"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Directors, Executive Officers and Corporate Governance</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 10 will be included under the captions &#8220;Directors,&#8221; &#8220;Executive Officers,&#8221; &#8220;Corporate Governance,&#8221; and &#8220;Delinquent Section 16(a) Reports&#8221; in our definitive Proxy Statement for the 2021 Annual Meeting of Stockholders to be filed with the SEC within 120 days after the end of our fiscal year (the &#8220;Proxy Statement&#8221;) and is incorporated herein by reference.</span></div><div style="text-align:justify;text-indent:15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of financial ethics applicable to our directors, officers and employees which is designed to deter wrongdoing and to promote:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">honest and ethical conduct;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">full, fair, accurate, timely and understandable disclosure in reports and documents that we file with the SEC and in our other public communications;</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">compliance with applicable laws, rules and regulations, including insider trading compliance; and</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:49.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">accountability for adherence to the code and prompt internal reporting of violations of the code, including illegal or unethical behavior regarding accounting or auditing practices.</span></div><div style="padding-left:49.5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may obtain a copy of our Code of Financial Ethics on our website at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.radnet.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under Investor Relations&#160;&#8212;&#160;Corporate Governance. The Audit Committee is responsible for reviewing the Code of Financial Ethics and amending as necessary. Any amendments will be disclosed on our website.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_154"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Executive Compensation</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 11 will be included under the captions &#8220;Compensation of Directors,&#8221; &#8220;Compensation Committee Report,&#8221; &#8220;Compensation Discussion and Analysis,&#8221; and "Executive Compensation Tables" in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_157"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 12 will be included under the captions &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Equity Compensation Plan Information&#8221; in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_160"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Certain Relationships and Related Transactions, and Director Independence</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 13 will be included under the captions &#8220;Compensation of Directors," "Compensation Committee Report," "Compensation Discussion and Analysis", and "Executive Compensation Tables" in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_163"></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Principal Accountant Fees and Services</span></td></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 14 will be included under the caption &#8220;Independent Registered Public Accounting Firm Fees&#8221; in the Proxy Statement and is incorporated herein by reference.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_166"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div style="text-align:center"><span><br/></span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_169"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 15. &#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibits and Financial Statements Schedule</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(a) Documents filed as part of this annual report on Form 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:84.677%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.191%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(1) Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Page No</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">The following financial statements are included in this report</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_52">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_52">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_55">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_55">59</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_61">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_61">60</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_64">Consolidated Statements of Comprehensive (Loss) Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_64">61</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_67">Consolidated Statements of Equity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_67">62</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_70">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_70">64</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_73">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64 to 86</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) Financial Statement Schedules</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedules are omitted because they are not applicable or the required information is shown in the consolidated financial statements or notes thereto.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_172"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following exhibits are filed herewith or incorporated by reference herein:</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex301.htm">Certificate of Incorporation of RadNet, Inc., a Delaware corporation (incorporated by reference to exhibit filed with Form 8-K on September 4, 2008).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708004043/radnet_8k-ex302.htm">Certificate of Amendment to Certificate of Incorporation of RadNet, Inc., a Delaware corporation, dated September 2, 2008 (incorporated by reference to exhibit filed with Form 8-K on September 4, 2008).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316820000383/radnet_ex0301.htm">Bylaws of RadNet, Inc., a Delaware corporation (incorporated by reference to Exhibit 3.1 of the Form 8-K filed on February 5, 2020).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316819004068/radnet_s3.htm">Description of Securities (incorporated by reference the Description of Common Stock contained in the registration statement on Form S-3ASR filed on December 26, 2019</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968712003650/radnet_8k-ex9902.htm">Pledge and Security Agreement, dated October 10, 2012, by and among Radnet Management, Inc., RadNet, Inc., the guarantors thereunder, and Barclays Bank PLC (incorporated by reference to exhibit filed with Form 8-K on October 12, 2012).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968712003650/radnet_8k-ex9902.htm">Form of Trademark Security Agreement by and among the guarantors thereunder and Barclays Bank PLC (filed as an exhibit E to the Pledge and Security Agreement, dated October 10, 2012, by among the guarantors thereunder and Barclays Bank PLC, included as Exhibit 10.2).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968715001710/radnet_8k-ex1001.htm">Joinder Agreement, dated as of April 30, 2015, among Barclays Bank Plc, Radnet Management, Inc., a California corporation, Radnet Inc., a Delaware corporation, and certain affiliates and subsidiaries of Radnet Management Inc. (incorporated by reference to exhibit filed with Form 8-K on May 1, 2015).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316816000845/radnet_8ka-ex1001.htm">Amendment No. 3 to Credit and Guaranty Agreement, dated as of July 1, 2016 by and among Radnet Management, Inc., Radnet, Inc. certain subsidiaries and affiliates of Radnet Management, Inc., the lenders party thereto from time to time, certain other financial institutions and Barclays Bank PLC, as administrative agent and collateral agent. (incorporated by reference to filed with Form 8-K/A on December 2, 2016).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316817000224/radnet_ex1001.htm">Amendment No. 4 to Credit and Guaranty Agreement, dated as of February 2, 2017 by and among Radnet Management, Inc., Radnet, Inc. certain subsidiaries and affiliates of Radnet Management, Inc., the lenders party thereto from time to time, certain other financial institutions and Barclays Bank PLC, as administrative agent and collateral agent. (incorporated by reference to filed with Form 8-K on February 2, 2017).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316817002201/radnet_ex1001.htm">Amendment No. 5, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement, dated as of August 22, 2017 by and among Radnet Management, Inc., RadNet, Inc., certain subsidiaries and affiliates of Radnet Management, Inc., the lenders party thereto, Barclays Bank PLC, as administrative agent and collateral agent and the lenders party thereto (incorporated by reference to exhibit filed with Form 8-K on August 23, 2017)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316819001121/radnet_8k-ex1001.htm">Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement dated as of April 18, 2019 by and among Radnet Management, Inc., RadNet, Inc., certain affiliates and subsidiaries of Radnet Management, Inc., and Barclays Bank Plc (incorporated by reference to exhibit filed with Form 8-K on April 19, 2019)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316819001121/radnet_8k-ex1002.htm">Amendment No. 7 to Credit and Guaranty Agreement dated as of April 18, 2019 by and among Radnet Management, Inc., RadNet, Inc., certain affiliates and subsidiaries of Radnet Management, Inc. and Barclays Bank Plc (incorporated by reference to exhibit filed with Form 8-K on April 19, 2019)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316820002941/radnet_ex1001.htm">Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement dated as of August 28, 2020 by and among Radnet Management, Inc., RadNet, Inc., certain subsidiaries and affiliates of RadNet, Inc., as guarantors, the lenders party thereto from time to time and Barclays Bank PLC, as administrative agent and collateral agent (incorporated by reference to exhibit filed with Form 8-K on September 1, 2020)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316817001571/radnet_8k-ex9901.htm">RadNet, Inc. 2006 Equity Incentive Plan (Amended and Restated as of March 9, 2017) (incorporated by reference to exhibit filed with Form 8-K on June 13, 2017).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316817002007/radnet_ex9902.htm">Form of Incentive Option Agreement for the 2006 Equity Incentive Plan (incorporated by reference to exhibit filed with Form S-8 registration statement on August 9, 2017).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316817002007/radnet_ex9903.htm">Form of Nonstatutory Option Agreement for the 2006 Equity Incentive Plan (incorporated by reference to exhibit filed with Form S-8 registration statement on August 9, 2017).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316817002007/radnet_ex9904.htm">Form of Restricted Stock Award for Officers under the 2006 Equity Incentive Plan (incorporated by reference to exhibit filed with Form S-8 registration statement on August 9, 2017).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316817002007/radnet_ex9905.htm">Form of Restricted Stock Award for Non-Employee Directors under the 2006 Equity Incentive Plan (incorporated by reference to exhibit filed with Form S-8 registration statement on August 9, 2017).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316817002007/radnet_ex9906.htm">Form of Restricted Stock Unit Agreement (deferred settlement) for Officers under the 2006 Equity Incentive Plan (incorporated by reference to exhibit filed with Form S-8 registration statement on August 9, 2017).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.16</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316817002007/radnet_ex9907.htm">Form of Restricted Stock Unit Agreement (deferred settlement) for Non-Employee Directors under the 2006 Equity Incentive Plan (incorporated by reference to exhibit filed with Form S-8 registration statement on August 9, 2017).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968708002117/radnet_10q-ex1001.txt">Form of Indemnification Agreement between the registrant and each of its officers and directors (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended March 31, 2008).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716006165/radnet_8k-ex1001.htm">Nonqualified Deferred Compensation Plan, effective as of May 5, 2016 (incorporated by reference to exhibit filed with Form 8-K on May 9, 2016).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement dated as of June 12, 1992 with Howard G. Berger, M.D. (incorporated by reference to exhibit filed with an amendment to Form 8-K report for June 12, 1992).*</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000119312504041365/dex101.htm">Amendment to Employment Agreement dated January 30, 2004 with Howard G. Berger, M.D. (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended January 31, 2004).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716005474/radnet_ex1017.htm">Second Amendment to Employment Agreement dated November 16, 2015 with Howard G. Berger, M.D. (incorporated by reference to exhibit filed with Form 10-K on March 15, 2016).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968702000206/primedex_ex10-15.txt">Employment Agreement dated as of May 1, 2001 with Norman R. Hames (incorporated by reference to exhibit filed with Form 10-K for the year ended October 31, 2001).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000119312504041365/dex103.htm">Amendment to Employment Agreement dated January 30, 2004 with Norman R. Hames (incorporated by reference to exhibit filed with Form 10-Q for the quarter ended January 31, 2004).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716005474/radnet_ex1023.htm">Second Amendment to Employment Agreement dated November 16, 2015 with Norman R. Hames (incorporated by reference to exhibit filed with Form 10-K on March 15, 2016).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.553%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000114420410013494/v177162_ex10-10.htm">Employment Agreement with Mark Stolper effective January 1, 2009 (incorporated by reference to exhibit filed with Form 10-K for the year ended December 31, 2009).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716005474/radnet_ex1025.htm">First Amendment to Employment Agreement dated November 16, 2015 with Mark Stolper (incorporated by reference to exhibit filed with Form 10-K on March 15, 2016).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968707001108/radnet_ex1037.txt">Retention Agreement with Stephen Forthuber dated November 15, 2006 (incorporated by reference to exhibit filed with Form 10-K/T for the year ended December 31, 2006).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000101968716005474/radnet_ex1027.htm">First Amendment to Retention Agreement dated November 16, 2015 with Stephen Forthuber (incorporated by reference to exhibit filed with Form 10-K on March 15, 2016).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316817001151/radnet_ex1001.htm">Employment Agreement dated as of January 1, 2009 Stephen M. Forthuber (incorporated by reference to exhibit filed with Form 10-Q on May 10, 2017).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000119312504015956/dex1016.htm">Amended and Restated Management and Service Agreement between Radnet Management, Inc. and Beverly Radiology Medical Group III dated January 1, 2004 (incorporated by reference to exhibit filed with Form 10-K for the year ended October 31, 2003).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000162828019003087/njinrevolvingcreditandterml.htm">Revolving Credit and Term Loan Agreement dated September 30, 2015 among New Jersey Imaging Network, LLC, the various lenders identified therein, and SunTrust Bank as administrative agent, issuing bank and swingline lender (incorporated by reference to exhibit filed with Form 10-K for the year ended December 31, 2018)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000162828019003087/njinarrevolvingcreditandter.htm">Amended and Restated Revolving Credit and Term Loan Agreement dated &#160;August 31, 2018 among New Jersey Imaging Network, LLC, the various lenders identified therein, and SunTrust Bank as administrative agent, issuing bank and swingline lender (incorporated by reference to exhibit filed with Form 10-K for the year ended December 31, 2018)</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/790526/000168316820000689/radnet_ex1001.htm">Employment Agreement dated as of March 2, 2020 with David J. Katz (incorporated by reference to exhibit 10.1 of the Form 8K/A filed on March 4, 2020).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10k2020exhibit211.htm">List of Subsidiaries.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10k2020exhibit231.htm">Consent of</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10k2020exhibit231.htm"> Independent</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10k2020exhibit231.htm"> Registered</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10k2020exhibit231.htm"> Public Accounting Firm.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5a2935eeac0a4d05a10ff02c7b77fcb4_181">Power of Attorney (included on signature page attached hereto).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42020exhibit311.htm">CEO Certification pursuant to Section 302.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42020exhibit312.htm">CFO Certification pursuant to Section 302.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42020exhibit321.htm">CEO Certification pursuant to Section 906.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q42020exhibit322.htm">CFO Certification pursuant to Section 906.</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Schema Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Calculation Linkbase Document</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.553%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Label Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Presentation Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Definition Linkbase Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Indicates management contract or compensatory plan.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_175"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 16. &#160;10-K Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_178"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.820%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RADNET, INC.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 16, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;HOWARD &#160;G. BERGER, M.D .</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D., President,</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer and Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i5a2935eeac0a4d05a10ff02c7b77fcb4_181"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">POWER OF ATTORNEY</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby severally constitutes and appoints Howard G. Berger, M.D. and Mark D. Stolper, and each of them, his true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution for him and in his name, place and stead, in any and all capacities to sign any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, granting unto said attorney-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite or necessary fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that each said attorneys-in-fact and agents or any of them or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of registrant in the capacities and on the dates indicated.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ HOWARD G. BERGER, M.D.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D., Director, Chief Executive Officer and President</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ JOHN V. CRUES, III, M.D.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John V. Crues, III, M.D., Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ RUTH VILLIGER-WILSON</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Ruth Villiger-Wilson, Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DAVID L. SWARTZ</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">David L. Swartz, Director</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ LAWRENCE L. LEVITT</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Lawrence L. Levitt, Director</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ LAURA P. JACOBS</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Laura P. Jacobs, Director</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 16, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="border-bottom:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ MARK D. STOLPER</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark D. Stolper,Chief Financial Officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (Principal Accounting Officer)</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: March 16, 2021</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>2
<FILENAME>a10k2020exhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i0ec02bf8d2c740f6acf10fab43424897_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 21.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUBSIDIARIES</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:78.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Managed Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management I, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management II, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Sub, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beach Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Village, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FRI II, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FRI, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glendale Advanced Imaging Center LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orange County Radiation Oncology, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pacific Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rolling Oaks Imaging Corporation</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rolling Oaks Radiology, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Santa Monica Imaging Group, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SoCal MR Site Management, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valley Imaging Partners Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ventura County Imaging Group, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">West Valley Imaging Group, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RMIS Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced NA, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Radiology Services of Delaware, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American Radiology Services LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona Diagnostic Radiology Group, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona Imaging Services, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Community Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DeepHealth, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostic Imaging Services, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ide Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Image Medical Corporation</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mid Rockland Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix Health, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orange County Radiation Oncology, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PantheonXT Partners, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiologix, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiology Alliance Delivery Systems, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiology and Nuclear Medicine Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Management I, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radnet Venture Investment Fund I, L.P.</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radsite LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raven Holdings U.S., Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.982%"><tr><td style="width:1.0%"></td><td style="width:78.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.612%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RMI-MR, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Simi Valley Imaging Group, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasure Coast Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Questar Imaging, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Questar Victorville, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scriptsender, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Florida</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kepdoktor Kft</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hungary</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced PET Imaging of Maryland, L.P.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced Radiology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advanced &#47;Upper Chesapeake Health Center, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baltimore County Radiology, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Baltimore Washington Imaging Center, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Calvert Imaging Center</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Carroll County Radiology, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Franklin Imaging, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Baltimore Diagnostic Imaging Partnership</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montgomery Community Magnetic Imaging Center Limited Partnership</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mount Airy Imaging Center, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MRI at St. Joseph Medical Center, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radiology Alliance Delivery System, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maryland</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Radar Medical Systems, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michigan</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging On Call, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging Services Company of New York, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Park West Circle Realty, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New York</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Garden State Radiology Network, LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Diagnostics of New Jersey, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integrated Health Network Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey Imaging Network, LLC</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey Imaging Partners, Inc.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Jersey</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">eRad, Inc.</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennsylvania</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Rhode Island LLC</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rhode Island</font></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Roentgen Reinsurance Company, Ltd</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turks and Caicos</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>a10k2020exhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i9120ef42b37b4f94b3a39c6f2ac8e246_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.35pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="margin-top:0.35pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consent of Independent Registered Public Accounting Firm</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) &#160;&#160;&#160;&#160;Registration Statement (Form S-3ASR No. 333-235711) of RadNet, Inc.&#59;</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;Registration Statements (Form S-8 Nos. 333-176324, 333-206311 and 333-219824) pertaining to the 2006 Equity Incentive Plan&#59; and</font></div><div style="padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;Registration Statements (Form S-8 No. 333-238874) pertaining to the 2017 Stock Incentive Plan of DeepHealth, Inc.</font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated March 16, 2021, with respect to the consolidated financial statements of RadNet, Inc. and subsidiaries, and the effectiveness of internal control over financial reporting of RadNet, Inc. and subsidiaries, included in this Annual Report (Form 10-K) of RadNet, Inc. and subsidiaries for the year ended December 31, 2020.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:0.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Los Angeles, California</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 16, 2021</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>q42020exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7f9d85bfffa24466b1c539a36fc560aa_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:198pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Howard G. Berger, M.D., certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-K of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; March 16, 2021</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">President, Chief Executive Officer and Chairman of the Board of Directors</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>q42020exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ibffb3b455890484ab5350dbd4a48c123_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark D. Stolper, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;I have reviewed this report on Form 10-K of RadNet, Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.732%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">c.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">d.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:1.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">a.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.387%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">b.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; March 16, 2021</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Vice President</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">and Chief Financial Officer</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>q42020exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i95108ab991a046f99e6d0d5a71bfcb95_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-K for the twelve month period ended December 31, 2020, as filed with the Securities and Exchange Commission on March 16, 2021 (the &#8220;Report&#8221;), I, Howard G. Berger, M.D., Chairman and Chief Executive Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Howard G. Berger, M.D.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</font></td></tr></table></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>7
<FILENAME>q42020exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i02918290978c4bb9ae89aef8f996fd23_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of RadNet, Inc. (the &#8220;Company&#8221;) on Form 10-K for the twelve month period ended December 31, 2020, as filed with the Securities and Exchange Commission on March 16, 2021 (the &#8220;Report&#8221;), I, Mark D. Stolper, Chief Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for the periods presented in the Report.</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark D. Stolper</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer)</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 16, 2021</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section 906 has been provided to the Company and will be furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>rdnt-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:cd605a11-4611-4df1-b35a-84491793f997,g:2afe2a05-cf4e-4f48-9c2a-eb0c739eec8b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rdnt="http://www.radnet.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.radnet.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rdnt-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.radnet.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME">
        <link:definition>1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTOFEQUITY" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENT OF EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1006007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESS" roleURI="http://www.radnet.com/role/NATUREOFBUSINESS">
        <link:definition>2101101 - Disclosure - NATURE OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NATUREOFBUSINESSDetailsNarrative" roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative">
        <link:definition>2402401 - Disclosure - NATURE OF BUSINESS (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue">
        <link:definition>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative">
        <link:definition>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives">
        <link:definition>2408404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements">
        <link:definition>2409405 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare">
        <link:definition>2410406 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures">
        <link:definition>2411407 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures">
        <link:definition>2412408 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RECENTACCOUNTINGSTANDARDS" roleURI="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS">
        <link:definition>2113103 - Disclosure - RECENT ACCOUNTING STANDARDS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS" roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS">
        <link:definition>2114104 - Disclosure - FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FACILITYACQUISITIONSANDDISPOSITIONSTables" roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSTables">
        <link:definition>2315302 - Disclosure - FACILITY ACQUISITIONS AND DISPOSITIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed" roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed">
        <link:definition>2416409 - Disclosure - FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Schedule of Assets and Liabilities Assumed)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative" roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative">
        <link:definition>2417410 - Disclosure - FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>2118105 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>2319303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill">
        <link:definition>2420411 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative">
        <link:definition>2421412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule">
        <link:definition>2422413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENT" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENT">
        <link:definition>2123106 - Disclosure - PROPERTY AND EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTTables" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables">
        <link:definition>2324304 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTDetails" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails">
        <link:definition>2425414 - Disclosure - PROPERTY AND EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTDetailsNarrative" roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative">
        <link:definition>2426415 - Disclosure - PROPERTY AND EQUIPMENT (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSES" roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES">
        <link:definition>2127107 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables">
        <link:definition>2328305 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails">
        <link:definition>2429416 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLE" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE">
        <link:definition>2130108 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLETables" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables">
        <link:definition>2331306 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt">
        <link:definition>2432417 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt_1" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt_1">
        <link:definition>2432417 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities">
        <link:definition>2433418 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative">
        <link:definition>2434419 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans">
        <link:definition>2435420 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Term Loans)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio">
        <link:definition>2436421 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails">
        <link:definition>2437422 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNotes" roleURI="http://www.radnet.com/role/LEASESNotes">
        <link:definition>2138109 - Disclosure - LEASES (Notes)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.radnet.com/role/LEASESTables">
        <link:definition>2339307 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsAdditionalInformation" roleURI="http://www.radnet.com/role/LEASESDetailsAdditionalInformation">
        <link:definition>2440423 - Disclosure - LEASES (Details - Additional Information)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsLeaseCost" roleURI="http://www.radnet.com/role/LEASESDetailsLeaseCost">
        <link:definition>2441424 - Disclosure - LEASES (Details - Lease Cost)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsSupplementalCashFlows" roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows">
        <link:definition>2442425 - Disclosure - LEASES (Details - Supplemental Cash Flows)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsSupplementalBalanceSheet" roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet">
        <link:definition>2443426 - Disclosure - LEASES (Details - Supplemental Balance Sheet)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsMaturitiesofOperatingandFinanceLease" roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease">
        <link:definition>2444427 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESDetailsMaturitiesofOperatingandFinanceLease_1" roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1">
        <link:definition>2444427 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.radnet.com/role/INCOMETAXES">
        <link:definition>2145110 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.radnet.com/role/INCOMETAXESTables">
        <link:definition>2346308 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsIncometaxexpense" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense">
        <link:definition>2447428 - Disclosure - INCOME TAXES (Details - Income tax expense)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates">
        <link:definition>2448429 - Disclosure - INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsNarrative" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsNarrative">
        <link:definition>2449430 - Disclosure - INCOME TAXES (Details - Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NCOMETAXESDetailsDeferredtaxassetsandliabilities" roleURI="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities">
        <link:definition>2450431 - Disclosure - NCOME TAXES (Details - Deferred tax assets and liabilities)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetailsUnrecognizedtaxbenefit" roleURI="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit">
        <link:definition>2451432 - Disclosure - INCOME TAXES (Details - Unrecognized tax benefit)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>2152111 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>2353309 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsNarrative" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative">
        <link:definition>2454433 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants">
        <link:definition>2455434 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONDetailsRSUs" roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs">
        <link:definition>2456435 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTS" roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS">
        <link:definition>2157112 - Disclosure - SUBSEQUENT EVENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTSDetailsNarrative" roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative">
        <link:definition>2458436 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rdnt_ContributionsFromNoncontrollingInterests" abstract="false" name="ContributionsFromNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NoncontrollingInterestSpecialDistribution" abstract="false" name="NoncontrollingInterestSpecialDistribution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition" abstract="false" name="IncreaseInNoncontrollingInterestDueToStepAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PaycheckProtectionProgramLoansMember" abstract="true" name="PaycheckProtectionProgramLoansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ProceedsReceivedFromInsurance" abstract="false" name="ProceedsReceivedFromInsurance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSixthAmendmentMember" abstract="true" name="FirstLienCreditAgreementSixthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" abstract="false" name="UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_WeightedAverageAmortizationPeriodRemainingInYears" abstract="false" name="WeightedAverageAmortizationPeriodRemainingInYears" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_OlneyOpenMRILLCMember" abstract="true" name="OlneyOpenMRILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LesseeLeaseTermofContract" abstract="false" name="LesseeLeaseTermofContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" abstract="true" name="USAttorneysOfficeForTheWesternDistrictofNewYorkMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_MedicalMalpracticeDeductiblePerIncidence" abstract="false" name="MedicalMalpracticeDeductiblePerIncidence" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NonCashSeverance" abstract="false" name="NonCashSeverance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" abstract="false" name="BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_PatientServicesNetMember" abstract="true" name="PatientServicesNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_A2019SWAPS1Member" abstract="true" name="A2019SWAPS1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_TurnerImagingMember" abstract="false" name="TurnerImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ImagingOnCallMember" abstract="true" name="ImagingOnCallMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_DeepHealthIncMember" abstract="true" name="DeepHealthIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIIIMember" abstract="true" name="PricingLevelIIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationStepAcquisitionCashAcquired" abstract="false" name="BusinessCombinationStepAcquisitionCashAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NumberOfCenters" abstract="false" name="NumberOfCenters" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_NumberofUnconsolidatedJointVentures" abstract="false" name="NumberofUnconsolidatedJointVentures" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_AggregateIntrinsicValue" abstract="true" name="AggregateIntrinsicValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_A2019SWAPSMember" abstract="true" name="A2019SWAPSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_GlendaleAdvancedImagingMember" abstract="true" name="GlendaleAdvancedImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" abstract="false" name="EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="rdnt_ProceedsFromGovernmentAssistance" abstract="false" name="ProceedsFromGovernmentAssistance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_AZTechMember" abstract="true" name="AZTechMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioTwoMember" abstract="true" name="LeverageRatioTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" abstract="true" name="ArizonaDiagnosticRadiologyGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" abstract="false" name="AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_AZTechRadiologyOpenMRILLCMember" abstract="true" name="AZTechRadiologyOpenMRILLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ScriptSenderMember" abstract="true" name="ScriptSenderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_LeverageRatioDomain" abstract="true" name="LeverageRatioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_MedicalInsuranceStopLossPolicyClaimAmount" abstract="false" name="MedicalInsuranceStopLossPolicyClaimAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ComputerandOfficeEquipmentMember" abstract="true" name="ComputerandOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_October2023Member" abstract="true" name="October2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BlueShieldMember" abstract="true" name="BlueShieldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" abstract="false" name="LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PricingLevelIMember" abstract="true" name="PricingLevelIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioThreeMember" abstract="true" name="LeverageRatioThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_FirstLienTermLoanMember" abstract="false" name="FirstLienTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_PropertyAndEquipmentMember" abstract="false" name="PropertyAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_SimiValleyImagingGroupLLCMember" abstract="true" name="SimiValleyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_RestatedAgreementMember" abstract="true" name="RestatedAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentSharesPurchased" abstract="false" name="EquityMethodInvestmentSharesPurchased" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_LeverageRatioFourMember" abstract="true" name="LeverageRatioFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_AdvanceMedicarePayments" abstract="false" name="AdvanceMedicarePayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" abstract="false" name="BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_VenturaCountyImagingGroupLLC.Member" abstract="true" name="VenturaCountyImagingGroupLLC.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_TradeNamesAmortizedMember" abstract="true" name="TradeNamesAmortizedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_GoodwillDeductibleForTaxPurposes" abstract="false" name="GoodwillDeductibleForTaxPurposes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" abstract="false" name="LossandOtherUnfavorableContractsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_LeverageRatioOneMember" abstract="true" name="LeverageRatioOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BoardMemberMember" abstract="true" name="BoardMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ZPOzoneParkLLCMember" abstract="true" name="ZPOzoneParkLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_WeightedAverageRemainingContractualLife" abstract="true" name="WeightedAverageRemainingContractualLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" abstract="false" name="UnrecognizedTaxBenefitsTaxImpactIfRecognized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct" abstract="false" name="ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CovenantNotToCompeteMember" abstract="true" name="CovenantNotToCompeteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ZPAtlanticLLCMember" abstract="true" name="ZPAtlanticLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_EquipmentAcquiredAndLeaseholdImprovements" abstract="false" name="EquipmentAcquiredAndLeaseholdImprovements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_WorkersCompensationPersonalInjury1Member" abstract="true" name="WorkersCompensationPersonalInjury1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_CedarsSinaiMedicalCenterMember" abstract="true" name="CedarsSinaiMedicalCenterMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed" abstract="false" name="EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="rdnt_RestatedPlanMember" abstract="false" name="RestatedPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="rdnt_IncreaseDecreaseInOtherNoncashItem" abstract="false" name="IncreaseDecreaseInOtherNoncashItem" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PrimedexHealthSystemsInc.andRadiologixMember" abstract="true" name="PrimedexHealthSystemsInc.andRadiologixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_COVID19PandemicMember" abstract="true" name="COVID19PandemicMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_Caps2016Member" abstract="false" name="Caps2016Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_FirstLienTermLoansAMember" abstract="false" name="FirstLienTermLoansAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" abstract="false" name="LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_Medicare1Member" abstract="true" name="Medicare1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" abstract="false" name="LineofCreditFacilityIncreaseBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" abstract="false" name="DeferredTaxAssetsOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DevelopedtechnologyMember" abstract="true" name="DevelopedtechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_PricingLevelVMember" abstract="true" name="PricingLevelVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ZPCompaniesMember" abstract="true" name="ZPCompaniesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" abstract="false" name="DebtInstrumentCovenantLiquidityRatioRequiredMinimum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_PricingLevelIVMember" abstract="true" name="PricingLevelIVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentNumberofLoansReceived" abstract="false" name="DebtInstrumentNumberofLoansReceived" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rdnt_ERADMember" abstract="true" name="ERADMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MedicalArtsRadiologyMember" abstract="true" name="MedicalArtsRadiologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_WestValleyImagingGroupLLCMember" abstract="true" name="WestValleyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_OperatingLeaseRightofUseAssetAmortization" abstract="false" name="OperatingLeaseRightofUseAssetAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_HealthCarePatientServiceOtherMember" abstract="true" name="HealthCarePatientServiceOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_October2025Member" abstract="true" name="October2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ContractsReceivableFactoredAmount" abstract="false" name="ContractsReceivableFactoredAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" abstract="false" name="DeferredTaxLiabilitiesOperatingRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CommercialInsurance1Member" abstract="true" name="CommercialInsurance1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_NonCashSeveranceShares" abstract="false" name="NonCashSeveranceShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" abstract="false" name="PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance" abstract="false" name="BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ZPElmhurstLLCMember" abstract="true" name="ZPElmhurstLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_BarclaysMember" abstract="true" name="BarclaysMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" abstract="false" name="JointVentureInvestmentAndFinancialInformationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" abstract="false" name="DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CHINationalServicesIncMember" abstract="true" name="CHINationalServicesIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" abstract="false" name="BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_Medicaid1Member" abstract="true" name="Medicaid1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementSeventhAmendmentMember" abstract="true" name="FirstLienCreditAgreementSeventhAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ZilkhaRadiologyMember" abstract="true" name="ZilkhaRadiologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_TradeNamesIndefiniteLifeMember" abstract="true" name="TradeNamesIndefiniteLifeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_MRIatWoodbridgeLLCMember" abstract="true" name="MRIatWoodbridgeLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_AwardsIssuedToDate" abstract="false" name="AwardsIssuedToDate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rdnt_HealthInsuranceMember" abstract="true" name="HealthInsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_DignityHealth.Member" abstract="true" name="DignityHealth.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution" abstract="false" name="NoncontrollingInterestDecreaseFromSpecialDistribution" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_DeepHealthInc.Member" abstract="true" name="DeepHealthInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_AdditionalEquityInterestAcquired" abstract="false" name="AdditionalEquityInterestAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="rdnt_DebtInstrumentCovenantLeverageRatioMaximum" abstract="false" name="DebtInstrumentCovenantLeverageRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="rdnt_VenturaCountyImagingGroupLLCMember" abstract="true" name="VenturaCountyImagingGroupLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_EquityContributionsJointVentures" abstract="false" name="EquityContributionsJointVentures" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_HealthCareManagementServiceMember" abstract="true" name="HealthCareManagementServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" abstract="false" name="EquityMethodInvestmentsOwnershipInterestPercentageAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="rdnt_HudsonValleyRadiologyAssociatesMember" abstract="true" name="HudsonValleyRadiologyAssociatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ScheduleOfLeverageRatioTableTextBlock" abstract="false" name="ScheduleOfLeverageRatioTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash" abstract="false" name="EquityMethodInvestmentOwnershipPercentageInExchangeforCash" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" abstract="false" name="ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_FutureServiceMember" abstract="true" name="FutureServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_RadiologixMember" abstract="false" name="RadiologixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_MedicVisionMember" abstract="false" name="MedicVisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_SimiAdventistMember" abstract="true" name="SimiAdventistMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementMember" abstract="true" name="FirstLienCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_PaymentsToAcquireInterestInSubsidiaries" abstract="false" name="PaymentsToAcquireInterestInSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_WhiteRabbit.aiInc.Member" abstract="true" name="WhiteRabbit.aiInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_JointVentureMember" abstract="true" name="JointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_CARESActDisclosurePolicyPolicyTextBlock" abstract="false" name="CARESActDisclosurePolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed" abstract="false" name="PaymentstoAcquireEquityMethodInvestmentsAssetsContributed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_NewJerseyImagingNetworkLLCMember" abstract="true" name="NewJerseyImagingNetworkLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_UninsuredRisksPolicyTextBlock" abstract="false" name="UninsuredRisksPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" abstract="false" name="DeferredTaxAssetsTaxBenefitMayNotBeRealized" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_October2020CapMember" abstract="false" name="October2020CapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_SantaMonicaImagingMember" abstract="true" name="SantaMonicaImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_IncreaseDecreaseInDeferredRent" abstract="false" name="IncreaseDecreaseInDeferredRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_GainLossonStepUpValuation" abstract="false" name="GainLossonStepUpValuation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MonthlyAmortizationOfDeferredHedgeGains" abstract="false" name="MonthlyAmortizationOfDeferredHedgeGains" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_RavenHoldingsMember" abstract="true" name="RavenHoldingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationPPPLoanAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_TurnerImagingSystemsMember" abstract="true" name="TurnerImagingSystemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_KernRadiologyImagingSystemsInc.Member" abstract="true" name="KernRadiologyImagingSystemsInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_PricingLevelIIMember" abstract="true" name="PricingLevelIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_StockholdersEquityDeficitMember" abstract="false" name="StockholdersEquityDeficitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" abstract="true" name="InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_DignityHealthMember" abstract="true" name="DignityHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_SunTrustMember" abstract="true" name="SunTrustMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_CapitationArrangementsMember" abstract="true" name="CapitationArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" abstract="false" name="BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_RamicMahwahLLCMember" abstract="true" name="RamicMahwahLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_KeyFinancialDataForJointVenturesAbstract" abstract="true" name="KeyFinancialDataForJointVenturesAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_RadNetMember" abstract="true" name="RadNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_FirstLienCreditAgreementEighthAmendmentMember" abstract="true" name="FirstLienCreditAgreementEighthAmendmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_NulogixMember" abstract="false" name="NulogixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_BeverlyRadiologyMedicalGroupIIIMember" abstract="true" name="BeverlyRadiologyMedicalGroupIIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_September2020CapMember" abstract="false" name="September2020CapMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ContractLossAccrual" abstract="false" name="ContractLossAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" abstract="false" name="UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_AssetAcquisitionAxis" abstract="true" name="AssetAcquisitionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_AssetAcquisitionDomain" abstract="true" name="AssetAcquisitionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LeverageRatioAxis" abstract="true" name="LeverageRatioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_ContractsReceivableFactoringReceivable" abstract="false" name="ContractsReceivableFactoringReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_PaymentstoAcquireEquityMethodInvestmentsCash" abstract="false" name="PaymentstoAcquireEquityMethodInvestmentsCash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MedicalArtsRadiologicalGroupPCMember" abstract="true" name="MedicalArtsRadiologicalGroupPCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_ManagementServiceContractsMember" abstract="true" name="ManagementServiceContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_IncreaseDecreaseinOperatingLeaseLiability" abstract="false" name="IncreaseDecreaseinOperatingLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_CapitalLeaseDebt" abstract="false" name="CapitalLeaseDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_SocialSecurityTaxEmployerDeferralCARESAct" abstract="false" name="SocialSecurityTaxEmployerDeferralCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_GardenStateRadiologyNetworkLLCMember" abstract="true" name="GardenStateRadiologyNetworkLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rdnt_ManagementServiceFees" abstract="false" name="ManagementServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" abstract="false" name="LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" abstract="false" name="EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_LongTermContractsTerm" abstract="false" name="LongTermContractsTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rdnt_ContractLossAccrualWrittenOff" abstract="false" name="ContractLossAccrualWrittenOff" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rdnt_MedicalEquipmentMember" abstract="true" name="MedicalEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="rdnt_DebtInstrumentPeriodicPaymentPercent" abstract="false" name="DebtInstrumentPeriodicPaymentPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>9
<FILENAME>rdnt-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:cd605a11-4611-4df1-b35a-84491793f997,g:2afe2a05-cf4e-4f48-9c2a-eb0c739eec8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CoverPage" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_fa206e7b-f268-4335-97fe-82d62d8d7cbe" xlink:href="rdnt-20201231.xsd#rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0be17d1d-046a-4b49-93ef-b1fd1a1014bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_fa206e7b-f268-4335-97fe-82d62d8d7cbe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0be17d1d-046a-4b49-93ef-b1fd1a1014bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_495f13a4-d000-41ab-87d7-9c02b0eaf774" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_fa206e7b-f268-4335-97fe-82d62d8d7cbe" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_495f13a4-d000-41ab-87d7-9c02b0eaf774" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1793ea0a-17e3-4f19-817a-78d88a41542d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_862af673-dff7-4485-b35e-67c7338210cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1793ea0a-17e3-4f19-817a-78d88a41542d" xlink:to="loc_us-gaap_LiabilitiesCurrent_862af673-dff7-4485-b35e-67c7338210cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_34a20776-3f07-41f2-bf7f-c8157c02dba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1793ea0a-17e3-4f19-817a-78d88a41542d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_34a20776-3f07-41f2-bf7f-c8157c02dba7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d0176ef1-cc82-4806-acfd-d94c6815e704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1793ea0a-17e3-4f19-817a-78d88a41542d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d0176ef1-cc82-4806-acfd-d94c6815e704" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_1937844c-7db6-4333-bb18-e9f4fe41323d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1793ea0a-17e3-4f19-817a-78d88a41542d" xlink:to="loc_us-gaap_LongTermNotesPayable_1937844c-7db6-4333-bb18-e9f4fe41323d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b88f40b9-998a-4ee0-a564-cd460e5f5f3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_1793ea0a-17e3-4f19-817a-78d88a41542d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b88f40b9-998a-4ee0-a564-cd460e5f5f3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a6aee243-55d2-4c2e-916b-13f168278adc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c0d3f31e-fc64-4df2-84b7-3ec8689f27e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a6aee243-55d2-4c2e-916b-13f168278adc" xlink:to="loc_us-gaap_Liabilities_c0d3f31e-fc64-4df2-84b7-3ec8689f27e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_666af272-d67d-4a27-8cca-919c6472ea3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_a6aee243-55d2-4c2e-916b-13f168278adc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_666af272-d67d-4a27-8cca-919c6472ea3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_19b4d618-2695-4f3b-8894-54d7e8954bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_a2e6f792-57b6-411d-ba1f-564abd301447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_19b4d618-2695-4f3b-8894-54d7e8954bb8" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_a2e6f792-57b6-411d-ba1f-564abd301447" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_19c1ed5e-d911-4c48-9a73-e782e3a0c0f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_19b4d618-2695-4f3b-8894-54d7e8954bb8" xlink:to="loc_us-gaap_DueToAffiliateCurrent_19c1ed5e-d911-4c48-9a73-e782e3a0c0f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_f463b43d-e2f6-41a5-b2d8-266220e9e394" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_19b4d618-2695-4f3b-8894-54d7e8954bb8" xlink:to="loc_us-gaap_DeferredRevenue_f463b43d-e2f6-41a5-b2d8-266220e9e394" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_68e6430b-72bc-42c4-b001-834a7cf0d728" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_19b4d618-2695-4f3b-8894-54d7e8954bb8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_68e6430b-72bc-42c4-b001-834a7cf0d728" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_21e50f1e-accc-417b-8eb4-116e60872a71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_19b4d618-2695-4f3b-8894-54d7e8954bb8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_21e50f1e-accc-417b-8eb4-116e60872a71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_1a916143-857e-43a0-8081-1bf2bb9b49fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_19b4d618-2695-4f3b-8894-54d7e8954bb8" xlink:to="loc_us-gaap_NotesPayableCurrent_1a916143-857e-43a0-8081-1bf2bb9b49fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_62c444b1-edef-4077-bc77-506c3cac9fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_284df87c-b6d9-4e61-b84f-9ababac9fb35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_62c444b1-edef-4077-bc77-506c3cac9fc6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_284df87c-b6d9-4e61-b84f-9ababac9fb35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_560d801c-54ad-464a-9026-84b1f1455eea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_62c444b1-edef-4077-bc77-506c3cac9fc6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_560d801c-54ad-464a-9026-84b1f1455eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_e692db4b-8cbe-4a98-a2a5-c2952b4350aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_62c444b1-edef-4077-bc77-506c3cac9fc6" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_e692db4b-8cbe-4a98-a2a5-c2952b4350aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f26f3264-aa7a-4f8b-abe2-f024e59538fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_62c444b1-edef-4077-bc77-506c3cac9fc6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f26f3264-aa7a-4f8b-abe2-f024e59538fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_591a6f6e-0220-43c1-a2d0-75d09a73ebd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2b3d0ae9-2246-48b9-9ebd-a6f7a58e3eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_591a6f6e-0220-43c1-a2d0-75d09a73ebd3" xlink:to="loc_us-gaap_StockholdersEquity_2b3d0ae9-2246-48b9-9ebd-a6f7a58e3eef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_0597d8b3-253b-499c-b434-a5c52185049b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_591a6f6e-0220-43c1-a2d0-75d09a73ebd3" xlink:to="loc_us-gaap_MinorityInterest_0597d8b3-253b-499c-b434-a5c52185049b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c3680a74-49ae-4e3a-b24b-bee4f74832ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8a41a965-310c-4f86-b298-bbdf797e6005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3680a74-49ae-4e3a-b24b-bee4f74832ea" xlink:to="loc_us-gaap_AssetsCurrent_8a41a965-310c-4f86-b298-bbdf797e6005" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2c3a55a5-7e8e-4fe9-b7b9-6a0adc446406" xlink:href="rdnt-20201231.xsd#rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3680a74-49ae-4e3a-b24b-bee4f74832ea" xlink:to="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_2c3a55a5-7e8e-4fe9-b7b9-6a0adc446406" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_62178d13-2eac-4fd3-a22b-73a7cc95f54a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3680a74-49ae-4e3a-b24b-bee4f74832ea" xlink:to="loc_us-gaap_Goodwill_62178d13-2eac-4fd3-a22b-73a7cc95f54a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_aa6d0e63-f791-4efa-9350-ae21490a21d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3680a74-49ae-4e3a-b24b-bee4f74832ea" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_aa6d0e63-f791-4efa-9350-ae21490a21d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ede2e6cd-ceaa-4237-8e11-a8181f083fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3680a74-49ae-4e3a-b24b-bee4f74832ea" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_ede2e6cd-ceaa-4237-8e11-a8181f083fb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7c21fd37-cba0-48a9-8ca2-87592cf50e96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3680a74-49ae-4e3a-b24b-bee4f74832ea" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7c21fd37-cba0-48a9-8ca2-87592cf50e96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_e9aac161-d5e6-49f5-b9d8-6a02996831cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3680a74-49ae-4e3a-b24b-bee4f74832ea" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_e9aac161-d5e6-49f5-b9d8-6a02996831cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_d7e3af4d-57af-4c02-8a92-0e8c63131f96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c3680a74-49ae-4e3a-b24b-bee4f74832ea" xlink:to="loc_us-gaap_DepositsAssets_d7e3af4d-57af-4c02-8a92-0e8c63131f96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_acbffbcf-4220-454d-859e-3cee97ee5916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_970259b0-af72-4df1-a041-c83758412661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_acbffbcf-4220-454d-859e-3cee97ee5916" xlink:to="loc_us-gaap_CommonStockValue_970259b0-af72-4df1-a041-c83758412661" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5e9a73d5-b9d7-44f8-9bdd-0cb89045acb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_acbffbcf-4220-454d-859e-3cee97ee5916" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5e9a73d5-b9d7-44f8-9bdd-0cb89045acb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_79c76c0c-2a88-4418-9a8d-a86a44f18908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_acbffbcf-4220-454d-859e-3cee97ee5916" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_79c76c0c-2a88-4418-9a8d-a86a44f18908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2fb552e3-3246-4eea-95c3-9095797d139f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_acbffbcf-4220-454d-859e-3cee97ee5916" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2fb552e3-3246-4eea-95c3-9095797d139f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b9c31a56-5fc2-4a4b-8000-32bcaa8b91dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_5404c1ce-1ddd-4406-902d-4300b08676a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b9c31a56-5fc2-4a4b-8000-32bcaa8b91dc" xlink:to="loc_us-gaap_InterestExpenseDebt_5404c1ce-1ddd-4406-902d-4300b08676a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_052c82cf-4f0c-4f9e-8233-4f5eb5938cd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b9c31a56-5fc2-4a4b-8000-32bcaa8b91dc" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_052c82cf-4f0c-4f9e-8233-4f5eb5938cd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation_a798ede2-06fa-4826-9bbc-9f4e1efe610e" xlink:href="rdnt-20201231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b9c31a56-5fc2-4a4b-8000-32bcaa8b91dc" xlink:to="loc_rdnt_GainLossonStepUpValuation_a798ede2-06fa-4826-9bbc-9f4e1efe610e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4db9b64b-e9a1-4b4c-a4ee-a12210f55e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b9c31a56-5fc2-4a4b-8000-32bcaa8b91dc" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_4db9b64b-e9a1-4b4c-a4ee-a12210f55e4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6e456190-05d7-4242-a83a-cc76df42e86c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b9c31a56-5fc2-4a4b-8000-32bcaa8b91dc" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6e456190-05d7-4242-a83a-cc76df42e86c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_ab9bb24f-1f5a-4780-b01e-aa729a762e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b9c31a56-5fc2-4a4b-8000-32bcaa8b91dc" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_ab9bb24f-1f5a-4780-b01e-aa729a762e37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_16d8f109-4b3f-4d0e-88d3-2ee54c44377f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6812ba1f-75cd-47ce-b357-7259e587d9f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_16d8f109-4b3f-4d0e-88d3-2ee54c44377f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6812ba1f-75cd-47ce-b357-7259e587d9f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ca99ecda-848f-498d-bf09-2bbd14a279f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_16d8f109-4b3f-4d0e-88d3-2ee54c44377f" xlink:to="loc_us-gaap_OperatingExpenses_ca99ecda-848f-498d-bf09-2bbd14a279f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_5c460554-cd3b-41b6-a089-9bbd790df61d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_16d8f109-4b3f-4d0e-88d3-2ee54c44377f" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_5c460554-cd3b-41b6-a089-9bbd790df61d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7cc05e03-13d8-4b78-a1c0-836f09ad1e2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d848739c-6893-4c8b-8c53-6a38a6dfd7c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_7cc05e03-13d8-4b78-a1c0-836f09ad1e2b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_d848739c-6893-4c8b-8c53-6a38a6dfd7c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_85f7cf8c-ac98-45d7-af08-3abf8f7f76fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_7cc05e03-13d8-4b78-a1c0-836f09ad1e2b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_85f7cf8c-ac98-45d7-af08-3abf8f7f76fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7721ca89-0ce6-4dfe-aef7-f2335e38e94f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_ddc4fd02-db8b-4b78-a6ad-817d890ddc28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7721ca89-0ce6-4dfe-aef7-f2335e38e94f" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_ddc4fd02-db8b-4b78-a6ad-817d890ddc28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a6b7d96d-5449-4782-a231-a6ca3fe1ccf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7721ca89-0ce6-4dfe-aef7-f2335e38e94f" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a6b7d96d-5449-4782-a231-a6ca3fe1ccf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_384bb51b-4e33-4be9-94eb-960a83b8c236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7721ca89-0ce6-4dfe-aef7-f2335e38e94f" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_384bb51b-4e33-4be9-94eb-960a83b8c236" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_901e2113-2de7-4d4c-b36b-c2bb29bd2d84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7721ca89-0ce6-4dfe-aef7-f2335e38e94f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_901e2113-2de7-4d4c-b36b-c2bb29bd2d84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_ecc78a8a-c9b2-4c48-be08-008b77845fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7721ca89-0ce6-4dfe-aef7-f2335e38e94f" xlink:to="loc_us-gaap_SeveranceCosts1_ecc78a8a-c9b2-4c48-be08-008b77845fdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_06b06ab0-13e5-4563-b59c-2937d40307e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_47e279b1-8fe9-4026-96f6-e92ad07205e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_06b06ab0-13e5-4563-b59c-2937d40307e4" xlink:to="loc_us-gaap_ProfitLoss_47e279b1-8fe9-4026-96f6-e92ad07205e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2cbd7b6a-89d1-4f52-9017-f4488d46c783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_06b06ab0-13e5-4563-b59c-2937d40307e4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_2cbd7b6a-89d1-4f52-9017-f4488d46c783" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_86c98072-d01b-4426-95cf-50042910ea4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1c28508a-e7ba-4720-ae8d-51fecbe87e40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_86c98072-d01b-4426-95cf-50042910ea4f" xlink:to="loc_us-gaap_ProfitLoss_1c28508a-e7ba-4720-ae8d-51fecbe87e40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ccdee842-44c6-4651-b65a-35891784efa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_86c98072-d01b-4426-95cf-50042910ea4f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ccdee842-44c6-4651-b65a-35891784efa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1d048da5-f36f-40ac-bb1d-8184ec8f9bf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_86c98072-d01b-4426-95cf-50042910ea4f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1d048da5-f36f-40ac-bb1d-8184ec8f9bf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a62d15e3-66a1-4c4c-a734-2d3b05ef76af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_86c98072-d01b-4426-95cf-50042910ea4f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_a62d15e3-66a1-4c4c-a734-2d3b05ef76af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a5fa210d-1175-4844-a7da-5b8fd5c54186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6da59ab6-c5bf-44d1-80d3-608aa0db587a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a5fa210d-1175-4844-a7da-5b8fd5c54186" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6da59ab6-c5bf-44d1-80d3-608aa0db587a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1b29f949-4c7d-4522-aa2d-b22cb46e0d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a5fa210d-1175-4844-a7da-5b8fd5c54186" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1b29f949-4c7d-4522-aa2d-b22cb46e0d02" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc8803b7-45a6-47aa-bb14-9a99b10c8ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_2ef89bb8-280f-4c51-a0f9-7a1a495f3c96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc8803b7-45a6-47aa-bb14-9a99b10c8ac4" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_2ef89bb8-280f-4c51-a0f9-7a1a495f3c96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_459ee1c2-b163-488e-97c7-823b92f18127" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc8803b7-45a6-47aa-bb14-9a99b10c8ac4" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_459ee1c2-b163-488e-97c7-823b92f18127" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_f26e316c-c3ad-4492-81f8-835004c531fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc8803b7-45a6-47aa-bb14-9a99b10c8ac4" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_f26e316c-c3ad-4492-81f8-835004c531fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_7a6fff56-2936-48c2-a116-13e28f15c907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc8803b7-45a6-47aa-bb14-9a99b10c8ac4" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_7a6fff56-2936-48c2-a116-13e28f15c907" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_e3360bf6-e987-4709-a2c2-1fd2d496f9c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc8803b7-45a6-47aa-bb14-9a99b10c8ac4" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_e3360bf6-e987-4709-a2c2-1fd2d496f9c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_9b49a01b-d1a0-413e-bbf1-378be49a72d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc8803b7-45a6-47aa-bb14-9a99b10c8ac4" xlink:to="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_9b49a01b-d1a0-413e-bbf1-378be49a72d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_c7a2de5d-b865-4d3d-9dbd-7ef20b6545d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc8803b7-45a6-47aa-bb14-9a99b10c8ac4" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_c7a2de5d-b865-4d3d-9dbd-7ef20b6545d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_c17c21d8-2355-46bf-8443-843c7c5b4525" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc8803b7-45a6-47aa-bb14-9a99b10c8ac4" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_c17c21d8-2355-46bf-8443-843c7c5b4525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_117ad28b-fc6b-45b1-b7cf-44894d3537b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_ProfitLoss_117ad28b-fc6b-45b1-b7cf-44894d3537b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_e201f532-a2c2-42ed-ba6f-28d16f5caebb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_e201f532-a2c2-42ed-ba6f-28d16f5caebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_83131ab4-9207-4b53-944d-1ac184f78e58" xlink:href="rdnt-20201231.xsd#rdnt_OperatingLeaseRightofUseAssetAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_83131ab4-9207-4b53-944d-1ac184f78e58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_8041f54f-d98c-49d7-99ef-0d279ee76e70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_8041f54f-d98c-49d7-99ef-0d279ee76e70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_88d1ab9c-e767-4ceb-9a33-055a2e25d373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_88d1ab9c-e767-4ceb-9a33-055a2e25d373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_115dbe54-f6be-4c1d-9cd1-2cd1f4eea0bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_115dbe54-f6be-4c1d-9cd1-2cd1f4eea0bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation_701e1729-352f-429a-af10-b196daef7954" xlink:href="rdnt-20201231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_rdnt_GainLossonStepUpValuation_701e1729-352f-429a-af10-b196daef7954" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_126036af-8dba-417b-b159-10ae16234e55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_126036af-8dba-417b-b159-10ae16234e55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_3faaa5da-c75b-4a37-bd69-e4efdb7546bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_ShareBasedCompensation_3faaa5da-c75b-4a37-bd69-e4efdb7546bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_dd47a40e-5c2b-429e-a21a-ab80604a8593" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseDecreaseInOtherNoncashItem"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_dd47a40e-5c2b-429e-a21a-ab80604a8593" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b8b97922-6f90-4c38-b043-9c50b55d873c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b8b97922-6f90-4c38-b043-9c50b55d873c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_cd836f1b-aa10-42c9-b162-b38fb8ef273d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_cd836f1b-aa10-42c9-b162-b38fb8ef273d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_200686ae-f284-49a7-bfa1-df313434b69d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_200686ae-f284-49a7-bfa1-df313434b69d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_b6eab5b2-7ee8-4299-819a-be0950c836f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_b6eab5b2-7ee8-4299-819a-be0950c836f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_45dcb09a-4ca0-40ed-923f-0246bcaff3b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_45dcb09a-4ca0-40ed-923f-0246bcaff3b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability_aa8d3d2c-f053-4612-ad3c-63f253269e57" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseDecreaseinOperatingLeaseLiability"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability_aa8d3d2c-f053-4612-ad3c-63f253269e57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInDeferredRent_18045b8b-2cf4-47a5-81eb-ee991ef0bc31" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseDecreaseInDeferredRent"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_rdnt_IncreaseDecreaseInDeferredRent_18045b8b-2cf4-47a5-81eb-ee991ef0bc31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_82a19a90-d13e-48d4-98c1-e8e65a1e1d99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_82a19a90-d13e-48d4-98c1-e8e65a1e1d99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_101e416a-346d-4b70-8e0c-60120aebc962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_101e416a-346d-4b70-8e0c-60120aebc962" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_fe9ab597-62f6-46d1-937b-5742985b557e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_fe9ab597-62f6-46d1-937b-5742985b557e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_e7157866-2796-4ad2-bfce-db5427733a77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:calculationArc order="21" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_e7157866-2796-4ad2-bfce-db5427733a77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c30bec35-550b-409f-8b6f-4e54d20c398c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="22" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42d52faf-f45c-48f3-a6a5-da315fafd7d4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c30bec35-550b-409f-8b6f-4e54d20c398c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2b23c500-8429-4d60-be32-df1eab301aa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7869236b-cbd6-48c6-a411-4437d1b0a0ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2b23c500-8429-4d60-be32-df1eab301aa9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7869236b-cbd6-48c6-a411-4437d1b0a0ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1912f387-e7ea-445d-a187-e64be45300c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2b23c500-8429-4d60-be32-df1eab301aa9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1912f387-e7ea-445d-a187-e64be45300c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6416fee0-0ea3-4500-a1e6-5e3f95988bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2b23c500-8429-4d60-be32-df1eab301aa9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6416fee0-0ea3-4500-a1e6-5e3f95988bb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5d615ea6-18cb-4026-8720-3a4df58316dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2b23c500-8429-4d60-be32-df1eab301aa9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5d615ea6-18cb-4026-8720-3a4df58316dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance_e8fa58b9-0f59-4e5e-971a-63aec511b7c2" xlink:href="rdnt-20201231.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_rdnt_ProceedsFromGovernmentAssistance_e8fa58b9-0f59-4e5e-971a-63aec511b7c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_624e90ab-6816-4899-a7ca-b07c744c55a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_624e90ab-6816-4899-a7ca-b07c744c55a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentsToAcquireInterestInSubsidiaries_2d87e20d-a318-4722-8271-f1ba68f620de" xlink:href="rdnt-20201231.xsd#rdnt_PaymentsToAcquireInterestInSubsidiaries"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_rdnt_PaymentsToAcquireInterestInSubsidiaries_2d87e20d-a318-4722-8271-f1ba68f620de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital_312bb350-78d6-4173-ae5c-ee3c04a9bb92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_us-gaap_ProceedsFromContributedCapital_312bb350-78d6-4173-ae5c-ee3c04a9bb92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_a11617d1-b7ef-47d5-a1a3-0622ef738330" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_a11617d1-b7ef-47d5-a1a3-0622ef738330" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_fba7d674-8f85-438b-aabb-19a4d65c5d8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_us-gaap_RepaymentsOfDebt_fba7d674-8f85-438b-aabb-19a4d65c5d8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_bf48be46-09c3-4810-accf-51a6e29e5be9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_bf48be46-09c3-4810-accf-51a6e29e5be9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_3f3274cd-91c4-4045-9a4c-534fc0c5ebd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_3f3274cd-91c4-4045-9a4c-534fc0c5ebd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_d1462511-59b8-4802-bcf5-4efab988f8fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_d1462511-59b8-4802-bcf5-4efab988f8fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_7501fdb2-511d-4d14-a3c4-83032d2c312c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_7501fdb2-511d-4d14-a3c4-83032d2c312c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_4d445138-ddfe-48bc-9b84-3c672b560b1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_4d445138-ddfe-48bc-9b84-3c672b560b1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_655c821c-5e8d-4658-b7d1-5a4efcbc5683" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ecdbe8a1-5d50-4b17-b9ce-230e841d1c96" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_655c821c-5e8d-4658-b7d1-5a4efcbc5683" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#NATUREOFBUSINESS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#NATUREOFBUSINESSDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_a3712126-d123-475b-a512-a4efc7ada0b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2ff9b51-2ac2-40da-ab0d-ce9cafcf72ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_a3712126-d123-475b-a512-a4efc7ada0b0" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2ff9b51-2ac2-40da-ab0d-ce9cafcf72ee" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d53e4763-e4b4-49b1-904b-cb9480ac3a45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_71386184-91e5-4e8e-84d6-e868ae384cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d53e4763-e4b4-49b1-904b-cb9480ac3a45" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_71386184-91e5-4e8e-84d6-e868ae384cb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_695a2f90-1264-4e73-b30f-0898afe8ad2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d53e4763-e4b4-49b1-904b-cb9480ac3a45" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_695a2f90-1264-4e73-b30f-0898afe8ad2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3aef60cd-d6ca-4494-9702-cdafdb4d717a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d53e4763-e4b4-49b1-904b-cb9480ac3a45" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3aef60cd-d6ca-4494-9702-cdafdb4d717a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_76d9e0b2-1175-4072-bc66-6b5fb0a812fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c841b069-09d0-4907-99ec-7cdc9c4afa44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_76d9e0b2-1175-4072-bc66-6b5fb0a812fc" xlink:to="loc_us-gaap_AssetsCurrent_c841b069-09d0-4907-99ec-7cdc9c4afa44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_869bd26f-2b7d-44b2-bcc6-e3b6ddc6cc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_76d9e0b2-1175-4072-bc66-6b5fb0a812fc" xlink:to="loc_us-gaap_AssetsNoncurrent_869bd26f-2b7d-44b2-bcc6-e3b6ddc6cc8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_318c2de0-7a5e-4d5f-9a0d-4032866ced8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_76d9e0b2-1175-4072-bc66-6b5fb0a812fc" xlink:to="loc_us-gaap_LiabilitiesCurrent_318c2de0-7a5e-4d5f-9a0d-4032866ced8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_c3546834-5b6d-400c-9a4c-9464cd2d9f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost_76d9e0b2-1175-4072-bc66-6b5fb0a812fc" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_c3546834-5b6d-400c-9a4c-9464cd2d9f24" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#RECENTACCOUNTINGSTANDARDS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSANDDISPOSITIONSTables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f002a60-0941-43a9-b650-4767c51b677e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_31286574-4389-46e0-95dc-4160410c6151" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f002a60-0941-43a9-b650-4767c51b677e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_31286574-4389-46e0-95dc-4160410c6151" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7109db79-cebc-4feb-b6c6-2264e2d55c9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f002a60-0941-43a9-b650-4767c51b677e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7109db79-cebc-4feb-b6c6-2264e2d55c9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_c6d16c18-0203-497e-a746-380082a50db6" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f002a60-0941-43a9-b650-4767c51b677e" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_c6d16c18-0203-497e-a746-380082a50db6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_9147bcf7-130b-4b6a-a723-abee0eb86ebb" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f002a60-0941-43a9-b650-4767c51b677e" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_9147bcf7-130b-4b6a-a723-abee0eb86ebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_a4fc2fc2-fa0f-477f-9eee-361b0902c8de" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f002a60-0941-43a9-b650-4767c51b677e" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_a4fc2fc2-fa0f-477f-9eee-361b0902c8de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4f923f97-9fdc-4eca-af09-7d9db1367789" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2f002a60-0941-43a9-b650-4767c51b677e" xlink:to="loc_us-gaap_Goodwill_4f923f97-9fdc-4eca-af09-7d9db1367789" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENT"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENTTables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_178a8178-06a3-425e-bef7-a4ed917aa8cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_feca496f-3b01-48cd-8eff-79f416d7e451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_178a8178-06a3-425e-bef7-a4ed917aa8cf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_feca496f-3b01-48cd-8eff-79f416d7e451" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_dad52d12-cdc6-4d41-9c78-d526297691fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_178a8178-06a3-425e-bef7-a4ed917aa8cf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_dad52d12-cdc6-4d41-9c78-d526297691fb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENTDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="simple" xlink:href="rdnt-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="rdnt-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_944f10ce-cf92-4efc-8a1b-a3cfc75c7e94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_dcb9519b-24f7-46d4-84fa-5720b6de56a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_944f10ce-cf92-4efc-8a1b-a3cfc75c7e94" xlink:to="loc_us-gaap_AccountsPayableCurrent_dcb9519b-24f7-46d4-84fa-5720b6de56a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_fda99c34-5926-4777-9b02-1bca0411cbd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_944f10ce-cf92-4efc-8a1b-a3cfc75c7e94" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_fda99c34-5926-4777-9b02-1bca0411cbd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1df2eb95-1eb4-47c1-b7fd-05321a28d64d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_944f10ce-cf92-4efc-8a1b-a3cfc75c7e94" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_1df2eb95-1eb4-47c1-b7fd-05321a28d64d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_218779bc-1822-479e-9614-5880cec8b030" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_944f10ce-cf92-4efc-8a1b-a3cfc75c7e94" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_218779bc-1822-479e-9614-5880cec8b030" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLE"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLETables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_fe9c951d-509d-41dc-af56-da3237421efd" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7eb28207-d131-4a8e-aedb-2877cfcb94f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_fe9c951d-509d-41dc-af56-da3237421efd" xlink:to="loc_us-gaap_LongTermDebt_7eb28207-d131-4a8e-aedb-2877cfcb94f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_3d643b59-401c-48e6-8a61-aaa062e488d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_fe9c951d-509d-41dc-af56-da3237421efd" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_3d643b59-401c-48e6-8a61-aaa062e488d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable_6ea366b0-3c54-4d49-8b6c-dee6811561d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_fe9c951d-509d-41dc-af56-da3237421efd" xlink:to="loc_us-gaap_LongTermLoansPayable_6ea366b0-3c54-4d49-8b6c-dee6811561d3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt_1" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt_1"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_937e644c-a657-4df9-baa4-333e86cdba27" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_952cb865-3d31-4daa-85cf-d8539424ed6d" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_937e644c-a657-4df9-baa4-333e86cdba27" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_952cb865-3d31-4daa-85cf-d8539424ed6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_339f7421-c912-4253-8e5f-d86a6e8f5c3e" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_937e644c-a657-4df9-baa4-333e86cdba27" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_339f7421-c912-4253-8e5f-d86a6e8f5c3e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ca90d104-032f-47e4-b7e9-ef91645526ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_86836b09-403d-4e81-902f-00f3178a70de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ca90d104-032f-47e4-b7e9-ef91645526ae" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_86836b09-403d-4e81-902f-00f3178a70de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ee3056ba-3df8-4a32-8141-f4b8c770c4bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ca90d104-032f-47e4-b7e9-ef91645526ae" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_ee3056ba-3df8-4a32-8141-f4b8c770c4bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c894dcc8-1243-418d-81b2-6024659372e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_ca90d104-032f-47e4-b7e9-ef91645526ae" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c894dcc8-1243-418d-81b2-6024659372e1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESNotes" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESNotes"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESNotes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESTables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsAdditionalInformation"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsLeaseCost"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost_ed25379f-eb46-42ec-800f-5ffe4d0e4851" xlink:href="rdnt-20201231.xsd#rdnt_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c625a217-ff79-414c-b8d2-e6b17bae8b85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_FinanceLeaseCost_ed25379f-eb46-42ec-800f-5ffe4d0e4851" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_c625a217-ff79-414c-b8d2-e6b17bae8b85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_9faca027-ff34-4746-9903-ff16d8294420" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rdnt_FinanceLeaseCost_ed25379f-eb46-42ec-800f-5ffe4d0e4851" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_9faca027-ff34-4746-9903-ff16d8294420" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsSupplementalCashFlows"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsSupplementalBalanceSheet"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3e118e5a-d9ec-4245-a936-95e2445408f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f76e08b2-37f1-4fb0-8625-f003525fd0f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_3e118e5a-d9ec-4245-a936-95e2445408f1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f76e08b2-37f1-4fb0-8625-f003525fd0f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5fe9c47e-f142-4acc-a9b8-a91f85244687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_3e118e5a-d9ec-4245-a936-95e2445408f1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5fe9c47e-f142-4acc-a9b8-a91f85244687" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_e9249761-ac5d-463d-8ff6-81dbc13ee224" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_16eee697-53b2-4ecd-8d6c-f25b543ef594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_e9249761-ac5d-463d-8ff6-81dbc13ee224" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_16eee697-53b2-4ecd-8d6c-f25b543ef594" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_7b37e21b-6d69-40b4-8395-51c1b4784ccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset_e9249761-ac5d-463d-8ff6-81dbc13ee224" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_7b37e21b-6d69-40b4-8395-51c1b4784ccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_a8b30f25-8be7-4c6b-8cc5-e1642678b146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_3784335d-0e87-47be-8bae-3c4991438c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_a8b30f25-8be7-4c6b-8cc5-e1642678b146" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_3784335d-0e87-47be-8bae-3c4991438c47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b846f32b-6b91-474a-8c9c-37ecf5f02d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_a8b30f25-8be7-4c6b-8cc5-e1642678b146" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b846f32b-6b91-474a-8c9c-37ecf5f02d14" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96251bb7-f660-4d7b-a0ec-d26c94bb9428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_46059d53-acb7-47ee-ac57-1b212b68696d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96251bb7-f660-4d7b-a0ec-d26c94bb9428" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_46059d53-acb7-47ee-ac57-1b212b68696d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_1985994f-2859-4d95-833b-3756d4444a17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_96251bb7-f660-4d7b-a0ec-d26c94bb9428" xlink:to="loc_us-gaap_OperatingLeaseLiability_1985994f-2859-4d95-833b-3756d4444a17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0abbb7fa-58dd-43c3-bfb1-249213967116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2c1ae7be-957b-443f-9d7a-7e23703945df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0abbb7fa-58dd-43c3-bfb1-249213967116" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_2c1ae7be-957b-443f-9d7a-7e23703945df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_1622e887-8e08-46d9-9e73-a5b2600f99dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0abbb7fa-58dd-43c3-bfb1-249213967116" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_1622e887-8e08-46d9-9e73-a5b2600f99dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e2c4566b-6017-4bc7-9b08-2e9daf3447a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0abbb7fa-58dd-43c3-bfb1-249213967116" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e2c4566b-6017-4bc7-9b08-2e9daf3447a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_7cb26b9b-0788-4811-8345-0160ef2f2eb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0abbb7fa-58dd-43c3-bfb1-249213967116" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_7cb26b9b-0788-4811-8345-0160ef2f2eb7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ddf876de-5461-4b38-8f6c-985a4378c199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0abbb7fa-58dd-43c3-bfb1-249213967116" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_ddf876de-5461-4b38-8f6c-985a4378c199" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_606d7cd8-3b6f-4cb4-acdb-fa930c17c746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_0abbb7fa-58dd-43c3-bfb1-249213967116" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_606d7cd8-3b6f-4cb4-acdb-fa930c17c746" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease_1"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b08eac4a-399e-4a96-9191-842efb579beb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_59862c60-7c35-42d7-9e7d-a1aa0c7ed6ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b08eac4a-399e-4a96-9191-842efb579beb" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_59862c60-7c35-42d7-9e7d-a1aa0c7ed6ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_9a75fef8-fd7a-4e8f-a9d1-1575ce958dda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b08eac4a-399e-4a96-9191-842efb579beb" xlink:to="loc_us-gaap_FinanceLeaseLiability_9a75fef8-fd7a-4e8f-a9d1-1575ce958dda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d3daf18-b53a-4079-bcf6-b529c4f86ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_08759758-8813-4b97-8b2c-04ab96dc6c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d3daf18-b53a-4079-bcf6-b529c4f86ceb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_08759758-8813-4b97-8b2c-04ab96dc6c15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c40f8568-747a-45e7-8c2f-726e89921590" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d3daf18-b53a-4079-bcf6-b529c4f86ceb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c40f8568-747a-45e7-8c2f-726e89921590" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3e87e5c4-b120-4343-83a8-2e07522e945d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d3daf18-b53a-4079-bcf6-b529c4f86ceb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3e87e5c4-b120-4343-83a8-2e07522e945d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_00b23fe6-c826-4a6b-8996-79f78a9aff3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d3daf18-b53a-4079-bcf6-b529c4f86ceb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_00b23fe6-c826-4a6b-8996-79f78a9aff3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0b00c42b-92a0-4de1-856d-264bfa3da208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d3daf18-b53a-4079-bcf6-b529c4f86ceb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0b00c42b-92a0-4de1-856d-264bfa3da208" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_dff13286-37d1-445f-9c97-f9ce96eb1204" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d3daf18-b53a-4079-bcf6-b529c4f86ceb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_dff13286-37d1-445f-9c97-f9ce96eb1204" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXES" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXES"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESTables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsIncometaxexpense"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6a561dda-80f2-4db9-a6e6-e967f100fcf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_eab2bbd2-3fb7-4859-af89-e3cc39f87306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6a561dda-80f2-4db9-a6e6-e967f100fcf6" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_eab2bbd2-3fb7-4859-af89-e3cc39f87306" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_0c1a5c09-c57a-474e-b876-57363fe71cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6a561dda-80f2-4db9-a6e6-e967f100fcf6" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_0c1a5c09-c57a-474e-b876-57363fe71cab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_3710e1e9-f970-4cb5-9c44-17cd52cec525" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6a561dda-80f2-4db9-a6e6-e967f100fcf6" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_3710e1e9-f970-4cb5-9c44-17cd52cec525" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_94879ea1-7341-445e-9157-b574cad26dfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6a561dda-80f2-4db9-a6e6-e967f100fcf6" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_94879ea1-7341-445e-9157-b574cad26dfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_6e0c466c-6f97-4544-9db4-f05ae47cf40b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6a561dda-80f2-4db9-a6e6-e967f100fcf6" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_6e0c466c-6f97-4544-9db4-f05ae47cf40b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_8636542c-b5d0-490a-b028-79dbc392966f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_8636542c-b5d0-490a-b028-79dbc392966f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_a0ead6b1-5aca-42d2-849c-44b12ecef346" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_a0ead6b1-5aca-42d2-849c-44b12ecef346" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_dcefd863-960e-459d-a7d5-a60c06acc0a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_dcefd863-960e-459d-a7d5-a60c06acc0a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_49c650c3-f208-4a20-b1dd-a11508959f56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:to="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_49c650c3-f208-4a20-b1dd-a11508959f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_998efb98-1dd7-4ee7-b1f4-7560c7973fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_998efb98-1dd7-4ee7-b1f4-7560c7973fa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount_2c143110-a981-471c-b688-567b3e828c63" xlink:href="rdnt-20201231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:to="loc_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount_2c143110-a981-471c-b688-567b3e828c63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_e3eea2fd-8c50-497c-b00a-7ed0db5cac16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_e3eea2fd-8c50-497c-b00a-7ed0db5cac16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_86a248c8-4706-45ee-ad09-94e54a82c8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_86a248c8-4706-45ee-ad09-94e54a82c8fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_b95e8238-79d2-47cf-8676-68967e250172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_b95e8238-79d2-47cf-8676-68967e250172" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_b178686e-2eca-4158-9124-3ebb7142cfbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_b178686e-2eca-4158-9124-3ebb7142cfbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_5c59e0e6-f8e7-4fe2-bd1c-f668d9910fe7" xlink:href="rdnt-20201231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_fbaa844d-44d4-4212-97c7-806be92cdceb" xlink:to="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_5c59e0e6-f8e7-4fe2-bd1c-f668d9910fe7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities" xlink:type="simple" xlink:href="rdnt-20201231.xsd#NCOMETAXESDetailsDeferredtaxassetsandliabilities"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_e2200e26-fe84-42a7-a600-b297af040387" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_8cdff6dc-8ba9-4d73-a0e6-25e63d37e932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_e2200e26-fe84-42a7-a600-b297af040387" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_8cdff6dc-8ba9-4d73-a0e6-25e63d37e932" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_ddc7eaa7-7bd3-473e-93bc-bc823e4d85c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_e2200e26-fe84-42a7-a600-b297af040387" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_ddc7eaa7-7bd3-473e-93bc-bc823e4d85c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_379d432c-6acf-459b-b8cf-fd5423d5ba3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_e2200e26-fe84-42a7-a600-b297af040387" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_379d432c-6acf-459b-b8cf-fd5423d5ba3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_ca4b1764-2fb2-4fa6-a80e-d111c6edb617" xlink:href="rdnt-20201231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_e2200e26-fe84-42a7-a600-b297af040387" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_ca4b1764-2fb2-4fa6-a80e-d111c6edb617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_ac57671b-4ecc-4c14-aad1-60aa13e4cb44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_e2200e26-fe84-42a7-a600-b297af040387" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_ac57671b-4ecc-4c14-aad1-60aa13e4cb44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4799460e-35cd-4a4e-aeea-bcf3873115ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_a37407ef-aff5-4249-b6e8-7f697bb1c8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4799460e-35cd-4a4e-aeea-bcf3873115ee" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_a37407ef-aff5-4249-b6e8-7f697bb1c8c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_426c57ca-2d1b-45c0-bb4a-67c56dbcffea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_4799460e-35cd-4a4e-aeea-bcf3873115ee" xlink:to="loc_us-gaap_DeferredTaxLiabilities_426c57ca-2d1b-45c0-bb4a-67c56dbcffea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_8f3514f4-fd4f-44a1-bafa-9c612c64475b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_21592eb7-e1a2-40c4-ae2d-eb629f802ad7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8f3514f4-fd4f-44a1-bafa-9c612c64475b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_21592eb7-e1a2-40c4-ae2d-eb629f802ad7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_e865f5b1-7ff6-4046-bbb3-94a092ad4122" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8f3514f4-fd4f-44a1-bafa-9c612c64475b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_e865f5b1-7ff6-4046-bbb3-94a092ad4122" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_4b6b8de8-bde1-44a9-a39d-e86589efc6f0" xlink:href="rdnt-20201231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8f3514f4-fd4f-44a1-bafa-9c612c64475b" xlink:to="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_4b6b8de8-bde1-44a9-a39d-e86589efc6f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_7f7e4e0c-59f2-4b81-8e4c-256b3e02d6d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8f3514f4-fd4f-44a1-bafa-9c612c64475b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_7f7e4e0c-59f2-4b81-8e4c-256b3e02d6d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_b7b70efd-236e-4b90-b645-49b64a8e3e89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8f3514f4-fd4f-44a1-bafa-9c612c64475b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_b7b70efd-236e-4b90-b645-49b64a8e3e89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_0ff03215-23ff-4f68-b0fe-1f20a1d1b0b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8f3514f4-fd4f-44a1-bafa-9c612c64475b" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_0ff03215-23ff-4f68-b0fe-1f20a1d1b0b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_44957092-d38b-4133-af7f-872d4de9606b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_8f3514f4-fd4f-44a1-bafa-9c612c64475b" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_44957092-d38b-4133-af7f-872d4de9606b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsUnrecognizedtaxbenefit"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONDetailsRSUs"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUBSEQUENTEVENTS"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUBSEQUENTEVENTSDetailsNarrative"/>
  <link:calculationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>rdnt-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:cd605a11-4611-4df1-b35a-84491793f997,g:2afe2a05-cf4e-4f48-9c2a-eb0c739eec8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CoverPage" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CoverPage" xlink:type="extended" id="iad8cf59de71b488497d3d8e2f62c099c_CoverPage"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="ibe34d057ae53435eaa8f9b7b2d0673f1_CONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i94005f7718a5442894675a8931827e9b_CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i0c3427937ae543509686a91e5d34b7ad_CONSOLIDATEDSTATEMENTSOFOPERATIONS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_ec005562-d7dc-4688-933d-7bc4ff2b684e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_RevenuesAbstract_ec005562-d7dc-4688-933d-7bc4ff2b684e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c34ac60-a8a4-4860-b964-bcaa2e64c639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_ec005562-d7dc-4688-933d-7bc4ff2b684e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c34ac60-a8a4-4860-b964-bcaa2e64c639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_305e07db-5490-4a74-bc06-f134d48c92bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_ec005562-d7dc-4688-933d-7bc4ff2b684e" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_305e07db-5490-4a74-bc06-f134d48c92bf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_14333907-f43c-40e5-8088-29d2cfdb3f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_14333907-f43c-40e5-8088-29d2cfdb3f68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_43a9b2ae-73f4-4ce1-95c6-0cec3f25486f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_43a9b2ae-73f4-4ce1-95c6-0cec3f25486f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_16e0d327-5a1f-4b7f-af14-b2c1a48388c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_16e0d327-5a1f-4b7f-af14-b2c1a48388c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_91f09df4-6460-4ae6-949f-2a63142bfe54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_91f09df4-6460-4ae6-949f-2a63142bfe54" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_40ba4ea1-85ec-4fba-99c6-7ac5e6dfd097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_SeveranceCosts1_40ba4ea1-85ec-4fba-99c6-7ac5e6dfd097" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f890e661-4f56-4bce-afd1-93e20b9a8fc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_OperatingExpenses_f890e661-4f56-4bce-afd1-93e20b9a8fc4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9c3dfffe-4946-472d-aa0f-b46e58f14724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_OperatingIncomeLoss_9c3dfffe-4946-472d-aa0f-b46e58f14724" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_54422f81-3bcd-4d4f-9a3d-cd504fad02ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_InterestExpenseDebt_54422f81-3bcd-4d4f-9a3d-cd504fad02ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_40337533-3db6-459d-8a8d-87b9577696a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_40337533-3db6-459d-8a8d-87b9577696a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_4f777024-9bac-4686-a793-4436ec2f4167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_4f777024-9bac-4686-a793-4436ec2f4167" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation_422ff7fd-ecac-4489-9173-9be03fdec2e7" xlink:href="rdnt-20201231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_rdnt_GainLossonStepUpValuation_422ff7fd-ecac-4489-9173-9be03fdec2e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b989d5fd-50dd-4679-8dc5-2e986a9b8031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b989d5fd-50dd-4679-8dc5-2e986a9b8031" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f988fcc5-ebcb-4dd9-82e6-8e50204009bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f988fcc5-ebcb-4dd9-82e6-8e50204009bb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e382845b-c74f-4fd1-8576-fcd6953a6082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_e382845b-c74f-4fd1-8576-fcd6953a6082" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_357e306e-3d46-4c5f-94a9-24b52a26f703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_357e306e-3d46-4c5f-94a9-24b52a26f703" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4674e8d2-6368-49cd-9e2c-48b0fc06446e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4674e8d2-6368-49cd-9e2c-48b0fc06446e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_64c6b422-f3ef-415f-9be4-1d7860bff733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_ProfitLoss_64c6b422-f3ef-415f-9be4-1d7860bff733" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1ca94a70-f097-4f10-aeb2-7cac5b69b3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1ca94a70-f097-4f10-aeb2-7cac5b69b3a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_84c2e6c7-b2ea-4dca-9a26-c06262a8f019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_NetIncomeLoss_84c2e6c7-b2ea-4dca-9a26-c06262a8f019" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ca7b444e-d928-49ce-9225-a4bdbccdc729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_EarningsPerShareBasic_ca7b444e-d928-49ce-9225-a4bdbccdc729" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_97be60bc-4ddc-47ae-9485-467848b9f046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_EarningsPerShareDiluted_97be60bc-4ddc-47ae-9485-467848b9f046" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a0e6e7ab-5085-47f6-a932-ca3fb8ff4559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a0e6e7ab-5085-47f6-a932-ca3fb8ff4559" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d9998f41-3657-4c03-984d-7cc6a7079a10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a0e6e7ab-5085-47f6-a932-ca3fb8ff4559" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d9998f41-3657-4c03-984d-7cc6a7079a10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5d6c81bb-d7e6-45e1-8f35-fe39fb3eab1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a0e6e7ab-5085-47f6-a932-ca3fb8ff4559" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5d6c81bb-d7e6-45e1-8f35-fe39fb3eab1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9b598b5c-fba9-41ae-92ff-f857f4638178" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_StatementTable_9b598b5c-fba9-41ae-92ff-f857f4638178" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8e7611f8-c75c-4ae1-9f88-26b5b3e18ee7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_9b598b5c-fba9-41ae-92ff-f857f4638178" xlink:to="loc_srt_ProductOrServiceAxis_8e7611f8-c75c-4ae1-9f88-26b5b3e18ee7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8e7611f8-c75c-4ae1-9f88-26b5b3e18ee7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8e7611f8-c75c-4ae1-9f88-26b5b3e18ee7" xlink:to="loc_srt_ProductsAndServicesDomain_8e7611f8-c75c-4ae1-9f88-26b5b3e18ee7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_671cce2d-51c6-4bd1-8629-00df48bb2fbf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8e7611f8-c75c-4ae1-9f88-26b5b3e18ee7" xlink:to="loc_srt_ProductsAndServicesDomain_671cce2d-51c6-4bd1-8629-00df48bb2fbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_99b897d6-1d6f-44d0-80ea-f7faa4f35fa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_671cce2d-51c6-4bd1-8629-00df48bb2fbf" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_99b897d6-1d6f-44d0-80ea-f7faa4f35fa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_16183569-a349-4ecb-af99-f342aef6ee41" xlink:href="rdnt-20201231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_671cce2d-51c6-4bd1-8629-00df48bb2fbf" xlink:to="loc_rdnt_CapitationArrangementsMember_16183569-a349-4ecb-af99-f342aef6ee41" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="extended" id="iaf859f63136d4f4495ced22151c9007b_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended" id="i93cb193205564b2abf22550411b94ca1_CONSOLIDATEDSTATEMENTOFEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9278dd63-f35a-4db0-8966-a31b0e56e244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_9278dd63-f35a-4db0-8966-a31b0e56e244" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_03b0266b-3447-4288-9f75-cbf577eddfb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_SharesOutstanding_03b0266b-3447-4288-9f75-cbf577eddfb0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2bb82f07-a301-4754-9006-f2d828650010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2bb82f07-a301-4754-9006-f2d828650010" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_66335b58-5909-45ec-a95b-8dfd9905165e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_66335b58-5909-45ec-a95b-8dfd9905165e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_aa12b7a4-3689-475a-aa0e-4cfcdc57386b" xlink:href="rdnt-20201231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_aa12b7a4-3689-475a-aa0e-4cfcdc57386b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ea13cd4a-5ced-4a97-9ba2-62c39db3a357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ea13cd4a-5ced-4a97-9ba2-62c39db3a357" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_023fac6a-ccc6-4ad2-8698-a7715e1cdfd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_023fac6a-ccc6-4ad2-8698-a7715e1cdfd6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_0fbceff6-885b-498c-8a43-a4044eef6194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_0fbceff6-885b-498c-8a43-a4044eef6194" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_8ce8de1f-6068-4a78-8e88-d6cb6def74a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_8ce8de1f-6068-4a78-8e88-d6cb6def74a7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_59a85cb0-fd50-4290-86a7-38805b9de553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_59a85cb0-fd50-4290-86a7-38805b9de553" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_0b24ce43-0e05-4406-a06d-f5b52bba07cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_0b24ce43-0e05-4406-a06d-f5b52bba07cf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeverance_0f8caa24-b85e-475b-a69b-e1c50e6c4c73" xlink:href="rdnt-20201231.xsd#rdnt_NonCashSeverance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_NonCashSeverance_0f8caa24-b85e-475b-a69b-e1c50e6c4c73" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeveranceShares_5f1d1778-cfda-402e-b92b-de8534c26efe" xlink:href="rdnt-20201231.xsd#rdnt_NonCashSeveranceShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_NonCashSeveranceShares_5f1d1778-cfda-402e-b92b-de8534c26efe" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_213e22c7-f885-46c2-b0ab-99c389be0792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_213e22c7-f885-46c2-b0ab-99c389be0792" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_564e35b6-4a0e-43c6-84ff-48caa023df84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_564e35b6-4a0e-43c6-84ff-48caa023df84" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_9d191fcd-5b62-4a8d-9cf1-f0799d04c048" xlink:href="rdnt-20201231.xsd#rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_9d191fcd-5b62-4a8d-9cf1-f0799d04c048" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_78732faa-e9de-4882-b458-d013b850e2a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_78732faa-e9de-4882-b458-d013b850e2a5" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution_65a87055-a51f-416c-841f-7aed0541e818" xlink:href="rdnt-20201231.xsd#rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution_65a87055-a51f-416c-841f-7aed0541e818" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_cb03ca65-c8b2-4391-95f6-e900efb6bd26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_cb03ca65-c8b2-4391-95f6-e900efb6bd26" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests_04cd2342-b440-494d-af39-05f6019e171e" xlink:href="rdnt-20201231.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_ContributionsFromNoncontrollingInterests_04cd2342-b440-494d-af39-05f6019e171e" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_89cce294-bf2d-4276-aa99-d923ea60ac05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_89cce294-bf2d-4276-aa99-d923ea60ac05" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition_792a1503-b8f7-47de-89a6-2dd3d13d2bfe" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition_792a1503-b8f7-47de-89a6-2dd3d13d2bfe" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_cc9500eb-e394-412a-b683-ed5cff445fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_cc9500eb-e394-412a-b683-ed5cff445fc5" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_bb20253a-5f51-4556-a953-0771c989a8cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_bb20253a-5f51-4556-a953-0771c989a8cf" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a97fef77-c75c-4469-8c29-80797df6eb46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a97fef77-c75c-4469-8c29-80797df6eb46" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8264f874-6cfd-4426-8df5-c51e46620b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8264f874-6cfd-4426-8df5-c51e46620b3f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_81142ef8-9395-4cd6-9256-bf448b8b86d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_ProfitLoss_81142ef8-9395-4cd6-9256-bf448b8b86d5" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_69da3c68-800d-4716-8d86-6beef9619019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_0974ebdd-713b-4cb8-ad77-67aeaa482438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_eaebf171-a194-415a-8345-1bf669438dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_9278dd63-f35a-4db0-8966-a31b0e56e244" xlink:to="loc_us-gaap_StatementTable_eaebf171-a194-415a-8345-1bf669438dd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ee3ff83c-3898-4714-90f4-2a927fdb7aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_eaebf171-a194-415a-8345-1bf669438dd0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ee3ff83c-3898-4714-90f4-2a927fdb7aa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ee3ff83c-3898-4714-90f4-2a927fdb7aa3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee3ff83c-3898-4714-90f4-2a927fdb7aa3" xlink:to="loc_us-gaap_EquityComponentDomain_ee3ff83c-3898-4714-90f4-2a927fdb7aa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b80bcc50-5219-4515-84b2-47a07869e085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee3ff83c-3898-4714-90f4-2a927fdb7aa3" xlink:to="loc_us-gaap_EquityComponentDomain_b80bcc50-5219-4515-84b2-47a07869e085" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:href="rdnt-20201231.xsd#rdnt_StockholdersEquityDeficitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b80bcc50-5219-4515-84b2-47a07869e085" xlink:to="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_024e86d8-63e0-40b2-a5d7-d969babdc5f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:to="loc_us-gaap_CommonStockMember_024e86d8-63e0-40b2-a5d7-d969babdc5f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c3793269-cba5-4cb0-94a9-a9ed8ca6b9a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c3793269-cba5-4cb0-94a9-a9ed8ca6b9a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_12c6355a-9fde-4e43-87de-fafc11c7578b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_12c6355a-9fde-4e43-87de-fafc11c7578b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_656ce726-28e4-4d8d-a4b0-ecdd83dac454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:to="loc_us-gaap_RetainedEarningsMember_656ce726-28e4-4d8d-a4b0-ecdd83dac454" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b3a8ef1f-be2d-4799-9273-59ac19056a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_b80bcc50-5219-4515-84b2-47a07869e085" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b3a8ef1f-be2d-4799-9273-59ac19056a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_84579f0b-c0d7-4952-96ff-331bf6d797c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_eaebf171-a194-415a-8345-1bf669438dd0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_84579f0b-c0d7-4952-96ff-331bf6d797c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84579f0b-c0d7-4952-96ff-331bf6d797c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_84579f0b-c0d7-4952-96ff-331bf6d797c9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_84579f0b-c0d7-4952-96ff-331bf6d797c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a15d3b6f-cae0-4d92-b3ee-8ea3980636aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_84579f0b-c0d7-4952-96ff-331bf6d797c9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a15d3b6f-cae0-4d92-b3ee-8ea3980636aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_ccd791f7-b0ab-456e-a9a0-7cd0f0499d39" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a15d3b6f-cae0-4d92-b3ee-8ea3980636aa" xlink:to="loc_rdnt_DeepHealthInc.Member_ccd791f7-b0ab-456e-a9a0-7cd0f0499d39" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i22557e0db9d541f3bda612322c35390b_CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_bc31aaec-d4e0-4dba-bb08-d95bba5483db" xlink:href="rdnt-20201231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_bc31aaec-d4e0-4dba-bb08-d95bba5483db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitalLeaseDebt_4e1efd37-7dce-4170-abf1-4f673b1e1ee9" xlink:href="rdnt-20201231.xsd#rdnt_CapitalLeaseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_CapitalLeaseDebt_4e1efd37-7dce-4170-abf1-4f673b1e1ee9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_48a46a5b-6780-41d1-a9d6-69d0dc5cfce2" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_48a46a5b-6780-41d1-a9d6-69d0dc5cfce2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_d0404781-75f5-41da-828c-16d442fd2328" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_d0404781-75f5-41da-828c-16d442fd2328" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_006bcba7-6cbb-48d2-b7df-9c307eb1dfa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_006bcba7-6cbb-48d2-b7df-9c307eb1dfa2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1007f880-3c1d-4536-97eb-df0008dacbaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1007f880-3c1d-4536-97eb-df0008dacbaa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_7f731684-cbfc-480d-9e87-3b49e640695e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_7f731684-cbfc-480d-9e87-3b49e640695e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_84d7a558-4d14-4821-9803-799077c33d47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_84d7a558-4d14-4821-9803-799077c33d47" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_caf46abf-56aa-4526-af35-65d264f2c174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_caf46abf-56aa-4526-af35-65d264f2c174" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_dc0126c0-0622-4266-8f93-7928e90a4be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_dc0126c0-0622-4266-8f93-7928e90a4be0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_b2ecae7f-4b50-43b4-a07f-0b6b0bb5ab78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_b2ecae7f-4b50-43b4-a07f-0b6b0bb5ab78" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance_25aef0ab-1ca7-4152-9bf2-1ab6f578714e" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance_25aef0ab-1ca7-4152-9bf2-1ab6f578714e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_afc1e08c-c103-4636-990e-fc24a6f1c94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_afc1e08c-c103-4636-990e-fc24a6f1c94d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationStepAcquisitionCashAcquired_5ded3726-5db1-4a02-9edc-ecbf30d27f74" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationStepAcquisitionCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_BusinessCombinationStepAcquisitionCashAcquired_5ded3726-5db1-4a02-9edc-ecbf30d27f74" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_46f748f0-d4a2-4712-af1a-6a05c569f465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_46f748f0-d4a2-4712-af1a-6a05c569f465" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_a89bec2b-d195-4abd-89a2-50f14160794a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_a89bec2b-d195-4abd-89a2-50f14160794a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1000aa8c-36cc-46a3-b951-92cd2eb446d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1000aa8c-36cc-46a3-b951-92cd2eb446d3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d4f696f0-90b3-4f05-b806-be3b943ee6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d4f696f0-90b3-4f05-b806-be3b943ee6b7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue_94ff4e8f-7c5f-4293-a6ea-7dab2f403caf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue_94ff4e8f-7c5f-4293-a6ea-7dab2f403caf" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestSpecialDistribution_711f82b6-9e40-483b-8873-096d04fef719" xlink:href="rdnt-20201231.xsd#rdnt_NoncontrollingInterestSpecialDistribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_NoncontrollingInterestSpecialDistribution_711f82b6-9e40-483b-8873-096d04fef719" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_72009ff8-6c82-4890-8087-8c3361144062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_72009ff8-6c82-4890-8087-8c3361144062" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_f73f8593-5ada-464d-b762-4e3fdb664aaa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:to="loc_srt_ConsolidatedEntitiesAxis_f73f8593-5ada-464d-b762-4e3fdb664aaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_f73f8593-5ada-464d-b762-4e3fdb664aaa_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f73f8593-5ada-464d-b762-4e3fdb664aaa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_f73f8593-5ada-464d-b762-4e3fdb664aaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_826aea98-3085-4653-8673-47902a5d6337" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f73f8593-5ada-464d-b762-4e3fdb664aaa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_826aea98-3085-4653-8673-47902a5d6337" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_de239797-c555-43d0-a017-11d5a91cc148" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_826aea98-3085-4653-8673-47902a5d6337" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_de239797-c555-43d0-a017-11d5a91cc148" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f723abae-cc4f-469f-bce3-b2cae6a79dfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f723abae-cc4f-469f-bce3-b2cae6a79dfc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f723abae-cc4f-469f-bce3-b2cae6a79dfc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f723abae-cc4f-469f-bce3-b2cae6a79dfc" xlink:to="loc_us-gaap_EquityComponentDomain_f723abae-cc4f-469f-bce3-b2cae6a79dfc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_047b3316-a85c-427c-aaae-46b0b2f2d9a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f723abae-cc4f-469f-bce3-b2cae6a79dfc" xlink:to="loc_us-gaap_EquityComponentDomain_047b3316-a85c-427c-aaae-46b0b2f2d9a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_06a5fd39-6dda-4624-8a0a-6ca88e36603c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_047b3316-a85c-427c-aaae-46b0b2f2d9a7" xlink:to="loc_us-gaap_NoncontrollingInterestMember_06a5fd39-6dda-4624-8a0a-6ca88e36603c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockholdersEquityDeficitMember_8a16f48b-c700-4b6d-b691-01c0d558c6e1" xlink:href="rdnt-20201231.xsd#rdnt_StockholdersEquityDeficitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_047b3316-a85c-427c-aaae-46b0b2f2d9a7" xlink:to="loc_rdnt_StockholdersEquityDeficitMember_8a16f48b-c700-4b6d-b691-01c0d558c6e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74e6ab94-a378-4f5d-b7dc-8ac33ac7de1d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74e6ab94-a378-4f5d-b7dc-8ac33ac7de1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_74e6ab94-a378-4f5d-b7dc-8ac33ac7de1d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74e6ab94-a378-4f5d-b7dc-8ac33ac7de1d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_74e6ab94-a378-4f5d-b7dc-8ac33ac7de1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6deb5d0d-e82c-4d09-95c7-91ba6ffbff15" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74e6ab94-a378-4f5d-b7dc-8ac33ac7de1d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6deb5d0d-e82c-4d09-95c7-91ba6ffbff15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NewJerseyImagingNetworkLLCMember_850788e0-52d0-4157-b97a-717d8e73614c" xlink:href="rdnt-20201231.xsd#rdnt_NewJerseyImagingNetworkLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6deb5d0d-e82c-4d09-95c7-91ba6ffbff15" xlink:to="loc_rdnt_NewJerseyImagingNetworkLLCMember_850788e0-52d0-4157-b97a-717d8e73614c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_661b804a-7122-4a0f-9697-bd631d320f73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_661b804a-7122-4a0f-9697-bd631d320f73" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_661b804a-7122-4a0f-9697-bd631d320f73_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_661b804a-7122-4a0f-9697-bd631d320f73" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_661b804a-7122-4a0f-9697-bd631d320f73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_661b804a-7122-4a0f-9697-bd631d320f73" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_52422a65-a1bc-4199-914f-e50433ff7c96" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_DeepHealthIncMember_52422a65-a1bc-4199-914f-e50433ff7c96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_b36f319b-f3b6-4d9f-a25c-875c66b41d13" xlink:href="rdnt-20201231.xsd#rdnt_NulogixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_NulogixMember_b36f319b-f3b6-4d9f-a25c-875c66b41d13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_0d14bbc9-9d72-4125-96f8-1277cc248ba6" xlink:href="rdnt-20201231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_0d14bbc9-9d72-4125-96f8-1277cc248ba6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLCMember_413d2f9c-dd22-49c8-b8b3-b3793d6ce2f2" xlink:href="rdnt-20201231.xsd#rdnt_VenturaCountyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_VenturaCountyImagingGroupLLCMember_413d2f9c-dd22-49c8-b8b3-b3793d6ce2f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_21450eb7-96f3-4155-a4c3-9a64a8b926c3" xlink:href="rdnt-20201231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_21450eb7-96f3-4155-a4c3-9a64a8b926c3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalArtsRadiologyMember_d3f733c2-0a46-46fd-a09d-d5431be8bc8a" xlink:href="rdnt-20201231.xsd#rdnt_MedicalArtsRadiologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_MedicalArtsRadiologyMember_d3f733c2-0a46-46fd-a09d-d5431be8bc8a" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#NATUREOFBUSINESS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="extended" id="ia6d95acf8a2e402e81bfdf5e7f667658_NATUREOFBUSINESS"/>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#NATUREOFBUSINESSDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="extended" id="if6b4623bb5e54ae488f7c66b69e815f4_NATUREOFBUSINESSDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_bb3b5514-9d18-4839-8db6-2ea86a2b75c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_bb3b5514-9d18-4839-8db6-2ea86a2b75c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_ad268652-fdc7-44e7-875b-7d44cab4ee53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_ad268652-fdc7-44e7-875b-7d44cab4ee53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_c29ccaa0-8b55-4c06-9ff1-14d9ad6bbf1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_c29ccaa0-8b55-4c06-9ff1-14d9ad6bbf1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_44f0f659-51f6-4d3f-8644-358538c1a91f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_44f0f659-51f6-4d3f-8644-358538c1a91f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9c4bc76a-607c-47f1-bf99-8f2b72a4ee9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9c4bc76a-607c-47f1-bf99-8f2b72a4ee9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6341e12a-4934-4c5d-8dcd-5583bb9bad8f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9c4bc76a-607c-47f1-bf99-8f2b72a4ee9c" xlink:to="loc_dei_LegalEntityAxis_6341e12a-4934-4c5d-8dcd-5583bb9bad8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6341e12a-4934-4c5d-8dcd-5583bb9bad8f_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_6341e12a-4934-4c5d-8dcd-5583bb9bad8f" xlink:to="loc_dei_EntityDomain_6341e12a-4934-4c5d-8dcd-5583bb9bad8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6952dd80-931b-408e-8801-b4315bb36158" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_6341e12a-4934-4c5d-8dcd-5583bb9bad8f" xlink:to="loc_dei_EntityDomain_6952dd80-931b-408e-8801-b4315bb36158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember_bcac110f-58cb-4890-9362-23d8cdfa51da" xlink:href="rdnt-20201231.xsd#rdnt_BeverlyRadiologyMedicalGroupIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_6952dd80-931b-408e-8801-b4315bb36158" xlink:to="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember_bcac110f-58cb-4890-9362-23d8cdfa51da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderMember_3b40868d-a210-4aad-a6ce-4fc7fae9e7f2" xlink:href="rdnt-20201231.xsd#rdnt_ScriptSenderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_6952dd80-931b-408e-8801-b4315bb36158" xlink:to="loc_rdnt_ScriptSenderMember_3b40868d-a210-4aad-a6ce-4fc7fae9e7f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_653abe2d-67b7-489b-8c0b-0e294f5dc11e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9c4bc76a-607c-47f1-bf99-8f2b72a4ee9c" xlink:to="loc_srt_TitleOfIndividualAxis_653abe2d-67b7-489b-8c0b-0e294f5dc11e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_653abe2d-67b7-489b-8c0b-0e294f5dc11e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_653abe2d-67b7-489b-8c0b-0e294f5dc11e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_653abe2d-67b7-489b-8c0b-0e294f5dc11e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ad2d79ee-a780-4704-a810-dd059be78e3e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_653abe2d-67b7-489b-8c0b-0e294f5dc11e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ad2d79ee-a780-4704-a810-dd059be78e3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_0a50b9d0-89cf-4cce-9dbf-129e48bc5a2e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ad2d79ee-a780-4704-a810-dd059be78e3e" xlink:to="loc_srt_ChiefExecutiveOfficerMember_0a50b9d0-89cf-4cce-9dbf-129e48bc5a2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BoardMemberMember_8b5dd27e-63ad-4a3b-8ed3-624eaeb0f685" xlink:href="rdnt-20201231.xsd#rdnt_BoardMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ad2d79ee-a780-4704-a810-dd059be78e3e" xlink:to="loc_rdnt_BoardMemberMember_8b5dd27e-63ad-4a3b-8ed3-624eaeb0f685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_4c101a75-df95-4110-b76d-761d0f7b89b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5e077803-bf5e-4035-8088-2bd715557b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4c101a75-df95-4110-b76d-761d0f7b89b0" xlink:to="loc_us-gaap_Assets_5e077803-bf5e-4035-8088-2bd715557b02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_02327c12-7ca0-43fe-a178-e741a88c2298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4c101a75-df95-4110-b76d-761d0f7b89b0" xlink:to="loc_us-gaap_Liabilities_02327c12-7ca0-43fe-a178-e741a88c2298" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermContractsTerm_0fd58227-18ab-4f96-a59f-19abff12090c" xlink:href="rdnt-20201231.xsd#rdnt_LongTermContractsTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4c101a75-df95-4110-b76d-761d0f7b89b0" xlink:to="loc_rdnt_LongTermContractsTerm_0fd58227-18ab-4f96-a59f-19abff12090c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1d6da853-7a27-4709-90fe-588a43fef827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4c101a75-df95-4110-b76d-761d0f7b89b0" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1d6da853-7a27-4709-90fe-588a43fef827" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_de796325-2fd2-45db-a557-c6988ef05686" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1d6da853-7a27-4709-90fe-588a43fef827" xlink:to="loc_srt_ConsolidatedEntitiesAxis_de796325-2fd2-45db-a557-c6988ef05686" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_de796325-2fd2-45db-a557-c6988ef05686_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_de796325-2fd2-45db-a557-c6988ef05686" xlink:to="loc_srt_ConsolidatedEntitiesDomain_de796325-2fd2-45db-a557-c6988ef05686_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_326f09a0-1c24-4070-864b-d278225882d7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_de796325-2fd2-45db-a557-c6988ef05686" xlink:to="loc_srt_ConsolidatedEntitiesDomain_326f09a0-1c24-4070-864b-d278225882d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_f89c4737-9e29-4bdf-a006-36fd0a2c031d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_326f09a0-1c24-4070-864b-d278225882d7" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_f89c4737-9e29-4bdf-a006-36fd0a2c031d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e45f7d0a-8572-4246-be06-46f6a62680ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1d6da853-7a27-4709-90fe-588a43fef827" xlink:to="loc_srt_RangeAxis_e45f7d0a-8572-4246-be06-46f6a62680ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e45f7d0a-8572-4246-be06-46f6a62680ea_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e45f7d0a-8572-4246-be06-46f6a62680ea" xlink:to="loc_srt_RangeMember_e45f7d0a-8572-4246-be06-46f6a62680ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bf3e62ea-55da-46af-9872-8dff20c9a674" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e45f7d0a-8572-4246-be06-46f6a62680ea" xlink:to="loc_srt_RangeMember_bf3e62ea-55da-46af-9872-8dff20c9a674" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ca632068-b96f-48d0-810a-3f197ecd39a0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bf3e62ea-55da-46af-9872-8dff20c9a674" xlink:to="loc_srt_MinimumMember_ca632068-b96f-48d0-810a-3f197ecd39a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b53b1988-231c-4b04-b3f5-331680ac10fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bf3e62ea-55da-46af-9872-8dff20c9a674" xlink:to="loc_srt_MaximumMember_b53b1988-231c-4b04-b3f5-331680ac10fc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended" id="ic1b36903e07c44e688f1f97d64e607aa_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended" id="i0c4ccc6c2a8c485e9bba3a7796703586_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended" id="i527d1756e72045a899c246d847463e4f_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="extended" id="i35801bd4e6c144aa801501e3faafb6f9_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_60a96585-4644-4ca2-bcbc-d0045e4c657f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fc269403-1ac6-4b3f-8464-03e4b0ba4972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_60a96585-4644-4ca2-bcbc-d0045e4c657f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fc269403-1ac6-4b3f-8464-03e4b0ba4972" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_adb27491-ac7a-4966-8125-be04aaa550be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_60a96585-4644-4ca2-bcbc-d0045e4c657f" xlink:to="loc_us-gaap_Revenues_adb27491-ac7a-4966-8125-be04aaa550be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f569ad4a-9c15-49fe-ac93-1cc02568a8da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_60a96585-4644-4ca2-bcbc-d0045e4c657f" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f569ad4a-9c15-49fe-ac93-1cc02568a8da" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_682ada89-2cdc-466b-8b29-c35cb51f1131" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f569ad4a-9c15-49fe-ac93-1cc02568a8da" xlink:to="loc_srt_ProductOrServiceAxis_682ada89-2cdc-466b-8b29-c35cb51f1131" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_682ada89-2cdc-466b-8b29-c35cb51f1131_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_682ada89-2cdc-466b-8b29-c35cb51f1131" xlink:to="loc_srt_ProductsAndServicesDomain_682ada89-2cdc-466b-8b29-c35cb51f1131_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_682ada89-2cdc-466b-8b29-c35cb51f1131" xlink:to="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_08228a38-16b8-4cdc-bbb2-aace9c1d9b1f" xlink:href="rdnt-20201231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_CommercialInsurance1Member_08228a38-16b8-4cdc-bbb2-aace9c1d9b1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_b35710ee-f1d9-4aae-9885-c7d37e82c8af" xlink:href="rdnt-20201231.xsd#rdnt_Medicare1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_Medicare1Member_b35710ee-f1d9-4aae-9885-c7d37e82c8af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_76bf52bb-fdcb-4d00-8933-12f44abd3244" xlink:href="rdnt-20201231.xsd#rdnt_Medicaid1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_Medicaid1Member_76bf52bb-fdcb-4d00-8933-12f44abd3244" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_c8fc1644-0660-4efe-b64d-ef4a74df56e6" xlink:href="rdnt-20201231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_c8fc1644-0660-4efe-b64d-ef4a74df56e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_14a27fd9-a04f-41af-90c6-d02d20a97d9f" xlink:href="rdnt-20201231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_14a27fd9-a04f-41af-90c6-d02d20a97d9f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_3d34621f-debc-435b-a08b-06a318528127" xlink:href="rdnt-20201231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_HealthCareManagementServiceMember_3d34621f-debc-435b-a08b-06a318528127" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_09d18bf4-60fb-4798-9d46-099d616b971f" xlink:href="rdnt-20201231.xsd#rdnt_ImagingOnCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_ImagingOnCallMember_09d18bf4-60fb-4798-9d46-099d616b971f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_251f5213-4de5-47c2-aa98-77c92d8d444f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_us-gaap_HealthCareOtherMember_251f5213-4de5-47c2-aa98-77c92d8d444f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_ce9b1f32-e6e0-4a5f-af37-a77844d7ea5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_ce9b1f32-e6e0-4a5f-af37-a77844d7ea5d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_b332ff8f-b3e6-4c08-b6cc-c678db11d4b5" xlink:href="rdnt-20201231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_CapitationArrangementsMember_b332ff8f-b3e6-4c08-b6cc-c678db11d4b5" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended" id="ic426a7a3d7e641e19ab8b8fdcc36dc09_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_40decee1-4c5a-453f-9e71-c956959c393a" xlink:href="rdnt-20201231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_AdvanceMedicarePayments_40decee1-4c5a-453f-9e71-c956959c393a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsReceivedFromInsurance_6729b9b3-3fb0-4a4a-b06a-7a8a88244521" xlink:href="rdnt-20201231.xsd#rdnt_ProceedsReceivedFromInsurance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ProceedsReceivedFromInsurance_6729b9b3-3fb0-4a4a-b06a-7a8a88244521" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_2a1e9532-0760-40e5-ab26-6e9253e28a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_2a1e9532-0760-40e5-ab26-6e9253e28a1c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e025e719-da81-4713-a3a4-e3bab49a0b08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e025e719-da81-4713-a3a4-e3bab49a0b08" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_74833f96-4f92-4da9-8f38-dbd10fcb5acc" xlink:href="rdnt-20201231.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_74833f96-4f92-4da9-8f38-dbd10fcb5acc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoredAmount_054a8b2d-e621-4ed2-b735-d25e8f4c2fc1" xlink:href="rdnt-20201231.xsd#rdnt_ContractsReceivableFactoredAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ContractsReceivableFactoredAmount_054a8b2d-e621-4ed2-b735-d25e8f4c2fc1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_5b697edb-e0d6-4a7e-984d-81f20da61ccc" xlink:href="rdnt-20201231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_5b697edb-e0d6-4a7e-984d-81f20da61ccc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_10306a9b-805d-44f8-ac95-8ff6ac66532b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_10306a9b-805d-44f8-ac95-8ff6ac66532b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bdc9af2d-628e-499c-a2f3-9a4120dc3acd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bdc9af2d-628e-499c-a2f3-9a4120dc3acd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_2927faa5-c73c-458a-ab6b-8276b771b709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_2927faa5-c73c-458a-ab6b-8276b771b709" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a585357c-6761-430f-840f-c519762b5267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a585357c-6761-430f-840f-c519762b5267" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c0418021-c9b1-4094-83ee-64e20a90c796" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_Goodwill_c0418021-c9b1-4094-83ee-64e20a90c796" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_75a89d16-5a81-446b-8e6a-43086dd5772e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_75a89d16-5a81-446b-8e6a-43086dd5772e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_105cbe3b-9d57-4f0e-9286-b380e16fa991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_105cbe3b-9d57-4f0e-9286-b380e16fa991" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8f5c4d2e-c2d5-4c1e-9486-81752a40a378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8f5c4d2e-c2d5-4c1e-9486-81752a40a378" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_52d96701-7584-4084-84c6-9ebc27c28c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_52d96701-7584-4084-84c6-9ebc27c28c00" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_6d0cd1ca-3760-4200-a343-96bd255e3ac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_6d0cd1ca-3760-4200-a343-96bd255e3ac7" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_4b0e8472-3499-4534-bd9b-4498fd3611c5" xlink:href="rdnt-20201231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_4b0e8472-3499-4534-bd9b-4498fd3611c5" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_92df6396-4a80-4b92-9a66-8671fe6715d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_SelfInsuranceReserve_92df6396-4a80-4b92-9a66-8671fe6715d7" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_fa568091-e633-468d-af71-b1d855faa335" xlink:href="rdnt-20201231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_fa568091-e633-468d-af71-b1d855faa335" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_03d10182-e0a0-4bdf-ae4d-7f7322b54f8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_03d10182-e0a0-4bdf-ae4d-7f7322b54f8f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_fabe8c8e-aa4c-4c3a-87c7-0ad0cf46f297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_fabe8c8e-aa4c-4c3a-87c7-0ad0cf46f297" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_c57f465b-e6cf-45a9-9991-7a7a2b512e86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_c57f465b-e6cf-45a9-9991-7a7a2b512e86" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrual_1d52d653-6a3d-4513-b596-7d4a26ab34ea" xlink:href="rdnt-20201231.xsd#rdnt_ContractLossAccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ContractLossAccrual_1d52d653-6a3d-4513-b596-7d4a26ab34ea" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_45e63181-cd31-4e10-bd1c-af0453c9a4dd" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_45e63181-cd31-4e10-bd1c-af0453c9a4dd" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_0286dc4e-5baa-4ddc-bc0a-747bdb3853bb" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_0286dc4e-5baa-4ddc-bc0a-747bdb3853bb" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrualWrittenOff_34a07cd8-89ef-41a0-89ec-95f7bdaf78a7" xlink:href="rdnt-20201231.xsd#rdnt_ContractLossAccrualWrittenOff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ContractLossAccrualWrittenOff_34a07cd8-89ef-41a0-89ec-95f7bdaf78a7" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e79fb32d-65d7-47e2-9882-1e7f60be93ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e79fb32d-65d7-47e2-9882-1e7f60be93ca" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_75b5d5a2-84ba-43fa-9d85-0c679f524a30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_75b5d5a2-84ba-43fa-9d85-0c679f524a30" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3f2d0a08-ad62-428e-9f6a-9894bc40485c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3f2d0a08-ad62-428e-9f6a-9894bc40485c" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_1d12bf00-3d8e-44e3-a1ea-b879e1c69eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_1d12bf00-3d8e-44e3-a1ea-b879e1c69eae" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_1a5e8e09-83ef-428e-807f-27fcb4373d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_1a5e8e09-83ef-428e-807f-27fcb4373d1a" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_231b8f18-b800-48cf-aa3f-16ba9908b1b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_231b8f18-b800-48cf-aa3f-16ba9908b1b8" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_99e73926-54f8-41f0-8581-6ccba0fc112c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_99e73926-54f8-41f0-8581-6ccba0fc112c" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_84f60519-a65a-4879-b258-8b1f783ecb46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_84f60519-a65a-4879-b258-8b1f783ecb46" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_47b120d6-4e28-4b61-a096-7b90f22073d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_47b120d6-4e28-4b61-a096-7b90f22073d6" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_dc0a8a7c-1423-415a-8356-fff4a351ca89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_dc0a8a7c-1423-415a-8356-fff4a351ca89" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_6424a50d-cded-428a-ac50-2f566982e566" xlink:href="rdnt-20201231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_6424a50d-cded-428a-ac50-2f566982e566" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_21d23cc5-e845-48ec-886b-dbb520d8050c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_LineOfCredit_21d23cc5-e845-48ec-886b-dbb520d8050c" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_eb30ab67-0af4-4060-9e0b-32ae4f903f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_eb30ab67-0af4-4060-9e0b-32ae4f903f59" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_bc62f37e-828d-42cf-9628-4bf535b9bf4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_bc62f37e-828d-42cf-9628-4bf535b9bf4c" xlink:type="arc" order="40"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_acc1f434-9c6e-476c-9a66-9eba9b7b2cae" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_acc1f434-9c6e-476c-9a66-9eba9b7b2cae" xlink:type="arc" order="41"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_fe680c45-e26a-4bbc-b364-406f6b8381c0" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_fe680c45-e26a-4bbc-b364-406f6b8381c0" xlink:type="arc" order="42"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_9aa6a4cb-5099-4d4e-a34c-f29bb51c7dba" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_9aa6a4cb-5099-4d4e-a34c-f29bb51c7dba" xlink:type="arc" order="43"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_0f94ab35-331e-49b7-a82c-eaff80d64af9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_0f94ab35-331e-49b7-a82c-eaff80d64af9" xlink:type="arc" order="44"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_a9584f43-4de4-4e3b-b4dd-1955237e4551" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_a9584f43-4de4-4e3b-b4dd-1955237e4551" xlink:type="arc" order="45"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_6a4980e3-ead8-4bb4-940b-567d0523d452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ShortTermBorrowings_6a4980e3-ead8-4bb4-940b-567d0523d452" xlink:type="arc" order="46"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_fb07f46f-40c0-43a3-9910-220ea6ef43f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_fb07f46f-40c0-43a3-9910-220ea6ef43f8" xlink:type="arc" order="47"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_842c38dc-a5d8-4db3-a7dc-760c35dd3015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_842c38dc-a5d8-4db3-a7dc-760c35dd3015" xlink:type="arc" order="48"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_44e10c6e-d665-4172-8106-1beeb47c5fe9" xlink:href="rdnt-20201231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_44e10c6e-d665-4172-8106-1beeb47c5fe9" xlink:type="arc" order="49"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_5ec50384-fc92-4ae1-b0bb-7ffd2c539192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_5ec50384-fc92-4ae1-b0bb-7ffd2c539192" xlink:type="arc" order="50"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_2b4310ac-f37c-4cfa-9c2e-cbb692e82d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_2b4310ac-f37c-4cfa-9c2e-cbb692e82d3a" xlink:type="arc" order="51"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdditionalEquityInterestAcquired_1624b696-2a53-4184-a0ce-a7e2f7432e4e" xlink:href="rdnt-20201231.xsd#rdnt_AdditionalEquityInterestAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_AdditionalEquityInterestAcquired_1624b696-2a53-4184-a0ce-a7e2f7432e4e" xlink:type="arc" order="52"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_32986fb2-4133-4f8e-a217-f50895759c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_32986fb2-4133-4f8e-a217-f50895759c0a" xlink:type="arc" order="53"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_68e1149d-1f12-43c1-a66f-ad6c7929b76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_68e1149d-1f12-43c1-a66f-ad6c7929b76b" xlink:type="arc" order="54"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_802ac562-b08e-414d-be7c-de784a017d3d" xlink:href="rdnt-20201231.xsd#rdnt_ManagementServiceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ManagementServiceFees_802ac562-b08e-414d-be7c-de784a017d3d" xlink:type="arc" order="55"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_2b1ab497-a390-42b9-ae18-bc68b72f73da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_2b1ab497-a390-42b9-ae18-bc68b72f73da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_2b1ab497-a390-42b9-ae18-bc68b72f73da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2b1ab497-a390-42b9-ae18-bc68b72f73da" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_2b1ab497-a390-42b9-ae18-bc68b72f73da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_2fd70e53-4c4b-4173-81bb-291e157cdaca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2b1ab497-a390-42b9-ae18-bc68b72f73da" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_2fd70e53-4c4b-4173-81bb-291e157cdaca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_a10efe76-7045-4e38-ac4b-c124c5d96bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_2fd70e53-4c4b-4173-81bb-291e157cdaca" xlink:to="loc_us-gaap_CommercialPaperMember_a10efe76-7045-4e38-ac4b-c124c5d96bd4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_1b3cd1f2-82a0-43c4-bdfa-16b7ae09f345" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_1b3cd1f2-82a0-43c4-bdfa-16b7ae09f345" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_1b3cd1f2-82a0-43c4-bdfa-16b7ae09f345_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_1b3cd1f2-82a0-43c4-bdfa-16b7ae09f345" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_1b3cd1f2-82a0-43c4-bdfa-16b7ae09f345_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_bb90de66-e9cf-4f8f-b6af-bf78fd2f9305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_1b3cd1f2-82a0-43c4-bdfa-16b7ae09f345" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_bb90de66-e9cf-4f8f-b6af-bf78fd2f9305" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_ef010644-20cd-4ff6-9998-4cb6310317a2" xlink:href="rdnt-20201231.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_bb90de66-e9cf-4f8f-b6af-bf78fd2f9305" xlink:to="loc_rdnt_Caps2016Member_ef010644-20cd-4ff6-9998-4cb6310317a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_8c6763c3-ed38-4ad0-8ae8-3433ba587480" xlink:href="rdnt-20201231.xsd#rdnt_A2019SWAPSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_bb90de66-e9cf-4f8f-b6af-bf78fd2f9305" xlink:to="loc_rdnt_A2019SWAPSMember_8c6763c3-ed38-4ad0-8ae8-3433ba587480" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_7c116eb2-0348-4d25-b8e0-e9992701f9e6" xlink:href="rdnt-20201231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_bb90de66-e9cf-4f8f-b6af-bf78fd2f9305" xlink:to="loc_rdnt_A2019SWAPS1Member_7c116eb2-0348-4d25-b8e0-e9992701f9e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_3fec309f-8eca-4270-986b-d69043fe7cf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_LitigationStatusAxis_3fec309f-8eca-4270-986b-d69043fe7cf8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_3fec309f-8eca-4270-986b-d69043fe7cf8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_3fec309f-8eca-4270-986b-d69043fe7cf8" xlink:to="loc_us-gaap_LitigationStatusDomain_3fec309f-8eca-4270-986b-d69043fe7cf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9169c748-54bb-4b0a-9b87-07ff0b429c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_3fec309f-8eca-4270-986b-d69043fe7cf8" xlink:to="loc_us-gaap_LitigationStatusDomain_9169c748-54bb-4b0a-9b87-07ff0b429c89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_3c673729-eafa-41cc-af3f-1a821dcef0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_9169c748-54bb-4b0a-9b87-07ff0b429c89" xlink:to="loc_us-gaap_SettledLitigationMember_3c673729-eafa-41cc-af3f-1a821dcef0a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_3cd4f375-32b4-41d6-8366-32e85f261e20" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_LitigationCaseAxis_3cd4f375-32b4-41d6-8366-32e85f261e20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_3cd4f375-32b4-41d6-8366-32e85f261e20_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_3cd4f375-32b4-41d6-8366-32e85f261e20" xlink:to="loc_srt_LitigationCaseTypeDomain_3cd4f375-32b4-41d6-8366-32e85f261e20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_db1e7d95-94a5-41d0-99e7-d6952dd214f7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_3cd4f375-32b4-41d6-8366-32e85f261e20" xlink:to="loc_srt_LitigationCaseTypeDomain_db1e7d95-94a5-41d0-99e7-d6952dd214f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_dcc31c67-06ed-4101-86b1-1554f1924979" xlink:href="rdnt-20201231.xsd#rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_db1e7d95-94a5-41d0-99e7-d6952dd214f7" xlink:to="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_dcc31c67-06ed-4101-86b1-1554f1924979" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f57234c5-40bb-4e4e-a5c7-7a1508f533e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_PlanNameAxis_f57234c5-40bb-4e4e-a5c7-7a1508f533e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f57234c5-40bb-4e4e-a5c7-7a1508f533e3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_f57234c5-40bb-4e4e-a5c7-7a1508f533e3" xlink:to="loc_us-gaap_PlanNameDomain_f57234c5-40bb-4e4e-a5c7-7a1508f533e3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_cc31818b-7e21-49f1-9fb1-ba9183744cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_f57234c5-40bb-4e4e-a5c7-7a1508f533e3" xlink:to="loc_us-gaap_PlanNameDomain_cc31818b-7e21-49f1-9fb1-ba9183744cb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_82ae16ca-a08d-4c50-a9d8-5c1af2d3dbfb" xlink:href="rdnt-20201231.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_cc31818b-7e21-49f1-9fb1-ba9183744cb5" xlink:to="loc_rdnt_RestatedPlanMember_82ae16ca-a08d-4c50-a9d8-5c1af2d3dbfb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_39353f37-2dbd-4b4f-a354-9fc5bb4e753f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_ProductOrServiceAxis_39353f37-2dbd-4b4f-a354-9fc5bb4e753f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_39353f37-2dbd-4b4f-a354-9fc5bb4e753f_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_39353f37-2dbd-4b4f-a354-9fc5bb4e753f" xlink:to="loc_srt_ProductsAndServicesDomain_39353f37-2dbd-4b4f-a354-9fc5bb4e753f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ed83e158-9184-4eb3-9af8-378be3333807" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_39353f37-2dbd-4b4f-a354-9fc5bb4e753f" xlink:to="loc_srt_ProductsAndServicesDomain_ed83e158-9184-4eb3-9af8-378be3333807" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember_90b5802a-3cb1-4b9b-aea3-9180948a6540" xlink:href="rdnt-20201231.xsd#rdnt_PatientServicesNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ed83e158-9184-4eb3-9af8-378be3333807" xlink:to="loc_rdnt_PatientServicesNetMember_90b5802a-3cb1-4b9b-aea3-9180948a6540" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7d591356-8446-4956-9170-17ed0b1ab32f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7d591356-8446-4956-9170-17ed0b1ab32f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_7d591356-8446-4956-9170-17ed0b1ab32f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7d591356-8446-4956-9170-17ed0b1ab32f" xlink:to="loc_us-gaap_SegmentDomain_7d591356-8446-4956-9170-17ed0b1ab32f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d486d07-c6a0-4a31-af5c-1ff0590c013e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7d591356-8446-4956-9170-17ed0b1ab32f" xlink:to="loc_us-gaap_SegmentDomain_9d486d07-c6a0-4a31-af5c-1ff0590c013e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember_34a083f7-eaaf-471d-bb15-1497eea8cb21" xlink:href="rdnt-20201231.xsd#rdnt_ERADMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d486d07-c6a0-4a31-af5c-1ff0590c013e" xlink:to="loc_rdnt_ERADMember_34a083f7-eaaf-471d-bb15-1497eea8cb21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_74ee2e65-465e-4faf-a7ef-fef142171f10" xlink:href="rdnt-20201231.xsd#rdnt_ImagingOnCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9d486d07-c6a0-4a31-af5c-1ff0590c013e" xlink:to="loc_rdnt_ImagingOnCallMember_74ee2e65-465e-4faf-a7ef-fef142171f10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8fe7321c-657a-42f7-a515-5fbefc54e803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_DebtInstrumentAxis_8fe7321c-657a-42f7-a515-5fbefc54e803" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8fe7321c-657a-42f7-a515-5fbefc54e803_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8fe7321c-657a-42f7-a515-5fbefc54e803" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8fe7321c-657a-42f7-a515-5fbefc54e803_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c740add2-3b01-444f-9a8d-400a91e60853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8fe7321c-657a-42f7-a515-5fbefc54e803" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c740add2-3b01-444f-9a8d-400a91e60853" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_1db80d2f-3aef-4f5d-8927-27189f920ebd" xlink:href="rdnt-20201231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c740add2-3b01-444f-9a8d-400a91e60853" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_1db80d2f-3aef-4f5d-8927-27189f920ebd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_0a7ac9bd-aa45-4df8-8906-8f145be57f35" xlink:href="rdnt-20201231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c740add2-3b01-444f-9a8d-400a91e60853" xlink:to="loc_rdnt_BarclaysMember_0a7ac9bd-aa45-4df8-8906-8f145be57f35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_1264a8b5-542d-4ec4-bdc9-f2a0ae3cd196" xlink:href="rdnt-20201231.xsd#rdnt_SunTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c740add2-3b01-444f-9a8d-400a91e60853" xlink:to="loc_rdnt_SunTrustMember_1264a8b5-542d-4ec4-bdc9-f2a0ae3cd196" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f37b5bb7-0711-4b65-bdef-112426e98711" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_RangeAxis_f37b5bb7-0711-4b65-bdef-112426e98711" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f37b5bb7-0711-4b65-bdef-112426e98711_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f37b5bb7-0711-4b65-bdef-112426e98711" xlink:to="loc_srt_RangeMember_f37b5bb7-0711-4b65-bdef-112426e98711_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0788a0d9-79f2-4d3b-a8e9-227da2bd96e3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f37b5bb7-0711-4b65-bdef-112426e98711" xlink:to="loc_srt_RangeMember_0788a0d9-79f2-4d3b-a8e9-227da2bd96e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d118b05d-3ff5-447b-8a35-474a52db165b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0788a0d9-79f2-4d3b-a8e9-227da2bd96e3" xlink:to="loc_srt_MinimumMember_d118b05d-3ff5-447b-8a35-474a52db165b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4d347f38-8ac1-4944-879d-453fc474576a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0788a0d9-79f2-4d3b-a8e9-227da2bd96e3" xlink:to="loc_srt_MaximumMember_4d347f38-8ac1-4944-879d-453fc474576a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_82ce136e-2ca6-4833-9e7e-3cae1af1128d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_82ce136e-2ca6-4833-9e7e-3cae1af1128d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_82ce136e-2ca6-4833-9e7e-3cae1af1128d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_82ce136e-2ca6-4833-9e7e-3cae1af1128d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_82ce136e-2ca6-4833-9e7e-3cae1af1128d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_010a9478-625d-4d36-b2cf-8454e39010f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_82ce136e-2ca6-4833-9e7e-3cae1af1128d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_010a9478-625d-4d36-b2cf-8454e39010f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyAndEquipmentMember_01ed0e02-4276-4c73-bfd4-f026b9f3f1a4" xlink:href="rdnt-20201231.xsd#rdnt_PropertyAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_010a9478-625d-4d36-b2cf-8454e39010f3" xlink:to="loc_rdnt_PropertyAndEquipmentMember_01ed0e02-4276-4c73-bfd4-f026b9f3f1a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_80c31447-169c-405d-b34e-e41f5569ff79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_010a9478-625d-4d36-b2cf-8454e39010f3" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_80c31447-169c-405d-b34e-e41f5569ff79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyTypeAxis_4bb80267-b476-48e4-bb56-7c99a2d7b4dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_ReinsurancePolicyTypeAxis_4bb80267-b476-48e4-bb56-7c99a2d7b4dc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyDomain_4bb80267-b476-48e4-bb56-7c99a2d7b4dc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReinsurancePolicyTypeAxis_4bb80267-b476-48e4-bb56-7c99a2d7b4dc" xlink:to="loc_us-gaap_ReinsurancePolicyDomain_4bb80267-b476-48e4-bb56-7c99a2d7b4dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyDomain_627690ba-e3d3-49b4-8944-b328eae93a23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReinsurancePolicyTypeAxis_4bb80267-b476-48e4-bb56-7c99a2d7b4dc" xlink:to="loc_us-gaap_ReinsurancePolicyDomain_627690ba-e3d3-49b4-8944-b328eae93a23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthInsuranceMember_06d802ad-6b57-47c3-ad5f-1ef4c3de39c4" xlink:href="rdnt-20201231.xsd#rdnt_HealthInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReinsurancePolicyDomain_627690ba-e3d3-49b4-8944-b328eae93a23" xlink:to="loc_rdnt_HealthInsuranceMember_06d802ad-6b57-47c3-ad5f-1ef4c3de39c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0980d6d3-5545-4c86-a143-3b46654fdcc3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_CounterpartyNameAxis_0980d6d3-5545-4c86-a143-3b46654fdcc3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0980d6d3-5545-4c86-a143-3b46654fdcc3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_0980d6d3-5545-4c86-a143-3b46654fdcc3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0980d6d3-5545-4c86-a143-3b46654fdcc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c06b51b-394c-4c4b-93c7-2ac1e2fc192b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_0980d6d3-5545-4c86-a143-3b46654fdcc3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c06b51b-394c-4c4b-93c7-2ac1e2fc192b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember_46ff3f37-eea5-4e7f-a996-7c5484bb7811" xlink:href="rdnt-20201231.xsd#rdnt_BlueShieldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c06b51b-394c-4c4b-93c7-2ac1e2fc192b" xlink:to="loc_rdnt_BlueShieldMember_46ff3f37-eea5-4e7f-a996-7c5484bb7811" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_215cbafd-ac4c-42d6-80c2-d964175dfa1f" xlink:href="rdnt-20201231.xsd#rdnt_DignityHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c06b51b-394c-4c4b-93c7-2ac1e2fc192b" xlink:to="loc_rdnt_DignityHealthMember_215cbafd-ac4c-42d6-80c2-d964175dfa1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_98f043ba-523c-4c92-964b-d236b8355f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_98f043ba-523c-4c92-964b-d236b8355f4f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98f043ba-523c-4c92-964b-d236b8355f4f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98f043ba-523c-4c92-964b-d236b8355f4f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_98f043ba-523c-4c92-964b-d236b8355f4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98f043ba-523c-4c92-964b-d236b8355f4f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadiologixMember_469a110b-87e3-4387-ad8a-606152412fab" xlink:href="rdnt-20201231.xsd#rdnt_RadiologixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:to="loc_rdnt_RadiologixMember_469a110b-87e3-4387-ad8a-606152412fab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_a9983fee-be60-4884-b8b4-32b97c692624" xlink:href="rdnt-20201231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_a9983fee-be60-4884-b8b4-32b97c692624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_dc68c47b-6ea1-4ec5-928e-47bfa7225d27" xlink:href="rdnt-20201231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_dc68c47b-6ea1-4ec5-928e-47bfa7225d27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_63c7af53-d4f3-43a3-a7e8-5549e7866ab5" xlink:href="rdnt-20201231.xsd#rdnt_NulogixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:to="loc_rdnt_NulogixMember_63c7af53-d4f3-43a3-a7e8-5549e7866ab5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_969d9358-fea4-40ea-81ef-f72407630013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_969d9358-fea4-40ea-81ef-f72407630013" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_969d9358-fea4-40ea-81ef-f72407630013_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_969d9358-fea4-40ea-81ef-f72407630013" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_969d9358-fea4-40ea-81ef-f72407630013_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_969d9358-fea4-40ea-81ef-f72407630013" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember_c9eead1d-828e-4747-a12c-c7d11efdec0b" xlink:href="rdnt-20201231.xsd#rdnt_September2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:to="loc_rdnt_September2020CapMember_c9eead1d-828e-4747-a12c-c7d11efdec0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember_376f37e9-10b9-466c-814b-53486f67c761" xlink:href="rdnt-20201231.xsd#rdnt_October2020CapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:to="loc_rdnt_October2020CapMember_376f37e9-10b9-466c-814b-53486f67c761" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_0246171b-51dc-4ce3-b717-7aff94be1a8e" xlink:href="rdnt-20201231.xsd#rdnt_October2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:to="loc_rdnt_October2023Member_0246171b-51dc-4ce3-b717-7aff94be1a8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_556c6caf-9fbe-4048-a663-baaa8831c282" xlink:href="rdnt-20201231.xsd#rdnt_October2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:to="loc_rdnt_October2025Member_556c6caf-9fbe-4048-a663-baaa8831c282" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b1352e4-5ce7-4dc2-95a0-b0a2f2ae31c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b1352e4-5ce7-4dc2-95a0-b0a2f2ae31c7" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8b1352e4-5ce7-4dc2-95a0-b0a2f2ae31c7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b1352e4-5ce7-4dc2-95a0-b0a2f2ae31c7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8b1352e4-5ce7-4dc2-95a0-b0a2f2ae31c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_563a948d-41be-4ad4-a958-43869adeea3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b1352e4-5ce7-4dc2-95a0-b0a2f2ae31c7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_563a948d-41be-4ad4-a958-43869adeea3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_94cf937d-99e6-4b32-92db-108dceaad8e9" xlink:href="rdnt-20201231.xsd#rdnt_Caps2016Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_563a948d-41be-4ad4-a958-43869adeea3d" xlink:to="loc_rdnt_Caps2016Member_94cf937d-99e6-4b32-92db-108dceaad8e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7b84d21b-4556-4700-ad86-73d000c27c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_563a948d-41be-4ad4-a958-43869adeea3d" xlink:to="loc_us-gaap_InterestRateSwapMember_7b84d21b-4556-4700-ad86-73d000c27c5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d3a526ab-067e-4056-8779-209d95ccf110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_VariableRateAxis_d3a526ab-067e-4056-8779-209d95ccf110" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_d3a526ab-067e-4056-8779-209d95ccf110_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_d3a526ab-067e-4056-8779-209d95ccf110" xlink:to="loc_us-gaap_VariableRateDomain_d3a526ab-067e-4056-8779-209d95ccf110_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_96ae8119-de7c-47e2-9301-6ba491d08cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_d3a526ab-067e-4056-8779-209d95ccf110" xlink:to="loc_us-gaap_VariableRateDomain_96ae8119-de7c-47e2-9301-6ba491d08cbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_adbb3238-f8c5-4ae4-aa6e-29be21f35d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_96ae8119-de7c-47e2-9301-6ba491d08cbb" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_adbb3238-f8c5-4ae4-aa6e-29be21f35d0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ea0ab187-a510-4ac5-84b9-df944689de7e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ea0ab187-a510-4ac5-84b9-df944689de7e" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ea0ab187-a510-4ac5-84b9-df944689de7e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ea0ab187-a510-4ac5-84b9-df944689de7e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ea0ab187-a510-4ac5-84b9-df944689de7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ea0ab187-a510-4ac5-84b9-df944689de7e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_898d63bd-5589-4ddb-8c40-b49f7a9fcbc6" xlink:href="rdnt-20201231.xsd#rdnt_MedicVisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:to="loc_rdnt_MedicVisionMember_898d63bd-5589-4ddb-8c40-b49f7a9fcbc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_2cc6eb31-d995-4841-8d72-347898e7e971" xlink:href="rdnt-20201231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:to="loc_rdnt_TurnerImagingSystemsMember_2cc6eb31-d995-4841-8d72-347898e7e971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingMember_066e4eb7-9dbc-4767-ae77-1346a65682f6" xlink:href="rdnt-20201231.xsd#rdnt_TurnerImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:to="loc_rdnt_TurnerImagingMember_066e4eb7-9dbc-4767-ae77-1346a65682f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member_a947725b-72b2-4065-9c7e-bb3eafb200c5" xlink:href="rdnt-20201231.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:to="loc_rdnt_WhiteRabbit.aiInc.Member_a947725b-72b2-4065-9c7e-bb3eafb200c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingMember_17c57b94-0953-4168-89d0-93519bb08750" xlink:href="rdnt-20201231.xsd#rdnt_SantaMonicaImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:to="loc_rdnt_SantaMonicaImagingMember_17c57b94-0953-4168-89d0-93519bb08750" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2d833d34-7251-4e6b-8acd-b5bfc8b56ef8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_dei_LegalEntityAxis_2d833d34-7251-4e6b-8acd-b5bfc8b56ef8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2d833d34-7251-4e6b-8acd-b5bfc8b56ef8_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_2d833d34-7251-4e6b-8acd-b5bfc8b56ef8" xlink:to="loc_dei_EntityDomain_2d833d34-7251-4e6b-8acd-b5bfc8b56ef8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_2d833d34-7251-4e6b-8acd-b5bfc8b56ef8" xlink:to="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_5972de1c-e310-41c5-9fc7-c24f2ea755ad" xlink:href="rdnt-20201231.xsd#rdnt_PrimedexHealthSystemsInc.andRadiologixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:to="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_5972de1c-e310-41c5-9fc7-c24f2ea755ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_f02810de-68b7-4fb1-b750-642b2193b344" xlink:href="rdnt-20201231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_f02810de-68b7-4fb1-b750-642b2193b344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadNetMember_f5c34fe1-4b6c-4886-a169-0c3299e4eaed" xlink:href="rdnt-20201231.xsd#rdnt_RadNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:to="loc_rdnt_RadNetMember_f5c34fe1-4b6c-4886-a169-0c3299e4eaed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember_28c99783-0dec-4a0c-8521-5a59f78869e5" xlink:href="rdnt-20201231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:to="loc_rdnt_CedarsSinaiMedicalCenterMember_28c99783-0dec-4a0c-8521-5a59f78869e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_543dedb2-eab0-4e73-b0be-067222340991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_543dedb2-eab0-4e73-b0be-067222340991" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_543dedb2-eab0-4e73-b0be-067222340991_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_543dedb2-eab0-4e73-b0be-067222340991" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_543dedb2-eab0-4e73-b0be-067222340991_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_47bcbcd8-d7ac-4c61-b50a-744c1f62d7c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_543dedb2-eab0-4e73-b0be-067222340991" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_47bcbcd8-d7ac-4c61-b50a-744c1f62d7c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_f04d6720-210b-432b-b0b0-c8c90ef0aeac" xlink:href="rdnt-20201231.xsd#rdnt_JointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_47bcbcd8-d7ac-4c61-b50a-744c1f62d7c1" xlink:to="loc_rdnt_JointVentureMember_f04d6720-210b-432b-b0b0-c8c90ef0aeac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_792dc201-a518-4903-bc2b-4f98460f3c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_792dc201-a518-4903-bc2b-4f98460f3c27" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_792dc201-a518-4903-bc2b-4f98460f3c27_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_792dc201-a518-4903-bc2b-4f98460f3c27" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_792dc201-a518-4903-bc2b-4f98460f3c27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_3a46bd85-088c-42ad-a48e-69c76df7348f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_792dc201-a518-4903-bc2b-4f98460f3c27" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_3a46bd85-088c-42ad-a48e-69c76df7348f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_064dc664-f937-4a78-b1f5-52609f099b26" xlink:href="rdnt-20201231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_3a46bd85-088c-42ad-a48e-69c76df7348f" xlink:to="loc_rdnt_COVID19PandemicMember_064dc664-f937-4a78-b1f5-52609f099b26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_204d8a18-51ad-4586-8b27-defaa07f40fe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_StatementScenarioAxis_204d8a18-51ad-4586-8b27-defaa07f40fe" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_204d8a18-51ad-4586-8b27-defaa07f40fe_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_204d8a18-51ad-4586-8b27-defaa07f40fe" xlink:to="loc_srt_ScenarioUnspecifiedDomain_204d8a18-51ad-4586-8b27-defaa07f40fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e1a20a86-9e7e-4850-953a-e6a4dcb10e8b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_204d8a18-51ad-4586-8b27-defaa07f40fe" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e1a20a86-9e7e-4850-953a-e6a4dcb10e8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_63de85b5-a31f-46dd-ab2b-ce9164ea3471" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_e1a20a86-9e7e-4850-953a-e6a4dcb10e8b" xlink:to="loc_srt_ScenarioForecastMember_63de85b5-a31f-46dd-ab2b-ce9164ea3471" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="extended" id="i581d69c02fdd499095364920c3db00e4_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_2bc4f460-a07f-4238-a4f9-e86c0163648c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_2bc4f460-a07f-4238-a4f9-e86c0163648c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_541c0f46-d5f5-4982-86ca-1b18e2524c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_541c0f46-d5f5-4982-86ca-1b18e2524c73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6403d856-bda9-4310-afd4-1723cf9f0c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6403d856-bda9-4310-afd4-1723cf9f0c73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1c2ea3e7-712b-4570-a185-3463868175a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1c2ea3e7-712b-4570-a185-3463868175a6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_b888f3f5-4ffd-4ea9-a607-ed5a1c644548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:to="loc_us-gaap_OffsettingAssetsTable_b888f3f5-4ffd-4ea9-a607-ed5a1c644548" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6e77e7cf-06f9-4017-8621-3bf6a883f060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_b888f3f5-4ffd-4ea9-a607-ed5a1c644548" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6e77e7cf-06f9-4017-8621-3bf6a883f060" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6e77e7cf-06f9-4017-8621-3bf6a883f060_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6e77e7cf-06f9-4017-8621-3bf6a883f060" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6e77e7cf-06f9-4017-8621-3bf6a883f060_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7c94b593-29af-4bc0-ba57-ee9d7cbf8915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6e77e7cf-06f9-4017-8621-3bf6a883f060" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7c94b593-29af-4bc0-ba57-ee9d7cbf8915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_d44311fe-33e8-4b7f-87a9-6301c24c9fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7c94b593-29af-4bc0-ba57-ee9d7cbf8915" xlink:to="loc_us-gaap_InterestRateCapMember_d44311fe-33e8-4b7f-87a9-6301c24c9fc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b2f21fac-a058-4515-9ad8-15794e0b3ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7c94b593-29af-4bc0-ba57-ee9d7cbf8915" xlink:to="loc_us-gaap_InterestRateSwapMember_b2f21fac-a058-4515-9ad8-15794e0b3ff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8b19269a-2296-4601-82f4-ccf9272c6ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OffsettingAssetsTable_b888f3f5-4ffd-4ea9-a607-ed5a1c644548" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8b19269a-2296-4601-82f4-ccf9272c6ab9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8b19269a-2296-4601-82f4-ccf9272c6ab9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8b19269a-2296-4601-82f4-ccf9272c6ab9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8b19269a-2296-4601-82f4-ccf9272c6ab9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3027c7ed-cf8c-4acf-9eda-80fdaa009cac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8b19269a-2296-4601-82f4-ccf9272c6ab9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3027c7ed-cf8c-4acf-9eda-80fdaa009cac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_814b7099-405c-4721-8915-ceafd057334c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3027c7ed-cf8c-4acf-9eda-80fdaa009cac" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_814b7099-405c-4721-8915-ceafd057334c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d9006bab-aa82-499b-8437-51867c514f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3027c7ed-cf8c-4acf-9eda-80fdaa009cac" xlink:to="loc_us-gaap_InterestExpenseMember_d9006bab-aa82-499b-8437-51867c514f99" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended" id="i637089ef62a8417c9000847d59724396_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d9b615b5-b553-4fd9-9536-548f3a1dc295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_10a46e5a-01bd-42b0-88fe-a796cb98416a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d9b615b5-b553-4fd9-9536-548f3a1dc295" xlink:to="loc_us-gaap_DerivativeLiabilities_10a46e5a-01bd-42b0-88fe-a796cb98416a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_6e156a7a-ee44-4067-9664-46720389dcc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d9b615b5-b553-4fd9-9536-548f3a1dc295" xlink:to="loc_us-gaap_DerivativeAssets_6e156a7a-ee44-4067-9664-46720389dcc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_372f96f8-9fad-4ca1-b46b-7c8e6236bac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d9b615b5-b553-4fd9-9536-548f3a1dc295" xlink:to="loc_us-gaap_DebtInstrumentFairValue_372f96f8-9fad-4ca1-b46b-7c8e6236bac3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0d39d4c7-668c-468f-bd9c-70dc6e8575d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d9b615b5-b553-4fd9-9536-548f3a1dc295" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0d39d4c7-668c-468f-bd9c-70dc6e8575d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_be8f9fef-79c7-477c-8035-c491cc705ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0d39d4c7-668c-468f-bd9c-70dc6e8575d5" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_be8f9fef-79c7-477c-8035-c491cc705ea0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_be8f9fef-79c7-477c-8035-c491cc705ea0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_be8f9fef-79c7-477c-8035-c491cc705ea0" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_be8f9fef-79c7-477c-8035-c491cc705ea0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_86f52741-b9df-4c07-81e9-7142c1cb882c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_be8f9fef-79c7-477c-8035-c491cc705ea0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_86f52741-b9df-4c07-81e9-7142c1cb882c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf31ccea-b8f2-4fd4-a82c-8014cab5a2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_86f52741-b9df-4c07-81e9-7142c1cb882c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf31ccea-b8f2-4fd4-a82c-8014cab5a2b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b1dc7477-a36d-4b5b-9e7c-8644c46e5071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf31ccea-b8f2-4fd4-a82c-8014cab5a2b1" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b1dc7477-a36d-4b5b-9e7c-8644c46e5071" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa58ce97-0332-4594-b37d-de94165e96e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0d39d4c7-668c-468f-bd9c-70dc6e8575d5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa58ce97-0332-4594-b37d-de94165e96e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa58ce97-0332-4594-b37d-de94165e96e6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa58ce97-0332-4594-b37d-de94165e96e6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_aa58ce97-0332-4594-b37d-de94165e96e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25e2bb12-f990-43aa-9c39-4b5ef33b5b06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa58ce97-0332-4594-b37d-de94165e96e6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25e2bb12-f990-43aa-9c39-4b5ef33b5b06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0c6a7273-7f8a-4ba3-960c-b933293673ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25e2bb12-f990-43aa-9c39-4b5ef33b5b06" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0c6a7273-7f8a-4ba3-960c-b933293673ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d1575cd3-5103-4c39-9aec-10d12db4eebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25e2bb12-f990-43aa-9c39-4b5ef33b5b06" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d1575cd3-5103-4c39-9aec-10d12db4eebc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d62ce351-8ebd-40a2-92f6-439d9a19fcd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25e2bb12-f990-43aa-9c39-4b5ef33b5b06" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d62ce351-8ebd-40a2-92f6-439d9a19fcd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9ec68fe8-1d04-420b-9837-ee535407afa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0d39d4c7-668c-468f-bd9c-70dc6e8575d5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9ec68fe8-1d04-420b-9837-ee535407afa8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9ec68fe8-1d04-420b-9837-ee535407afa8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ec68fe8-1d04-420b-9837-ee535407afa8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9ec68fe8-1d04-420b-9837-ee535407afa8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_998624ac-4bbf-48b2-9cc1-5c39c5b489c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ec68fe8-1d04-420b-9837-ee535407afa8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_998624ac-4bbf-48b2-9cc1-5c39c5b489c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_693b0504-e515-4bc6-9147-da618dd81f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_998624ac-4bbf-48b2-9cc1-5c39c5b489c0" xlink:to="loc_us-gaap_InterestRateCapMember_693b0504-e515-4bc6-9147-da618dd81f07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b8f70539-658e-4d06-8908-17db8896657d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_998624ac-4bbf-48b2-9cc1-5c39c5b489c0" xlink:to="loc_us-gaap_InterestRateSwapMember_b8f70539-658e-4d06-8908-17db8896657d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended" id="icc5351353bb14c25bbdf4a0346710a2e_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb3ded43-f6b5-44ff-adb1-5b061d8912b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_fe718160-c9c4-41dd-9fe2-d1a22c1914e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb3ded43-f6b5-44ff-adb1-5b061d8912b1" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_fe718160-c9c4-41dd-9fe2-d1a22c1914e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_777fb95d-7e8c-46d7-b120-1dbdd2ed3e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_fe718160-c9c4-41dd-9fe2-d1a22c1914e9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_777fb95d-7e8c-46d7-b120-1dbdd2ed3e37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_874d8483-ea31-4b26-bdaf-fee4a59d682d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb3ded43-f6b5-44ff-adb1-5b061d8912b1" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_874d8483-ea31-4b26-bdaf-fee4a59d682d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6b9276e5-4100-493b-9093-cae34bff3cb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_874d8483-ea31-4b26-bdaf-fee4a59d682d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6b9276e5-4100-493b-9093-cae34bff3cb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6b9276e5-4100-493b-9093-cae34bff3cb3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6b9276e5-4100-493b-9093-cae34bff3cb3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6b9276e5-4100-493b-9093-cae34bff3cb3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_975eee3a-66ba-4d0b-951f-7dc38ae2677e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6b9276e5-4100-493b-9093-cae34bff3cb3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_975eee3a-66ba-4d0b-951f-7dc38ae2677e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fd07b964-9540-4f2b-8d1b-b15027c97b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_975eee3a-66ba-4d0b-951f-7dc38ae2677e" xlink:to="loc_us-gaap_RestrictedStockMember_fd07b964-9540-4f2b-8d1b-b15027c97b58" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="extended" id="i0ed5b8ae5df940e5bc7826437ebf3df5_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended" id="if8a4a7aad6cd49cd9f8796389607827e_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_b1b98bd1-9a35-4b40-ae26-811958a7f006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:href="rdnt-20201231.xsd#rdnt_KeyFinancialDataForJointVenturesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_b1b98bd1-9a35-4b40-ae26-811958a7f006" xlink:to="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_233d1d07-25ee-4e78-802b-79c3362e514f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_AssetsCurrent_233d1d07-25ee-4e78-802b-79c3362e514f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_20ab8a8d-f4e9-458f-8401-248327c5dfd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_AssetsNoncurrent_20ab8a8d-f4e9-458f-8401-248327c5dfd5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_20dccde3-bb72-4bf7-997d-33e398d406a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_LiabilitiesCurrent_20dccde3-bb72-4bf7-997d-33e398d406a4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_cee875a9-469e-4e7f-9d2a-7c01cbc3304f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_cee875a9-469e-4e7f-9d2a-7c01cbc3304f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_f747d313-0cfb-482a-b6a7-74b24ddc8d47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_f747d313-0cfb-482a-b6a7-74b24ddc8d47" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_bd2dbe32-912e-453d-bf8c-7a5b7794b759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_EquityMethodInvestments_bd2dbe32-912e-453d-bf8c-7a5b7794b759" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_d2843a1a-3f10-4bd6-8059-8bdad199716b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_d2843a1a-3f10-4bd6-8059-8bdad199716b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7e3ae771-e246-4b61-9a18-de7bfb5fdc56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7e3ae771-e246-4b61-9a18-de7bfb5fdc56" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_555d496f-615b-4c75-a1f9-24bd3f55cfce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_Revenues_555d496f-615b-4c75-a1f9-24bd3f55cfce" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d290a74d-3e02-4e5f-a653-8db786a6479c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_ProfitLoss_d290a74d-3e02-4e5f-a653-8db786a6479c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d67a57f-8df4-4d48-a69f-fe7b08d45bed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_b1b98bd1-9a35-4b40-ae26-811958a7f006" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d67a57f-8df4-4d48-a69f-fe7b08d45bed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_c16cbbb0-e506-4bd2-b818-f045441963e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d67a57f-8df4-4d48-a69f-fe7b08d45bed" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_c16cbbb0-e506-4bd2-b818-f045441963e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_c16cbbb0-e506-4bd2-b818-f045441963e6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_c16cbbb0-e506-4bd2-b818-f045441963e6" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_c16cbbb0-e506-4bd2-b818-f045441963e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_83f5a913-12bd-4483-a7e0-8456966bdbef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_c16cbbb0-e506-4bd2-b818-f045441963e6" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_83f5a913-12bd-4483-a7e0-8456966bdbef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_f5f2671a-a6d0-46f3-9949-8c5de3641cc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_83f5a913-12bd-4483-a7e0-8456966bdbef" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_f5f2671a-a6d0-46f3-9949-8c5de3641cc7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#RECENTACCOUNTINGSTANDARDS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="extended" id="idcce3ccc668b4569a604d6bfe99bea92_RECENTACCOUNTINGSTANDARDS"/>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS" xlink:type="extended" id="i5a22f5253037455f9a037d88699984c2_FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS"/>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSANDDISPOSITIONSTables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSTables" xlink:type="extended" id="i1572554f80c24be6b4b68cfb52f0f589_FACILITYACQUISITIONSANDDISPOSITIONSTables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed" xlink:type="extended" id="i20264cdd183f448da5ed47bfb4a8a2d7_FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7fb64eca-23dd-448c-8d54-e147cb8e4458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7fb64eca-23dd-448c-8d54-e147cb8e4458" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_cf5e16f7-1d60-4887-86b2-e50d22f80d5c" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_cf5e16f7-1d60-4887-86b2-e50d22f80d5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_01b3c0bb-d53b-496b-851c-7177708d7eb1" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_01b3c0bb-d53b-496b-851c-7177708d7eb1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_32ef9f46-105e-4887-b1ac-2a32f55c5bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_32ef9f46-105e-4887-b1ac-2a32f55c5bee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_5ce78faf-6fc7-4e84-b6ac-0ac2c107db14" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_5ce78faf-6fc7-4e84-b6ac-0ac2c107db14" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f543faee-b466-43bd-9586-935bf82c426a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_us-gaap_Goodwill_f543faee-b466-43bd-9586-935bf82c426a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_22ede120-7fe9-438a-b8a5-fe52e8013d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_22ede120-7fe9-438a-b8a5-fe52e8013d0b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_614e41ad-1c06-4b83-989f-4fc1e5b524f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_614e41ad-1c06-4b83-989f-4fc1e5b524f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionAxis_c58d7484-51a4-4e2a-bd7b-16613731946b" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_614e41ad-1c06-4b83-989f-4fc1e5b524f7" xlink:to="loc_rdnt_AssetAcquisitionAxis_c58d7484-51a4-4e2a-bd7b-16613731946b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionDomain_c58d7484-51a4-4e2a-bd7b-16613731946b_default" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_AssetAcquisitionAxis_c58d7484-51a4-4e2a-bd7b-16613731946b" xlink:to="loc_rdnt_AssetAcquisitionDomain_c58d7484-51a4-4e2a-bd7b-16613731946b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionDomain_0bea53fd-aee3-4a8a-9ffb-08d5973e5091" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_AssetAcquisitionAxis_c58d7484-51a4-4e2a-bd7b-16613731946b" xlink:to="loc_rdnt_AssetAcquisitionDomain_0bea53fd-aee3-4a8a-9ffb-08d5973e5091" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPAtlanticLLCMember_ade1f199-56bd-4322-8ef0-1c76d0347a55" xlink:href="rdnt-20201231.xsd#rdnt_ZPAtlanticLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AssetAcquisitionDomain_0bea53fd-aee3-4a8a-9ffb-08d5973e5091" xlink:to="loc_rdnt_ZPAtlanticLLCMember_ade1f199-56bd-4322-8ef0-1c76d0347a55" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmhurstLLCMember_d44e5106-f1e5-4e88-bcdb-dfdd1d91f8c8" xlink:href="rdnt-20201231.xsd#rdnt_ZPElmhurstLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AssetAcquisitionDomain_0bea53fd-aee3-4a8a-9ffb-08d5973e5091" xlink:to="loc_rdnt_ZPElmhurstLLCMember_d44e5106-f1e5-4e88-bcdb-dfdd1d91f8c8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative" xlink:type="extended" id="i957ce5836f2d43a983ad7c6705daf5e5_FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_fddf9d6f-5e3a-4b6a-887d-37a062cbd21b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_fddf9d6f-5e3a-4b6a-887d-37a062cbd21b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a2772b65-fcc5-4d08-a723-43923732ff92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a2772b65-fcc5-4d08-a723-43923732ff92" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_60601f0b-a675-4444-b800-0035037dcb82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_60601f0b-a675-4444-b800-0035037dcb82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_b504434b-555e-4358-b8f8-40dbe478cbf3" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_b504434b-555e-4358-b8f8-40dbe478cbf3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_d856b48b-06fe-4507-9b77-dd63c63bd55e" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_d856b48b-06fe-4507-9b77-dd63c63bd55e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_54eaeed7-8316-4f44-9dce-57b594012609" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_54eaeed7-8316-4f44-9dce-57b594012609" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_840edf54-4187-4a52-a7ac-df78272f1931" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_Goodwill_840edf54-4187-4a52-a7ac-df78272f1931" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eac461b4-0e43-4687-82b4-a9e3dfa11a56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eac461b4-0e43-4687-82b4-a9e3dfa11a56" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_403a4e94-9b64-4703-8e0e-466fd537da6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_403a4e94-9b64-4703-8e0e-466fd537da6c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_6963376f-888b-4773-8a13-9de5cc90bfa6" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_6963376f-888b-4773-8a13-9de5cc90bfa6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_7d53fac0-c262-4ee6-9261-553a1d2672bf" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_7d53fac0-c262-4ee6-9261-553a1d2672bf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_09ef2a60-1cdf-4f90-9575-4ce09d889f00" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_09ef2a60-1cdf-4f90-9575-4ce09d889f00" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_9a7dd502-5eae-4358-b578-de9387c69292" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_9a7dd502-5eae-4358-b578-de9387c69292" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_a10ccce6-55c2-48c1-ba2c-2ff8ad04c2cd" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_a10ccce6-55c2-48c1-ba2c-2ff8ad04c2cd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_455ff82e-8c10-4ea8-a6c1-718bf0b1659d" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_455ff82e-8c10-4ea8-a6c1-718bf0b1659d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_1e0611bd-845e-452a-978a-9804ef0c8c3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_1e0611bd-845e-452a-978a-9804ef0c8c3f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_04bd7397-4640-4655-87bb-b4e1132b8a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_04bd7397-4640-4655-87bb-b4e1132b8a70" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_0e459725-8598-49bb-a852-b0d6149580c7" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_0e459725-8598-49bb-a852-b0d6149580c7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_7591a357-6a96-4a42-ac2a-4b053ea08a42" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_7591a357-6a96-4a42-ac2a-4b053ea08a42" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_c86932df-de0d-4c22-b222-30700764f670" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_c86932df-de0d-4c22-b222-30700764f670" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_a9fcfd4e-8968-4ed6-88ea-419e0d6c5f55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_a9fcfd4e-8968-4ed6-88ea-419e0d6c5f55" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d51622c8-c497-443d-a0e2-4b9f6745915e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d51622c8-c497-443d-a0e2-4b9f6745915e" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fe804c07-ee5d-4e07-89c6-506a82440be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fe804c07-ee5d-4e07-89c6-506a82440be4" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_1a665c93-6ba1-40fb-adc6-c88994e2d9e9" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_1a665c93-6ba1-40fb-adc6-c88994e2d9e9" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a0afd31d-b69a-45b1-bfb6-a8c730034318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a0afd31d-b69a-45b1-bfb6-a8c730034318" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_55eb001f-9379-454f-a067-bf6605bfe69e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_55eb001f-9379-454f-a067-bf6605bfe69e" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_45ea60d8-e9da-4588-b5f8-ab933cd52dea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_45ea60d8-e9da-4588-b5f8-ab933cd52dea" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b770249c-61d6-4732-96aa-67fd3625c3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b770249c-61d6-4732-96aa-67fd3625c3d9" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_64052f7a-09f9-4c46-ab97-4a0db4151d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_64052f7a-09f9-4c46-ab97-4a0db4151d9d" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f080bc49-0920-4ba3-b15f-863906cbbf3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f080bc49-0920-4ba3-b15f-863906cbbf3b" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c7fef52a-f7c4-4a9e-ad0b-74fce007ee04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c7fef52a-f7c4-4a9e-ad0b-74fce007ee04" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_8a2f892c-31f3-4144-bdd1-3d9361d2d78c" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_8a2f892c-31f3-4144-bdd1-3d9361d2d78c" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_18cd081e-f7c1-48d8-92f4-b1dfaf800bc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_18cd081e-f7c1-48d8-92f4-b1dfaf800bc8" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed_01b4710c-b38a-4530-8cf8-2f0eb60e7196" xlink:href="rdnt-20201231.xsd#rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed_01b4710c-b38a-4530-8cf8-2f0eb60e7196" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed_dbd8d82a-1b00-4339-84ae-dbb26324197e" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed_dbd8d82a-1b00-4339-84ae-dbb26324197e" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash_4ae2bec4-a4a2-4de0-a305-f3d1849123b8" xlink:href="rdnt-20201231.xsd#rdnt_PaymentstoAcquireEquityMethodInvestmentsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash_4ae2bec4-a4a2-4de0-a305-f3d1849123b8" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash_98e2630b-2c27-4194-8ac4-d999562e7fb5" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash_98e2630b-2c27-4194-8ac4-d999562e7fb5" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_1ce7b948-b5f4-4f39-b25a-3756b5147997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_1ce7b948-b5f4-4f39-b25a-3756b5147997" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdditionalEquityInterestAcquired_665ce1af-a8c9-412b-88b9-ce9dbe313bd0" xlink:href="rdnt-20201231.xsd#rdnt_AdditionalEquityInterestAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_AdditionalEquityInterestAcquired_665ce1af-a8c9-412b-88b9-ce9dbe313bd0" xlink:type="arc" order="38"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_432acc1e-0f4e-4924-85f9-ba954c7e50f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_432acc1e-0f4e-4924-85f9-ba954c7e50f5" xlink:type="arc" order="39"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2c98c08d-5836-4b82-818f-cf3fa5921aa7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2c98c08d-5836-4b82-818f-cf3fa5921aa7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_2c98c08d-5836-4b82-818f-cf3fa5921aa7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2c98c08d-5836-4b82-818f-cf3fa5921aa7" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_2c98c08d-5836-4b82-818f-cf3fa5921aa7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a3e075ba-f5cb-409d-9044-b54048cef481" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2c98c08d-5836-4b82-818f-cf3fa5921aa7" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a3e075ba-f5cb-409d-9044-b54048cef481" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_6c7142ee-ed06-4e2c-a84b-46e95719c823" xlink:href="rdnt-20201231.xsd#rdnt_ArizonaDiagnosticRadiologyGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a3e075ba-f5cb-409d-9044-b54048cef481" xlink:to="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_6c7142ee-ed06-4e2c-a84b-46e95719c823" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingMember_801d2a05-fc8f-40be-8c7c-3a20812c82b6" xlink:href="rdnt-20201231.xsd#rdnt_SantaMonicaImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a3e075ba-f5cb-409d-9044-b54048cef481" xlink:to="loc_rdnt_SantaMonicaImagingMember_801d2a05-fc8f-40be-8c7c-3a20812c82b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_1a85b913-9edb-4ba7-aa27-5fb7a3e0503e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_srt_OwnershipAxis_1a85b913-9edb-4ba7-aa27-5fb7a3e0503e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_1a85b913-9edb-4ba7-aa27-5fb7a3e0503e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_1a85b913-9edb-4ba7-aa27-5fb7a3e0503e" xlink:to="loc_srt_OwnershipDomain_1a85b913-9edb-4ba7-aa27-5fb7a3e0503e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b700672a-8174-4b72-b12d-01de3626fc6d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_1a85b913-9edb-4ba7-aa27-5fb7a3e0503e" xlink:to="loc_srt_OwnershipDomain_b700672a-8174-4b72-b12d-01de3626fc6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_f15fcf1f-a6c5-4b53-99fa-4d16d9c1633f" xlink:href="rdnt-20201231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b700672a-8174-4b72-b12d-01de3626fc6d" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_f15fcf1f-a6c5-4b53-99fa-4d16d9c1633f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a9d4034d-f806-44cc-85c2-34d28933b015" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_dei_LegalEntityAxis_a9d4034d-f806-44cc-85c2-34d28933b015" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_a9d4034d-f806-44cc-85c2-34d28933b015_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_a9d4034d-f806-44cc-85c2-34d28933b015" xlink:to="loc_dei_EntityDomain_a9d4034d-f806-44cc-85c2-34d28933b015_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0e55d1d8-aa09-45e7-8354-9133c1e86d81" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_a9d4034d-f806-44cc-85c2-34d28933b015" xlink:to="loc_dei_EntityDomain_0e55d1d8-aa09-45e7-8354-9133c1e86d81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_349f68e8-cce2-4b3e-8664-78d7a0a0c3ed" xlink:href="rdnt-20201231.xsd#rdnt_PrimedexHealthSystemsInc.andRadiologixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0e55d1d8-aa09-45e7-8354-9133c1e86d81" xlink:to="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_349f68e8-cce2-4b3e-8664-78d7a0a0c3ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadNetMember_3d0955f9-67a6-4269-843c-33b0b32c06f0" xlink:href="rdnt-20201231.xsd#rdnt_RadNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0e55d1d8-aa09-45e7-8354-9133c1e86d81" xlink:to="loc_rdnt_RadNetMember_3d0955f9-67a6-4269-843c-33b0b32c06f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CHINationalServicesIncMember_ebfcccc0-daef-48aa-9a9b-88af425ac6fb" xlink:href="rdnt-20201231.xsd#rdnt_CHINationalServicesIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_0e55d1d8-aa09-45e7-8354-9133c1e86d81" xlink:to="loc_rdnt_CHINationalServicesIncMember_ebfcccc0-daef-48aa-9a9b-88af425ac6fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_62df79b1-e984-47b0-bde5-02e0e2b275dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_62df79b1-e984-47b0-bde5-02e0e2b275dc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_62df79b1-e984-47b0-bde5-02e0e2b275dc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_62df79b1-e984-47b0-bde5-02e0e2b275dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_62df79b1-e984-47b0-bde5-02e0e2b275dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0e639819-ceae-46a1-86d0-13e4cf238c88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_62df79b1-e984-47b0-bde5-02e0e2b275dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0e639819-ceae-46a1-86d0-13e4cf238c88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_bcf14207-8530-473f-a970-20a1da9af174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0e639819-ceae-46a1-86d0-13e4cf238c88" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_bcf14207-8530-473f-a970-20a1da9af174" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_843b3451-478c-4b6c-a5d9-8735bd38738f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0e639819-ceae-46a1-86d0-13e4cf238c88" xlink:to="loc_us-gaap_TradeNamesMember_843b3451-478c-4b6c-a5d9-8735bd38738f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_285ceb83-f85e-4c8b-b20f-3501c3b64b69" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_srt_CounterpartyNameAxis_285ceb83-f85e-4c8b-b20f-3501c3b64b69" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_285ceb83-f85e-4c8b-b20f-3501c3b64b69_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_285ceb83-f85e-4c8b-b20f-3501c3b64b69" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_285ceb83-f85e-4c8b-b20f-3501c3b64b69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9ffe1843-ae5e-4eba-9f74-649c7fb01521" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_285ceb83-f85e-4c8b-b20f-3501c3b64b69" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9ffe1843-ae5e-4eba-9f74-649c7fb01521" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealth.Member_73834f17-213d-43e8-ba4e-5fbaa3b87f8e" xlink:href="rdnt-20201231.xsd#rdnt_DignityHealth.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9ffe1843-ae5e-4eba-9f74-649c7fb01521" xlink:to="loc_rdnt_DignityHealth.Member_73834f17-213d-43e8-ba4e-5fbaa3b87f8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_11460de3-c377-4051-930c-b93ad88f5acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_11460de3-c377-4051-930c-b93ad88f5acf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11460de3-c377-4051-930c-b93ad88f5acf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_11460de3-c377-4051-930c-b93ad88f5acf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_11460de3-c377-4051-930c-b93ad88f5acf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_11460de3-c377-4051-930c-b93ad88f5acf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_a0c476b6-9a80-47fa-a0a3-94b0ff363d09" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_DeepHealthInc.Member_a0c476b6-9a80-47fa-a0a3-94b0ff363d09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_a9fce211-d1b9-4771-8d64-4b9b165b4a26" xlink:href="rdnt-20201231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_a9fce211-d1b9-4771-8d64-4b9b165b4a26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_4c2ff8d2-cf18-4a1a-ae63-9db6845ae553" xlink:href="rdnt-20201231.xsd#rdnt_NulogixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_NulogixMember_4c2ff8d2-cf18-4a1a-ae63-9db6845ae553" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KernRadiologyImagingSystemsInc.Member_50c902e2-e22a-44c6-a8ba-20b82278eed7" xlink:href="rdnt-20201231.xsd#rdnt_KernRadiologyImagingSystemsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_KernRadiologyImagingSystemsInc.Member_50c902e2-e22a-44c6-a8ba-20b82278eed7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZilkhaRadiologyMember_3a258ba7-58d1-4af6-9d81-02c26b69dcf4" xlink:href="rdnt-20201231.xsd#rdnt_ZilkhaRadiologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_ZilkhaRadiologyMember_3a258ba7-58d1-4af6-9d81-02c26b69dcf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_a506abb9-5ec9-4d3f-8acd-7a7c835c0913" xlink:href="rdnt-20201231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_a506abb9-5ec9-4d3f-8acd-7a7c835c0913" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_b4cb2148-528b-4302-b886-1ce97491f202" xlink:href="rdnt-20201231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_b4cb2148-528b-4302-b886-1ce97491f202" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLC.Member_590a1725-6476-4293-8542-70544a2f7133" xlink:href="rdnt-20201231.xsd#rdnt_VenturaCountyImagingGroupLLC.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_VenturaCountyImagingGroupLLC.Member_590a1725-6476-4293-8542-70544a2f7133" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_1785a2df-5544-4dda-9d57-4f7ab7bc4be4" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_DeepHealthIncMember_1785a2df-5544-4dda-9d57-4f7ab7bc4be4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_63ffd452-02c5-40d4-abb4-a355188a0002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_63ffd452-02c5-40d4-abb4-a355188a0002" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_63ffd452-02c5-40d4-abb4-a355188a0002_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_63ffd452-02c5-40d4-abb4-a355188a0002" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_63ffd452-02c5-40d4-abb4-a355188a0002_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_837dbb35-42a9-4ddb-8a77-0dbf063df2e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_63ffd452-02c5-40d4-abb4-a355188a0002" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_837dbb35-42a9-4ddb-8a77-0dbf063df2e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_950b621c-234e-4197-8330-2cc1f5d3ae4f" xlink:href="rdnt-20201231.xsd#rdnt_ImagingOnCallMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_837dbb35-42a9-4ddb-8a77-0dbf063df2e3" xlink:to="loc_rdnt_ImagingOnCallMember_950b621c-234e-4197-8330-2cc1f5d3ae4f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionAxis_11cedc0b-c332-4803-b234-dfc8ed7008d4" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_rdnt_AssetAcquisitionAxis_11cedc0b-c332-4803-b234-dfc8ed7008d4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionDomain_11cedc0b-c332-4803-b234-dfc8ed7008d4_default" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_AssetAcquisitionAxis_11cedc0b-c332-4803-b234-dfc8ed7008d4" xlink:to="loc_rdnt_AssetAcquisitionDomain_11cedc0b-c332-4803-b234-dfc8ed7008d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionDomain_7747b9e5-5e2d-4a7f-89a3-49bf5b190d18" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_AssetAcquisitionAxis_11cedc0b-c332-4803-b234-dfc8ed7008d4" xlink:to="loc_rdnt_AssetAcquisitionDomain_7747b9e5-5e2d-4a7f-89a3-49bf5b190d18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechMember_1506a9b2-7679-4b45-9094-8680e73269a8" xlink:href="rdnt-20201231.xsd#rdnt_AZTechMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AssetAcquisitionDomain_7747b9e5-5e2d-4a7f-89a3-49bf5b190d18" xlink:to="loc_rdnt_AZTechMember_1506a9b2-7679-4b45-9094-8680e73269a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIatWoodbridgeLLCMember_cc45b621-2d4a-4369-83b4-ba90b57c427d" xlink:href="rdnt-20201231.xsd#rdnt_MRIatWoodbridgeLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AssetAcquisitionDomain_7747b9e5-5e2d-4a7f-89a3-49bf5b190d18" xlink:to="loc_rdnt_MRIatWoodbridgeLLCMember_cc45b621-2d4a-4369-83b4-ba90b57c427d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember_8481b768-3958-4fac-a801-d2453a166519" xlink:href="rdnt-20201231.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AssetAcquisitionDomain_7747b9e5-5e2d-4a7f-89a3-49bf5b190d18" xlink:to="loc_rdnt_OlneyOpenMRILLCMember_8481b768-3958-4fac-a801-d2453a166519" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended" id="i6fb580bd854a40bbb87cde068b35d1b7_GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended" id="id6bd527590d941beb82ebc6575b2c91b_GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="extended" id="ic6aea5ca4cf04b24a44740e72d74c424_GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_7892dfcf-53d7-4909-b8d1-f53357c8bf8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_7892dfcf-53d7-4909-b8d1-f53357c8bf8c" xlink:to="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d967af73-e937-4d9c-8d7b-65adf8b486c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:to="loc_us-gaap_Goodwill_d967af73-e937-4d9c-8d7b-65adf8b486c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6ae5e9af-4d21-4cb0-9d6c-cb2e89f0ff97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6ae5e9af-4d21-4cb0-9d6c-cb2e89f0ff97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_1a47a048-7215-4507-ab44-2ad58b8ef427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_1a47a048-7215-4507-ab44-2ad58b8ef427" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_8e48f667-a216-4fcb-bb13-d3c6b1d9a828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:to="loc_us-gaap_GoodwillTransfers_8e48f667-a216-4fcb-bb13-d3c6b1d9a828" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e7f4f3f6-95e5-4455-946b-655013e79bba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_dc8aca1b-5d0b-48cc-bbe2-3796a6088059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_7892dfcf-53d7-4909-b8d1-f53357c8bf8c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_dc8aca1b-5d0b-48cc-bbe2-3796a6088059" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d1491b31-521c-4d23-a08b-83ac6235af19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_dc8aca1b-5d0b-48cc-bbe2-3796a6088059" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d1491b31-521c-4d23-a08b-83ac6235af19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d1491b31-521c-4d23-a08b-83ac6235af19_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d1491b31-521c-4d23-a08b-83ac6235af19" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d1491b31-521c-4d23-a08b-83ac6235af19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d1491b31-521c-4d23-a08b-83ac6235af19" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalArtsRadiologicalGroupPCMember_e2d18e6d-edae-40f5-bd1b-055b7744261f" xlink:href="rdnt-20201231.xsd#rdnt_MedicalArtsRadiologicalGroupPCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_MedicalArtsRadiologicalGroupPCMember_e2d18e6d-edae-40f5-bd1b-055b7744261f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_48e4ce44-34f0-4555-b0b0-e9e12a13bff5" xlink:href="rdnt-20201231.xsd#rdnt_DignityHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_DignityHealthMember_48e4ce44-34f0-4555-b0b0-e9e12a13bff5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_f6da9a80-0c30-43cd-b0df-63d5122ef28e" xlink:href="rdnt-20201231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_f6da9a80-0c30-43cd-b0df-63d5122ef28e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_5e622a81-2bba-4523-8b6d-f092c33b3f4c" xlink:href="rdnt-20201231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_5e622a81-2bba-4523-8b6d-f092c33b3f4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KernRadiologyImagingSystemsInc.Member_c3771e26-7936-4932-9698-b7b1e3b2681b" xlink:href="rdnt-20201231.xsd#rdnt_KernRadiologyImagingSystemsInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_KernRadiologyImagingSystemsInc.Member_c3771e26-7936-4932-9698-b7b1e3b2681b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZilkhaRadiologyMember_ec587f93-a804-4c9a-a992-6fb940aafa1d" xlink:href="rdnt-20201231.xsd#rdnt_ZilkhaRadiologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_ZilkhaRadiologyMember_ec587f93-a804-4c9a-a992-6fb940aafa1d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RamicMahwahLLCMember_a262b93b-ec51-4914-b64b-245d57b6731e" xlink:href="rdnt-20201231.xsd#rdnt_RamicMahwahLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_RamicMahwahLLCMember_a262b93b-ec51-4914-b64b-245d57b6731e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_d9b24184-3376-4a56-9188-dcc228cd71e1" xlink:href="rdnt-20201231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_d9b24184-3376-4a56-9188-dcc228cd71e1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_5f179bed-472f-4492-ad2c-40e75f78d208" xlink:href="rdnt-20201231.xsd#rdnt_NulogixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_NulogixMember_5f179bed-472f-4492-ad2c-40e75f78d208" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember_d5751153-9dd8-4b37-b52a-6fb87e47e4bb" xlink:href="rdnt-20201231.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_OlneyOpenMRILLCMember_d5751153-9dd8-4b37-b52a-6fb87e47e4bb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIatWoodbridgeLLCMember_b7dfdde8-3dfc-4ef6-83c7-9907b8809e76" xlink:href="rdnt-20201231.xsd#rdnt_MRIatWoodbridgeLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_MRIatWoodbridgeLLCMember_b7dfdde8-3dfc-4ef6-83c7-9907b8809e76" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_72a4e4e1-7199-406b-8f1d-2d9dcd2ce57a" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_DeepHealthInc.Member_72a4e4e1-7199-406b-8f1d-2d9dcd2ce57a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechRadiologyOpenMRILLCMember_a33b3053-9135-4e5f-8b8b-0e13caa69bf6" xlink:href="rdnt-20201231.xsd#rdnt_AZTechRadiologyOpenMRILLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_AZTechRadiologyOpenMRILLCMember_a33b3053-9135-4e5f-8b8b-0e13caa69bf6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPOzoneParkLLCMember_7a3b8856-b045-4747-b2ef-60c9f3c748ff" xlink:href="rdnt-20201231.xsd#rdnt_ZPOzoneParkLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_ZPOzoneParkLLCMember_7a3b8856-b045-4747-b2ef-60c9f3c748ff" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmhurstLLCMember_7e36d806-b2ce-4354-8839-3424b6823dbb" xlink:href="rdnt-20201231.xsd#rdnt_ZPElmhurstLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_ZPElmhurstLLCMember_7e36d806-b2ce-4354-8839-3424b6823dbb" xlink:type="arc" order="14"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="extended" id="i8c5f66049a3a42fcb166f4d388bae70c_GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"/>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="extended" id="i6270a1631f754ac688deb93cb51f79a1_GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d1cb2c15-0474-4596-bec3-bd223fa027ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d1cb2c15-0474-4596-bec3-bd223fa027ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_54d27f0e-5bb8-45b1-8a96-5c94fa35e06e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_54d27f0e-5bb8-45b1-8a96-5c94fa35e06e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_394e3f45-39c9-4cf5-a9dc-ab4141d6f653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_394e3f45-39c9-4cf5-a9dc-ab4141d6f653" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2599f884-674e-45e0-b9b1-bbb2d219a433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2599f884-674e-45e0-b9b1-bbb2d219a433" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_00de1e7f-0927-4062-bb76-ae579b672120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_00de1e7f-0927-4062-bb76-ae579b672120" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_adc1e07f-8053-437e-8bb2-3aa748cd71c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_adc1e07f-8053-437e-8bb2-3aa748cd71c7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2953a7bb-8d8e-47a1-9f68-59300c01b40f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2953a7bb-8d8e-47a1-9f68-59300c01b40f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageAmortizationPeriodRemainingInYears_cf311615-60ce-47a0-b35f-b459cb439d56" xlink:href="rdnt-20201231.xsd#rdnt_WeightedAverageAmortizationPeriodRemainingInYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_rdnt_WeightedAverageAmortizationPeriodRemainingInYears_cf311615-60ce-47a0-b35f-b459cb439d56" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6847db92-65b8-4e9e-ac26-45ef7d9517eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6847db92-65b8-4e9e-ac26-45ef7d9517eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ab79986-b4ac-4d8b-947e-3f88b122c3fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6847db92-65b8-4e9e-ac26-45ef7d9517eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ab79986-b4ac-4d8b-947e-3f88b122c3fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6ab79986-b4ac-4d8b-947e-3f88b122c3fc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ab79986-b4ac-4d8b-947e-3f88b122c3fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_6ab79986-b4ac-4d8b-947e-3f88b122c3fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ab79986-b4ac-4d8b-947e-3f88b122c3fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_54f970f0-1815-4ea1-a5c1-02a8cb5eb08c" xlink:href="rdnt-20201231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_rdnt_ManagementServiceContractsMember_54f970f0-1815-4ea1-a5c1-02a8cb5eb08c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember_efbdc37e-3e83-48ce-b889-c2505d822bd2" xlink:href="rdnt-20201231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_rdnt_CovenantNotToCompeteMember_efbdc37e-3e83-48ce-b889-c2505d822bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedtechnologyMember_e6917ae3-fd36-4b73-b2b6-9b3634b671e6" xlink:href="rdnt-20201231.xsd#rdnt_DevelopedtechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_rdnt_DevelopedtechnologyMember_e6917ae3-fd36-4b73-b2b6-9b3634b671e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TradeNamesAmortizedMember_5f3a2d44-974e-4b5d-93ed-98f9474fc4f6" xlink:href="rdnt-20201231.xsd#rdnt_TradeNamesAmortizedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_rdnt_TradeNamesAmortizedMember_5f3a2d44-974e-4b5d-93ed-98f9474fc4f6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TradeNamesIndefiniteLifeMember_3945b72f-1463-45aa-859f-af7ab2e301ee" xlink:href="rdnt-20201231.xsd#rdnt_TradeNamesIndefiniteLifeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_rdnt_TradeNamesIndefiniteLifeMember_3945b72f-1463-45aa-859f-af7ab2e301ee" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_ecac247b-b173-45e2-801f-89dc3325b59f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_ecac247b-b173-45e2-801f-89dc3325b59f" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENT"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="extended" id="i49f354c834134d618b7ac091c66c1289_PROPERTYANDEQUIPMENT"/>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENTTables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="extended" id="i568386383f524f6b897ee4d8ec9fd5e2_PROPERTYANDEQUIPMENTTables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended" id="ia62e27dd3b04430289972140e6af39d7_PROPERTYANDEQUIPMENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_aed87d60-39b3-47bf-a4e5-ceba8ec2ba64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_76ad744b-c2a8-48c3-bf00-432f8801a07f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_aed87d60-39b3-47bf-a4e5-ceba8ec2ba64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_76ad744b-c2a8-48c3-bf00-432f8801a07f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7811fd68-34db-4f97-8099-16f33a1c5b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_aed87d60-39b3-47bf-a4e5-ceba8ec2ba64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7811fd68-34db-4f97-8099-16f33a1c5b00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_af5aa283-8056-477e-be18-c303bad70e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_aed87d60-39b3-47bf-a4e5-ceba8ec2ba64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_af5aa283-8056-477e-be18-c303bad70e3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee53a6b1-a8a4-4bff-ab20-229b1b632dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_aed87d60-39b3-47bf-a4e5-ceba8ec2ba64" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee53a6b1-a8a4-4bff-ab20-229b1b632dff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2a8cafce-9ca9-4bfd-9f9c-5de73e36eaff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee53a6b1-a8a4-4bff-ab20-229b1b632dff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2a8cafce-9ca9-4bfd-9f9c-5de73e36eaff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2a8cafce-9ca9-4bfd-9f9c-5de73e36eaff_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2a8cafce-9ca9-4bfd-9f9c-5de73e36eaff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2a8cafce-9ca9-4bfd-9f9c-5de73e36eaff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2a8cafce-9ca9-4bfd-9f9c-5de73e36eaff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_e6e4d305-d84d-461b-a33a-0f1b09b59c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:to="loc_us-gaap_LandMember_e6e4d305-d84d-461b-a33a-0f1b09b59c06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_9ebdc158-35dc-4a9d-9191-52a7489da45a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:to="loc_us-gaap_EquipmentMember_9ebdc158-35dc-4a9d-9191-52a7489da45a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_452f6aca-c5ad-42a9-b8fe-ae781910f490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_452f6aca-c5ad-42a9-b8fe-ae781910f490" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_849abcf8-4b5f-4b3b-882d-827e02363247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_849abcf8-4b5f-4b3b-882d-827e02363247" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_e47df93f-57b1-4522-98a3-aafa9625c208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:to="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_e47df93f-57b1-4522-98a3-aafa9625c208" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENTDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="extended" id="i799b2c65ad2742e29f295fe437c6ad0b_PROPERTYANDEQUIPMENTDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b18ffecf-20b6-45c5-9448-e2f15790c770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_aa167c36-4544-4630-b68c-0649748cb78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b18ffecf-20b6-45c5-9448-e2f15790c770" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_aa167c36-4544-4630-b68c-0649748cb78a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_7c329e62-e4d4-4a0f-8303-583b177bf7e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b18ffecf-20b6-45c5-9448-e2f15790c770" xlink:to="loc_us-gaap_ConstructionInProgressGross_7c329e62-e4d4-4a0f-8303-583b177bf7e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_323f5aa3-a0d6-4d0f-acca-85defd0173e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b18ffecf-20b6-45c5-9448-e2f15790c770" xlink:to="loc_us-gaap_DepreciationAndAmortization_323f5aa3-a0d6-4d0f-acca-85defd0173e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2cff164-92d5-4f3d-8ba7-865f24fe94d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b18ffecf-20b6-45c5-9448-e2f15790c770" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2cff164-92d5-4f3d-8ba7-865f24fe94d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79f73e69-dcdd-4256-b6e1-308edf74f953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2cff164-92d5-4f3d-8ba7-865f24fe94d8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79f73e69-dcdd-4256-b6e1-308edf74f953" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_79f73e69-dcdd-4256-b6e1-308edf74f953_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79f73e69-dcdd-4256-b6e1-308edf74f953" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_79f73e69-dcdd-4256-b6e1-308edf74f953_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79f73e69-dcdd-4256-b6e1-308edf74f953" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_9217d91f-f50a-40e4-80f7-5198e63b3b07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:to="loc_us-gaap_ConstructionInProgressMember_9217d91f-f50a-40e4-80f7-5198e63b3b07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember_dda9bf59-69ab-4717-9400-20549c088730" xlink:href="rdnt-20201231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:to="loc_rdnt_MedicalEquipmentMember_dda9bf59-69ab-4717-9400-20549c088730" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember_16eb2337-f489-4d8c-91a8-15ea5fd5f91a" xlink:href="rdnt-20201231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:to="loc_rdnt_ComputerandOfficeEquipmentMember_16eb2337-f489-4d8c-91a8-15ea5fd5f91a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_0d9b9f76-c01a-421d-834f-ee07383dee8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_0d9b9f76-c01a-421d-834f-ee07383dee8e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="simple" xlink:href="rdnt-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="extended" id="id2dfaa4d6aa84f3e82768fa05cd5d382_ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="extended" id="i920bfcedec494b3e94e78d2ed2533482_ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="rdnt-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="extended" id="i7aceb750d2f94ce0bbe99508cd900d66_ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLE"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="extended" id="if83ab9164dd4417bb2017a88fb1b5500_CREDITFACILITIESANDNOTESPAYABLE"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLETables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="extended" id="i3fb444d8cc274af1a4265d4d874ae338_CREDITFACILITIESANDNOTESPAYABLETables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="extended" id="i40d068a111234bb0bfd937fde4326114_CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_63ea3017-9ddf-43fa-b7ed-fd53f306d527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_us-gaap_LongTermDebt_63ea3017-9ddf-43fa-b7ed-fd53f306d527" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e2eee40d-8eca-40fb-a01d-563b7fb8e4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e2eee40d-8eca-40fb-a01d-563b7fb8e4f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable_936863a8-4a8d-40d8-8f36-fc629f50088b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_us-gaap_LongTermLoansPayable_936863a8-4a8d-40d8-8f36-fc629f50088b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_6a2a8d37-4fb8-4497-ac78-29bbe045a2f2" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_6a2a8d37-4fb8-4497-ac78-29bbe045a2f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_c702c392-eb0c-4faa-b2c1-eab72ce9d6d0" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_c702c392-eb0c-4faa-b2c1-eab72ce9d6d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_d46da35f-7b9c-4abf-abed-ba81361a9599" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_d46da35f-7b9c-4abf-abed-ba81361a9599" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2c5b32ca-320b-41de-9fc8-5b2f06f9c1eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2c5b32ca-320b-41de-9fc8-5b2f06f9c1eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_238a284d-0dee-497d-8d9b-b889be774ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_us-gaap_DebtInstrumentTable_238a284d-0dee-497d-8d9b-b889be774ea0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3f0b27af-bf72-4387-a1e2-4aec6e734c3c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_238a284d-0dee-497d-8d9b-b889be774ea0" xlink:to="loc_srt_RangeAxis_3f0b27af-bf72-4387-a1e2-4aec6e734c3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3f0b27af-bf72-4387-a1e2-4aec6e734c3c_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3f0b27af-bf72-4387-a1e2-4aec6e734c3c" xlink:to="loc_srt_RangeMember_3f0b27af-bf72-4387-a1e2-4aec6e734c3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2a30a603-1400-47da-9d86-fd62461d4873" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3f0b27af-bf72-4387-a1e2-4aec6e734c3c" xlink:to="loc_srt_RangeMember_2a30a603-1400-47da-9d86-fd62461d4873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_158c12c4-bd41-493d-bd80-dd65cff8107b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2a30a603-1400-47da-9d86-fd62461d4873" xlink:to="loc_srt_MinimumMember_158c12c4-bd41-493d-bd80-dd65cff8107b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d01a66bb-709d-4dde-a83c-1f738b437a3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2a30a603-1400-47da-9d86-fd62461d4873" xlink:to="loc_srt_MaximumMember_d01a66bb-709d-4dde-a83c-1f738b437a3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_42edae9a-143f-4925-8f31-912403e78f49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_238a284d-0dee-497d-8d9b-b889be774ea0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_42edae9a-143f-4925-8f31-912403e78f49" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_42edae9a-143f-4925-8f31-912403e78f49_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_42edae9a-143f-4925-8f31-912403e78f49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_42edae9a-143f-4925-8f31-912403e78f49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c2a48eb6-7ef0-4f1d-a4ca-041519834ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_42edae9a-143f-4925-8f31-912403e78f49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c2a48eb6-7ef0-4f1d-a4ca-041519834ccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_59a0610e-a954-4f08-9380-091f11c44b71" xlink:href="rdnt-20201231.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2a48eb6-7ef0-4f1d-a4ca-041519834ccd" xlink:to="loc_rdnt_TermLoanMember_59a0610e-a954-4f08-9380-091f11c44b71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_90f73867-c0ca-4681-b17a-801e06e4d9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2a48eb6-7ef0-4f1d-a4ca-041519834ccd" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_90f73867-c0ca-4681-b17a-801e06e4d9bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ba64887c-88c1-439d-8faf-6936938dfc57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_238a284d-0dee-497d-8d9b-b889be774ea0" xlink:to="loc_us-gaap_DebtInstrumentAxis_ba64887c-88c1-439d-8faf-6936938dfc57" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ba64887c-88c1-439d-8faf-6936938dfc57_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ba64887c-88c1-439d-8faf-6936938dfc57" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ba64887c-88c1-439d-8faf-6936938dfc57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d0825112-425c-47d5-a5f9-f0c3b9b6a0cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ba64887c-88c1-439d-8faf-6936938dfc57" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d0825112-425c-47d5-a5f9-f0c3b9b6a0cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_f3b1021b-51f4-46fc-8df3-1052a1eaa98d" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d0825112-425c-47d5-a5f9-f0c3b9b6a0cb" xlink:to="loc_rdnt_FirstLienTermLoanMember_f3b1021b-51f4-46fc-8df3-1052a1eaa98d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_3df87e66-98dc-44a1-a2b1-3fdf7e65903e" xlink:href="rdnt-20201231.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d0825112-425c-47d5-a5f9-f0c3b9b6a0cb" xlink:to="loc_rdnt_RestatedAgreementMember_3df87e66-98dc-44a1-a2b1-3fdf7e65903e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="extended" id="ied0f51c1c0044b78bce1a601e7d5a835_CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="extended" id="i743b7f2cf0444624811b5c901566862a_CREDITFACILITYANDNOTESPAYABLEDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d5049cf1-a157-47f3-ab83-c4c9d08f881a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d5049cf1-a157-47f3-ab83-c4c9d08f881a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ce3fee52-f24e-4acf-b797-3a55cb03eed0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ce3fee52-f24e-4acf-b797-3a55cb03eed0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_7da68c59-2801-422f-a9c2-cb99865d3c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LineOfCredit_7da68c59-2801-422f-a9c2-cb99865d3c29" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b8ec8805-56e2-433b-b1e3-ac39e638cb13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b8ec8805-56e2-433b-b1e3-ac39e638cb13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4aa2854e-a906-49ca-b0da-1a1e260494b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4aa2854e-a906-49ca-b0da-1a1e260494b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fe0d513d-7358-48c6-969d-7473c9201232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fe0d513d-7358-48c6-969d-7473c9201232" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_aeaa53cd-a8f4-400d-a52a-c7085bff76dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_aeaa53cd-a8f4-400d-a52a-c7085bff76dd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_eeea900a-53fe-4f4b-a251-8d70abfb4f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_eeea900a-53fe-4f4b-a251-8d70abfb4f6b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_90f6e4e0-3f5d-4d1a-b3ff-ad5e889e4a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_90f6e4e0-3f5d-4d1a-b3ff-ad5e889e4a4b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1959f58a-3c99-47b1-abed-953cb26e5975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1959f58a-3c99-47b1-abed-953cb26e5975" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_6c4e98fb-6682-46d0-a507-9a0061c94826" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_6c4e98fb-6682-46d0-a507-9a0061c94826" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_3704333c-ab8b-4509-9b36-5ddf2148b636" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_3704333c-ab8b-4509-9b36-5ddf2148b636" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6e2c22ab-1c80-4805-b3ba-b4ff57015e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6e2c22ab-1c80-4805-b3ba-b4ff57015e8c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_8ed7251c-358f-4792-bfa9-1dc5caf64c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_8ed7251c-358f-4792-bfa9-1dc5caf64c41" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_6f9e6ae6-fb88-4371-8dc3-51226a89b2a3" xlink:href="rdnt-20201231.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_6f9e6ae6-fb88-4371-8dc3-51226a89b2a3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_738004a1-233c-4265-842f-40ba08d6c02a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_738004a1-233c-4265-842f-40ba08d6c02a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_941b032f-2e5d-47c9-965e-8319ff1a1008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_941b032f-2e5d-47c9-965e-8319ff1a1008" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_72f0fe16-0004-4e25-bd24-205c2a1084c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_72f0fe16-0004-4e25-bd24-205c2a1084c0" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cc831301-772e-41c1-945f-dcbc7524468d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cc831301-772e-41c1-945f-dcbc7524468d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c55e686a-7c1e-46e3-b50c-ca6c6e686a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentTerm_c55e686a-7c1e-46e3-b50c-ca6c6e686a7f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived_8f99e0ea-3975-46e4-9df7-599063e8becf" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_rdnt_DebtInstrumentNumberofLoansReceived_8f99e0ea-3975-46e4-9df7-599063e8becf" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_af6a640e-4562-4658-9dcf-a29ab66403c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_af6a640e-4562-4658-9dcf-a29ab66403c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_af6a640e-4562-4658-9dcf-a29ab66403c3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_af6a640e-4562-4658-9dcf-a29ab66403c3" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_af6a640e-4562-4658-9dcf-a29ab66403c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_fbefc61c-7d5c-44b8-9d0c-abfd0a469f48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_af6a640e-4562-4658-9dcf-a29ab66403c3" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_fbefc61c-7d5c-44b8-9d0c-abfd0a469f48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_e819da20-8f2c-40fe-9095-a8cc40e925bb" xlink:href="rdnt-20201231.xsd#rdnt_COVID19PandemicMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_fbefc61c-7d5c-44b8-9d0c-abfd0a469f48" xlink:to="loc_rdnt_COVID19PandemicMember_e819da20-8f2c-40fe-9095-a8cc40e925bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_05e0c9b5-8b4e-4e6e-a284-67ad1fd323df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_VariableRateAxis_05e0c9b5-8b4e-4e6e-a284-67ad1fd323df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_05e0c9b5-8b4e-4e6e-a284-67ad1fd323df_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_05e0c9b5-8b4e-4e6e-a284-67ad1fd323df" xlink:to="loc_us-gaap_VariableRateDomain_05e0c9b5-8b4e-4e6e-a284-67ad1fd323df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6ced35b1-695d-4530-b10c-1b7e238f17ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_05e0c9b5-8b4e-4e6e-a284-67ad1fd323df" xlink:to="loc_us-gaap_VariableRateDomain_6ced35b1-695d-4530-b10c-1b7e238f17ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_d749449e-dbfa-4193-b592-7c247203900a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6ced35b1-695d-4530-b10c-1b7e238f17ba" xlink:to="loc_us-gaap_EurodollarMember_d749449e-dbfa-4193-b592-7c247203900a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_d6bfa9f2-81d4-424a-afb6-a96ced9baa53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_6ced35b1-695d-4530-b10c-1b7e238f17ba" xlink:to="loc_us-gaap_BaseRateMember_d6bfa9f2-81d4-424a-afb6-a96ced9baa53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_c74deebe-9efb-44f6-9764-ba547962da13" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_rdnt_LeverageRatioAxis_c74deebe-9efb-44f6-9764-ba547962da13" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_c74deebe-9efb-44f6-9764-ba547962da13_default" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_c74deebe-9efb-44f6-9764-ba547962da13" xlink:to="loc_rdnt_LeverageRatioDomain_c74deebe-9efb-44f6-9764-ba547962da13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_90696782-67d2-43fd-be3d-b69faa5efdf6" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_c74deebe-9efb-44f6-9764-ba547962da13" xlink:to="loc_rdnt_LeverageRatioDomain_90696782-67d2-43fd-be3d-b69faa5efdf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_2165ff1c-9f91-4a3a-a76d-bf92d68b944e" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_90696782-67d2-43fd-be3d-b69faa5efdf6" xlink:to="loc_rdnt_LeverageRatioThreeMember_2165ff1c-9f91-4a3a-a76d-bf92d68b944e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_cb433700-652b-42aa-b898-c17ab3e7236d" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_90696782-67d2-43fd-be3d-b69faa5efdf6" xlink:to="loc_rdnt_PricingLevelIIIMember_cb433700-652b-42aa-b898-c17ab3e7236d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d41caae5-057b-4c11-8d55-a093b1fd8584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_DebtInstrumentAxis_d41caae5-057b-4c11-8d55-a093b1fd8584" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d41caae5-057b-4c11-8d55-a093b1fd8584_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d41caae5-057b-4c11-8d55-a093b1fd8584" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d41caae5-057b-4c11-8d55-a093b1fd8584_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d41caae5-057b-4c11-8d55-a093b1fd8584" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_60d41798-0325-4576-b8ed-fed8239381cc" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_FirstLienTermLoanMember_60d41798-0325-4576-b8ed-fed8239381cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_84a0d8e7-4afd-4455-9cff-3d03fe171283" xlink:href="rdnt-20201231.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_RestatedAgreementMember_84a0d8e7-4afd-4455-9cff-3d03fe171283" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_5e14948d-0bd6-41d9-8987-b7341a471de6" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_5e14948d-0bd6-41d9-8987-b7341a471de6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_affc5ebc-2a7f-4731-abbe-caec385b1813" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_affc5ebc-2a7f-4731-abbe-caec385b1813" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_1f4c0777-7957-453b-89ff-60e5b1741946" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_1f4c0777-7957-453b-89ff-60e5b1741946" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_56f82a4d-3788-4f58-b1e0-77e0e762b151" xlink:href="rdnt-20201231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_56f82a4d-3788-4f58-b1e0-77e0e762b151" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_724f5934-c0a4-4bd2-9d06-d430ca708f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_724f5934-c0a4-4bd2-9d06-d430ca708f25" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_724f5934-c0a4-4bd2-9d06-d430ca708f25_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_724f5934-c0a4-4bd2-9d06-d430ca708f25" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_724f5934-c0a4-4bd2-9d06-d430ca708f25_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_3d8d2cad-3472-44c6-ab83-bf918e37352b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_724f5934-c0a4-4bd2-9d06-d430ca708f25" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_3d8d2cad-3472-44c6-ab83-bf918e37352b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_8021e9d2-44f4-49a5-8061-9efc5ee1a663" xlink:href="rdnt-20201231.xsd#rdnt_BarclaysMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_3d8d2cad-3472-44c6-ab83-bf918e37352b" xlink:to="loc_rdnt_BarclaysMember_8021e9d2-44f4-49a5-8061-9efc5ee1a663" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_2f2ce086-76e0-4373-a7e0-511c406c618a" xlink:href="rdnt-20201231.xsd#rdnt_SunTrustMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_3d8d2cad-3472-44c6-ab83-bf918e37352b" xlink:to="loc_rdnt_SunTrustMember_2f2ce086-76e0-4373-a7e0-511c406c618a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_bd033c5c-8bc2-4a23-9784-01ef76af68b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_CreditFacilityAxis_bd033c5c-8bc2-4a23-9784-01ef76af68b9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_bd033c5c-8bc2-4a23-9784-01ef76af68b9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_bd033c5c-8bc2-4a23-9784-01ef76af68b9" xlink:to="loc_us-gaap_CreditFacilityDomain_bd033c5c-8bc2-4a23-9784-01ef76af68b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_29e372f1-0fee-4dd8-9734-df38554e39ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_bd033c5c-8bc2-4a23-9784-01ef76af68b9" xlink:to="loc_us-gaap_CreditFacilityDomain_29e372f1-0fee-4dd8-9734-df38554e39ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f6b30fac-f14e-4bf1-9013-2507ba19030b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_29e372f1-0fee-4dd8-9734-df38554e39ef" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f6b30fac-f14e-4bf1-9013-2507ba19030b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d8502167-6d71-45d4-81dd-aed51770d9b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d8502167-6d71-45d4-81dd-aed51770d9b3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d8502167-6d71-45d4-81dd-aed51770d9b3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d8502167-6d71-45d4-81dd-aed51770d9b3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d8502167-6d71-45d4-81dd-aed51770d9b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d8502167-6d71-45d4-81dd-aed51770d9b3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_229eb18c-6b13-4521-9967-2d0898c5701c" xlink:href="rdnt-20201231.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_rdnt_TermLoanMember_229eb18c-6b13-4521-9967-2d0898c5701c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoansAMember_bed7166a-85c3-4edf-8920-2361a863f86e" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienTermLoansAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_rdnt_FirstLienTermLoansAMember_bed7166a-85c3-4edf-8920-2361a863f86e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ed7888b1-989e-4c4d-a196-35d53dacbfdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_us-gaap_LineOfCreditMember_ed7888b1-989e-4c4d-a196-35d53dacbfdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_ee3308c3-c238-418d-87f9-c5a8debecdaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_us-gaap_LetterOfCreditMember_ee3308c3-c238-418d-87f9-c5a8debecdaf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_e9ea7ced-ce91-4a0e-92c0-b49f0fdf7a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_us-gaap_MediumTermNotesMember_e9ea7ced-ce91-4a0e-92c0-b49f0fdf7a90" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_c83a7714-40bd-4495-a799-919bec55e7a5" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_c83a7714-40bd-4495-a799-919bec55e7a5" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans" xlink:type="extended" id="iee3c10acf07647bbb1c0f52f6ebb7697_CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_72a537c4-90ac-42b1-8850-f5ed897af6c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c3d64c45-6220-4bcc-9736-55809df55398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_72a537c4-90ac-42b1-8850-f5ed897af6c4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c3d64c45-6220-4bcc-9736-55809df55398" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9559827f-0a2d-40c3-9c6a-70c5e2f2b41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_72a537c4-90ac-42b1-8850-f5ed897af6c4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9559827f-0a2d-40c3-9c6a-70c5e2f2b41b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c15ebc29-1035-4974-91dd-1ed63d724be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_72a537c4-90ac-42b1-8850-f5ed897af6c4" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c15ebc29-1035-4974-91dd-1ed63d724be6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_056cc0db-e826-40ef-86b2-7c497c077146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_72a537c4-90ac-42b1-8850-f5ed897af6c4" xlink:to="loc_us-gaap_DebtInstrumentTable_056cc0db-e826-40ef-86b2-7c497c077146" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_220d2424-e70b-4cf6-bf20-095199df2806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_056cc0db-e826-40ef-86b2-7c497c077146" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_220d2424-e70b-4cf6-bf20-095199df2806" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_220d2424-e70b-4cf6-bf20-095199df2806_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_220d2424-e70b-4cf6-bf20-095199df2806" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_220d2424-e70b-4cf6-bf20-095199df2806_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e12ae2b8-28cb-4ea3-9a3f-fe73606b745c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_220d2424-e70b-4cf6-bf20-095199df2806" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e12ae2b8-28cb-4ea3-9a3f-fe73606b745c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_fc46a9a7-f1ec-49ea-be43-3ad4783fb6de" xlink:href="rdnt-20201231.xsd#rdnt_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e12ae2b8-28cb-4ea3-9a3f-fe73606b745c" xlink:to="loc_rdnt_TermLoanMember_fc46a9a7-f1ec-49ea-be43-3ad4783fb6de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_09c0d35d-9bcf-4c88-8945-7ed90a7236ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_056cc0db-e826-40ef-86b2-7c497c077146" xlink:to="loc_us-gaap_DebtInstrumentAxis_09c0d35d-9bcf-4c88-8945-7ed90a7236ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_09c0d35d-9bcf-4c88-8945-7ed90a7236ff_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_09c0d35d-9bcf-4c88-8945-7ed90a7236ff" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_09c0d35d-9bcf-4c88-8945-7ed90a7236ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2dede647-143a-4d81-9540-0e8a158d1e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_09c0d35d-9bcf-4c88-8945-7ed90a7236ff" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2dede647-143a-4d81-9540-0e8a158d1e44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_ee833f7c-78a7-4bd2-9e9f-c6d167ad2bbf" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2dede647-143a-4d81-9540-0e8a158d1e44" xlink:to="loc_rdnt_FirstLienTermLoanMember_ee833f7c-78a7-4bd2-9e9f-c6d167ad2bbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_bd59341d-b19e-495f-9e3f-5c2dc631be76" xlink:href="rdnt-20201231.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2dede647-143a-4d81-9540-0e8a158d1e44" xlink:to="loc_rdnt_RestatedAgreementMember_bd59341d-b19e-495f-9e3f-5c2dc631be76" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended" id="ia4ec0cb6dda845e781b686410340b235_CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_9d5594c3-c5b5-4bd2-8466-7b57bb8f008f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_73ed0909-94f8-4f0d-9cb2-a2b6b3e72f4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d5594c3-c5b5-4bd2-8466-7b57bb8f008f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_73ed0909-94f8-4f0d-9cb2-a2b6b3e72f4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d5594c3-c5b5-4bd2-8466-7b57bb8f008f" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8a2426a8-e4ea-4066-a5bd-e8fbb5a79d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8a2426a8-e4ea-4066-a5bd-e8fbb5a79d8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8a2426a8-e4ea-4066-a5bd-e8fbb5a79d8f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a2426a8-e4ea-4066-a5bd-e8fbb5a79d8f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8a2426a8-e4ea-4066-a5bd-e8fbb5a79d8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a33f7269-d6d3-4b72-bbd5-1a3b1122accd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a2426a8-e4ea-4066-a5bd-e8fbb5a79d8f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a33f7269-d6d3-4b72-bbd5-1a3b1122accd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_b533bfc8-e9e2-4c63-9ad3-3b22b9589e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a33f7269-d6d3-4b72-bbd5-1a3b1122accd" xlink:to="loc_us-gaap_LineOfCreditMember_b533bfc8-e9e2-4c63-9ad3-3b22b9589e34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_52137816-7760-4a02-9ef7-9befbbce7355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:to="loc_us-gaap_CreditFacilityAxis_52137816-7760-4a02-9ef7-9befbbce7355" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_52137816-7760-4a02-9ef7-9befbbce7355_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_52137816-7760-4a02-9ef7-9befbbce7355" xlink:to="loc_us-gaap_CreditFacilityDomain_52137816-7760-4a02-9ef7-9befbbce7355_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e81bbb57-7ab8-4cda-a3d2-06f3cb60025a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_52137816-7760-4a02-9ef7-9befbbce7355" xlink:to="loc_us-gaap_CreditFacilityDomain_e81bbb57-7ab8-4cda-a3d2-06f3cb60025a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_17ebcef2-d363-411b-8ae4-cbb9d11a8e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_e81bbb57-7ab8-4cda-a3d2-06f3cb60025a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_17ebcef2-d363-411b-8ae4-cbb9d11a8e03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_95b1e311-8681-4d67-8be0-4d293eebc294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:to="loc_us-gaap_VariableRateAxis_95b1e311-8681-4d67-8be0-4d293eebc294" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_95b1e311-8681-4d67-8be0-4d293eebc294_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_95b1e311-8681-4d67-8be0-4d293eebc294" xlink:to="loc_us-gaap_VariableRateDomain_95b1e311-8681-4d67-8be0-4d293eebc294_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4bbd4627-ed51-45a5-b40a-9f7475f047cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_95b1e311-8681-4d67-8be0-4d293eebc294" xlink:to="loc_us-gaap_VariableRateDomain_4bbd4627-ed51-45a5-b40a-9f7475f047cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_7eda918a-04c5-4545-ad77-b7a9b0c01e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4bbd4627-ed51-45a5-b40a-9f7475f047cf" xlink:to="loc_us-gaap_EurodollarMember_7eda918a-04c5-4545-ad77-b7a9b0c01e58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_ac4d2621-ba6b-4150-b252-2bd8a4511aab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4bbd4627-ed51-45a5-b40a-9f7475f047cf" xlink:to="loc_us-gaap_BaseRateMember_ac4d2621-ba6b-4150-b252-2bd8a4511aab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cfd3d5b1-12c4-4148-9cd0-b76e8f2313a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:to="loc_us-gaap_DebtInstrumentAxis_cfd3d5b1-12c4-4148-9cd0-b76e8f2313a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_cfd3d5b1-12c4-4148-9cd0-b76e8f2313a9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_cfd3d5b1-12c4-4148-9cd0-b76e8f2313a9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_cfd3d5b1-12c4-4148-9cd0-b76e8f2313a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d0ce9cea-88c7-48c0-b2ce-d7223a30dc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_cfd3d5b1-12c4-4148-9cd0-b76e8f2313a9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d0ce9cea-88c7-48c0-b2ce-d7223a30dc5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_823d5845-2afc-4f9d-bdca-46f2daef0546" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d0ce9cea-88c7-48c0-b2ce-d7223a30dc5f" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_823d5845-2afc-4f9d-bdca-46f2daef0546" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_29e18f2a-fe7d-4ff3-85b0-b5e4a76e68e5" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:to="loc_rdnt_LeverageRatioAxis_29e18f2a-fe7d-4ff3-85b0-b5e4a76e68e5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_29e18f2a-fe7d-4ff3-85b0-b5e4a76e68e5_default" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_29e18f2a-fe7d-4ff3-85b0-b5e4a76e68e5" xlink:to="loc_rdnt_LeverageRatioDomain_29e18f2a-fe7d-4ff3-85b0-b5e4a76e68e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_29e18f2a-fe7d-4ff3-85b0-b5e4a76e68e5" xlink:to="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_0cbbc9be-8c5f-44a9-a746-9de989895442" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:to="loc_rdnt_LeverageRatioOneMember_0cbbc9be-8c5f-44a9-a746-9de989895442" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_958ff31b-ebdc-440f-be05-e3458346fd93" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:to="loc_rdnt_LeverageRatioTwoMember_958ff31b-ebdc-440f-be05-e3458346fd93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_b1aad928-1993-4d40-a799-822483f1e6ed" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:to="loc_rdnt_LeverageRatioThreeMember_b1aad928-1993-4d40-a799-822483f1e6ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember_e0517d48-cfa8-4d32-bd65-dbb8b643e8bb" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:to="loc_rdnt_LeverageRatioFourMember_e0517d48-cfa8-4d32-bd65-dbb8b643e8bb" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="extended" id="id043bdb95b7b47b28461af1c38199d6b_CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_a88b89ee-1c22-41d9-bf47-1bfc4885ef47" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_a88b89ee-1c22-41d9-bf47-1bfc4885ef47" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_594791c1-26c8-4f2a-8107-0d16b9656c02" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_594791c1-26c8-4f2a-8107-0d16b9656c02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_93c98be3-02c3-492f-b15b-b65049c921de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_93c98be3-02c3-492f-b15b-b65049c921de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7878a45b-d230-457c-b997-2e24e56f3f4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7878a45b-d230-457c-b997-2e24e56f3f4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_2d1f1f7d-0928-405b-ab8e-e4c0c7c6f3a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_2d1f1f7d-0928-405b-ab8e-e4c0c7c6f3a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:to="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_db5405b5-8aa4-4f12-8d6f-73fd3239c9e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:to="loc_us-gaap_CreditFacilityAxis_db5405b5-8aa4-4f12-8d6f-73fd3239c9e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_db5405b5-8aa4-4f12-8d6f-73fd3239c9e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_db5405b5-8aa4-4f12-8d6f-73fd3239c9e5" xlink:to="loc_us-gaap_CreditFacilityDomain_db5405b5-8aa4-4f12-8d6f-73fd3239c9e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6886ace1-c30a-40e5-bece-4c888fae9181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_db5405b5-8aa4-4f12-8d6f-73fd3239c9e5" xlink:to="loc_us-gaap_CreditFacilityDomain_6886ace1-c30a-40e5-bece-4c888fae9181" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b60ffead-cb2b-4d50-90bc-f2fe144c9f04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6886ace1-c30a-40e5-bece-4c888fae9181" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b60ffead-cb2b-4d50-90bc-f2fe144c9f04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_15e042f5-505e-4af0-a425-bd230691a3ab" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:to="loc_rdnt_LeverageRatioAxis_15e042f5-505e-4af0-a425-bd230691a3ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_15e042f5-505e-4af0-a425-bd230691a3ab_default" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rdnt_LeverageRatioAxis_15e042f5-505e-4af0-a425-bd230691a3ab" xlink:to="loc_rdnt_LeverageRatioDomain_15e042f5-505e-4af0-a425-bd230691a3ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rdnt_LeverageRatioAxis_15e042f5-505e-4af0-a425-bd230691a3ab" xlink:to="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_9158a4de-9f9e-401b-8c9b-73c616db98bb" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:to="loc_rdnt_PricingLevelIMember_9158a4de-9f9e-401b-8c9b-73c616db98bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_7db1289a-02ac-4fe6-a1f8-35f22aeb839b" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:to="loc_rdnt_PricingLevelIIMember_7db1289a-02ac-4fe6-a1f8-35f22aeb839b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_57dbcafa-4e80-4fea-a8f6-2791218a410d" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:to="loc_rdnt_PricingLevelIIIMember_57dbcafa-4e80-4fea-a8f6-2791218a410d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_9ea134b3-c1e1-470d-8e32-25969a6ced6c" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:to="loc_rdnt_PricingLevelIVMember_9ea134b3-c1e1-470d-8e32-25969a6ced6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_bc9730bf-0466-43de-a111-168954d15b15" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:to="loc_rdnt_PricingLevelVMember_bc9730bf-0466-43de-a111-168954d15b15" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f71ab11a-0577-46e1-ba7e-8aa66baa0fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:to="loc_us-gaap_DebtInstrumentAxis_f71ab11a-0577-46e1-ba7e-8aa66baa0fbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f71ab11a-0577-46e1-ba7e-8aa66baa0fbe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f71ab11a-0577-46e1-ba7e-8aa66baa0fbe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f71ab11a-0577-46e1-ba7e-8aa66baa0fbe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ac52e9af-fe2f-4a6e-8dbd-1832fda014c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f71ab11a-0577-46e1-ba7e-8aa66baa0fbe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ac52e9af-fe2f-4a6e-8dbd-1832fda014c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_f6e506f4-c38e-424c-b420-391945aa980f" xlink:href="rdnt-20201231.xsd#rdnt_RestatedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ac52e9af-fe2f-4a6e-8dbd-1832fda014c9" xlink:to="loc_rdnt_RestatedAgreementMember_f6e506f4-c38e-424c-b420-391945aa980f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f7f174fa-c73f-4e77-a930-d6a2a8521937" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:to="loc_us-gaap_VariableRateAxis_f7f174fa-c73f-4e77-a930-d6a2a8521937" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f7f174fa-c73f-4e77-a930-d6a2a8521937_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_f7f174fa-c73f-4e77-a930-d6a2a8521937" xlink:to="loc_us-gaap_VariableRateDomain_f7f174fa-c73f-4e77-a930-d6a2a8521937_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e17a7790-bc45-46ec-9602-ff7751d578f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_f7f174fa-c73f-4e77-a930-d6a2a8521937" xlink:to="loc_us-gaap_VariableRateDomain_e17a7790-bc45-46ec-9602-ff7751d578f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_7f665ca9-9de5-4dd9-86c7-82d89f062bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e17a7790-bc45-46ec-9602-ff7751d578f3" xlink:to="loc_us-gaap_EurodollarMember_7f665ca9-9de5-4dd9-86c7-82d89f062bd8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_61cca58b-78fa-44fb-af6e-2f1b7c433ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_e17a7790-bc45-46ec-9602-ff7751d578f3" xlink:to="loc_us-gaap_BaseRateMember_61cca58b-78fa-44fb-af6e-2f1b7c433ff7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESNotes" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESNotes"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/LEASESNotes" xlink:type="extended" id="if0236316f8e34a8d9741630dc393d00d_LEASESNotes"/>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESTables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/LEASESTables" xlink:type="extended" id="ief5d45237e2d4195b9ab5c37757e7638_LEASESTables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsAdditionalInformation"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="extended" id="i09e63cbd65254ff489de9e3b19eef877_LEASESDetailsAdditionalInformation">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f40bfffb-0eda-4440-98a5-f3ee148b07e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f40bfffb-0eda-4440-98a5-f3ee148b07e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_67de6852-db32-4b60-9900-8373574ab7dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_67de6852-db32-4b60-9900-8373574ab7dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract_b6116388-7ae9-4133-b7ea-2ac25fca61e7" xlink:href="rdnt-20201231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_rdnt_LesseeLeaseTermofContract_b6116388-7ae9-4133-b7ea-2ac25fca61e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_101798b5-dda3-4d81-8ec3-ef0310057ae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_101798b5-dda3-4d81-8ec3-ef0310057ae9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_380e48a7-e3a1-4bf3-be39-9adf15eb0454" xlink:href="rdnt-20201231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_380e48a7-e3a1-4bf3-be39-9adf15eb0454" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_f37584cd-6019-46aa-bbbc-4fbad180fcbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_f37584cd-6019-46aa-bbbc-4fbad180fcbe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4ab17689-b0a7-4c41-9434-08307772a567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4ab17689-b0a7-4c41-9434-08307772a567" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_470f1fab-cbcd-4041-9c3d-d58198a02dd8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4ab17689-b0a7-4c41-9434-08307772a567" xlink:to="loc_srt_RangeAxis_470f1fab-cbcd-4041-9c3d-d58198a02dd8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_470f1fab-cbcd-4041-9c3d-d58198a02dd8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_470f1fab-cbcd-4041-9c3d-d58198a02dd8" xlink:to="loc_srt_RangeMember_470f1fab-cbcd-4041-9c3d-d58198a02dd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1d4fd096-ecf6-4bba-b085-ecb068f795b5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_470f1fab-cbcd-4041-9c3d-d58198a02dd8" xlink:to="loc_srt_RangeMember_1d4fd096-ecf6-4bba-b085-ecb068f795b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ad28b11f-41f3-436a-8a29-7983fb3d19db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1d4fd096-ecf6-4bba-b085-ecb068f795b5" xlink:to="loc_srt_MinimumMember_ad28b11f-41f3-436a-8a29-7983fb3d19db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b01a31c5-c91a-4f1a-b84a-1793c0623b8b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1d4fd096-ecf6-4bba-b085-ecb068f795b5" xlink:to="loc_srt_MaximumMember_b01a31c5-c91a-4f1a-b84a-1793c0623b8b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsLeaseCost"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="extended" id="ife09ee64e8404f96a9dae0881460a07e_LEASESDetailsLeaseCost"/>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsSupplementalCashFlows"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows" xlink:type="extended" id="i3b3ba53195c443fa8d5ce26b2f878a62_LEASESDetailsSupplementalCashFlows"/>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsSupplementalBalanceSheet"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="extended" id="i2aefb52a3c8a44f7a572c03e5cef0842_LEASESDetailsSupplementalBalanceSheet"/>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="extended" id="i4bf36ced93da4f00b04da75df5f3b350_LEASESDetailsMaturitiesofOperatingandFinanceLease"/>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXES" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXES"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/INCOMETAXES" xlink:type="extended" id="ifd682b71fc7a4784a81b07fcebd8d8cb_INCOMETAXES"/>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESTables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="extended" id="i44ed3e9d4b024cb89ca1ec6325d02550_INCOMETAXESTables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsIncometaxexpense"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense" xlink:type="extended" id="i5719605dd47d4dc79ca639e692870be7_INCOMETAXESDetailsIncometaxexpense"/>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" xlink:type="extended" id="i4fa91bab15bc40b990793fdeff642f87_INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"/>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="extended" id="i97ad306337434d5da4f89979b1492423_INCOMETAXESDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_5e5149e1-d705-42ab-8b8c-ddb04fd06bad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_us-gaap_OperatingLossCarryforwards_5e5149e1-d705-42ab-8b8c-ddb04fd06bad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_a1724108-a8cf-45f7-bdcf-8e4fa179192f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_a1724108-a8cf-45f7-bdcf-8e4fa179192f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_aa715392-05b8-489a-b4c2-775306a02ff0" xlink:href="rdnt-20201231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_aa715392-05b8-489a-b4c2-775306a02ff0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_2ea81f2e-9ab6-4c4c-9d22-9bf451dc9eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_2ea81f2e-9ab6-4c4c-9d22-9bf451dc9eeb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_3d9f5e4f-ebcd-41bd-b5c6-07d7f1cfdc56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_3d9f5e4f-ebcd-41bd-b5c6-07d7f1cfdc56" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_ab982d3d-2e06-40c1-9b78-8d270328fa59" xlink:href="rdnt-20201231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_ab982d3d-2e06-40c1-9b78-8d270328fa59" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_8ac3a32a-12fc-41f7-8591-bd369c2f6064" xlink:href="rdnt-20201231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_8ac3a32a-12fc-41f7-8591-bd369c2f6064" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6195ab37-848d-455a-b567-f8bafcc87c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6195ab37-848d-455a-b567-f8bafcc87c47" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_4bac80b3-9233-4e73-b9fd-a366b92c9334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_4bac80b3-9233-4e73-b9fd-a366b92c9334" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bfa3b86a-f5c2-4a7c-8836-bdd3c0932e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_4bac80b3-9233-4e73-b9fd-a366b92c9334" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bfa3b86a-f5c2-4a7c-8836-bdd3c0932e2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bfa3b86a-f5c2-4a7c-8836-bdd3c0932e2c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bfa3b86a-f5c2-4a7c-8836-bdd3c0932e2c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bfa3b86a-f5c2-4a7c-8836-bdd3c0932e2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60e83797-0a93-400d-85f1-108b9eacac73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bfa3b86a-f5c2-4a7c-8836-bdd3c0932e2c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60e83797-0a93-400d-85f1-108b9eacac73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember_d693e9f1-7fad-4ae5-bf46-2aaa37aeed82" xlink:href="rdnt-20201231.xsd#rdnt_RavenHoldingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60e83797-0a93-400d-85f1-108b9eacac73" xlink:to="loc_rdnt_RavenHoldingsMember_d693e9f1-7fad-4ae5-bf46-2aaa37aeed82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_4dc2a55d-6022-492c-95dd-bcdaabfd252d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_4bac80b3-9233-4e73-b9fd-a366b92c9334" xlink:to="loc_us-gaap_TaxPeriodAxis_4dc2a55d-6022-492c-95dd-bcdaabfd252d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_4dc2a55d-6022-492c-95dd-bcdaabfd252d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_4dc2a55d-6022-492c-95dd-bcdaabfd252d" xlink:to="loc_us-gaap_TaxPeriodDomain_4dc2a55d-6022-492c-95dd-bcdaabfd252d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_6bdc226a-dcb7-492b-955f-1560d5db8002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_4dc2a55d-6022-492c-95dd-bcdaabfd252d" xlink:to="loc_us-gaap_TaxPeriodDomain_6bdc226a-dcb7-492b-955f-1560d5db8002" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2018Member_a7bb1170-7607-4fd7-978e-cf3da68a47e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxYear2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_6bdc226a-dcb7-492b-955f-1560d5db8002" xlink:to="loc_us-gaap_TaxYear2018Member_a7bb1170-7607-4fd7-978e-cf3da68a47e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_3327190a-843f-47af-be01-29354eae5832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_4bac80b3-9233-4e73-b9fd-a366b92c9334" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_3327190a-843f-47af-be01-29354eae5832" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_3327190a-843f-47af-be01-29354eae5832_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3327190a-843f-47af-be01-29354eae5832" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_3327190a-843f-47af-be01-29354eae5832_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e3d657bf-c37f-4ce9-85ae-3c498abd6c31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3327190a-843f-47af-be01-29354eae5832" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_e3d657bf-c37f-4ce9-85ae-3c498abd6c31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_7c3ce73b-c980-4a49-9bf8-c3324b6afe6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e3d657bf-c37f-4ce9-85ae-3c498abd6c31" xlink:to="loc_us-gaap_DomesticCountryMember_7c3ce73b-c980-4a49-9bf8-c3324b6afe6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_7a1ebf8d-3a2d-40a3-a254-fd2b4a8242cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e3d657bf-c37f-4ce9-85ae-3c498abd6c31" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_7a1ebf8d-3a2d-40a3-a254-fd2b4a8242cc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities" xlink:type="simple" xlink:href="rdnt-20201231.xsd#NCOMETAXESDetailsDeferredtaxassetsandliabilities"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities" xlink:type="extended" id="id45b4141156446bfac2b3be02128711c_NCOMETAXESDetailsDeferredtaxassetsandliabilities"/>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsUnrecognizedtaxbenefit"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit" xlink:type="extended" id="i67ce3cb33a4146bbb6b2ef817d4289f5_INCOMETAXESDetailsUnrecognizedtaxbenefit"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended" id="i12c8e8a93a7c4c1ca3a08df4fffb0858_STOCKBASEDCOMPENSATION"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended" id="i119b67e333ac4075a4c620045abfefb3_STOCKBASEDCOMPENSATIONTables"/>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended" id="ib4a0ded0d1cb4513a15ec15af50a5b24_STOCKBASEDCOMPENSATIONDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c6d4a3db-4426-4e16-859a-c10e5272e8de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c6d4a3db-4426-4e16-859a-c10e5272e8de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b77259fa-d370-4d74-820f-c66702493d5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b77259fa-d370-4d74-820f-c66702493d5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6947c275-6c37-4ff9-8469-76176b28d86d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6947c275-6c37-4ff9-8469-76176b28d86d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c4f9f33-d33c-4163-b08a-c0eb279abd85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c4f9f33-d33c-4163-b08a-c0eb279abd85" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_caca8a87-6594-4576-9997-4c177f253d11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_caca8a87-6594-4576-9997-4c177f253d11" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_21a607a5-e696-4bf3-b52c-0d53f83bc33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_21a607a5-e696-4bf3-b52c-0d53f83bc33e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_42684bf4-72a6-447f-bd59-33113905b9b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_42684bf4-72a6-447f-bd59-33113905b9b2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_96176883-021a-4615-a86a-359236b6d2dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_96176883-021a-4615-a86a-359236b6d2dd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6182a180-f3f0-4e7b-ade9-a973977ded39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6182a180-f3f0-4e7b-ade9-a973977ded39" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AwardsIssuedToDate_2d2e67c0-3b9f-4e96-9f65-6e10356dc744" xlink:href="rdnt-20201231.xsd#rdnt_AwardsIssuedToDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_rdnt_AwardsIssuedToDate_2d2e67c0-3b9f-4e96-9f65-6e10356dc744" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_24ee610e-3e16-4439-97f2-d8dd8a33acc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_24ee610e-3e16-4439-97f2-d8dd8a33acc8" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e3088b57-a530-459b-be17-903a0ed1f2fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e3088b57-a530-459b-be17-903a0ed1f2fc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5773c8bf-5857-4cde-8be3-f810f808f538" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5773c8bf-5857-4cde-8be3-f810f808f538" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_dab537f1-7d79-49be-bd12-4626643e973b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_dab537f1-7d79-49be-bd12-4626643e973b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_886fc893-a428-41e3-ae7c-36ad570a9af1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_886fc893-a428-41e3-ae7c-36ad570a9af1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_53994aba-ae66-4423-8a81-83f7f3f33e52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_53994aba-ae66-4423-8a81-83f7f3f33e52" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_40a09dbd-bc33-4bb3-a781-d7de595ac075" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_40a09dbd-bc33-4bb3-a781-d7de595ac075" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40a09dbd-bc33-4bb3-a781-d7de595ac075_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_40a09dbd-bc33-4bb3-a781-d7de595ac075" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_40a09dbd-bc33-4bb3-a781-d7de595ac075_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed584d0e-45f9-41eb-9382-ffca8227708b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_40a09dbd-bc33-4bb3-a781-d7de595ac075" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed584d0e-45f9-41eb-9382-ffca8227708b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_73d129e5-4573-4019-8a83-d426805b1b24" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed584d0e-45f9-41eb-9382-ffca8227708b" xlink:to="loc_rdnt_DeepHealthIncMember_73d129e5-4573-4019-8a83-d426805b1b24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_03dd3eb9-8993-489f-8e4a-e70318b52b9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:to="loc_us-gaap_PlanNameAxis_03dd3eb9-8993-489f-8e4a-e70318b52b9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_03dd3eb9-8993-489f-8e4a-e70318b52b9b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_03dd3eb9-8993-489f-8e4a-e70318b52b9b" xlink:to="loc_us-gaap_PlanNameDomain_03dd3eb9-8993-489f-8e4a-e70318b52b9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fcad15c7-1e60-489f-89e5-3417eca41f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_03dd3eb9-8993-489f-8e4a-e70318b52b9b" xlink:to="loc_us-gaap_PlanNameDomain_fcad15c7-1e60-489f-89e5-3417eca41f93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_9ed1d281-21ab-4a3b-b6eb-649f61f412f4" xlink:href="rdnt-20201231.xsd#rdnt_RestatedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fcad15c7-1e60-489f-89e5-3417eca41f93" xlink:to="loc_rdnt_RestatedPlanMember_9ed1d281-21ab-4a3b-b6eb-649f61f412f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1a3dba60-c91e-4d25-8ffb-34ca7198e92a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:to="loc_us-gaap_AwardTypeAxis_1a3dba60-c91e-4d25-8ffb-34ca7198e92a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1a3dba60-c91e-4d25-8ffb-34ca7198e92a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_1a3dba60-c91e-4d25-8ffb-34ca7198e92a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1a3dba60-c91e-4d25-8ffb-34ca7198e92a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f77645b2-8f0a-4b1b-b7dd-d655c4bb475e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_1a3dba60-c91e-4d25-8ffb-34ca7198e92a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f77645b2-8f0a-4b1b-b7dd-d655c4bb475e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_f86bc376-db9a-42f8-9f31-f4fa19481186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f77645b2-8f0a-4b1b-b7dd-d655c4bb475e" xlink:to="loc_us-gaap_StockOptionMember_f86bc376-db9a-42f8-9f31-f4fa19481186" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_d999fbd1-6d66-4a22-8956-1b0c836bd319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f77645b2-8f0a-4b1b-b7dd-d655c4bb475e" xlink:to="loc_us-gaap_RestrictedStockMember_d999fbd1-6d66-4a22-8956-1b0c836bd319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_18ebf882-0433-44d9-9ba4-522f120ca443" xlink:href="rdnt-20201231.xsd#rdnt_FutureServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f77645b2-8f0a-4b1b-b7dd-d655c4bb475e" xlink:to="loc_rdnt_FutureServiceMember_18ebf882-0433-44d9-9ba4-522f120ca443" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fbcf9c2a-83a7-41ac-8f8b-71c244f25dbc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:to="loc_srt_RangeAxis_fbcf9c2a-83a7-41ac-8f8b-71c244f25dbc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fbcf9c2a-83a7-41ac-8f8b-71c244f25dbc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fbcf9c2a-83a7-41ac-8f8b-71c244f25dbc" xlink:to="loc_srt_RangeMember_fbcf9c2a-83a7-41ac-8f8b-71c244f25dbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f1a6334-ac99-445e-9f63-382c49bf40a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fbcf9c2a-83a7-41ac-8f8b-71c244f25dbc" xlink:to="loc_srt_RangeMember_6f1a6334-ac99-445e-9f63-382c49bf40a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1386346f-a4c9-4756-9219-d26143ecbb5f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f1a6334-ac99-445e-9f63-382c49bf40a6" xlink:to="loc_srt_MinimumMember_1386346f-a4c9-4756-9219-d26143ecbb5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e3ff588-c55f-4886-82d2-9a772a63d45a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6f1a6334-ac99-445e-9f63-382c49bf40a6" xlink:to="loc_srt_MaximumMember_9e3ff588-c55f-4886-82d2-9a772a63d45a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended" id="i2fda14a0e7d048c5baf8165526b59f3c_STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a63ba56-5749-4387-808f-4e65c7c6c565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a63ba56-5749-4387-808f-4e65c7c6c565" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_586cbfe5-c9c7-48ee-a069-ac4296d05a11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a63ba56-5749-4387-808f-4e65c7c6c565" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_586cbfe5-c9c7-48ee-a069-ac4296d05a11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72cd88b6-4ca8-4d8e-9c92-7fc2a95e7d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a63ba56-5749-4387-808f-4e65c7c6c565" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72cd88b6-4ca8-4d8e-9c92-7fc2a95e7d02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0d5961f9-91d8-44cf-beaa-083ed10bf792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a63ba56-5749-4387-808f-4e65c7c6c565" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0d5961f9-91d8-44cf-beaa-083ed10bf792" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1704f878-446f-4bc7-baef-310bfb4d9ab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_271b7acf-b43b-4f77-9678-1cef18caffc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_271b7acf-b43b-4f77-9678-1cef18caffc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ad50259f-0573-4cf9-92b3-5d7ccf004f00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ad50259f-0573-4cf9-92b3-5d7ccf004f00" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_65346056-e4c2-4391-a2f9-e160049d0059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ad50259f-0573-4cf9-92b3-5d7ccf004f00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_65346056-e4c2-4391-a2f9-e160049d0059" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ad6ea65f-68a9-42d7-aa9c-e71ad98a92e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ad50259f-0573-4cf9-92b3-5d7ccf004f00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ad6ea65f-68a9-42d7-aa9c-e71ad98a92e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0dfa061c-f215-489a-a2fa-26f4ddc57b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a34531a5-f478-478f-8808-d9c9b250e0ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a34531a5-f478-478f-8808-d9c9b250e0ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_a29eb070-da7b-40b3-9d95-ebfe28296a49" xlink:href="rdnt-20201231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_a29eb070-da7b-40b3-9d95-ebfe28296a49" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d7154977-569d-4355-ab15-16bd7ae33d3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_a29eb070-da7b-40b3-9d95-ebfe28296a49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d7154977-569d-4355-ab15-16bd7ae33d3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7fcf5675-8db6-49ba-87b4-be74c8e6d12f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_a29eb070-da7b-40b3-9d95-ebfe28296a49" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7fcf5675-8db6-49ba-87b4-be74c8e6d12f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_3cb683c3-e10b-4e15-b1d6-356b2cb68d0e" xlink:href="rdnt-20201231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_rdnt_AggregateIntrinsicValue_3cb683c3-e10b-4e15-b1d6-356b2cb68d0e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_85de7548-c930-431f-8622-ff4b5a9e1cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_3cb683c3-e10b-4e15-b1d6-356b2cb68d0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_85de7548-c930-431f-8622-ff4b5a9e1cc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_b115f3f9-cb49-4cae-8ab9-d9b97d6a34fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rdnt_AggregateIntrinsicValue_3cb683c3-e10b-4e15-b1d6-356b2cb68d0e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_b115f3f9-cb49-4cae-8ab9-d9b97d6a34fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c53e4fd6-0e95-444a-95f8-59d0d88a0f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c53e4fd6-0e95-444a-95f8-59d0d88a0f6b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_75978cf0-2c01-4ebb-92a0-7b43f2679ee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c53e4fd6-0e95-444a-95f8-59d0d88a0f6b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_75978cf0-2c01-4ebb-92a0-7b43f2679ee2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75978cf0-2c01-4ebb-92a0-7b43f2679ee2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_75978cf0-2c01-4ebb-92a0-7b43f2679ee2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_75978cf0-2c01-4ebb-92a0-7b43f2679ee2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16f760c5-f68c-473d-9280-3325be6c5717" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_75978cf0-2c01-4ebb-92a0-7b43f2679ee2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16f760c5-f68c-473d-9280-3325be6c5717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_ad75aabb-88d2-45d4-a28f-206de27d287f" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16f760c5-f68c-473d-9280-3325be6c5717" xlink:to="loc_rdnt_DeepHealthInc.Member_ad75aabb-88d2-45d4-a28f-206de27d287f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_94a9e389-0126-42b4-8d98-be232f800602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c53e4fd6-0e95-444a-95f8-59d0d88a0f6b" xlink:to="loc_us-gaap_AwardTypeAxis_94a9e389-0126-42b4-8d98-be232f800602" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_94a9e389-0126-42b4-8d98-be232f800602_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_94a9e389-0126-42b4-8d98-be232f800602" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_94a9e389-0126-42b4-8d98-be232f800602_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98dcae35-2df5-4702-9a3f-3fbe08eacd5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_94a9e389-0126-42b4-8d98-be232f800602" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98dcae35-2df5-4702-9a3f-3fbe08eacd5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_51f074e0-b51b-43a3-965e-f8e5561ecfbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98dcae35-2df5-4702-9a3f-3fbe08eacd5c" xlink:to="loc_us-gaap_StockOptionMember_51f074e0-b51b-43a3-965e-f8e5561ecfbe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONDetailsRSUs"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="extended" id="ib139f9ef83004857b7851f679547a12d_STOCKBASEDCOMPENSATIONDetailsRSUs">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_880051c8-5225-4ce7-93ef-34aca5d427d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_32f97ad2-5f4a-47f5-976d-7f310b6ecc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_880051c8-5225-4ce7-93ef-34aca5d427d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_32f97ad2-5f4a-47f5-976d-7f310b6ecc8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_11428136-2904-443d-b6bc-17bcd85b15ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_32f97ad2-5f4a-47f5-976d-7f310b6ecc8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_11428136-2904-443d-b6bc-17bcd85b15ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_01bc2df7-c08d-40b8-97a3-2924faddb858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_32f97ad2-5f4a-47f5-976d-7f310b6ecc8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_01bc2df7-c08d-40b8-97a3-2924faddb858" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d1706981-d0e5-41a7-9471-b5650ef27222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_32f97ad2-5f4a-47f5-976d-7f310b6ecc8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d1706981-d0e5-41a7-9471-b5650ef27222" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_4e2ad2ec-796b-4f4e-924c-316c5d079327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_4f43c735-dac0-44c2-a247-a786903fc285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_880051c8-5225-4ce7-93ef-34aca5d427d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_4f43c735-dac0-44c2-a247-a786903fc285" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7414a566-5cbb-44ec-be1f-5d099e068378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_880051c8-5225-4ce7-93ef-34aca5d427d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7414a566-5cbb-44ec-be1f-5d099e068378" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_37233333-e145-4d85-893e-719cf4b3bcd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7414a566-5cbb-44ec-be1f-5d099e068378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_37233333-e145-4d85-893e-719cf4b3bcd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1215f30e-35f9-44a8-8605-8b2ff58c2bc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7414a566-5cbb-44ec-be1f-5d099e068378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1215f30e-35f9-44a8-8605-8b2ff58c2bc3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_913deb4e-63dc-48c0-8b18-2686d90ccc5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7414a566-5cbb-44ec-be1f-5d099e068378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_913deb4e-63dc-48c0-8b18-2686d90ccc5b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a0699c53-f58d-4d86-941f-288d58f762da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e91125c-c50d-4255-8d86-0001f89ad322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_880051c8-5225-4ce7-93ef-34aca5d427d0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e91125c-c50d-4255-8d86-0001f89ad322" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8534d9de-b6ae-4f04-b763-39f73217c494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e91125c-c50d-4255-8d86-0001f89ad322" xlink:to="loc_us-gaap_AwardTypeAxis_8534d9de-b6ae-4f04-b763-39f73217c494" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8534d9de-b6ae-4f04-b763-39f73217c494_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8534d9de-b6ae-4f04-b763-39f73217c494" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8534d9de-b6ae-4f04-b763-39f73217c494_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b227edb-84bd-4fd2-9406-fbc80220840f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8534d9de-b6ae-4f04-b763-39f73217c494" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b227edb-84bd-4fd2-9406-fbc80220840f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ffb84282-746e-4726-965a-a75f508de9b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b227edb-84bd-4fd2-9406-fbc80220840f" xlink:to="loc_us-gaap_RestrictedStockMember_ffb84282-746e-4726-965a-a75f508de9b6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUBSEQUENTEVENTS"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="extended" id="ic38acf0d4a594c818060e886b8bbf8c8_SUBSEQUENTEVENTS"/>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUBSEQUENTEVENTSDetailsNarrative"/>
  <link:definitionLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative" xlink:type="extended" id="i65ac025e1d7f41fe9bdcd86b370f9154_SUBSEQUENTEVENTSDetailsNarrative">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_71db9126-21e0-4881-b347-25efd0937e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_71db9126-21e0-4881-b347-25efd0937e8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_6534fae0-9485-44c4-9393-85f29867419a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_6534fae0-9485-44c4-9393-85f29867419a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_25e0ef39-ecac-4641-850d-353807c0190a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_25e0ef39-ecac-4641-850d-353807c0190a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0ed2370e-d95c-4212-be19-f217d0647d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0ed2370e-d95c-4212-be19-f217d0647d96" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct_57a3aee2-9a87-41b9-b2fe-141168dae714" xlink:href="rdnt-20201231.xsd#rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:to="loc_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct_57a3aee2-9a87-41b9-b2fe-141168dae714" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:to="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b835e220-b534-49d2-8dd7-61e1e9f864c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b835e220-b534-49d2-8dd7-61e1e9f864c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b835e220-b534-49d2-8dd7-61e1e9f864c6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b835e220-b534-49d2-8dd7-61e1e9f864c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b835e220-b534-49d2-8dd7-61e1e9f864c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1494bb4a-123d-426a-9c87-015b225d6db5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b835e220-b534-49d2-8dd7-61e1e9f864c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1494bb4a-123d-426a-9c87-015b225d6db5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPCompaniesMember_5b4d775d-f7d1-427b-a134-3aa90455ab63" xlink:href="rdnt-20201231.xsd#rdnt_ZPCompaniesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1494bb4a-123d-426a-9c87-015b225d6db5" xlink:to="loc_rdnt_ZPCompaniesMember_5b4d775d-f7d1-427b-a134-3aa90455ab63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a0f6946a-cd5a-43a0-822f-2c1ef7f1bf0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a0f6946a-cd5a-43a0-822f-2c1ef7f1bf0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a0f6946a-cd5a-43a0-822f-2c1ef7f1bf0d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a0f6946a-cd5a-43a0-822f-2c1ef7f1bf0d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a0f6946a-cd5a-43a0-822f-2c1ef7f1bf0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a75ccdfc-32c9-4708-b753-558d962bb24f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a0f6946a-cd5a-43a0-822f-2c1ef7f1bf0d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a75ccdfc-32c9-4708-b753-558d962bb24f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d63815c2-b932-4bdb-a10a-a8fc7b820644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a75ccdfc-32c9-4708-b753-558d962bb24f" xlink:to="loc_us-gaap_SubsequentEventMember_d63815c2-b932-4bdb-a10a-a8fc7b820644" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_496f9537-e239-431c-ae2d-439030db5e9a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:to="loc_dei_LegalEntityAxis_496f9537-e239-431c-ae2d-439030db5e9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_496f9537-e239-431c-ae2d-439030db5e9a_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_496f9537-e239-431c-ae2d-439030db5e9a" xlink:to="loc_dei_EntityDomain_496f9537-e239-431c-ae2d-439030db5e9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9daffd36-f6b8-44d7-a42e-3bfa10319285" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_496f9537-e239-431c-ae2d-439030db5e9a" xlink:to="loc_dei_EntityDomain_9daffd36-f6b8-44d7-a42e-3bfa10319285" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_5e1e649c-0349-45a9-8f23-8983ecc66f3b" xlink:href="rdnt-20201231.xsd#rdnt_SimiAdventistMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9daffd36-f6b8-44d7-a42e-3bfa10319285" xlink:to="loc_rdnt_SimiAdventistMember_5e1e649c-0349-45a9-8f23-8983ecc66f3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_baade897-538b-4c3c-9261-5913e7e6c651" xlink:href="rdnt-20201231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9daffd36-f6b8-44d7-a42e-3bfa10319285" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_baade897-538b-4c3c-9261-5913e7e6c651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d7e67fb1-d1a6-486a-aeac-813e2440f6ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:to="loc_srt_OwnershipAxis_d7e67fb1-d1a6-486a-aeac-813e2440f6ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_d7e67fb1-d1a6-486a-aeac-813e2440f6ba_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_d7e67fb1-d1a6-486a-aeac-813e2440f6ba" xlink:to="loc_srt_OwnershipDomain_d7e67fb1-d1a6-486a-aeac-813e2440f6ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_45e3077e-ad1c-4c74-883f-84326f3ff643" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_d7e67fb1-d1a6-486a-aeac-813e2440f6ba" xlink:to="loc_srt_OwnershipDomain_45e3077e-ad1c-4c74-883f-84326f3ff643" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_81356e34-d42b-4c40-84d3-3add3e23e709" xlink:href="rdnt-20201231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_45e3077e-ad1c-4c74-883f-84326f3ff643" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_81356e34-d42b-4c40-84d3-3add3e23e709" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>rdnt-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:cd605a11-4611-4df1-b35a-84491793f997,g:2afe2a05-cf4e-4f48-9c2a-eb0c739eec8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f466fa16-8ee0-4ed1-9549-2f6bfa780f74_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ImagingOnCallMember_046ed2c8-1f4b-40d3-848f-9161ec1dc004_verboseLabel_en-US" xlink:label="lab_rdnt_ImagingOnCallMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging on call and software</link:label>
    <link:label id="lab_rdnt_ImagingOnCallMember_b216ecbb-4091-4e02-8d4c-1073bbf8cbec_terseLabel_en-US" xlink:label="lab_rdnt_ImagingOnCallMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging On Call</link:label>
    <link:label id="lab_rdnt_ImagingOnCallMember_label_en-US" xlink:label="lab_rdnt_ImagingOnCallMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging On Call [Member]</link:label>
    <link:label id="lab_rdnt_ImagingOnCallMember_documentation_en-US" xlink:label="lab_rdnt_ImagingOnCallMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Imaging On Call [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember" xlink:href="rdnt-20201231.xsd#rdnt_ImagingOnCallMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ImagingOnCallMember" xlink:to="lab_rdnt_ImagingOnCallMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_06cb41e1-d601-4e12-a80d-56c96d91421a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_f9d34d6e-f3b8-4e1b-819d-9afe2e2d17e0_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment No. 7 First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Seventh Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSeventhAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIMember_6c598603-7f73-4bf3-b42e-f8fb8384c84f_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIMember" xlink:to="lab_rdnt_PricingLevelIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_497e85f8-41ee-4c9d-a2ee-8d858ba4bc79_terseLabel_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical malpractice deductible per incidence</link:label>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_label_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical malpractice deductible per incidence</link:label>
    <link:label id="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence_documentation_en-US" xlink:label="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical malpractice deductible per incidence</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:href="rdnt-20201231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:to="lab_rdnt_MedicalMalpracticeDeductiblePerIncidence" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_948793ff-6020-4bde-b827-15200e880b00_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_9477e9af-42d1-4f33-a588-35ef4652d888_terseLabel_en-US" xlink:label="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorneys Office For The Western District of New York</link:label>
    <link:label id="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_label_en-US" xlink:label="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorneys Office For The Western District of New York [Member]</link:label>
    <link:label id="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_documentation_en-US" xlink:label="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Attorneys Office For The Western District of New York [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:href="rdnt-20201231.xsd#rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:to="lab_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_93a3bfa2-0e63-4850-9a8c-470dd2613cd1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNoncurrentNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Noncurrent, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNoncurrentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_61832ede-77f7-49e4-8747-de1e0aecd468_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsGross_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsGross" xlink:to="lab_us-gaap_DeferredFinanceCostsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_3ce75eeb-9e2b-4f24-82c6-bab45441a6a3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFTWARE DEVELOPMENT COSTS</link:label>
    <link:label id="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research, Development, and Computer Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:to="lab_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_9450dd0d-c991-4cc2-ac7a-8d47234fe84c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3fbc1f31-7b77-459c-9d44-196956337e71_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_173c87e9-25b5-480a-a680-4e89b89a088d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_f4513a60-9324-4142-9541-1929e124f5c9_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial ownership percentage after dilution</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Initial Ownership Percentage After Dilution</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Initial Ownership Percentage After Dilution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:to="lab_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_7cde434e-bc91-4aa0-a6b7-12291b77480d_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfavorable lease contracts acquired, gross</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts, Gross</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_eb78b3bf-a0a1-439d-8634-a9040bca8897_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions paid to noncontrolling&#160;interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_7989f9d6-f4cf-44b9-bfb8-57bd4c098071_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation of leased equipment</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_3edc6742-7f5a-4f64-a4cc-6a57ad00d2f2_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_1cdfc1a2-605d-41bb-8a50-5264514ca0d8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment at cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DevelopedtechnologyMember_52d9a722-fd50-414e-a128-89f60e932f8c_terseLabel_en-US" xlink:label="lab_rdnt_DevelopedtechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology</link:label>
    <link:label id="lab_rdnt_DevelopedtechnologyMember_label_en-US" xlink:label="lab_rdnt_DevelopedtechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology [Member]</link:label>
    <link:label id="lab_rdnt_DevelopedtechnologyMember_documentation_en-US" xlink:label="lab_rdnt_DevelopedtechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedtechnologyMember" xlink:href="rdnt-20201231.xsd#rdnt_DevelopedtechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DevelopedtechnologyMember" xlink:to="lab_rdnt_DevelopedtechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_e0ee775b-6e56-4ec8-a803-3834e9a2af5d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_07dac0cc-214e-4ba0-9fb2-420f47e391bd_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember_17289bc5-137d-41f3-a440-a94e7aa32845_terseLabel_en-US" xlink:label="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beverly Radiology Medical Group III</link:label>
    <link:label id="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember_label_en-US" xlink:label="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beverly Radiology Medical Group III [Member]</link:label>
    <link:label id="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember_documentation_en-US" xlink:label="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beverly Radiology Medical Group III [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:href="rdnt-20201231.xsd#rdnt_BeverlyRadiologyMedicalGroupIIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:to="lab_rdnt_BeverlyRadiologyMedicalGroupIIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_94df7fab-af52-4729-b16e-3912c9c52e6b_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_18bf6ff9-019f-46fb-8b88-374227a4b388_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a2b459af-a7ad-4e63-a994-ab61a6d4939e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_67dd999b-15fb-4cf2-8aa9-22ebc6286c67_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_a81bb309-b619-4ab4-a41c-bf4d673ee373_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssets_2b1da70c-b0cd-4e5e-a7e3-34fb2940cb53_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits and other</link:label>
    <link:label id="lab_us-gaap_DepositsAssets_label_en-US" xlink:label="lab_us-gaap_DepositsAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposits Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssets" xlink:to="lab_us-gaap_DepositsAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_78ec2821-f785-4746-b2c0-9a7ccd986b7f_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2616eb2d-1729-4e20-8b1d-944c858d8821_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3007d2c9-7e7b-49c1-aa43-ff259927ff45_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_0801d099-9a75-4ddd-b727-75efe4382b3e_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_45465b53-9cf4-4f41-a60d-8b85f96d9b84_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_2add2c81-9961-41fd-80a0-9999455e5e36_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under the equity compensation plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_a080a347-a4a6-4450-ae85-207c221862c9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_667ff08d-ca43-457e-986c-16e324d1c777_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_9b480df3-0a86-43fd-ae85-5bcc88657e52_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_5e6028a0-5644-4a09-8304-825b5eeabcc5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CARESActDisclosurePolicyPolicyTextBlock_3e0139f4-ff3e-4742-8f8c-d016efb9ef1d_terseLabel_en-US" xlink:label="lab_rdnt_CARESActDisclosurePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 PANDEMIC AND CARES ACT FUNDING</link:label>
    <link:label id="lab_rdnt_CARESActDisclosurePolicyPolicyTextBlock_label_en-US" xlink:label="lab_rdnt_CARESActDisclosurePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act Disclosure Policy [Policy Text Block]</link:label>
    <link:label id="lab_rdnt_CARESActDisclosurePolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_rdnt_CARESActDisclosurePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARES Act Disclosure Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CARESActDisclosurePolicyPolicyTextBlock" xlink:href="rdnt-20201231.xsd#rdnt_CARESActDisclosurePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CARESActDisclosurePolicyPolicyTextBlock" xlink:to="lab_rdnt_CARESActDisclosurePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_8624a134-3306-4661-83ee-0ee5a5bd1c70_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_6b97adaf-eec7-4de1-84cc-8ebed2b1c294_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_a87ada00-5245-4147-9029-351edee47c3e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_062517d0-7613-4afe-bdfe-fd535413906f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_88595543-6638-4fbc-8a64-3ee84e4c68c0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing and purchase of interest in joint ventures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_f50a4c52-2335-4c90-904a-30b1105865a9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire additional interest in subsidiaries</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalEquipmentMember_13b40dec-aaa1-43ef-89e0-e40fbe3f190a_terseLabel_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment</link:label>
    <link:label id="lab_rdnt_MedicalEquipmentMember_label_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Member]</link:label>
    <link:label id="lab_rdnt_MedicalEquipmentMember_documentation_en-US" xlink:label="lab_rdnt_MedicalEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember" xlink:href="rdnt-20201231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalEquipmentMember" xlink:to="lab_rdnt_MedicalEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1e14a138-20f9-4890-a62f-23b76a87d2d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bf2e227e-d1a1-4afb-aef4-a47a04ad2c78_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3d8bf027-7e2f-4036-b1fa-83da0ebb48bc_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss_d4dd80aa-0f32-46dd-80b3-a3e55000ed9c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest acquiree remeasurement loss</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_ec6b5764-f6b8-4f8c-a35b-ae49232b4ae2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_ad5042eb-5d16-447b-8cf5-07a06adda922_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_2820d751-9e1f-4212-8856-ee2fb8dbded4_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total notes payable obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicaid1Member_0da54785-3c68-4e6c-aee5-de36b60678f6_terseLabel_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_label_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicaid1Member_documentation_en-US" xlink:label="lab_rdnt_Medicaid1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member" xlink:href="rdnt-20201231.xsd#rdnt_Medicaid1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicaid1Member" xlink:to="lab_rdnt_Medicaid1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_52bdd035-edf0-4e95-9e5f-a8e1b5de670b_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_2e13a19f-4664-4673-875d-469b80bb76aa_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeepHealthInc.Member_af0c9537-5d98-440a-9128-03889bc07a85_terseLabel_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc.</link:label>
    <link:label id="lab_rdnt_DeepHealthInc.Member_label_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:label id="lab_rdnt_DeepHealthInc.Member_documentation_en-US" xlink:label="lab_rdnt_DeepHealthInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeepHealthInc.Member" xlink:to="lab_rdnt_DeepHealthInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedAgreementMember_908bf0b9-b948-4570-ab6a-c0c9b49afd88_verboseLabel_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_69a2daca-722e-47ec-b575-d5e40f157c9b_terseLabel_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_label_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:label id="lab_rdnt_RestatedAgreementMember_documentation_en-US" xlink:label="lab_rdnt_RestatedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember" xlink:href="rdnt-20201231.xsd#rdnt_RestatedAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedAgreementMember" xlink:to="lab_rdnt_RestatedAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenue_949feee8-938f-4286-b59b-cb9db8914428_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenue_label_en-US" xlink:label="lab_us-gaap_DeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenue" xlink:to="lab_us-gaap_DeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_33fce199-4c6b-492b-9d40-ad811db481cd_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_86b90d4c-76e0-49d3-849f-987041a1eba5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_2c283145-5365-46b0-8050-927f5771172b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_c6253169-d5f3-46a5-8ad2-ed2e7528e1ef_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CovenantNotToCompeteMember_f078d6e0-bdc0-4328-bf34-bffd27cb1f40_terseLabel_en-US" xlink:label="lab_rdnt_CovenantNotToCompeteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant not to compete and other contracts</link:label>
    <link:label id="lab_rdnt_CovenantNotToCompeteMember_label_en-US" xlink:label="lab_rdnt_CovenantNotToCompeteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Covenant Not To Compete [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember" xlink:href="rdnt-20201231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CovenantNotToCompeteMember" xlink:to="lab_rdnt_CovenantNotToCompeteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_0f59d844-f4d1-40cd-be31-0203040e2f73_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c36a3ba-7724-489d-ad5a-cb99b1cffaac_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EFFECT OF EXCHANGE RATE CHANGES ON CASH</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_07315b09-1584-415b-9ff9-c4fc09edd5e8_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option to purchase additional equity method investment</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Option To Purchase Additional Equity Method Investment</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Option To Purchase Additional Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:to="lab_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_d4b972b4-f49b-4740-907d-75e517007805_terseLabel_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly amortization of deferred hedge gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:label id="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains_documentation_en-US" xlink:label="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Monthly Amortization Of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:href="rdnt-20201231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:to="lab_rdnt_MonthlyAmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AZTechMember_e2607ee3-d14e-4f9f-bdf1-2b5552d01242_terseLabel_en-US" xlink:label="lab_rdnt_AZTechMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ Tech</link:label>
    <link:label id="lab_rdnt_AZTechMember_label_en-US" xlink:label="lab_rdnt_AZTechMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ Tech [Member]</link:label>
    <link:label id="lab_rdnt_AZTechMember_documentation_en-US" xlink:label="lab_rdnt_AZTechMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ Tech Radiology &amp; Open MRI, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechMember" xlink:href="rdnt-20201231.xsd#rdnt_AZTechMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AZTechMember" xlink:to="lab_rdnt_AZTechMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_bc449a44-2718-4e99-9cf5-c2586dcad1d1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_39e26a4b-78f1-4f8b-99ab-9b2b2bbb2bb7_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_ed26a9f3-4186-4bfe-8121-c2012f0c0e76_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_889a0003-8c87-4620-ba6a-b7e2f6601cea_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loans, maturity term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioAxis_180777eb-6063-4312-8c82-2255755bf391_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_label_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:label id="lab_rdnt_LeverageRatioAxis_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioAxis" xlink:to="lab_rdnt_LeverageRatioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLCMember_938f4e35-cca0-49b7-ba52-a0007bb2e50d_terseLabel_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLCMember" xlink:href="rdnt-20201231.xsd#rdnt_VenturaCountyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_VenturaCountyImagingGroupLLCMember" xlink:to="lab_rdnt_VenturaCountyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_b6a24099-a7dd-4461-9122-2681d4e04100_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_39d52057-30cd-4606-a754-e36b73c17474_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_459b87c4-e5bd-4ed8-88c7-5dda9a9b46c0_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_fa47a579-ea44-41aa-96d2-e9460bf01b78_terseLabel_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion debt obligations</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_label_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Excluding Current Maturities</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_documentation_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:to="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_86334b46-dbf5-4eb1-a05a-c5552362cb4f_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_e6e57a34-05df-4243-b50b-74301cab7fcf_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PRINCIPLES OF CONSOLIDATION</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_01ff2128-bf6f-43ea-9431-f332fbf7fc8d_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares issued after execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ab5ca01b-bed6-4dee-ba9e-2661188a6601_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVenturesAbstract_74906389-3ae4-4021-9644-076200a811cf_terseLabel_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Data:</link:label>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVenturesAbstract_label_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key financial data for joint ventures</link:label>
    <link:label id="lab_rdnt_KeyFinancialDataForJointVenturesAbstract_documentation_en-US" xlink:label="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Key financial data for joint ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:href="rdnt-20201231.xsd#rdnt_KeyFinancialDataForJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:to="lab_rdnt_KeyFinancialDataForJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_681f1270-4bff-40f3-8ddf-be707d3ccbd1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FinanceLeaseCost_a4c85bd4-81db-4eab-8584-372df2376340_totalLabel_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease cost</link:label>
    <link:label id="lab_rdnt_FinanceLeaseCost_label_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:label id="lab_rdnt_FinanceLeaseCost_documentation_en-US" xlink:label="lab_rdnt_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost" xlink:href="rdnt-20201231.xsd#rdnt_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FinanceLeaseCost" xlink:to="lab_rdnt_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_e9dcdeb2-0129-4c69-ab4a-720623ec0313_terseLabel_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Factoring receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_label_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoringReceivable_documentation_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factoring Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:href="rdnt-20201231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractsReceivableFactoringReceivable" xlink:to="lab_rdnt_ContractsReceivableFactoringReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_48f33022-480b-49d1-9763-c1999d929c9b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_3e1ac8c0-647b-419e-b013-de8a5d24459b_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest accrued</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillTransfers_04acfa59-7f85-4765-9d5c-90da3a5e73e9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill transferred to other assets</link:label>
    <link:label id="lab_us-gaap_GoodwillTransfers_label_en-US" xlink:label="lab_us-gaap_GoodwillTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillTransfers" xlink:to="lab_us-gaap_GoodwillTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_17570de1-f24b-4f3b-a7c1-6da2b8da0647_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of RadNet stock issued in acquisition</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_6e6c6b38-b26c-45a8-9cdd-4ef568cb3b1c_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2023Member_f6db2c13-4159-4223-aa1b-c470cfc25629_terseLabel_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023</link:label>
    <link:label id="lab_rdnt_October2023Member_label_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:label id="lab_rdnt_October2023Member_documentation_en-US" xlink:label="lab_rdnt_October2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member" xlink:href="rdnt-20201231.xsd#rdnt_October2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2023Member" xlink:to="lab_rdnt_October2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TradeNamesAmortizedMember_0ff8ef82-aa77-4275-a0b6-33721a705130_terseLabel_en-US" xlink:label="lab_rdnt_TradeNamesAmortizedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names amortized</link:label>
    <link:label id="lab_rdnt_TradeNamesAmortizedMember_label_en-US" xlink:label="lab_rdnt_TradeNamesAmortizedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names Amortized [Member]</link:label>
    <link:label id="lab_rdnt_TradeNamesAmortizedMember_documentation_en-US" xlink:label="lab_rdnt_TradeNamesAmortizedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names Amortized [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TradeNamesAmortizedMember" xlink:href="rdnt-20201231.xsd#rdnt_TradeNamesAmortizedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TradeNamesAmortizedMember" xlink:to="lab_rdnt_TradeNamesAmortizedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b32f335c-7266-4a42-b5bb-c92be00e3d0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge from prior periods reclassified to earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_759d8570-fb84-40b6-abbc-6258b3be0a0f_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued after execution (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_d7bf4d1d-eb52-4eac-8df5-9031b8268008_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_50fc10d3-04d8-4f99-86c5-3773beadbad6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Liabilities Arising from Contingencies, Amount Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:to="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_6c715ef5-2688-4e93-9755-f87260d1c5b7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_1158fffb-81ef-42c9-95a9-9b74399b3e8e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY INVESTMENTS AT FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_65e3f7ec-2d87-4526-93f5-7d05df905f12_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in income on derivative (current period ineffective portion)</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_446ddf56-662a-4818-97d1-7b1206c80045_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FutureServiceMember_ca83d4b5-8c15-4538-b344-786d5deee8c0_terseLabel_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_label_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Service [Member]</link:label>
    <link:label id="lab_rdnt_FutureServiceMember_documentation_en-US" xlink:label="lab_rdnt_FutureServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember" xlink:href="rdnt-20201231.xsd#rdnt_FutureServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FutureServiceMember" xlink:to="lab_rdnt_FutureServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_b1955944-4fd4-42f2-825f-31b07cb07974_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ASSETS</link:label>
    <link:label id="lab_us-gaap_OtherAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsAbstract" xlink:to="lab_us-gaap_OtherAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_93d8a5ea-0267-4bad-a002-7704d7a57238_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DERIVATIVE INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_0e58711b-0a21-4df1-8139-a3c79a4eba23_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_4280d4a0-5654-4686-9956-3c3a164dff04_terseLabel_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP Loan</link:label>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_label_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, PPP Loan, Amount</link:label>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_documentation_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, PPP Loan, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:href="rdnt-20201231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:to="lab_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_d58016f7-64eb-449e-9adf-c46d5e746399_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIIIMember_31f2070d-4496-47c8-a402-46301df2a37b_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIIIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level III [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIIIMember" xlink:to="lab_rdnt_PricingLevelIIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4f594e34-4c66-485f-9184-b315b17abfea_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_feba7646-1408-433b-b179-9529f2fc0c62_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractLossAccrual_80d60f7d-bb90-40da-9df6-67fc777b60b7_terseLabel_en-US" xlink:label="lab_rdnt_ContractLossAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract loss accrual</link:label>
    <link:label id="lab_rdnt_ContractLossAccrual_label_en-US" xlink:label="lab_rdnt_ContractLossAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract loss accrual</link:label>
    <link:label id="lab_rdnt_ContractLossAccrual_documentation_en-US" xlink:label="lab_rdnt_ContractLossAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract loss accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrual" xlink:href="rdnt-20201231.xsd#rdnt_ContractLossAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractLossAccrual" xlink:to="lab_rdnt_ContractLossAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_b558b6f5-6aae-486c-8cf5-3c8f88b15cd1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_2497be6f-d229-44ca-b5ae-b2fd0bba5f1e_terseLabel_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, increase borrowing capacity</link:label>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_label_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase Borrowing Capacity</link:label>
    <link:label id="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_documentation_en-US" xlink:label="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Increase Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:href="rdnt-20201231.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:to="lab_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_1f7186a1-184f-4a58-9ea1-8f8e40b096d5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_2150ce8f-5a99-422b-af27-2052e06aaec1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock for acquisitions</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_60b99cd3-7821-4c48-8039-bbac7b870f59_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_24443074-d87c-494b-a691-d9bb74064251_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_d005022a-2411-4a59-8489-2eea9f29ba0d_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_273818ec-d98c-461f-b2c2-3aacdd1e46ae_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_af0ff8d8-7a85-4c67-8162-cf90843920dd_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares issued at execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_fc0089b9-6336-4aa0-ad17-7ff451ea40e5_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0fad7f85-ad97-45f2-9f64-ff834a63eb80_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_67ad6ae0-f24a-4d42-97fe-7367dae8fb23_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_ffcf8daf-e352-4ee4-871d-ab8aa9611455_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add additional shares issuable upon exercise of stock options and warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_ebe6beb5-322e-457a-86fd-7929b543fa63_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Underlying Equity in Net Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:to="lab_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_a352871c-c19f-4283-9d69-2be2fce46e40_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_d2c95c86-f52a-42a2-9060-b69c8de31b24_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts receivable</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_77d19bf4-8042-48e0-afb1-ce46e5091b81_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="rdnt-20201231.xsd#rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_45b014c8-d2c7-4c9d-8ff6-8c3f56cb0535_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write off of the reporting unit trade name</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_fd6673b3-d993-4cdd-989c-58ceabfe2104_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureMember_299e2b32-c731-40a9-9587-3b9b81bd5446_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture</link:label>
    <link:label id="lab_rdnt_JointVentureMember_label_en-US" xlink:label="lab_rdnt_JointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember" xlink:href="rdnt-20201231.xsd#rdnt_JointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureMember" xlink:to="lab_rdnt_JointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9ae6d409-2d42-4eb8-bc22-756b343e9bec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's unvested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash_f441b010-e258-4f34-932e-223c58ea6460_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest percentage in exchange for cash</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Ownership Percentage In Exchange for Cash</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Ownership Percentage In Exchange for Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash" xlink:to="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_f2f1b0b7-1d11-4c69-a85b-38c8002f2e24_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_9e54c9ac-145b-4aab-8649-1b99386f59de_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:href="rdnt-20201231.xsd#rdnt_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_rdnt_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_b7e4c70e-d982-4466-aad6-0d081bb1c70e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b66aba2d-7701-403b-8957-2a60b385614e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SantaMonicaImagingMember_5c400daa-c31d-4e08-888a-318b91a59391_terseLabel_en-US" xlink:label="lab_rdnt_SantaMonicaImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Santa Monica Imaging Group</link:label>
    <link:label id="lab_rdnt_SantaMonicaImagingMember_label_en-US" xlink:label="lab_rdnt_SantaMonicaImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Santa Monica Imaging Group [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingMember" xlink:href="rdnt-20201231.xsd#rdnt_SantaMonicaImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SantaMonicaImagingMember" xlink:to="lab_rdnt_SantaMonicaImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed_bfa4dd46-e5d0-419b-bd3e-18d4cdd9a765_terseLabel_en-US" xlink:label="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity method investments, Assets</link:label>
    <link:label id="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed_label_en-US" xlink:label="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments Assets Contributed</link:label>
    <link:label id="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed_documentation_en-US" xlink:label="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments Assets Contributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed" xlink:href="rdnt-20201231.xsd#rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed" xlink:to="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_8712dfa3-6da1-460e-8922-0a39e03451d7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONCENTRATION OF CREDIT RISKS</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_e2f377f9-8b5d-40fe-90e5-94cb92146387_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioDomain_808c9026-e0c6-4463-b1ce-76dfd54321e6_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_label_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio [Domain]</link:label>
    <link:label id="lab_rdnt_LeverageRatioDomain_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Leverage Ratio [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioDomain" xlink:to="lab_rdnt_LeverageRatioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_5e884225-1714-4e25-957b-0dbdcb5ec57b_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_a645d106-d26d-4a32-9ec7-bab7b0823faa_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups accounts payable</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_1621d6b7-51ce-4acd-bcbf-04f4305cdbf0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of forward interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Number of Instruments Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:to="lab_us-gaap_DerivativeAssetNumberOfInstrumentsHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RadNetMember_a5cf7f88-6473-420b-aebd-f4917a4c0161_terseLabel_en-US" xlink:label="lab_rdnt_RadNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RadNet</link:label>
    <link:label id="lab_rdnt_RadNetMember_label_en-US" xlink:label="lab_rdnt_RadNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RadNet [Member]</link:label>
    <link:label id="lab_rdnt_RadNetMember_documentation_en-US" xlink:label="lab_rdnt_RadNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RadNet [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadNetMember" xlink:href="rdnt-20201231.xsd#rdnt_RadNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RadNetMember" xlink:to="lab_rdnt_RadNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributedCapital_a2a9a3c3-41fa-43f4-b2b5-0d6cb5a7545a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributedCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling partners</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributedCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributedCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributed Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributedCapital" xlink:to="lab_us-gaap_ProceedsFromContributedCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b29d6caf-7204-4365-bd72-c374864bba7f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_e6b4b6d5-2a37-4cce-b523-3def94d80606_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_383a7d41-e4a1-4686-9ae0-efe81d7a14dc_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life (in years)</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_label_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life</link:label>
    <link:label id="lab_rdnt_WeightedAverageRemainingContractualLife_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life abstract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:href="rdnt-20201231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife" xlink:to="lab_rdnt_WeightedAverageRemainingContractualLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_6deb69fd-ec21-4768-a235-c1e21a26d99d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in cumulative foreign currency&#160;translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_KernRadiologyImagingSystemsInc.Member_d2e44512-fc8f-4442-b3c4-8280305d23cd_terseLabel_en-US" xlink:label="lab_rdnt_KernRadiologyImagingSystemsInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kern Radiology Imaging Systems Inc.</link:label>
    <link:label id="lab_rdnt_KernRadiologyImagingSystemsInc.Member_label_en-US" xlink:label="lab_rdnt_KernRadiologyImagingSystemsInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kern Radiology Imaging Systems Inc. [Member]</link:label>
    <link:label id="lab_rdnt_KernRadiologyImagingSystemsInc.Member_documentation_en-US" xlink:label="lab_rdnt_KernRadiologyImagingSystemsInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kern Radiology Imaging Systems Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KernRadiologyImagingSystemsInc.Member" xlink:href="rdnt-20201231.xsd#rdnt_KernRadiologyImagingSystemsInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_KernRadiologyImagingSystemsInc.Member" xlink:to="lab_rdnt_KernRadiologyImagingSystemsInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_fd3567cd-1b6b-4a78-90fb-b20c637c0c36_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale to noncontrolling interests, net of taxes</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_3bef924d-6a7a-46cc-942a-ac43babe41be_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_dfc6cd05-c855-4a62-874e-25daf405f9fb_terseLabel_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities:</link:label>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashFlowLesseeAbstract" xlink:href="rdnt-20201231.xsd#rdnt_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CashFlowLesseeAbstract" xlink:to="lab_rdnt_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BoardMemberMember_ea776892-559d-42cd-ad3b-248a4d404e51_terseLabel_en-US" xlink:label="lab_rdnt_BoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member</link:label>
    <link:label id="lab_rdnt_BoardMemberMember_label_en-US" xlink:label="lab_rdnt_BoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member [Member]</link:label>
    <link:label id="lab_rdnt_BoardMemberMember_documentation_en-US" xlink:label="lab_rdnt_BoardMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Board Member [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BoardMemberMember" xlink:href="rdnt-20201231.xsd#rdnt_BoardMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BoardMemberMember" xlink:to="lab_rdnt_BoardMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_f3cfe427-0865-49c9-ba54-f86baeab4c92_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_20dc8f0a-659c-4d2c-954c-d5f31441f202_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sales of Business, Affiliate and Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_b7baf882-e594-43fa-b613-0e106e76850e_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_dabe5d46-914f-49ae-b2e7-d686cd17afe8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book value of RadNet joint venture interests</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_9adda243-24e5-4661-9655-68001246d097_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_9a9ffca0-b3fc-4e73-9bd1-35caefddaaca_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_2fe33114-29b6-45a6-a21b-1d7afac9d18e_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_58ed3013-3841-4fed-9d7f-9b8de89f4172_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxYear2018Member_9b915583-75c4-4a51-bd0b-7824b056410f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxYear2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2018</link:label>
    <link:label id="lab_us-gaap_TaxYear2018Member_label_en-US" xlink:label="lab_us-gaap_TaxYear2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Year 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2018Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxYear2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxYear2018Member" xlink:to="lab_us-gaap_TaxYear2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_f888e126-9641-4056-9117-7cefcfbb4a59_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups revenues</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_48c8fa72-a3c8-4429-849d-a16fceb73f86_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_849e33fd-b2a4-43ab-8a79-bd5a8af562ad_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_33f7cdaa-9330-4d6b-9083-69b4604cfa1f_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE INCOME (LOSS)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_2e9ecbb6-f6da-4168-aef2-3e830d019bb6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_d5634308-398e-41bc-8691-252714de4203_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_e32ba91c-0b56-460d-b277-db67229c09d7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_0040d0fb-8c71-4a73-a366-14a17e26362d_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfavorable lease contracts acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_8eb38231-f5c3-48b2-a6d5-29aae3f24af5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7a850845-f199-4ccb-b468-d92db491d27a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_3a851f5f-8f5d-475e-928b-607cdcb1cf5e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_13e333b5-4d64-45fb-a167-4dcabe2f2411_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">USE OF ESTIMATES</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_cd904de2-00cf-4b0a-bef4-8527a2d94460_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_3524f590-9c53-4548-8c6f-5f9cc4dfb859_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPAtlanticLLCMember_631d5c03-80e4-47a5-9f63-04d508d13b7f_terseLabel_en-US" xlink:label="lab_rdnt_ZPAtlanticLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Atlantic</link:label>
    <link:label id="lab_rdnt_ZPAtlanticLLCMember_label_en-US" xlink:label="lab_rdnt_ZPAtlanticLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Atlantic LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPAtlanticLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPAtlanticLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Atlantic LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPAtlanticLLCMember" xlink:href="rdnt-20201231.xsd#rdnt_ZPAtlanticLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPAtlanticLLCMember" xlink:to="lab_rdnt_ZPAtlanticLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_f1c08478-4393-4f3a-89f8-7f28f27c9a58_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 CAPS - Interest Rate Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_74ae0599-b3f8-41f6-bab2-b104d3597525_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_cecf9054-04e8-4fd6-8e20-da83de10ba9b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_c9904d90-6d36-4d4c-a556-1cf514b6c31b_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_aa176a78-505a-4989-9f26-0664b3df7477_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Return to provision</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIMember_3b417ac2-d9af-4b9d-85a0-9088b2492b98_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level I [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIMember" xlink:to="lab_rdnt_PricingLevelIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_efdb8681-ae3f-471c-8ef9-6cd12809bb2d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_2e23852d-8253-458b-bd3a-097615faf705_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from affiliates</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_797db773-ce39-43e8-b9b7-d2d79a7cf143_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_67d9d26d-5ff7-45b8-aa8d-947d5c1b186f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency accrual liability</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:to="lab_us-gaap_LossContingencyAccrualAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_f675623c-6783-46f6-8bea-149b3410506e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued upon conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="lab_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_fa2011b8-fca1-49ac-af23-4ccec4d1fac9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_792361da-751d-48c0-8e72-64108960620e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings in these joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_c4551ab2-4a7c-4b9d-ab6c-0a41ea4e7285_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(LOSS) INCOME BEFORE INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_78befea6-97ab-4965-bed0-418c690f9ddf_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loans</link:label>
    <link:label id="lab_rdnt_FirstLienTermLoanMember_label_en-US" xlink:label="lab_rdnt_FirstLienTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienTermLoanMember" xlink:to="lab_rdnt_FirstLienTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceFees_2cc21ff6-46ac-47c2-a7ab-cd2b970915fa_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_label_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees</link:label>
    <link:label id="lab_rdnt_ManagementServiceFees_documentation_en-US" xlink:label="lab_rdnt_ManagementServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management service fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees" xlink:href="rdnt-20201231.xsd#rdnt_ManagementServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceFees" xlink:to="lab_rdnt_ManagementServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_bfda9432-62dc-4e90-93f8-33539f1a57a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_11c550c3-b415-4911-957f-a6af93f8cd68_negatedLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_c3faf1ec-0b83-41a9-8a97-de302b00b819_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_405addd5-52d1-4100-81f3-154b379c0bea_terseLabel_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of unconsolidated joint ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_label_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_rdnt_NumberofUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:href="rdnt-20201231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberofUnconsolidatedJointVentures" xlink:to="lab_rdnt_NumberofUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_31051deb-a4d6-4ee8-aa67-222660f628fc_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_3a1f8252-e905-4dea-8f5c-4cdb8fb7e2ac_terseLabel_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_WestValleyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">West Valley Imaging Group, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember" xlink:href="rdnt-20201231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WestValleyImagingGroupLLCMember" xlink:to="lab_rdnt_WestValleyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GardenStateRadiologyNetworkLLCMember_aca02ac3-5167-4945-bb3c-c33ef8bc1ca0_terseLabel_en-US" xlink:label="lab_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Garden State Radiology Network LLC</link:label>
    <link:label id="lab_rdnt_GardenStateRadiologyNetworkLLCMember_label_en-US" xlink:label="lab_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Garden State Radiology Network LLC [Member]</link:label>
    <link:label id="lab_rdnt_GardenStateRadiologyNetworkLLCMember_documentation_en-US" xlink:label="lab_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Garden State Radiology Network LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:href="rdnt-20201231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:to="lab_rdnt_GardenStateRadiologyNetworkLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IncreaseDecreaseInOtherNoncashItem_b29fdc80-a8b3-4714-afee-88a73e708598_negatedTerseLabel_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non cash item in other expenses</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInOtherNoncashItem_label_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Other Noncash Item</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInOtherNoncashItem_documentation_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease In Other Noncash Item</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseDecreaseInOtherNoncashItem"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:to="lab_rdnt_IncreaseDecreaseInOtherNoncashItem" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_05e13331-b4c9-4783-abe7-743740e17f79_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IncreaseDecreaseInDeferredRent_742a50f4-ad27-454b-9200-1491d6b2ebcd_terseLabel_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInDeferredRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred rent</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInDeferredRent_label_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInDeferredRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred rent</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseInDeferredRent_documentation_en-US" xlink:label="lab_rdnt_IncreaseDecreaseInDeferredRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting rent yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInDeferredRent" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseDecreaseInDeferredRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IncreaseDecreaseInDeferredRent" xlink:to="lab_rdnt_IncreaseDecreaseInDeferredRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_00fe9129-db36-4044-ba82-a10b1ca3f4e8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired through acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_bf4f26ce-940b-4afc-b5bf-ef03023172bc_terseLabel_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired and leasehold improvements</link:label>
    <link:label id="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements_label_en-US" xlink:label="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired and leasehold improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:href="rdnt-20201231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:to="lab_rdnt_EquipmentAcquiredAndLeaseholdImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_03d6812e-e200-47ab-b3ce-5de5634b5f0b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER INCOME AND EXPENSES</link:label>
    <link:label id="lab_us-gaap_OtherExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OtherExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherExpensesAbstract" xlink:to="lab_us-gaap_OtherExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_c45541cb-dd15-40b4-8d0a-096a7797e37d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PP&amp;E useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_eef618b0-dc3c-4303-bc96-bad2dec3a0b7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_60482789-ed20-4161-92e3-dde2ce9df4b7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BarclaysMember_c26f2a71-b0fa-41ff-ba75-8f16f63cdc9e_terseLabel_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays</link:label>
    <link:label id="lab_rdnt_BarclaysMember_label_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:label id="lab_rdnt_BarclaysMember_documentation_en-US" xlink:label="lab_rdnt_BarclaysMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Barclays [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember" xlink:href="rdnt-20201231.xsd#rdnt_BarclaysMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BarclaysMember" xlink:to="lab_rdnt_BarclaysMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_77c9c9ff-ab80-428e-a752-80b37d4b2d19_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_fbd73fce-5268-4065-b529-1ab8bf3405ff_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued at execution (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_64586486-ae4c-4d13-94a5-b9c1a31b23ff_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContributionsFromNoncontrollingInterests_e27439b3-58ef-4b9c-9ea3-39ae4e04174a_terseLabel_en-US" xlink:label="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:label id="lab_rdnt_ContributionsFromNoncontrollingInterests_label_en-US" xlink:label="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from noncontrolling interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests" xlink:href="rdnt-20201231.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContributionsFromNoncontrollingInterests" xlink:to="lab_rdnt_ContributionsFromNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_45c6c1cd-32c2-4679-8b14-986eb8aba464_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Deferred Tax Asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_36c3e926-2979-454e-977a-576079ea76fc_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_947286a1-4644-40ff-961e-5a356f15fa9d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_b7378328-9691-45b5-8c64-1d3bd96fcdb8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEFERRED FINANCING COSTS</link:label>
    <link:label id="lab_us-gaap_DeferredChargesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredChargesPolicyTextBlock" xlink:to="lab_us-gaap_DeferredChargesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_af55d6cb-ee20-408a-8eb2-a29b6be96f35_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_961ae88b-3a5b-4727-bd07-fe198bccc08a_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_dcb08096-ddb8-4130-a526-519c9eb44ad3_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_d22f2624-90a8-483a-ac24-39f4a3894349_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:to="lab_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_aa40dfe7-dab7-4ae4-9bf2-595708a01b2c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_311039e9-105a-4331-870d-bd8f25ff6411_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_5c9c1dab-3640-453b-b456-47f3762656ef_terseLabel_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases Weighted Average Discount Rate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:href="rdnt-20201231.xsd#rdnt_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_rdnt_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed_7a7721ba-40b2-46ce-aa1c-6cc9177c75f5_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest percentage in exchange for assets</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Ownership Percentage In Exchange for Assets Contributed</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Ownership Percentage In Exchange for Assets Contributed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed" xlink:to="lab_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_cd48c416-7524-4d6a-afa1-97bf872c0018_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_993180ed-7aee-41b9-8d31-066d105a95e4_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_9d9af3cb-607b-4f51-946b-e56f23e92585_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_0cab0d39-2c5a-4cde-8160-567abf2bd7bd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance_3a679c0c-313e-4aff-b268-7353054ded8e_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment of New Jersey Imaging Network investment balance</link:label>
    <link:label id="lab_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance_label_en-US" xlink:label="lab_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Adjustment Of Investment Balance</link:label>
    <link:label id="lab_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Adjustment Of Investment Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance" xlink:to="lab_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_467ee26f-98c0-4201-9ebc-e4eb25cb73c7_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer matching contribution, percent</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_676f7057-2d16-4f4c-a1d9-8e9f756b351b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Economic interest</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_a2601f5f-3c0e-440e-9639-cc9a7d8f75a4_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, greater than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:to="lab_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_e8c91e0d-7376-443b-9a21-38b59d55c2f6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS - Interest Rate Contracts</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f2664591-bec5-4338-881c-ef885d8c2fec_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_ae03f5f0-d43b-45a3-baa3-736cc180680b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_d1449d16-cb34-46a1-92b6-9415c23d66d2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0c4c645c-8a57-485d-a398-4a3aaa6e3131_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_59724280-708b-40f5-9c72-0f543b48e754_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_f1aba38b-c565-4a5a-811b-ce0eaaa1cb35_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred financing costs, net of accumulated amortization</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_145742c8-cc5e-45cc-ae24-c783436b6bd3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise price Per Common Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_466c1110-a3d1-405f-8e9a-a147723e3242_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_695fca76-081a-4df1-8fd3-8104150169f7_terseLabel_en-US" xlink:label="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, fair value</link:label>
    <link:label id="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Issued in Business Combination, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:to="lab_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_3c9176c4-dc8b-40ef-9991-c8b9afe56548_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementMember" xlink:to="lab_rdnt_FirstLienCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_14c2797b-7b27-4f2f-836f-e07a35e19360_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_725c44c8-49fe-4575-b084-96fb146a55b4_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioOneMember_2a12c98a-8e65-45c8-ae1a-d86e6d920044_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 5.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioOneMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioOneMember" xlink:to="lab_rdnt_LeverageRatioOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_4e7084ae-9b4e-40e7-96d3-b9d040f98a61_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_b4bf3f29-8b56-4d2e-89ae-d5fef22e9168_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on sale and disposal of equipment and other</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_8f9316ce-410b-4e73-b332-f8ca23fe28b1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_919728fc-2901-4df6-9789-4b9699cd9f20_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationStepAcquisitionCashAcquired_20599c08-7982-44ff-8393-d9ec5952aad7_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationStepAcquisitionCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Step acquisition, cash acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationStepAcquisitionCashAcquired_label_en-US" xlink:label="lab_rdnt_BusinessCombinationStepAcquisitionCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Cash Acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationStepAcquisitionCashAcquired_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationStepAcquisitionCashAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationStepAcquisitionCashAcquired" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationStepAcquisitionCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationStepAcquisitionCashAcquired" xlink:to="lab_rdnt_BusinessCombinationStepAcquisitionCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_01e7633e-93b8-4141-895b-827e36069712_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:to="lab_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_ce717c04-4811-401a-bf5a-cc8d24de864d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current tax</link:label>
    <link:label id="lab_us-gaap_OtherTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_OtherTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherTaxExpenseBenefit" xlink:to="lab_us-gaap_OtherTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_c854b6a3-e123-4562-af06-adf4f48f1e84_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_6db93470-1777-4521-8883-263a4294b7f2_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_0ce0be7b-06ea-406d-b2f6-29dd2962b2f3_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired</link:label>
    <link:label id="lab_us-gaap_Goodwill_bc3b8860-98f3-4fd5-a504-c90b3ad0a065_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_b6d4181a-28af-4f9d-955a-4777e78782fe_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_ffcfba12-aca6-4651-a790-de727bd1fcc6_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest percentage acquired</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Ownership Interest Percentage Acquired</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Ownership Interest Percentage Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:to="lab_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets_04310406-8a25-49ce-82be-92daa909ffba_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of internal use software</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_a11e8cc5-3d6a-4e30-b46f-af6c288894ef_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal payments on notes and leases payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_e740e231-ad59-4496-b77f-cb035c4ee79c_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued after acquisition, term</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_a99ee2af-535a-4976-ae73-37f529945ad4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition, closing costs</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:to="lab_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_e8bf69f3-3559-45a8-85fd-5f35111cc76b_verboseLabel_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans</link:label>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_label_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans [Member]</link:label>
    <link:label id="lab_rdnt_PaycheckProtectionProgramLoansMember_documentation_en-US" xlink:label="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paycheck Protection Program Loans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember" xlink:href="rdnt-20201231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PaycheckProtectionProgramLoansMember" xlink:to="lab_rdnt_PaycheckProtectionProgramLoansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_5425c269-917d-4927-afb1-f7a6a38daa19_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_8e67cc72-a9bd-412f-b95a-f3ea1af93682_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BlueShieldMember_bdfec1e0-129a-4669-a0c0-52b7e8c2445c_terseLabel_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield</link:label>
    <link:label id="lab_rdnt_BlueShieldMember_label_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield [Member]</link:label>
    <link:label id="lab_rdnt_BlueShieldMember_documentation_en-US" xlink:label="lab_rdnt_BlueShieldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blue Shield [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember" xlink:href="rdnt-20201231.xsd#rdnt_BlueShieldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BlueShieldMember" xlink:to="lab_rdnt_BlueShieldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_3cf7e93d-6a52-40b3-8474-3002a4854cc7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_8ada4873-07bf-46ee-9f75-a3c05b07ebd8_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, milestone two, shares issued (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:to="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_ceffe4ab-6324-464c-a45d-d271f11d22e8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_adcc51c1-17e0-4f43-9710-c18dd67f2536_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_3c697bf9-ed7a-4c77-85b8-c81439bb2f01_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a4e39efb-6496-4da9-a63b-ea5c36ede35e_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_a44eb7c2-d1eb-4175-9aaf-f7d0d972d107_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_b80efb71-df75-47d7-b3a7-9ea51c9b0252_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6e2911bf-f252-4cd2-972f-176e527ffb1b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c31f67cc-9345-4d2c-96c2-1a6f34d68a68_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares used in calculating diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_f0e94b56-db8a-4056-95d7-4e5e9dd95327_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_5595c59d-2d18-474d-94e8-474e54e5c79d_terseLabel_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment</link:label>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_label_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
    <link:label id="lab_rdnt_ComputerandOfficeEquipmentMember_documentation_en-US" xlink:label="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember" xlink:href="rdnt-20201231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ComputerandOfficeEquipmentMember" xlink:to="lab_rdnt_ComputerandOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2025Member_50f24cf5-47e1-4deb-b09a-f24244d4dbf5_terseLabel_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025</link:label>
    <link:label id="lab_rdnt_October2025Member_label_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:label id="lab_rdnt_October2025Member_documentation_en-US" xlink:label="lab_rdnt_October2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member" xlink:href="rdnt-20201231.xsd#rdnt_October2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2025Member" xlink:to="lab_rdnt_October2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_5d3c0292-3887-4cd0-b5f0-bb28a5c89fbd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_39fc3a97-3ca9-491f-b81f-22553749cb2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_7080d39c-52bc-415f-984c-dba0c456e06e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_11e1e09c-209f-422f-beb1-45e8f9801039_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_70e51c3e-4de3-4ebe-9b73-a97b0655d7d6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_727dadf9-0513-4ca1-861c-97c2b864c6b2_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Abstract]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_8e87a791-1ade-4404-b2f2-7c81d39700c8_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of cash flow hedge</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredHedgeGains_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Hedge Gains</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredHedgeGains" xlink:to="lab_us-gaap_AmortizationOfDeferredHedgeGains" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_0fe22ab2-1c91-41bc-84a0-58d3494d12a3_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_e1b4e28c-95be-40ed-81c3-2527393b9064_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, Balance at beginning of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_e50c5634-14b6-4b18-b249-fb16b54129fb_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefit, Balance at end of year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_9fc72085-abe7-4b76-81a4-221d792233f1_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_6543b998-fdaf-4540-873e-158409a961ba_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - $.0001 par value, 200,000,000 shares authorized; 51,640,537 and 50,314,328 shares issued and outstanding at December 31, 2020 and 2019 respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsReceivedFromInsurance_5a99b936-dab4-4939-ad8a-49a14f17dbfa_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsReceivedFromInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance insurance carrier payments</link:label>
    <link:label id="lab_rdnt_ProceedsReceivedFromInsurance_label_en-US" xlink:label="lab_rdnt_ProceedsReceivedFromInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds Received From Insurance</link:label>
    <link:label id="lab_rdnt_ProceedsReceivedFromInsurance_documentation_en-US" xlink:label="lab_rdnt_ProceedsReceivedFromInsurance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds Received From Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsReceivedFromInsurance" xlink:href="rdnt-20201231.xsd#rdnt_ProceedsReceivedFromInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsReceivedFromInsurance" xlink:to="lab_rdnt_ProceedsReceivedFromInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_16f5f4c9-5a15-47e3-be60-a7b20ab6c4a4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e2a630cd-cc2f-42c7-932a-17fd141aafec_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_85626a2e-bbe5-4d29-8863-aed5319b7380_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_f5fd45a2-f1a6-4850-9b6c-808596e0fee7_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsLineItems" xlink:to="lab_us-gaap_OffsettingAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NonCashSeverance_2a4c5b2c-3d56-45c2-aed7-a6cde619b476_terseLabel_en-US" xlink:label="lab_rdnt_NonCashSeverance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash severance</link:label>
    <link:label id="lab_rdnt_NonCashSeverance_label_en-US" xlink:label="lab_rdnt_NonCashSeverance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non cash severance</link:label>
    <link:label id="lab_rdnt_NonCashSeverance_documentation_en-US" xlink:label="lab_rdnt_NonCashSeverance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non cash severance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeverance" xlink:href="rdnt-20201231.xsd#rdnt_NonCashSeverance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NonCashSeverance" xlink:to="lab_rdnt_NonCashSeverance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_ce377547-0cab-443b-b56e-f0534d2253ff_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's Reporting Status Current</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_309314a1-f7b9-417e-ae9b-51d5c005e3a7_verboseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of Use Assets</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_8f6167b5-c5d3-4454-9b64-6a5fa427760e_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_a8211288-5592-4577-ae08-a8b83cf8dfe0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution_18b2f591-9874-45bf-8e16-0fe06a7071f3_negatedTerseLabel_en-US" xlink:label="lab_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special distribution from noncontrolling interest</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution_label_en-US" xlink:label="lab_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease From Special Distribution</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution_documentation_en-US" xlink:label="lab_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease From Special Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution" xlink:href="rdnt-20201231.xsd#rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution" xlink:to="lab_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_177843f1-1ce6-4357-bb90-5510691d4f6b_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE (LOSS) INCOME</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NoncontrollingInterestSpecialDistribution_7f40cebf-19b9-4031-a466-aa146ee9b85c_terseLabel_en-US" xlink:label="lab_rdnt_NoncontrollingInterestSpecialDistribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special distribution from noncontrolling interest</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestSpecialDistribution_label_en-US" xlink:label="lab_rdnt_NoncontrollingInterestSpecialDistribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Special Distribution</link:label>
    <link:label id="lab_rdnt_NoncontrollingInterestSpecialDistribution_documentation_en-US" xlink:label="lab_rdnt_NoncontrollingInterestSpecialDistribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Special Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestSpecialDistribution" xlink:href="rdnt-20201231.xsd#rdnt_NoncontrollingInterestSpecialDistribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NoncontrollingInterestSpecialDistribution" xlink:to="lab_rdnt_NoncontrollingInterestSpecialDistribution" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_9d4ad421-6a8d-47d4-b0ca-ff8f107ad291_terseLabel_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee revenue</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_label_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:label id="lab_rdnt_HealthCareManagementServiceMember_documentation_en-US" xlink:label="lab_rdnt_HealthCareManagementServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Management Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember" xlink:href="rdnt-20201231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCareManagementServiceMember" xlink:to="lab_rdnt_HealthCareManagementServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_bfe3b510-1012-4afd-9804-95b020f7de3c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_084041b4-06be-4033-8b7a-4ceb293ea39c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4a75f9a2-39d0-4506-8e93-f03e2667fb73_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EurodollarMember_aecfa76e-09c6-407a-8b9d-561d3b440373_terseLabel_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar</link:label>
    <link:label id="lab_us-gaap_EurodollarMember_label_en-US" xlink:label="lab_us-gaap_EurodollarMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eurodollar [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EurodollarMember" xlink:to="lab_us-gaap_EurodollarMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_02d5a047-80d8-4215-98ab-613b83f9b726_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount_506b188f-4bf7-4f79-89b6-39c4f210554d_terseLabel_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on change in control</link:label>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount_label_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Gain on Change in Control, Amount</link:label>
    <link:label id="lab_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount_documentation_en-US" xlink:label="lab_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Gain on Change in Control, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount" xlink:href="rdnt-20201231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount" xlink:to="lab_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_c9f628b8-5df1-4e09-8e74-634cac8cadbc_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_bf64f292-617f-4813-bd5d-2698c3f36e4a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_3ce1587a-3eb4-4c87-a2af-943486eb7c95_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred Tax Liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_cec2d0a3-666b-44ca-863a-3708dc22c020_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_fb2ced6e-45ba-4886-9b04-8c3493a35c1e_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total RadNet, Inc.'s stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_1e8da003-aab8-4b98-b07d-f28551759743_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_fb6e0cca-7c5e-418c-841a-3c3f0ecb9242_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_65f06b7b-7b63-42c0-b19e-c0325ad7fc97_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_7c50d25b-2389-4cae-923f-5b7ceeb29b17_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_0086a041-9ef5-499c-b73c-830015a5a4d1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued salary and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_1769a340-1ab9-4dcf-ac6b-1ba4def3887f_terseLabel_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred social security taxes</link:label>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_label_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:label id="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_documentation_en-US" xlink:label="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Social Security Tax, Employer, Deferral, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:href="rdnt-20201231.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:to="lab_rdnt_SocialSecurityTaxEmployerDeferralCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_dfc5e026-fb85-4242-894a-a8b7a8c21f33_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_e81df89a-c56e-44c5-96db-d5e674b55d94_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_d805076c-7013-47ae-80c6-30497ac90085_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_63e16e26-ad64-4de3-9e9d-a712ab6dabfd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_fd8cefd6-de9d-4da8-8c1a-7f44111842b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non deductible expenses</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_e4159f89-5e66-4c8f-a7fe-5b0459235a0d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Derivative Instruments on Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermLoansPayable_08ca5c4b-ddc2-4534-93ff-1cc23289ab5b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermLoansPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment notes payable at interest rates ranging from 4.4% to 5.6%, due through 2020, collateralized by medical equipment</link:label>
    <link:label id="lab_us-gaap_LongTermLoansPayable_label_en-US" xlink:label="lab_us-gaap_LongTermLoansPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermLoansPayable" xlink:to="lab_us-gaap_LongTermLoansPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_f04796d3-1d5d-4b53-9906-4e9f3c240fc7_terseLabel_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock upon exercise of options</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_label_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:label id="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_documentation_en-US" xlink:label="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:href="rdnt-20201231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:to="lab_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_f797d462-a48a-44bf-8402-4b0d0c160f21_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_689260b2-7c1a-4f3d-abfb-0ed60c0e69c6_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_9dc31c41-a0d6-46ee-9a8c-4e6c9a3a737e_terseLabel_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares purchased (in shares)</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_label_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:label id="lab_rdnt_EquityMethodInvestmentSharesPurchased_documentation_en-US" xlink:label="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Shares Purchased</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityMethodInvestmentSharesPurchased" xlink:to="lab_rdnt_EquityMethodInvestmentSharesPurchased" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_a779d0ef-4a81-46c4-80fb-57cbfe91521e_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_438ef845-e75d-4290-83bf-c0e2c2f21a4d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_0d816cde-cd46-49ef-8793-636a9a0017a0_terseLabel_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other patient revenue</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_label_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:label id="lab_rdnt_HealthCarePatientServiceOtherMember_documentation_en-US" xlink:label="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:href="rdnt-20201231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthCarePatientServiceOtherMember" xlink:to="lab_rdnt_HealthCarePatientServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RestatedPlanMember_b41c5519-80ce-4951-a8e1-de05063eb744_terseLabel_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan</link:label>
    <link:label id="lab_rdnt_RestatedPlanMember_label_en-US" xlink:label="lab_rdnt_RestatedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restated Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember" xlink:href="rdnt-20201231.xsd#rdnt_RestatedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RestatedPlanMember" xlink:to="lab_rdnt_RestatedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_f6df70e7-7024-4550-a7cc-26cb078b10eb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFTWARE REVENUE RECOGNITION</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_114e3b60-94d6-48a3-9884-b52a1829a1d3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_119da49b-71dd-4585-9af0-8e3d4fc242e4_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_a474fa48-2a79-42f2-84d1-6fa9e1cf4041_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage ratio, less than</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_label_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:label id="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Leverage Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:to="lab_rdnt_DebtInstrumentCovenantLeverageRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_8faea0b6-b6e9-419f-8204-38b7b945fdb9_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_c54fadda-b9c4-4b5f-8bf7-18451525f47f_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_a9007f63-fb40-450d-8b4c-bcc2d6080d03_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_e02ae144-d17c-413b-bd60-c2f6ff92919d_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_6babd5bf-7bbf-4adf-a7da-4fd7d8dc0be9_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_5bfb5b73-4f4b-4372-aa5e-03ee71424ddd_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_6d2ee042-0c42-4164-8e26-e8a397d34977_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_93f0da58-d4a1-467f-a5dd-017426fa8193_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ManagementServiceContractsMember_4a95b100-2442-43eb-83ad-35cbea9f6861_terseLabel_en-US" xlink:label="lab_rdnt_ManagementServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Contracts</link:label>
    <link:label id="lab_rdnt_ManagementServiceContractsMember_label_en-US" xlink:label="lab_rdnt_ManagementServiceContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Service Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember" xlink:href="rdnt-20201231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ManagementServiceContractsMember" xlink:to="lab_rdnt_ManagementServiceContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_eb12527b-4443-430e-ba3d-174a4fffe316_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_f07e98d2-ff6c-4e76-8286-103f3602817f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CedarsSinaiMedicalCenterMember_954e3558-08d5-4745-8de0-8a089dfc2d92_terseLabel_en-US" xlink:label="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cedars Sinai Medical Center</link:label>
    <link:label id="lab_rdnt_CedarsSinaiMedicalCenterMember_label_en-US" xlink:label="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cedars Sinai Medical Center [Member]</link:label>
    <link:label id="lab_rdnt_CedarsSinaiMedicalCenterMember_documentation_en-US" xlink:label="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cedars Sinai Medical Center [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember" xlink:href="rdnt-20201231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CedarsSinaiMedicalCenterMember" xlink:to="lab_rdnt_CedarsSinaiMedicalCenterMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_830eb231-4fee-45ed-b3c4-8c262a0d0099_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate caps premium liability</link:label>
    <link:label id="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_label_en-US" xlink:label="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Guarantee Insurance Contracts, Unearned Premium Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:to="lab_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_079c33e1-1eb2-40dc-9c41-76a5e445e154_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_d992a792-c562-4ec1-b678-3951764cc110_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_56fa5214-8bf3-425a-a900-2e567d022d5a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_882e9758-9208-426f-b887-0b4bdfaa4f66_verboseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software in development</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_58283065-dbad-49bb-b8fa-083c30b105ca_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_October2020CapMember_8f4d2c6b-be7a-4936-bd44-f07306f9c6cc_terseLabel_en-US" xlink:label="lab_rdnt_October2020CapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2020</link:label>
    <link:label id="lab_rdnt_October2020CapMember_label_en-US" xlink:label="lab_rdnt_October2020CapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember" xlink:href="rdnt-20201231.xsd#rdnt_October2020CapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_October2020CapMember" xlink:to="lab_rdnt_October2020CapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_9326c9f8-4fbe-48a4-9c03-277fd198be42_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_8c9a84e3-fc33-480b-bbfb-ac3075a4d04f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_e7eaa6d4-a01b-44e4-806c-bde74e9a67d0_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_dece4a2e-184d-44c5-9abb-f2d596ddef42_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nulogix return of capital</link:label>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_dd81b056-1e05-4cf2-a638-e80308e3ea86_negatedLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nulogix return of capital</link:label>
    <link:label id="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_label_en-US" xlink:label="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution, Return of Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:to="lab_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_9e057b6c-7297-4f80-baaf-e19ffce97135_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests in partnerships</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_3165c976-539c-42f6-8e0d-f46da294fe85_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected employee contribution</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_ccdd5beb-19b1-4274-a304-5efe74e5f497_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_ec5bbaed-6e1f-4854-a1c0-88a7f87bfb79_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_6e525830-813e-4b37-b11e-932159f428d5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_65b0fe03-4fbf-4055-9cb4-7254f18ca659_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemDomain_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain" xlink:to="lab_us-gaap_UnusualOrInfrequentItemDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_ecbfdf93-460e-4c7f-bda5-58d5747d3689_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_59330ba0-325c-4ca0-bdf3-ba4030640f2c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_77ba3636-c606-4177-8c44-d13b2be5aff4_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_60ffeccb-fa45-4e66-b1de-8d9c7567f4f8_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PropertyAndEquipmentMember_17661d05-2a2c-4db8-bc05-97a460d70bcd_terseLabel_en-US" xlink:label="lab_rdnt_PropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Propery and equipment, net</link:label>
    <link:label id="lab_rdnt_PropertyAndEquipmentMember_label_en-US" xlink:label="lab_rdnt_PropertyAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Propery and equipment, net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyAndEquipmentMember" xlink:href="rdnt-20201231.xsd#rdnt_PropertyAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PropertyAndEquipmentMember" xlink:to="lab_rdnt_PropertyAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a934e5a4-16c6-45f0-803c-d5c2a3d73b06_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7e57885b-4579-4a04-ab6d-f933fc55954c_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCREASE (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_8cf9e38a-611e-4bf4-980c-a761a002c0fd_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other expenses (income)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsurancePolicyDomain_74870c78-0586-4e5f-8918-31dfff692c25_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsurancePolicyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Policy [Domain]</link:label>
    <link:label id="lab_us-gaap_ReinsurancePolicyDomain_label_en-US" xlink:label="lab_us-gaap_ReinsurancePolicyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Policy [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsurancePolicyDomain" xlink:to="lab_us-gaap_ReinsurancePolicyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_24b36083-9f40-47c3-a636-b11ca5e4e08c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1b50b454-9250-4d0c-8b5b-6a1d7058a26a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HudsonValleyRadiologyAssociatesMember_25012f19-3b55-4013-a7ef-ac6129cf1392_terseLabel_en-US" xlink:label="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hudson Valley Radiology Associates</link:label>
    <link:label id="lab_rdnt_HudsonValleyRadiologyAssociatesMember_label_en-US" xlink:label="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hudson Valley Radiology Associates [Member]</link:label>
    <link:label id="lab_rdnt_HudsonValleyRadiologyAssociatesMember_documentation_en-US" xlink:label="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hudson Valley Radiology Associates [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:href="rdnt-20201231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:to="lab_rdnt_HudsonValleyRadiologyAssociatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_15ae6881-2c11-496c-8478-b5c418aafba6_terseLabel_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:label id="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Assets And Liabilities Lessee [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="rdnt-20201231.xsd#rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct_f3d62b9c-2722-4e4d-9cf4-67534ad6248b_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General distribution funds, CARES Act</link:label>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct_label_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Government Assistance, General Distribution, CARES Act</link:label>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Government Assistance, General Distribution, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct" xlink:href="rdnt-20201231.xsd#rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct" xlink:to="lab_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_9a8b9b9e-bb5c-4a81-8d21-537eaf9ac5b4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State deferred tax</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_89ded1f0-ff77-4694-8e97-522fdbfb1815_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_71ece40f-6037-4307-9c82-2144a735665a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_bfeb8830-3c22-4510-b8d7-93d12b843fdd_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_5585b463-0807-4523-9920-41a2165baddd_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_0f14726e-fa06-45ff-92ca-6dc5701d51de_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dissolution of GSRN</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:to="lab_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_424d473c-7948-4d6c-a1da-8bbe1ba07e08_terseLabel_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease not yet commenced</link:label>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_label_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</link:label>
    <link:label id="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_documentation_en-US" xlink:label="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:href="rdnt-20201231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:to="lab_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f766d9ff-0eaa-4d33-93db-ba110fb74a47_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_230f53e4-73cf-466f-9e2e-3195f019c641_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_acd90498-7743-4493-890d-d4e8b430c71e_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_20fc7b57-1cd4-424d-b8b5-bb0017bf6023_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6289755f-beeb-46e0-9680-1c2b575aeb2c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_29ece190-f326-4654-ab2f-57b5d6c6bd1a_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_08766c6d-bb8f-4249-8bd6-492d0fc447aa_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_6cc295ef-d5f5-475f-bcd1-6d1ee1aaf465_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt;3.50x but &#8804; 4.00x</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioThreeMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioThreeMember" xlink:to="lab_rdnt_LeverageRatioThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_89c9883d-6d69-4064-9c34-711e4dc29473_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_43b4966e-5e77-4269-8ae7-8a81c0126306_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of RSA Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_bf6cae04-561f-49ad-b8cb-bec97619050c_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_78cd1ec4-886d-46ea-9740-96afd4acb3cc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_45b65c5e-88ae-4162-b9c5-061dc0a284fd_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net (loss) income per share attributable to RadNet, Inc. common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_e585f116-9552-4917-b964-7be8aa8111ed_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_d7330ea5-9599-4553-bb94-a4c4bc410325_terseLabel_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture Investment and Financial Information</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_label_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture investment and financial information [Table Text Block]</link:label>
    <link:label id="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture investment and financial information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:href="rdnt-20201231.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:to="lab_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_2883930f-404a-425c-a842-89906b59b55f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_58d952da-5f8e-4f5a-96af-67f4d0629efb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, subject to expiration</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalArtsRadiologyMember_f80fdc2b-40c3-47df-8ae6-a4b89ba9c92c_terseLabel_en-US" xlink:label="lab_rdnt_MedicalArtsRadiologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Arts Radiology</link:label>
    <link:label id="lab_rdnt_MedicalArtsRadiologyMember_label_en-US" xlink:label="lab_rdnt_MedicalArtsRadiologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Arts Radiology [Member]</link:label>
    <link:label id="lab_rdnt_MedicalArtsRadiologyMember_documentation_en-US" xlink:label="lab_rdnt_MedicalArtsRadiologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Arts Radiology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalArtsRadiologyMember" xlink:href="rdnt-20201231.xsd#rdnt_MedicalArtsRadiologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalArtsRadiologyMember" xlink:to="lab_rdnt_MedicalArtsRadiologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8123947d-7bd7-4ca7-9474-287c295e4af0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued as consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_83574fbb-4d84-4e29-8c55-f3e753ec5df2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_d989bf58-7d9b-4999-b37a-5fe14de7a8ef_negatedLabel_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current portion</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_label_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Current Maturities</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_documentation_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:to="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_ddf69bd2-225d-466e-a050-768aa84b0eab_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_f937e6eb-9529-40db-b66d-2fd99597530e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_d3b8a80f-d145-4d22-8a48-5c8edca33355_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Term Loans and Financing Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_7682fbfd-f206-46c5-91be-166c9937503e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_c878c984-5b67-487b-b570-429a28080bed_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_6831fc23-f7da-46e7-9d91-1cc71724aa18_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_0ffa7b0a-89da-4bce-b3c9-a72f3f907eae_terseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, tax benefit may not be realized</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_label_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Benefit May Not Be Realized</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Benefit May Not Be Realized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:href="rdnt-20201231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:to="lab_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AssetAcquisitionDomain_265034e0-3e4c-44ae-b0b1-6ea3830ea6d5_terseLabel_en-US" xlink:label="lab_rdnt_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_rdnt_AssetAcquisitionDomain_label_en-US" xlink:label="lab_rdnt_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_rdnt_AssetAcquisitionDomain_documentation_en-US" xlink:label="lab_rdnt_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionDomain" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AssetAcquisitionDomain" xlink:to="lab_rdnt_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_535d57eb-5ee5-499b-9c79-296f1cfa5253_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, unamortized discount, current</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_07d90430-5909-41af-a002-2f0827957bb9_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_fe562597-5419-41e2-9f08-4e48609b0ee5_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_4a6500a1-443c-4cd6-85dd-80c9d8add0e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of operations, excluding depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpenses" xlink:to="lab_us-gaap_OperatingCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienTermLoansAMember_a0a7391d-865b-49a6-be3d-0622ef20aadb_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienTermLoansAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FirstLienTermLoansAMember</link:label>
    <link:label id="lab_rdnt_FirstLienTermLoansAMember_label_en-US" xlink:label="lab_rdnt_FirstLienTermLoansAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FirstLienTermLoansAMember</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoansAMember" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienTermLoansAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienTermLoansAMember" xlink:to="lab_rdnt_FirstLienTermLoansAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_3fd5c36a-7296-4ba7-a73d-018c68093ede_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d5976a6a-6911-48b4-af41-f02d097b24c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_a14979a6-2502-4ba2-8aa3-4ee939adc0b0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DerivativeBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:to="lab_us-gaap_DerivativeBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CapitationArrangementsMember_4b644233-b5af-48d0-94b9-2e5ee214cfe2_terseLabel_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue under capitation arrangements</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_label_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:label id="lab_rdnt_CapitationArrangementsMember_documentation_en-US" xlink:label="lab_rdnt_CapitationArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitation Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember" xlink:href="rdnt-20201231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CapitationArrangementsMember" xlink:to="lab_rdnt_CapitationArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_4e92e18e-7f90-44b4-a370-f2e0d0177a5f_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_beabdda4-cf28-43a8-add0-86a732d1d880_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_5731e423-a535-408c-a3c8-a86bf0a541c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Remaining Contractual Term (Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_c992f6b0-89af-4133-b9d5-8e7f9f91e1ba_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LongTermContractsTerm_04af9db0-e485-408a-bbb7-f8da7f20b0bf_terseLabel_en-US" xlink:label="lab_rdnt_LongTermContractsTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term contracts, term</link:label>
    <link:label id="lab_rdnt_LongTermContractsTerm_label_en-US" xlink:label="lab_rdnt_LongTermContractsTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Contracts, Term</link:label>
    <link:label id="lab_rdnt_LongTermContractsTerm_documentation_en-US" xlink:label="lab_rdnt_LongTermContractsTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Contracts, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermContractsTerm" xlink:href="rdnt-20201231.xsd#rdnt_LongTermContractsTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LongTermContractsTerm" xlink:to="lab_rdnt_LongTermContractsTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e006c3b8-7f5f-4705-91b3-1ad04132d7cb_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_aa376117-078a-475c-be53-5e2eaf395ef8_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_85bdf691-87ce-45cc-a626-669506134d32_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_3d9adb11-4423-4de0-a602-c76c11ef80b8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_23c2e1cc-5de2-410c-9b39-bb35e9c689a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other reconciling items</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherReconcilingItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_90b72dcb-cab8-4e36-a782-1f2e9d616ea3_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_64c9ecff-cf41-494f-afc4-13cf76fec30b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS COMBINATION</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_37d1d248-a54c-49a0-893e-fac2a98db826_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_56d02f24-39ae-4648-8e11-1632d5e2d39d_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b963d493-0922-4b05-ae43-fd1898e759c1_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expenses (income)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d0078861-9a99-4f01-8071-add34768f651_netLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock upon exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d46e9248-7ac4-4957-9e5c-e135b23f6a67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_12f29db3-07e5-43fb-8ba3-6a6b5d1f38f6_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_3f47c853-16b3-4c20-989e-d0df67d86279_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AZTechRadiologyOpenMRILLCMember_8e6ef361-d55e-443d-b7d4-7184631a8447_terseLabel_en-US" xlink:label="lab_rdnt_AZTechRadiologyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ-Tech Radiology &amp; Open MRI, LLC</link:label>
    <link:label id="lab_rdnt_AZTechRadiologyOpenMRILLCMember_label_en-US" xlink:label="lab_rdnt_AZTechRadiologyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ-Tech Radiology &amp; Open MRI, LLC [Member]</link:label>
    <link:label id="lab_rdnt_AZTechRadiologyOpenMRILLCMember_documentation_en-US" xlink:label="lab_rdnt_AZTechRadiologyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AZ-Tech Radiology &amp; Open MRI, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechRadiologyOpenMRILLCMember" xlink:href="rdnt-20201231.xsd#rdnt_AZTechRadiologyOpenMRILLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AZTechRadiologyOpenMRILLCMember" xlink:to="lab_rdnt_AZTechRadiologyOpenMRILLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_9dbb1029-35e0-4104-a738-b4086702ded8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_5723d237-e3e8-4ddd-8cb3-d9f702c71581_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value, vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_c8ad644a-e65d-4a36-8675-821a95eb4eaa_terseLabel_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_label_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</link:label>
    <link:label id="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_documentation_en-US" xlink:label="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:href="rdnt-20201231.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:to="lab_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_2169532f-c029-4302-9b40-78229020a19e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of cash flow hedge, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_22c1b692-6a5e-4ee7-b154-8d597a7b2761_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_49480e58-c221-4766-a692-60a46849c96a_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_f311acdd-2b14-478a-9942-48b68dc5b483_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_92ee09a0-5567-407d-a878-c823eb05479b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PaymentsToAcquireInterestInSubsidiaries_45194409-fece-4cd7-9789-9200085872f4_negatedTerseLabel_en-US" xlink:label="lab_rdnt_PaymentsToAcquireInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of noncontrolling interests</link:label>
    <link:label id="lab_rdnt_PaymentsToAcquireInterestInSubsidiaries_label_en-US" xlink:label="lab_rdnt_PaymentsToAcquireInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries</link:label>
    <link:label id="lab_rdnt_PaymentsToAcquireInterestInSubsidiaries_documentation_en-US" xlink:label="lab_rdnt_PaymentsToAcquireInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentsToAcquireInterestInSubsidiaries" xlink:href="rdnt-20201231.xsd#rdnt_PaymentsToAcquireInterestInSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PaymentsToAcquireInterestInSubsidiaries" xlink:to="lab_rdnt_PaymentsToAcquireInterestInSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_e1332ea9-af45-482b-8590-e4dd863b889a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current and long term liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_99c2c7b7-d21f-4be4-a24e-2d8a37bfe48e_terseLabel_en-US" xlink:label="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Primedex Health Systems Inc. and Radiologix</link:label>
    <link:label id="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_label_en-US" xlink:label="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Primedex Health Systems Inc. and Radiologix [Member]</link:label>
    <link:label id="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_documentation_en-US" xlink:label="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Primedex Health Systems Inc. and Radiologix [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:href="rdnt-20201231.xsd#rdnt_PrimedexHealthSystemsInc.andRadiologixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:to="lab_rdnt_PrimedexHealthSystemsInc.andRadiologixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_00581ba1-d4bc-48ab-bafd-d308c037fad6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncertain tax provisions</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_ea4c73f6-e8b8-49fb-9405-20844123960b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_bc9b7661-5731-4ecc-a64c-b70b59114a4c_terseLabel_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostic Radiology Group LLC</link:label>
    <link:label id="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_label_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostic Radiology Group LLC [Member]</link:label>
    <link:label id="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arizona Diagnostic Radiology Group LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:href="rdnt-20201231.xsd#rdnt_ArizonaDiagnosticRadiologyGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:to="lab_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_118769f6-000b-430b-9ffe-101ac749d528_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt issuance, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_132a806b-b1e0-4e69-bec5-66784c5f4c1d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_1d12f5d3-776b-4e20-887d-1c9f7e8d1268_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d3d0565f-94c8-4d8e-9022-0d7768d4a0d2_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME FROM OPERATIONS</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CHINationalServicesIncMember_ee460872-b5e5-4658-a6fc-8d76ea1c6afe_terseLabel_en-US" xlink:label="lab_rdnt_CHINationalServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHI National Services Inc.</link:label>
    <link:label id="lab_rdnt_CHINationalServicesIncMember_label_en-US" xlink:label="lab_rdnt_CHINationalServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHI National Services Inc. [Member]</link:label>
    <link:label id="lab_rdnt_CHINationalServicesIncMember_documentation_en-US" xlink:label="lab_rdnt_CHINationalServicesIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CHI National Services Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CHINationalServicesIncMember" xlink:href="rdnt-20201231.xsd#rdnt_CHINationalServicesIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CHINationalServicesIncMember" xlink:to="lab_rdnt_CHINationalServicesIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RadiologixMember_7f5597b8-9ca4-4577-9b49-ed66a732760e_terseLabel_en-US" xlink:label="lab_rdnt_RadiologixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radiologix</link:label>
    <link:label id="lab_rdnt_RadiologixMember_label_en-US" xlink:label="lab_rdnt_RadiologixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radiologix [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadiologixMember" xlink:href="rdnt-20201231.xsd#rdnt_RadiologixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RadiologixMember" xlink:to="lab_rdnt_RadiologixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_ab60633d-9cc9-4b09-8333-773ddeedb23a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional deferred finance costs on revolving loan amendment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_715ce7ca-fbdd-4a5a-ab50-cae85cf4ab3a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Service Fee Revenue</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Transactions Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:to="lab_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_854733f1-a1f5-4ea3-bd3e-2c6eaa0fddcd_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GoodwillDeductibleForTaxPurposes_656000f6-7a91-4990-bcd8-d35f6b81a2fa_terseLabel_en-US" xlink:label="lab_rdnt_GoodwillDeductibleForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes</link:label>
    <link:label id="lab_rdnt_GoodwillDeductibleForTaxPurposes_label_en-US" xlink:label="lab_rdnt_GoodwillDeductibleForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes</link:label>
    <link:label id="lab_rdnt_GoodwillDeductibleForTaxPurposes_documentation_en-US" xlink:label="lab_rdnt_GoodwillDeductibleForTaxPurposes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill deductible for tax purposes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GoodwillDeductibleForTaxPurposes" xlink:href="rdnt-20201231.xsd#rdnt_GoodwillDeductibleForTaxPurposes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GoodwillDeductibleForTaxPurposes" xlink:to="lab_rdnt_GoodwillDeductibleForTaxPurposes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_f1919266-9fcd-4b7e-b21d-fa2b0f7cc5f6_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance accrual</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserve" xlink:to="lab_us-gaap_SelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_9d647818-3880-4747-8e3d-f50f0181d981_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3268ac36-a17f-4133-93ad-02e755b58212_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_2c85426b-17f6-4f6e-b25c-4d3ca77fb846_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition of equity method interest upon acquisition of control in NJIN</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScriptSenderMember_2ef5e1a6-25f6-44b3-af1e-a506e44fe9e0_terseLabel_en-US" xlink:label="lab_rdnt_ScriptSenderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScriptSender LLC</link:label>
    <link:label id="lab_rdnt_ScriptSenderMember_label_en-US" xlink:label="lab_rdnt_ScriptSenderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ScriptSender LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderMember" xlink:href="rdnt-20201231.xsd#rdnt_ScriptSenderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScriptSenderMember" xlink:to="lab_rdnt_ScriptSenderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_93e6dee6-faf0-4e7b-8140-5695bc69e76f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment award, award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_0438ea17-bc18-40b4-b5ee-1c7987a6759c_terseLabel_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems</link:label>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_label_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems [Member]</link:label>
    <link:label id="lab_rdnt_TurnerImagingSystemsMember_documentation_en-US" xlink:label="lab_rdnt_TurnerImagingSystemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging Systems [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember" xlink:href="rdnt-20201231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TurnerImagingSystemsMember" xlink:to="lab_rdnt_TurnerImagingSystemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f03ebdea-9b0a-410e-b65e-22e482b03e3d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_4820b106-38df-42d4-aa7e-4c0cc2e06c93_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer and office equipment, furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_84c98e10-b763-4377-9e61-e3c06affa0cd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2e318062-a631-4e6a-b88e-01ee974b6b1b_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA's vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_18c93a4a-c5f6-4be5-ae6a-d939992a0774_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_2c93e129-0cbc-4411-a30e-ec1e57ff5b8b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability_1ef2548a-8951-4d96-bfc5-432324a4d252_negatedTerseLabel_en-US" xlink:label="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability_label_en-US" xlink:label="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease in Operating Lease Liability</link:label>
    <link:label id="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability_documentation_en-US" xlink:label="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase Decrease in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseDecreaseinOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:to="lab_rdnt_IncreaseDecreaseinOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DignityHealth.Member_c3c9c98d-7711-4424-92d8-098c24ce2688_terseLabel_en-US" xlink:label="lab_rdnt_DignityHealth.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health.</link:label>
    <link:label id="lab_rdnt_DignityHealth.Member_label_en-US" xlink:label="lab_rdnt_DignityHealth.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health. [Member]</link:label>
    <link:label id="lab_rdnt_DignityHealth.Member_documentation_en-US" xlink:label="lab_rdnt_DignityHealth.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealth.Member" xlink:href="rdnt-20201231.xsd#rdnt_DignityHealth.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DignityHealth.Member" xlink:to="lab_rdnt_DignityHealth.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_33ff7bbd-c4ba-4d5b-b93c-169f65be3867_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_09c73ded-c4f5-4f3f-ba1a-e416bd01b3d7_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_8121e1ae-5f6d-409b-8338-53c02fe37e68_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5f41409c-0f3a-487b-b53f-af757ff50b46_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_89c8fed0-91c9-40bd-9e63-f73fc5b4fc99_terseLabel_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:label id="lab_us-gaap_OffsettingAssetsTable_label_en-US" xlink:label="lab_us-gaap_OffsettingAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Offsetting Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OffsettingAssetsTable" xlink:to="lab_us-gaap_OffsettingAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_262d2d0d-a75e-440f-a5c2-5b283f3d56b9_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount on First Lien Term Loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_9e169c90-5202-4a90-9c52-609aab7a681c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount on term loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_030bc264-8879-43dc-8ec6-24fcc339abb6_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_073ee2c4-f573-4405-bce0-1f79403936d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_e221754a-1cc2-49ec-89d9-06f7e854a53c_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TermLoanMember_e751257a-7362-4a29-b03b-e60f024eafd5_terseLabel_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_rdnt_TermLoanMember_label_en-US" xlink:label="lab_rdnt_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember" xlink:href="rdnt-20201231.xsd#rdnt_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TermLoanMember" xlink:to="lab_rdnt_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_9b8d1eed-cfb1-4141-9c33-7bcf5ffc7174_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_afd6c817-7a79-4799-80cb-e933b7a856e8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d32ecdb5-183b-4ba7-8ede-b22550cf8683_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember_679419f0-766c-47de-8f94-57c826f2c93b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment under financing/capital lease</link:label>
    <link:label id="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember_label_en-US" xlink:label="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held under Capital Leases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:to="lab_us-gaap_AssetsHeldUnderCapitalLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OlneyOpenMRILLCMember_4a056c75-e1b2-4f6b-af9c-883246e10215_terseLabel_en-US" xlink:label="lab_rdnt_OlneyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Olney Open MRI, LLC</link:label>
    <link:label id="lab_rdnt_OlneyOpenMRILLCMember_label_en-US" xlink:label="lab_rdnt_OlneyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Olney Open MRI, LLC [Member]</link:label>
    <link:label id="lab_rdnt_OlneyOpenMRILLCMember_documentation_en-US" xlink:label="lab_rdnt_OlneyOpenMRILLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Olney Open MRI, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember" xlink:href="rdnt-20201231.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OlneyOpenMRILLCMember" xlink:to="lab_rdnt_OlneyOpenMRILLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_fa94f5d1-ac83-497a-84c8-f342387978ae_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRMG and NY Groups operating expenses</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_ffe690e8-9de8-45ed-8c46-278fc653636f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_780a388d-fc6a-47db-90b1-f322c07bd9ed_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity method investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_104abf3a-fab6-4135-9708-c467997d4c8f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment at cost</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_dec6141f-3ef5-4554-9c23-3239c99a04fe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c1b3f4cc-a654-49a8-ae32-757cd849c6e8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_EquityContributionsJointVentures_dad0ff69-4602-4621-ad8d-d40515fd3767_terseLabel_en-US" xlink:label="lab_rdnt_EquityContributionsJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing and purchase of interest in joint ventures</link:label>
    <link:label id="lab_rdnt_EquityContributionsJointVentures_label_en-US" xlink:label="lab_rdnt_EquityContributionsJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing and purchase of interest in joint ventures</link:label>
    <link:label id="lab_rdnt_EquityContributionsJointVentures_documentation_en-US" xlink:label="lab_rdnt_EquityContributionsJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity contributions in existing joint ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityContributionsJointVentures" xlink:href="rdnt-20201231.xsd#rdnt_EquityContributionsJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_EquityContributionsJointVentures" xlink:to="lab_rdnt_EquityContributionsJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_StockholdersEquityDeficitMember_8329341b-e45b-4866-b80a-d058a3167a12_terseLabel_en-US" xlink:label="lab_rdnt_StockholdersEquityDeficitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Radnet, Inc. Stockholders' Equity</link:label>
    <link:label id="lab_rdnt_StockholdersEquityDeficitMember_label_en-US" xlink:label="lab_rdnt_StockholdersEquityDeficitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Radnet, Inc.'s Equity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockholdersEquityDeficitMember" xlink:href="rdnt-20201231.xsd#rdnt_StockholdersEquityDeficitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_StockholdersEquityDeficitMember" xlink:to="lab_rdnt_StockholdersEquityDeficitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_44ac69b3-b003-48bb-8aae-3b4d87bd374c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options cancelled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_90896b96-fba3-4f4e-b522-64e17f0f1c94_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress, gross</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressGross_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressGross" xlink:to="lab_us-gaap_ConstructionInProgressGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6b9c2de7-2d4f-44f6-9df0-861fb6dc88ee_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_4b6ccb5b-40b8-46b5-ad6b-e2254e039f74_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&gt; 4.00x but &#8804; 5.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioTwoMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioTwoMember" xlink:to="lab_rdnt_LeverageRatioTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_213e2e89-a4d7-4775-bf3e-20b24020bee7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_ad41eb2c-e671-4478-98e3-9199e5427225_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENT IN JOINT VENTURES</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CapitalLeaseDebt_fdd69a80-cd18-4cf1-a733-ad41c670f077_terseLabel_en-US" xlink:label="lab_rdnt_CapitalLeaseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital lease debt</link:label>
    <link:label id="lab_rdnt_CapitalLeaseDebt_label_en-US" xlink:label="lab_rdnt_CapitalLeaseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital lease debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitalLeaseDebt" xlink:href="rdnt-20201231.xsd#rdnt_CapitalLeaseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CapitalLeaseDebt" xlink:to="lab_rdnt_CapitalLeaseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_5a36aaea-2ae1-46c5-9a01-48d032f227b8_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt periodic payment, amortization increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment Terms, Amortization Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPSMember_d4835579-8d7f-4bc7-b829-a38415a4a5a8_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_label_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPSMember_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember" xlink:href="rdnt-20201231.xsd#rdnt_A2019SWAPSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPSMember" xlink:to="lab_rdnt_A2019SWAPSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_5feb48f3-911f-4316-9d41-da3057d03898_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_f324169b-800b-490e-a40f-dcf25a4db2fd_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock for acquisitions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_82e87083-dd87-4972-b20f-59c1fed65218_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_df7fb135-e305-436f-93f2-7ee97eeb3c41_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_bcbeaf54-c90b-41a3-baf6-9b599e9c249d_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity a Voluntary Filer</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ERADMember_e9b3752f-36ee-4d4d-9d4d-749792cab487_terseLabel_en-US" xlink:label="lab_rdnt_ERADMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">eRAD</link:label>
    <link:label id="lab_rdnt_ERADMember_label_en-US" xlink:label="lab_rdnt_ERADMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">eRAD [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember" xlink:href="rdnt-20201231.xsd#rdnt_ERADMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ERADMember" xlink:to="lab_rdnt_ERADMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_e110602d-4720-418f-abba-352eaaad97a5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_b4e22139-1d63-4ea2-b8db-2c44cee57f1c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment owned, at fair value</link:label>
    <link:label id="lab_us-gaap_InvestmentOwnedAtFairValue_label_en-US" xlink:label="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Owned, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentOwnedAtFairValue" xlink:to="lab_us-gaap_InvestmentOwnedAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_3ca744ae-1c34-4e20-a039-ed21dd430a23_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_e4b99fe2-19c9-4649-a988-9676e9c4a4b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Agreement and First Lien Term Loans</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_d70ddf38-f5fe-499b-9b34-46d1661ceb94_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_c1f63e9e-60a0-45aa-a2d6-283de10fa0bf_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPCompaniesMember_ddcbe023-6bb7-4286-a456-221d74493ca6_terseLabel_en-US" xlink:label="lab_rdnt_ZPCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Companies</link:label>
    <link:label id="lab_rdnt_ZPCompaniesMember_label_en-US" xlink:label="lab_rdnt_ZPCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Companies [Member]</link:label>
    <link:label id="lab_rdnt_ZPCompaniesMember_documentation_en-US" xlink:label="lab_rdnt_ZPCompaniesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Companies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPCompaniesMember" xlink:href="rdnt-20201231.xsd#rdnt_ZPCompaniesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPCompaniesMember" xlink:to="lab_rdnt_ZPCompaniesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SimiAdventistMember_4cf6959a-bd42-4c7b-b69b-b653a3963a68_terseLabel_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist</link:label>
    <link:label id="lab_rdnt_SimiAdventistMember_label_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist [Member]</link:label>
    <link:label id="lab_rdnt_SimiAdventistMember_documentation_en-US" xlink:label="lab_rdnt_SimiAdventistMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Adventist</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember" xlink:href="rdnt-20201231.xsd#rdnt_SimiAdventistMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SimiAdventistMember" xlink:to="lab_rdnt_SimiAdventistMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_cf88b39a-50eb-4af3-a969-f00d2a1d7ce8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a2ced6c1-be0d-48bf-be21-5dd4292681f2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AssetAcquisitionAxis_4660bc5e-c476-4196-8555-a1c2b14ad31f_terseLabel_en-US" xlink:label="lab_rdnt_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_rdnt_AssetAcquisitionAxis_label_en-US" xlink:label="lab_rdnt_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_rdnt_AssetAcquisitionAxis_documentation_en-US" xlink:label="lab_rdnt_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionAxis" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AssetAcquisitionAxis" xlink:to="lab_rdnt_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_f3813d50-0f48-4d20-a6f8-9f7c0c54e988_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_2ea5b6bd-058d-412e-a7a5-025d0f372fa2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_49816dfc-eee4-4180-96cf-f83f83d56f30_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock_2d9a298c-c58c-4846-a2b9-8039ddfdcc85_terseLabel_en-US" xlink:label="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LOSS AND OTHER UNFAVORABLE CONTRACTS</link:label>
    <link:label id="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock_label_en-US" xlink:label="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss and Other Unfavorable Contracts [Policy Text Block]</link:label>
    <link:label id="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock_documentation_en-US" xlink:label="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss and Other Unfavorable Contracts [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:href="rdnt-20201231.xsd#rdnt_LossandOtherUnfavorableContractsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:to="lab_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TurnerImagingMember_25d35644-e2f8-4d41-aafc-4a4900ed1c22_terseLabel_en-US" xlink:label="lab_rdnt_TurnerImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging</link:label>
    <link:label id="lab_rdnt_TurnerImagingMember_label_en-US" xlink:label="lab_rdnt_TurnerImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Turner Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingMember" xlink:href="rdnt-20201231.xsd#rdnt_TurnerImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TurnerImagingMember" xlink:to="lab_rdnt_TurnerImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_f1ffdf88-9581-4247-b5ec-e0f4774432a6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_f2d06dc1-5bc7-4f5d-81ac-7679f299b4d0_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total credit facilities outstanding</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_e3b262e6-e413-4f4e-8601-f40f4c6b281a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the sale of equity interests in a joint venture</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_8b65a653-ca7e-4c83-92bb-bc5ce416f812_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_8d3470c0-f8c2-41f3-9909-7501f87aa708_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_b6d82670-1eac-41fc-87c1-ae0772efefd1_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on term loan debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_8446db1e-7133-457a-9131-f2da29144f82_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment in Joint Ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_afccc1de-e885-4fc5-bdc2-de6ba217608f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0477eb17-450c-4650-937b-5ec0c63f0f99_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_fb116816-a85f-4400-8f4b-31b54c0b4017_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_446507a6-14cb-45da-8f04-001a6b9d3904_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_9e4d2bed-d405-468b-bb35-b56124a8667a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_796bd185-82ea-4a61-9f8b-066c210797f6_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of replacement awards attributable to pre-combination</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:to="lab_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_a93b6892-0e16-4489-8fe8-7e6cc1805bab_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_04ff558b-da78-4892-9f3a-af2f98b59c37_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_3b66bfd0-790b-49f1-b4e5-6e0001dd0dfc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_bcfe2a40-54fe-432e-a1a2-bb4c052ac46d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_bf69dc16-453c-4f74-af34-3324ea188715_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_1c7a353c-8c3b-46c2-8870-821e0aab546d_terseLabel_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Leverage Ratio</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_label_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:label id="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Leverage Ratio [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:href="rdnt-20201231.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:to="lab_rdnt_ScheduleOfLeverageRatioTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_08f10301-0c97-4bbc-af35-2d218aac9e32_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCOUNTS RECEIVABLE</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_22cd798b-de87-40cd-84da-c84e936464a7_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal current tax</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_898ee6f8-6255-495b-adac-5ceeed1229a1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_2d13e543-fee6-4651-94f2-f9657d407665_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State current tax</link:label>
    <link:label id="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_label_en-US" xlink:label="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Income Tax Expense (Benefit), Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:to="lab_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_68f89879-2add-4790-9185-77c0b30784fe_terseLabel_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</link:label>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="rdnt-20201231.xsd#rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue_31c7bf83-f3ee-46d0-a753-274ccf5b7fc3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business consideration liability adjustment recorded amount</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Liabilities Arising from Contingencies, Amount Recognized, Other than at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:to="lab_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_b5c75bee-68ab-4049-8443-070ff7ab7c33_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, milestone one, shares issued (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone One, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:to="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_9d0c3d95-2402-4bdd-914a-c7705b4b3f1d_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management services provided to BRMG and NY Groups</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Measure of Activity, Income or Loss before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:to="lab_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_209492b5-7741-4dfa-b696-ac30f0a90d34_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows from financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_2f8b03ee-7aac-4cf9-97e5-150cc33b730b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_02adb0de-de7d-4202-b7c0-06ad7a7771b2_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_4e3854be-390b-45d0-9f8b-9a6822d421bf_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_17f1d6d0-4e5b-428d-afcb-dbd8be0f19f3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_79cc2983-7d10-4e4f-825c-8d564777d038_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital lease assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_e53e63cf-259d-45aa-b84d-5c4c9466547e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortiztion total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_741a12d8-2327-4426-a4a6-7195bad379ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SunTrustMember_7af307db-e7b3-4c0a-af6b-002686aacee1_terseLabel_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust</link:label>
    <link:label id="lab_rdnt_SunTrustMember_label_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:label id="lab_rdnt_SunTrustMember_documentation_en-US" xlink:label="lab_rdnt_SunTrustMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SunTrust [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember" xlink:href="rdnt-20201231.xsd#rdnt_SunTrustMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SunTrustMember" xlink:to="lab_rdnt_SunTrustMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_cabe35d1-b87f-41b4-93cd-0dd6b97ab18c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NATURE OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Description and Basis of Presentation [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:to="lab_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdditionalEquityInterestAcquired_21cb35c4-5c20-4d80-88c9-47a9bfce4f3d_terseLabel_en-US" xlink:label="lab_rdnt_AdditionalEquityInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional equity interest acquired</link:label>
    <link:label id="lab_rdnt_AdditionalEquityInterestAcquired_label_en-US" xlink:label="lab_rdnt_AdditionalEquityInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional equity interest acquired</link:label>
    <link:label id="lab_rdnt_AdditionalEquityInterestAcquired_documentation_en-US" xlink:label="lab_rdnt_AdditionalEquityInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional equity interest acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdditionalEquityInterestAcquired" xlink:href="rdnt-20201231.xsd#rdnt_AdditionalEquityInterestAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdditionalEquityInterestAcquired" xlink:to="lab_rdnt_AdditionalEquityInterestAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_cf536e94-4e45-4773-877f-7856bf3f5cd0_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_d1ce52ba-cffd-4dda-a5db-7dc737517ad0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Finance Lease Liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_c59f5b8f-bc38-46e1-9e09-69af27f29cb0_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_11f44c9a-cb45-4027-b21f-4373ab6705a1_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f107ad79-e43c-43a8-b225-7de005767b88_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_0a77f6f7-75f9-4318-a710-e69741b6aaa5_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest, ownership percentage</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_791baabb-81fc-4b66-b6c9-2812e7f79ef9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider relief funding</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_e1c48411-cd3d-4d4f-a24e-2cbc5dc54362_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LeverageRatioFourMember_b344122a-4a53-4032-b27d-c9af2edd928d_terseLabel_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">&#8804; 3.50x</link:label>
    <link:label id="lab_rdnt_LeverageRatioFourMember_label_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Four [Member]</link:label>
    <link:label id="lab_rdnt_LeverageRatioFourMember_documentation_en-US" xlink:label="lab_rdnt_LeverageRatioFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leverage Ratio Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LeverageRatioFourMember" xlink:to="lab_rdnt_LeverageRatioFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_b888bef7-806f-40f4-84e5-f529fef01ec6_negatedTerseLabel_en-US" xlink:label="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect on gain on sale of noncontrolling interest</link:label>
    <link:label id="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_label_en-US" xlink:label="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest</link:label>
    <link:label id="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_documentation_en-US" xlink:label="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:href="rdnt-20201231.xsd#rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:to="lab_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b3732f35-e7ac-4356-b44a-67c616f5cb65_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized expense weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_e15650f8-b7fa-4778-90b3-755524a50324_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_b1b6c33e-195b-4884-b9c3-011713bd8b5b_terseLabel_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging</link:label>
    <link:label id="lab_rdnt_GlendaleAdvancedImagingMember_label_en-US" xlink:label="lab_rdnt_GlendaleAdvancedImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Glendale Advanced Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember" xlink:href="rdnt-20201231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GlendaleAdvancedImagingMember" xlink:to="lab_rdnt_GlendaleAdvancedImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AwardsIssuedToDate_3fe049ed-87bc-48db-a0b8-d5a408d97bef_terseLabel_en-US" xlink:label="lab_rdnt_AwardsIssuedToDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards issued to date (in shares)</link:label>
    <link:label id="lab_rdnt_AwardsIssuedToDate_label_en-US" xlink:label="lab_rdnt_AwardsIssuedToDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards issued to date</link:label>
    <link:label id="lab_rdnt_AwardsIssuedToDate_documentation_en-US" xlink:label="lab_rdnt_AwardsIssuedToDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards issued to date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AwardsIssuedToDate" xlink:href="rdnt-20201231.xsd#rdnt_AwardsIssuedToDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AwardsIssuedToDate" xlink:to="lab_rdnt_AwardsIssuedToDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_adbd3a0a-05df-4341-ba74-8a64f134c398_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_c0378eca-17ea-48de-addc-ea03c2273edf_terseLabel_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets and Liabilities Lessee</link:label>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities Lessee [Table Text Block]</link:label>
    <link:label id="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Table Text Block] for Assets And Liabilities Lessee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="rdnt-20201231.xsd#rdnt_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_05c2bb78-28c5-47b6-88f4-050fbdd89c75_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash change in fair value of interest rate hedge</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_4ffcd9a2-9afe-4106-9df6-a1a3da92af9e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_3b467d91-5260-4348-b7d3-66561241a2dc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_280e070c-3f7e-4acc-ae24-aa7e2639782a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_96365389-ba25-4bab-b67c-8d9ac8410646_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain" xlink:to="lab_us-gaap_CreditDerivativesContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_3091b573-408e-45e0-9d92-9be716d95b62_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_dd6be7f7-cc0b-4ad0-911c-9bc274077ba3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current and long term liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_66c3b3c1-a25a-427c-a1d4-63eade92ee45_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income&#160;to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Caps2016Member_a51d3e4c-9700-4e1b-a3f9-d0d6d83e623c_terseLabel_en-US" xlink:label="lab_rdnt_Caps2016Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Caps</link:label>
    <link:label id="lab_rdnt_Caps2016Member_label_en-US" xlink:label="lab_rdnt_Caps2016Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2016 Caps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member" xlink:href="rdnt-20201231.xsd#rdnt_Caps2016Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Caps2016Member" xlink:to="lab_rdnt_Caps2016Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_61d5925b-6fa9-4461-9e4e-685c216bda4a_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_2fa1f96a-0737-4a82-8cfe-156f495e5657_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State franchise tax, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_440a3a55-a32e-4d22-ad73-ba487677fc54_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_e30e1048-06c5-44ec-8bdd-c69c5768a9ef_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_b8fe5917-1982-4d81-8e6f-c6fa52256cfc_terseLabel_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Notes Payables [Abstract]</link:label>
    <link:label id="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_label_en-US" xlink:label="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Long-term Debt and Capital Lease Obligations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:to="lab_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_ae5ee4f8-356c-4685-be00-8dd84781091c_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_0cc4c1a0-a013-4421-9988-0d9cb1583cd9_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECLASSIFICATION</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_154a143f-15d8-4085-81a7-0e9e2e21a0a9_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_6628f29d-8fcd-402c-aed2-2a215828ab2e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUES</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c485c7b5-b1fc-4f62-9d3b-81da15520be1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumption of debt as consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RamicMahwahLLCMember_38e66d05-7a1e-445c-8e1a-ea66d425b698_terseLabel_en-US" xlink:label="lab_rdnt_RamicMahwahLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramic Mahwah LLC</link:label>
    <link:label id="lab_rdnt_RamicMahwahLLCMember_label_en-US" xlink:label="lab_rdnt_RamicMahwahLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramic Mahwah LLC [Member]</link:label>
    <link:label id="lab_rdnt_RamicMahwahLLCMember_documentation_en-US" xlink:label="lab_rdnt_RamicMahwahLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ramic Mahwah LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RamicMahwahLLCMember" xlink:href="rdnt-20201231.xsd#rdnt_RamicMahwahLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RamicMahwahLLCMember" xlink:to="lab_rdnt_RamicMahwahLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_a7ce388a-7bcb-4c51-9ad4-7bbed8918fac_terseLabel_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC</link:label>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_label_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC [Member]</link:label>
    <link:label id="lab_rdnt_SimiValleyImagingGroupLLCMember_documentation_en-US" xlink:label="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simi Valley Imaging Group, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember" xlink:href="rdnt-20201231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_SimiValleyImagingGroupLLCMember" xlink:to="lab_rdnt_SimiValleyImagingGroupLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_73ea2b12-6182-4f25-957e-6a4973848a86_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b641224f-0b83-477c-817e-8e8e6592d2c1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_6932de5e-dbd3-45d6-8292-e176cbd77cdc_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_6e743ead-25cf-4169-880a-6264cc547e74_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization year 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_2fb9eb57-a67e-4b5f-a617-ffc529edc39e_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_f6fe70f7-3fdb-40c3-94e4-b6efb92b85c3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_1ac39429-b88f-4753-940a-71f9e7c61f0b_terseLabel_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_label_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_rdnt_AggregateIntrinsicValue_documentation_en-US" xlink:label="lab_rdnt_AggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue" xlink:href="rdnt-20201231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AggregateIntrinsicValue" xlink:to="lab_rdnt_AggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b322463f-7e62-42c6-8bae-008701e4785e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NumberOfCenters_4d2fb832-cf03-4c89-a9d3-1f3d2831bb81_terseLabel_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_label_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:label id="lab_rdnt_NumberOfCenters_documentation_en-US" xlink:label="lab_rdnt_NumberOfCenters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters" xlink:href="rdnt-20201231.xsd#rdnt_NumberOfCenters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NumberOfCenters" xlink:to="lab_rdnt_NumberOfCenters" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_40f71707-5707-47f5-a3e0-f0c7af165f4c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_449b81c7-71b5-46be-9a18-dc99185c8f60_terseLabel_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from paycheck protection program loans</link:label>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_label_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:label id="lab_rdnt_ProceedsFromGovernmentAssistance_documentation_en-US" xlink:label="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Government Assistance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance" xlink:href="rdnt-20201231.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ProceedsFromGovernmentAssistance" xlink:to="lab_rdnt_ProceedsFromGovernmentAssistance" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPOzoneParkLLCMember_d10e0343-23ab-40ba-b9e0-e142f6aede7d_terseLabel_en-US" xlink:label="lab_rdnt_ZPOzoneParkLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Ozone Park, LLC</link:label>
    <link:label id="lab_rdnt_ZPOzoneParkLLCMember_label_en-US" xlink:label="lab_rdnt_ZPOzoneParkLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Ozone Park, LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPOzoneParkLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPOzoneParkLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Ozone Park, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPOzoneParkLLCMember" xlink:href="rdnt-20201231.xsd#rdnt_ZPOzoneParkLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPOzoneParkLLCMember" xlink:to="lab_rdnt_ZPOzoneParkLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_d3ca93bd-b670-4f1d-8a6a-8cbca73ace23_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c102417d-23bc-431b-9dc0-2fe4e9a5eded_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash_cdd07a29-ca7e-45af-a3ef-06425b3854c9_terseLabel_en-US" xlink:label="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire equity method investments, cash</link:label>
    <link:label id="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash_label_en-US" xlink:label="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments Cash</link:label>
    <link:label id="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash_documentation_en-US" xlink:label="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Equity Method Investments Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash" xlink:href="rdnt-20201231.xsd#rdnt_PaymentstoAcquireEquityMethodInvestmentsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash" xlink:to="lab_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_bd31085d-7f0c-4efd-b7c8-444ee1634fc4_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_774caa35-cf9e-48f7-a477-dd9397bfa342_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Income Tax Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_468631fb-7f64-4bb6-9347-8dd955208be1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_39cb908c-d196-4cce-87c9-b96e13ff12d7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_3825ab06-c588-4677-b493-f275eb2a3eb7_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_2b85a7ba-cca2-43a7-ae14-44fb240066a3_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WeightedAverageAmortizationPeriodRemainingInYears_528e6e83-64f7-43d8-ab12-54585d08b992_terseLabel_en-US" xlink:label="lab_rdnt_WeightedAverageAmortizationPeriodRemainingInYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period remaining in years</link:label>
    <link:label id="lab_rdnt_WeightedAverageAmortizationPeriodRemainingInYears_label_en-US" xlink:label="lab_rdnt_WeightedAverageAmortizationPeriodRemainingInYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period remaining in years</link:label>
    <link:label id="lab_rdnt_WeightedAverageAmortizationPeriodRemainingInYears_documentation_en-US" xlink:label="lab_rdnt_WeightedAverageAmortizationPeriodRemainingInYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period remaining in years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageAmortizationPeriodRemainingInYears" xlink:href="rdnt-20201231.xsd#rdnt_WeightedAverageAmortizationPeriodRemainingInYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WeightedAverageAmortizationPeriodRemainingInYears" xlink:to="lab_rdnt_WeightedAverageAmortizationPeriodRemainingInYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_56d508de-55ba-44e4-b885-a4bbb599e7d2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_99efc588-f0da-4e3b-a02c-e810828d00b0_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_f4f77eec-230e-40de-affd-0ce506659b4e_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation liability, current</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_dfe0ad29-7e4f-49d8-ac44-1c4a0fb4bebd_totalLabel_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property, equipment and right-of-use-assets</link:label>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:label id="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_documentation_en-US" xlink:label="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="rdnt-20201231.xsd#rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_a0fe0e94-13f8-4d52-a83f-b810efc5278f_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET (LOSS) INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_b2827a46-0be1-4081-bb93-76d5c526ae7a_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET (LOSS) INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_3bda6e80-b425-4223-9b98-be923f8ec640_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_fb355e61-93e8-41cc-a9f1-1d73a627d078_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-LIVED ASSETS</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_e19af9fd-b02c-47a6-b481-02c7cc707f1b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_181f82db-fa64-4bf5-ad5d-8b7df88f6367_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_6c7e26f4-8fda-42a7-b628-fdb699d9ba87_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_18e3a186-244d-4784-b328-fb2e57d68fac_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_SecuritiesFinancingTransactionAxis_label_en-US" xlink:label="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Financing Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis" xlink:to="lab_us-gaap_SecuritiesFinancingTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_35be463c-3d7a-479f-b3f4-4d9e09a07585_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_548fad82-dcd9-4d07-8e79-12a7f45cfc31_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_8f3963c0-69e3-4d7d-89a6-8ba61aa3e83d_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contribution, percent</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_310930c8-5bd2-4794-a808-33008ad24310_negatedLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution of earnings</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_35ba5fd1-3391-4c5d-be03-87930c2c8809_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_6a37c746-cfef-4739-be5b-08541ba6202d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_1fe7f8e3-a1a9-45a7-bc8e-6f68cea32da5_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_453cb7c5-a21c-4934-9028-3dfad6846197_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_35fb0b1b-d9ad-4dc8-9add-cf978773fe14_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_f201311a-7dfb-48ef-9f43-d9276b03ed35_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Deferred Tax Assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_4dd7b98b-729d-4396-aa70-27d74f4626be_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b31da160-0f57-48c6-85fd-f32fc9de13fc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b1f32284-6804-46b3-b6b2-32058179a614_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_da12978b-3d53-4e58-a747-16cb49dd9b92_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_5e6084b8-37ef-48f4-b69b-1a5eb471725d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_11f0c2e3-1eee-4a43-a690-fb4bacdb5181_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_1549d186-c518-4c6b-933e-6f95a229082f_terseLabel_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, milestone three, shares issued (in shares)</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_label_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:label id="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_documentation_en-US" xlink:label="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:to="lab_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_d0ff820a-7190-44af-8ecd-08ffe67814b1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c315cd5a-cf5d-4323-9aca-aa7ad0d634b4_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeepHealthIncMember_fc6030c4-03d5-4e75-87a0-fa61c40b5ff1_terseLabel_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DeepHealth Inc.</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_label_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deep Health Inc [Member]</link:label>
    <link:label id="lab_rdnt_DeepHealthIncMember_documentation_en-US" xlink:label="lab_rdnt_DeepHealthIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deep Health, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeepHealthIncMember" xlink:to="lab_rdnt_DeepHealthIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_0cb3aafb-bb93-4a4c-b692-118ed4a114aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Options Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NulogixMember_aa1e5692-1abb-440d-aa35-b917fde56afb_terseLabel_en-US" xlink:label="lab_rdnt_NulogixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nulogix, Inc.</link:label>
    <link:label id="lab_rdnt_NulogixMember_label_en-US" xlink:label="lab_rdnt_NulogixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nulogix, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember" xlink:href="rdnt-20201231.xsd#rdnt_NulogixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NulogixMember" xlink:to="lab_rdnt_NulogixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_28e94929-5afc-4d81-9e17-85a767f6f0b8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_0b969d97-38fe-48da-a45e-a8573eaf2026_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred charges</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDeferredCharges" xlink:to="lab_us-gaap_AmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_f883c27c-92c8-4459-b1bd-30022b933841_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Separately Recognized Transactions [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:to="lab_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_99eba568-150b-4ba0-ba69-61eae6b4fd75_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemAxis_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis" xlink:to="lab_us-gaap_UnusualOrInfrequentItemAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_6c96857e-326e-4e0c-a190-7a107440b730_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsurancePolicyTypeAxis_4cefadca-fbc0-45c1-9d30-c7929fbbbd89_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsurancePolicyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Policy, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ReinsurancePolicyTypeAxis_label_en-US" xlink:label="lab_us-gaap_ReinsurancePolicyTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Policy, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsurancePolicyTypeAxis" xlink:to="lab_us-gaap_ReinsurancePolicyTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_36d2ff0e-1753-4bc8-b563-11752c7252cf_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of equipment</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_834e2fd5-f5db-4a56-a950-9493d5441b29_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PatientServicesNetMember_2f698eba-18cd-4480-97fa-77525bfeb7a5_verboseLabel_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net service fee revenue</link:label>
    <link:label id="lab_rdnt_PatientServicesNetMember_label_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Services, Net [Member]</link:label>
    <link:label id="lab_rdnt_PatientServicesNetMember_documentation_en-US" xlink:label="lab_rdnt_PatientServicesNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patient Services, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember" xlink:href="rdnt-20201231.xsd#rdnt_PatientServicesNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PatientServicesNetMember" xlink:to="lab_rdnt_PatientServicesNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_Medicare1Member_0a048a6e-a334-4741-861d-a953ecd3ff07_terseLabel_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_rdnt_Medicare1Member_label_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:label id="lab_rdnt_Medicare1Member_documentation_en-US" xlink:label="lab_rdnt_Medicare1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member" xlink:href="rdnt-20201231.xsd#rdnt_Medicare1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_Medicare1Member" xlink:to="lab_rdnt_Medicare1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_81fe8077-71c4-48e4-bc76-d50e298ce6b3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_095b4a17-761b-46b0-9527-fde9d7c042a5_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration liability adjustment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_47dacd29-703c-4482-a2b2-54ca22ed007f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of restricted stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e2008315-297d-4132-830c-1e118a47397f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_9a79a88a-a917-4db6-9eea-4009cd712362_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_d403afd1-ce67-414d-b146-fbc528100c0e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_4480dc20-3a41-48c4-9474-b52a7f1ba0b8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a1ae17ca-7b90-4282-a98f-e3004fd178ce_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_ea466f48-e582-4f8a-8ef7-b3ab7eb7c0b1_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_c9c41e4e-cbc5-4d18-80c1-264dba6b1ae6_terseLabel_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNINSURED RISKS</link:label>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_label_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uninsured Risks [Policy Text Block]</link:label>
    <link:label id="lab_rdnt_UninsuredRisksPolicyTextBlock_documentation_en-US" xlink:label="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uninsured Risks [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UninsuredRisksPolicyTextBlock" xlink:href="rdnt-20201231.xsd#rdnt_UninsuredRisksPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UninsuredRisksPolicyTextBlock" xlink:to="lab_rdnt_UninsuredRisksPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_3f007059-29aa-4fa7-aa83-04c1be373aaa_terseLabel_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMPLOYEE BENEFIT PLAN</link:label>
    <link:label id="lab_us-gaap_PostemploymentBenefitPlansPolicy_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefit Plans, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitPlansPolicy" xlink:to="lab_us-gaap_PostemploymentBenefitPlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_84c0cb7d-c799-4e9a-a343-cd1aafc6b264_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of joint ventures, net of dividends</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments, Net of Dividends or Distributions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_TradeNamesIndefiniteLifeMember_4aefac86-1615-41e8-980a-a9432e663951_terseLabel_en-US" xlink:label="lab_rdnt_TradeNamesIndefiniteLifeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names indefinite life</link:label>
    <link:label id="lab_rdnt_TradeNamesIndefiniteLifeMember_label_en-US" xlink:label="lab_rdnt_TradeNamesIndefiniteLifeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names Indefinite Life [Member]</link:label>
    <link:label id="lab_rdnt_TradeNamesIndefiniteLifeMember_documentation_en-US" xlink:label="lab_rdnt_TradeNamesIndefiniteLifeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names Indefinite Life [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TradeNamesIndefiniteLifeMember" xlink:href="rdnt-20201231.xsd#rdnt_TradeNamesIndefiniteLifeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_TradeNamesIndefiniteLifeMember" xlink:to="lab_rdnt_TradeNamesIndefiniteLifeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_September2020CapMember_84d0fabb-1e10-416c-af82-2f5ebfac574b_terseLabel_en-US" xlink:label="lab_rdnt_September2020CapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2020</link:label>
    <link:label id="lab_rdnt_September2020CapMember_label_en-US" xlink:label="lab_rdnt_September2020CapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember" xlink:href="rdnt-20201231.xsd#rdnt_September2020CapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_September2020CapMember" xlink:to="lab_rdnt_September2020CapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_0b15a46f-746d-4702-811e-cdf20d382924_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FOREIGN CURRENCY TRANSLATION</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_72d925cd-9cff-4114-8269-760fabbacc12_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INDEFINITE LIVED INTANGIBLES</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_31ac33b2-ea92-4304-9372-edad1bc77035_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt periodic payment, percent of total amount</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_label_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:label id="lab_rdnt_DebtInstrumentPeriodicPaymentPercent_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:to="lab_rdnt_DebtInstrumentPeriodicPaymentPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_6309f4ed-f2cb-485a-a1e6-36da45922370_terseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities</link:label>
    <link:label id="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:href="rdnt-20201231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:to="lab_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_COVID19PandemicMember_f5e08d29-03aa-4388-8ea9-95476c8156d2_terseLabel_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_label_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic [Member]</link:label>
    <link:label id="lab_rdnt_COVID19PandemicMember_documentation_en-US" xlink:label="lab_rdnt_COVID19PandemicMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C O V I D19 Pandemic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember" xlink:href="rdnt-20201231.xsd#rdnt_COVID19PandemicMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_COVID19PandemicMember" xlink:to="lab_rdnt_COVID19PandemicMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_035a527c-c255-4114-a0c6-92b6ace5293b_terseLabel_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to affiliates</link:label>
    <link:label id="lab_us-gaap_DueToAffiliateCurrent_label_en-US" xlink:label="lab_us-gaap_DueToAffiliateCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Affiliate, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToAffiliateCurrent" xlink:to="lab_us-gaap_DueToAffiliateCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_c97721ff-2aab-4f60-8736-9b509cfd5c50_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_87c397f0-9618-435c-8f8b-6acf2fd38155_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NonCashSeveranceShares_cac01cae-3cc7-4a07-bbf9-a49aecfc3d3a_terseLabel_en-US" xlink:label="lab_rdnt_NonCashSeveranceShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash severance (in shares)</link:label>
    <link:label id="lab_rdnt_NonCashSeveranceShares_label_en-US" xlink:label="lab_rdnt_NonCashSeveranceShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Severance Shares</link:label>
    <link:label id="lab_rdnt_NonCashSeveranceShares_documentation_en-US" xlink:label="lab_rdnt_NonCashSeveranceShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Cash Severance Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeveranceShares" xlink:href="rdnt-20201231.xsd#rdnt_NonCashSeveranceShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NonCashSeveranceShares" xlink:to="lab_rdnt_NonCashSeveranceShares" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_76913267-c289-4fda-abc5-6178088d2f9c_terseLabel_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation/personal injury</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_label_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:label id="lab_rdnt_WorkersCompensationPersonalInjury1Member_documentation_en-US" xlink:label="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation/Personal Injury1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:href="rdnt-20201231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WorkersCompensationPersonalInjury1Member" xlink:to="lab_rdnt_WorkersCompensationPersonalInjury1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_8040f554-df05-40a9-a669-3f1a6334c27a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_5c9af8a8-688f-4649-b4fe-ca797df6b3b8_terseLabel_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of PPP loans received</link:label>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_label_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Loans Received</link:label>
    <link:label id="lab_rdnt_DebtInstrumentNumberofLoansReceived_documentation_en-US" xlink:label="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Number of Loans Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DebtInstrumentNumberofLoansReceived" xlink:to="lab_rdnt_DebtInstrumentNumberofLoansReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_01d96ffe-4c63-405a-a69a-3add98fc1770_totalLabel_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_label_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Including Current Maturities</link:label>
    <link:label id="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_documentation_en-US" xlink:label="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Short-term Debt and Capital Lease Obligations, Including Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:to="lab_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_f599fa7e-611f-47c3-a21e-7eb8385e57cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional amounts</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetNotionalAmount" xlink:to="lab_us-gaap_DerivativeAssetNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_57915f8d-aa4d-43f5-b3f6-22474ae92854_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_59388b1e-bad1-438e-aaa7-5d7640942018_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_ab8f73d8-8497-4fe0-9a02-98209585def6_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING STANDARDS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_5571df29-7ec1-423e-8809-c16323131d81_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_e83b098d-4677-4fbf-8af8-934b82c7020b_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_b8bb42c8-ed9a-4694-949a-749ec40d375e_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Eighth Amendment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementEighthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_5728b403-2c6a-41c5-bce5-2c0433f3c6a2_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_fc6ceecc-a434-4554-9fe2-5146d49fd92f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_44c74eb1-379a-4848-8a5f-b31e62ee1d22_netLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net (loss) income per share attributable to RadNet, inc. common stockholders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_6283bf03-4d30-4e1b-9dfd-10692430a50a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_c3481b9f-23ca-42f4-9ace-139925c71d66_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases - years</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZPElmhurstLLCMember_c66bd358-3f10-452f-a64b-8cb545d5b9e7_terseLabel_en-US" xlink:label="lab_rdnt_ZPElmhurstLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmhurst</link:label>
    <link:label id="lab_rdnt_ZPElmhurstLLCMember_55dbbd37-eea5-48a1-927e-ad2f6a88c45b_verboseLabel_en-US" xlink:label="lab_rdnt_ZPElmhurstLLCMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmhurst LLC</link:label>
    <link:label id="lab_rdnt_ZPElmhurstLLCMember_label_en-US" xlink:label="lab_rdnt_ZPElmhurstLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmhurst LLC [Member]</link:label>
    <link:label id="lab_rdnt_ZPElmhurstLLCMember_documentation_en-US" xlink:label="lab_rdnt_ZPElmhurstLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZP Elmhurst LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmhurstLLCMember" xlink:href="rdnt-20201231.xsd#rdnt_ZPElmhurstLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZPElmhurstLLCMember" xlink:to="lab_rdnt_ZPElmhurstLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_6824bd0a-301d-4cfc-9204-f60ce7e50299_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_88d3e63d-7fbf-469f-94b7-a247e224d6a5_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_73a8d543-c5f0-44fb-8d3b-8cfeb1455c86_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_5b55f487-82b0-4704-a7a4-1728be7f85ee_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WEIGHTED AVERAGE SHARES OUTSTANDING</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d457a4b6-ccad-4dc1-b214-52b32c47b01c_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicVisionMember_243bcb0a-8486-43ab-b4b2-a3ab1048be39_terseLabel_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision</link:label>
    <link:label id="lab_rdnt_MedicVisionMember_label_en-US" xlink:label="lab_rdnt_MedicVisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medic Vision [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember" xlink:href="rdnt-20201231.xsd#rdnt_MedicVisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicVisionMember" xlink:to="lab_rdnt_MedicVisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_ff16a26c-1459-4145-b39e-8f0b71ff5d86_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_abdfa342-f892-4d7d-b0e2-d1d0744afee3_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Promissory note</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_ead89f99-37f6-41e3-841c-89f9b7d55bbe_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate value exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_5b7fa71b-6a94-43f7-b967-75be12e59f90_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_5e68bb36-b618-4e70-89d5-962b54262bae_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_95c17f44-a051-4565-a09e-1706f0aa936f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued under the equity compensation plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_0a8567f7-a1c0-4837-a71f-e681dfaeb30d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_93c1c81f-3e33-4ab2-801d-1c96c0e54c1e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_d5448773-db69-4a8f-84e4-443f621d69d1_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_e05b1616-9525-4eec-a77b-606f3a0ddaf3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value, granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_9a18bc44-0710-4d96-b912-7a516b74afa1_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible promissory note</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ac491075-d334-4ece-a22a-bbab2d71adde_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_715f7108-964f-4494-bf55-bb7c9c85ef92_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_HealthInsuranceMember_90983dfd-9e33-430c-bee0-6061ecba7ff9_terseLabel_en-US" xlink:label="lab_rdnt_HealthInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance</link:label>
    <link:label id="lab_rdnt_HealthInsuranceMember_label_en-US" xlink:label="lab_rdnt_HealthInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Insurance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthInsuranceMember" xlink:href="rdnt-20201231.xsd#rdnt_HealthInsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_HealthInsuranceMember" xlink:to="lab_rdnt_HealthInsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_4d93dd4e-e9fb-42c5-a99a-64aa58c1cd80_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_8265e4e9-df78-417b-b86d-d1cdf38f4001_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_4e41aafe-dae9-4ffe-be3b-0702947195d5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity and Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_4a13e061-616e-4b23-a561-7dafda91b0ec_terseLabel_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stop loss policy claim amount</link:label>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_label_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Insurance, Stop Loss Policy Claim Amount</link:label>
    <link:label id="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_documentation_en-US" xlink:label="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Insurance, Stop Loss Policy Claim Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:href="rdnt-20201231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:to="lab_rdnt_MedicalInsuranceStopLossPolicyClaimAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_af6fb5f8-5403-4084-836c-4b83e3ff7262_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLC.Member_767eebda-737a-406c-9f76-66814fe09ee5_terseLabel_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLC.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC.</link:label>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLC.Member_label_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLC.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC. [Member]</link:label>
    <link:label id="lab_rdnt_VenturaCountyImagingGroupLLC.Member_documentation_en-US" xlink:label="lab_rdnt_VenturaCountyImagingGroupLLC.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ventura County Imaging Group, LLC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLC.Member" xlink:href="rdnt-20201231.xsd#rdnt_VenturaCountyImagingGroupLLC.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_VenturaCountyImagingGroupLLC.Member" xlink:to="lab_rdnt_VenturaCountyImagingGroupLLC.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1fb0fa99-2b1b-4e42-8324-774790ad4cbb_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_8010b20f-06a0-4bfb-9676-6a7028414b3b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_d57b6173-9b84-41a3-a4de-b1b74ac87daf_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of loss recognized in income on derivative (current period ineffective portion)</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareOtherMember_9c3a36e5-c533-404a-89ea-2841c232aab9_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_HealthCareOtherMember_label_en-US" xlink:label="lab_us-gaap_HealthCareOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareOtherMember" xlink:to="lab_us-gaap_HealthCareOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_4aca81e5-99dd-4158-8b79-4a4c875d939a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_8232eb5c-4fe8-499f-beb2-c5ad2c6ee99c_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of businesses acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfBusinessesAcquired_label_en-US" xlink:label="lab_us-gaap_NumberOfBusinessesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Businesses Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfBusinessesAcquired" xlink:to="lab_us-gaap_NumberOfBusinessesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ee2f16f3-0e97-4fb4-9ae8-abb01290f182_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_5030b92d-32e8-4ff8-86fe-982c36c96504_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_b9c5015e-715e-4a2d-b07f-f32bb9761c3e_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncurrent liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf16c889-00df-4f6b-9b95-0c2b92f86b49_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_facf4257-8766-4904-b5d9-a70104d1ad02_negatedLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of the statute of limitations for the assessment of taxes</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_09e300d9-c99f-4141-b3f8-e0cd6e3cfcea_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ZilkhaRadiologyMember_e62feb08-3774-4e78-81d3-30142bba81f5_terseLabel_en-US" xlink:label="lab_rdnt_ZilkhaRadiologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zilkha Radiology</link:label>
    <link:label id="lab_rdnt_ZilkhaRadiologyMember_label_en-US" xlink:label="lab_rdnt_ZilkhaRadiologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zilkha Radiology [Member]</link:label>
    <link:label id="lab_rdnt_ZilkhaRadiologyMember_documentation_en-US" xlink:label="lab_rdnt_ZilkhaRadiologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Zilkha Radiology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZilkhaRadiologyMember" xlink:href="rdnt-20201231.xsd#rdnt_ZilkhaRadiologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ZilkhaRadiologyMember" xlink:to="lab_rdnt_ZilkhaRadiologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_08d56363-da38-48fa-a9d5-396a74fc7a25_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TOTAL</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_9cb96bfb-7f38-4ecc-9a59-dc5bde543162_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d8c524c1-aec2-4a47-9043-1e99b9a675fe_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_37489cf3-16f6-46ad-a053-8599f99d9671_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_b0cd5bc6-d826-4eba-82c7-d15c0ff13ba0_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Finance Lease Liabilities</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Finance Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_RavenHoldingsMember_61c962fc-7b2f-4def-b0ef-00e5519d597f_terseLabel_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings</link:label>
    <link:label id="lab_rdnt_RavenHoldingsMember_label_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings [Member]</link:label>
    <link:label id="lab_rdnt_RavenHoldingsMember_documentation_en-US" xlink:label="lab_rdnt_RavenHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raven Holdings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember" xlink:href="rdnt-20201231.xsd#rdnt_RavenHoldingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_RavenHoldingsMember" xlink:to="lab_rdnt_RavenHoldingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_e0057a90-b071-49c4-ba60-06f5898a941b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases - years</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_10465a11-811b-4bbb-850f-d6956486762f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_b562908a-1ab1-40c8-bbb2-a3d0798a7c2c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractLossAccrualWrittenOff_c7f19194-6ec4-4ad2-9d3c-5101e32dc7d9_terseLabel_en-US" xlink:label="lab_rdnt_ContractLossAccrualWrittenOff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract loss accrual, written off</link:label>
    <link:label id="lab_rdnt_ContractLossAccrualWrittenOff_label_en-US" xlink:label="lab_rdnt_ContractLossAccrualWrittenOff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Loss Accrual, Written Off</link:label>
    <link:label id="lab_rdnt_ContractLossAccrualWrittenOff_documentation_en-US" xlink:label="lab_rdnt_ContractLossAccrualWrittenOff" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Loss Accrual, Written Off</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrualWrittenOff" xlink:href="rdnt-20201231.xsd#rdnt_ContractLossAccrualWrittenOff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractLossAccrualWrittenOff" xlink:to="lab_rdnt_ContractLossAccrualWrittenOff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_c4507344-4908-4009-ac5f-d1c20cb65d92_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_54c3bee2-509d-4f83-85b2-ed5e299c76ff_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_GainLossonStepUpValuation_40801e4b-3df1-4ed2-8053-bcc67c2454f7_negatedTerseLabel_en-US" xlink:label="lab_rdnt_GainLossonStepUpValuation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on re-measurement of pre-existing interest</link:label>
    <link:label id="lab_rdnt_GainLossonStepUpValuation_2953f8b0-5a64-4dda-b251-c9d82575334d_negatedLabel_en-US" xlink:label="lab_rdnt_GainLossonStepUpValuation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on re-measurement of pre-existing interest</link:label>
    <link:label id="lab_rdnt_GainLossonStepUpValuation_label_en-US" xlink:label="lab_rdnt_GainLossonStepUpValuation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Step Up Valuation</link:label>
    <link:label id="lab_rdnt_GainLossonStepUpValuation_documentation_en-US" xlink:label="lab_rdnt_GainLossonStepUpValuation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Step Up Valuation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation" xlink:href="rdnt-20201231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_GainLossonStepUpValuation" xlink:to="lab_rdnt_GainLossonStepUpValuation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_89175fe0-72ff-4fb4-b558-5796f8dbfa28_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_3f4de2e9-94b2-4df9-84bd-c89185b2002b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_7452b9e3-2505-447e-8104-41abb3069e7c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_662082e9-6b86-4257-9cc1-271c1a63698a_terseLabel_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc.</link:label>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_label_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:label id="lab_rdnt_WhiteRabbit.aiInc.Member_documentation_en-US" xlink:label="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WhiteRabbit.ai Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member" xlink:href="rdnt-20201231.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_WhiteRabbit.aiInc.Member" xlink:to="lab_rdnt_WhiteRabbit.aiInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_2cfa5aae-853f-40f7-87f3-ed9d7e6dd9f0_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ec36cf77-15e6-44c0-8f1e-6fcc602c1f13_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income attributable to RadNet, Inc. common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_414207d1-c42d-4e75-b8f7-47ddd57449aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_595c3708-d2b3-499c-bda1-7ddd5509befe_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions paid to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_b5de2ba6-b2dd-4375-aecd-7e15a4353a00_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_347c6b1f-36a2-41ea-92bb-1af936195988_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_d84a0b9c-5a77-4ef2-a602-ef943ffb6666_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_5d61ffb5-0dce-4b19-b626-ef2316ca1225_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING EXPENSES</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_d57f14cb-bf10-4f72-97b7-dc3461c8dfb8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of imaging facilities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBuildings_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBuildings" xlink:to="lab_us-gaap_PaymentsToAcquireBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_60868be0-d796-4865-be1a-bacb9da82860_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_222368e1-786b-44f0-a66f-2a3c3d8fbd0c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition_e647c02a-748f-45cf-acd0-983687d4697e_terseLabel_en-US" xlink:label="lab_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Re-measurement of noncontrolling interest upon change in control</link:label>
    <link:label id="lab_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition_label_en-US" xlink:label="lab_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Noncontrolling Interest Due To Step Acquisition</link:label>
    <link:label id="lab_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition_documentation_en-US" xlink:label="lab_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Noncontrolling Interest Due To Step Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition" xlink:to="lab_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_27268778-6c8d-42da-9312-91a525493eca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DignityHealthMember_b9781cc6-4134-4ec9-96bf-7b30dadd1bca_terseLabel_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health</link:label>
    <link:label id="lab_rdnt_DignityHealthMember_label_en-US" xlink:label="lab_rdnt_DignityHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dignity Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember" xlink:href="rdnt-20201231.xsd#rdnt_DignityHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DignityHealthMember" xlink:to="lab_rdnt_DignityHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_abb635b2-6104-4c84-b665-d8683d174008_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_fa2cb8ac-25ca-499b-90a3-21c2f2d3c9a6_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_6de94a36-81da-4328-a85e-13eb118172ca_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_fa98f544-8256-4f9f-9bb3-d7fa2fe85df9_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_5373e6a5-b003-4414-b72d-74e41d078681_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, lease not yet commenced, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_ffd5a911-4dcc-416e-8502-6d2657f75ee1_terseLabel_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditDerivativesByContractTypeAxis_label_en-US" xlink:label="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Derivatives Contract Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis" xlink:to="lab_us-gaap_CreditDerivativesByContractTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_adec5b5f-0c40-4e35-abd0-a4b710b87f3f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_b5e973fa-5c18-48a2-8732-7749237849f9_verboseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_29ae126a-8578-41dc-9031-54681e2a6cf3_terseLabel_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets acquired</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_label_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</link:label>
    <link:label id="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_documentation_en-US" xlink:label="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:to="lab_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_e1805789-52df-42ef-ab90-020e0769f857_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest accrued during period</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:href="rdnt-20201231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_e3b32215-e606-4ef6-a9d8-0b147ea83a68_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_01fb701c-9ede-4c5c-8574-29b7ff87a0c9_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Economic interest</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:to="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_320ebf26-17ba-4309-865d-a371ba0d5e48_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_d725d755-707b-4c67-95f9-0ee1837f60da_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_b4b6586f-71f6-4d2c-b2e8-f401e39e04be_totalLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net assets</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentAggregateCost_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Aggregate Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentAggregateCost" xlink:to="lab_us-gaap_EquityMethodInvestmentAggregateCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e5837254-8502-414c-843e-d175901a760f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_cd9b8628-8c1c-47f9-b736-3e05c0930bb6_terseLabel_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service fee revenue</link:label>
    <link:label id="lab_us-gaap_HealthCarePatientServiceMember_label_en-US" xlink:label="lab_us-gaap_HealthCarePatientServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care, Patient Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCarePatientServiceMember" xlink:to="lab_us-gaap_HealthCarePatientServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef07e9e0-8ade-4b79-8aee-48472dd4e7b1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_135ddc12-a986-4b71-8e51-a0cb62e7ea2d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CREDIT FACILITIES AND NOTES PAYABLE</link:label>
    <link:label id="lab_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Capital Leases Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:to="lab_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_a9214cd3-9610-454f-b68a-5efb8e60220a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Periodic payment, principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_c4580199-de54-4f4b-80b0-9c067c65e401_terseLabel_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term of contract</link:label>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_label_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Term of Contract</link:label>
    <link:label id="lab_rdnt_LesseeLeaseTermofContract_documentation_en-US" xlink:label="lab_rdnt_LesseeLeaseTermofContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee Lease Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract" xlink:href="rdnt-20201231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_LesseeLeaseTermofContract" xlink:to="lab_rdnt_LesseeLeaseTermofContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_ffcef4ed-6b05-4738-b718-e546a218b5f1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelIVMember_479f5788-ff91-4e3c-9a16-5ba4d0fa0eef_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelIVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelIVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level IV [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelIVMember" xlink:to="lab_rdnt_PricingLevelIVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_7c11e794-a15d-4820-b897-23b6e5c18d2f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility, borrowings available</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_8da98059-bddd-4fda-9626-cd76b7a8f93a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add nonvested restricted stock subject only to service vesting (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_NewJerseyImagingNetworkLLCMember_6e0a71bd-82c0-4ce0-85c7-5de9a53f65e8_terseLabel_en-US" xlink:label="lab_rdnt_NewJerseyImagingNetworkLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey Imaging Network, LLC</link:label>
    <link:label id="lab_rdnt_NewJerseyImagingNetworkLLCMember_label_en-US" xlink:label="lab_rdnt_NewJerseyImagingNetworkLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey Imaging Network, LLC [Member]</link:label>
    <link:label id="lab_rdnt_NewJerseyImagingNetworkLLCMember_documentation_en-US" xlink:label="lab_rdnt_NewJerseyImagingNetworkLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Jersey Imaging Network, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NewJerseyImagingNetworkLLCMember" xlink:href="rdnt-20201231.xsd#rdnt_NewJerseyImagingNetworkLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_NewJerseyImagingNetworkLLCMember" xlink:to="lab_rdnt_NewJerseyImagingNetworkLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_a58583b1-a114-4bdb-a9fe-8bde2c8e3f22_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits, tax impact if recognized</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Tax Impact If Recognized</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Tax Impact If Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:href="rdnt-20201231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_8e8bff23-931e-41ce-a28a-4fab6372c827_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, net</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_22415c7c-f40d-4d45-b09f-e16355f1c1e5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_5ce17d28-f84b-4715-b87a-9ded6f818930_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred true-ups and other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_438dc139-a1a1-47cb-8b2c-9c94bbfe1ea9_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9b06776c-02ad-4a83-8d70-90117c48c0c0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding during the period (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_69473de3-879c-468e-863f-66110769036d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_8b60b0a4-cefe-4a3e-bbbd-7d380013b30e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_19171487-b287-4104-966f-9db1e3934634_periodStartLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_2fbe9208-c363-4fb1-b5f6-019ee978c781_periodEndLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_aa25b046-0478-4a4c-83db-c916b9e2df08_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total value of RadNet joint venture interests</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_c854feea-876e-4934-acb0-b9539a0a2d4a_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_CommercialInsurance1Member_f75d5557-6312-4467-9ab6-14813932cc74_terseLabel_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial insurance</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_label_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:label id="lab_rdnt_CommercialInsurance1Member_documentation_en-US" xlink:label="lab_rdnt_CommercialInsurance1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Insurance1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member" xlink:href="rdnt-20201231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_CommercialInsurance1Member" xlink:to="lab_rdnt_CommercialInsurance1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_99ef2b3c-7fff-40a1-b1e3-653f5c58eba6_terseLabel_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance medicare payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_label_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:label id="lab_rdnt_AdvanceMedicarePayments_documentation_en-US" xlink:label="lab_rdnt_AdvanceMedicarePayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance Medicare Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments" xlink:href="rdnt-20201231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_AdvanceMedicarePayments" xlink:to="lab_rdnt_AdvanceMedicarePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MRIatWoodbridgeLLCMember_818459a6-1fbe-43b5-92cd-b381db8ec4ed_terseLabel_en-US" xlink:label="lab_rdnt_MRIatWoodbridgeLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRI at Woodbridge, LLC</link:label>
    <link:label id="lab_rdnt_MRIatWoodbridgeLLCMember_label_en-US" xlink:label="lab_rdnt_MRIatWoodbridgeLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRI at Woodbridge, LLC [Member]</link:label>
    <link:label id="lab_rdnt_MRIatWoodbridgeLLCMember_documentation_en-US" xlink:label="lab_rdnt_MRIatWoodbridgeLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MRI at Woodbridge, LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIatWoodbridgeLLCMember" xlink:href="rdnt-20201231.xsd#rdnt_MRIatWoodbridgeLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MRIatWoodbridgeLLCMember" xlink:to="lab_rdnt_MRIatWoodbridgeLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_7f2c78ec-394f-4324-ad24-53104aad56a2_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_0eb3e121-58cb-4f05-aa78-5f535a610bf9_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity a Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_60179fd0-c260-4039-baf5-43f51fceda2c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest percentage</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermNotesPayable_2094df75-361c-4d0a-bb86-e0549bf5e43f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes payable, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_LongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermNotesPayable" xlink:to="lab_us-gaap_LongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_25de1ef6-7060-418e-8075-0f33764710f2_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_4ceabf26-9279-4515-99c0-243e50cfff37_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_23568149-9d18-43a5-ad6a-ca79159eb490_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to fund loan to related parties</link:label>
    <link:label id="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_label_en-US" xlink:label="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Fund Long-term Loans to Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:to="lab_us-gaap_PaymentsToFundLongtermLoansToRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_298b433e-278a-431a-a973-e2b760ba30ec_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_6b7de150-6145-499f-90f6-fa3dd2200dbe_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_d51360b3-bac7-4291-8eb7-bcee747680d6_terseLabel_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment No. 6 First Lien Credit Agreement</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_label_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:label id="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember_documentation_en-US" xlink:label="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Lien Credit Agreement Sixth Amendment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:to="lab_rdnt_FirstLienCreditAgreementSixthAmendmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3e5b894c-3a98-4350-9f80-f88d5070a9a5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45a9afdb-234e-48cd-9974-b16d1f8e9fb2_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH AND CASH EQUIVALENTS, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_705aa918-b623-4263-898e-f2a96b5e761b_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_ff55f6e6-f95c-49fb-9f3f-3b0ddd11a07a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Annual Principal Maturities of Notes Payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_35710d1a-58c2-43ac-a43c-b8347ecaf9e7_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_be36803a-c38c-495a-9edf-542e9782dfe1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_2ed6a1ed-f177-42cb-8804-ccd32faf0e5a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of ownership interest</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_dad034be-3936-4b0d-ae27-e38f44a64cab_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_3ee6e534-b3df-495b-a531-79665938cdf4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of finance lease liability</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_40230d4c-e25c-42ba-a641-65fb83a7219d_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of finance lease</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_39cbf38c-e576-4025-a333-b0e01c85aaa6_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_ea344c84-ac09-4a18-a8a8-2a505cf815e4_terseLabel_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) related to change in rate</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_label_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</link:label>
    <link:label id="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_documentation_en-US" xlink:label="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:href="rdnt-20201231.xsd#rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:to="lab_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_ad7950a6-d6ad-4075-8db6-0319336156bb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Carrying Value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_OperatingLeaseRightofUseAssetAmortization_aa9d876a-605a-4ce5-bd62-bf82e0578525_terseLabel_en-US" xlink:label="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of operating lease right-of-use assets</link:label>
    <link:label id="lab_rdnt_OperatingLeaseRightofUseAssetAmortization_label_en-US" xlink:label="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Right of Use Asset Amortization</link:label>
    <link:label id="lab_rdnt_OperatingLeaseRightofUseAssetAmortization_documentation_en-US" xlink:label="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease Right of Use Asset Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:href="rdnt-20201231.xsd#rdnt_OperatingLeaseRightofUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:to="lab_rdnt_OperatingLeaseRightofUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_a51144f9-2a3b-49b8-972f-d256c62769d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_2650cd85-6921-4def-983a-9255304e10ff_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_MedicalArtsRadiologicalGroupPCMember_99446364-80cd-458c-ab0f-fcc0cc3497fe_terseLabel_en-US" xlink:label="lab_rdnt_MedicalArtsRadiologicalGroupPCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Arts Radiological Group, PC</link:label>
    <link:label id="lab_rdnt_MedicalArtsRadiologicalGroupPCMember_label_en-US" xlink:label="lab_rdnt_MedicalArtsRadiologicalGroupPCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Arts Radiological Group, PC [Member]</link:label>
    <link:label id="lab_rdnt_MedicalArtsRadiologicalGroupPCMember_documentation_en-US" xlink:label="lab_rdnt_MedicalArtsRadiologicalGroupPCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Arts Radiological Group, PC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalArtsRadiologicalGroupPCMember" xlink:href="rdnt-20201231.xsd#rdnt_MedicalArtsRadiologicalGroupPCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_MedicalArtsRadiologicalGroupPCMember" xlink:to="lab_rdnt_MedicalArtsRadiologicalGroupPCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_703a51a9-1eb2-49ff-a24b-d7ea69870982_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facilities available</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_4a0d982f-5a27-4ce1-b9d2-e3dff851a7dc_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_b865b963-d792-4767-be60-64cc3dab4603_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_9b0c161b-0347-40c2-af35-4201357dbf9f_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and write off of deferred financing costs and loan discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bb0e5ee9-cf88-4cbb-8cb6-f3ad6081e954_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_5efac2c8-0fe7-4575-b995-cedf6187b93f_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_PricingLevelVMember_2e65791f-aa4a-4c23-a790-43a6452068be_terseLabel_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_label_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:label id="lab_rdnt_PricingLevelVMember_documentation_en-US" xlink:label="lab_rdnt_PricingLevelVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pricing Level V [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_PricingLevelVMember" xlink:to="lab_rdnt_PricingLevelVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_bee3d7ef-3fc7-46d1-b2d7-a0fbf9b815d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill disposed of through sale or transfer</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_4ac06f5c-81b9-4ece-b8e8-4475c1384df8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_40817ca6-8848-42c8-8809-b9b2f25f64b4_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_e0063c6d-ca18-433f-876e-21b7ce6b2817_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b7fbc811-0215-4f76-b932-6a53857b1f2f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_93057f09-d209-4aff-a077-5b15ea922d33_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity investments at fair value</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a20c54c3-e1c7-464a-af90-a26ec45562d6_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6aec98bf-bf9f-4b89-bf44-7e604b7b6db9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_4549cc12-968f-408a-aa67-7157b28529f6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LONG-TERM LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f17a4bac-a238-48f6-a77a-76cb7a33c6ee_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_564ef6a5-fc9e-420a-9590-b613f8417b95_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of notes payable</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f7c90fde-857a-4f36-a463-8d5014b3a104_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_25a3672b-4a5e-4edd-9aff-d08e025cf80a_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unused capacity, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_5541bd03-3f30-4abb-b3ec-e99da8915e6b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_118f7b64-f1ef-445a-8a8a-fc1246494fef_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_A2019SWAPS1Member_2d83c1c9-0140-4ca5-95b8-6b19f42a5a4b_terseLabel_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_label_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:label id="lab_rdnt_A2019SWAPS1Member_documentation_en-US" xlink:label="lab_rdnt_A2019SWAPS1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 SWAPS1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member" xlink:href="rdnt-20201231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_A2019SWAPS1Member" xlink:to="lab_rdnt_A2019SWAPS1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_ContractsReceivableFactoredAmount_301071bb-db54-4031-af25-48694a2cc1f2_terseLabel_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Factored accounts receivable</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoredAmount_label_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factored Amount</link:label>
    <link:label id="lab_rdnt_ContractsReceivableFactoredAmount_documentation_en-US" xlink:label="lab_rdnt_ContractsReceivableFactoredAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contracts Receivable, Factored Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoredAmount" xlink:href="rdnt-20201231.xsd#rdnt_ContractsReceivableFactoredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_ContractsReceivableFactoredAmount" xlink:to="lab_rdnt_ContractsReceivableFactoredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_353a9989-fcfe-42f5-ad2a-0680dea8e61c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CURRENT LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_448504bc-efbb-49ea-b772-f6d5fa28732f_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RECENT ACCOUNTING STANDARDS</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_8345b009-1314-40fb-b7c4-620eb1e3bafc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolving credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_52005816-5804-44e2-b2df-82247e2a386a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_9f884a9b-41bd-40ec-81f7-e4a379f88a00_negatedTerseLabel_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use asset</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_label_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Right-Of-Use Assets</link:label>
    <link:label id="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_documentation_en-US" xlink:label="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Operating Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:href="rdnt-20201231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:to="lab_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_279a7cb9-c58f-4f59-8820-9a424140a2af_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>rdnt-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:cd605a11-4611-4df1-b35a-84491793f997,g:2afe2a05-cf4e-4f48-9c2a-eb0c739eec8b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.radnet.com/role/CoverPage" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6f7119ad-5841-48e2-9e54-67124e6cd663" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_DocumentType_6f7119ad-5841-48e2-9e54-67124e6cd663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_ef0ec219-98fb-4512-a200-e83c1c7b664f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_DocumentAnnualReport_ef0ec219-98fb-4512-a200-e83c1c7b664f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_90df4523-1c95-41e7-9ddf-c7c4cafe12d9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_DocumentPeriodEndDate_90df4523-1c95-41e7-9ddf-c7c4cafe12d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_7ee9b199-952d-4bf4-86df-de09f4234118" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_CurrentFiscalYearEndDate_7ee9b199-952d-4bf4-86df-de09f4234118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_d8cd3a91-efb0-4dc4-8841-6e37e7966094" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_DocumentTransitionReport_d8cd3a91-efb0-4dc4-8841-6e37e7966094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a1f012ad-dfbe-4ec5-b1a5-cbf7a6554c34" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityFileNumber_a1f012ad-dfbe-4ec5-b1a5-cbf7a6554c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_da933d11-5e37-4d94-90f6-636ce3bd782e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityRegistrantName_da933d11-5e37-4d94-90f6-636ce3bd782e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_97e2d488-2f00-438b-a6dc-ef99435028fb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityIncorporationStateCountryCode_97e2d488-2f00-438b-a6dc-ef99435028fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_a9910bdc-a46a-4333-8dd5-e9b5cf9085d8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityTaxIdentificationNumber_a9910bdc-a46a-4333-8dd5-e9b5cf9085d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e10a2f99-f4ed-4547-a57b-1364874de161" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityAddressAddressLine1_e10a2f99-f4ed-4547-a57b-1364874de161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_e4d71cd5-ff0c-4214-a232-87ffe9cdac59" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityAddressCityOrTown_e4d71cd5-ff0c-4214-a232-87ffe9cdac59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b99a513c-523c-4984-ab34-303ad67b5c7f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityAddressStateOrProvince_b99a513c-523c-4984-ab34-303ad67b5c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ad983268-30da-411e-a5a9-596451305ac2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityAddressPostalZipCode_ad983268-30da-411e-a5a9-596451305ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_21ccd9e5-4936-4746-9684-ceac0d78543b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_CityAreaCode_21ccd9e5-4936-4746-9684-ceac0d78543b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_0d4f93bd-94a2-4ddd-bad9-f0a9708cd82e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_LocalPhoneNumber_0d4f93bd-94a2-4ddd-bad9-f0a9708cd82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_402e00fe-23bc-4019-9fa1-600688b72495" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_Security12bTitle_402e00fe-23bc-4019-9fa1-600688b72495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d2892574-2baa-4ee2-b2ac-4eb5d9923850" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_TradingSymbol_d2892574-2baa-4ee2-b2ac-4eb5d9923850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_719b000a-2194-4ca8-90b2-54fe129e36ef" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_SecurityExchangeName_719b000a-2194-4ca8-90b2-54fe129e36ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_e53d4831-c755-4826-9f0d-68f96408caeb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_e53d4831-c755-4826-9f0d-68f96408caeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_3148eb82-537f-43bf-babc-de0e67c615e2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityVoluntaryFilers_3148eb82-537f-43bf-babc-de0e67c615e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_7939b610-ccb6-4a9a-834e-e543a0d48afe" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityCurrentReportingStatus_7939b610-ccb6-4a9a-834e-e543a0d48afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9d45236e-3c6a-42e0-b47b-c7d93072510f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityInteractiveDataCurrent_9d45236e-3c6a-42e0-b47b-c7d93072510f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_489a4db4-5a7b-42ef-8e24-483a62ec8c0e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityFilerCategory_489a4db4-5a7b-42ef-8e24-483a62ec8c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_25501adb-8f4c-4228-b9ea-871cd3a46a2a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntitySmallBusiness_25501adb-8f4c-4228-b9ea-871cd3a46a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f2547a51-5653-419f-ad9a-b1e5af90dd0a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityEmergingGrowthCompany_f2547a51-5653-419f-ad9a-b1e5af90dd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_c2b6c89f-663f-444c-93f6-1071c900624d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_IcfrAuditorAttestationFlag_c2b6c89f-663f-444c-93f6-1071c900624d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ca1121b7-8b26-4f89-8b0c-f790547f4d8e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityShellCompany_ca1121b7-8b26-4f89-8b0c-f790547f4d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_d3119106-0e67-430a-959d-2c1710d8b8e1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityPublicFloat_d3119106-0e67-430a-959d-2c1710d8b8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e8359cf4-f348-4187-8114-f2ce9813881b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e8359cf4-f348-4187-8114-f2ce9813881b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_ba61d58c-c42b-4635-b793-8d3f2247b66b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_ba61d58c-c42b-4635-b793-8d3f2247b66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_ebd9fc21-d03f-418d-86c1-36f8faea63c0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_EntityCentralIndexKey_ebd9fc21-d03f-418d-86c1-36f8faea63c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_42567a8b-095a-434a-926b-8e327e9f5ade" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_AmendmentFlag_42567a8b-095a-434a-926b-8e327e9f5ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_19501a19-933e-4acb-a94d-81cac4d475ae" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_DocumentFiscalPeriodFocus_19501a19-933e-4acb-a94d-81cac4d475ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_db6320ba-6fc8-4bb9-92b4-3715eb90cc10" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_94e3b7bc-4998-4f01-8416-8a8872377de6" xlink:to="loc_dei_DocumentFiscalYearFocus_db6320ba-6fc8-4bb9-92b4-3715eb90cc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_ed97680b-2d1c-4fef-b164-6e4dbd8af0c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9565278c-2e3d-4fb7-9276-0a4a2c864017" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ed97680b-2d1c-4fef-b164-6e4dbd8af0c1" xlink:to="loc_us-gaap_AssetsAbstract_9565278c-2e3d-4fb7-9276-0a4a2c864017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ceef2697-7e91-45dd-bd75-73dc34945ba1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9565278c-2e3d-4fb7-9276-0a4a2c864017" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ceef2697-7e91-45dd-bd75-73dc34945ba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_08527aac-b78d-40fb-8c01-d85a919e947c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ceef2697-7e91-45dd-bd75-73dc34945ba1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_08527aac-b78d-40fb-8c01-d85a919e947c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_53b7bfa9-b79c-41e2-8f31-311c665ba265" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ceef2697-7e91-45dd-bd75-73dc34945ba1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_53b7bfa9-b79c-41e2-8f31-311c665ba265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_3354e507-8352-46ec-8185-341afdc3292a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ceef2697-7e91-45dd-bd75-73dc34945ba1" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_3354e507-8352-46ec-8185-341afdc3292a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1a8126ad-8323-4ca6-9cd5-2963c01b7f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ceef2697-7e91-45dd-bd75-73dc34945ba1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_1a8126ad-8323-4ca6-9cd5-2963c01b7f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_293791d2-f59a-4fdd-8a3e-21e6eb87fd1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ceef2697-7e91-45dd-bd75-73dc34945ba1" xlink:to="loc_us-gaap_AssetsCurrent_293791d2-f59a-4fdd-8a3e-21e6eb87fd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_e0675b35-56e4-4c66-a6f1-8eca7342dabf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9565278c-2e3d-4fb7-9276-0a4a2c864017" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_e0675b35-56e4-4c66-a6f1-8eca7342dabf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_53d7e0b3-ac9e-4ed4-bd00-fe357545ac97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_e0675b35-56e4-4c66-a6f1-8eca7342dabf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_53d7e0b3-ac9e-4ed4-bd00-fe357545ac97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1525b92a-c034-42bb-93b2-5e0100b1a08d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_e0675b35-56e4-4c66-a6f1-8eca7342dabf" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1525b92a-c034-42bb-93b2-5e0100b1a08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_89adbda0-7e6d-47ce-87b9-a8a3676e33b1" xlink:href="rdnt-20201231.xsd#rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract_e0675b35-56e4-4c66-a6f1-8eca7342dabf" xlink:to="loc_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_89adbda0-7e6d-47ce-87b9-a8a3676e33b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsAbstract_43fb9daa-7a2b-46b7-9895-7f81ae5acf65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9565278c-2e3d-4fb7-9276-0a4a2c864017" xlink:to="loc_us-gaap_OtherAssetsAbstract_43fb9daa-7a2b-46b7-9895-7f81ae5acf65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2ebb2b96-0b68-49b8-9257-de30d2764cc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_43fb9daa-7a2b-46b7-9895-7f81ae5acf65" xlink:to="loc_us-gaap_Goodwill_2ebb2b96-0b68-49b8-9257-de30d2764cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0b143c40-c3de-4e2e-a88b-301c70a1bc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_43fb9daa-7a2b-46b7-9895-7f81ae5acf65" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0b143c40-c3de-4e2e-a88b-301c70a1bc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_0c0ebc76-04f3-4d68-a9a8-7fda60226872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNoncurrentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_43fb9daa-7a2b-46b7-9895-7f81ae5acf65" xlink:to="loc_us-gaap_DeferredFinanceCostsNoncurrentNet_0c0ebc76-04f3-4d68-a9a8-7fda60226872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_8dfe40bb-db46-4d59-9e58-b210500246c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_43fb9daa-7a2b-46b7-9895-7f81ae5acf65" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_8dfe40bb-db46-4d59-9e58-b210500246c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_980e20fa-4c16-479d-93df-5e4bffad4119" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_43fb9daa-7a2b-46b7-9895-7f81ae5acf65" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_980e20fa-4c16-479d-93df-5e4bffad4119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssets_319c39f9-0886-4717-ae6a-f26ee645dd49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositsAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherAssetsAbstract_43fb9daa-7a2b-46b7-9895-7f81ae5acf65" xlink:to="loc_us-gaap_DepositsAssets_319c39f9-0886-4717-ae6a-f26ee645dd49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cefaee44-3f57-4ed5-853c-5ce476bfcdab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9565278c-2e3d-4fb7-9276-0a4a2c864017" xlink:to="loc_us-gaap_Assets_cefaee44-3f57-4ed5-853c-5ce476bfcdab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16839012-8dd4-4964-8769-843a8a413429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_ed97680b-2d1c-4fef-b164-6e4dbd8af0c1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16839012-8dd4-4964-8769-843a8a413429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_fe13622e-2839-4d71-85c9-a0d443218c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16839012-8dd4-4964-8769-843a8a413429" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_fe13622e-2839-4d71-85c9-a0d443218c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_85c3c81b-0d6d-4afc-8729-ef28d881d91f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe13622e-2839-4d71-85c9-a0d443218c00" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_85c3c81b-0d6d-4afc-8729-ef28d881d91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToAffiliateCurrent_7a02d588-7f61-492f-a73d-3b02e6fc63be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueToAffiliateCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe13622e-2839-4d71-85c9-a0d443218c00" xlink:to="loc_us-gaap_DueToAffiliateCurrent_7a02d588-7f61-492f-a73d-3b02e6fc63be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenue_ecee0d1e-6b90-4ffc-b935-3e655a3cc188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe13622e-2839-4d71-85c9-a0d443218c00" xlink:to="loc_us-gaap_DeferredRevenue_ecee0d1e-6b90-4ffc-b935-3e655a3cc188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_a21e8953-816e-43b4-9e5a-fe4bfed91a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe13622e-2839-4d71-85c9-a0d443218c00" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_a21e8953-816e-43b4-9e5a-fe4bfed91a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_26f2339d-237b-4b11-ac9a-fac2f2ec27f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe13622e-2839-4d71-85c9-a0d443218c00" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_26f2339d-237b-4b11-ac9a-fac2f2ec27f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_f559311b-77e8-4613-ac28-d63e311adc10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe13622e-2839-4d71-85c9-a0d443218c00" xlink:to="loc_us-gaap_NotesPayableCurrent_f559311b-77e8-4613-ac28-d63e311adc10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7323002d-b73b-466e-b985-1dc2690bb282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fe13622e-2839-4d71-85c9-a0d443218c00" xlink:to="loc_us-gaap_LiabilitiesCurrent_7323002d-b73b-466e-b985-1dc2690bb282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_f3b31eb9-43dc-4fea-9814-8d80359171cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16839012-8dd4-4964-8769-843a8a413429" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_f3b31eb9-43dc-4fea-9814-8d80359171cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b1e06669-9d75-4c76-99a4-d6b990f9c6f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_f3b31eb9-43dc-4fea-9814-8d80359171cc" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b1e06669-9d75-4c76-99a4-d6b990f9c6f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_413c209f-6a99-43d7-8a1f-59045ee342ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_f3b31eb9-43dc-4fea-9814-8d80359171cc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_413c209f-6a99-43d7-8a1f-59045ee342ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermNotesPayable_69cf6b39-3a83-4e81-b623-b90d4575f401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_f3b31eb9-43dc-4fea-9814-8d80359171cc" xlink:to="loc_us-gaap_LongTermNotesPayable_69cf6b39-3a83-4e81-b623-b90d4575f401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5d885bf0-75dc-44cc-93ce-9ce2fb9def5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_f3b31eb9-43dc-4fea-9814-8d80359171cc" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5d885bf0-75dc-44cc-93ce-9ce2fb9def5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9d30301d-3444-4125-b0e8-94918534cb19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_f3b31eb9-43dc-4fea-9814-8d80359171cc" xlink:to="loc_us-gaap_Liabilities_9d30301d-3444-4125-b0e8-94918534cb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_8c5c9815-a3b0-40c5-bee5-f74c21702706" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16839012-8dd4-4964-8769-843a8a413429" xlink:to="loc_us-gaap_StockholdersEquityAbstract_8c5c9815-a3b0-40c5-bee5-f74c21702706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7f0e6b66-ecdf-4b76-b9c1-d6435e011739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8c5c9815-a3b0-40c5-bee5-f74c21702706" xlink:to="loc_us-gaap_CommonStockValue_7f0e6b66-ecdf-4b76-b9c1-d6435e011739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b2f5141a-3242-4960-805d-be88e0230bcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8c5c9815-a3b0-40c5-bee5-f74c21702706" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b2f5141a-3242-4960-805d-be88e0230bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_24b375fb-5552-41a7-b1d3-866d9aefa1d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8c5c9815-a3b0-40c5-bee5-f74c21702706" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_24b375fb-5552-41a7-b1d3-866d9aefa1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_492e5390-6aff-48d3-9660-a018d4a8627f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8c5c9815-a3b0-40c5-bee5-f74c21702706" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_492e5390-6aff-48d3-9660-a018d4a8627f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2743093d-9749-4cec-90c3-6438b7113bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8c5c9815-a3b0-40c5-bee5-f74c21702706" xlink:to="loc_us-gaap_StockholdersEquity_2743093d-9749-4cec-90c3-6438b7113bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d072e705-242c-428d-8924-1003f2b2a591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8c5c9815-a3b0-40c5-bee5-f74c21702706" xlink:to="loc_us-gaap_MinorityInterest_d072e705-242c-428d-8924-1003f2b2a591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dd4b667b-c395-419b-88b1-380047ec554e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_8c5c9815-a3b0-40c5-bee5-f74c21702706" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dd4b667b-c395-419b-88b1-380047ec554e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_320027bd-6e25-4399-a4f0-5e65f4e15e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16839012-8dd4-4964-8769-843a8a413429" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_320027bd-6e25-4399-a4f0-5e65f4e15e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f8c02523-7a28-4900-86ab-fba8628bbb9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_516218a5-336e-45e1-ab96-399edcc530ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f8c02523-7a28-4900-86ab-fba8628bbb9c" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_516218a5-336e-45e1-ab96-399edcc530ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1bb2ecd9-18a8-4d1e-b0ed-d619dd1c1d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f8c02523-7a28-4900-86ab-fba8628bbb9c" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1bb2ecd9-18a8-4d1e-b0ed-d619dd1c1d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_8807eed8-677f-4170-971a-616fe7ddfe9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f8c02523-7a28-4900-86ab-fba8628bbb9c" xlink:to="loc_us-gaap_CommonStockSharesIssued_8807eed8-677f-4170-971a-616fe7ddfe9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f42d68df-6910-4607-9554-c541e7d46557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f8c02523-7a28-4900-86ab-fba8628bbb9c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f42d68df-6910-4607-9554-c541e7d46557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_33c3bd84-84cb-4576-93d3-34002350b299" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_9b598b5c-fba9-41ae-92ff-f857f4638178" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_33c3bd84-84cb-4576-93d3-34002350b299" xlink:to="loc_us-gaap_StatementTable_9b598b5c-fba9-41ae-92ff-f857f4638178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8e7611f8-c75c-4ae1-9f88-26b5b3e18ee7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9b598b5c-fba9-41ae-92ff-f857f4638178" xlink:to="loc_srt_ProductOrServiceAxis_8e7611f8-c75c-4ae1-9f88-26b5b3e18ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_671cce2d-51c6-4bd1-8629-00df48bb2fbf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8e7611f8-c75c-4ae1-9f88-26b5b3e18ee7" xlink:to="loc_srt_ProductsAndServicesDomain_671cce2d-51c6-4bd1-8629-00df48bb2fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_99b897d6-1d6f-44d0-80ea-f7faa4f35fa5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_671cce2d-51c6-4bd1-8629-00df48bb2fbf" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_99b897d6-1d6f-44d0-80ea-f7faa4f35fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_16183569-a349-4ecb-af99-f342aef6ee41" xlink:href="rdnt-20201231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_671cce2d-51c6-4bd1-8629-00df48bb2fbf" xlink:to="loc_rdnt_CapitationArrangementsMember_16183569-a349-4ecb-af99-f342aef6ee41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_9b598b5c-fba9-41ae-92ff-f857f4638178" xlink:to="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_ec005562-d7dc-4688-933d-7bc4ff2b684e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_RevenuesAbstract_ec005562-d7dc-4688-933d-7bc4ff2b684e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c34ac60-a8a4-4860-b964-bcaa2e64c639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ec005562-d7dc-4688-933d-7bc4ff2b684e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6c34ac60-a8a4-4860-b964-bcaa2e64c639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_305e07db-5490-4a74-bc06-f134d48c92bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ec005562-d7dc-4688-933d-7bc4ff2b684e" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_305e07db-5490-4a74-bc06-f134d48c92bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_14333907-f43c-40e5-8088-29d2cfdb3f68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_14333907-f43c-40e5-8088-29d2cfdb3f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_43a9b2ae-73f4-4ce1-95c6-0cec3f25486f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_43a9b2ae-73f4-4ce1-95c6-0cec3f25486f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_16e0d327-5a1f-4b7f-af14-b2c1a48388c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_16e0d327-5a1f-4b7f-af14-b2c1a48388c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_91f09df4-6460-4ae6-949f-2a63142bfe54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_91f09df4-6460-4ae6-949f-2a63142bfe54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_40ba4ea1-85ec-4fba-99c6-7ac5e6dfd097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_SeveranceCosts1_40ba4ea1-85ec-4fba-99c6-7ac5e6dfd097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f890e661-4f56-4bce-afd1-93e20b9a8fc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_738de2b0-064b-48b1-8427-83da414ca71a" xlink:to="loc_us-gaap_OperatingExpenses_f890e661-4f56-4bce-afd1-93e20b9a8fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9c3dfffe-4946-472d-aa0f-b46e58f14724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_OperatingIncomeLoss_9c3dfffe-4946-472d-aa0f-b46e58f14724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_54422f81-3bcd-4d4f-9a3d-cd504fad02ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_InterestExpenseDebt_54422f81-3bcd-4d4f-9a3d-cd504fad02ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_40337533-3db6-459d-8a8d-87b9577696a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_40337533-3db6-459d-8a8d-87b9577696a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_4f777024-9bac-4686-a793-4436ec2f4167" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1_4f777024-9bac-4686-a793-4436ec2f4167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation_422ff7fd-ecac-4489-9173-9be03fdec2e7" xlink:href="rdnt-20201231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_rdnt_GainLossonStepUpValuation_422ff7fd-ecac-4489-9173-9be03fdec2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b989d5fd-50dd-4679-8dc5-2e986a9b8031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_b989d5fd-50dd-4679-8dc5-2e986a9b8031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f988fcc5-ebcb-4dd9-82e6-8e50204009bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f988fcc5-ebcb-4dd9-82e6-8e50204009bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e382845b-c74f-4fd1-8576-fcd6953a6082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherExpensesAbstract_bfe5dc36-0cc9-44a5-81a2-211846dc91f7" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_e382845b-c74f-4fd1-8576-fcd6953a6082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_357e306e-3d46-4c5f-94a9-24b52a26f703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_357e306e-3d46-4c5f-94a9-24b52a26f703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4674e8d2-6368-49cd-9e2c-48b0fc06446e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4674e8d2-6368-49cd-9e2c-48b0fc06446e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_64c6b422-f3ef-415f-9be4-1d7860bff733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_ProfitLoss_64c6b422-f3ef-415f-9be4-1d7860bff733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1ca94a70-f097-4f10-aeb2-7cac5b69b3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1ca94a70-f097-4f10-aeb2-7cac5b69b3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_84c2e6c7-b2ea-4dca-9a26-c06262a8f019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_NetIncomeLoss_84c2e6c7-b2ea-4dca-9a26-c06262a8f019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_ca7b444e-d928-49ce-9225-a4bdbccdc729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_EarningsPerShareBasic_ca7b444e-d928-49ce-9225-a4bdbccdc729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_97be60bc-4ddc-47ae-9485-467848b9f046" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_EarningsPerShareDiluted_97be60bc-4ddc-47ae-9485-467848b9f046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a0e6e7ab-5085-47f6-a932-ca3fb8ff4559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f4961a98-47cc-47fc-86f7-5abacdf00358" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a0e6e7ab-5085-47f6-a932-ca3fb8ff4559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d9998f41-3657-4c03-984d-7cc6a7079a10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a0e6e7ab-5085-47f6-a932-ca3fb8ff4559" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d9998f41-3657-4c03-984d-7cc6a7079a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5d6c81bb-d7e6-45e1-8f35-fe39fb3eab1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a0e6e7ab-5085-47f6-a932-ca3fb8ff4559" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5d6c81bb-d7e6-45e1-8f35-fe39fb3eab1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b11e561-0fa7-46d2-b886-042a9bca7fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3cd8193b-0ffb-43de-b4bc-a5747c39b75f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b11e561-0fa7-46d2-b886-042a9bca7fe0" xlink:to="loc_us-gaap_ProfitLoss_3cd8193b-0ffb-43de-b4bc-a5747c39b75f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c60385d0-67e5-41f4-b73a-a8aea92ba996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b11e561-0fa7-46d2-b886-042a9bca7fe0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_c60385d0-67e5-41f4-b73a-a8aea92ba996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_823c16fc-6353-4a8b-b946-64f96c339f64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b11e561-0fa7-46d2-b886-042a9bca7fe0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_823c16fc-6353-4a8b-b946-64f96c339f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c436b132-fdad-43c0-8ec8-e478c95bf915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b11e561-0fa7-46d2-b886-042a9bca7fe0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_c436b132-fdad-43c0-8ec8-e478c95bf915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e269e779-0522-4ad5-90ad-4dc83ab14486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b11e561-0fa7-46d2-b886-042a9bca7fe0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_e269e779-0522-4ad5-90ad-4dc83ab14486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_96ed62f5-29f9-4c8e-bce7-57ecb4a8aceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b11e561-0fa7-46d2-b886-042a9bca7fe0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_96ed62f5-29f9-4c8e-bce7-57ecb4a8aceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_434399d0-b52f-44c9-a3f2-9986faf3381e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1b11e561-0fa7-46d2-b886-042a9bca7fe0" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_434399d0-b52f-44c9-a3f2-9986faf3381e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTOFEQUITY"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_cbcf5083-00b6-4d0c-9a99-2b2237df58e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_eaebf171-a194-415a-8345-1bf669438dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_cbcf5083-00b6-4d0c-9a99-2b2237df58e4" xlink:to="loc_us-gaap_StatementTable_eaebf171-a194-415a-8345-1bf669438dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ee3ff83c-3898-4714-90f4-2a927fdb7aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eaebf171-a194-415a-8345-1bf669438dd0" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ee3ff83c-3898-4714-90f4-2a927fdb7aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b80bcc50-5219-4515-84b2-47a07869e085" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ee3ff83c-3898-4714-90f4-2a927fdb7aa3" xlink:to="loc_us-gaap_EquityComponentDomain_b80bcc50-5219-4515-84b2-47a07869e085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:href="rdnt-20201231.xsd#rdnt_StockholdersEquityDeficitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b80bcc50-5219-4515-84b2-47a07869e085" xlink:to="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_024e86d8-63e0-40b2-a5d7-d969babdc5f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:to="loc_us-gaap_CommonStockMember_024e86d8-63e0-40b2-a5d7-d969babdc5f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_c3793269-cba5-4cb0-94a9-a9ed8ca6b9a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_c3793269-cba5-4cb0-94a9-a9ed8ca6b9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_12c6355a-9fde-4e43-87de-fafc11c7578b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_12c6355a-9fde-4e43-87de-fafc11c7578b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_656ce726-28e4-4d8d-a4b0-ecdd83dac454" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_StockholdersEquityDeficitMember_6150b0b4-342c-498e-ac98-0479164da3a4" xlink:to="loc_us-gaap_RetainedEarningsMember_656ce726-28e4-4d8d-a4b0-ecdd83dac454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b3a8ef1f-be2d-4799-9273-59ac19056a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_b80bcc50-5219-4515-84b2-47a07869e085" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b3a8ef1f-be2d-4799-9273-59ac19056a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_84579f0b-c0d7-4952-96ff-331bf6d797c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eaebf171-a194-415a-8345-1bf669438dd0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_84579f0b-c0d7-4952-96ff-331bf6d797c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a15d3b6f-cae0-4d92-b3ee-8ea3980636aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_84579f0b-c0d7-4952-96ff-331bf6d797c9" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a15d3b6f-cae0-4d92-b3ee-8ea3980636aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_ccd791f7-b0ab-456e-a9a0-7cd0f0499d39" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a15d3b6f-cae0-4d92-b3ee-8ea3980636aa" xlink:to="loc_rdnt_DeepHealthInc.Member_ccd791f7-b0ab-456e-a9a0-7cd0f0499d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_9278dd63-f35a-4db0-8966-a31b0e56e244" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_eaebf171-a194-415a-8345-1bf669438dd0" xlink:to="loc_us-gaap_StatementLineItems_9278dd63-f35a-4db0-8966-a31b0e56e244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_9278dd63-f35a-4db0-8966-a31b0e56e244" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_03b0266b-3447-4288-9f75-cbf577eddfb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_SharesOutstanding_03b0266b-3447-4288-9f75-cbf577eddfb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2bb82f07-a301-4754-9006-f2d828650010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2bb82f07-a301-4754-9006-f2d828650010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_66335b58-5909-45ec-a95b-8dfd9905165e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_66335b58-5909-45ec-a95b-8dfd9905165e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_aa12b7a4-3689-475a-aa0e-4cfcdc57386b" xlink:href="rdnt-20201231.xsd#rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue_aa12b7a4-3689-475a-aa0e-4cfcdc57386b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ea13cd4a-5ced-4a97-9ba2-62c39db3a357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ea13cd4a-5ced-4a97-9ba2-62c39db3a357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_023fac6a-ccc6-4ad2-8698-a7715e1cdfd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_023fac6a-ccc6-4ad2-8698-a7715e1cdfd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_0fbceff6-885b-498c-8a43-a4044eef6194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_0fbceff6-885b-498c-8a43-a4044eef6194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_8ce8de1f-6068-4a78-8e88-d6cb6def74a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_8ce8de1f-6068-4a78-8e88-d6cb6def74a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_59a85cb0-fd50-4290-86a7-38805b9de553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_59a85cb0-fd50-4290-86a7-38805b9de553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_0b24ce43-0e05-4406-a06d-f5b52bba07cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited_0b24ce43-0e05-4406-a06d-f5b52bba07cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeverance_0f8caa24-b85e-475b-a69b-e1c50e6c4c73" xlink:href="rdnt-20201231.xsd#rdnt_NonCashSeverance"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_NonCashSeverance_0f8caa24-b85e-475b-a69b-e1c50e6c4c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NonCashSeveranceShares_5f1d1778-cfda-402e-b92b-de8534c26efe" xlink:href="rdnt-20201231.xsd#rdnt_NonCashSeveranceShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_NonCashSeveranceShares_5f1d1778-cfda-402e-b92b-de8534c26efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_213e22c7-f885-46c2-b0ab-99c389be0792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_213e22c7-f885-46c2-b0ab-99c389be0792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_564e35b6-4a0e-43c6-84ff-48caa023df84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_564e35b6-4a0e-43c6-84ff-48caa023df84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_9d191fcd-5b62-4a8d-9cf1-f0799d04c048" xlink:href="rdnt-20201231.xsd#rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest_9d191fcd-5b62-4a8d-9cf1-f0799d04c048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_78732faa-e9de-4882-b458-d013b850e2a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_78732faa-e9de-4882-b458-d013b850e2a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution_65a87055-a51f-416c-841f-7aed0541e818" xlink:href="rdnt-20201231.xsd#rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution_65a87055-a51f-416c-841f-7aed0541e818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_cb03ca65-c8b2-4391-95f6-e900efb6bd26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_cb03ca65-c8b2-4391-95f6-e900efb6bd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContributionsFromNoncontrollingInterests_04cd2342-b440-494d-af39-05f6019e171e" xlink:href="rdnt-20201231.xsd#rdnt_ContributionsFromNoncontrollingInterests"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_ContributionsFromNoncontrollingInterests_04cd2342-b440-494d-af39-05f6019e171e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_89cce294-bf2d-4276-aa99-d923ea60ac05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_89cce294-bf2d-4276-aa99-d923ea60ac05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition_792a1503-b8f7-47de-89a6-2dd3d13d2bfe" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition_792a1503-b8f7-47de-89a6-2dd3d13d2bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_cc9500eb-e394-412a-b683-ed5cff445fc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent_cc9500eb-e394-412a-b683-ed5cff445fc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_bb20253a-5f51-4556-a953-0771c989a8cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_bb20253a-5f51-4556-a953-0771c989a8cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a97fef77-c75c-4469-8c29-80797df6eb46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a97fef77-c75c-4469-8c29-80797df6eb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8264f874-6cfd-4426-8df5-c51e46620b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_8264f874-6cfd-4426-8df5-c51e46620b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_81142ef8-9395-4cd6-9256-bf448b8b86d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_ProfitLoss_81142ef8-9395-4cd6-9256-bf448b8b86d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_69da3c68-800d-4716-8d86-6beef9619019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_69da3c68-800d-4716-8d86-6beef9619019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_0974ebdd-713b-4cb8-ad77-67aeaa482438" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_84cc1976-a64d-4ce7-a840-14be5f969725" xlink:to="loc_us-gaap_SharesOutstanding_0974ebdd-713b-4cb8-ad77-67aeaa482438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_337ebf23-8986-4f9b-8dbc-922a722b385c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c3b51f8a-3eb7-4be0-9aa2-df8a2a5070c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_337ebf23-8986-4f9b-8dbc-922a722b385c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c3b51f8a-3eb7-4be0-9aa2-df8a2a5070c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7fea2b51-8292-4eaf-8e45-f8f50af1251f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c3b51f8a-3eb7-4be0-9aa2-df8a2a5070c6" xlink:to="loc_us-gaap_ProfitLoss_7fea2b51-8292-4eaf-8e45-f8f50af1251f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c3b51f8a-3eb7-4be0-9aa2-df8a2a5070c6" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c68223e2-b8b3-4fbd-8a27-8dc823287af9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c68223e2-b8b3-4fbd-8a27-8dc823287af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_3d757457-9f07-4936-babd-6da68a0d0e26" xlink:href="rdnt-20201231.xsd#rdnt_OperatingLeaseRightofUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_rdnt_OperatingLeaseRightofUseAssetAmortization_3d757457-9f07-4936-babd-6da68a0d0e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_04611c2a-bef1-480c-870a-fcda9401faa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions_04611c2a-bef1-480c-870a-fcda9401faa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_0bcd5f08-e998-40ba-84be-dda39ac589aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_0bcd5f08-e998-40ba-84be-dda39ac589aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_0aaef162-d5fb-425f-81f9-e6a1ca8819dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_0aaef162-d5fb-425f-81f9-e6a1ca8819dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_93c63058-3208-4224-9f28-ac8161504d13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_93c63058-3208-4224-9f28-ac8161504d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GainLossonStepUpValuation_79426d10-9a94-4445-9d51-5f079ed04f8d" xlink:href="rdnt-20201231.xsd#rdnt_GainLossonStepUpValuation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_rdnt_GainLossonStepUpValuation_79426d10-9a94-4445-9d51-5f079ed04f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_59f5ff77-fc2d-429b-9795-4c86a63cbfc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_59f5ff77-fc2d-429b-9795-4c86a63cbfc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredHedgeGains_ac592db3-8d5c-49ca-8211-b797bcabf2a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_us-gaap_AmortizationOfDeferredHedgeGains_ac592db3-8d5c-49ca-8211-b797bcabf2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_2ca3ce7d-a298-43d5-a13e-43eb2e77b060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_2ca3ce7d-a298-43d5-a13e-43eb2e77b060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_56682a24-7b31-4ea9-980b-4818fcb98cf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_us-gaap_ShareBasedCompensation_56682a24-7b31-4ea9-980b-4818fcb98cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_037140d8-9e15-47ab-80e8-cb94ec98e9d8" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseDecreaseInOtherNoncashItem"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_rdnt_IncreaseDecreaseInOtherNoncashItem_037140d8-9e15-47ab-80e8-cb94ec98e9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7c19299f-4cf8-45ce-83ed-bb1def38bbbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4ab8f509-9698-46f1-95be-6a3f4c1c2818" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7c19299f-4cf8-45ce-83ed-bb1def38bbbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_00972299-0c1a-4bea-a554-d9a36565fd89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c3b51f8a-3eb7-4be0-9aa2-df8a2a5070c6" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_00972299-0c1a-4bea-a554-d9a36565fd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e4644aee-5531-4bf9-8faa-e30a107be5c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_00972299-0c1a-4bea-a554-d9a36565fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e4644aee-5531-4bf9-8faa-e30a107be5c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_72dd6e3e-bf0a-42f3-ab2c-0f86f2bb091c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherCurrentAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_00972299-0c1a-4bea-a554-d9a36565fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherCurrentAssets_72dd6e3e-bf0a-42f3-ab2c-0f86f2bb091c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_60f8bc54-2432-4ad1-8a3d-78818c9ca01b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_00972299-0c1a-4bea-a554-d9a36565fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_60f8bc54-2432-4ad1-8a3d-78818c9ca01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_86252d77-b03f-4978-955f-525d0a38d084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_00972299-0c1a-4bea-a554-d9a36565fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_86252d77-b03f-4978-955f-525d0a38d084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability_108b1e47-2015-40be-a1a7-2f93e7e0aab0" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseDecreaseinOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_00972299-0c1a-4bea-a554-d9a36565fd89" xlink:to="loc_rdnt_IncreaseDecreaseinOperatingLeaseLiability_108b1e47-2015-40be-a1a7-2f93e7e0aab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_IncreaseDecreaseInDeferredRent_22a59e8a-e223-4470-a7cf-189c50a1cb6c" xlink:href="rdnt-20201231.xsd#rdnt_IncreaseDecreaseInDeferredRent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_00972299-0c1a-4bea-a554-d9a36565fd89" xlink:to="loc_rdnt_IncreaseDecreaseInDeferredRent_22a59e8a-e223-4470-a7cf-189c50a1cb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f1f1cb22-191b-4e0f-855c-a11d9ee77ad2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_00972299-0c1a-4bea-a554-d9a36565fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f1f1cb22-191b-4e0f-855c-a11d9ee77ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c27e81ec-0e59-4ad0-81a8-66c18b93b241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_00972299-0c1a-4bea-a554-d9a36565fd89" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_c27e81ec-0e59-4ad0-81a8-66c18b93b241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f4e64b34-0885-42d0-b09c-46887e77c73a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_c3b51f8a-3eb7-4be0-9aa2-df8a2a5070c6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f4e64b34-0885-42d0-b09c-46887e77c73a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9edf1d4-56d7-463c-a38c-dd460d20df24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_337ebf23-8986-4f9b-8dbc-922a722b385c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9edf1d4-56d7-463c-a38c-dd460d20df24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBuildings_1caf24ed-a86d-4d84-a90e-76aa0503e962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBuildings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9edf1d4-56d7-463c-a38c-dd460d20df24" xlink:to="loc_us-gaap_PaymentsToAcquireBuildings_1caf24ed-a86d-4d84-a90e-76aa0503e962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_d169255d-b094-40e4-b451-042b9d5bc591" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9edf1d4-56d7-463c-a38c-dd460d20df24" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_d169255d-b094-40e4-b451-042b9d5bc591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_be05095e-95b7-496b-ab3d-6833a27ac5f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9edf1d4-56d7-463c-a38c-dd460d20df24" xlink:to="loc_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment_be05095e-95b7-496b-ab3d-6833a27ac5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_38e1cd8f-4e63-46ba-a775-a4d2cb15c3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9edf1d4-56d7-463c-a38c-dd460d20df24" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_38e1cd8f-4e63-46ba-a775-a4d2cb15c3ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_aab2b876-24a2-4b89-a4eb-00e63a2be773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9edf1d4-56d7-463c-a38c-dd460d20df24" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_aab2b876-24a2-4b89-a4eb-00e63a2be773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_bdff55b7-6423-48e9-bb14-2d7329e950e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfIntangibleAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9edf1d4-56d7-463c-a38c-dd460d20df24" xlink:to="loc_us-gaap_ProceedsFromSaleOfIntangibleAssets_bdff55b7-6423-48e9-bb14-2d7329e950e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_8fca7640-3c8b-4d09-ae99-20ff9c3cb1c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9edf1d4-56d7-463c-a38c-dd460d20df24" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_8fca7640-3c8b-4d09-ae99-20ff9c3cb1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_53213248-4b74-484c-8c73-e010a6263589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9edf1d4-56d7-463c-a38c-dd460d20df24" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_53213248-4b74-484c-8c73-e010a6263589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_db72898d-3718-4b30-bd5b-5637ba801e62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_a9edf1d4-56d7-463c-a38c-dd460d20df24" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_db72898d-3718-4b30-bd5b-5637ba801e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_337ebf23-8986-4f9b-8dbc-922a722b385c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_a2b75983-bdeb-4efa-a554-c2d7355336ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities_a2b75983-bdeb-4efa-a554-c2d7355336ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_9169a321-7963-4eb6-a345-3723519d178e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_us-gaap_RepaymentsOfDebt_9169a321-7963-4eb6-a345-3723519d178e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d708997d-265d-476f-9332-fcaf74f59dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d708997d-265d-476f-9332-fcaf74f59dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_0339bbef-9d45-4b4d-9268-15fc904ebef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_0339bbef-9d45-4b4d-9268-15fc904ebef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistance_2c5842d2-3729-4176-9e98-8f540d636cd9" xlink:href="rdnt-20201231.xsd#rdnt_ProceedsFromGovernmentAssistance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_rdnt_ProceedsFromGovernmentAssistance_2c5842d2-3729-4176-9e98-8f540d636cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_2c90b626-f661-4725-a7eb-35a6fc53e6d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_2c90b626-f661-4725-a7eb-35a6fc53e6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_74e28431-6f9d-43a1-af9f-3b2691bec8cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets_74e28431-6f9d-43a1-af9f-3b2691bec8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributedCapital_5b4ed3b0-8883-4582-bedc-201c2b272c75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromContributedCapital"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_us-gaap_ProceedsFromContributedCapital_5b4ed3b0-8883-4582-bedc-201c2b272c75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_94024628-8756-4f1e-accf-b30bd2b12173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_94024628-8756-4f1e-accf-b30bd2b12173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_096d2a46-6a7e-4cf0-b08b-794c5b29eec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_096d2a46-6a7e-4cf0-b08b-794c5b29eec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentsToAcquireInterestInSubsidiaries_19e4b7a9-81a5-484a-baec-7425086ba5ea" xlink:href="rdnt-20201231.xsd#rdnt_PaymentsToAcquireInterestInSubsidiaries"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_rdnt_PaymentsToAcquireInterestInSubsidiaries_19e4b7a9-81a5-484a-baec-7425086ba5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_6c2855ff-82a2-4b4c-b5ce-54e0cbdd1b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_6c2855ff-82a2-4b4c-b5ce-54e0cbdd1b0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_83e65ad1-8052-4493-a6d4-931e296ea267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_42b266f8-7994-449b-8a72-96bf9f36286a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_83e65ad1-8052-4493-a6d4-931e296ea267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f393f81a-9c64-447c-9dcc-009b5fa93024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_337ebf23-8986-4f9b-8dbc-922a722b385c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f393f81a-9c64-447c-9dcc-009b5fa93024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_97bfc9ba-c83b-4ded-87f5-1a3347cb63cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_337ebf23-8986-4f9b-8dbc-922a722b385c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_97bfc9ba-c83b-4ded-87f5-1a3347cb63cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_61304eb1-b023-4cfb-bf54-bd992c271f79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_337ebf23-8986-4f9b-8dbc-922a722b385c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_61304eb1-b023-4cfb-bf54-bd992c271f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8d001db7-979b-4c69-81a0-835084de853a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_337ebf23-8986-4f9b-8dbc-922a722b385c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8d001db7-979b-4c69-81a0-835084de853a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_4e00d894-175a-43f3-a0da-ba917e330fd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_337ebf23-8986-4f9b-8dbc-922a722b385c" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_4e00d894-175a-43f3-a0da-ba917e330fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_b0361b02-9f2a-40ef-9ede-46836043cb34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4e00d894-175a-43f3-a0da-ba917e330fd4" xlink:to="loc_us-gaap_InterestPaidNet_b0361b02-9f2a-40ef-9ede-46836043cb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_80db24ea-0693-4173-9350-8fa4a0683bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4e00d894-175a-43f3-a0da-ba917e330fd4" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_80db24ea-0693-4173-9350-8fa4a0683bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_4e00d894-175a-43f3-a0da-ba917e330fd4" xlink:to="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_f73f8593-5ada-464d-b762-4e3fdb664aaa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:to="loc_srt_ConsolidatedEntitiesAxis_f73f8593-5ada-464d-b762-4e3fdb664aaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_826aea98-3085-4653-8673-47902a5d6337" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_f73f8593-5ada-464d-b762-4e3fdb664aaa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_826aea98-3085-4653-8673-47902a5d6337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_de239797-c555-43d0-a017-11d5a91cc148" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_826aea98-3085-4653-8673-47902a5d6337" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_de239797-c555-43d0-a017-11d5a91cc148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f723abae-cc4f-469f-bce3-b2cae6a79dfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f723abae-cc4f-469f-bce3-b2cae6a79dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_047b3316-a85c-427c-aaae-46b0b2f2d9a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f723abae-cc4f-469f-bce3-b2cae6a79dfc" xlink:to="loc_us-gaap_EquityComponentDomain_047b3316-a85c-427c-aaae-46b0b2f2d9a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_06a5fd39-6dda-4624-8a0a-6ca88e36603c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_047b3316-a85c-427c-aaae-46b0b2f2d9a7" xlink:to="loc_us-gaap_NoncontrollingInterestMember_06a5fd39-6dda-4624-8a0a-6ca88e36603c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_StockholdersEquityDeficitMember_8a16f48b-c700-4b6d-b691-01c0d558c6e1" xlink:href="rdnt-20201231.xsd#rdnt_StockholdersEquityDeficitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_047b3316-a85c-427c-aaae-46b0b2f2d9a7" xlink:to="loc_rdnt_StockholdersEquityDeficitMember_8a16f48b-c700-4b6d-b691-01c0d558c6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74e6ab94-a378-4f5d-b7dc-8ac33ac7de1d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74e6ab94-a378-4f5d-b7dc-8ac33ac7de1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_6deb5d0d-e82c-4d09-95c7-91ba6ffbff15" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_74e6ab94-a378-4f5d-b7dc-8ac33ac7de1d" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_6deb5d0d-e82c-4d09-95c7-91ba6ffbff15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NewJerseyImagingNetworkLLCMember_850788e0-52d0-4157-b97a-717d8e73614c" xlink:href="rdnt-20201231.xsd#rdnt_NewJerseyImagingNetworkLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_6deb5d0d-e82c-4d09-95c7-91ba6ffbff15" xlink:to="loc_rdnt_NewJerseyImagingNetworkLLCMember_850788e0-52d0-4157-b97a-717d8e73614c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_661b804a-7122-4a0f-9697-bd631d320f73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_661b804a-7122-4a0f-9697-bd631d320f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_661b804a-7122-4a0f-9697-bd631d320f73" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_52422a65-a1bc-4199-914f-e50433ff7c96" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_DeepHealthIncMember_52422a65-a1bc-4199-914f-e50433ff7c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_b36f319b-f3b6-4d9f-a25c-875c66b41d13" xlink:href="rdnt-20201231.xsd#rdnt_NulogixMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_NulogixMember_b36f319b-f3b6-4d9f-a25c-875c66b41d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_0d14bbc9-9d72-4125-96f8-1277cc248ba6" xlink:href="rdnt-20201231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_0d14bbc9-9d72-4125-96f8-1277cc248ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLCMember_413d2f9c-dd22-49c8-b8b3-b3793d6ce2f2" xlink:href="rdnt-20201231.xsd#rdnt_VenturaCountyImagingGroupLLCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_VenturaCountyImagingGroupLLCMember_413d2f9c-dd22-49c8-b8b3-b3793d6ce2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_21450eb7-96f3-4155-a4c3-9a64a8b926c3" xlink:href="rdnt-20201231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_21450eb7-96f3-4155-a4c3-9a64a8b926c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalArtsRadiologyMember_d3f733c2-0a46-46fd-a09d-d5431be8bc8a" xlink:href="rdnt-20201231.xsd#rdnt_MedicalArtsRadiologyMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_72c2fced-7e88-46e8-8451-7639afd8b71b" xlink:to="loc_rdnt_MedicalArtsRadiologyMember_d3f733c2-0a46-46fd-a09d-d5431be8bc8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_311e8ed4-4da6-41fc-be77-892dd2f820de" xlink:to="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_bc31aaec-d4e0-4dba-bb08-d95bba5483db" xlink:href="rdnt-20201231.xsd#rdnt_EquipmentAcquiredAndLeaseholdImprovements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_EquipmentAcquiredAndLeaseholdImprovements_bc31aaec-d4e0-4dba-bb08-d95bba5483db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitalLeaseDebt_4e1efd37-7dce-4170-abf1-4f673b1e1ee9" xlink:href="rdnt-20201231.xsd#rdnt_CapitalLeaseDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_CapitalLeaseDebt_4e1efd37-7dce-4170-abf1-4f673b1e1ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_48a46a5b-6780-41d1-a9d6-69d0dc5cfce2" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_48a46a5b-6780-41d1-a9d6-69d0dc5cfce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_d0404781-75f5-41da-828c-16d442fd2328" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_d0404781-75f5-41da-828c-16d442fd2328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_006bcba7-6cbb-48d2-b7df-9c307eb1dfa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_006bcba7-6cbb-48d2-b7df-9c307eb1dfa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1007f880-3c1d-4536-97eb-df0008dacbaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_1007f880-3c1d-4536-97eb-df0008dacbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_7f731684-cbfc-480d-9e87-3b49e640695e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_7f731684-cbfc-480d-9e87-3b49e640695e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_84d7a558-4d14-4821-9803-799077c33d47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_84d7a558-4d14-4821-9803-799077c33d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_caf46abf-56aa-4526-af35-65d264f2c174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_caf46abf-56aa-4526-af35-65d264f2c174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_dc0126c0-0622-4266-8f93-7928e90a4be0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_dc0126c0-0622-4266-8f93-7928e90a4be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_b2ecae7f-4b50-43b4-a07f-0b6b0bb5ab78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_b2ecae7f-4b50-43b4-a07f-0b6b0bb5ab78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance_25aef0ab-1ca7-4152-9bf2-1ab6f578714e" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance_25aef0ab-1ca7-4152-9bf2-1ab6f578714e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_afc1e08c-c103-4636-990e-fc24a6f1c94d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_afc1e08c-c103-4636-990e-fc24a6f1c94d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationStepAcquisitionCashAcquired_5ded3726-5db1-4a02-9edc-ecbf30d27f74" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationStepAcquisitionCashAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_BusinessCombinationStepAcquisitionCashAcquired_5ded3726-5db1-4a02-9edc-ecbf30d27f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_46f748f0-d4a2-4712-af1a-6a05c569f465" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_46f748f0-d4a2-4712-af1a-6a05c569f465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_a89bec2b-d195-4abd-89a2-50f14160794a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_a89bec2b-d195-4abd-89a2-50f14160794a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1000aa8c-36cc-46a3-b951-92cd2eb446d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_1000aa8c-36cc-46a3-b951-92cd2eb446d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d4f696f0-90b3-4f05-b806-be3b943ee6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_d4f696f0-90b3-4f05-b806-be3b943ee6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue_94ff4e8f-7c5f-4293-a6ea-7dab2f403caf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue_94ff4e8f-7c5f-4293-a6ea-7dab2f403caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NoncontrollingInterestSpecialDistribution_711f82b6-9e40-483b-8873-096d04fef719" xlink:href="rdnt-20201231.xsd#rdnt_NoncontrollingInterestSpecialDistribution"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_rdnt_NoncontrollingInterestSpecialDistribution_711f82b6-9e40-483b-8873-096d04fef719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_72009ff8-6c82-4890-8087-8c3361144062" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_83b6677c-0ce2-42ad-b3fe-baf1f9ef92be" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation_72009ff8-6c82-4890-8087-8c3361144062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#NATUREOFBUSINESS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0406bf8-d1eb-4a01-bedb-537019b5f2bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_9c8bfa88-ec45-4d04-b74a-ec9e4b9574c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f0406bf8-d1eb-4a01-bedb-537019b5f2bc" xlink:to="loc_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock_9c8bfa88-ec45-4d04-b74a-ec9e4b9574c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#NATUREOFBUSINESSDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_842c568e-02c8-4622-85d4-d7b193149dcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberOfCenters_e1234d67-36d5-457a-a19f-1f1c8d161568" xlink:href="rdnt-20201231.xsd#rdnt_NumberOfCenters"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_842c568e-02c8-4622-85d4-d7b193149dcb" xlink:to="loc_rdnt_NumberOfCenters_e1234d67-36d5-457a-a19f-1f1c8d161568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9c4bc76a-607c-47f1-bf99-8f2b72a4ee9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_842c568e-02c8-4622-85d4-d7b193149dcb" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9c4bc76a-607c-47f1-bf99-8f2b72a4ee9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6341e12a-4934-4c5d-8dcd-5583bb9bad8f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9c4bc76a-607c-47f1-bf99-8f2b72a4ee9c" xlink:to="loc_dei_LegalEntityAxis_6341e12a-4934-4c5d-8dcd-5583bb9bad8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6952dd80-931b-408e-8801-b4315bb36158" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6341e12a-4934-4c5d-8dcd-5583bb9bad8f" xlink:to="loc_dei_EntityDomain_6952dd80-931b-408e-8801-b4315bb36158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember_bcac110f-58cb-4890-9362-23d8cdfa51da" xlink:href="rdnt-20201231.xsd#rdnt_BeverlyRadiologyMedicalGroupIIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_6952dd80-931b-408e-8801-b4315bb36158" xlink:to="loc_rdnt_BeverlyRadiologyMedicalGroupIIIMember_bcac110f-58cb-4890-9362-23d8cdfa51da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScriptSenderMember_3b40868d-a210-4aad-a6ce-4fc7fae9e7f2" xlink:href="rdnt-20201231.xsd#rdnt_ScriptSenderMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_6952dd80-931b-408e-8801-b4315bb36158" xlink:to="loc_rdnt_ScriptSenderMember_3b40868d-a210-4aad-a6ce-4fc7fae9e7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_653abe2d-67b7-489b-8c0b-0e294f5dc11e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9c4bc76a-607c-47f1-bf99-8f2b72a4ee9c" xlink:to="loc_srt_TitleOfIndividualAxis_653abe2d-67b7-489b-8c0b-0e294f5dc11e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ad2d79ee-a780-4704-a810-dd059be78e3e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_653abe2d-67b7-489b-8c0b-0e294f5dc11e" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ad2d79ee-a780-4704-a810-dd059be78e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_0a50b9d0-89cf-4cce-9dbf-129e48bc5a2e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ad2d79ee-a780-4704-a810-dd059be78e3e" xlink:to="loc_srt_ChiefExecutiveOfficerMember_0a50b9d0-89cf-4cce-9dbf-129e48bc5a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BoardMemberMember_8b5dd27e-63ad-4a3b-8ed3-624eaeb0f685" xlink:href="rdnt-20201231.xsd#rdnt_BoardMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ad2d79ee-a780-4704-a810-dd059be78e3e" xlink:to="loc_rdnt_BoardMemberMember_8b5dd27e-63ad-4a3b-8ed3-624eaeb0f685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_9c4bc76a-607c-47f1-bf99-8f2b72a4ee9c" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_bb3b5514-9d18-4839-8db6-2ea86a2b75c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_bb3b5514-9d18-4839-8db6-2ea86a2b75c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_ad268652-fdc7-44e7-875b-7d44cab4ee53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues_ad268652-fdc7-44e7-875b-7d44cab4ee53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_c29ccaa0-8b55-4c06-9ff1-14d9ad6bbf1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense_c29ccaa0-8b55-4c06-9ff1-14d9ad6bbf1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_44f0f659-51f6-4d3f-8644-358538c1a91f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_10577cb8-1319-4b1c-9cc0-f748cbee5a8f" xlink:to="loc_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax_44f0f659-51f6-4d3f-8644-358538c1a91f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1d6da853-7a27-4709-90fe-588a43fef827" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_842c568e-02c8-4622-85d4-d7b193149dcb" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1d6da853-7a27-4709-90fe-588a43fef827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_de796325-2fd2-45db-a557-c6988ef05686" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1d6da853-7a27-4709-90fe-588a43fef827" xlink:to="loc_srt_ConsolidatedEntitiesAxis_de796325-2fd2-45db-a557-c6988ef05686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_326f09a0-1c24-4070-864b-d278225882d7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_de796325-2fd2-45db-a557-c6988ef05686" xlink:to="loc_srt_ConsolidatedEntitiesDomain_326f09a0-1c24-4070-864b-d278225882d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_f89c4737-9e29-4bdf-a006-36fd0a2c031d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_326f09a0-1c24-4070-864b-d278225882d7" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_f89c4737-9e29-4bdf-a006-36fd0a2c031d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e45f7d0a-8572-4246-be06-46f6a62680ea" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1d6da853-7a27-4709-90fe-588a43fef827" xlink:to="loc_srt_RangeAxis_e45f7d0a-8572-4246-be06-46f6a62680ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bf3e62ea-55da-46af-9872-8dff20c9a674" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e45f7d0a-8572-4246-be06-46f6a62680ea" xlink:to="loc_srt_RangeMember_bf3e62ea-55da-46af-9872-8dff20c9a674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ca632068-b96f-48d0-810a-3f197ecd39a0" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bf3e62ea-55da-46af-9872-8dff20c9a674" xlink:to="loc_srt_MinimumMember_ca632068-b96f-48d0-810a-3f197ecd39a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b53b1988-231c-4b04-b3f5-331680ac10fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bf3e62ea-55da-46af-9872-8dff20c9a674" xlink:to="loc_srt_MaximumMember_b53b1988-231c-4b04-b3f5-331680ac10fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_4c101a75-df95-4110-b76d-761d0f7b89b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_1d6da853-7a27-4709-90fe-588a43fef827" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_4c101a75-df95-4110-b76d-761d0f7b89b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_5e077803-bf5e-4035-8088-2bd715557b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4c101a75-df95-4110-b76d-761d0f7b89b0" xlink:to="loc_us-gaap_Assets_5e077803-bf5e-4035-8088-2bd715557b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_02327c12-7ca0-43fe-a178-e741a88c2298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4c101a75-df95-4110-b76d-761d0f7b89b0" xlink:to="loc_us-gaap_Liabilities_02327c12-7ca0-43fe-a178-e741a88c2298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongTermContractsTerm_0fd58227-18ab-4f96-a59f-19abff12090c" xlink:href="rdnt-20201231.xsd#rdnt_LongTermContractsTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_4c101a75-df95-4110-b76d-761d0f7b89b0" xlink:to="loc_rdnt_LongTermContractsTerm_0fd58227-18ab-4f96-a59f-19abff12090c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_53d6fa5e-a681-40d7-982c-3480cb2cef11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_701dd2d8-c954-4dbc-932f-2053a4179803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_53d6fa5e-a681-40d7-982c-3480cb2cef11" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_701dd2d8-c954-4dbc-932f-2053a4179803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_55daf28e-2df2-4794-ad4f-1d740d78c08d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_55daf28e-2df2-4794-ad4f-1d740d78c08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5b2aa8f3-ebe8-4ba2-b16f-5c0e00bd3c53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_UseOfEstimates_5b2aa8f3-ebe8-4ba2-b16f-5c0e00bd3c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_4e14b705-c9c7-48ae-ab19-aeb1d2ba54bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_4e14b705-c9c7-48ae-ab19-aeb1d2ba54bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_b56060f5-5091-42c0-9a34-fc417b865615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_b56060f5-5091-42c0-9a34-fc417b865615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CARESActDisclosurePolicyPolicyTextBlock_b165b0bc-0c26-420e-aa9e-7235355e862f" xlink:href="rdnt-20201231.xsd#rdnt_CARESActDisclosurePolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_rdnt_CARESActDisclosurePolicyPolicyTextBlock_b165b0bc-0c26-420e-aa9e-7235355e862f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_afa6f6a5-9171-4403-b8f7-ce499fb59723" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_afa6f6a5-9171-4403-b8f7-ce499fb59723" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_424f9c6e-4998-42eb-b730-e256b6c1bb69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_424f9c6e-4998-42eb-b730-e256b6c1bb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_4d0236b1-1958-4c88-9026-0b1a5ee177c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock_4d0236b1-1958-4c88-9026-0b1a5ee177c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_b728f755-9e27-41b1-87e7-8810965858fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_b728f755-9e27-41b1-87e7-8810965858fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c2832abf-23c2-4e0e-9c67-0f8fa6b39580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c2832abf-23c2-4e0e-9c67-0f8fa6b39580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredChargesPolicyTextBlock_6c8c7ce5-1e30-4da0-aa99-3cecf8b1b598" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_DeferredChargesPolicyTextBlock_6c8c7ce5-1e30-4da0-aa99-3cecf8b1b598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3aa78e82-242c-4cd7-b42f-0449c8ffc88a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_3aa78e82-242c-4cd7-b42f-0449c8ffc88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_d5a26634-31ac-4eaa-b1d6-31116886612b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_d5a26634-31ac-4eaa-b1d6-31116886612b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_acfcd4f1-18b2-40ec-942d-ad3bbe938413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy_acfcd4f1-18b2-40ec-942d-ad3bbe938413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_b6867279-c1ce-439e-a772-36ebe9c8f432" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_b6867279-c1ce-439e-a772-36ebe9c8f432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_ca4ba4ec-74d0-4ebe-90fa-03fb7c87fb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_ca4ba4ec-74d0-4ebe-90fa-03fb7c87fb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_14d806b6-b142-4d3f-ae82-0d83e5d66f08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_14d806b6-b142-4d3f-ae82-0d83e5d66f08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UninsuredRisksPolicyTextBlock_279c5eb9-c331-4c51-9f45-1cf9b0ff6be6" xlink:href="rdnt-20201231.xsd#rdnt_UninsuredRisksPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_rdnt_UninsuredRisksPolicyTextBlock_279c5eb9-c331-4c51-9f45-1cf9b0ff6be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitPlansPolicy_6ad7fedd-e48b-44f1-9245-62c136853509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PostemploymentBenefitPlansPolicy"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_PostemploymentBenefitPlansPolicy_6ad7fedd-e48b-44f1-9245-62c136853509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock_0c4a484c-3af6-46c7-888a-bddfec353711" xlink:href="rdnt-20201231.xsd#rdnt_LossandOtherUnfavorableContractsPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock_0c4a484c-3af6-46c7-888a-bddfec353711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_c7b4bbe3-e5e7-44a9-9457-c5dfb1a86da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_c7b4bbe3-e5e7-44a9-9457-c5dfb1a86da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_d36fde2f-6766-4977-88b5-9c1dad632678" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_d36fde2f-6766-4977-88b5-9c1dad632678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_ecd97448-14a2-43a9-bd78-320333c76546" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_ecd97448-14a2-43a9-bd78-320333c76546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_4df80be7-e826-43b3-b2a6-80c4bcf2cfe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_4df80be7-e826-43b3-b2a6-80c4bcf2cfe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_2ebb3f40-23b9-4967-bdf2-806053edc67e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_2ebb3f40-23b9-4967-bdf2-806053edc67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5c2db611-66b3-40ae-80c5-412e2ddbe917" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5c2db611-66b3-40ae-80c5-412e2ddbe917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_64e914d4-7794-413a-97dc-775453d0e511" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_64e914d4-7794-413a-97dc-775453d0e511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_f3444c53-ff9b-4995-8a3a-1407244d0beb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_f3444c53-ff9b-4995-8a3a-1407244d0beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_ec2bdf9f-a391-479d-a309-74d911ea607d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_ec2bdf9f-a391-479d-a309-74d911ea607d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f5cff0c8-b86b-45f8-b9db-bc2033d81312" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d6e264b-f2e5-45f0-a21d-e6a5aaa1b830" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f5cff0c8-b86b-45f8-b9db-bc2033d81312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e3a3c1e6-2524-493a-b67c-376449504428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_7b5ae601-e99a-4711-9876-90003c3e930b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3a3c1e6-2524-493a-b67c-376449504428" xlink:to="loc_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock_7b5ae601-e99a-4711-9876-90003c3e930b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_57df296f-fcea-4bfd-b9c8-c5d872124bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3a3c1e6-2524-493a-b67c-376449504428" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_57df296f-fcea-4bfd-b9c8-c5d872124bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_d61616c3-156a-427c-b98e-170c96530374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3a3c1e6-2524-493a-b67c-376449504428" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_d61616c3-156a-427c-b98e-170c96530374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ec2fda39-f65c-48d7-bda2-31e8fa71ddb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3a3c1e6-2524-493a-b67c-376449504428" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ec2fda39-f65c-48d7-bda2-31e8fa71ddb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_98c405bd-fc79-44a5-914f-9aaba6bc8a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3a3c1e6-2524-493a-b67c-376449504428" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_98c405bd-fc79-44a5-914f-9aaba6bc8a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_fd6330a9-0fe3-4382-bd9d-cca06a5d8dd5" xlink:href="rdnt-20201231.xsd#rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e3a3c1e6-2524-493a-b67c-376449504428" xlink:to="loc_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock_fd6330a9-0fe3-4382-bd9d-cca06a5d8dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5249ccbf-8c4b-44d2-ac82-12eddfb7091b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f569ad4a-9c15-49fe-ac93-1cc02568a8da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5249ccbf-8c4b-44d2-ac82-12eddfb7091b" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f569ad4a-9c15-49fe-ac93-1cc02568a8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_682ada89-2cdc-466b-8b29-c35cb51f1131" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f569ad4a-9c15-49fe-ac93-1cc02568a8da" xlink:to="loc_srt_ProductOrServiceAxis_682ada89-2cdc-466b-8b29-c35cb51f1131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_682ada89-2cdc-466b-8b29-c35cb51f1131" xlink:to="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CommercialInsurance1Member_08228a38-16b8-4cdc-bbb2-aace9c1d9b1f" xlink:href="rdnt-20201231.xsd#rdnt_CommercialInsurance1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_CommercialInsurance1Member_08228a38-16b8-4cdc-bbb2-aace9c1d9b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicare1Member_b35710ee-f1d9-4aae-9885-c7d37e82c8af" xlink:href="rdnt-20201231.xsd#rdnt_Medicare1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_Medicare1Member_b35710ee-f1d9-4aae-9885-c7d37e82c8af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Medicaid1Member_76bf52bb-fdcb-4d00-8933-12f44abd3244" xlink:href="rdnt-20201231.xsd#rdnt_Medicaid1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_Medicaid1Member_76bf52bb-fdcb-4d00-8933-12f44abd3244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WorkersCompensationPersonalInjury1Member_c8fc1644-0660-4efe-b64d-ef4a74df56e6" xlink:href="rdnt-20201231.xsd#rdnt_WorkersCompensationPersonalInjury1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_WorkersCompensationPersonalInjury1Member_c8fc1644-0660-4efe-b64d-ef4a74df56e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCarePatientServiceOtherMember_14a27fd9-a04f-41af-90c6-d02d20a97d9f" xlink:href="rdnt-20201231.xsd#rdnt_HealthCarePatientServiceOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_HealthCarePatientServiceOtherMember_14a27fd9-a04f-41af-90c6-d02d20a97d9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthCareManagementServiceMember_3d34621f-debc-435b-a08b-06a318528127" xlink:href="rdnt-20201231.xsd#rdnt_HealthCareManagementServiceMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_HealthCareManagementServiceMember_3d34621f-debc-435b-a08b-06a318528127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_09d18bf4-60fb-4798-9d46-099d616b971f" xlink:href="rdnt-20201231.xsd#rdnt_ImagingOnCallMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_ImagingOnCallMember_09d18bf4-60fb-4798-9d46-099d616b971f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareOtherMember_251f5213-4de5-47c2-aa98-77c92d8d444f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCareOtherMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_us-gaap_HealthCareOtherMember_251f5213-4de5-47c2-aa98-77c92d8d444f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCarePatientServiceMember_ce9b1f32-e6e0-4a5f-af37-a77844d7ea5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HealthCarePatientServiceMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_us-gaap_HealthCarePatientServiceMember_ce9b1f32-e6e0-4a5f-af37-a77844d7ea5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CapitationArrangementsMember_b332ff8f-b3e6-4c08-b6cc-c678db11d4b5" xlink:href="rdnt-20201231.xsd#rdnt_CapitationArrangementsMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0c2b5d58-2c43-4c1e-b9eb-091f24a58138" xlink:to="loc_rdnt_CapitationArrangementsMember_b332ff8f-b3e6-4c08-b6cc-c678db11d4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_60a96585-4644-4ca2-bcbc-d0045e4c657f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_f569ad4a-9c15-49fe-ac93-1cc02568a8da" xlink:to="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_60a96585-4644-4ca2-bcbc-d0045e4c657f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fc269403-1ac6-4b3f-8464-03e4b0ba4972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_60a96585-4644-4ca2-bcbc-d0045e4c657f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fc269403-1ac6-4b3f-8464-03e4b0ba4972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_adb27491-ac7a-4966-8125-be04aaa550be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems_60a96585-4644-4ca2-bcbc-d0045e4c657f" xlink:to="loc_us-gaap_Revenues_adb27491-ac7a-4966-8125-be04aaa550be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ca77220a-933c-47ba-8bad-4b12192676ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ca77220a-933c-47ba-8bad-4b12192676ab" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_2b1ab497-a390-42b9-ae18-bc68b72f73da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_2b1ab497-a390-42b9-ae18-bc68b72f73da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_2fd70e53-4c4b-4173-81bb-291e157cdaca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_2b1ab497-a390-42b9-ae18-bc68b72f73da" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_2fd70e53-4c4b-4173-81bb-291e157cdaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_a10efe76-7045-4e38-ac4b-c124c5d96bd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_2fd70e53-4c4b-4173-81bb-291e157cdaca" xlink:to="loc_us-gaap_CommercialPaperMember_a10efe76-7045-4e38-ac4b-c124c5d96bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionAxis_1b3cd1f2-82a0-43c4-bdfa-16b7ae09f345" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionAxis_1b3cd1f2-82a0-43c4-bdfa-16b7ae09f345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_bb90de66-e9cf-4f8f-b6af-bf78fd2f9305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuritiesFinancingTransactionTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionAxis_1b3cd1f2-82a0-43c4-bdfa-16b7ae09f345" xlink:to="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_bb90de66-e9cf-4f8f-b6af-bf78fd2f9305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_ef010644-20cd-4ff6-9998-4cb6310317a2" xlink:href="rdnt-20201231.xsd#rdnt_Caps2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_bb90de66-e9cf-4f8f-b6af-bf78fd2f9305" xlink:to="loc_rdnt_Caps2016Member_ef010644-20cd-4ff6-9998-4cb6310317a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPSMember_8c6763c3-ed38-4ad0-8ae8-3433ba587480" xlink:href="rdnt-20201231.xsd#rdnt_A2019SWAPSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_bb90de66-e9cf-4f8f-b6af-bf78fd2f9305" xlink:to="loc_rdnt_A2019SWAPSMember_8c6763c3-ed38-4ad0-8ae8-3433ba587480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_A2019SWAPS1Member_7c116eb2-0348-4d25-b8e0-e9992701f9e6" xlink:href="rdnt-20201231.xsd#rdnt_A2019SWAPS1Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SecuritiesFinancingTransactionTypeDomain_bb90de66-e9cf-4f8f-b6af-bf78fd2f9305" xlink:to="loc_rdnt_A2019SWAPS1Member_7c116eb2-0348-4d25-b8e0-e9992701f9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_3fec309f-8eca-4270-986b-d69043fe7cf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_LitigationStatusAxis_3fec309f-8eca-4270-986b-d69043fe7cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_9169c748-54bb-4b0a-9b87-07ff0b429c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_3fec309f-8eca-4270-986b-d69043fe7cf8" xlink:to="loc_us-gaap_LitigationStatusDomain_9169c748-54bb-4b0a-9b87-07ff0b429c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_3c673729-eafa-41cc-af3f-1a821dcef0a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_9169c748-54bb-4b0a-9b87-07ff0b429c89" xlink:to="loc_us-gaap_SettledLitigationMember_3c673729-eafa-41cc-af3f-1a821dcef0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_3cd4f375-32b4-41d6-8366-32e85f261e20" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_LitigationCaseAxis_3cd4f375-32b4-41d6-8366-32e85f261e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_db1e7d95-94a5-41d0-99e7-d6952dd214f7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_3cd4f375-32b4-41d6-8366-32e85f261e20" xlink:to="loc_srt_LitigationCaseTypeDomain_db1e7d95-94a5-41d0-99e7-d6952dd214f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_dcc31c67-06ed-4101-86b1-1554f1924979" xlink:href="rdnt-20201231.xsd#rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_db1e7d95-94a5-41d0-99e7-d6952dd214f7" xlink:to="loc_rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember_dcc31c67-06ed-4101-86b1-1554f1924979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f57234c5-40bb-4e4e-a5c7-7a1508f533e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_PlanNameAxis_f57234c5-40bb-4e4e-a5c7-7a1508f533e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_cc31818b-7e21-49f1-9fb1-ba9183744cb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f57234c5-40bb-4e4e-a5c7-7a1508f533e3" xlink:to="loc_us-gaap_PlanNameDomain_cc31818b-7e21-49f1-9fb1-ba9183744cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_82ae16ca-a08d-4c50-a9d8-5c1af2d3dbfb" xlink:href="rdnt-20201231.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_cc31818b-7e21-49f1-9fb1-ba9183744cb5" xlink:to="loc_rdnt_RestatedPlanMember_82ae16ca-a08d-4c50-a9d8-5c1af2d3dbfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_39353f37-2dbd-4b4f-a354-9fc5bb4e753f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_ProductOrServiceAxis_39353f37-2dbd-4b4f-a354-9fc5bb4e753f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ed83e158-9184-4eb3-9af8-378be3333807" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_39353f37-2dbd-4b4f-a354-9fc5bb4e753f" xlink:to="loc_srt_ProductsAndServicesDomain_ed83e158-9184-4eb3-9af8-378be3333807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PatientServicesNetMember_90b5802a-3cb1-4b9b-aea3-9180948a6540" xlink:href="rdnt-20201231.xsd#rdnt_PatientServicesNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ed83e158-9184-4eb3-9af8-378be3333807" xlink:to="loc_rdnt_PatientServicesNetMember_90b5802a-3cb1-4b9b-aea3-9180948a6540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_7d591356-8446-4956-9170-17ed0b1ab32f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_7d591356-8446-4956-9170-17ed0b1ab32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9d486d07-c6a0-4a31-af5c-1ff0590c013e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_7d591356-8446-4956-9170-17ed0b1ab32f" xlink:to="loc_us-gaap_SegmentDomain_9d486d07-c6a0-4a31-af5c-1ff0590c013e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ERADMember_34a083f7-eaaf-471d-bb15-1497eea8cb21" xlink:href="rdnt-20201231.xsd#rdnt_ERADMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d486d07-c6a0-4a31-af5c-1ff0590c013e" xlink:to="loc_rdnt_ERADMember_34a083f7-eaaf-471d-bb15-1497eea8cb21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_74ee2e65-465e-4faf-a7ef-fef142171f10" xlink:href="rdnt-20201231.xsd#rdnt_ImagingOnCallMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9d486d07-c6a0-4a31-af5c-1ff0590c013e" xlink:to="loc_rdnt_ImagingOnCallMember_74ee2e65-465e-4faf-a7ef-fef142171f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8fe7321c-657a-42f7-a515-5fbefc54e803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_DebtInstrumentAxis_8fe7321c-657a-42f7-a515-5fbefc54e803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c740add2-3b01-444f-9a8d-400a91e60853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8fe7321c-657a-42f7-a515-5fbefc54e803" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c740add2-3b01-444f-9a8d-400a91e60853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_1db80d2f-3aef-4f5d-8927-27189f920ebd" xlink:href="rdnt-20201231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c740add2-3b01-444f-9a8d-400a91e60853" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_1db80d2f-3aef-4f5d-8927-27189f920ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_0a7ac9bd-aa45-4df8-8906-8f145be57f35" xlink:href="rdnt-20201231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c740add2-3b01-444f-9a8d-400a91e60853" xlink:to="loc_rdnt_BarclaysMember_0a7ac9bd-aa45-4df8-8906-8f145be57f35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_1264a8b5-542d-4ec4-bdc9-f2a0ae3cd196" xlink:href="rdnt-20201231.xsd#rdnt_SunTrustMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c740add2-3b01-444f-9a8d-400a91e60853" xlink:to="loc_rdnt_SunTrustMember_1264a8b5-542d-4ec4-bdc9-f2a0ae3cd196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f37b5bb7-0711-4b65-bdef-112426e98711" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_RangeAxis_f37b5bb7-0711-4b65-bdef-112426e98711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0788a0d9-79f2-4d3b-a8e9-227da2bd96e3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f37b5bb7-0711-4b65-bdef-112426e98711" xlink:to="loc_srt_RangeMember_0788a0d9-79f2-4d3b-a8e9-227da2bd96e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d118b05d-3ff5-447b-8a35-474a52db165b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0788a0d9-79f2-4d3b-a8e9-227da2bd96e3" xlink:to="loc_srt_MinimumMember_d118b05d-3ff5-447b-8a35-474a52db165b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_4d347f38-8ac1-4944-879d-453fc474576a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0788a0d9-79f2-4d3b-a8e9-227da2bd96e3" xlink:to="loc_srt_MaximumMember_4d347f38-8ac1-4944-879d-453fc474576a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_82ce136e-2ca6-4833-9e7e-3cae1af1128d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_82ce136e-2ca6-4833-9e7e-3cae1af1128d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_010a9478-625d-4d36-b2cf-8454e39010f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_82ce136e-2ca6-4833-9e7e-3cae1af1128d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_010a9478-625d-4d36-b2cf-8454e39010f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PropertyAndEquipmentMember_01ed0e02-4276-4c73-bfd4-f026b9f3f1a4" xlink:href="rdnt-20201231.xsd#rdnt_PropertyAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_010a9478-625d-4d36-b2cf-8454e39010f3" xlink:to="loc_rdnt_PropertyAndEquipmentMember_01ed0e02-4276-4c73-bfd4-f026b9f3f1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_80c31447-169c-405d-b34e-e41f5569ff79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_010a9478-625d-4d36-b2cf-8454e39010f3" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_80c31447-169c-405d-b34e-e41f5569ff79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyTypeAxis_4bb80267-b476-48e4-bb56-7c99a2d7b4dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyTypeAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_ReinsurancePolicyTypeAxis_4bb80267-b476-48e4-bb56-7c99a2d7b4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurancePolicyDomain_627690ba-e3d3-49b4-8944-b328eae93a23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReinsurancePolicyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePolicyTypeAxis_4bb80267-b476-48e4-bb56-7c99a2d7b4dc" xlink:to="loc_us-gaap_ReinsurancePolicyDomain_627690ba-e3d3-49b4-8944-b328eae93a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HealthInsuranceMember_06d802ad-6b57-47c3-ad5f-1ef4c3de39c4" xlink:href="rdnt-20201231.xsd#rdnt_HealthInsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReinsurancePolicyDomain_627690ba-e3d3-49b4-8944-b328eae93a23" xlink:to="loc_rdnt_HealthInsuranceMember_06d802ad-6b57-47c3-ad5f-1ef4c3de39c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_0980d6d3-5545-4c86-a143-3b46654fdcc3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_CounterpartyNameAxis_0980d6d3-5545-4c86-a143-3b46654fdcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c06b51b-394c-4c4b-93c7-2ac1e2fc192b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_0980d6d3-5545-4c86-a143-3b46654fdcc3" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c06b51b-394c-4c4b-93c7-2ac1e2fc192b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BlueShieldMember_46ff3f37-eea5-4e7f-a996-7c5484bb7811" xlink:href="rdnt-20201231.xsd#rdnt_BlueShieldMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c06b51b-394c-4c4b-93c7-2ac1e2fc192b" xlink:to="loc_rdnt_BlueShieldMember_46ff3f37-eea5-4e7f-a996-7c5484bb7811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_215cbafd-ac4c-42d6-80c2-d964175dfa1f" xlink:href="rdnt-20201231.xsd#rdnt_DignityHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3c06b51b-394c-4c4b-93c7-2ac1e2fc192b" xlink:to="loc_rdnt_DignityHealthMember_215cbafd-ac4c-42d6-80c2-d964175dfa1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_98f043ba-523c-4c92-964b-d236b8355f4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_98f043ba-523c-4c92-964b-d236b8355f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_98f043ba-523c-4c92-964b-d236b8355f4f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadiologixMember_469a110b-87e3-4387-ad8a-606152412fab" xlink:href="rdnt-20201231.xsd#rdnt_RadiologixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:to="loc_rdnt_RadiologixMember_469a110b-87e3-4387-ad8a-606152412fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_a9983fee-be60-4884-b8b4-32b97c692624" xlink:href="rdnt-20201231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_a9983fee-be60-4884-b8b4-32b97c692624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_dc68c47b-6ea1-4ec5-928e-47bfa7225d27" xlink:href="rdnt-20201231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_dc68c47b-6ea1-4ec5-928e-47bfa7225d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_63c7af53-d4f3-43a3-a7e8-5549e7866ab5" xlink:href="rdnt-20201231.xsd#rdnt_NulogixMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8745e721-7299-4ac8-b6a4-065be61b0428" xlink:to="loc_rdnt_NulogixMember_63c7af53-d4f3-43a3-a7e8-5549e7866ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesByContractTypeAxis_969d9358-fea4-40ea-81ef-f72407630013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditDerivativesByContractTypeAxis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_CreditDerivativesByContractTypeAxis_969d9358-fea4-40ea-81ef-f72407630013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditDerivativesContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesByContractTypeAxis_969d9358-fea4-40ea-81ef-f72407630013" xlink:to="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_September2020CapMember_c9eead1d-828e-4747-a12c-c7d11efdec0b" xlink:href="rdnt-20201231.xsd#rdnt_September2020CapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:to="loc_rdnt_September2020CapMember_c9eead1d-828e-4747-a12c-c7d11efdec0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2020CapMember_376f37e9-10b9-466c-814b-53486f67c761" xlink:href="rdnt-20201231.xsd#rdnt_October2020CapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:to="loc_rdnt_October2020CapMember_376f37e9-10b9-466c-814b-53486f67c761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2023Member_0246171b-51dc-4ce3-b717-7aff94be1a8e" xlink:href="rdnt-20201231.xsd#rdnt_October2023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:to="loc_rdnt_October2023Member_0246171b-51dc-4ce3-b717-7aff94be1a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_October2025Member_556c6caf-9fbe-4048-a663-baaa8831c282" xlink:href="rdnt-20201231.xsd#rdnt_October2025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditDerivativesContractTypeDomain_259aa0fc-1871-42c7-8c97-c37ce99ad2f6" xlink:to="loc_rdnt_October2025Member_556c6caf-9fbe-4048-a663-baaa8831c282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8b1352e4-5ce7-4dc2-95a0-b0a2f2ae31c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8b1352e4-5ce7-4dc2-95a0-b0a2f2ae31c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_563a948d-41be-4ad4-a958-43869adeea3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8b1352e4-5ce7-4dc2-95a0-b0a2f2ae31c7" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_563a948d-41be-4ad4-a958-43869adeea3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_Caps2016Member_94cf937d-99e6-4b32-92db-108dceaad8e9" xlink:href="rdnt-20201231.xsd#rdnt_Caps2016Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_563a948d-41be-4ad4-a958-43869adeea3d" xlink:to="loc_rdnt_Caps2016Member_94cf937d-99e6-4b32-92db-108dceaad8e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_7b84d21b-4556-4700-ad86-73d000c27c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_563a948d-41be-4ad4-a958-43869adeea3d" xlink:to="loc_us-gaap_InterestRateSwapMember_7b84d21b-4556-4700-ad86-73d000c27c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_d3a526ab-067e-4056-8779-209d95ccf110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_VariableRateAxis_d3a526ab-067e-4056-8779-209d95ccf110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_96ae8119-de7c-47e2-9301-6ba491d08cbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_d3a526ab-067e-4056-8779-209d95ccf110" xlink:to="loc_us-gaap_VariableRateDomain_96ae8119-de7c-47e2-9301-6ba491d08cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_adbb3238-f8c5-4ae4-aa6e-29be21f35d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_96ae8119-de7c-47e2-9301-6ba491d08cbb" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_adbb3238-f8c5-4ae4-aa6e-29be21f35d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ea0ab187-a510-4ac5-84b9-df944689de7e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ea0ab187-a510-4ac5-84b9-df944689de7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_ea0ab187-a510-4ac5-84b9-df944689de7e" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicVisionMember_898d63bd-5589-4ddb-8c40-b49f7a9fcbc6" xlink:href="rdnt-20201231.xsd#rdnt_MedicVisionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:to="loc_rdnt_MedicVisionMember_898d63bd-5589-4ddb-8c40-b49f7a9fcbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingSystemsMember_2cc6eb31-d995-4841-8d72-347898e7e971" xlink:href="rdnt-20201231.xsd#rdnt_TurnerImagingSystemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:to="loc_rdnt_TurnerImagingSystemsMember_2cc6eb31-d995-4841-8d72-347898e7e971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TurnerImagingMember_066e4eb7-9dbc-4767-ae77-1346a65682f6" xlink:href="rdnt-20201231.xsd#rdnt_TurnerImagingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:to="loc_rdnt_TurnerImagingMember_066e4eb7-9dbc-4767-ae77-1346a65682f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WhiteRabbit.aiInc.Member_a947725b-72b2-4065-9c7e-bb3eafb200c5" xlink:href="rdnt-20201231.xsd#rdnt_WhiteRabbit.aiInc.Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:to="loc_rdnt_WhiteRabbit.aiInc.Member_a947725b-72b2-4065-9c7e-bb3eafb200c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingMember_17c57b94-0953-4168-89d0-93519bb08750" xlink:href="rdnt-20201231.xsd#rdnt_SantaMonicaImagingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_e8ea90dd-be34-49b8-bb3d-54e77794b4e1" xlink:to="loc_rdnt_SantaMonicaImagingMember_17c57b94-0953-4168-89d0-93519bb08750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_2d833d34-7251-4e6b-8acd-b5bfc8b56ef8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_dei_LegalEntityAxis_2d833d34-7251-4e6b-8acd-b5bfc8b56ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_2d833d34-7251-4e6b-8acd-b5bfc8b56ef8" xlink:to="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_5972de1c-e310-41c5-9fc7-c24f2ea755ad" xlink:href="rdnt-20201231.xsd#rdnt_PrimedexHealthSystemsInc.andRadiologixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:to="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_5972de1c-e310-41c5-9fc7-c24f2ea755ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GlendaleAdvancedImagingMember_f02810de-68b7-4fb1-b750-642b2193b344" xlink:href="rdnt-20201231.xsd#rdnt_GlendaleAdvancedImagingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:to="loc_rdnt_GlendaleAdvancedImagingMember_f02810de-68b7-4fb1-b750-642b2193b344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadNetMember_f5c34fe1-4b6c-4886-a169-0c3299e4eaed" xlink:href="rdnt-20201231.xsd#rdnt_RadNetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:to="loc_rdnt_RadNetMember_f5c34fe1-4b6c-4886-a169-0c3299e4eaed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CedarsSinaiMedicalCenterMember_28c99783-0dec-4a0c-8521-5a59f78869e5" xlink:href="rdnt-20201231.xsd#rdnt_CedarsSinaiMedicalCenterMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_aa426c59-05d1-4945-84e4-3a773e365293" xlink:to="loc_rdnt_CedarsSinaiMedicalCenterMember_28c99783-0dec-4a0c-8521-5a59f78869e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_543dedb2-eab0-4e73-b0be-067222340991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_543dedb2-eab0-4e73-b0be-067222340991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_47bcbcd8-d7ac-4c61-b50a-744c1f62d7c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis_543dedb2-eab0-4e73-b0be-067222340991" xlink:to="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_47bcbcd8-d7ac-4c61-b50a-744c1f62d7c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_JointVentureMember_f04d6720-210b-432b-b0b0-c8c90ef0aeac" xlink:href="rdnt-20201231.xsd#rdnt_JointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain_47bcbcd8-d7ac-4c61-b50a-744c1f62d7c1" xlink:to="loc_rdnt_JointVentureMember_f04d6720-210b-432b-b0b0-c8c90ef0aeac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_792dc201-a518-4903-bc2b-4f98460f3c27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_792dc201-a518-4903-bc2b-4f98460f3c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_3a46bd85-088c-42ad-a48e-69c76df7348f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_792dc201-a518-4903-bc2b-4f98460f3c27" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_3a46bd85-088c-42ad-a48e-69c76df7348f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_064dc664-f937-4a78-b1f5-52609f099b26" xlink:href="rdnt-20201231.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_3a46bd85-088c-42ad-a48e-69c76df7348f" xlink:to="loc_rdnt_COVID19PandemicMember_064dc664-f937-4a78-b1f5-52609f099b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_204d8a18-51ad-4586-8b27-defaa07f40fe" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_srt_StatementScenarioAxis_204d8a18-51ad-4586-8b27-defaa07f40fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_e1a20a86-9e7e-4850-953a-e6a4dcb10e8b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_204d8a18-51ad-4586-8b27-defaa07f40fe" xlink:to="loc_srt_ScenarioUnspecifiedDomain_e1a20a86-9e7e-4850-953a-e6a4dcb10e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_63de85b5-a31f-46dd-ab2b-ce9164ea3471" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_e1a20a86-9e7e-4850-953a-e6a4dcb10e8b" xlink:to="loc_srt_ScenarioForecastMember_63de85b5-a31f-46dd-ab2b-ce9164ea3471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_af357c73-e369-4c72-9628-f427fe1267d0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdvanceMedicarePayments_40decee1-4c5a-453f-9e71-c956959c393a" xlink:href="rdnt-20201231.xsd#rdnt_AdvanceMedicarePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_AdvanceMedicarePayments_40decee1-4c5a-453f-9e71-c956959c393a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsReceivedFromInsurance_6729b9b3-3fb0-4a4a-b06a-7a8a88244521" xlink:href="rdnt-20201231.xsd#rdnt_ProceedsReceivedFromInsurance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ProceedsReceivedFromInsurance_6729b9b3-3fb0-4a4a-b06a-7a8a88244521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_2a1e9532-0760-40e5-ab26-6e9253e28a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_2a1e9532-0760-40e5-ab26-6e9253e28a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_e025e719-da81-4713-a3a4-e3bab49a0b08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_e025e719-da81-4713-a3a4-e3bab49a0b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_74833f96-4f92-4da9-8f38-dbd10fcb5acc" xlink:href="rdnt-20201231.xsd#rdnt_SocialSecurityTaxEmployerDeferralCARESAct"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_SocialSecurityTaxEmployerDeferralCARESAct_74833f96-4f92-4da9-8f38-dbd10fcb5acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoredAmount_054a8b2d-e621-4ed2-b735-d25e8f4c2fc1" xlink:href="rdnt-20201231.xsd#rdnt_ContractsReceivableFactoredAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ContractsReceivableFactoredAmount_054a8b2d-e621-4ed2-b735-d25e8f4c2fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractsReceivableFactoringReceivable_5b697edb-e0d6-4a7e-984d-81f20da61ccc" xlink:href="rdnt-20201231.xsd#rdnt_ContractsReceivableFactoringReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ContractsReceivableFactoringReceivable_5b697edb-e0d6-4a7e-984d-81f20da61ccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_10306a9b-805d-44f8-ac95-8ff6ac66532b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_10306a9b-805d-44f8-ac95-8ff6ac66532b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bdc9af2d-628e-499c-a2f3-9a4120dc3acd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bdc9af2d-628e-499c-a2f3-9a4120dc3acd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_2927faa5-c73c-458a-ab6b-8276b771b709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_2927faa5-c73c-458a-ab6b-8276b771b709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a585357c-6761-430f-840f-c519762b5267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a585357c-6761-430f-840f-c519762b5267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c0418021-c9b1-4094-83ee-64e20a90c796" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_Goodwill_c0418021-c9b1-4094-83ee-64e20a90c796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_75a89d16-5a81-446b-8e6a-43086dd5772e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_75a89d16-5a81-446b-8e6a-43086dd5772e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_105cbe3b-9d57-4f0e-9286-b380e16fa991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_105cbe3b-9d57-4f0e-9286-b380e16fa991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_8f5c4d2e-c2d5-4c1e-9486-81752a40a378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_8f5c4d2e-c2d5-4c1e-9486-81752a40a378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_52d96701-7584-4084-84c6-9ebc27c28c00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_52d96701-7584-4084-84c6-9ebc27c28c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrent_6d0cd1ca-3760-4200-a343-96bd255e3ac7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrent_6d0cd1ca-3760-4200-a343-96bd255e3ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_4b0e8472-3499-4534-bd9b-4498fd3611c5" xlink:href="rdnt-20201231.xsd#rdnt_MedicalMalpracticeDeductiblePerIncidence"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_MedicalMalpracticeDeductiblePerIncidence_4b0e8472-3499-4534-bd9b-4498fd3611c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_92df6396-4a80-4b92-9a66-8671fe6715d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_SelfInsuranceReserve_92df6396-4a80-4b92-9a66-8671fe6715d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_fa568091-e633-468d-af71-b1d855faa335" xlink:href="rdnt-20201231.xsd#rdnt_MedicalInsuranceStopLossPolicyClaimAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_MedicalInsuranceStopLossPolicyClaimAmount_fa568091-e633-468d-af71-b1d855faa335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_03d10182-e0a0-4bdf-ae4d-7f7322b54f8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_03d10182-e0a0-4bdf-ae4d-7f7322b54f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_fabe8c8e-aa4c-4c3a-87c7-0ad0cf46f297" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_fabe8c8e-aa4c-4c3a-87c7-0ad0cf46f297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_c57f465b-e6cf-45a9-9991-7a7a2b512e86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_c57f465b-e6cf-45a9-9991-7a7a2b512e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrual_1d52d653-6a3d-4513-b596-7d4a26ab34ea" xlink:href="rdnt-20201231.xsd#rdnt_ContractLossAccrual"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ContractLossAccrual_1d52d653-6a3d-4513-b596-7d4a26ab34ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_45e63181-cd31-4e10-bd1c-af0453c9a4dd" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross_45e63181-cd31-4e10-bd1c-af0453c9a4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_0286dc4e-5baa-4ddc-bc0a-747bdb3853bb" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_0286dc4e-5baa-4ddc-bc0a-747bdb3853bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ContractLossAccrualWrittenOff_34a07cd8-89ef-41a0-89ec-95f7bdaf78a7" xlink:href="rdnt-20201231.xsd#rdnt_ContractLossAccrualWrittenOff"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ContractLossAccrualWrittenOff_34a07cd8-89ef-41a0-89ec-95f7bdaf78a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e79fb32d-65d7-47e2-9882-1e7f60be93ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_e79fb32d-65d7-47e2-9882-1e7f60be93ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_75b5d5a2-84ba-43fa-9d85-0c679f524a30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_75b5d5a2-84ba-43fa-9d85-0c679f524a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3f2d0a08-ad62-428e-9f6a-9894bc40485c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3f2d0a08-ad62-428e-9f6a-9894bc40485c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualAtCarryingValue_1d12bf00-3d8e-44e3-a1ea-b879e1c69eae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyAccrualAtCarryingValue"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_LossContingencyAccrualAtCarryingValue_1d12bf00-3d8e-44e3-a1ea-b879e1c69eae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_1a5e8e09-83ef-428e-807f-27fcb4373d1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_1a5e8e09-83ef-428e-807f-27fcb4373d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_231b8f18-b800-48cf-aa3f-16ba9908b1b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNumberOfInstrumentsHeld"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DerivativeAssetNumberOfInstrumentsHeld_231b8f18-b800-48cf-aa3f-16ba9908b1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetNotionalAmount_99e73926-54f8-41f0-8581-6ccba0fc112c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssetNotionalAmount"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DerivativeAssetNotionalAmount_99e73926-54f8-41f0-8581-6ccba0fc112c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_84f60519-a65a-4879-b258-8b1f783ecb46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeBasisSpreadOnVariableRate"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_DerivativeBasisSpreadOnVariableRate_84f60519-a65a-4879-b258-8b1f783ecb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_47b120d6-4e28-4b61-a096-7b90f22073d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized_47b120d6-4e28-4b61-a096-7b90f22073d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_dc0a8a7c-1423-415a-8356-fff4a351ca89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_dc0a8a7c-1423-415a-8356-fff4a351ca89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_6424a50d-cded-428a-ac50-2f566982e566" xlink:href="rdnt-20201231.xsd#rdnt_MonthlyAmortizationOfDeferredHedgeGains"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_MonthlyAmortizationOfDeferredHedgeGains_6424a50d-cded-428a-ac50-2f566982e566" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_21d23cc5-e845-48ec-886b-dbb520d8050c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_LineOfCredit_21d23cc5-e845-48ec-886b-dbb520d8050c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_eb30ab67-0af4-4060-9e0b-32ae4f903f59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_eb30ab67-0af4-4060-9e0b-32ae4f903f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_bc62f37e-828d-42cf-9628-4bf535b9bf4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="41" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_bc62f37e-828d-42cf-9628-4bf535b9bf4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_acc1f434-9c6e-476c-9a66-9eba9b7b2cae" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment"/>
    <link:presentationArc order="42" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment_acc1f434-9c6e-476c-9a66-9eba9b7b2cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_fe680c45-e26a-4bbc-b364-406f6b8381c0" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired"/>
    <link:presentationArc order="43" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired_fe680c45-e26a-4bbc-b364-406f6b8381c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_9aa6a4cb-5099-4d4e-a34c-f29bb51c7dba" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution"/>
    <link:presentationArc order="44" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution_9aa6a4cb-5099-4d4e-a34c-f29bb51c7dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_0f94ab35-331e-49b7-a82c-eaff80d64af9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="45" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_0f94ab35-331e-49b7-a82c-eaff80d64af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentSharesPurchased_a9584f43-4de4-4e3b-b4dd-1955237e4551" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentSharesPurchased"/>
    <link:presentationArc order="46" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_EquityMethodInvestmentSharesPurchased_a9584f43-4de4-4e3b-b4dd-1955237e4551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_6a4980e3-ead8-4bb4-940b-567d0523d452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="47" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ShortTermBorrowings_6a4980e3-ead8-4bb4-940b-567d0523d452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_fb07f46f-40c0-43a3-9910-220ea6ef43f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="48" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_fb07f46f-40c0-43a3-9910-220ea6ef43f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_842c38dc-a5d8-4db3-a7dc-760c35dd3015" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToFundLongtermLoansToRelatedParties"/>
    <link:presentationArc order="49" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_PaymentsToFundLongtermLoansToRelatedParties_842c38dc-a5d8-4db3-a7dc-760c35dd3015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NumberofUnconsolidatedJointVentures_44e10c6e-d665-4172-8106-1beeb47c5fe9" xlink:href="rdnt-20201231.xsd#rdnt_NumberofUnconsolidatedJointVentures"/>
    <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_NumberofUnconsolidatedJointVentures_44e10c6e-d665-4172-8106-1beeb47c5fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_5ec50384-fc92-4ae1-b0bb-7ffd2c539192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="51" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_5ec50384-fc92-4ae1-b0bb-7ffd2c539192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_2b4310ac-f37c-4cfa-9c2e-cbb692e82d3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="52" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_2b4310ac-f37c-4cfa-9c2e-cbb692e82d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdditionalEquityInterestAcquired_1624b696-2a53-4184-a0ce-a7e2f7432e4e" xlink:href="rdnt-20201231.xsd#rdnt_AdditionalEquityInterestAcquired"/>
    <link:presentationArc order="53" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_AdditionalEquityInterestAcquired_1624b696-2a53-4184-a0ce-a7e2f7432e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_32986fb2-4133-4f8e-a217-f50895759c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="54" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_32986fb2-4133-4f8e-a217-f50895759c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_68e1149d-1f12-43c1-a66f-ad6c7929b76b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="55" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_68e1149d-1f12-43c1-a66f-ad6c7929b76b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceFees_802ac562-b08e-414d-be7c-de784a017d3d" xlink:href="rdnt-20201231.xsd#rdnt_ManagementServiceFees"/>
    <link:presentationArc order="56" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c6795fb1-294c-4ece-9fde-4fc6bad5e7ab" xlink:to="loc_rdnt_ManagementServiceFees_802ac562-b08e-414d-be7c-de784a017d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1eeb62c1-91ca-4eb8-b24f-ef6a103d707b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsTable_b888f3f5-4ffd-4ea9-a607-ed5a1c644548" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1eeb62c1-91ca-4eb8-b24f-ef6a103d707b" xlink:to="loc_us-gaap_OffsettingAssetsTable_b888f3f5-4ffd-4ea9-a607-ed5a1c644548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_6e77e7cf-06f9-4017-8621-3bf6a883f060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_b888f3f5-4ffd-4ea9-a607-ed5a1c644548" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_6e77e7cf-06f9-4017-8621-3bf6a883f060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7c94b593-29af-4bc0-ba57-ee9d7cbf8915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_6e77e7cf-06f9-4017-8621-3bf6a883f060" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7c94b593-29af-4bc0-ba57-ee9d7cbf8915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_d44311fe-33e8-4b7f-87a9-6301c24c9fc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7c94b593-29af-4bc0-ba57-ee9d7cbf8915" xlink:to="loc_us-gaap_InterestRateCapMember_d44311fe-33e8-4b7f-87a9-6301c24c9fc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b2f21fac-a058-4515-9ad8-15794e0b3ff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_7c94b593-29af-4bc0-ba57-ee9d7cbf8915" xlink:to="loc_us-gaap_InterestRateSwapMember_b2f21fac-a058-4515-9ad8-15794e0b3ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8b19269a-2296-4601-82f4-ccf9272c6ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_b888f3f5-4ffd-4ea9-a607-ed5a1c644548" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8b19269a-2296-4601-82f4-ccf9272c6ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3027c7ed-cf8c-4acf-9eda-80fdaa009cac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8b19269a-2296-4601-82f4-ccf9272c6ab9" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3027c7ed-cf8c-4acf-9eda-80fdaa009cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_814b7099-405c-4721-8915-ceafd057334c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3027c7ed-cf8c-4acf-9eda-80fdaa009cac" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_814b7099-405c-4721-8915-ceafd057334c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_d9006bab-aa82-499b-8437-51867c514f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_3027c7ed-cf8c-4acf-9eda-80fdaa009cac" xlink:to="loc_us-gaap_InterestExpenseMember_d9006bab-aa82-499b-8437-51867c514f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OffsettingAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsTable_b888f3f5-4ffd-4ea9-a607-ed5a1c644548" xlink:to="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_2bc4f460-a07f-4238-a4f9-e86c0163648c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_2bc4f460-a07f-4238-a4f9-e86c0163648c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_541c0f46-d5f5-4982-86ca-1b18e2524c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_541c0f46-d5f5-4982-86ca-1b18e2524c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6403d856-bda9-4310-afd4-1723cf9f0c73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6403d856-bda9-4310-afd4-1723cf9f0c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1c2ea3e7-712b-4570-a185-3463868175a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OffsettingAssetsLineItems_35274c15-7d6d-4eb5-b7d1-7f35fd954ef0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_1c2ea3e7-712b-4570-a185-3463868175a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b2270023-41bd-4b0e-995e-437d84dad0f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0d39d4c7-668c-468f-bd9c-70dc6e8575d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b2270023-41bd-4b0e-995e-437d84dad0f6" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0d39d4c7-668c-468f-bd9c-70dc6e8575d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_be8f9fef-79c7-477c-8035-c491cc705ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0d39d4c7-668c-468f-bd9c-70dc6e8575d5" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_be8f9fef-79c7-477c-8035-c491cc705ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_86f52741-b9df-4c07-81e9-7142c1cb882c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_be8f9fef-79c7-477c-8035-c491cc705ea0" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_86f52741-b9df-4c07-81e9-7142c1cb882c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf31ccea-b8f2-4fd4-a82c-8014cab5a2b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_86f52741-b9df-4c07-81e9-7142c1cb882c" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf31ccea-b8f2-4fd4-a82c-8014cab5a2b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b1dc7477-a36d-4b5b-9e7c-8644c46e5071" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_bf31ccea-b8f2-4fd4-a82c-8014cab5a2b1" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_b1dc7477-a36d-4b5b-9e7c-8644c46e5071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa58ce97-0332-4594-b37d-de94165e96e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0d39d4c7-668c-468f-bd9c-70dc6e8575d5" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa58ce97-0332-4594-b37d-de94165e96e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25e2bb12-f990-43aa-9c39-4b5ef33b5b06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_aa58ce97-0332-4594-b37d-de94165e96e6" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25e2bb12-f990-43aa-9c39-4b5ef33b5b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_0c6a7273-7f8a-4ba3-960c-b933293673ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25e2bb12-f990-43aa-9c39-4b5ef33b5b06" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_0c6a7273-7f8a-4ba3-960c-b933293673ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d1575cd3-5103-4c39-9aec-10d12db4eebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25e2bb12-f990-43aa-9c39-4b5ef33b5b06" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d1575cd3-5103-4c39-9aec-10d12db4eebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_d62ce351-8ebd-40a2-92f6-439d9a19fcd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_25e2bb12-f990-43aa-9c39-4b5ef33b5b06" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_d62ce351-8ebd-40a2-92f6-439d9a19fcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9ec68fe8-1d04-420b-9837-ee535407afa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0d39d4c7-668c-468f-bd9c-70dc6e8575d5" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9ec68fe8-1d04-420b-9837-ee535407afa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_998624ac-4bbf-48b2-9cc1-5c39c5b489c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9ec68fe8-1d04-420b-9837-ee535407afa8" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_998624ac-4bbf-48b2-9cc1-5c39c5b489c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_693b0504-e515-4bc6-9147-da618dd81f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_998624ac-4bbf-48b2-9cc1-5c39c5b489c0" xlink:to="loc_us-gaap_InterestRateCapMember_693b0504-e515-4bc6-9147-da618dd81f07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b8f70539-658e-4d06-8908-17db8896657d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_998624ac-4bbf-48b2-9cc1-5c39c5b489c0" xlink:to="loc_us-gaap_InterestRateSwapMember_b8f70539-658e-4d06-8908-17db8896657d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d9b615b5-b553-4fd9-9536-548f3a1dc295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0d39d4c7-668c-468f-bd9c-70dc6e8575d5" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d9b615b5-b553-4fd9-9536-548f3a1dc295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_10a46e5a-01bd-42b0-88fe-a796cb98416a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d9b615b5-b553-4fd9-9536-548f3a1dc295" xlink:to="loc_us-gaap_DerivativeLiabilities_10a46e5a-01bd-42b0-88fe-a796cb98416a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_6e156a7a-ee44-4067-9664-46720389dcc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d9b615b5-b553-4fd9-9536-548f3a1dc295" xlink:to="loc_us-gaap_DerivativeAssets_6e156a7a-ee44-4067-9664-46720389dcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_372f96f8-9fad-4ca1-b46b-7c8e6236bac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_d9b615b5-b553-4fd9-9536-548f3a1dc295" xlink:to="loc_us-gaap_DebtInstrumentFairValue_372f96f8-9fad-4ca1-b46b-7c8e6236bac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_22ca8cda-3d19-4d16-ab1c-4f10ada5b660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_75fbc99e-257c-416d-bac3-3c3517fb87af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22ca8cda-3d19-4d16-ab1c-4f10ada5b660" xlink:to="loc_us-gaap_NetIncomeLoss_75fbc99e-257c-416d-bac3-3c3517fb87af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_b9d390ab-40e7-408f-b19e-ace92b4a5ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22ca8cda-3d19-4d16-ab1c-4f10ada5b660" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_b9d390ab-40e7-408f-b19e-ace92b4a5ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bdc2692d-0136-4ed1-b252-9e21ad72f136" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b9d390ab-40e7-408f-b19e-ace92b4a5ae4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_bdc2692d-0136-4ed1-b252-9e21ad72f136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_47a9c14b-83f9-43cb-a7ec-a393dd9f08f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_b9d390ab-40e7-408f-b19e-ace92b4a5ae4" xlink:to="loc_us-gaap_EarningsPerShareBasic_47a9c14b-83f9-43cb-a7ec-a393dd9f08f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedAbstract_d486ff06-0bee-46ab-b45b-8e486e74bfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22ca8cda-3d19-4d16-ab1c-4f10ada5b660" xlink:to="loc_us-gaap_EarningsPerShareDilutedAbstract_d486ff06-0bee-46ab-b45b-8e486e74bfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5ad89129-3594-4add-b3ae-eae4cad7e152" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_d486ff06-0bee-46ab-b45b-8e486e74bfeb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5ad89129-3594-4add-b3ae-eae4cad7e152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_6089fffd-8a09-4da9-96d7-df9f02233a81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_d486ff06-0bee-46ab-b45b-8e486e74bfeb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_6089fffd-8a09-4da9-96d7-df9f02233a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_bf6ca1c3-9dc1-4518-9c8b-59f08f738f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_d486ff06-0bee-46ab-b45b-8e486e74bfeb" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_bf6ca1c3-9dc1-4518-9c8b-59f08f738f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7edd81b7-2a2e-4bcd-a0d0-b90d02d3d43e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_d486ff06-0bee-46ab-b45b-8e486e74bfeb" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7edd81b7-2a2e-4bcd-a0d0-b90d02d3d43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_da7a092b-fbf0-41cf-9b42-5b790036feeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedAbstract_d486ff06-0bee-46ab-b45b-8e486e74bfeb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_da7a092b-fbf0-41cf-9b42-5b790036feeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_874d8483-ea31-4b26-bdaf-fee4a59d682d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_22ca8cda-3d19-4d16-ab1c-4f10ada5b660" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_874d8483-ea31-4b26-bdaf-fee4a59d682d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6b9276e5-4100-493b-9093-cae34bff3cb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_874d8483-ea31-4b26-bdaf-fee4a59d682d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6b9276e5-4100-493b-9093-cae34bff3cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_975eee3a-66ba-4d0b-951f-7dc38ae2677e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6b9276e5-4100-493b-9093-cae34bff3cb3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_975eee3a-66ba-4d0b-951f-7dc38ae2677e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fd07b964-9540-4f2b-8d1b-b15027c97b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_975eee3a-66ba-4d0b-951f-7dc38ae2677e" xlink:to="loc_us-gaap_RestrictedStockMember_fd07b964-9540-4f2b-8d1b-b15027c97b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb3ded43-f6b5-44ff-adb1-5b061d8912b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_874d8483-ea31-4b26-bdaf-fee4a59d682d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb3ded43-f6b5-44ff-adb1-5b061d8912b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_fe718160-c9c4-41dd-9fe2-d1a22c1914e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_cb3ded43-f6b5-44ff-adb1-5b061d8912b1" xlink:to="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_fe718160-c9c4-41dd-9fe2-d1a22c1914e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_777fb95d-7e8c-46d7-b120-1dbdd2ed3e37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract_fe718160-c9c4-41dd-9fe2-d1a22c1914e9" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_777fb95d-7e8c-46d7-b120-1dbdd2ed3e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d385b778-5de2-4c5f-bec6-a348e67e038c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_69a0de36-e458-4609-8b39-9536f139cf07" xlink:href="rdnt-20201231.xsd#rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d385b778-5de2-4c5f-bec6-a348e67e038c" xlink:to="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_69a0de36-e458-4609-8b39-9536f139cf07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_2b9746b0-4d91-4721-baf6-71f870a17280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_69a0de36-e458-4609-8b39-9536f139cf07" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_2b9746b0-4d91-4721-baf6-71f870a17280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityContributionsJointVentures_36034da0-9234-4f72-af3c-c09b0e1c2910" xlink:href="rdnt-20201231.xsd#rdnt_EquityContributionsJointVentures"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_69a0de36-e458-4609-8b39-9536f139cf07" xlink:to="loc_rdnt_EquityContributionsJointVentures_36034da0-9234-4f72-af3c-c09b0e1c2910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_70baa27f-899b-4101-84af-69bdc3c9cde7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_69a0de36-e458-4609-8b39-9536f139cf07" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_70baa27f-899b-4101-84af-69bdc3c9cde7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_7305ec73-89ae-4eb0-8370-a69fdfeaacec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_69a0de36-e458-4609-8b39-9536f139cf07" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_7305ec73-89ae-4eb0-8370-a69fdfeaacec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_87e1041b-d7c5-43c2-82b5-e1cd9e14a3c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_69a0de36-e458-4609-8b39-9536f139cf07" xlink:to="loc_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee_87e1041b-d7c5-43c2-82b5-e1cd9e14a3c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_cdf9681b-79f0-4721-8791-6df48994f3fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_69a0de36-e458-4609-8b39-9536f139cf07" xlink:to="loc_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital_cdf9681b-79f0-4721-8791-6df48994f3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss_4708d19f-8dee-4f1c-9c27-74fbfc70731d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_69a0de36-e458-4609-8b39-9536f139cf07" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss_4708d19f-8dee-4f1c-9c27-74fbfc70731d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_46bc52fc-f0ea-4563-94c0-556beb698c52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_69a0de36-e458-4609-8b39-9536f139cf07" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_46bc52fc-f0ea-4563-94c0-556beb698c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_4dc4131d-f050-4ec8-b2af-40b16023fb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward_69a0de36-e458-4609-8b39-9536f139cf07" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_4dc4131d-f050-4ec8-b2af-40b16023fb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6557e00b-3932-4bf5-bca1-89aac27b8be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d67a57f-8df4-4d48-a69f-fe7b08d45bed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6557e00b-3932-4bf5-bca1-89aac27b8be8" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d67a57f-8df4-4d48-a69f-fe7b08d45bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_c16cbbb0-e506-4bd2-b818-f045441963e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d67a57f-8df4-4d48-a69f-fe7b08d45bed" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_c16cbbb0-e506-4bd2-b818-f045441963e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_83f5a913-12bd-4483-a7e0-8456966bdbef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_c16cbbb0-e506-4bd2-b818-f045441963e6" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_83f5a913-12bd-4483-a7e0-8456966bdbef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_f5f2671a-a6d0-46f3-9949-8c5de3641cc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_83f5a913-12bd-4483-a7e0-8456966bdbef" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember_f5f2671a-a6d0-46f3-9949-8c5de3641cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_b1b98bd1-9a35-4b40-ae26-811958a7f006" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_8d67a57f-8df4-4d48-a69f-fe7b08d45bed" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_b1b98bd1-9a35-4b40-ae26-811958a7f006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:href="rdnt-20201231.xsd#rdnt_KeyFinancialDataForJointVenturesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_b1b98bd1-9a35-4b40-ae26-811958a7f006" xlink:to="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_233d1d07-25ee-4e78-802b-79c3362e514f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_AssetsCurrent_233d1d07-25ee-4e78-802b-79c3362e514f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_20ab8a8d-f4e9-458f-8401-248327c5dfd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_AssetsNoncurrent_20ab8a8d-f4e9-458f-8401-248327c5dfd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_20dccde3-bb72-4bf7-997d-33e398d406a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_LiabilitiesCurrent_20dccde3-bb72-4bf7-997d-33e398d406a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_cee875a9-469e-4e7f-9d2a-7c01cbc3304f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_cee875a9-469e-4e7f-9d2a-7c01cbc3304f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentAggregateCost_f747d313-0cfb-482a-b6a7-74b24ddc8d47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentAggregateCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_EquityMethodInvestmentAggregateCost_f747d313-0cfb-482a-b6a7-74b24ddc8d47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_bd2dbe32-912e-453d-bf8c-7a5b7794b759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_EquityMethodInvestments_bd2dbe32-912e-453d-bf8c-7a5b7794b759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_d2843a1a-3f10-4bd6-8059-8bdad199716b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets_d2843a1a-3f10-4bd6-8059-8bdad199716b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7e3ae771-e246-4b61-9a18-de7bfb5fdc56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_7e3ae771-e246-4b61-9a18-de7bfb5fdc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_555d496f-615b-4c75-a1f9-24bd3f55cfce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_Revenues_555d496f-615b-4c75-a1f9-24bd3f55cfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_d290a74d-3e02-4e5f-a653-8db786a6479c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_KeyFinancialDataForJointVenturesAbstract_ba1fe6c9-f091-4c0f-b9ce-8273be678b07" xlink:to="loc_us-gaap_ProfitLoss_d290a74d-3e02-4e5f-a653-8db786a6479c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#RECENTACCOUNTINGSTANDARDS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_0af99613-1ced-47c8-b6df-f56fc954404a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_7c5bdb15-e9d5-44b5-a3e3-ee6edc1d1a5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract_0af99613-1ced-47c8-b6df-f56fc954404a" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_7c5bdb15-e9d5-44b5-a3e3-ee6edc1d1a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_55836943-dca6-4197-a250-8199e465b84b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_cc0b4068-a718-4c93-b739-28db658b5bc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_55836943-dca6-4197-a250-8199e465b84b" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_cc0b4068-a718-4c93-b739-28db658b5bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSANDDISPOSITIONSTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_e1ffd019-4438-47a9-aecc-09525a09f96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_017573cf-9c33-4520-85b4-da5d132c48da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_e1ffd019-4438-47a9-aecc-09525a09f96e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_017573cf-9c33-4520-85b4-da5d132c48da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_c351bf06-bfb7-47e8-a1b5-8c746e4d758a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_614e41ad-1c06-4b83-989f-4fc1e5b524f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_c351bf06-bfb7-47e8-a1b5-8c746e4d758a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_614e41ad-1c06-4b83-989f-4fc1e5b524f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionAxis_c58d7484-51a4-4e2a-bd7b-16613731946b" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_614e41ad-1c06-4b83-989f-4fc1e5b524f7" xlink:to="loc_rdnt_AssetAcquisitionAxis_c58d7484-51a4-4e2a-bd7b-16613731946b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionDomain_0bea53fd-aee3-4a8a-9ffb-08d5973e5091" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AssetAcquisitionAxis_c58d7484-51a4-4e2a-bd7b-16613731946b" xlink:to="loc_rdnt_AssetAcquisitionDomain_0bea53fd-aee3-4a8a-9ffb-08d5973e5091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPAtlanticLLCMember_ade1f199-56bd-4322-8ef0-1c76d0347a55" xlink:href="rdnt-20201231.xsd#rdnt_ZPAtlanticLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AssetAcquisitionDomain_0bea53fd-aee3-4a8a-9ffb-08d5973e5091" xlink:to="loc_rdnt_ZPAtlanticLLCMember_ade1f199-56bd-4322-8ef0-1c76d0347a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmhurstLLCMember_d44e5106-f1e5-4e88-bcdb-dfdd1d91f8c8" xlink:href="rdnt-20201231.xsd#rdnt_ZPElmhurstLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AssetAcquisitionDomain_0bea53fd-aee3-4a8a-9ffb-08d5973e5091" xlink:to="loc_rdnt_ZPElmhurstLLCMember_d44e5106-f1e5-4e88-bcdb-dfdd1d91f8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_614e41ad-1c06-4b83-989f-4fc1e5b524f7" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7fb64eca-23dd-448c-8d54-e147cb8e4458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_7fb64eca-23dd-448c-8d54-e147cb8e4458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_cf5e16f7-1d60-4887-86b2-e50d22f80d5c" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_cf5e16f7-1d60-4887-86b2-e50d22f80d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_01b3c0bb-d53b-496b-851c-7177708d7eb1" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_01b3c0bb-d53b-496b-851c-7177708d7eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_32ef9f46-105e-4887-b1ac-2a32f55c5bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_32ef9f46-105e-4887-b1ac-2a32f55c5bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_5ce78faf-6fc7-4e84-b6ac-0ac2c107db14" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_5ce78faf-6fc7-4e84-b6ac-0ac2c107db14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f543faee-b466-43bd-9586-935bf82c426a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_us-gaap_Goodwill_f543faee-b466-43bd-9586-935bf82c426a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_22ede120-7fe9-438a-b8a5-fe52e8013d0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_27d7992b-a444-4ac0-9273-44ad1bf071d0" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_22ede120-7fe9-438a-b8a5-fe52e8013d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_00a85982-0b2d-429d-8e42-d0d2429c5d75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_00a85982-0b2d-429d-8e42-d0d2429c5d75" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2c98c08d-5836-4b82-818f-cf3fa5921aa7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2c98c08d-5836-4b82-818f-cf3fa5921aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_a3e075ba-f5cb-409d-9044-b54048cef481" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_2c98c08d-5836-4b82-818f-cf3fa5921aa7" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_a3e075ba-f5cb-409d-9044-b54048cef481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_6c7142ee-ed06-4e2c-a84b-46e95719c823" xlink:href="rdnt-20201231.xsd#rdnt_ArizonaDiagnosticRadiologyGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a3e075ba-f5cb-409d-9044-b54048cef481" xlink:to="loc_rdnt_ArizonaDiagnosticRadiologyGroupLLCMember_6c7142ee-ed06-4e2c-a84b-46e95719c823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SantaMonicaImagingMember_801d2a05-fc8f-40be-8c7c-3a20812c82b6" xlink:href="rdnt-20201231.xsd#rdnt_SantaMonicaImagingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_a3e075ba-f5cb-409d-9044-b54048cef481" xlink:to="loc_rdnt_SantaMonicaImagingMember_801d2a05-fc8f-40be-8c7c-3a20812c82b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_1a85b913-9edb-4ba7-aa27-5fb7a3e0503e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_srt_OwnershipAxis_1a85b913-9edb-4ba7-aa27-5fb7a3e0503e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b700672a-8174-4b72-b12d-01de3626fc6d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_1a85b913-9edb-4ba7-aa27-5fb7a3e0503e" xlink:to="loc_srt_OwnershipDomain_b700672a-8174-4b72-b12d-01de3626fc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_f15fcf1f-a6c5-4b53-99fa-4d16d9c1633f" xlink:href="rdnt-20201231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b700672a-8174-4b72-b12d-01de3626fc6d" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_f15fcf1f-a6c5-4b53-99fa-4d16d9c1633f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_a9d4034d-f806-44cc-85c2-34d28933b015" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_dei_LegalEntityAxis_a9d4034d-f806-44cc-85c2-34d28933b015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_0e55d1d8-aa09-45e7-8354-9133c1e86d81" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_a9d4034d-f806-44cc-85c2-34d28933b015" xlink:to="loc_dei_EntityDomain_0e55d1d8-aa09-45e7-8354-9133c1e86d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_349f68e8-cce2-4b3e-8664-78d7a0a0c3ed" xlink:href="rdnt-20201231.xsd#rdnt_PrimedexHealthSystemsInc.andRadiologixMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0e55d1d8-aa09-45e7-8354-9133c1e86d81" xlink:to="loc_rdnt_PrimedexHealthSystemsInc.andRadiologixMember_349f68e8-cce2-4b3e-8664-78d7a0a0c3ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RadNetMember_3d0955f9-67a6-4269-843c-33b0b32c06f0" xlink:href="rdnt-20201231.xsd#rdnt_RadNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0e55d1d8-aa09-45e7-8354-9133c1e86d81" xlink:to="loc_rdnt_RadNetMember_3d0955f9-67a6-4269-843c-33b0b32c06f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CHINationalServicesIncMember_ebfcccc0-daef-48aa-9a9b-88af425ac6fb" xlink:href="rdnt-20201231.xsd#rdnt_CHINationalServicesIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_0e55d1d8-aa09-45e7-8354-9133c1e86d81" xlink:to="loc_rdnt_CHINationalServicesIncMember_ebfcccc0-daef-48aa-9a9b-88af425ac6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_62df79b1-e984-47b0-bde5-02e0e2b275dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_62df79b1-e984-47b0-bde5-02e0e2b275dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0e639819-ceae-46a1-86d0-13e4cf238c88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_62df79b1-e984-47b0-bde5-02e0e2b275dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0e639819-ceae-46a1-86d0-13e4cf238c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_bcf14207-8530-473f-a970-20a1da9af174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0e639819-ceae-46a1-86d0-13e4cf238c88" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_bcf14207-8530-473f-a970-20a1da9af174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_843b3451-478c-4b6c-a5d9-8735bd38738f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0e639819-ceae-46a1-86d0-13e4cf238c88" xlink:to="loc_us-gaap_TradeNamesMember_843b3451-478c-4b6c-a5d9-8735bd38738f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_285ceb83-f85e-4c8b-b20f-3501c3b64b69" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_srt_CounterpartyNameAxis_285ceb83-f85e-4c8b-b20f-3501c3b64b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9ffe1843-ae5e-4eba-9f74-649c7fb01521" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_285ceb83-f85e-4c8b-b20f-3501c3b64b69" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9ffe1843-ae5e-4eba-9f74-649c7fb01521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealth.Member_73834f17-213d-43e8-ba4e-5fbaa3b87f8e" xlink:href="rdnt-20201231.xsd#rdnt_DignityHealth.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9ffe1843-ae5e-4eba-9f74-649c7fb01521" xlink:to="loc_rdnt_DignityHealth.Member_73834f17-213d-43e8-ba4e-5fbaa3b87f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_11460de3-c377-4051-930c-b93ad88f5acf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_11460de3-c377-4051-930c-b93ad88f5acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_11460de3-c377-4051-930c-b93ad88f5acf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_a0c476b6-9a80-47fa-a0a3-94b0ff363d09" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_DeepHealthInc.Member_a0c476b6-9a80-47fa-a0a3-94b0ff363d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_a9fce211-d1b9-4771-8d64-4b9b165b4a26" xlink:href="rdnt-20201231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_a9fce211-d1b9-4771-8d64-4b9b165b4a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_4c2ff8d2-cf18-4a1a-ae63-9db6845ae553" xlink:href="rdnt-20201231.xsd#rdnt_NulogixMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_NulogixMember_4c2ff8d2-cf18-4a1a-ae63-9db6845ae553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KernRadiologyImagingSystemsInc.Member_50c902e2-e22a-44c6-a8ba-20b82278eed7" xlink:href="rdnt-20201231.xsd#rdnt_KernRadiologyImagingSystemsInc.Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_KernRadiologyImagingSystemsInc.Member_50c902e2-e22a-44c6-a8ba-20b82278eed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZilkhaRadiologyMember_3a258ba7-58d1-4af6-9d81-02c26b69dcf4" xlink:href="rdnt-20201231.xsd#rdnt_ZilkhaRadiologyMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_ZilkhaRadiologyMember_3a258ba7-58d1-4af6-9d81-02c26b69dcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_a506abb9-5ec9-4d3f-8acd-7a7c835c0913" xlink:href="rdnt-20201231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_a506abb9-5ec9-4d3f-8acd-7a7c835c0913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_b4cb2148-528b-4302-b886-1ce97491f202" xlink:href="rdnt-20201231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_b4cb2148-528b-4302-b886-1ce97491f202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_VenturaCountyImagingGroupLLC.Member_590a1725-6476-4293-8542-70544a2f7133" xlink:href="rdnt-20201231.xsd#rdnt_VenturaCountyImagingGroupLLC.Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_VenturaCountyImagingGroupLLC.Member_590a1725-6476-4293-8542-70544a2f7133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_1785a2df-5544-4dda-9d57-4f7ab7bc4be4" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c05fb388-3f49-4722-8448-d47a6ed41efb" xlink:to="loc_rdnt_DeepHealthIncMember_1785a2df-5544-4dda-9d57-4f7ab7bc4be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_63ffd452-02c5-40d4-abb4-a355188a0002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_63ffd452-02c5-40d4-abb4-a355188a0002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_837dbb35-42a9-4ddb-8a77-0dbf063df2e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_63ffd452-02c5-40d4-abb4-a355188a0002" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_837dbb35-42a9-4ddb-8a77-0dbf063df2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ImagingOnCallMember_950b621c-234e-4197-8330-2cc1f5d3ae4f" xlink:href="rdnt-20201231.xsd#rdnt_ImagingOnCallMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_837dbb35-42a9-4ddb-8a77-0dbf063df2e3" xlink:to="loc_rdnt_ImagingOnCallMember_950b621c-234e-4197-8330-2cc1f5d3ae4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionAxis_11cedc0b-c332-4803-b234-dfc8ed7008d4" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_rdnt_AssetAcquisitionAxis_11cedc0b-c332-4803-b234-dfc8ed7008d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetAcquisitionDomain_7747b9e5-5e2d-4a7f-89a3-49bf5b190d18" xlink:href="rdnt-20201231.xsd#rdnt_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AssetAcquisitionAxis_11cedc0b-c332-4803-b234-dfc8ed7008d4" xlink:to="loc_rdnt_AssetAcquisitionDomain_7747b9e5-5e2d-4a7f-89a3-49bf5b190d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechMember_1506a9b2-7679-4b45-9094-8680e73269a8" xlink:href="rdnt-20201231.xsd#rdnt_AZTechMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AssetAcquisitionDomain_7747b9e5-5e2d-4a7f-89a3-49bf5b190d18" xlink:to="loc_rdnt_AZTechMember_1506a9b2-7679-4b45-9094-8680e73269a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIatWoodbridgeLLCMember_cc45b621-2d4a-4369-83b4-ba90b57c427d" xlink:href="rdnt-20201231.xsd#rdnt_MRIatWoodbridgeLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AssetAcquisitionDomain_7747b9e5-5e2d-4a7f-89a3-49bf5b190d18" xlink:to="loc_rdnt_MRIatWoodbridgeLLCMember_cc45b621-2d4a-4369-83b4-ba90b57c427d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember_8481b768-3958-4fac-a801-d2453a166519" xlink:href="rdnt-20201231.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AssetAcquisitionDomain_7747b9e5-5e2d-4a7f-89a3-49bf5b190d18" xlink:to="loc_rdnt_OlneyOpenMRILLCMember_8481b768-3958-4fac-a801-d2453a166519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7d60d183-249f-4464-8b97-08e9944e605e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfBusinessesAcquired_fddf9d6f-5e3a-4b6a-887d-37a062cbd21b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfBusinessesAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_NumberOfBusinessesAcquired_fddf9d6f-5e3a-4b6a-887d-37a062cbd21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a2772b65-fcc5-4d08-a723-43923732ff92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_a2772b65-fcc5-4d08-a723-43923732ff92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_60601f0b-a675-4444-b800-0035037dcb82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_60601f0b-a675-4444-b800-0035037dcb82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_b504434b-555e-4358-b8f8-40dbe478cbf3" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset_b504434b-555e-4358-b8f8-40dbe478cbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_d856b48b-06fe-4507-9b77-dd63c63bd55e" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_d856b48b-06fe-4507-9b77-dd63c63bd55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_54eaeed7-8316-4f44-9dce-57b594012609" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities_54eaeed7-8316-4f44-9dce-57b594012609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_840edf54-4187-4a52-a7ac-df78272f1931" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_Goodwill_840edf54-4187-4a52-a7ac-df78272f1931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eac461b4-0e43-4687-82b4-a9e3dfa11a56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_eac461b4-0e43-4687-82b4-a9e3dfa11a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_403a4e94-9b64-4703-8e0e-466fd537da6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_403a4e94-9b64-4703-8e0e-466fd537da6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_6963376f-888b-4773-8a13-9de5cc90bfa6" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution_6963376f-888b-4773-8a13-9de5cc90bfa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_7d53fac0-c262-4ee6-9261-553a1d2672bf" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution_7d53fac0-c262-4ee6-9261-553a1d2672bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_09ef2a60-1cdf-4f90-9575-4ce09d889f00" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm_09ef2a60-1cdf-4f90-9575-4ce09d889f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_9a7dd502-5eae-4358-b578-de9387c69292" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution_9a7dd502-5eae-4358-b578-de9387c69292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_a10ccce6-55c2-48c1-ba2c-2ff8ad04c2cd" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution_a10ccce6-55c2-48c1-ba2c-2ff8ad04c2cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_455ff82e-8c10-4ea8-a6c1-718bf0b1659d" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards_455ff82e-8c10-4ea8-a6c1-718bf0b1659d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_1e0611bd-845e-452a-978a-9804ef0c8c3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure_1e0611bd-845e-452a-978a-9804ef0c8c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_04bd7397-4640-4655-87bb-b4e1132b8a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_04bd7397-4640-4655-87bb-b4e1132b8a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_0e459725-8598-49bb-a852-b0d6149580c7" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares_0e459725-8598-49bb-a852-b0d6149580c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_7591a357-6a96-4a42-ac2a-4b053ea08a42" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares_7591a357-6a96-4a42-ac2a-4b053ea08a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_c86932df-de0d-4c22-b222-30700764f670" xlink:href="rdnt-20201231.xsd#rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares_c86932df-de0d-4c22-b222-30700764f670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_a9fcfd4e-8968-4ed6-88ea-419e0d6c5f55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_a9fcfd4e-8968-4ed6-88ea-419e0d6c5f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d51622c8-c497-443d-a0e2-4b9f6745915e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_d51622c8-c497-443d-a0e2-4b9f6745915e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fe804c07-ee5d-4e07-89c6-506a82440be4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_fe804c07-ee5d-4e07-89c6-506a82440be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_1a665c93-6ba1-40fb-adc6-c88994e2d9e9" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities_1a665c93-6ba1-40fb-adc6-c88994e2d9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a0afd31d-b69a-45b1-bfb6-a8c730034318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_a0afd31d-b69a-45b1-bfb6-a8c730034318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_55eb001f-9379-454f-a067-bf6605bfe69e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_55eb001f-9379-454f-a067-bf6605bfe69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_45ea60d8-e9da-4588-b5f8-ab933cd52dea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_45ea60d8-e9da-4588-b5f8-ab933cd52dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b770249c-61d6-4732-96aa-67fd3625c3d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireEquityMethodInvestments"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_PaymentsToAcquireEquityMethodInvestments_b770249c-61d6-4732-96aa-67fd3625c3d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_64052f7a-09f9-4c46-ab97-4a0db4151d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_64052f7a-09f9-4c46-ab97-4a0db4151d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f080bc49-0920-4ba3-b15f-863906cbbf3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned_f080bc49-0920-4ba3-b15f-863906cbbf3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c7fef52a-f7c4-4a9e-ad0b-74fce007ee04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_c7fef52a-f7c4-4a9e-ad0b-74fce007ee04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_8a2f892c-31f3-4144-bdd1-3d9361d2d78c" xlink:href="rdnt-20201231.xsd#rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts_8a2f892c-31f3-4144-bdd1-3d9361d2d78c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_18cd081e-f7c1-48d8-92f4-b1dfaf800bc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_18cd081e-f7c1-48d8-92f4-b1dfaf800bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed_01b4710c-b38a-4530-8cf8-2f0eb60e7196" xlink:href="rdnt-20201231.xsd#rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed_01b4710c-b38a-4530-8cf8-2f0eb60e7196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed_dbd8d82a-1b00-4339-84ae-dbb26324197e" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed_dbd8d82a-1b00-4339-84ae-dbb26324197e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash_4ae2bec4-a4a2-4de0-a305-f3d1849123b8" xlink:href="rdnt-20201231.xsd#rdnt_PaymentstoAcquireEquityMethodInvestmentsCash"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash_4ae2bec4-a4a2-4de0-a305-f3d1849123b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash_98e2630b-2c27-4194-8ac4-d999562e7fb5" xlink:href="rdnt-20201231.xsd#rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash_98e2630b-2c27-4194-8ac4-d999562e7fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_1ce7b948-b5f4-4f39-b25a-3756b5147997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_1ce7b948-b5f4-4f39-b25a-3756b5147997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AdditionalEquityInterestAcquired_665ce1af-a8c9-412b-88b9-ce9dbe313bd0" xlink:href="rdnt-20201231.xsd#rdnt_AdditionalEquityInterestAcquired"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_rdnt_AdditionalEquityInterestAcquired_665ce1af-a8c9-412b-88b9-ce9dbe313bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentOwnedAtFairValue_432acc1e-0f4e-4924-85f9-ba954c7e50f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentOwnedAtFairValue"/>
    <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ba54064b-d3ff-46b0-958d-86ceb1f52e15" xlink:to="loc_us-gaap_InvestmentOwnedAtFairValue_432acc1e-0f4e-4924-85f9-ba954c7e50f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9cb82fb-6904-4b74-91ef-7bb1b0e32010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_34f33a7a-13cd-4714-b6c4-1de2514ab116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9cb82fb-6904-4b74-91ef-7bb1b0e32010" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_34f33a7a-13cd-4714-b6c4-1de2514ab116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc41c2aa-8f78-4c38-95bd-77f2cbcd05dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_cf92adab-0f69-49bf-9819-6af1193c0527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc41c2aa-8f78-4c38-95bd-77f2cbcd05dd" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_cf92adab-0f69-49bf-9819-6af1193c0527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_b9fa1f0d-3f91-40d2-aa74-fc6990cdae22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_cc41c2aa-8f78-4c38-95bd-77f2cbcd05dd" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_b9fa1f0d-3f91-40d2-aa74-fc6990cdae22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_74dd1a19-47ca-4fdd-aea2-c0433df539f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_dc8aca1b-5d0b-48cc-bbe2-3796a6088059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_74dd1a19-47ca-4fdd-aea2-c0433df539f3" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_dc8aca1b-5d0b-48cc-bbe2-3796a6088059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d1491b31-521c-4d23-a08b-83ac6235af19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_dc8aca1b-5d0b-48cc-bbe2-3796a6088059" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d1491b31-521c-4d23-a08b-83ac6235af19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d1491b31-521c-4d23-a08b-83ac6235af19" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalArtsRadiologicalGroupPCMember_e2d18e6d-edae-40f5-bd1b-055b7744261f" xlink:href="rdnt-20201231.xsd#rdnt_MedicalArtsRadiologicalGroupPCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_MedicalArtsRadiologicalGroupPCMember_e2d18e6d-edae-40f5-bd1b-055b7744261f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DignityHealthMember_48e4ce44-34f0-4555-b0b0-e9e12a13bff5" xlink:href="rdnt-20201231.xsd#rdnt_DignityHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_DignityHealthMember_48e4ce44-34f0-4555-b0b0-e9e12a13bff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WestValleyImagingGroupLLCMember_f6da9a80-0c30-43cd-b0df-63d5122ef28e" xlink:href="rdnt-20201231.xsd#rdnt_WestValleyImagingGroupLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_WestValleyImagingGroupLLCMember_f6da9a80-0c30-43cd-b0df-63d5122ef28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_HudsonValleyRadiologyAssociatesMember_5e622a81-2bba-4523-8b6d-f092c33b3f4c" xlink:href="rdnt-20201231.xsd#rdnt_HudsonValleyRadiologyAssociatesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_HudsonValleyRadiologyAssociatesMember_5e622a81-2bba-4523-8b6d-f092c33b3f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_KernRadiologyImagingSystemsInc.Member_c3771e26-7936-4932-9698-b7b1e3b2681b" xlink:href="rdnt-20201231.xsd#rdnt_KernRadiologyImagingSystemsInc.Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_KernRadiologyImagingSystemsInc.Member_c3771e26-7936-4932-9698-b7b1e3b2681b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZilkhaRadiologyMember_ec587f93-a804-4c9a-a992-6fb940aafa1d" xlink:href="rdnt-20201231.xsd#rdnt_ZilkhaRadiologyMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_ZilkhaRadiologyMember_ec587f93-a804-4c9a-a992-6fb940aafa1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RamicMahwahLLCMember_a262b93b-ec51-4914-b64b-245d57b6731e" xlink:href="rdnt-20201231.xsd#rdnt_RamicMahwahLLCMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_RamicMahwahLLCMember_a262b93b-ec51-4914-b64b-245d57b6731e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GardenStateRadiologyNetworkLLCMember_d9b24184-3376-4a56-9188-dcc228cd71e1" xlink:href="rdnt-20201231.xsd#rdnt_GardenStateRadiologyNetworkLLCMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_GardenStateRadiologyNetworkLLCMember_d9b24184-3376-4a56-9188-dcc228cd71e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_NulogixMember_5f179bed-472f-4492-ad2c-40e75f78d208" xlink:href="rdnt-20201231.xsd#rdnt_NulogixMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_NulogixMember_5f179bed-472f-4492-ad2c-40e75f78d208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OlneyOpenMRILLCMember_d5751153-9dd8-4b37-b52a-6fb87e47e4bb" xlink:href="rdnt-20201231.xsd#rdnt_OlneyOpenMRILLCMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_OlneyOpenMRILLCMember_d5751153-9dd8-4b37-b52a-6fb87e47e4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MRIatWoodbridgeLLCMember_b7dfdde8-3dfc-4ef6-83c7-9907b8809e76" xlink:href="rdnt-20201231.xsd#rdnt_MRIatWoodbridgeLLCMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_MRIatWoodbridgeLLCMember_b7dfdde8-3dfc-4ef6-83c7-9907b8809e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_72a4e4e1-7199-406b-8f1d-2d9dcd2ce57a" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_DeepHealthInc.Member_72a4e4e1-7199-406b-8f1d-2d9dcd2ce57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AZTechRadiologyOpenMRILLCMember_a33b3053-9135-4e5f-8b8b-0e13caa69bf6" xlink:href="rdnt-20201231.xsd#rdnt_AZTechRadiologyOpenMRILLCMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_AZTechRadiologyOpenMRILLCMember_a33b3053-9135-4e5f-8b8b-0e13caa69bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPOzoneParkLLCMember_7a3b8856-b045-4747-b2ef-60c9f3c748ff" xlink:href="rdnt-20201231.xsd#rdnt_ZPOzoneParkLLCMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_ZPOzoneParkLLCMember_7a3b8856-b045-4747-b2ef-60c9f3c748ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPElmhurstLLCMember_7e36d806-b2ce-4354-8839-3424b6823dbb" xlink:href="rdnt-20201231.xsd#rdnt_ZPElmhurstLLCMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f023678e-4bc6-4690-8c32-9c3b59a58cd4" xlink:to="loc_rdnt_ZPElmhurstLLCMember_7e36d806-b2ce-4354-8839-3424b6823dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_7892dfcf-53d7-4909-b8d1-f53357c8bf8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_dc8aca1b-5d0b-48cc-bbe2-3796a6088059" xlink:to="loc_us-gaap_GoodwillLineItems_7892dfcf-53d7-4909-b8d1-f53357c8bf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_7892dfcf-53d7-4909-b8d1-f53357c8bf8c" xlink:to="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d967af73-e937-4d9c-8d7b-65adf8b486c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:to="loc_us-gaap_Goodwill_d967af73-e937-4d9c-8d7b-65adf8b486c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_6ae5e9af-4d21-4cb0-9d6c-cb2e89f0ff97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_6ae5e9af-4d21-4cb0-9d6c-cb2e89f0ff97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_1a47a048-7215-4507-ab44-2ad58b8ef427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_1a47a048-7215-4507-ab44-2ad58b8ef427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillTransfers_8e48f667-a216-4fcb-bb13-d3c6b1d9a828" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillTransfers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:to="loc_us-gaap_GoodwillTransfers_8e48f667-a216-4fcb-bb13-d3c6b1d9a828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e7f4f3f6-95e5-4455-946b-655013e79bba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_6dd23f70-a9d4-4548-bfd0-315b1e008954" xlink:to="loc_us-gaap_Goodwill_e7f4f3f6-95e5-4455-946b-655013e79bba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5a3d4f1b-ba24-427b-b1f0-220a599547e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_GoodwillDeductibleForTaxPurposes_ef3cb97c-f135-490e-8cf7-a1750edc457f" xlink:href="rdnt-20201231.xsd#rdnt_GoodwillDeductibleForTaxPurposes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5a3d4f1b-ba24-427b-b1f0-220a599547e9" xlink:to="loc_rdnt_GoodwillDeductibleForTaxPurposes_ef3cb97c-f135-490e-8cf7-a1750edc457f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_09e0fe23-7e16-442c-a66d-4851417c19f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5a3d4f1b-ba24-427b-b1f0-220a599547e9" xlink:to="loc_us-gaap_AdjustmentForAmortization_09e0fe23-7e16-442c-a66d-4851417c19f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_8e98552b-9173-41bd-84ac-5499dd96c716" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5a3d4f1b-ba24-427b-b1f0-220a599547e9" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_8e98552b-9173-41bd-84ac-5499dd96c716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="simple" xlink:href="rdnt-20201231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_493fcda2-5183-49c0-b8d8-b7d380d27190" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6847db92-65b8-4e9e-ac26-45ef7d9517eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_493fcda2-5183-49c0-b8d8-b7d380d27190" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6847db92-65b8-4e9e-ac26-45ef7d9517eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ab79986-b4ac-4d8b-947e-3f88b122c3fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6847db92-65b8-4e9e-ac26-45ef7d9517eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ab79986-b4ac-4d8b-947e-3f88b122c3fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_6ab79986-b4ac-4d8b-947e-3f88b122c3fc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ManagementServiceContractsMember_54f970f0-1815-4ea1-a5c1-02a8cb5eb08c" xlink:href="rdnt-20201231.xsd#rdnt_ManagementServiceContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_rdnt_ManagementServiceContractsMember_54f970f0-1815-4ea1-a5c1-02a8cb5eb08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CovenantNotToCompeteMember_efbdc37e-3e83-48ce-b889-c2505d822bd2" xlink:href="rdnt-20201231.xsd#rdnt_CovenantNotToCompeteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_rdnt_CovenantNotToCompeteMember_efbdc37e-3e83-48ce-b889-c2505d822bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DevelopedtechnologyMember_e6917ae3-fd36-4b73-b2b6-9b3634b671e6" xlink:href="rdnt-20201231.xsd#rdnt_DevelopedtechnologyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_rdnt_DevelopedtechnologyMember_e6917ae3-fd36-4b73-b2b6-9b3634b671e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TradeNamesAmortizedMember_5f3a2d44-974e-4b5d-93ed-98f9474fc4f6" xlink:href="rdnt-20201231.xsd#rdnt_TradeNamesAmortizedMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_rdnt_TradeNamesAmortizedMember_5f3a2d44-974e-4b5d-93ed-98f9474fc4f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TradeNamesIndefiniteLifeMember_3945b72f-1463-45aa-859f-af7ab2e301ee" xlink:href="rdnt-20201231.xsd#rdnt_TradeNamesIndefiniteLifeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_rdnt_TradeNamesIndefiniteLifeMember_3945b72f-1463-45aa-859f-af7ab2e301ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_ecac247b-b173-45e2-801f-89dc3325b59f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_572f9186-2083-42c6-8ecb-6d354d5e4ec2" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_ecac247b-b173-45e2-801f-89dc3325b59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6847db92-65b8-4e9e-ac26-45ef7d9517eb" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d1cb2c15-0474-4596-bec3-bd223fa027ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d1cb2c15-0474-4596-bec3-bd223fa027ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_54d27f0e-5bb8-45b1-8a96-5c94fa35e06e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_54d27f0e-5bb8-45b1-8a96-5c94fa35e06e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_394e3f45-39c9-4cf5-a9dc-ab4141d6f653" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_394e3f45-39c9-4cf5-a9dc-ab4141d6f653" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2599f884-674e-45e0-b9b1-bbb2d219a433" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2599f884-674e-45e0-b9b1-bbb2d219a433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_00de1e7f-0927-4062-bb76-ae579b672120" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_00de1e7f-0927-4062-bb76-ae579b672120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_adc1e07f-8053-437e-8bb2-3aa748cd71c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_adc1e07f-8053-437e-8bb2-3aa748cd71c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2953a7bb-8d8e-47a1-9f68-59300c01b40f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2953a7bb-8d8e-47a1-9f68-59300c01b40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageAmortizationPeriodRemainingInYears_cf311615-60ce-47a0-b35f-b459cb439d56" xlink:href="rdnt-20201231.xsd#rdnt_WeightedAverageAmortizationPeriodRemainingInYears"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_35d320e8-25b0-47aa-96f0-9130d9805d18" xlink:to="loc_rdnt_WeightedAverageAmortizationPeriodRemainingInYears_cf311615-60ce-47a0-b35f-b459cb439d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENT"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ef631bd1-1321-4ec2-b772-50da43c3c6c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a28e4c18-2cd1-42a3-8748-6f6bcf65701a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ef631bd1-1321-4ec2-b772-50da43c3c6c1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_a28e4c18-2cd1-42a3-8748-6f6bcf65701a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4e8b874e-b58b-4028-9d5a-3cc582e6bf2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6a7de8cd-8c5a-4f7c-8d35-885885852825" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4e8b874e-b58b-4028-9d5a-3cc582e6bf2b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6a7de8cd-8c5a-4f7c-8d35-885885852825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_31273e37-3256-4918-80d6-7ec884a33846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee53a6b1-a8a4-4bff-ab20-229b1b632dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_31273e37-3256-4918-80d6-7ec884a33846" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee53a6b1-a8a4-4bff-ab20-229b1b632dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2a8cafce-9ca9-4bfd-9f9c-5de73e36eaff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee53a6b1-a8a4-4bff-ab20-229b1b632dff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2a8cafce-9ca9-4bfd-9f9c-5de73e36eaff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_2a8cafce-9ca9-4bfd-9f9c-5de73e36eaff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_e6e4d305-d84d-461b-a33a-0f1b09b59c06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:to="loc_us-gaap_LandMember_e6e4d305-d84d-461b-a33a-0f1b09b59c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_9ebdc158-35dc-4a9d-9191-52a7489da45a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:to="loc_us-gaap_EquipmentMember_9ebdc158-35dc-4a9d-9191-52a7489da45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_452f6aca-c5ad-42a9-b8fe-ae781910f490" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_452f6aca-c5ad-42a9-b8fe-ae781910f490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_849abcf8-4b5f-4b3b-882d-827e02363247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_849abcf8-4b5f-4b3b-882d-827e02363247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_e47df93f-57b1-4522-98a3-aafa9625c208" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsHeldUnderCapitalLeasesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a65ec6d1-0daf-4a05-8d29-cbdd3209b437" xlink:to="loc_us-gaap_AssetsHeldUnderCapitalLeasesMember_e47df93f-57b1-4522-98a3-aafa9625c208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_aed87d60-39b3-47bf-a4e5-ceba8ec2ba64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ee53a6b1-a8a4-4bff-ab20-229b1b632dff" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_aed87d60-39b3-47bf-a4e5-ceba8ec2ba64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_76ad744b-c2a8-48c3-bf00-432f8801a07f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_aed87d60-39b3-47bf-a4e5-ceba8ec2ba64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_76ad744b-c2a8-48c3-bf00-432f8801a07f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7811fd68-34db-4f97-8099-16f33a1c5b00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_aed87d60-39b3-47bf-a4e5-ceba8ec2ba64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_7811fd68-34db-4f97-8099-16f33a1c5b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_af5aa283-8056-477e-be18-c303bad70e3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_aed87d60-39b3-47bf-a4e5-ceba8ec2ba64" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_af5aa283-8056-477e-be18-c303bad70e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#PROPERTYANDEQUIPMENTDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b8ca4a51-2fcc-4cc4-a8d6-89223bcb85f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2cff164-92d5-4f3d-8ba7-865f24fe94d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b8ca4a51-2fcc-4cc4-a8d6-89223bcb85f7" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2cff164-92d5-4f3d-8ba7-865f24fe94d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79f73e69-dcdd-4256-b6e1-308edf74f953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2cff164-92d5-4f3d-8ba7-865f24fe94d8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79f73e69-dcdd-4256-b6e1-308edf74f953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_79f73e69-dcdd-4256-b6e1-308edf74f953" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_9217d91f-f50a-40e4-80f7-5198e63b3b07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:to="loc_us-gaap_ConstructionInProgressMember_9217d91f-f50a-40e4-80f7-5198e63b3b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_MedicalEquipmentMember_dda9bf59-69ab-4717-9400-20549c088730" xlink:href="rdnt-20201231.xsd#rdnt_MedicalEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:to="loc_rdnt_MedicalEquipmentMember_dda9bf59-69ab-4717-9400-20549c088730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ComputerandOfficeEquipmentMember_16eb2337-f489-4d8c-91a8-15ea5fd5f91a" xlink:href="rdnt-20201231.xsd#rdnt_ComputerandOfficeEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:to="loc_rdnt_ComputerandOfficeEquipmentMember_16eb2337-f489-4d8c-91a8-15ea5fd5f91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_0d9b9f76-c01a-421d-834f-ee07383dee8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2ed305e0-0eda-428a-9fbe-cf1b107d0b44" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_0d9b9f76-c01a-421d-834f-ee07383dee8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b18ffecf-20b6-45c5-9448-e2f15790c770" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a2cff164-92d5-4f3d-8ba7-865f24fe94d8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b18ffecf-20b6-45c5-9448-e2f15790c770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_aa167c36-4544-4630-b68c-0649748cb78a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b18ffecf-20b6-45c5-9448-e2f15790c770" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_aa167c36-4544-4630-b68c-0649748cb78a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressGross_7c329e62-e4d4-4a0f-8303-583b177bf7e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b18ffecf-20b6-45c5-9448-e2f15790c770" xlink:to="loc_us-gaap_ConstructionInProgressGross_7c329e62-e4d4-4a0f-8303-583b177bf7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_323f5aa3-a0d6-4d0f-acca-85defd0173e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_b18ffecf-20b6-45c5-9448-e2f15790c770" xlink:to="loc_us-gaap_DepreciationAndAmortization_323f5aa3-a0d6-4d0f-acca-85defd0173e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="simple" xlink:href="rdnt-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_6b2c1e7f-53a7-4c90-abf2-614777fac175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_b803e653-d44b-43c1-a9b6-825d96d418c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_6b2c1e7f-53a7-4c90-abf2-614777fac175" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_b803e653-d44b-43c1-a9b6-825d96d418c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_ab98c1b2-e8ca-4f08-81be-384f57ccb173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_7006574d-56ae-4924-a8fb-39b0d1696ab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ab98c1b2-e8ca-4f08-81be-384f57ccb173" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_7006574d-56ae-4924-a8fb-39b0d1696ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="rdnt-20201231.xsd#ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_bca9790a-c829-4b5f-9f7c-6f02847465d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_57a43fcc-8898-4fcd-ab12-a0e60c46d369" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_bca9790a-c829-4b5f-9f7c-6f02847465d7" xlink:to="loc_us-gaap_AccountsPayableCurrent_57a43fcc-8898-4fcd-ab12-a0e60c46d369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_cdc0d736-ef61-4457-95be-f44d57829c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_bca9790a-c829-4b5f-9f7c-6f02847465d7" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_cdc0d736-ef61-4457-95be-f44d57829c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_fc59a5bd-382d-4f91-bdd9-228b74b7fa71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_bca9790a-c829-4b5f-9f7c-6f02847465d7" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_fc59a5bd-382d-4f91-bdd9-228b74b7fa71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_d6a2e274-5be9-48fa-8de1-77d1c2119176" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_bca9790a-c829-4b5f-9f7c-6f02847465d7" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_d6a2e274-5be9-48fa-8de1-77d1c2119176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_cc98933f-543e-4d9e-ba14-ce4eff483072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_bca9790a-c829-4b5f-9f7c-6f02847465d7" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_cc98933f-543e-4d9e-ba14-ce4eff483072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLE"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ad3f4eba-a7e8-42ab-a37b-ae2495e6779f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_2a4caeca-cfe5-4f4e-9b30-4e2a7e67a263" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ad3f4eba-a7e8-42ab-a37b-ae2495e6779f" xlink:to="loc_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock_2a4caeca-cfe5-4f4e-9b30-4e2a7e67a263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLETables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9bc7a54f-7f9d-43ce-876e-ee5aaccf31f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_50e055ef-73dd-4284-a4a1-369f4bf48a8b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9bc7a54f-7f9d-43ce-876e-ee5aaccf31f0" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_50e055ef-73dd-4284-a4a1-369f4bf48a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_9546cf3a-c074-418a-8c4e-4798a99f3fb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9bc7a54f-7f9d-43ce-876e-ee5aaccf31f0" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_9546cf3a-c074-418a-8c4e-4798a99f3fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_93434388-900b-49bc-a2da-064d0455ef42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9bc7a54f-7f9d-43ce-876e-ee5aaccf31f0" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_93434388-900b-49bc-a2da-064d0455ef42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_face538a-3630-4ef9-833a-411537e89ce4" xlink:href="rdnt-20201231.xsd#rdnt_ScheduleOfLeverageRatioTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9bc7a54f-7f9d-43ce-876e-ee5aaccf31f0" xlink:to="loc_rdnt_ScheduleOfLeverageRatioTableTextBlock_face538a-3630-4ef9-833a-411537e89ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7be77634-2cd0-4120-99f4-bf8f2026de81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_238a284d-0dee-497d-8d9b-b889be774ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7be77634-2cd0-4120-99f4-bf8f2026de81" xlink:to="loc_us-gaap_DebtInstrumentTable_238a284d-0dee-497d-8d9b-b889be774ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3f0b27af-bf72-4387-a1e2-4aec6e734c3c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_238a284d-0dee-497d-8d9b-b889be774ea0" xlink:to="loc_srt_RangeAxis_3f0b27af-bf72-4387-a1e2-4aec6e734c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2a30a603-1400-47da-9d86-fd62461d4873" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3f0b27af-bf72-4387-a1e2-4aec6e734c3c" xlink:to="loc_srt_RangeMember_2a30a603-1400-47da-9d86-fd62461d4873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_158c12c4-bd41-493d-bd80-dd65cff8107b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2a30a603-1400-47da-9d86-fd62461d4873" xlink:to="loc_srt_MinimumMember_158c12c4-bd41-493d-bd80-dd65cff8107b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d01a66bb-709d-4dde-a83c-1f738b437a3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2a30a603-1400-47da-9d86-fd62461d4873" xlink:to="loc_srt_MaximumMember_d01a66bb-709d-4dde-a83c-1f738b437a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_42edae9a-143f-4925-8f31-912403e78f49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_238a284d-0dee-497d-8d9b-b889be774ea0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_42edae9a-143f-4925-8f31-912403e78f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c2a48eb6-7ef0-4f1d-a4ca-041519834ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_42edae9a-143f-4925-8f31-912403e78f49" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c2a48eb6-7ef0-4f1d-a4ca-041519834ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_59a0610e-a954-4f08-9380-091f11c44b71" xlink:href="rdnt-20201231.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2a48eb6-7ef0-4f1d-a4ca-041519834ccd" xlink:to="loc_rdnt_TermLoanMember_59a0610e-a954-4f08-9380-091f11c44b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_90f73867-c0ca-4681-b17a-801e06e4d9bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c2a48eb6-7ef0-4f1d-a4ca-041519834ccd" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_90f73867-c0ca-4681-b17a-801e06e4d9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ba64887c-88c1-439d-8faf-6936938dfc57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_238a284d-0dee-497d-8d9b-b889be774ea0" xlink:to="loc_us-gaap_DebtInstrumentAxis_ba64887c-88c1-439d-8faf-6936938dfc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d0825112-425c-47d5-a5f9-f0c3b9b6a0cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ba64887c-88c1-439d-8faf-6936938dfc57" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d0825112-425c-47d5-a5f9-f0c3b9b6a0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_f3b1021b-51f4-46fc-8df3-1052a1eaa98d" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d0825112-425c-47d5-a5f9-f0c3b9b6a0cb" xlink:to="loc_rdnt_FirstLienTermLoanMember_f3b1021b-51f4-46fc-8df3-1052a1eaa98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_3df87e66-98dc-44a1-a2b1-3fdf7e65903e" xlink:href="rdnt-20201231.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d0825112-425c-47d5-a5f9-f0c3b9b6a0cb" xlink:to="loc_rdnt_RestatedAgreementMember_3df87e66-98dc-44a1-a2b1-3fdf7e65903e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_238a284d-0dee-497d-8d9b-b889be774ea0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_63ea3017-9ddf-43fa-b7ed-fd53f306d527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_us-gaap_LongTermDebt_63ea3017-9ddf-43fa-b7ed-fd53f306d527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e2eee40d-8eca-40fb-a01d-563b7fb8e4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_e2eee40d-8eca-40fb-a01d-563b7fb8e4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermLoansPayable_936863a8-4a8d-40d8-8f36-fc629f50088b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermLoansPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_us-gaap_LongTermLoansPayable_936863a8-4a8d-40d8-8f36-fc629f50088b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_6a2a8d37-4fb8-4497-ac78-29bbe045a2f2" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities_6a2a8d37-4fb8-4497-ac78-29bbe045a2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_c702c392-eb0c-4faa-b2c1-eab72ce9d6d0" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities_c702c392-eb0c-4faa-b2c1-eab72ce9d6d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_d46da35f-7b9c-4abf-abed-ba81361a9599" xlink:href="rdnt-20201231.xsd#rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities_d46da35f-7b9c-4abf-abed-ba81361a9599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2c5b32ca-320b-41de-9fc8-5b2f06f9c1eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4c910550-772f-40e6-9ea0-1c070e53b6cf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_2c5b32ca-320b-41de-9fc8-5b2f06f9c1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt_1" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt_1"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_db33bac5-4bb8-4511-91bb-1189df884f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_23a6ad8c-4797-4b3d-ad29-982e52fafb63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_db33bac5-4bb8-4511-91bb-1189df884f97" xlink:to="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_23a6ad8c-4797-4b3d-ad29-982e52fafb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7d46a548-b43e-422e-9abe-c1fcf9a09a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_23a6ad8c-4797-4b3d-ad29-982e52fafb63" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_7d46a548-b43e-422e-9abe-c1fcf9a09a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_15028976-5b96-45c8-ba56-592abf89678b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_23a6ad8c-4797-4b3d-ad29-982e52fafb63" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_15028976-5b96-45c8-ba56-592abf89678b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1c5641c2-ff6f-4441-a3d9-df35da7434a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_23a6ad8c-4797-4b3d-ad29-982e52fafb63" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_1c5641c2-ff6f-4441-a3d9-df35da7434a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_db9c7418-e0c6-4c75-ba8b-caecc4bfa600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract_23a6ad8c-4797-4b3d-ad29-982e52fafb63" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_db9c7418-e0c6-4c75-ba8b-caecc4bfa600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2b60109c-3035-4c14-bcba-86ed24f653ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2b60109c-3035-4c14-bcba-86ed24f653ff" xlink:to="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemAxis_af6a640e-4562-4658-9dcf-a29ab66403c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_UnusualOrInfrequentItemAxis_af6a640e-4562-4658-9dcf-a29ab66403c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemDomain_fbefc61c-7d5c-44b8-9d0c-abfd0a469f48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnusualOrInfrequentItemDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemAxis_af6a640e-4562-4658-9dcf-a29ab66403c3" xlink:to="loc_us-gaap_UnusualOrInfrequentItemDomain_fbefc61c-7d5c-44b8-9d0c-abfd0a469f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_COVID19PandemicMember_e819da20-8f2c-40fe-9095-a8cc40e925bb" xlink:href="rdnt-20201231.xsd#rdnt_COVID19PandemicMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemDomain_fbefc61c-7d5c-44b8-9d0c-abfd0a469f48" xlink:to="loc_rdnt_COVID19PandemicMember_e819da20-8f2c-40fe-9095-a8cc40e925bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_05e0c9b5-8b4e-4e6e-a284-67ad1fd323df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_VariableRateAxis_05e0c9b5-8b4e-4e6e-a284-67ad1fd323df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_6ced35b1-695d-4530-b10c-1b7e238f17ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_05e0c9b5-8b4e-4e6e-a284-67ad1fd323df" xlink:to="loc_us-gaap_VariableRateDomain_6ced35b1-695d-4530-b10c-1b7e238f17ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_d749449e-dbfa-4193-b592-7c247203900a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6ced35b1-695d-4530-b10c-1b7e238f17ba" xlink:to="loc_us-gaap_EurodollarMember_d749449e-dbfa-4193-b592-7c247203900a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_d6bfa9f2-81d4-424a-afb6-a96ced9baa53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_6ced35b1-695d-4530-b10c-1b7e238f17ba" xlink:to="loc_us-gaap_BaseRateMember_d6bfa9f2-81d4-424a-afb6-a96ced9baa53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_c74deebe-9efb-44f6-9764-ba547962da13" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_rdnt_LeverageRatioAxis_c74deebe-9efb-44f6-9764-ba547962da13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_90696782-67d2-43fd-be3d-b69faa5efdf6" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_c74deebe-9efb-44f6-9764-ba547962da13" xlink:to="loc_rdnt_LeverageRatioDomain_90696782-67d2-43fd-be3d-b69faa5efdf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_2165ff1c-9f91-4a3a-a76d-bf92d68b944e" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_90696782-67d2-43fd-be3d-b69faa5efdf6" xlink:to="loc_rdnt_LeverageRatioThreeMember_2165ff1c-9f91-4a3a-a76d-bf92d68b944e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_cb433700-652b-42aa-b898-c17ab3e7236d" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_90696782-67d2-43fd-be3d-b69faa5efdf6" xlink:to="loc_rdnt_PricingLevelIIIMember_cb433700-652b-42aa-b898-c17ab3e7236d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d41caae5-057b-4c11-8d55-a093b1fd8584" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_DebtInstrumentAxis_d41caae5-057b-4c11-8d55-a093b1fd8584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d41caae5-057b-4c11-8d55-a093b1fd8584" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_60d41798-0325-4576-b8ed-fed8239381cc" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_FirstLienTermLoanMember_60d41798-0325-4576-b8ed-fed8239381cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_84a0d8e7-4afd-4455-9cff-3d03fe171283" xlink:href="rdnt-20201231.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_RestatedAgreementMember_84a0d8e7-4afd-4455-9cff-3d03fe171283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_5e14948d-0bd6-41d9-8987-b7341a471de6" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_5e14948d-0bd6-41d9-8987-b7341a471de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_affc5ebc-2a7f-4731-abbe-caec385b1813" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementSixthAmendmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_FirstLienCreditAgreementSixthAmendmentMember_affc5ebc-2a7f-4731-abbe-caec385b1813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_1f4c0777-7957-453b-89ff-60e5b1741946" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementEighthAmendmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_FirstLienCreditAgreementEighthAmendmentMember_1f4c0777-7957-453b-89ff-60e5b1741946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PaycheckProtectionProgramLoansMember_56f82a4d-3788-4f58-b1e0-77e0e762b151" xlink:href="rdnt-20201231.xsd#rdnt_PaycheckProtectionProgramLoansMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1b8e31dc-fce5-4133-99a3-98271aa2a654" xlink:to="loc_rdnt_PaycheckProtectionProgramLoansMember_56f82a4d-3788-4f58-b1e0-77e0e762b151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_724f5934-c0a4-4bd2-9d06-d430ca708f25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_724f5934-c0a4-4bd2-9d06-d430ca708f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_3d8d2cad-3472-44c6-ab83-bf918e37352b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_724f5934-c0a4-4bd2-9d06-d430ca708f25" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_3d8d2cad-3472-44c6-ab83-bf918e37352b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_BarclaysMember_8021e9d2-44f4-49a5-8061-9efc5ee1a663" xlink:href="rdnt-20201231.xsd#rdnt_BarclaysMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_3d8d2cad-3472-44c6-ab83-bf918e37352b" xlink:to="loc_rdnt_BarclaysMember_8021e9d2-44f4-49a5-8061-9efc5ee1a663" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SunTrustMember_2f2ce086-76e0-4373-a7e0-511c406c618a" xlink:href="rdnt-20201231.xsd#rdnt_SunTrustMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_3d8d2cad-3472-44c6-ab83-bf918e37352b" xlink:to="loc_rdnt_SunTrustMember_2f2ce086-76e0-4373-a7e0-511c406c618a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_bd033c5c-8bc2-4a23-9784-01ef76af68b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_CreditFacilityAxis_bd033c5c-8bc2-4a23-9784-01ef76af68b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_29e372f1-0fee-4dd8-9734-df38554e39ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_bd033c5c-8bc2-4a23-9784-01ef76af68b9" xlink:to="loc_us-gaap_CreditFacilityDomain_29e372f1-0fee-4dd8-9734-df38554e39ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_f6b30fac-f14e-4bf1-9013-2507ba19030b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_29e372f1-0fee-4dd8-9734-df38554e39ef" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_f6b30fac-f14e-4bf1-9013-2507ba19030b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d8502167-6d71-45d4-81dd-aed51770d9b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d8502167-6d71-45d4-81dd-aed51770d9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d8502167-6d71-45d4-81dd-aed51770d9b3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_229eb18c-6b13-4521-9967-2d0898c5701c" xlink:href="rdnt-20201231.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_rdnt_TermLoanMember_229eb18c-6b13-4521-9967-2d0898c5701c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoansAMember_bed7166a-85c3-4edf-8920-2361a863f86e" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienTermLoansAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_rdnt_FirstLienTermLoansAMember_bed7166a-85c3-4edf-8920-2361a863f86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_ed7888b1-989e-4c4d-a196-35d53dacbfdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_us-gaap_LineOfCreditMember_ed7888b1-989e-4c4d-a196-35d53dacbfdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_ee3308c3-c238-418d-87f9-c5a8debecdaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_us-gaap_LetterOfCreditMember_ee3308c3-c238-418d-87f9-c5a8debecdaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_e9ea7ced-ce91-4a0e-92c0-b49f0fdf7a90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_us-gaap_MediumTermNotesMember_e9ea7ced-ce91-4a0e-92c0-b49f0fdf7a90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_c83a7714-40bd-4495-a799-919bec55e7a5" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementSeventhAmendmentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_52f7b1d4-ba47-42ba-9e0b-a2eec60f289d" xlink:to="loc_rdnt_FirstLienCreditAgreementSeventhAmendmentMember_c83a7714-40bd-4495-a799-919bec55e7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_68f80705-7984-46f9-86a5-e0dd44855630" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d5049cf1-a157-47f3-ab83-c4c9d08f881a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d5049cf1-a157-47f3-ab83-c4c9d08f881a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ce3fee52-f24e-4acf-b797-3a55cb03eed0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_ce3fee52-f24e-4acf-b797-3a55cb03eed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_7da68c59-2801-422f-a9c2-cb99865d3c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LineOfCredit_7da68c59-2801-422f-a9c2-cb99865d3c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b8ec8805-56e2-433b-b1e3-ac39e638cb13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b8ec8805-56e2-433b-b1e3-ac39e638cb13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4aa2854e-a906-49ca-b0da-1a1e260494b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4aa2854e-a906-49ca-b0da-1a1e260494b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fe0d513d-7358-48c6-969d-7473c9201232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_fe0d513d-7358-48c6-969d-7473c9201232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_aeaa53cd-a8f4-400d-a52a-c7085bff76dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_aeaa53cd-a8f4-400d-a52a-c7085bff76dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_eeea900a-53fe-4f4b-a251-8d70abfb4f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_eeea900a-53fe-4f4b-a251-8d70abfb4f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_90f6e4e0-3f5d-4d1a-b3ff-ad5e889e4a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_90f6e4e0-3f5d-4d1a-b3ff-ad5e889e4a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1959f58a-3c99-47b1-abed-953cb26e5975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_1959f58a-3c99-47b1-abed-953cb26e5975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_6c4e98fb-6682-46d0-a507-9a0061c94826" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentPeriodicPaymentPercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentPercent_6c4e98fb-6682-46d0-a507-9a0061c94826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_3704333c-ab8b-4509-9b36-5ddf2148b636" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease_3704333c-ab8b-4509-9b36-5ddf2148b636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6e2c22ab-1c80-4805-b3ba-b4ff57015e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6e2c22ab-1c80-4805-b3ba-b4ff57015e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_8ed7251c-358f-4792-bfa9-1dc5caf64c41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_8ed7251c-358f-4792-bfa9-1dc5caf64c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_6f9e6ae6-fb88-4371-8dc3-51226a89b2a3" xlink:href="rdnt-20201231.xsd#rdnt_LineofCreditFacilityIncreaseBorrowingCapacity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity_6f9e6ae6-fb88-4371-8dc3-51226a89b2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsGross_738004a1-233c-4265-842f-40ba08d6c02a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsGross"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DeferredFinanceCostsGross_738004a1-233c-4265-842f-40ba08d6c02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_941b032f-2e5d-47c9-965e-8319ff1a1008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountCurrent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountCurrent_941b032f-2e5d-47c9-965e-8319ff1a1008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDeferredCharges_72f0fe16-0004-4e25-bd24-205c2a1084c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfDeferredCharges"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_AmortizationOfDeferredCharges_72f0fe16-0004-4e25-bd24-205c2a1084c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cc831301-772e-41c1-945f-dcbc7524468d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_cc831301-772e-41c1-945f-dcbc7524468d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_c55e686a-7c1e-46e3-b50c-ca6c6e686a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_us-gaap_DebtInstrumentTerm_c55e686a-7c1e-46e3-b50c-ca6c6e686a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentNumberofLoansReceived_8f99e0ea-3975-46e4-9df7-599063e8becf" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentNumberofLoansReceived"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bdf7db7f-7326-4435-8157-1f9bff252e9f" xlink:to="loc_rdnt_DebtInstrumentNumberofLoansReceived_8f99e0ea-3975-46e4-9df7-599063e8becf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2af55830-6f26-44df-a0d9-739f280b7520" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_056cc0db-e826-40ef-86b2-7c497c077146" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2af55830-6f26-44df-a0d9-739f280b7520" xlink:to="loc_us-gaap_DebtInstrumentTable_056cc0db-e826-40ef-86b2-7c497c077146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_220d2424-e70b-4cf6-bf20-095199df2806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_056cc0db-e826-40ef-86b2-7c497c077146" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_220d2424-e70b-4cf6-bf20-095199df2806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e12ae2b8-28cb-4ea3-9a3f-fe73606b745c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_220d2424-e70b-4cf6-bf20-095199df2806" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e12ae2b8-28cb-4ea3-9a3f-fe73606b745c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_TermLoanMember_fc46a9a7-f1ec-49ea-be43-3ad4783fb6de" xlink:href="rdnt-20201231.xsd#rdnt_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e12ae2b8-28cb-4ea3-9a3f-fe73606b745c" xlink:to="loc_rdnt_TermLoanMember_fc46a9a7-f1ec-49ea-be43-3ad4783fb6de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_09c0d35d-9bcf-4c88-8945-7ed90a7236ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_056cc0db-e826-40ef-86b2-7c497c077146" xlink:to="loc_us-gaap_DebtInstrumentAxis_09c0d35d-9bcf-4c88-8945-7ed90a7236ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2dede647-143a-4d81-9540-0e8a158d1e44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_09c0d35d-9bcf-4c88-8945-7ed90a7236ff" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2dede647-143a-4d81-9540-0e8a158d1e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienTermLoanMember_ee833f7c-78a7-4bd2-9e9f-c6d167ad2bbf" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2dede647-143a-4d81-9540-0e8a158d1e44" xlink:to="loc_rdnt_FirstLienTermLoanMember_ee833f7c-78a7-4bd2-9e9f-c6d167ad2bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_bd59341d-b19e-495f-9e3f-5c2dc631be76" xlink:href="rdnt-20201231.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2dede647-143a-4d81-9540-0e8a158d1e44" xlink:to="loc_rdnt_RestatedAgreementMember_bd59341d-b19e-495f-9e3f-5c2dc631be76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_72a537c4-90ac-42b1-8850-f5ed897af6c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_056cc0db-e826-40ef-86b2-7c497c077146" xlink:to="loc_us-gaap_DebtInstrumentLineItems_72a537c4-90ac-42b1-8850-f5ed897af6c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_c3d64c45-6220-4bcc-9736-55809df55398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_72a537c4-90ac-42b1-8850-f5ed897af6c4" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_c3d64c45-6220-4bcc-9736-55809df55398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9559827f-0a2d-40c3-9c6a-70c5e2f2b41b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_72a537c4-90ac-42b1-8850-f5ed897af6c4" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_9559827f-0a2d-40c3-9c6a-70c5e2f2b41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_c15ebc29-1035-4974-91dd-1ed63d724be6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_72a537c4-90ac-42b1-8850-f5ed897af6c4" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_c15ebc29-1035-4974-91dd-1ed63d724be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_356f9b18-8b70-4831-9a61-902a9a97f869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_356f9b18-8b70-4831-9a61-902a9a97f869" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8a2426a8-e4ea-4066-a5bd-e8fbb5a79d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8a2426a8-e4ea-4066-a5bd-e8fbb5a79d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a33f7269-d6d3-4b72-bbd5-1a3b1122accd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a2426a8-e4ea-4066-a5bd-e8fbb5a79d8f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a33f7269-d6d3-4b72-bbd5-1a3b1122accd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_b533bfc8-e9e2-4c63-9ad3-3b22b9589e34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a33f7269-d6d3-4b72-bbd5-1a3b1122accd" xlink:to="loc_us-gaap_LineOfCreditMember_b533bfc8-e9e2-4c63-9ad3-3b22b9589e34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_52137816-7760-4a02-9ef7-9befbbce7355" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:to="loc_us-gaap_CreditFacilityAxis_52137816-7760-4a02-9ef7-9befbbce7355" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_e81bbb57-7ab8-4cda-a3d2-06f3cb60025a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_52137816-7760-4a02-9ef7-9befbbce7355" xlink:to="loc_us-gaap_CreditFacilityDomain_e81bbb57-7ab8-4cda-a3d2-06f3cb60025a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_17ebcef2-d363-411b-8ae4-cbb9d11a8e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_e81bbb57-7ab8-4cda-a3d2-06f3cb60025a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_17ebcef2-d363-411b-8ae4-cbb9d11a8e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_95b1e311-8681-4d67-8be0-4d293eebc294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:to="loc_us-gaap_VariableRateAxis_95b1e311-8681-4d67-8be0-4d293eebc294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4bbd4627-ed51-45a5-b40a-9f7475f047cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_95b1e311-8681-4d67-8be0-4d293eebc294" xlink:to="loc_us-gaap_VariableRateDomain_4bbd4627-ed51-45a5-b40a-9f7475f047cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_7eda918a-04c5-4545-ad77-b7a9b0c01e58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4bbd4627-ed51-45a5-b40a-9f7475f047cf" xlink:to="loc_us-gaap_EurodollarMember_7eda918a-04c5-4545-ad77-b7a9b0c01e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_ac4d2621-ba6b-4150-b252-2bd8a4511aab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4bbd4627-ed51-45a5-b40a-9f7475f047cf" xlink:to="loc_us-gaap_BaseRateMember_ac4d2621-ba6b-4150-b252-2bd8a4511aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_cfd3d5b1-12c4-4148-9cd0-b76e8f2313a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:to="loc_us-gaap_DebtInstrumentAxis_cfd3d5b1-12c4-4148-9cd0-b76e8f2313a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d0ce9cea-88c7-48c0-b2ce-d7223a30dc5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_cfd3d5b1-12c4-4148-9cd0-b76e8f2313a9" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d0ce9cea-88c7-48c0-b2ce-d7223a30dc5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FirstLienCreditAgreementMember_823d5845-2afc-4f9d-bdca-46f2daef0546" xlink:href="rdnt-20201231.xsd#rdnt_FirstLienCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d0ce9cea-88c7-48c0-b2ce-d7223a30dc5f" xlink:to="loc_rdnt_FirstLienCreditAgreementMember_823d5845-2afc-4f9d-bdca-46f2daef0546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_29e18f2a-fe7d-4ff3-85b0-b5e4a76e68e5" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:to="loc_rdnt_LeverageRatioAxis_29e18f2a-fe7d-4ff3-85b0-b5e4a76e68e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_29e18f2a-fe7d-4ff3-85b0-b5e4a76e68e5" xlink:to="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioOneMember_0cbbc9be-8c5f-44a9-a746-9de989895442" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:to="loc_rdnt_LeverageRatioOneMember_0cbbc9be-8c5f-44a9-a746-9de989895442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioTwoMember_958ff31b-ebdc-440f-be05-e3458346fd93" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:to="loc_rdnt_LeverageRatioTwoMember_958ff31b-ebdc-440f-be05-e3458346fd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioThreeMember_b1aad928-1993-4d40-a799-822483f1e6ed" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:to="loc_rdnt_LeverageRatioThreeMember_b1aad928-1993-4d40-a799-822483f1e6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioFourMember_e0517d48-cfa8-4d32-bd65-dbb8b643e8bb" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_98487bbd-507d-4bd1-9dd4-299eacf36915" xlink:to="loc_rdnt_LeverageRatioFourMember_e0517d48-cfa8-4d32-bd65-dbb8b643e8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_9d5594c3-c5b5-4bd2-8466-7b57bb8f008f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6ab5fd8b-2760-4c46-92a3-ea8d181da1b6" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_9d5594c3-c5b5-4bd2-8466-7b57bb8f008f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_73ed0909-94f8-4f0d-9cb2-a2b6b3e72f4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9d5594c3-c5b5-4bd2-8466-7b57bb8f008f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_73ed0909-94f8-4f0d-9cb2-a2b6b3e72f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="simple" xlink:href="rdnt-20201231.xsd#CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_313844c7-ca39-4f9e-af71-ef8585014007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_313844c7-ca39-4f9e-af71-ef8585014007" xlink:to="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_db5405b5-8aa4-4f12-8d6f-73fd3239c9e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:to="loc_us-gaap_CreditFacilityAxis_db5405b5-8aa4-4f12-8d6f-73fd3239c9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6886ace1-c30a-40e5-bece-4c888fae9181" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_db5405b5-8aa4-4f12-8d6f-73fd3239c9e5" xlink:to="loc_us-gaap_CreditFacilityDomain_6886ace1-c30a-40e5-bece-4c888fae9181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b60ffead-cb2b-4d50-90bc-f2fe144c9f04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6886ace1-c30a-40e5-bece-4c888fae9181" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b60ffead-cb2b-4d50-90bc-f2fe144c9f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioAxis_15e042f5-505e-4af0-a425-bd230691a3ab" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:to="loc_rdnt_LeverageRatioAxis_15e042f5-505e-4af0-a425-bd230691a3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:href="rdnt-20201231.xsd#rdnt_LeverageRatioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioAxis_15e042f5-505e-4af0-a425-bd230691a3ab" xlink:to="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIMember_9158a4de-9f9e-401b-8c9b-73c616db98bb" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:to="loc_rdnt_PricingLevelIMember_9158a4de-9f9e-401b-8c9b-73c616db98bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIMember_7db1289a-02ac-4fe6-a1f8-35f22aeb839b" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIIMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:to="loc_rdnt_PricingLevelIIMember_7db1289a-02ac-4fe6-a1f8-35f22aeb839b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIIIMember_57dbcafa-4e80-4fea-a8f6-2791218a410d" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIIIMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:to="loc_rdnt_PricingLevelIIIMember_57dbcafa-4e80-4fea-a8f6-2791218a410d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelIVMember_9ea134b3-c1e1-470d-8e32-25969a6ced6c" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelIVMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:to="loc_rdnt_PricingLevelIVMember_9ea134b3-c1e1-470d-8e32-25969a6ced6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_PricingLevelVMember_bc9730bf-0466-43de-a111-168954d15b15" xlink:href="rdnt-20201231.xsd#rdnt_PricingLevelVMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeverageRatioDomain_61a3b92c-7e61-4e70-be3b-2eac9f7d4960" xlink:to="loc_rdnt_PricingLevelVMember_bc9730bf-0466-43de-a111-168954d15b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f71ab11a-0577-46e1-ba7e-8aa66baa0fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:to="loc_us-gaap_DebtInstrumentAxis_f71ab11a-0577-46e1-ba7e-8aa66baa0fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ac52e9af-fe2f-4a6e-8dbd-1832fda014c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f71ab11a-0577-46e1-ba7e-8aa66baa0fbe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ac52e9af-fe2f-4a6e-8dbd-1832fda014c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedAgreementMember_f6e506f4-c38e-424c-b420-391945aa980f" xlink:href="rdnt-20201231.xsd#rdnt_RestatedAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ac52e9af-fe2f-4a6e-8dbd-1832fda014c9" xlink:to="loc_rdnt_RestatedAgreementMember_f6e506f4-c38e-424c-b420-391945aa980f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_f7f174fa-c73f-4e77-a930-d6a2a8521937" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:to="loc_us-gaap_VariableRateAxis_f7f174fa-c73f-4e77-a930-d6a2a8521937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e17a7790-bc45-46ec-9602-ff7751d578f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_f7f174fa-c73f-4e77-a930-d6a2a8521937" xlink:to="loc_us-gaap_VariableRateDomain_e17a7790-bc45-46ec-9602-ff7751d578f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EurodollarMember_7f665ca9-9de5-4dd9-86c7-82d89f062bd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EurodollarMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e17a7790-bc45-46ec-9602-ff7751d578f3" xlink:to="loc_us-gaap_EurodollarMember_7f665ca9-9de5-4dd9-86c7-82d89f062bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_61cca58b-78fa-44fb-af6e-2f1b7c433ff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_e17a7790-bc45-46ec-9602-ff7751d578f3" xlink:to="loc_us-gaap_BaseRateMember_61cca58b-78fa-44fb-af6e-2f1b7c433ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7911a41a-d618-4850-8dc2-3aac673c0440" xlink:to="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_a88b89ee-1c22-41d9-bf47-1bfc4885ef47" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:to="loc_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum_a88b89ee-1c22-41d9-bf47-1bfc4885ef47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_594791c1-26c8-4f2a-8107-0d16b9656c02" xlink:href="rdnt-20201231.xsd#rdnt_DebtInstrumentCovenantLeverageRatioMaximum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:to="loc_rdnt_DebtInstrumentCovenantLeverageRatioMaximum_594791c1-26c8-4f2a-8107-0d16b9656c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_93c98be3-02c3-492f-b15b-b65049c921de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_93c98be3-02c3-492f-b15b-b65049c921de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7878a45b-d230-457c-b997-2e24e56f3f4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_7878a45b-d230-457c-b997-2e24e56f3f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_2d1f1f7d-0928-405b-ab8e-e4c0c7c6f3a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_298b96f6-f202-4781-9911-7ff45c55f48f" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_2d1f1f7d-0928-405b-ab8e-e4c0c7c6f3a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESNotes" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESNotes"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESNotes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_237b4ae7-cb4f-4ddf-a562-4de981f2b661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_18de5214-2193-422d-b92d-389c1c5d78cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_237b4ae7-cb4f-4ddf-a562-4de981f2b661" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_18de5214-2193-422d-b92d-389c1c5d78cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_deb1e329-dd72-4667-b902-c07d0ab29874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_237b4ae7-cb4f-4ddf-a562-4de981f2b661" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_deb1e329-dd72-4667-b902-c07d0ab29874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7e9a44d1-f508-4fc5-84b7-178ed3f53e3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_6d526f18-3ff6-4381-a5f8-6d149fb8f45c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e9a44d1-f508-4fc5-84b7-178ed3f53e3f" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_6d526f18-3ff6-4381-a5f8-6d149fb8f45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_dfed4472-b2c7-4a94-872a-5aece0e3fdd8" xlink:href="rdnt-20201231.xsd#rdnt_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e9a44d1-f508-4fc5-84b7-178ed3f53e3f" xlink:to="loc_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock_dfed4472-b2c7-4a94-872a-5aece0e3fdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_cab76b16-8706-481b-bd99-5a5ea02ffcd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e9a44d1-f508-4fc5-84b7-178ed3f53e3f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_cab76b16-8706-481b-bd99-5a5ea02ffcd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_20ad7e3a-5ab5-470f-9a90-e89519aa4752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7e9a44d1-f508-4fc5-84b7-178ed3f53e3f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_20ad7e3a-5ab5-470f-9a90-e89519aa4752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsAdditionalInformation"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsAdditionalInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a1636c52-fbe6-4751-af11-d73be1be00bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_4ab17689-b0a7-4c41-9434-08307772a567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a1636c52-fbe6-4751-af11-d73be1be00bf" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_4ab17689-b0a7-4c41-9434-08307772a567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_470f1fab-cbcd-4041-9c3d-d58198a02dd8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4ab17689-b0a7-4c41-9434-08307772a567" xlink:to="loc_srt_RangeAxis_470f1fab-cbcd-4041-9c3d-d58198a02dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1d4fd096-ecf6-4bba-b085-ecb068f795b5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_470f1fab-cbcd-4041-9c3d-d58198a02dd8" xlink:to="loc_srt_RangeMember_1d4fd096-ecf6-4bba-b085-ecb068f795b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ad28b11f-41f3-436a-8a29-7983fb3d19db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1d4fd096-ecf6-4bba-b085-ecb068f795b5" xlink:to="loc_srt_MinimumMember_ad28b11f-41f3-436a-8a29-7983fb3d19db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b01a31c5-c91a-4f1a-b84a-1793c0623b8b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1d4fd096-ecf6-4bba-b085-ecb068f795b5" xlink:to="loc_srt_MaximumMember_b01a31c5-c91a-4f1a-b84a-1793c0623b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_4ab17689-b0a7-4c41-9434-08307772a567" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f40bfffb-0eda-4440-98a5-f3ee148b07e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_f40bfffb-0eda-4440-98a5-f3ee148b07e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_67de6852-db32-4b60-9900-8373574ab7dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_67de6852-db32-4b60-9900-8373574ab7dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeLeaseTermofContract_b6116388-7ae9-4133-b7ea-2ac25fca61e7" xlink:href="rdnt-20201231.xsd#rdnt_LesseeLeaseTermofContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_rdnt_LesseeLeaseTermofContract_b6116388-7ae9-4133-b7ea-2ac25fca61e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_101798b5-dda3-4d81-8ec3-ef0310057ae9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_101798b5-dda3-4d81-8ec3-ef0310057ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_380e48a7-e3a1-4bf3-be39-9adf15eb0454" xlink:href="rdnt-20201231.xsd#rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_380e48a7-e3a1-4bf3-be39-9adf15eb0454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_f37584cd-6019-46aa-bbbc-4fbad180fcbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_f96ecb48-2f6b-4853-a673-7cd17ba4b66b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_f37584cd-6019-46aa-bbbc-4fbad180fcbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsLeaseCost"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsLeaseCost" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0a5d0290-51c3-4fb6-b6ea-c56db5034f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_133c6b95-df79-4307-937a-b4d02e0e99f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a5d0290-51c3-4fb6-b6ea-c56db5034f54" xlink:to="loc_us-gaap_OperatingLeaseCost_133c6b95-df79-4307-937a-b4d02e0e99f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_3a9f2848-a3fc-439e-8a12-680fd97657ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a5d0290-51c3-4fb6-b6ea-c56db5034f54" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_3a9f2848-a3fc-439e-8a12-680fd97657ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_d3d8c120-4645-4638-8c76-50b7df581708" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a5d0290-51c3-4fb6-b6ea-c56db5034f54" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_d3d8c120-4645-4638-8c76-50b7df581708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseCost_cd371aba-45c5-454d-8b04-cd88b0bbd1d1" xlink:href="rdnt-20201231.xsd#rdnt_FinanceLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0a5d0290-51c3-4fb6-b6ea-c56db5034f54" xlink:to="loc_rdnt_FinanceLeaseCost_cd371aba-45c5-454d-8b04-cd88b0bbd1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsSupplementalCashFlows"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_06b88fc5-b90d-42db-b4bf-b34c422221c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_CashFlowLesseeAbstract_0afc284b-d5c6-4398-b854-41f844894fec" xlink:href="rdnt-20201231.xsd#rdnt_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_06b88fc5-b90d-42db-b4bf-b34c422221c5" xlink:to="loc_rdnt_CashFlowLesseeAbstract_0afc284b-d5c6-4398-b854-41f844894fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_542ee30e-f105-4d59-bd42-863718032ebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_0afc284b-d5c6-4398-b854-41f844894fec" xlink:to="loc_us-gaap_OperatingLeasePayments_542ee30e-f105-4d59-bd42-863718032ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_378e7305-e3b1-4b01-bdc0-bd19eb79b249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_0afc284b-d5c6-4398-b854-41f844894fec" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_378e7305-e3b1-4b01-bdc0-bd19eb79b249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_cf482aca-3c9c-402a-840a-9878d4217b5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_CashFlowLesseeAbstract_0afc284b-d5c6-4398-b854-41f844894fec" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_cf482aca-3c9c-402a-840a-9878d4217b5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_a6dd7ce9-c243-4e9c-a4c8-6459444006e2" xlink:href="rdnt-20201231.xsd#rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_06b88fc5-b90d-42db-b4bf-b34c422221c5" xlink:to="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_a6dd7ce9-c243-4e9c-a4c8-6459444006e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3a3d902d-e4c6-4dd5-a599-f6ed70c2f4e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_a6dd7ce9-c243-4e9c-a4c8-6459444006e2" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3a3d902d-e4c6-4dd5-a599-f6ed70c2f4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_491804bf-db42-480a-9d77-fee67a530c7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_a6dd7ce9-c243-4e9c-a4c8-6459444006e2" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_491804bf-db42-480a-9d77-fee67a530c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsSupplementalBalanceSheet"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_de05280f-07f4-4fe5-9c38-c97aa3fdca4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9f5341c9-d624-4588-8661-d3f74c9ef4a5" xlink:href="rdnt-20201231.xsd#rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_de05280f-07f4-4fe5-9c38-c97aa3fdca4c" xlink:to="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9f5341c9-d624-4588-8661-d3f74c9ef4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_39bcccdb-4c4c-4d1e-ba55-f406b53a7287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9f5341c9-d624-4588-8661-d3f74c9ef4a5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_39bcccdb-4c4c-4d1e-ba55-f406b53a7287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_4b49f0c1-e6ee-4a64-a018-5fe0c7c4fdc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9f5341c9-d624-4588-8661-d3f74c9ef4a5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_4b49f0c1-e6ee-4a64-a018-5fe0c7c4fdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c901dfd5-f1de-4754-88a2-dd782bcb30df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9f5341c9-d624-4588-8661-d3f74c9ef4a5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c901dfd5-f1de-4754-88a2-dd782bcb30df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_9c1709c3-7012-4574-81db-f8750d27114b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_9f5341c9-d624-4588-8661-d3f74c9ef4a5" xlink:to="loc_us-gaap_OperatingLeaseLiability_9c1709c3-7012-4574-81db-f8750d27114b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_1dfd6f08-9507-43cf-ae8d-447a33130ac6" xlink:href="rdnt-20201231.xsd#rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_de05280f-07f4-4fe5-9c38-c97aa3fdca4c" xlink:to="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_1dfd6f08-9507-43cf-ae8d-447a33130ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_1d0df958-3b56-4ee8-9276-678e4d5359ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_1dfd6f08-9507-43cf-ae8d-447a33130ac6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_1d0df958-3b56-4ee8-9276-678e4d5359ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_c26f61dd-6f16-4c7b-8313-27bed8cf13f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_1dfd6f08-9507-43cf-ae8d-447a33130ac6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization_c26f61dd-6f16-4c7b-8313-27bed8cf13f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_6b9c833c-89d4-4b00-bf61-66456da2f7aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_1dfd6f08-9507-43cf-ae8d-447a33130ac6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_6b9c833c-89d4-4b00-bf61-66456da2f7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_b807a83e-9649-433a-8d39-71b69325aae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_1dfd6f08-9507-43cf-ae8d-447a33130ac6" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_b807a83e-9649-433a-8d39-71b69325aae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_31870435-5abd-4cb4-bbe5-27b09a1afe89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_1dfd6f08-9507-43cf-ae8d-447a33130ac6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_31870435-5abd-4cb4-bbe5-27b09a1afe89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_bd9bacde-0731-4c05-9662-d3df3d5e4e03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_1dfd6f08-9507-43cf-ae8d-447a33130ac6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_bd9bacde-0731-4c05-9662-d3df3d5e4e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_6e4b598a-cc76-44b8-8988-6bbcb8767f69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_1dfd6f08-9507-43cf-ae8d-447a33130ac6" xlink:to="loc_us-gaap_FinanceLeaseLiability_6e4b598a-cc76-44b8-8988-6bbcb8767f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_63a708fc-a64f-41a6-8f0e-ccddc1ca0d27" xlink:href="rdnt-20201231.xsd#rdnt_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_de05280f-07f4-4fe5-9c38-c97aa3fdca4c" xlink:to="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_63a708fc-a64f-41a6-8f0e-ccddc1ca0d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e90fdcc3-38cb-4099-85c6-0e4561ac918e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_63a708fc-a64f-41a6-8f0e-ccddc1ca0d27" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_e90fdcc3-38cb-4099-85c6-0e4561ac918e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_8c40f644-d91c-4ef2-a8f8-7340af4f362e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingLeaseTermAbstract_63a708fc-a64f-41a6-8f0e-ccddc1ca0d27" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_8c40f644-d91c-4ef2-a8f8-7340af4f362e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_8501c423-e6d2-4665-ba0e-681dbe45049e" xlink:href="rdnt-20201231.xsd#rdnt_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_de05280f-07f4-4fe5-9c38-c97aa3fdca4c" xlink:to="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_8501c423-e6d2-4665-ba0e-681dbe45049e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0854b593-305a-4247-bdc7-7df635fc4eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_8501c423-e6d2-4665-ba0e-681dbe45049e" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0854b593-305a-4247-bdc7-7df635fc4eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b9292c96-76ab-4793-a6fb-6951b724ff3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_LeasesWeightedAverageDiscountRateAbstract_8501c423-e6d2-4665-ba0e-681dbe45049e" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_b9292c96-76ab-4793-a6fb-6951b724ff3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f150172c-e4bf-4401-a01f-332bc1e6f08a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf7af20b-61fc-4bea-ad3a-58b126a921fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f150172c-e4bf-4401-a01f-332bc1e6f08a" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf7af20b-61fc-4bea-ad3a-58b126a921fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_83cc0e1e-4847-4ca4-a67d-e4fdcb42163d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf7af20b-61fc-4bea-ad3a-58b126a921fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_83cc0e1e-4847-4ca4-a67d-e4fdcb42163d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6b37ecd1-16ca-4756-9add-b72b255f4913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf7af20b-61fc-4bea-ad3a-58b126a921fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6b37ecd1-16ca-4756-9add-b72b255f4913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d8c8bbd2-3a17-4190-b6c8-d00c71334585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf7af20b-61fc-4bea-ad3a-58b126a921fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d8c8bbd2-3a17-4190-b6c8-d00c71334585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1e5d7b7b-6ed6-4572-a71d-4fcc55f9bb31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf7af20b-61fc-4bea-ad3a-58b126a921fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_1e5d7b7b-6ed6-4572-a71d-4fcc55f9bb31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8add0cf3-0228-44d8-974f-6d6f7b78a267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf7af20b-61fc-4bea-ad3a-58b126a921fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8add0cf3-0228-44d8-974f-6d6f7b78a267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a2bd89a9-2387-4699-baff-0f395f379dee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf7af20b-61fc-4bea-ad3a-58b126a921fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_a2bd89a9-2387-4699-baff-0f395f379dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_29890b79-bf7e-40e9-a1fa-f82dca7dfad0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf7af20b-61fc-4bea-ad3a-58b126a921fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_29890b79-bf7e-40e9-a1fa-f82dca7dfad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ebfed898-a317-4dbd-904f-adf4b8f31f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf7af20b-61fc-4bea-ad3a-58b126a921fc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_ebfed898-a317-4dbd-904f-adf4b8f31f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0f541aa6-7491-4afe-a83e-7f837a29c30d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf7af20b-61fc-4bea-ad3a-58b126a921fc" xlink:to="loc_us-gaap_OperatingLeaseLiability_0f541aa6-7491-4afe-a83e-7f837a29c30d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_05323872-a640-40cf-8cf2-db3216b71424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f150172c-e4bf-4401-a01f-332bc1e6f08a" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_05323872-a640-40cf-8cf2-db3216b71424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_8caed3ea-b777-4d92-bef9-590cb5b9f3b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_05323872-a640-40cf-8cf2-db3216b71424" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_8caed3ea-b777-4d92-bef9-590cb5b9f3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6b18b857-76a1-4560-9128-f59cdf8410f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_05323872-a640-40cf-8cf2-db3216b71424" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_6b18b857-76a1-4560-9128-f59cdf8410f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e074505b-d9e3-4b54-9fd2-123797a43a56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_05323872-a640-40cf-8cf2-db3216b71424" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e074505b-d9e3-4b54-9fd2-123797a43a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_35c83600-7dbb-4760-ac15-3ab71429664d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_05323872-a640-40cf-8cf2-db3216b71424" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_35c83600-7dbb-4760-ac15-3ab71429664d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2364dc84-593a-4d9a-b6a2-71c0c59479c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_05323872-a640-40cf-8cf2-db3216b71424" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_2364dc84-593a-4d9a-b6a2-71c0c59479c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_fe9f68f4-9bcf-4831-9a29-73c1eb7bbb80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_05323872-a640-40cf-8cf2-db3216b71424" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_fe9f68f4-9bcf-4831-9a29-73c1eb7bbb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b9326f01-83a0-464c-92ed-fed9cdb3e36d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_05323872-a640-40cf-8cf2-db3216b71424" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_b9326f01-83a0-464c-92ed-fed9cdb3e36d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_3f76aa61-f9ba-45dc-86e2-d2b1c92e9eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_05323872-a640-40cf-8cf2-db3216b71424" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_3f76aa61-f9ba-45dc-86e2-d2b1c92e9eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_3a558469-7529-4cd8-addf-5090ac1d7bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_05323872-a640-40cf-8cf2-db3216b71424" xlink:to="loc_us-gaap_FinanceLeaseLiability_3a558469-7529-4cd8-addf-5090ac1d7bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="simple" xlink:href="rdnt-20201231.xsd#LEASESDetailsMaturitiesofOperatingandFinanceLease_1"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXES" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a2b219a9-948c-4832-a7b0-2698208e9d27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_daec2cd5-42dd-4b8d-a82f-977084c9c568" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a2b219a9-948c-4832-a7b0-2698208e9d27" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_daec2cd5-42dd-4b8d-a82f-977084c9c568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f885e75d-093d-4cb7-8168-492a0430ec3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_aee65b0c-8f1e-41a1-a429-34f6906b7bc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f885e75d-093d-4cb7-8168-492a0430ec3b" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_aee65b0c-8f1e-41a1-a429-34f6906b7bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_6c86c697-ba1d-4a87-9576-936ece4b0c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f885e75d-093d-4cb7-8168-492a0430ec3b" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_6c86c697-ba1d-4a87-9576-936ece4b0c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4feb6546-2143-47c7-94f3-400317db5298" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f885e75d-093d-4cb7-8168-492a0430ec3b" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4feb6546-2143-47c7-94f3-400317db5298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_57bea5fb-6b39-4b26-b810-fd09007aaa7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f885e75d-093d-4cb7-8168-492a0430ec3b" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_57bea5fb-6b39-4b26-b810-fd09007aaa7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsIncometaxexpense"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_c71be16a-7054-4da8-946f-cf171fe2e0c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b0a7c15b-d607-4832-bb67-cb6a1fe9918a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c71be16a-7054-4da8-946f-cf171fe2e0c0" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b0a7c15b-d607-4832-bb67-cb6a1fe9918a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_c1deca39-9623-44c2-9542-ad4d96f042cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c71be16a-7054-4da8-946f-cf171fe2e0c0" xlink:to="loc_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_c1deca39-9623-44c2-9542-ad4d96f042cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherTaxExpenseBenefit_3f2c0b0c-fb95-401b-8313-10051de06ded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c71be16a-7054-4da8-946f-cf171fe2e0c0" xlink:to="loc_us-gaap_OtherTaxExpenseBenefit_3f2c0b0c-fb95-401b-8313-10051de06ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4531ed90-5c9e-46a3-b9c6-4f6c48b64140" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c71be16a-7054-4da8-946f-cf171fe2e0c0" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4531ed90-5c9e-46a3-b9c6-4f6c48b64140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4c8832b0-8476-416a-be1f-99356ac1daa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c71be16a-7054-4da8-946f-cf171fe2e0c0" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_4c8832b0-8476-416a-be1f-99356ac1daa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ff179398-15ab-45f8-9f5f-dcf19b2b7047" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_c71be16a-7054-4da8-946f-cf171fe2e0c0" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ff179398-15ab-45f8-9f5f-dcf19b2b7047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_935282f0-c29d-4ba9-aa74-0e861d4f75a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_935282f0-c29d-4ba9-aa74-0e861d4f75a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_0c463875-ed32-42e2-ba05-bb22509ebefe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_0c463875-ed32-42e2-ba05-bb22509ebefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_f1a942c1-17a9-4cb6-8ca7-3f37748d1d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_f1a942c1-17a9-4cb6-8ca7-3f37748d1d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_653756ea-d527-4acb-8ff3-f169d4cac6f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense_653756ea-d527-4acb-8ff3-f169d4cac6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6f5ebba4-c953-4334-a238-b20ce5627aea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_6f5ebba4-c953-4334-a238-b20ce5627aea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_898059f7-8c4e-412b-8d6b-670ba779d9cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_898059f7-8c4e-412b-8d6b-670ba779d9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_f68da51d-a8af-4ffa-abdf-f54a6073c140" xlink:href="rdnt-20201231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount_f68da51d-a8af-4ffa-abdf-f54a6073c140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount_1fc69c7d-fbdd-4867-8976-78c761eeb1b0" xlink:href="rdnt-20201231.xsd#rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount_1fc69c7d-fbdd-4867-8976-78c761eeb1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_f137f276-7d81-4743-82b1-e31557174a95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_f137f276-7d81-4743-82b1-e31557174a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_3afd87a5-ef68-476b-bd6a-b14b7734ad26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_3afd87a5-ef68-476b-bd6a-b14b7734ad26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_1ad146fa-711d-464f-8603-8235c2d38b87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherReconcilingItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherReconcilingItems_1ad146fa-711d-464f-8603-8235c2d38b87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ef34cfa3-f271-42ef-9f6b-2e1ea9338f24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d3da2a31-4721-4f5d-bd0c-6367e6258469" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ef34cfa3-f271-42ef-9f6b-2e1ea9338f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_70c21503-be2b-41aa-9062-a5e115495327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_4bac80b3-9233-4e73-b9fd-a366b92c9334" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_70c21503-be2b-41aa-9062-a5e115495327" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_4bac80b3-9233-4e73-b9fd-a366b92c9334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bfa3b86a-f5c2-4a7c-8836-bdd3c0932e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_4bac80b3-9233-4e73-b9fd-a366b92c9334" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bfa3b86a-f5c2-4a7c-8836-bdd3c0932e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60e83797-0a93-400d-85f1-108b9eacac73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bfa3b86a-f5c2-4a7c-8836-bdd3c0932e2c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60e83797-0a93-400d-85f1-108b9eacac73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RavenHoldingsMember_d693e9f1-7fad-4ae5-bf46-2aaa37aeed82" xlink:href="rdnt-20201231.xsd#rdnt_RavenHoldingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_60e83797-0a93-400d-85f1-108b9eacac73" xlink:to="loc_rdnt_RavenHoldingsMember_d693e9f1-7fad-4ae5-bf46-2aaa37aeed82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_4dc2a55d-6022-492c-95dd-bcdaabfd252d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_4bac80b3-9233-4e73-b9fd-a366b92c9334" xlink:to="loc_us-gaap_TaxPeriodAxis_4dc2a55d-6022-492c-95dd-bcdaabfd252d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_6bdc226a-dcb7-492b-955f-1560d5db8002" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_4dc2a55d-6022-492c-95dd-bcdaabfd252d" xlink:to="loc_us-gaap_TaxPeriodDomain_6bdc226a-dcb7-492b-955f-1560d5db8002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxYear2018Member_a7bb1170-7607-4fd7-978e-cf3da68a47e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxYear2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_6bdc226a-dcb7-492b-955f-1560d5db8002" xlink:to="loc_us-gaap_TaxYear2018Member_a7bb1170-7607-4fd7-978e-cf3da68a47e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_3327190a-843f-47af-be01-29354eae5832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_4bac80b3-9233-4e73-b9fd-a366b92c9334" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_3327190a-843f-47af-be01-29354eae5832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_e3d657bf-c37f-4ce9-85ae-3c498abd6c31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_3327190a-843f-47af-be01-29354eae5832" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_e3d657bf-c37f-4ce9-85ae-3c498abd6c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_7c3ce73b-c980-4a49-9bf8-c3324b6afe6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e3d657bf-c37f-4ce9-85ae-3c498abd6c31" xlink:to="loc_us-gaap_DomesticCountryMember_7c3ce73b-c980-4a49-9bf8-c3324b6afe6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_7a1ebf8d-3a2d-40a3-a254-fd2b4a8242cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_e3d657bf-c37f-4ce9-85ae-3c498abd6c31" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_7a1ebf8d-3a2d-40a3-a254-fd2b4a8242cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_4bac80b3-9233-4e73-b9fd-a366b92c9334" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_5e5149e1-d705-42ab-8b8c-ddb04fd06bad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_us-gaap_OperatingLossCarryforwards_5e5149e1-d705-42ab-8b8c-ddb04fd06bad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_a1724108-a8cf-45f7-bdcf-8e4fa179192f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_a1724108-a8cf-45f7-bdcf-8e4fa179192f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_aa715392-05b8-489a-b4c2-775306a02ff0" xlink:href="rdnt-20201231.xsd#rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized_aa715392-05b8-489a-b4c2-775306a02ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_2ea81f2e-9ab6-4c4c-9d22-9bf451dc9eeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_2ea81f2e-9ab6-4c4c-9d22-9bf451dc9eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_3d9f5e4f-ebcd-41bd-b5c6-07d7f1cfdc56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_3d9f5e4f-ebcd-41bd-b5c6-07d7f1cfdc56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_ab982d3d-2e06-40c1-9b78-8d270328fa59" xlink:href="rdnt-20201231.xsd#rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized_ab982d3d-2e06-40c1-9b78-8d270328fa59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_8ac3a32a-12fc-41f7-8591-bd369c2f6064" xlink:href="rdnt-20201231.xsd#rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod_8ac3a32a-12fc-41f7-8591-bd369c2f6064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6195ab37-848d-455a-b567-f8bafcc87c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_b41cdb9d-5fe9-4e46-99b6-d500c4a06941" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_6195ab37-848d-455a-b567-f8bafcc87c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities" xlink:type="simple" xlink:href="rdnt-20201231.xsd#NCOMETAXESDetailsDeferredtaxassetsandliabilities"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_39b9e4f7-da6b-4787-a3f6-23faccf45693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_47889aa8-3960-4214-b266-83b9627341ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39b9e4f7-da6b-4787-a3f6-23faccf45693" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_47889aa8-3960-4214-b266-83b9627341ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8accc512-f6be-4d9c-8e14-eb6508d00cc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_47889aa8-3960-4214-b266-83b9627341ff" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8accc512-f6be-4d9c-8e14-eb6508d00cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_735dedcb-3843-41e1-a497-e3578304d813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_47889aa8-3960-4214-b266-83b9627341ff" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_735dedcb-3843-41e1-a497-e3578304d813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_0bf944d8-2cc7-4a26-91b5-a316139c4264" xlink:href="rdnt-20201231.xsd#rdnt_DeferredTaxAssetsOperatingLeaseLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_47889aa8-3960-4214-b266-83b9627341ff" xlink:to="loc_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities_0bf944d8-2cc7-4a26-91b5-a316139c4264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_5d15bedf-3b39-4d09-a14a-3e8f798cc9ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_47889aa8-3960-4214-b266-83b9627341ff" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_5d15bedf-3b39-4d09-a14a-3e8f798cc9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_29d6bf48-fb77-4b04-9b17-1b453e8e6079" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_47889aa8-3960-4214-b266-83b9627341ff" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_29d6bf48-fb77-4b04-9b17-1b453e8e6079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_b869e990-f5e8-466b-93e5-ee9437d5c60f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_47889aa8-3960-4214-b266-83b9627341ff" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_b869e990-f5e8-466b-93e5-ee9437d5c60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4cd15745-4353-404f-8171-d14a75df9d63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_47889aa8-3960-4214-b266-83b9627341ff" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4cd15745-4353-404f-8171-d14a75df9d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7b4fcadf-9ce2-4f9f-bb4e-3cfcf5bbf901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_47889aa8-3960-4214-b266-83b9627341ff" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_7b4fcadf-9ce2-4f9f-bb4e-3cfcf5bbf901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_faaa8151-5f37-4e63-ae25-6b3ba2495955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_39b9e4f7-da6b-4787-a3f6-23faccf45693" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_faaa8151-5f37-4e63-ae25-6b3ba2495955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_c415d3b7-c0e7-44f2-83ba-18724aecc368" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_faaa8151-5f37-4e63-ae25-6b3ba2495955" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_c415d3b7-c0e7-44f2-83ba-18724aecc368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_a2cc56e7-5406-4e65-90cd-49c3c1566895" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_faaa8151-5f37-4e63-ae25-6b3ba2495955" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill_a2cc56e7-5406-4e65-90cd-49c3c1566895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_fe21a435-95c2-4fff-864b-c15844ac1d56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_faaa8151-5f37-4e63-ae25-6b3ba2495955" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_fe21a435-95c2-4fff-864b-c15844ac1d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_bc3ab85b-3173-446e-a8b9-b00cf7f5ba77" xlink:href="rdnt-20201231.xsd#rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_faaa8151-5f37-4e63-ae25-6b3ba2495955" xlink:to="loc_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets_bc3ab85b-3173-446e-a8b9-b00cf7f5ba77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_45f42aab-bdda-4067-a2da-fc76f23a2eb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_faaa8151-5f37-4e63-ae25-6b3ba2495955" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_45f42aab-bdda-4067-a2da-fc76f23a2eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_7ef7286d-9e80-4ebd-a276-d47ef63f26ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_faaa8151-5f37-4e63-ae25-6b3ba2495955" xlink:to="loc_us-gaap_DeferredTaxLiabilities_7ef7286d-9e80-4ebd-a276-d47ef63f26ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_b75a61ea-0491-4dfd-a54d-6357a168ff6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_faaa8151-5f37-4e63-ae25-6b3ba2495955" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_b75a61ea-0491-4dfd-a54d-6357a168ff6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit" xlink:type="simple" xlink:href="rdnt-20201231.xsd#INCOMETAXESDetailsUnrecognizedtaxbenefit"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a429df82-bd6e-40b4-8bd3-7f9d5383823e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5fa62d08-a83d-4a5c-9d50-a90cefcd8e87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a429df82-bd6e-40b4-8bd3-7f9d5383823e" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5fa62d08-a83d-4a5c-9d50-a90cefcd8e87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_30512bde-a3fa-4d20-8c1d-1e79cc0e617c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5fa62d08-a83d-4a5c-9d50-a90cefcd8e87" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_30512bde-a3fa-4d20-8c1d-1e79cc0e617c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_44ed688a-d411-4031-a973-fdac11a5b463" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5fa62d08-a83d-4a5c-9d50-a90cefcd8e87" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_44ed688a-d411-4031-a973-fdac11a5b463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0fded2c2-5472-4279-ac49-28e0bf6d2abc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5fa62d08-a83d-4a5c-9d50-a90cefcd8e87" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_0fded2c2-5472-4279-ac49-28e0bf6d2abc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_91c87452-fdf5-43c3-ba7f-05fbc8f013e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5fa62d08-a83d-4a5c-9d50-a90cefcd8e87" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_91c87452-fdf5-43c3-ba7f-05fbc8f013e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ed5347ee-006b-40f8-bf04-f7dd310a9e4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5fa62d08-a83d-4a5c-9d50-a90cefcd8e87" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ed5347ee-006b-40f8-bf04-f7dd310a9e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_def3fe84-7e3f-477d-9cb8-1534d03983d4" xlink:href="rdnt-20201231.xsd#rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5fa62d08-a83d-4a5c-9d50-a90cefcd8e87" xlink:to="loc_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate_def3fe84-7e3f-477d-9cb8-1534d03983d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_6d578212-e827-465f-9111-8e211dad1cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_5fa62d08-a83d-4a5c-9d50-a90cefcd8e87" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_6d578212-e827-465f-9111-8e211dad1cfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67a394de-9854-4896-a576-36fb3904fbc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_26394082-9166-4754-8c1b-f63fb0d9a3a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67a394de-9854-4896-a576-36fb3904fbc0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_26394082-9166-4754-8c1b-f63fb0d9a3a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6e9f88c2-ed0e-40e5-8cab-b190cc588086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f599eaa3-aa62-4bc2-9763-0527b69e1651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6e9f88c2-ed0e-40e5-8cab-b190cc588086" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_f599eaa3-aa62-4bc2-9763-0527b69e1651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_364e8a8c-9d84-4b62-bc57-02fbaa323a79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6e9f88c2-ed0e-40e5-8cab-b190cc588086" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_364e8a8c-9d84-4b62-bc57-02fbaa323a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91ebc29e-f06e-4949-8688-c197b61d9115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_91ebc29e-f06e-4949-8688-c197b61d9115" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_40a09dbd-bc33-4bb3-a781-d7de595ac075" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_40a09dbd-bc33-4bb3-a781-d7de595ac075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed584d0e-45f9-41eb-9382-ffca8227708b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_40a09dbd-bc33-4bb3-a781-d7de595ac075" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed584d0e-45f9-41eb-9382-ffca8227708b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthIncMember_73d129e5-4573-4019-8a83-d426805b1b24" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ed584d0e-45f9-41eb-9382-ffca8227708b" xlink:to="loc_rdnt_DeepHealthIncMember_73d129e5-4573-4019-8a83-d426805b1b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_03dd3eb9-8993-489f-8e4a-e70318b52b9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:to="loc_us-gaap_PlanNameAxis_03dd3eb9-8993-489f-8e4a-e70318b52b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fcad15c7-1e60-489f-89e5-3417eca41f93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_03dd3eb9-8993-489f-8e4a-e70318b52b9b" xlink:to="loc_us-gaap_PlanNameDomain_fcad15c7-1e60-489f-89e5-3417eca41f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_RestatedPlanMember_9ed1d281-21ab-4a3b-b6eb-649f61f412f4" xlink:href="rdnt-20201231.xsd#rdnt_RestatedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fcad15c7-1e60-489f-89e5-3417eca41f93" xlink:to="loc_rdnt_RestatedPlanMember_9ed1d281-21ab-4a3b-b6eb-649f61f412f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_1a3dba60-c91e-4d25-8ffb-34ca7198e92a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:to="loc_us-gaap_AwardTypeAxis_1a3dba60-c91e-4d25-8ffb-34ca7198e92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f77645b2-8f0a-4b1b-b7dd-d655c4bb475e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_1a3dba60-c91e-4d25-8ffb-34ca7198e92a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f77645b2-8f0a-4b1b-b7dd-d655c4bb475e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_f86bc376-db9a-42f8-9f31-f4fa19481186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f77645b2-8f0a-4b1b-b7dd-d655c4bb475e" xlink:to="loc_us-gaap_StockOptionMember_f86bc376-db9a-42f8-9f31-f4fa19481186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_d999fbd1-6d66-4a22-8956-1b0c836bd319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f77645b2-8f0a-4b1b-b7dd-d655c4bb475e" xlink:to="loc_us-gaap_RestrictedStockMember_d999fbd1-6d66-4a22-8956-1b0c836bd319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_FutureServiceMember_18ebf882-0433-44d9-9ba4-522f120ca443" xlink:href="rdnt-20201231.xsd#rdnt_FutureServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f77645b2-8f0a-4b1b-b7dd-d655c4bb475e" xlink:to="loc_rdnt_FutureServiceMember_18ebf882-0433-44d9-9ba4-522f120ca443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fbcf9c2a-83a7-41ac-8f8b-71c244f25dbc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:to="loc_srt_RangeAxis_fbcf9c2a-83a7-41ac-8f8b-71c244f25dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f1a6334-ac99-445e-9f63-382c49bf40a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fbcf9c2a-83a7-41ac-8f8b-71c244f25dbc" xlink:to="loc_srt_RangeMember_6f1a6334-ac99-445e-9f63-382c49bf40a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1386346f-a4c9-4756-9219-d26143ecbb5f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f1a6334-ac99-445e-9f63-382c49bf40a6" xlink:to="loc_srt_MinimumMember_1386346f-a4c9-4756-9219-d26143ecbb5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9e3ff588-c55f-4886-82d2-9a772a63d45a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6f1a6334-ac99-445e-9f63-382c49bf40a6" xlink:to="loc_srt_MaximumMember_9e3ff588-c55f-4886-82d2-9a772a63d45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3d800d4-c3c9-4e35-ac60-734283a8b141" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c6d4a3db-4426-4e16-859a-c10e5272e8de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c6d4a3db-4426-4e16-859a-c10e5272e8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b77259fa-d370-4d74-820f-c66702493d5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b77259fa-d370-4d74-820f-c66702493d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6947c275-6c37-4ff9-8469-76176b28d86d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_6947c275-6c37-4ff9-8469-76176b28d86d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c4f9f33-d33c-4163-b08a-c0eb279abd85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3c4f9f33-d33c-4163-b08a-c0eb279abd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_caca8a87-6594-4576-9997-4c177f253d11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_caca8a87-6594-4576-9997-4c177f253d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_21a607a5-e696-4bf3-b52c-0d53f83bc33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_21a607a5-e696-4bf3-b52c-0d53f83bc33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_42684bf4-72a6-447f-bd59-33113905b9b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_42684bf4-72a6-447f-bd59-33113905b9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_96176883-021a-4615-a86a-359236b6d2dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_96176883-021a-4615-a86a-359236b6d2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6182a180-f3f0-4e7b-ade9-a973977ded39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6182a180-f3f0-4e7b-ade9-a973977ded39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AwardsIssuedToDate_2d2e67c0-3b9f-4e96-9f65-6e10356dc744" xlink:href="rdnt-20201231.xsd#rdnt_AwardsIssuedToDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_rdnt_AwardsIssuedToDate_2d2e67c0-3b9f-4e96-9f65-6e10356dc744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_24ee610e-3e16-4439-97f2-d8dd8a33acc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_24ee610e-3e16-4439-97f2-d8dd8a33acc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e3088b57-a530-459b-be17-903a0ed1f2fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e3088b57-a530-459b-be17-903a0ed1f2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5773c8bf-5857-4cde-8be3-f810f808f538" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_5773c8bf-5857-4cde-8be3-f810f808f538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_dab537f1-7d79-49be-bd12-4626643e973b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_dab537f1-7d79-49be-bd12-4626643e973b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_886fc893-a428-41e3-ae7c-36ad570a9af1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_886fc893-a428-41e3-ae7c-36ad570a9af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_53994aba-ae66-4423-8a81-83f7f3f33e52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e1b94321-4a8d-4660-91f6-0b1326712fea" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_53994aba-ae66-4423-8a81-83f7f3f33e52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd93c9f1-e7d0-40bf-a608-0b5c18ed1a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c53e4fd6-0e95-444a-95f8-59d0d88a0f6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bd93c9f1-e7d0-40bf-a608-0b5c18ed1a22" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c53e4fd6-0e95-444a-95f8-59d0d88a0f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_75978cf0-2c01-4ebb-92a0-7b43f2679ee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c53e4fd6-0e95-444a-95f8-59d0d88a0f6b" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_75978cf0-2c01-4ebb-92a0-7b43f2679ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16f760c5-f68c-473d-9280-3325be6c5717" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_75978cf0-2c01-4ebb-92a0-7b43f2679ee2" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16f760c5-f68c-473d-9280-3325be6c5717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_DeepHealthInc.Member_ad75aabb-88d2-45d4-a28f-206de27d287f" xlink:href="rdnt-20201231.xsd#rdnt_DeepHealthInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_16f760c5-f68c-473d-9280-3325be6c5717" xlink:to="loc_rdnt_DeepHealthInc.Member_ad75aabb-88d2-45d4-a28f-206de27d287f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_94a9e389-0126-42b4-8d98-be232f800602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c53e4fd6-0e95-444a-95f8-59d0d88a0f6b" xlink:to="loc_us-gaap_AwardTypeAxis_94a9e389-0126-42b4-8d98-be232f800602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98dcae35-2df5-4702-9a3f-3fbe08eacd5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_94a9e389-0126-42b4-8d98-be232f800602" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98dcae35-2df5-4702-9a3f-3fbe08eacd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_51f074e0-b51b-43a3-965e-f8e5561ecfbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_98dcae35-2df5-4702-9a3f-3fbe08eacd5c" xlink:to="loc_us-gaap_StockOptionMember_51f074e0-b51b-43a3-965e-f8e5561ecfbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c53e4fd6-0e95-444a-95f8-59d0d88a0f6b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a63ba56-5749-4387-808f-4e65c7c6c565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a63ba56-5749-4387-808f-4e65c7c6c565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_586cbfe5-c9c7-48ee-a069-ac4296d05a11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a63ba56-5749-4387-808f-4e65c7c6c565" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_586cbfe5-c9c7-48ee-a069-ac4296d05a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72cd88b6-4ca8-4d8e-9c92-7fc2a95e7d02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a63ba56-5749-4387-808f-4e65c7c6c565" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_72cd88b6-4ca8-4d8e-9c92-7fc2a95e7d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0d5961f9-91d8-44cf-beaa-083ed10bf792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a63ba56-5749-4387-808f-4e65c7c6c565" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0d5961f9-91d8-44cf-beaa-083ed10bf792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1704f878-446f-4bc7-baef-310bfb4d9ab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_6a63ba56-5749-4387-808f-4e65c7c6c565" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1704f878-446f-4bc7-baef-310bfb4d9ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_271b7acf-b43b-4f77-9678-1cef18caffc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_271b7acf-b43b-4f77-9678-1cef18caffc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ad50259f-0573-4cf9-92b3-5d7ccf004f00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ad50259f-0573-4cf9-92b3-5d7ccf004f00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_65346056-e4c2-4391-a2f9-e160049d0059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ad50259f-0573-4cf9-92b3-5d7ccf004f00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_65346056-e4c2-4391-a2f9-e160049d0059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ad6ea65f-68a9-42d7-aa9c-e71ad98a92e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ad50259f-0573-4cf9-92b3-5d7ccf004f00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ad6ea65f-68a9-42d7-aa9c-e71ad98a92e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0dfa061c-f215-489a-a2fa-26f4ddc57b04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ad50259f-0573-4cf9-92b3-5d7ccf004f00" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0dfa061c-f215-489a-a2fa-26f4ddc57b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a34531a5-f478-478f-8808-d9c9b250e0ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a34531a5-f478-478f-8808-d9c9b250e0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_WeightedAverageRemainingContractualLife_a29eb070-da7b-40b3-9d95-ebfe28296a49" xlink:href="rdnt-20201231.xsd#rdnt_WeightedAverageRemainingContractualLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_rdnt_WeightedAverageRemainingContractualLife_a29eb070-da7b-40b3-9d95-ebfe28296a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d7154977-569d-4355-ab15-16bd7ae33d3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_a29eb070-da7b-40b3-9d95-ebfe28296a49" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_d7154977-569d-4355-ab15-16bd7ae33d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7fcf5675-8db6-49ba-87b4-be74c8e6d12f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_WeightedAverageRemainingContractualLife_a29eb070-da7b-40b3-9d95-ebfe28296a49" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_7fcf5675-8db6-49ba-87b4-be74c8e6d12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_AggregateIntrinsicValue_3cb683c3-e10b-4e15-b1d6-356b2cb68d0e" xlink:href="rdnt-20201231.xsd#rdnt_AggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9e59c75d-9927-4695-9dc2-0285b52c2c3e" xlink:to="loc_rdnt_AggregateIntrinsicValue_3cb683c3-e10b-4e15-b1d6-356b2cb68d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_85de7548-c930-431f-8622-ff4b5a9e1cc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_3cb683c3-e10b-4e15-b1d6-356b2cb68d0e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_85de7548-c930-431f-8622-ff4b5a9e1cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_b115f3f9-cb49-4cae-8ab9-d9b97d6a34fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rdnt_AggregateIntrinsicValue_3cb683c3-e10b-4e15-b1d6-356b2cb68d0e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_b115f3f9-cb49-4cae-8ab9-d9b97d6a34fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="simple" xlink:href="rdnt-20201231.xsd#STOCKBASEDCOMPENSATIONDetailsRSUs"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e11b58d8-6110-48a2-b45f-2e565d5fe8e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e91125c-c50d-4255-8d86-0001f89ad322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e11b58d8-6110-48a2-b45f-2e565d5fe8e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e91125c-c50d-4255-8d86-0001f89ad322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8534d9de-b6ae-4f04-b763-39f73217c494" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e91125c-c50d-4255-8d86-0001f89ad322" xlink:to="loc_us-gaap_AwardTypeAxis_8534d9de-b6ae-4f04-b763-39f73217c494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b227edb-84bd-4fd2-9406-fbc80220840f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8534d9de-b6ae-4f04-b763-39f73217c494" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b227edb-84bd-4fd2-9406-fbc80220840f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_ffb84282-746e-4726-965a-a75f508de9b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4b227edb-84bd-4fd2-9406-fbc80220840f" xlink:to="loc_us-gaap_RestrictedStockMember_ffb84282-746e-4726-965a-a75f508de9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_880051c8-5225-4ce7-93ef-34aca5d427d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8e91125c-c50d-4255-8d86-0001f89ad322" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_880051c8-5225-4ce7-93ef-34aca5d427d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_32f97ad2-5f4a-47f5-976d-7f310b6ecc8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_880051c8-5225-4ce7-93ef-34aca5d427d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_32f97ad2-5f4a-47f5-976d-7f310b6ecc8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_11428136-2904-443d-b6bc-17bcd85b15ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_32f97ad2-5f4a-47f5-976d-7f310b6ecc8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_11428136-2904-443d-b6bc-17bcd85b15ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_01bc2df7-c08d-40b8-97a3-2924faddb858" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_32f97ad2-5f4a-47f5-976d-7f310b6ecc8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_01bc2df7-c08d-40b8-97a3-2924faddb858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d1706981-d0e5-41a7-9471-b5650ef27222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_32f97ad2-5f4a-47f5-976d-7f310b6ecc8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_d1706981-d0e5-41a7-9471-b5650ef27222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_4e2ad2ec-796b-4f4e-924c-316c5d079327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_32f97ad2-5f4a-47f5-976d-7f310b6ecc8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_4e2ad2ec-796b-4f4e-924c-316c5d079327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_4f43c735-dac0-44c2-a247-a786903fc285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_880051c8-5225-4ce7-93ef-34aca5d427d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_4f43c735-dac0-44c2-a247-a786903fc285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7414a566-5cbb-44ec-be1f-5d099e068378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_880051c8-5225-4ce7-93ef-34aca5d427d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7414a566-5cbb-44ec-be1f-5d099e068378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_37233333-e145-4d85-893e-719cf4b3bcd4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7414a566-5cbb-44ec-be1f-5d099e068378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_37233333-e145-4d85-893e-719cf4b3bcd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1215f30e-35f9-44a8-8605-8b2ff58c2bc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7414a566-5cbb-44ec-be1f-5d099e068378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1215f30e-35f9-44a8-8605-8b2ff58c2bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_913deb4e-63dc-48c0-8b18-2686d90ccc5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7414a566-5cbb-44ec-be1f-5d099e068378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_913deb4e-63dc-48c0-8b18-2686d90ccc5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a0699c53-f58d-4d86-941f-288d58f762da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_7414a566-5cbb-44ec-be1f-5d099e068378" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a0699c53-f58d-4d86-941f-288d58f762da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUBSEQUENTEVENTS"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_8fd5249e-3631-40ba-9546-c6787a7a8277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_3c483073-da07-4752-a061-eb288c8cb658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_8fd5249e-3631-40ba-9546-c6787a7a8277" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_3c483073-da07-4752-a061-eb288c8cb658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative" xlink:type="simple" xlink:href="rdnt-20201231.xsd#SUBSEQUENTEVENTSDetailsNarrative"/>
  <link:presentationLink xlink:role="http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_41880d34-00d8-4a3b-8487-06e4747dd20a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_41880d34-00d8-4a3b-8487-06e4747dd20a" xlink:to="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b835e220-b534-49d2-8dd7-61e1e9f864c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b835e220-b534-49d2-8dd7-61e1e9f864c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1494bb4a-123d-426a-9c87-015b225d6db5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b835e220-b534-49d2-8dd7-61e1e9f864c6" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1494bb4a-123d-426a-9c87-015b225d6db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ZPCompaniesMember_5b4d775d-f7d1-427b-a134-3aa90455ab63" xlink:href="rdnt-20201231.xsd#rdnt_ZPCompaniesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1494bb4a-123d-426a-9c87-015b225d6db5" xlink:to="loc_rdnt_ZPCompaniesMember_5b4d775d-f7d1-427b-a134-3aa90455ab63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_a0f6946a-cd5a-43a0-822f-2c1ef7f1bf0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_a0f6946a-cd5a-43a0-822f-2c1ef7f1bf0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_a75ccdfc-32c9-4708-b753-558d962bb24f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_a0f6946a-cd5a-43a0-822f-2c1ef7f1bf0d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_a75ccdfc-32c9-4708-b753-558d962bb24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d63815c2-b932-4bdb-a10a-a8fc7b820644" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_a75ccdfc-32c9-4708-b753-558d962bb24f" xlink:to="loc_us-gaap_SubsequentEventMember_d63815c2-b932-4bdb-a10a-a8fc7b820644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_496f9537-e239-431c-ae2d-439030db5e9a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:to="loc_dei_LegalEntityAxis_496f9537-e239-431c-ae2d-439030db5e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9daffd36-f6b8-44d7-a42e-3bfa10319285" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_496f9537-e239-431c-ae2d-439030db5e9a" xlink:to="loc_dei_EntityDomain_9daffd36-f6b8-44d7-a42e-3bfa10319285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiAdventistMember_5e1e649c-0349-45a9-8f23-8983ecc66f3b" xlink:href="rdnt-20201231.xsd#rdnt_SimiAdventistMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9daffd36-f6b8-44d7-a42e-3bfa10319285" xlink:to="loc_rdnt_SimiAdventistMember_5e1e649c-0349-45a9-8f23-8983ecc66f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_baade897-538b-4c3c-9261-5913e7e6c651" xlink:href="rdnt-20201231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9daffd36-f6b8-44d7-a42e-3bfa10319285" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_baade897-538b-4c3c-9261-5913e7e6c651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_d7e67fb1-d1a6-486a-aeac-813e2440f6ba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:to="loc_srt_OwnershipAxis_d7e67fb1-d1a6-486a-aeac-813e2440f6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_45e3077e-ad1c-4c74-883f-84326f3ff643" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_d7e67fb1-d1a6-486a-aeac-813e2440f6ba" xlink:to="loc_srt_OwnershipDomain_45e3077e-ad1c-4c74-883f-84326f3ff643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_SimiValleyImagingGroupLLCMember_81356e34-d42b-4c40-84d3-3add3e23e709" xlink:href="rdnt-20201231.xsd#rdnt_SimiValleyImagingGroupLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_45e3077e-ad1c-4c74-883f-84326f3ff643" xlink:to="loc_rdnt_SimiValleyImagingGroupLLCMember_81356e34-d42b-4c40-84d3-3add3e23e709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3e22011f-a2a4-4164-99dd-85584bc4c24a" xlink:to="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_71db9126-21e0-4881-b347-25efd0937e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_71db9126-21e0-4881-b347-25efd0937e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_6534fae0-9485-44c4-9393-85f29867419a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_6534fae0-9485-44c4-9393-85f29867419a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_25e0ef39-ecac-4641-850d-353807c0190a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest_25e0ef39-ecac-4641-850d-353807c0190a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0ed2370e-d95c-4212-be19-f217d0647d96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_0ed2370e-d95c-4212-be19-f217d0647d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct_57a3aee2-9a87-41b9-b2fe-141168dae714" xlink:href="rdnt-20201231.xsd#rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_a651caa8-7ed2-4ebc-9bc2-5c9c6456da01" xlink:to="loc_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct_57a3aee2-9a87-41b9-b2fe-141168dae714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>rdnt-20201231_g1.jpg
<TEXT>
begin 644 rdnt-20201231_g1.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@#
MP 3* P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ ^/?V'_V'_P!N3_@KK^W)\=_A1\*/V[O$'@C_ (0CQ!J%^[ZM
MX@U.6*6)]3FA6*-891MVX^F.*^P/^(3;_@J9_P!)=O\ RH:Y_P#'J/\ @TV_
MY2F?M=_]O'_I\GK]_J /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_T
MEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O
M_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH
M:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?
M_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZ
MOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_
MJ* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@
M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\
M27;_ ,J&N?\ QZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV
M_P#*AKG_ ,>H_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M$%_C?^U=\:Y;T>&?!?QKU6\U&/3+<2W,Y;1] BBAB0D R22R1QKN95!<%F4
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M!^S7+X@T#QGHVAZCJ/A8>+EM;O2TU2!)(0LIM72XV.X1CB/J& /('+_LX?\
M!<#XN_M5_&_X&^$_A'_P3/\ B--\-_B_X9^WW_Q;NIY!I6B7BV;33VP9;4K-
M%!,OV9YY'@WN',22*JEP#]":*_,#X:?\'#OQ>^./Q]^.O[*/P4_X)J:KXB\?
M_ W^V$U:&V^)UI%I=RVF7LEI<NUU/:QM%&7C/EA8Y))&91Y:+ODC^B_^"-7_
M  5;\&?\%>_V4[K]HCP]\,KCP9JFB^)9]"\1^&I]4%ZMO<QPPSK)%.(XS+$\
M4\9!,:$,'7!VAF /K2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y
M _X+\?\ *&S]H3_LG\W_ *.BK^,*O[/?^"_'_*&S]H3_ +)_-_Z.BK^,*@#]
M_O\ @TV_Y2F?M=_]O'_I\GK]_J_ '_@TV_Y2F?M=_P#;Q_Z?)Z_?Z@ HHHH
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M/VE[N_T'4_&<NNS>"M%72IY[WQ"]SJRW=K;V4,:%KB:>"9'C11\PR<X4D?T
M51E\+^&9_$$7BV?P[8OJL$!@@U-[1#<1Q$DE%DQN"G)X!QR: /P"_P"#6;XH
M?#;P3_P2+_:YC\8^/M&TI[!KZ]O4U#4HH6@MY-%\F.5@S A&E!C5NA?Y1D\5
MB_\ !"W]L#0?V1_^#:[]IWXFV'PNT#XDZWX:^*-Y=7'P[UJW2\MYK6]L-!LD
MNKZUY9[)&\Z23( 9;:5=RX++_1+39H8KB)H)XE='4JZ.N0P/!!!ZB@#^3O\
M;Y^/_A3X^?LE?L;?M07WBKQEK6J6?C+4D^(>H3^$;S2?"OAB1;BP:VT31K9(
M8].BB@@MY219AG< /,Y;:J??/_!T3XCTZU_:]_82_:[N8;R+X<:=XR6[U'Q5
M/I\T5O:1?VCI-V/.#H&B9K>.214<*S")\ [&Q^X<FA:)+80Z5+HUHUK;LAM[
M9K=3'$4(*%5QA=I QCICBI-0TW3M6M38ZK807,+,"T-Q$'4D'(.",<$ CW%
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M?VAO#7BF?X(ZOX9M] UOQ!X6U._L9;!PE_;7,0N+"6.>-XX[J.[$:.IF59$
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MHP)_:?G^)(9(9;"5S\UP%99HFCRX*AUSM->@_P#!+S]I?XJ?\&XO_!3WQ/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?('_!?C_E#9^T)_V3^;_P!'
M15_&%7]GO_!?C_E#9^T)_P!D_F_]'15_&%0!^_W_  :;?\I3/VN_^WC_ -/D
M]?O]7X _\&FW_*4S]KO_ +>/_3Y/7[_4 %%<S\:OBKX<^!'P;\6_'#QC#<R:
M1X-\,W^N:K'9Q;YFMK2WDN)1&N1N<I&V!GDXKX\_9Y_;I_;D^-ESIGQU\/>$
M/AYX@\$^(_"G@'Q / >D2W2W^BZ;X@O+N*6>/4QO2]GM8426:)K>%'\EUC:,
MJ6D /NFBOF?]N;XR?\%'?AQH'B3QI^QK\$_AEJ>C^"=$?4M3;XCZ]>PW7B)H
MX3/+;:?':)LAVQ@*)[B0!YBR>6J)YK[G@K]OWP!K7_!.'1?^"C?C?PQ=>&]$
MU3X;6OBN70=0ND6>)I[=)(K-9'VJ[R2.D4;D*',B' W8 ![Y17R_^Q%\7O\
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M-_Z.BK^,*O[/?^"_'_*&S]H3_LG\W_HZ*OXPJ /W^_X--O\ E*9^UW_V\?\
MI\GK]_J_ '_@TV_Y2F?M=_\ ;Q_Z?)Z_?Z@#)\>:CX-T?P-K.K?$66R3P]:Z
M3<S:Z^I(K6RV2Q,TYE# @Q^6&W @C&<U^1/C[X9?$S_@@9^U!X^^._[$ET=8
M_9QLE\'R?%+X,:[=/<7&D0:SJNHVD5SH5PP,D:P7+;A:,65S=RY)^5H_UT^(
M7@'PA\5? .N?"_X@Z)'J>@>)-'N=*US39G94N[.XB:&:)BI# -&[*2"#SP17
M@/@__@EC^SMX<^*:>/?$FM^,/%FDZ;!H1\,^$_&/C+4=4L],N=*DNY+6X?[3
M<.UZT;76Z(7/F^2\8=#OPR@'8_MX_LM>.?VQ?V;O$7P&\!_M+>)OAA<Z[ILU
MI+K/ANPL;@7"2+M,%PES"[- PR'6&2%V5F4O@D'QW_@G3:7?_!1__@DUX'T7
M_@HA\(/"_BBXU.&\TOQ/I$^D1?V7JK:7JMQ9V]]' JJB+(+2*X38JJ"P:,*N
MS'JGB[_@GI\ O&7QO\1_'J^\1?$>RU3QA:P0>*M*T3XK:Y8:5JBPP)!&9+.W
MNTB4B)%4[ H8%MP;>V=;]H+]AS]G/]I+X+>'_@%XU\*W^D>'?".I6.H>$(O!
M.NW6@SZ%<V<;Q6TEI+821-#Y<;NBJ#M /3@8 /DO]F;]B:3_ ()W_P#!2;7/
MV8/V,O$FJZ=\%?BG\%M8\2WGP]N]5FNK+P5XBMK^SM8;RT:5G>WBNUNY1Y6<
MLUM(P)6%4C\5_8JU.P^&G_!H7X]\'^,8CI>J>&/@]\3_  UX@TVX4)+8ZL;[
M6K<V\BYX<RS1\=3Y@[G%?J+\&/V?/AG\!K&[B\#6FJ7-_J?E?VOX@\2>(+S5
M]5U'R@PC$][>RRSRJFY]D9?9'O8(JAB*XKQ'_P $]_V5_%7B[5O$VL>!;QK+
MQ%XGA\2^)?"<.NW<>A:SK,1C,=_=:<L@MYY=T,+MN0I(\222*[HK  B_X)E^
M ?%_PK_X)R? 7X:_$"TFM]<T'X.>&K#5K6X!#V]Q%IENDD+9Y!1@4Q_LU[A1
M10 5Y;^VQ?WVE_LI>.=0TR]FMKB+0W:*>"0HZ'<O(8<@UZE7E'[<_P#R:/X]
M_P"P"_\ Z&M ';?#6UM;GX<Z!<7%M')))HEHTCN@)8F%222>IK;_ +.T_P#Y
M\8?^_0K(^%W_ "3/P[_V K3_ -$I6[0!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\
M9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A
M1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9V
MG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/
M_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ
M%']G:?\ \^,/_?H5-10!$EC91L'CLXE8="L8!%2T44 ?('_!?C_E#9^T)_V3
M^;_T=%7\85?V>_\ !?C_ )0V?M"?]D_F_P#1T5?QA4 ?O]_P:;?\I3/VN_\
MMX_]/D]?O]7X _\ !IM_RE,_:[_[>/\ T^3U^_U !1110 4444 %%%% !111
M0 5Y1^W/_P FC^/?^P"__H:UZO7E'[<__)H_CW_L O\ ^AK0!W7PN_Y)GX=_
M[ 5I_P"B4K=K"^%W_),_#O\ V K3_P!$I6[0 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\@?\%^/^4-G[0G_
M &3^;_T=%7\85?V>_P#!?C_E#9^T)_V3^;_T=%7\85 '[_?\&FW_ "E,_:[_
M .WC_P!/D]?O]7X _P#!IM_RE,_:[_[>/_3Y/7[_ % !1110 4444 %%%% !
M1110 5Y1^W/_ ,FC^/?^P"__ *&M>KUY1^W/_P FC^/?^P"__H:T =U\+O\
MDF?AW_L!6G_HE*W:POA=_P DS\._]@*T_P#1*5NT %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_P#!?C_E#9^T)_V3^;_T=%7\85 '[_?\&FW_ "E,_:[_ .WC_P!/D]?O]7X
M_P#!IM_RE,_:[_[>/_3Y/7[_ % !1110 4444 %%%% !1110 5Y1^W/_ ,FC
M^/?^P"__ *&M>KUY1^W/_P FC^/?^P"__H:T =U\+O\ DF?AW_L!6G_HE*W:
MPOA=_P DS\._]@*T_P#1*5NT %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\^?\%*O^
M":O[./\ P5&_9QOOV??V@M#V2)ON/"WBFSB4W_AZ_P!N%N;=CU!X$D1.V1?E
M."%9?X]/^"AW[!'QL_X)K_M3Z_\ LJ?'=;*75-)"7&GZIILX>VU2PER8+N/^
M) Z@Y1P&1@RD<9/]K'[2'[0'PV_95^ OB[]H[XOZP+'PUX+T&XU75I^-QCB0
ML(T!(W2.VV-%ZL[JHY-?F5^R_P#\$7O /_!4G]AOXA?M-?\ !1WPC):?%K]I
M[74\9Z;K4,>=0\!Z>D31:%9VI< [(K1@7B;'F),(Y/FC5E /YZO^"<G_  3D
M_:._X*=_M':?^SO^SMX>WR/MN/$?B.\C86&@6&X![NY<#@#HJ#YI&PJ@D\?U
M-_L]_P#!NG_P2;^"G[.6A_ /Q;^R7X3\>W>FVY.K>-O%.CH^KZK=. 99FN$Q
M)$A(^2%&"1K@#)W,WL7_  36_P"":O[./_!+G]G&Q_9]_9]T/?(^RX\4^*;R
M)1?^(;_;AKFX8= .1'$#MC7Y1DEF;Z#H ^!=1_X-I?\ @E/IU]+K'P6^'_CS
MX7:A,V][_P"'/Q4UFR</_>"R7$J*>G 4#CI4'_#DO]HCX=_-^S;_ ,%P/VI]
M V?ZBV\=>);3Q5;0^BK%=0Q_*/0FOT!HH _/[_AE3_@X?^%O/P^_X*K?"'XG
MK'_JH?B=\$4T?>.P=])D9C_O=3UH_P"%]_\ !R+\*_\ D>_V!?V=/BL(OO?\
M*R^*=YH1F'^S_;"-M)]Z_0&B@#\_C_P6+_;?^' S^TC_ ,$&/VAM+\O_ %__
M  K&]TWQEMQUV_97BW_AUIT?_!RC_P $X_"\BP_M#Z#\9/@_(6"O'\3/@WJU
MH8V]&^S13@?G7W_221QS1M%+&K(RD,K#((/4$4 ?+'PP_P""W_\ P2+^+_EK
MX._X*&_"Z)Y@/+B\0>)H](D8GH-E_P"2V?;&:^A?A_\ &+X1_%FS_M#X6?%/
MPYXFM]N[S_#^N6]ZF/7="[#%<3\3_P!@G]AOXV&1OC#^QO\ "WQ0\OWYM>\
M:==29]0\D)8'W!S7SU\0?^#<?_@C#\0[O^U9_P!B/2-#OE;=;WWA'Q!J>CO
M_P#>1;.YC0$>ZD>U 'V]17Y_?\0^_P ._!/[W]F[_@I+^UM\,O+_ -1IWA_X
MT33Z>/0/;W4,F\#L"]'_  [D_P""S_PR/F? _P#X+MZAJ]K'_J]%^)_P1TG4
MO,]-][&ZS#T.%YSF@#] :*_/[S/^#FGX5GY[;]D7XK6$73RWU[0]3FQ]<VRY
MH'_!23_@LG\-/W?QT_X(/:SJ5M'_ *S6/AC\:M(U;S?799LBS#Z%N: /T!HK
M\_O^(@_X5>"3Y7[2?_!.K]K/X7;/]??^*/@K/+8#U*3VLLGF*/4**Z?X>?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO^"!7_! KX=_\$L/AW%\9_C/::?XA^.OB'3]NKZN@$MOX:MW&6T^R8]6[2W
MYD(VKB,?/^DM !1110 4444 %%%% !1110 4444 ?('_  7X_P"4-G[0G_9/
MYO\ T=%7\85?V>_\%^/^4-G[0G_9/YO_ $=%7\85 '[_ '_!IM_RE,_:[_[>
M/_3Y/7[_ %?@#_P:;?\ *4S]KO\ [>/_ $^3U^_U !1110 4444 %%%% !11
M10 5Y1^W/_R:/X]_[ +_ /H:UZO7E'[<_P#R:/X]_P"P"_\ Z&M '=?"[_DF
M?AW_ + 5I_Z)2MVL+X7?\DS\._\ 8"M/_1*5NT %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M]):* "BBB@ HHHH **** "BBB@ HHHH **** /D#_@OQ_P H;/VA/^R?S?\
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M0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\
M?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!
ML45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2
MT?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+
M0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\
M?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!
ML45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2
MT?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+
M0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\
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MLWOB#PU\.OB9)J%J='MO".M7DT\EU?,TXN$N+6&]NH&MUB9I7CB\LF-V>/\
M2VB@#E/@3\(/"_[/GP0\'? 3P.'_ +%\$^%M/T'2?-QO-M9VT=O$6QQG9&N?
M>NKHHH *\H_;G_Y-'\>_]@%__0UKU>O*/VY_^31_'O\ V 7_ /0UH [KX7?\
MDS\._P#8"M/_ $2E;M87PN_Y)GX=_P"P%:?^B4K=H **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_
M-_PMG_@JQ_P6@O/';_Z;\$?V,;N33=$.=UMKWQ&G0?:)AV<:=$%0 \QSA'4E
M937N_P#P6'_;<\3_ +$W['=[J/P<LCJ7Q9^(>K6W@OX.Z%" TU[XAU!C% ZJ
M3@B%2\QS\I,:J2-XKLO^":G[$?AG_@GM^QGX-_9DT6^&H:EIEFUYXNUYB6DU
MG6[EO.OKQW;YGWS,P4L2PC6-<_** /=Z*** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#Y _P""_'_*&S]H3_LG\W_HZ*OXPJ_L]_X+\?\ *&S]
MH3_LG\W_ *.BK^,*@#]_O^#3;_E*9^UW_P!O'_I\GK]_J_ '_@TV_P"4IG[7
M?_;Q_P"GR>OW^H **** "BBB@ HHHH **** "O*/VY_^31_'O_8!?_T-:]7K
MRC]N?_DT?Q[_ -@%_P#T-: .Z^%W_),_#O\ V K3_P!$I6[6%\+O^29^'?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9OC
M/QCX6^'?@_5?'_CC7;;2]%T/39]0U?4[R39%:6L,;22S.W95168GL :^ _\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC^/?^P"__H:T =3\,_%GAN'X<>'X9=8A5DT2T5E)Z$0IQ6Y_PF/AC_H-0?\
M?59_PPL+%OAKX>9K*(DZ':$DQCG]RE;G]G:?_P ^,/\ WZ% %/\ X3'PQ_T&
MH/\ OJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z% %/_ (3'
MPQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3
M'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_
M^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\
MWZ% %/\ X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\
M^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\ \^,/_?H4?V=I
M_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']
MG:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\
MWZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^JN?V=I_
M_/C#_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G
M:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY
M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
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M^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\
M0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\
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M#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\
M0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'P
MQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&H/\
MOJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z% 'GG[27[5_P6
M_97^ GB[]HOXK>*HK;P_X-T*XU/4FC.9)%C4E8HQ_%)(^V-%_B=U'>OE'_@A
MY\(_$VE?";Q=_P %"_VI)(8/C%^TUKJ^+/$5O,27T/10I71]'0MR(X+4JV"
MP,H1LF,&N3_X*)06W_!3'_@I!\._^"2GAB!)_AS\.OLGQ)_:4F@4>7<0Q.&T
M?P_(1P3<2E9Y8C@F(QR*<QFOT<CTK3(8UBBTV!54 *JPJ  .@ Q0!4_X3'PQ
M_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4
M_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C
M#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\
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MQ[_V 7_]#6@#NOA=_P DS\._]@*T_P#1*5NUA?"[_DF?AW_L!6G_ *)2MV@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"?\
M9/YO_1T5?QA5_9[_ ,%^/^4-G[0G_9/YO_1T5?QA4 ?O]_P:;?\ *4S]KO\
M[>/_ $^3U^_U?@#_ ,&FW_*4S]KO_MX_]/D]?O\ 4 %%%% !1110 4444 %%
M%% !7E'[<_\ R:/X]_[ +_\ H:UZO7E'[<__ ":/X]_[ +_^AK0!W7PN_P"2
M9^'?^P%:?^B4K=K"^%W_ "3/P[_V K3_ -$I6[0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC=M !^OU%?@#_P 1SG_6+K_S-G_WEH_XCG/^L77_ )FS_P"\M '[_45^0/\
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M_P"31_'O_8!?_P!#6O5Z\H_;G_Y-'\>_]@%__0UH [KX7?\ ),_#O_8"M/\
MT2E;M87PN_Y)GX=_[ 5I_P"B4K=H **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHJMK.L:3X=TB[\0:]J4%E8V-M)<7MY=2A(H(D4L\CL>%55!))X
M% 'Q#_P7(_:&^)5M\)O"/_!.C]F#5C#\7OVG=:?PGH=S"26T30@@;6=7?:0R
MI#:%ER"&!E++DQD5]7?LS_L\_#7]DW]G_P '_LV?!_2!9>&_!6@V^E:5%@;W
M2) &ED( W2R/ND=NK.[,>37Q#_P21T?5OV_?VLOB?_P6P^(^F3C1-?,O@/\
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M\#/^YF_]1C5J_K]H **** "BBB@ HHHH **** "BBB@#Y _X+\?\H;/VA/\
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M_B-\>?BSX<\&:!;?Z[6/%&M06-LIQG;YDS*I8]E!R>P- &E]B\;_ /0;LO\
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M8[]M[_1/V!/^"=5M\'O"=W_J/BA^T_>/9W+1'^.'0K0M<!MOS(\C/&V1G H
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MCPSJ C*3>(S:&[U>X!'S>9?W)DN&!Y)7?MY. *]ZHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_L!6G_HE*W:POA=_R3/P[_V K3_T2E;M !1110 4444 %%%% !1110 4444
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M<\$Z?X<\+^'-/CL=$T32X!'!:0(,!5'<]26.69B68DDD]%110 4444 %%%%
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M^'/P]^%OAZ+PC\,O FC>'-)@_P!1IF@Z7%9V\?&/ECB55' '05LT44 %%%%
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MHK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\
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M_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH
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M  2#\>?&3XMZ;^VM_P %COB;8?&+XH63_:/"OP^LX&7P3X"R=PBLK)^+N=>
M;F<$DJIPS(LI^^P !@"L?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$
MEU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z%"]_[Z6C_A)=7_Z%
M"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\ OI: -BBL?_A)=7_Z
M%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
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M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
M"2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L4
M5C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?
M\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C
M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
M"2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L4
M5C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C_P#"2ZO_ -"A>_\ ?2T?
M\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\ "2ZO_P!"A>_]]+0!L45C
M_P#"2ZO_ -"A>_\ ?2T?\)+J_P#T*%[_ -]+0!L45C_\)+J__0H7O_?2T?\
M"2ZO_P!"A>_]]+0!L45EV>O:E<W203>&;J%6;#2NRX7W-:E 'R!_P7X_Y0V?
MM"?]D_F_]'15_&%7]GO_  7X_P"4-G[0G_9/YO\ T=%7\85 '[_?\&FW_*4S
M]KO_ +>/_3Y/7[_5^ /_  :;?\I3/VN_^WC_ -/D]?O]0!S/QIN_B=8?!SQ;
M??!/2;6_\9P>&;^3PC8W\RQP7.IBW<VL<CM\JHTPC!8\ $DU^;7[:WP!^*?_
M  4Z^)&O_#&P_8\\4^!O'JCX;ZGI_C?Q7-IJ-\-Y++5M4N;V]@NK:ZE^U2-
M)((DM2XD>13(8E7<OZET4 ?(/_!:+X*?M!_M#?LS>&OAM^SG\#M4\;:Q:?%;
MPOX@N[>PUG2[)(+/3M4ANYRSW]W "Q2-@JKNRQ&<#FO:?VF/CG\;O@Q\*])^
M(_P@_9%\2?$V_FUNU@U[P?HNOZ=9ZGIVGR+(9KJ/[1*(+J2)EC7R%F7?YF0X
M"DUZK10!\Y_#_P"#7B7X^_M<:3^VY\5?@U?^!H_#7PXU'PEX8\,^([BRFU6[
M34;NTN;NYO!93SP11J+*&.&(3.W[^X:18R56OE[PI^Q'^UG\"?\ @F)\1/\
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M@T[2M*LTM[:UB7A8XXHP%11V50 * /@'P[_P10^*W[7.N6?Q._X+2_M>ZO\
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M[=17,^%OC5\&_')4>"OBUX9U@N?D_LO7K>XW?3RW.>A_*NFH **** "BBB@
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MO;UI9T)/)".HST P*^DZ* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH ^0/^"_'_*&S]H3_ +)_-_Z.BK^,*O[/?^"_
M'_*&S]H3_LG\W_HZ*OXPJ /W^_X--O\ E*9^UW_V\?\ I\GK]_J_ '_@TV_Y
M2F?M=_\ ;Q_Z?)Z_?Z@ HHHH **** "BBB@ HHHH *\H_;G_ .31_'O_ & 7
M_P#0UKU>O*/VY_\ DT?Q[_V 7_\ 0UH [KX7?\DS\._]@*T_]$I6[6%\+O\
MDF?AW_L!6G_HE*W: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG6]^)WP8\7^.KA6W"X\8?%77KAB_=B([N-23[C%>C>"_^"#7_!';P%M_L/\
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M110 4444 %%%% !1110 4444 ? '_!T=_P H*/CG_P!RS_ZD^DU_(%7]>O\
MP=+:KI=G_P $-?C7IMWJ5O%<7;>&EM+>295>8KXETIF"*3EL*"3CH 37\A5
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MO\.^$=$M_P#4:/X8T6"PM8^,<10(J#\JZ.B@ HHHH **** "BBB@ HHKP?\
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M_P"AK7J]>4?MS_\ )H_CW_L O_Z&M '=?"[_ ))GX=_[ 5I_Z)2MVL+X7?\
M),_#O_8"M/\ T2E;M !1110 4444 %%%% !117R!_P %ZOVH_CM^Q=_P2>^*
MW[2_[-'CG_A&O&WAK^PO[$UO^S+6\^S?:-=T^UF_<W44L+[H9Y4^9#C=D88
M@ ^OZ*_D"_XBCO\ @NO_ -'S?^8R\,?_ "LH_P"(H[_@NO\ ]'S?^8R\,?\
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M ) GPE_9*^%-G)]__A)->UO7+^$?['V0"!F'^UQ7WSJ>L:3HMN;O6-4MK2(
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M'ZD_Q%T9= &G^-/$?C;5M3O(_/U_3K:7Y;BY:'+132H3Y><.?;'\W=?U'?\
M!<3_ (*Q?\$A?VOO^"8GQ9_9D\/?\%!M!DU;7=.L)]/B\*:-)J]W<SV6J6EZ
MD$43/;Q,96MA'N:= BN9/FV[6_EQH **** /Z%?^"'&B?\%4?VV_^"6WPO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD_P_NZ_V%X&UJ[V9ZX^TL,X[9ZY.>U0C_@WI^'=EQX:_X*I?MNZ,%_U0TO\
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M#"?8?"UI#M&,<;(QCCCZ5^%G_!R#_P &VT>E1Z[_ ,%!?^"=_P /PMJHDO\
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M]U),=/\ 3;KS;C_R)UKVO_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y
M^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\
M MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\
M"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**
MQ_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0
M?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!
M](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F
M]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?
MF]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH
M V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"V
MH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL
M?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2
M/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](
M_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_
M\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_
M ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ
M-BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_
MX0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\
MA!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^
M?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y
M^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\
M MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\
M"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**
MQ_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0
M?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!
M](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F
M]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH V**Q_\ A!](_P"?
MF]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"VH_X0?2/^?F]_\"VH
M V**Q_\ A!](_P"?F]_\"VH_X0?2/^?F]_\  MJ -BBL?_A!](_Y^;W_ ,"V
MH_X0?2/^?F]_\"VH V**R[/PEIMC=)=PW%T6C;*A[EB/Q%:E 'R!_P %^/\
ME#9^T)_V3^;_ -'15_&%7]GO_!?C_E#9^T)_V3^;_P!'15_&%0!^_P!_P:;?
M\I3/VN_^WC_T^3U^_P!7X _\&FW_ "E,_:[_ .WC_P!/D]?O]0!C_$+P#X0^
M*O@'7/A?\0=$CU/0/$FCW.E:YILSLJ7=G<1-#-$Q4A@&C=E)!!YX(KP'P?\
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MZO7E'[<__)H_CW_L O\ ^AK0!W7PN_Y)GX=_[ 5I_P"B4K=K"^%W_),_#O\
MV K3_P!$I6[0 4444 %%%% !1110 5\@?\%ZOV7/CM^VC_P2>^*W[-'[-'@;
M_A)?&WB7^PO[$T3^T[6S^T_9]=T^ZF_?74L4*;88)7^9QG;@98@'Z_HH _D"
M_P"(7'_@NO\ ]&,_^9-\,?\ RSH_XA<?^"Z__1C/_F3?#'_RSK^OVB@#^0+_
M (A<?^"Z_P#T8S_YDWPQ_P#+.OZ/O^""O[+GQV_8N_X)/?"G]FC]I?P-_P (
MUXV\-?V[_;>B?VG:WGV;[1KNH74/[ZUEEA?=#/$_RN<;L'# @?7]% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7\@7_  <B_P#!2+_A
MXA_P4<U[_A"M>^U_#WX9>;X7\$>3+NAN?*D/VR_7'!\^X#;7'WH8H/2OZO?V
MJOA3\1_CI^SCXT^#/PD^,'_"O_$/BGP_<:7I_C1=&.H/I'GKY<D\< G@+2B-
MGV'S%V.5?G;M/X@_\0,?_647_P PG_\ ?J@#\ :_0?\ X-K/^"D7_#O7_@HY
MH>G^-M>^R?#WXI^5X7\9^=+MAM9))/\ 0;]L\#R;A@K.>%AGG-?>_P#Q Q_]
M91?_ #"?_P!^J/\ B!C_ .LHO_F$_P#[]4 ?O]17!_LO_##XC_!3]GCP;\(/
MBY\7O^$^\1>&?#]OIFI^-&T<V#ZPT*"-;F2 SS;)615WGS&W/N;C=M'>4 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 ?('_!?C_E#9^T)_P!D_F_]'15_&%7]
MGO\ P7X_Y0V?M"?]D_F_]'15_&%0!^_W_!IM_P I3/VN_P#MX_\ 3Y/7[_5^
M /\ P:;?\I3/VN_^WC_T^3U^_P!0 4444 %%%% !1110 4444 %>4?MS_P#)
MH_CW_L O_P"AK7J]>4?MS_\ )H_CW_L O_Z&M '=?"[_ ))GX=_[ 5I_Z)2M
MVL+X7?\ ),_#O_8"M/\ T2E;M !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"?]D_F_\ 1T5?
MQA5_9[_P7X_Y0V?M"?\ 9/YO_1T5?QA4 ?O]_P &FW_*4S]KO_MX_P#3Y/7[
M_5^ /_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110 5Y1^W/\
M\FC^/?\ L O_ .AK7J]>4?MS_P#)H_CW_L O_P"AK0!W7PN_Y)GX=_[ 5I_Z
M)2MVL+X7?\DS\._]@*T_]$I6[0 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!\@?\ !?C_ )0V?M"?]D_F_P#1
MT5?QA5_9[_P7X_Y0V?M"?]D_F_\ 1T5?QA4 ?O\ ?\&FW_*4S]KO_MX_]/D]
M?O\ 5^ /_!IM_P I3/VN_P#MX_\ 3Y/7[_4 %%%% !1110 4444 %%%% !7E
M'[<__)H_CW_L O\ ^AK7J]>4?MS_ /)H_CW_ + +_P#H:T =U\+O^29^'?\
ML!6G_HE*W:POA=_R3/P[_P!@*T_]$I6[0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\@?\%^/^4-G[0G_9/Y
MO_1T5?QA5_9[_P %^/\ E#9^T)_V3^;_ -'15_&%0!^_W_!IM_RE,_:[_P"W
MC_T^3U^_U?@#_P &FW_*4S]KO_MX_P#3Y/7[_4 %%%% !1110 4444 %%%%
M!7E'[<__ ":/X]_[ +_^AK7J]>4?MS_\FC^/?^P"_P#Z&M '=?"[_DF?AW_L
M!6G_ *)2MVL+X7?\DS\._P#8"M/_ $2E;M !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"?\
M9/YO_1T5?QA5_9[_ ,%^/^4-G[0G_9/YO_1T5?QA4 ?O]_P:;?\ *4S]KO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 ?('_  7X_P"4-G[0G_9/YO\ T=%7\85?V>_\%^/^4-G[0G_9
M/YO_ $=%7\85 '[_ '_!IM_RE,_:[_[>/_3Y/7[_ %?@#_P:;?\ *4S]KO\
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MO$?Q9OOB#\0?&/B?P"E_IWBC4+^:26_MFL4N$:RMW+0JGDS&6..U1?,9F=R
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MB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\
M@,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_
M (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_
M .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-
M_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V**
M ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_
M .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH
MQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'
M_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\
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MB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\
M@,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_
M (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_
M .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-
M_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V**
M ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 ?('_  7X_P"4-G[0G_9/YO\ T=%7\85?V>_\
M%^/^4-G[0G_9/YO_ $=%7\85 '[_ '_!IM_RE,_:[_[>/_3Y/7[_ %?@#_P:
M;?\ *4S]KO\ [>/_ $^3U^_U !1110 4444 %%%% !1110 5Y1^W/_R:/X]_
M[ +_ /H:UZO7E'[<_P#R:/X]_P"P"_\ Z&M '=?"[_DF?AW_ + 5I_Z)2MVL
M+X7?\DS\._\ 8"M/_1*5NT %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1?\ P O/_C- 'T917SG_ ,/;O^"='_1TFB_^ %Y_\9H_X>W?\$Z/^CI-%_\
M "\_^,T ?1E%?.?_  ]N_P""='_1TFB_^ %Y_P#&:/\ A[=_P3H_Z.DT7_P
MO/\ XS0!]&45\Y_\/;O^"='_ $=)HO\ X 7G_P 9H_X>W?\ !.C_ *.DT7_P
M O/_ (S0!]&45\Y_\/;O^"='_1TFB_\ @!>?_&:/^'MW_!.C_HZ31?\ P O/
M_C- 'T917SG_ ,/;O^"='_1TFB_^ %Y_\9H_X>W?\$Z/^CI-%_\  "\_^,T
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MX>W?\$Z/^CI-%_\  "\_^,T ?1E%?.?_  ]N_P""='_1TFB_^ %Y_P#&:/\
MA[=_P3H_Z.DT7_P O/\ XS0!]&45\XO_ ,%</^"<T:%V_:CT? _NZ?>D_D(*
M4?\ !6__ ()SD C]J/1N?6PO/_C- 'T;17SG_P /;O\ @G1_T=)HO_@!>?\
MQFC_ (>W?\$Z/^CI-%_\ +S_ .,T ?1E%?.?_#V[_@G1_P!'2:+_ . %Y_\
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M_&: /HRBOG/_ (>W?\$Z/^CI-%_\ +S_ .,T?\/;O^"='_1TFB_^ %Y_\9H
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M /\ @IA^PM\4O&NF?#OP#^T3I.I:UK-VEKIEA%:72M/,QPJ O$%!)]2*]UH
M^0/^"_'_ "AL_:$_[)_-_P"CHJ_C"K^SW_@OQ_RAL_:$_P"R?S?^CHJ_C"H
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M:H_X9?\ V:?^C>/ O_A)6?\ \:KN:* .&_X9?_9I_P"C>/ O_A)6?_QJO%?
M_P"S_P# :X_;K\<^'+CX)>$9-/MO!6F2V]@_ANU,,4C.VYU0Q[58]R!DU]1U
MS>F?"GPCI'Q1U3XP6<,XUK5]-@L;UVG)C,,1)0!.QR>O>@#*_P"&7_V:?^C>
M/ O_ (25G_\ &J/^&7_V:?\ HWCP+_X25G_\:KN:* .&_P"&7_V:?^C>/ O_
M (25G_\ &J/^&7_V:?\ HWCP+_X25G_\:KN:* .&_P"&7_V:?^C>/ O_ (25
MG_\ &J/^&7_V:?\ HWCP+_X25G_\:KN:* .&_P"&7_V:?^C>/ O_ (25G_\
M&J/^&7_V:?\ HWCP+_X25G_\:KN:* .&_P"&7_V:?^C>/ O_ (25G_\ &J/^
M&7_V:?\ HWCP+_X25G_\:KN:* .&_P"&7_V:?^C>/ O_ (25G_\ &J/^&7_V
M:?\ HWCP+_X25G_\:KN:* .&_P"&7_V:?^C>/ O_ (25G_\ &J/^&7_V:?\
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M (25G_\ &J[FB@#AO^&7_P!FG_HWCP+_ .$E9_\ QJC_ (9?_9I_Z-X\"_\
MA)6?_P :KN:* .&_X9?_ &:?^C>/ O\ X25G_P#&J/\ AE_]FG_HWCP+_P"$
ME9__ !JNYHH X;_AE_\ 9I_Z-X\"_P#A)6?_ ,:H_P"&7_V:?^C>/ O_ (25
MG_\ &J[FB@#AO^&7_P!FG_HWCP+_ .$E9_\ QJC_ (9?_9I_Z-X\"_\ A)6?
M_P :KN:* .&_X9?_ &:?^C>/ O\ X25G_P#&J/\ AE_]FG_HWCP+_P"$E9__
M !JNYHH X;_AE_\ 9I_Z-X\"_P#A)6?_ ,:H_P"&7_V:?^C>/ O_ (25G_\
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M_P#&J[FB@#AO^&7_ -FG_HWCP+_X25G_ /&J/^&7_P!FG_HWCP+_ .$E9_\
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M .&_X9?_ &:?^C>/ O\ X25G_P#&J/\ AE_]FG_HWCP+_P"$E9__ !JNYHH
MX;_AE_\ 9I_Z-X\"_P#A)6?_ ,:H_P"&7_V:?^C>/ O_ (25G_\ &J[FB@#A
MO^&7_P!FG_HWCP+_ .$E9_\ QJC_ (9?_9I_Z-X\"_\ A)6?_P :KN:* .&_
MX9?_ &:?^C>/ O\ X25G_P#&J/\ AE_]FG_HWCP+_P"$E9__ !JNYHH X;_A
ME_\ 9I_Z-X\"_P#A)6?_ ,:H_P"&7_V:?^C>/ O_ (25G_\ &J[FB@#AO^&7
M_P!FG_HWCP+_ .$E9_\ QJC_ (9?_9I_Z-X\"_\ A)6?_P :KN:* .&_X9?_
M &:?^C>/ O\ X25G_P#&J/\ AE_]FG_HWCP+_P"$E9__ !JNYHH X;_AE_\
M9I_Z-X\"_P#A)6?_ ,:H_P"&7_V:?^C>/ O_ (25G_\ &J[FB@#AO^&7_P!F
MG_HWCP+_ .$E9_\ QJO+_P!M#]G?]G_0/V6/&^LZ%\#/!UE>6^B.]O=6GABT
MCDB;<O*LL8*GW%?1-8GQ(^'WASXJ^!=3^'?BZ*5]-U:V,%XL$I1RA(/##H>*
M .&^&W[,_P"SA=_#O0+JZ_9^\$2RRZ+:O)))X4LV9V,*DDDQY))[UM_\,O\
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M_P#XU1_PR_\ LT_]&\>!?_"2L_\ XU7<T4 <-_PR_P#LT_\ 1O'@7_PDK/\
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M_L]_X+\?\H;/VA/^R?S?^CHJ_C"H _?[_@TV_P"4IG[7?_;Q_P"GR>OW^K\
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M!">,]<TZZO3<ZWIFD:?I]B%\Z[O;^^@LK>)=Q &99T+,3A4#,>%-?CK^U/\
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MOAW:Z-;:'86X3P_>>#!=K(^I:+(&=KE+B^*O</(VY"MO$JKY4@H _1BBBB@
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M@^X[[7D#E(W*(^TUZU<7%O9V\EW=SI%%$A>661@JHH&223P !WKXC_X+;?\
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M?_!0OX,MH=LLFB_LWZW?^*/%^OHG"ZQ=6 M]/T:*0=9=DQO;A!_JXX[0,/\
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M,DC0VT%O#%$BM([$AW9BTAKUZB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]IFABE;RE#0O]>44 %%%% !1110 4444 %%%% 'R!_P7X_Y0V?M"?]D_F_\
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MK'_"C_B-Y_99_P"C'OB!_P"%%8_X4 ?M]17X@_\ $;S^RS_T8]\0/_"BL?\
M"C_B-Y_99_Z,>^('_A16/^% '[?45^(/_$;S^RS_ -&/?$#_ ,**Q_PH_P"(
MWG]EG_HQ[X@?^%%8_P"% '[?45^(/_$;S^RS_P!&/?$#_P **Q_PH_XC>?V6
M?^C'OB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\**Q_PH_XC>?V6?\ HQ[X
M@?\ A16/^% '[?45^(/_ !&\_LL_]&/?$#_PHK'_  H_XC>?V6?^C'OB!_X4
M5C_A0!^WU%?B#_Q&\_LL_P#1CWQ _P#"BL?\*/\ B-Y_99_Z,>^('_A16/\
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M>?V6?^C'OB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\**Q_PH_XC>?V6?\
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M7X@_\1O/[+/_ $8]\0/_  HK'_"C_B-Y_99_Z,>^('_A16/^% '[?45^(/\
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M%% !1110 5^(/_![S_R:S\#_ /LH&H_^D(K]OJ_$'_@]Y_Y-9^!__90-1_\
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M6?\ HVKX?_\ A&V/_P :H_X9/_99_P"C:OA__P"$;8__ !JN_HH X#_AD_\
M99_Z-J^'_P#X1MC_ /&J/^&3_P!EG_HVKX?_ /A&V/\ \:KOZ* . _X9/_99
M_P"C:OA__P"$;8__ !JC_AD_]EG_ *-J^'__ (1MC_\ &J[^B@#@/^&3_P!E
MG_HVKX?_ /A&V/\ \:H_X9/_ &6?^C:OA_\ ^$;8_P#QJN_HH X#_AD_]EG_
M *-J^'__ (1MC_\ &J/^&3_V6?\ HVKX?_\ A&V/_P :KOZ* . _X9/_ &6?
M^C:OA_\ ^$;8_P#QJC_AD_\ 99_Z-J^'_P#X1MC_ /&J[^B@#@/^&3_V6?\
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M (1MC_\ &J/^&3_V6?\ HVKX?_\ A&V/_P :KOZ* . _X9/_ &6?^C:OA_\
M^$;8_P#QJC_AD_\ 99_Z-J^'_P#X1MC_ /&J[^B@#@/^&3_V6?\ HVKX?_\
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M !JC_AD_]EG_ *-J^'__ (1MC_\ &J[^B@#@/^&3_P!EG_HVKX?_ /A&V/\
M\:H_X9/_ &6?^C:OA_\ ^$;8_P#QJN_HH X#_AD_]EG_ *-J^'__ (1MC_\
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M6?\ HVKX?_\ A&V/_P :KOZ* . _X9/_ &6?^C:OA_\ ^$;8_P#QJC_AD_\
M99_Z-J^'_P#X1MC_ /&J[^B@#@/^&3_V6?\ HVKX?_\ A&V/_P :H_X9/_99
M_P"C:OA__P"$;8__ !JN_HH X#_AD_\ 99_Z-J^'_P#X1MC_ /&J/^&3_P!E
MG_HVKX?_ /A&V/\ \:KOZ* . _X9/_99_P"C:OA__P"$;8__ !JC_AD_]EG_
M *-J^'__ (1MC_\ &J[^B@#@/^&3_P!EG_HVKX?_ /A&V/\ \:H_X9/_ &6?
M^C:OA_\ ^$;8_P#QJN_HH X#_AD_]EG_ *-J^'__ (1MC_\ &J/^&3_V6?\
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MG\??V-W^+6A_L+_MRZ'X3F\'?$[P??WUM-XXBC_LN>[M;JVB%I)+-^ZAF<7
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M]AKL\T<$6G/;&T\\W!FEBC**A*O*BG!90?FK]EK]HO\ X(Y?MS_&[X4_'?\
M9^\1^)_B!\1_!EIJ&J:9-XD\=>([NX^'%I<63)J$^H+?W;P6BL$2U*MN$LC(
M4W(K2)XA\?OBO\(/V<_VQM,_X+O?#M= O_V<O$OCFV\(_$:WL=7,@OM2A%QI
MMOXZM[='\N26"26XL]@5Y7M=]R@/G;D /U]L[J*^M(KV%9%2:-719H6C< C(
MW(X#*?4$ CH0*DK.\)>+O"GC[PS8^-/ WB6PUG1]4MEN--U72[Q+BWNH6&5D
MCD0E74CH02#6C0 4444 %%%?.'[;W[$W[0G[5'BK0_$'P8_X*)_$CX*VNE:?
M);WNE^![.TEBU*1GW":4SJ2&4?*,<8H ^CZ*^ ?^'/W[=?\ TGI_: _\%.E_
M_$4?\.?OVZ_^D]/[0'_@ITO_ .(H ^_J*^ ?^'/W[=?_ $GI_: _\%.E_P#Q
M%?$__!=OPM^UQ_P2G_8[7Q]??\%MOCIXK\4>-=4_L+PQX2NX["U2\1D+7D[R
M1)YB1109!9,'S)H1D;L@ Y^P_P"#D7S_ /@XY?3SX]_XQ\FQ\+X_])_T/S!<
M?+KO7;SJ!*^;T^QMGJ*_?:OX Z_HL_X(7>$OVNO^"K7[' ^)=E_P6Z^.OA?Q
M1X0U5M"\5>$[6/3[I;+:H:UF225/,>*6#;AGR?,CF7+;"2 ?NA17P#_PY^_;
MK_Z3T_M ?^"G2_\ XBC_ (<_?MU_])Z?V@/_  4Z7_\ $4 ??U%? /\ PY^_
M;K_Z3T_M ?\ @ITO_P"(KZ/_ &(?V5_C/^ROX5US0/C/^VMXX^-5UJNH1W%E
MJGCBUMHI=-C5-IAB$  *L?F.><T 1?\ !33XU?'']G/]@#XM_'+]FOPW_:OC
MGPOX)O+_ ,/6WV/[3Y<J+\UQY6#YODH7FV$$-Y6"""17SA^S7/X%_;&^ GP]
M_:1_X)K_ /!1OXD^*+^T\;^%+OXE6FO>.WU-M6T]=4M'U6QU#3KPNFCRFU%R
MVRR2U!V;5#QR?-]>?M:_M"Z7^RE^S[K_ .T'KVD3WVG>&3:3ZG;6D#RS-:O=
MPQ3&*- 6DD$<CLB $LP4=Z_+'_@I9^SI^Q9X+U;PO_P49_X(M?&_P[X<_:1U
M?QEI-MX<\'_"GQ'#)9_$875]$EU:7>F6[%0JQ-+<3R;%0+!*9P6PZ 'V[_P7
M$_:;^+_[(7_!.GQ5\<O@YJU]I5Q8ZWHEIX@\0Z5:K->:-H]SJ5O;WMW;*ZLO
MG+#(RHS*0A</C*BN4^ '[6GPF_9T\=^,OB3XY_:,U^S_ &=/$@\/:9\(O$WQ
M1\0:AJ+Z[XC=;U]1?3;R_,EU-8S1'3Q#O=HY98[AK;]UU\3_ &H/VD/V</BO
M_P %@?BI^Q!_P5B\::-X3^#VE?".P/P?TGQWK*:7X>\13WMO_P 3357EG9(9
MKZ%I&MK<NQ\C[/,\067+UX1^P5^U[X _9+^(O@3]@O\ X*:?&(6OP6^$NNWO
MB3]E_P"+_BS0+NSTSQ[;0EX--\RZN(UC0:?%-<M%P8Y6>T>)PEO;O<@'V3_P
M6$^('Q.\-_%/]DR3X+?'GQSX.L?BK\>M)\*>*T\.ZY/:"_TBZMY92IAD!$$H
M\L8=420;F#9P,4OA_P#M$_M'?LR?\%R='_X)NGXW:[\4/AGX^^#T_C!(?%GV
M>YU7P3>03W$?-W#$DDUI-Y"*%N-[!YUVL #O\_\ ^"VWQ_\ V=_BCXM_8:OO
M$'C>RL=(UW]IW1-4:SUN\_L^Z.D/#/$M\\3LDUO XEA82.$*B9-VQL@?H!\#
MOV6/V8O@KXBUCXL?!3X8:-::YXQBADUSQA'(UYJ.L1*H\KS;Z9I)IXPN"JER
MHZ@4 >-?\%NO&GQ ^$W_  3"^+GQP^$7Q'\0>%/%G@SPNVI^'M;\/ZM);203
MK-$/G0'RYE*DJ5D5@ Q(PV&&AXGTWQ5:_P#!)>]\567Q7\7Q>*;?X)2>((?%
M_P#PDMT=1&K+HQN!=&3S.1YPWF''D]MFWBN,_P"#ACQKX/\ "7_!'7X[6?BG
MQ5IVG3:KX+>TTR&^O$B>[G:>%5BB5B#(Y+ ;5R>:X?Q5\"_^"8L/_!';4/CQ
M;_ _X&^1_P *#EFA\51>%M'RU_\ V&7&VX\O/VC?R!NW[O>@#TK_ ()6_'Q-
M-_X)/?"7]J']ISXRZUJVK^+?"6GZAXA\0>(]1GO;B^U"[DV106\"[B9))'2*
M*WMX]TC%%57=N?8/AS^WM^RC\3KOQUI>D_%(Z1J'PRLA?>/M(\9Z'?:!>Z'9
M&)IEO9[?4X8)5M6B5G%QM,1 /S<&ORQTOXJ:7X8_X(:_L,_M(:9<:MXH^'_P
M;\8:#J'QJM/ &M7"ZAH^F?V=J-A+>.UA*D\9M)KE79%96! )X!(]T\9?''_@
ME5XA^%'QW_;L_8\^$NH?M#ZKI'[/NIZ7X[UN]\5Z]JUG?:4S131>'[E]2EE7
M,@$L\B1HTMO%;R%PGG() #[5^$O[?_[*OQL^)&C?"/P/X]U./Q!XE\--XA\+
M6'B#P=JNCC7=+79NN[&2_M84O$42(Q\IF(5E<C:P8_+7[)O[3FK_ +.7QG_;
MR\<?&SQ]\1_''A?X5^/],FTK3ME[KU]96;:%!=O;6EO$K>5'YDKG"JD2 EY&
M559QX+X<_:6^ _BC_@I3^P'\6-$_:NTCQQ8ZAX,\=:9+/X5TJ.W\/:/=3:-I
M:VVB:;';QDK(KDH;6::XNXSY0E*[HQ7H/[.OC?P9\0OBW_P4^\+> O%NFZUJ
M=_?[K#3])OH[B>Y \(I;DQI&2S@3*T1(!^<%>O% $7[9O[=OB_\ :1_X)K_L
MX_MH^"_'?C?X:WVM_%SX=2>+K"QCU/0M/N+74KNVDNK8RW,<0U"S"MCS8W>!
MPI^8@D5]R_ +]OW]DO\ :=^*_B3X'?!?XJ-J7BOPI8PW^K:->Z!?Z?(UC*Y2
M.]MC=P1+>6K.-HN+<R1$E?F^9<_EK\3?VE?V</&7_!!3]C/PSI_Q?\-7K:+X
M_P#A)I>O0OJ,9BM[JSFM3?6LC,=GF6ZHQGCSNB5E,@4.I;ZEUGXJ_#N7_@Y=
M\(VFE?$/0I)-1_8UOK'9#JD#-/(_B6WN881ALEVC4RJHY*!F'RY- 'M?_!73
M]OW4/^"<O[&FH_&SP;X6M=>\:ZYKECX7^'.AWSE;>]UV^=DMQ*5()C14EF90
M076$J&4MN&O\/?V&O&%KX#M-1^+W[8?Q:UOXF262OJGC?2O'%S86<-\R@NUK
MHL9&E"!'R(XI[28[,"0R'+'Q_P#X.#?V2_C9^U/^POI6O_LY>&9=?\:_!_XF
MZ-\1M!\,6XS+K3:<)TEM8Q_%(8;F5U0 L[1A%!9@#[%\#?\ @JC^P+\>_A39
M?%7PQ^T_X/TY9XD74?#NOZ];V6KZ3=D /8W5E*XFBN5?*>5MRS ;-P*D@$?P
MF^-6I_LB? CP#\,/VX_C#>>)?B?K>IZMIUC+I6A3W^I^+9;>YN9C=VVGZ?%+
M(J?9!%.ZH@CMD=58H !5[5_^"GG["GA_]F35?VP]>^/]G8_#_0M6N=*UO5;W
M2;Z&YT_4+>7R9[*>Q> 7<-RDGRM \(D&5^7# GY]_;S_ &T/AGX&_:X_9ITG
MXLZ5HGPB;Q=9>+)]&^-OQ TRW6]\,6ZQ0(=/L6NU-O97VH1>0S"Z5O+1!$T+
MROM3X2\9?%_X2V'_  1=_P""D'PU/Q+DEUB7]I/Q3=PP>)%>UU&YBNKS2OLT
ML\<L<3)-/Y<S+&R(SF*7:F(W"@'Z[>"/^"E/[$OQ'O/'VG^"_CI:WTWPSOM-
ML_%R1Z3>CRKC42RV$5MNA']H/<.ICB6U\XR/A%!9E!Z/X%_MD_L\_M&>-O$_
MPP^&7C&]'BKP8T'_  D_A/Q%X;U#1=5T^.9=T$[V>H003&&1>4F5#&W9L\5\
M=_\ !7?QYH/A;]E/]G']KKP+I^I^)?@]\.OBOHFO?$.3X:ZC/'+;>'#I=]8_
MVC!+I\B2^5:/<QOMB<8P,X"DCT7]@[Q-_P $P_VA?VIM4_:?_88O]5^(/B<?
M#XZ+XI^*LWBW7M4@L[)KJWGMM'D?4YW1IG99)_+0&2!8#YGEB=!( 0_\%L?V
MP?$O['GPO^%?B'5?&?B'P=\,_$_Q:L=%^,'Q!\*6K27^@:))!.X,;JK-;+-<
M)#$]P@,D:,XBQ*\9'9_ 'X7:H_QI\"?'C]EG]L7Q1X\^!6M>%]474-!U/QR?
M$MD]^WV<V=_;ZC=/->.-JW4;PO<21AF0JD95L]9^VW^TY^SU\!!X*^'G[5>G
MZ&W@+XHZQ>>'-;O?%%JDNEVO^@S7*?;?-!B2V?R3$SRC8&D3<0,FO@WX!?LN
M_!W]B/\ X+*_#+P]_P $B?C.;SX:?$O2]>O_ (_?"3P_XF_M;0/#MM#:9L=5
M&UY!8O+=LD42N=S%&2+$7F*H!]]?%G_@HM^Q_P# W5IK#XI?%*YTNPL_$$6A
MZIXI/A?4YM!TS4I'5%M+O5HK9K&TDWNJ,)IDV.RJ^UF /2?&;]KCX#_ 76#X
M;\?>)-3GU:/0Y-:N-&\,>%M1UR]MM-1BK7LUOIMO/+#!N5E65U579&52S*17
MY2_LD?%W_@G/#^SMXU_X)G_\%5KKQW%\6M \>Z[8^*/A3>^+?% 7QXUWK=QJ
M-E=Z986ERL%W]J:>)U$:@M*#*0%<2'V#P#^U[\%_^":/_!63XY^#/V[]0B^&
M?A'XM_#_ ,#7GPB\0^)+B6YTUK/2-(-C>Z-]L(93)%<R32!6;Y_-=CS*F\ ^
MBOVB_P#@K_\ L_?"RT^!.J?":+6?'ND?'?Q9:67A[Q1X5\(ZGJNG)IY$LEQ(
M)+2%O-N]L$D:V:;KA7W.T6V)Q7M?Q"_;"^!/PRO['0O$6J^(;K6;_P /C74\
M-^'_  -J^JZM;Z:3M%U<6%E:RW-JF[*#SHT)=&C +J5'P=^W5XO_ &<OA%X'
M_8;^+W@?X=:5\(_@WH/[3B7%BMSI":)INEZ;<66KB"]FA*1K8QW3/]H E",!
M< R!7+J.K_9F^-_A_P" W_!:C]I&Y_:-\76_A[1?CMX)\$^(_@EXD\2S?8;3
M5M*TS398+VRA>X"!)X9[DRM;'$FV1Y"H!S0!]1>+O^"EG["W@C]G;0?VK]>_
M:/T(^ /%%W':>'_$%DLURM[</+Y(A6*%&E$@E/ENK(#&_P K[2"*Z/\ 9K_;
M,_9K_:^D\61_LZ_$M/$?_"#^(/[%\2M'IEU;+;7GE)*%0W$48GC:-U=)HM\3
MJ05=AS7X\?M+>&-"^%W_  2%_:I\=>,-9TO3?A[\6_VUXO$OPJL-1G2.WU30
MCXFTCS;VUCD/S6LWV>YG4*-C0*)E_=R G]R] U;0-?TBWU[POJ=G>V%[$LUK
M>V$R20SH0-KHZ$JP( P02, 4 7*_ ']OG_E<E^"O_<N?^D=Q7[_5^ /[?/\
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MLH? O7/'6H:'XTOKK5K30XD9[6%[0(KMN8<%N* /TL_9/_Y-9^&G_9/]&_\
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M?^C+/_,<6?\ \?H_X;Y_X/)?^C+/_,<6?_Q^@#]_J*_ '_AOG_@\E_Z,L_\
M,<6?_P ?H_X;Y_X/)?\ HRS_ ,QQ9_\ Q^@#]_J*_ '_ (;Y_P"#R7_HRS_S
M'%G_ /'Z/^&^?^#R7_HRS_S'%G_\?H _?ZJD6@:% GEP:):(INC<E4ME \\G
M)EZ??SSNZ^]?@9_PWS_P>2_]&6?^8XL__C]'_#?/_!Y+_P!&6?\ F.+/_P"/
MT ?OE?\ AWP_JFIVFM:GH5G<WFGLQL+N>U1Y;8L,,8V(RF1P<$9J>PL+'2K*
M'3-,LHK:VMXUC@MX(PB1H!@*JC@ #@ =*_ ;_AOG_@\E_P"C+/\ S'%G_P#'
MZ/\ AOG_ (/)?^C+/_,<6?\ \?H _?ZH)M,TVXTYM'N-/@DM'A,+VKQ QM&1
M@H5(P5QQCIBOP(_X;Y_X/)?^C+/_ #'%G_\ 'Z/^&^?^#R7_ *,L_P#,<6?_
M ,?H _?72-'TCP_ID.BZ#I=M8V=LFRWM+2!8HHE_NJJ@!1[ 5QGQE^ /A/XV
M>'])\"^)8[>'P[8:I!>WFEP:?'NNA"ZR1P"0_P"IB9EQ($7=(A*;E5F#?A[_
M ,-\_P#!Y+_T99_YCBS_ /C]'_#?/_!Y+_T99_YCBS_^/T ?O]17X _\-\_\
M'DO_ $99_P"8XL__ (_1_P -\_\ !Y+_ -&6?^8XL_\ X_0!^_U4M2\-^'=9
MO[/5-7T&RN[K3I#)I]S<VJ226SD8+1LP)0D<9&*_ [_AOG_@\E_Z,L_\QQ9_
M_'Z/^&^?^#R7_HRS_P QQ9__ !^@#]][C3--NKVWU*ZTZ"2XM-_V6XDA4O#N
M&&V,1E<C@XZBIZ_ '_AOG_@\E_Z,L_\ ,<6?_P ?H_X;Y_X/)?\ HRS_ ,QQ
M9_\ Q^@#]_J*_ '_ (;Y_P"#R7_HRS_S'%G_ /'Z/^&^?^#R7_HRS_S'%G_\
M?H _?ZBOP!_X;Y_X/)?^C+/_ #'%G_\ 'Z/^&^?^#R7_ *,L_P#,<6?_ ,?H
M _?ZBOP!_P"&^?\ @\E_Z,L_\QQ9_P#Q^C_AOG_@\E_Z,L_\QQ9__'Z /W^K
MY8_X+9?LX?&?]KG_ ()<?%W]G/\ 9Y\&_P#"0^,O%&CV<&A:-_:-M:?:9$U&
MUF8>;<R1Q)B.-VR[J/EP.2 ?RH_X;Y_X/)?^C+/_ #'%G_\ 'Z/^&^?^#R7_
M *,L_P#,<6?_ ,?H ^ /^(7'_@NO_P!&,_\ F3?#'_RSH_XA<?\ @NO_ -&,
M_P#F3?#'_P LZ^__ /AOG_@\E_Z,L_\ ,<6?_P ?H_X;Y_X/)?\ HRS_ ,QQ
M9_\ Q^@#VC_@U7_X)2?M]?\ !-SQ_P#&?6_VT?@+_P (9:^+-'T2#P_+_P )
M3I6H_:I+>6\:48L;J8IM$L?+A0=W&<''[+5^ /\ PWS_ ,'DO_1EG_F.+/\
M^/T?\-\_\'DO_1EG_F.+/_X_0!^_U%?@#_PWS_P>2_\ 1EG_ )CBS_\ C]'_
M  WS_P 'DO\ T99_YCBS_P#C] '[_57O](TK5(9K?4],M[F.X@,,Z3PJXDC/
M5&!'*GT/%?@3_P -\_\ !Y+_ -&6?^8XL_\ X_1_PWS_ ,'DO_1EG_F.+/\
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M#]_J*_ '_AOG_@\E_P"C+/\ S'%G_P#'Z/\ AOG_ (/)?^C+/_,<6?\ \?H
M_?ZBOP!_X;Y_X/)?^C+/_,<6?_Q^C_AOG_@\E_Z,L_\ ,<6?_P ?H _?ZBOP
M!_X;Y_X/)?\ HRS_ ,QQ9_\ Q^C_ (;Y_P"#R7_HRS_S'%G_ /'Z /W^K^?'
M_@X9_P""7?\ P7 _X*C_ +>=YXS^%/['=Q>_"[P3IZZ)\.VE^(GAVW%U#D27
M-^89M15XVGF)P'57\J* ,H92*T/^&^?^#R7_ *,L_P#,<6?_ ,?H_P"&^?\
M@\E_Z,L_\QQ9_P#Q^@#X _XA<?\ @NO_ -&,_P#F3?#'_P LZ^]?^#=W_@F!
M_P %O/\ @EQ^W=!XJ^+G['EQ8_"SQSIK:-\0WB^(?AZX%FBYDM-0$,.H-)(T
M$W!"*S>5/.%5F(%6O^&^?^#R7_HRS_S'%G_\?H_X;Y_X/)?^C+/_ #'%G_\
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MX;\4P16OB;P]8ZC%!.L\$=_:),L<J_==0X.&'8CD5^!__#?/_!Y+_P!&6?\
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M((]#530O#V@>%]-31_#.AV>G6D;$I:V-LD,:DG)(5  ,GFOP-_X;Y_X/)?\
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MCQ!8Q:_K]OH<%G96EE;P2HCLB2-C&[!(ZYH _H^HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /D#_@OQ_P H;/VA/^R?S?\
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MX4 ?M]17X@_\1O/[+/\ T8]\0/\ PHK'_"C_ (C>?V6?^C'OB!_X45C_ (4
M?M]17X@_\1O/[+/_ $8]\0/_  HK'_"C_B-Y_99_Z,>^('_A16/^% '[?45^
M(/\ Q&\_LL_]&/?$#_PHK'_"C_B-Y_99_P"C'OB!_P"%%8_X4 ?M]17X@_\
M$;S^RS_T8]\0/_"BL?\ "C_B-Y_99_Z,>^('_A16/^% '[?45^(/_$;S^RS_
M -&/?$#_ ,**Q_PH_P"(WG]EG_HQ[X@?^%%8_P"% '[?45^(/_$;S^RS_P!&
M/?$#_P **Q_PH_XC>?V6?^C'OB!_X45C_A0!^WU%?B#_ ,1O/[+/_1CWQ _\
M**Q_PH_XC>?V6?\ HQ[X@?\ A16/^% '[?45^(/_ !&\_LL_]&/?$#_PHK'_
M  H_XC>?V6?^C'OB!_X45C_A0!^WU%?B#_Q&\_LL_P#1CWQ _P#"BL?\*/\
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M]&/?$#_PHK'_  H_XC>?V6?^C'OB!_X45C_A0!^WU%?B#_Q&\_LL_P#1CWQ
M_P#"BL?\*/\ B-Y_99_Z,>^('_A16/\ A0!^WU%?B#_Q&\_LL_\ 1CWQ _\
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M%8_X4 ?M]17X@_\ $;S^RS_T8]\0/_"BL?\ "C_B-Y_99_Z,>^('_A16/^%
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M '[?45^(/_$;S^RS_P!&/?$#_P **Q_PH_XC>?V6?^C'OB!_X45C_A0!]_\
M_!?C_E#9^T)_V3^;_P!'15_&%7[I?\%'/^#M+]GC]MS]AWXE?LG^%OV2/&FA
?ZAXZ\-OIMIJVH:Y:20VKLZ-O=4&XCY>@]:_"V@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>rdnt-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rdnt="http://www.radnet.com/20201231"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rdnt-20201231.xsd" xlink:type="simple"/>
    <context id="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3f632fde5d0946eaae6fa48e47fe915a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibaa2464885764c41ae09dcb977e30937_I20210305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2021-03-05</instant>
        </period>
    </context>
    <context id="i36f65120df6f499e96c85073c30fef44_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1bc65197cb4a4267a98b35b45d061e65_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i91cab1d2676f4c75984b340531fdb510_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibeb4b5f80227407994e895e9fdf49c2c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i234d43f26e4d4788b2228afca82d6341_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCarePatientServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ic0cb6103e98c484a80f4c648cf9a807a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf8d37678bac4561b537c7457bdd558b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ife6ce5fe36734a9a814d0f68137a31b0_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CapitationArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i4c84452f39434559bef5a8d233042be6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ibb4c0755ae114d328c14dac7820d1e90_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i7dc4ab6f79444662b0f8c57ff6fbf123_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ic5e6c5ca93f94736bb1c3bfc63efbccf_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i023faad94c6344268f372203aa84692b_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="ibf6a4235673d476da3ca1a82e301b586_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i8189d3507f114e55b1eb07765a0f8fdb_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i4642cbc638c646e88712849889f662b5_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i6b406d963f1849e7bc859162bb04f9c4_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ided679c17b004e37bf6e8caf9a77bfb8_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if58d2cdaa8dc40528b9291019c26a4d5_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie3b1f19594f8442296a0ad23c159cb2f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i86f3f1e4adc845aa8ff6eecc119258e8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7d7d69f790144635b6dfa34118ab2074_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i2e34bb1f702e49a0b37e15b35cc7d11e_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ib1a562ce319b492e8ddb3e7f62714b25_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i09006b479cba4028a203556db5818971_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ibae6485d220c4366bf04745e679dee34_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i56a7504cf2d24b3c95f46157e23014d6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i74beb185d82c45bb93d9dce1efe2e18e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ica4a33e11a3249c8ad15dd466a5a1d51_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iaface0b8920a4f0488a80ec15c2e0796_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic7d78ac548ab47a6892df2497561bd63_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i86411c359d1a4e08bd83fa3becd2af69_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id8cb870c78c7468b82991b63a957577f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1fe1e680ce184c668d237cef4fa45980_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia696c9fb613641ca908b22d1a1b6fda4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6cc5dbf72ca544cd8fdd6e81e4269864_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i99f93a3af86d4cf18e3b0b79c87477e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iac2767be8a5846ac88dc5a19d3c5cdd0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia89915e83e8f47d7b74a40ecdf68fe96_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icd9fc193c5854fdc93bcf728fb8b4b34_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id4830b5a7c0d4df5923a89542ecd633a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia1cd86610d3e409eb7e61fdffe0b0402_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i416ef7c3fc3f4c4c990703d137b448b8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i19057998bb654587aa0fe2496a826358_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3baa465341b441d8ae234bdc7ac7a2c0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id829ecfe8db8402f80f8ee378ed8854e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i89e9405f6f814d8a9a3df0257feaca2a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i314621482e04419e975d6e27278101d0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iac06a801037b41eea48e4721682546dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ief57d143117e41c48907a4d78682dee8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-01</endDate>
        </period>
    </context>
    <context id="i0d288cd107d84361b2e08ab554ae5ed7_D20190801-20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-01</endDate>
        </period>
    </context>
    <context id="i46ed970e221a4949933067bb7c822615_I20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-01</instant>
        </period>
    </context>
    <context id="i1a886167e5d546978b5a20d615e9fc78_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="ida4995e095e84733a7a3db2b2c529f94_D20190801-20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-01</endDate>
        </period>
    </context>
    <context id="i3b935882b4d8429a874b97a0270ab625_I20190301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-01</instant>
        </period>
    </context>
    <context id="ib6d052daae794a8fac16e845d601f61e_D20190227-20190227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-27</startDate>
            <endDate>2019-02-27</endDate>
        </period>
    </context>
    <context id="i9a9e5ef103564deb822d473edf70473d_I20190227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-27</instant>
        </period>
    </context>
    <context id="i107a79c6ba52476ebe7de9b31052579f_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:NewJerseyImagingNetworkLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="i4ff1137ebe584b6e9251f4be6a157e86_I20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:NewJerseyImagingNetworkLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-01</instant>
        </period>
    </context>
    <context id="i0394c754617f470ca05634e5df485f1f_D20181001-20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MedicalArtsRadiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-01</endDate>
        </period>
    </context>
    <context id="iadcbd5b4c90e437fae076570fd592eab_I20181001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MedicalArtsRadiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-01</instant>
        </period>
    </context>
    <context id="id037acfdb2974904b3b0606b4fe20b4d_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MedicalArtsRadiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia978d78cb33c49d0b2db28864fec1dce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MedicalArtsRadiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5527d962127c4f0890eb1bf05ca35aac_D20180901-20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="ife75574fa4f34d78b8d99e90205c9f7b_D20180901-20180930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">rdnt:StockholdersEquityDeficitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-01</startDate>
            <endDate>2018-09-30</endDate>
        </period>
    </context>
    <context id="i7c749423cff34945b7292f9e192be48f_I20180101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2018-01-01</instant>
        </period>
    </context>
    <context id="i9bcc7eba5c6e48c898708be79cf90c04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:BeverlyRadiologyMedicalGroupIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i58b03b73c60d49f3939e2ad703919efe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">rdnt:BoardMemberMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:BeverlyRadiologyMedicalGroupIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7d60bb5091324738b842894a8d612608_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i80ff729336ff43a7b8f70a9e53ad3932_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4e0c5a3c996d40d6b9a18855f3170e9f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:ScriptSenderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9aa53910584d4308b3a9af105783ce91_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i59d8b9f6e0ef49d4a4d3fe5016d69357_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2a6ccbfae5264333868c009a4c975e8d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i891c10b64f17493bb11c320547b8151e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if13c433b6a59448e80ed8ed7eba74c84_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:CommercialInsurance1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ia42b0a40b551449aa8cf5aab61557ad1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i55ae38103bc54357bc2d68bf08c2da7f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie1d4292049a343c6bc7508d9b0441dfa_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicare1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i624a2cd5a57c45c195d9eea635adda77_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic586562cfaa14df5b15da5de1aa5bd11_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i44ff6aefd98947aea4638300eb0bc851_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:Medicaid1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie7d1f53911394e648410f42738dfedaa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idfb18a43c61343ecb86bc5802bdfcb00_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i066fe4ef9d6f479db95ce1cf95386477_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:WorkersCompensationPersonalInjury1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i614755c7eae243538ab15e0aa1c51f04_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8a20030cccbd4aa184a599982173e41c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0b5081b915b84065ab6982f64bd2cdc2_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCarePatientServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ie97dd2adff264063a2311999801b83cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6faacec13adc4cfaa3714f042eb08eca_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5b4058b6aea4480f93436186354111d6_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:HealthCareManagementServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="ib673d95e637f4dcdb5dc1061d5a63735_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia8efa81ad11b426eb95ebed781413689_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i411513ce21ff409cb97e6b96a1937d9b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i6e3cd3d7d43342508d2f3e021c52f178_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia05b082668734b48affdda6293f59c04_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8f11681d86e440a8a138ad9a36324ab1_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthCareOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i378af55f9d9f47e98887a9393d7f737d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id29d143ec6924d1587f745bf76712764_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id1db908b8572402e87b53c44f73c46c9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0c6d94c52f45408a9a65cb42ed24c2d7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iff9c306f9afc4473a51abdf18b8b4dee_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rdnt:PatientServicesNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ERADMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="id626261985f3405eb1ffba0c34b5000f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0d4beeb600334777869da4212f754cd3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:PropertyAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i924340cebec24f3d98853f0b12bf9470_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i235a1122e4214ab5937abc9704a2165a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ife26e87c47284440b905cc0d64ac26ec_I20201001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="ie584d839922d4a17968542922cbe6707_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if0aee577b90c4f58aa31701ba3a01b9b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReinsurancePolicyTypeAxis">rdnt:HealthInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic130af0a16044225945a7112208da137_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReinsurancePolicyTypeAxis">rdnt:HealthInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifce3d08cb6c9413a851bd3ff47c40964_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf9ac2491d4342e0b58df2c8c84ae62b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:BlueShieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icd66928c30e1473b9c9c069d01b5bdbb_I20061130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RadiologixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2006-11-30</instant>
        </period>
    </context>
    <context id="i964d58a775bd4fa199e750e6ee03db8e_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:PrimedexHealthSystemsInc.andRadiologixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="i40918c356ba546019d9cf3855b255d7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b4b71ee39b549678fe63c62bb7e85e5_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">rdnt:USAttorneysOfficeForTheWesternDistrictofNewYorkMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i50d9608d8beb4655b129134c49d35159_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">rdnt:USAttorneysOfficeForTheWesternDistrictofNewYorkMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i4d8112539b844f619adaf708f61bd146_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:Caps2016Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i67ac9c2904dc49e2ac4bc506d54d17e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:September2020CapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id90a9127362e454283d08c7e3fd0c691_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2020CapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i34ed4d9f350d499789b3e42719f10a5b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">rdnt:Caps2016Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i654a8e8ed7bb4f3bbb5cd9c288d0b69d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4ee370d9a22543fb9f2dab8cc9aa4803_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i79371fc04e834bfcaea740fd6bc52153_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="if60e961bba2a4bbfae302a70f01ee39d_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib856840ca6324eeba1a6b1494e0c38f1_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i61555f9eb90b46f688385e53cb2d0b54_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditDerivativesByContractTypeAxis">rdnt:October2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i0b6ec598f73740f98940d9eb5201b90a_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="if4f79b8708a34406aeaa4254bff7bf57_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i9921f768cd544944875eaeacb5eb5af9_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="iab09020dae044987a27d5a27395d9975_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SecuritiesFinancingTransactionAxis">rdnt:A2019SWAPS1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ifb0a905a8db84850b58584bad8c4af86_D20200701-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iccd401f36a0c470ea4320cd33aebeea3_D20231101-20251031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2025-10-31</endDate>
        </period>
    </context>
    <context id="icc5d103d5dec4837a37b5436811017d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46e5bfcb59a44381930228cdbedb0c73_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2fefeb1f7013464bbd2ec16f399ab7af_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iee473bf952d14518a4aa17edb183780b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic23c6521ea5a4ca0beeee403496fb2b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie3f8d60d96a441aba20d06c47362b2b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i565b0d00fc96454389f20aa5dbe8bf55_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9421b4c3defc4cf7b17e066a06b1caa7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ad49d0deed647c0a498c2366fc5efb5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3d6a973db2ba408383529fed3405f008_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i311a05ca14ed4565b8093ad84dc6c1f8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6a0f55d2766d408490715ca7893da207_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i50b5d4270b9a405a974ddd1764a0c39e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i75a252a681e34b079a5a7f189f4bf384_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i48064a0601f7427da1f6463f58e86cf6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc527a4818a643d49fe09cfa85c4c780_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2fe005478a77480f8ca9f42839c796df_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib5bf62651ffd4565b1634ab1e49d1658_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic953d4eafcbf4d7cb0bf03e5e5a554d1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4c602f38cb744dff881ca06c457467bc_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc5f93ef9014432796ae78b5a5f1277a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie29a29bde2bc4177a697491ea4430974_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie15c1fc805524eb3949f0526154afb88_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1092fa5159474e67b00fbddb2636707c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3f52dc1b8df24f608f50e003a77157f1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i95972ba545c2413db9a96bb8f5a78f19_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id37d5b32618d4989a2d4ae3321a56a10_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if56b240e264240e4b120a420105c6f77_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e91f8345bde4d118909d99c801fab52_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee2fd20ee7b4470a880084f9e273f9a5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie40d3a8fbcef47b19505b8259baa9c2d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a358573454349cf8e2a7aa01f671b00_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3bceea0558df4aa7a7b357ca906e3844_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if1c392fb7a5b4f1bb1f098f0d9a1675e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if76464750e804b1b92602d1d98c066fa_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i473019f6980c4551a0817c8df1b09e13_I20170324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-24</instant>
        </period>
    </context>
    <context id="i9ded1c2d91fb4066b0d52f289dbc6bf1_D20170324-20170324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-03-24</startDate>
            <endDate>2017-03-24</endDate>
        </period>
    </context>
    <context id="i2dbe4948ad594309b6b27c4836c67b68_D20180301-20180301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-01</endDate>
        </period>
    </context>
    <context id="i4843fa912a25453896424af36c06d915_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:MedicVisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id8e2a3314e2147c8878b4abe3dfe0373_D20180201-20180201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingSystemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-02-01</startDate>
            <endDate>2018-02-01</endDate>
        </period>
    </context>
    <context id="i5596086792694e92ace9a030c37a797a_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="ie5c53a008eee4b64b7e27857cbb84f0d_I20191011">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:TurnerImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-11</instant>
        </period>
    </context>
    <context id="ie7a0400670894eb7a7e0b89fd33e8d63_D20191105-20191105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:WhiteRabbit.aiInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-05</startDate>
            <endDate>2019-11-05</endDate>
        </period>
    </context>
    <context id="i39bb82566bf248d0b0fd688dde04dbe9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice6bd37091d347f3832020ccc4810992_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessCombinationSeparatelyRecognizedTransactionsAxis">rdnt:JointVentureMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:GlendaleAdvancedImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i84c20c51ca704a07878759c0f075f79e_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticRadiologyGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="ieef3f7dbd23c40ba8dec17264c4c7404_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:ArizonaDiagnosticRadiologyGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CHINationalServicesIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="ice510c28777843f7908e514b19c6921c_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i03c69569d3d64c1ca16e558b4cf75bee_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="idd3a6d6c4d174d43891d0ceddc82c6fa_I20170401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-04-01</instant>
        </period>
    </context>
    <context id="iacffbad6df7e4b20a00f3fce533dc4dc_I20170401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-04-01</instant>
        </period>
    </context>
    <context id="ied3dcc77eee243f38eab75f3a00f0e81_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:CedarsSinaiMedicalCenterMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i7b637d843dc04b2db741ddae2d1a65cd_D20190101-20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">rdnt:SantaMonicaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:RadNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-01-01</endDate>
        </period>
    </context>
    <context id="ie59b21d255d147928f8d589fb25170fa_D20141006-20141106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-10-06</startDate>
            <endDate>2014-11-06</endDate>
        </period>
    </context>
    <context id="i4c644318cb64465f94242234734b4336_I20180412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-12</instant>
        </period>
    </context>
    <context id="i92c0f7af41664881930d4f739dc6b4cb_D20180412-20180412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-12</startDate>
            <endDate>2018-04-12</endDate>
        </period>
    </context>
    <context id="i2554f6fee6574c18aa40868ebe1c695b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic7055474fff84385849f9083f2f9de03_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia5ea44f74d23424abb3bafc1c81918e2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iabdd0283752a4382b0580526189689c1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2197fe5a97c5429da1cc14762c73c186_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:ZPAtlanticLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="i9d6cef46192147a3a9e8eb7ca0715056_I20201101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:ZPElmhurstLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-01</instant>
        </period>
    </context>
    <context id="iaeade28b6efd4a5892b49eea2eb7af2c_D20200831-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:AZTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-31</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:AZTechMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="if217300975284a948f8e3b27f3d0605e_D20200601-20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-01</endDate>
        </period>
    </context>
    <context id="i89d9310e311f4127811afce11cd60c48_I20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-01</instant>
        </period>
    </context>
    <context id="i465e71fce78e4f91b93ebe3aac52f888_D20200302-20200302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-02</startDate>
            <endDate>2020-03-02</endDate>
        </period>
    </context>
    <context id="i15cd63800a8f437f9409f248d1e8148d_I20200302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-02</instant>
        </period>
    </context>
    <context id="i6b97202f8ab7436596da79bcd433c721_D20200102-20200102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-02</startDate>
            <endDate>2020-01-02</endDate>
        </period>
    </context>
    <context id="ibb22327f2e344552abfc54aa4c8a3bff_I20200102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="rdnt:AssetAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-02</instant>
        </period>
    </context>
    <context id="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-01</instant>
        </period>
    </context>
    <context id="ic1ca963b4ec644fb9fafe95a4d9cb74f_I20190731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-31</instant>
        </period>
    </context>
    <context id="ia72ddff7bc5d4634b0956b82982d346c_D20190401-20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:KernRadiologyImagingSystemsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-01</endDate>
        </period>
    </context>
    <context id="i4fb7800d73114cc8a0a897cae7906feb_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:KernRadiologyImagingSystemsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="i6013424b82d141dba94b68360286b828_D20190401-20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZilkhaRadiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-01</endDate>
        </period>
    </context>
    <context id="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZilkhaRadiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="i9e74f1c4a6d74c37aa2e96e236ce886f_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="ia312590d9b814f1386f70c721698d7d1_D20190228-20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-28</startDate>
            <endDate>2019-02-28</endDate>
        </period>
    </context>
    <context id="i4337c29255b447709dce2086107be291_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="i4874f4e250774b1fbb5b0f4c47efae14_I20190228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-28</instant>
        </period>
    </context>
    <context id="i456f5191d4dd4b73882fca5d3f1ad088_D20190201-20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-01</endDate>
        </period>
    </context>
    <context id="i6a60c6284cf54e1ca418b050d90465a0_I20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-01</instant>
        </period>
    </context>
    <context id="iaf7fe2658d284b5cb2907e0de5419820_D20190201-20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-01</startDate>
            <endDate>2019-02-01</endDate>
        </period>
    </context>
    <context id="i8b95c89ccfed4e1fb901493260558cab_I20190201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-02-01</instant>
        </period>
    </context>
    <context id="ieac963b9dd7b42a5bc5034ac64e4e8ee_D20190301-20190301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLC.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-01</endDate>
        </period>
    </context>
    <context id="i612c3bc5981e4ff8bd89f7fc44a3a3fe_I20190301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealth.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLC.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-01</instant>
        </period>
    </context>
    <context id="i091d9ede79dd4469affa6d73b62fd16c_I20190301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLC.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-01</instant>
        </period>
    </context>
    <context id="i029867b23b704961b44fc1543f234b9f_D20190301-20190301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">rdnt:DignityHealth.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:VenturaCountyImagingGroupLLC.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-01</startDate>
            <endDate>2019-03-01</endDate>
        </period>
    </context>
    <context id="i3e571ad52d964e1389114033d8e4b89c_D20200601-20200601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">rdnt:ImagingOnCallMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-01</endDate>
        </period>
    </context>
    <context id="i5528883c400f402890b0b9e360fa9757_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MedicalArtsRadiologicalGroupPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icd9c48ca86d84fb980d466453795b682_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DignityHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0b0b910fae6b4ba090ec1c469a5c973a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:WestValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifa266170ed154d5198ecd30150de0a0d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:HudsonValleyRadiologyAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0e225ee197db4962846379c1f756351b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:KernRadiologyImagingSystemsInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i774974bb637346659642b95eb18c0d88_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZilkhaRadiologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4b7b602ee54a433b9e40d150fe55fbb3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RamicMahwahLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6e8e0ca3243444e7970426cdcd410ff4_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:GardenStateRadiologyNetworkLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i6e940ec7fd4d4b28bb5546113a619040_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:NulogixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4351f86bc864495c813b7164d4002e89_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:OlneyOpenMRILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i037ebcff3f474b6a85350f30a450750f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:MRIatWoodbridgeLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i41f3fcd0c1b7458b8c2b5611fd14cbe3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:AZTechRadiologyOpenMRILLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iffd13c35af724f7495f80a4ffd36d14a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPOzoneParkLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iff9d9ba698244f9295f632171332ff38_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPElmhurstLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9bf401f259054b239c444a7ba3779a78_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id05c02a9c24c46eb8f9844d8050a58a4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:ManagementServiceContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5df3beb96ec040a792ee0fc37556ccd6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3126da00ef154364bff57a0c60402471_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:CovenantNotToCompeteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id061ad1af2d248bfb7f45397fa7e8c96_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedtechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf3163cdc65c43c2bb456cfbfe498c0e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:DevelopedtechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i61448a8add4f4771a367c78ff3a9877b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:TradeNamesAmortizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i830cf944df0341d7a34972034686fd2b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:TradeNamesAmortizedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rdnt:TradeNamesIndefiniteLifeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1af3ae0e5caa47a7a61c06002e11c661_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i38c4184cf981409f99903c799615fc7c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i90897045b27b47d3851512df495fb317_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia4ba3f78a0f049ebbe6bbd419db532c1_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib3ebc23af28648849d72a86f89b15a59_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4215872a7995444cb1ddcef9705d75d5_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibdea4c2c6a394718bbe4f06a3a8dc179_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f79bab3685041179f8a090705f8145d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0e015b6f1727458c8d7a3e194aee3c2d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1b6f7873910a406998fcb4834647b21b_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iab72392226114b9c9189e2d1cfb7fe7c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i285fdbc8c707469b8e163fb3a3e1934f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:AssetsHeldUnderCapitalLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ifbc658ed6a3a4a78a3c5bf60feff2cd1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i78316bdeb53c42e49f72d68723354ca6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:MedicalEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9f7c6c92238d4993b8ecc28a6fac055a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rdnt:ComputerandOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9c47a542e8864e56810edc15688328c9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05a8cf1c3f364c8385b06277f3785c9f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4293895b42684cfab6b3bb70114b012f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10c7eb7f995c42fd9e9471533755d56c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if541ba545c6849c9b80ae7c8f6901cfc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib81178c4dfa84fc9bdd6fffca1947078_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienTermLoansAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibdfce80209e24d048368e13932f4df63_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ba89948df004b25bb090cc21c311d86_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i393ed2858c1548b6b82e961dc7975352_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i82d3729db9c24aed80f38ee4cff8b9e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8ffc456155284a328dd24dd400e38ed4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie76ddddf094d4fa9a36625b0a91bb963_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8f3bcd1c38c94c46890195526ab00dc7_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="i03d496ffc98f4cbea3c2e52184411ed8_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="i9fd684fe4e424d05a9e16bcf1667b1d8_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="i6c94cda8e234414db8eeb093634ddc93_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="id542a67b5a124e768231f2834084c93e_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="i565421d3700145cc93c48dbb3d1a4773_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="i2d53766b85e942388c2185f85329d9fe_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="ie6a7dcb8d79a4eb49b6cbd0775ce1798_D20160701-20160701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-01</endDate>
        </period>
    </context>
    <context id="ie8288ed7887c48afb55992d498cc71a8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i995ae7f592fb4fefb0bb03523e52883b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iae3bdf0809064518b238f69ea108dcd7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i80b7b2a03f3941348f06c63609e7c6cb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:LeverageRatioThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1263f290830a4060aed96f7ad872c48a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibacf3bc799af4bb38a866940c2a2c3bb_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i750fa1f8302a426fb9a669a5704e685e_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i81c400dac51f406a9711305492c3b4c2_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i2c266838663e4aa9bd0e5ea532d2b79c_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ibaa9f7ca79134dada648ef42e6c6db50_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i43b7dfec154e47c7ae3282f11f953037_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i9a3f1fe7a6fb45e28d7055b802128ddd_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i77430f8ce1d24d29b21836836ac4c9f5_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="iddf06388c8db452292fd4be8fac89b3d_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i66e971e62a534f359ea61e7860897264_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i726b0bebd34a4e46a057d38e4f1ba269_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i219c247a7c464cf9815c4651e1be0884_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ie388174914b1418aaa031d162e279aa9_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i5f4b411c521e4514876b71fb6b7b4ad2_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i65e5beb9352246028536bb875e13ba71_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i63f437b3e9a640edad9d5b48f6ada9eb_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ie69f018701ff451c852994840d5678f4_I20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-31</instant>
        </period>
    </context>
    <context id="i3142f65c94ae47beb9a1aff303e0d018_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i1f40b418b6d84fc884519577e1396a36_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="ic6ed187b6ae14da3a3469e3302627e8c_D20180831-20180831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-31</startDate>
            <endDate>2018-08-31</endDate>
        </period>
    </context>
    <context id="i54f63ff21ef3452fba37a70277f1b7dd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:EurodollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rdnt:LeverageRatioAxis">rdnt:PricingLevelIIIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic509aa6e20d8451e869c6c1adc35cb1b_D20180101-20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="i48cfb04da83545e39b2c1c70193a8083_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i56bc70ab4f98412fb60048a93886fb28_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4a1fe13162294ec8b4af081e02f06560_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementEighthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:BarclaysMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35416759782a4ffcae881c1975663437_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:RestatedAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">rdnt:SunTrustMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8545538a2ef54e1b9d395b7b7743a4a3_I20170822">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-22</instant>
        </period>
    </context>
    <context id="i296abca1ec384478903ec34e3f7c3244_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:FirstLienCreditAgreementSixthAmendmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="i3a18b41ec6e94cbbbda45664ee69a4e0_I20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-18</instant>
        </period>
    </context>
    <context id="i66691542788640c6b83e170f22e99fd2_D20190418-20190418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">rdnt:FirstLienCreditAgreementSeventhAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-18</startDate>
            <endDate>2019-04-18</endDate>
        </period>
    </context>
    <context id="i9ec14573b907475cbd068c8d85492abd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e615f475e34430ead7ea3449fb67aa1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">rdnt:PaycheckProtectionProgramLoansMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:UnusualOrInfrequentItemAxis">rdnt:COVID19PandemicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7393b27f4af1422f97fa04785bd0e65e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie6dad76471cb45619fba56de651a701e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2b790074af0343b2807bdb47a7b6fc97_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i443f461b18dc4cbc8d9de4443701c2c5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">us-gaap:TaxYear2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9828ffc96914aafb4d9efce6667921c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5e81d491c9834d05aaea374ea32dd36c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:RavenHoldingsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i80da3a0cfbcd4daabbb76961c2faeb86_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i38edc38946a14643a72d3091d803e56d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaeedfaefcdd24073a7791f2cf8216e31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1e82aebaacf64a089fdc7fe9fdc1e466_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="if04aa1ab93ce4b9a8e416308089ebf97_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7aaf101d3fad496781ceeb004ddadb94_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i82674e78aaef409482561fb16833fed8_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id7924f95e7254282bcfd904f5e8c2a33_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a16c03189374ecc8b0cfdb8f468e8f7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib2855760db5544e182b346d57d04d55d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idf9d07d86bdb4bdf9c4770c8c4998e95_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4d7b881e14e742dcb65f5f1ced340221_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:DeepHealthInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7d23330ea44497788f06f832afc7e77_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibdc31c4ffa00452f9f099766b10087be_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rdnt:FutureServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i109a113f281d4536a92aad55cbd4446b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rdnt:RestatedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic762f9e446734268b2ec4cc6053e0784_I20210316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="i37f85f9b11184e229c14b88e0c866f9a_D20210301-20210316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-16</endDate>
        </period>
    </context>
    <context id="ib7780ac5dfb3420c990d47876f42a92d_D20210301-20210316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-16</endDate>
        </period>
    </context>
    <context id="i3d7ba65a559c49258e9c430b845e4b63_I20210316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="i5392aaed1912447ab767bc58444d59ac_D20210301-20210316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">rdnt:SimiValleyImagingGroupLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">rdnt:SimiAdventistMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-16</endDate>
        </period>
    </context>
    <context id="ibd5cb14789334c5ba54f208a8b80147c_D20210101-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000790526</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">rdnt:ZPCompaniesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="center">
        <measure>rdnt:Center</measure>
    </unit>
    <unit id="numberofagreement">
        <measure>rdnt:numberOfAgreement</measure>
    </unit>
    <unit id="joint_venture">
        <measure>rdnt:joint_venture</measure>
    </unit>
    <unit id="loan">
        <measure>rdnt:loan</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF80L2ZyYWc6ZTgxYWIyZjU4YTllNDhmYmFlYmY5MWY1ZDM5ZmY2NzAvdGFibGU6ZTdhMjVlMTllN2U2NDhkNzkzYzEwOTZjNzY1NGNjMDMvdGFibGVyYW5nZTplN2EyNWUxOWU3ZTY0OGQ3OTNjMTA5NmM3NjU0Y2MwM18zLTEtMS0xLTA_e8e730f1-58a3-4070-867f-6a31bf41df1d">0000790526</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF80L2ZyYWc6ZTgxYWIyZjU4YTllNDhmYmFlYmY5MWY1ZDM5ZmY2NzAvdGFibGU6ZTdhMjVlMTllN2U2NDhkNzkzYzEwOTZjNzY1NGNjMDMvdGFibGVyYW5nZTplN2EyNWUxOWU3ZTY0OGQ3OTNjMTA5NmM3NjU0Y2MwM180LTEtMS0xLTA_17fc1705-311f-458d-8855-9003ff98f8c4">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF80L2ZyYWc6ZTgxYWIyZjU4YTllNDhmYmFlYmY5MWY1ZDM5ZmY2NzAvdGFibGU6ZTdhMjVlMTllN2U2NDhkNzkzYzEwOTZjNzY1NGNjMDMvdGFibGVyYW5nZTplN2EyNWUxOWU3ZTY0OGQ3OTNjMTA5NmM3NjU0Y2MwM182LTEtMS0xLTA_2b7f07cb-e338-47f4-be71-a2339b0a5bab">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF80L2ZyYWc6ZTgxYWIyZjU4YTllNDhmYmFlYmY5MWY1ZDM5ZmY2NzAvdGFibGU6ZTdhMjVlMTllN2U2NDhkNzkzYzEwOTZjNzY1NGNjMDMvdGFibGVyYW5nZTplN2EyNWUxOWU3ZTY0OGQ3OTNjMTA5NmM3NjU0Y2MwM183LTEtMS0xLTA_41f9e787-4c59-4f77-8666-7c84278777c7">2020</dei:DocumentFiscalYearFocus>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i9aa53910584d4308b3a9af105783ce91_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE1Ng_34d0b0f5-d4d7-4f53-b8d4-f97aa42926e1">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i9aa53910584d4308b3a9af105783ce91_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE2OQ_cb2940f3-3de2-419f-b70c-92ae0342fb0b">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <rdnt:WeightedAverageAmortizationPeriodRemainingInYears
      contextRef="i38c4184cf981409f99903c799615fc7c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85NC9mcmFnOjE2MjIwMGJlY2E3ZDRhMWViNDExNWQ3ZGZiN2RmMDBkL3RleHRyZWdpb246MTYyMjAwYmVjYTdkNGExZWI0MTE1ZDdkZmI3ZGYwMGRfODk_a1822f62-5368-4c90-94c1-b2ca0df8fc0c">P0Y</rdnt:WeightedAverageAmortizationPeriodRemainingInYears>
    <us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xNDkzL2ZyYWc6NmEyYTRlNzBjYzhiNDA4MjhjODgxZmY2ZWM2NzVlY2QvdGV4dHJlZ2lvbjo2YTJhNGU3MGNjOGI0MDgyOGM4ODFmZjZlYzY3NWVjZF8zMjk4NTM0ODgzNDQy_d897b2f3-cbc9-419f-9b14-f9c4ce8df9f7">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i80da3a0cfbcd4daabbb76961c2faeb86_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc2OA_936612e8-22fa-4ff0-b720-c4675549c40d">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i80da3a0cfbcd4daabbb76961c2faeb86_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc4OA_046091b3-dd3f-4a0f-84b9-3f6b7a937f8c">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <dei:DocumentType
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDky_14fa1730-774f-4c92-8b89-0013a82c8ec7">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDg4_797432f2-f8b1-42ef-a4a3-406bf21ae017">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8yMTk5MDIzMjU5MDM0_6159f374-8465-4b7d-ac99-d11e077218dc">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8yMTk5MDIzMjU5MDM0_91cb0d8d-f3c9-44d7-a7ab-59b29e4a785b">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDg2_be64219e-5397-40ae-b91a-cc49307b2c26">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDkz_48b6628d-2bf2-4e2f-bde1-592d869d6453">001-33307</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDk1_33f4b91b-3d50-4847-b276-303cb1ebfe0c">RadNet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl8wLTAtMS0xLTA_ba98a73d-55cc-4c87-819e-11140edf60d7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl8wLTItMS0xLTA_866d3ee8-e4e8-4c07-a781-35b1e2e8b930">13-3326724</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl8zLTAtMS0xLTA_f8ff3346-fa98-4f47-824d-9c36039829dd">1510 Cotner Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl80LTAtMS0xLTA_cf35d786-31ea-4230-acd9-7b55f50a44cd">Los Angeles,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl80LTEtMS0xLTA_028e72e2-8c81-448e-8b74-5d7704766953">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6NTBjMjM4YmU1YTAyNDNkNTlmMmMzZDMzNjA2MjI5N2IvdGFibGVyYW5nZTo1MGMyMzhiZTVhMDI0M2Q1OWYyYzNkMzM2MDYyMjk3Yl80LTItMS0xLTA_55c664d4-8791-4df7-b667-2b280239b824">90025</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDk2_183bd283-4717-44a7-a384-c6bc37a16ac6">310</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDg5_45ff9f1c-859c-44f9-a824-06cc8bc741d2">478-7808</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6MTMxMjY2N2M0MjIwNDgxZjkzNWEyMDZiODY4MzEwNmQvdGFibGVyYW5nZToxMzEyNjY3YzQyMjA0ODFmOTM1YTIwNmI4NjgzMTA2ZF8xLTAtMS0xLTA_f9b57a1a-44be-4ba4-bce1-ce6296008041">Common Stock, $.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6MTMxMjY2N2M0MjIwNDgxZjkzNWEyMDZiODY4MzEwNmQvdGFibGVyYW5nZToxMzEyNjY3YzQyMjA0ODFmOTM1YTIwNmI4NjgzMTA2ZF8xLTEtMS0xLTA_f4913953-5ea2-4c15-8c08-8d965ed19196">RDNT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6MTMxMjY2N2M0MjIwNDgxZjkzNWEyMDZiODY4MzEwNmQvdGFibGVyYW5nZToxMzEyNjY3YzQyMjA0ODFmOTM1YTIwNmI4NjgzMTA2ZF8xLTItMS0xLTA_e054f121-1665-41dc-a275-f147cb69e7d0">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDkw_5a3dcfcb-0bc6-4485-b77a-17d5037fe1ff">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDk3_3dbca137-473d-4220-9370-82db91f71191">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDkx_2bf0a266-e29f-4e92-ae65-60f218d63723">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDk4_b44ca52d-54fc-4f71-b38c-c1c7db038f19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6ZGFlMzc1ZTg1MDRmNDNmZmIwYzE4OWZjZWExMjU2MjAvdGFibGVyYW5nZTpkYWUzNzVlODUwNGY0M2ZmYjBjMTg5ZmNlYTEyNTYyMF8wLTItMS0xLTA_519ecec1-5291-451c-b7c9-9a34047f82c9">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6ZGFlMzc1ZTg1MDRmNDNmZmIwYzE4OWZjZWExMjU2MjAvdGFibGVyYW5nZTpkYWUzNzVlODUwNGY0M2ZmYjBjMTg5ZmNlYTEyNTYyMF8xLTMtMS0xLTA_86c4dac8-f74b-4e3f-ad9e-cc6a5e6f7efb">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGFibGU6ZGFlMzc1ZTg1MDRmNDNmZmIwYzE4OWZjZWExMjU2MjAvdGFibGVyYW5nZTpkYWUzNzVlODUwNGY0M2ZmYjBjMTg5ZmNlYTEyNTYyMF8yLTEtMS0xLTA_edf14735-f481-4c34-8ab1-a57839a5de26">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMjk4NTM0ODg2Nzg5_55829180-2688-421c-87f0-7eb8f70a678e">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDk0_f6b594e2-39b6-4340-8e8e-9e96f40f2bc1">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="i3f632fde5d0946eaae6fa48e47fe915a_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8yNDAx_a358749e-b25b-4131-9a50-a6672eda786c"
      unitRef="usd">691200000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ibaa2464885764c41ae09dcb977e30937_I20210305"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8yNjUz_5bd799c9-1f85-400a-b3a4-8d8393a3fa07"
      unitRef="shares">52272092</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xL2ZyYWc6ZmIzZTY1Mjk0YzI3NDkyNWFkZWQyNGUwOTUwZTA2YzgvdGV4dHJlZ2lvbjpmYjNlNjUyOTRjMjc0OTI1YWRlZDI0ZTA5NTBlMDZjOF8zMDg3_e3fb5af2-e8f9-417c-a7b0-77f5cce7874d">Portions of the registrant&#x2019;s definitive proxy statement for the 2021 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#x2019;s fiscal year.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNC0xLTEtMS0w_81a79e75-e8d0-40f4-822b-6a18684148dd"
      unitRef="usd">102018000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNC0zLTEtMS0w_82728ad0-6469-4715-b4ba-52de9383e806"
      unitRef="usd">40165000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNS0xLTEtMS0w_9ff6b6f9-94d4-444d-81b0-f60c4b6ddd76"
      unitRef="usd">129585000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNS0zLTEtMS0w_4212a05f-99e7-4d20-b465-fda8ee9002e9"
      unitRef="usd">154763000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNi0xLTEtMS0w_b02f2749-39bf-4f24-8a9e-c780196f6ea3"
      unitRef="usd">5836000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNi0zLTEtMS0w_bddcf963-cb7b-4381-b01d-1e9fd64d971f"
      unitRef="usd">1242000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNy0xLTEtMS0w_e223b7de-c00b-4de0-af06-100c4b54e9cb"
      unitRef="usd">32985000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNy0zLTEtMS0w_9962060a-f412-446a-8037-90dd09eadff6"
      unitRef="usd">45004000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfOS0xLTEtMS0w_b5d2d051-7c91-4256-931c-783ea3c76044"
      unitRef="usd">270424000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfOS0zLTEtMS0w_5e8c5a50-dbb8-4062-ac06-a40232f8e9fd"
      unitRef="usd">241174000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTEtMS0xLTEtMA_94602ec2-acb5-451f-95c8-4e6783802574"
      unitRef="usd">399335000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTEtMy0xLTEtMA_bf8f6b59-c0d2-497a-8d93-81ab97f7c970"
      unitRef="usd">367795000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTItMS0xLTEtMA_f656869f-2bbd-4da0-818c-da3017db58d0"
      unitRef="usd">483661000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTItMy0xLTEtMA_fe227025-cc96-45df-9b96-7cd49caa32df"
      unitRef="usd">445477000</us-gaap:OperatingLeaseRightOfUseAsset>
    <rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTMtMS0xLTEtMA_953957d2-17d4-494b-a215-1ad55fc0c9fa"
      unitRef="usd">882996000</rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTMtMy0xLTEtMA_79cd031a-cfce-4155-ad4c-7f11f0037fc9"
      unitRef="usd">813272000</rdnt:PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:Goodwill
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTUtMS0xLTEtMA_335921e0-cd29-44bb-90fc-55abcac1c0f9"
      unitRef="usd">472879000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTUtMy0xLTEtMA_7db9fdd8-8b98-49e2-b5e4-040d3331e41b"
      unitRef="usd">441973000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTYtMS0xLTEtMA_ed056aca-7f30-4879-bdea-46088074e168"
      unitRef="usd">52393000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTYtMy0xLTEtMA_ab7f84a9-4f8a-4467-ac01-3137cd11ce8c"
      unitRef="usd">42994000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTctMS0xLTEtMA_f9e93b04-471b-4a0b-8c62-5e55c7951138"
      unitRef="usd">1767000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:DeferredFinanceCostsNoncurrentNet
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTctMy0xLTEtMA_eb61bd90-bd22-438b-b683-f86a7c4dfd24"
      unitRef="usd">1559000</us-gaap:DeferredFinanceCostsNoncurrentNet>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTgtMS0xLTEtMA_2d07d7fa-fa37-4509-9ea6-adaf5239494b"
      unitRef="usd">34528000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTgtMy0xLTEtMA_bdc6d0dc-1368-4e20-9ac2-5143dac9742a"
      unitRef="usd">34470000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTktMS0xLTEtMA_f350e6c2-c7d7-4bab-aae0-cb15557431f2"
      unitRef="usd">34687000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMTktMy0xLTEtMA_500c7f77-b356-429b-a67f-18ddd760d5bb"
      unitRef="usd">34548000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DepositsAssets
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjAtMS0xLTEtMA_cd1c28f9-aa47-499e-b0e5-9674aa84d555"
      unitRef="usd">36983000</us-gaap:DepositsAssets>
    <us-gaap:DepositsAssets
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjAtMy0xLTEtMA_9df41dfb-7b81-4dbb-af89-a587b37cbb73"
      unitRef="usd">36996000</us-gaap:DepositsAssets>
    <us-gaap:Assets
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjEtMS0xLTEtMA_41f97540-953a-42b3-bff5-cbe3ea5186bf"
      unitRef="usd">1786657000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjEtMy0xLTEtMA_658bde59-a955-4415-a1a5-83ec1e221c61"
      unitRef="usd">1646986000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjQtMS0xLTEtMA_51e3275c-3dc6-47b1-9eea-6fc9de533cac"
      unitRef="usd">236684000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjQtMy0xLTEtMA_f310a5aa-4756-405a-b284-a92c58c19416"
      unitRef="usd">207585000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjUtMS0xLTEtMA_eeaa7d8b-4062-44be-b67e-8024ff6555ba"
      unitRef="usd">14010000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DueToAffiliateCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjUtMy0xLTEtMA_8e2439dd-f229-46ed-9a26-84d71beb61d8"
      unitRef="usd">14347000</us-gaap:DueToAffiliateCurrent>
    <us-gaap:DeferredRevenue
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjYtMS0xLTEtMA_445ccbcb-ba2b-49b2-a63d-83a1c5e85db6"
      unitRef="usd">39257000</us-gaap:DeferredRevenue>
    <us-gaap:DeferredRevenue
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjYtMy0xLTEtMA_2e28b59a-557a-440d-98c6-860de3af1d03"
      unitRef="usd">1316000</us-gaap:DeferredRevenue>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjgtMS0xLTEtMA_1cc7a3ad-415c-4a29-8cd1-2751b514964e"
      unitRef="usd">2578000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjgtMy0xLTEtMA_4f0bd617-04bf-4fb1-b06a-a85aeafcd776"
      unitRef="usd">3283000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjktMS0xLTEtMA_d091b483-1ee4-4c41-b4be-68eee7195e60"
      unitRef="usd">65794000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMjktMy0xLTEtMA_dd95416c-0228-4a93-8583-c6ea1f652608"
      unitRef="usd">61206000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzAtMS0xLTEtMA_fbfca8a9-c7a3-45de-822e-28ab943a72b1"
      unitRef="usd">39791000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzAtMy0xLTEtMA_5659cefe-eada-475e-b3f7-7773ed875731"
      unitRef="usd">39691000</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzItMS0xLTEtMA_16df8354-162b-4b4f-9376-ddb03eff19f2"
      unitRef="usd">398114000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzItMy0xLTEtMA_69f9a1f7-5e7a-4a11-9f4d-57578e47cead"
      unitRef="usd">327428000</us-gaap:LiabilitiesCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzUtMS0xLTEtMA_2bd10ce8-b8e3-4e76-98a9-0219e16f7356"
      unitRef="usd">743000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzUtMy0xLTEtMA_7b18a4fc-0dab-4e5f-97ec-1cba7cbd83b8"
      unitRef="usd">3264000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzYtMS0xLTEtMA_007a7c16-df00-4942-8106-b54cd414fcc4"
      unitRef="usd">463096000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzYtMy0xLTEtMA_309e4d1a-14c5-4030-9a74-93e3278acde2"
      unitRef="usd">420922000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:LongTermNotesPayable
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzctMS0xLTEtMA_164eee0b-3a62-4e1c-8b93-35daca469d2d"
      unitRef="usd">612913000</us-gaap:LongTermNotesPayable>
    <us-gaap:LongTermNotesPayable
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzctMy0xLTEtMA_0dc7815c-5163-4c1d-99bb-9cc568ff813b"
      unitRef="usd">652704000</us-gaap:LongTermNotesPayable>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzktMS0xLTEtMA_f42dcce3-06f6-4819-936e-9f369f2d0740"
      unitRef="usd">53488000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfMzktMy0xLTEtMA_da4cf9e0-af33-4adf-b664-8998163e6bb6"
      unitRef="usd">9529000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDAtMS0xLTEtMA_9c51a4ae-02a7-4936-990f-8fcae6bbbb80"
      unitRef="usd">1528354000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDAtMy0xLTEtMA_7cd85802-f740-4075-bffb-b67bad033308"
      unitRef="usd">1413847000</us-gaap:Liabilities>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1MDA_97547f9d-bcfd-490a-8672-7877487932ca"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1MDA_fc9f5980-a50f-4213-97df-dc7089846988"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1MTU_511cf06b-8a48-4da1-ad47-a5caab8e0c25"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1MTU_f52e9898-2c7c-4002-9519-f3489cd766bd"
      unitRef="shares">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1Mjg_1657fa9d-48cd-42b9-9815-b19ee4c1c01a"
      unitRef="shares">51640537</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1Mjg_a96901e5-0708-4d0a-b7fc-fb00f24087f6"
      unitRef="shares">51640537</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1NDE_387dc9e4-d059-4f51-808e-4168a3a98ace"
      unitRef="shares">50314328</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMC0xLTEtMC90ZXh0cmVnaW9uOmJhNjU5ZjU4ODdhODQzZmE4MTBjM2FkZTMzNmNjZDk2XzMyOTg1MzQ4ODM1NDE_613c5352-e7d5-4f08-bff6-da451220d5a2"
      unitRef="shares">50314328</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMS0xLTEtMA_a4e7ece8-906a-4096-a8d9-36f6a94315cd"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDMtMy0xLTEtMA_845a66d5-f231-4d4c-8282-108dcc93d9f6"
      unitRef="usd">5000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDQtMS0xLTEtMA_7a3ebe74-c7e1-4b5b-956c-8d097cd5bf9f"
      unitRef="usd">307788000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDQtMy0xLTEtMA_f266ad31-1948-46bd-b78f-1d6ed9940ac1"
      unitRef="usd">262865000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDUtMS0xLTEtMA_52d8c914-c1ac-4d4a-b273-76e439f842ef"
      unitRef="usd">-24051000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDUtMy0xLTEtMA_276df60a-80f2-42d5-9e47-11ced68cc02d"
      unitRef="usd">-8026000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDYtMS0xLTEtMA_41473ae8-9468-457b-b2ea-a2c5d55303f0"
      unitRef="usd">-117999000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDYtMy0xLTEtMA_48a9ca8e-5436-41f0-8985-79a81c0515de"
      unitRef="usd">-103159000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDctMS0xLTEtMA_b852ee06-446e-4df8-b8fe-042affb0a8d9"
      unitRef="usd">165743000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDctMy0xLTEtMA_392c281a-7290-4c6a-b4b0-ed4ad81c1b7a"
      unitRef="usd">151685000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDgtMS0xLTEtMA_dd2a0c83-6203-4453-986e-e35d51e90816"
      unitRef="usd">92560000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDgtMy0xLTEtMA_c24f2d97-cee9-4180-adb7-0b3714f267a1"
      unitRef="usd">81454000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDktMS0xLTEtMA_5129661f-5998-4017-bf39-6bf582013845"
      unitRef="usd">258303000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNDktMy0xLTEtMA_93925b38-83ff-4da8-90d2-999e612997f9"
      unitRef="usd">233139000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNTAtMS0xLTEtMA_2ed8e920-51b4-4e85-af7e-e888557a9bf1"
      unitRef="usd">1786657000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF81NS9mcmFnOjQ5NzQzNDg2ZDc3MDRkZDc5ZDM4MmNmNDU4MTc5Y2M1L3RhYmxlOmNkNDNiYjEyZmUxMDQzYzA4MTk5ZDlkMWExNGJjN2RmL3RhYmxlcmFuZ2U6Y2Q0M2JiMTJmZTEwNDNjMDgxOTlkOWQxYTE0YmM3ZGZfNTAtMy0xLTEtMA_592c79a9-724f-49d9-a571-026d58fc9cee"
      unitRef="usd">1646986000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91cab1d2676f4c75984b340531fdb510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNS0xLTEtMS0w_6f07de40-d92d-43bb-a490-b23e8a0dac5f"
      unitRef="usd">931722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibeb4b5f80227407994e895e9fdf49c2c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNS0zLTEtMS0w_9a42ac4e-e38a-49ba-97f4-d167d63a3d41"
      unitRef="usd">1028236000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i234d43f26e4d4788b2228afca82d6341_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNS01LTEtMS0w_7f9c82c3-08b8-48b8-93e8-a945e98c1a21"
      unitRef="usd">868741000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0cb6103e98c484a80f4c648cf9a807a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi0xLTEtMS0w_8c884659-6dcb-46e5-8db6-aac158797ae9"
      unitRef="usd">140118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf8d37678bac4561b537c7457bdd558b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi0zLTEtMS0w_55b38fd8-9ad4-4261-990e-b1789ea6fc5a"
      unitRef="usd">125943000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife6ce5fe36734a9a814d0f68137a31b0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi01LTEtMS0w_8c3ff17a-2763-4e4d-934c-adabe6efa7de"
      unitRef="usd">106405000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNy0xLTEtMS0w_f585c198-af12-4287-b169-bad4d58b6629"
      unitRef="usd">1071840000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNy0zLTEtMS0w_13d289dd-00f9-4c35-b0fc-8b0b3ea7108c"
      unitRef="usd">1154179000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNy01LTEtMS0w_1a10aaab-aac0-42dd-bfd2-9f6d1aed5eb1"
      unitRef="usd">975146000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi0xLTEtMS0yNjg3_c75629b7-d6fa-4880-b7df-4d9288764e0e"
      unitRef="usd">26264000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi0zLTEtMS04MTY5_bce8345f-1346-49a4-aac6-5f6df952f2d3"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfNi01LTEtMS04MTY5_41746b53-767d-4696-a607-f5fbd4fdea1c"
      unitRef="usd">0</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfOS0xLTEtMS0w_9d488863-df69-4469-8275-dd5833bb368f"
      unitRef="usd">965902000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfOS0zLTEtMS0w_65014e28-8d07-48cc-bc08-1f497ef5ba3f"
      unitRef="usd">999692000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:OperatingCostsAndExpenses
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfOS01LTEtMS0w_89077501-f90d-4319-a4b7-e93167813c57"
      unitRef="usd">867547000</us-gaap:OperatingCostsAndExpenses>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTAtMS0xLTEtMA_0fdea395-25ea-4f5e-b550-c46e54d472f7"
      unitRef="usd">86795000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTAtMy0xLTEtMA_a261dc1c-eb4e-4e21-9755-ffae4e6a7827"
      unitRef="usd">80607000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTAtNS0xLTEtMA_73f351e9-9e47-499d-baa5-fa6bbd7f3335"
      unitRef="usd">72899000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTEtMS0xLTEtMA_4f642166-f69a-45d2-877d-06e2c4aabebf"
      unitRef="usd">-1200000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTEtMy0xLTEtMA_13f7fe19-f2bc-4ab4-8b63-a7fc488ee163"
      unitRef="usd">-2383000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTEtNS0xLTEtMA_3ae9171f-fdc1-47ec-a48f-e68dcc3e0527"
      unitRef="usd">2054000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTItMS0xLTEtMA_3f141138-4b9f-48f4-a281-52272fa101fc"
      unitRef="usd">4170000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTItMy0xLTEtMA_db726c03-50ce-4164-9661-61b3322e50a1"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTItNS0xLTEtMA_46d8dd3e-dff1-43b4-a196-e5a7a6bc5369"
      unitRef="usd">3937000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:SeveranceCosts1
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTMtMS0xLTEtMA_24617a36-0144-4982-ba3e-83e3201a10ee"
      unitRef="usd">4353000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTMtMy0xLTEtMA_ca2a1c7f-a5cc-4924-bf05-ae696962cc0a"
      unitRef="usd">1619000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTMtNS0xLTEtMA_e61e7420-5162-4bcb-a06d-a576516a3a01"
      unitRef="usd">1931000</us-gaap:SeveranceCosts1>
    <us-gaap:OperatingExpenses
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTQtMS0xLTEtMA_ae7f7770-d727-4ded-a6a1-82fed5715718"
      unitRef="usd">1062420000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTQtMy0xLTEtMA_40151a93-e5b3-494b-b4b3-603ae254bda5"
      unitRef="usd">1084301000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTQtNS0xLTEtMA_916128ab-bc23-42d6-a564-f2d086785001"
      unitRef="usd">944260000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTUtMS0xLTEtMA_a9b6109c-4d49-4938-8fe7-9745b868b323"
      unitRef="usd">35684000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTUtMy0xLTEtMA_b4855ac6-0a32-4b8b-a360-6a6846b540ad"
      unitRef="usd">69878000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTUtNS0xLTEtMA_162d7b0a-9ec0-4d66-99d5-ac478e90eac8"
      unitRef="usd">30886000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseDebt
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTgtMS0xLTEtMA_6baad78b-0a8a-41e7-83f1-b0951e89e529"
      unitRef="usd">45882000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTgtMy0xLTEtMA_bd9df417-e333-42a6-80f5-d99473444406"
      unitRef="usd">48044000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTgtNS0xLTEtMA_d4821252-21bf-4d69-954d-8de7855ecd66"
      unitRef="usd">43456000</us-gaap:InterestExpenseDebt>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktMS0xLTEtMA_55c40e81-df3f-4ab4-8b69-9ba4cc92aaf1"
      unitRef="usd">7945000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktMy0xLTEtMA_a5ba5ed9-c9d0-4ac4-979d-25780421b8ca"
      unitRef="usd">8350000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktNS0xLTEtMA_93524dbe-77f9-4608-8070-729b603bad5c"
      unitRef="usd">11377000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktMS0xLTEtMjY5Mg_56a05377-da5b-46bd-b5be-428149f70abb"
      unitRef="usd">-2528000</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktMy0xLTEtMjY5Ng_1afe12e2-b4dc-4b4a-9207-b2ed2ff3233c"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMTktNS0xLTEtMjY5Ng_a563437a-fb51-48bd-84c0-51707cff8c4f"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1>
    <rdnt:GainLossonStepUpValuation
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjAtMS0xLTEtMA_684fd0fa-e455-4212-8cd3-890d4f064e19"
      unitRef="usd">0</rdnt:GainLossonStepUpValuation>
    <rdnt:GainLossonStepUpValuation
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjAtMy0xLTEtMA_286276c0-b527-4819-8e0a-1f704835018e"
      unitRef="usd">768000</rdnt:GainLossonStepUpValuation>
    <rdnt:GainLossonStepUpValuation
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjAtNS0xLTEtMA_aca7c47a-679c-48db-90d4-6643059c979b"
      unitRef="usd">39539000</rdnt:GainLossonStepUpValuation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjEtMS0xLTEtMA_e8a01097-a1b3-490a-941e-736dcb604492"
      unitRef="usd">4047000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjEtMy0xLTEtMA_ee62ec58-c58c-493e-a5fc-96b08384ee09"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjEtNS0xLTEtMA_29a69d31-3cbe-4134-9a23-ee2eddd861a1"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjItMS0xLTEtMA_207286d9-d617-4f86-baa5-125e7188aa6d"
      unitRef="usd">-120000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjItMy0xLTEtMA_1ee0dd0d-fd12-4ba4-975b-5c43e7f2a8fa"
      unitRef="usd">-1283000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjItNS0xLTEtMA_0fc484d0-e138-4d92-9218-3ca012c1e0e8"
      unitRef="usd">181000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjMtMS0xLTEtMA_5c6a3f8c-f1c1-4ac1-a92f-c8676909b8e0"
      unitRef="usd">-36538000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjMtMy0xLTEtMA_008bf3e9-2cd3-4820-93b3-cc13519c18fc"
      unitRef="usd">-40209000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjMtNS0xLTEtMA_dd50dcef-14b0-41f4-8cf0-5b569c40aa82"
      unitRef="usd">7641000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjQtMS0xLTEtMA_96a859b1-eac9-494f-9b05-eff10d896c61"
      unitRef="usd">-854000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjQtMy0xLTEtMA_01e3c4cb-f5be-4a92-ae04-0772d86ec926"
      unitRef="usd">29669000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjQtNS0xLTEtMA_e6836949-683c-4ebc-92d3-9b62d7ce2371"
      unitRef="usd">38527000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjUtMS0xLTEtMA_57dee9ee-43dc-4822-bf03-e4adc140f830"
      unitRef="usd">895000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjUtMy0xLTEtMA_fce0eeeb-682f-46f5-9e89-b9cfcc9c0332"
      unitRef="usd">6229000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjUtNS0xLTEtMA_6e52e15d-af9a-45e6-9331-e1dcc97a00ab"
      unitRef="usd">394000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjYtMS0xLTEtMA_8da033af-7b5a-4640-b9ae-58bb2efb0916"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjYtMy0xLTEtMA_acb40148-56ca-4d7a-b91d-a5001061ad4e"
      unitRef="usd">23440000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjYtNS0xLTEtMA_10fef2b6-11f5-4c95-ba75-d757bf17ee51"
      unitRef="usd">38133000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjctMS0xLTEtMA_7353eb7c-77ff-46c1-b1f1-491844e0a27d"
      unitRef="usd">13091000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjctMy0xLTEtMA_214ce95d-ab6d-445f-abcb-8441d88f5a09"
      unitRef="usd">8684000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjctNS0xLTEtMA_d14180e7-fd0f-4e59-bcfc-db51b8f86d87"
      unitRef="usd">5890000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjktMS0xLTEtMA_fe91ba44-b4b8-439c-8b23-bbc8ba7c6b79"
      unitRef="usd">-14840000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjktMy0xLTEtMA_50255600-25b9-4153-abbd-8d2aa3ab078a"
      unitRef="usd">14756000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMjktNS0xLTEtMA_49bb9b4d-1d28-4284-92aa-79794edb0437"
      unitRef="usd">32243000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzEtMS0xLTEtMA_2b79a7be-701c-4435-96dd-7548a7359afc"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzEtMy0xLTEtMA_478d50bd-653f-48f4-9359-c18b35dc4aed"
      unitRef="usdPerShare">0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzEtNS0xLTEtMA_9e81e679-534c-4329-a809-e27fe8d2a13c"
      unitRef="usdPerShare">0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzMtMS0xLTEtMA_f52e53f0-2c6e-45c0-8e8a-d6dfe325bf16"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzMtMy0xLTEtMA_ab90daec-9ffd-43e1-a009-45898079227d"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzMtNS0xLTEtMA_996d9afa-dca4-40cc-8b59-bd5667813bce"
      unitRef="usdPerShare">0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzYtMS0xLTEtMA_f7403caa-5d30-4bcd-9cf6-76a281aa0764"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzYtMy0xLTEtMA_81a1d2a3-e3ee-4981-875d-82f35373ff22"
      unitRef="shares">49674858</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzYtNS0xLTEtMA_cc5f5b03-65f6-4236-a60b-840b8c0782e8"
      unitRef="shares">48114275</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzctMS0xLTEtMA_0da89059-fa40-4252-af6d-bea63f549df4"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzctMy0xLTEtMA_d8e25b6c-f236-45f3-a566-6909d4ebba20"
      unitRef="shares">50244006</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82MS9mcmFnOmY1YzQ0OTkyNjlhNTQ4ZDU4OGM1M2UxMDZlMTc1NjgxL3RhYmxlOjZiMmRmOGZmZDc2YTRjMzFhMDRhOTJhNjBiMjkzM2YyL3RhYmxlcmFuZ2U6NmIyZGY4ZmZkNzZhNGMzMWEwNGE5MmE2MGIyOTMzZjJfMzctNS0xLTEtMA_0624d49d-404d-43ba-9f72-af08dbbef2ab"
      unitRef="shares">48678999</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMi0xLTEtMS0w_34a85374-abd2-4e1e-8f06-b58a0eb30bbd"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMi0zLTEtMS0w_5da04bcb-8716-4b67-b05b-f203a838be53"
      unitRef="usd">23440000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMi01LTEtMS0w_5efed053-1709-42a3-b2e4-1c76ca46e6c9"
      unitRef="usd">38133000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMy0xLTEtMS0w_cbf5f794-447c-4ddb-a956-a282dd41ca32"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMy0zLTEtMS0w_3acc5901-1b5b-41c9-bb02-9f4dd0952fdd"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfMy01LTEtMS0w_00065286-5434-4b05-acb4-01f4cf4a15fa"
      unitRef="usd">-69000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNC0xLTEtMS0w_50e40fca-106b-4410-b67b-2dadb33288fe"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNC0zLTEtMS0w_6c46fe16-e525-4fdb-b5cd-47a21e0ae102"
      unitRef="usd">-10253000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNC01LTEtMS0w_9619d481-34b9-44f8-bc29-e9dc0d97b6b5"
      unitRef="usd">2876000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS0xLTEtMS0yNjI0_27f6b73d-950a-498e-8012-e923c207b550"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS0zLTEtMS0yNjI0_7793fcf7-3e4a-41a2-af75-5d8bdefece81"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS01LTEtMS0yNjI0_e5ba7e24-b194-4593-b79b-60ecb6099c62"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS0xLTEtMS0w_4fe1981f-4dfb-42e3-96d7-b6bcef9a88ba"
      unitRef="usd">-17774000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS0zLTEtMS0w_91b58cb1-135b-4416-8cdc-58a7fbb71029"
      unitRef="usd">13155000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNS01LTEtMS0w_8c1b1700-e986-43af-9791-13c9252878a2"
      unitRef="usd">40940000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNi0xLTEtMS0w_e488acbc-ddd0-427a-af62-62d454e6133c"
      unitRef="usd">13091000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNi0zLTEtMS0w_fcbd6438-bb3c-4aa8-a192-b76e99c6c8ca"
      unitRef="usd">8684000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfNi01LTEtMS0w_919bb3a5-2921-42b6-81c0-14ebac27884f"
      unitRef="usd">5890000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfOC0xLTEtMS0w_fc1acf7d-224e-4757-a636-94e8068826da"
      unitRef="usd">-30865000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfOC0zLTEtMS0w_f5ebbdcc-3ed8-45de-9601-509fc646f0c0"
      unitRef="usd">4471000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82NC9mcmFnOjFhYmY0OTJjNzk2OTRiOWRiMmQ3OWY4YmE2OTNmNjg4L3RhYmxlOmEzYTQ4YzJmOTFmZTRiZDlhMjM1MTRhMzMyNmI4MThkL3RhYmxlcmFuZ2U6YTNhNDhjMmY5MWZlNGJkOWEyMzUxNGEzMzI2YjgxOGRfOC01LTEtMS0w_e0bbd59d-0420-4fb3-b494-4ced50750490"
      unitRef="usd">35050000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesOutstanding
      contextRef="ibb4c0755ae114d328c14dac7820d1e90_I20171231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItMS0xLTEtMA_b800759e-87ff-447f-af97-37363f27a256"
      unitRef="shares">47723915</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibb4c0755ae114d328c14dac7820d1e90_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItMy0xLTEtMA_5fa4ca6c-0d0a-4491-930a-2eff61315bf3"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7dc4ab6f79444662b0f8c57ff6fbf123_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItNS0xLTEtMA_8eb73383-698c-4a9e-b5b4-8f54daca4d41"
      unitRef="usd">212261000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5e6c5ca93f94736bb1c3bfc63efbccf_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItNy0xLTEtMA_713a7e3a-0575-44e0-b495-9b33eed519bd"
      unitRef="usd">-548000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i023faad94c6344268f372203aa84692b_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItOS0xLTEtMA_1c217ea8-1822-4149-aaff-7c00ebf5dfdc"
      unitRef="usd">-150158000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibf6a4235673d476da3ca1a82e301b586_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItMTEtMS0xLTA_02c4a1ef-262a-46df-9dfe-8a829190fb11"
      unitRef="usd">61560000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8189d3507f114e55b1eb07765a0f8fdb_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItMTMtMS0xLTA_4aa8d5c9-2288-45c8-9b14-74bae842a9b3"
      unitRef="usd">8365000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4642cbc638c646e88712849889f662b5_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTItMTUtMS0xLTA_bbd9ca4b-6dc6-4a5a-8ba9-9b344d17ace1"
      unitRef="usd">69925000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i6b406d963f1849e7bc859162bb04f9c4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTMtMS0xLTEtMA_cc007417-2953-494e-9313-078a8d44a898"
      unitRef="shares">10000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTMtNS0xLTEtMA_eaedcd4e-c324-4420-94c8-028a566f6234"
      unitRef="usd">20000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTMtMTEtMS0xLTA_61130ba6-98c9-4a86-926b-2bd84fbeb7ca"
      unitRef="usd">20000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTMtMTUtMS0xLTA_840f52cc-0749-4c35-ac30-c1076a0acef5"
      unitRef="usd">20000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i6b406d963f1849e7bc859162bb04f9c4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTQtMS0xLTEtMA_fb73eff0-2f3a-43d4-bcda-848d3bdf1610"
      unitRef="shares">713160</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTQtNS0xLTEtMA_00031024-968a-44bb-a19b-f787b8c4dfe4"
      unitRef="usd">7719000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTQtMTEtMS0xLTA_a6526b5e-fba4-4816-8a75-050041a4023b"
      unitRef="usd">7719000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTQtMTUtMS0xLTA_bc7295b7-3f41-4650-b11a-15a157fb99ee"
      unitRef="usd">7719000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="i6b406d963f1849e7bc859162bb04f9c4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTUtMS0xLTEtMA_ef6b676d-2c3e-4b4c-b379-a637c0f0672a"
      unitRef="shares">1150</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTUtNS0xLTEtMA_f87a7ca4-d819-4237-94b0-23fa621b9dff"
      unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTUtMTEtMS0xLTA_d530c8a2-c390-4cfd-99b3-8093a5aa65c6"
      unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTUtMTUtMS0xLTA_e2add45e-2dc6-4963-bab4-a66435b7ae31"
      unitRef="usd">7000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i6b406d963f1849e7bc859162bb04f9c4_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTYtMS0xLTEtMA_02d6ca22-1332-49b6-8976-99b00f81aaa9"
      unitRef="shares">531560</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTYtNS0xLTEtMA_b43f6fcc-0d61-46e3-b121-0bb83ee9f62c"
      unitRef="usd">8000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTYtMTEtMS0xLTA_1a99b2ed-324a-4cc6-811d-eb70c4e99bee"
      unitRef="usd">8000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTYtMTUtMS0xLTA_4f886e94-de1a-472a-af2e-d90fcda5a28f"
      unitRef="usd">8000000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTctNS0xLTEtMA_14afaa80-86fb-49cc-9f6a-521e2304c395"
      unitRef="usd">11991000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTctMTEtMS0xLTA_ff3f3bea-77f3-4ae4-bfdf-73bae7a05d7e"
      unitRef="usd">11991000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTctMTMtMS0xLTA_1fe06322-6052-4945-9632-70a91f3adcbb"
      unitRef="usd">22666000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTctMTUtMS0xLTA_b798882c-daa2-46e9-b81a-68f7b558d87e"
      unitRef="usd">34657000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution
      contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTgtNS0xLTEtMA_70b35377-0332-49a0-810d-dbdcc532a5f3"
      unitRef="usd">-2894000</rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution>
    <rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution
      contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTgtMTEtMS0xLTA_5b2c76cf-c009-423c-910e-e738afcda84f"
      unitRef="usd">-2894000</rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution>
    <rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution
      contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTgtMTMtMS0xLTA_31a94ced-e94c-4a66-ba85-a98d685204a9"
      unitRef="usd">9175000</rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution>
    <rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTgtMTUtMS0xLTA_24b0029b-3360-4fda-b4c1-c5ce6b929dca"
      unitRef="usd">6281000</rdnt:NoncontrollingInterestDecreaseFromSpecialDistribution>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i7ea0d594faba4f849e4b37ee3b13fe50_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTktNS0xLTEtMA_908a5cb1-d520-42b3-be4c-698aba04bd82"
      unitRef="usd">43000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTktMTEtMS0xLTA_cbec997e-255e-44d7-8fe7-4c411012d617"
      unitRef="usd">43000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTktMTMtMS0xLTA_3f9cd49e-7deb-45e0-9c56-fb96799035b7"
      unitRef="usd">157000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMTktMTUtMS0xLTA_a9121790-1b4e-462d-a550-898593b83c82"
      unitRef="usd">200000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <rdnt:ContributionsFromNoncontrollingInterests
      contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjAtMTMtMS0xLTA_67c8db07-aa2f-4848-a8d8-b92b279366e1"
      unitRef="usd">2640000</rdnt:ContributionsFromNoncontrollingInterests>
    <rdnt:ContributionsFromNoncontrollingInterests
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjAtMTUtMS0xLTA_c9b7a556-d60b-4898-98a8-f90b0d738a23"
      unitRef="usd">2640000</rdnt:ContributionsFromNoncontrollingInterests>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjEtMTMtMS0xLTA_9560c5f8-77ef-40b9-9c30-76c8268fa991"
      unitRef="usd">1427000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjEtMTUtMS0xLTA_fc6b702e-7a97-4171-b2ff-ef46f7cea1c8"
      unitRef="usd">1427000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <rdnt:IncreaseInNoncontrollingInterestDueToStepAcquisition
      contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjItMTMtMS0xLTA_5220d4c3-9f49-4a9f-b781-8b7c9f9801d7"
      unitRef="usd">44267000</rdnt:IncreaseInNoncontrollingInterestDueToStepAcquisition>
    <rdnt:IncreaseInNoncontrollingInterestDueToStepAcquisition
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjItMTUtMS0xLTA_cf03f716-da73-44f9-a4fd-7917a90c4765"
      unitRef="usd">44267000</rdnt:IncreaseInNoncontrollingInterestDueToStepAcquisition>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="ided679c17b004e37bf6e8caf9a77bfb8_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjMtNy0xLTEtMA_5d867a78-468e-426b-9340-a60f917a3ba2"
      unitRef="usd">-69000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjMtMTEtMS0xLTA_56f62a65-9928-458d-951c-855747c6f740"
      unitRef="usd">-69000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjMtMTUtMS0xLTA_21e78537-5187-4032-999b-3be49fa15185"
      unitRef="usd">-69000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="ided679c17b004e37bf6e8caf9a77bfb8_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjQtNy0xLTEtMA_f94c43bb-21a8-4ec7-9d23-74b7f6d90c28"
      unitRef="usd">2876000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjQtMTEtMS0xLTA_a4927f8a-c258-4bbb-9e92-5fa4c9bff605"
      unitRef="usd">2876000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjQtMTUtMS0xLTA_db44dea8-80c5-4833-819f-20bd25371b54"
      unitRef="usd">2876000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="if58d2cdaa8dc40528b9291019c26a4d5_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjUtOS0xLTEtMA_869324c3-804c-464e-b9ea-21542b832ccc"
      unitRef="usd">32243000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie4ca0924788f4f61a2ae1cb583ad53dd_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjUtMTEtMS0xLTA_ffec13bf-c1ac-4662-8af3-b8eec161fb5b"
      unitRef="usd">32243000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="id652fa9b280b441cb69225ed1f6d7548_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjUtMTMtMS0xLTA_33436f9f-b9b9-4f96-b0bc-fa6407664297"
      unitRef="usd">5890000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjUtMTUtMS0xLTA_dd6c9237-5a6e-4138-bc48-657e10e78f78"
      unitRef="usd">38133000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="ie3b1f19594f8442296a0ad23c159cb2f_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtMS0xLTEtMA_59a4a4b4-51f3-4117-9359-b656ac36dbf1"
      unitRef="shares">48977485</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie3b1f19594f8442296a0ad23c159cb2f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtMy0xLTEtMA_47271fef-284a-4728-9d1f-90bf904f88de"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i86f3f1e4adc845aa8ff6eecc119258e8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtNS0xLTEtMA_717cd3c9-4ec7-4765-ab26-fc8bdea18353"
      unitRef="usd">242835000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d7d69f790144635b6dfa34118ab2074_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtNy0xLTEtMA_515dce09-68db-4686-825a-1605fd812ce0"
      unitRef="usd">2259000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e34bb1f702e49a0b37e15b35cc7d11e_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtOS0xLTEtMA_626ece2a-fa16-4b82-99df-607db1cfd666"
      unitRef="usd">-117915000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib1a562ce319b492e8ddb3e7f62714b25_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtMTEtMS0xLTA_cecbacf6-e334-47e2-973f-67c8cfdf279d"
      unitRef="usd">127184000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i09006b479cba4028a203556db5818971_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtMTMtMS0xLTA_d5274b95-c33e-4939-a995-29828b2f67ef"
      unitRef="usd">73069000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibae6485d220c4366bf04745e679dee34_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjYtMTUtMS0xLTA_88797638-4dce-438c-8e75-d138ff4eca44"
      unitRef="usd">200253000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjctMS0xLTEtMA_f77a3592-6c74-4f78-a944-af05c9cbe8a8"
      unitRef="shares">12500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjctNS0xLTEtMA_c159c338-4d51-4210-b323-802c6515a66f"
      unitRef="usd">75000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjctMTEtMS0xLTA_a65b7a4d-4ae7-4bcf-b2df-0cfbcc3c7fbd"
      unitRef="usd">75000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjctMTUtMS0xLTA_21231473-ae9e-45a1-a9c0-6c663fb6d5a3"
      unitRef="usd">75000</rdnt:ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjgtMS0xLTEtMA_35bfaba6-23d3-458d-b103-beb299da075a"
      unitRef="shares">771042</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjgtNS0xLTEtMA_0f5b147a-b557-4b2a-ba85-57b5ed0df0fe"
      unitRef="usd">8735000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjgtMTEtMS0xLTA_9a909f2c-c103-40f7-b99f-580db8f7aeb4"
      unitRef="usd">8735000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjgtMTUtMS0xLTA_7deb47c4-f9ee-49cc-ac11-6d8ac945474e"
      unitRef="usd">8735000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjktMS0xLTEtMA_f297e70a-8254-43f0-96e1-b46ba63959df"
      unitRef="shares">1500</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjktNS0xLTEtMA_5b81f1ea-1348-4721-88c3-f18dd40c5dde"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjktMTEtMS0xLTA_a95bb50e-cbeb-4073-a78b-14389e49fdc1"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMjktMTUtMS0xLTA_f3b9e382-05e6-4898-a747-63e3d35664e0"
      unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensationForfeited>
    <rdnt:NonCashSeveranceShares
      contextRef="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtMS0xLTEtMA_0e21f6d5-332e-4b9b-a9c1-ce995f2a9b33"
      unitRef="shares">12692</rdnt:NonCashSeveranceShares>
    <rdnt:NonCashSeverance
      contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtNS0xLTEtMA_d7aea602-5d8c-44d5-a8fb-e3e8f2efd5e8"
      unitRef="usd">188000</rdnt:NonCashSeverance>
    <rdnt:NonCashSeverance
      contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtMTEtMS0xLTA_27bc8661-b315-4d04-ae47-36dcd68c4674"
      unitRef="usd">188000</rdnt:NonCashSeverance>
    <rdnt:NonCashSeverance
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtMTUtMS0xLTA_af30a186-4280-4d53-814f-80d9e9d40238"
      unitRef="usd">188000</rdnt:NonCashSeverance>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="if0bc682126ce4d2e94fba0d9ef67a5bf_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtMS0xLTEtMA_e17a6fdd-81fb-473c-a6b4-a285af528f19"
      unitRef="shares">542109</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtNS0xLTEtMA_546c61f0-5875-4ecb-9180-ca24e0560fa7"
      unitRef="usd">7500000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtMTEtMS0xLTA_563475f4-4d0f-486d-b302-d9f6899fa114"
      unitRef="usd">7500000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtMTUtMS0xLTA_c2459570-a9cf-47dd-b447-c3b926aad621"
      unitRef="usd">7500000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ia784349f3da44e3c8f6d605cfc2378b5_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItNS0xLTEtMA_eac134cb-b56d-4365-be67-43d81a0a4ceb"
      unitRef="usd">3537000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItMTEtMS0xLTA_8fe42ca7-1d3e-41c0-95a4-b03c702e996e"
      unitRef="usd">3537000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i56a7504cf2d24b3c95f46157e23014d6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItMTMtMS0xLTA_2691c10d-cd01-425d-baee-419f0e3eee7b"
      unitRef="usd">2008000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItMTUtMS0xLTA_5bee75ac-e1f1-43a9-92a9-471dfc8e8618"
      unitRef="usd">5545000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <rdnt:ContributionsFromNoncontrollingInterests
      contextRef="i56a7504cf2d24b3c95f46157e23014d6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtMTMtMS0xLTA_7234280f-1272-46ea-b6b6-4a139f595064"
      unitRef="usd">750000</rdnt:ContributionsFromNoncontrollingInterests>
    <rdnt:ContributionsFromNoncontrollingInterests
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtMTUtMS0xLTA_196983f5-e898-4951-bbe9-04284d0b0ec9"
      unitRef="usd">750000</rdnt:ContributionsFromNoncontrollingInterests>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i56a7504cf2d24b3c95f46157e23014d6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTMtMS0xLTA_a880f519-b4a4-43a8-9122-9e25bb1bbbb4"
      unitRef="usd">3057000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTUtMS0xLTA_50b86ff4-b966-4718-b1a7-15fc41c76b36"
      unitRef="usd">3057000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i74beb185d82c45bb93d9dce1efe2e18e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtNy0xLTEtMA_327f1457-1422-414c-823c-9ecc406b8d8d"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtMTEtMS0xLTA_ad30c14e-dbc9-473b-925e-f2531a892dc2"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtMTUtMS0xLTA_545fe19c-bef5-47e7-84be-33ecc99a667b"
      unitRef="usd">-32000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i74beb185d82c45bb93d9dce1efe2e18e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtNy0xLTEtMA_ed8bbe18-807c-43f3-91da-8a11e4f2edd7"
      unitRef="usd">-10253000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtMTEtMS0xLTA_217df6b9-b066-4749-ac2c-f321ee3dbb61"
      unitRef="usd">-10253000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtMTUtMS0xLTA_751ffbea-6b58-4d99-95d8-bff13b4e47ab"
      unitRef="usd">-10253000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:ProfitLoss
      contextRef="ica4a33e11a3249c8ad15dd466a5a1d51_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctOS0xLTEtMA_8033eeae-046f-4107-802d-a96b2b15576f"
      unitRef="usd">14756000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i92cdb8a0279d48b29cccde7be9fe5983_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctMTEtMS0xLTA_6b4058f4-eee4-4702-b170-171227ec2655"
      unitRef="usd">14756000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i56a7504cf2d24b3c95f46157e23014d6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctMTMtMS0xLTA_34fe360d-a688-48c1-bce2-c017ee892946"
      unitRef="usd">8684000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctMTUtMS0xLTA_99c1fcb9-7d6c-41f1-bffe-81b0bce88c09"
      unitRef="usd">23440000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="iaface0b8920a4f0488a80ec15c2e0796_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMS0xLTEtMA_b5fc80a0-bc3e-4512-853b-c9c2224f1e1c"
      unitRef="shares">50314328</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaface0b8920a4f0488a80ec15c2e0796_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMy0xLTEtMA_fcf00887-8a4c-40b7-91b2-9f33d7604750"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7d78ac548ab47a6892df2497561bd63_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtNS0xLTEtMA_f618c692-dc22-43fd-b81a-aa0f5dc3fe91"
      unitRef="usd">262865000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i86411c359d1a4e08bd83fa3becd2af69_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtNy0xLTEtMA_341b64dc-374f-4bc6-82ea-e41c3446d611"
      unitRef="usd">-8026000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id8cb870c78c7468b82991b63a957577f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtOS0xLTEtMA_b59842d0-f0e9-4c86-a816-fbe9c19ed88d"
      unitRef="usd">-103159000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1fe1e680ce184c668d237cef4fa45980_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTEtMS0xLTA_80577815-bf7c-4ef9-8391-0ff0c37f2af9"
      unitRef="usd">151685000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia696c9fb613641ca908b22d1a1b6fda4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTMtMS0xLTA_62119b44-b65f-4882-bffc-065e32ee2710"
      unitRef="usd">81454000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTUtMS0xLTA_7afb80bb-4789-40d3-916e-05fd5d28663b"
      unitRef="usd">233139000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i6cc5dbf72ca544cd8fdd6e81e4269864_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtMS0xLTEtMjU1Nw_d33e21ca-221a-46e7-a62c-fe97484de1a6"
      unitRef="shares">491674</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzAtMTUtMS0xLTI1NzM_747b4548-0d57-49df-a089-515a3c716f64"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i99f93a3af86d4cf18e3b0b79c87477e8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtMS0xLTEtMjU2MQ_a4b14915-dc24-472f-8faf-c1c5c52140dd"
      unitRef="shares">10920</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iac2767be8a5846ac88dc5a19d3c5cdd0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzEtMTUtMS0xLTI1NzM_44c3438d-c530-439b-9278-662528f3cec5"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="ia89915e83e8f47d7b74a40ecdf68fe96_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItNS0xLTEtMjU4OA_f6a26b76-5981-467a-9fb0-4f0e49aa2ef2"
      unitRef="usd">12463000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItMTEtMS0xLTI1ODg_803b0d0b-426e-4a5a-ac47-3f78a998db82"
      unitRef="usd">12463000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzItMTUtMS0xLTI1ODg_5fcef480-46e2-46f0-8c97-ad844a07ddad"
      unitRef="usd">12463000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="i99f93a3af86d4cf18e3b0b79c87477e8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtMS0xLTEtMjU2NQ_96a44e00-59ff-49ac-b526-02d5bc8d4a45"
      unitRef="shares">823615</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="icd9fc193c5854fdc93bcf728fb8b4b34_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtNS0xLTEtMjU5NA_0ad636ba-9184-4cb8-bbbd-78c1d6e567da"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="id4830b5a7c0d4df5923a89542ecd633a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtMTEtMS0xLTI1OTQ_0f6ff9b1-87e8-42a9-ace3-6564f2dad1b2"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="iac2767be8a5846ac88dc5a19d3c5cdd0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzMtMTUtMS0xLTI1OTQ_49e7e097-b0b8-4c0d-b294-3076a19e6e0a"
      unitRef="usd">33011000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest
      contextRef="ia89915e83e8f47d7b74a40ecdf68fe96_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtNS0xLTEtNzIxOA_0c6534aa-f439-44d2-8e04-17ed0861423c"
      unitRef="usd">551000</rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest>
    <rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest
      contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTEtMS0xLTcyMTg_bd38820e-64bb-4805-b1d1-4e9bd8e6f010"
      unitRef="usd">551000</rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest>
    <rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTUtMS0xLTcyMTg_59c2b7f8-11a3-4751-9336-9a084414e869"
      unitRef="usd">551000</rdnt:AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ia1cd86610d3e409eb7e61fdffe0b0402_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTMtMS0xLTI2MDE_bbe1302e-3db3-4c1c-b74c-b2e83472dfba"
      unitRef="usd">1985000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzQtMTUtMS0xLTI2MDE_bf8539a3-c6c5-4d99-8ec8-8f45abec6cc8"
      unitRef="usd">1985000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="i416ef7c3fc3f4c4c990703d137b448b8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtNy0xLTEtMjYwNg_27faad34-df62-4bfa-91e1-201f8b7e1b7e"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtMTEtMS0xLTI2MDY_02a24ec5-3f77-4a36-b091-5de4cd43b762"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzUtMTUtMS0xLTI2MDY_b6d09e81-89a1-4a7b-981a-1598d75b6b7e"
      unitRef="usd">-101000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i416ef7c3fc3f4c4c990703d137b448b8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtNy0xLTEtMjYwNg_d03f724a-bae9-4fab-83bb-4a2a8cf79900"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtMTEtMS0xLTI2MDY_0b616f02-da33-4557-93b1-64e14fdd4ca0"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzYtMTUtMS0xLTI2MDY_ad60bcdd-0627-4372-a4e9-cb75b233ff73"
      unitRef="usd">-19372000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i416ef7c3fc3f4c4c990703d137b448b8_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctNy0xLTEtMjYwNg_357cf1e2-c6cc-46a8-b0a1-c5ea3942439b"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctMTEtMS0xLTI2MDY_c11b03f6-7e66-4a12-a639-84901bbed7db"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzctMTUtMS0xLTI2MDY_dfd3f417-9beb-4915-a313-64a0ce775313"
      unitRef="usd">-3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:ProfitLoss
      contextRef="i19057998bb654587aa0fe2496a826358_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtOS0xLTEtMjYxMw_e21cb004-2c74-4e65-aeda-1ca0c44f34f4"
      unitRef="usd">-14840000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ifb551cbc6fe044b2bad87184220fa8cf_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTEtMS0xLTI2MTM_78d27627-5940-4ec2-9e3d-9680926b39a8"
      unitRef="usd">-14840000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia1cd86610d3e409eb7e61fdffe0b0402_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTMtMS0xLTI2MTM_4e73f71b-ff48-4ebc-9f2d-68a328f80374"
      unitRef="usd">13091000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzgtMTUtMS0xLTI2MTM_95f9bb60-38ec-4f89-b775-c360c7a30155"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:SharesOutstanding
      contextRef="i3baa465341b441d8ae234bdc7ac7a2c0_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktMS0xLTEtMjU2OQ_bc3da239-827a-40a0-a2f8-4e9a5c1f67e5"
      unitRef="shares">51640537</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3baa465341b441d8ae234bdc7ac7a2c0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktMy0xLTEtMjU2OQ_ab8a6250-fe01-4921-9192-1787243822b3"
      unitRef="usd">5000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id829ecfe8db8402f80f8ee378ed8854e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktNS0xLTEtMjU2OQ_d11c637a-7179-4808-9a79-7b26c91efc04"
      unitRef="usd">307788000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i89e9405f6f814d8a9a3df0257feaca2a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktNy0xLTEtMjU2OQ_3e2814b8-461d-4336-96bd-a3bc6b2d6ef6"
      unitRef="usd">-24051000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i314621482e04419e975d6e27278101d0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktOS0xLTEtMjU2OQ_d5b1caac-b218-4748-b5f6-6833479f44b4"
      unitRef="usd">-117999000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iac06a801037b41eea48e4721682546dc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktMTEtMS0xLTI1Njk_299e33fd-a69d-45be-8ecc-9e62f3052b1b"
      unitRef="usd">165743000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ief57d143117e41c48907a4d78682dee8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktMTMtMS0xLTI1Njk_a6327f59-347c-4df6-96d3-fdb1b41976f4"
      unitRef="usd">92560000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF82Ny9mcmFnOjUxNDEyMmJkZWViODQwN2Q5NzZiNzU2ZTcwNDllNzk1L3RhYmxlOjQ3NjMwYTc0YTVkMTRmOTRhMzFmNDUwNDU3ODZjN2E0L3RhYmxlcmFuZ2U6NDc2MzBhNzRhNWQxNGY5NGEzMWY0NTA0NTc4NmM3YTRfMzktMTUtMS0xLTI1Njk_43fc0499-8b15-421f-a7bb-d0c4405f96a9"
      unitRef="usd">258303000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMy0xLTEtMS0w_a690f1f6-c0ac-42db-9ce0-3058e232b959"
      unitRef="usd">-1749000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMy0zLTEtMS0w_4787fc70-fc12-44fb-bf4e-81dac791b4df"
      unitRef="usd">23440000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMy01LTEtMS0w_85808450-6900-4e6b-9b4b-6eaa18fe841a"
      unitRef="usd">38133000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNS0xLTEtMS0w_7bb7f3cc-1869-485b-a7ad-d8f6668dfd07"
      unitRef="usd">86795000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNS0zLTEtMS0w_32c47142-ec41-4c78-8d4e-0e4f5d4e4eb9"
      unitRef="usd">80607000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNS01LTEtMS0w_1b931e98-53a6-4708-81db-6d4c0b860d92"
      unitRef="usd">72899000</us-gaap:DepreciationDepletionAndAmortization>
    <rdnt:OperatingLeaseRightofUseAssetAmortization
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNi0xLTEtMS0w_b28fb72f-3e8d-42c1-b2da-80d22c02426b"
      unitRef="usd">67915000</rdnt:OperatingLeaseRightofUseAssetAmortization>
    <rdnt:OperatingLeaseRightofUseAssetAmortization
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNi0zLTEtMS0w_7a5c2bf1-1495-4c02-99ab-153b1efb69d2"
      unitRef="usd">66842000</rdnt:OperatingLeaseRightofUseAssetAmortization>
    <rdnt:OperatingLeaseRightofUseAssetAmortization
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNi01LTEtMS0w_aa305a04-bd98-4b15-bf45-66283241c817"
      unitRef="usd">0</rdnt:OperatingLeaseRightofUseAssetAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOC0xLTEtMS0w_97c3465c-070f-424e-b35c-8f8ba8566067"
      unitRef="usd">-1577000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOC0zLTEtMS0w_3a897a95-c178-4792-b7fd-fa58c7a5ad42"
      unitRef="usd">-248000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOC01LTEtMS0w_4830648d-3d33-44e9-8679-df931aa09402"
      unitRef="usd">-13469000</us-gaap:IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOS0xLTEtMS0w_5e1c399b-a746-4b73-a059-602961b2de29"
      unitRef="usd">4413000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOS0zLTEtMS0w_3b8d62b6-16bb-4fb1-ab3b-2fcb3f119b30"
      unitRef="usd">4184000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfOS01LTEtMS0w_f0b665f4-0043-43fb-9845-c15a53463077"
      unitRef="usd">3898000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTAtMS0xLTEtMA_0fafaa18-a9e3-43d8-b208-d435435f02ea"
      unitRef="usd">-1200000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTAtMy0xLTEtMA_b5c436d3-8993-4094-b529-eb93a5596494"
      unitRef="usd">-2383000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainLossOnDispositionOfAssets
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTAtNS0xLTEtMA_e0db9589-7673-44c7-b6fc-066f5cc1a667"
      unitRef="usd">2054000</us-gaap:GainLossOnDispositionOfAssets>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTEtMS0xLTEtMA_15420bd4-df20-41e0-a087-0ab6d19a0f3d"
      unitRef="usd">4047000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTEtMy0xLTEtMA_029a5480-b133-4ad5-b9fa-231070231468"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTEtNS0xLTEtMA_3e732186-1538-4190-90d9-d311be4d2b33"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <rdnt:GainLossonStepUpValuation
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTItMS0xLTEtMA_0f9c58dc-ab48-45a7-b32a-17992c4e0848"
      unitRef="usd">0</rdnt:GainLossonStepUpValuation>
    <rdnt:GainLossonStepUpValuation
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTItMy0xLTEtMA_6710b75e-dba3-4eb0-ab95-2db35e70fcd1"
      unitRef="usd">768000</rdnt:GainLossonStepUpValuation>
    <rdnt:GainLossonStepUpValuation
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTItNS0xLTEtMA_44bb9b8a-ef9c-4299-a7bb-5732cf0e1082"
      unitRef="usd">39539000</rdnt:GainLossonStepUpValuation>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtMS0xLTEtMA_c8935475-e400-48a2-a920-52be689b9160"
      unitRef="usd">4170000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtMy0xLTEtMA_c2f2a732-6991-4866-b075-5221185b4eb2"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtNS0xLTEtMA_503d6c16-e69f-4759-86df-69a1a7f1d5fe"
      unitRef="usd">3937000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtMS0xLTEtMjcyNQ_67cd0925-ffc9-49ce-9772-a8b717b6eb64"
      unitRef="usd">3448000</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtMy0xLTEtMjcyOQ_1d024de1-fd3f-46e9-a8c3-0e563c382986"
      unitRef="usd">0</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:AmortizationOfDeferredHedgeGains
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTMtNS0xLTEtMjcyOQ_cb615ba2-5721-4b65-b4b2-49fac2bdadd4"
      unitRef="usd">0</us-gaap:AmortizationOfDeferredHedgeGains>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtMS0xLTEtMjczMw_ce98cdbc-3201-4101-af83-2b4830a090dd"
      unitRef="usd">-2528000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtMy0xLTEtMjczMw_ebb183ad-30ca-4488-b251-bab92562d5f3"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtNS0xLTEtMjczMw_a2c1a646-d15a-4d54-a93e-5d6f2fc37a8c"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:ShareBasedCompensation
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtMS0xLTEtMA_8cec152c-41a8-41ed-8a09-7e40b81a0eaf"
      unitRef="usd">12405000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtMy0xLTEtMA_24c3d222-dd5b-45fa-8a27-a029d89e3553"
      unitRef="usd">8730000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTQtNS0xLTEtMA_2f083040-79a2-42ef-9d1e-878f1d75645f"
      unitRef="usd">7662000</us-gaap:ShareBasedCompensation>
    <rdnt:IncreaseDecreaseInOtherNoncashItem
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTUtMS0xLTEtMA_c66f0a29-1c5b-40b1-9d3f-e4fa0a2d43fb"
      unitRef="usd">-242000</rdnt:IncreaseDecreaseInOtherNoncashItem>
    <rdnt:IncreaseDecreaseInOtherNoncashItem
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTUtMy0xLTEtMA_e49c548c-be42-43ce-814a-3c3ca4c67fca"
      unitRef="usd">371000</rdnt:IncreaseDecreaseInOtherNoncashItem>
    <rdnt:IncreaseDecreaseInOtherNoncashItem
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTUtNS0xLTEtMA_c8ee35a1-c271-4d18-a4d5-5ea5df75bbe7"
      unitRef="usd">0</rdnt:IncreaseDecreaseInOtherNoncashItem>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTctMS0xLTEtMA_f878b421-1291-4bb9-9a73-72de6acc27bb"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTctMy0xLTEtMA_60b79ef9-eab5-44f2-a379-3e452fd60d0e"
      unitRef="usd">-3123000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTctNS0xLTEtMA_39e46fb6-25b5-40a4-8ebe-b155240329e5"
      unitRef="usd">1749000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTktMS0xLTEtMA_6326371c-98d3-4dcc-95b6-0b1d67379d7c"
      unitRef="usd">-25206000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTktMy0xLTEtMA_bf845ce8-6843-49d4-bebd-444e29d14cfc"
      unitRef="usd">17482000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMTktNS0xLTEtMA_68f9ec5a-3bca-4c76-9eef-df105617bf8b"
      unitRef="usd">-2145000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjAtMS0xLTEtMA_9809c9ba-0c7b-4edc-9d32-2918d2feb126"
      unitRef="usd">-6588000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjAtMy0xLTEtMA_f55a19b9-d953-4caa-9002-a0f6eb2e1c46"
      unitRef="usd">3557000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherCurrentAssets
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjAtNS0xLTEtMA_ca0e55b6-0264-43da-9f12-1f614a458d10"
      unitRef="usd">9248000</us-gaap:IncreaseDecreaseInOtherCurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjEtMS0xLTEtMA_e2ea2ccb-0c83-4cfb-bc46-ab2e9e6083ed"
      unitRef="usd">5425000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjEtMy0xLTEtMA_9201b247-1082-4ff9-ae2e-733fc75cf2fd"
      unitRef="usd">2326000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjEtNS0xLTEtMA_4a5dc253-c9ed-43e6-ac0b-0f55131cf89c"
      unitRef="usd">1687000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjItMS0xLTEtMA_96b69160-4200-41d9-9f22-44c8db462c4d"
      unitRef="usd">611000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjItMy0xLTEtMA_7769d1d4-5d23-401a-b6d7-bfa31e9c98df"
      unitRef="usd">3888000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjItNS0xLTEtMA_3ab37790-d644-4ee9-89af-d84a26e43774"
      unitRef="usd">6935000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <rdnt:IncreaseDecreaseinOperatingLeaseLiability
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjMtMS0xLTEtMA_1f3ff7ef-5787-491d-b39d-666d8bad883c"
      unitRef="usd">53906000</rdnt:IncreaseDecreaseinOperatingLeaseLiability>
    <rdnt:IncreaseDecreaseinOperatingLeaseLiability
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjMtMy0xLTEtMA_5e7367d6-389e-49bc-be0b-e1ca598d852a"
      unitRef="usd">66831000</rdnt:IncreaseDecreaseinOperatingLeaseLiability>
    <rdnt:IncreaseDecreaseinOperatingLeaseLiability
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjMtNS0xLTEtMA_ffef190a-06f2-410b-9b0c-3317a5d70d6b"
      unitRef="usd">0</rdnt:IncreaseDecreaseinOperatingLeaseLiability>
    <rdnt:IncreaseDecreaseInDeferredRent
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjQtMS0xLTEtMA_e5fb12a8-d198-4c12-92f0-5a89b0fb9820"
      unitRef="usd">0</rdnt:IncreaseDecreaseInDeferredRent>
    <rdnt:IncreaseDecreaseInDeferredRent
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjQtMy0xLTEtMA_40631a84-352a-422f-9e38-109311048f47"
      unitRef="usd">0</rdnt:IncreaseDecreaseInDeferredRent>
    <rdnt:IncreaseDecreaseInDeferredRent
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjQtNS0xLTEtMA_96e6f641-d630-454a-8dfc-6e86ad88b62c"
      unitRef="usd">6312000</rdnt:IncreaseDecreaseInDeferredRent>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjUtMS0xLTEtMA_3e01ca54-879c-475b-b1ab-37206b455a90"
      unitRef="usd">37941000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjUtMy0xLTEtMA_70709423-c96c-4cf8-8a02-83aeb8eec329"
      unitRef="usd">-1082000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjUtNS0xLTEtMA_4318c0cd-ab2e-4dec-b74d-f4eaf81d3a00"
      unitRef="usd">-208000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjYtMS0xLTEtMA_0c64925c-7213-4442-ab44-a614198a9371"
      unitRef="usd">45069000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjYtMy0xLTEtMA_99a18fdd-669d-4392-be3a-4a8de49e5d4e"
      unitRef="usd">17316000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjYtNS0xLTEtMA_5467b233-13e9-4d36-94e4-b6a263c4ac2a"
      unitRef="usd">26221000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjctMS0xLTEtMA_d06470ee-75a7-44cb-a083-d56f58a7bfc2"
      unitRef="usd">233759000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjctMy0xLTEtMA_9c9d0628-1f1e-4bb8-90ac-15af6fcd4572"
      unitRef="usd">104322000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjctNS0xLTEtMA_1682b942-5249-4adc-9315-af1268900455"
      unitRef="usd">116754000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjktMS0xLTEtMA_e92b4be3-fd25-4ef7-abc4-2c86fbfe0fd2"
      unitRef="usd">31265000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjktMy0xLTEtMA_ce9523b4-0233-422f-9b0f-35e855ad2a64"
      unitRef="usd">27150000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireBuildings
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMjktNS0xLTEtMA_0cb3aa74-d2f1-4e5d-ae8b-87c1ee3845be"
      unitRef="usd">73192000</us-gaap:PaymentsToAcquireBuildings>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzAtMS0xLTEtMA_e3d45c33-c518-41cc-9326-dba1d5300647"
      unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzAtMy0xLTEtMA_1cb14599-7289-4a89-9d78-d943a7356bed"
      unitRef="usd">143000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzAtNS0xLTEtMA_496705e2-5318-4828-882f-6cc93d692c87"
      unitRef="usd">2200000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzEtMS0xLTEtMA_72cef21d-8fdd-40eb-9e0b-0c49cbd9ad6c"
      unitRef="usd">94172000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzEtMy0xLTEtMA_11a67231-1333-44d6-bc30-701e5cceda08"
      unitRef="usd">74153000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzEtNS0xLTEtMA_09785fd1-3602-472d-afbf-f6ee22fff544"
      unitRef="usd">72180000</us-gaap:PaymentsToAcquireOtherPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzItMS0xLTEtMA_b3535805-a7ed-49a0-bffa-f1a081851e0e"
      unitRef="usd">828000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzItMy0xLTEtMA_8f9ff99f-bb7a-4a3a-85ec-72d5205761c0"
      unitRef="usd">1160000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzItNS0xLTEtMA_f7a4a6c6-a574-4ece-ac63-9c0c5d3a9e06"
      unitRef="usd">2575000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzMtMS0xLTEtMA_98632047-93be-4ae5-8407-9382a284b3ef"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzMtMy0xLTEtMA_9fd693dc-d68e-4889-ab00-7ff71dacc9fd"
      unitRef="usd">132000</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzMtNS0xLTEtMA_80e96a60-c7ee-4993-9241-f3fa5ceb2de4"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzUtMS0xLTEtMA_4fb12831-2ed1-40d2-a0e1-9af5ecc20cdf"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzUtMy0xLTEtMA_02fb88f1-4080-4e88-9969-6edb54a3cd78"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfIntangibleAssets
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzUtNS0xLTEtMA_390d50ae-ad6b-4485-a08b-6d5fd4fd0b19"
      unitRef="usd">248000</us-gaap:ProceedsFromSaleOfIntangibleAssets>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzYtMS0xLTEtMA_29fdcf0f-3330-44bf-ace0-e10f52cf134f"
      unitRef="usd">0</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzYtMy0xLTEtMA_b41309a3-c630-42e6-96b6-04d86368ce58"
      unitRef="usd">792000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzYtNS0xLTEtMA_c98d8397-25ca-4544-bb3f-f593ba810cd2"
      unitRef="usd">0</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzgtMS0xLTEtMA_11a6c022-6072-4e85-918c-0925b923be41"
      unitRef="usd">1635000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzgtMy0xLTEtMA_6d699531-dd2b-4c84-9894-11c33b37f564"
      unitRef="usd">103000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzgtNS0xLTEtMA_cf5d9c75-bc6e-4168-b5ae-4984feb99bbb"
      unitRef="usd">2000000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzktMS0xLTEtMA_4427851f-fb65-4490-bfe8-046963f6c95e"
      unitRef="usd">-126244000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzktMy0xLTEtMA_dd2766dd-5a6e-464a-91dd-8072ddbfa311"
      unitRef="usd">-99465000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfMzktNS0xLTEtMA_5639326c-3529-499f-99a2-50caa1ee9d33"
      unitRef="usd">-146749000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDEtMS0xLTEtMA_19d2a393-e9cb-493a-9b9f-17c30c068f0b"
      unitRef="usd">3562000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDEtMy0xLTEtMA_8f328457-667b-4f68-a17d-6b8b9fda5769"
      unitRef="usd">6494000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDEtNS0xLTEtMA_9f824440-be49-46c0-a0f1-7bb1b91b1957"
      unitRef="usd">6072000</us-gaap:RepaymentsOfLongTermDebtAndCapitalSecurities>
    <us-gaap:RepaymentsOfDebt
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDItMS0xLTEtMA_f481d6dd-86f7-4f10-90e8-93d753c617f3"
      unitRef="usd">43296000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDItMy0xLTEtMA_6b2365e1-7e69-4ca1-8e40-26e0b5e56509"
      unitRef="usd">40742000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDItNS0xLTEtMA_5c7c8f8a-b600-4103-914b-0b9762e0599d"
      unitRef="usd">33830000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtMS0xLTEtNjE5OQ_1c81f725-59c0-44e7-af76-239352cc3591"
      unitRef="usd">741000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtMy0xLTEtNjE5OQ_c519b0e4-6a04-4c16-91a9-ca2d064ef8f7"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtNS0xLTEtNjE5OQ_6f9802bd-f799-435c-96dd-a56ad4c2fbf9"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDMtMS0xLTEtMA_062039ab-c120-448e-b3f0-d6c422abf657"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDMtMy0xLTEtMA_87ad818f-1542-4751-82d2-83c8fcb2262c"
      unitRef="usd">97144000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDMtNS0xLTEtMA_6c528607-6cc4-4446-9c3d-233054d598c5"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfDebt>
    <rdnt:ProceedsFromGovernmentAssistance
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtMS0xLTEtNjIxMQ_10043e29-7021-4eed-ab09-98eb053d8e6d"
      unitRef="usd">4023000</rdnt:ProceedsFromGovernmentAssistance>
    <rdnt:ProceedsFromGovernmentAssistance
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtMy0xLTEtNjIxMQ_c0f2dafc-2791-4c9d-8faf-a8df71a29f1b"
      unitRef="usd">0</rdnt:ProceedsFromGovernmentAssistance>
    <rdnt:ProceedsFromGovernmentAssistance
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtNS0xLTEtNjIxMQ_f7fd6d30-7d0f-4d91-b79d-456032913072"
      unitRef="usd">0</rdnt:ProceedsFromGovernmentAssistance>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtMS0xLTEtMA_66f77811-f384-41b0-a7b3-3a76c9fc02cc"
      unitRef="usd">1985000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtMy0xLTEtMA_b15d018d-910e-4633-b82f-076ae04a8661"
      unitRef="usd">3057000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDQtNS0xLTEtMA_1d59c9b2-6701-4ebe-9891-735ff9b40c29"
      unitRef="usd">1427000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDUtMS0xLTEtMA_40efd8d9-accc-4e49-b5c8-0ac1a9945271"
      unitRef="usd">0</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDUtMy0xLTEtMA_10de8fc1-f61b-47f4-8721-9883c4ca628d"
      unitRef="usd">5275000</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDUtNS0xLTEtMA_737aeffa-4115-41f0-a2bc-29473d8d5bf9"
      unitRef="usd">0</us-gaap:ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtMS0xLTEtMA_d729c8aa-f733-42e4-ba11-26546380915e"
      unitRef="usd">0</us-gaap:ProceedsFromContributedCapital>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtMy0xLTEtMA_d23a2b3f-9997-403e-b9dd-99674e93c2d1"
      unitRef="usd">750000</us-gaap:ProceedsFromContributedCapital>
    <us-gaap:ProceedsFromContributedCapital
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDYtNS0xLTEtMA_0e6bd985-4e75-4fb5-ab20-3c586268db16"
      unitRef="usd">2640000</us-gaap:ProceedsFromContributedCapital>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDctMS0xLTEtMA_286f88bb-c9d8-4d63-a29e-efd2504cceeb"
      unitRef="usd">250900000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDctMy0xLTEtMA_27aab733-1f8d-40ce-ac62-b4a2a8030758"
      unitRef="usd">261200000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDctNS0xLTEtMA_208f9bb3-3c99-4ac6-a5b5-5b79a6315332"
      unitRef="usd">204300000</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDgtMS0xLTEtMA_f9b124f3-84ca-4444-8631-10d9f565bde9"
      unitRef="usd">250900000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDgtMy0xLTEtMA_4967a75b-e81d-4a43-bbc9-40702bec4c5d"
      unitRef="usd">289200000</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDgtNS0xLTEtMA_b146007e-a050-4529-a7ad-5a99c465b5e7"
      unitRef="usd">176300000</us-gaap:RepaymentsOfLinesOfCredit>
    <rdnt:PaymentsToAcquireInterestInSubsidiaries
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDktMS0xLTEtMA_1529812f-7dce-4c3e-a0f5-d3eec0141c41"
      unitRef="usd">0</rdnt:PaymentsToAcquireInterestInSubsidiaries>
    <rdnt:PaymentsToAcquireInterestInSubsidiaries
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDktMy0xLTEtMA_440ec7a0-d191-43f3-a821-700c27ff7e63"
      unitRef="usd">0</rdnt:PaymentsToAcquireInterestInSubsidiaries>
    <rdnt:PaymentsToAcquireInterestInSubsidiaries
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNDktNS0xLTEtMA_d31a579f-04f9-4322-924e-a66e82729e9c"
      unitRef="usd">200000</rdnt:PaymentsToAcquireInterestInSubsidiaries>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTAtMS0xLTEtMA_79415d70-4f3e-42b3-9627-bb4099c2e4b0"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTAtMy0xLTEtMA_511307cf-5b12-4c64-a0d6-3002f28c0064"
      unitRef="usd">75000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTAtNS0xLTEtMA_57430c4e-1c4a-430d-a93a-44ce6add6034"
      unitRef="usd">20000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTEtMS0xLTEtMA_e565bf8a-99b7-4ef6-ad38-42a07126a760"
      unitRef="usd">-45561000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTEtMy0xLTEtMA_ecc913a3-236b-46e3-9203-3373abf8cf2e"
      unitRef="usd">24951000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTEtNS0xLTEtMA_cce5960e-8825-4f6d-856e-c9eea9c708ff"
      unitRef="usd">-10869000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTItMS0xLTEtMA_b1ed7879-07de-4e15-a138-64f9f7cd5f8f"
      unitRef="usd">-101000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTItMy0xLTEtMA_2b11e1d6-a1cd-48c5-a13a-04d8db76771e"
      unitRef="usd">-32000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTItNS0xLTEtMA_519020fe-9a3f-4b82-a8d6-68d02cc1c1e9"
      unitRef="usd">-69000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTMtMS0xLTEtMA_4640b9d8-f4bd-4abd-a9fc-215428fde9d4"
      unitRef="usd">61853000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTMtMy0xLTEtMA_5883d53d-e378-49cc-8e72-2be753985331"
      unitRef="usd">29776000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTMtNS0xLTEtMA_8e3e94d5-8450-4472-86cc-aa87e3d07bd2"
      unitRef="usd">-40933000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTQtMS0xLTEtMA_34ebd1be-813f-484b-900f-2afa84199a46"
      unitRef="usd">40165000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibae6485d220c4366bf04745e679dee34_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTQtMy0xLTEtMA_dbc62fb8-10c5-40ce-b373-7192da4e27fd"
      unitRef="usd">10389000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4642cbc638c646e88712849889f662b5_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTQtNS0xLTEtMA_b7ad8467-140e-414d-814e-048e1c677e2a"
      unitRef="usd">51322000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTUtMS0xLTEtMA_a382d158-d2d3-49c5-89c0-baa3df8e10ab"
      unitRef="usd">102018000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTUtMy0xLTEtMA_1f4f7deb-b0b4-4a9e-b9a3-712a76619117"
      unitRef="usd">40165000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibae6485d220c4366bf04745e679dee34_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTUtNS0xLTEtMA_59304e41-bcda-46ab-beeb-e9431eb86b70"
      unitRef="usd">10389000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTctMS0xLTEtMA_e8537a4b-4e1a-4d97-af70-fc0b4e72c6ec"
      unitRef="usd">39521000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTctMy0xLTEtMA_ebf7e4d0-b2f0-406a-bebd-994d5f8f79a3"
      unitRef="usd">46254000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTctNS0xLTEtMA_de8cac4f-bf64-4608-b9ca-ccc76d6d2f3b"
      unitRef="usd">37016000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTgtMS0xLTEtMA_8fefad57-8315-44ba-80ae-362095d3979a"
      unitRef="usd">5069000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTgtMy0xLTEtMA_067c1cbb-9e31-4a6f-bb43-d19c40755912"
      unitRef="usd">5884000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RhYmxlOjZhMDZmYzEzYTczMzQzZDE4OWIzNGE3MTFmZmQxMjk1L3RhYmxlcmFuZ2U6NmEwNmZjMTNhNzMzNDNkMTg5YjM0YTcxMWZmZDEyOTVfNTgtNS0xLTEtMA_a1c44ee1-e9f0-4ef6-88f4-15321d0ec19f"
      unitRef="usd">4933000</us-gaap:IncomeTaxesPaidNet>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfNDA1_298edbae-5ac9-4295-b3aa-9edb15595c36"
      unitRef="usd">52000000.0</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfNDA5_45dae2ad-234a-4f48-9e6a-3676d3a93f5d"
      unitRef="usd">51700000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:EquipmentAcquiredAndLeaseholdImprovements
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfNDE3_0ec3e1b9-bebf-43b4-a9ba-c9406de24130"
      unitRef="usd">47800000</rdnt:EquipmentAcquiredAndLeaseholdImprovements>
    <rdnt:CapitalLeaseDebt
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfODAz_20c50e58-993e-4a5c-bf0a-7dfdb4f4c054"
      unitRef="usd">20000.0</rdnt:CapitalLeaseDebt>
    <rdnt:CapitalLeaseDebt
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfODA3_8a338a6c-9252-4d95-a201-3b24571a5e00"
      unitRef="usd">100000</rdnt:CapitalLeaseDebt>
    <rdnt:CapitalLeaseDebt
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfODE1_9f74b6e4-0fba-4d46-b20e-bafbf170ecda"
      unitRef="usd">6700000</rdnt:CapitalLeaseDebt>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution
      contextRef="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MzEzOQ_f4488766-f847-4c2f-be62-17b993d53730"
      unitRef="shares">823615</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution
      contextRef="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MzE0Mw_50329ef5-866d-4d89-8ee9-74cbe146f94e"
      unitRef="usd">13900000</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i0d288cd107d84361b2e08ab554ae5ed7_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MjA2Mg_e174b3ee-cd18-4cec-9e4f-ecbc3617d1ff"
      unitRef="usd">1500000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i46ed970e221a4949933067bb7c822615_I20190801"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MjA3OQ_e5cb3393-ec1c-4253-963a-14d33a1c1e38"
      unitRef="number">0.75</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i1a886167e5d546978b5a20d615e9fc78_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2Mjg2Mw_9a13002a-15ec-483b-a454-c4fac8a06745"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i1a886167e5d546978b5a20d615e9fc78_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2Mjk3Ng_9a13002a-15ec-483b-a454-c4fac8a06745"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ida4995e095e84733a7a3db2b2c529f94_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MzA0MA_40b3fe15-1bd6-454c-b6b1-5ffa7f2226be"
      unitRef="usd">1300000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i3b935882b4d8429a874b97a0270ab625_I20190301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjc0ODc3OTA3NTE3Mw_859a55fe-c957-4e1d-aa88-b945ea2b46bd"
      unitRef="usd">4300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="ib6d052daae794a8fac16e845d601f61e_D20190227-20190227"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjc0ODc3OTA3NTE4MA_e96f4b9f-a3f0-4121-9dc0-dbddf1a10976"
      unitRef="shares">440207</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i9a9e5ef103564deb822d473edf70473d_I20190227"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjc0ODc3OTA3NTE4NA_9c6803d0-84e2-4218-8938-61bd0e9f1d96"
      unitRef="usd">6000000.0</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="i9a9e5ef103564deb822d473edf70473d_I20190227"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjc0ODc3OTA3NTE5MQ_b35c1b75-d30e-4263-850b-95804e6007dd"
      unitRef="usd">700000</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <rdnt:BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance
      contextRef="i107a79c6ba52476ebe7de9b31052579f_D20181001-20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTI3MQ_a426b975-6e54-4d6e-be76-e4a8cbd7e1a1"
      unitRef="usd">44300000</rdnt:BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i4ff1137ebe584b6e9251f4be6a157e86_I20181001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTI2Nw_2db3b96e-b210-42be-9724-d111bf73484a"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i107a79c6ba52476ebe7de9b31052579f_D20181001-20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTI2MA_27707fda-5a61-449a-a3d1-53c394533ce3"
      unitRef="usd">39500000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <rdnt:BusinessCombinationStepAcquisitionCashAcquired
      contextRef="i107a79c6ba52476ebe7de9b31052579f_D20181001-20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTI1Mw_b1136bdd-980d-40e4-87d2-2b623bcfc1da"
      unitRef="usd">5400000</rdnt:BusinessCombinationStepAcquisitionCashAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i0394c754617f470ca05634e5df485f1f_D20181001-20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTI0Ng_682f2df2-c64d-486c-8cf7-88c5ccdd3d43"
      unitRef="usd">50900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred
      contextRef="i0394c754617f470ca05634e5df485f1f_D20181001-20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTIzOQ_8c7f8351-55d9-4c2d-b7aa-781ed909529b"
      unitRef="usd">2700000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i0394c754617f470ca05634e5df485f1f_D20181001-20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTIzMw_a0ae072c-662b-4a35-86a1-a4f0379a88ab"
      unitRef="usd">8000000.0</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized
      contextRef="iadcbd5b4c90e437fae076570fd592eab_I20181001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTIyNg_c14bd9ae-d54b-4acc-b6b0-492da9eb7927"
      unitRef="usd">700000</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="id037acfdb2974904b3b0606b4fe20b4d_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTIxOQ_6bba612e-2720-43f7-9010-032ffa6e6a81"
      unitRef="usd">1700000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue
      contextRef="ia978d78cb33c49d0b2db28864fec1dce_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjc0ODc3OTA3NTE5OA_ffa1a07c-355d-47a4-94f6-455df7c5d473"
      unitRef="usd">2400000</us-gaap:BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue>
    <rdnt:NoncontrollingInterestSpecialDistribution
      contextRef="i5527d962127c4f0890eb1bf05ca35aac_D20180901-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTE5NQ_5a1661f4-9bfa-472c-9ed6-fb080bf1adde"
      unitRef="usd">9200000</rdnt:NoncontrollingInterestSpecialDistribution>
    <rdnt:NoncontrollingInterestSpecialDistribution
      contextRef="ife75574fa4f34d78b8d99e90205c9f7b_D20180901-20180930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTIwOA_7b085806-1d00-4066-bc3a-88ca7787051e"
      unitRef="usd">3000000.0</rdnt:NoncontrollingInterestSpecialDistribution>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i7c749423cff34945b7292f9e192be48f_I20180101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTE1Nw_c4a8b119-eaa4-48d4-a016-9aaea99e711e"
      unitRef="usd">15000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation
      contextRef="i7c749423cff34945b7292f9e192be48f_I20180101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83MC9mcmFnOjU3ZmIzMjU1ZWY1YzQ3ZDdhZThhZTc4OGMwNzRlMzg0L3RleHRyZWdpb246NTdmYjMyNTVlZjVjNDdkN2FlOGFlNzg4YzA3NGUzODRfMjE5OTAyMzI2MTE4OA_60905546-4d69-4c94-a3dd-cccb6459afdb"
      unitRef="usd">4000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation>
    <us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNzY3Mw_5bbc3bb6-f6ee-4d26-a2e1-a7add423fa3f">NATURE OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2020, we operated directly or indirectly through joint ventures with hospitals, 331 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures. In addition to our imaging services, we have certain other software subsidiaries which design and sell computerized systems for the imaging industry and internally develop Artificial Intelligence suites to enhance interpretation of radiographic images. Our operations comprise a single segment for financial reporting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#x201c;RadNet&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d; or the &#x201c;Company&#x201d; in this report&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#x201c;VIE&#x201d;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#x2019;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#x2019;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management, namely Howard G. Berger, M.D., our President and Chief Executive Officer, and John V. Crues, III, M.D., RadNet's Medical Director; both of whom are members of our Board of Directors.  Dr. Berger owns, indirectly, 99% of the equity interests in Beverly Radiology Medical Group III (BRMG) and a controlling interest in two professional corporations in New York City.  BRMG is responsible for the professional medical services at nearly all of our facilities located in California.  Dr. Crues owns six professional corporations which provide medical services in Delaware, Maryland, New Jersey and New York.  Additionally, Dr. Crues is a 1% owner of BRMG.  These VIEs are collectively referred to as the consolidated medical group ("the Group").&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity. Through management agreements with us, substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Group on a combined basis recognized $147.6 million, $157.4 million, and $132.9 million of revenue, net of management services fees to RadNet, for the years ended December 31, 2020, 2019, and 2018, respectively and $147.6 million, $157.4 million, and $132.9 million of operating expenses for the years ended December 31, 2020, 2019, and 2018, respectively. RadNet, Inc. recognized $600.7 million, $618.9 million, and $505.2 million of total billed net service fee revenue for the years ended December 31, 2020, 2019, and 2018, respectively, for management services provided to them relating primarily to the technical portion of billed revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December 31, 2020 and December 31, 2019, we have included approximately $82.3 million and $100.3 million, respectively, of accounts receivable and approximately $15.2 million and $7.0 million of accounts payable and accrued liabilities related to the Group, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of them. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also own a 49% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender LLC is dependent on the Company to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At all of our centers not serviced by the Group we have entered into long-term contracts (typically 10 to 40 years in length) with independent radiology groups to provide physician services at those centers. These radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee based on the value of the services we provide.  We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us and we have no economic controlling interest in these radiology practices. As such, the financial results of these practices are not consolidated in our financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock>
    <rdnt:NumberOfCenters
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfMjMz_8cf8ba6f-e5b6-40c3-81dc-46fa918f5ac7"
      unitRef="center">331</rdnt:NumberOfCenters>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i9bcc7eba5c6e48c898708be79cf90c04_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfMzU4NA_e874c50f-8208-452e-89e8-9f428e1b1f0c"
      unitRef="number">0.99</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i58b03b73c60d49f3939e2ad703919efe_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDAwNA_decbcecc-d0b3-408d-9626-30260a8eb214"
      unitRef="number">0.01</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDgxNQ_5a7b0555-3ca4-4759-a0ea-1ba100bdc1ec"
      unitRef="usd">147600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDgxOQ_1e8f6d58-e674-4973-965c-1c194e40a120"
      unitRef="usd">157400000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDgyNw_de19d6df-0d02-426c-a535-5bc4e44050bb"
      unitRef="usd">132900000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityRevenues>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDkzOQ_bd46a425-45c5-4e5f-a132-b52d84dd28b4"
      unitRef="usd">147600000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDk0Mw_25288aef-f13b-4498-a967-cc5bf588625f"
      unitRef="usd">157400000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNDk1MQ_3b8f28d5-0737-4ca7-8195-725512c80104"
      unitRef="usd">132900000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityExpense>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTA1MA_df4b48ca-5aab-4d2b-9c98-c594ffab11d6"
      unitRef="usd">600700000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTA1NA_f513c65b-8fef-47b4-80d2-2bb2fe6ec92e"
      unitRef="usd">618900000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTA2Mg_c86eb51c-e886-4923-b384-a754c973e961"
      unitRef="usd">505200000</us-gaap:VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax>
    <us-gaap:Assets
      contextRef="i7d60bb5091324738b842894a8d612608_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTUyMw_3b2803e7-58d1-42b6-8e8f-1b02d540a6e0"
      unitRef="usd">82300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i80ff729336ff43a7b8f70a9e53ad3932_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTUzMA_64c06885-3aa0-4e94-a432-94e169d27df1"
      unitRef="usd">100300000</us-gaap:Assets>
    <us-gaap:Liabilities
      contextRef="i7d60bb5091324738b842894a8d612608_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTU4OQ_5bd2b7a9-1449-404c-b11c-7a23621e84e4"
      unitRef="usd">15200000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i80ff729336ff43a7b8f70a9e53ad3932_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTU5Ng_93088c58-9156-419f-a736-0cb0e91c1578"
      unitRef="usd">7000000.0</us-gaap:Liabilities>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i4e0c5a3c996d40d6b9a18855f3170e9f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfNTk3OA_9a22a3bd-d028-4aa6-b2b6-82f6459da23b"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <rdnt:LongTermContractsTerm
      contextRef="i9aa53910584d4308b3a9af105783ce91_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfMzI5ODUzNDg5MTI3NA_e9a45383-7eba-4bcd-869c-7241d734c6c7">P10Y</rdnt:LongTermContractsTerm>
    <rdnt:LongTermContractsTerm
      contextRef="i59d8b9f6e0ef49d4a4d3fe5016d69357_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83Ni9mcmFnOjZmMDgzNDg2ZjM4ZDQ0N2RhNWMzNDFkMDk0Y2FjYWVmL3RleHRyZWdpb246NmYwODM0ODZmMzhkNDQ3ZGE1YzM0MWQwOTRjYWNhZWZfMzI5ODUzNDg5MTI4Ng_cde48027-da23-4d10-8269-1ea624b41735">P40Y</rdnt:LongTermContractsTerm>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Mzc_89cf675a-610f-4e11-a735-e5da53f1e4b2">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PRINCIPLES OF CONSOLIDATION &#x2013; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#x201c;financial statements&#x201d;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#x2019;s control. As a result, actual amounts could materially differ from these estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RECLASSIFICATION - For the year 2019, we have reclassified certain amounts previously classified as held for sale related to property and equipment and goodwill to conform to our 2020 presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;REVENUES &#x2013; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;1, 2018, we adopted the new revenue recognition accounting standard issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) and codified in the ASC as topic 606 (&#x201c;ASC 606&#x201d;). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding our revenue recognition policies and significant judgments employed in the determination of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total net revenues for the years ended December 31, 2020, 2019, and 2018 are presented in the table below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging on call and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  Patient volumes and the related revenues for our services were significantly impacted during the latter portion of the first quarter through the middle of the third quarter of 2020 as a result of federal, state and local government mandated restrictions requiring many people to remain at home and forced the closure of or limitations on certain businesses, as well as suspended elective procedures by health care facilities.  Many of these restrictions &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;have been eased or completely lifted across the states the Company operates in however, we are unable to predict the future impact of the pandemic on our operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the twelve months ended December 31, 2020, we received $43.2 million of accelerated Medicare payments, $5.0 million from Blue Shield, $26.3 million from the general distribution and $4.0 million from the Paycheck Protection Program established through the Coronavirus Aid, Relief and Economic Security (&#x201c;CARES&#x201d;) Act.  The accelerated Medicare payments are recorded under the caption &#x201c; Deferred Revenue&#x201c;  in our consolidated balance sheet and will be withheld from reimbursements for services in 2021 and 2022.  The general distribution funds were accounted for as government grants and recognized as other revenue, once reasonable assurance that the applicable terms and conditions required to retain the funds were met, under the caption &#x201c;Provider relief funding&#x201d; in our Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The CARES Act also provides for a payment deferral of the employer portion of Social Security tax incurred during the pandemic, allowing half of such payroll taxes to be deferred until December 2021 and the remaining half until December 2022.  At December 31, 2020, the Company had deferred $16.3 million of Social Security taxes.  These payment deferrals are recorded as payroll tax liability under the caption &#x201c;Accounts payable, accrued expenses and other&#x201d; in our consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;We believe the extent of the COVID-19 pandemic&#x2019;s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast.  Such factors include, but are not limited to, the scope and duration of stay-at-home practices, business closures  and restrictions, suspensions of elective procedures and continued decline in procedure volumes for an indeterminable length of time and incremental expenses required for supplies and personal protective equipment.  Because of these uncertainties, we cannot estimate the length or impact of the pandemic on our business.  If we incur declines in cash flows and results of operations, such declines could have an impact on the inputs and assumptions used in significant accounting estimates, including implicit prices concessions related to uninsured patient  accounts, and potential impairment of goodwill and long-lived assets.  During the fourth quarter of 2020, procedure volumes continued to increase and have had a positive impact on our patient revenue.  However, the impact of COVID-19 in future periods may vary and could adversely impact our results of operations.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ACCOUNTS RECEIVABLE &#x2013; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections from our payors and record an estimated price concession based upon specific payor collection issues that we have identified and our historical experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. The aggregate amounts factored under these facilities, net of discounts recorded to reflect market interest rates is $29.5 million.  Proceeds are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.  At December 31, 2020 we have $20.5 million remaining to be collected on these agreements.  We do not utilize factoring arrangements as an integral part of our financing for working capital.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE REVENUE RECOGNITION &#x2013; Our software division has developed and sells Picture Archiving Communications Systems (&#x201c;PACS&#x201d;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2020, 2019 and 2018, we recorded approximately $8.6 million, $10.1 million, and $6.8 million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statement of operations. At December 31, 2020 we had deferred revenue of approximately $1.2 million associated with these sales which we expect to recognize into revenue over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE DEVELOPMENT COSTS &#x2013; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CONCENTRATION OF CREDIT RISKS &#x2013; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection, and to date have made all payments due to us in a timely manner.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CASH AND CASH EQUIVALENTS &#x2013; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DEFERRED FINANCING COSTS &#x2013; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are solely related to our Barclays Revolving Credit Facilities.  Deferred financing costs, net of accumulated amortization, were $1.8 million and $1.6 million for the twelve months ended December 31, 2020 and 2019, respectively.  See Note 8, Revolving Credit Facility, Notes Payable, and Capital Leases for more information on our revolving lines of credit.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;PROPERTY AND EQUIPMENT &#x2013; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;BUSINESS COMBINATION &#x2013; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GOODWILL AND INDEFINITE LIVED INTANGIBLES &#x2013; Goodwill totaled $472.9 million and $442.0 million million at December 31, 2020 and December 31, 2019, respectively. Indefinite lived intangible assets at December 31, 2020 were $7.1 million and $11.3 million at December 31, 2019 and are associated with the value of certain trade name intangibles. Goodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We tested both goodwill and trade name intangibles for impairment&#160;on October 1, 2020.  However, during the year we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full. Separate from this, our annual impairment test as of October 1, 2020 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the testing of goodwill and trade name intangibles at October 1, 2018, our Teleradiology reporting unit, Imaging On Call, (IOC), experienced a reduction of professional medical group clients and a loss of a contract with a major local health provider during 2018.  This affected its estimated fair value and resulted in impairment charges to our reporting unit of $3.9 million for the twelve months ended December 31, 2018, with goodwill representing $3.8 million of the total and the remainder being its trade name of approximately $0.1 million.  The estimated fair value of IOC reporting unit was determined by using the discounted cash flow method.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LONG-LIVED ASSETS &#x2013; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#x2019;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell. We determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INCOME TAXES &#x2013; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. Income taxes are further explained in Note 10, Income Taxes.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liability, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable.  As most of our leases do not provide an implicit rate, we use our incremental borrowing rate ("IBR") based on the information available at commencement date in determining the present value of lease payments.  Our IBR used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and is adjusted when those rates experience a substantial change. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. Our ROU assets consist of facility and equipment assets on operating leases. No events have occurred which have impaired the integrity of our ROU assets in 2020. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order. See Note 9, Leases, for more information.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UNINSURED RISKS &#x2013; On November&#160;1, 2008 we obtained a fully funded and insured workers&#x2019; compensation policy, thereby eliminating any uninsured risks for employee injuries occurring on or after that date. This fully funded policy remained in effect through November 1, 2013 and continues to cover any claims incurred through this date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2013 we entered into a high-deductible workers&#x2019; compensation insurance policy. We have recorded liabilities of $4.1 million and $3.8 million for each of the years ending December 31, 2020 and December 31, 2019, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits. The policy has a deductible which is $10,000 per incidence for the years ended December 31, 2020 and December 31, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2020, this policy remains in effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents. We have recorded liabilities as of December 31, 2020 and 2019 of $6.6 million and $4.9 million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shield for a stop loss policy that provides coverage for any claims that exceed $250,000 up to a maximum of $1.0 million in order for us to limit our exposure for unusual or catastrophic claims.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EMPLOYEE BENEFIT PLAN &#x2013; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately. We can elect to provide a matching contribution in the amount to a maximum of 1.0% per 4.0% of employee contribution, and have done so since 2017.  We contributed $2.9 million in matching for the year ended December 31, 2019 and have elected not to fund a matching contribution for the plan year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LOSS AND OTHER UNFAVORABLE CONTRACTS &#x2013; We assess the profitability of our contracts to provide management services to our contracted physician groups and identify those contracts where current operating results or forecasts indicate probable future losses. Anticipated future revenue is compared to anticipated costs and if the anticipated future cost exceeds the revenue, a loss contract accrual is recorded. In connection with the acquisition of Radiologix in November&#160;2006, we acquired certain management service agreements which met this criterion and recorded to other non-current liabilities an $8.9 million loss contract accrual.  Of the $4.6 million ending balance at December 31, 2018, approximately $4.0 million, ($2.8 million net of taxes), was settled against the purchase consideration of Hudson Valley Radiology Associates, P.L.L.C. (HVRA) by our VIE entity Lenox Hill Radiology and Medical Associates, P.C. and the remaining balance of approximately $558,000 was written off upon ending a contract with a physician group.  See Note 4, Facility Acquisitions and Dispositions for further information on the purchase of HVRA.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the Restated Plan 14,000,000 shares of common stock. We can issue options, stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options and warrants generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE1Ng_34d0b0f5-d4d7-4f53-b8d4-f97aa42926e1"&gt;three&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE2OQ_cb2940f3-3de2-419f-b70c-92ae0342fb0b"&gt;five&lt;/span&gt; to ten years from date of grant.  The compensation expense associated with option grants is calculated based on a valuation model, typically the Black&#x2013;Scholes model, which requires certain management assumptions with respect to volatility.  The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 11, Stock-Based Compensation, for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FOREIGN CURRENCY TRANSLATION &#x2013; The functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMPREHENSIVE (LOSS) INCOME &#x2013; Accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;establishes rules for reporting and displaying comprehensive income (loss) and its components. Our unrealized gains or losses on foreign currency translation adjustments and our interest rate cap and swap agreements are included in comprehensive income (loss). The components of comprehensive income (loss) for the three years in the period ended December 31, 2020 are included in the consolidated statements of comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the second quarter of 2019, we accrued a liability of $2.3 million related to allegations by the US Attorney's Office for the Western District of New York that RadNet submitted certain claims which incorrectly identified the physician who furnished the radiology services.&#160; The final settlement, which admits no wrong-doing on behalf of RadNet, was $2.2 million&#160;and paid in September 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DERIVATIVE INSTRUMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2016 CAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps matured in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively, which were designated at inception as cash flow hedges of future cash interest payments associated with portions of our variable rate bank debt. Under these arrangements, we purchased a cap on 3 month LIBOR at 2.0%. We were liable for a $5.3 million premium to enter into the caps which accrued to current liabilities on our balance sheet and paid over the life of the 2016 Caps.  The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$788&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,383)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,876&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2019 SWAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional. Under these arrangements, we arranged the 2019 swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million through October 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Effective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Loss Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Loss Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(20,160)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(5,870)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Ineffective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of  loss recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(2,528)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Income (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,448)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity and Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 CAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 CAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Barclays revolving credit facility had no aggregate principal amount outstanding as of December 31, 2020 and December 31, 2019, respectively.  Our SunTrust revolving credit facility had no aggregate principal amount outstanding as of December 31, 2020 and December 31, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and SunTrust term loans. Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,674,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,114,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net (loss) income per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,674,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,114,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,244,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,678,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net (loss) income per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY INVESTMENTS AT FAIR VALUE- As of December 31, 2020, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial 12.50% equity interest in Medic Vision - Imaging Solutions Ltd for $1.0 million. We also received an option to exercise warrants to acquire up to an additional 12.50% equity interest for $1.4 million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional 1.96% for $200,000. Our initial equity interest has been diluted to 12.25% and our total equity investment stands at 14.21%.  In accordance with accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;as we exercise no significant influence over Medic Vision&#x2019;s operations, the investment is recorded at its cost of $1.2 million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was noted as of the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million.  On January 1, 2019 we funded a convertible promissory note in the amount of $143,000 that converted to an additional 80,000 preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture formations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective November 1, 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial control of our Arizona centers.  We hold a 49% economic interest and CHI holds the majority 51% economic interest, respectively in ADRG and account for the venture under the equity method .  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment contribution&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sale of joint venture interest:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2017, we formed in conjunction with Cedars Sinai Medical Center (&#x201c;CSMC&#x201d;) the Santa Monica Imaging Group, LLC (&#x201c;SMIG&#x201d;), consisting of two multi-modality imaging centers located in Santa Monica, CA with RadNet holding a 40% economic interest and CSMC holding a 60% economic interest.  RadNet accounts for our share of the venture under the equity method.  On January 1, 2019, CSMC purchased from the us an additional 5% economic interest in SMIG valued at $134,000.  As a result of the transaction, our economic interest in SMIG has been reduced to 35%.  We recorded a loss of $2,000 on the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Change in control of existing joint ventures&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 6, 2014, we acquired a 49% equity interest in Garden State Radiology Network, LLC ("GSRN") for cash consideration of $2.2 million.  The venture consisted of two imaging centers located in New Jersey.  On August 1, 2019, the entity was dissolved by transferring ownership of the assets of the centers with each partner receiving full ownership of one center. See Note 4, Facility Acquisitions and Dispositions, for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 12, 2018 we acquired&#160;25%&#160;share capital in Nulogix, Inc. for cash consideration of&#160;$2.0 million.  On August 1, 2019 we completed via the issuance of RadNet common stock valued at $1.5 million, the acquisition of the remaining 75% economic interest and we now consolidate the financial statements of Nulogix.  &#160;See Note 4, Facility Acquisitions and Dispositions, for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2018, we obtained control over the operations of NJIN through an agreement with the other equity interest holder for no cash consideration.  As such, we consolidated the financial statements of NJIN effective that date.  The economic interest of each party remained the same after consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment and financial information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the years ended December 31, 2020 and December 31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dissolution of GSRN&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nulogix return of capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(792)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nulogix change in control&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We charged management service fees from the centers underlying these joint ventures of approximately  $11.3 million, $11.4 million and $13.8 million for the years ended December 31, 2020, 2019 and 2018, respectively . We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2020 and 2019, respectively, and for the years ended December 31, 2020, 2019 and 2018, respectively, (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NjI_0fefba80-c42f-41f4-877f-105d6ee82223">PRINCIPLES OF CONSOLIDATION &#x2013; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#x201c;financial statements&#x201d;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#x2019;s economic performance.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MTE_6290a8e1-2f92-4d0b-b264-771732be3ce2">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#x2019;s control. As a result, actual amounts could materially differ from these estimates.</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NTI_95d60c45-e232-4a45-896a-bb96c3f4f4c6">RECLASSIFICATION - For the year 2019, we have reclassified certain amounts previously classified as held for sale related to property and equipment and goodwill to conform to our 2020 presentation.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Nzg_15909263-924e-422c-9123-6f9b0078df85">REVENUES &#x2013; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January&#160;1, 2018, we adopted the new revenue recognition accounting standard issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) and codified in the ASC as topic 606 (&#x201c;ASC 606&#x201d;). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding our revenue recognition policies and significant judgments employed in the determination of revenue.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueRecognitionPolicyTextBlock>
    <us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NzQ_64e4d53c-71dc-47e6-961d-cbab5c08453a">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our total net revenues for the years ended December 31, 2020, 2019, and 2018 are presented in the table below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial insurance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;584,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;642,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers' compensation/personal injury&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other patient revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Imaging on call and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service fee revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,028,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue under capitation arrangements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,071,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a6ccbfae5264333868c009a4c975e8d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMS0xLTEtMS0w_b08ed44b-fa3a-4d01-b333-4d6c5eaf6050"
      unitRef="usd">584035000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i891c10b64f17493bb11c320547b8151e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMS0zLTEtMS0w_4f1dff3e-b192-47e4-be02-75e580c3a90f"
      unitRef="usd">642341000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if13c433b6a59448e80ed8ed7eba74c84_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMS01LTEtMS0w_9ada6388-a04a-453d-9944-7f93e594b807"
      unitRef="usd">542011000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia42b0a40b551449aa8cf5aab61557ad1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMi0xLTEtMS0w_bc703d9e-22e0-4a45-ae5e-60e839f8672a"
      unitRef="usd">217928000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i55ae38103bc54357bc2d68bf08c2da7f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMi0zLTEtMS0w_7ff17749-d861-45d5-864d-a3262064ea75"
      unitRef="usd">237427000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie1d4292049a343c6bc7508d9b0441dfa_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMi01LTEtMS0w_1e4a45a3-024f-464f-b6ee-a2f1a09290e8"
      unitRef="usd">192881000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i624a2cd5a57c45c195d9eea635adda77_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMy0xLTEtMS0w_6fe8a512-b245-4d8c-ac96-477d0e4c6ff7"
      unitRef="usd">25619000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic586562cfaa14df5b15da5de1aa5bd11_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMy0zLTEtMS0w_2c7cc934-2232-4970-8de9-d1e046232861"
      unitRef="usd">28283000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44ff6aefd98947aea4638300eb0bc851_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMy01LTEtMS0w_4865c39a-c83b-4277-8e25-d4f18c1da9bd"
      unitRef="usd">25615000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7d1f53911394e648410f42738dfedaa_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNC0xLTEtMS0w_2f5580b3-e808-4ce4-98cf-6375b1a0b3ad"
      unitRef="usd">33478000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfb18a43c61343ecb86bc5802bdfcb00_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNC0zLTEtMS0w_a460b5a7-80f3-4b2e-aa8d-8358cdd80efc"
      unitRef="usd">42792000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i066fe4ef9d6f479db95ce1cf95386477_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNC01LTEtMS0w_0a2c1de9-93d0-41ed-924f-314a14ae4756"
      unitRef="usd">34193000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i614755c7eae243538ab15e0aa1c51f04_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNS0xLTEtMS0w_93a8d3d3-f0fd-4f8f-b0d5-ee2fc2428ab8"
      unitRef="usd">25314000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a20030cccbd4aa184a599982173e41c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNS0zLTEtMS0w_15e432fa-f5d2-4336-832e-6be11268df95"
      unitRef="usd">23862000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b5081b915b84065ab6982f64bd2cdc2_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNS01LTEtMS0w_6f07ccfd-746e-4952-9923-59040fa024be"
      unitRef="usd">25117000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie97dd2adff264063a2311999801b83cb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNi0xLTEtMS0w_9e145514-da97-489f-8270-179084a76e52"
      unitRef="usd">11253000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6faacec13adc4cfaa3714f042eb08eca_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNi0zLTEtMS0w_22056673-3a12-41f6-bb38-dc08177e2d99"
      unitRef="usd">11659000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b4058b6aea4480f93436186354111d6_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNi01LTEtMS0w_5e65017c-a5de-4b54-8cdd-b6c863cb3b5a"
      unitRef="usd">13882000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib673d95e637f4dcdb5dc1061d5a63735_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNy0xLTEtMS0w_82545733-24cc-40ed-bc44-de2a3a048d86"
      unitRef="usd">10798000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8efa81ad11b426eb95ebed781413689_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNy0zLTEtMS0w_dceb33fe-2eba-4840-8cf3-c7d118450813"
      unitRef="usd">17317000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i411513ce21ff409cb97e6b96a1937d9b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfNy01LTEtMS0w_d3a9f54a-d96d-4b4d-8a36-746b79637341"
      unitRef="usd">16261000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e3cd3d7d43342508d2f3e021c52f178_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOC0xLTEtMS0w_41020217-749f-414d-b26b-b448575ce8fd"
      unitRef="usd">23297000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia05b082668734b48affdda6293f59c04_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOC0zLTEtMS0w_0a26fd35-c7cb-421e-a891-48c7dfc5c2c6"
      unitRef="usd">24555000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f11681d86e440a8a138ad9a36324ab1_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOC01LTEtMS0w_d49d7ca7-90be-4990-92cf-a1d159ad2486"
      unitRef="usd">18781000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91cab1d2676f4c75984b340531fdb510_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOS0xLTEtMS0w_2c7ddc69-48d4-4d94-b1af-5667f2ffbd94"
      unitRef="usd">931722000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibeb4b5f80227407994e895e9fdf49c2c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOS0zLTEtMS0w_be555b70-b421-43b3-b9a0-adbb766839c0"
      unitRef="usd">1028236000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i234d43f26e4d4788b2228afca82d6341_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfOS01LTEtMS0w_4feb08ec-a7bc-40f0-9cc9-eb80b24ed79a"
      unitRef="usd">868741000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic0cb6103e98c484a80f4c648cf9a807a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTItMS0xLTEtMA_bf4a7cb6-50b5-4491-ad0a-caa5f408fa42"
      unitRef="usd">140118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf8d37678bac4561b537c7457bdd558b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTItMy0xLTEtMA_f3f7b8b9-789e-453d-a76e-236c55b6da21"
      unitRef="usd">125943000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ife6ce5fe36734a9a814d0f68137a31b0_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTItNS0xLTEtMA_c8abbf63-944b-4a0e-88f3-8edc39ff36b6"
      unitRef="usd">106405000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTMtMS0xLTEtMA_2f8db778-6aca-4784-86c4-869741f47059"
      unitRef="usd">1071840000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTMtMy0xLTEtMA_ef630487-8a45-405a-9244-900906ed5da5"
      unitRef="usd">1154179000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjdlYWQ5Yjg5NWZiMDQ4MDE4N2UwZTY0YmI2ZTU2YzljL3RhYmxlcmFuZ2U6N2VhZDliODk1ZmIwNDgwMTg3ZTBlNjRiYjZlNTZjOWNfMTMtNS0xLTEtMA_7404cb70-3682-4958-8bda-43fbc6b4cdf1"
      unitRef="usd">975146000</us-gaap:Revenues>
    <rdnt:CARESActDisclosurePolicyPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNjU5NzA2OTg3Njg2OA_a2990772-7294-4a07-8fc6-a84a40ffdc7d">COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  Patient volumes and the related revenues for our services were significantly impacted during the latter portion of the first quarter through the middle of the third quarter of 2020 as a result of federal, state and local government mandated restrictions requiring many people to remain at home and forced the closure of or limitations on certain businesses, as well as suspended elective procedures by health care facilities.  Many of these restrictions &lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;have been eased or completely lifted across the states the Company operates in however, we are unable to predict the future impact of the pandemic on our operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;During the twelve months ended December 31, 2020, we received $43.2 million of accelerated Medicare payments, $5.0 million from Blue Shield, $26.3 million from the general distribution and $4.0 million from the Paycheck Protection Program established through the Coronavirus Aid, Relief and Economic Security (&#x201c;CARES&#x201d;) Act.  The accelerated Medicare payments are recorded under the caption &#x201c; Deferred Revenue&#x201c;  in our consolidated balance sheet and will be withheld from reimbursements for services in 2021 and 2022.  The general distribution funds were accounted for as government grants and recognized as other revenue, once reasonable assurance that the applicable terms and conditions required to retain the funds were met, under the caption &#x201c;Provider relief funding&#x201d; in our Consolidated Statements of Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The CARES Act also provides for a payment deferral of the employer portion of Social Security tax incurred during the pandemic, allowing half of such payroll taxes to be deferred until December 2021 and the remaining half until December 2022.  At December 31, 2020, the Company had deferred $16.3 million of Social Security taxes.  These payment deferrals are recorded as payroll tax liability under the caption &#x201c;Accounts payable, accrued expenses and other&#x201d; in our consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;We believe the extent of the COVID-19 pandemic&#x2019;s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast.  Such factors include, but are not limited to, the scope and duration of stay-at-home practices, business closures  and restrictions, suspensions of elective procedures and continued decline in procedure volumes for an indeterminable length of time and incremental expenses required for supplies and personal protective equipment.  Because of these uncertainties, we cannot estimate the length or impact of the pandemic on our business.  If we incur declines in cash flows and results of operations, such declines could have an impact on the inputs and assumptions used in significant accounting estimates, including implicit prices concessions related to uninsured patient  accounts, and potential impairment of goodwill and long-lived assets.  During the fourth quarter of 2020, procedure volumes continued to increase and have had a positive impact on our patient revenue.  However, the impact of COVID-19 in future periods may vary and could adversely impact our results of operations.</rdnt:CARESActDisclosurePolicyPolicyTextBlock>
    <rdnt:AdvanceMedicarePayments
      contextRef="i378af55f9d9f47e98887a9393d7f737d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2NzM1Ng_f7dd4eba-0d74-4cd5-9c5b-d59b9606a62d"
      unitRef="usd">43200000</rdnt:AdvanceMedicarePayments>
    <rdnt:ProceedsReceivedFromInsurance
      contextRef="i378af55f9d9f47e98887a9393d7f737d_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2NzM0OA_84bdc95b-b509-43ca-95fc-8d46f419834f"
      unitRef="usd">5000000.0</rdnt:ProceedsReceivedFromInsurance>
    <us-gaap:RevenueNotFromContractWithCustomer
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2NzM0MA_4f53d2e7-4e1c-47e2-b8e0-501ca262b6de"
      unitRef="usd">26300000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id29d143ec6924d1587f745bf76712764_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2ODEwMA_9a62cb2d-0799-467a-8f39-6a2cb885bfb9"
      unitRef="usd">4000000.0</us-gaap:DebtInstrumentFaceAmount>
    <rdnt:SocialSecurityTaxEmployerDeferralCARESAct
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2OTc3OQ_e243847d-eb0e-47b6-b317-d08b94c9b243"
      unitRef="usd">16300000</rdnt:SocialSecurityTaxEmployerDeferralCARESAct>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NjM_6c23ffab-e33a-4311-8384-01da6ada75a3">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ACCOUNTS RECEIVABLE &#x2013; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections from our payors and record an estimated price concession based upon specific payor collection issues that we have identified and our historical experience.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. The aggregate amounts factored under these facilities, net of discounts recorded to reflect market interest rates is $29.5 million.  Proceeds are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.  At December 31, 2020 we have $20.5 million remaining to be collected on these agreements.  We do not utilize factoring arrangements as an integral part of our financing for working capital.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <rdnt:ContractsReceivableFactoredAmount
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM3OTM5OA_dd9d41a7-e18b-44bf-9686-6a552643f860"
      unitRef="usd">29500000</rdnt:ContractsReceivableFactoredAmount>
    <rdnt:ContractsReceivableFactoringReceivable
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjc0ODc3OTE2NjcwMw_3d4d39a3-2087-4c50-843e-552baac032f3"
      unitRef="usd">20500000</rdnt:ContractsReceivableFactoringReceivable>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzI5ODUzNDk5MTQ1Nw_1d0c9a75-c96d-4e84-9917-d0703b85efb3">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SOFTWARE REVENUE RECOGNITION &#x2013; Our software division has developed and sells Picture Archiving Communications Systems (&#x201c;PACS&#x201d;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2020, 2019 and 2018, we recorded approximately $8.6 million, $10.1 million, and $6.8 million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statement of operations. At December 31, 2020 we had deferred revenue of approximately $1.2 million associated with these sales which we expect to recognize into revenue over the next 12 months.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1db908b8572402e87b53c44f73c46c9_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1OTI2NQ_1dba258d-94d4-42c1-8d03-dfc1236f059e"
      unitRef="usd">8600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c6d94c52f45408a9a65cb42ed24c2d7_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1OTI4MQ_d6602cc1-9cd4-4970-956f-cef64533825d"
      unitRef="usd">10100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff9c306f9afc4473a51abdf18b8b4dee_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1OTI4OQ_cc543052-ad69-437b-9000-3914261a6aa3"
      unitRef="usd">6800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1OTI1Nw_32d26786-f5f0-410d-9f21-ff744e1802de"
      unitRef="usd">1200000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MDQ_0ceef9b4-ccd9-48b7-af9c-03587693af73">SOFTWARE DEVELOPMENT COSTS &#x2013; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</us-gaap:ResearchDevelopmentAndComputerSoftwarePolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NTM_c198e97f-45dc-466d-a166-43622530b200">CONCENTRATION OF CREDIT RISKS &#x2013; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection, and to date have made all payments due to us in a timely manner.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3ODk_992934cb-fe8c-482a-a9bb-d00874f9b256">CASH AND CASH EQUIVALENTS &#x2013; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NDk_2ef8e4b0-2282-45ed-82f3-411e96a14e16">DEFERRED FINANCING COSTS &#x2013; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are solely related to our Barclays Revolving Credit Facilities.  Deferred financing costs, net of accumulated amortization, were $1.8 million and $1.6 million for the twelve months ended December 31, 2020 and 2019, respectively.</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTM3NjE_d17f7609-5679-440b-a785-62977db94d92"
      unitRef="usd">1800000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTM3Njg_fc8fd21b-434d-4a3e-96dd-fdee15c24925"
      unitRef="usd">1600000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3ODE_4aef4b17-d85c-46ba-a551-df89e7cacea4">PROPERTY AND EQUIPMENT &#x2013; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id626261985f3405eb1ffba0c34b5000f_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTQ0MDE_9174965a-db01-4374-8177-1641682e824b">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i0d4beeb600334777869da4212f754cd3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTQ0MDc_5c878e03-1000-4729-a369-7ac0ced1e7d3">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i924340cebec24f3d98853f0b12bf9470_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTQ1MjY_13f03a0d-3c0b-4b51-84f5-1d82fef9871f">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i235a1122e4214ab5937abc9704a2165a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTQ1MzI_946977aa-4f65-4d61-9c02-0b732e42ea00">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MzI_a9026243-40dc-44ff-a11f-05dd1efb23fa">BUSINESS COMBINATION &#x2013; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Nzc_21e03ab2-72f9-4d31-8f91-b4955a0311d0">GOODWILL AND INDEFINITE LIVED INTANGIBLES &#x2013; Goodwill totaled $472.9 million and $442.0 million million at December 31, 2020 and December 31, 2019, respectively. Indefinite lived intangible assets at December 31, 2020 were $7.1 million and $11.3 million at December 31, 2019 and are associated with the value of certain trade name intangibles. Goodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy>
    <us-gaap:Goodwill
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0ODcxNg_35f5a4a3-5346-4c76-97cf-01fd26b61da3"
      unitRef="usd">472900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0ODcwOA_0d2810a5-fdf2-465b-8ae3-9a7b9a0f4064"
      unitRef="usd">442000000.0</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0ODcyNA_4c1bccf5-6c54-4ba6-a024-0eb31cada69a"
      unitRef="usd">7100000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0ODczMg_53b9d562-d702-4295-9017-a732b8a53a41"
      unitRef="usd">11300000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ife26e87c47284440b905cc0d64ac26ec_I20201001"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjc0ODc3OTE5MTU4Mw_f8e833c3-c31b-44c3-a942-b3b40e7cf8d3"
      unitRef="usd">4200000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ie584d839922d4a17968542922cbe6707_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjc0ODc3OTE2Mzc1NA_ce1faed4-0efa-4c80-8489-9fd7f82d0824"
      unitRef="usd">3900000</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ie584d839922d4a17968542922cbe6707_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTcyMjU_97c89579-429a-4d24-90e2-bac93ce7dc40"
      unitRef="usd">3800000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ie584d839922d4a17968542922cbe6707_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMTczMDU_f9599b7c-5812-4f79-90d7-fd27424b7b6c"
      unitRef="usd">100000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NDQ_68471206-6bee-43bc-af62-8424284df996">LONG-LIVED ASSETS &#x2013; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#x2019;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell. We determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MDM_b2e1a378-2853-4970-ab06-c9d68a130192">INCOME TAXES &#x2013; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Njc_5fafbf28-58fd-4a33-aa7c-1fb9565a779c">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#x201c;ROU&#x201d;) assets, current operating lease liability, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable.  As most of our leases do not provide an implicit rate, we use our incremental borrowing rate ("IBR") based on the information available at commencement date in determining the present value of lease payments.  Our IBR used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and is adjusted when those rates experience a substantial change. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. Our ROU assets consist of facility and equipment assets on operating leases. No events have occurred which have impaired the integrity of our ROU assets in 2020. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.</us-gaap:LesseeLeasesPolicyTextBlock>
    <rdnt:UninsuredRisksPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3OTk_ee435df8-eb67-457d-bbb2-d84d36084154">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UNINSURED RISKS &#x2013; On November&#160;1, 2008 we obtained a fully funded and insured workers&#x2019; compensation policy, thereby eliminating any uninsured risks for employee injuries occurring on or after that date. This fully funded policy remained in effect through November 1, 2013 and continues to cover any claims incurred through this date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2013 we entered into a high-deductible workers&#x2019; compensation insurance policy. We have recorded liabilities of $4.1 million and $3.8 million for each of the years ending December 31, 2020 and December 31, 2019, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits. The policy has a deductible which is $10,000 per incidence for the years ended December 31, 2020 and December 31, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2020, this policy remains in effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents. We have recorded liabilities as of December 31, 2020 and 2019 of $6.6 million and $4.9 million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue &lt;/span&gt;&lt;/div&gt;Shield for a stop loss policy that provides coverage for any claims that exceed $250,000 up to a maximum of $1.0 million in order for us to limit our exposure for unusual or catastrophic claims.</rdnt:UninsuredRisksPolicyTextBlock>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM3MDI2OA_6fc7b291-d82e-4477-b263-af865192953c"
      unitRef="usd">4100000</us-gaap:WorkersCompensationLiabilityCurrent>
    <us-gaap:WorkersCompensationLiabilityCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2MzY3MQ_b04b27cc-82af-4b90-a5ca-77911c59a993"
      unitRef="usd">3800000</us-gaap:WorkersCompensationLiabilityCurrent>
    <rdnt:MedicalMalpracticeDeductiblePerIncidence
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE3Njg_1e327127-3fe1-4e21-ae6e-9f6334591c36"
      unitRef="usd">10000</rdnt:MedicalMalpracticeDeductiblePerIncidence>
    <rdnt:MedicalMalpracticeDeductiblePerIncidence
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE3Njg_7dd542bc-74cf-4ee8-94c0-6d398fc8894c"
      unitRef="usd">10000</rdnt:MedicalMalpracticeDeductiblePerIncidence>
    <us-gaap:SelfInsuranceReserve
      contextRef="if0aee577b90c4f58aa31701ba3a01b9b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2MjA4MA_4fc25466-3734-4fba-8a21-26e370053fb2"
      unitRef="usd">6600000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve
      contextRef="ic130af0a16044225945a7112208da137_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2MjA2MA_39fe8447-bd3e-4231-8ac9-42aa8e096af5"
      unitRef="usd">4900000</us-gaap:SelfInsuranceReserve>
    <rdnt:MedicalInsuranceStopLossPolicyClaimAmount
      contextRef="ifce3d08cb6c9413a851bd3ff47c40964_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjI2OTc_e3748c07-82bb-4559-9a42-e20252b4f74a"
      unitRef="usd">250000</rdnt:MedicalInsuranceStopLossPolicyClaimAmount>
    <rdnt:MedicalInsuranceStopLossPolicyClaimAmount
      contextRef="ibf9ac2491d4342e0b58df2c8c84ae62b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjI3MTk_e17f6aad-4332-4367-bced-2bedfb7b00af"
      unitRef="usd">1000000.0</rdnt:MedicalInsuranceStopLossPolicyClaimAmount>
    <us-gaap:PostemploymentBenefitPlansPolicy
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3OTM_53250e6c-1f8e-4001-95a7-b2a5762e8c3f">EMPLOYEE BENEFIT PLAN &#x2013; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.</us-gaap:PostemploymentBenefitPlansPolicy>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjMyNDI_f1ff3039-9b51-4f75-8251-a4e5c5fc5f87"
      unitRef="number">0.010</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjMyNDk_04ba74e7-7e25-4e5c-adb6-088be440b2c5"
      unitRef="number">0.040</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjMyOTg_5798d978-2297-48ce-a907-ec8e4b442701"
      unitRef="usd">2900000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzI5ODUzNDk5MTQ2Mg_fe260aa1-5e96-4b96-9ec5-3694c3e4326e"
      unitRef="usd">0</us-gaap:DefinedContributionPlanCostRecognized>
    <rdnt:LossandOtherUnfavorableContractsPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Mzk_7d3d447b-da49-47fd-8c9d-f423621da3f7">LOSS AND OTHER UNFAVORABLE CONTRACTS &#x2013; We assess the profitability of our contracts to provide management services to our contracted physician groups and identify those contracts where current operating results or forecasts indicate probable future losses. Anticipated future revenue is compared to anticipated costs and if the anticipated future cost exceeds the revenue, a loss contract accrual is recorded. In connection with the acquisition of Radiologix in November&#160;2006, we acquired certain management service agreements which met this criterion and recorded to other non-current liabilities an $8.9 million loss contract accrual.  Of the $4.6 million ending balance at December 31, 2018, approximately $4.0 million, ($2.8 million net of taxes), was settled against the purchase consideration of Hudson Valley Radiology Associates, P.L.L.C. (HVRA) by our VIE entity Lenox Hill Radiology and Medical Associates, P.C. and the remaining balance of approximately $558,000 was written off upon ending a contract with a physician group.  See Note 4, Facility Acquisitions and Dispositions for further information on the purchase of HVRA.</rdnt:LossandOtherUnfavorableContractsPolicyTextBlock>
    <rdnt:ContractLossAccrual
      contextRef="icd66928c30e1473b9c9c069d01b5bdbb_I20061130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjQwMDE_b4a155ce-7be1-41ba-951b-f751894474bc"
      unitRef="usd">8900000</rdnt:ContractLossAccrual>
    <rdnt:ContractLossAccrual
      contextRef="ibae6485d220c4366bf04745e679dee34_I20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjQwMzU_ff3f2b61-cf29-4b80-8cd1-46aa0d4c4f9e"
      unitRef="usd">4600000</rdnt:ContractLossAccrual>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross
      contextRef="i964d58a775bd4fa199e750e6ee03db8e_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjQwODI_f224ab2e-b39e-4dda-abf5-80897dc6449c"
      unitRef="usd">4000000.0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts
      contextRef="i964d58a775bd4fa199e750e6ee03db8e_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjQwODc_dc1bc7e6-8590-4e74-8e2a-a79ae8091a1f"
      unitRef="usd">2800000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts>
    <rdnt:ContractLossAccrualWrittenOff
      contextRef="ibae6485d220c4366bf04745e679dee34_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjQzMTg_6c2fd2f7-945b-4603-a0a8-b111ea553764"
      unitRef="usd">558000</rdnt:ContractLossAccrualWrittenOff>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MDg_408ee88a-8edc-4394-91ee-e6347a3488de">EQUITY BASED COMPENSATION &#x2013; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#x201c;Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the Restated Plan 14,000,000 shares of common stock. We can issue options, stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options and warrants generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE1Ng_34d0b0f5-d4d7-4f53-b8d4-f97aa42926e1"&gt;three&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE2OQ_cb2940f3-3de2-419f-b70c-92ae0342fb0b"&gt;five&lt;/span&gt; to ten years from date of grant.  The compensation expense associated with option grants is calculated based on a valuation model, typically the Black&#x2013;Scholes model, which requires certain management assumptions with respect to volatility.  The compensation expense recognized for all equity-based awards is recognized over the awards&#x2019; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 11, Stock-Based Compensation, for more information.</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i40918c356ba546019d9cf3855b255d7a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjU1OTE_c8a90d81-1a02-488d-b6db-9945fd75b006"
      unitRef="shares">14000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i59d8b9f6e0ef49d4a4d3fe5016d69357_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjU5MzQ_3a100b69-6d8c-4195-85b7-5839270a938a">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i59d8b9f6e0ef49d4a4d3fe5016d69357_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjU5NTY_c7c5541e-8229-49b2-8899-960833c5bd47">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA4MDU_47cde96f-63be-44ab-b083-559f415374f7">FOREIGN CURRENCY TRANSLATION &#x2013; The functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NTU_8851e51d-5208-464f-bf67-84b885265576">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COMPREHENSIVE (LOSS) INCOME &#x2013; Accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;establishes rules for reporting and displaying comprehensive income (loss) and its components. Our unrealized gains or losses on foreign currency translation adjustments and our interest rate cap and swap agreements are included in comprehensive income (loss). The components of comprehensive income (loss) for the three years in the period ended December 31, 2020 are included in the consolidated statements of comprehensive income (loss).&lt;/span&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Mzg_046aa217-a3f2-4277-8e14-07cbe6af9115">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:LossContingencyAccrualAtCarryingValue
      contextRef="i4b4b71ee39b549678fe63c62bb7e85e5_I20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjg2MzE_10d2b941-43c8-4fc1-bd8d-3b62202ac414"
      unitRef="usd">2300000</us-gaap:LossContingencyAccrualAtCarryingValue>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i50d9608d8beb4655b129134c49d35159_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjg5MTY_e25e79db-33ef-46a0-8c19-ff7536e8222c"
      unitRef="usd">2200000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA4MTI_09381dc0-d8c0-413d-94b6-e23beb022d06">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;DERIVATIVE INSTRUMENTS &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2016 CAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps matured in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively, which were designated at inception as cash flow hedges of future cash interest payments associated with portions of our variable rate bank debt. Under these arrangements, we purchased a cap on 3 month LIBOR at 2.0%. We were liable for a $5.3 million premium to enter into the caps which accrued to current liabilities on our balance sheet and paid over the life of the 2016 Caps.  The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$788&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,383)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,876&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2019 SWAPS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional. Under these arrangements, we arranged the 2019 swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million through October 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Effective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Loss Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Loss Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(20,160)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(5,870)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="i4d8112539b844f619adaf708f61bd146_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzI5ODUzNDkzMDYzNw_0b89ed67-fff8-4069-b74a-81afd5a15b23"
      unitRef="numberofagreement">2</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i67ac9c2904dc49e2ac4bc506d54d17e5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjkxODI_58f417b5-5393-4bc5-93c1-c72fa542ed51"
      unitRef="usd">150000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="id90a9127362e454283d08c7e3fd0c691_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjkxODk_b8d1e272-5ede-4418-9b60-45dd492ed5d0"
      unitRef="usd">350000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i34ed4d9f350d499789b3e42719f10a5b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjk0MTc_ec15ab51-82c5-4e56-8b85-69009710e236"
      unitRef="number">0.020</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized
      contextRef="i4d8112539b844f619adaf708f61bd146_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjk0NDE_452adb06-d5b6-4fa8-a20f-3f21f57bf6dc"
      unitRef="usd">5300000</us-gaap:FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MTM_0778aa7e-5829-4b0c-a21c-cd3a9724d074">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.663%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Gain (Loss) Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Gain (Loss) Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$788&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,383)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,876&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.958%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:33.065%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Effective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount of Loss Recognized on Derivative, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Location of Loss Recognized&lt;br/&gt;in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(20,160)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(5,870)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Comprehensive Loss&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Interest Rate Contracts - Ineffective Portion&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;For the twelve months ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss recognized in income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of  loss recognized in Income on derivative (current period ineffective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Location of loss reclassified from accumulated OCI into income (prior period effective portion)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(2,528)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Income (Expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$(3,448)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity and Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i654a8e8ed7bb4f3bbb5cd9c288d0b69d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjgzZTQ0ZDJlODIyNzQ0YjQ4NTE2ZGQ5ZGIxZjQyYjU1L3RhYmxlcmFuZ2U6ODNlNDRkMmU4MjI3NDRiNDg1MTZkZDlkYjFmNDJiNTVfMy0xLTEtMS0w_77fb19aa-2a20-4641-9e84-6c1ef08bf0e4"
      unitRef="usd">788000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i4ee370d9a22543fb9f2dab8cc9aa4803_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjgzZTQ0ZDJlODIyNzQ0YjQ4NTE2ZGQ5ZGIxZjQyYjU1L3RhYmxlcmFuZ2U6ODNlNDRkMmU4MjI3NDRiNDg1MTZkZDlkYjFmNDJiNTVfNC0xLTEtMS0w_c914d880-19a8-4fbe-851b-e6218a8a01e7"
      unitRef="usd">-4383000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
      contextRef="i79371fc04e834bfcaea740fd6bc52153_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjgzZTQ0ZDJlODIyNzQ0YjQ4NTE2ZGQ5ZGIxZjQyYjU1L3RhYmxlcmFuZ2U6ODNlNDRkMmU4MjI3NDRiNDg1MTZkZDlkYjFmNDJiNTVfNS0xLTEtMS0w_1dba6daf-6d4b-43b9-b334-2d2f5a4b6b7d"
      unitRef="usd">2876000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax>
    <us-gaap:DerivativeAssetNumberOfInstrumentsHeld
      contextRef="if60e961bba2a4bbfae302a70f01ee39d_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzMzOTYyMQ_2e04cff3-b03a-4553-b4b6-9d517154dbfd"
      unitRef="numberofagreement">4000</us-gaap:DerivativeAssetNumberOfInstrumentsHeld>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if60e961bba2a4bbfae302a70f01ee39d_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzA0MTY_3be123ec-e3f5-4af6-b485-da78a0ff308a"
      unitRef="usd">500000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="ib856840ca6324eeba1a6b1494e0c38f1_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzA0NTI_66292264-73ff-4ace-8439-a1ae70b4a55c"
      unitRef="usd">50000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="i61555f9eb90b46f688385e53cb2d0b54_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzA0ODM_01446590-3ccf-4eea-987f-7d2badfa8b9d"
      unitRef="usd">200000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i0b6ec598f73740f98940d9eb5201b90a_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzA4NDk_9edb138e-5461-4a36-a084-b80b30fdb894"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if4f79b8708a34406aeaa4254bff7bf57_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzMzOTYwNw_5e3688e9-e53d-4206-bfc5-2ad230d70fda"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i9921f768cd544944875eaeacb5eb5af9_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzA4ODM_facc6d04-b147-4995-8686-b7731047fb6e"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="iab09020dae044987a27d5a27395d9975_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzMzOTYxNA_74e1cdf0-c334-40a4-ac9a-b2fc796ed787"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="iab09020dae044987a27d5a27395d9975_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk1NA_74e1cdf0-c334-40a4-ac9a-b2fc796ed787"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i9921f768cd544944875eaeacb5eb5af9_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk2MQ_facc6d04-b147-4995-8686-b7731047fb6e"
      unitRef="number">0.0205</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if4f79b8708a34406aeaa4254bff7bf57_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk2NQ_5e3688e9-e53d-4206-bfc5-2ad230d70fda"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeBasisSpreadOnVariableRate
      contextRef="i0b6ec598f73740f98940d9eb5201b90a_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk3Mg_9edb138e-5461-4a36-a084-b80b30fdb894"
      unitRef="number">0.0196</us-gaap:DerivativeBasisSpreadOnVariableRate>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="iab09020dae044987a27d5a27395d9975_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk3Ng_74e1cdf0-c334-40a4-ac9a-b2fc796ed787"
      unitRef="usd">400000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:DerivativeAssetNotionalAmount
      contextRef="if4f79b8708a34406aeaa4254bff7bf57_I20190630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk4MA_5e3688e9-e53d-4206-bfc5-2ad230d70fda"
      unitRef="usd">100000000</us-gaap:DerivativeAssetNotionalAmount>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="ifb0a905a8db84850b58584bad8c4af86_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk5MA_b358f117-a13f-4f30-9c35-8d0fa1acbb64"
      unitRef="usd">24400000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains
      contextRef="ifb0a905a8db84850b58584bad8c4af86_D20200701-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0Mzk5Nw_5348f221-5880-44bf-b1f0-e4352474237a"
      unitRef="usd">400000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <rdnt:MonthlyAmortizationOfDeferredHedgeGains
      contextRef="iccd401f36a0c470ea4320cd33aebeea3_D20231101-20251031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjc0ODc3OTE4OTgxNA_1a2b1d72-c379-44f7-9baf-166e66eba75a"
      unitRef="usd">300000</rdnt:MonthlyAmortizationOfDeferredHedgeGains>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="icc5d103d5dec4837a37b5436811017d4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjc5ZDZhZDYyNjkxNTQ1OWVhMGY4YzY4MjE4YzdlNDVjL3RhYmxlcmFuZ2U6NzlkNmFkNjI2OTE1NDU5ZWEwZjhjNjgyMThjN2U0NWNfMy0xLTEtMS0yNzY4_6197dc76-3f03-43c0-87a7-dae4a851125a"
      unitRef="usd">-20160000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i46e5bfcb59a44381930228cdbedb0c73_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjc5ZDZhZDYyNjkxNTQ1OWVhMGY4YzY4MjE4YzdlNDVjL3RhYmxlcmFuZ2U6NzlkNmFkNjI2OTE1NDU5ZWEwZjhjNjgyMThjN2U0NWNfMy0xLTEtMS0w_3da0a911-95fc-4c7d-8c3d-f37bf96f2bf4"
      unitRef="usd">-5870000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i2fefeb1f7013464bbd2ec16f399ab7af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjJhM2ZhZDY5ZjE2NTQ4MDA5YWM1ZmYxNWI5NjBjNjM2L3RhYmxlcmFuZ2U6MmEzZmFkNjlmMTY1NDgwMDlhYzVmZjE1Yjk2MGM2MzZfMy0xLTEtMS0yODAz_0caa4c81-6817-4912-8bcf-38c083001f23"
      unitRef="usd">2528000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="iee473bf952d14518a4aa17edb183780b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjJhM2ZhZDY5ZjE2NTQ4MDA5YWM1ZmYxNWI5NjBjNjM2L3RhYmxlcmFuZ2U6MmEzZmFkNjlmMTY1NDgwMDlhYzVmZjE1Yjk2MGM2MzZfMy0zLTEtMS0yODEw_0c726bee-ba27-427e-9ece-aeaabf65c9ca"
      unitRef="usd">3448000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3OTA_33839724-4615-4a4d-8230-dbe5f68ae04b">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;FAIR VALUE MEASUREMENTS &#x2013; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 CAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 CAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;counterparty&#x2019;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Long Term Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Barclays revolving credit facility had no aggregate principal amount outstanding as of December 31, 2020 and December 31, 2019, respectively.  Our SunTrust revolving credit facility had no aggregate principal amount outstanding as of December 31, 2020 and December 31, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and SunTrust term loans. Level 2 inputs primarily related to comparable market prices.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3MTA_a1952d5a-5a53-4e22-aa3d-4cb48b4f3018">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 CAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.752%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.641%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current and long term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016 CAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019 SWAPS - Interest Rate Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.923%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.709%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;As of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Face Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan Agreement and First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;708,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;705,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DerivativeLiabilities
      contextRef="ic23c6521ea5a4ca0beeee403496fb2b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfMy0xLTEtMS0w_20078fb6-81e9-46b2-b845-1440e3eaa2d6"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ie3f8d60d96a441aba20d06c47362b2b0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfMy0zLTEtMS0w_b00bc10c-eec9-4e73-8593-040a9789bf49"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i565b0d00fc96454389f20aa5dbe8bf55_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfMy01LTEtMS0w_7c7860d0-6ccb-429c-8b16-84b5604fc2ad"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i9421b4c3defc4cf7b17e066a06b1caa7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfMy03LTEtMS0w_38c569d1-e17c-4904-b71c-cce9d93b4023"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i0ad49d0deed647c0a498c2366fc5efb5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfNC0xLTEtMS0w_037b456e-efb5-4452-b689-c8085e5b7b4a"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i3d6a973db2ba408383529fed3405f008_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfNC0zLTEtMS0w_90d7371d-ac9a-41a4-a875-007f45cd7c80"
      unitRef="usd">37989000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i311a05ca14ed4565b8093ad84dc6c1f8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfNC01LTEtMS0w_c9d4c8ea-f0dc-41cd-9d62-9d05582d5bdb"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i6a0f55d2766d408490715ca7893da207_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjk3YzU2MTVlMDU3ZDQ3YWFhY2Y4OTZmNTBmYjZjZWQ5L3RhYmxlcmFuZ2U6OTdjNTYxNWUwNTdkNDdhYWFjZjg5NmY1MGZiNmNlZDlfNC03LTEtMS0w_b77c992b-f364-4acb-ac3d-ebbf922b6c2f"
      unitRef="usd">37989000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeAssets
      contextRef="i50b5d4270b9a405a974ddd1764a0c39e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfMy0xLTEtMS0w_192794aa-aa2d-4798-afa9-75ce8ad0bbbd"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i75a252a681e34b079a5a7f189f4bf384_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfMy0zLTEtMS0w_82bd990a-dbea-4550-8dc7-51da02e7190e"
      unitRef="usd">1081000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i48064a0601f7427da1f6463f58e86cf6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfMy01LTEtMS0w_61598000-59c9-4347-b2d6-16d8f818228e"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="idc527a4818a643d49fe09cfa85c4c780_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfMy03LTEtMS0w_868f1abb-4f7d-4764-aaa9-65e5066bb56c"
      unitRef="usd">1081000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i2fe005478a77480f8ca9f42839c796df_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfNC0xLTEtMS0xNzU0_0e7e2779-3081-4c43-8058-70f58b3e52c3"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ib5bf62651ffd4565b1634ab1e49d1658_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfNC0zLTEtMS0xNzU0_ab0e7e54-5749-41b7-88db-db93ceb955c4"
      unitRef="usd">9477000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="ic953d4eafcbf4d7cb0bf03e5e5a554d1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfNC01LTEtMS0xNzU0_e3ba7b28-52a2-4b14-b9bc-6b1e3bc1a040"
      unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i4c602f38cb744dff881ca06c457467bc_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjY4NTA0ZjE1MzVmMzQ3MmZiZTE0MzY0OTVhNmRhM2JhL3RhYmxlcmFuZ2U6Njg1MDRmMTUzNWYzNDcyZmJlMTQzNjQ5NWE2ZGEzYmFfNC03LTEtMS0xNzU0_117933a2-4197-4a63-b6b9-8e697a027ef6"
      unitRef="usd">9477000</us-gaap:DerivativeAssets>
    <us-gaap:DebtInstrumentFairValue
      contextRef="idc5f93ef9014432796ae78b5a5f1277a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmVhMWIxM2E4NmY3MzRmMTc4ODQ2MDNlZjRkYTAwYmRhL3RhYmxlcmFuZ2U6ZWExYjEzYTg2ZjczNGYxNzg4NDYwM2VmNGRhMDBiZGFfMi0xLTEtMS0w_1a079a05-2582-4b95-9646-77ddb301d6cb"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie29a29bde2bc4177a697491ea4430974_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmVhMWIxM2E4NmY3MzRmMTc4ODQ2MDNlZjRkYTAwYmRhL3RhYmxlcmFuZ2U6ZWExYjEzYTg2ZjczNGYxNzg4NDYwM2VmNGRhMDBiZGFfMi0zLTEtMS0w_8c24258f-db90-4f27-8057-dd43ea0b68e4"
      unitRef="usd">661640000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie15c1fc805524eb3949f0526154afb88_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmVhMWIxM2E4NmY3MzRmMTc4ODQ2MDNlZjRkYTAwYmRhL3RhYmxlcmFuZ2U6ZWExYjEzYTg2ZjczNGYxNzg4NDYwM2VmNGRhMDBiZGFfMi01LTEtMS0w_7624892e-4a60-40c8-9f54-eed0f590fde0"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1092fa5159474e67b00fbddb2636707c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmVhMWIxM2E4NmY3MzRmMTc4ODQ2MDNlZjRkYTAwYmRhL3RhYmxlcmFuZ2U6ZWExYjEzYTg2ZjczNGYxNzg4NDYwM2VmNGRhMDBiZGFfMi03LTEtMS0w_3e59f439-b316-4b95-a653-2d74cca4c21d"
      unitRef="usd">661640000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmVhMWIxM2E4NmY3MzRmMTc4ODQ2MDNlZjRkYTAwYmRhL3RhYmxlcmFuZ2U6ZWExYjEzYTg2ZjczNGYxNzg4NDYwM2VmNGRhMDBiZGFfMi05LTEtMS0w_15c5439e-71f2-4de7-8396-bc4bd43489cb"
      unitRef="usd">662403000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i3f52dc1b8df24f608f50e003a77157f1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmI2MTkwZWViODQyYjRhYTc5MTlkZWU2YTU0NjRiYjk0L3RhYmxlcmFuZ2U6YjYxOTBlZWI4NDJiNGFhNzkxOWRlZTZhNTQ2NGJiOTRfMi0xLTEtMS0w_6957c13c-10e1-4b9e-a865-78bfa8e1488b"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i95972ba545c2413db9a96bb8f5a78f19_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmI2MTkwZWViODQyYjRhYTc5MTlkZWU2YTU0NjRiYjk0L3RhYmxlcmFuZ2U6YjYxOTBlZWI4NDJiNGFhNzkxOWRlZTZhNTQ2NGJiOTRfMi0zLTEtMS0w_f0d64555-4fa4-4c1c-98d0-ea611fce93c6"
      unitRef="usd">708948000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="id37d5b32618d4989a2d4ae3321a56a10_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmI2MTkwZWViODQyYjRhYTc5MTlkZWU2YTU0NjRiYjk0L3RhYmxlcmFuZ2U6YjYxOTBlZWI4NDJiNGFhNzkxOWRlZTZhNTQ2NGJiOTRfMi01LTEtMS0w_9165e921-ef81-4ded-91f2-00de53bdde9a"
      unitRef="usd">0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="if56b240e264240e4b120a420105c6f77_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmI2MTkwZWViODQyYjRhYTc5MTlkZWU2YTU0NjRiYjk0L3RhYmxlcmFuZ2U6YjYxOTBlZWI4NDJiNGFhNzkxOWRlZTZhNTQ2NGJiOTRfMi03LTEtMS0w_df8c62bb-ef10-47bd-b7a3-9943bf6905bb"
      unitRef="usd">708948000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmI2MTkwZWViODQyYjRhYTc5MTlkZWU2YTU0NjRiYjk0L3RhYmxlcmFuZ2U6YjYxOTBlZWI4NDJiNGFhNzkxOWRlZTZhNTQ2NGJiOTRfMi05LTEtMS0w_bfaafb2b-ec88-43ca-a500-100d37cdddfb"
      unitRef="usd">705699000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LineOfCredit
      contextRef="i8e91f8345bde4d118909d99c801fab52_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzM1OTc_58221b12-f162-4271-b56b-efbd81c74859"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="iee2fd20ee7b4470a880084f9e273f9a5_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzM1OTc_858e8509-06f9-4875-ad6c-20cbdec8cbd0"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="ie40d3a8fbcef47b19505b8259baa9c2d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzM3NDA_23cda816-02d2-4738-84cf-d266f681a2ac"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCredit
      contextRef="i1a358573454349cf8e2a7aa01f671b00_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzM3NDA_f8d81cd3-87fe-4731-aff8-c167481f117e"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Mjc_1b437c43-88fa-4f9d-b2bb-00c6436c8a4a">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,674,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,114,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net (loss) income per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,674,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,114,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,244,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,678,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net (loss) income per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3Nzk_2ce9118a-e926-4d9d-ba4d-a50d8d4fd1d7">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.631%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,674,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,114,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net (loss) income per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,674,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,114,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add nonvested restricted stock subject only to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add additional shares issuable upon exercise of stock options and warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360,185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;384,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares used in calculating diluted net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,891,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,244,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,678,999&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net (loss) income per share attributable to RadNet, Inc. common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock subject to service vesting&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable upon the exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;554,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMi0xLTEtMS0w_1371a80a-3849-404f-aca0-8ac2adb82d39"
      unitRef="usd">-14840000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMi0zLTEtMS0w_0abc2ada-9431-4bdf-84f6-b42ce67e9ba7"
      unitRef="usd">14756000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMi01LTEtMS0w_8da59ef7-540a-40b7-9939-8e5753ae6768"
      unitRef="usd">32243000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNS0xLTEtMS0w_9a40c5a9-02c3-4080-a162-aed52d356afd"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNS0zLTEtMS0w_3b2c88c5-57df-4ede-a3ad-3d94ee7a8d5e"
      unitRef="shares">49674858</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNS01LTEtMS0w_b8e484bc-2dde-4cc1-8bbb-7556f349d2b4"
      unitRef="shares">48114275</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNi0xLTEtMS0w_09443510-284a-4abb-9058-c3abe72b45e5"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNi0zLTEtMS0w_9ba57f85-fa2c-473e-90e8-77d28cec4435"
      unitRef="usdPerShare">0.30</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfNi01LTEtMS0w_48e9e998-ac2f-49dc-83da-39fcce39d412"
      unitRef="usdPerShare">0.67</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOC0xLTEtMS0w_800e1935-7415-4b0c-bd4b-ac764a1159b5"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOC0zLTEtMS0w_a633b334-7383-4773-a408-2098a4bf2a47"
      unitRef="shares">49674858</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOC01LTEtMS0w_98b96434-3edc-44f9-9c93-f53f2f9c2dda"
      unitRef="shares">48114275</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOS0xLTEtMS0w_903485a1-4677-4e86-af7d-e01cb2498215"
      unitRef="shares">0</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOS0zLTEtMS0w_a8ad4d10-ff7f-455b-943d-20eb1d69c6f3"
      unitRef="shares">208963</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfOS01LTEtMS0w_0b4a0c72-71f1-4080-b277-03ab09b45ee5"
      unitRef="shares">180631</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTAtMS0xLTEtMA_d266e57c-2fe9-46cc-9c33-05d555ae5d75"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTAtMy0xLTEtMA_bac5a474-d4ba-4d52-a1fd-59424b379e57"
      unitRef="shares">360185</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTAtNS0xLTEtMA_06d29ba2-3c18-4ae0-9e61-6fd0970094ba"
      unitRef="shares">384093</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTEtMS0xLTEtMA_5d8f26cf-92cc-4151-aefb-6924f98d2a51"
      unitRef="shares">50891791</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTEtMy0xLTEtMA_06f20840-b0e5-4b7b-86e4-cce1e828c89e"
      unitRef="shares">50244006</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTEtNS0xLTEtMA_8feb44ab-6137-4225-b0bf-b275d827f63a"
      unitRef="shares">48678999</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTItMS0xLTEtMA_21e5a0e9-437f-4cbf-bc94-26dbe9f349b2"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTItMy0xLTEtMA_9813f89d-2a4a-440c-9fee-38acf05c5000"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTItNS0xLTEtMA_9da0eb3b-fbca-4958-911e-0d645a839c5b"
      unitRef="usdPerShare">0.66</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i3bceea0558df4aa7a7b357ca906e3844_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtMS0xLTEtMzU3NQ_c6a7c3b2-a23e-4b17-ac27-865e7721c881"
      unitRef="shares">329159</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if1c392fb7a5b4f1bb1f098f0d9a1675e_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtMy0xLTEtMzU4MQ_0ea10f8c-8dd1-410f-90b6-b0fa744b120f"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if76464750e804b1b92602d1d98c066fa_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtNS0xLTEtMzU4NQ_039a5268-ed6b-4490-ba92-859e4c155b5f"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtMS0xLTEtMA_39baba8c-f73b-40ee-96e8-b720ab173db8"
      unitRef="shares">554444</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtMy0xLTEtMA_b900cc14-db77-4492-85c6-4fbfb2327d95"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjllZTkzZTQ4ODFlYTRlOTY5NWRiYTIxZDQ4MDY0Y2ZiL3RhYmxlcmFuZ2U6OWVlOTNlNDg4MWVhNGU5Njk1ZGJhMjFkNDgwNjRjZmJfMTUtNS0xLTEtMA_0c090f5c-6c18-4c2c-a13c-3a36fc7dfb95"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzI5ODUzNDk5MTQ1Ng_38d894d1-65d2-4945-a641-d32e40bbcc7d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;EQUITY INVESTMENTS AT FAIR VALUE- As of December 31, 2020, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.&lt;/span&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i473019f6980c4551a0817c8df1b09e13_I20170324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU1NDg_31d7c40c-2088-44c1-8a45-b8bf131dfe12"
      unitRef="number">0.1250</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i9ded1c2d91fb4066b0d52f289dbc6bf1_D20170324-20170324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU2MTE_6609526a-921d-49f5-a599-9c514788d222"
      unitRef="usd">1000000.0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i473019f6980c4551a0817c8df1b09e13_I20170324"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU3MDI_31d7c40c-2088-44c1-8a45-b8bf131dfe12"
      unitRef="number">0.1250</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <rdnt:EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment
      contextRef="i473019f6980c4551a0817c8df1b09e13_I20170324"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU3MjU_b2838e39-cc03-4944-abc4-01d291b85b0f"
      unitRef="usd">1400000</rdnt:EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment>
    <rdnt:EquityMethodInvestmentsOwnershipInterestPercentageAcquired
      contextRef="i2dbe4948ad594309b6b27c4836c67b68_D20180301-20180301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU4ODk_a4e32cec-c249-4951-8f54-a119346febaa"
      unitRef="number">0.0196</rdnt:EquityMethodInvestmentsOwnershipInterestPercentageAcquired>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i2dbe4948ad594309b6b27c4836c67b68_D20180301-20180301"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU4OTY_65a624af-62a2-4afc-a001-efe07dfd5e8d"
      unitRef="usd">200000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <rdnt:EquityMethodInvestmentInitialOwnershipPercentageAfterDilution
      contextRef="i2dbe4948ad594309b6b27c4836c67b68_D20180301-20180301"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU5NDg_39b195b6-b006-4cf8-a80b-5ea9a95c3e84"
      unitRef="number">0.1225</rdnt:EquityMethodInvestmentInitialOwnershipPercentageAfterDilution>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i4843fa912a25453896424af36c06d915_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzU5OTM_4b3ab6ef-35fc-4f27-9048-b47793dd6d20"
      unitRef="number">0.1421</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i4843fa912a25453896424af36c06d915_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzYxNTM_002db41e-ef27-415e-84eb-08929589eaa3"
      unitRef="usd">1200000</us-gaap:EquityMethodInvestmentAggregateCost>
    <rdnt:EquityMethodInvestmentSharesPurchased
      contextRef="id8e2a3314e2147c8878b4abe3dfe0373_D20180201-20180201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzY1MTk_91d46066-380a-46d3-8d9a-fd177b478fbb"
      unitRef="shares">2100000</rdnt:EquityMethodInvestmentSharesPurchased>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="id8e2a3314e2147c8878b4abe3dfe0373_D20180201-20180201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzY1Nzc_ae7af38a-3b7a-46ee-8700-c11a17ca8dcc"
      unitRef="usd">2000000.0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:ShortTermBorrowings
      contextRef="i5596086792694e92ace9a030c37a797a_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzY2NjY_89aa9278-3be6-47db-a6bc-a5de77df5c56"
      unitRef="usd">143000</us-gaap:ShortTermBorrowings>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="ie5c53a008eee4b64b7e27857cbb84f0d_I20191011"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzY3MDE_01df74f5-1267-402c-8d59-f42afdf77044"
      unitRef="shares">80000</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ie7a0400670894eb7a7e0b89fd33e8d63_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzcxMDI_b6370806-a491-4a27-817d-87fb261e9f69"
      unitRef="usd">1000000.0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToFundLongtermLoansToRelatedParties
      contextRef="ie7a0400670894eb7a7e0b89fd33e8d63_D20191105-20191105"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzcxMzM_ce3c3f5e-9520-4ebd-b8ed-9f5b67b6f8b4"
      unitRef="usd">2500000</us-gaap:PaymentsToFundLongtermLoansToRelatedParties>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA4MDY_8e0d8712-2e85-4034-9131-7800673419be">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;INVESTMENT IN JOINT VENTURES &#x2013; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture formations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective November 1, 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial control of our Arizona centers.  We hold a 49% economic interest and CHI holds the majority 51% economic interest, respectively in ADRG and account for the venture under the equity method .  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment contribution&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sale of joint venture interest:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2017, we formed in conjunction with Cedars Sinai Medical Center (&#x201c;CSMC&#x201d;) the Santa Monica Imaging Group, LLC (&#x201c;SMIG&#x201d;), consisting of two multi-modality imaging centers located in Santa Monica, CA with RadNet holding a 40% economic interest and CSMC holding a 60% economic interest.  RadNet accounts for our share of the venture under the equity method.  On January 1, 2019, CSMC purchased from the us an additional 5% economic interest in SMIG valued at $134,000.  As a result of the transaction, our economic interest in SMIG has been reduced to 35%.  We recorded a loss of $2,000 on the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Change in control of existing joint ventures&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 6, 2014, we acquired a 49% equity interest in Garden State Radiology Network, LLC ("GSRN") for cash consideration of $2.2 million.  The venture consisted of two imaging centers located in New Jersey.  On August 1, 2019, the entity was dissolved by transferring ownership of the assets of the centers with each partner receiving full ownership of one center. See Note 4, Facility Acquisitions and Dispositions, for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 12, 2018 we acquired&#160;25%&#160;share capital in Nulogix, Inc. for cash consideration of&#160;$2.0 million.  On August 1, 2019 we completed via the issuance of RadNet common stock valued at $1.5 million, the acquisition of the remaining 75% economic interest and we now consolidate the financial statements of Nulogix.  &#160;See Note 4, Facility Acquisitions and Dispositions, for further information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 1, 2018, we obtained control over the operations of NJIN through an agreement with the other equity interest holder for no cash consideration.  As such, we consolidated the financial statements of NJIN effective that date.  The economic interest of each party remained the same after consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture investment and financial information&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the years ended December 31, 2020 and December 31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dissolution of GSRN&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nulogix return of capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(792)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nulogix change in control&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We charged management service fees from the centers underlying these joint ventures of approximately  $11.3 million, $11.4 million and $13.8 million for the years ended December 31, 2020, 2019 and 2018, respectively . We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2020 and 2019, respectively, and for the years ended December 31, 2020, 2019 and 2018, respectively, (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <rdnt:NumberofUnconsolidatedJointVentures
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzcyNzM_35e5612b-8421-4d32-8e74-7c508e395771"
      unitRef="joint_venture">13</rdnt:NumberofUnconsolidatedJointVentures>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i39bb82566bf248d0b0fd688dde04dbe9_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzczNDQ_6a603801-ff7c-4ff9-adb9-aa849d36ea30"
      unitRef="number">0.35</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="ice6bd37091d347f3832020ccc4810992_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzczNTA_bb00da08-8d83-44ca-8649-4ec0446e52d7"
      unitRef="number">0.55</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i84c20c51ca704a07878759c0f075f79e_I20201101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1NjkwMg_02f60118-c4a4-44d6-af0f-6ceb9947676d"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ieef3f7dbd23c40ba8dec17264c4c7404_I20201101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM1NjkwOA_6c5bc240-8533-478b-981a-8843ea206b65"
      unitRef="number">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="ice510c28777843f7908e514b19c6921c_D20200801-20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0NDU5OQ_36717efd-a02b-43fb-8925-07ac32e92e68"
      unitRef="usd">1600000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i03c69569d3d64c1ca16e558b4cf75bee_I20190101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0NDYwNg_da769b8a-021f-46db-b999-0613a96abfd2"
      unitRef="number">0.35</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="idd3a6d6c4d174d43891d0ceddc82c6fa_I20170401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzgzNDY_e0bf5041-092d-4366-8314-15a1ecf72e99"
      unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="iacffbad6df7e4b20a00f3fce533dc4dc_I20170401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzgzODY_5320ff6c-0608-491e-8e1a-fd421c42582c"
      unitRef="number">0.60</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <rdnt:AdditionalEquityInterestAcquired
      contextRef="ied3dcc77eee243f38eab75f3a00f0e81_I20190101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM2NjA2OQ_ce13212b-1e35-4d7a-a7d8-fc1cff05aa1d"
      unitRef="number">0.05</rdnt:AdditionalEquityInterestAcquired>
    <us-gaap:InvestmentOwnedAtFairValue
      contextRef="ied3dcc77eee243f38eab75f3a00f0e81_I20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzg1ODA_9ede96a6-5b10-4c95-9df8-dd3ef859d798"
      unitRef="usd">134000</us-gaap:InvestmentOwnedAtFairValue>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i03c69569d3d64c1ca16e558b4cf75bee_I20190101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzg2Njc_da769b8a-021f-46db-b999-0613a96abfd2"
      unitRef="number">0.35</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i7b637d843dc04b2db741ddae2d1a65cd_D20190101-20190101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzg2OTQ_c2745603-e7e1-4560-abfa-33c1fd905257"
      unitRef="usd">-2000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i1a886167e5d546978b5a20d615e9fc78_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzg3OTg_9a13002a-15ec-483b-a454-c4fac8a06745"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ie59b21d255d147928f8d589fb25170fa_D20141006-20141106"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzg4OTE_afc6988a-802b-404d-86af-3b539a39a1f4"
      unitRef="usd">2200000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i4c644318cb64465f94242234734b4336_I20180412"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzkyMzA_bd16b156-3695-4a82-8d56-0eb8afb99fe5"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i92c0f7af41664881930d4f739dc6b4cb_D20180412-20180412"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzkyOTA_0529417c-788e-423b-9e15-b123c58d1bfc"
      unitRef="usd">2000000.0</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i0d288cd107d84361b2e08ab554ae5ed7_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzkzNzY_1c0bcd0a-ad4a-4502-892b-10b48e164454"
      unitRef="usd">1500000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i46ed970e221a4949933067bb7c822615_I20190801"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzk0MTM_ff1bec31-09b8-4d52-8455-9c87efe010e6"
      unitRef="number">0.75</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNDA3NDE_fd904850-911f-40e6-85bc-0694c12e3e12">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of our investment in joint ventures during the years ended December 31, 2020 and December 31, 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(134)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dissolution of GSRN&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nulogix return of capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(792)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nulogix change in control&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,598)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity contributions in existing and purchase of interest in joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in earnings in these joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Distribution of earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,522)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ibae6485d220c4366bf04745e679dee34_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfNS0xLTEtMS0w_e5d86ee0-badf-4b4b-89d5-d720ad37aa3d"
      unitRef="usd">37973000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:EquityContributionsJointVentures
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfNi0xLTEtMS0w_adcbe00b-b572-42e4-a2e6-7ea3536d8d77"
      unitRef="usd">103000</rdnt:EquityContributionsJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfNy0xLTEtMS0w_4a18553d-8f59-4d16-81ef-705d0f24dc30"
      unitRef="usd">8350000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfOC0xLTEtMS0w_2599c8c3-80ab-4d1b-a110-4f59569c4802"
      unitRef="usd">-134000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfOS0xLTEtMS0w_b514d41f-ac53-4336-bcb7-3a292f3dddf3"
      unitRef="usd">-1428000</us-gaap:GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee>
    <us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTAtMS0xLTEtMA_7b31861c-cb50-439c-be38-071c2ed312b9"
      unitRef="usd">792000</us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTEtMS0xLTEtMA_b295009f-1564-4ae3-9cde-5eac0d8d38ca"
      unitRef="usd">1004000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTItMS0xLTEtMA_848e9941-70f1-480f-8fb8-2a88dba0b118"
      unitRef="usd">8598000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTMtMS0xLTEtMA_c6cf268f-8a0b-40f6-9ad6-c61305f2b497"
      unitRef="usd">34470000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:EquityContributionsJointVentures
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfOS0xLTEtMS0zMDEx_671bee68-5237-4f19-be27-ed27f418ae33"
      unitRef="usd">1635000</rdnt:EquityContributionsJointVentures>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTAtMS0xLTEtMzAxMQ_5e5de49b-a239-4a00-8fb5-d98ea71c15bc"
      unitRef="usd">7945000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTEtMS0xLTEtMzAxMQ_811d1859-21b7-4358-a894-b06555a73f21"
      unitRef="usd">9522000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjM2YTZlMTVjYTM2ZTRjOGRiN2NmMGU5ZmQxYTkxZTc0L3RhYmxlcmFuZ2U6MzZhNmUxNWNhMzZlNGM4ZGI3Y2YwZTlmZDFhOTFlNzRfMTItMS0xLTEtMzAxMQ_f4cac74c-b129-42e4-bd68-f0ea4e911922"
      unitRef="usd">34528000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <rdnt:ManagementServiceFees
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0NDI2Nw_e4e4273b-5bd2-4017-9b59-f4d7bf5e94f7"
      unitRef="usd">11300000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0NDI4Nw_ddf5fd9f-3e3e-471e-b127-027d885af8a5"
      unitRef="usd">11400000</rdnt:ManagementServiceFees>
    <rdnt:ManagementServiceFees
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMjE5OTAyMzM0NDMwMw_3b3b5be1-d1de-4fd3-a312-6f9da162b366"
      unitRef="usd">13800000</rdnt:ManagementServiceFees>
    <rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfMzI5ODUzNDkzMDYyMg_7479fe82-dd6a-42d8-86f3-85817b493e69">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2020 and 2019, respectively, and for the years ended December 31, 2020, 2019 and 2018, respectively, (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance Sheet Data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,545)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,217)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncurrent liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21,582)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net assets&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total value of RadNet joint venture interests&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="i2554f6fee6574c18aa40868ebe1c695b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfMi0xLTEtMS0w_62c1a606-bc51-4268-a2e5-1408dae19c6b"
      unitRef="usd">27085000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ic7055474fff84385849f9083f2f9de03_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfMi0zLTEtMS0w_41f06991-1c66-40e2-b6c3-7a1415dbfa32"
      unitRef="usd">27427000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="i2554f6fee6574c18aa40868ebe1c695b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfMy0xLTEtMS0w_989db149-31d3-4c7a-aa91-3608d47c3e65"
      unitRef="usd">68686000</us-gaap:AssetsNoncurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="ic7055474fff84385849f9083f2f9de03_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfMy0zLTEtMS0w_aa8f1c40-b389-42a1-b43b-e0c42886736f"
      unitRef="usd">61037000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i2554f6fee6574c18aa40868ebe1c695b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNC0xLTEtMS0w_b8b992e6-5204-4baa-bd14-6568d0375df7"
      unitRef="usd">12545000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic7055474fff84385849f9083f2f9de03_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNC0zLTEtMS0w_e12e6b28-5a40-43fa-815a-788f6531f287"
      unitRef="usd">9217000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="i2554f6fee6574c18aa40868ebe1c695b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNS0xLTEtMS0w_06d6908c-9479-4ae2-aa5c-958d6a6cf8a3"
      unitRef="usd">21582000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ic7055474fff84385849f9083f2f9de03_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNS0zLTEtMS0w_7e70d902-605e-4e56-ada0-43bece44451d"
      unitRef="usd">18872000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNi0xLTEtMS0w_d64745ee-f854-4d69-8bdb-23f0989fe532"
      unitRef="usd">61644000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestmentAggregateCost
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNi0zLTEtMS0w_f38e5095-e14b-41c9-8a6a-741b1ece6d8b"
      unitRef="usd">60375000</us-gaap:EquityMethodInvestmentAggregateCost>
    <us-gaap:EquityMethodInvestments
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNy0xLTEtMS0w_3d46efe7-73b7-40e3-9895-a5855f2d2043"
      unitRef="usd">28079000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfNy0zLTEtMS0w_2ee7597b-6f93-4745-a265-812bdc3df773"
      unitRef="usd">28001000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfOC0xLTEtMS0w_b7b5ee8f-9bc9-47c9-a9f2-d1f8fbecb68b"
      unitRef="usd">6449000</us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
    <us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfOC0zLTEtMS0w_6cbaca4e-4e9a-4d67-85f2-b76e27c21489"
      unitRef="usd">6469000</us-gaap:EquityMethodInvestmentUnderlyingEquityInNetAssets>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfOS0xLTEtMS0w_f0b1ba7e-902d-4bd1-a4e6-8491e7c15479"
      unitRef="usd">34528000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOjg4MDIyM2NkNWI3MjQ3NWE4Mjk0MjM5M2UyNTg4MzljL3RhYmxlcmFuZ2U6ODgwMjIzY2Q1YjcyNDc1YTgyOTQyMzkzZTI1ODgzOWNfOS0zLTEtMS0w_ad2ba1d8-d79b-4a63-b0d6-817d8ab896ff"
      unitRef="usd">34470000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Revenues
      contextRef="ia5ea44f74d23424abb3bafc1c81918e2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMS0xLTEtMS0w_119f03f0-2f40-410c-b9e4-e128803d089f"
      unitRef="usd">101921000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iabdd0283752a4382b0580526189689c1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMS0zLTEtMS0w_2e01e542-35d5-460a-8863-939b641959c6"
      unitRef="usd">108051000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2197fe5a97c5429da1cc14762c73c186_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMS01LTEtMS0w_4a13c534-f0fe-4d1a-8869-7ff8191aa543"
      unitRef="usd">155820000</us-gaap:Revenues>
    <us-gaap:ProfitLoss
      contextRef="ia5ea44f74d23424abb3bafc1c81918e2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMi0xLTEtMS0w_51b8ebfa-76fc-4fb8-9f05-ad4ef1f2969d"
      unitRef="usd">16850000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iabdd0283752a4382b0580526189689c1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMi0zLTEtMS0w_70cc5e77-f7b2-4cd8-9309-9850dc6d439a"
      unitRef="usd">18624000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2197fe5a97c5429da1cc14762c73c186_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RhYmxlOmQ2YjRkYjVjNWVjODRiNWE5NTJlODIwZDUxZmZjYzFiL3RhYmxlcmFuZ2U6ZDZiNGRiNWM1ZWM4NGI1YTk1MmU4MjBkNTFmZmNjMWJfMi01LTEtMS0w_287863f2-c6c1-442b-9c9b-9be1195594be"
      unitRef="usd">24596000</us-gaap:ProfitLoss>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84NS9mcmFnOmU5MGFkMDUxYmQ3YTQ2NWU5YTA3M2JiN2IwNjVjNmI3L3RleHRyZWdpb246ZTkwYWQwNTFiZDdhNDY1ZTlhMDczYmI3YjA2NWM2YjdfNjc4MQ_88f51e15-dc9f-4255-84ae-b2405257cbc1">RECENT ACCOUNTING STANDARDS&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2020-04 on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  ASU 2016-13 replaces the incurred loss methodology previously utilized for valuing financial instruments with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology.  We adopted the standard on January &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1, 2020 using the modified retrospective approach.  See the Accounts Receivable section to Note 2 for further information on our allowances for credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-15 (&#x201c;ASU 2018-15&#x201d;),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles-Goodwill and Other-Internal-Use Software.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;ASU 2018-15 aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU was effective in the first quarter of 2020 with early adoption permitted and can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on our consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-03 ("ASU 2020-03"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements to Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in this update represent changes to clarify or improve the codification and correct unintended application. ASU 2020-03 was effective immediately upon issuance and its adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13 ("ASU 2018-13"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure Framework &#x2013; Changes to the Disclosure Requirements for Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard removes, modifies and adds certain disclosures related to recurring and nonrecurring fair value measurements. We adopted ASC 2018-13 effective January 1, 2020 and it had no effect on our disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740).  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 is effective beginning in the first quarter of 2021. Early adoption is permitted. Certain amendments in this update must be applied on a prospective basis, certain amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. We are currently evaluating the impact this ASU will have on our financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. We do not expect the adoption of this guidance will have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2021-01 provides clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2021-01 on our financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84NS9mcmFnOmU5MGFkMDUxYmQ3YTQ2NWU5YTA3M2JiN2IwNjVjNmI3L3RleHRyZWdpb246ZTkwYWQwNTFiZDdhNDY1ZTlhMDczYmI3YjA2NWM2YjdfMTA0NDUzNjA0ODYwNTQ_aaaf7129-93da-4435-b53e-5a3467728f3a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2020-04 on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;  ASU 2016-13 replaces the incurred loss methodology previously utilized for valuing financial instruments with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology.  We adopted the standard on January &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1, 2020 using the modified retrospective approach.  See the Accounts Receivable section to Note 2 for further information on our allowances for credit losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-15 (&#x201c;ASU 2018-15&#x201d;),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles-Goodwill and Other-Internal-Use Software.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;ASU 2018-15 aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU was effective in the first quarter of 2020 with early adoption permitted and can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on our consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the FASB issued ASU 2020-03 ("ASU 2020-03"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements to Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amendments in this update represent changes to clarify or improve the codification and correct unintended application. ASU 2020-03 was effective immediately upon issuance and its adoption did not have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU No. 2018-13 ("ASU 2018-13"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure Framework &#x2013; Changes to the Disclosure Requirements for Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This standard removes, modifies and adds certain disclosures related to recurring and nonrecurring fair value measurements. We adopted ASC 2018-13 effective January 1, 2020 and it had no effect on our disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting standards not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740).  &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 is effective beginning in the first quarter of 2021. Early adoption is permitted. Certain amendments in this update must be applied on a prospective basis, certain amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. We are currently evaluating the impact this ASU will have on our financial statements and related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments&#x2014;Equity Securities (Topic 321), Investments&#x2014;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. We do not expect the adoption of this guidance will have a material impact on our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848), Scope&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. ASU 2021-01 provides clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2021-01 on our financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzg5OA_211ad05c-cb37-4d44-9a7e-fd7dffe2f1c1">FACILITY ACQUISITIONS AND DISPOSITIONS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October and November 2020, we completed our acquisition of certain assets of ZP Atlantic LLC, and ZP Elmhurst LLC.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.625%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Atlantic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Elmhurst&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 31, 2020 we completed our acquisition of certain assets of AZ-Tech Radiology &amp;amp; Open MRI, LLC, consisting of eight multi-modality imaging centers located in the Phoenix, Arizona area for purchase consideration of $5.5 million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $2.5 million in property and equipment, $7.6 million in right-of-use assets, $0.1 million in other assets, $7.6 million in operating lease liabilities, and $2.9 million in goodwill were recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued 915,132 shares at $16.93 per share (823,615 issued at execution, with up to 91,517 shares to be issued 18 months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $34.6 million including i) 823,615 shares issued on the date of closing with fair value of $13.9 million, ii) a liability of 91,517 shares with a fair value of $1.5 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $2.0 million, iv) acquisition date fair value of contingent consideration of $17.0 million and v) $0.1 million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with 390,789, 586,184, and 195,393 shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We preliminarily recorded $0.1 million in current assets, $3.5 million in deferred tax liabilities, $14.8 million in intangible assets, primarily in-process research and development ("IPR&amp;amp;D'), and $23.3 million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#x2019;s assembled workforce and IPR&amp;amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;amp;D were determined by the income method and the assets will not be amortized until regulatory approval is obtained, but will be assessed for impairment annually, or more frequently if indicators of impairment become present&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 2, 2020 our consolidated subsidiary New Jersey Imaging Networks ("NJIN") completed the acquisition of certain assets of MRI at Woodbridge, LLC consisting of a single multi-modality imaging center located in Avenel, New Jersey for cash consideration of $2.6 million.  NJIN made a fair value determination of the acquired assets and assumed liabilities and approximately $0.5 million in property and equipment, $1.1 million in right-of-use assets, $0.3 million in intangible assets, $1.1 million in operating lease liabilities, $0.1 million in finance lease liabilities, and $1.8 million in goodwill were recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On January 2, 2020 we completed our acquisition of certain assets of Olney Open MRI, LLC, consisting of a single multi-modality imaging center located in Columbia, Maryland for cash consideration of $1.8 million.  We have made a fair value determination of the acquired assets and assumed liabilities and approximately $0.8 million in property and equipment, $1.3 million in right-of-use assets, $0.3 million in intangible assets, $1.3 million in operating lease liabilities and $0.6 million in goodwill were recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2019 we completed a step-up acquisition upon the dissolution of our former 49% owned joint venture, Garden State Radiology LLC ("GSRN").  GSRN consisted of two multi-modality centers operating in New Jersey.  GSRN became our wholly owned subsidiary with the withdrawal of the 51% majority partner for the full ownership of one center with no other consideration.  We made a fair value determination of our original 49% interest which resulted in a step-up gain of&#160; approximately $1.3 million. We determined a fair value of  the remaining acquired imaging center of $3.1 million in assets and $0.4 million in liabilities were recognized.  We recorded $1.0&#160;thousand in other assets, $0.7 million in fixed assets, $0.4 million in right-of-use assets, $0.4 million in operating lease liabilities, and $2.0 million in goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2019 we completed a step-up acquisition of our former 25% owned joint venture, Nulogix, via a stock issuance of RadNet common shares valued at $1.5 million to obtain the remaining 75% outstanding Nulogix shares. We made a fair value determination of the acquired assets and approximately $0.2 million in fixed assets, $0.7 million in intangible assets, $0.3 million in deferred tax liability and goodwill of $1.3 million were recorded.  We also made a fair value determination of our 25% pre-existing interest in the business and recognized a loss of $0.5 million which is included in operating expenses within the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2019 we completed our acquisition of certain assets of Kern Radiology Imaging Systems Inc., consisting of four multi-modality imaging centers located in Bakersfield, California for purchase consideration of $19.3 million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $10.1 million in property and equipment, $9.7 million in right-of-use assets, $36.0&#160;thousand in other assets, $3.4 million in intangible assets, $14.5 million in operating lease liabilities, and $10.5 million in goodwill were recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2019 we completed our acquisition of certain assets of Zilkha Radiology Inc. consisting of two multi-modality centers located in Islip, New York for purchase consideration of $4.5 million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $2.2 million in property and equipment, $5.1 million in right-of-use assets, $0.1 million in intangible assets, $5.1 million in operating lease liabilities, $0.3 million  in finance lease liabilities and $2.6 million in goodwill were recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 28, 2019, one of VIE entities, Lenox Hill Radiology and Medical Imaging Associates, P.C. ("LHR"), purchased the membership interest of Hudson Valley Radiology Associates, P.L.L.C. ("HVRA") for $6.0 million of RadNet common stock and contingent consideration valued at $0.7 million to guarantee the share value issued for a period of six months post acquisition date.  LHR has performed a fair value purchase price allocation and recorded equipment of $10.0&#160;thousand, a covenant not to compete of $50.0&#160;thousand, trade name of $0.4 million, other intangible assets of $0.3 million and goodwill of $3.1 million from the transaction. In connection with the acquisition, RadNet also settled against the purchase consideration, $2.8 million, net of taxes, of an unfavorable vendor contract with HVRA stemming from the previous acquisition of Radiologix, Inc. in November 2006. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 1, 2019 our majority owned subsidiary, West Valley Imaging Group, LLC ("WVIG") completed its acquisition of certain assets of West Valley Imaging Center, LLC ("West Valley"), consisting of a single multi-modality imaging center located in West Hills, CA for purchase consideration of $3.0 million all of which was initially funded by the Company.  We have made a fair value determination of the acquired assets and approximately $0.3 million in equipment and fixed assets, $7.0&#160;thousand in other assets, $0.2 million in intangible assets and $2.5 million in goodwill were recorded.  Subsequent to the transaction, our partner in WVIG, Cedars Sinai Medical Center, contributed $0.8 million in cash to maintain its 25% economic interest in the venture.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Joint venture formations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 13, 2019 we formed a wholly owned subsidiary, Ventura County Imaging Group, LLC ("VCIG").  On March 1, 2019, Dignity Health joined as a venture partner.  Total agreed contribution of both parties was $10.4 million of cash and assets with RadNet contributing net assets with a book value of $4.3 million for a 60% economic interest and Dignity Health contributing $6.1 million in cash and assets for a 40% economic interest.  For its contribution, RadNet transferred net assets of three wholly owned multi-modality imaging centers.  Dignity Health contributed approximately $0.8 million in assets to acquire 5% economic interest and paid RadNet $5.3 million for an additional 35% economic interest.  We maintain controlling economic interest in VCIG and fully consolidate the results into our financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dispositions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary to RadVantage P.C. (an unrelated corporation) for approximately $1.0&#160;thousand.  With this transaction, we have exited the teleradiology business.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzg5OQ_f2b2d057-a286-401d-af44-835a7dc67692">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.625%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.047%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Atlantic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ZP Elmhurst&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of Use Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of Use Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,181)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,571)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMS0yLTEtMS0xNzA0_65b045a7-d544-41b8-b896-2b72fd2ee676"
      unitRef="usd">7931000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMS0zLTEtMS0xNzEw_c633190c-83ed-4492-b7e4-34a14d8aa610"
      unitRef="usd">10681000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMi0yLTEtMS0xNzA0_9ff98853-d125-414e-be5b-6b6d8e9668fa"
      unitRef="usd">6181000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMi0zLTEtMS0xNzEw_c859ddae-f457-4707-bad8-bece40f0e3cd"
      unitRef="usd">12571000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMy0yLTEtMS0xNzA0_e6b86be0-26a7-4cf3-9cb2-21a22b9998f0"
      unitRef="usd">62000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfMy0zLTEtMS0xNzEw_f294cebb-9cca-4c7e-9f07-e376dd53d71e"
      unitRef="usd">75000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNC0yLTEtMS0xNzA0_a9174539-6550-4580-88a4-2c4c823d1ebe"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNC0zLTEtMS0xNzEw_f3d2d1b4-81a3-49cd-ad09-1b3b27a2273f"
      unitRef="usd">50000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNS0yLTEtMS0xNzA0_a182efc8-43d7-4749-ab5c-cdbf88fb78b4"
      unitRef="usd">6181000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNS0zLTEtMS0xNzEw_8eed48b3-19f5-4ab1-a0cd-1a5a2169dd03"
      unitRef="usd">12571000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:Goodwill
      contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNi0yLTEtMS0xNzA0_e94a1970-edba-4bc3-b325-c8123e1e8cf1"
      unitRef="usd">828000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNi0zLTEtMS0xNzEw_52a00cfd-7bf3-4fd1-93bb-8fb94dc39f8d"
      unitRef="usd">1463000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNy0xLTEtMS01NzA1_74e310aa-edde-4ccb-98a3-42cbf71036e9"
      unitRef="usd">8871000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i9d6cef46192147a3a9e8eb7ca0715056_I20201101"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RhYmxlOjRhYmZkYTJhNTUyMjQ3OTk4ODUxMTlkMWI4NDFhZmQwL3RhYmxlcmFuZ2U6NGFiZmRhMmE1NTIyNDc5OTg4NTExOWQxYjg0MWFmZDBfNy0yLTEtMS01NzA3_8fe53e20-6688-4c01-8b7e-cac158050d86"
      unitRef="usd">12269000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="iaeade28b6efd4a5892b49eea2eb7af2c_D20200831-20200831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODE5Mw_2979e746-e8b7-4711-b36f-51b6e6857d8e"
      unitRef="center">8</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iaeade28b6efd4a5892b49eea2eb7af2c_D20200831-20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODE5Nw_bcfab398-7aea-458a-ac3b-ebd368438fba"
      unitRef="usd">5500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODIwNw_27d9feef-c80c-4d20-a8af-0f827c76005f"
      unitRef="usd">2500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODIxNQ_121803ef-8dea-442e-9ddd-8c173a0ed87e"
      unitRef="usd">7600000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODIyMw_aa949e66-7273-4844-ba4e-5b8cb5748b5e"
      unitRef="usd">100000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODIzMw_d92476bb-dd49-4cb0-b1c9-6e74b2155a00"
      unitRef="usd">7600000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:Goodwill
      contextRef="i9d15bec8c9bf46ff8da74539af2d38c9_I20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODI0MQ_d35590ce-95d9-491e-8136-2a7159823a77"
      unitRef="usd">2900000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDA4Mw_2340e759-44dd-4567-94df-7f104e292e5d"
      unitRef="shares">915132</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i89d9310e311f4127811afce11cd60c48_I20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDA4Nw_a158a4b4-6365-47a1-afd9-59aceb292b88"
      unitRef="usdPerShare">16.93</us-gaap:CommonStockParOrStatedValuePerShare>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution
      contextRef="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDA5MQ_f4488766-f847-4c2f-be62-17b993d53730"
      unitRef="shares">823615</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution
      contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDA5NQ_e806a22b-bd6e-4048-afe9-2a32c47623d6"
      unitRef="shares">91517</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm
      contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDA5OQ_2fed1836-aa33-4ade-aff0-b8f37c089230">P18M</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDEwNA_dec5ddb9-f685-4c49-abc4-b9dfd33d7be8"
      unitRef="usd">34600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution
      contextRef="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDExMg_f4488766-f847-4c2f-be62-17b993d53730"
      unitRef="shares">823615</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution
      contextRef="ie6c6f91c80f64bfd90d06ac2197d3ec9_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDExNg_50329ef5-866d-4d89-8ee9-74cbe146f94e"
      unitRef="usd">13900000</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution
      contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDEyNA_e806a22b-bd6e-4048-afe9-2a32c47623d6"
      unitRef="shares">91517</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution
      contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDEyOA_b0684e66-8e09-4250-9187-2455ebdcc8e0"
      unitRef="usd">1500000</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm
      contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDEzNg_2fed1836-aa33-4ade-aff0-b8f37c089230">P18M</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm>
    <rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards
      contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE0MA_61bca10c-4c9b-4dab-b84c-e757d6f3fee1"
      unitRef="usd">2000000.0</rdnt:BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards>
    <us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure
      contextRef="i89d9310e311f4127811afce11cd60c48_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE0OA_2acb0d14-e9e1-4937-9c98-a9f2059e13c6"
      unitRef="usd">17000000.0</us-gaap:EquityIssuedInBusinessCombinationFairValueDisclosure>
    <us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
      contextRef="i89d9310e311f4127811afce11cd60c48_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE1Ng_65d1b644-e0b2-4c29-bf52-88a90c61a88c"
      unitRef="usd">100000</us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts>
    <rdnt:BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares
      contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE2NA_258a5a89-2a87-43f5-8841-9f6c5d7ca639"
      unitRef="shares">390789</rdnt:BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares>
    <rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares
      contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE2OA_1018121f-8dae-44a8-b0f7-097ac0d255dc"
      unitRef="shares">586184</rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares>
    <rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares
      contextRef="if217300975284a948f8e3b27f3d0605e_D20200601-20200601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE3Mg_b2e44929-74f2-4bea-acb6-d1226406e680"
      unitRef="shares">195393</rdnt:BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets
      contextRef="i89d9310e311f4127811afce11cd60c48_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE3Ng_6585ffab-5bc0-4810-bf3d-708321471e09"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i89d9310e311f4127811afce11cd60c48_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE4NA_9165db22-0b0f-4c05-8529-801e9f116d6a"
      unitRef="usd">3500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i89d9310e311f4127811afce11cd60c48_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDE5Mg_86bff03e-0b79-42f5-90f6-e6d2d25043ca"
      unitRef="usd">14800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i89d9310e311f4127811afce11cd60c48_I20200601"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI5MDIwMA_2718ea42-d1c3-4f51-9284-0ea64965c353"
      unitRef="usd">23300000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i465e71fce78e4f91b93ebe3aac52f888_D20200302-20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI0MA_ac2ca5d7-c2d9-4be2-ae17-f15bc00ec580"
      unitRef="usd">2600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI0OA_7c0f197f-40ba-4dff-b693-9bf9d6c6a5ea"
      unitRef="usd">500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI1Ng_fb57b821-33de-4af5-8c6f-f2761a597a2a"
      unitRef="usd">1100000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI2NA_2e029a41-e6ed-49be-83a0-b1c5c13a00dc"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI3Mg_74c09d2b-f2e1-4b7d-8093-ffe7e28a0a97"
      unitRef="usd">1100000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities
      contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI4MA_6605e8d4-893c-4629-8b48-435b44091087"
      unitRef="usd">100000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities>
    <us-gaap:Goodwill
      contextRef="i15cd63800a8f437f9409f248d1e8148d_I20200302"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTI5MA_b048114d-33c3-4c0f-b7d1-c75b1744a6de"
      unitRef="usd">1800000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6b97202f8ab7436596da79bcd433c721_D20200102-20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODcyNA_e477880c-ce36-4b5f-87f8-09b2846d135e"
      unitRef="usd">1800000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="ibb22327f2e344552abfc54aa4c8a3bff_I20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODczMg_9db7f6d9-55f0-4482-8de7-56cdb023b8f9"
      unitRef="usd">800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="ibb22327f2e344552abfc54aa4c8a3bff_I20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODc0MA_e0349b8d-7872-49a5-b39e-87b0c827e97c"
      unitRef="usd">1300000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="ibb22327f2e344552abfc54aa4c8a3bff_I20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODc1Ng_d18af8d6-8d98-45fa-b4dc-5fc61c893ecd"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="ibb22327f2e344552abfc54aa4c8a3bff_I20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODc2OA_742981ab-c14d-4ef1-8b7d-ba33761564ff"
      unitRef="usd">1300000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:Goodwill
      contextRef="ibb22327f2e344552abfc54aa4c8a3bff_I20200102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4ODgwNA_58594d1c-bd95-4628-9585-15401618b683"
      unitRef="usd">600000</us-gaap:Goodwill>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i1a886167e5d546978b5a20d615e9fc78_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTgx_9a13002a-15ec-483b-a454-c4fac8a06745"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ida4995e095e84733a7a3db2b2c529f94_D20190801-20190801"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzg5NQ_18937a93-613d-4d92-a5d2-ed67b23389f7"
      unitRef="center">2</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzgx_a155ca09-9397-4c91-b4d6-a897a2f9e07b"
      unitRef="number">0.51</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i1a886167e5d546978b5a20d615e9fc78_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNTE5_9a13002a-15ec-483b-a454-c4fac8a06745"
      unitRef="number">0.49</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ida4995e095e84733a7a3db2b2c529f94_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNTgy_40b3fe15-1bd6-454c-b6b1-5ffa7f2226be"
      unitRef="usd">1300000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNjU4_719ca332-278b-470f-8e70-17d3121d9d5e"
      unitRef="usd">3100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNjc1_86240d4f-c492-4fa4-878f-0b57a5aa156e"
      unitRef="usd">400000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNzIz_271ab4ef-1206-46f8-a800-f0d428445c3e"
      unitRef="usd">1000.0</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNzQz_e9443433-ea17-4aed-a62a-93378d2a2e85"
      unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNzYz_024c7823-5d1b-443f-b1b6-baf4e9c166c5"
      unitRef="usd">400000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfNzkw_86240d4f-c492-4fa4-878f-0b57a5aa156e"
      unitRef="usd">400000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:Goodwill
      contextRef="id2a7b6c1dd71401c9bca8e83aa872ac7_I20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfODI5_617d0648-1572-4046-baa6-27ee869b3f44"
      unitRef="usd">2000000.0</us-gaap:Goodwill>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ic1ca963b4ec644fb9fafe95a4d9cb74f_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfOTEz_628c19d1-c09d-4b6c-b036-3e58e9feea71"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i0d288cd107d84361b2e08ab554ae5ed7_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTAwMQ_172ae7ba-97e5-4492-ad6a-f295abdb23a7"
      unitRef="usd">1500000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i46ed970e221a4949933067bb7c822615_I20190801"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTAyOA_921ff1a7-9f3a-4255-8b22-fb4c153a5900"
      unitRef="number">0.75</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i46ed970e221a4949933067bb7c822615_I20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTEzNQ_e1bb45f8-4ee2-402e-9b0f-58bca4c82d60"
      unitRef="usd">200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i46ed970e221a4949933067bb7c822615_I20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTE1NQ_b2e58979-7dda-48a9-a755-bb941183f1a9"
      unitRef="usd">700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i46ed970e221a4949933067bb7c822615_I20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTE4MA_a998055a-638c-4263-ba6e-6bdf4ada25e2"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i46ed970e221a4949933067bb7c822615_I20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTIyNQ_b579e86f-bbbe-42f7-b57e-1dea0d56de62"
      unitRef="usd">1300000</us-gaap:Goodwill>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="ic1ca963b4ec644fb9fafe95a4d9cb74f_I20190731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTI5MQ_628c19d1-c09d-4b6c-b036-3e58e9feea71"
      unitRef="number">0.25</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="i0d288cd107d84361b2e08ab554ae5ed7_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTM1Nw_2833185d-0f60-4fe5-8a77-12096fdc3bd2"
      unitRef="usd">-500000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="ia72ddff7bc5d4634b0956b82982d346c_D20190401-20190401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzkwNw_5b4bfa3b-805f-454b-a19b-18dc8c4588d6"
      unitRef="center">4</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia72ddff7bc5d4634b0956b82982d346c_D20190401-20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTY3MA_6581a106-9048-46c1-b884-ab97cd092bc7"
      unitRef="usd">19300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTc3NQ_b61ea421-74d8-4df9-93da-ec396e870e7a"
      unitRef="usd">10100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTgwNQ_dc8583a1-0aff-4ccf-89aa-b0382cdcf608"
      unitRef="usd">9700000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTgzMg_dbd99b7d-aeda-4b7f-a4c5-b2ea6d4c2f6f"
      unitRef="usd">36000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTg1Mg_a2668ad9-4b25-4018-92c6-3c2f0687dac6"
      unitRef="usd">3400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTg3Nw_7cefca38-fe1b-4cfe-b9dc-46b6299fa237"
      unitRef="usd">14500000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <us-gaap:Goodwill
      contextRef="i4fb7800d73114cc8a0a897cae7906feb_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTkxNg_b47d0d4b-8aaa-4310-bd6f-b401e35ecb99"
      unitRef="usd">10500000</us-gaap:Goodwill>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i6013424b82d141dba94b68360286b828_D20190401-20190401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzkxNQ_d3eaaac6-9a8e-4b95-ba76-8f459833d334"
      unitRef="center">2</us-gaap:NumberOfBusinessesAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i6013424b82d141dba94b68360286b828_D20190401-20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjEzMw_5f2ed3b0-1290-4eed-af30-708b1fdaec3f"
      unitRef="usd">4500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjIzOA_7cdf03f1-a573-446c-98d0-ca5c6856a8b0"
      unitRef="usd">2200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset
      contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjI2OA_ed7070e7-29c1-4568-b2da-228467a7c49b"
      unitRef="usd">5100000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjI5NQ_f489267b-369a-4950-81d8-829f4b84f46d"
      unitRef="usd">100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities
      contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjMyMA_9d40dcb2-86c1-4d21-8f94-f4be67fb6a1d"
      unitRef="usd">5100000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities
      contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjM1NQ_d193deec-89b5-4174-ae00-1426ae8c4dd3"
      unitRef="usd">300000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities>
    <us-gaap:Goodwill
      contextRef="i64e741abdb7047a3b0f1ed90ef1fd409_I20190401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjM5Mg_e60304fe-39e3-47c2-b813-fc08dbd79252"
      unitRef="usd">2600000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
      contextRef="i9e74f1c4a6d74c37aa2e96e236ce886f_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjYyNw_899528f3-46f4-42c6-af79-068d80d7a1fe"
      unitRef="usd">6000000.0</us-gaap:BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia312590d9b814f1386f70c721698d7d1_D20190228-20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjY5Mg_c7a524fe-7ee3-44cb-8dc6-5d7fde134d0b"
      unitRef="usd">700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment
      contextRef="i9e74f1c4a6d74c37aa2e96e236ce886f_I20190228"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjg2NQ_35f3ceec-2624-40fa-a871-2ee33f493b5e"
      unitRef="usd">10000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4337c29255b447709dce2086107be291_I20190228"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjg5OA_9ba8e8ad-8208-4364-a986-dfbadfbc777b"
      unitRef="usd">50000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i4874f4e250774b1fbb5b0f4c47efae14_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjkxNg_4b95084f-3fc9-4887-bad8-08f7c4b758d6"
      unitRef="usd">400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i9e74f1c4a6d74c37aa2e96e236ce886f_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjk0Nw_77905dfa-bde0-4356-a241-945facafbf96"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i9e74f1c4a6d74c37aa2e96e236ce886f_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjk2Ng_aeffdcde-47a2-4687-8cf2-583fb74f9f03"
      unitRef="usd">3100000</us-gaap:Goodwill>
    <rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts
      contextRef="i964d58a775bd4fa199e750e6ee03db8e_I20190228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzA4Mw_dc1bc7e6-8590-4e74-8e2a-a79ae8091a1f"
      unitRef="usd">2800000</rdnt:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i456f5191d4dd4b73882fca5d3f1ad088_D20190201-20190201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzUxOQ_fea2ab8b-c34f-42ae-8d8e-22e9d83975de"
      unitRef="usd">3000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i6a60c6284cf54e1ca418b050d90465a0_I20190201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzY1NA_9297365d-9f7f-4614-bf39-32127156197f"
      unitRef="usd">300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i6a60c6284cf54e1ca418b050d90465a0_I20190201"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzY4OA_6011fca5-920a-4513-a4ba-780113f2e079"
      unitRef="usd">7000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i6a60c6284cf54e1ca418b050d90465a0_I20190201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzcwOA_f4a934b1-2275-4481-ab59-643c4756a190"
      unitRef="usd">200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:Goodwill
      contextRef="i6a60c6284cf54e1ca418b050d90465a0_I20190201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzczNg_ea5a95e9-319d-4e78-b46e-4d9a49a273a5"
      unitRef="usd">2500000</us-gaap:Goodwill>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="iaf7fe2658d284b5cb2907e0de5419820_D20190201-20190201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzg2MA_b94c455e-e792-481f-add3-9cd122ca7871"
      unitRef="usd">800000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="i8b95c89ccfed4e1fb901493260558cab_I20190201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzg4Nw_7defe955-cb26-4bae-9611-ede5bb64579a"
      unitRef="number">0.25</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="ieac963b9dd7b42a5bc5034ac64e4e8ee_D20190301-20190301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA0Njk_6cb5662a-68e5-4012-87e4-74be65340958"
      unitRef="usd">10400000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i612c3bc5981e4ff8bd89f7fc44a3a3fe_I20190301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA1NDg_9a52bad3-3e17-46b1-b7be-450eb922f323"
      unitRef="usd">4300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i091d9ede79dd4469affa6d73b62fd16c_I20190301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA1NTc_d5d48172-8070-4d16-9b59-308357fa2137"
      unitRef="number">0.60</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:PaymentsToAcquireEquityMethodInvestments
      contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA2MTA_1098b63f-1812-4f07-be28-eb1335a1cebc"
      unitRef="usd">6100000</us-gaap:PaymentsToAcquireEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i612c3bc5981e4ff8bd89f7fc44a3a3fe_I20190301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA2Mzg_4d535a42-3e43-443a-984c-9ed731fe2e5b"
      unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:NumberOfBusinessesAcquired
      contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMzI5ODUzNDkyMzkyNQ_dc7a82b0-0248-415e-9d79-8942aa879000"
      unitRef="center">3</us-gaap:NumberOfBusinessesAcquired>
    <rdnt:PaymentstoAcquireEquityMethodInvestmentsAssetsContributed
      contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA4MDk_a2a4cbb1-43e4-47cf-a142-e4d3541e756c"
      unitRef="usd">800000</rdnt:PaymentstoAcquireEquityMethodInvestmentsAssetsContributed>
    <rdnt:EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed
      contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA4MzM_8cd57d6f-912c-4e7a-ba9e-54d1fcf4e59c"
      unitRef="number">0.05</rdnt:EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed>
    <rdnt:PaymentstoAcquireEquityMethodInvestmentsCash
      contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA4NzA_2b7ca0a4-7da6-4197-b48e-f006d3e73bb2"
      unitRef="usd">5300000</rdnt:PaymentstoAcquireEquityMethodInvestmentsCash>
    <rdnt:EquityMethodInvestmentOwnershipPercentageInExchangeforCash
      contextRef="i029867b23b704961b44fc1543f234b9f_D20190301-20190301"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMTA4OTE_f9b4371c-af38-4d4a-ab3d-6acab50b52e2"
      unitRef="number">0.35</rdnt:EquityMethodInvestmentOwnershipPercentageInExchangeforCash>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="i3e571ad52d964e1389114033d8e4b89c_D20200601-20200601"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF84OC9mcmFnOjg0Zjg1MmIyNmNiZTQxZDA4NDdhMzJlZDBlNjQ2ZDU0L3RleHRyZWdpb246ODRmODUyYjI2Y2JlNDFkMDg0N2EzMmVkMGU2NDZkNTRfMjE5OTAyMzI4OTg0Mw_7e1686f6-75a3-4fb0-89f5-eb59150a641b"
      unitRef="usd">1000.0</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfMTE3Mg_7d052876-0a63-4edd-918d-54d88cb86cff">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is recorded as a result of business combinations. Activity in goodwill for the years ended December 31, 2019 and December 31, 2020 is provided below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$418,093&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to our preliminary allocation of the purchase price of Medical Arts Radiological Group, P.C.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of certain assets of Dignity Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of certain assets of West Valley Imaging Center, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill disposed through sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired by Lenox Hill Radiology through the membership purchase of HVRA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of certain assets of Kern Radiology, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of certain assets of Zilkha Radiology, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of certain assets of Ramic Mahwah, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of GSRN&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of Nulogix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill transferred from assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$441,973&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of Olney Open MRI, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of MRI at Woodbridge, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of DeepHealth, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of AZ-Tech Radiology &amp;amp; Open MRI, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of ZP Ozone Park, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of ZP Elmhurst LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$472,879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2020 is $148.3 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortization expense was $3.7 million, $3.1 million, and $2.7 million for the years ended December 31, 2020, 2019 and 2018, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over 25 years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software in development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfMTE3OA_328b2988-009d-462e-b6a0-8bf866fd815e">Activity in goodwill for the years ended December 31, 2019 and December 31, 2020 is provided below (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$418,093&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to our preliminary allocation of the purchase price of Medical Arts Radiological Group, P.C.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of certain assets of Dignity Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of certain assets of West Valley Imaging Center, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill disposed through sale of assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired by Lenox Hill Radiology through the membership purchase of HVRA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of certain assets of Kern Radiology, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of certain assets of Zilkha Radiology, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of certain assets of Ramic Mahwah, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of GSRN&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of Nulogix&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill transferred from assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$441,973&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of Olney Open MRI, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of MRI at Woodbridge, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of DeepHealth, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of AZ-Tech Radiology &amp;amp; Open MRI, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of ZP Ozone Park, LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired through the acquisition of ZP Elmhurst LLC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$472,879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="ibae6485d220c4366bf04745e679dee34_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTUtMS0xLTEtMA_1561f28b-f254-4850-a83c-e05fd98f2e57"
      unitRef="usd">418093000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i5528883c400f402890b0b9e360fa9757_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTYtMS0xLTEtMA_b381da8a-e176-451f-bca3-448101b4d366"
      unitRef="usd">722000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="icd9c48ca86d84fb980d466453795b682_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTctMS0xLTEtMA_1e576869-3744-4170-a253-433563fc90d5"
      unitRef="usd">1000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0b0b910fae6b4ba090ec1c469a5c973a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTgtMS0xLTEtMA_eabe3267-c696-4299-b884-63fcf174ea63"
      unitRef="usd">2490000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTktMS0xLTEtMA_15ae2982-97c8-49d8-b946-40d29dcd9ad3"
      unitRef="usd">123000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ifa266170ed154d5198ecd30150de0a0d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjAtMS0xLTEtMA_f4ae8292-dfe9-486d-a77f-94959721b620"
      unitRef="usd">3125000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i0e225ee197db4962846379c1f756351b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjEtMS0xLTEtMA_8bece3f8-8b31-40e5-b554-8b8caade0e9c"
      unitRef="usd">10507000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i774974bb637346659642b95eb18c0d88_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjItMS0xLTEtMA_4a72bcc8-f9d7-450d-9ff3-aed1b2805ce3"
      unitRef="usd">2577000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4b7b602ee54a433b9e40d150fe55fbb3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjMtMS0xLTEtMA_b7dcc263-f218-46c6-8809-e0a855903a63"
      unitRef="usd">231000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6e8e0ca3243444e7970426cdcd410ff4_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjQtMS0xLTEtMA_9dfd1f59-c9f7-4196-933e-2f86c0086cac"
      unitRef="usd">2021000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6e940ec7fd4d4b28bb5546113a619040_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjUtMS0xLTEtMA_aa787951-b496-47d8-abc9-3f481ca083c6"
      unitRef="usd">1337000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillTransfers
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMjYtMS0xLTEtMTUzMQ_b7976aa0-f4f5-4f4d-88ac-eb99fe98fa3e"
      unitRef="usd">992000</us-gaap:GoodwillTransfers>
    <us-gaap:Goodwill
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMzAtMS0xLTEtMA_863959d0-8cb4-4b9a-8990-5a5829f3ff26"
      unitRef="usd">441973000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i4351f86bc864495c813b7164d4002e89_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTMtMS0xLTEtMTU1OA_fb52e92d-3198-4264-a829-e62075273636"
      unitRef="usd">601000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i037ebcff3f474b6a85350f30a450750f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTQtMS0xLTEtMTU1OA_7093289c-2c36-4010-91c6-55ed6d03fc62"
      unitRef="usd">1833000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iac2767be8a5846ac88dc5a19d3c5cdd0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTUtMS0xLTEtMTU1OA_91172faf-6299-4ec6-84f7-fea9693f1a34"
      unitRef="usd">23299000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i41f3fcd0c1b7458b8c2b5611fd14cbe3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTYtMS0xLTEtMTU1OA_8e686b3c-e3eb-4b69-9e56-77fd1c1e030f"
      unitRef="usd">2882000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iffd13c35af724f7495f80a4ffd36d14a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTctMS0xLTEtMjM1Ng_a382e5b4-c322-4032-bf23-0a1adefc15a7"
      unitRef="usd">828000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iff9d9ba698244f9295f632171332ff38_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTgtMS0xLTEtMjM1Ng_302fa2fc-37af-4565-b4b9-34005e9035eb"
      unitRef="usd">1463000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOmQ0MDM3MjZiZGJkMDRkMTFhNjY3ZGJiM2U4MmJjMGI3L3RhYmxlcmFuZ2U6ZDQwMzcyNmJkYmQwNGQxMWE2NjdkYmIzZTgyYmMwYjdfMTktMS0xLTEtNTY3Ng_6f374742-3c7e-4f39-a7a4-6f0c02d4741b"
      unitRef="usd">472879000</us-gaap:Goodwill>
    <rdnt:GoodwillDeductibleForTaxPurposes
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfMjk2_c6b75cf3-4a52-4ae0-86a5-7657886c2ec6"
      unitRef="usd">148300000</rdnt:GoodwillDeductibleForTaxPurposes>
    <us-gaap:AdjustmentForAmortization
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfNjAz_48611bd8-fe9f-4bb5-8238-0f51124a1175"
      unitRef="usd">3700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfNjA3_43e7d52f-a13e-4358-be8b-75ccfa7b8fae"
      unitRef="usd">3100000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfNjE1_5267e11d-61cb-43b6-8db1-8f7fefc8dc57"
      unitRef="usd">2700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfODMw_4da849bc-d7ec-49cf-b150-3239468aae43">P25Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RleHRyZWdpb246ZTUxZTY0YjUwOWIyNDk4OWFhNGZhNGRhNTMyYzIwYThfMTE3NA_80fbb3fa-1004-4cff-ba28-3710957caaf0">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.464%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.736%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.536%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Weighted average amortization period remaining in years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Management Service Contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;13,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;24,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;10.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Covenant not to compete and other contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Developed Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Trade Names indefinite life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Software in development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;15,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total Annual Amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;36,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;52,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS0xLTEtMS0w_bb92b0ca-9f78-4e0e-a944-65d0d7a75d29"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS0zLTEtMS0w_04807d56-bf5d-4c2f-9d8e-c8ebe62ceea7"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS01LTEtMS0w_22df2f4a-59c7-415e-9b38-c4c2fcc3f7d8"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS03LTEtMS0w_cd154936-8079-4db0-a07d-de425dba222e"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS05LTEtMS0w_fcf6efca-225c-4e99-ac8e-ce4d5052db27"
      unitRef="usd">2287000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS0xMS0xLTEtMA_33269783-bba0-4194-907f-73e16704489d"
      unitRef="usd">13533000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9bf401f259054b239c444a7ba3779a78_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS0xMy0xLTEtMA_9307e56b-b313-484a-a051-1f9276726def"
      unitRef="usd">24968000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <rdnt:WeightedAverageAmortizationPeriodRemainingInYears
      contextRef="id05c02a9c24c46eb8f9844d8050a58a4_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMS0xNS0xLTEtMA_c6319fb0-1511-494f-917d-87ac967345d3">P10Y10M24D</rdnt:WeightedAverageAmortizationPeriodRemainingInYears>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi0xLTEtMS0w_771c4a70-a213-4b34-9a4b-d1630690d119"
      unitRef="usd">1024000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi0zLTEtMS0w_0819bc6f-f8e7-4a09-abb4-8764c9805453"
      unitRef="usd">994000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi01LTEtMS0w_f2ebced3-04df-4cee-8767-9697561ee84d"
      unitRef="usd">883000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi03LTEtMS0w_795384a7-af0f-47cf-9b98-036671d30302"
      unitRef="usd">467000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi05LTEtMS0w_fecc89cc-54bd-43ad-8ce6-a6eda69c5d5e"
      unitRef="usd">233000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi0xMS0xLTEtMA_6291582a-8d8c-4945-a906-f8b98f9a44c9"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5df3beb96ec040a792ee0fc37556ccd6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi0xMy0xLTEtMA_0c3fdc36-9866-47d2-bfd6-7938c8223109"
      unitRef="usd">3601000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <rdnt:WeightedAverageAmortizationPeriodRemainingInYears
      contextRef="i3126da00ef154364bff57a0c60402471_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMi0xNS0xLTEtMA_0a379905-a346-4c2e-a12b-0b6f92fa0425">P3Y10M24D</rdnt:WeightedAverageAmortizationPeriodRemainingInYears>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy0xLTEtMS0w_9c6fc668-eccd-4782-b354-b532840a729c"
      unitRef="usd">244000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy0zLTEtMS0w_22ceaaf7-4df1-453f-a2a0-1b7ed609f238"
      unitRef="usd">142000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy01LTEtMS0w_9c9d8527-6fbf-4a7e-8f89-bb63e43c6954"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy03LTEtMS0w_7b4651cb-f9db-4010-99fd-85ed76ff1c11"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy05LTEtMS0w_c38adbda-52ab-4e09-be18-12dce4b771c2"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy0xMS0xLTEtMA_b06fd673-4e29-4f52-ade5-77ff7a95c5ff"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id061ad1af2d248bfb7f45397fa7e8c96_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy0xMy0xLTEtMA_2ab893f3-3b15-4325-9963-62936be03ab9"
      unitRef="usd">386000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <rdnt:WeightedAverageAmortizationPeriodRemainingInYears
      contextRef="ibf3163cdc65c43c2bb456cfbfe498c0e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfMy0xNS0xLTEtMA_c24da227-4dd8-45ea-bd0e-9331ba355db3">P1Y7M6D</rdnt:WeightedAverageAmortizationPeriodRemainingInYears>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC0xLTEtMS0w_89510caf-8ac8-45d1-a075-1d0b788541a6"
      unitRef="usd">75000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC0zLTEtMS0w_69f013a8-c501-4881-b716-da1bdb707014"
      unitRef="usd">75000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC01LTEtMS0w_19baa591-ce10-4b03-a7e1-0e6c9d46acdd"
      unitRef="usd">66000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC03LTEtMS0w_2b8ceb54-7c4e-4d0d-a6f1-1e79a0670eae"
      unitRef="usd">64000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC05LTEtMS0w_e032c13f-4992-49ea-ac49-6e00bf0dfe5a"
      unitRef="usd">64000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC0xMS0xLTEtMA_aca02c82-2bf6-458c-9b64-18737a51d4ea"
      unitRef="usd">309000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i61448a8add4f4771a367c78ff3a9877b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC0xMy0xLTEtMA_bed1105b-2458-4c89-93ec-24c67d597f9f"
      unitRef="usd">653000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <rdnt:WeightedAverageAmortizationPeriodRemainingInYears
      contextRef="i830cf944df0341d7a34972034686fd2b_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNC0xNS0xLTEtMA_b09e0822-23aa-4bae-95a9-e36fc88ee678">P5Y4M24D</rdnt:WeightedAverageAmortizationPeriodRemainingInYears>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS0xLTEtMS0w_58491991-75e0-4181-957e-7460908b003b"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS0zLTEtMS0w_c899ab80-0920-46e4-b402-c4b16de8d225"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS01LTEtMS0w_e7ec69cc-d578-495d-8545-084422b2684e"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS03LTEtMS0w_6e5ccf64-1336-44ce-a2ae-bfba5498deca"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS05LTEtMS0w_cfef856f-5a1c-4af0-88b3-2c01a7e6e5df"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS0xMS0xLTEtMA_d51d2bb2-8a3b-4095-b023-3330d3f90f67"
      unitRef="usd">7100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5091546c66fb4cedaeb8f3c3a3452dad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNS0xMy0xLTEtMA_288e3dd0-6ec3-410b-a1c1-77f099f59f62"
      unitRef="usd">7100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi0xLTEtMS0w_2dacd31b-3bae-4665-916f-b2eddc67e385"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi0zLTEtMS0w_aa1e74bc-cd5d-4197-b597-3780f8ec7244"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi01LTEtMS0w_a394b7b8-53d9-4a57-9742-81bf921b8236"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi03LTEtMS0w_acdb39e1-487b-44ef-a4cd-a765a0db3269"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi05LTEtMS0w_5709d7cd-36a8-4ca2-87b5-3b3e07c8da32"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi0xMS0xLTEtMA_37bc1093-eb7a-4a52-925b-97879b923cc0"
      unitRef="usd">15685000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1af3ae0e5caa47a7a61c06002e11c661_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNi0xMy0xLTEtMA_7711541d-83e9-4c5b-bdff-5d3068f496e2"
      unitRef="usd">15685000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy0xLTEtMS0w_fa39842d-ec8d-461e-8857-13ef11a46ead"
      unitRef="usd">3630000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy0zLTEtMS0w_870514df-3c26-480a-8aad-e4269a672c16"
      unitRef="usd">3498000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy01LTEtMS0w_d148ad08-230c-4145-a06c-b9de014fc09f"
      unitRef="usd">3236000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy03LTEtMS0w_76350d2b-8c17-46ad-9d16-9203478e9ce6"
      unitRef="usd">2818000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy05LTEtMS0w_3b8fa96b-02d1-44b2-9c8c-c384d2bd79a7"
      unitRef="usd">2584000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy0xMS0xLTEtMA_c4a8056d-6b45-4f8d-b5ff-4ecfcd24e2f0"
      unitRef="usd">36627000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85MS9mcmFnOmU1MWU2NGI1MDliMjQ5ODlhYTRmYTRkYTUzMmMyMGE4L3RhYmxlOjljMjQyNjU1NDhmYjRkYzM4ODVkNDU5OTNiNmQ3OWYyL3RhYmxlcmFuZ2U6OWMyNDI2NTU0OGZiNGRjMzg4NWQ0NTk5M2I2ZDc5ZjJfNy0xMy0xLTEtMA_92f37da9-67cc-4407-9712-9917d894927b"
      unitRef="usd">52393000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfNTY1_2bbf935f-35a3-4df3-a9f2-cc513a7e40b2">PROPERTY AND EQUIPMENT&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment and accumulated depreciation and amortization are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under financing/capital lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(627,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(571,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in our property and equipment at December 31, 2020  is approximately $57.5 million total of construction in process amounts consisting of $26.0 million in medical equipment, $7.7 million in computer and office equipment, and $23.8 million in leasehold improvements.&lt;/span&gt;&lt;/div&gt;Depreciation and amortization expense of property and equipment, including amortization of equipment under finance/capital leases, for the years ended December 31, 2020, 2019 and 2018 was $83.1 million, $77.5 million, and $70.2 million, respectively.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfNTY4_c044954d-68ed-454d-b2f2-25b1d40ab42c">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment and accumulated depreciation and amortization are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;480,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;426,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer and office equipment, furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;377,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under financing/capital lease&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,026,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(627,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(571,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i90897045b27b47d3851512df495fb317_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMi0xLTEtMS0w_094706cc-7e53-4cea-9256-0fb8e7b16313"
      unitRef="usd">250000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ia4ba3f78a0f049ebbe6bbd419db532c1_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMi0zLTEtMS0w_878c44b2-2bf6-45e2-8afd-5834eb8ebbdf"
      unitRef="usd">250000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ib3ebc23af28648849d72a86f89b15a59_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMy0xLTEtMS0w_088db926-b7c1-4da5-98f9-721ec88aca67"
      unitRef="usd">480631000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i4215872a7995444cb1ddcef9705d75d5_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMy0zLTEtMS0w_e72e4755-b94e-4378-aa32-614365a29672"
      unitRef="usd">426682000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ibdea4c2c6a394718bbe4f06a3a8dc179_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNC0xLTEtMS0w_add08b4c-0f3c-4fe8-9359-d1939f514680"
      unitRef="usd">132446000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i0f79bab3685041179f8a090705f8145d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNC0zLTEtMS0w_23837eaa-6a3d-4e63-a65e-0dbf575f23c5"
      unitRef="usd">120490000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i0e015b6f1727458c8d7a3e194aee3c2d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNi0xLTEtMS0w_a3284106-d541-4ece-b6a1-698abd712759"
      unitRef="usd">399253000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i1b6f7873910a406998fcb4834647b21b_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNi0zLTEtMS0w_563bc329-33f1-436f-9924-a78a78048591"
      unitRef="usd">377676000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="iab72392226114b9c9189e2d1cfb7fe7c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNy0xLTEtMS0w_358fef69-3ccc-42d5-9e7b-ca6a974ae678"
      unitRef="usd">13984000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i285fdbc8c707469b8e163fb3a3e1934f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfNy0zLTEtMS0w_510a029c-14a1-4fbd-9aa6-2a5eefa12123"
      unitRef="usd">14105000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfOC0xLTEtMS0w_82709cc8-549c-4209-a326-d13debc7bb4c"
      unitRef="usd">1026564000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfOC0zLTEtMS0w_77450895-b8d2-4864-8329-82b3919a7a2e"
      unitRef="usd">939203000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfOS0xLTEtMS0w_0af18829-99fe-4678-89a2-70de9593d556"
      unitRef="usd">627229000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfOS0zLTEtMS0w_183d027f-0176-4a41-9bed-f60a9bb19996"
      unitRef="usd">571408000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMTItMS0xLTEtMA_fd03daae-13ad-44f5-a180-79eca3a50a3b"
      unitRef="usd">399335000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RhYmxlOjQ2YzNmOWVmZjQxZDQ1ZmViMTM5ZGZhMmMwYzZjMjFhL3RhYmxlcmFuZ2U6NDZjM2Y5ZWZmNDFkNDVmZWIxMzlkZmEyYzBjNmMyMWFfMTItMy0xLTEtMA_bfb3ff36-ca8d-413e-af13-c317c51879e0"
      unitRef="usd">367795000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ifbc658ed6a3a4a78a3c5bf60feff2cd1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfMjEw_286542b4-c7f3-40c9-8edd-3211ab3c0738"
      unitRef="usd">57500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i78316bdeb53c42e49f72d68723354ca6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfMjY4_db4159e1-ccf4-448c-af55-0cf883645373"
      unitRef="usd">26000000.0</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i9f7c6c92238d4993b8ecc28a6fac055a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfMjkz_f6b21553-5ce5-467c-b73c-d782723e1d57"
      unitRef="usd">7700000</us-gaap:ConstructionInProgressGross>
    <us-gaap:ConstructionInProgressGross
      contextRef="i0e015b6f1727458c8d7a3e194aee3c2d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfMzM0_10bddc07-a696-4677-8a1c-d6c01c61ec94"
      unitRef="usd">23800000</us-gaap:ConstructionInProgressGross>
    <us-gaap:DepreciationAndAmortization
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfNTM0_15c66ee5-4e0d-4393-9adf-f3751ecf32cf"
      unitRef="usd">83100000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfNTM4_e0813eb0-6a01-4257-9d8b-f67d040eb03c"
      unitRef="usd">77500000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF85Ny9mcmFnOjdmYjg4YjllZThkYTQyMTViYjNkOTViZjAyNWVjZDZiL3RleHRyZWdpb246N2ZiODhiOWVlOGRhNDIxNWJiM2Q5NWJmMDI1ZWNkNmJfNTQ2_0f32b696-5c9b-415e-ae1b-dbd958827cc3"
      unitRef="usd">70200000</us-gaap:DepreciationAndAmortization>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90ZXh0cmVnaW9uOjUwYTIxYmE5MzdlYTQyZDVhMTYzMjJjZDQ5M2E3OTcxXzE0Ng_41849b1e-3688-4909-ad97-d0ab882eafcb">ACCOUNTS PAYABLE AND ACCRUED EXPENSES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued expenses were comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued salary and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90ZXh0cmVnaW9uOjUwYTIxYmE5MzdlYTQyZDVhMTYzMjJjZDQ5M2E3OTcxXzE0OQ_c5c860c9-149f-4615-8ae5-81df3ecc6577">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued expenses were comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued salary and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzItMS0xLTEtMA_825608af-2dce-4624-af98-9383597db501"
      unitRef="usd">70071000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzItMy0xLTEtMA_7194df34-cc64-4568-bddb-d019c429cb12"
      unitRef="usd">64300000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzMtMS0xLTEtMA_19ebe7b0-7231-4cce-b9d3-9b4d2cc23866"
      unitRef="usd">84312000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzMtMy0xLTEtMA_9241c15c-2a48-4708-805d-731e19732267"
      unitRef="usd">83853000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzQtMS0xLTEtMA_e0b1078d-a6cf-49d0-bfc7-3b4df0533d14"
      unitRef="usd">58051000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzQtMy0xLTEtMA_f0e0bede-2223-4c9f-9013-61c66bc6b364"
      unitRef="usd">42003000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzUtMS0xLTEtMA_a94fd17f-3350-47cc-ae4a-8b03c43924cf"
      unitRef="usd">24250000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzUtMy0xLTEtMA_fba5ecda-1e7c-41ad-9ed4-ee8af312800e"
      unitRef="usd">17429000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzYtMS0xLTEtMA_78d7bf68-1b42-4ccc-be18-266aee58743d"
      unitRef="usd">236684000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDAvZnJhZzo1MGEyMWJhOTM3ZWE0MmQ1YTE2MzIyY2Q0OTNhNzk3MS90YWJsZToyMjYwNTNiNDA5OTc0YzMxYjNiMjgxMWRlNzlmYzQzZi90YWJsZXJhbmdlOjIyNjA1M2I0MDk5NzRjMzFiM2IyODExZGU3OWZjNDNmXzYtMy0xLTEtMA_2f979ef1-7fd0-477c-b3d1-598cd4775d0a"
      unitRef="usd">207585000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzMyOTg1MzQ5MzI5NTI_a4d57ea4-011a-4103-af73-f5264cac7e3d">CREDIT FACILITIES AND NOTES PAYABLE&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020 and December 31, 2019 our debt obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment notes payable at interest rates ranging from 4.4% to 5.6%, due through 2020, collateralized by medical equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total notes payable obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in our consolidated balance sheets at December 31, 2020 are $601.3 million of First Lien Term Loans and $51.4 million of SunTrust Term Loan debt for a combined total of $652.7 million (net of unamortized discounts of $9.7 million) in thousands:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Face Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at December 31, 2020 and had reserved an additional $7.3 million for certain letters of credit.  The remaining $187.7 million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2020.  We also had no balance under our $30.0 million SunTrust Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2020, and with no letters of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2020 we were in compliance with all covenants under our credit facilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Senior Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, our Barclays credit facilities were comprised of one tranche of term loans (&#x201c;First Lien Term Loans&#x201d;) and a revolving credit facility of $195.0 million (the &#x201c;Barclays Revolving Credit Facility&#x201d;), both of which are provided pursuant to the Amended and Restated First Lien Credit and Guaranty Agreement dated July 1, 2016, among RadNet, Barclays Bank plc, as administrative agent, and the lenders identified therein (as amended, the "First Lien Credit Agreement").  Deferred financing costs at December 31, 2020, net of accumulated amortization, was $1.8 million and is specifically related to our Barclays Revolving Credit Facility.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our First Lien Term Loans bear interest at either an Adjusted Eurodollar Rate or a Base Rate (each as defined in the First Lien Credit Agreement) plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eurodollar Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 5.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 4.00x but &#x2264; 5.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt;3.50x but &#x2264; 4.00x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020 the effective Adjusted Eurodollar Rate and the Base Rate for the First Lien Term Loans was 1.00% and 3.25%, respectively and the applicable margin for Adjusted Eurodollar Rate and Base Rate borrowings was 3.75% and 2.75%, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The First Lien Credit Agreement provides for quarterly payments of principal under the First Lien Term Loans in the amount of approximately $9.7 million.  The  First Lien Term Loans will mature on July 1, 2023 unless otherwise accelerated under the terms of the First Lien Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;SunTrust Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, our SunTrust credit facilities, which relate to our consolidated subsidiary The New Jersey Imaging Network, L.L.C.("NJIN"), were comprised of one term loan (the "SunTrust Term Loan") and a revolving credit facility of $30.0 million (the "SunTrust Revolving Credit Facility") both of which are provided pursuant to the Amended and Restated revolving Credit and Term Loan Agreement dated August 31, 2018, among NJIN, as borrower, with SunTrust Bank, as &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;administrative agent, and the lenders identified therein (as amended, the "SunTrust Credit Agreement").  Our SunTrust Term Loan bears interest at either an Adjusted LIBOR Rate or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Eurodollar Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loans and other obligations outstanding under the SunTrust Credit Agreement currently bear interest at a three month LIBOR election at 0.22% plus an applicable margin and fees based on Pricing Level III described above.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $750,000, representing annual amortization equal to 5.0% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $375,000, with the remaining balance to be paid at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Revolving Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Revolving Credit Facility:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either an Adjusted Eurodollar Rate or a Base Rate (in each case, as more fully defined in the First Lien Credit Agreement) plus an applicable margin.  The applicable margin for borrowing under the Barclays Revolving Credit Facility varies based on our leverage ratio in accordance with the same schedule set forth above for First Lien Term Loans. As of December 31, 2020, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was 6.00%.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Adjusted Eurodollar Rate revolving loans, currently 3.75%, and fronting fees accrue at 0.25% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the First Lien Credit Agreement. In addition a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barlcays Revolving Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Barclays Revolving Credit Facility will terminate on the earlier to occur of July 1, 2023 or termination due to specific events of default pursuant to the First Lien Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Barclays Revolving Credit Facility was amended in August 2020 to add $57.5 million of revolving commitments, which additional commitments increased the maximum borrowing capacity to $195.0 million.  Total issue costs added in relation to this amendment amounted to approximately $0.7 million and was capitalized as deferred financing costs and will be amortized over the remaining term of the First Lien Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;SunTrust Revolving Credit Facility:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The SunTrust Credit Agreement established a $30.0 million revolving credit facility available to NJIN for funding requirements. The SunTrust Revolving Credit Facility terminates on the earliest of (i) August 31, 2023, (ii) the &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;voluntary termination thereof by NJIN pursuant to Section 2.8 of the SunTrust Credit Agreement, or (iii) the date on which all amounts outstanding under the SunTrust Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  As of December 31, 2020, NJIN had no borrowings under the SunTrust Revolving Credit Facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Recent Amendments to Credit Facilities&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Barclays Credit Facilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement ("the Eighth Amendment").  The Eighth Amendment amends the First Lien Credit Agreement to add $57.5 million of revolving commitments to the Barclays Revolving Credit Facility increasing the maximum borrowing capacity under the Barclays Revolving Credit Facility to $195.0 million while leaving the maturity date of July 1, 2023 unchanged.  Total issue costs added in relation to the Eighth Amendment amounted to approximately $0.7 million and was capitalized as deferred financing costs and will be amortized over the remaining term of the First Lien Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 18, 2019 we entered into the following two amendments to the First Lien Credit Agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#x201c;Sixth Amendment&#x201d;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#x201c;Seventh Amendment&#x201d;).  Among other things, the Sixth Amendment amended the First Lien Credit Agreement to issue $100.0 million in incremental First Lien Term Loans and to add an additional $20.0 million of revolving commitments to the Barclay's Revolving Credit Facility.  The Seventh Amendment amended the First Lien Credit Agreement to extend the maturity date of the Barclays Revolving Credit Facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the First Lien Credit Agreement.  Total issue costs added in relation to the Sixth and Seventh amendments in 2019 amounted to approximately $4.4 million. Of this amount, $2.1 million was identified and capitalized as discount on debt, $0.7 million was capitalized as deferred financing costs, and $1.6 million was expensed. Amounts capitalized will be amortized over the remaining term of the First Lien Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Paycheck Protection Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a 1.0% fixed interest rate and are due in 2 years.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received four loans totaling $4.0 million.  We accounted for the funds received as debt and recorded a liability for the full amount of proceeds received and accrued interest over the term of the loans.  In December 2020 we met the eligibility requirements for forgiveness and the loans were written off to gain on debt extinguishment.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzU0OTc1NTgxNzE1Mzc_ea335c30-f216-4aac-bc9d-274993477288">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020 and December 31, 2019 our debt obligations consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans collateralized by RadNet's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;649,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount on First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,579)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment notes payable at interest rates ranging from 4.4% to 5.6%, due through 2020, collateralized by medical equipment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;692,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,791)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39,691)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;612,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebt
      contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzEtMS0xLTEtMA_a15f1b33-6baa-48d0-9670-9f9f10ddb4ef"
      unitRef="usd">611028000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i9c47a542e8864e56810edc15688328c9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzEtMy0xLTEtMA_02a7a96e-8a71-46c9-9c40-b4e6110cbe80"
      unitRef="usd">649824000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzItMS0xLTEtMA_33cfe0bd-0d7b-43b3-8fce-0697421ddb3b"
      unitRef="usd">9699000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i9c47a542e8864e56810edc15688328c9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzItMy0xLTEtMA_3134cedd-917b-42d0-9484-842d09092d36"
      unitRef="usd">13579000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzMtMS0xLTEtMA_9a1fb91b-7749-4b19-a15d-964b1c3ccc2a"
      unitRef="usd">51375000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i05a8cf1c3f364c8385b06277f3785c9f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzMtMy0xLTEtMA_e41904c1-4452-4aa6-b729-550d08e2ba74"
      unitRef="usd">55875000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4293895b42684cfab6b3bb70114b012f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNhOTJhZGVmYjgzNDQxMmY4YmFjMzNiMjA3MjMyOGFjXzIxOTkwMjMyNTU2ODI_19e47a86-0830-4c1f-90f1-1163c549558d"
      unitRef="number">0.044</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i10c7eb7f995c42fd9e9471533755d56c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzYtMC0xLTEtMC90ZXh0cmVnaW9uOjNhOTJhZGVmYjgzNDQxMmY4YmFjMzNiMjA3MjMyOGFjXzIxOTkwMjMyNTU2ODk_36754a4e-bcd5-4dce-bb06-afb6dcdbe4a3"
      unitRef="number">0.056</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermLoansPayable
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzYtMS0xLTEtMA_e476f94e-f531-4d56-a66b-66b6589b27d9"
      unitRef="usd">0</us-gaap:LongTermLoansPayable>
    <us-gaap:LongTermLoansPayable
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzYtMy0xLTEtMA_cb5634f5-df7b-43f0-918f-3a70756c2ea0"
      unitRef="usd">275000</us-gaap:LongTermLoansPayable>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzgtMS0xLTEtMA_ffa48061-8b3a-43a4-a67b-61ba1711c2ac"
      unitRef="usd">652704000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzgtMy0xLTEtMA_e917d03c-d972-4340-86bc-83560b91462e"
      unitRef="usd">692395000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzktMS0xLTEtMA_28f2925c-4698-4c8d-bf5e-389579863820"
      unitRef="usd">39791000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzktMy0xLTEtMA_6cd72ce4-17bd-4926-b702-7170ea5323e0"
      unitRef="usd">39691000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzEwLTEtMS0xLTA_0da7e71f-9f5d-4829-bc7a-3ec31aa032d4"
      unitRef="usd">612913000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities>
    <rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTpjMTliN2Y2ODdkMTQ0ZTQ1YTI1MzQ4MWNhNjJkNzk2Ni90YWJsZXJhbmdlOmMxOWI3ZjY4N2QxNDRlNDVhMjUzNDgxY2E2MmQ3OTY2XzEwLTMtMS0xLTA_5cd0cace-fbd7-4fcb-93bd-05eca994bf39"
      unitRef="usd">652704000</rdnt:LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzkwNjA_32dacb0c-39a1-4dcd-a3a3-7c382d22f43a">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.090%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;573,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total notes payable obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMTgxZjdlNDcwNjI0YThhYTNjMGNkYjU2ZDEzNGYzMi90YWJsZXJhbmdlOmExODFmN2U0NzA2MjRhOGFhM2MwY2RiNTZkMTM0ZjMyXzAtMS0xLTEtMA_464ded19-1fbd-4ef5-bf8e-d8df8d577172"
      unitRef="usd">43670000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMTgxZjdlNDcwNjI0YThhYTNjMGNkYjU2ZDEzNGYzMi90YWJsZXJhbmdlOmExODFmN2U0NzA2MjRhOGFhM2MwY2RiNTZkMTM0ZjMyXzEtMS0xLTEtMA_94fab6dc-b538-42d1-8568-4e184a7e7514"
      unitRef="usd">44795000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMTgxZjdlNDcwNjI0YThhYTNjMGNkYjU2ZDEzNGYzMi90YWJsZXJhbmdlOmExODFmN2U0NzA2MjRhOGFhM2MwY2RiNTZkMTM0ZjMyXzItMS0xLTEtMA_9bc6fcca-237a-402e-8e7a-4554893788a0"
      unitRef="usd">573938000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMTgxZjdlNDcwNjI0YThhYTNjMGNkYjU2ZDEzNGYzMi90YWJsZXJhbmdlOmExODFmN2U0NzA2MjRhOGFhM2MwY2RiNTZkMTM0ZjMyXzYtMS0xLTEtMA_4f048279-2142-40e8-8036-0dca8b39367f"
      unitRef="usd">662403000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzkwNjE_e6829124-80eb-40dd-b9e3-8d0f4c6a0a06">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in our consolidated balance sheets at December 31, 2020 are $601.3 million of First Lien Term Loans and $51.4 million of SunTrust Term Loan debt for a combined total of $652.7 million (net of unamortized discounts of $9.7 million) in thousands:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Face Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;First Lien Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;SunTrust Term Loan Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Term Loans&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;662,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652,704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE1OTg_0195c96c-68a7-4d88-83ac-d9c28df29213"
      unitRef="usd">601300000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE2MzA_ae7fcb0a-62ea-4ba1-a76e-141276caa37b"
      unitRef="usd">51400000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if541ba545c6849c9b80ae7c8f6901cfc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE2ODQ_e0c8e099-4d70-479f-abec-0c0a42f5ab67"
      unitRef="usd">652700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib81178c4dfa84fc9bdd6fffca1947078_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE3MjA_32020314-377f-4f3d-8078-bab3db3b3ccb"
      unitRef="usd">9700000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzEtMS0xLTEtMA_14d4e2a7-efa7-48f0-9d22-7670438703bb"
      unitRef="usd">611028000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzEtMy0xLTEtMA_2aa3c18d-1d0e-4bdf-8e09-7b3117df0153"
      unitRef="usd">9699000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2379c8aa72e346f1aa2f6cdd2a7e1ed1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzEtNS0xLTEtMA_fd24192a-c176-40f5-803a-524e1b2c7700"
      unitRef="usd">601329000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzItMS0xLTEtMA_8cad6be3-f189-4783-afc2-780af3ad9654"
      unitRef="usd">51375000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzItMy0xLTEtMA_341a2de0-193d-45b5-84b0-580ac1cc3517"
      unitRef="usd">0</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="id01c21b5705f4510ad0f4ee4ee991f8f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzItNS0xLTEtMA_39e026ff-63a3-446d-9258-469a74d3c9e2"
      unitRef="usd">51375000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if541ba545c6849c9b80ae7c8f6901cfc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzMtMS0xLTEtMA_8bef48f9-eb02-4792-baba-0adc0a5f0984"
      unitRef="usd">662403000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet
      contextRef="if541ba545c6849c9b80ae7c8f6901cfc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzMtMy0xLTEtMA_a65c2756-4053-4006-ba68-e3d23c354f88"
      unitRef="usd">9699000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if541ba545c6849c9b80ae7c8f6901cfc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTozNWI4ZjdkZjJiMWI0YzNmODg2YmYxMWMxNGE4NjNjMS90YWJsZXJhbmdlOjM1YjhmN2RmMmIxYjRjM2Y4ODZiZjExYzE0YTg2M2MxXzMtNS0xLTEtMA_4fc66bf4-dd9f-4773-88d8-3ab14233b6f3"
      unitRef="usd">652704000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCredit
      contextRef="ibdfce80209e24d048368e13932f4df63_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE3NTA_d8444ebe-aa6b-47bd-b901-4100250b4ca7"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ibdfce80209e24d048368e13932f4df63_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE3ODM_88d2c43f-01bd-4a66-b296-d681e63f752e"
      unitRef="usd">195000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i4ba89948df004b25bb090cc21c311d86_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE4NTg_c564066d-a5c0-4db4-91cf-25802739f328"
      unitRef="usd">7300000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i393ed2858c1548b6b82e961dc7975352_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzE5MDc_2b20f84b-4228-47b1-89e3-1734de084c32"
      unitRef="usd">187700000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LineOfCredit
      contextRef="i82d3729db9c24aed80f38ee4cff8b9e5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIwMDM_ba8407ac-1ac8-4f53-92c7-44524fab6e3a"
      unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8ffc456155284a328dd24dd400e38ed4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIwMjQ_5b7e815f-3f17-4f10-8bd5-05eec8d28f89"
      unitRef="usd">30000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ie76ddddf094d4fa9a36625b0a91bb963_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzMyOTg1MzQ5MzQ2MDA_46008970-f822-4e99-894c-f20a0c5e44b8"
      unitRef="usd">0</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ibdfce80209e24d048368e13932f4df63_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyNjYzMzA_88d2c43f-01bd-4a66-b296-d681e63f752e"
      unitRef="usd">195000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i4ba89948df004b25bb090cc21c311d86_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyNzE1ODU_c0629714-2cb5-4d73-9627-f6a97b710faa"
      unitRef="usd">1800000</us-gaap:DeferredFinanceCostsNet>
    <rdnt:ScheduleOfLeverageRatioTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzU0OTc1NTgxNzE1Mzg_37d78594-d67a-4734-a27c-c2adb00c6adb">&lt;div style="text-align:justify;text-indent:54pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our First Lien Term Loans bear interest at either an Adjusted Eurodollar Rate or a Base Rate (each as defined in the First Lien Credit Agreement) plus an applicable margin according to the following schedule:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.850%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.342%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:32.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;First Lien Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Eurodollar Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Base Rate Spread&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 5.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt; 4.00x but &#x2264; 5.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&amp;gt;3.50x but &#x2264; 4.00x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.50%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2264; 3.50x&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.25%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.128%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pricing Level&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Leverage Ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Eurodollar Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Base Rate Loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Margin for Letter of Credit Fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Applicable Percentage for Commitment Fee&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;I&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Greater than or equal to 3.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.45%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;II&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 3.00:1.00 but greater than or equal to 2.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.25%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.85pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.40%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;III&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.50:1.00 but greater than or equal to&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.00%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.35%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:0.05pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;IV&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 2.00:1.00 but greater than or equal to 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less than 1.50:1.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.30%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:2.9pt;padding-left:4.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;per annum&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</rdnt:ScheduleOfLeverageRatioTableTextBlock>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i8f3bcd1c38c94c46890195526ab00dc7_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzEtMS0xLTEtMA_49da63fa-9df2-4a18-b9f3-a89051c406b7"
      unitRef="number">0.0450</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i03d496ffc98f4cbea3c2e52184411ed8_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzEtMi0xLTEtMA_9093b73e-a9c3-4a8e-a27c-bedbc807e70e"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9fd684fe4e424d05a9e16bcf1667b1d8_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzItMS0xLTEtMA_9eec2bd8-1dcf-4876-a754-a35cba55bc42"
      unitRef="number">0.0375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6c94cda8e234414db8eeb093634ddc93_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzItMi0xLTEtMA_bba94d2c-28b7-454e-8b19-03ab85ce0c12"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id542a67b5a124e768231f2834084c93e_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzMtMS0xLTEtMA_11729564-474e-4295-a9b0-5363c7e02647"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i565421d3700145cc93c48dbb3d1a4773_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzMtMi0xLTEtMA_f4ca8e19-e0ab-44c8-b2ee-80632cc44600"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i2d53766b85e942388c2185f85329d9fe_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzQtMS0xLTEtMA_a51ca22a-11d4-4331-8edd-c1d5d27fb454"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ie6a7dcb8d79a4eb49b6cbd0775ce1798_D20160701-20160701"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTo4Y2Q4OTcwNmYyZWQ0NTIzYWZlNGM0Y2Y4YjE4YjJmNy90YWJsZXJhbmdlOjhjZDg5NzA2ZjJlZDQ1MjNhZmU0YzRjZjhiMThiMmY3XzQtMi0xLTEtMA_577e7f94-5f89-4bb4-9628-55fc7b7dcc44"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ie8288ed7887c48afb55992d498cc71a8_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODg2NTk_13337719-f1bb-483d-96a6-7627c3c909f0"
      unitRef="number">0.0100</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i995ae7f592fb4fefb0bb03523e52883b_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODg2Njc_dff15b73-50cf-4313-a365-807eae572b58"
      unitRef="number">0.0325</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iae3bdf0809064518b238f69ea108dcd7_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODg3Njk_d9914d17-9f4c-4458-97f8-4c0a31793333"
      unitRef="number">0.0375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i80b7b2a03f3941348f06c63609e7c6cb_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODg3Nzc_30cdd39f-71b5-4c34-bbc4-14597c6f53fb"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="i1263f290830a4060aed96f7ad872c48a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODkxNDQ_3e839835-659e-422b-b333-07d91738758b"
      unitRef="usd">9700000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i8ffc456155284a328dd24dd400e38ed4_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyNjk2NjI_5b7e815f-3f17-4f10-8bd5-05eec8d28f89"
      unitRef="usd">30000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="ibacf3bc799af4bb38a866940c2a2c3bb_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzEtMS0xLTEtNjkwL3RleHRyZWdpb246ZTEyMDAyYmJiNzI3NGEwMmExNzQ3ZTg5NmViNTg1NTBfMzI5ODUzNDg4MzM3MA_89b0e5f8-8503-4d00-ae12-d86129bcad4f"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i750fa1f8302a426fb9a669a5704e685e_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzEtMi0xLTEtNjc1L3RleHRyZWdpb246MDdkNmMwY2ZkZjg0NDY5YmE5MWNiMmI0OGQ4YTUwZTFfMzI5ODUzNDg4MzM1Mw_f56cbe43-6e2d-45d8-acaa-033025c5fc37"
      unitRef="number">0.0275</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i81c400dac51f406a9711305492c3b4c2_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzEtMy0xLTEtNjYwL3RleHRyZWdpb246MGZlZmJlMTYzYzU2NDliMWFlM2VmMjM4YzIzNzc0MDlfMzI5ODUzNDg4MzM1NQ_aa0ad2d1-f7e8-46c2-98ea-38c066a6d451"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i2c266838663e4aa9bd0e5ea532d2b79c_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzEtNC0xLTEtNjQ1L3RleHRyZWdpb246YmExMTE0ZjliNTJjNDQ5ODljOTVmYjYyMzBmNTgwNWRfMzI5ODUzNDg4MzM1Mw_16234487-50de-49d4-9e51-56f9b3de23c3"
      unitRef="number">0.0275</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i2c266838663e4aa9bd0e5ea532d2b79c_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzEtNS0xLTEtNjMwL3RleHRyZWdpb246OTc2MDUzMTY5OTQ4NGQ0ZDgxNjZlZDg0NTM0NzVkM2RfMzI5ODUzNDg4MzM1Mw_229a628f-48c0-420b-994a-9d78f957bc92"
      unitRef="number">0.0045</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="ibaa9f7ca79134dada648ef42e6c6db50_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItMS0xLTEtNjkzL3RleHRyZWdpb246NTU1N2U3YTI4NmIzNDVkNWE5YTFhYWU3MzY1MjM4ZDBfMzI5ODUzNDg4MzQwOA_88545767-2ba8-4420-b003-ecd7b92caeb8"
      unitRef="number">3.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="ibaa9f7ca79134dada648ef42e6c6db50_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItMS0xLTEtNjkzL3RleHRyZWdpb246NTU1N2U3YTI4NmIzNDVkNWE5YTFhYWU3MzY1MjM4ZDBfMzI5ODUzNDg4MzM5NA_40e27e74-59cd-4e8f-afe9-868f4f1d9f1d"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i43b7dfec154e47c7ae3282f11f953037_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItMi0xLTEtNjg3L3RleHRyZWdpb246NTM3Y2YwY2Q5ZjY1NGI5Mzg1ZjA4YmUwOWVjMjgxMTJfMzI5ODUzNDg4MzM3Nw_2c419a27-8695-4bf9-afa2-4b866cfc6383"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i9a3f1fe7a6fb45e28d7055b802128ddd_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItMy0xLTEtNjcyL3RleHRyZWdpb246ZGQzYTE1OWI5YmVhNDRiZTg0ZmUzNGM4MTRlMDUxODVfMzI5ODUzNDg4MzM2NQ_822327c5-f889-4cdc-8fbb-2fa78dd6cd1c"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i77430f8ce1d24d29b21836836ac4c9f5_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItNC0xLTEtNjUxL3RleHRyZWdpb246ZjNlODYxNGU3YTFhNDliMmFmODViMmUyNzA5MTM3ODdfMzI5ODUzNDg4MzM2MQ_3ba65f80-5dc7-4666-8f93-38213bf561e5"
      unitRef="number">0.0225</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i77430f8ce1d24d29b21836836ac4c9f5_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzItNS0xLTEtNjM5L3RleHRyZWdpb246ZDc4MTQzNTA0OTRhNDY4OWI2ZGQ4NTE3MGMwYTBiYjBfMzI5ODUzNDg4MzM2MQ_050a485b-43c8-4e85-8cbc-ca3663e6c914"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="iddf06388c8db452292fd4be8fac89b3d_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtMS0xLTEtNjk5L3RleHRyZWdpb246YmMyOGQ2M2NlNDQ2NGQwN2FkOWY2YzNlNDU2NDg4MzFfMzI5ODUzNDg4MzQwMg_3abb5eef-bf82-4de7-811a-7a961c441bbb"
      unitRef="number">2.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="iddf06388c8db452292fd4be8fac89b3d_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtMS0xLTEtNjk5L3RleHRyZWdpb246YmMyOGQ2M2NlNDQ2NGQwN2FkOWY2YzNlNDU2NDg4MzFfMzI5ODUzNDg4MzQxMQ_4c11215b-dc93-44f6-ab64-275f718563be"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i66e971e62a534f359ea61e7860897264_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtMi0xLTEtNjc4L3RleHRyZWdpb246MmMwMDdjOTQxNzIxNDAxMGJjYTEyZTA5YjZhN2I4YThfMzI5ODUzNDg4MzM1Mw_a56ffe4c-7d84-47c8-8a7b-49df0d3d1173"
      unitRef="number">0.0200</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i726b0bebd34a4e46a057d38e4f1ba269_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtMy0xLTEtNjYzL3RleHRyZWdpb246ODI2YTUyOThiZGU5NGQ4ZTk0MTQ5MmRiNGViMmVmNzRfMzI5ODUzNDg4MzM1Mw_2b306b0f-c063-4ba2-ae57-909665c580f4"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i219c247a7c464cf9815c4651e1be0884_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtNC0xLTEtNjQ4L3RleHRyZWdpb246ZGY0YzlkYWIwODA5NGYzNmE0N2YzZjA5MjFiZWIyMjRfMzI5ODUzNDg4MzM1Mw_90da6057-b134-4c00-9249-ed2721b99685"
      unitRef="number">0.0200</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i219c247a7c464cf9815c4651e1be0884_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzMtNS0xLTEtNjMzL3RleHRyZWdpb246ZTczYjgyZjdhZTJhNGI0M2IwOTBmN2FmYzE0NDBiMjJfMzI5ODUzNDg4MzM1Mw_27fe537f-6bf8-4acc-9af7-cad7b817275d"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="ie388174914b1418aaa031d162e279aa9_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtMS0xLTEtNjk2L3RleHRyZWdpb246MjJlYTY3MjBmYjQ0NGE2Y2E0ZTc1MWIwMDQ3ZjlkMDFfMzI5ODUzNDg4MzQwOA_9598f1d2-8ace-4880-b770-00c6657802a7"
      unitRef="number">2.00</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum
      contextRef="ie388174914b1418aaa031d162e279aa9_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtMS0xLTEtNjk2L3RleHRyZWdpb246MjJlYTY3MjBmYjQ0NGE2Y2E0ZTc1MWIwMDQ3ZjlkMDFfMzI5ODUzNDg4MzM5NA_bf65795a-1679-419b-b430-81e2511dc5c7"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i5f4b411c521e4514876b71fb6b7b4ad2_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtMi0xLTEtNjg0L3RleHRyZWdpb246ZWQ4MWRmMjkyMjQ2NGYxOGFkZDdiODY1ODIxMjgwZGZfMzI5ODUzNDg4MzM2MQ_d655f907-fccf-4360-971f-7b7bed3f063b"
      unitRef="number">0.0175</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i65e5beb9352246028536bb875e13ba71_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtMy0xLTEtNjY2L3RleHRyZWdpb246NTljMmQwYjhlMGUyNDYxNjljZDY1YTAyMGE0YWIwZWFfMzI5ODUzNDg4MzM1Mw_f3a6a0bc-ca0f-44d8-8271-87f0425eef19"
      unitRef="number">0.0075</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i63f437b3e9a640edad9d5b48f6ada9eb_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtNC0xLTEtNjU0L3RleHRyZWdpb246MzI5NGE4ODQ1NTVjNDgyNGJlMTJiNGM1ZWRiODM4NTVfMzI5ODUzNDg4MzM1Mw_0ef276c2-d851-462e-a648-d11af93f48a7"
      unitRef="number">0.0175</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i63f437b3e9a640edad9d5b48f6ada9eb_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzQtNS0xLTEtNjQyL3RleHRyZWdpb246MzMzNGI2NTBlZjMwNGMyYmE2NjNlYTg1NTM4NzQ4MzlfMzI5ODUzNDg4MzM2MQ_8131f5b5-ad69-44c2-91b1-3c63a7214685"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:DebtInstrumentCovenantLeverageRatioMaximum
      contextRef="ie69f018701ff451c852994840d5678f4_I20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzUtMS0xLTEtNzA4L3RleHRyZWdpb246OGJmZmJiZWQ3MjgwNDE1NGFmZjExZGIzZThmOGZkYjhfMzI5ODUzNDg4MzM1NQ_b98c70b5-04b5-4500-a65e-7842e3c8b8cb"
      unitRef="number">1.50</rdnt:DebtInstrumentCovenantLeverageRatioMaximum>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i3142f65c94ae47beb9a1aff303e0d018_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzUtMi0xLTEtNjgxL3RleHRyZWdpb246ZThlZWI2ZGI4ODgwNDYzZTk1MTcyOThjMjI2MTI4MjhfMzI5ODUzNDg4MzM1Mw_4801d74f-be08-409b-b100-47c5ace46115"
      unitRef="number">0.0150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1f40b418b6d84fc884519577e1396a36_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzUtMy0xLTEtNjY5L3RleHRyZWdpb246NzNhZmQ4MzFmOTE1NDE3NmIyZjQ5MjlkNTQ4YTMyNGVfMzI5ODUzNDg4MzM1Mw_3a71fc7b-473d-4267-b545-6f6f69466dc2"
      unitRef="number">0.0050</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ic6ed187b6ae14da3a3469e3302627e8c_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzUtNC0xLTEtNjU3L3RleHRyZWdpb246Nzc3Y2UwNmEwMTdhNGNjMzhmYWJmZjU0YTY3ZDY3M2NfMzI5ODUzNDg4MzM1Mw_10e9c106-2c36-48d1-a80f-b17814e7d313"
      unitRef="number">0.0150</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="ic6ed187b6ae14da3a3469e3302627e8c_D20180831-20180831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90YWJsZTphMzNkN2JkMTdhNzg0YzBkOTViMjEzMjIzZTUyYjdkYi90YWJsZXJhbmdlOmEzM2Q3YmQxN2E3ODRjMGQ5NWIyMTMyMjNlNTJiN2RiXzUtNS0xLTEtNjM2L3RleHRyZWdpb246N2EyYmQyYWM5ZDAzNDg3ZmFlNTg2YjJhMWRmMmIxZmNfMzI5ODUzNDg4MzM1Mw_f28264e1-b5ad-41d7-9b3e-b859b30a6aa2"
      unitRef="number">0.0030</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i54f63ff21ef3452fba37a70277f1b7dd_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDAxMjI_7c0cd832-f315-47e8-ac67-fcd5ffcbbcea"
      unitRef="number">0.0022</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal
      contextRef="ic509aa6e20d8451e869c6c1adc35cb1b_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzg4MjE_dd063329-c1cd-4580-b89b-0c1a85fb55c0"
      unitRef="usd">750000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <rdnt:DebtInstrumentPeriodicPaymentPercent
      contextRef="ic509aa6e20d8451e869c6c1adc35cb1b_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzg4Njc_f017f343-a486-4ee9-93a9-04217d1c9ab2"
      unitRef="number">0.050</rdnt:DebtInstrumentPeriodicPaymentPercent>
    <rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease
      contextRef="i48cfb04da83545e39b2c1c70193a8083_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzg5OTQ_2c174fdf-4bc1-44fc-9d13-6208ffdc7e7d"
      unitRef="usd">375000</rdnt:DebtInstrumentPeriodicPaymentTermsAmortizationIncrease>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i4ba89948df004b25bb090cc21c311d86_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODIzOTA_d64c5907-ce5b-4964-8429-0b1b5881c5e7"
      unitRef="number">0.0600</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iae3bdf0809064518b238f69ea108dcd7_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODI1NzU_d9914d17-9f4c-4458-97f8-4c0a31793333"
      unitRef="number">0.0375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i56bc70ab4f98412fb60048a93886fb28_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODI2MDk_8c92a5af-91a5-46a0-9f48-2807fa069d32"
      unitRef="number">0.0025</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="i56bc70ab4f98412fb60048a93886fb28_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODI4MTE_39c69cb1-ce8d-4edf-8ba7-b619358b1d93"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="i4a1fe13162294ec8b4af081e02f06560_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDExNzU_25379d52-eb81-4511-bdca-b39743d56f04"
      unitRef="usd">57500000</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ibdfce80209e24d048368e13932f4df63_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDEyMTE_88d2c43f-01bd-4a66-b296-d681e63f752e"
      unitRef="usd">195000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i4a1fe13162294ec8b4af081e02f06560_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDEyNDc_1e1a51f9-811c-467b-81a5-b0ddf2d7716f"
      unitRef="usd">700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i35416759782a4ffcae881c1975663437_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMyODQxMzY_a6b2a362-0091-421e-9999-a47d87a630e5"
      unitRef="usd">30000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="i4a1fe13162294ec8b4af081e02f06560_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQzODU_f87c8f6a-8cc1-4f4e-807c-3175e38b255a"
      unitRef="usd">57500000</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i4a1fe13162294ec8b4af081e02f06560_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQzOTM_90b92c10-941c-4cce-99cd-143da10dea2e"
      unitRef="usd">195000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i4a1fe13162294ec8b4af081e02f06560_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0MDE_08221469-2135-4928-b882-2f3d90040bbb"
      unitRef="usd">700000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:LineOfCredit
      contextRef="i8545538a2ef54e1b9d395b7b7743a4a3_I20170822"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0MDk_12602768-9251-42fe-90c4-ddc8e0134953"
      unitRef="usd">100000000.0</us-gaap:LineOfCredit>
    <rdnt:LineofCreditFacilityIncreaseBorrowingCapacity
      contextRef="i296abca1ec384478903ec34e3f7c3244_I20190418"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0MTc_fc8d0630-b43c-412c-9bf4-29052889208c"
      unitRef="usd">20000000.0</rdnt:LineofCreditFacilityIncreaseBorrowingCapacity>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="i3a18b41ec6e94cbbbda45664ee69a4e0_I20190418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0MjU_b5c05987-5faf-4956-843c-04ce3679ac9d"
      unitRef="usd">4400000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DebtInstrumentUnamortizedDiscountCurrent
      contextRef="i3a18b41ec6e94cbbbda45664ee69a4e0_I20190418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0MzM_a7d2956c-068f-4614-be88-ed4ca52e37de"
      unitRef="usd">2100000</us-gaap:DebtInstrumentUnamortizedDiscountCurrent>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i3a18b41ec6e94cbbbda45664ee69a4e0_I20190418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0NDE_25c20ba8-e23b-4681-b87a-c48cf358e0af"
      unitRef="usd">700000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:AmortizationOfDeferredCharges
      contextRef="i66691542788640c6b83e170f22e99fd2_D20190418-20190418"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ0NDk_81ac3679-bd9e-439f-b21d-ee277ed845e9"
      unitRef="usd">1600000</us-gaap:AmortizationOfDeferredCharges>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9ec14573b907475cbd068c8d85492abd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ1OTU_32bf309f-b1ef-4bf6-bb86-cc06638cfa12"
      unitRef="number">0.010</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i6e615f475e34430ead7ea3449fb67aa1_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ2MDA_37c091fb-c66a-4ed4-afc6-babe3b78e912">P2Y</us-gaap:DebtInstrumentTerm>
    <rdnt:DebtInstrumentNumberofLoansReceived
      contextRef="i6e615f475e34430ead7ea3449fb67aa1_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ2MDY_bc731f8d-53e9-47ca-b2e4-55e9f694ffb0"
      unitRef="loan">4</rdnt:DebtInstrumentNumberofLoansReceived>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id29d143ec6924d1587f745bf76712764_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDMvZnJhZzpjZjg3ZGM2NzIxNTg0OTY3YjI3MjViNDRiODE4ZjU3ZS90ZXh0cmVnaW9uOmNmODdkYzY3MjE1ODQ5NjdiMjcyNWI0NGI4MThmNTdlXzIxOTkwMjMzMDQ2MjI_0f1c3193-6bb2-4347-863f-d12a27fd48cc"
      unitRef="usd">4000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1ODU_0fd6c563-9ffd-4577-bd71-112555ff7bac">LEASES&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Adoption of Standard&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued a new standard related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (&#x201c;ROU&#x201d;) assets and lease liabilities on the balance sheet for all leases with terms in excess of twelve months. Sufficient disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The standard was effective for us beginning January 1, 2019. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will not apply the standard to the comparative periods presented in the consolidated financial statements. We also elected the transition package of three practical expedients permitted within the standard, which eliminates the requirements to reassess prior conclusions about lease identification, lease classification, and initial direct costs.  The adoption of the standard had a material impact on our consolidated balance sheets, but did not have material impact on our consolidated income statements or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Liability&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have operating leases for medical facilities, administrative offices, warehouse space and major medical equipment.  We lease the premises at which these facilities are located and do not have options to purchase the facilities we rent. Our most common initial term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at the facilities we lease. We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year. Additionally, we have operating and finance leases for certain medical and office equipment, with lease terms generally lasting from 5 to 8 years.  Our Incremental Borrowing Rate ("IBR") used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and our IBR is adjusted when those rates experience a substantial change.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use &amp;amp; Equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts for the twelve months ended December 31, 2019 include the transition adjustment for the adoption of Topic 842.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously disclosed in our 2018 Annual Report on Form 10-K and under the previous lease accounting, rental expense for the year ended December 31, 2018 was $83.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands, except lease term and discount rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $8.8 million.  These operating leases will commence in 2021 with lease terms of 3 to 15 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1OTI_3ad240ec-878e-4dfd-8511-e55b37e04331">LEASES&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Adoption of Standard&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2016, the FASB issued a new standard related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (&#x201c;ROU&#x201d;) assets and lease liabilities on the balance sheet for all leases with terms in excess of twelve months. Sufficient disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The standard was effective for us beginning January 1, 2019. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will not apply the standard to the comparative periods presented in the consolidated financial statements. We also elected the transition package of three practical expedients permitted within the standard, which eliminates the requirements to reassess prior conclusions about lease identification, lease classification, and initial direct costs.  The adoption of the standard had a material impact on our consolidated balance sheets, but did not have material impact on our consolidated income statements or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lease Liability&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have operating leases for medical facilities, administrative offices, warehouse space and major medical equipment.  We lease the premises at which these facilities are located and do not have options to purchase the facilities we rent. Our most common initial term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at the facilities we lease. We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year. Additionally, we have operating and finance leases for certain medical and office equipment, with lease terms generally lasting from 5 to 8 years.  Our Incremental Borrowing Rate ("IBR") used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and our IBR is adjusted when those rates experience a substantial change.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use &amp;amp; Equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts for the twelve months ended December 31, 2019 include the transition adjustment for the adoption of Topic 842.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously disclosed in our 2018 Annual Report on Form 10-K and under the previous lease accounting, rental expense for the year ended December 31, 2018 was $83.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands, except lease term and discount rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $8.8 million.  These operating leases will commence in 2021 with lease terms of 3 to 15 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i7393b27f4af1422f97fa04785bd0e65e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzIwODg_bf3ade6c-f716-45df-b652-e9e58976f104">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ie6dad76471cb45619fba56de651a701e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzIwOTQ_e3f65566-d506-408d-a06f-5ec9c0ffb4a5">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i7393b27f4af1422f97fa04785bd0e65e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzIxODI_632e2db4-87e7-4612-9fa6-1ccb7c39c2bd">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="ie6dad76471cb45619fba56de651a701e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzIxODg_dd0d7df3-848b-4081-ba31-9a9ffc2205dd">P35Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <rdnt:LesseeLeaseTermofContract
      contextRef="i9aa53910584d4308b3a9af105783ce91_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzI0NTU_58f3d60c-b712-4b4d-92a6-4174f4d73c47">P5Y</rdnt:LesseeLeaseTermofContract>
    <rdnt:LesseeLeaseTermofContract
      contextRef="i59d8b9f6e0ef49d4a4d3fe5016d69357_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzI0NjE_bbc58111-3747-4154-ab67-ca2958e425d1">P8Y</rdnt:LesseeLeaseTermofContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1OTM_60dc678b-73ea-4608-be94-9a6ff77df851">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.197%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.252%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use &amp;amp; Equipment assets obtained in exchange for lease obligations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Operating leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Financing leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amounts for the twelve months ended December 31, 2019 include the transition adjustment for the adoption of Topic 842.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzQtMS0xLTEtMjc4_a9bee75c-ac1b-4aff-8eb3-8e9a53266407"
      unitRef="usd">99323000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzQtMS0xLTEtMA_9fee3b81-d0d1-4269-8d77-c4d92fa15725"
      unitRef="usd">95348000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzctMS0xLTEtMjgy_02279927-c6b2-44e3-9c1f-edd15a700b31"
      unitRef="usd">3122000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzctMS0xLTEtMA_db612a1f-bb5f-4f2b-8ae9-d391db126c31"
      unitRef="usd">3135000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzgtMS0xLTEtMjgy_0fa7b899-2bf8-4cd1-83a0-6c32c4433b85"
      unitRef="usd">210000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzgtMS0xLTEtMA_f674b751-e867-4d53-b9e6-8c66b5ceddfd"
      unitRef="usd">395000</us-gaap:FinanceLeaseInterestExpense>
    <rdnt:FinanceLeaseCost
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzktMS0xLTEtMjg2_524ab2ad-f6f1-4c19-ac02-b2828742b77e"
      unitRef="usd">3332000</rdnt:FinanceLeaseCost>
    <rdnt:FinanceLeaseCost
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpjODQyNzNjMzVkNjY0MTk1YTM3MGM0NjIyYWJiNjU0Yy90YWJsZXJhbmdlOmM4NDI3M2MzNWQ2NjQxOTVhMzcwYzQ2MjJhYmI2NTRjXzktMS0xLTEtMA_a1e48932-0be2-48e8-91cf-a714024229e6"
      unitRef="usd">3530000</rdnt:FinanceLeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzQtMS0xLTEtMzA3_144ac3db-5e33-467c-bfa0-9202f672e006"
      unitRef="usd">89821000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzQtMS0xLTEtMA_cad7747c-702e-48b9-9aa3-8071fd37fa87"
      unitRef="usd">95922000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzUtMS0xLTEtMzA3_9c27e1bf-8ca9-4040-97ac-0da5986f864e"
      unitRef="usd">210000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzUtMS0xLTEtMA_4c234d46-1dc8-4e28-8632-8e3d6ffe1190"
      unitRef="usd">395000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzYtMS0xLTEtMzA3_9a6308a0-32e6-41bf-902d-9cfc22d65d34"
      unitRef="usd">3304000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzYtMS0xLTEtMA_1809001e-41e8-4e17-add2-e152fcf71b9d"
      unitRef="usd">5939000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzgtMS0xLTEtMzEx_52e1dada-28e8-43d0-822b-4339794ed1a9"
      unitRef="usd">106099000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzgtMS0xLTEtMA_691ddf55-10db-49bf-8620-19130d22775d"
      unitRef="usd">482399000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzktMS0xLTEtMzEx_50f63212-8004-494a-b97d-68c485d6a661"
      unitRef="usd">24000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTpkZGNjOWY2ZDk3Zjc0YzJjOTkzYTA5Mzc3NzE4YmNhNS90YWJsZXJhbmdlOmRkY2M5ZjZkOTdmNzRjMmM5OTNhMDkzNzc3MThiY2E1XzktMS0xLTEtMA_a924afb4-4609-4b8c-882e-a098cf89052c"
      unitRef="usd">14105000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeasesRentExpenseNet
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzIxOTkwMjMyNjc3MzE_a284bb90-80f9-4bbb-be93-3748352b3f54"
      unitRef="usd">83000000.0</us-gaap:OperatingLeasesRentExpenseNet>
    <rdnt:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1OTQ_86f0c917-61c3-45a4-b380-95d451cd7b7d">Supplemental balance sheet information related to leases was as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands, except lease term and discount rates)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;445,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;463,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;482,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,220)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of finance lease&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Remaining Lease Term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases - years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted Average Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</rdnt:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzQtMS0xLTEtNDE3_0b3b7c83-058a-47db-b988-7df95ea299a8"
      unitRef="usd">483661000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzQtMS0xLTEtMA_efab19ef-38f3-41e0-a4be-2c41f94e772c"
      unitRef="usd">445477000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzUtMS0xLTEtNDE3_ac3e471e-3658-41a0-9edf-dd0b554d1ea9"
      unitRef="usd">65794000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzUtMS0xLTEtMA_5647ef4a-e05e-43cb-8fa1-aeb6de6cd9f9"
      unitRef="usd">61206000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzYtMS0xLTEtNDE3_a4402791-61f1-47c8-9c26-67dba7e47428"
      unitRef="usd">463096000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzYtMS0xLTEtMA_25212ac2-72fc-42c1-90bc-d81d08c3a421"
      unitRef="usd">420922000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzctMS0xLTEtNDE3_5a2f246e-14fd-411a-a31a-cc0432b87b94"
      unitRef="usd">528890000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzctMS0xLTEtMA_1d707f33-5e3f-4937-99ae-d73c9da12afe"
      unitRef="usd">482128000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEwLTEtMS0xLTM0MA_1491f1fe-bb7c-4a7f-8f2b-2162c265c553"
      unitRef="usd">13984000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEwLTEtMS0xLTA_42636328-34a2-4975-ad1c-cb98b9b2498f"
      unitRef="usd">14105000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzExLTEtMS0xLTM0MA_b36fda98-8f42-48af-a3ca-cf5b06e85dff"
      unitRef="usd">6220000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzExLTEtMS0xLTA_1f68f355-e95f-4bef-bd0a-2bee43cf2486"
      unitRef="usd">3135000</us-gaap:FinanceLeaseRightOfUseAssetAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEyLTEtMS0xLTM0MA_c7dc4f07-d95b-4af1-80a4-e98ce970c033"
      unitRef="usd">7764000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEyLTEtMS0xLTA_feb7e8a9-2ff3-4751-a491-85e6bf6371ae"
      unitRef="usd">10970000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEzLTEtMS0xLTM0MA_902a1b0c-9fb3-45e9-a6ac-b50abb94e81f"
      unitRef="usd">2578000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzEzLTEtMS0xLTA_d46d1604-479e-4665-84f6-8d472e1f89c8"
      unitRef="usd">3283000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE0LTEtMS0xLTM0MA_4ef1f0c8-c2f5-4675-9e2e-4ed7951b987a"
      unitRef="usd">743000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE0LTEtMS0xLTA_ad97a6f2-9340-4273-ab0b-649860e24fca"
      unitRef="usd">3264000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE1LTEtMS0xLTM0MA_49d8e31f-9d5f-49d0-abdb-dc6765bca735"
      unitRef="usd">3321000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE1LTEtMS0xLTA_750885ab-0b5d-4bec-b856-c5f2cac204b4"
      unitRef="usd">6547000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE4LTEtMS0xLTM5MQ_9c9768a1-d8a3-4470-b5cf-10ad62be9199">P9Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE4LTEtMS0xLTA_6eaf861d-86e1-47f9-98d5-82085559bc9c">P8Y9M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE5LTEtMS0xLTM5MQ_16762176-0700-4f2a-b4b5-11c1f714571e">P2Y6M</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzE5LTEtMS0xLTA_e450705a-573b-4477-a7bb-77f551c5a169">P3Y3M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzIyLTEtMS0xLTM5NA_7abdd715-8e3e-43cc-ba15-be2e89aa29e9"
      unitRef="number">0.064</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzIyLTEtMS0xLTA_1b3c9c79-a6ff-4a13-ba97-9745437ff526"
      unitRef="number">0.064</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzIzLTEtMS0xLTM5NA_89bbc70d-ff3c-4927-b29c-4048405a281b"
      unitRef="number">0.044</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTphODM1MzY2NjIwMjQ0ZGZmYmMzY2MxZjdhM2JkYzY1NC90YWJsZXJhbmdlOmE4MzUzNjY2MjAyNDRkZmZiYzNjYzFmN2EzYmRjNjU0XzIzLTEtMS0xLTA_26c51646-5cb7-42ae-b6af-4bc9757a03a1"
      unitRef="number">0.044</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1OTU_df40a80f-edc0-4fc6-acaf-4a8428050aa3">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzM1OTY_39c2e4e6-4230-423a-b823-26b5fc9c638c">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(In thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Operating&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Financing&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total Lease Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(188,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzMtMS0xLTEtMA_a48dc49f-d6e7-49ff-b579-43812bf82ecb"
      unitRef="usd">97307000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzMtMi0xLTEtMA_a690b40e-6abb-4dd4-b4e9-ec47878cf081"
      unitRef="usd">2654000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzQtMS0xLTEtMA_2b3b238a-4ea0-4da4-bd8c-c1462efe3a58"
      unitRef="usd">91479000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzQtMi0xLTEtMA_87fbdf86-f7f7-492d-9668-0b687a529313"
      unitRef="usd">719000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzUtMS0xLTEtMA_39c067ec-1c99-4353-93c9-f30fc5160e54"
      unitRef="usd">83648000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzUtMi0xLTEtMA_6a5eee94-5cef-42b6-98c2-3fec686fa03b"
      unitRef="usd">14000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzYtMS0xLTEtMA_4c7d64cc-117b-4d7b-b9ce-d4885997ab7d"
      unitRef="usd">69686000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzYtMi0xLTEtMA_c5e0b654-9fa6-4190-82f7-2907144ede33"
      unitRef="usd">13000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzctMS0xLTEtMA_4626eefd-476b-44c3-ba89-eb9796d400d1"
      unitRef="usd">59469000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzctMi0xLTEtMA_fc488daf-f072-4ed0-a457-2a93045187e0"
      unitRef="usd">4000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzgtMS0xLTEtMA_141779ec-da37-4b87-aeac-295b3794cfb7"
      unitRef="usd">316112000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzgtMi0xLTEtMA_ac556918-ef95-4715-8987-300f35411be0"
      unitRef="usd">2000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzktMS0xLTEtMA_43075df4-2884-4cbf-a48f-7e38329ddae3"
      unitRef="usd">717701000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzktMi0xLTEtMA_e8f6b68c-eac5-4712-8921-aa3a8e169e0a"
      unitRef="usd">3406000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzEwLTEtMS0xLTA_d22bafb3-b6a4-4184-b1f5-f454cdd4410d"
      unitRef="usd">188811000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzEwLTItMS0xLTA_a85b3adf-ee68-4134-bacb-52ec4d4a8e99"
      unitRef="usd">85000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzExLTEtMS0xLTA_3d65fa63-8c93-45e0-a97c-ae5342d1d8e9"
      unitRef="usd">528890000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90YWJsZTozYjkzZjJjY2ZiZDQ0OWYxOWZmNjY1YWJmZjM3ZDRhNy90YWJsZXJhbmdlOjNiOTNmMmNjZmJkNDQ5ZjE5ZmY2NjVhYmZmMzdkNGE3XzExLTItMS0xLTA_2a62bc28-ba93-4cd5-bbaf-58e367b8d26b"
      unitRef="usd">3321000</us-gaap:FinanceLeaseLiability>
    <rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzMyOTY_c2027151-5b0b-451b-a5ea-affeabc45074"
      unitRef="usd">8800000</rdnt:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="i7393b27f4af1422f97fa04785bd0e65e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzMzNjY_563a84e4-2f35-4270-be9b-c98c8a8325ab">P3Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="ie6dad76471cb45619fba56de651a701e_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMDkvZnJhZzo1YTk2YjAxZjM2Yzk0NzcyYTRiMTAzYjE1NDQ1MDJiNy90ZXh0cmVnaW9uOjVhOTZiMDFmMzZjOTQ3NzJhNGIxMDNiMTU0NDUwMmI3XzMzNzI_76d8fc66-231c-4ed8-9eb6-d313923e1f17">P15Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ2MDI_6dcd7b0f-942c-4eed-b05d-bbda88019f49">INCOME TAXES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2020, 2019 and 2018, we recognized income tax expense comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal current tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,020)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the statutory U.S. federal rate and effective rates is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:66.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.314%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State franchise tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other non deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,748)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;PPP Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain on change in control&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred true-ups and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Uncertain tax provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other reconciling items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our deferred tax assets and liabilities comprise the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Deferred Tax Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, the Company had federal net operating loss carryforwards of approximately $251.6 million, which comprise of definite and indefinite net operating losses.  We had federal net operating loss carryforwards of approximately $186.2 million, which expire at various intervals from the years 2023 to 2037, and had carryforwards of $65.4 million of net operating losses which do not expire.  Federal net operating losses generated following December 31, 2017 carryover indefinitely and may generally be used to offset up to 80% of future taxable net income.  The Company also had state net operating loss carryforwards of approximately $57.9 million, which expire at various intervals from the years 2020 through 2039. As of December 31, 2020, $24.6 million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code. Future ownership changes as determined under Section 382 of the Internal Revenue Code could further limit the utilization of net operating loss carryforwards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2020, we have determined that deferred tax assets of $216.6 million are more likely-than-not to be realized. We have also taken into consideration deferred tax liabilities of $28.5 million are related to book basis in goodwill that has an indefinite life.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2015. We are currently under audit in the state of California for the tax years of 2016 and 2017.  It is too early to assess the impact such audits may have on the financial position of the Company, however we do not anticipate the results of any open examinations would result in a material change to our financial position.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December 31, 2020, the Company has unrecognized tax benefits of $5.5 million of which $4.4 million  will affect the effective tax rate if recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations for the assessment of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) related to change in rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2020 the Company accrued approximately $0.1 million of interest and penalties. As of December 31, 2020, accrued interest and penalties amounted to approximately $0.4 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic, some of the more significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. At December 31, 2020, the Company has taken advantage of the accelerated tax depreciation related to qualified improvement property and the Paycheck Protection Program loan allowed under the CARES Act.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#x201c;CAA&#x201d;). The CAA includes provisions extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the impact of the CAA and its impact on our financial statements in 2021 and beyond.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;In June 29, 2020, the state of California passed Assembly Bill 85 which suspends the California net operating loss deduction for the 2020-2022 tax years and the R&amp;amp;D credit usage for the same period (for credit usages in excess of $5M). These suspensions were considered in preparation of the 2020 financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ2MTA_d27bbaad-e026-49e1-8b7a-dc1fb8b448f4">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2020, 2019 and 2018, we recognized income tax expense comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal current tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(256)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(303)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,020)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State deferred tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,743)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,104)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzItMS0xLTEtMA_de8b5282-10f4-4527-82f4-cec5870fdaa0"
      unitRef="usd">-256000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzItMy0xLTEtMA_75c6a173-9b9d-433d-ad99-50cbd5902783"
      unitRef="usd">-161000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzItNS0xLTEtMA_5664381c-7cb2-413c-afb4-b8fe77254154"
      unitRef="usd">-765000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzMtMS0xLTEtMA_6a7c1554-0462-46d0-9b10-be94ab853ac9"
      unitRef="usd">-1608000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzMtMy0xLTEtMA_25a663ae-54f1-4432-bfcc-56d4bf57d1c4"
      unitRef="usd">7715000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzMtNS0xLTEtMA_2a2ce33f-6881-44a8-add2-53a436bde270"
      unitRef="usd">7263000</us-gaap:StateAndLocalIncomeTaxExpenseBenefitContinuingOperations>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzQtMS0xLTEtMA_7a708255-08b4-4ee3-9ad1-b896eaeb784e"
      unitRef="usd">27000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzQtMy0xLTEtMA_f33ca54e-3578-4ef2-88cf-2bad1676cacd"
      unitRef="usd">22000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:OtherTaxExpenseBenefit
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzQtNS0xLTEtMA_1a0cf53f-af5f-4481-bfbb-5979fcec38f5"
      unitRef="usd">20000</us-gaap:OtherTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzUtMS0xLTEtMA_c287a1fe-e96f-443a-80e6-0b59ea22ebc9"
      unitRef="usd">-303000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzUtMy0xLTEtMA_7a71e04e-1f03-484f-a2d8-1c6ed052cda1"
      unitRef="usd">3396000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzUtNS0xLTEtMA_47f77369-1ebe-4f3f-8b0a-06565b63c40b"
      unitRef="usd">-2020000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzYtMS0xLTEtMA_4afc6bed-51c4-49cf-9f63-66442a4674a1"
      unitRef="usd">3035000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzYtMy0xLTEtMA_4a317da1-ae0e-4a02-8e34-441f7d36e937"
      unitRef="usd">-4743000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzYtNS0xLTEtMA_2b2129c9-7cb2-427e-94c5-91e46986a06b"
      unitRef="usd">-4104000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzgtMS0xLTEtMA_e5cf3099-13db-4235-a96a-bc21e59effa4"
      unitRef="usd">895000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzgtMy0xLTEtMA_5f061051-4b80-43d2-8cfb-93c8e50a3f60"
      unitRef="usd">6229000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpkZmU4MjhhOWMzOTg0ZjkyOWZlMDllY2U4MTllOTM4My90YWJsZXJhbmdlOmRmZTgyOGE5YzM5ODRmOTI5ZmUwOWVjZTgxOWU5MzgzXzgtNS0xLTEtMA_3c288503-13b0-46f5-971f-b9be1ae565d2"
      unitRef="usd">394000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ2MDc_82f382d8-d6b4-4db7-b257-8055f36b6f10">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the statutory U.S. federal rate and effective rates is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:66.959%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.314%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.897%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Federal tax&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(179)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;State franchise tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other non deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests in partnerships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,748)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,824)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Changes in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Return to provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2,252)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;PPP Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(850)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Gain on change in control&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(8,303)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Deferred true-ups and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(761)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(4,254)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Uncertain tax provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other reconciling items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(171)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;6,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzItMS0xLTEtMA_24800f11-f001-4b2d-80b6-111687158f21"
      unitRef="usd">-179000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzItNS0xLTEtMA_af408cca-680e-48de-9b24-a50de051568f"
      unitRef="usd">6231000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzItOS0xLTEtMA_d97c3c7f-1d6c-4cc8-bac2-ec1f8bcf9c41"
      unitRef="usd">8256000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzMtMS0xLTEtMA_c193db2a-fd2c-479a-ad4a-1c03bf548f48"
      unitRef="usd">779000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzMtNS0xLTEtMA_98c59f33-e003-467e-8a11-71df2f16c786"
      unitRef="usd">3891000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzMtOS0xLTEtMA_5a5ece74-aa4b-41a7-8cef-a687c7067025"
      unitRef="usd">1332000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzQtMS0xLTEtMA_61846817-85bc-4a7d-83e4-382c38855bd8"
      unitRef="usd">301000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzQtNS0xLTEtMA_54e17b92-12e4-44ad-b239-5f5d3be215ef"
      unitRef="usd">674000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzQtOS0xLTEtMA_b92ac05d-632f-46bb-89fa-59afcea1405e"
      unitRef="usd">471000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzUtMS0xLTEtMA_ca170ee0-f6f9-429a-87d0-9d0fdabf8d66"
      unitRef="usd">2748000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzUtNS0xLTEtMA_4d955d0b-b46c-45f4-bb91-03152ed80635"
      unitRef="usd">1824000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzUtOS0xLTEtMA_5dce9f9c-ff39-42ab-8f6e-e304407a47d1"
      unitRef="usd">1237000</us-gaap:IncomeTaxReconciliationMinorityInterestIncomeExpense>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzYtMS0xLTEtMA_52dee6e1-dbdb-4600-98b0-d62ebbbe8b10"
      unitRef="usd">-33000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzYtNS0xLTEtMA_38059192-3a98-446a-8812-f87fd5d5d453"
      unitRef="usd">-462000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzYtOS0xLTEtMA_efebfca3-cd2b-47c6-9663-3fb91b691f5a"
      unitRef="usd">1760000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzctMS0xLTEtODcxNA_d5e1ad4a-70b1-4146-8506-0e60c7d2ba17"
      unitRef="usd">-2252000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzctNS0xLTEtODcxOA_62ef91d1-b6e3-4095-bb5e-0147eae3dd8b"
      unitRef="usd">-1324000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzctOS0xLTEtODcyMg_0e8ad0a3-d453-4952-bce7-6e389f4d399a"
      unitRef="usd">1494000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtMS0xLTEtODcxNA_0cc16ea7-c6f5-4ca9-9497-4006173c87ec"
      unitRef="usd">-850000</rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount>
    <rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtNS0xLTEtODcxOA_8ece2a07-7bcc-4d8e-8563-5c2546be2bf4"
      unitRef="usd">0</rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount>
    <rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtOS0xLTEtODcyMg_aaca022c-05db-4546-90c2-15263e2e0932"
      unitRef="usd">0</rdnt:EffectiveIncomeTaxRateReconciliationPPPLoanAmount>
    <rdnt:EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtMS0xLTEtMA_3e45b1ff-a91d-480a-a1b1-59576f43ae00"
      unitRef="usd">0</rdnt:EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount>
    <rdnt:EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtNS0xLTEtMA_b03c71d2-c0a2-4252-b84d-f92e225aca9a"
      unitRef="usd">0</rdnt:EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount>
    <rdnt:EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzgtOS0xLTEtMA_7605ccce-3cb4-4d1c-a484-0c41b8182db6"
      unitRef="usd">-8303000</rdnt:EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzktMS0xLTEtMA_8dab6733-2a82-42c0-bbce-7308c8c9ce1b"
      unitRef="usd">4839000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzktNS0xLTEtMA_6c7eb436-5d2c-4ff1-bc03-4b7c91348915"
      unitRef="usd">-761000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzktOS0xLTEtMA_8dbce254-14a0-4b4c-9a34-f950a255eb5f"
      unitRef="usd">-4254000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzExLTEtMS0xLTg3Mjc_58108c2c-7f99-4539-8d6e-48c501e98a1e"
      unitRef="usd">1036000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzExLTUtMS0xLTg3MzE_a5aa3b76-0213-4027-bda4-361a41e3f672"
      unitRef="usd">-217000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzExLTktMS0xLTg3MzU_5e5082c2-974c-4579-b75a-e629d4e24653"
      unitRef="usd">1046000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEwLTEtMS0xLTA_5bc75453-9272-402f-b3cf-9897266357e6"
      unitRef="usd">2000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEwLTUtMS0xLTA_16a32aa5-b235-4134-a36e-2742dc280ea9"
      unitRef="usd">21000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxReconciliationOtherReconcilingItems
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEwLTktMS0xLTA_f27e3ca5-ef19-434f-b1b4-a8c3a38f35bc"
      unitRef="usd">-171000</us-gaap:IncomeTaxReconciliationOtherReconcilingItems>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEyLTEtMS0xLTA_1d51e1a7-6bfe-4c27-bbff-e481e54a6bc6"
      unitRef="usd">895000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEyLTUtMS0xLTA_e31166e2-67e1-4dcd-85e2-0be85cee5323"
      unitRef="usd">6229000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToxNTZjMTQ2YTJjMzk0NTI3YjExMjRkNzg0ZTVmZTQ1My90YWJsZXJhbmdlOjE1NmMxNDZhMmMzOTQ1MjdiMTEyNGQ3ODRlNWZlNDUzXzEyLTktMS0xLTA_a31f0acc-417c-4f60-a271-4787b93a23b5"
      unitRef="usd">394000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ2MDE_8db80698-6200-4bb1-bc99-dfbe0b36f5b1">Our deferred tax assets and liabilities comprise the following (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.692%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating losses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,315)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,298)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,450)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28,457)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24,637)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,669)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(112,956)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,619)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,510)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Deferred Tax Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(181,938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(158,630)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net Deferred Tax Asset&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzItMS0xLTEtMA_d348c7e9-0880-49d3-947e-d311114d2205"
      unitRef="usd">59154000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzItMy0xLTEtMA_c1815ccb-4be1-4ea1-ac85-b1fed418176c"
      unitRef="usd">34490000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzMtMS0xLTEtMA_17debf04-e5f9-4d5b-bd63-413dde10958f"
      unitRef="usd">3948000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzMtMy0xLTEtMA_dd3e5a43-1208-49d0-a099-0f9cf2be0d8e"
      unitRef="usd">4280000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <rdnt:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzQtMS0xLTEtMA_8fd13a06-a30e-4f74-bd31-c3406ee05b0c"
      unitRef="usd">124139000</rdnt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <rdnt:DeferredTaxAssetsOperatingLeaseLiabilities
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzQtMy0xLTEtMA_305bcaf2-bef7-4512-a391-e05b0f7803ea"
      unitRef="usd">126546000</rdnt:DeferredTaxAssetsOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzctMS0xLTEtMA_63bebd83-d666-4340-9ef9-aa120ab675e0"
      unitRef="usd">1903000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzctMy0xLTEtMA_71d54a40-0e89-4c86-9a54-c8f4b2586d14"
      unitRef="usd">1374000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzgtMS0xLTEtMA_fb302282-f011-44e9-b53f-0ac13c8b99b1"
      unitRef="usd">21284000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzgtMy0xLTEtMA_ff3a0986-554a-4700-817f-f74841d1593d"
      unitRef="usd">27220000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzktMS0xLTEtMA_3c21e77a-c09e-4b9b-a529-a5383beb1b44"
      unitRef="usd">11512000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzktMy0xLTEtMA_dc7346fb-e359-42db-915c-ea730300ffb1"
      unitRef="usd">4616000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzEwLTEtMS0xLTA_9e338d42-693b-4f11-bc98-fe4ecd12ccc7"
      unitRef="usd">5315000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzEwLTMtMS0xLTA_33e5bc0b-1cc7-4e00-8f1e-18d1733acc51"
      unitRef="usd">5348000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzExLTEtMS0xLTA_5796f91d-b94d-4ae6-acaa-10016253d3cd"
      unitRef="usd">216625000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzExLTMtMS0xLTA_06f0cb90-144d-427a-a233-a7174413c6a8"
      unitRef="usd">193178000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzEzLTEtMS0xLTA_03ca8d50-e548-47e5-8cbd-dbc503827e3d"
      unitRef="usd">24298000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzEzLTMtMS0xLTA_d5be626e-29c9-495f-8318-f4b1a5f66056"
      unitRef="usd">6450000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE0LTEtMS0xLTA_9a119225-a2ea-492f-93a2-2b616fef36d3"
      unitRef="usd">28457000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE0LTMtMS0xLTA_3029327e-87d4-4bac-a71e-435f5355ea0b"
      unitRef="usd">24637000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE1LTEtMS0xLTA_cbcbb6d5-c7e5-4e01-ab54-aa1bb754b962"
      unitRef="usd">9608000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE1LTMtMS0xLTA_4d0d9c31-4bfb-413a-be3a-354b53fcfc93"
      unitRef="usd">6669000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE2LTEtMS0xLTA_08002384-b0c6-422f-b761-37b18ae1c82b"
      unitRef="usd">112956000</rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets>
    <rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE2LTMtMS0xLTA_ba35f96f-04f3-42cb-b2ca-a132f6f6252d"
      unitRef="usd">115364000</rdnt:DeferredTaxLiabilitiesOperatingRightOfUseAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE4LTEtMS0xLTA_a3e02f91-46ad-4152-99dc-0608ce884eb8"
      unitRef="usd">6619000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE4LTMtMS0xLTA_8161419f-5049-43f8-aa2c-e6999f6037f2"
      unitRef="usd">5510000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE5LTEtMS0xLTA_40c2bbd2-f035-401a-83e9-1be888bfdb5d"
      unitRef="usd">181938000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzE5LTMtMS0xLTA_419efc47-389c-45c4-b8e0-9e30bafa0421"
      unitRef="usd">158630000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzIxLTEtMS0xLTA_ff0960e9-ff2a-45ac-aa84-98a6cdfbae75"
      unitRef="usd">34687000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZTpiZWRmMjAwZjEzZTA0OTc1YjA0NjJjYTgzN2NkMmQ4Ny90YWJsZXJhbmdlOmJlZGYyMDBmMTNlMDQ5NzViMDQ2MmNhODM3Y2QyZDg3XzIxLTMtMS0xLTA_1fb4fa97-84cd-42cf-a3c9-c7b6c4c9538f"
      unitRef="usd">34548000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i2b790074af0343b2807bdb47a7b6fc97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzE0NjU_3dac6c1a-12b2-4d07-a555-efe669327f49"
      unitRef="usd">251600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i2b790074af0343b2807bdb47a7b6fc97_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzIxOTkwMjMyNjczODg_9d3deee7-d458-44be-9a58-c5a7fa980370"
      unitRef="usd">186200000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i443f461b18dc4cbc8d9de4443701c2c5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzE2OTE_6a1f2d08-87b1-4edc-a9ee-8d12f8e85f58"
      unitRef="usd">65400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ic9828ffc96914aafb4d9efce6667921c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzE5OTY_721d40c6-4fdc-470d-b3b9-567a49ef7a6a"
      unitRef="usd">57900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="i5e81d491c9834d05aaea374ea32dd36c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzIwNzg_5fcbf436-8ca7-45a6-818d-ebb5552d83d0"
      unitRef="usd">24600000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzMxODY_899481a1-72dd-40d6-ae85-b0eb4b45b2b7"
      unitRef="usd">216600000</rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzMzMDQ_689802ff-6aa8-4de5-af97-e447f93f1d73"
      unitRef="usd">28500000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzM5OTU_2e366547-12a0-4af2-9fe4-24a65a17af01"
      unitRef="usd">5500000</us-gaap:UnrecognizedTaxBenefits>
    <rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQwMDc_54004cb9-2f70-442e-8caf-61857214b655"
      unitRef="usd">4400000</rdnt:UnrecognizedTaxBenefitsTaxImpactIfRecognized>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ1OTg_36117727-1839-420f-a86c-a8182ccfbb8b">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expiration of the statute of limitations for the assessment of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(393)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase (decrease) related to change in rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzItMS0xLTEtMA_3d472c88-f3ba-41b5-9e5c-90839744f53d"
      unitRef="usd">4320000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibae6485d220c4366bf04745e679dee34_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzItMy0xLTEtMA_a29134b6-9ca8-4469-b3bf-b817400bfe29"
      unitRef="usd">4629000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i4642cbc638c646e88712849889f662b5_I20171231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzItNS0xLTEtMA_25d5b1f5-fef0-4c6f-bb1f-2b82cdd3e523"
      unitRef="usd">3615000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzMtMS0xLTEtMA_3c1eb674-235b-4175-8b49-bd4c966b5a48"
      unitRef="usd">1382000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzMtMy0xLTEtMA_e93684d1-1144-4a14-b2c8-d80185dcd34c"
      unitRef="usd">34000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzMtNS0xLTEtMA_7573a62b-4a8a-46a1-b0c5-1dce956fdac4"
      unitRef="usd">896000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzQtMS0xLTEtMA_853d4201-9953-4876-8c51-4e887bf38cdb"
      unitRef="usd">3000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzQtMy0xLTEtMA_b5892e5a-5f6f-4334-8834-d8c000954c0b"
      unitRef="usd">119000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzQtNS0xLTEtMA_1e75295f-93fd-45cd-8b63-cd77bd3f4a09"
      unitRef="usd">111000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzUtMS0xLTEtMA_4284f9ce-6df4-4292-adf0-eb9a614f56b2"
      unitRef="usd">221000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzUtMy0xLTEtMA_148605b1-3970-47e1-b5e1-d6830e1b969f"
      unitRef="usd">393000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzUtNS0xLTEtMA_2cc863d4-7b31-42da-afba-9dc947db578a"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzYtMS0xLTEtMA_5a767189-2f0b-4a45-9e7c-303faf19756a"
      unitRef="usd">0</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate
      contextRef="i4c84452f39434559bef5a8d233042be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzYtMy0xLTEtMA_7041dc84-1fe8-487f-ab57-8690cf96efb7"
      unitRef="usd">-1000</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate
      contextRef="i6d7f0a555a284b0d967a505535d69900_D20180101-20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzYtNS0xLTEtMA_6fe8fe49-f65a-40e2-a049-98d9d3f0a0ac"
      unitRef="usd">7000</rdnt:UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzctMS0xLTEtMA_68b4afc1-f13a-4440-8ef8-b3a6d0cbaed8"
      unitRef="usd">5484000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i1bc65197cb4a4267a98b35b45d061e65_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzctMy0xLTEtMA_951288e1-8981-402f-9fe5-be31ce1aa6e1"
      unitRef="usd">4320000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ibae6485d220c4366bf04745e679dee34_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90YWJsZToyOGNiM2I3M2FhMWE0ZGM1YjMxNmRjMGUzZWM2YjcxMC90YWJsZXJhbmdlOjI4Y2IzYjczYWExYTRkYzViMzE2ZGMwZTNlYzZiNzEwXzctNS0xLTEtMA_06133d96-2873-4d3b-948b-0179af061e91"
      unitRef="usd">4629000</us-gaap:UnrecognizedTaxBenefits>
    <rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ0OTQ_bc7be372-7a5e-4183-bcb3-689e00cd34bb"
      unitRef="usd">100000</rdnt:UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMTUvZnJhZzpjNzljYTIxNTM3MmQ0ODM5YWUxZDNmYzM4Mjc1ZWI5Ni90ZXh0cmVnaW9uOmM3OWNhMjE1MzcyZDQ4MzlhZTFkM2ZjMzgyNzVlYjk2XzQ1OTE_1b4c101b-79c9-44c3-b04c-fc86f55c60a9"
      unitRef="usd">400000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI2Nzk_2297e74c-ad3a-4f8a-a69c-2bb89d7353b1">STOCK-BASED COMPENSATION&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have one long-term equity incentive plan which we refer to as the 2006 Equity Incentive Plan, which we first amended and restated as of April 20, 2015 and again on March 9, 2017 (&#x201c;the Restated Plan&#x201d;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the 2017 Restated Plan 14,000,000 shares of common stock.  We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc2OA_936612e8-22fa-4ff0-b720-c4675549c40d"&gt;three&lt;/span&gt; to five years and expire &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc4OA_046091b3-dd3f-4a0f-84b9-3f6b7a937f8c"&gt;five&lt;/span&gt; to ten years from the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2020, we had outstanding options to acquire 527,899 shares of our common stock, of which options to acquire 307,196 shares were exercisable. The following summarizes all of our option transactions for the twelve months ended December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,679,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2020 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2020.  As of December 31, 2020, total unrecognized stock-based compensation expense related to non-vested employee awards was $0.6 million which is expected to be recognized over a weighted average period of approximately 1.50 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%"&gt;DeepHealth Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;412,434&#160;options at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2020, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $3.9 million which is expected to be recognized over a weighted average period of approximately 2.29 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted, June 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,895)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,710,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Awards (&#x201c;RSA&#x2019;s&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan permits the award of restricted stock awards (&#x201c;RSA&#x2019;s&#x201d;). As of December 31, 2020, we have issued a total of 6,551,872 RSA&#x2019;s of which 329,159 were unvested at December 31, 2020 . The following summarizes all unvested RSA&#x2019;s activities during the twelve months ended December 31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(516,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the fair value of all RSA&#x2019;s based of the closing price of our common stock on award date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other stock bonus awards&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2020 we issued 66,078 shares relating to these awards, approximately amounting to $1.0 million of compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Plan summary&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In summary, of the 14,000,000 shares of common stock reserved for issuance under the Restated Plan, at December 31, 2020, we had issued 15,424,316 total shares between options, RSA&#x2019;s and other stock awards. With options cancelled and RSA&#x2019;s forfeited amounting to 3,281,040 and 61,703 shares, respectively, there remain 1,918,427 shares available under the Restated Plan for future issuance.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i40918c356ba546019d9cf3855b255d7a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIxOTkwMjMyNjA0MTE_c8a90d81-1a02-488d-b6db-9945fd75b006"
      unitRef="shares">14000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i38edc38946a14643a72d3091d803e56d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc3NA_250c2b5b-f325-4232-aa3a-31b623419d82">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i38edc38946a14643a72d3091d803e56d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc5NA_54450bf4-0055-4222-82cc-4bac77d94267">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzg3Mg_8f062e1c-1d10-43b7-9ddd-3ffb8d79e8c4"
      unitRef="shares">527899</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzkzMQ_dc76b1d0-dc86-40da-bbf7-b1f9730fe233"
      unitRef="shares">307196</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI2ODE_ac5426eb-b16e-46f4-ac92-c1edd7f7aa88">The following summarizes all of our option transactions for the twelve months ended December 31, 2020:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.822%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the 2006 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;527,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.34&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,441,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;307,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,679,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.506%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.711%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.587%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.713%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Options&lt;br/&gt;Under the Deep Health Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise price&lt;br/&gt;Per Common Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted, June 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;412,434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,895)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance, December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,710,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.40&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i1e82aebaacf64a089fdc7fe9fdc1e466_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzEtMi0xLTEtMA_84ff246b-feb6-4db2-8f19-ccca2de49144"
      unitRef="shares">478951</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i1e82aebaacf64a089fdc7fe9fdc1e466_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzEtNC0xLTEtMA_1acc34f5-af8b-481d-ab42-43aeb1069f1b"
      unitRef="usdPerShare">8.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="if04aa1ab93ce4b9a8e416308089ebf97_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzItMi0xLTEtMA_abba6ffb-ab99-41da-a399-d097016252fe"
      unitRef="shares">48948</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="if04aa1ab93ce4b9a8e416308089ebf97_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzItNC0xLTEtMA_9f8c3beb-229f-42cd-8ce0-f97e3f82a2b1"
      unitRef="usdPerShare">20.43</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzUtMi0xLTEtMA_8f062e1c-1d10-43b7-9ddd-3ffb8d79e8c4"
      unitRef="shares">527899</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzUtNC0xLTEtMA_65d98cb3-4e10-4725-8bda-670331607092"
      unitRef="usdPerShare">9.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="if04aa1ab93ce4b9a8e416308089ebf97_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzUtNi0xLTEtMA_802befed-16ec-42a8-9924-457348feb9c7">P6Y4M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzUtOC0xLTEtMA_416b2bdf-7fcf-4b80-a8a8-8ecf00ac74bb"
      unitRef="usd">5441129000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzYtMi0xLTEtMA_dc76b1d0-dc86-40da-bbf7-b1f9730fe233"
      unitRef="shares">307196</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzYtNC0xLTEtMA_3131385d-aa4d-4383-9790-44e49906a078"
      unitRef="usdPerShare">7.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="if04aa1ab93ce4b9a8e416308089ebf97_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzYtNi0xLTEtMA_79854c82-f683-4aad-91d4-e028e95f8ebc">P5Y5M26D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="iaeedfaefcdd24073a7791f2cf8216e31_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo2M2E4OWJjNWM0ZTk0YzQ5YTk2OWE4MmYxMzRlZGMxZS90YWJsZXJhbmdlOjYzYTg5YmM1YzRlOTRjNDlhOTY5YTgyZjEzNGVkYzFlXzYtOC0xLTEtMA_743232a7-64da-4694-930c-9bdcf9e6cf79"
      unitRef="usd">3679803000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i36f65120df6f499e96c85073c30fef44_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzE0Nzg_9cd0b0dc-4b64-469c-80ef-aea8be987308"
      unitRef="usd">600000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzE1NjQ_e21b39b8-8a5b-40d2-a109-df157c36d503">P1Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i7aaf101d3fad496781ceeb004ddadb94_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIxOTkwMjMyNTkzNTg_37efa57d-e1c2-42e3-8770-17e4f21ec4b6"
      unitRef="shares">412434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i82674e78aaef409482561fb16833fed8_D20201001-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIxOTkwMjMyNTkzMjk_69262bc1-aef9-4e53-9a42-f86ae19b4dc0"
      unitRef="usdPerShare">16.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="id7924f95e7254282bcfd904f5e8c2a33_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIxOTkwMjMyNTkzMzc_3f446a15-6c9b-4aa7-9d4a-ba6beb54759f"
      unitRef="usd">3900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i3a16c03189374ecc8b0cfdb8f468e8f7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIxOTkwMjMyNTkzNjI_d5d25025-2e5c-4b6e-b9c8-5200c7eb53e8">P2Y3M14D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib2855760db5544e182b346d57d04d55d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzEtMi0xLTEtMTg2Mw_accc9538-f3e0-4b2c-bf48-e4823bf396a0"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="idf9d07d86bdb4bdf9c4770c8c4998e95_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzItMi0xLTEtMTg2Mw_03658ef7-1e43-4ec4-90ea-5e613e412c67"
      unitRef="shares">412434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idf9d07d86bdb4bdf9c4770c8c4998e95_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzMtMi0xLTEtMTg2Mw_7cdf54b6-0fd0-4ba5-8f0c-a7e47a59c360"
      unitRef="shares">11895</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i4d7b881e14e742dcb65f5f1ced340221_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzQtMi0xLTEtMTg2Mw_d8d1b014-247e-45a1-89c7-eb53cd297e62"
      unitRef="shares">400539</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="idf9d07d86bdb4bdf9c4770c8c4998e95_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzQtNi0xLTEtMTkwMw_b38cf684-d54c-41fd-b3a8-41208e50d6f7">P8Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i4d7b881e14e742dcb65f5f1ced340221_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzQtOC0xLTEtMTkxNA_b9bf8727-3adc-4a4e-8bc7-50ce2135b7c8"
      unitRef="usd">7710376000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i4d7b881e14e742dcb65f5f1ced340221_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzUtMi0xLTEtMTg2Mw_0ba204b8-f67c-45b5-b682-80be8816a565"
      unitRef="shares">26545</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="idf9d07d86bdb4bdf9c4770c8c4998e95_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzUtNi0xLTEtMTkwNw_7e8648de-2173-4ca7-a98e-f68e681677f9">P8Y4M24D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i4d7b881e14e742dcb65f5f1ced340221_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTo0YWNkNGJmN2U4OWI0YjZhYWVmNzlkOWIzYzU4ZTVkZS90YWJsZXJhbmdlOjRhY2Q0YmY3ZTg5YjRiNmFhZWY3OWQ5YjNjNThlNWRlXzUtOC0xLTEtMTkxNA_16b945c6-eb4c-48d3-a441-898f646c8024"
      unitRef="usd">510994000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <rdnt:AwardsIssuedToDate
      contextRef="i3bceea0558df4aa7a7b357ca906e3844_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzE3MTc_a605e8ec-8c1f-4743-8c54-7d472b186e89"
      unitRef="shares">6551872</rdnt:AwardsIssuedToDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i3bceea0558df4aa7a7b357ca906e3844_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzE3MzU_fb501e03-b830-4d5f-ac65-fa88b636f074"
      unitRef="shares">329159</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI2Nzc_86bf7d7e-1983-4c95-ad71-24574d65ae1c">The following summarizes all unvested RSA&#x2019;s activities during the twelve months ended December 31, 2020:&#160;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.637%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.640%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Term (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Changes during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(516,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSA's unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;329,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ib7d23330ea44497788f06f832afc7e77_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzEtMS0xLTEtMA_b3230c9d-2ead-4196-af8e-504da099b7ab"
      unitRef="shares">387934</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ib7d23330ea44497788f06f832afc7e77_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzEtNS0xLTEtMA_537d4f60-bd1b-4cac-b4a2-2075832769ec"
      unitRef="usdPerShare">11.61</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzMtMS0xLTEtMA_37f4d147-1b14-4842-ba4c-0544286c69af"
      unitRef="shares">457596</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzMtNS0xLTEtMA_20da9958-4730-490b-8e75-607b6472cc0b"
      unitRef="usdPerShare">19.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzQtMS0xLTEtMA_43640f3c-cc1c-48af-9424-09a8a5ef4db8"
      unitRef="shares">516371</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzQtNS0xLTEtMA_83057278-bd2a-42c8-9b4b-5bd584958a94"
      unitRef="usdPerShare">16.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i3bceea0558df4aa7a7b357ca906e3844_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzYtMS0xLTEtMA_c6a7c3b2-a23e-4b17-ac27-865e7721c881"
      unitRef="shares">329159</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i594c6f77fd7b4e50a7b93599cfa89338_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzYtMy0xLTEtMA_b07889ce-d98a-4567-af57-0b94d97dac50">P0Y10M13D</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i3bceea0558df4aa7a7b357ca906e3844_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90YWJsZTplMGE1NDdlNjExNzQ0ZjRiODNmZWM3M2JmYzE4N2M4Zi90YWJsZXJhbmdlOmUwYTU0N2U2MTE3NDRmNGI4M2ZlYzczYmZjMTg3YzhmXzYtNS0xLTEtMA_1388a3c7-0a4f-4619-92fe-53a9ab0070b8"
      unitRef="usdPerShare">16.69</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ibdc31c4ffa00452f9f099766b10087be_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIyNDA_246d9732-1f72-4e0d-8f59-d98d760a87d9"
      unitRef="shares">66078</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibdc31c4ffa00452f9f099766b10087be_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIyODk_f8b12dd5-0cba-4e1a-b842-a3371dc4f6b2"
      unitRef="usd">1000000.0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i40918c356ba546019d9cf3855b255d7a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzIzNTM_c8a90d81-1a02-488d-b6db-9945fd75b006"
      unitRef="shares">14000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="i109a113f281d4536a92aad55cbd4446b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI0NDc_ba93e5a5-f0e5-4bfb-8669-4dcc5cbc8d20"
      unitRef="shares">15424316</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i109a113f281d4536a92aad55cbd4446b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI1NjY_98ded452-7c34-407b-ab25-3cf5654623f4"
      unitRef="shares">3281040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i109a113f281d4536a92aad55cbd4446b_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI1NzM_3400ab3f-8b8a-4af1-9687-dc4c1f607bf4"
      unitRef="shares">61703</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
      contextRef="i40918c356ba546019d9cf3855b255d7a_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1XzI2MTE_85f1e7d4-650b-4c5c-9f33-9e0b5495ca58"
      unitRef="shares">1918427</us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzQyNA_629e7d88-3e8e-42c9-9ecb-c44a5ef0f4f9">SUBSEQUENT EVENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $0.5&#160;million. RadNet contributed $0.3&#160;million in assets for a 60% economic interest and Simi Adventist contributed assets totaling $0.2&#160;million for a 40% economic interest.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Over January and February 2021, we completed additional acquisitions of ZP companies in the New York City area for total purchase consideration of approximately $53.4&#160;million.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2021, we received $6.2&#160;million in general distribution funds under the CARES Act.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="ic762f9e446734268b2ec4cc6053e0784_I20210316"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5MTI_49198b43-f3d0-4ade-b3c9-31aea97d5d20"
      unitRef="usd">500000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="i37f85f9b11184e229c14b88e0c866f9a_D20210301-20210316"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5MTk_5b130348-b0aa-4e85-b9da-35e7b110f9bb"
      unitRef="usd">300000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="ib7780ac5dfb3420c990d47876f42a92d_D20210301-20210316"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5MjY_a3e0fb15-4082-4c62-b6ee-208e9a8c7b6a"
      unitRef="number">0.60</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
      contextRef="i3d7ba65a559c49258e9c430b845e4b63_I20210316"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5MzQ_cf063490-5723-4cf8-bb83-5f1b75788c42"
      unitRef="usd">200000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest
      contextRef="i5392aaed1912447ab767bc58444d59ac_D20210301-20210316"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5MzA_48a6c43a-85b3-47c2-ac44-f3f8d2396916"
      unitRef="number">0.40</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ibd5cb14789334c5ba54f208a8b80147c_D20210101-20210228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5NDE_35c9acd5-d931-42e9-b5df-15aab4d7720c"
      unitRef="usd">53400000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <rdnt:ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct
      contextRef="i37f85f9b11184e229c14b88e0c866f9a_D20210301-20210316"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMzMvZnJhZzpmZGYzZDE3YjA2NWQ0NDJlODM5MDdjZWFlZWE4NzU3YS90ZXh0cmVnaW9uOmZkZjNkMTdiMDY1ZDQ0MmU4MzkwN2NlYWVlYTg3NTdhXzIxOTkwMjMyNTc5NDg_15bf62cd-b05f-4728-8c9a-9733ec688612"
      unitRef="usd">6200000</rdnt:ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131448552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 05, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RadNet, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3326724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1510 Cotner Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Los Angeles,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">90025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">478-7808<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RDNT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity a Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity a Voluntary Filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity's Reporting Status Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 691.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,272,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s definitive proxy statement for the 2021 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this annual report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the close of the registrant&#8217;s fiscal year.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000790526<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909130813304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>CURRENT ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 102,018<span></span>
</td>
<td class="nump">$ 40,165<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">129,585<span></span>
</td>
<td class="nump">154,763<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from affiliates</a></td>
<td class="nump">5,836<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">32,985<span></span>
</td>
<td class="nump">45,004<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">270,424<span></span>
</td>
<td class="nump">241,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract', window );"><strong>PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">399,335<span></span>
</td>
<td class="nump">367,795<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use-assets</a></td>
<td class="nump">483,661<span></span>
</td>
<td class="nump">445,477<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Total property, equipment and right-of-use-assets</a></td>
<td class="nump">882,996<span></span>
</td>
<td class="nump">813,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsAbstract', window );"><strong>OTHER ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">472,879<span></span>
</td>
<td class="nump">441,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Other intangible assets</a></td>
<td class="nump">52,393<span></span>
</td>
<td class="nump">42,994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNoncurrentNet', window );">Deferred financing costs</a></td>
<td class="nump">1,767<span></span>
</td>
<td class="nump">1,559<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="nump">34,528<span></span>
</td>
<td class="nump">34,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">34,687<span></span>
</td>
<td class="nump">34,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositsAssets', window );">Deposits and other</a></td>
<td class="nump">36,983<span></span>
</td>
<td class="nump">36,996<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,786,657<span></span>
</td>
<td class="nump">1,646,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>CURRENT LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable, accrued expenses and other</a></td>
<td class="nump">236,684<span></span>
</td>
<td class="nump">207,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToAffiliateCurrent', window );">Due to affiliates</a></td>
<td class="nump">14,010<span></span>
</td>
<td class="nump">14,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">39,257<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of finance lease liability</a></td>
<td class="nump">2,578<span></span>
</td>
<td class="nump">3,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">65,794<span></span>
</td>
<td class="nump">61,206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of notes payable</a></td>
<td class="nump">39,791<span></span>
</td>
<td class="nump">39,691<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">398,114<span></span>
</td>
<td class="nump">327,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>LONG-TERM LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term finance lease liability</a></td>
<td class="nump">743<span></span>
</td>
<td class="nump">3,264<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liability</a></td>
<td class="nump">463,096<span></span>
</td>
<td class="nump">420,922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermNotesPayable', window );">Notes payable, net of current portion</a></td>
<td class="nump">612,913<span></span>
</td>
<td class="nump">652,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">53,488<span></span>
</td>
<td class="nump">9,529<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">1,528,354<span></span>
</td>
<td class="nump">1,413,847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>EQUITY</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock - $.0001 par value, 200,000,000 shares authorized; 51,640,537 and 50,314,328 shares issued and outstanding at December 31, 2020 and 2019 respectively</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">307,788<span></span>
</td>
<td class="nump">262,865<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(24,051)<span></span>
</td>
<td class="num">(8,026)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(117,999)<span></span>
</td>
<td class="num">(103,159)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total RadNet, Inc.'s stockholders' equity</a></td>
<td class="nump">165,743<span></span>
</td>
<td class="nump">151,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">92,560<span></span>
</td>
<td class="nump">81,454<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">258,303<span></span>
</td>
<td class="nump">233,139<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 1,786,657<span></span>
</td>
<td class="nump">$ 1,646,986<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property, Plant, and Equipment and Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNoncurrentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNoncurrentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToAffiliateCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToAffiliateCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909133249800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock - authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock - issued (in shares)</a></td>
<td class="nump">51,640,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock - outstanding (in shares)</a></td>
<td class="nump">50,314,328<span></span>
</td>
<td class="nump">50,314,328<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909132015992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,071,840<span></span>
</td>
<td class="nump">$ 1,154,179<span></span>
</td>
<td class="nump">$ 975,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Provider relief funding</a></td>
<td class="nump">26,264<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>OPERATING EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpenses', window );">Cost of operations, excluding depreciation and amortization</a></td>
<td class="nump">965,902<span></span>
</td>
<td class="nump">999,692<span></span>
</td>
<td class="nump">867,547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">86,795<span></span>
</td>
<td class="nump">80,607<span></span>
</td>
<td class="nump">72,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss (gain) on sale and disposal of equipment and other</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">2,383<span></span>
</td>
<td class="num">(2,054)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Loss on impairment</a></td>
<td class="nump">4,170<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">4,353<span></span>
</td>
<td class="nump">1,619<span></span>
</td>
<td class="nump">1,931<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,062,420<span></span>
</td>
<td class="nump">1,084,301<span></span>
</td>
<td class="nump">944,260<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">INCOME FROM OPERATIONS</a></td>
<td class="nump">35,684<span></span>
</td>
<td class="nump">69,878<span></span>
</td>
<td class="nump">30,886<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherExpensesAbstract', window );"><strong>OTHER INCOME AND EXPENSES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="nump">45,882<span></span>
</td>
<td class="nump">48,044<span></span>
</td>
<td class="nump">43,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of joint ventures</a></td>
<td class="num">(7,945)<span></span>
</td>
<td class="num">(8,350)<span></span>
</td>
<td class="num">(11,377)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1', window );">Non-cash change in fair value of interest rate hedge</a></td>
<td class="nump">2,528<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_GainLossonStepUpValuation', window );">Gain on re-measurement of pre-existing interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(768)<span></span>
</td>
<td class="num">(39,539)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="num">(4,047)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expenses (income)</a></td>
<td class="nump">120<span></span>
</td>
<td class="nump">1,283<span></span>
</td>
<td class="num">(181)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other expenses (income)</a></td>
<td class="nump">36,538<span></span>
</td>
<td class="nump">40,209<span></span>
</td>
<td class="num">(7,641)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">(LOSS) INCOME BEFORE INCOME TAXES</a></td>
<td class="num">(854)<span></span>
</td>
<td class="nump">29,669<span></span>
</td>
<td class="nump">38,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(895)<span></span>
</td>
<td class="num">(6,229)<span></span>
</td>
<td class="num">(394)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET (LOSS) INCOME</a></td>
<td class="num">(1,749)<span></span>
</td>
<td class="nump">23,440<span></span>
</td>
<td class="nump">38,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interests</a></td>
<td class="nump">13,091<span></span>
</td>
<td class="nump">8,684<span></span>
</td>
<td class="nump">5,890<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="num">$ (14,840)<span></span>
</td>
<td class="nump">$ 14,756<span></span>
</td>
<td class="nump">$ 32,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)</a></td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>WEIGHTED AVERAGE SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">50,891,791<span></span>
</td>
<td class="nump">49,674,858<span></span>
</td>
<td class="nump">48,114,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">50,891,791<span></span>
</td>
<td class="nump">50,244,006<span></span>
</td>
<td class="nump">48,678,999<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 931,722<span></span>
</td>
<td class="nump">$ 1,028,236<span></span>
</td>
<td class="nump">$ 868,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 140,118<span></span>
</td>
<td class="nump">$ 125,943<span></span>
</td>
<td class="nump">$ 106,405<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_GainLossonStepUpValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Step Up Valuation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_GainLossonStepUpValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909124551352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET (LOSS) INCOME</a></td>
<td class="num">$ (1,749)<span></span>
</td>
<td class="nump">$ 23,440<span></span>
</td>
<td class="nump">$ 38,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="num">(19,372)<span></span>
</td>
<td class="num">(10,253)<span></span>
</td>
<td class="nump">2,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,448<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">COMPREHENSIVE (LOSS) INCOME</a></td>
<td class="num">(17,774)<span></span>
</td>
<td class="nump">13,155<span></span>
</td>
<td class="nump">40,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">13,091<span></span>
</td>
<td class="nump">8,684<span></span>
</td>
<td class="nump">5,890<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</a></td>
<td class="num">$ (30,865)<span></span>
</td>
<td class="nump">$ 4,471<span></span>
</td>
<td class="nump">$ 35,050<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909129572152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENT OF EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>DeepHealth, Inc.</div></th>
<th class="th"><div>Radnet, Inc. Stockholders' Equity</div></th>
<th class="th">
<div>Radnet, Inc. Stockholders' Equity </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>DeepHealth, Inc.</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,723,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance, value at Dec. 31, 2017</a></td>
<td class="nump">$ 69,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 212,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (548)<span></span>
</td>
<td class="num">$ (150,158)<span></span>
</td>
<td class="nump">$ 8,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue', window );">Issuance of stock upon exercise of options</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">713,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="nump">7,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of restricted stock</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of stock for acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">531,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock for acquisitions</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="nump">34,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,666<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution', window );">Special distribution from noncontrolling interest</a></td>
<td class="num">(6,281)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Purchase of noncontrolling interests</a></td>
<td class="num">(200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(157)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContributionsFromNoncontrollingInterests', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">2,640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(1,427)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,427)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition', window );">Re-measurement of noncontrolling interest upon change in control</a></td>
<td class="nump">44,267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(69)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="nump">2,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="nump">2,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">38,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,243<span></span>
</td>
<td class="nump">5,890<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2018</a></td>
<td class="nump">200,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,259<span></span>
</td>
<td class="num">(117,915)<span></span>
</td>
<td class="nump">73,069<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,977,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of stock upon exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue', window );">Issuance of stock upon exercise of options</a></td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">771,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="nump">8,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Forfeiture of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited', window );">Forfeiture of restricted stock</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NonCashSeverance', window );">Non-cash severance</a></td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NonCashSeveranceShares', window );">Non-cash severance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,692<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of stock for acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">542,109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock for acquisitions</a></td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale to noncontrolling interests, net of taxes</a></td>
<td class="nump">5,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,008<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContributionsFromNoncontrollingInterests', window );">Contributions from noncontrolling interests</a></td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(3,057)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,057)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="num">(10,253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,253)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">23,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,756<span></span>
</td>
<td class="nump">8,684<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2019</a></td>
<td class="nump">233,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,026)<span></span>
</td>
<td class="num">(103,159)<span></span>
</td>
<td class="nump">81,454<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,314,328<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Shares issued under the equity compensation plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">491,674<span></span>
</td>
<td class="nump">10,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Shares issued under the equity compensation plan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition', window );">Stock-based compensation</a></td>
<td class="nump">12,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of stock for acquisitions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">823,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of stock for acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,011<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest', window );">Tax effect on gain on sale of noncontrolling interest</a></td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(551)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions paid to noncontrolling&#160;interests</a></td>
<td class="num">(1,985)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,985)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent', window );">Change in cumulative foreign currency&#160;translation adjustment</a></td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="num">(19,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19,372)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(1,749)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,840)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,840)<span></span>
</td>
<td class="nump">13,091<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance, value at Dec. 31, 2020</a></td>
<td class="nump">$ 258,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 165,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 307,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (24,051)<span></span>
</td>
<td class="num">$ (117,999)<span></span>
</td>
<td class="nump">$ 92,560<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,640,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContributionsFromNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContributionsFromNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase In Noncontrolling Interest Due To Step Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NonCashSeverance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non cash severance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NonCashSeverance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NonCashSeveranceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non Cash Severance Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NonCashSeveranceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Decrease From Special Distribution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph c(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909137936376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (1,749)<span></span>
</td>
<td class="nump">$ 23,440<span></span>
</td>
<td class="nump">$ 38,133<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income&#160;to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">86,795<span></span>
</td>
<td class="nump">80,607<span></span>
</td>
<td class="nump">72,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingLeaseRightofUseAssetAmortization', window );">Amortization of operating lease right-of-use assets</a></td>
<td class="nump">67,915<span></span>
</td>
<td class="nump">66,842<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions', window );">Equity in earnings of joint ventures, net of dividends</a></td>
<td class="nump">1,577<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">13,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization and write off of deferred financing costs and loan discount</a></td>
<td class="nump">4,413<span></span>
</td>
<td class="nump">4,184<span></span>
</td>
<td class="nump">3,898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">Loss (gain) on sale and disposal of equipment and other</a></td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">2,383<span></span>
</td>
<td class="num">(2,054)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain on extinguishment of debt</a></td>
<td class="num">(4,047)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_GainLossonStepUpValuation', window );">Gain on re-measurement of pre-existing interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(768)<span></span>
</td>
<td class="num">(39,539)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Loss on impairment</a></td>
<td class="nump">4,170<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredHedgeGains', window );">Amortization of cash flow hedge</a></td>
<td class="nump">3,448<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Non-cash change in fair value of interest rate hedge</a></td>
<td class="nump">2,528<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">12,405<span></span>
</td>
<td class="nump">8,730<span></span>
</td>
<td class="nump">7,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_IncreaseDecreaseInOtherNoncashItem', window );">Other non cash item in other expenses</a></td>
<td class="nump">242<span></span>
</td>
<td class="num">(371)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,123)<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">25,206<span></span>
</td>
<td class="num">(17,482)<span></span>
</td>
<td class="nump">2,145<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">6,588<span></span>
</td>
<td class="num">(3,557)<span></span>
</td>
<td class="num">(9,248)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="num">(5,425)<span></span>
</td>
<td class="num">(2,326)<span></span>
</td>
<td class="num">(1,687)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="num">(611)<span></span>
</td>
<td class="num">(3,888)<span></span>
</td>
<td class="num">(6,935)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_IncreaseDecreaseinOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(53,906)<span></span>
</td>
<td class="num">(66,831)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_IncreaseDecreaseInDeferredRent', window );">Deferred rent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">37,941<span></span>
</td>
<td class="num">(1,082)<span></span>
</td>
<td class="num">(208)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="nump">45,069<span></span>
</td>
<td class="nump">17,316<span></span>
</td>
<td class="nump">26,221<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">233,759<span></span>
</td>
<td class="nump">104,322<span></span>
</td>
<td class="nump">116,754<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBuildings', window );">Purchase of imaging facilities</a></td>
<td class="num">(31,265)<span></span>
</td>
<td class="num">(27,150)<span></span>
</td>
<td class="num">(73,192)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Equity investments at fair value</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(143)<span></span>
</td>
<td class="num">(2,200)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(94,172)<span></span>
</td>
<td class="num">(74,153)<span></span>
</td>
<td class="num">(72,180)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Proceeds from sale of equipment</a></td>
<td class="nump">828<span></span>
</td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">2,575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture', window );">Proceeds from the sale of equity interests in a joint venture</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfIntangibleAssets', window );">Proceeds from sale of internal use software</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Nulogix return of capital</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">792<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Equity contributions in existing and purchase of interest in joint ventures</a></td>
<td class="num">(1,635)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(126,244)<span></span>
</td>
<td class="num">(99,465)<span></span>
</td>
<td class="num">(146,749)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities', window );">Principal payments on notes and leases payable</a></td>
<td class="num">(3,562)<span></span>
</td>
<td class="num">(6,494)<span></span>
</td>
<td class="num">(6,072)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Payments on term loan debt</a></td>
<td class="num">(43,296)<span></span>
</td>
<td class="num">(40,742)<span></span>
</td>
<td class="num">(33,830)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Additional deferred finance costs on revolving loan amendment</a></td>
<td class="num">(741)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from debt issuance, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">97,144<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ProceedsFromGovernmentAssistance', window );">Proceeds from paycheck protection program loans</a></td>
<td class="nump">4,023<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions paid to noncontrolling interests</a></td>
<td class="num">(1,985)<span></span>
</td>
<td class="num">(3,057)<span></span>
</td>
<td class="num">(1,427)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets', window );">Proceeds from sale of noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,275<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromContributedCapital', window );">Contributions from noncontrolling partners</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="nump">2,640<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Proceeds from revolving credit facility</a></td>
<td class="nump">250,900<span></span>
</td>
<td class="nump">261,200<span></span>
</td>
<td class="nump">204,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Payments on revolving credit facility</a></td>
<td class="num">(250,900)<span></span>
</td>
<td class="num">(289,200)<span></span>
</td>
<td class="num">(176,300)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_PaymentsToAcquireInterestInSubsidiaries', window );">Purchase of noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(200)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock upon exercise of options</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(45,561)<span></span>
</td>
<td class="nump">24,951<span></span>
</td>
<td class="num">(10,869)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">EFFECT OF EXCHANGE RATE CHANGES ON CASH</a></td>
<td class="num">(101)<span></span>
</td>
<td class="num">(32)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">NET INCREASE (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS</a></td>
<td class="nump">61,853<span></span>
</td>
<td class="nump">29,776<span></span>
</td>
<td class="num">(40,933)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, beginning of period</a></td>
<td class="nump">40,165<span></span>
</td>
<td class="nump">10,389<span></span>
</td>
<td class="nump">51,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">CASH AND CASH EQUIVALENTS, end of period</a></td>
<td class="nump">102,018<span></span>
</td>
<td class="nump">40,165<span></span>
</td>
<td class="nump">10,389<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the period for interest</a></td>
<td class="nump">39,521<span></span>
</td>
<td class="nump">46,254<span></span>
</td>
<td class="nump">37,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid during the period for income taxes</a></td>
<td class="nump">5,069<span></span>
</td>
<td class="nump">5,884<span></span>
</td>
<td class="nump">4,933<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements', window );">Equipment acquired and leasehold improvements</a></td>
<td class="nump">52,000<span></span>
</td>
<td class="nump">51,700<span></span>
</td>
<td class="nump">47,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_CapitalLeaseDebt', window );">Capital lease debt</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">6,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain (loss) on equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration liability adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,123)<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">13,091<span></span>
</td>
<td class="nump">8,684<span></span>
</td>
<td class="nump">5,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=rdnt_StockholdersEquityDeficitMember', window );">Radnet, Inc. Stockholders' Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (14,840)<span></span>
</td>
<td class="nump">14,756<span></span>
</td>
<td class="nump">32,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember', window );">Variable Interest Entity, Not Primary Beneficiary | Medical Arts Radiology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income&#160;to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration liability adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue', window );">Business consideration liability adjustment recorded amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_CapitalLeaseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_CapitalLeaseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquipmentAcquiredAndLeaseholdImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquipmentAcquiredAndLeaseholdImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_GainLossonStepUpValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) on Step Up Valuation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_GainLossonStepUpValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_IncreaseDecreaseInDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting rent yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_IncreaseDecreaseInDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_IncreaseDecreaseInOtherNoncashItem">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease In Other Noncash Item</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_IncreaseDecreaseInOtherNoncashItem</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_IncreaseDecreaseinOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease in Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_IncreaseDecreaseinOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseRightofUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Right of Use Asset Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseRightofUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PaymentsToAcquireInterestInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Interest in Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PaymentsToAcquireInterestInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromGovernmentAssistance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Government Assistance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromGovernmentAssistance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount, measured at other than acquisition-date fair value, of all the liabilities assumed that arise from contingencies and were recognized by the entity, if the acquisition-date fair value cannot be determined and other criteria (as defined) related to the contingencies have been met.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2443-110228<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for acquisition of buildings (properties) whether for investment or use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received by a corporation from a shareholder during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=rdnt_StockholdersEquityDeficitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=rdnt_StockholdersEquityDeficitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MedicalArtsRadiologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MedicalArtsRadiologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909127984296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock', window );">NATURE OF BUSINESS</a></td>
<td class="text">NATURE OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a national provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. At December 31, 2020, we operated directly or indirectly through joint ventures with hospitals, 331 centers located in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Our centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Our services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The vast majority of our centers offer multi-modality imaging services. Our multi-modality strategy diversifies revenue streams, reduces exposure to reimbursement changes and provides patients and referring physicians one location to serve the needs of multiple procedures. In addition to our imaging services, we have certain other software subsidiaries which design and sell computerized systems for the imaging industry and internally develop Artificial Intelligence suites to enhance interpretation of radiographic images. Our operations comprise a single segment for financial reporting purposes.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of RadNet, Inc as well as its subsidiaries in which RadNet has a controlling financial interest. The consolidated financial statements also include certain variable interest entities in which we are the primary beneficiary (as described in more detail below). All material intercompany transactions and balances have been eliminated upon consolidation.   All of these affiliated entities are referred to collectively as &#8220;RadNet&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company&#8221; in this report</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting regulations stipulate that generally any entity with a) insufficient equity to finance its activities without additional subordinated financial support provided by any parties, or b) equity holders that, as a group, lack the characteristics which evidence a controlling financial interest, is considered a Variable Interest Entity (&#8220;VIE&#8221;). We consolidate all VIEs in which we are the primary beneficiary. We determine whether we are the primary beneficiary of a VIE through a qualitative analysis that identifies which variable interest holder has the controlling financial interest in the VIE. The variable interest holder who has both of the following has the controlling financial interest and is the primary beneficiary: (1) the power to direct the activities of the VIE that most significantly impact the VIE&#8217;s economic performance and (2) the obligation to absorb losses of, or the right to receive benefits from, the VIE that could potentially be significant to the VIE. In performing our analysis, we consider all relevant facts and circumstances, including: the design and activities of the VIE, the terms of the contracts the VIE has entered into, the nature of the VIE&#8217;s variable interests issued and how they were negotiated with or marketed to potential investors, and which parties participated significantly in the design or redesign of the entity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VIEs that we consolidate as the primary beneficiary consist of professional corporations which are owned or controlled by individuals within our senior management, namely Howard G. Berger, M.D., our President and Chief Executive Officer, and John V. Crues, III, M.D., RadNet's Medical Director; both of whom are members of our Board of Directors.  Dr. Berger owns, indirectly, 99% of the equity interests in Beverly Radiology Medical Group III (BRMG) and a controlling interest in two professional corporations in New York City.  BRMG is responsible for the professional medical services at nearly all of our facilities located in California.  Dr. Crues owns six professional corporations which provide medical services in Delaware, Maryland, New Jersey and New York.  Additionally, Dr. Crues is a 1% owner of BRMG.  These VIEs are collectively referred to as the consolidated medical group ("the Group").</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RadNet provides non-medical, technical and administrative services to the Group for which it receives a management fee, pursuant to the related management agreements. Through the management agreements we have exclusive authority over all non-medical decision making related to the ongoing business operations and we determine the annual budget. The Group has insignificant operating assets and liabilities, and de minimis equity. Through management agreements with us, substantially all cash flows of the Group after expenses, including professional salaries, are transferred to us. We consolidate the revenue and expenses, assets and liabilities of the Group.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Group on a combined basis recognized $147.6 million, $157.4 million, and $132.9 million of revenue, net of management services fees to RadNet, for the years ended December 31, 2020, 2019, and 2018, respectively and $147.6 million, $157.4 million, and $132.9 million of operating expenses for the years ended December 31, 2020, 2019, and 2018, respectively. RadNet, Inc. recognized $600.7 million, $618.9 million, and $505.2 million of total billed net service fee revenue for the years ended December 31, 2020, 2019, and 2018, respectively, for management services provided to them relating primarily to the technical portion of billed revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows of the Group are included in the accompanying consolidated statements of cash flows. All intercompany balances and transactions have been eliminated in consolidation. In our consolidated balance sheets at December 31, 2020 and December 31, 2019, we have included approximately $82.3 million and $100.3 million, respectively, of accounts receivable and approximately $15.2 million and $7.0 million of accounts payable and accrued liabilities related to the Group, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The creditors of the Group do not have recourse to our general credit and there are no other arrangements that could expose us to losses on behalf of them. However, RadNet may be required to provide financial support to cover any operating expenses in excess of operating revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also own a 49% economic interest in ScriptSender, LLC, which provides secure data transmission services of medical information. Through a management agreement, RadNet provides management and accounting services and receives an agreed upon fee. ScriptSender LLC is dependent on the Company to finance its own activities, and as such we determined that it is a VIE but we are not a primary beneficiary since we do not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At all of our centers not serviced by the Group we have entered into long-term contracts (typically 10 to 40 years in length) with independent radiology groups to provide physician services at those centers. These radiology practices provide professional services, including supervision and interpretation of diagnostic imaging procedures, in our diagnostic imaging centers. The radiology practices maintain full control over the provision of professional services. Under these arrangements, in addition to obtaining technical fees for the use of our diagnostic imaging equipment and the provision of technical services, we provide management services and receive a fee based on the value of the services we provide.  We own the diagnostic imaging equipment and, therefore, receive 100% of the technical reimbursements associated with imaging procedures. The radiology practice groups retain the professional reimbursements associated with imaging procedures after deducting management service fees paid to us and we have no economic controlling interest in these radiology practices. As such, the financial results of these practices are not consolidated in our financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909231138808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RECLASSIFICATION - For the year 2019, we have reclassified certain amounts previously classified as held for sale related to property and equipment and goodwill to conform to our 2020 presentation.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;1, 2018, we adopted the new revenue recognition accounting standard issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) and codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding our revenue recognition policies and significant judgments employed in the determination of revenue.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total net revenues for the years ended December 31, 2020, 2019, and 2018 are presented in the table below (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,035&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642,341&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,011&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,619&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,283&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,615&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,314&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,862&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,117&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging on call and software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,317&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,261&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931,722&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028,236&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868,741&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154,179&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975,146&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  Patient volumes and the related revenues for our services were significantly impacted during the latter portion of the first quarter through the middle of the third quarter of 2020 as a result of federal, state and local government mandated restrictions requiring many people to remain at home and forced the closure of or limitations on certain businesses, as well as suspended elective procedures by health care facilities.  Many of these restrictions </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">have been eased or completely lifted across the states the Company operates in however, we are unable to predict the future impact of the pandemic on our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the twelve months ended December 31, 2020, we received $43.2 million of accelerated Medicare payments, $5.0 million from Blue Shield, $26.3 million from the general distribution and $4.0 million from the Paycheck Protection Program established through the Coronavirus Aid, Relief and Economic Security (&#8220;CARES&#8221;) Act.  The accelerated Medicare payments are recorded under the caption &#8220; Deferred Revenue&#8220;  in our consolidated balance sheet and will be withheld from reimbursements for services in 2021 and 2022.  The general distribution funds were accounted for as government grants and recognized as other revenue, once reasonable assurance that the applicable terms and conditions required to retain the funds were met, under the caption &#8220;Provider relief funding&#8221; in our Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The CARES Act also provides for a payment deferral of the employer portion of Social Security tax incurred during the pandemic, allowing half of such payroll taxes to be deferred until December 2021 and the remaining half until December 2022.  At December 31, 2020, the Company had deferred $16.3 million of Social Security taxes.  These payment deferrals are recorded as payroll tax liability under the caption &#8220;Accounts payable, accrued expenses and other&#8221; in our consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We believe the extent of the COVID-19 pandemic&#8217;s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast.  Such factors include, but are not limited to, the scope and duration of stay-at-home practices, business closures  and restrictions, suspensions of elective procedures and continued decline in procedure volumes for an indeterminable length of time and incremental expenses required for supplies and personal protective equipment.  Because of these uncertainties, we cannot estimate the length or impact of the pandemic on our business.  If we incur declines in cash flows and results of operations, such declines could have an impact on the inputs and assumptions used in significant accounting estimates, including implicit prices concessions related to uninsured patient  accounts, and potential impairment of goodwill and long-lived assets.  During the fourth quarter of 2020, procedure volumes continued to increase and have had a positive impact on our patient revenue.  However, the impact of COVID-19 in future periods may vary and could adversely impact our results of operations.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections from our payors and record an estimated price concession based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. The aggregate amounts factored under these facilities, net of discounts recorded to reflect market interest rates is $29.5 million.  Proceeds are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.  At December 31, 2020 we have $20.5 million remaining to be collected on these agreements.  We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; Our software division has developed and sells Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer. </span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, we recorded approximately $8.6 million, $10.1 million, and $6.8 million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statement of operations. At December 31, 2020 we had deferred revenue of approximately $1.2 million associated with these sales which we expect to recognize into revenue over the next 12 months.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection, and to date have made all payments due to us in a timely manner.  </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are solely related to our Barclays Revolving Credit Facilities.  Deferred financing costs, net of accumulated amortization, were $1.8 million and $1.6 million for the twelve months ended December 31, 2020 and 2019, respectively.  See Note 8, Revolving Credit Facility, Notes Payable, and Capital Leases for more information on our revolving lines of credit.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BUSINESS COMBINATION &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GOODWILL AND INDEFINITE LIVED INTANGIBLES &#8211; Goodwill totaled $472.9 million and $442.0 million million at December 31, 2020 and December 31, 2019, respectively. Indefinite lived intangible assets at December 31, 2020 were $7.1 million and $11.3 million at December 31, 2019 and are associated with the value of certain trade name intangibles. Goodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We tested both goodwill and trade name intangibles for impairment&#160;on October 1, 2020.  However, during the year we ceased employing certain indefinite lived trade names with a total value of $4.2 million and they were written off in full. Separate from this, our annual impairment test as of October 1, 2020 noted no other impairment, and we have not identified any indicators of impairment through December 31, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the testing of goodwill and trade name intangibles at October 1, 2018, our Teleradiology reporting unit, Imaging On Call, (IOC), experienced a reduction of professional medical group clients and a loss of a contract with a major local health provider during 2018.  This affected its estimated fair value and resulted in impairment charges to our reporting unit of $3.9 million for the twelve months ended December 31, 2018, with goodwill representing $3.8 million of the total and the remainder being its trade name of approximately $0.1 million.  The estimated fair value of IOC reporting unit was determined by using the discounted cash flow method.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell. We determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized. Income taxes are further explained in Note 10, Income Taxes.&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liability, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable.  As most of our leases do not provide an implicit rate, we use our incremental borrowing rate ("IBR") based on the information available at commencement date in determining the present value of lease payments.  Our IBR used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and is adjusted when those rates experience a substantial change. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. Our ROU assets consist of facility and equipment assets on operating leases. No events have occurred which have impaired the integrity of our ROU assets in 2020. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order. See Note 9, Leases, for more information.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNINSURED RISKS &#8211; On November&#160;1, 2008 we obtained a fully funded and insured workers&#8217; compensation policy, thereby eliminating any uninsured risks for employee injuries occurring on or after that date. This fully funded policy remained in effect through November 1, 2013 and continues to cover any claims incurred through this date.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2013 we entered into a high-deductible workers&#8217; compensation insurance policy. We have recorded liabilities of $4.1 million and $3.8 million for each of the years ending December 31, 2020 and December 31, 2019, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits. The policy has a deductible which is $10,000 per incidence for the years ended December 31, 2020 and December 31, 2019, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2020, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents. We have recorded liabilities as of December 31, 2020 and 2019 of $6.6 million and $4.9 million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shield for a stop loss policy that provides coverage for any claims that exceed $250,000 up to a maximum of $1.0 million in order for us to limit our exposure for unusual or catastrophic claims.&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately. We can elect to provide a matching contribution in the amount to a maximum of 1.0% per 4.0% of employee contribution, and have done so since 2017.  We contributed $2.9 million in matching for the year ended December 31, 2019 and have elected not to fund a matching contribution for the plan year ended December 31, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LOSS AND OTHER UNFAVORABLE CONTRACTS &#8211; We assess the profitability of our contracts to provide management services to our contracted physician groups and identify those contracts where current operating results or forecasts indicate probable future losses. Anticipated future revenue is compared to anticipated costs and if the anticipated future cost exceeds the revenue, a loss contract accrual is recorded. In connection with the acquisition of Radiologix in November&#160;2006, we acquired certain management service agreements which met this criterion and recorded to other non-current liabilities an $8.9 million loss contract accrual.  Of the $4.6 million ending balance at December 31, 2018, approximately $4.0 million, ($2.8 million net of taxes), was settled against the purchase consideration of Hudson Valley Radiology Associates, P.L.L.C. (HVRA) by our VIE entity Lenox Hill Radiology and Medical Associates, P.C. and the remaining balance of approximately $558,000 was written off upon ending a contract with a physician group.  See Note 4, Facility Acquisitions and Dispositions for further information on the purchase of HVRA.</span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the Restated Plan 14,000,000 shares of common stock. We can issue options, stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options and warrants generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE1Ng_34d0b0f5-d4d7-4f53-b8d4-f97aa42926e1">three</span> to five years and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE2OQ_cb2940f3-3de2-419f-b70c-92ae0342fb0b">five</span> to ten years from date of grant.  The compensation expense associated with option grants is calculated based on a valuation model, typically the Black&#8211;Scholes model, which requires certain management assumptions with respect to volatility.  The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 11, Stock-Based Compensation, for more information.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FOREIGN CURRENCY TRANSLATION &#8211; The functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPREHENSIVE (LOSS) INCOME &#8211; Accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying comprehensive income (loss) and its components. Our unrealized gains or losses on foreign currency translation adjustments and our interest rate cap and swap agreements are included in comprehensive income (loss). The components of comprehensive income (loss) for the three years in the period ended December 31, 2020 are included in the consolidated statements of comprehensive income (loss).</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the second quarter of 2019, we accrued a liability of $2.3 million related to allegations by the US Attorney's Office for the Western District of New York that RadNet submitted certain claims which incorrectly identified the physician who furnished the radiology services.&#160; The final settlement, which admits no wrong-doing on behalf of RadNet, was $2.2 million&#160;and paid in September 2019.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 CAPS</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps matured in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively, which were designated at inception as cash flow hedges of future cash interest payments associated with portions of our variable rate bank debt. Under these arrangements, we purchased a cap on 3 month LIBOR at 2.0%. We were liable for a $5.3 million premium to enter into the caps which accrued to current liabilities on our balance sheet and paid over the life of the 2016 Caps.  The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"/><td style="width:28.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$788</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,383)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 SWAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional. Under these arrangements, we arranged the 2019 swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million through October 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.065%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Effective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Loss Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(20,160)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(5,870)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of  loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(2,528)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,448)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 CAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 CAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,640&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,640&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,403&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,699&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays revolving credit facility had no aggregate principal amount outstanding as of December 31, 2020 and December 31, 2019, respectively.  Our SunTrust revolving credit facility had no aggregate principal amount outstanding as of December 31, 2020 and December 31, 2019, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and SunTrust term loans. Level 2 inputs primarily related to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,243&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,674,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,114,275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net (loss) income per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,674,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,114,275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,963&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384,093&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,244,006&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,678,999&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net (loss) income per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,444&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY INVESTMENTS AT FAIR VALUE- As of December 31, 2020, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic Vision, based in Israel, specializes in software packages that provide compliant radiation dose structured reporting and enhanced images from reduced dose CT scans.  On March 24, 2017, we acquired an initial 12.50% equity interest in Medic Vision - Imaging Solutions Ltd for $1.0 million. We also received an option to exercise warrants to acquire up to an additional 12.50% equity interest for $1.4 million within one year from the initial share purchase date, if exercised in full. On March 1, 2018 we exercised our warrant in part and acquired an additional 1.96% for $200,000. Our initial equity interest has been diluted to 12.25% and our total equity investment stands at 14.21%.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as we exercise no significant influence over Medic Vision&#8217;s operations, the investment is recorded at its cost of $1.2 million, given that the fair value is not readily determinable. No observable price changes or impairment in our investment was noted as of the year ended December 31, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Turner Imaging Systems, based in Utah, develops and markets portable X-ray imaging systems that provide a user the ability to acquire X-ray images wherever and whenever they are needed. On February 1, 2018, we purchased 2.1 million preferred shares in Turner Imaging Systems for $2.0 million.  On January 1, 2019 we funded a convertible promissory note in the amount of $143,000 that converted to an additional 80,000 preferred shares on October 11, 2019.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WhiteRabbit.ai Inc., based in California, is currently developing an artificial intelligence suite which aims to improve the speed and accuracy of cancer detection in radiology and improve patient care. On November 5, 2019 we acquired an equity interest in the company for $1.0 million and also loaned the company $2.5 million in support of its operations.  No observable price changes or impairment in our investment was noted for the year ended December 31, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture formations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective November 1, 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial control of our Arizona centers.  We hold a 49% economic interest and CHI holds the majority 51% economic interest, respectively in ADRG and account for the venture under the equity method .  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of joint venture interest:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2017, we formed in conjunction with Cedars Sinai Medical Center (&#8220;CSMC&#8221;) the Santa Monica Imaging Group, LLC (&#8220;SMIG&#8221;), consisting of two multi-modality imaging centers located in Santa Monica, CA with RadNet holding a 40% economic interest and CSMC holding a 60% economic interest.  RadNet accounts for our share of the venture under the equity method.  On January 1, 2019, CSMC purchased from the us an additional 5% economic interest in SMIG valued at $134,000.  As a result of the transaction, our economic interest in SMIG has been reduced to 35%.  We recorded a loss of $2,000 on the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in control of existing joint ventures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 6, 2014, we acquired a 49% equity interest in Garden State Radiology Network, LLC ("GSRN") for cash consideration of $2.2 million.  The venture consisted of two imaging centers located in New Jersey.  On August 1, 2019, the entity was dissolved by transferring ownership of the assets of the centers with each partner receiving full ownership of one center. See Note 4, Facility Acquisitions and Dispositions, for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2018 we acquired&#160;25%&#160;share capital in Nulogix, Inc. for cash consideration of&#160;$2.0 million.  On August 1, 2019 we completed via the issuance of RadNet common stock valued at $1.5 million, the acquisition of the remaining 75% economic interest and we now consolidate the financial statements of Nulogix.  &#160;See Note 4, Facility Acquisitions and Dispositions, for further information.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, we obtained control over the operations of NJIN through an agreement with the other equity interest holder for no cash consideration.  As such, we consolidated the financial statements of NJIN effective that date.  The economic interest of each party remained the same after consolidation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2020 and December 31, 2019 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,973&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of ownership interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dissolution of GSRN</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,428)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix return of capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(792)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix change in control</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,004)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,598)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,945&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,522)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately  $11.3 million, $11.4 million and $13.8 million for the years ended December 31, 2020, 2019 and 2018, respectively . We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2020 and 2019, respectively, and for the years ended December 31, 2020, 2019 and 2018, respectively, (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,085&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,427&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,686&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,217)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,582)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,872)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,644&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,375&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,079&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,001&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,449&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,921&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,051&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,820&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909128635096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RECENT ACCOUNTING STANDARDS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract', window );"><strong>Accounting Standards Update and Change in Accounting Principle [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">RECENT ACCOUNTING STANDARDS</a></td>
<td class="text">RECENT ACCOUNTING STANDARDS<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2020-04 on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ASU 2016-13 replaces the incurred loss methodology previously utilized for valuing financial instruments with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology.  We adopted the standard on January </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1, 2020 using the modified retrospective approach.  See the Accounts Receivable section to Note 2 for further information on our allowances for credit losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15 (&#8220;ASU 2018-15&#8221;),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal-Use Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;ASU 2018-15 aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU was effective in the first quarter of 2020 with early adoption permitted and can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on our consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-03 ("ASU 2020-03"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this update represent changes to clarify or improve the codification and correct unintended application. ASU 2020-03 was effective immediately upon issuance and its adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13 ("ASU 2018-13"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard removes, modifies and adds certain disclosures related to recurring and nonrecurring fair value measurements. We adopted ASC 2018-13 effective January 1, 2020 and it had no effect on our disclosures.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 is effective beginning in the first quarter of 2021. Early adoption is permitted. Certain amendments in this update must be applied on a prospective basis, certain amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. We are currently evaluating the impact this ASU will have on our financial statements and related disclosures.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. We do not expect the adoption of this guidance will have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-01 provides clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2021-01 on our financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=SL108384541-122693<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (i)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (j)<br> -URI http://asc.fasb.org/extlink&amp;oid=113356391&amp;loc=SL49131195-203048<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -URI http://asc.fasb.org/extlink&amp;oid=112272810&amp;loc=d3e31137-122693<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(1)<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(2)<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909126677832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS</a></td>
<td class="text">FACILITY ACQUISITIONS AND DISPOSITIONS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October and November 2020, we completed our acquisition of certain assets of ZP Atlantic LLC, and ZP Elmhurst LLC.  We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.625%"><tr><td style="width:1.0%"/><td style="width:40.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.837%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Atlantic</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmhurst</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment</span></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,931&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,681&#160;</span></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of Use Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,181&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,571&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of Use Liabilities</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,181)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,571)</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</span></td><td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,871&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,269&#160;</span></td><td style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 31, 2020 we completed our acquisition of certain assets of AZ-Tech Radiology &amp; Open MRI, LLC, consisting of eight multi-modality imaging centers located in the Phoenix, Arizona area for purchase consideration of $5.5 million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $2.5 million in property and equipment, $7.6 million in right-of-use assets, $0.1 million in other assets, $7.6 million in operating lease liabilities, and $2.9 million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020, we completed our acquisition of all the equity interests of DeepHealth Inc., ("DeepHealth") an artificial intelligence and machine learning company in an all stock purchase.  As initial purchase consideration, we issued 915,132 shares at $16.93 per share (823,615 issued at execution, with up to 91,517 shares to be issued 18 months after acquisition subject to adjustment for any indemnification claims).  The transaction was accounted for as an acquisition of a business and total purchase consideration determined to be approximately $34.6 million including i) 823,615 shares issued on the date of closing with fair value of $13.9 million, ii) a liability of 91,517 shares with a fair value of $1.5 million to be issued 18 months after acquisition subject to adjustment for any indemnification claims and will be marked to market in subsequent periods, iii) replacement awards attributable to pre-combination service issued to DeepHealth option holders with allocated fair value of $2.0 million, iv) acquisition date fair value of contingent consideration of $17.0 million and v) $0.1 million in closing costs reimbursed to the seller.  The fair values of replacement awards attributable to pre-combination service and contingent consideration are recorded in additional paid in capital upon closing of the transaction. For the contingent consideration, there are three arrangements that will be settled in a fixed number of shares upon achievement of three individual specific milestones which are mutually exclusive of each other, with 390,789, 586,184, and 195,393 shares, respectively, issuable for each milestone arrangement. The fair value of the contingent consideration was estimated at the date of acquisition based on our share price and estimated probability of the achievement of the respective milestones.  We preliminarily recorded $0.1 million in current assets, $3.5 million in deferred tax liabilities, $14.8 million in intangible assets, primarily in-process research and development ("IPR&amp;D'), and $23.3 million in goodwill. The goodwill is primarily attributable to expected post-acquisition synergies from integrating DeepHealth&#8217;s assembled workforce and IPR&amp;D technologies. The fair values of the identifiable intangible assets related to IPR&amp;D were determined by the income method and the assets will not be amortized until regulatory approval is obtained, but will be assessed for impairment annually, or more frequently if indicators of impairment become present</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 2, 2020 our consolidated subsidiary New Jersey Imaging Networks ("NJIN") completed the acquisition of certain assets of MRI at Woodbridge, LLC consisting of a single multi-modality imaging center located in Avenel, New Jersey for cash consideration of $2.6 million.  NJIN made a fair value determination of the acquired assets and assumed liabilities and approximately $0.5 million in property and equipment, $1.1 million in right-of-use assets, $0.3 million in intangible assets, $1.1 million in operating lease liabilities, $0.1 million in finance lease liabilities, and $1.8 million in goodwill were recorded.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On January 2, 2020 we completed our acquisition of certain assets of Olney Open MRI, LLC, consisting of a single multi-modality imaging center located in Columbia, Maryland for cash consideration of $1.8 million.  We have made a fair value determination of the acquired assets and assumed liabilities and approximately $0.8 million in property and equipment, $1.3 million in right-of-use assets, $0.3 million in intangible assets, $1.3 million in operating lease liabilities and $0.6 million in goodwill were recorded.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019 we completed a step-up acquisition upon the dissolution of our former 49% owned joint venture, Garden State Radiology LLC ("GSRN").  GSRN consisted of two multi-modality centers operating in New Jersey.  GSRN became our wholly owned subsidiary with the withdrawal of the 51% majority partner for the full ownership of one center with no other consideration.  We made a fair value determination of our original 49% interest which resulted in a step-up gain of&#160; approximately $1.3 million. We determined a fair value of  the remaining acquired imaging center of $3.1 million in assets and $0.4 million in liabilities were recognized.  We recorded $1.0&#160;thousand in other assets, $0.7 million in fixed assets, $0.4 million in right-of-use assets, $0.4 million in operating lease liabilities, and $2.0 million in goodwill.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019 we completed a step-up acquisition of our former 25% owned joint venture, Nulogix, via a stock issuance of RadNet common shares valued at $1.5 million to obtain the remaining 75% outstanding Nulogix shares. We made a fair value determination of the acquired assets and approximately $0.2 million in fixed assets, $0.7 million in intangible assets, $0.3 million in deferred tax liability and goodwill of $1.3 million were recorded.  We also made a fair value determination of our 25% pre-existing interest in the business and recognized a loss of $0.5 million which is included in operating expenses within the consolidated statements of operations. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019 we completed our acquisition of certain assets of Kern Radiology Imaging Systems Inc., consisting of four multi-modality imaging centers located in Bakersfield, California for purchase consideration of $19.3 million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $10.1 million in property and equipment, $9.7 million in right-of-use assets, $36.0&#160;thousand in other assets, $3.4 million in intangible assets, $14.5 million in operating lease liabilities, and $10.5 million in goodwill were recorded.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2019 we completed our acquisition of certain assets of Zilkha Radiology Inc. consisting of two multi-modality centers located in Islip, New York for purchase consideration of $4.5 million.  We made a fair value determination of the acquired assets and assumed liabilities and approximately $2.2 million in property and equipment, $5.1 million in right-of-use assets, $0.1 million in intangible assets, $5.1 million in operating lease liabilities, $0.3 million  in finance lease liabilities and $2.6 million in goodwill were recorded.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2019, one of VIE entities, Lenox Hill Radiology and Medical Imaging Associates, P.C. ("LHR"), purchased the membership interest of Hudson Valley Radiology Associates, P.L.L.C. ("HVRA") for $6.0 million of RadNet common stock and contingent consideration valued at $0.7 million to guarantee the share value issued for a period of six months post acquisition date.  LHR has performed a fair value purchase price allocation and recorded equipment of $10.0&#160;thousand, a covenant not to compete of $50.0&#160;thousand, trade name of $0.4 million, other intangible assets of $0.3 million and goodwill of $3.1 million from the transaction. In connection with the acquisition, RadNet also settled against the purchase consideration, $2.8 million, net of taxes, of an unfavorable vendor contract with HVRA stemming from the previous acquisition of Radiologix, Inc. in November 2006. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 1, 2019 our majority owned subsidiary, West Valley Imaging Group, LLC ("WVIG") completed its acquisition of certain assets of West Valley Imaging Center, LLC ("West Valley"), consisting of a single multi-modality imaging center located in West Hills, CA for purchase consideration of $3.0 million all of which was initially funded by the Company.  We have made a fair value determination of the acquired assets and approximately $0.3 million in equipment and fixed assets, $7.0&#160;thousand in other assets, $0.2 million in intangible assets and $2.5 million in goodwill were recorded.  Subsequent to the transaction, our partner in WVIG, Cedars Sinai Medical Center, contributed $0.8 million in cash to maintain its 25% economic interest in the venture.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture formations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 13, 2019 we formed a wholly owned subsidiary, Ventura County Imaging Group, LLC ("VCIG").  On March 1, 2019, Dignity Health joined as a venture partner.  Total agreed contribution of both parties was $10.4 million of cash and assets with RadNet contributing net assets with a book value of $4.3 million for a 60% economic interest and Dignity Health contributing $6.1 million in cash and assets for a 40% economic interest.  For its contribution, RadNet transferred net assets of three wholly owned multi-modality imaging centers.  Dignity Health contributed approximately $0.8 million in assets to acquire 5% economic interest and paid RadNet $5.3 million for an additional 35% economic interest.  We maintain controlling economic interest in VCIG and fully consolidate the results into our financial statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dispositions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 1, 2020 we completed our sale of certain assets of our Imaging On Call subsidiary to RadVantage P.C. (an unrelated corporation) for approximately $1.0&#160;thousand.  With this transaction, we have exited the teleradiology business.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909126551848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is recorded as a result of business combinations. Activity in goodwill for the years ended December 31, 2019 and December 31, 2020 is provided below (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$418,093</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to our preliminary allocation of the purchase price of Medical Arts Radiological Group, P.C.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Dignity Health</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of West Valley Imaging Center, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill disposed through sale of assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired by Lenox Hill Radiology through the membership purchase of HVRA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Kern Radiology, Inc.</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,507&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Zilkha Radiology, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Ramic Mahwah, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of GSRN</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of Nulogix</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,337&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill transferred from assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$441,973</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of Olney Open MRI, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of MRI at Woodbridge, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of DeepHealth, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of AZ-Tech Radiology &amp; Open MRI, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of ZP Ozone Park, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of ZP Elmhurst LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$472,879</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of goodwill from these acquisitions that is deductible for tax purposes as of December 31, 2020 is $148.3 million.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets are primarily related to our business combinations and software development.  They include the estimated fair values of such items as service agreements, customer lists, covenants not to compete, acquired technologies, and trade names.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization expense was $3.7 million, $3.1 million, and $2.7 million for the years ended December 31, 2020, 2019 and 2018, respectively.  Intangible assets are amortized using the straight-line method over their useful life determined at acquisition. Management service agreements are amortized over 25 years using the straight line method.  Software development is capitalized and amortized over the useful life of the software when placed into service.  Trade names are reviewed annually for impairment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,533&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,968&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,601&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.9</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software in development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,685&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,685&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,630&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,498&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,236&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,627&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,393&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909126626120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426,682&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,446&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,490&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,253&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377,676&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under financing/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026,564&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939,203&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(627,229)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(571,408)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,335&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,795&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our property and equipment at December 31, 2020  is approximately $57.5 million total of construction in process amounts consisting of $26.0 million in medical equipment, $7.7 million in computer and office equipment, and $23.8 million in leasehold improvements.</span></div>Depreciation and amortization expense of property and equipment, including amortization of equipment under finance/capital leases, for the years ended December 31, 2020, 2019 and 2018 was $83.1 million, $77.5 million, and $70.2 million, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909126611576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</a></td>
<td class="text">ACCOUNTS PAYABLE AND ACCRUED EXPENSES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses were comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,071&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,300&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,312&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,853&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,051&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,003&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,684&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,585&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909126609080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock', window );">CREDIT FACILITIES AND NOTES PAYABLE</a></td>
<td class="text">CREDIT FACILITIES AND NOTES PAYABLE<div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and December 31, 2019 our debt obligations consisted of the following (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,028&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649,824&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,375&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,875&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment notes payable at interest rates ranging from 4.4% to 5.6%, due through 2020, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,704&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692,395&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,791)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,691)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion debt obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,913&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,704&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,670&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,795&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573,938&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,403&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our consolidated balance sheets at December 31, 2020 are $601.3 million of First Lien Term Loans and $51.4 million of SunTrust Term Loan debt for a combined total of $652.7 million (net of unamortized discounts of $9.7 million) in thousands:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,028&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,699)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601,329&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,403&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,699)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,704&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no outstanding balance under our $195.0 million Barclays Revolving Credit Facility at December 31, 2020 and had reserved an additional $7.3 million for certain letters of credit.  The remaining $187.7 million of our Barclays Revolving Credit Facility was available to draw upon as of  December 31, 2020.  We also had no balance under our $30.0 million SunTrust Revolving Credit Facility related to our consolidated subsidiary NJIN at December 31, 2020, and with no letters of credit reserved against the facility, the full amount was available to draw upon. At December 31, 2020 we were in compliance with all covenants under our credit facilities.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Senior Credit Facilities:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, our Barclays credit facilities were comprised of one tranche of term loans (&#8220;First Lien Term Loans&#8221;) and a revolving credit facility of $195.0 million (the &#8220;Barclays Revolving Credit Facility&#8221;), both of which are provided pursuant to the Amended and Restated First Lien Credit and Guaranty Agreement dated July 1, 2016, among RadNet, Barclays Bank plc, as administrative agent, and the lenders identified therein (as amended, the "First Lien Credit Agreement").  Deferred financing costs at December 31, 2020, net of accumulated amortization, was $1.8 million and is specifically related to our Barclays Revolving Credit Facility.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our First Lien Term Loans bear interest at either an Adjusted Eurodollar Rate or a Base Rate (each as defined in the First Lien Credit Agreement) plus an applicable margin according to the following schedule:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 5.50x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 4.00x but &#8804; 5.50x</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;3.50x but &#8804; 4.00x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.50x</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020 the effective Adjusted Eurodollar Rate and the Base Rate for the First Lien Term Loans was 1.00% and 3.25%, respectively and the applicable margin for Adjusted Eurodollar Rate and Base Rate borrowings was 3.75% and 2.75%, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Lien Credit Agreement provides for quarterly payments of principal under the First Lien Term Loans in the amount of approximately $9.7 million.  The  First Lien Term Loans will mature on July 1, 2023 unless otherwise accelerated under the terms of the First Lien Credit Agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, our SunTrust credit facilities, which relate to our consolidated subsidiary The New Jersey Imaging Network, L.L.C.("NJIN"), were comprised of one term loan (the "SunTrust Term Loan") and a revolving credit facility of $30.0 million (the "SunTrust Revolving Credit Facility") both of which are provided pursuant to the Amended and Restated revolving Credit and Term Loan Agreement dated August 31, 2018, among NJIN, as borrower, with SunTrust Bank, as </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">administrative agent, and the lenders identified therein (as amended, the "SunTrust Credit Agreement").  Our SunTrust Term Loan bears interest at either an Adjusted LIBOR Rate or a Base Rate (each as defined in the SunTrust Credit Agreement), plus an applicable margin according to the following schedule:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.128%"><tr><td style="width:1.0%"/><td style="width:8.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loans and other obligations outstanding under the SunTrust Credit Agreement currently bear interest at a three month LIBOR election at 0.22% plus an applicable margin and fees based on Pricing Level III described above.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scheduled amortization of the SunTrust Term Loan began December 31, 2018 with quarterly payments of $750,000, representing annual amortization equal to 5.0% of the original principal amount of the SunTrust Term Loan. At scheduled intervals, the quarterly amortization increases by $375,000, with the remaining balance to be paid at maturity.</span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Revolving Credit Facilities:</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Revolving Credit Facility:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans borrowed under the Barclays Revolving Credit Facility bear interest at either an Adjusted Eurodollar Rate or a Base Rate (in each case, as more fully defined in the First Lien Credit Agreement) plus an applicable margin.  The applicable margin for borrowing under the Barclays Revolving Credit Facility varies based on our leverage ratio in accordance with the same schedule set forth above for First Lien Term Loans. As of December 31, 2020, the effective interest rate payable on revolving loans under the Barclays Revolving Credit Facility was 6.00%.</span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For letters of credit issued under the Barclays Revolving Credit Facility, letter of credit fees accrue at the applicable margin for Adjusted Eurodollar Rate revolving loans, currently 3.75%, and fronting fees accrue at 0.25% per annum, in each case on the average aggregate daily maximum amount available to be drawn under all letters of credit issued under the First Lien Credit Agreement. In addition a commitment fee of 0.50% per annum accrues on the unused revolver commitments under the Barlcays Revolving Credit Facility. </span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Barclays Revolving Credit Facility will terminate on the earlier to occur of July 1, 2023 or termination due to specific events of default pursuant to the First Lien Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays Revolving Credit Facility was amended in August 2020 to add $57.5 million of revolving commitments, which additional commitments increased the maximum borrowing capacity to $195.0 million.  Total issue costs added in relation to this amendment amounted to approximately $0.7 million and was capitalized as deferred financing costs and will be amortized over the remaining term of the First Lien Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">SunTrust Revolving Credit Facility:</span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SunTrust Credit Agreement established a $30.0 million revolving credit facility available to NJIN for funding requirements. The SunTrust Revolving Credit Facility terminates on the earliest of (i) August 31, 2023, (ii) the </span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">voluntary termination thereof by NJIN pursuant to Section 2.8 of the SunTrust Credit Agreement, or (iii) the date on which all amounts outstanding under the SunTrust Credit Agreement have been declared or have automatically become due and payable (whether by acceleration or otherwise).  As of December 31, 2020, NJIN had no borrowings under the SunTrust Revolving Credit Facility. </span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:54pt"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Recent Amendments to Credit Facilities</span></div><div style="padding-right:4.5pt;text-align:justify"><span><br/></span></div><div style="padding-right:4.5pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barclays Credit Facilities:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 28, 2020, RadNet Management, Inc. and RadNet, Inc. entered into Amendment No. 8, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement ("the Eighth Amendment").  The Eighth Amendment amends the First Lien Credit Agreement to add $57.5 million of revolving commitments to the Barclays Revolving Credit Facility increasing the maximum borrowing capacity under the Barclays Revolving Credit Facility to $195.0 million while leaving the maturity date of July 1, 2023 unchanged.  Total issue costs added in relation to the Eighth Amendment amounted to approximately $0.7 million and was capitalized as deferred financing costs and will be amortized over the remaining term of the First Lien Credit Agreement.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 18, 2019 we entered into the following two amendments to the First Lien Credit Agreement: (i) Amendment No. 6, Consent and Incremental Joinder Agreement to Credit and Guaranty Agreement (the &#8220;Sixth Amendment&#8221;); and (ii) Amendment No. 7 to Credit and Guaranty Agreement (the &#8220;Seventh Amendment&#8221;).  Among other things, the Sixth Amendment amended the First Lien Credit Agreement to issue $100.0 million in incremental First Lien Term Loans and to add an additional $20.0 million of revolving commitments to the Barclay's Revolving Credit Facility.  The Seventh Amendment amended the First Lien Credit Agreement to extend the maturity date of the Barclays Revolving Credit Facility by an additional two years to July 1, 2023, unless sooner terminated in accordance with the terms of the First Lien Credit Agreement.  Total issue costs added in relation to the Sixth and Seventh amendments in 2019 amounted to approximately $4.4 million. Of this amount, $2.1 million was identified and capitalized as discount on debt, $0.7 million was capitalized as deferred financing costs, and $1.6 million was expensed. Amounts capitalized will be amortized over the remaining term of the First Lien Credit Agreement.</span></div><div style="margin-top:10pt;padding-left:4.5pt;padding-right:4.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Paycheck Protection Program</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Paycheck Protection Program (PPP) includes funds available for loans to small business and Medicare providers to support operations during the COVID-19 pandemic. The funds are administered by the Small Business Administration (SBA), through approved lenders and do not require collateral or personal guarantees.  We received our loans based on being a Medicare provider. The terms and conditions for participation require entities to certify that economic uncertainty related to the COVID-19 pandemic makes the loan necessary to support their current operations, and that they will use the funds to retain workers (e.g., by paying salaries, providing paid sick/medical leave and health insurance benefits) and pay certain debts (mortgage obligations) and expenses (e.g. rent, utilities, telephone).  The loans have a 1.0% fixed interest rate and are due in 2 years.  The loans are eligible for forgiveness subject to salary limitations and employee retention levels. Certain of our consolidated subsidiaries received four loans totaling $4.0 million.  We accounted for the funds received as debt and recorded a liability for the full amount of proceeds received and accrued interest over the term of the loans.  In December 2020 we met the eligibility requirements for forgiveness and the loans were written off to gain on debt extinguishment.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -URI http://asc.fasb.org/topic&amp;trid=2208923<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909126611576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Notes)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adoption of Standard</span></div><div style="margin-top:10pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued a new standard related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (&#8220;ROU&#8221;) assets and lease liabilities on the balance sheet for all leases with terms in excess of twelve months. Sufficient disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The standard was effective for us beginning January 1, 2019. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will not apply the standard to the comparative periods presented in the consolidated financial statements. We also elected the transition package of three practical expedients permitted within the standard, which eliminates the requirements to reassess prior conclusions about lease identification, lease classification, and initial direct costs.  The adoption of the standard had a material impact on our consolidated balance sheets, but did not have material impact on our consolidated income statements or cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Liability</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating leases for medical facilities, administrative offices, warehouse space and major medical equipment.  We lease the premises at which these facilities are located and do not have options to purchase the facilities we rent. Our most common initial term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at the facilities we lease. We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year. Additionally, we have operating and finance leases for certain medical and office equipment, with lease terms generally lasting from 5 to 8 years.  Our Incremental Borrowing Rate ("IBR") used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and our IBR is adjusted when those rates experience a substantial change.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.197%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.251%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.252%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,122&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,135&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,332&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,530&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,821&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,922&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,939&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,099&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,399&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts for the twelve months ended December 31, 2019 include the transition adjustment for the adoption of Topic 842.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed in our 2018 Annual Report on Form 10-K and under the previous lease accounting, rental expense for the year ended December 31, 2018 was $83.0 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,794&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,206&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,890&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,128&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,220)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,135)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance lease</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,283&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,547&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:59.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.489%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,307&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,654&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,648&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,469&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717,701&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,406&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,811)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,890&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $8.8 million.  These operating leases will commence in 2021 with lease terms of 3 to 15 years.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adoption of Standard</span></div><div style="margin-top:10pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2016, the FASB issued a new standard related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (&#8220;ROU&#8221;) assets and lease liabilities on the balance sheet for all leases with terms in excess of twelve months. Sufficient disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. The standard was effective for us beginning January 1, 2019. We have elected the optional transition method to apply the standard as of the effective date and therefore, we will not apply the standard to the comparative periods presented in the consolidated financial statements. We also elected the transition package of three practical expedients permitted within the standard, which eliminates the requirements to reassess prior conclusions about lease identification, lease classification, and initial direct costs.  The adoption of the standard had a material impact on our consolidated balance sheets, but did not have material impact on our consolidated income statements or cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Liability</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operating leases for medical facilities, administrative offices, warehouse space and major medical equipment.  We lease the premises at which these facilities are located and do not have options to purchase the facilities we rent. Our most common initial term varies in length from 5 to 15 years. Including renewal options negotiated with the landlord, we can have a total span of 10 to 35 years at the facilities we lease. We also lease smaller satellite X-Ray locations on mutually renewable terms, usually lasting one year. Additionally, we have operating and finance leases for certain medical and office equipment, with lease terms generally lasting from 5 to 8 years.  Our Incremental Borrowing Rate ("IBR") used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and our IBR is adjusted when those rates experience a substantial change.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.197%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.251%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.252%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,122&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,135&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,332&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,530&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,821&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,922&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,939&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,099&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,399&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts for the twelve months ended December 31, 2019 include the transition adjustment for the adoption of Topic 842.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed in our 2018 Annual Report on Form 10-K and under the previous lease accounting, rental expense for the year ended December 31, 2018 was $83.0 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,794&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,206&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,890&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,128&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,220)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,135)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance lease</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,283&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,547&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:59.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.489%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,307&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,654&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,648&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,469&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717,701&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,406&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,811)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,890&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we have additional operating leases for facilities and medical equipment that have not yet commenced of  approximately $8.8 million.  These operating leases will commence in 2021 with lease terms of 3 to 15 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909125180968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(765)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,608)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,263&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,020)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,035&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,743)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,104)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:66.959%"><tr><td style="width:1.0%"/><td style="width:44.314%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.897%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,256&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,748)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,760&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(850)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on change in control</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,839&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,254)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other reconciling items</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between carrying amounts of assets and liabilities for financial and income tax reporting purposes and operating loss carryforwards.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our deferred tax assets and liabilities comprise the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,154&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,490&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,139&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,546&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,284&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,220&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,315)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,348)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,178&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,457)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,637)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,669)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,956)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,364)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181,938)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158,630)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax Asset</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,687&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,548&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company had federal net operating loss carryforwards of approximately $251.6 million, which comprise of definite and indefinite net operating losses.  We had federal net operating loss carryforwards of approximately $186.2 million, which expire at various intervals from the years 2023 to 2037, and had carryforwards of $65.4 million of net operating losses which do not expire.  Federal net operating losses generated following December 31, 2017 carryover indefinitely and may generally be used to offset up to 80% of future taxable net income.  The Company also had state net operating loss carryforwards of approximately $57.9 million, which expire at various intervals from the years 2020 through 2039. As of December 31, 2020, $24.6 million of our federal net operating loss carryforwards acquired in connection with the 2011 acquisition of Raven Holdings U.S., Inc. and the 2019 acquisition of Nulogix Health, Inc. are subject to limitations related to their utilization under Section 382 of the Internal Revenue Code. Future ownership changes as determined under Section 382 of the Internal Revenue Code could further limit the utilization of net operating loss carryforwards.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We considered all evidence available when determining whether deferred tax assets are more likely-than-not to be realized, including projected future taxable income, scheduled reversals of deferred tax liabilities, prudent tax planning strategies, and recent financial operations. The evaluation of this evidence requires significant judgment about the forecasts of future taxable income, based on the plans and estimates we are using to manage the underlying businesses. In evaluating the objective evidence that historical results provide, we consider three years of cumulative operating income. As of December 31, 2020, we have determined that deferred tax assets of $216.6 million are more likely-than-not to be realized. We have also taken into consideration deferred tax liabilities of $28.5 million are related to book basis in goodwill that has an indefinite life.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file consolidated income tax returns in the U.S. federal jurisdiction and various states and foreign jurisdictions. We continue to reinvest earnings of the non-US entities for the foreseeable future and therefore have not recognized any U.S. tax expense on these earnings. With limited exceptions, we are no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2015. We are currently under audit in the state of California for the tax years of 2016 and 2017.  It is too early to assess the impact such audits may have on the financial position of the Company, however we do not anticipate the results of any open examinations would result in a material change to our financial position.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December 31, 2020, the Company has unrecognized tax benefits of $5.5 million of which $4.4 million  will affect the effective tax rate if recognized.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,629&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,615&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,629&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. During the year ended December 31, 2020 the Company accrued approximately $0.1 million of interest and penalties. As of December 31, 2020, accrued interest and penalties amounted to approximately $0.4 million.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On March 27, 2020, the United States enacted the Coronavirus Aid, Relief and Economic Security Act (CARES Act). The Cares Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort to curtail the effect of COVID-19. The CARES Act provides sweeping tax changes in response to the COVID-19 pandemic, some of the more significant provisions are removal of certain limitations on utilization of net operating losses, increasing the loss carryback period for certain losses to five years, and increasing the ability to deduct interest expense, as well as amending certain provisions of the previously enacted Tax Cuts and Jobs Act. At December 31, 2020, the Company has taken advantage of the accelerated tax depreciation related to qualified improvement property and the Paycheck Protection Program loan allowed under the CARES Act.  </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On December 27, 2020, the United States enacted the Consolidated Appropriations Act of 2021 (&#8220;CAA&#8221;). The CAA includes provisions extending certain CARES Act provisions and adds coronavirus relief, tax and health extenders. The Company will continue to evaluate the impact of the CAA and its impact on our financial statements in 2021 and beyond.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In June 29, 2020, the state of California passed Assembly Bill 85 which suspends the California net operating loss deduction for the 2020-2022 tax years and the R&amp;D credit usage for the same period (for credit usages in excess of $5M). These suspensions were considered in preparation of the 2020 financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909221781848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Incentive Plans</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have one long-term equity incentive plan which we refer to as the 2006 Equity Incentive Plan, which we first amended and restated as of April 20, 2015 and again on March 9, 2017 (&#8220;the Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the 2017 Restated Plan 14,000,000 shares of common stock.  We can issue options (incentive and non-qualified), stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Options</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc2OA_936612e8-22fa-4ff0-b720-c4675549c40d">three</span> to five years and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF8xMjEvZnJhZzo5ZDQxZWYyNDM5Yjc0MDAxYTRlODRkZDg1NzY3OTMzNS90ZXh0cmVnaW9uOjlkNDFlZjI0MzliNzQwMDFhNGU4NGRkODU3Njc5MzM1Xzc4OA_046091b3-dd3f-4a0f-84b9-3f6b7a937f8c">five</span> to ten years from the date of grant.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, we had outstanding options to acquire 527,899 shares of our common stock, of which options to acquire 307,196 shares were exercisable. The following summarizes all of our option transactions for the twelve months ended December 31, 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.824%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478,951&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.21&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,899&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.34&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.34</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,441,129&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307,196&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.49</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,679,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aggregate intrinsic value in the table above represents the total pretax intrinsic value (the difference between our closing stock price on December 31, 2020 and the exercise price, multiplied by the number of in-the-money options as applicable) that would have been received by the holder had all holders exercised their options on December 31, 2020.  As of December 31, 2020, total unrecognized stock-based compensation expense related to non-vested employee awards was $0.6 million which is expected to be recognized over a weighted average period of approximately 1.50 years.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:174%">DeepHealth Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of fiscal 2020, in connection with the completion of the DeepHealth acquisition, we granted&#160;412,434&#160;options at a grant date fair value of $16.93&#160;per share unit to DeepHealth employees in replacement of their stock options that were outstanding as of the closing date.  As of December 31, 2020, total unrecognized stock based compensation expense related to non-vested DeepHealth options was approximately $3.9 million which is expected to be recognized over a weighted average period of approximately 2.29 years.</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"/><td style="width:48.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted, June 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,895)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,539&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.40</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,710,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,545&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.40</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510,994&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards (&#8220;RSA&#8217;s&#8221;)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan permits the award of restricted stock awards (&#8220;RSA&#8217;s&#8221;). As of December 31, 2020, we have issued a total of 6,551,872 RSA&#8217;s of which 329,159 were unvested at December 31, 2020 . The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2020:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2019</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387,934&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.61&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,596&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.66&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(516,371)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,159&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.69&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the fair value of all RSA&#8217;s based of the closing price of our common stock on award date.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other stock bonus awards</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Plan also permits the award of stock bonuses not subject to any future service period. These awards are valued and expensed based on the closing price of our common stock on the date of award. During the twelve months ended December 31, 2020 we issued 66,078 shares relating to these awards, approximately amounting to $1.0 million of compensation expense.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan summary</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In summary, of the 14,000,000 shares of common stock reserved for issuance under the Restated Plan, at December 31, 2020, we had issued 15,424,316 total shares between options, RSA&#8217;s and other stock awards. With options cancelled and RSA&#8217;s forfeited amounting to 3,281,040 and 61,703 shares, respectively, there remain 1,918,427 shares available under the Restated Plan for future issuance.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909126602024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021 we entered into the Simi Valley Imaging Group, LLC, a partnership with Simi Valley Hospital and Health Services ("Simi Adventist").  The operation will offer multi-modality imaging services out of two locations in Ventura County, California.  Total investment in the venture is $0.5&#160;million. RadNet contributed $0.3&#160;million in assets for a 60% economic interest and Simi Adventist contributed assets totaling $0.2&#160;million for a 40% economic interest.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over January and February 2021, we completed additional acquisitions of ZP companies in the New York City area for total purchase consideration of approximately $53.4&#160;million.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2021, we received $6.2&#160;million in general distribution funds under the CARES Act.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909130774088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">PRINCIPLES OF CONSOLIDATION</a></td>
<td class="text">PRINCIPLES OF CONSOLIDATION &#8211; The operating activities of subsidiaries are included in the accompanying consolidated financial statements (&#8220;financial statements&#8221;) from the date of acquisition. Investments in companies in which we have the ability to exercise significant influence, but not control, are accounted for by the equity method. All intercompany transactions and balances, with our consolidated entities and the unsettled amount of intercompany transactions with our equity method investees, have been eliminated in consolidation. As stated in Note 1 above, the Group consists of VIEs and we consolidate the operating activities and balance sheets of each. Additionally, we determined that our unconsolidated joint venture, ScriptSender, LLC, is also a VIE as it is dependent on our operational funding but we are not a primary beneficiary since RadNet does not have the power to direct the activities of the entity that most significantly impact the entity&#8217;s economic performance.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">USE OF ESTIMATES</a></td>
<td class="text">USE OF ESTIMATES - The financial statements have been prepared in accordance with U.S. generally accepted accounting principles (GAAP), which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. These estimates and assumptions affect various matters, including our reported amounts of assets and liabilities in our consolidated balance sheets at the dates of the financial statements; our disclosure of contingent assets and liabilities at the dates of the financial statements; and our reported amounts of revenues and expenses in our consolidated statements of operations during the reporting periods. These estimates involve judgments with respect to numerous factors that are difficult to predict and are beyond management&#8217;s control. As a result, actual amounts could materially differ from these estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">RECLASSIFICATION</a></td>
<td class="text">RECLASSIFICATION - For the year 2019, we have reclassified certain amounts previously classified as held for sale related to property and equipment and goodwill to conform to our 2020 presentation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">REVENUES</a></td>
<td class="text">REVENUES &#8211; Our revenues generally relate to net patient fees&#160;received from various payors and patients themselves under contracts in which our performance obligations are to provide diagnostic services to the patients. Revenues are recorded during the period when our obligations to provide diagnostic services are satisfied. Our performance obligations for diagnostic services are generally satisfied over a period of less than one day. The contractual relationships with patients, in most cases, also involve a third-party payor (Medicare, Medicaid, managed care health plans and commercial insurance companies, including plans offered through the health insurance exchanges) and the transaction prices for the services provided are dependent upon the terms provided by (Medicare and Medicaid) or negotiated with (managed care health plans and commercial <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance companies) the third-party payors. The payment arrangements with third-party payors for the services we provide to the related patients typically specify payments at amounts less than our standard charges and generally provide for payments based upon predetermined rates per diagnostic services or discounted fee-for-service rates. Management continually reviews the contractual estimation process to consider and incorporate updates to laws and regulations and the frequent changes in managed care contractual terms resulting from contract renegotiations and renewals.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As it relates to the Group, this service fee revenue includes payments for both the professional medical interpretation revenue recognized by them as well as the payment for all other aspects related to our providing the imaging services, for which we earn management fees. As it relates to others centers, this service fee revenue is earned through providing the use of our diagnostic imaging equipment and the provision of technical services as well as providing administration services such as clerical and administrative personnel, bookkeeping and accounting services, billing and collection, provision of medical and office supplies, secretarial, reception and transcription services, maintenance of medical records, and advertising, marketing and promotional activities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are based upon the estimated amounts we expect to be entitled to receive from patients and third-party payors. Estimates of contractual allowances under Medicare, Medicaid, managed care and commercial insurance plans are based upon historical collection experience of the payments received from such payors in accordance with the underlying contractual agreements.  Revenues related to uninsured patients and uninsured copayment and deductible amounts for patients who have health care coverage may have price concessions applied.  We also record estimated implicit price concessions (based primarily on historical collection experience) related to uninsured accounts to record self-pay revenues at the estimated amounts we expect to collect.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under capitation arrangements with various health plans, we earn a per-enrollee amount each month for making available diagnostic imaging services to all plan enrollees under the capitation arrangement. Revenue under capitation arrangements is recognized in the period in which we are obligated to provide services to plan enrollees under contracts with various health plans.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January&#160;1, 2018, we adopted the new revenue recognition accounting standard issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;) and codified in the ASC as topic 606 (&#8220;ASC 606&#8221;). The revenue recognition standard in ASC 606 outlines a single comprehensive model for recognizing revenue as performance obligations, defined in a contract with a customer as goods or services transferred to the customer in exchange for consideration, are satisfied. The standard also requires expanded disclosures regarding our revenue recognition policies and significant judgments employed in the determination of revenue.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_CARESActDisclosurePolicyPolicyTextBlock', window );">COVID-19 PANDEMIC AND CARES ACT FUNDING</a></td>
<td class="text">COVID-19 PANDEMIC AND CARES ACT FUNDING -  On March 11, 2020 the World Health Organization (WHO) designated COVID-19 as a global pandemic.  Patient volumes and the related revenues for our services were significantly impacted during the latter portion of the first quarter through the middle of the third quarter of 2020 as a result of federal, state and local government mandated restrictions requiring many people to remain at home and forced the closure of or limitations on certain businesses, as well as suspended elective procedures by health care facilities.  Many of these restrictions <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">have been eased or completely lifted across the states the Company operates in however, we are unable to predict the future impact of the pandemic on our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the twelve months ended December 31, 2020, we received $43.2 million of accelerated Medicare payments, $5.0 million from Blue Shield, $26.3 million from the general distribution and $4.0 million from the Paycheck Protection Program established through the Coronavirus Aid, Relief and Economic Security (&#8220;CARES&#8221;) Act.  The accelerated Medicare payments are recorded under the caption &#8220; Deferred Revenue&#8220;  in our consolidated balance sheet and will be withheld from reimbursements for services in 2021 and 2022.  The general distribution funds were accounted for as government grants and recognized as other revenue, once reasonable assurance that the applicable terms and conditions required to retain the funds were met, under the caption &#8220;Provider relief funding&#8221; in our Consolidated Statements of Operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The CARES Act also provides for a payment deferral of the employer portion of Social Security tax incurred during the pandemic, allowing half of such payroll taxes to be deferred until December 2021 and the remaining half until December 2022.  At December 31, 2020, the Company had deferred $16.3 million of Social Security taxes.  These payment deferrals are recorded as payroll tax liability under the caption &#8220;Accounts payable, accrued expenses and other&#8221; in our consolidated balance sheet.</span></div>We believe the extent of the COVID-19 pandemic&#8217;s impact on our operating results and financial condition has been and will continue to be driven by many factors, most of which are beyond our control and ability to forecast.  Such factors include, but are not limited to, the scope and duration of stay-at-home practices, business closures  and restrictions, suspensions of elective procedures and continued decline in procedure volumes for an indeterminable length of time and incremental expenses required for supplies and personal protective equipment.  Because of these uncertainties, we cannot estimate the length or impact of the pandemic on our business.  If we incur declines in cash flows and results of operations, such declines could have an impact on the inputs and assumptions used in significant accounting estimates, including implicit prices concessions related to uninsured patient  accounts, and potential impairment of goodwill and long-lived assets.  During the fourth quarter of 2020, procedure volumes continued to increase and have had a positive impact on our patient revenue.  However, the impact of COVID-19 in future periods may vary and could adversely impact our results of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">ACCOUNTS RECEIVABLE</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ACCOUNTS RECEIVABLE &#8211; Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections from our payors and record an estimated price concession based upon specific payor collection issues that we have identified and our historical experience.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into factoring agreements with various institutions and sold certain accounts receivable under non-recourse agreements. These transactions are accounted for as a reduction in accounts receivable as the agreements transfer effective control over and risk related to the receivables to the buyers. The aggregate amounts factored under these facilities, net of discounts recorded to reflect market interest rates is $29.5 million.  Proceeds are reflected as operating activities on our statement of cash flows and on our balance sheet as prepaid expenses and other current assets for the current portion and deposits and other for the long term portion.  At December 31, 2020 we have $20.5 million remaining to be collected on these agreements.  We do not utilize factoring arrangements as an integral part of our financing for working capital.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">SOFTWARE REVENUE RECOGNITION</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SOFTWARE REVENUE RECOGNITION &#8211; Our software division has developed and sells Picture Archiving Communications Systems (&#8220;PACS&#8221;) and related services. The PACS sales are made primarily through our sales force and generally include hardware, software, installation, training and first-year warranty support. Hardware which is not unique or special purpose, is purchased from a third-party and resold to customers with a small mark-up.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that our core software products, such as PACS, are essential to most of our arrangements as hardware, software and related services are sold as an integrated package.  Revenue is recognized when a performance obligation is satisfied by transferring a promised good or service to a customer. </span></div><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, we recorded approximately $8.6 million, $10.1 million, and $6.8 million, respectively, in revenue related to our software business which is included in net service fee revenue in our consolidated statement of operations. At December 31, 2020 we had deferred revenue of approximately $1.2 million associated with these sales which we expect to recognize into revenue over the next 12 months.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock', window );">SOFTWARE DEVELOPMENT COSTS</a></td>
<td class="text">SOFTWARE DEVELOPMENT COSTS &#8211; When we develop our own software and artificial intelligence solutions we capitalize and amortize those costs over their useful life. Costs related to the research and development of new software products and enhancements to existing software intended for resale to our customers are expensed as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">CONCENTRATION OF CREDIT RISKS</a></td>
<td class="text">CONCENTRATION OF CREDIT RISKS &#8211; Financial instruments that potentially subject us to credit risk are primarily cash equivalents and accounts receivable. We have placed our cash and cash equivalents with one major financial institution. At times, the cash in the financial institution is temporarily in excess of the amount insured by the Federal Deposit Insurance Corporation, or FDIC. Substantially all of our accounts receivable are due under fee-for-service contracts from third party payors, such as insurance companies and government-sponsored healthcare programs, or directly from patients. We continuously monitor collections and maintain an allowance for bad debts based upon our historical collection experience. In addition, we have notes receivable stemming from our factoring of accounts receivable as stated above.  Companies with which we factor our receivables are well known established buyers of such instruments, have agreed to assume the full risk of their collection, and to date have made all payments due to us in a timely manner.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">CASH AND CASH EQUIVALENTS</a></td>
<td class="text">CASH AND CASH EQUIVALENTS &#8211; We consider all highly liquid investments that mature in three months or less when purchased to be cash equivalents. The carrying amount of cash and cash equivalents approximates the fair market value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">DEFERRED FINANCING COSTS</a></td>
<td class="text">DEFERRED FINANCING COSTS &#8211; Costs of financing are deferred and amortized using the effective interest rate method.  Deferred financing costs are solely related to our Barclays Revolving Credit Facilities.  Deferred financing costs, net of accumulated amortization, were $1.8 million and $1.6 million for the twelve months ended December 31, 2020 and 2019, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">PROPERTY AND EQUIPMENT</a></td>
<td class="text">PROPERTY AND EQUIPMENT &#8211; Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation and amortization of property and equipment are provided using the straight-line method over the estimated useful lives, which range from 3 to 15 years. Leasehold improvements are amortized at the lesser of lease term or their estimated useful lives, which range from 3 to 15 years. Maintenance and repairs are charged to expense as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">BUSINESS COMBINATION</a></td>
<td class="text">BUSINESS COMBINATION &#8211; When the qualifications for business combination accounting treatment are met, it requires us to recognize separately from goodwill the assets acquired and the liabilities assumed at their acquisition date fair values. Goodwill as of the acquisition date is measured as the excess of consideration transferred over the net of the acquisition date fair values of the assets acquired and the liabilities assumed. While we use our best estimates and assumptions to accurately value assets acquired and liabilities assumed at the acquisition date, our estimates are inherently uncertain and subject to refinement. As a result, during the measurement period, which may be up to one year from the acquisition date, we record adjustments to the assets acquired and liabilities assumed with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the values of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to our consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy', window );">GOODWILL AND INDEFINITE LIVED INTANGIBLES</a></td>
<td class="text">GOODWILL AND INDEFINITE LIVED INTANGIBLES &#8211; Goodwill totaled $472.9 million and $442.0 million million at December 31, 2020 and December 31, 2019, respectively. Indefinite lived intangible assets at December 31, 2020 were $7.1 million and $11.3 million at December 31, 2019 and are associated with the value of certain trade name intangibles. Goodwill and trade name intangibles are recorded as a result of business combinations. When we determine the carrying value of goodwill exceeds its fair value, an impairment charge would be recognized which should not exceed the total amount of goodwill allocated to that reporting unit. We determined fair values for each of the reporting units using the market approach, when available and appropriate, or the income approach, or a combination of both. We assess the valuation methodology based upon the relevance and availability of the data at the time we perform the valuation. If multiple valuation methodologies are used, the results are weighted appropriately.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">LONG-LIVED ASSETS</a></td>
<td class="text">LONG-LIVED ASSETS &#8211; We evaluate our long-lived assets (property and equipment) and intangibles, other than goodwill, for impairment when events or changes indicate the carrying amount of an asset may not be recoverable. Accounting standards requires that if the sum of the undiscounted expected future cash flows from a long-lived asset or definite-lived intangible is less than the carrying value of that asset, an asset impairment charge must be recognized. The amount of the impairment charge is calculated as the excess of the asset&#8217;s carrying value over its fair value, which generally represents the discounted future cash flows from that asset or in the case of assets we expect to sell, at fair value less costs to sell. We determined that there were no events or changes in circumstances that indicated our long-lived assets were impaired during any periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES &#8211; Income tax expense is computed using an asset and liability method and using expected annual effective tax rates. Under this method, deferred income tax assets and liabilities result from temporary differences in the financial reporting bases and the income tax reporting bases of assets and liabilities. The measurement of deferred tax assets is reduced, if necessary, by the amount of any tax benefit that, based on available evidence, is not expected to be realized. When it appears more likely than not that deferred taxes will not be realized, a valuation allowance is recorded to reduce the deferred tax asset to its estimated realizable value. For net deferred tax assets we consider estimates of future taxable income in determining whether our net deferred tax assets are more likely than not to be realized.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">LEASES</a></td>
<td class="text">LEASES - We determine if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (&#8220;ROU&#8221;) assets, current operating lease liability, and long term operating lease liability in our consolidated balance sheets. Finance leases are included in property and equipment, current finance lease liability, and long-term finance lease liability in our consolidated balance sheets.&#160;&#160;ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. We use the implicit rate when readily determinable.  As most of our leases do not provide an implicit rate, we use our incremental borrowing rate ("IBR") based on the information available at commencement date in determining the present value of lease payments.  Our IBR used to discount the stream of lease payments is closely related to the interest rates charged on our collateralized debt obligations and is adjusted when those rates experience a substantial change. We include options to extend a lease when it is reasonably certain that we will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.  For a contract in which we are a lessee that contains fixed payments for both lease and non-lease components, we have elected to account for the components as a single lease component, as permitted. For finance leases, interest expense on the lease liability is recognized using the effective interest method and amortization of the right-of-use asset is recognized on a straight-line basis over the shorter of the estimated useful life of the asset or the lease term. ROU assets are tested for impairment if circumstances suggest that the carrying amount may not be recoverable. Our ROU assets consist of facility and equipment assets on operating leases. No events have occurred which have impaired the integrity of our ROU assets in 2020. Our facility leases require us to maintain insurance policies which would cover major damage to our facilities. We maintain business interruption insurance to cover loss of business due to a facility becoming non-operational under certain circumstances. Our equipment leases are covered by warranty and service contracts which cover repairs and provide regular maintenance to keep the equipment in functioning order.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_UninsuredRisksPolicyTextBlock', window );">UNINSURED RISKS</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNINSURED RISKS &#8211; On November&#160;1, 2008 we obtained a fully funded and insured workers&#8217; compensation policy, thereby eliminating any uninsured risks for employee injuries occurring on or after that date. This fully funded policy remained in effect through November 1, 2013 and continues to cover any claims incurred through this date.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2013 we entered into a high-deductible workers&#8217; compensation insurance policy. We have recorded liabilities of $4.1 million and $3.8 million for each of the years ending December 31, 2020 and December 31, 2019, respectively, for the estimated future cash obligations associated with the unpaid portion of the workers compensation claims incurred.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our affiliated physicians carry an annual medical malpractice insurance policy that protects us for claims that are filed during the policy year and that fall within policy limits. The policy has a deductible which is $10,000 per incidence for the years ended December 31, 2020 and December 31, 2019, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2008, in order to eliminate the exposure for claims not reported during the regular malpractice policy period, we purchased a medical malpractice claims made tail policy, which provides coverage for any claims reported in the event that our medical malpractice policy expires. As of December 31, 2020, this policy remains in effect.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into an arrangement with Blue Shield to administer and process claims under a self-insured plan that provides health insurance coverage for our employees and dependents. We have recorded liabilities as of December 31, 2020 and 2019 of $6.6 million and $4.9 million, respectively, for the estimated future cash obligations associated with the unpaid portion of the medical and dental claims incurred by our participants. Additionally, we entered into an agreement with Blue </span></div>Shield for a stop loss policy that provides coverage for any claims that exceed $250,000 up to a maximum of $1.0 million in order for us to limit our exposure for unusual or catastrophic claims.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitPlansPolicy', window );">EMPLOYEE BENEFIT PLAN</a></td>
<td class="text">EMPLOYEE BENEFIT PLAN &#8211; We adopted a profit-sharing/savings plan pursuant to Section 401(k) of the Internal Revenue Code that covers substantially all non-professional employees. Eligible employees may contribute on a tax-deferred basis a percentage of compensation, up to the maximum allowable under tax law. Employee contributions vest immediately.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock', window );">LOSS AND OTHER UNFAVORABLE CONTRACTS</a></td>
<td class="text">LOSS AND OTHER UNFAVORABLE CONTRACTS &#8211; We assess the profitability of our contracts to provide management services to our contracted physician groups and identify those contracts where current operating results or forecasts indicate probable future losses. Anticipated future revenue is compared to anticipated costs and if the anticipated future cost exceeds the revenue, a loss contract accrual is recorded. In connection with the acquisition of Radiologix in November&#160;2006, we acquired certain management service agreements which met this criterion and recorded to other non-current liabilities an $8.9 million loss contract accrual.  Of the $4.6 million ending balance at December 31, 2018, approximately $4.0 million, ($2.8 million net of taxes), was settled against the purchase consideration of Hudson Valley Radiology Associates, P.L.L.C. (HVRA) by our VIE entity Lenox Hill Radiology and Medical Associates, P.C. and the remaining balance of approximately $558,000 was written off upon ending a contract with a physician group.  See Note 4, Facility Acquisitions and Dispositions for further information on the purchase of HVRA.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">EQUITY BASED COMPENSATION</a></td>
<td class="text">EQUITY BASED COMPENSATION &#8211; We have one long-term incentive plan that we adopted in 2006 and which we first amended and restated as of April 20, 2015, and again on March 9, 2017 (the &#8220;Restated Plan&#8221;). The Restated Plan was approved by our stockholders at our annual stockholders meeting on June 8, 2017. We have reserved for issuance under the Restated Plan 14,000,000 shares of common stock. We can issue options, stock awards, stock appreciation rights, stock units and cash awards under the Restated Plan. Certain options granted under the Restated Plan to employees are intended to qualify as incentive stock options under existing tax regulations. Stock options and warrants generally vest over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE1Ng_34d0b0f5-d4d7-4f53-b8d4-f97aa42926e1">three</span> to five years and expire <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVhMjkzNWVlYWMwYTRkMDVhMTBmZjAyYzdiNzdmY2I0L3NlYzo1YTI5MzVlZWFjMGE0ZDA1YTEwZmYwMmM3Yjc3ZmNiNF83OS9mcmFnOmY1OWJjNDUxMTE3OTQ5YTliMDIwOWRiYmM3OTAwMzhlL3RleHRyZWdpb246ZjU5YmM0NTExMTc5NDlhOWIwMjA5ZGJiYzc5MDAzOGVfNTQ5NzU1ODE4NjE2OQ_cb2940f3-3de2-419f-b70c-92ae0342fb0b">five</span> to ten years from date of grant.  The compensation expense associated with option grants is calculated based on a valuation model, typically the Black&#8211;Scholes model, which requires certain management assumptions with respect to volatility.  The compensation expense recognized for all equity-based awards is recognized over the awards&#8217; service periods. Equity-based compensation is classified in operating expenses within the same line item as the majority of the cash compensation paid to employees.  In connection with our acquisition of DeepHealth Inc. on June 1, 2020, we assumed the DeepHealth, Inc. 2017 Stock Incentive Plan, including outstanding options awards that can be exercised for our common stock.  No additional awards will be granted under the DeepHealth, Inc. 2017 Equity Incentive Plan.  See Note 4, Facility Acquisitions and Note 11, Stock-Based Compensation, for more information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">FOREIGN CURRENCY TRANSLATION</a></td>
<td class="text">FOREIGN CURRENCY TRANSLATION &#8211; The functional currency of our foreign subsidiaries is the local currency. Assets and liabilities denominated in foreign currencies are translated using the exchange rate at the balance sheet dates. Revenues and expenses are translated using average exchange rates prevailing during the reporting period. Any translation adjustments resulting from this process are shown separately as a component of accumulated other comprehensive income (loss). Gains and losses related to the foreign currency portion of international transactions are included in the determination of net income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">COMPREHENSIVE INCOME (LOSS)</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COMPREHENSIVE (LOSS) INCOME &#8211; Accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">establishes rules for reporting and displaying comprehensive income (loss) and its components. Our unrealized gains or losses on foreign currency translation adjustments and our interest rate cap and swap agreements are included in comprehensive income (loss). The components of comprehensive income (loss) for the three years in the period ended December 31, 2020 are included in the consolidated statements of comprehensive income (loss).</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES - We are party to various legal proceedings, claims, and regulatory, tax or government inquiries and investigations that arise in the ordinary course of business. With respect to these matters, we evaluate the developments on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Based on current information, we do not believe that reasonably possible or probable losses associated with pending legal proceedings would either individually or in the aggregate, have a material adverse effect on our business and consolidated financial statements. However, the outcome of these matters is inherently uncertain. Therefore, if one or more of these matters were resolved against us for amounts in excess of management's expectations, our results of operations and financial condition, including in a particular reporting period in which any such outcome becomes probable and estimable, could be materially adversely affected.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">DERIVATIVE INSTRUMENTS</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DERIVATIVE INSTRUMENTS </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2016 CAPS</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2016, we entered into two forward interest rate cap agreements ("2016 Caps"). The 2016 Caps matured in September and October 2020. The 2016 Caps had notional amounts of $150,000,000 and $350,000,000, respectively, which were designated at inception as cash flow hedges of future cash interest payments associated with portions of our variable rate bank debt. Under these arrangements, we purchased a cap on 3 month LIBOR at 2.0%. We were liable for a $5.3 million premium to enter into the caps which accrued to current liabilities on our balance sheet and paid over the life of the 2016 Caps.  The gain or loss of the hedge (i.e. change in fair value) was reported as a component of accumulated other comprehensive income (loss) in the consolidated statement of equity.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"/><td style="width:28.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$788</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,383)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2019 SWAPS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the second quarter of 2019, we entered into four forward interest rate agreements ("2019 swaps").  The 2019 swaps have total notional amounts of $500,000,000, consisting of two agreements of $50,000,000 each and two agreements of  $200,000,000 each.   The 2019 swaps will secure a constant interest rate associated with portions of our variable rate bank debt and have an effective date of October 13, 2020. They will mature in October 2023 for the two smaller notional and October 2025 for the two larger notional. Under these arrangements, we arranged the 2019 swaps with locked in 1 month LIBOR rates at 1.96% for the $100,000,000 notional and at 2.05% for the $400,000,000 notional. As of the effective date, we will be liable for premium payments if interest rates decline below arranged rates, but will receive interest payments if rates remain above the arranged rates.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, we designated our 2019 Swaps as cash flow hedges of floating-rate borrowings. In accordance with accounting guidance, derivatives that have been designated and qualify as cash flow hedging instruments are reported at fair value. The gain or loss on the effective portion of the hedge (i.e. change in fair value) is reported as a component of comprehensive loss in the consolidated statement of equity.  The remaining gain or loss, if any, is recognized currently in earnings.  The cash flows for both our $400,000,000 notional interest rate swap contract locked in at 2.05% due October 2025 and our $100,000,000 notional interest rate swap contract locked in at 1.96% do not match the cash flows for our First Lien Term Loans and so we have determined that they are not currently effective as cash flow hedges. Accordingly, all changes in their fair value after April 1, 2020 for the $400,000,000 notional and after July 1, 2020 for the $100,000,000 notional will be recognized in earnings.&#160;As of July 1, 2020, the total change in fair value relating to swaps included in other comprehensive income was approximately $24.4 million, net of taxes.  This amount will be amortized to interest expense through October 2023 at approximately $0.4 million per month and continuing at approximately $0.3 million through October 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.065%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Effective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Loss Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(20,160)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(5,870)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FAIR VALUE MEASUREMENTS &#8211; Assets and liabilities subject to fair value measurements are required to be disclosed within a fair value hierarchy. The fair value hierarchy ranks the quality and reliability of inputs used to determine fair value. Accordingly, assets and liabilities carried at, or permitted to be carried at, fair value are classified within the fair value hierarchy in one of the following categories based on the lowest level input that is significant to a fair value measurement:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Fair value is determined by using unadjusted quoted prices that are available in active markets for identical assets and liabilities.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Fair value is determined by using inputs other than Level&#160;1 quoted prices that are directly or indirectly observable. Inputs can include quoted prices for similar assets and liabilities in active markets or quoted prices for identical assets and liabilities in inactive markets. Related inputs can also include those used in valuation or other pricing models such as interest rates and yield curves that can be corroborated by observable market data.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Fair value is determined by using inputs that are unobservable and not corroborated by market data. Use of these inputs involves significant and subjective judgment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Derivatives:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 CAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 CAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair value of these contracts was determined using Level 2 inputs. More specifically, the fair value was determined by calculating the value of the difference between the fixed interest rate of the interest rate swaps and the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">counterparty&#8217;s forward LIBOR curve. The forward LIBOR curve is readily available in the public markets or can be derived from information available in the public markets.</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Long Term Debt</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,640&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,640&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,403&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,699&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Barclays revolving credit facility had no aggregate principal amount outstanding as of December 31, 2020 and December 31, 2019, respectively.  Our SunTrust revolving credit facility had no aggregate principal amount outstanding as of December 31, 2020 and December 31, 2019, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated fair values of our long-term debt, which is discussed in Note 8, was determined using Level 2 inputs for the Barclays and SunTrust term loans. Level 2 inputs primarily related to comparable market prices.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider the carrying amounts of cash and cash equivalents, receivables, other current assets, current liabilities and other notes payables to approximate their fair value because of the relatively short period of time between the origination of these instruments and their expected realization or payment. Additionally, we consider the carrying amount of our capital lease obligations to approximate their fair value because the weighted average interest rate used to formulate the carrying amounts approximates current market rates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">EARNINGS PER SHARE</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EARNINGS PER SHARE - Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,243&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,674,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,114,275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net (loss) income per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,674,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,114,275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,963&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384,093&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,244,006&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,678,999&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net (loss) income per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,444&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">EQUITY INVESTMENTS AT FAIR VALUE</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EQUITY INVESTMENTS AT FAIR VALUE- As of December 31, 2020, we have three equity investments for which a fair value is not readily determinable and we do not have significant influence and therefore the total amounts invested are recognized at cost.  In accordance with accounting guidance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if there is no readily determinable fair value, the guidance allows entities the ability to measure investments at cost less impairment, whereby impairment is based on a qualitative assessment.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">INVESTMENT IN JOINT VENTURES</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">INVESTMENT IN JOINT VENTURES &#8211; We have 13 unconsolidated joint ventures with ownership interests ranging from 35% to 55%. These joint ventures represent partnerships with hospitals, health systems or radiology practices and were formed for the purpose of owning and operating diagnostic imaging centers.&#160;&#160;Professional services at the joint venture diagnostic imaging centers are performed by contracted radiology practices or a radiology practice that participates in the joint venture.&#160;&#160;Our investment in these joint ventures is accounted for under the equity method, as we do not have a controlling financial interest in such ventures. We evaluate our investment in joint ventures, including cost in excess of book value (equity method goodwill) for impairment whenever indicators of impairment exist. No indicators of impairment existed as of December 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture formations</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective November 1, 2020, Arizona Diagnostic Radiology Group LLC ("ADRG"), an entity we formed in conjunction with CHI National Services Inc. ("CHI"), assumed operational and managerial control of our Arizona centers.  We hold a 49% economic interest and CHI holds the majority 51% economic interest, respectively in ADRG and account for the venture under the equity method .  The entity was formed in part to leverage CHI's established presence in the Phoenix, Arizona market as a major health care provider.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment contribution</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the month of August 2020, we made additional cash contributions to our Santa Monica Imaging Group, LLC partnership in the amount of $1.6 million in support of its expanded operations.  We maintain our 35% economic interest in the partnership.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of joint venture interest:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2017, we formed in conjunction with Cedars Sinai Medical Center (&#8220;CSMC&#8221;) the Santa Monica Imaging Group, LLC (&#8220;SMIG&#8221;), consisting of two multi-modality imaging centers located in Santa Monica, CA with RadNet holding a 40% economic interest and CSMC holding a 60% economic interest.  RadNet accounts for our share of the venture under the equity method.  On January 1, 2019, CSMC purchased from the us an additional 5% economic interest in SMIG valued at $134,000.  As a result of the transaction, our economic interest in SMIG has been reduced to 35%.  We recorded a loss of $2,000 on the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in control of existing joint ventures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 6, 2014, we acquired a 49% equity interest in Garden State Radiology Network, LLC ("GSRN") for cash consideration of $2.2 million.  The venture consisted of two imaging centers located in New Jersey.  On August 1, 2019, the entity was dissolved by transferring ownership of the assets of the centers with each partner receiving full ownership of one center. See Note 4, Facility Acquisitions and Dispositions, for further information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2018 we acquired&#160;25%&#160;share capital in Nulogix, Inc. for cash consideration of&#160;$2.0 million.  On August 1, 2019 we completed via the issuance of RadNet common stock valued at $1.5 million, the acquisition of the remaining 75% economic interest and we now consolidate the financial statements of Nulogix.  &#160;See Note 4, Facility Acquisitions and Dispositions, for further information.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2018, we obtained control over the operations of NJIN through an agreement with the other equity interest holder for no cash consideration.  As such, we consolidated the financial statements of NJIN effective that date.  The economic interest of each party remained the same after consolidation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Joint venture investment and financial information</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2020 and December 31, 2019 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,973&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of ownership interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dissolution of GSRN</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,428)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix return of capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(792)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix change in control</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,004)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,598)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,945&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,522)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charged management service fees from the centers underlying these joint ventures of approximately  $11.3 million, $11.4 million and $13.8 million for the years ended December 31, 2020, 2019 and 2018, respectively . We eliminate any unrealized portion of our management service fees with our equity in earnings of joint ventures.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2020 and 2019, respectively, and for the years ended December 31, 2020, 2019 and 2018, respectively, (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,085&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,427&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,686&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,217)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,582)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,872)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,644&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,375&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,079&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,001&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,449&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,921&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,051&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,820&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">RECENT ACCOUNTING STANDARDS</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards adopted</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-04 ("ASU 2020-04"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2020-04 provides optional expedients and exceptions for applying generally accepted accounting principles to certain contract modifications and hedging relationships that reference London Inter-bank Offered Rate (LIBOR) or another reference rate expected to be discontinued. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2020-04 on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU No. 2016-13 ("ASU 2016-13), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  ASU 2016-13 replaces the incurred loss methodology previously utilized for valuing financial instruments with an expected loss methodology that is referred to as the current expected credit loss (CECL) methodology.  We adopted the standard on January </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1, 2020 using the modified retrospective approach.  See the Accounts Receivable section to Note 2 for further information on our allowances for credit losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-15 (&#8220;ASU 2018-15&#8221;),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other-Internal-Use Software.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;ASU 2018-15 aligns the requirements for deferring implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This ASU was effective in the first quarter of 2020 with early adoption permitted and can be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The adoption of this standard did not have a material impact on our consolidated balance sheet.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU 2020-03 ("ASU 2020-03"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amendments in this update represent changes to clarify or improve the codification and correct unintended application. ASU 2020-03 was effective immediately upon issuance and its adoption did not have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13 ("ASU 2018-13"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This standard removes, modifies and adds certain disclosures related to recurring and nonrecurring fair value measurements. We adopted ASC 2018-13 effective January 1, 2020 and it had no effect on our disclosures.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting standards not yet adopted</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12 ("ASU 2019-12"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740).  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASU 2019-12 removes certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other areas of the standard. ASU 2019-12 is effective beginning in the first quarter of 2021. Early adoption is permitted. Certain amendments in this update must be applied on a prospective basis, certain amendments must be applied on a retrospective basis, and certain amendments must be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings/(deficit) in the period of adoption. We are currently evaluating the impact this ASU will have on our financial statements and related disclosures.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU 2020-01 ("ASU 2020-01"), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments&#8212;Equity Securities (Topic 321), Investments&#8212;Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815), </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">clarifying the interaction between accounting standards related to equity securities, equity method investments, and certain derivatives. ASU 2020-01 is effective for fiscal years beginning after December 15, 2020. We do not expect the adoption of this guidance will have a material impact on our financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the FASB issued ASU 2021-01 ("ASU 2021-01"),&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848), Scope</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ASU 2021-01 provides clarifies the scope of Topic 848 so that derivatives affected by the discounting transition are explicitly eligible for certain option expedients and exceptions in Topic 848. The guidance is effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating the potential impact of ASU 2021-01 on our financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_CARESActDisclosurePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>CARES Act Disclosure Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_CARESActDisclosurePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LossandOtherUnfavorableContractsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss and Other Unfavorable Contracts [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LossandOtherUnfavorableContractsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UninsuredRisksPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Uninsured Risks [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UninsuredRisksPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6052-115624<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 450<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491354&amp;loc=d3e6049-115624<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitPlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitPlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19347-109286<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909128597960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock', window );">Schedule of Service Fee Revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total net revenues for the years ended December 31, 2020, 2019, and 2018 are presented in the table below (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial insurance</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584,035&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">642,341&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542,011&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237,427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,881&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,619&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,283&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,615&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers' compensation/personal injury</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other patient revenue</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,314&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,862&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,117&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fee revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,882&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imaging on call and software</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,798&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,317&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,261&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,555&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service fee revenue</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931,722&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,028,236&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868,741&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue under capitation arrangements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140,118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,943&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,071,840&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154,179&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975,146&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Effect of Derivative Instruments on Comprehensive Income</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive (loss) income, net of taxes is as follows (amounts in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"/><td style="width:28.663%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Gain (Loss) Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Gain (Loss) Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$788</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,383)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2018</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,876</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Income</span></td></tr></table></div>A tabular presentation of the effect of derivative instruments on our consolidated statement of comprehensive loss of the 2019 swaps which remain ineffective is as follows (amounts in thousands):<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:28.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.065%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Effective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount of Loss Recognized on Derivative, net of taxes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Location of Loss Recognized<br/>in Income on Derivative</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(20,160)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(5,870)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Comprehensive Loss</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tabular presentation of the effect of derivative instruments on our statement of operations of the 2019 Swaps for the Swaps that became ineffective in 2020 is as follows (amounts in thousands):</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Interest Rate Contracts - Ineffective Portion</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the twelve months ended</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss recognized in income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of  loss recognized in Income on derivative (current period ineffective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Location of loss reclassified from accumulated OCI into income (prior period effective portion)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(2,528)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Income (Expense)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$(3,448)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity and Interest Expense</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Fair Value of Assets and Liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair values of certain of our financial assets that are subject to fair value measurements, and the classification of these assets in our consolidated balance sheets, as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 CAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,989&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:45.752%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.641%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current and long term liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016 CAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019 SWAPS - Interest Rate Contracts</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,477&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the estimated fair value and carrying amount of our SunTrust (Term Loan Agreement) and Barclays (First Lien Term Loans) long-term debt as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,640&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,640&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,403&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.709%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Face Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan Agreement and First Lien Term Loans</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">708,948&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705,699&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share</a></td>
<td class="text">Earnings per share is based upon the weighted average number of shares of common stock and common stock equivalents outstanding, net of common stock held in treasury, as follows (in thousands except share and per share data):<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.243%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,840)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,756&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,243&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,674,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,114,275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net (loss) income per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</span></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,674,858&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,114,275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add nonvested restricted stock subject only to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,963&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add additional shares issuable upon exercise of stock options and warrants</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360,185&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">384,093&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares used in calculating diluted net income per share</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,891,791&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,244,006&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,678,999&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net (loss) income per share attributable to RadNet, Inc. common stockholders</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.29&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.66&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock subject to service vesting</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,159&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable upon the exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">554,444&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Investment in Joint Ventures</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of our investment in joint ventures during the years ended December 31, 2020 and December 31, 2019 (in thousands):</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,973&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of ownership interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(134)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dissolution of GSRN</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,428)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix return of capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(792)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nulogix change in control</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,004)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,598)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity contributions in existing and purchase of interest in joint ventures</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in earnings in these joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,945&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distribution of earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,522)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock', window );">Joint Venture Investment and Financial Information</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of key unaudited financial data for these joint ventures as of December 31, 2020 and 2019, respectively, and for the years ended December 31, 2020, 2019 and 2018, respectively, (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance Sheet Data:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,085&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,427&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,686&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,037&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,545)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,217)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncurrent liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,582)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,872)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,644&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,375&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book value of RadNet joint venture interests</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,079&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,001&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,449&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total value of RadNet joint venture interests</span></td><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,528&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,470&#160;</span></td><td style="border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101,921&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,051&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,820&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,596&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Joint venture investment and financial information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=35711157&amp;loc=d3e42567-110969<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909127768408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FACILITY ACQUISITIONS AND DISPOSITIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities</a></td>
<td class="text">We made a fair value determination of the acquired assets and assumed liabilities and the following were recorded (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.625%"><tr><td style="width:1.0%"/><td style="width:40.047%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.837%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.816%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Atlantic</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ZP Elmhurst</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and Equipment</span></td><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,931&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,681&#160;</span></td><td style="border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of Use Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,181&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,571&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible Assets</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of Use Liabilities</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,181)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,571)</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="border-left:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="border-right:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL</span></td><td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,871&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,269&#160;</span></td><td style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1486-128463<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909124263128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Goodwill and Other Intangible Assets</a></td>
<td class="text">Activity in goodwill for the years ended December 31, 2019 and December 31, 2020 is provided below (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2018</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$418,093</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to our preliminary allocation of the purchase price of Medical Arts Radiological Group, P.C.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Dignity Health</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of West Valley Imaging Center, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill disposed through sale of assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired by Lenox Hill Radiology through the membership purchase of HVRA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Kern Radiology, Inc.</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,507&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Zilkha Radiology, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of certain assets of Ramic Mahwah, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of GSRN</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of Nulogix</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,337&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill transferred from assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">992&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$441,973</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of Olney Open MRI, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of MRI at Woodbridge, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,833&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of DeepHealth, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of AZ-Tech Radiology &amp; Open MRI, LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,882&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of ZP Ozone Park, LLC</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired through the acquisition of ZP Elmhurst LLC</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,463&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$472,879</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Annual Amortization Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows annual amortization expense, by asset classes that will be recorded over the next five years (in thousands):&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:22.464%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.736%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.536%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Weighted average amortization period remaining in years</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Management Service Contracts</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,287&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,533&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,968&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Covenant not to compete and other contracts</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,601&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.9</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Developed Technology</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">244&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">386&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names amortized</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">66&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">309&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trade Names indefinite life</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,100&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Software in development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,685&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,685&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total Annual Amortization</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,630&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,498&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,236&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,818&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36,627&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">52,393&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909127823896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment and accumulated depreciation and amortization are as follows (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical equipment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">480,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426,682&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer and office equipment, furniture and fixtures</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,446&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,490&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,253&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">377,676&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under financing/capital lease</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,105&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment cost</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,026,564&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939,203&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(627,229)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(571,408)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399,335&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,795&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909126536776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Expenses</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued expenses were comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,071&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,300&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,312&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,853&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued salary and benefits</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,051&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,003&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,429&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236,684&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,585&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131319816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020 and December 31, 2019 our debt obligations consisted of the following (in thousands):</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans collateralized by RadNet's tangible and intangible assets</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,028&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649,824&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount on First Lien Term Loans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,579)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,375&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,875&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment notes payable at interest rates ranging from 4.4% to 5.6%, due through 2020, collateralized by medical equipment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,704&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">692,395&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less current portion</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,791)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39,691)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion debt obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">612,913&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,704&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Annual Principal Maturities of Notes Payable</a></td>
<td class="text">The following is a listing of annual principal maturities of notes payable exclusive of all related discounts and repayments on our revolving credit facilities for years ending December&#160;31 (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:84.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.710%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,670&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,795&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">573,938&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total notes payable obligations</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,403&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Term Loans and Financing Activity</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in our consolidated balance sheets at December 31, 2020 are $601.3 million of First Lien Term Loans and $51.4 million of SunTrust Term Loan debt for a combined total of $652.7 million (net of unamortized discounts of $9.7 million) in thousands:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Face Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Discount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Carrying<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Lien Term Loans</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611,028&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,699)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601,329&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SunTrust Term Loan Agreement</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,375&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Term Loans</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">662,403&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,699)</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652,704&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ScheduleOfLeverageRatioTableTextBlock', window );">Schedule of Leverage Ratio</a></td>
<td class="text"><div style="text-align:justify;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our First Lien Term Loans bear interest at either an Adjusted Eurodollar Rate or a Base Rate (each as defined in the First Lien Credit Agreement) plus an applicable margin according to the following schedule:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.181%"><tr><td style="width:1.0%"/><td style="width:31.850%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">First Lien Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Eurodollar Rate Spread</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Base Rate Spread</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 5.50x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.50%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt; 4.00x but &#8804; 5.50x</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.75%</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&gt;3.50x but &#8804; 4.00x</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8804; 3.50x</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.128%"><tr><td style="width:1.0%"/><td style="width:8.790%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.761%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.226%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.700%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pricing Level</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Leverage Ratio</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Eurodollar Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Base Rate Loans</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Margin for Letter of Credit Fees</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Applicable Percentage for Commitment Fee</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater than or equal to 3.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.45%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">II</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 3.00:1.00 but greater than or equal to 2.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.85pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">III</span></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.50:1.00 but greater than or equal to</span></div><div style="margin-top:2.9pt;padding-left:4.5pt;padding-right:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.35%</span></div><div style="margin-top:0.05pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IV</span></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 2.00:1.00 but greater than or equal to 1.50:1.00</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">V</span></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less than 1.50:1.00</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></div><div style="margin-top:2.9pt;padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">per annum</span></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ScheduleOfLeverageRatioTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Leverage Ratio [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ScheduleOfLeverageRatioTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909133202264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:58.197%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.251%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.252%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,323&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Finance lease cost:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Depreciation of leased equipment</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,122&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,135&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Interest on lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total finance lease cost</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,332&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,530&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="6" style="background-color:#eeeeee;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from operating leases</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,821&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,922&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,939&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Operating leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:100%;position:relative;top:-3.85pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,099&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,399&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Financing leases</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,105&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amounts for the twelve months ended December 31, 2019 include the transition adjustment for the adoption of Topic 842.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Assets and Liabilities Lessee</a></td>
<td class="text">Supplemental balance sheet information related to leases was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.345%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands, except lease term and discount rates)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445,477&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,794&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,206&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">463,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total operating lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,890&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482,128&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Leases</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,220)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,135)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,764&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,970&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of finance lease</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,578&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,283&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,547&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Remaining Lease Term</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases - years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases - years</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5</span></td><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted Average Discount Rate</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#eeeeee;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Finance Lease Liability</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:59.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.489%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,307&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,654&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,648&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,469&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717,701&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,406&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,811)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,890&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Operating Lease Liability</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%"><tr><td style="width:1.0%"/><td style="width:59.724%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.487%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.489%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Operating</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Financing</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Leases</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97,307&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,654&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,479&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,648&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,469&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total Lease Payments</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717,701&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,406&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188,811)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528,890&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,321&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Table Text Block] for Assets And Liabilities Lessee [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131046440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2020, 2019 and 2018, we recognized income tax expense comprised of the following (in thousands):</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal current tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(256)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(765)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State current tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,608)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,263&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal deferred tax</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(303)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,020)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State deferred tax</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,035&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,743)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,104)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Income Tax Expense</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the statutory U.S. federal rate and effective rates is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:66.959%"><tr><td style="width:1.0%"/><td style="width:44.314%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.275%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.897%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="24" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Federal tax</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(179)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,231&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,256&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State franchise tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other non deductible expenses</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">674&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">471&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interests in partnerships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,748)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,237)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,760&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Return to provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,252)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,494&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PPP Loan</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(850)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Gain on change in control</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8,303)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred true-ups and other</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,839&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(761)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4,254)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Uncertain tax provisions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,046&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other reconciling items</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Income tax expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">895&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text">Our deferred tax assets and liabilities comprise the following (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.692%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating losses</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,154&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,490&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,948&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,139&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,546&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,903&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,284&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,220&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,315)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,348)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,178&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,298)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,450)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,457)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,637)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,669)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use asset</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(112,956)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,364)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,619)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,510)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Deferred Tax Liabilities</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(181,938)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(158,630)</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Deferred Tax Asset</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,687&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,548&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text">A reconciliation of the total gross amounts of unrecognized tax benefits for the years ended are as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of year</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,629&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,615&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to prior year tax positions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,382&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">896&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increases related to current year tax positions</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the statute of limitations for the assessment of taxes</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(393)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) related to change in rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of year</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,484&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,320&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,629&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909128633416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Options Activity</a></td>
<td class="text">The following summarizes all of our option transactions for the twelve months ended December 31, 2020:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.822%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.824%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the 2006 Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual<br/>Life(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478,951&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.21&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">527,899&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.34&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.34</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,441,129&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307,196&#160;</span></td><td style="border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.49</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,679,803&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%"><tr><td style="width:1.0%"/><td style="width:48.506%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.711%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.587%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Options<br/>Under the Deep Health Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise price<br/>Per Common Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining<br/>Contractual Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2019</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted, June 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">412,434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,895)</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance, December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400,539&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.40</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,710,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable at December 31, 2020</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,545&#160;</span></td><td style="background-color:#eeeeee;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.40</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510,994&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of RSA Activity</a></td>
<td class="text">The following summarizes all unvested RSA&#8217;s activities during the twelve months ended December 31, 2020:&#160;<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:59.222%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.640%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Remaining<br/>Contractual<br/>Term (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-Average<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2019</span></td><td colspan="2" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387,934&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.61&#160;</span></td><td style="background-color:#eeeeee;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes during the period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,596&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.66&#160;</span></td><td style="background-color:#eeeeee;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(516,371)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#eeeeee;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSA's unvested at December 31, 2020</span></td><td colspan="2" style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">329,159&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td colspan="3" style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.87</span></td><td colspan="3" style="background-color:#eeeeee;padding:0 1pt"/><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.69&#160;</span></td><td style="background-color:#eeeeee;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131817384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NATURE OF BUSINESS (Details Narrative)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>Center</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberOfCenters', window );">Number of centers | Center</a></td>
<td class="nump">331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues', window );">BRMG and NY Groups revenues</a></td>
<td class="nump">$ 147,600<span></span>
</td>
<td class="nump">$ 157,400<span></span>
</td>
<td class="nump">$ 132,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense', window );">BRMG and NY Groups operating expenses</a></td>
<td class="nump">147,600<span></span>
</td>
<td class="nump">157,400<span></span>
</td>
<td class="nump">132,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax', window );">Management services provided to BRMG and NY Groups</a></td>
<td class="nump">600,700<span></span>
</td>
<td class="nump">618,900<span></span>
</td>
<td class="nump">$ 505,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">1,786,657<span></span>
</td>
<td class="nump">1,646,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">$ 1,528,354<span></span>
</td>
<td class="nump">1,413,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LongTermContractsTerm', window );">Long-term contracts, term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LongTermContractsTerm', window );">Long-term contracts, term</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_BeverlyRadiologyMedicalGroupIIIMember', window );">Beverly Radiology Medical Group III | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="nump">99.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_BeverlyRadiologyMedicalGroupIIIMember', window );">Beverly Radiology Medical Group III | Board Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_ScriptSenderMember', window );">ScriptSender LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">BRMG and NY Groups accounts receivable</a></td>
<td class="nump">$ 82,300<span></span>
</td>
<td class="nump">100,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">BRMG and NY Groups accounts payable</a></td>
<td class="nump">$ 15,200<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LongTermContractsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Contracts, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LongTermContractsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberOfCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Centers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberOfCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income between the reporting entity and the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph d<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5747-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_BeverlyRadiologyMedicalGroupIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_BeverlyRadiologyMedicalGroupIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=rdnt_BoardMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=rdnt_BoardMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_ScriptSenderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_ScriptSenderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909130612120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 1,071,840<span></span>
</td>
<td class="nump">$ 1,154,179<span></span>
</td>
<td class="nump">$ 975,146<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenue</a></td>
<td class="nump">1,071,840<span></span>
</td>
<td class="nump">1,154,179<span></span>
</td>
<td class="nump">975,146<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member', window );">Commercial insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">584,035<span></span>
</td>
<td class="nump">642,341<span></span>
</td>
<td class="nump">542,011<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">217,928<span></span>
</td>
<td class="nump">237,427<span></span>
</td>
<td class="nump">192,881<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">25,619<span></span>
</td>
<td class="nump">28,283<span></span>
</td>
<td class="nump">25,615<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member', window );">Workers' compensation/personal injury</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">33,478<span></span>
</td>
<td class="nump">42,792<span></span>
</td>
<td class="nump">34,193<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember', window );">Other patient revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">25,314<span></span>
</td>
<td class="nump">23,862<span></span>
</td>
<td class="nump">25,117<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember', window );">Management fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">11,253<span></span>
</td>
<td class="nump">11,659<span></span>
</td>
<td class="nump">13,882<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_ImagingOnCallMember', window );">Imaging on call and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">10,798<span></span>
</td>
<td class="nump">17,317<span></span>
</td>
<td class="nump">16,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">23,297<span></span>
</td>
<td class="nump">24,555<span></span>
</td>
<td class="nump">18,781<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">931,722<span></span>
</td>
<td class="nump">1,028,236<span></span>
</td>
<td class="nump">868,741<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember', window );">Revenue under capitation arrangements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems', window );"><strong>Revenue from External Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="nump">$ 140,118<span></span>
</td>
<td class="nump">$ 125,943<span></span>
</td>
<td class="nump">$ 106,405<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CommercialInsurance1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicare1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicare1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_Medicaid1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_Medicaid1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_WorkersCompensationPersonalInjury1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCarePatientServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_HealthCareManagementServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_ImagingOnCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_ImagingOnCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCareOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthCarePatientServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_CapitationArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909039802760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1">24 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 05, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 12, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 01, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2018 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 24, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 06, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>joint_venture </div>
<div>numberOfAgreement </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>joint_venture </div>
<div>numberOfAgreement </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 11, 2019 </div>
<div>shares</div>
</th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($) </div>
<div>numberOfAgreement</div>
</th>
<th class="th">
<div>Feb. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 01, 2017</div></th>
<th class="th">
<div>Nov. 30, 2006 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Provider relief funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,264,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_SocialSecurityTaxEmployerDeferralCARESAct', window );">Deferred social security taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,300,000<span></span>
</td>
<td class="nump">16,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContractsReceivableFactoredAmount', window );">Factored accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContractsReceivableFactoringReceivable', window );">Factoring receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,500,000<span></span>
</td>
<td class="nump">20,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,071,840,000<span></span>
</td>
<td class="nump">1,154,179,000<span></span>
</td>
<td class="nump">975,146,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">472,879,000<span></span>
</td>
<td class="nump">472,879,000<span></span>
</td>
<td class="nump">441,973,000<span></span>
</td>
<td class="nump">418,093,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="nump">7,100,000<span></span>
</td>
<td class="nump">11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Loss on impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,170,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,937,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrent', window );">Workers' compensation liability, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="nump">4,100,000<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MedicalMalpracticeDeductiblePerIncidence', window );">Medical malpractice deductible per incidence</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employee contribution, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Expected employee contribution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContractLossAccrual', window );">Contract loss accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContractLossAccrualWrittenOff', window );">Contract loss accrual, written off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">558,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Amount of loss recognized in income on derivative (current period ineffective portion)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains', window );">Monthly amortization of deferred hedge gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 61,644,000<span></span>
</td>
<td class="nump">$ 61,644,000<span></span>
</td>
<td class="nump">60,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NumberofUnconsolidatedJointVentures', window );">Number of unconsolidated joint ventures | joint_venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Payments to acquire additional interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,635,000<span></span>
</td>
<td class="nump">103,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss on equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ManagementServiceFees', window );">Management service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,300,000<span></span>
</td>
<td class="nump">11,400,000<span></span>
</td>
<td class="nump">13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember', window );">Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains', window );">Monthly amortization of deferred hedge gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">C O V I D19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AdvanceMedicarePayments', window );">Advance medicare payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ProceedsReceivedFromInsurance', window );">Advance insurance carrier payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember', window );">Medic Vision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.21%<span></span>
</td>
<td class="nump">14.21%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment', window );">Option to purchase additional equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired', window );">Ownership interest percentage acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution', window );">Initial ownership percentage after dilution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember', window );">Turner Imaging Systems</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentSharesPurchased', window );">Shares purchased (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingMember', window );">Turner Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Preferred stock issued upon conversion (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member', window );">WhiteRabbit.ai Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties', window );">Payments to fund loan to related parties</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember', window );">Santa Monica Imaging Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Payments to acquire additional interest in subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember', window );">Santa Monica Imaging Group | RadNet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss on equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember', window );">Santa Monica Imaging Group | Cedars Sinai Medical Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AdditionalEquityInterestAcquired', window );">Additional equity interest acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentOwnedAtFairValue', window );">Investment owned, at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member', window );">2016 Caps | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_September2020CapMember', window );">September 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2020CapMember', window );">October 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="nump">350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_RadiologixMember', window );">Radiologix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ContractLossAccrual', window );">Contract loss accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember', window );">Hudson Valley Radiology Associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember', window );">Hudson Valley Radiology Associates | Primedex Health Systems Inc. and Radiologix</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross', window );">Unfavorable lease contracts acquired, gross</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts', window );">Unfavorable lease contracts acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember', window );">Garden State Radiology Network LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss on equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember', window );">Nulogix, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Investment at cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Loss on equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsurancePolicyTypeAxis=rdnt_HealthInsuranceMember', window );">Health Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self-insurance accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,600,000<span></span>
</td>
<td class="nump">$ 6,600,000<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Blue Shield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount', window );">Stop loss policy claim amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Dignity Health | Glendale Advanced Imaging | Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Propery and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Blue Shield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount', window );">Stop loss policy claim amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
<td class="nump">$ 1,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Dignity Health | Glendale Advanced Imaging | Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Economic interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Propery and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">PP&amp;E useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember', window );">Paycheck Protection Program Loans | C O V I D19 Pandemic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000.0<span></span>
</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember', window );">Barclays</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_SunTrustMember', window );">SunTrust</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingOnCallMember', window );">Imaging On Call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Loss on impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Write off of the reporting unit trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember', window );">Net service fee revenue | eRAD</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Service fee revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
<td class="nump">$ 10,100,000<span></span>
</td>
<td class="nump">$ 6,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember', window );">US Attorneys Office For The Western District of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualAtCarryingValue', window );">Loss contingency accrual liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember', window );">Settled Litigation | US Attorneys Office For The Western District of New York</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Litigation settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member', window );">2016 Caps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | numberOfAgreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized', window );">Interest rate caps premium liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld', window );">Number of forward interest rate cap agreements | numberOfAgreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | 2019 SWAPS - Interest Rate Contracts | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.96%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember', window );">2019 SWAPS | October 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS1 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetNotionalAmount', window );">Notional amounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member', window );">2019 SWAPS1 | 2019 SWAPS - Interest Rate Contracts | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeBasisSpreadOnVariableRate', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Promissory note | Turner Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Convertible promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdditionalEquityInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional equity interest acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdditionalEquityInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AdvanceMedicarePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advance Medicare Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AdvanceMedicarePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts, Gross</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractLossAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract loss accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractLossAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractLossAccrualWrittenOff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract Loss Accrual, Written Off</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractLossAccrualWrittenOff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractsReceivableFactoredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Factored Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractsReceivableFactoredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ContractsReceivableFactoringReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contracts Receivable, Factoring Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ContractsReceivableFactoringReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Initial Ownership Percentage After Dilution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentSharesPurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Shares Purchased</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentSharesPurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Option To Purchase Additional Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments, Ownership Interest Percentage Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ManagementServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Management service fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ManagementServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MedicalInsuranceStopLossPolicyClaimAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical Insurance, Stop Loss Policy Claim Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MedicalInsuranceStopLossPolicyClaimAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MedicalMalpracticeDeductiblePerIncidence">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Medical malpractice deductible per incidence</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MedicalMalpracticeDeductiblePerIncidence</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_MonthlyAmortizationOfDeferredHedgeGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Monthly Amortization Of Deferred Hedge Gains</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_MonthlyAmortizationOfDeferredHedgeGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NumberofUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Unconsolidated Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NumberofUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsReceivedFromInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds Received From Insurance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsReceivedFromInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_SocialSecurityTaxEmployerDeferralCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Social Security Tax, Employer, Deferral, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_SocialSecurityTaxEmployerDeferralCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payments on the derivative asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetNumberOfInstrumentsHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetNumberOfInstrumentsHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unearned premium revenue under contracts issued by an insurance entity that provide protection to the holder of a financial obligation from a financial loss in the event of a default.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentOwnedAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99383244&amp;loc=d3e12121-115841<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 5D<br> -Subparagraph (SX 210.12-13D(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=SL120429264-123010<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-12B(Column C))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401592&amp;loc=d3e611197-123010<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentOwnedAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss contingency liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToFundLongtermLoansToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToFundLongtermLoansToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_MedicVisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingSystemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_TurnerImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_WhiteRabbit.aiInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_RadNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_RadNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_CedarsSinaiMedicalCenterMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_CedarsSinaiMedicalCenterMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=rdnt_Caps2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_September2020CapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_September2020CapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2020CapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2020CapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_RadiologixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_RadiologixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_PrimedexHealthSystemsInc.andRadiologixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_PrimedexHealthSystemsInc.andRadiologixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsurancePolicyTypeAxis=rdnt_HealthInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsurancePolicyTypeAxis=rdnt_HealthInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_BlueShieldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_BlueShieldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_DignityHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_DignityHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_GlendaleAdvancedImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis=rdnt_JointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_PropertyAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_PropertyAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_SunTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_SunTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingOnCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ImagingOnCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rdnt_PatientServicesNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=rdnt_ERADMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=rdnt_ERADMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_Caps2016Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditDerivativesByContractTypeAxis=rdnt_October2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SecuritiesFinancingTransactionAxis=rdnt_A2019SWAPS1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131522872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="num">$ (19,372)<span></span>
</td>
<td class="num">$ (10,253)<span></span>
</td>
<td class="nump">$ 2,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="nump">3,448<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">2016 CAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="nump">788<span></span>
</td>
<td class="num">(4,383)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,876<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Change in fair value of cash flow hedge, net of taxes</a></td>
<td class="num">(20,160)<span></span>
</td>
<td class="num">$ (5,870)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 SWAPS - Interest Rate Contracts | Other Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of loss recognized in income on derivative (current period ineffective portion)</a></td>
<td class="num">(2,528)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 SWAPS - Interest Rate Contracts | Equity and Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OffsettingAssetsLineItems', window );"><strong>Offsetting Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Change in fair value of cash flow hedge from prior periods reclassified to earnings</a></td>
<td class="num">$ (3,448)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OffsettingAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OffsettingAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131446936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">$ 662,403<span></span>
</td>
<td class="nump">$ 705,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">2016 CAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">37,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | 2016 CAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | 2016 CAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,081<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">37,989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | 2016 CAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | 2019 SWAPS - Interest Rate Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Current and long term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Current and long term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">661,640<span></span>
</td>
<td class="nump">708,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">661,640<span></span>
</td>
<td class="nump">708,948<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimate of Fair Value Measurement | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Term Loan Agreement and First Lien Term Loans</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909130206824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income attributable to RadNet, Inc. common stockholders</a></td>
<td class="num">$ (14,840)<span></span>
</td>
<td class="nump">$ 14,756<span></span>
</td>
<td class="nump">$ 32,243<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding during the period (in shares)</a></td>
<td class="nump">50,891,791<span></span>
</td>
<td class="nump">49,674,858<span></span>
</td>
<td class="nump">48,114,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net (loss) income per share attributable to RadNet, inc. common stockholders (in dollars per share)</a></td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="nump">$ 0.30<span></span>
</td>
<td class="nump">$ 0.67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedAbstract', window );"><strong>DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding during the period (in shares)</a></td>
<td class="nump">50,891,791<span></span>
</td>
<td class="nump">49,674,858<span></span>
</td>
<td class="nump">48,114,275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Add nonvested restricted stock subject only to service vesting (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">208,963<span></span>
</td>
<td class="nump">180,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Add additional shares issuable upon exercise of stock options and warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">360,185<span></span>
</td>
<td class="nump">384,093<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares used in calculating diluted net income per share (in shares)</a></td>
<td class="nump">50,891,791<span></span>
</td>
<td class="nump">50,244,006<span></span>
</td>
<td class="nump">48,678,999<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net (loss) income per share attributable to RadNet, Inc. common stockholders (in dollars per share)</a></td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="nump">554,444<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract', window );"><strong>Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e2646-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909315082136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward', window );"><strong>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Beginning balance</a></td>
<td class="nump">$ 34,470<span></span>
</td>
<td class="nump">$ 37,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityContributionsJointVentures', window );">Equity contributions in existing and purchase of interest in joint ventures</a></td>
<td class="nump">1,635<span></span>
</td>
<td class="nump">103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings in these joint ventures</a></td>
<td class="nump">7,945<span></span>
</td>
<td class="nump">8,350<span></span>
</td>
<td class="nump">$ 11,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Sale of ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee', window );">Dissolution of GSRN</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,428)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital', window );">Nulogix return of capital</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(792)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss', window );">Equity interest acquiree remeasurement loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,004)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distribution of earnings</a></td>
<td class="num">(9,522)<span></span>
</td>
<td class="num">(8,598)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Ending balance</a></td>
<td class="nump">$ 34,528<span></span>
</td>
<td class="nump">$ 34,470<span></span>
</td>
<td class="nump">$ 37,973<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityContributionsJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity contributions in existing joint ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityContributionsJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of loss recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=SL94080555-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131741256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_KeyFinancialDataForJointVenturesAbstract', window );"><strong>Balance Sheet Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 270,424<span></span>
</td>
<td class="nump">$ 241,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(398,114)<span></span>
</td>
<td class="num">(327,428)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentAggregateCost', window );">Total net assets</a></td>
<td class="nump">61,644<span></span>
</td>
<td class="nump">60,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Book value of RadNet joint venture interests</a></td>
<td class="nump">28,079<span></span>
</td>
<td class="nump">28,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets', window );">Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill</a></td>
<td class="nump">6,449<span></span>
</td>
<td class="nump">6,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Total value of RadNet joint venture interests</a></td>
<td class="nump">34,528<span></span>
</td>
<td class="nump">34,470<span></span>
</td>
<td class="nump">$ 37,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">1,071,840<span></span>
</td>
<td class="nump">1,154,179<span></span>
</td>
<td class="nump">975,146<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(1,749)<span></span>
</td>
<td class="nump">23,440<span></span>
</td>
<td class="nump">38,133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember', window );">Equity Method Investment, Nonconsolidated Investee or Group of Investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_KeyFinancialDataForJointVenturesAbstract', window );"><strong>Balance Sheet Data:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">27,085<span></span>
</td>
<td class="nump">27,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Noncurrent assets</a></td>
<td class="nump">68,686<span></span>
</td>
<td class="nump">61,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="num">(12,545)<span></span>
</td>
<td class="num">(9,217)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Noncurrent liabilities</a></td>
<td class="num">(21,582)<span></span>
</td>
<td class="num">(18,872)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Net revenue</a></td>
<td class="nump">101,921<span></span>
</td>
<td class="nump">108,051<span></span>
</td>
<td class="nump">155,820<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">$ 16,850<span></span>
</td>
<td class="nump">$ 18,624<span></span>
</td>
<td class="nump">$ 24,596<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_KeyFinancialDataForJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Key financial data for joint ventures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_KeyFinancialDataForJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentAggregateCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the aggregate cost of investments accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentAggregateCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909135358920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Schedule of Assets and Liabilities Assumed) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 01, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Jan. 01, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 472,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 441,973<span></span>
</td>
<td class="nump">$ 418,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AssetAcquisitionAxis=rdnt_ZPAtlanticLLCMember', window );">ZP Atlantic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,181)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">TOTAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AssetAcquisitionAxis=rdnt_ZPElmhurstLLCMember', window );">ZP Elmhurst</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right of Use Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Right of Use Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,571)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">TOTAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetAcquisitionAxis=rdnt_ZPAtlanticLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetAcquisitionAxis=rdnt_ZPAtlanticLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetAcquisitionAxis=rdnt_ZPElmhurstLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetAcquisitionAxis=rdnt_ZPElmhurstLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909040382248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2020 </div>
<div>USD ($) </div>
<div>Center</div>
</th>
<th class="th">
<div>Jun. 01, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 02, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 01, 2019 </div>
<div>USD ($) </div>
<div>Center</div>
</th>
<th class="th">
<div>Apr. 01, 2019 </div>
<div>USD ($) </div>
<div>Center</div>
</th>
<th class="th">
<div>Mar. 01, 2019 </div>
<div>USD ($) </div>
<div>Center</div>
</th>
<th class="th">
<div>Feb. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 12, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 06, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Nov. 01, 2020</div></th>
<th class="th"><div>Jul. 31, 2019</div></th>
<th class="th">
<div>Jan. 01, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Apr. 01, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 472,879,000<span></span>
</td>
<td class="nump">$ 441,973,000<span></span>
</td>
<td class="nump">$ 418,093,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Sale of ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (134,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture', window );">Proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 132,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AssetAcquisitionAxis=rdnt_AZTechMember', window );">AZ Tech</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Center</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 5,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right-of-use assets acquired</a></td>
<td class="nump">7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other assets acquired</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities acquired</a></td>
<td class="nump">7,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AssetAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember', window );">MRI at Woodbridge, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right-of-use assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities', window );">Finance lease liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AssetAcquisitionAxis=rdnt_OlneyOpenMRILLCMember', window );">Olney Open MRI, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right-of-use assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=rdnt_ImagingOnCallMember', window );">Imaging On Call</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture', window );">Proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">915,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution', window );">Shares issued after execution (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm', window );">Shares issued after acquisition, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution', window );">Fair value of shares issued after execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards', window );">Fair value of replacement awards attributable to pre-combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure', window );">Contingent consideration, fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts', window );">Business acquisition, closing costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares', window );">Contingent consideration, milestone one, shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">390,789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares', window );">Contingent consideration, milestone two, shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">586,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares', window );">Contingent consideration, milestone three, shares issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,393<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets', window );">Current assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember', window );">Garden State Radiology Network LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right-of-use assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Sale of ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Assets assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember', window );">Nulogix, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Sale of ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_KernRadiologyImagingSystemsInc.Member', window );">Kern Radiology Imaging Systems Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right-of-use assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZilkhaRadiologyMember', window );">Zilkha Radiology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset', window );">Right-of-use assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities', window );">Finance lease liabilities acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember', window );">Hudson Valley Radiology Associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Value of RadNet stock issued in acquisition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment', window );">Equipment acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_WestValleyImagingGroupLLCMember', window );">West Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLC.Member', window );">Ventura County Imaging Group, LLC.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution', window );">Shares issued at execution (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">823,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution', window );">Fair value of shares issued at execution</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=rdnt_DignityHealth.Member', window );">Dignity Health. | Ventura County Imaging Group, LLC.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfBusinessesAcquired', window );">Number of businesses acquired | Center</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Fixed assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed', window );">Payments to acquire equity method investments, Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed', window );">Equity interest percentage in exchange for assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash', window );">Payments to acquire equity method investments, cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash', window );">Equity interest percentage in exchange for cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Noncompete Agreements | Hudson Valley Radiology Associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names | Hudson Valley Radiology Associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Intangible assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=rdnt_PrimedexHealthSystemsInc.andRadiologixMember', window );">Primedex Health Systems Inc. and Radiologix | Hudson Valley Radiology Associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts', window );">Unfavorable lease contracts acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember', window );">West Valley Imaging Group, LLC | West Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireEquityMethodInvestments', window );">Payments to acquire equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Noncontrolling interest, ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticRadiologyGroupLLCMember', window );">Arizona Diagnostic Radiology Group LLC | RadNet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticRadiologyGroupLLCMember', window );">Arizona Diagnostic Radiology Group LLC | CHI National Services Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember', window );">Santa Monica Imaging Group | RadNet</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity interest percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Sale of ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Consideration Arrangements, Milestone One, Equity Interest Issued or Issuable, Number of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Finance Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment Ownership Percentage In Exchange for Assets Contributed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment Ownership Percentage In Exchange for Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Equity Method Investments Assets Contributed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_PaymentstoAcquireEquityMethodInvestmentsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Equity Method Investments Cash</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_PaymentstoAcquireEquityMethodInvestmentsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of equity issued in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfBusinessesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of businesses acquired by the entity during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfBusinessesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetAcquisitionAxis=rdnt_AZTechMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetAcquisitionAxis=rdnt_AZTechMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AssetAcquisitionAxis=rdnt_OlneyOpenMRILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AssetAcquisitionAxis=rdnt_OlneyOpenMRILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=rdnt_ImagingOnCallMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=rdnt_ImagingOnCallMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_KernRadiologyImagingSystemsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_KernRadiologyImagingSystemsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZilkhaRadiologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZilkhaRadiologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_WestValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_WestValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLC.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLC.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=rdnt_DignityHealth.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=rdnt_DignityHealth.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_PrimedexHealthSystemsInc.andRadiologixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_PrimedexHealthSystemsInc.andRadiologixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_WestValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticRadiologyGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_ArizonaDiagnosticRadiologyGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_RadNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_RadNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_CHINationalServicesIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_CHINationalServicesIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_SantaMonicaImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909130108616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 441,973<span></span>
</td>
<td class="nump">$ 418,093<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Goodwill disposed of through sale or transfer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(123)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillTransfers', window );">Goodwill transferred to other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">472,879<span></span>
</td>
<td class="nump">441,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MedicalArtsRadiologicalGroupPCMember', window );">Medical Arts Radiological Group, PC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">722<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DignityHealthMember', window );">Dignity Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_WestValleyImagingGroupLLCMember', window );">West Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember', window );">Hudson Valley Radiology Associates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_KernRadiologyImagingSystemsInc.Member', window );">Kern Radiology Imaging Systems Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,507<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZilkhaRadiologyMember', window );">Zilkha Radiology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_RamicMahwahLLCMember', window );">Ramic Mahwah LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember', window );">Garden State Radiology Network LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember', window );">Nulogix, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,337<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_OlneyOpenMRILLCMember', window );">Olney Open MRI, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="nump">601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember', window );">MRI at Woodbridge, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="nump">1,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="nump">23,299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_AZTechRadiologyOpenMRILLCMember', window );">AZ-Tech Radiology &amp; Open MRI, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="nump">2,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPOzoneParkLLCMember', window );">ZP Ozone Park, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="nump">828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmhurstLLCMember', window );">ZP Elmhurst LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired through acquisitions</a></td>
<td class="nump">$ 1,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MedicalArtsRadiologicalGroupPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MedicalArtsRadiologicalGroupPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DignityHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DignityHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_WestValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_WestValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_KernRadiologyImagingSystemsInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_KernRadiologyImagingSystemsInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZilkhaRadiologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZilkhaRadiologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_RamicMahwahLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_RamicMahwahLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_GardenStateRadiologyNetworkLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_NulogixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_OlneyOpenMRILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_OlneyOpenMRILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MRIatWoodbridgeLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_AZTechRadiologyOpenMRILLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_AZTechRadiologyOpenMRILLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPOzoneParkLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPOzoneParkLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmhurstLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPElmhurstLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909126679672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_GoodwillDeductibleForTaxPurposes', window );">Goodwill deductible for tax purposes</a></td>
<td class="nump">$ 148.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 3.7<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Amortization period</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_GoodwillDeductibleForTaxPurposes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Goodwill deductible for tax purposes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_GoodwillDeductibleForTaxPurposes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909130863752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2021</a></td>
<td class="nump">$ 3,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2022</a></td>
<td class="nump">3,498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2023</a></td>
<td class="nump">3,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2024</a></td>
<td class="nump">2,818<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2025</a></td>
<td class="nump">2,584<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">36,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">52,393<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember', window );">Management Service Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2021</a></td>
<td class="nump">2,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2022</a></td>
<td class="nump">2,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2023</a></td>
<td class="nump">2,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2024</a></td>
<td class="nump">2,287<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2025</a></td>
<td class="nump">2,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">13,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 24,968<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageAmortizationPeriodRemainingInYears', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">10 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember', window );">Covenant not to compete and other contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2021</a></td>
<td class="nump">$ 1,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2022</a></td>
<td class="nump">994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2023</a></td>
<td class="nump">883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2024</a></td>
<td class="nump">467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2025</a></td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 3,601<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageAmortizationPeriodRemainingInYears', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">3 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedtechnologyMember', window );">Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2021</a></td>
<td class="nump">$ 244<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2022</a></td>
<td class="nump">142<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 386<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageAmortizationPeriodRemainingInYears', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_TradeNamesAmortizedMember', window );">Trade Names amortized</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2021</a></td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2022</a></td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2023</a></td>
<td class="nump">66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2024</a></td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2025</a></td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 653<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageAmortizationPeriodRemainingInYears', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_TradeNamesIndefiniteLifeMember', window );">Trade Names indefinite life</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">7,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">7,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software in development</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Amortization year 2021</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Amortization year 2022</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Amortization year 2023</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Amortization year 2024</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">Amortization year 2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Amortization year thereafter</a></td>
<td class="nump">15,685<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Amortiztion total</a></td>
<td class="nump">$ 15,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageAmortizationPeriodRemainingInYears', window );">Weighted average amortization period remaining in years</a></td>
<td class="text">0 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageAmortizationPeriodRemainingInYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period remaining in years</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageAmortizationPeriodRemainingInYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_ManagementServiceContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_CovenantNotToCompeteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedtechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_DevelopedtechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_TradeNamesAmortizedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_TradeNamesAmortizedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_TradeNamesIndefiniteLifeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rdnt_TradeNamesIndefiniteLifeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131491384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">$ 1,026,564<span></span>
</td>
<td class="nump">$ 939,203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Accumulated depreciation</a></td>
<td class="num">(627,229)<span></span>
</td>
<td class="num">(571,408)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Total property and equipment</a></td>
<td class="nump">399,335<span></span>
</td>
<td class="nump">367,795<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">250<span></span>
</td>
<td class="nump">250<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Medical equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">480,631<span></span>
</td>
<td class="nump">426,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Computer and office equipment, furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">132,446<span></span>
</td>
<td class="nump">120,490<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">399,253<span></span>
</td>
<td class="nump">377,676<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember', window );">Equipment under financing/capital lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total property and equipment cost</a></td>
<td class="nump">$ 13,984<span></span>
</td>
<td class="nump">$ 14,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_AssetsHeldUnderCapitalLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131421480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT (Details - Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 83,100<span></span>
</td>
<td class="nump">$ 77,500<span></span>
</td>
<td class="nump">$ 70,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in Progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">57,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember', window );">Medical Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">26,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember', window );">Computer and Office Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">7,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConstructionInProgressGross', window );">Construction in progress, gross</a></td>
<td class="nump">$ 23,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConstructionInProgressGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConstructionInProgressGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_MedicalEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rdnt_ComputerandOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909133069368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">$ 70,071<span></span>
</td>
<td class="nump">$ 64,300<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">84,312<span></span>
</td>
<td class="nump">83,853<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued salary and benefits</a></td>
<td class="nump">58,051<span></span>
</td>
<td class="nump">42,003<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">24,250<span></span>
</td>
<td class="nump">17,429<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Total</a></td>
<td class="nump">$ 236,684<span></span>
</td>
<td class="nump">$ 207,585<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909135240088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermLoansPayable', window );">Equipment notes payable at interest rates ranging from 4.4% to 5.6%, due through 2020, collateralized by medical equipment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities', window );">Total debt obligations</a></td>
<td class="nump">652,704<span></span>
</td>
<td class="nump">692,395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities', window );">Less current portion</a></td>
<td class="num">(39,791)<span></span>
</td>
<td class="num">(39,691)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities', window );">Long-term portion debt obligations</a></td>
<td class="nump">612,913<span></span>
</td>
<td class="nump">652,704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | First Lien Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">611,028<span></span>
</td>
<td class="nump">649,824<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on First Lien Term Loans</a></td>
<td class="num">(9,699)<span></span>
</td>
<td class="num">(13,579)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan | SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Debt</a></td>
<td class="nump">$ 51,375<span></span>
</td>
<td class="nump">$ 55,875<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Notes Payable, Other Payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Notes Payable, Other Payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate</a></td>
<td class="nump">5.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Short-term Debt and Capital Lease Obligations, Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Short-term Debt and Capital Lease Obligations, Excluding Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-term Debt, Short-term Debt and Capital Lease Obligations, Including Current Maturities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermLoansPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermLoansPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131074392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract', window );"><strong>Maturities of Notes Payables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 43,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">44,795<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2023</a></td>
<td class="nump">573,938<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Total notes payable obligations</a></td>
<td class="nump">$ 662,403<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909136069848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 18, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Jul. 01, 2016</div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>loan</div>
</th>
<th class="th">
<div>Dec. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 22, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">652,704,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienTermLoansAMember', window );">FirstLienTermLoansAMember</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember', window );">Amendment No. 7 First Lien Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Issuance costs</a></td>
<td class="nump">4,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent', window );">Debt instrument, unamortized discount, current</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDeferredCharges', window );">Amortization of deferred charges</a></td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Deferred financing costs, net of accumulated amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Credit facility, borrowings available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 187,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember', window );">Barclays | Revolving Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember', window );">SunTrust | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentPercent', window );">Debt periodic payment, percent of total amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease', window );">Debt periodic payment, amortization increase</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember', window );">SunTrust | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember', window );">First Lien Term Loans | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">601,329,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Discount on term loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,699,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,579,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember', window );">First Lien Term Loans | Barclays | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets | Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember', window );">SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets | SunTrust | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">First Lien Credit Agreement | Barclays | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember', window );">First Lien Credit Agreement | SunTrust | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember', window );">Amendment No. 6 First Lien Credit Agreement | Medium-term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Total credit facilities outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember', window );">Amendment No. 6 First Lien Credit Agreement | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity', window );">Line of credit facility, increase borrowing capacity</a></td>
<td class="nump">$ 20,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember', window );">First Lien Credit Agreement Eighth Amendment | Barclays | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facilities available</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">195,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity', window );">Line of credit facility, increase borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsGross', window );">Issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember', window );">Paycheck Protection Program Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate, stated percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III | SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember', window );">Eurodollar | Amendment No. 6 First Lien Credit Agreement | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember', window );">Eurodollar | &gt;3.50x but &#8804; 4.00x | First Lien Credit Agreement | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember', window );">Eurodollar | &gt;3.50x but &#8804; 4.00x | Amendment No. 6 First Lien Credit Agreement | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember', window );">Eurodollar | Pricing Level III | SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.22%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember', window );">Base Rate | Amendment No. 6 First Lien Credit Agreement | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember', window );">Base Rate | &gt;3.50x but &#8804; 4.00x | First Lien Credit Agreement | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember', window );">Base Rate | &gt;3.50x but &#8804; 4.00x | Amendment No. 6 First Lien Credit Agreement | Revolving Credit Facility | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember', window );">Base Rate | Pricing Level III | SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember', window );">C O V I D19 Pandemic | Paycheck Protection Program Loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">PPP loans, maturity term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentNumberofLoansReceived', window );">Number of PPP loans received | loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentNumberofLoansReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number of Loans Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentNumberofLoansReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Periodic Payment Terms, Amortization Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LineofCreditFacilityIncreaseBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Increase Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LineofCreditFacilityIncreaseBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortization of deferred charges applied against earnings during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienTermLoansAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienTermLoansAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_FirstLienCreditAgreementSeventhAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_BarclaysMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=rdnt_SunTrustMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementSixthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementEighthAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_PaycheckProtectionProgramLoansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemAxis=rdnt_COVID19PandemicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131705560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Term Loans) - Term Loan<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">$ 662,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Discount</a></td>
<td class="num">(9,699)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Carrying Value</a></td>
<td class="nump">652,704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">First Lien Term Loans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">611,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Discount</a></td>
<td class="num">(9,699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Carrying Value</a></td>
<td class="nump">601,329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember', window );">Restated Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face Value</a></td>
<td class="nump">51,375<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Discount</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total Carrying Value</a></td>
<td class="nump">$ 51,375<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28567-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=rdnt_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131365704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio) - Line of Credit - Revolving Credit Facility - First Lien Credit Agreement<br></strong></div></th>
<th class="th"><div>Jul. 01, 2016</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Eurodollar | &gt; 5.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">4.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Eurodollar | &gt; 4.00x but &#8804; 5.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Eurodollar | &gt;3.50x but &#8804; 4.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Eurodollar | &#8804; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Base Rate | &gt; 5.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Base Rate | &gt; 4.00x but &#8804; 5.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Base Rate | &gt;3.50x but &#8804; 4.00x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Base Rate | &#8804; 3.50x</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_FirstLienCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_LeverageRatioFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909208553688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details) - Restated Agreement<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember', window );">Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember', window );">Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">3.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember', window );">Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember', window );">Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum', window );">Leverage ratio, greater than</a></td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">2.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember', window );">Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum', window );">Leverage ratio, less than</a></td>
<td class="nump">1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level I | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level II | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">0.22%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level III | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level IV | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity, commitment fee percentage</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V | Eurodollar</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Pricing Level V | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLeverageRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Leverage Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLeverageRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Liquidity Ratio Required, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=rdnt_RestatedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelIVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeverageRatioAxis=rdnt_PricingLevelVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_EurodollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_EurodollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131859816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details - Additional Information) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Rental expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 83.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount', window );">Operating lease not yet commenced</a></td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LesseeLeaseTermofContract', window );">Lease term of contract</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating lease, lease not yet commenced, term of contract</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">35 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LesseeLeaseTermofContract', window );">Lease term of contract</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Operating lease, lease not yet commenced, term of contract</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LesseeLeaseTermofContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Lease Term of Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LesseeLeaseTermofContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41499-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909126413256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details - Lease Cost) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 99,323<span></span>
</td>
<td class="nump">$ 95,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Depreciation of leased equipment</a></td>
<td class="nump">3,122<span></span>
</td>
<td class="nump">3,135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_FinanceLeaseCost', window );">Total finance lease cost</a></td>
<td class="nump">$ 3,332<span></span>
</td>
<td class="nump">$ 3,530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909126383960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Details - Supplemental Cash Flows) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 89,821<span></span>
</td>
<td class="nump">$ 95,922<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from financing leases</a></td>
<td class="nump">210<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from financing leases</a></td>
<td class="nump">3,304<span></span>
</td>
<td class="nump">5,939<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">106,099<span></span>
</td>
<td class="nump">482,399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Financing leases</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="nump">$ 14,105<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131035032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Details - Supplemental Balance Sheet) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 483,661<span></span>
</td>
<td class="nump">$ 445,477<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">65,794<span></span>
</td>
<td class="nump">61,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">463,096<span></span>
</td>
<td class="nump">420,922<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">528,890<span></span>
</td>
<td class="nump">482,128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Equipment at cost</a></td>
<td class="nump">13,984<span></span>
</td>
<td class="nump">14,105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization', window );">Accumulated depreciation</a></td>
<td class="num">(6,220)<span></span>
</td>
<td class="num">(3,135)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Equipment, net</a></td>
<td class="nump">$ 7,764<span></span>
</td>
<td class="nump">10,970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]</a></td>
<td class="text">us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current portion of finance lease</a></td>
<td class="nump">$ 2,578<span></span>
</td>
<td class="nump">3,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities</a></td>
<td class="nump">743<span></span>
</td>
<td class="nump">3,264<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 3,321<span></span>
</td>
<td class="nump">$ 6,547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted Average Remaining Lease Term [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases - years</a></td>
<td class="text">9 years 2 months 12 days<span></span>
</td>
<td class="text">8 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases - years</a></td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">3 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Leases Weighted Average Discount Rate [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">4.40%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease Assets And Liabilities Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases Weighted Average Discount Rate [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease Assets And Liabilities Lessee [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated amortization of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131874984">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES (Details - Maturities of Operating and Finance Lease) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 97,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">91,479<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">83,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">69,686<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">59,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">316,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total Lease Payments</a></td>
<td class="nump">717,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(188,811)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total</a></td>
<td class="nump">528,890<span></span>
</td>
<td class="nump">$ 482,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">2,654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">719<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total Lease Payments</a></td>
<td class="nump">3,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(85)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total</a></td>
<td class="nump">$ 3,321<span></span>
</td>
<td class="nump">$ 6,547<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909230441736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Income tax expense) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal current tax</a></td>
<td class="num">$ (256)<span></span>
</td>
<td class="num">$ (161)<span></span>
</td>
<td class="num">$ (765)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations', window );">State current tax</a></td>
<td class="num">(1,608)<span></span>
</td>
<td class="nump">7,715<span></span>
</td>
<td class="nump">7,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherTaxExpenseBenefit', window );">Other current tax</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal deferred tax</a></td>
<td class="num">(303)<span></span>
</td>
<td class="nump">3,396<span></span>
</td>
<td class="num">(2,020)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State deferred tax</a></td>
<td class="nump">3,035<span></span>
</td>
<td class="num">(4,743)<span></span>
</td>
<td class="num">(4,104)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 895<span></span>
</td>
<td class="nump">$ 6,229<span></span>
</td>
<td class="nump">$ 394<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909130782280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Federal tax</a></td>
<td class="num">$ (179,000)<span></span>
</td>
<td class="nump">$ 6,231,000<span></span>
</td>
<td class="nump">$ 8,256,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State franchise tax, net of federal benefit</a></td>
<td class="nump">779,000<span></span>
</td>
<td class="nump">3,891,000<span></span>
</td>
<td class="nump">1,332,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Other non deductible expenses</a></td>
<td class="nump">301,000<span></span>
</td>
<td class="nump">674,000<span></span>
</td>
<td class="nump">471,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling interests in partnerships</a></td>
<td class="num">(2,748,000)<span></span>
</td>
<td class="num">(1,824,000)<span></span>
</td>
<td class="num">(1,237,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Changes in valuation allowance</a></td>
<td class="num">(33,000)<span></span>
</td>
<td class="num">(462,000)<span></span>
</td>
<td class="nump">1,760,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Return to provision</a></td>
<td class="num">(2,252,000)<span></span>
</td>
<td class="num">(1,324,000)<span></span>
</td>
<td class="nump">1,494,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount', window );">PPP Loan</a></td>
<td class="num">(850,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount', window );">Gain on change in control</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(8,303,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Deferred true-ups and other</a></td>
<td class="nump">4,839,000<span></span>
</td>
<td class="num">(761,000)<span></span>
</td>
<td class="num">(4,254,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Uncertain tax provisions</a></td>
<td class="nump">1,036,000<span></span>
</td>
<td class="num">(217,000)<span></span>
</td>
<td class="nump">1,046,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems', window );">Other reconciling items</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="num">(171,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 895,000<span></span>
</td>
<td class="nump">$ 6,229,000<span></span>
</td>
<td class="nump">$ 394,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Gain on Change in Control, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, PPP Loan, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherReconcilingItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherReconcilingItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131367048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized', window );">Deferred tax assets, tax benefit may not be realized</a></td>
<td class="nump">$ 216,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Deferred tax liabilities goodwill</a></td>
<td class="nump">28,457<span></span>
</td>
<td class="nump">$ 24,637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">5,484<span></span>
</td>
<td class="nump">$ 4,320<span></span>
</td>
<td class="nump">$ 4,629<span></span>
</td>
<td class="nump">$ 3,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized', window );">Unrecognized tax benefits, tax impact if recognized</a></td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod', window );">Unrecognized tax benefits, income tax penalties and interest accrued during period</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Unrecognized tax benefits, income tax penalties and interest accrued</a></td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">251,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">186,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">57,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2018Member', window );">Tax Year 2018 | Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">65,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember', window );">Raven Holdings | Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Operating loss carryforwards, subject to expiration</a></td>
<td class="nump">$ 24,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Benefit May Not Be Realized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Tax Impact If Recognized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121554379&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121554379&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=us-gaap_TaxYear2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=us-gaap_TaxYear2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_RavenHoldingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909130819992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>NCOME TAXES (Details - Deferred tax assets and liabilities) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating losses</a></td>
<td class="nump">$ 59,154<span></span>
</td>
<td class="nump">$ 34,490<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accrued expenses</a></td>
<td class="nump">3,948<span></span>
</td>
<td class="nump">4,280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities', window );">Operating lease liability</a></td>
<td class="nump">124,139<span></span>
</td>
<td class="nump">126,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Equity compensation</a></td>
<td class="nump">1,903<span></span>
</td>
<td class="nump">1,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">21,284<span></span>
</td>
<td class="nump">27,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">11,512<span></span>
</td>
<td class="nump">4,616<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(5,315)<span></span>
</td>
<td class="num">(5,348)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total Deferred Tax Assets</a></td>
<td class="nump">216,625<span></span>
</td>
<td class="nump">193,178<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(24,298)<span></span>
</td>
<td class="num">(6,450)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill', window );">Goodwill</a></td>
<td class="num">(28,457)<span></span>
</td>
<td class="num">(24,637)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">Intangibles</a></td>
<td class="num">(9,608)<span></span>
</td>
<td class="num">(6,669)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets', window );">Operating lease right-of-use asset</a></td>
<td class="num">(112,956)<span></span>
</td>
<td class="num">(115,364)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(6,619)<span></span>
</td>
<td class="num">(5,510)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total Deferred Tax Liabilities</a></td>
<td class="num">(181,938)<span></span>
</td>
<td class="num">(158,630)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net Deferred Tax Asset</a></td>
<td class="nump">$ 34,687<span></span>
</td>
<td class="nump">$ 34,548<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxAssetsOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxAssetsOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Operating Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121554379&amp;loc=d3e9972-128506<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 740<br> -Section 25<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121554379&amp;loc=d3e9979-128506<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909130704856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details - Unrecognized tax benefit) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit, Balance at beginning of year</a></td>
<td class="nump">$ 4,320<span></span>
</td>
<td class="nump">$ 4,629<span></span>
</td>
<td class="nump">$ 3,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease related to prior year tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year tax positions</a></td>
<td class="nump">1,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax positions</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Expiration of the statute of limitations for the assessment of taxes</a></td>
<td class="num">(221)<span></span>
</td>
<td class="num">(393)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate', window );">Increase (decrease) related to change in rate</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefit, Balance at end of year</a></td>
<td class="nump">$ 5,484<span></span>
</td>
<td class="nump">$ 4,320<span></span>
</td>
<td class="nump">$ 4,629<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909128192456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details Narrative) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="nump">527,899<span></span>
</td>
<td class="nump">527,899<span></span>
</td>
<td class="nump">478,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable shares (in shares)</a></td>
<td class="nump">307,196<span></span>
</td>
<td class="nump">307,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AwardsIssuedToDate', window );">Awards issued to date (in shares)</a></td>
<td class="nump">6,551,872<span></span>
</td>
<td class="nump">6,551,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">RSA's unvested (in shares)</a></td>
<td class="nump">329,159<span></span>
</td>
<td class="nump">329,159<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember', window );">Future Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized (in shares)</a></td>
<td class="nump">14,000,000<span></span>
</td>
<td class="nump">14,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Stock-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,424,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options cancelled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,281,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">RSA's forfeited (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance', window );">Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)</a></td>
<td class="nump">1,918,427<span></span>
</td>
<td class="nump">1,918,427<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember', window );">Restated Plan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Share-based payment award, award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Share-based payment award, expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized stock-based compensation expense</a></td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="nump">$ 3,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized expense weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 3 months 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Options granted (in dollars per share)</a></td>
<td class="nump">$ 16.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember', window );">DeepHealth Inc. | Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">412,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AwardsIssuedToDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Awards issued to date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AwardsIssuedToDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rdnt_FutureServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rdnt_FutureServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rdnt_RestatedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rdnt_RestatedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909132137544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details-Outstanding options and warrants) - Equity Option<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (in shares)</a></td>
<td class="nump">478,951<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">48,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares)</a></td>
<td class="nump">527,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end (in shares)</a></td>
<td class="nump">307,196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise price Per Common Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.21<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">20.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending Balance (in dollars per share) | $ / shares</a></td>
<td class="nump">9.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at the end (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 7.59<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">6 years 4 months 2 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">5 years 5 months 26 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 5,441,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 3,679,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member', window );">DeepHealth, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning Balance (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">412,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(11,895)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending Balance (in shares)</a></td>
<td class="nump">400,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end (in shares)</a></td>
<td class="nump">26,545<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_WeightedAverageRemainingContractualLife', window );"><strong>Weighted Average Remaining Contractual Life (in years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Balance at end of period</a></td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Exercisable at the end</a></td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_AggregateIntrinsicValue', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate value outstanding | $</a></td>
<td class="nump">$ 7,710,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate value exercisable | $</a></td>
<td class="nump">$ 510,994<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_AggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_AggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_WeightedAverageRemainingContractualLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Contractual Life abstract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_WeightedAverageRemainingContractualLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_DeepHealthInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131735272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Details - RSU's) - Restricted Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">RSA's outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">387,934<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">RSA's granted (in shares) | shares</a></td>
<td class="nump">457,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">RSA's vested (in shares) | shares</a></td>
<td class="num">(516,371)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">RSA's outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">329,159<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms', window );">Weighted-Average Remaining Contractual Term (Years)</a></td>
<td class="text">10 months 13 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-average fair value, beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value, granted (in dollars per share) | $ / shares</a></td>
<td class="nump">19.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value, vested (in dollars per share) | $ / shares</a></td>
<td class="nump">16.37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Weighted-average fair value, ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 16.69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909132148376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENTS (Details Narrative) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 16, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,528<span></span>
</td>
<td class="nump">$ 34,470<span></span>
</td>
<td class="nump">$ 37,973<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1', window );">Contributions</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct', window );">General distribution funds, CARES Act</a></td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Simi Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Simi Adventist</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Simi Adventist | Simi Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest', window );">Economic interest</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event | Simi Valley Imaging Group, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investment in joint ventures</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPCompaniesMember', window );">ZP Companies | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Government Assistance, General Distribution, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6373374&amp;loc=d3e70478-108055<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=rdnt_SimiValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=rdnt_SimiValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_SimiAdventistMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_SimiAdventistMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=rdnt_SimiValleyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_ZPCompaniesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_ZPCompaniesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139909131549960">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation', window );">Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
<td class="nump">$ 4,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_NewJerseyImagingNetworkLLCMember', window );">New Jersey Imaging Network, LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationStepAcquisitionCashAcquired', window );">Business Combination, Step Acquisition, Cash Acquired</a></td>
<td class="th" style="border-bottom: 0px;">rdnt_BusinessCombinationStepAcquisitionCashAcquired</td>
<td class="nump">$ 5,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity Method Investment, Ownership Percentage</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
<td class="nump">49.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
<td class="nump">$ 39,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance', window );">Business Combination, Step Acquisition, Adjustment Of Investment Balance</a></td>
<td class="th" style="border-bottom: 0px;">rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance</td>
<td class="nump">44,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=rdnt_StockholdersEquityDeficitMember', window );">Total Radnet, Inc.'s Equity [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NoncontrollingInterestSpecialDistribution', window );">Noncontrolling Interest, Special Distribution</a></td>
<td class="th" style="border-bottom: 0px;">rdnt_NoncontrollingInterestSpecialDistribution</td>
<td class="nump">3,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember', window );">Noncontrolling Interest [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_rdnt_NoncontrollingInterestSpecialDistribution', window );">Noncontrolling Interest, Special Distribution</a></td>
<td class="th" style="border-bottom: 0px;">rdnt_NoncontrollingInterestSpecialDistribution</td>
<td class="nump">9,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_MedicalArtsRadiologyMember', window );">Medical Arts Radiology [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized', window );">Business Combination, Liabilities Arising from Contingencies, Amount Recognized</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">Business Combination, Consideration Transferred, Liabilities Incurred</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
<td class="nump">2,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business Combination, Consideration Transferred</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
<td class="nump">50,900,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
<td class="nump">8,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLCMember', window );">Ventura County Imaging Group, LLC [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
<td class="nump">4,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember', window );">Hudson Valley Radiology Associates [Member] | Variable Interest Entity, Not Primary Beneficiary [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized', window );">Business Combination, Liabilities Arising from Contingencies, Amount Recognized</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized</td>
<td class="nump">700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned', window );">Business Acquisition, Equity Interest Issued or Issuable, Value Assigned</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
<td class="nump">$ 6,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
<td class="nump">440,207<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Step Acquisition, Adjustment Of Investment Balance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_BusinessCombinationStepAcquisitionCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Step Acquisition, Cash Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_BusinessCombinationStepAcquisitionCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rdnt_NoncontrollingInterestSpecialDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Special Distribution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rdnt_NoncontrollingInterestSpecialDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rdnt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6405-128476<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease obligation assumed in business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_NewJerseyImagingNetworkLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=rdnt_NewJerseyImagingNetworkLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=rdnt_StockholdersEquityDeficitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=rdnt_StockholdersEquityDeficitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_MedicalArtsRadiologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_MedicalArtsRadiologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_VenturaCountyImagingGroupLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=rdnt_HudsonValleyRadiologyAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>81
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M<*;V,)]&MR#Y\S$939.I(\OAR6GH#,P-KP3@2R"%H$Q5):V^ ?8VSW<J/+(
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M$]7W(M< ]7_-F'P;Z 6J3GKP/U!+ P04    "  8?7!2!$2:\NX)  ";-P
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MUF?7;0F'JI>8V<.Q%K-(LM)Y5.ZEVTUU="ZR=-46(# BS-P<+O&Q'A$31OR
MZ0'I@YI"EPRPUT(?L"KAV%[#+S?9;!ENJV%;BH A,$OV@)B9#Z 8U0/0 S2%
M0)BWG4B*(F [1S@I_:W3(+?F 1P%H+Z[S-%M[T U;5=$ -N9P&@OA7.TEFV6
MN<___"=9XO]J]\%D!@/,B*<[T05K>J$(!+8SB"LQ6$G>*DO<2B2%)0VW[$TF
M:W(G2HY;8T"73(+ &'$-E[I@39<4D\!V*G&B;-QVDF57*LN)B.[*K[),)+/O
MVY4ILC#)XRV!"^?_V>1%&070)X!BN#I[Z@,Z[P UFU)%58B=JBBG%V&4U8V?
M7,U9F"_1(I;JEF)^)[K+#3&9!_$]5_.T%^J\"]7T5?$88N<QK^>K26<L]NU-
M".QDIJ=]V_-NG462Z:R%?)GGDF/.XC#/HT4DJN-$A%G9T</6FXREY5 CBJX0
M.UWY+"/V)JX&.%'; .<C 1B)CRG5<P2 $:*7EHM^L"D XW[0YK B),1.2$Z3
M>??$Q >C ! 'QR'<"(.)P\3#OD8QQC7.-C:!+LF(3[F^[P <X8$>>(#38.SM
MSZ'JT)M CSJM9Y8B/\1.?IJQM\W1H 48$Y.3,#_P/.:WT#*B> EQ?_Y<ARAJ
M0>S4XO4F.\2D#9CPMK:&*-I [+3A9<,= DP0]%%C#\S$CFFZIN@#L=.''YWP
M$+.N>QYV&&F9ZJK23NVE_3E#'FI67-_3SX=1+]2D"]5T1U5O:J_>+YOT4+-D
ME^/>EH2FJF93>\U^_JB'FN5W8 2Z&S.Q8YKN[-T*Z*CC:3*HZ$8N[D56[E30
M!6 8X/NZ#SU DPY0TPM5G*F].)M>=*8'5&S=H&T/JE)%GSMK?^[HC)K5BC."
MG98J2E6MHL^=L_<9G5&S*?:X,4#HA9ITH9J.J2I(.T;M+QZ=4;/Z<<Z,36JB
M**?Z1+87:@J@)"ELVPBJW%)[N7WAG(1"=5(?DW2 FI:K:DKMU?25IB04:)JI
MHP]!IYVPYET^58)9W^[Z%4<*#)CQ4Z(E9Q_0>0>HZ;0JU.PGM=D,JME I]03
M=]Z-:WJL2 #[OVC<6>_&G:F"SUZA<6? 5)\R?6 Z F"8>5R;[EST@TT!F._N
M=;]-A_?NO+]"XQZ 40"Z8THQU:=Y  YS[/I:_1BS[L8=NJ1+?%=OW '<P'>(
M$7FH<W<HUEO\*0#T,>-MP5=TB+U6YPZMP)@!7$B:SRAIJ91,L2'V/^C<F>(L
MK(.S5%% D>1D\AS8)/)ZJ%@*)+97;/23:QF\+M;(3#[! NQZVO#H$X"3U++M
M80>FB ?K>,#@F?Z ^\TD%MJ)<U)#O!XGHF(>[,?Z>-!$DS=@PERC0/6"33IA
MS<=]% OA=A;RXB;D$P=:>D+=MB?/N.(*_*6/%D /I=9*]Y>=4@=K-W)/^\'.
M.F%-WQ0KX'96<!,^(K%8B)ED.0FZ"V6(Y6M>=B?MM\N@+.-0I\_UV]:]4),N
M5--712.XG4:\$EWG9LT?X$"OG--.6-,+Q0VXG1O\5^@Z!XNNL7I]4.==J*;?
M>P\$VLORJS%V#MWN#ZBG=R<]<>?=N*;'JMSSC@<(?@YCY^:$0_)F?5+6"W7>
MA6I&0C$/;F<>O1H #CU%X#&=^8(PYNN-PD5/W!3 8>H$;?FNV FWLY,^/4#)
M@8! F(2#<)\Z>L4'<-CEGGYW<@S@]!X @%#'\_11ZCF &Q#FZ!7@ L*5M^\"
MO0D @ %I?6:/*X+%[02K=Q, +L&8FRQ)=E?24:J/:X9[/[TI?[;V6YC=1;(\
MQ6(A19WWGCQ=LNTOP;8?BG1=_1KG-BV*=%6]78I0<M<2(/^^2-/BZ4/Y Y_=
M[_&._P!02P,$%     @ &'UP4GZ8JEH[#0  ^#P  !@   !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6R]6VUOVS@2_BM$;G'7 G4CONBMUQ9P;:<;H'5R<=J]
MKXI,Q]K:DE>2D_9P/_Z&DFU:Y(AVL=C[DLCR0YH/AYQY."3?/A?EMVHI94V^
MKU=Y]>YB6=>;-Y>75;J4ZZ1Z76QD#M\LBG*=U/"Q?+RL-J5,YDVA]>J2>5YP
MN4ZR_.+]V^;=;?G^;;&M5UDN;TM2;=?KI/SQ0:Z*YW<7]&+_XBY[7-;JQ>7[
MMYOD4<YD_65S6\*GRT,M\VPM\RHK<E+*Q;N+(7TS#H4JT""^9O*Y.GHFBLI#
M47Q3'Z[G[RX\U2*YDFFMJDC@WY,<R=5*U03M^&-7Z<7A-U7!X^=][5<->2#S
MD%1R5*Q^R^;U\MU%=$'F<I%L5_5=\?RKW!'R57UIL:J:O^1YA_4N2+JMZF*]
M*PPM6&=Y^S_YONN(HP(TZ"G =@6864#T%."[ OS< F)7H.GJRY9*TP_CI$[>
MORV+9U(J--2F'IK.;$H#_2Q7=I_5)7R;0;GZ_>AF.KOY=#T>WD_&9'8/_SY/
MIO<S<G-%1L/9K^3JT\UO,S(@7V9C\N*7E^07DN7D?EELJR2?5V\O:VB#JNDR
MW?W>A_;W6,_O448^%WF]K,@DG\MYMX)+:/R! =LS^,"<-8YE^IIP^HHPCWE(
M@T9G%Z<Q4GQ\?O'(P88?[,&;^GB?/72G7]W=?"8WMY.[X?WU]",9CNZOOU[?
M7T]FCI\1AY\1S<^(GI^9@D=YL2JJZB78,RW6$K-D6T785*'\Q]/[ 0T%=-+3
M<??:*,:%\+JHL8WB$>7\@.JP\ \L?&=G#>>_PPP!+U17I"[ #:5%GF8K27*@
MU_+Z^]]HX/T3OE2OTJ1:DDU9/&4P],C##P+NLTSJ+']L_4]69[)ZX^C>X-"P
MP-F]8PE..,V2UK7E<Y*LB[+._M.\P+JZK2XXZIXH"&/?Z&H$Y05>:'2UC0I9
M%,=X5X<'1J&3T?"( "D61SVWDN!V2:G\ZZ!8#+;P(:DJ6:/.(;3:!C2IR1-!
M!9%@!D\;Y>$<HP/'R,EQ\L<VJW\H!R>3,@=NE6+Z>Y'E-7F"0;8M9?6J&4CP
M>IZI4=3C R.K:=0/#3N-;! 3D<$1J8B+H,>6\8%G?+XMU>A\+K-: JE%0TPN
M9%G"_%AD>0+3"4R<%A7,,(5<%4D.U*NTV.8UQCRV&BP$Y09S!$0C85"W03R*
M(YPY]72X\YS</X'/(R\>01"]),"^2L!;*&+ :5/ )]4#$L;!1GF5YINB7LH2
M#72>;1R06P97!,5X9/3(&$$-F.>+'KI'T9TZZ7X$HHJG_*[FZC:KE@VOQLP/
MJ %W%79:(CQA#EX$9KI\)Z3+AVD^["P^I1RLP>_ C-SS 8<[D-^SJO%),&,E
M3%:<(#O5\A$"&82!.3<Q%(]]WC,[J98 E)\>HT R6V^2K%0$41X<F46A1<5&
M67:R(3SF80\+K3"H6V*8$:,)O@M89Y"EG#^B@F-78Z<EPO2)(P1E47)!NGRT
MUJ"^6S(5^:#AD"Z3_%&J,+$ \Y"G9+55SO,PZ @$1ND@Z=L.P6<621MED71!
MNB2U;J%NX3*KB_3;0"VDYN#UU["ZK'HU"[6%!F7",X,Y HM";I%!5$L0L!X^
M6K50MVRY4<Z;Y# "&]-!F%LKPS4^'9RBXB?Q58RM+IBI0$8(:,!#:E([6ZA0
MK52H6ZJ,#F/P,/Q ^RK?I]PA/%8@3LI^T]FZPG(<-F3 *;,"%Z)0CM<(77Y:
MH=#8O0QJ^%6-K;1&;V1EJT.RY"%;-7K]H,CV7Z<0OI5^,7#J^^T:WD.=FVT)
MLQB4:ETF,,*;%(13^#,M,)A;8 S31AM5:C4BLZ?D885Z 8;( I]Y@6$%!*;6
M8)&IA;'JJ/!Q,S M'YA;/K33)]V"'E1JJ%?6,SO4!WYD^C0$->"^;ZY?,%A\
M+(V[9+1V8&[MT))QD$#BN2^8Z<\P&.,L,%D@,!I$/6&5:7' W.)@O)?G=?(=
M=UW,CN>#@%*3!H+BD6FS,5I9S/M&EE8'S*T.;HSUXWZB_D 9V>%\ #K+GBT(
M#E:.W/3("*['(S,M#YA;'ASL4O;H-78RHH].0\8() "WW--Z'??9J83%H?6P
MTMWB+LL.T3R,A36P;-B >K;'0F#,ZYOD.N"S$WF*O?O=)#^4[WT%\2 MM\!L
M'^WUHNXX.J"$[< M?"\P$V (C(:<6@X!410!8[2'L98"S"T%IN<FME"*2!*"
M\]"W.")AWA.<659%<#0(^Q:R3 L"=D(0&'G1Z^G7R>S\O"C7\9N[X_?M7AHH
M1;].'E4?+I+4,4PX$J-A2@9FX,!P+*2^.<4Q'(RGN&>2<QW-N3N:'_);3W*?
M-4WJHT4,2N[D.G^$0 94F$(10['C=$F7E([JW!W5C^T%,P#&/5!44_R0Q4%I
M(=$97%EH*GP,%PKJ6^PP'*-1'[VC[0!WN+\MBU3*>4469;%NTU7'&2J4FQVR
M(VM]B8!@HEI#T48Q/^P)_EP'?^X._EU2X(H[Q)HAVBZEFP5 TDW!HI1/I@1&
M"(1RTWTYZ^F2U<* NX4!;L&&89ZLB,J75\6B?DYZJ)V6#:<A8P32JZBY5@W<
MK1JFVU7QF'T'T0"&V25Y-EF=K% B=L"WB"!)@-BRD:N>+A&M&KA;->P\HUI"
ME]G#MED.-OL ^X2B<BB;X\BPS_4 J+M!@%)'\@0TX%: P&">Y6H0%/C1OC[0
M.H*?J2.V5;M(;N/$:0W!D4P!A#\FA,D/ <:Q, /E&*U0!+UI!:Y5!/\Y%7%U
M/1U.1^?OKFH5(4ZHB#++TVP#\QMT:!MJBYSD1;W3G\VBYR!2T<U73%7X@1F@
M,%@@8G,S!85Y88^D$%I2"+>DN#UB!S-BO=L@ZME;$-C> F>QN8Y#<5YH[0!B
M.,XCWC,7A!85PBTJAO-YIIP V,_8#I.[S;!F#^*I6#TU2UA%.H&.F/?%9('K
M")/WR:V)L1/29:LUAO@9C:&,1[*JVBJVA^3:_D5+'Z5X<J=AA$#BD)I^8NRL
MJ<OQZ+S#ST@.F'?I4J;?E&*L=R>0X/&Q3-H1C!.TQ8'PS(3H"$%9-CQ;90BM
M,L2)] ,$*AVZ-DDV5R<B\B)O8EJQ6AUOB^'T;(DPH'%D!BD,QCTKB8?6)EA/
M^DMHR2'<D@-74ST\49JG90@"\5EH1BEG15UV6H<(MPX9=01(0]&@MDG*.I<E
M;D'71L..F@T)K04H F*!Z".G!89P"XRNZ;3W3,&[9O5^D8TF  62IO"]V-IL
MQW"!O2D_QG">X'TB2FB!(=Q'*X[CX<\QM(\[#'"*&#"*$8X(D(9!+TE?BQO_
M_!3)SW@8WQ8A)KO3D#$"&?3F$7RM9/P32J8S.@_AKME86Z_541&U-4JVF^8T
MA2S3K.V 8M-,5I3OZ=P) K$<#8)A?72UPO'="N>@]E_LY/[+3OY0G_UQ:W\?
MT37"]P-3V2 X)F+?3,QCU5$OZCOPY&N)X[LESN3J:C*Z5Z=:)_\>_3J<?IR0
MN^']A+3/,W(S;8Z[HA21'1#J602Q[113KV*@7FY:VO@GSG).[LGU='0W&<XF
MY,5XTCZ]U.^N6W)D.!VW#Y-_?;G^.ORD#OJBC&U]$M#(S'F-$!B+P]#,>R,P
M$/-Q[]G/H\.?;LG3R^D5>9"/6:Y.\#5905EFQ1PE:HL4X5$K<8O 8%D>Q291
M&^;3XQ1YEZ>6/+Y;\CAX2K65X62(G-'PVJ/*78HV#NF),5K=<4]T*6K=XX?.
M=?GLR^WMI^;D^? 3&5_/1I]N9E_N)IU3Z#",KV[N/@_OKV^FCC6ZK_6(?^(,
M1;-IHI3R?%NJL:(2D6U7DD51.E6D;PL('OO,\@HV3 3,-Q<\6&VA=[2#U&6H
MU8CO5B.G&:HCTOT[R;XM(9#]+PP56<<Y$93H=0*!UB*!6XM,]%G-SKD/E5]9
M%JNY.D0'<:TY)HAR#&PYX7?2:2U)#$9#2W0A,!%&?>HDT.HD<*N349M7W6V6
M]^57 J=2V!&Q,=2F@9SG"'M9:-$1G'%Z<W?M0,FH-NNZEO6RF!]M2V&7. ),
M&?">;<5 ZX+ K0M&/8>F]'D$DAPN&:!=?CKK@4"PDU0(K/\D5:#507!"'70%
M^C4NT+N5ZQ <N"]@_,G;*L'1?8H3.PWGW%<)D.C$O=ATR@@L"BQ_A:#\*.Z;
M CK2!>X5_ETRSV7]"NR0OB;-:4OEI6!!_P_2;D*XNDN'MB#Z2^VB(TS@CC#G
MV:6MHWN12$3F':%18(<(*D+?%)0(#%26Z DEH0XEH3N4?$W*3&7C#W.$3, Y
MU#]>D6E1D]LR4Q<CR0>9RT669NKYO^0S+.Q3\,O#$M;\8-NL6!6/+AN&VN6'
MU&G#__OEIE#[\=#MQ__<Z=-Q:/MRVAM=0NW+P[_6EX]W]8?GM4M[X-#M@3]L
M*WA356>TJK%RJ>R7K'MNV(Q"Y,*=L%IY>70E="W+Q^9JK6H"U-K>K3R\/5S?
M'3:75HWW'^B;<7L)5U?3W@G^G)2PRJI DRR@2N]U"+&B;*_9MA_J8M-</'TH
MZKI8-X]+F4 '* !\ORB*>O]!_<#ALO/[_P%02P,$%     @ &'UP4CEQX<V!
M#0  M",  !@   !X;"]W;W)K<VAE971S+W-H965T."YX;6RM6FES&S<2_2LH
MK;,K5=$42<GW427)LJ-4?)1E.[NUM1_ &9"#>&8P 3"BF%^_KQO '!+E.+OY
M8&L.H-'H?OVZ&\/G&V._ND(I+ZZKLG8O]@KOFZ>'ARXK5"7=U#2JQIN5L97T
MN+7K0]=8)7.>5)6'B]GLX6$E=;WW\CD_^V!?/C>M+W6M/ECAVJJ2=GNJ2K-Y
ML3??2P\^ZG7AZ<'AR^>-7*M+Y3\W'RSN#CLIN:Y4[;2IA56K%WLG\Z>GQS2>
M!WS1:N,&UX)VLC3F*]U<Y"_V9J20*E7F28+$GRMUILJ2!$&-WZ+,O6Y)FCB\
M3M)?\]ZQEZ5TZLR4O^C<%R_V'N^)7*UD6_J/9O.CBOMY0/(R4SK^7VSBV-F>
MR%KG314G0X-*U^&OO(YV^)X)BSAAP7J'A5C+5]++E\^MV0A+HR&-+GBK/!O*
MZ9J<<NDMWFK,\R_?G7SZ_/%<O'\M3C]?7KP[O[Q\?N@AE]X>9E'&:9"QN$/&
M?"'>FMH73IS7N<K' @ZA4*?5(FEUNOBFQ%<JFXJC^40L9HO9-^0==;L\8GE'
M=\A[;]>RUK]+ L)$G)G:F5+G,N"BSL4'JYRJ?7A@5N*UKF6=:5F*2SQ4 *%W
MXM\G2^<M8/2?;VATW&ETS!H=_U]V_[,RQ"]*2(M_HN:]8 .--5<Z5Y:VM;)*
M.8\-ZWH]$2M]K?+[3GLE$*T-)F";(M=R71OG=29T)=<8*9RR5SI33NA:^$*)
MSS7FY,$T;BI.O("_5+7$(LEG$[&!U$9922-S;1&$Y588"QG=G2^L:=>%^-5H
M+'R%U5OX 0'@"U$8UV@O2S<11T=SD>&ELDZ4)F.)T.3$ZM^Q0[A3EAKL5&M<
MOU*EW, "$_&Z-!8NGHBWX)H2>YZ(=^"(GR!%;2?L=;K_%SAC*MZWMELB&DPT
MQ=9I8*".&B5K9+*12UUJF,L);\1*9G0'M=@XT7[:\1(>1.D)/F3^7#L% @EO
M<&,L_.+"Z@,;9V6+Y;%:K<@+,(DA-*I.@_VW'R\.)B(S5=.2,< 19FTE%!;[
M9Y_PIL'ZW@+*JM*.Z7,XY,,YC:G;K%32BDKEV&4-BU6R2H,F J1FI3,MV6T
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M'MU9_JA[0*'H5%(\5=N]F(:T&2:8&]51=X+?ET\(/GKJ$G7=/BK?\?VM_V)
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M QGNB4N$(YQ2X&?3WH JW,#=^+P%6"!<F@84GC"=C'AMXAUN',Y(KL9=U&L
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M#XH3D(04 Q)$9WMQU<"BX<IY!EH?AR%<XUW\3-:J*O)<@P^+8;'O6F]HR#R
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M>T%:R[_;7(ZZDQ"YN:$;"EH&?S4X=93PD"4#%I$.G8A%:?$:\'Q2$,( !L[
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MT*$G4'2JDTPMVCJ)$<2\P(I G->/31:;\WS<5>PT,I<_<07S[7@XI395OH9
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M?* #%EH8Q]JN"EL95=5,"$.Y_(XFN<51=P59HQ4O'V]@-9)!6?R5K7AGW4N
M^XUW,&-E9_RF*8$3I.!>QZRN5B^SCMP[G/7M[DU8, 0L@:Y%3;$41>!PQY7W
MY9?,+/B-3H1\9F+^.%=(,99NP.]38[+R"VU0O>+[ZG]02P,$%     @ &'UP
M4IJLFYO<!@  @!$  !D   !X;"]W;W)K<VAE971S+W-H965T,3(N>&ULK5AY
M;]LV%/\J#UY0=(!FZ[(M=TD YU@3+!>2K $Z[ ]:HBVNE*B25!SWT^\]2I:=
M+,D:=( AF33?[]T'O;M4^HO).;?P4,C2[/5R:ZL/@X%)<UXPTU<5+_&7N=(%
ML[C4BX&I-&>9(RKD(/3]T:!@HNSM[[J]*[V_JVHK1<FO-)BZ*)A>'7"IEGN]
MH+?>N!:+W-+&8'^W8@M^P^T?U97&U:!#R43!2R-4"9K/]WK3X,-!3.?=@4^"
M+\W6=R!-9DI]H<5IMM?S22 N>6H)@>'KGA]R*0D(Q?C:8O8ZED2X_7V-_IO3
M'769,<,/E;P3F<WW>DD/,CYGM;37:GG"6WV&A)<J:=P3ELW98=2#M#96%2TQ
M2E"(LGFSA]8.6P2)_P)!V!*$3NZ&D9/RB%FVOZO5$C2=1C3ZXE1UU"B<*,DI
M-U;CKP+I[/['R\NCN].S,YA>','E[<GQ-9Q>W$XO/IX>G!W#].;F^/9F=V"1
M$YT?I"WJ08,:OH :A'"N2IL;."XSGCT&&*"(G9SA6LZ#\%7$(Y[V(0H\"/W0
M?P4OZO2.'%[TDMY*94LA); R@]/2LG(A9I+#U!AN#1P)DTIE:LWAS^G,6(W1
M\]<K;...;>S8QO^SN5]%I<3]8"J6\KT>9J;A^I[WOHL5=&80!E,L51J]!<P
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MI)+>;5ZZS)WQS?S7J5/R!PMS]'!KN:?S6$CM!Q\A/2)ZQ/08DGQX0YRC\]I
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MGXM48R5K^^K#6E!I@<H25M]:WF")6?AKN3%68XW\?<%5,KA*.E?)+Q_JS_#
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ML0?NKD <@NF3Z>X62B@NM^EU)?$?'!BJ@J,M4\4"87HHO,7Z0681^5$MHXT
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M/+8&;W6)L9U,;F%KWEC4#^CG7="NR6PA!W"8JB4IHE@9G(X<T<Q9WII$E-,
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M, G?';A67Y,:Q,'H-!PU!\>--JB6;-FZ-8;53;F7Z<$U":4]U2$JCI:@"/0
M:7L,&/J)/9M0.;U*/+G<*!)9+!'E66%;<;;JQE!KK72W,0CGL3!D  )4[K?;
M7'>P8W#&8V3H>R)%O0^B'[Q5U6F.^\I7-=%[4MK]WMJ(.D&45G9.M*\UHKM[
MUI87\^"<PL^T<#69H8U&P_!MV,:_VY@J'[!M)[!<;1RJHW;WV1\$>(BGM!(P
MH2_JZYM.P;TCOO7;LRT7N/,E7C\\VRAFUF44D+<!ET>6>#_U-EL-]E]?E\X1
M,V$+DO;2X&MD,L#$3Z,BUS Y/Q6=2/B#9"\G&RK3U^%J+KFN (?5.(8=S=2#
MFJ,].9+%4FZTU..M+;3O"71?)36 ;K[@'!;RW=Q*V+W+<"&^U,'CK*3-C<'1
MBV;(*DX-XRP.W?S"C\CY@>34SK6FKJD0GW4H .P:#0.[-#X;4R"AEP@)/VO%
M7-;:J*G>,;(_[)!(/M(AGGF-B,8-]UN>NW!BG_/AUT7*,GJ_(#C[J,GA9'_8
M?%7)LQ%CR0]2FMU$#S4N5X][5YFN3Q)CM(LSF;PB.F\5[_])C";C1@.5BMZ9
M/_*RDFVC;0]_\I6N4Y%]0;Z^<-&Q9?DGW]?R&[MI=^JQJ8=RZ^Q'_I8C<IN2
MTU>"Y])E"P*$,1XVNG$ $C8BE:ORURBJ2I(7>)XSO8->MYGVE.](O;QVGY+P
MKKNVS=YOPGJA(__UV5)R0RZO85,^YC)+MOOF2UO:IS4^R4S=B1@@:#IX4.X5
M6*TS6=>ISJ^W-7\OWS1X1<!P5D%J*D77<"JL9T_<$T2&]0$8^/"T+!%I?0 E
MA[TZ $:MD36A7(\VC?-G=&PF:,>H5\0GUZ@=],*3UM?R<2GA[0D["=<B37C?
M-Y[=1D_HT^-OXM;HW)=1N)R9R$WN]KT_O+V]I>,]?)S)<L'8/ Q!1:1KPZF9
M65!M-2F0PLB:B.]?^"!;O<OAC,\62SIK)O32US\0'VS<)Z/K+[^./_P-NEX"
M@ERHV/F31PU8Y9X$QV.8.1L/X[XJ<5\VMBUH@^;NZO(HJ([=L>'0^8]R_X)(
M332=["I+X<:A/"K.0*AE)YJY8"CI@,9OI(U8*H+$@Q,W@"IG*1/)L[M-&3A^
MG ^Q[>G,.:G;6UQ&T#D-[W)7TCMZR%JY+(/\Z!R0FA+C-*G"YQI2HC3MS@>U
M3]!L%2FBRC?I2AW>#<O A[5<C]?JP5MEJA.$M;+*_1\WV? =,;IP?W"&:R@-
M$OBL$NW.D8@/93@+ U(7BF'>,HE2'CX%7B[TC.>#5L7?CLL3D%2EN!IZ+J,4
M,4%EMC <C28RDU.5VZ.RQ*[.1Y'' B,YSXPF'(U1M%OLO<]3)0P7JT5>;4PB
MH,CE','0EXI.LZ[.IX'_&WCY8SDMK894O&]H7-5/\<I%VR8$>BM!BRI]!__/
M8#]LL[:8_ [O8PV0;)Y$JI!]O(,PV8MEJI\DF5U.]J S'M:EP''M6?='O;;O
MHI+Y5!8[K4V6#P'RN;%ALQ7_C?>,?;PM=_2=?BLH'/DFN3^@29F"V])411.7
MANKOTN8P&CJ/I6Q!(NGQ;*<AURKL-8-=Z@:)X\9PO3QVM9!NVN:$7)XFJYO;
M#:%7.YEN/YTVC5?(MA OL$U)%S,6JS\]B;P,.17HOCFT;CM8?MPXN+^09L8_
M3Z#ST>#<G>&OGE:_@+AT!__KY>[G$VY;ST+)4WQ*6ST=8=Q/$MQ-KI?\,X")
MSM%]\B7<!"&&%N#]5".@^QM"4/TNY/U_ 5!+ P04    "  8?7!2 /:5#(H)
M  "N*   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6SM6FMSV[@5_2L8
MU=VQ9QA9?.CE.)ZQDWC6;=)D[&RWG4X_0"0D(2$)+@E&\?[ZGGM!4I1DIVG[
ML?HB\0'<Y[D'%QA>;DSYI5HK9<6W+,VK5X.UM<7%^7D5KU4FJZ$I5(XW2U-F
MTN*V7)U71:EDPI.R]#P8C2;GF=3YX.J2GWTLKRY-;5.=JX^EJ.HLD^7CC4K-
MYM7 '[0/[O5J;>G!^=5E(5?J0=E?BH\E[LX[*8G.5%YIDXM2+5\-KOV+FS&-
MYP%_U6I3]:X%>;(PY@O=W"6O!B,R2*4JMB1!XN^K>JW2E 3!C-\:F8-.)4WL
M7[?2;]EW^+*0E7IMTE]U8M>O!K.!2-12UJF]-YN?5>,/&QB;M.)?L7%C?0R.
MZ\J:K)D,"S*=NW_YK8E#;\)L],R$H)D0L-U.$5OY1EIY=5F:C2AI-*31!;O*
MLV&<SBDI#[;$6XUY]NK=V^N'MP_B]"_&JNKL\MQ")KTYCYOY-VY^\,Q\/Q#O
M36[7E7B;)RK9%7 .8SJ+@M:BF^"[$M^H>"A"WQ/!*!A]1U[8>1BRO/ Y#Q62
M5HE_7"\J6P($__R.S*B3&;',Z+M1>RI:/S)/7">F8$R:I7BP,D]DF8B[7-RJ
M15FC-."Z/_&$72MQ>_UP(W15U2H14N1 >=5.*%4J+1Y;(U+G(ZYT'I=T(^!K
M7A6R5'G\*#!#Q";#K5SH5%L\R4R^$BAFF>O?)1E3B<4C9/Y6ZU+C%2DO56Q6
MN6Y-+0GA+\SR10WYIS_]818$HY?W'W[A*__EF9!5I6S%VM@BD6JG3\,XR""9
M"YG*/%;"40Y81<@T;1W8:+L65I59!4>$^A:KJB+-=J/2KTIDC+2A>*B72QUK
ME5N1Z"I.3567F UG&P=<5#+20#K-XK/BZB=9*I>+E#R$%R5+7^H<)FF94FRM
M N58CB6Y _TD >&J<XN4:-3@RF,7:[A16O >P@DIL:S68@F2(T-T11J6I<D:
MUX;B$\1TN=O(2JCELK&*HE C_FJE\YPF_DGFC .N G\^%+\JL988R6Q&WI%7
MC"%8S:EV6<J471MV7A9%^LCC.J72Q1*/MJH3.,S>X#'XT)3*$QN%1" IN;%/
MB8%PNF_PQ%(*56J35 +K0H7HP4"=-X/RRJ0Z8: ^%6=V3::5V7&MYU$AXR]8
M'9SEI8(N*F(=0XKZ5JA$<[9@0*8M32<(-<I;B^'16L=K:*#L07/5H)NATJ6;
MZH837L"9DDR/T[KBRI +K&<-IG6""1KXXZKQFJ=QBLF]IQ123:4#.Q-HB2T$
M5K;!@>P1P$YLUY+*'(L- HJ9&B'&3!I8E[O!W*FCRA.+FHHAX:0Q5'Y$"-C"
M9*H/>W*\ _)0,'F*=[JEC1:': HH]8!J4[D$X0S9H+PL9=P4/>*0(.2:F+>I
M/X2(GF]0K&M#1 *2BAT$,_FY)X6R4Y!1#!$798H5,)9I4BEMDU<\Q;NM5B:"
MU,3L(@E.S#8L+O"<\*(NXW4KMC=]0]@@O1\0KPQ9(ZR#>[J$$D.)KZARQ3R5
MJGP%WN)J'Y-@?RP>E2P1OSO"4$)Q@D2UP=Q6?ZY6!L):R+(-R&B2&@8L$"5S
M9[&$2$M%4T@&C#\B'6&C@\)P:#^':UM;+GI5!JI5Z,B@-<58)?[VXEX^NE"Q
M4<0@M:TQ[+$Q>)$J1\@>&,J] -(Y\R97;,(0ZUFB'1>ECVS['D8H!Z[X51\O
M#7UV&:=A#B#;Y'LN.DWZ>658P;!RQY)MY&=MX"EU=[06DA#(OC$EUG@:?$^,
M=SJXN[D?G-$:P(1&RP@Q?%.-H(*,0NW4%O+1%8>N!"TVBJ/3+;XT!8L Z!-(
M*9E> *MRA;==S:4T&D;KW_$T40N4(Q:A51-V=IP,OKDG'3+YC,:/@+%6Q&30
MV,@EQ@/J*(X2??2">(,1"87Y2CER(6)&;KB:6Q=H8H[_#:RD=6 )BU#@%^+O
MC"%%O9M YZ6R!0!"W=?I':NN*QA7G7$SQFN1^+!;^DQKXD3,YUX8A'0Q]L)H
M)F[[^>9!%U" XL4"T%(?OTNVR<;LT/.#P/T#X7=M6$W^1$<1H!+"^5A\XO)8
M'BAD,6'HQ(W#$?H&K&8M(CJ:0_+<YL;M,_:;*EJJ_[>(O29-A00Y<[O#K001
M!U'#=JG,H*YV>-WFK>?N12_RO5Z#L7] QR=B-O=F@>_R,4=(GY_<+,O;R6U<
M;[L7_W8*XCR*!#2%<W'?;Q-_DEGQ4KSM,MRTB&9!E>^<1YO'Z.7H.+=[Q7&Q
M#[A*G/IG(,&)-YK/130+O!#_MP=.1,*//'\TYN'73=!)!3<8_8;RJ61RXIH4
M[;<DKC[9G59>?T'_9 H=BUD4@!BY)?JJ 0IP1M.K.J^IWJ%D)JYS]'JIN%>%
M*1GHM-N$?R_^W'29B2K;A8\E-3&2,3,6MZ.E@W1;Y:U5Q(7/.#=C7)_,PN$(
MVTJL!B8?[M;';J/^G]7(3BEXW,@7MD?B;E5N.9>Y[6S?Q$.^:79R^P2TLRUI
M\'4"8(3>9$(%$$5C+YI.Q>NZI#@)BG.3JKVZZ<KM44S&WG0>B8GO!:/)@<H^
M"T63$$B<B"@8<:$Y-GI.LN;B' <S;S8?L9D!&&]+EXV/O8*Q+9?YH3>?173A
M<'T=QW56NU0D?68]G7C8F9V)4R;1LZTP#UT'29IZTPD+@L73T5.!V273$Q%X
MX^F,>328A7O<WG=M&H4T!M*?(N7=(( SF* FWCB:HE6A-,*5ZZ^('-C@7M&9
M4I=W\8EP<\ %+YHN:#X,Q&RXM^QL7P?#L0B'X:&6-RT(N2TX$#\91N*/S>^>
MZ(@?NM_WTM9EL\U]@KH/E]V]M6*K=\MCM,[0H0I=[Y1& Y'F#X7"+#\% T\Y
M4Y-Q1$\#,?>!^[F8HHAP'PJJ"*S,/K\&MN?>9#8!K.AV+,9S+YJ 4*F'0/^S
MM*QNXOE^(%I4NTQ\;/NAJ0\DC7QD,D*1O*.]$S8;M=M9-"OWJ3\#UGUP\.D,
M6'1R^A7@8'#-D3N@@&TW*;L>\^G-1[_]I[W$_BX"X9;-%H#V H_*=?742U'7
M21O=TGS3M&L"59\0ECI>_,0;C .UO$ENA1"G<RX.^E4(#W=V!=\Y@!IW!U#C
M__( ZD?F'0^@C@=0QP.HXP'4\0#J> !U/( Z'D =#Z".!U#' ZCC =3Q .IX
M '4\@#H>0!T/H/[_#J#.>]^090K-(WTIAT:2L.D^)^N>=A_C7;MOT+;#W9=\
M[]%[ZIR6B26FCH;3\<!Q9'MC3<%?I"V,M2;CR[626&9H -XOC;'M#2GH/E&\
M^A=02P,$%     @ &'UP4OILK6(V#0  -B$  !D   !X;"]W;W)K<VAE971S
M+W-H965T,3<N>&ULI5IM<]LV$OXK&)_OQIZA99'4:]YF%-MMW6D2CYVT=W-S
M'R 1DM"0A J"5MQ??\\N0(JRY31MOU@2!2SVY=G=9R&_VAK[N5HKY<27(B^K
MUT=KYS8OSL^KQ5H5LNJ9C2KQS=+80CI\M*OS:F.5S'A3D9\G_?[HO)"Z/'KS
MBI_=V#>O3.UR7:H;*ZJZ**1]>*MRLWU]%!\U#V[U:NWHP?F;5QNY4G?*?=K<
M6'PZ;Z5DNE!EI4TIK%J^/IK%+]X.:#TO^%FK;=5Y+\B2N3&?Z<-U]OJH3PJI
M7"T<29!XN5<7*L])$-3X+<@\:H^DC=WWC?3OV';8,I>5NC#Y+SISZ]='DR.1
MJ:6L<W=KMC^H8,^0Y"U,7O%?L?5KT_1(+.K*F2)LA@:%+OVK_!+\T-DPZ3^S
M(0D;$M;;'\1:7DHGW[RR9BLLK88T>L.F\FXHITL*RIVS^%9CGWMS_?[BP[LK
M\7'V[ZN[5^<.$NGY^2+L?NMW)\_LCA/QSI1N78FK,E/9OH!SJ-+JDS3ZO$V^
M*O%2+7HBC2.1])/^5^2EK7TIRTN?LZ]<F$*)C_*+N-35(C=5;97X[VQ>.0M$
M_.\K1PS:(P9\Q. ONO#;=PL 3;BU$@]*VDHH\JF 1U0Q5[;U"OV-IT*6&;V9
M1&*KD!X+LRKU[UBOO<4.%JLOR-U*"3S86%WA2[-D^4N3(QMUN1(GNL034U<0
M5YV^>'J:/XP.$M^I3%F9 Y;6JM+Q$<?B)!F.3NDU'L7\.AX-3\6=DT[MK3R)
MHU%_<BK&T3@>XF\R2L4'*&/W5B5CD20XKCT,&:;P=>9EI/WT5*11.AWAW CJ
M-2?M+4NC?CH4)X-H/,!RO,;]P:FX?NJ88S&9#O%W%"7)%*_I="!F[,QRH7,M
MN7 $GU4XIW;&/HA/O;N>6 ;]+)U.L5#+I>(2PX\JH2LAJ^#IZH7X#X?TZG!(
M#S@Y.#<>3T^]@FE,ZD;P=C!Y:66Y6".LM#82)2HX5&WTFJM2+;43X_$4_IA,
M8Q%':9H$EY>P"YK44'B>J\8?E4C[L1B-!V(PCL5[. ');6$!(4673EE5.5A6
MBHVTKE2V6NM-19$8#Q!91'B2#/@U2<>GXF(MRY7B]?<RK[TW)?D#BBL$DX,S
M2DZAVGC4%[?*U19P-&)CS;WFN@_9R3!AF2G)CJ,!8G1S<R-^,A)?3X: P+_^
M,4GBY&7[^CV:D<#F!2M YP=#GJP\F40,J<L6/K969S6,HI :]M4@FJ13@G7,
M6$J&4.,3#+".CJ$XM>I6T*^?$C;C,>G:'XR"PUM,D2>=*BH!E,<4W_B;D=DJ
MN4MQ>!==C%H<8Y0PP%(8BQ5#5Q4;8]%O1:;Q%(FVP*:Y<ENEX!=I[0/I) M3
MEWZ'K"KEO .0 G/H[+0B)%NQU"5"IP$O^K93::S"(8X$;6J[,00E=N &6.3'
M*+R5/PURMM)F54]\J.U^WCYS<E.^_DSINGPJ]T4GU=Y3LNPIAW..Q7 :Q<,!
MN7L G/7%;+$ 'K).?D33P02(2"9]\6&W7X$7M"H_B#A!R0%FXF04#0&!J]]J
M>DQV0(S/@SB:]E/*263;K,T)<G)FZKE;UO#Q8N&#DB"A)@/41H"A'P 5Q]$0
M[7<0C>*1^/E0>@VC-$8EIE?*SH_&(6ZM7Z@CSKR_CW' *!HEA+=XFD;Q>++O
MOTXP7H@;2XZ#.5ST8-FFH.)] IN3*56!432@I/S>F&RK\QS?3/ $^4!+1E08
MKDN'Q*3*@^(Q]6T!VT8CU+K'7K5$J\[,\JS&!PXDDB9.HBEU';R#=2,DI'<*
M"8FG;/,P[A^T^:<.L*B^3A"(=.(;V' "_;"-T/'441X6H\G8OQD""#-.F ,=
MFI!Z@7#+\D&L9=96Y?()[O:3@O-O@WKR18-QJOQ!'"?#N#<"]4,5-B6:_5HO
MUKN4P'JDD"YUZ$*Z;#\^/4LAZ7Y1?U>A>#+J)8\50H9H$"OI4.JM1E+Z?H&Z
MC\IA3=&A-?!02D4^Z:?CB)4FA9Z<>CP:]@;-,?3@D#WA],R@H[F@1*_MH0=W
MK- 8J4-GG5+R*(+QV*MC[O%HY]'<8[Z0#T%(CB=S)6IB5C#(+)<$DWI#'R;]
M?W([KAT13F21I$9+&OFRV1,?.QB!FPR[H>+6_A>B,ASWIG\O*'U\M*9>K2DR
MT][SX#Y.!CM$TAJ#0O[-@)(+U S?Q:@MEV$\VVJW9GW@_M@OJG3#OV[E/9K5
M#R;/(+1B A91U^QQ0,*NZ>-=[^O<K/07\8.2N5LW&^"0JI[_RBW3H+05VG'I
MI$Z:,R[P&"*U%;5#I?C=%]8:,+#B+FB;3I*&%UZ32TM8?JN@9$TQS0B#/O!F
M&VA2("-,"C.%+1CF<-:?$PN'U3F 6ULN=ZP\K^YJ>C!5'O?>7T@61FN<#BV
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M,-A""_#]TB#YP@<ZH/U7B3?_!U!+ P04    "  8?7!2^S3FZ08(   -%0
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MM/0V$'N8>KME L*L/;_Z-#^)]AVY&839U?7.^_35M2<0FT/JH-L^79BO5E
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MYNU;0JSI]%D0N"77-/[C+ +3]N=VXG05>N)&.^JPX;>D)PV--Z#]K=:NF_@
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M'6P#I :YE\ZC'':VC/)'D906:_64N!PS&/HJY@QO%%-6Y<Y)!@)BU])#QEJ
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MX^L/=?Z"OV7@X!AIZ%.4 [EV)$I&F_XMRY-Y\)&I[29_!)/H3P; X6\?;XX
M* @\HFHS581H^)AD#T R=#BK>-8*;L4' 2;L9N7$.#1S-CP7T8&L&&LEY:K6
M$>X[!A)RD ;DSA,%C_R+.5C1?P!O*(GC6=-U%<_GB9''I$28Y^!+ D%DW6_X
MW4(ABH)>19Y%]F]F*'@>4?"E)#Q7B*:\(= "8XG-,+[B4E<8MUFK;)TH%CTK
M<FN5P1((@X8$ ,R$:SGN58 *QFQ*L3E@A]HE]K ID/;93V 5V&)3D!D-HI6$
M(DEC,*?F1"+ W%S)O8AFXJ4E<VTK8"F4OPTG@$2"F"@7Z 1( TXEB1?LA\^S
M@BT-@A-_'$K(BMVP;'XMLV<X]3S4(F*3DCQS7*5TA!N,ZNC@A]&?&+%VXC:P
M@4N+%.4S^J]8> ))$S@N0>-:/< IZW@PS6_TL#<GO587L ,4<48C## DM.BY
MT1:-_A8&;_JMMGF<E+AW"7";Z3)6">B2;[JGK9[_.RY,S'%D6P#>AXU1TM^<
M5(?#QV^C[6RI9E^"VSPK1<6!CX]YM$+M!, 6%\N*;V:8Y:"3/\4YR,L!JK43
M!9K7@F89Z7C15,T 6J Y:SE$O,&(L &J-7<<X6T&@N^L\Y0+6JD,#9 7<2#:
MA?[^Q<@$!Q?10_O FC![>1$ZN8I7#YN\4-9L-IP#QH7S[=#;\*'+6ZD%/<;Z
MA-7XP5X2;8:Z >!:<W84'WB&;6AA8F& .BO\%8'Q1RB-@1VV&B@T0$$D5(1G
MC/#D;6!U(>7HIV89VO@A2F=J, M=J3)LAO8MJUBX*#IVB6;*T6J8#UV83[V
MR8U#4@@WD1H8P$ 1+"H<@SPR3H4YG3& 5X<T68QZC'F:D3YE<*^,OJ('9$.X
MX?IZA<A#-MOPZV64+#@E@0TEU!;Q?58A'Y3,3VA8QHDE=H,(+'20ZYKQ=A\%
M5!F4=9S"967+:&ZG>]-QZ;Q^DS;L5X56A82BPMV;":)MFT][H,T9> ]Q"J-%
MLQS56!,B(W<!HFD%!9K);I]J<V%4FXN]&HCD!DV#R6@X&G\>O+L:U:DQWSR(
MB8!,-P^H&Y8< R-_%GN$C(7'K)WI$-W+QJRI^BNML2&,%W4"U[$0&J=/C:=8
M0DF:5QP7:P0LX@9+6F:9S+1A)'*=8BX K-IS:I!I+(Y2CG"!^(I+DK7:OI45
MDH/.1F[$CD4SREBL52/:=5:P2QFS!BB&X)C/9 ))'%/'XV)TR4N<3>*SCNUM
M#6Y:/[U!_CW2H($V.39*EJMQ5?A&'<"TC,N-=:H"6CJ1OYKCY&-,L_08MXY2
MP/.#,*WY>3AU#!YU/')WX,[K9Q+7J;-T;=X$B@+UJ%])V%:B07@@<?'%=3\P
M[]&#&N_PPP88I'#9Z/$1S9?2\;L0X%S!6K@*6T@A/L!Y[8@O+!\AT;' 0Q6?
M'3N- 3O$KP\&_)ON1:NO&5<+M8J94G/-D.AE$7&UV6$FY,"2@_QM4;$,%L"P
MA>?P(Q6!7G".1US'H (2!3:10 =.]-=:E+"C:IT5<>F^K1]/,I0C(%OU"_5,
MW2#XFV[;0L*1$2Q8A#H4;8@/P<4UP/EY1CD_@, )J 4NPKL^$\2WE,[A,2<+
M*2\UQY)D"(PWH%<]R\G1P\Z79!\S[K1M F=[+R>=WKR_^PT$>2"19.2H-Q^N
MQTT!_;\PG!>C+K)%^<P9$>+(7D:8?O6D$L KYB@%6"Y%< MZ/^K[ S!&X5D
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M\<=U'C-'9LF#=3(KY;Q'J1JNI,8#R,HEIV-C#EEA3I\?8$TM2[+';36!'TP
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MWOIUDVQW7ZJ%J.8U_IU"%@.84;D#LB'*4J\.L=E_*4U\F<=Z-3?-FIT)MMA
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M.</BB1;@]X409?-""-I_1YS^!U!+ P04    "  8?7!2*L!B(/H"   1!@
M&0   'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q]56UOVC 0_BNG:!]:"34O
MO!8!4J#=AM2MK-!-V[0/)CF(-<=FME.V?[^S RF56B1$SN>[YWGLW%U&>Z5_
MFP+1PM]22#,."FMWPS T68$E,U=JAY)V-DJ7S-)2;T.ST\ARGU2*,(FB7E@R
M+H/)R/L6>C)2E15<XD*#J<J2Z7]3%&H_#N+@Z'C@V\(Z1S@9[=@6EV@?=PM-
MJ[!!R7F)TG E0>-F'*3Q<-IQ\3[@*\>].;'!G62MU&^WF.?C('*"4&!F'0*C
MQQ/.4 @'1#+^'#"#AM(EGMI']/?^['26-3,X4^(;SVTQ#@8!Y+AAE; /:O\1
M#^?I.KQ,">/_85_']CL!9)6QJCPDDX*2R_K)_A[NX21A$+V1D!P2$J^[)O(J
M;YAEDY%6>] NFM"<X8_JLTD<E^ZE+*VF74YY=O(^G<WOYJOOD,Z^/,Z7\]7\
M_O,2TL\W<#-?+NZ/CHL56PLTEZ/0$JE+#;,#P;0F2-X@B!/XI*0M#-S*'/.7
M "&I;20G1\G3Y"SB#697T(Y;D$1)= :OW5Q!V^.UW\";5H8\QL!,E6LNF:L6
M S_3M;&:BN;7&8I.0]'Q%)TW*);42WDE$-0&&KHT^U-QPVLZO]"80VH,6@-,
M>K,JR77'V9H+"D3SVOV?I79-/30[EN$XH*XUJ)\PF'Q#JJ$<@<&&<0U/3%1(
MM6Q1EX<+<$IM01%'7>Q9%SOH$L^ZO-_%;Y2@/N=R"WO42&V;*4VO'2ZXI'U5
M&0HTET/XL8#4"B8MSYQ]*\JBTL;"0M.\T?:?![PE[AU-  OOH-^Z;L?TC*-6
M;Q"#GQY.Y*/!XYWU6C'MQ$FKVX_AGM3H9B>!?A?FTC*YY53(1W\W<K\76">7
M#1<>\1(N:LQ+^*!4ON="P" 90-SJ]-JPNE^E=Z1KT!KTO;ZDE?2NX;6B"4_:
MM$2]]</(0*8J:>N.;;S-O$OK-G\.KX?E)Z:WG,I&X(92HZM^-P!=#Z!Z8=7.
M-_U:61HAWBQH9J-V ;2_4<H>%XZ@^0I,_@-02P,$%     @ &'UP4GNQ[]2B
M!0  40X  !D   !X;"]W;W)K<VAE971S+W-H965T,C,N>&ULI5=[;^(X$/\J
M(ZXZ[4HY2)P 2;>M1!_75M>7@-M*>[H_3#(0WR9QUC:EW4]_8P<H[;;=1950
MG!C/;]X/[RVD^JIS1 /W95'I_59N3+W;Z>@TQY+KMJRQHG^F4I7<T*>:=72M
MD&>.J"PZS/=[G9*+JG6PY_9NU,&>G)M"5'BC0,_+DJN'0RSD8K\5M%8;0S'+
MC=WH'.S5?(8C-'_7-XJ^.FN43)18:2$K4#C=;PV"W<.N/>\.?!:XT!OO8#69
M2/G5?IQG^RW?"H0%IL8B<%KN\ B+P@*1&-^6F*TU2TNX^;Y"_]/I3KI,N,8C
M6=R*S.3[K;@%&4[YO#!#N3C#I3Y.P%06VCUAT9SMABU(Y]K(<DE,$I2B:E9^
MO[3#!D'LOT+ E@3,R=TP<E(><\,/]I1<@+*G"<V^.%4=-0DG*NN4D5'TKR Z
M<W!Z?7U\>WYQ 8.K8[@>GYT,X?QJ/+@Z/3^\.('!:'0R'L&',9\4J#_N=0RQ
MM(2== E_V,"S5^ #!I>R,KF&DRK#["E AV1="\Q6 A^R-Q&/,6U#&'C ?.:_
M@1>N#1 ZO/ U TB9+411 *\R.*\,KV:"E(6!UF@T' N=%E+/%<(_@XDVBL+H
MWS?81FNVD6,;O<)V1-F5S8F/G,(3$:Y-CNI'05XR_=L<!C;>A7D 4<%LQ8&R
M&(@!/"!7&M#Z!,BB6$Z(:6/5('%R/-ME/@@-M9)WPM),;#;#!X(VN9QK(M ?
M=^&0%[Q*$;BV:CW'C6$G"F+/3T(89/]1:%-NDX6-!#E7!(V%H "GR@"\*&3*
M7=82CI6WGJLTI^2C8R)U1KO$3*2\@($BC"'/A"SDS.V<*CFO/;AI'[6AS]B&
M>=-O<Z%(>I/3D5GND-VF%BMF*2I#I8Q4<.ZW:HA99<UXAKPP.03OQ;M%;> S
MJ8@/<%[RF:AF<$260.7!Q<41,"]*_$<FF="UU!M,-&^B9HGX(6#AQQ=DFCS
M!5;R'L[L]LI #T]D+9U_="[J1P,3\MGGX0!"+V#=]^KZ%ZKJD;='84W)&_A>
MU^^_%_J+*+[F_ =PYG7[[\8>\E*D<,GS!<^73@FW]/OI:'A%POAL2[JKN0WC
M>PB\,-S0@^I.I:>H+/54R7(E;(Y%YI+:1462L)_D8$(Y& 5>T@^W$^NZJ"A<
MKVD4@,OA>6.3GK^E;D0)W, MT4R4R&;8X 1>'&XISC%BW>3CRNVAQY)D.Y#!
MES_&F.8;N?$[+^M/S[1D7AQO64.^W,#U=UDAW'#UM4&)6;PUQDE1YG-%Q:(Q
M4M0+WW8NE>B=J$_R]I,W&E1WW:"ZO]R@!E4UMZ6VE,J([TUA/KDG,VE\J2^]
M"6RGS%U=\Q3W6U3S-:H[;!V,R0)3265_8<NAL>,&Z%PN-/4BQYMO\L:&MV>+
MG$L$2 N[4C/)*<"<D2=(,V,JE>U6\@Z;ME?AO8$IC8'+!OB\@3&;K_1@]A':
M1V0?72#Y:.2=4I&&L30DSZT;]PB;$S9-KT\%K%$)F9$ =BRV&A&?AN,EK^BT
M[7PP(M5M,SNB <F.%1IV*-I8W/^%-0B]+B4-;41>THNIIK83 KK#BA-R)8UM
MJZDL:S3HVKET8T6Z9A5X5K<DB2".0XAZ?4JA$'[_+68!^T3%WR9W2)C'>$>M
MOB9%;:Y439ZP*((@8NOCKZUAW(.@W8.QXAG"%2_)0TL[$6"_:W^]'O0B^PO]
M!'K=$+KMZ F!H"%E2E8D10HQQ9\R7:U]+_#]Y7.U-Y)3L^ TRY$_LD8SYXI?
MQ0RZ7B_NKI;5;A,1+R7)CK5DZ+LU2F*WLK#G'!G;@<CVJSBR^SVOQZQGN\P+
M:4)Z*8,[&V-^B6KF+C.:G#JO3#/QKW?7]Z5!<TUX/-Y<MBZYHL%#0X%3(O7;
M?<I9U5Q@F@\C:W=IF$A#5Q#WFM.=#Y4]0/]/I32K#\M@?8L\^!]02P,$%
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M6W-'"Q:E2:#S5 A]< Q!N[(G_P!02P,$%     @ &'UP4LWMP@I(!@  KA
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M+>[O4CYHA-PTM?^&*Y![2YIUYNNH\8;,\8:.F_LMU&UUL;?VALRXGKN7,EW
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M($)YN>0,%D(!@/<+(>3VIAB@.8(>_@M02P,$%     @ &'UP4J1YBO+?$@
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MMW+DV1I"6_F!=)X1AI@/]:)D"/>)I"E]1ITYG]%9V9QBK0Y3Y/W'"/P)1MB
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MEQU=+J)H@8J)XO.\*7CF2K<8^3#6;2,*(Z"_1YRKUXEQ4#6B_7\!4$L#!!0
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M:3&A?NIOSL,D^P6[8JS= _-M(GE4&"L%$8OS?_*C"$3% #H-!J@P0&T-<&&
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M!N#S%>=J?Z,W* ZX.O\ 4$L#!!0    ( !A]<%*]LR_'VP,  '@+   9
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MK1:KT;S5SKVTB\*N$=;T@F9\J>T_9<DASX0T;$U8TP3Z/PP L*8,#+X3 LI
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M(V:A#S)!X!_>8[6D4#&$%25#[XX)7."6(J*.C!PL%!!A1061[DE\T0A:BPF
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MLID.:9VW]8P6ZUV+]8GBB_3#_S-7BD?IH<^HQT1R@[X^XUQM3I('Y'M'O?\
M4$L#!!0    ( !A]<%+I)\UUM@(  .L&   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0Q+GAM;(U574_;,!3]*U<1#R!M39.TA:&V4DH85(*"*(R':0]N<MM:
M)'9F.[3LU\]VTJQ VO4E\<<]Y][C*Q_W5UR\R"6B@G66,CEPEDKEYZXKXR5F
M1+9XCDSOS+G(B-)3L7!E+I D%I2EKM]N]]R,4.8,^W;M7@S[O% I97@O0!99
M1L3;"%.^&CB>LUEXH(NE,@ONL)^3!4Y1/>7W0L_<FB6A&3)).0.!\X$3>N=1
MS\3;@!\45W)K#$;)C/,7,QDG Z=M"L(48V48B/Z]X@6FJ2'29?RN.)TZI0%N
MCS?LWZUVK65&)%[P])DF:CEPSAQ(<$Z*5#WPU356>KJ&+^:IM%]85;%M!^)"
M*IY58%U!1EGY)^OJ'+8 7F\'P*\ _D= 9P<@J #!H8!.!>C8DRFEV'.(B"+#
MON K$"9:LYF!/4R+UO(I,VV?*J%WJ<:IX=7=7?0\OKF!<!+!W>/UY0.,)X_A
MY&H\NKF$<#J]?)S"<82*T%3"5Y@0(8AIU8F>/$TC.#XZ@2.@#&YIFNI.RKZK
M=%V&W8VK&D9E#?Z.&CP?;CE32PF7+,'D/8&K!=6J_(VJD;^7,<*X!8'W!?RV
MWVXHZ.)@N/>M 1X=#C_;HR:H>Q18OF!7CSA/5OIT@; $QDP1MJ"S%"&4$I6$
MB,HXY;(0"#_#F51"WZ5?>])VZK0=F[;SO[2Z)X6^GB:E]AE09 UY(7(NL;'9
M)6O7LAK7>1UZG;-6T'=?&XKIUL5T]Q839EPH^H=8L\"U=CV)3<F[GY('K=,Z
M==G\IACO?4ST.<;?XGDGH5=+Z!TN(4=!>=*D8#^)WX4W)$(V]=?=LH$,Q<+:
MJ828%TR5=Z=>K1T[M$;U87VDG;PTWG\TY3-P2\2",@DISC5ENW6J3TB4UEI.
M%,^MV<RXTM9EATO]&J$P 7I_SKG:3$R"^GT;_@502P,$%     @ &'UP4I-X
M*7O_!0  .R4  !D   !X;"]W;W)K<VAE971S+W-H965T-#(N>&ULO=I=;]HZ
M& ?PKV*A76S2V8A?@8DBT=)ME;IN&MW9Q=&Y<(F!:$G,20RL^_3'22AF<AP"
MLKAI>?/S?QR2'X9DN)79SWPIA *_DCC-KSI+I5;ON]U\MA0)S]_)E4CU,W.9
M)5SIN]FBFZ\RP<-R4!)W41"P;L*CM#,:EH]]S49#N59QE(JO&<C72<*SYVL1
MR^U5!W9>'O@6+9:J>* [&J[X0DR%^K[ZFNE[W7V5,$I$FD<R!9F87W7&\/TU
M&Q0#RE?\'8EM?G ;%%-YDO)G<><NO.H$14<B%C-5E.#ZWT;<B#@N*ND^_ML5
M[>PSBX&'MU^J?R@GKR?SQ'-Q(^,?4:B65YU^!X1BSM>Q^B:WG\1N0K2H-Y-Q
M7OX%V]UK@PZ8K7,ED]U@W4$2I=5__FNW(0X&H)YC -H-0&7?55#9Y80K/AIF
M<@NRXM6Z6G&CG&HY6C<7I<6[,E69?C;2X]3HXY<ODQ]W]_=@_# !7QX_W7X#
M=P^/XX>/=]?WMV \G=X^3L'KB5 \BG/P%HS3=,UC,$YDIJ+?O-RR4[VKA.M8
MO &O0)2"QZ5<YSP-\V%7Z0Z+G.YLU\UUU0UR= ,1^"Q3M<S!;1J*\,\"73VU
M_?S0R_RN46/%B9B] QC^!5" @N_3"7C]ZDU#6;S?;+@LBQUE/T1II,3;>[U'
MA> N53Q=1$^Q .,\%RH'_]SKUX,[)9+\WX8TLD\C91IQI/VQM9\%SXK9P+K-
M6]7IE76* W(SP@P'P^ZF)IWNT^GIZ:@NO:K##M/)H%^?SO;I[/1T7)?.['2$
M67UZ;Y_>.SV=U*7WK'34AXZY]_?I_=/3:5UZWTZG?5*?/MBG#TY,5TNAY9\K
MD=7U,+"W/V.H5]\$# Q009LVRBZ45#RN926PPBG" ^P(/] 1-H9_YJG^;-*?
M0@I,1;:)9@+<:* R_6&2-QS8$)D = %(H'$+8D^4[ K]L4^AONOM-)3!,RRK
MU617J&4#1C-X!F>UH$#;LX8&#&CP#-%J38$V:0T-&-/@&:C5L@)K5',W8%B#
MI[K6+ NT>8.88M?1;8"#K80[0LO ^DQ%9, <M"/C&FIV[4>Y8-1'/=^(3",#
M^.%668DLDJ%>]Q8KZRA=% NK8DO5+JJ.),&@&@KTC:1:7B$"0O[<1!@R1J)F
M(V_D1J1<"YE*I3<CF,ED)92>3QH"6;RQ^I'C9")#)KH$F<B0B7R1N2MTN*O
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M)E:<W%[HMPTMUNF=>"8TWK#3QQ5^!#%I O#]0J#\6<-<L_//JLY/4$L#!!0
M   ( !A]<%+:T7$"60(  %P%   9    >&PO=V]R:W-H965T<R]S:&5E=#0W
M+GAM;(5486_:,!#]*Z>H'UII:T("H:T@4H!60VH[5.BF:=H' P>QZMB9[4#[
M[V<[:<;6T'Y)[NQ[]]Y+?![LA7Q2&:*&YYQQ-?0RK8LKWU>K#'.BSD6!W.QL
MA,R)-JG<^JJ02-8.E#,_#(+8SPGE7C)P:S.9#$2I&>4XDZ#*/"?R981,[(=>
MQWM=>*#;3-L%/QD49(MSU(_%3)K,;[JL:8Y<4<%!XF;HI9VK46SK7<$WBGMU
M$(-ULA3BR2;3]= +K"!DN-*V S&O'8Z1,=O(R/A=]_0:2@L\C%^[WSCOQLN2
M*!P+]IVN=3;T+CQ8XX:43#^(_1>L_?1LOY5@RCUA7]<&'JQ*I45>@XV"G/+J
M39[K[W  "#M' &$-")WNBLBIG!!-DH$4>Y"VVG2S@;/JT$8<Y?:GS+4TN]3@
M=#)^N)Y,%W"3CJ>WT\7T>@[I_03NORY,-$M_I*/;:SB=H":4*?@,*><E87 O
M-,*,O) E0[@CNI144U1G< *4PR(3I2)\K0:^-A(MD;^JY8PJ.>$1.1-<G4/4
M^01A$ :/\PF<GIS]V\4W!AN78>,R=&VC(VW_2@2Q<>K5JWP%/].ETM(<CU_O
M,$4-4^28ND>8C.Y.F^T*U7<H.RB[I!O%_6#@[UK(N@U9]R.RL(VL0L6'9-W^
M9:^=K->0]3XBB]K(>F_(>OWH,KIH9XL;MOA=MH70YIQQ]Z>*^J")):-;8H>Y
M]63%;SYQ'(?=(/I/B'\P+/;>N2-R2[D"AAL##,[[QI"L9KE*M"C<_"R%-M/H
MPLQ<?RAM@=G?"*.R3NQ(-A=J\@=02P,$%     @ &'UP4M'R52AJ"0  B3L
M !D   !X;"]W;W)K<VAE971S+W-H965T-#@N>&ULS9MM;^,V$H#_"N&[Z_6
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MDPLT=7&:(E7/;4J]C0F FZ[=BPF DZ[FF*%<-]&.(1H;\593[!8 NVS0.*3
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MLT#/KSA7SQUSF19OH? O4$L#!!0    ( !A]<%(<$7W;.P,  (P.   9
M>&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;+67:V_:,!2&_XJ5:=4F;21V J4=
M(''5F%B'H-LT3?M@X !6G9@YYE)I/WZV@02FD10)OD!\.:_/>6Q>XLI:R*=X
M#J#0)N117'7F2BWN73<>SR&D<4$L(-(C4R%#JG13SMQX(8%.;%#(7>)Y)3>D
M+')J%=O7E[6*6"K.(NA+%"_#D,KG!G"QKCK8V7<,V&RN3(=;JRSH#(:@OB[Z
M4K?<1&7"0HAB)B(D85IUZOB^08HFP,[XQF ='SPC4\I(B"?3Z$ZJCF<R @YC
M922H_EI!$S@W2CJ/WSM1)UG3!!X^[]4[MGA=S(C&T!3\.YNH>=4I.V@"4[KD
M:B#6'V%7D$UP+'AL/]%Z-]=ST'@9*Q'N@G4&(8NVWW2S W$0@(,3 6070&S>
MVX5LEBVJ:*TBQ1I),UNKF0=;JHW6R;'([,I023W*=)RJ-0?M5O<1=>K-;J_[
MV&T/4?VAA1Z^/.JG?OU'O=%KHS<M4)3Q&+U'GZF<L0@-[0E #8UC@C3;'JQ
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M+BR[KN2OG5IV5,-^S3/2I^==&U0Y#%KED/"BN)C H&G-;JJ[W[2JF:EHV <
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M@1URW:2V@\DGY#%3,RXTNCA%R*#>PN2K?.C,%T8NW-SV+ U.@>YUCH,Z*'L
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MGG0<_S5.!VV?QO#R^>3]DX77,&LJ8<[+OXJ-VET/T@':0$[K4CWPPQ_0 -D
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MJT2')HY7K>.+XGM[^5ASI:\R]G&GKZ<@C$!_SSE7IQ?307OAG?T/4$L#!!0
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MKK#U>R#9*BVR FP89)3G__BI*,0> ,8M %0 T%M V (("D!P*" L .&A@*@
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M/O+T4G&ZT>+0GLO70IM3?GNY-R]B5%J!^7\KA'ZYL4?][M5N^1]02P,$%
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M5!#&0*]O.%?O Q.@Z7KG_P-02P,$%     @ &'UP4FB3SX\6!@  JQ\  !D
M  !X;"]W;W)K<VAE971S+W-H965T-C(N>&ULS5E;;]LV%/XKA%%@+9#&XL47
M%8D!QT[18$L3Q,WV,.R!D6E;J"2Z)&4GPW[\2$DVY8LH=5D YR&699Z/'WD.
MOW-(7JRY^"X7C"GP'$>)O&PME%I^:K=EL& QE>=\R1+]RXR+F"K]5<S;<BD8
MG69&<=1&GM=MQS1,6H.+[-V]&%SP5$5APNX%D&D<4_%RQ2*^OFS!UN;%0SA?
M*/.B/;A8TCF;,/6XO!?Z6WN+,@UCELB0)T"PV65K"#^-B6\,LA:_AVPM2\_
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M[!/4VPO9!@UW)\.J/':7X#MB OX!]7M_;.4:GT@QCJUT8[=T_P][N9H>Z@\
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M%LL]/%#ER$SO$3<PR:20A$8Q7<$_,Y8DH.Z;EOSW#'ZKQ&\9_-8)_-E\^%$
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M(]WZK7-7<^A]224N"8HDL,! ;_\05W59G",7-UID]DQU+K06J;U< <65SWR
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M"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ &'UP4KYAM!4R!0  "RP   \
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M.]OT;_EL_"/:X@502P$"% ,4    "  8?7!2!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( !A]<%)W
MS:.T[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( !A]<%*97)PC$ 8  )PG   3              "  <T!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ &'UP4B[[".NB!@
M0QH  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( !A]<%([6?5.80<  ,<=   8              " @>8.
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  8?7!2] NM
M#H4"  "6!@  &               @(%]%@  >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ &'UP4LMJAQB#!P  AQX  !@
M ("!.!D  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( !A]
M<%+A7L/FU@,  %4+   8              " @?$@  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    "  8?7!2!$2:\NX)  ";-P  &
M        @('])   >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ &'UP4GZ8JEH[#0  ^#P  !@              ("!(2\  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( !A]<%(Y<>'-@0T  +0C   8
M              " @9(\  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    "  8?7!2YI=1UG$M  "!A0  &               @(%)2@  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ &'UP4A#Q 0]T"
M=Q8  !D              ("!\'<  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    "  8?7!2(">R&3<.  #N*P  &0              @(&;
M@   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( !A]<%*:
MK)N;W 8  ( 1   9              " @0F/  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ &'UP4JTH"=A7 P  80<  !D
M     ("!')8  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
M"  8?7!293$3*Z\"  #/!0  &0              @(&JF0  >&PO=V]R:W-H
M965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( !A]<%*9OG':PP\  ",R   9
M              " @9"<  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L!
M A0#%     @ &'UP4@#VE0R*"0  KB@  !D              ("!BJP  'AL
M+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    "  8?7!2^FRM8C8-
M   V(0  &0              @(%+M@  >&PO=V]R:W-H965T<R]S:&5E=#$W
M+GAM;%!+ 0(4 Q0    ( !A]<%+[-.;I!@@   T5   9              "
M@;C#  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ &'UP
M4C_1@'1R P  , <  !D              ("!]<L  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    "  8?7!2!;D74EL\  !&R   &0
M        @(&>SP  >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   ( !A]<%*9)90X_0H  "DA   9              " @3 , 0!X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ &'UP4BK 8B#Z @  $08
M !D              ("!9!<! 'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    "  8?7!2>['OU*(%  !1#@  &0              @(&5&@$
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( !A]<%+-T<GS
M$P,  &,&   9              " @6X@ 0!X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ &'UP4@/];9#! @  O@4  !D
M ("!N",! 'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    "  8
M?7!2S>W""D@&  "N$   &0              @(&P)@$ >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( !A]<%)6K?D!=@4  &D/   9
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M970S,2YX;6Q02P$"% ,4    "  8?7!2I'F*\M\2   &=0  &0
M    @(&21P$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (
M !A]<%*M,@JS]P,  )0.   9              " @:A: 0!X;"]W;W)K<VAE
M971S+W-H965T,S,N>&UL4$L! A0#%     @ &'UP4G>V[!*K!   ?QP  !D
M             ("!UEX! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"
M% ,4    "  8?7!2AV!D7%L%  #L$@  &0              @(&X8P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( !A]<%*]LR_'VP,
M '@+   9              " @4II 0!X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L! A0#%     @ &'UP4A\HT;^(!   )Q   !D              ("!
M7&T! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    "  8?7!2
MLU+CS=,#  "Y#@  &0              @($;<@$ >&PO=V]R:W-H965T<R]S
M:&5E=#,X+GAM;%!+ 0(4 Q0    ( !A]<%++2P\3X@T  #Q:   9
M      " @25V 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%
M  @ &'UP4M[6M(]X!0  1QH  !D              ("!/H0! 'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    "  8?7!2Z2?-=;8"  #K!@
M&0              @('MB0$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+
M 0(4 Q0    ( !A]<%*3>"E[_P4  #LE   9              " @=J, 0!X
M;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ &'UP4CC](Z:#
M P  9@T  !D              ("!$),! 'AL+W=O<FMS:&5E=',O<VAE970T
M,RYX;6Q02P$"% ,4    "  8?7!2M@U_:3P#   9"P  &0
M@('*E@$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( !A]
M<%*^L_8,J@(  /X&   9              " @3V: 0!X;"]W;W)K<VAE971S
M+W-H965T-#4N>&UL4$L! A0#%     @ &'UP4HT:?G3S P  8@T  !D
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M=#4P+GAM;%!+ 0(4 Q0    ( !A]<%*&;P-/'04  ((D   9
M  " @>VS 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @
M&'UP4KE9'H,A P  !@P  !D              ("!0;D! 'AL+W=O<FMS:&5E
M=',O<VAE970U,BYX;6Q02P$"% ,4    "  8?7!2N@D%B:P"  #Y!@  &0
M            @(&9O $ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4
M Q0    ( !A]<%(=8G4F#P,  ),(   9              " @7R_ 0!X;"]W
M;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ &'UP4BO%J7& !
M6A   !D              ("!PL(! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX
M;6Q02P$"% ,4    "  8?7!2>)=X260#  #0#   &0              @(%Y
MQP$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( !A]<%(U
M'S]8! ,  'X)   9              " @13+ 0!X;"]W;W)K<VAE971S+W-H
M965T-3<N>&UL4$L! A0#%     @ &'UP4@.GTCI4!   _ X  !D
M     ("!3\X! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( !A]<%)#3=L#VP0  +D3   9              "
M@5_E 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ &'UP
M4L\K(!U^ P  JPH  !D              ("!<>H! 'AL+W=O<FMS:&5E=',O
M<VAE970V-"YX;6Q02P$"% ,4    "  8?7!20T_;OL0#  !!#P  &0
M        @($F[@$ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0
M   ( !A]<%*FU'#:@ 4  -D7   9              " @2'R 0!X;"]W;W)K
M<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ &'UP4@U4LYM& @  @ L
M  T              ( !V/<! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  8
M?7!2EXJ[',     3 @  "P              @ %)^@$ 7W)E;',O+G)E;'-0
M2P$"% ,4    "  8?7!2OF&T%3(%   ++   #P              @ $R^P$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ &'UP4A[?F5X< @  /2<  !H
M             ( !D0 " 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ &'UP4J5_#G'N 0  D"8  !,              ( !Y0(" %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&     $H 2@ ]%   ! 4"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>360</ContextCount>
  <ElementCount>582</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>154</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENT OF EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENT OF EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - NATURE OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESS</Role>
      <ShortName>NATURE OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2113103 - Disclosure - RECENT ACCOUNTING STANDARDS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS</Role>
      <ShortName>RECENT ACCOUNTING STANDARDS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2114104 - Disclosure - FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS</Role>
      <ShortName>FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2118105 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2123106 - Disclosure - PROPERTY AND EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENT</Role>
      <ShortName>PROPERTY AND EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2127107 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2130108 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2138109 - Disclosure - LEASES (Notes)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/LEASESNotes</Role>
      <ShortName>LEASES (Notes)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2145110 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2152111 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2157112 - Disclosure - SUBSEQUENT EVENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUBSEQUENTEVENTS</Role>
      <ShortName>SUBSEQUENT EVENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2315302 - Disclosure - FACILITY ACQUISITIONS AND DISPOSITIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSTables</Role>
      <ShortName>FACILITY ACQUISITIONS AND DISPOSITIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2319303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2324304 - Disclosure - PROPERTY AND EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/PROPERTYANDEQUIPMENT</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2328305 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2331306 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2339307 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESNotes</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2346308 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXES</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2353309 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - NATURE OF BUSINESS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative</Role>
      <ShortName>NATURE OF BUSINESS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/NATUREOFBUSINESS</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2409405 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2410406 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2411407 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2412408 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2416409 - Disclosure - FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Schedule of Assets and Liabilities Assumed)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed</Role>
      <ShortName>FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Schedule of Assets and Liabilities Assumed)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2417410 - Disclosure - FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative</Role>
      <ShortName>FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2421412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2422413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - PROPERTY AND EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2426415 - Disclosure - PROPERTY AND EQUIPMENT (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative</Role>
      <ShortName>PROPERTY AND EQUIPMENT (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails</Role>
      <ShortName>ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2432417 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2433418 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative</Role>
      <ShortName>CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Term Loans)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Term Loans)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails</Role>
      <ShortName>CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2440423 - Disclosure - LEASES (Details - Additional Information)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsAdditionalInformation</Role>
      <ShortName>LEASES (Details - Additional Information)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2441424 - Disclosure - LEASES (Details - Lease Cost)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsLeaseCost</Role>
      <ShortName>LEASES (Details - Lease Cost)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2442425 - Disclosure - LEASES (Details - Supplemental Cash Flows)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows</Role>
      <ShortName>LEASES (Details - Supplemental Cash Flows)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - LEASES (Details - Supplemental Balance Sheet)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet</Role>
      <ShortName>LEASES (Details - Supplemental Balance Sheet)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2444427 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease</Role>
      <ShortName>LEASES (Details - Maturities of Operating and Finance Lease)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/LEASESTables</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2447428 - Disclosure - INCOME TAXES (Details - Income tax expense)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense</Role>
      <ShortName>INCOME TAXES (Details - Income tax expense)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2448429 - Disclosure - INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates</Role>
      <ShortName>INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>58</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2449430 - Disclosure - INCOME TAXES (Details - Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsNarrative</Role>
      <ShortName>INCOME TAXES (Details - Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2450431 - Disclosure - NCOME TAXES (Details - Deferred tax assets and liabilities)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities</Role>
      <ShortName>NCOME TAXES (Details - Deferred tax assets and liabilities)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2451432 - Disclosure - INCOME TAXES (Details - Unrecognized tax benefit)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit</Role>
      <ShortName>INCOME TAXES (Details - Unrecognized tax benefit)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/INCOMETAXESTables</ParentRole>
      <Position>61</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2454433 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2455434 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2456435 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs</Role>
      <ShortName>STOCK-BASED COMPENSATION (Details - RSU's)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2458436 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative</Role>
      <ShortName>SUBSEQUENT EVENTS (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.radnet.com/role/SUBSEQUENTEVENTS</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="rdnt-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - rdnt-20201231.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - rdnt-20201231.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="rdnt-20201231.htm">rdnt-20201231.htm</File>
    <File>a10k2020exhibit211.htm</File>
    <File>a10k2020exhibit231.htm</File>
    <File>q42020exhibit311.htm</File>
    <File>q42020exhibit312.htm</File>
    <File>q42020exhibit321.htm</File>
    <File>q42020exhibit322.htm</File>
    <File>rdnt-20201231.xsd</File>
    <File>rdnt-20201231_cal.xml</File>
    <File>rdnt-20201231_def.xml</File>
    <File>rdnt-20201231_lab.xml</File>
    <File>rdnt-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>rdnt-20201231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>87
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "rdnt-20201231.htm": {
   "axisCustom": 2,
   "axisStandard": 39,
   "contextCount": 360,
   "dts": {
    "calculationLink": {
     "local": [
      "rdnt-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rdnt-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "rdnt-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rdnt-20201231_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rdnt-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "rdnt-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 840,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 5,
    "http://www.radnet.com/20201231": 1,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 10
   },
   "keyCustom": 89,
   "keyStandard": 493,
   "memberCustom": 95,
   "memberStandard": 47,
   "nsprefix": "rdnt",
   "nsuri": "http://www.radnet.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.radnet.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113103 - Disclosure - RECENT ACCOUNTING STANDARDS",
     "role": "http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS",
     "shortName": "RECENT ACCOUNTING STANDARDS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS",
     "role": "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS",
     "shortName": "FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2118105 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123106 - Disclosure - PROPERTY AND EQUIPMENT",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENT",
     "shortName": "PROPERTY AND EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127107 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES",
     "role": "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130108 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtAndCapitalLeasesDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2138109 - Disclosure - LEASES (Notes)",
     "role": "http://www.radnet.com/role/LEASESNotes",
     "shortName": "LEASES (Notes)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2145110 - Disclosure - INCOME TAXES",
     "role": "http://www.radnet.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152111 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157112 - Disclosure - SUBSEQUENT EVENTS",
     "role": "http://www.radnet.com/role/SUBSEQUENTEVENTS",
     "shortName": "SUBSEQUENT EVENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConsolidationPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315302 - Disclosure - FACILITY ACQUISITIONS AND DISPOSITIONS (Tables)",
     "role": "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSTables",
     "shortName": "FACILITY ACQUISITIONS AND DISPOSITIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2319303 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324304 - Disclosure - PROPERTY AND EQUIPMENT (Tables)",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables",
     "shortName": "PROPERTY AND EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328305 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)",
     "role": "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2331306 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Tables)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2339307 - Disclosure - LEASES (Tables)",
     "role": "http://www.radnet.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2346308 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://www.radnet.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353309 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - NATURE OF BUSINESS (Details Narrative)",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
     "shortName": "NATURE OF BUSINESS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:NumberOfCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Summary of net revenue)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfPrincipalTransactionsRevenueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i2a6ccbfae5264333868c009a4c975e8d_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueNotFromContractWithCustomer",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ReceivablesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "rdnt:ContractsReceivableFactoredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Derivatives)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "us-gaap:DerivativesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i654a8e8ed7bb4f3bbb5cd9c288d0b69d_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409405 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Fair Value Measurements)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410406 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Earnings Per Share)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:EarningsPerSharePolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "0",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesRestrictedStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i1bc65197cb4a4267a98b35b45d061e65_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411407 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Investment in Joint Ventures)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "rdnt:EquityContributionsJointVentures",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412408 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Key Financial Data on Joint Ventures)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:JointVentureInvestmentAndFinancialInformationTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i7c749423cff34945b7292f9e192be48f_I20180101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416409 - Disclosure - FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Schedule of Assets and Liabilities Assumed)",
     "role": "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed",
     "shortName": "FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Schedule of Assets and Liabilities Assumed)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i7c881bdc05b14c6095859ee1b6f1c8b2_I20201101",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i7c749423cff34945b7292f9e192be48f_I20180101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417410 - Disclosure - FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Narrative)",
     "role": "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
     "shortName": "FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "iaeade28b6efd4a5892b49eea2eb7af2c_D20200831-20200831",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:NumberOfBusinessesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "center",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OperatingCostsAndExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i1bc65197cb4a4267a98b35b45d061e65_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Schedule of Goodwill)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i4c84452f39434559bef5a8d233042be6_D20190101-20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:GoodwillDeductibleForTaxPurposes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421412 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:GoodwillDeductibleForTaxPurposes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422413 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)",
     "role": "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Annual Amortization Schedule)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - PROPERTY AND EQUIPMENT (Details)",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
     "shortName": "PROPERTY AND EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426415 - Disclosure - PROPERTY AND EQUIPMENT (Details - Narrative)",
     "role": "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
     "shortName": "PROPERTY AND EQUIPMENT (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)",
     "role": "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails",
     "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermLoansPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432417 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Schedule of Debt)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermLoansPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433418 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Annual Note Payable Maturities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DeferredChargesPolicyTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)",
     "role": "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
     "shortName": "CREDIT FACILITY AND NOTES PAYABLE (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "ib81178c4dfa84fc9bdd6fffca1947078_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if541ba545c6849c9b80ae7c8f6901cfc_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Term Loans)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Term Loans)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if541ba545c6849c9b80ae7c8f6901cfc_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:ScheduleOfLeverageRatioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i8f3bcd1c38c94c46890195526ab00dc7_D20160701-20160701",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rdnt:ScheduleOfLeverageRatioTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i8f3bcd1c38c94c46890195526ab00dc7_D20160701-20160701",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentBasisSpreadOnVariableRate1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "ibacf3bc799af4bb38a866940c2a2c3bb_I20180831",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)",
     "role": "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
     "shortName": "CREDIT FACILITIES AND NOTES PAYABLE (Details - Margin Spread Based on Leverage Ratio, Debt Instrument) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "ibacf3bc799af4bb38a866940c2a2c3bb_I20180831",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i6d7f0a555a284b0d967a505535d69900_D20180101-20181231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440423 - Disclosure - LEASES (Details - Additional Information)",
     "role": "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
     "shortName": "LEASES (Details - Additional Information)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i6d7f0a555a284b0d967a505535d69900_D20180101-20181231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441424 - Disclosure - LEASES (Details - Lease Cost)",
     "role": "http://www.radnet.com/role/LEASESDetailsLeaseCost",
     "shortName": "LEASES (Details - Lease Cost)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442425 - Disclosure - LEASES (Details - Supplemental Cash Flows)",
     "role": "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows",
     "shortName": "LEASES (Details - Supplemental Cash Flows)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - LEASES (Details - Supplemental Balance Sheet)",
     "role": "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet",
     "shortName": "LEASES (Details - Supplemental Balance Sheet)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444427 - Disclosure - LEASES (Details - Maturities of Operating and Finance Lease)",
     "role": "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease",
     "shortName": "LEASES (Details - Maturities of Operating and Finance Lease)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447428 - Disclosure - INCOME TAXES (Details - Income tax expense)",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense",
     "shortName": "INCOME TAXES (Details - Income tax expense)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448429 - Disclosure - INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates)",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates",
     "shortName": "INCOME TAXES (Details - Reconciliation of the statutory U.S. federal rate and effective rates)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449430 - Disclosure - INCOME TAXES (Details - Narrative)",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
     "shortName": "INCOME TAXES (Details - Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "rdnt:DeferredTaxAssetsTaxBenefitMayNotBeRealized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "ibb4c0755ae114d328c14dac7820d1e90_I20171231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENT OF EQUITY",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
     "shortName": "CONSOLIDATED STATEMENT OF EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "ibb4c0755ae114d328c14dac7820d1e90_I20171231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450431 - Disclosure - NCOME TAXES (Details - Deferred tax assets and liabilities)",
     "role": "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities",
     "shortName": "NCOME TAXES (Details - Deferred tax assets and liabilities)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i1bc65197cb4a4267a98b35b45d061e65_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451432 - Disclosure - INCOME TAXES (Details - Unrecognized tax benefit)",
     "role": "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit",
     "shortName": "INCOME TAXES (Details - Unrecognized tax benefit)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i4c84452f39434559bef5a8d233042be6_D20190101-20191231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454433 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
     "shortName": "STOCK-BASED COMPENSATION (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i1e82aebaacf64a089fdc7fe9fdc1e466_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455434 - Disclosure - STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
     "shortName": "STOCK-BASED COMPENSATION (Details-Outstanding options and warrants)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i1e82aebaacf64a089fdc7fe9fdc1e466_I20191231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "ib7d23330ea44497788f06f832afc7e77_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456435 - Disclosure - STOCK-BASED COMPENSATION (Details - RSU's)",
     "role": "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs",
     "shortName": "STOCK-BASED COMPENSATION (Details - RSU's)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "ib7d23330ea44497788f06f832afc7e77_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i36f65120df6f499e96c85073c30fef44_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458436 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)",
     "role": "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
     "shortName": "SUBSEQUENT EVENTS (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i37f85f9b11184e229c14b88e0c866f9a_D20210301-20210316",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "rdnt:OperatingLeaseRightofUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - NATURE OF BUSINESS",
     "role": "http://www.radnet.com/role/NATUREOFBUSINESS",
     "shortName": "NATURE OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "if7577c2631984ff0a8bf58dfbd9d6d0a_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i7c749423cff34945b7292f9e192be48f_I20180101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - rdnt-20201231.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - rdnt-20201231.htm",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "rdnt-20201231.htm",
      "contextRef": "i7c749423cff34945b7292f9e192be48f_I20180101",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 154,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r612",
      "r613",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r615"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r610"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity's Reporting Status Current"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r617"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity a Voluntary Filer"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity a Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r612",
      "r613",
      "r614"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r611"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "rdnt_A2019SWAPS1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 SWAPS1 [Member]",
        "label": "2019 SWAPS1 [Member]",
        "terseLabel": "2019 SWAPS1"
       }
      }
     },
     "localname": "A2019SWAPS1Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_A2019SWAPSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2019 SWAPS [Member]",
        "label": "2019 SWAPS [Member]",
        "terseLabel": "2019 SWAPS"
       }
      }
     },
     "localname": "A2019SWAPSMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AZTechMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AZ Tech Radiology &amp; Open MRI, LLC [Member]",
        "label": "AZ Tech [Member]",
        "terseLabel": "AZ Tech"
       }
      }
     },
     "localname": "AZTechMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AZTechRadiologyOpenMRILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AZ-Tech Radiology &amp; Open MRI, LLC",
        "label": "AZ-Tech Radiology &amp; Open MRI, LLC [Member]",
        "terseLabel": "AZ-Tech Radiology &amp; Open MRI, LLC"
       }
      }
     },
     "localname": "AZTechRadiologyOpenMRILLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AdditionalEquityInterestAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional equity interest acquired",
        "label": "Additional equity interest acquired",
        "terseLabel": "Additional equity interest acquired"
       }
      }
     },
     "localname": "AdditionalEquityInterestAcquired",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest",
        "label": "Adjustment to Additional Paid in Capital, Income Tax Effect from Sale of Noncontrolling Interest",
        "negatedTerseLabel": "Tax effect on gain on sale of noncontrolling interest"
       }
      }
     },
     "localname": "AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromSaleOfNoncontrollingInterest",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_AdvanceMedicarePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advance Medicare Payments",
        "label": "Advance Medicare Payments",
        "terseLabel": "Advance medicare payments"
       }
      }
     },
     "localname": "AdvanceMedicarePayments",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_AggregateIntrinsicValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate Intrinsic Value",
        "label": "Aggregate Intrinsic Value",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "AggregateIntrinsicValue",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_ArizonaDiagnosticRadiologyGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arizona Diagnostic Radiology Group LLC",
        "label": "Arizona Diagnostic Radiology Group LLC [Member]",
        "terseLabel": "Arizona Diagnostic Radiology Group LLC"
       }
      }
     },
     "localname": "ArizonaDiagnosticRadiologyGroupLLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AssetAcquisitionAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_AssetAcquisitionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisition",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Table Text Block] for Assets And Liabilities Lessee [Table]",
        "label": "Assets And Liabilities Lessee [Table Text Block]",
        "terseLabel": "Assets and Liabilities Lessee"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_AwardsIssuedToDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Awards issued to date",
        "label": "Awards issued to date",
        "terseLabel": "Awards issued to date (in shares)"
       }
      }
     },
     "localname": "AwardsIssuedToDate",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BarclaysMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Barclays [Member]",
        "label": "Barclays [Member]",
        "terseLabel": "Barclays"
       }
      }
     },
     "localname": "BarclaysMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BeverlyRadiologyMedicalGroupIIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beverly Radiology Medical Group III [Member]",
        "label": "Beverly Radiology Medical Group III [Member]",
        "terseLabel": "Beverly Radiology Medical Group III"
       }
      }
     },
     "localname": "BeverlyRadiologyMedicalGroupIIIMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BlueShieldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blue Shield [Member]",
        "label": "Blue Shield [Member]",
        "terseLabel": "Blue Shield"
       }
      }
     },
     "localname": "BlueShieldMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BoardMemberMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Board Member [Member]",
        "label": "Board Member [Member]",
        "terseLabel": "Board Member"
       }
      }
     },
     "localname": "BoardMemberMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Contingent Consideration Arrangements, Milestone One, Equity Interest Issued or Issuable, Number of Shares",
        "label": "Business Acquisition, Contingent Consideration Arrangements, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Contingent consideration, milestone one, shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationArrangementsEquityInterestIssuedorIssuableNumberofShares",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares",
        "label": "Business Acquisition, Contingent Consideration Arrangements, Milestone Three, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Contingent consideration, milestone three, shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationArrangementsMilestoneThreeEquityInterestIssuedorIssuableNumberofShares",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares",
        "label": "Business Acquisition, Contingent Consideration Arrangements, Milestone Two, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Contingent consideration, milestone two, shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionContingentConsiderationArrangementsMilestoneTwoEquityInterestIssuedorIssuableNumberofShares",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Replacement Awards",
        "terseLabel": "Fair value of replacement awards attributable to pre-combination"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfReplacementAwards",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued After Execution",
        "terseLabel": "Fair value of shares issued after execution"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAfterExecution",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Fair Value Of Shares Issued At Execution",
        "terseLabel": "Fair value of shares issued at execution"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableFairValueOfSharesIssuedAtExecution",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Maximum Number of Shares Issued After Execution",
        "terseLabel": "Shares issued after execution (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableMaximumNumberofSharesIssuedAfterExecution",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares At Execution",
        "terseLabel": "Shares issued at execution (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesAtExecution",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Issued After Acquisition Term",
        "terseLabel": "Shares issued after acquisition, term"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedorIssuableNumberofSharesIssuedAfterAcquisitionTerm",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Other",
        "terseLabel": "Other assets acquired",
        "verboseLabel": "Other Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Finance Lease Liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Finance Lease Liabilities",
        "terseLabel": "Finance lease liabilities acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedFinanceLeaseLiabilities",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Operating Lease Liabilities",
        "negatedLabel": "Right of Use Liabilities",
        "terseLabel": "Operating lease liabilities acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOperatingLeaseLiabilities",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "label": "Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed Right Of Use Asset",
        "terseLabel": "Right-of-use assets acquired",
        "verboseLabel": "Right of Use Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedRightOfUseAsset",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts",
        "terseLabel": "Unfavorable lease contracts acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContracts",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts, Gross",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Unfavorable Lease Contracts, Gross",
        "terseLabel": "Unfavorable lease contracts acquired, gross"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedUnfavorableLeaseContractsGross",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Step Acquisition, Adjustment Of Investment Balance",
        "label": "Business Combination, Step Acquisition, Adjustment Of Investment Balance",
        "terseLabel": "Adjustment of New Jersey Imaging Network investment balance"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionAdjustmentOfInvestmentBalance",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_BusinessCombinationStepAcquisitionCashAcquired": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Step Acquisition, Cash Acquired",
        "label": "Business Combination, Step Acquisition, Cash Acquired",
        "terseLabel": "Step acquisition, cash acquired"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionCashAcquired",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_CARESActDisclosurePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CARES Act Disclosure Policy",
        "label": "CARES Act Disclosure Policy [Policy Text Block]",
        "terseLabel": "COVID-19 PANDEMIC AND CARES ACT FUNDING"
       }
      }
     },
     "localname": "CARESActDisclosurePolicyPolicyTextBlock",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_CHINationalServicesIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CHI National Services Inc.",
        "label": "CHI National Services Inc. [Member]",
        "terseLabel": "CHI National Services Inc."
       }
      }
     },
     "localname": "CHINationalServicesIncMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_COVID19PandemicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "C O V I D19 Pandemic",
        "label": "C O V I D19 Pandemic [Member]",
        "terseLabel": "C O V I D19 Pandemic"
       }
      }
     },
     "localname": "COVID19PandemicMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CapitalLeaseDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital lease debt",
        "terseLabel": "Capital lease debt"
       }
      }
     },
     "localname": "CapitalLeaseDebt",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_CapitationArrangementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitation Arrangements [Member]",
        "label": "Capitation Arrangements [Member]",
        "terseLabel": "Revenue under capitation arrangements"
       }
      }
     },
     "localname": "CapitationArrangementsMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Caps2016Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "2016 Caps [Member]",
        "terseLabel": "2016 Caps"
       }
      }
     },
     "localname": "Caps2016Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow Lessee [Abstract]",
        "label": "Cash Flow Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_CedarsSinaiMedicalCenterMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cedars Sinai Medical Center [Member]",
        "label": "Cedars Sinai Medical Center [Member]",
        "terseLabel": "Cedars Sinai Medical Center"
       }
      }
     },
     "localname": "CedarsSinaiMedicalCenterMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_CommercialInsurance1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Insurance1 [Member]",
        "label": "Commercial Insurance1 [Member]",
        "terseLabel": "Commercial insurance"
       }
      }
     },
     "localname": "CommercialInsurance1Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ComputerandOfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer and Office Equipment [Member]",
        "label": "Computer and Office Equipment [Member]",
        "terseLabel": "Computer and Office Equipment"
       }
      }
     },
     "localname": "ComputerandOfficeEquipmentMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ContractLossAccrual": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract loss accrual",
        "label": "Contract loss accrual",
        "terseLabel": "Contract loss accrual"
       }
      }
     },
     "localname": "ContractLossAccrual",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ContractLossAccrualWrittenOff": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Loss Accrual, Written Off",
        "label": "Contract Loss Accrual, Written Off",
        "terseLabel": "Contract loss accrual, written off"
       }
      }
     },
     "localname": "ContractLossAccrualWrittenOff",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ContractsReceivableFactoredAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts Receivable, Factored Amount",
        "label": "Contracts Receivable, Factored Amount",
        "terseLabel": "Factored accounts receivable"
       }
      }
     },
     "localname": "ContractsReceivableFactoredAmount",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ContractsReceivableFactoringReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts Receivable, Factoring Receivable",
        "label": "Contracts Receivable, Factoring Receivable",
        "terseLabel": "Factoring receivable"
       }
      }
     },
     "localname": "ContractsReceivableFactoringReceivable",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ContributionsFromNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contributions from noncontrolling interests",
        "terseLabel": "Contributions from noncontrolling interests"
       }
      }
     },
     "localname": "ContributionsFromNoncontrollingInterests",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_CovenantNotToCompeteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Covenant Not To Compete [Member]",
        "terseLabel": "Covenant not to compete and other contracts"
       }
      }
     },
     "localname": "CovenantNotToCompeteMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DebtInstrumentCovenantLeverageRatioMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "label": "Debt Instrument, Covenant, Leverage Ratio, Maximum",
        "terseLabel": "Leverage ratio, less than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLeverageRatioMaximum",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentCovenantLiquidityRatioRequiredMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "label": "Debt Instrument, Covenant, Liquidity Ratio Required, Minimum",
        "terseLabel": "Leverage ratio, greater than"
       }
      }
     },
     "localname": "DebtInstrumentCovenantLiquidityRatioRequiredMinimum",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "rdnt_DebtInstrumentNumberofLoansReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Number of Loans Received",
        "label": "Debt Instrument, Number of Loans Received",
        "terseLabel": "Number of PPP loans received"
       }
      }
     },
     "localname": "DebtInstrumentNumberofLoansReceived",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment, Percent",
        "label": "Debt Instrument, Periodic Payment, Percent",
        "terseLabel": "Debt periodic payment, percent of total amount"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPercent",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_DebtInstrumentPeriodicPaymentTermsAmortizationIncrease": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "label": "Debt Instrument, Periodic Payment Terms, Amortization Increase",
        "terseLabel": "Debt periodic payment, amortization increase"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentTermsAmortizationIncrease",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeepHealthInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DeepHealth, Inc. [Member]",
        "label": "DeepHealth, Inc. [Member]",
        "terseLabel": "DeepHealth, Inc."
       }
      }
     },
     "localname": "DeepHealthInc.Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DeepHealthIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deep Health, Inc. [Member]",
        "label": "Deep Health Inc [Member]",
        "terseLabel": "DeepHealth Inc."
       }
      }
     },
     "localname": "DeepHealthIncMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DeferredTaxAssetsOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Operating Lease Liabilities",
        "label": "Deferred Tax Assets, Operating Lease Liabilities",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLeaseLiabilities",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeferredTaxAssetsTaxBenefitMayNotBeRealized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Benefit May Not Be Realized",
        "label": "Deferred Tax Assets, Tax Benefit May Not Be Realized",
        "terseLabel": "Deferred tax assets, tax benefit may not be realized"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxBenefitMayNotBeRealized",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DeferredTaxLiabilitiesOperatingRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Operating Right-Of-Use Assets",
        "label": "Deferred Tax Liabilities, Operating Right-Of-Use Assets",
        "negatedTerseLabel": "Operating lease right-of-use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOperatingRightOfUseAssets",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_DevelopedtechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology [Member]",
        "label": "Developed technology [Member]",
        "terseLabel": "Developed Technology"
       }
      }
     },
     "localname": "DevelopedtechnologyMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DignityHealth.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dignity Health. [Member]",
        "label": "Dignity Health. [Member]",
        "terseLabel": "Dignity Health."
       }
      }
     },
     "localname": "DignityHealth.Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_DignityHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dignity Health [Member]",
        "terseLabel": "Dignity Health"
       }
      }
     },
     "localname": "DignityHealthMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ERADMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "eRAD [Member]",
        "terseLabel": "eRAD"
       }
      }
     },
     "localname": "ERADMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Gain on Change in Control, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Gain on Change in Control, Amount",
        "terseLabel": "Gain on change in control"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationGainonChangeinControlAmount",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EffectiveIncomeTaxRateReconciliationPPPLoanAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 11.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, PPP Loan, Amount",
        "label": "Effective Income Tax Rate Reconciliation, PPP Loan, Amount",
        "terseLabel": "PPP Loan"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPPPLoanAmount",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquipmentAcquiredAndLeaseholdImprovements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Equipment acquired and leasehold improvements",
        "terseLabel": "Equipment acquired and leasehold improvements"
       }
      }
     },
     "localname": "EquipmentAcquiredAndLeaseholdImprovements",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityContributionsJointVentures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity contributions in existing joint ventures",
        "label": "Equity contributions in existing and purchase of interest in joint ventures",
        "terseLabel": "Equity contributions in existing and purchase of interest in joint ventures"
       }
      }
     },
     "localname": "EquityContributionsJointVentures",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityMethodInvestmentInitialOwnershipPercentageAfterDilution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Initial Ownership Percentage After Dilution",
        "label": "Equity Method Investment, Initial Ownership Percentage After Dilution",
        "terseLabel": "Initial ownership percentage after dilution"
       }
      }
     },
     "localname": "EquityMethodInvestmentInitialOwnershipPercentageAfterDilution",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment Ownership Percentage In Exchange for Assets Contributed",
        "label": "Equity Method Investment Ownership Percentage In Exchange for Assets Contributed",
        "terseLabel": "Equity interest percentage in exchange for assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentageInExchangeforAssetsContributed",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_EquityMethodInvestmentOwnershipPercentageInExchangeforCash": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment Ownership Percentage In Exchange for Cash",
        "label": "Equity Method Investment Ownership Percentage In Exchange for Cash",
        "terseLabel": "Equity interest percentage in exchange for cash"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentageInExchangeforCash",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_EquityMethodInvestmentSharesPurchased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Shares Purchased",
        "label": "Equity Method Investment, Shares Purchased",
        "terseLabel": "Shares purchased (in shares)"
       }
      }
     },
     "localname": "EquityMethodInvestmentSharesPurchased",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Option To Purchase Additional Equity Method Investment",
        "label": "Equity Method Investments, Option To Purchase Additional Equity Method Investment",
        "terseLabel": "Option to purchase additional equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentsOptionToPurchaseAdditionalEquityMethodInvestment",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_EquityMethodInvestmentsOwnershipInterestPercentageAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investments, Ownership Interest Percentage Acquired",
        "label": "Equity Method Investments, Ownership Interest Percentage Acquired",
        "terseLabel": "Ownership interest percentage acquired"
       }
      }
     },
     "localname": "EquityMethodInvestmentsOwnershipInterestPercentageAcquired",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "rdnt_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Assets And Liabilities Lessee [Abstract]",
        "label": "Finance Lease Assets And Liabilities Lessee [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "FinanceLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsLeaseCost": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease Cost",
        "label": "Finance Lease Cost",
        "totalLabel": "Total finance lease cost"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_FirstLienCreditAgreementEighthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Eighth Amendment",
        "label": "First Lien Credit Agreement Eighth Amendment [Member]",
        "terseLabel": "First Lien Credit Agreement Eighth Amendment"
       }
      }
     },
     "localname": "FirstLienCreditAgreementEighthAmendmentMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Lien Credit Agreement [Member]",
        "terseLabel": "First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSeventhAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Seventh Amendment [Member]",
        "label": "First Lien Credit Agreement Seventh Amendment [Member]",
        "terseLabel": "Amendment No. 7 First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSeventhAmendmentMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienCreditAgreementSixthAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Lien Credit Agreement Sixth Amendment [Member]",
        "label": "First Lien Credit Agreement Sixth Amendment [Member]",
        "terseLabel": "Amendment No. 6 First Lien Credit Agreement"
       }
      }
     },
     "localname": "FirstLienCreditAgreementSixthAmendmentMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "First Lien Term Loan [Member]",
        "terseLabel": "First Lien Term Loans"
       }
      }
     },
     "localname": "FirstLienTermLoanMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FirstLienTermLoansAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "FirstLienTermLoansAMember",
        "terseLabel": "FirstLienTermLoansAMember"
       }
      }
     },
     "localname": "FirstLienTermLoansAMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_FutureServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future Services [Member]",
        "label": "Future Service [Member]",
        "terseLabel": "Future Service"
       }
      }
     },
     "localname": "FutureServiceMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_GainLossonStepUpValuation": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (Loss) on Step Up Valuation",
        "label": "Gain (Loss) on Step Up Valuation",
        "negatedLabel": "Gain on re-measurement of pre-existing interest",
        "negatedTerseLabel": "Gain on re-measurement of pre-existing interest"
       }
      }
     },
     "localname": "GainLossonStepUpValuation",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_GardenStateRadiologyNetworkLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Garden State Radiology Network LLC [Member]",
        "label": "Garden State Radiology Network LLC [Member]",
        "terseLabel": "Garden State Radiology Network LLC"
       }
      }
     },
     "localname": "GardenStateRadiologyNetworkLLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_GlendaleAdvancedImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Glendale Advanced Imaging [Member]",
        "terseLabel": "Glendale Advanced Imaging"
       }
      }
     },
     "localname": "GlendaleAdvancedImagingMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_GoodwillDeductibleForTaxPurposes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goodwill deductible for tax purposes",
        "label": "Goodwill deductible for tax purposes",
        "terseLabel": "Goodwill deductible for tax purposes"
       }
      }
     },
     "localname": "GoodwillDeductibleForTaxPurposes",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_HealthCareManagementServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Management Service [Member]",
        "label": "Health Care, Management Service [Member]",
        "terseLabel": "Management fee revenue"
       }
      }
     },
     "localname": "HealthCareManagementServiceMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthCarePatientServiceOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care, Patient Service Other [Member]",
        "label": "Health Care, Patient Service Other [Member]",
        "terseLabel": "Other patient revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceOtherMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HealthInsuranceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Health Insurance [Member]",
        "terseLabel": "Health Insurance"
       }
      }
     },
     "localname": "HealthInsuranceMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_HudsonValleyRadiologyAssociatesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hudson Valley Radiology Associates [Member]",
        "label": "Hudson Valley Radiology Associates [Member]",
        "terseLabel": "Hudson Valley Radiology Associates"
       }
      }
     },
     "localname": "HudsonValleyRadiologyAssociatesMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ImagingOnCallMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Imaging On Call [Member]",
        "label": "Imaging On Call [Member]",
        "terseLabel": "Imaging On Call",
        "verboseLabel": "Imaging on call and software"
       }
      }
     },
     "localname": "ImagingOnCallMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_IncreaseDecreaseInDeferredRent": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period, excluding the portion taken into income, in the liability reflecting rent yet to be earned for which cash or other forms of consideration was received or recorded as a receivable.",
        "label": "Deferred rent",
        "terseLabel": "Deferred rent"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRent",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_IncreaseDecreaseInOtherNoncashItem": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease In Other Noncash Item",
        "label": "Increase Decrease In Other Noncash Item",
        "negatedTerseLabel": "Other non cash item in other expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncashItem",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_IncreaseDecreaseinOperatingLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase Decrease in Operating Lease Liability",
        "label": "Increase Decrease in Operating Lease Liability",
        "negatedTerseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseinOperatingLeaseLiability",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_IncreaseInNoncontrollingInterestDueToStepAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase In Noncontrolling Interest Due To Step Acquisition",
        "label": "Increase In Noncontrolling Interest Due To Step Acquisition",
        "terseLabel": "Re-measurement of noncontrolling interest upon change in control"
       }
      }
     },
     "localname": "IncreaseInNoncontrollingInterestDueToStepAcquisition",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]",
        "terseLabel": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Roll Forward]"
       }
      }
     },
     "localname": "InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesRollForward",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_JointVentureInvestmentAndFinancialInformationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Joint venture investment and financial information",
        "label": "Joint venture investment and financial information [Table Text Block]",
        "terseLabel": "Joint Venture Investment and Financial Information"
       }
      }
     },
     "localname": "JointVentureInvestmentAndFinancialInformationTableTextBlock",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_JointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint Venture [Member]",
        "terseLabel": "Joint Venture"
       }
      }
     },
     "localname": "JointVentureMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_KernRadiologyImagingSystemsInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kern Radiology Imaging Systems Inc. [Member]",
        "label": "Kern Radiology Imaging Systems Inc. [Member]",
        "terseLabel": "Kern Radiology Imaging Systems Inc."
       }
      }
     },
     "localname": "KernRadiologyImagingSystemsInc.Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_KeyFinancialDataForJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Key financial data for joint ventures",
        "label": "Key financial data for joint ventures",
        "terseLabel": "Balance Sheet Data:"
       }
      }
     },
     "localname": "KeyFinancialDataForJointVenturesAbstract",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LeasesWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases Weighted Average Discount Rate [Abstract]",
        "label": "Leases Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Leases Weighted Average Discount Rate [Abstract]"
       }
      }
     },
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LesseeLeaseTermofContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Lease Term of Contract",
        "label": "Lessee Lease Term of Contract",
        "terseLabel": "Lease term of contract"
       }
      }
     },
     "localname": "LesseeLeaseTermofContract",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount",
        "label": "Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount",
        "terseLabel": "Operating lease not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LeverageRatioAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Axis]",
        "terseLabel": "Leverage Ratio [Axis]"
       }
      }
     },
     "localname": "LeverageRatioAxis",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_LeverageRatioDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Leverage Ratio [Axis]",
        "label": "Leverage Ratio [Domain]",
        "terseLabel": "Leverage Ratio [Domain]"
       }
      }
     },
     "localname": "LeverageRatioDomain",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Four [Member]",
        "label": "Leverage Ratio Four [Member]",
        "terseLabel": "\u2264 3.50x"
       }
      }
     },
     "localname": "LeverageRatioFourMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio One [Member]",
        "label": "Leverage Ratio One [Member]",
        "terseLabel": "> 5.50x"
       }
      }
     },
     "localname": "LeverageRatioOneMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Three [Member]",
        "label": "Leverage Ratio Three [Member]",
        "terseLabel": ">3.50x but \u2264 4.00x"
       }
      }
     },
     "localname": "LeverageRatioThreeMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LeverageRatioTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leverage Ratio Two [Member]",
        "label": "Leverage Ratio Two [Member]",
        "terseLabel": "> 4.00x but \u2264 5.50x"
       }
      }
     },
     "localname": "LeverageRatioTwoMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_LineofCreditFacilityIncreaseBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line of Credit Facility, Increase Borrowing Capacity",
        "label": "Line of Credit Facility, Increase Borrowing Capacity",
        "terseLabel": "Line of credit facility, increase borrowing capacity"
       }
      }
     },
     "localname": "LineofCreditFacilityIncreaseBorrowingCapacity",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LongTermContractsTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Contracts, Term",
        "label": "Long-term Contracts, Term",
        "terseLabel": "Long-term contracts, term"
       }
      }
     },
     "localname": "LongTermContractsTerm",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt_1": {
       "order": 1.0,
       "parentTag": "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Current Maturities",
        "label": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Current Maturities",
        "negatedLabel": "Less current portion"
       }
      }
     },
     "localname": "LongtermDebtShorttermDebtandCapitalLeaseObligationsCurrentMaturities",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt_1": {
       "order": 2.0,
       "parentTag": "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Excluding Current Maturities",
        "label": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Excluding Current Maturities",
        "terseLabel": "Long-term portion debt obligations"
       }
      }
     },
     "localname": "LongtermDebtShorttermDebtandCapitalLeaseObligationsExcludingCurrentMaturities",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Including Current Maturities",
        "label": "Long-term Debt, Short-term Debt and Capital Lease Obligations, Including Current Maturities",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_LossandOtherUnfavorableContractsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss and Other Unfavorable Contracts [Policy Text Block]",
        "label": "Loss and Other Unfavorable Contracts [Policy Text Block]",
        "terseLabel": "LOSS AND OTHER UNFAVORABLE CONTRACTS"
       }
      }
     },
     "localname": "LossandOtherUnfavorableContractsPolicyTextBlock",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_MRIatWoodbridgeLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MRI at Woodbridge, LLC [Member]",
        "label": "MRI at Woodbridge, LLC [Member]",
        "terseLabel": "MRI at Woodbridge, LLC"
       }
      }
     },
     "localname": "MRIatWoodbridgeLLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ManagementServiceContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management Service Contracts [Member]",
        "terseLabel": "Management Service Contracts"
       }
      }
     },
     "localname": "ManagementServiceContractsMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ManagementServiceFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Management service fees.",
        "label": "Management service fees",
        "terseLabel": "Management service fees"
       }
      }
     },
     "localname": "ManagementServiceFees",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_MedicVisionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medic Vision [Member]",
        "terseLabel": "Medic Vision"
       }
      }
     },
     "localname": "MedicVisionMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_Medicaid1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid1 [Member]",
        "label": "Medicaid1 [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "Medicaid1Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MedicalArtsRadiologicalGroupPCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Arts Radiological Group, PC [Member]",
        "label": "Medical Arts Radiological Group, PC [Member]",
        "terseLabel": "Medical Arts Radiological Group, PC"
       }
      }
     },
     "localname": "MedicalArtsRadiologicalGroupPCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MedicalArtsRadiologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Arts Radiology [Member]",
        "label": "Medical Arts Radiology [Member]",
        "terseLabel": "Medical Arts Radiology"
       }
      }
     },
     "localname": "MedicalArtsRadiologyMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MedicalEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Equipment [Member]",
        "label": "Medical Equipment [Member]",
        "terseLabel": "Medical Equipment"
       }
      }
     },
     "localname": "MedicalEquipmentMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MedicalInsuranceStopLossPolicyClaimAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Insurance, Stop Loss Policy Claim Amount",
        "label": "Medical Insurance, Stop Loss Policy Claim Amount",
        "terseLabel": "Stop loss policy claim amount"
       }
      }
     },
     "localname": "MedicalInsuranceStopLossPolicyClaimAmount",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_MedicalMalpracticeDeductiblePerIncidence": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical malpractice deductible per incidence",
        "label": "Medical malpractice deductible per incidence",
        "terseLabel": "Medical malpractice deductible per incidence"
       }
      }
     },
     "localname": "MedicalMalpracticeDeductiblePerIncidence",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_Medicare1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare1 [Member]",
        "label": "Medicare1 [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "Medicare1Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_MonthlyAmortizationOfDeferredHedgeGains": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Monthly Amortization Of Deferred Hedge Gains",
        "label": "Monthly Amortization Of Deferred Hedge Gains",
        "terseLabel": "Monthly amortization of deferred hedge gains"
       }
      }
     },
     "localname": "MonthlyAmortizationOfDeferredHedgeGains",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NewJerseyImagingNetworkLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Jersey Imaging Network, LLC [Member]",
        "label": "New Jersey Imaging Network, LLC [Member]",
        "terseLabel": "New Jersey Imaging Network, LLC"
       }
      }
     },
     "localname": "NewJerseyImagingNetworkLLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_NonCashSeverance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non cash severance.",
        "label": "Non cash severance",
        "terseLabel": "Non-cash severance"
       }
      }
     },
     "localname": "NonCashSeverance",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NonCashSeveranceShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non Cash Severance Shares",
        "label": "Non Cash Severance Shares",
        "terseLabel": "Non-cash severance (in shares)"
       }
      }
     },
     "localname": "NonCashSeveranceShares",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "rdnt_NoncontrollingInterestDecreaseFromSpecialDistribution": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Decrease From Special Distribution",
        "label": "Noncontrolling Interest, Decrease From Special Distribution",
        "negatedTerseLabel": "Special distribution from noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromSpecialDistribution",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NoncontrollingInterestSpecialDistribution": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Special Distribution",
        "label": "Noncontrolling Interest, Special Distribution",
        "terseLabel": "Special distribution from noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestSpecialDistribution",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_NulogixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nulogix, Inc. [Member]",
        "terseLabel": "Nulogix, Inc."
       }
      }
     },
     "localname": "NulogixMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_NumberOfCenters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Centers",
        "label": "Number Of Centers",
        "terseLabel": "Number of centers"
       }
      }
     },
     "localname": "NumberOfCenters",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_NumberofUnconsolidatedJointVentures": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Unconsolidated Joint Ventures",
        "label": "Number of Unconsolidated Joint Ventures",
        "terseLabel": "Number of unconsolidated joint ventures"
       }
      }
     },
     "localname": "NumberofUnconsolidatedJointVentures",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "rdnt_October2020CapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "October 2020 [Member]",
        "terseLabel": "October 2020"
       }
      }
     },
     "localname": "October2020CapMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_October2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2023 [Member]",
        "label": "October 2023 [Member]",
        "terseLabel": "October 2023"
       }
      }
     },
     "localname": "October2023Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_October2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2025 [Member]",
        "label": "October 2025 [Member]",
        "terseLabel": "October 2025"
       }
      }
     },
     "localname": "October2025Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_OlneyOpenMRILLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Olney Open MRI, LLC",
        "label": "Olney Open MRI, LLC [Member]",
        "terseLabel": "Olney Open MRI, LLC"
       }
      }
     },
     "localname": "OlneyOpenMRILLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Assets And Liabilities Lessee [Abstract]",
        "label": "Operating Lease Assets And Liabilities Lessee [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_OperatingLeaseRightofUseAssetAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease Right of Use Asset Amortization",
        "label": "Operating Lease Right of Use Asset Amortization",
        "terseLabel": "Amortization of operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightofUseAssetAmortization",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PatientServicesNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patient Services, Net [Member]",
        "label": "Patient Services, Net [Member]",
        "verboseLabel": "Net service fee revenue"
       }
      }
     },
     "localname": "PatientServicesNetMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PaycheckProtectionProgramLoansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Paycheck Protection Program Loans",
        "label": "Paycheck Protection Program Loans [Member]",
        "verboseLabel": "Paycheck Protection Program Loans"
       }
      }
     },
     "localname": "PaycheckProtectionProgramLoansMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PaymentsToAcquireInterestInSubsidiaries": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Interest in Subsidiaries",
        "label": "Payments to Acquire Interest in Subsidiaries",
        "negatedTerseLabel": "Purchase of noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInSubsidiaries",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PaymentstoAcquireEquityMethodInvestmentsAssetsContributed": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Equity Method Investments Assets Contributed",
        "label": "Payments to Acquire Equity Method Investments Assets Contributed",
        "terseLabel": "Payments to acquire equity method investments, Assets"
       }
      }
     },
     "localname": "PaymentstoAcquireEquityMethodInvestmentsAssetsContributed",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PaymentstoAcquireEquityMethodInvestmentsCash": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Equity Method Investments Cash",
        "label": "Payments to Acquire Equity Method Investments Cash",
        "terseLabel": "Payments to acquire equity method investments, cash"
       }
      }
     },
     "localname": "PaymentstoAcquireEquityMethodInvestmentsCash",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PricingLevelIIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level III [Member]",
        "label": "Pricing Level III [Member]",
        "terseLabel": "Pricing Level III"
       }
      }
     },
     "localname": "PricingLevelIIIMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level II [Member]",
        "label": "Pricing Level II [Member]",
        "terseLabel": "Pricing Level II"
       }
      }
     },
     "localname": "PricingLevelIIMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level I [Member]",
        "label": "Pricing Level I [Member]",
        "terseLabel": "Pricing Level I"
       }
      }
     },
     "localname": "PricingLevelIMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelIVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level IV [Member]",
        "label": "Pricing Level IV [Member]",
        "terseLabel": "Pricing Level IV"
       }
      }
     },
     "localname": "PricingLevelIVMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PricingLevelVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pricing Level V [Member]",
        "label": "Pricing Level V [Member]",
        "terseLabel": "Pricing Level V"
       }
      }
     },
     "localname": "PricingLevelVMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PrimedexHealthSystemsInc.andRadiologixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primedex Health Systems Inc. and Radiologix [Member]",
        "label": "Primedex Health Systems Inc. and Radiologix [Member]",
        "terseLabel": "Primedex Health Systems Inc. and Radiologix"
       }
      }
     },
     "localname": "PrimedexHealthSystemsInc.andRadiologixMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ProceedsFromGovernmentAssistance": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Government Assistance",
        "label": "Proceeds From Government Assistance",
        "terseLabel": "Proceeds from paycheck protection program loans"
       }
      }
     },
     "localname": "ProceedsFromGovernmentAssistance",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Government Assistance, General Distribution, CARES Act",
        "label": "Proceeds from Government Assistance, General Distribution, CARES Act",
        "terseLabel": "General distribution funds, CARES Act"
       }
      }
     },
     "localname": "ProceedsFromGovernmentAssistanceGeneralDistributionCARESAct",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_ProceedsReceivedFromInsurance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds Received From Insurance",
        "label": "Proceeds Received From Insurance",
        "terseLabel": "Advance insurance carrier payments"
       }
      }
     },
     "localname": "ProceedsReceivedFromInsurance",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_PropertyAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Propery and equipment, net [Member]",
        "terseLabel": "Propery and equipment, net"
       }
      }
     },
     "localname": "PropertyAndEquipmentMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property, Plant, and Equipment and Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "label": "Property, Plant, and Equipment and Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "totalLabel": "Total property, equipment and right-of-use-assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_RadNetMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RadNet [Member]",
        "label": "RadNet [Member]",
        "terseLabel": "RadNet"
       }
      }
     },
     "localname": "RadNetMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RadiologixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Radiologix [Member]",
        "terseLabel": "Radiologix"
       }
      }
     },
     "localname": "RadiologixMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RamicMahwahLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ramic Mahwah LLC [Member]",
        "label": "Ramic Mahwah LLC [Member]",
        "terseLabel": "Ramic Mahwah LLC"
       }
      }
     },
     "localname": "RamicMahwahLLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RavenHoldingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Raven Holdings [Member]",
        "label": "Raven Holdings [Member]",
        "terseLabel": "Raven Holdings"
       }
      }
     },
     "localname": "RavenHoldingsMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RestatedAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restated Agreement [Member]",
        "label": "Restated Agreement [Member]",
        "terseLabel": "Restated Agreement",
        "verboseLabel": "SunTrust Term Loan Agreement collateralized by NJIN's tangible and intangible assets"
       }
      }
     },
     "localname": "RestatedAgreementMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RestatedPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restated Plan [Member]",
        "terseLabel": "Restated Plan"
       }
      }
     },
     "localname": "RestatedPlanMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "label": "Right Of Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "terseLabel": "Right-of-use &amp; Equipment assets obtained in exchange for lease obligations:"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_SantaMonicaImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Santa Monica Imaging Group [Member]",
        "terseLabel": "Santa Monica Imaging Group"
       }
      }
     },
     "localname": "SantaMonicaImagingMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ScheduleOfLeverageRatioTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Leverage Ratio [Table Text Block]",
        "label": "Schedule Of Leverage Ratio [Table Text Block]",
        "terseLabel": "Schedule of Leverage Ratio"
       }
      }
     },
     "localname": "ScheduleOfLeverageRatioTableTextBlock",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_ScriptSenderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScriptSender LLC [Member]",
        "terseLabel": "ScriptSender LLC"
       }
      }
     },
     "localname": "ScriptSenderMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_September2020CapMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "September 2020 [Member]",
        "terseLabel": "September 2020"
       }
      }
     },
     "localname": "September2020CapMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value",
        "label": "Share-Based Compensation Arrangement By Share-based Payment Award, Options, Grants In Period, Gross, Value",
        "terseLabel": "Issuance of stock upon exercise of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsGrantsInPeriodGrossValue",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_SimiAdventistMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simi Adventist",
        "label": "Simi Adventist [Member]",
        "terseLabel": "Simi Adventist"
       }
      }
     },
     "localname": "SimiAdventistMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SimiValleyImagingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Simi Valley Imaging Group, LLC",
        "label": "Simi Valley Imaging Group, LLC [Member]",
        "terseLabel": "Simi Valley Imaging Group, LLC"
       }
      }
     },
     "localname": "SimiValleyImagingGroupLLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SocialSecurityTaxEmployerDeferralCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Social Security Tax, Employer, Deferral, CARES Act",
        "label": "Social Security Tax, Employer, Deferral, CARES Act",
        "terseLabel": "Deferred social security taxes"
       }
      }
     },
     "localname": "SocialSecurityTaxEmployerDeferralCARESAct",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_StockholdersEquityDeficitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Radnet, Inc.'s Equity [Member]",
        "terseLabel": "Radnet, Inc. Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityDeficitMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_SunTrustMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SunTrust [Member]",
        "label": "SunTrust [Member]",
        "terseLabel": "SunTrust"
       }
      }
     },
     "localname": "SunTrustMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TradeNamesAmortizedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade Names Amortized [Member]",
        "label": "Trade Names Amortized [Member]",
        "terseLabel": "Trade Names amortized"
       }
      }
     },
     "localname": "TradeNamesAmortizedMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TradeNamesIndefiniteLifeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade Names Indefinite Life [Member]",
        "label": "Trade Names Indefinite Life [Member]",
        "terseLabel": "Trade Names indefinite life"
       }
      }
     },
     "localname": "TradeNamesIndefiniteLifeMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TurnerImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Turner Imaging [Member]",
        "terseLabel": "Turner Imaging"
       }
      }
     },
     "localname": "TurnerImagingMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_TurnerImagingSystemsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Turner Imaging Systems [Member]",
        "label": "Turner Imaging Systems [Member]",
        "terseLabel": "Turner Imaging Systems"
       }
      }
     },
     "localname": "TurnerImagingSystemsMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_USAttorneysOfficeForTheWesternDistrictofNewYorkMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Attorneys Office For The Western District of New York [Member]",
        "label": "US Attorneys Office For The Western District of New York [Member]",
        "terseLabel": "US Attorneys Office For The Western District of New York"
       }
      }
     },
     "localname": "USAttorneysOfficeForTheWesternDistrictofNewYorkMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_UninsuredRisksPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uninsured Risks [Policy Text Block]",
        "label": "Uninsured Risks [Policy Text Block]",
        "terseLabel": "UNINSURED RISKS"
       }
      }
     },
     "localname": "UninsuredRisksPolicyTextBlock",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "rdnt_UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued During Period",
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued during period"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesandInterestAccruedDuringPeriod",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate",
        "label": "Unrecognized Tax Benefits, Increase (Decrease) Change in Enacted Tax Rate",
        "terseLabel": "Increase (decrease) related to change in rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreaseDecreaseChangeinEnactedTaxRate",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_UnrecognizedTaxBenefitsTaxImpactIfRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unrecognized Tax Benefits, Tax Impact If Recognized",
        "label": "Unrecognized Tax Benefits, Tax Impact If Recognized",
        "terseLabel": "Unrecognized tax benefits, tax impact if recognized"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsTaxImpactIfRecognized",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "rdnt_VenturaCountyImagingGroupLLC.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ventura County Imaging Group, LLC. [Member]",
        "label": "Ventura County Imaging Group, LLC. [Member]",
        "terseLabel": "Ventura County Imaging Group, LLC."
       }
      }
     },
     "localname": "VenturaCountyImagingGroupLLC.Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_VenturaCountyImagingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ventura County Imaging Group, LLC [Member]",
        "label": "Ventura County Imaging Group, LLC [Member]",
        "terseLabel": "Ventura County Imaging Group, LLC"
       }
      }
     },
     "localname": "VenturaCountyImagingGroupLLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WeightedAverageAmortizationPeriodRemainingInYears": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period remaining in years",
        "label": "Weighted average amortization period remaining in years",
        "terseLabel": "Weighted average amortization period remaining in years"
       }
      }
     },
     "localname": "WeightedAverageAmortizationPeriodRemainingInYears",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "durationItemType"
    },
    "rdnt_WeightedAverageRemainingContractualLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Contractual Life abstract",
        "label": "Weighted Average Remaining Contractual Life",
        "terseLabel": "Weighted Average Remaining Contractual Life (in years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingContractualLife",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term [Abstract]",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted Average Remaining Lease Term [Abstract]"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "stringItemType"
    },
    "rdnt_WestValleyImagingGroupLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "West Valley Imaging Group, LLC [Member]",
        "label": "West Valley Imaging Group, LLC [Member]",
        "terseLabel": "West Valley Imaging Group, LLC"
       }
      }
     },
     "localname": "WestValleyImagingGroupLLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WhiteRabbit.aiInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "WhiteRabbit.ai Inc. [Member]",
        "label": "WhiteRabbit.ai Inc. [Member]",
        "terseLabel": "WhiteRabbit.ai Inc."
       }
      }
     },
     "localname": "WhiteRabbit.aiInc.Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_WorkersCompensationPersonalInjury1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers' Compensation/Personal Injury1 [Member]",
        "label": "Workers' Compensation/Personal Injury1 [Member]",
        "terseLabel": "Workers' compensation/personal injury"
       }
      }
     },
     "localname": "WorkersCompensationPersonalInjury1Member",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPAtlanticLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Atlantic LLC",
        "label": "ZP Atlantic LLC [Member]",
        "terseLabel": "ZP Atlantic"
       }
      }
     },
     "localname": "ZPAtlanticLLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPCompaniesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Companies",
        "label": "ZP Companies [Member]",
        "terseLabel": "ZP Companies"
       }
      }
     },
     "localname": "ZPCompaniesMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPElmhurstLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Elmhurst LLC",
        "label": "ZP Elmhurst LLC [Member]",
        "terseLabel": "ZP Elmhurst",
        "verboseLabel": "ZP Elmhurst LLC"
       }
      }
     },
     "localname": "ZPElmhurstLLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZPOzoneParkLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ZP Ozone Park, LLC",
        "label": "ZP Ozone Park, LLC [Member]",
        "terseLabel": "ZP Ozone Park, LLC"
       }
      }
     },
     "localname": "ZPOzoneParkLLCMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "rdnt_ZilkhaRadiologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Zilkha Radiology [Member]",
        "label": "Zilkha Radiology [Member]",
        "terseLabel": "Zilkha Radiology"
       }
      }
     },
     "localname": "ZilkhaRadiologyMember",
     "nsuri": "http://www.radnet.com/20201231",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r441",
      "r442",
      "r450",
      "r451",
      "r607"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r441",
      "r442",
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r71",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r329",
      "r332",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r544",
      "r586",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r329",
      "r332",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r544",
      "r586",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r215",
      "r309",
      "r311",
      "r545",
      "r585",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r215",
      "r309",
      "r311",
      "r545",
      "r585",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r318",
      "r329",
      "r332",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r544",
      "r586",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r318",
      "r329",
      "r332",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r544",
      "r586",
      "r588"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r278",
      "r330",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r218",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable, accrued expenses and other",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails",
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r7",
      "r35",
      "r219",
      "r220"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r57"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r38",
      "r75",
      "r76",
      "r77",
      "r572",
      "r593",
      "r596"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r74",
      "r77",
      "r79",
      "r146",
      "r147",
      "r148",
      "r449",
      "r589",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r36",
      "r368"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r364",
      "r365",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r121",
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in additional paid-in capital (APIC) for recognition of cost for employee stock purchase program (ESPP) award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income\u00a0to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r334",
      "r359",
      "r369"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredCharges": {
     "auth_ref": [
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of amortization of deferred charges applied against earnings during the period.",
        "label": "Amortization of Deferred Charges",
        "terseLabel": "Amortization of deferred charges"
       }
      }
     },
     "localname": "AmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfDeferredHedgeGains": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 20.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense charged against earnings by an Entity to record deferred gains and losses on hedge instruments. Examples include gain on economic hedges, amortization of gain on designated fair value hedge and so forth.",
        "label": "Amortization of Deferred Hedge Gains",
        "terseLabel": "Amortization of cash flow hedge"
       }
      }
     },
     "localname": "AmortizationOfDeferredHedgeGains",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r93",
      "r121",
      "r500"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization and write off of deferred financing costs and loan discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted average shares for which the exercise price exceeds average market price of common stock (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r134",
      "r202",
      "r207",
      "r213",
      "r231",
      "r441",
      "r450",
      "r488",
      "r553",
      "r569"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "BRMG and NY Groups accounts receivable",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r64",
      "r134",
      "r231",
      "r441",
      "r450",
      "r488"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 1.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "CURRENT ASSETS"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldUnderCapitalLeasesMember": {
     "auth_ref": [
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived property, plant or equipment assets held by a lessee through a capital lease arrangement.",
        "label": "Assets Held under Capital Leases [Member]",
        "terseLabel": "Equipment under financing/capital lease"
       }
      }
     },
     "localname": "AssetsHeldUnderCapitalLeasesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r134",
      "r231",
      "r441",
      "r450",
      "r488"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 2.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "terseLabel": "Noncurrent assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r336",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r328",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r328",
      "r331",
      "r417",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition.",
        "label": "Business Acquisition, Transaction Costs",
        "terseLabel": "Business acquisition, closing costs"
       }
      }
     },
     "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": {
     "auth_ref": [
      "r429"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned",
        "terseLabel": "Value of RadNet stock issued in acquisition"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Shares issued (in shares)",
        "verboseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r425",
      "r426",
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "verboseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r425",
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Common stock issued as consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "auth_ref": [
      "r424",
      "r425",
      "r426",
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "terseLabel": "Assumption of debt as consideration"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r120",
      "r430"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in value of contingent consideration",
        "verboseLabel": "Contingent consideration liability adjustment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount, measured at acquisition-date fair value, of all liabilities assumed that arise from contingencies and were recognized by the entity.",
        "label": "Business Combination, Liabilities Arising from Contingencies, Amount Recognized",
        "terseLabel": "Contingent consideration liability"
       }
      }
     },
     "localname": "BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount, measured at other than acquisition-date fair value, of all the liabilities assumed that arise from contingencies and were recognized by the entity, if the acquisition-date fair value cannot be determined and other criteria (as defined) related to the contingencies have been met.",
        "label": "Business Combination, Liabilities Arising from Contingencies, Amount Recognized, Other than at Fair Value",
        "terseLabel": "Business consideration liability adjustment recorded amount"
       }
      }
     },
     "localname": "BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognizedOtherThanAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "terseLabel": "Assets assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease obligation assumed in business combination.",
        "label": "Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation",
        "terseLabel": "Capital lease assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCapitalLeaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets",
        "terseLabel": "Current assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "terseLabel": "Deferred tax liabilities acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment",
        "terseLabel": "Equipment acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "calculation": {
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Intangible assets acquired",
        "verboseLabel": "Intangible Assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r420"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "calculation": {
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Fixed assets acquired",
        "verboseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "TOTAL"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsAxis": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosures related to transactions that are recognized separately from the acquisition of assets and assumptions of liabilities in the business combination by type of transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Axis]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Axis]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationSeparatelyRecognizedTransactionsDomain": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of transaction that is recognized separately from the acquisition of assets and assumptions of liabilities in a business combination by transaction.",
        "label": "Business Combination, Separately Recognized Transactions [Domain]",
        "terseLabel": "Business Combination, Separately Recognized Transactions [Domain]"
       }
      }
     },
     "localname": "BusinessCombinationSeparatelyRecognizedTransactionsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Disposition of equity method interest upon acquisition of control in NJIN"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of loss recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss",
        "negatedTerseLabel": "Equity interest acquiree remeasurement loss"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r131",
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "BUSINESS COMBINATION"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": {
     "auth_ref": [
      "r5",
      "r145",
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the business description and basis of presentation concepts.  Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity.  Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Business Description and Basis of Presentation [Text Block]",
        "terseLabel": "NATURE OF BUSINESS"
       }
      }
     },
     "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r45",
      "r123"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r16",
      "r124",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r117",
      "r123",
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of period",
        "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r117",
      "r489"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "NET INCREASE (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Promissory note"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r279",
      "r601",
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r146",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock - par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock - authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock - issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r33",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock - outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock - $.0001 par value, 200,000,000 shares authorized; 51,640,537 and 50,314,328 shares issued and outstanding at December 31, 2020 and 2019 respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "EQUITY BASED COMPENSATION"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r81",
      "r83",
      "r84",
      "r91",
      "r563",
      "r580"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "COMPREHENSIVE (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r81",
      "r83",
      "r90",
      "r437",
      "r438",
      "r461",
      "r562",
      "r579"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r81",
      "r83",
      "r89",
      "r436",
      "r461",
      "r561",
      "r578"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "COMPREHENSIVE (LOSS) INCOME"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "COMPREHENSIVE INCOME (LOSS)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r185",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "CONCENTRATION OF CREDIT RISKS"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "PRINCIPLES OF CONSOLIDATION"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressGross": {
     "auth_ref": [
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress, Gross",
        "terseLabel": "Construction in progress, gross"
       }
      }
     },
     "localname": "ConstructionInProgressGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in Progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r298",
      "r299",
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r31",
      "r32",
      "r291",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "terseLabel": "Preferred stock issued upon conversion (in shares)"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CreditDerivativesByContractTypeAxis": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type of contract of credit derivatives.",
        "label": "Credit Derivatives Contract Type [Axis]",
        "terseLabel": "Credit Derivatives Contract Type [Axis]"
       }
      }
     },
     "localname": "CreditDerivativesByContractTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditDerivativesContractTypeDomain": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents major types of credit derivative contracts.",
        "label": "Credit Derivatives Contract Type [Domain]",
        "terseLabel": "Credit Derivatives Contract Type [Domain]"
       }
      }
     },
     "localname": "CreditDerivativesContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r397",
      "r408"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal current tax"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtAndCapitalLeasesDisclosuresTextBlock": {
     "auth_ref": [
      "r289",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for debt and capital lease obligations can be reported. Information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants. Also includes descriptions and amounts of capital leasing arrangements that consist of direct financing, sales type and leveraged leases. Disclosure may include the effect on the balance sheet and the income statement resulting from a change in lease classification for leases that at inception would have been classified differently had guidance been in effect at the inception of the original lease.",
        "label": "Debt and Capital Leases Disclosures [Text Block]",
        "terseLabel": "CREDIT FACILITIES AND NOTES PAYABLE"
       }
      }
     },
     "localname": "DebtAndCapitalLeasesDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r554",
      "r555",
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r29",
      "r283",
      "r555",
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Total Carrying Value"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r499",
      "r502"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Face Value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Term Loan Agreement and First Lien Term Loans"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r59",
      "r285",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt instrument, interest rate",
        "verboseLabel": "Interest rate, stated percentage"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments applied to principal.",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "terseLabel": "Periodic payment, principal"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r60",
      "r139",
      "r291",
      "r293",
      "r294",
      "r295",
      "r498",
      "r499",
      "r502",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "PPP loans, maturity term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r498",
      "r502"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt": {
       "order": 2.0,
       "parentTag": "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Discount on First Lien Term Loans",
        "terseLabel": "Discount on term loans"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountCurrent": {
     "auth_ref": [
      "r498",
      "r502"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt discount to be amortized within one year or within the normal operating cycle, if longer.",
        "label": "Debt Instrument, Unamortized Discount, Current",
        "terseLabel": "Debt instrument, unamortized discount, current"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "auth_ref": [
      "r498",
      "r499",
      "r500",
      "r501",
      "r502"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount (premium).",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "negatedLabel": "Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r51",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "DEFERRED FINANCING COSTS"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.",
        "label": "Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance",
        "terseLabel": "Shares available for future issuance, options, warrants, shares of restricted stock and other bonus awards (in shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r398",
      "r408"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal deferred tax"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsGross": {
     "auth_ref": [
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Gross",
        "terseLabel": "Issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r51",
      "r500"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Deferred financing costs, net of accumulated amortization"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNoncurrentNet": {
     "auth_ref": [
      "r51",
      "r500"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Noncurrent, Net",
        "terseLabel": "Deferred financing costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNoncurrentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r374",
      "r375"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenue": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r398",
      "r408"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State deferred tax"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r388"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total Deferred Tax Assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r390"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net Deferred Tax Asset"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating losses"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Operating loss carryforwards, subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the allowance for doubtful accounts.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r389"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r375",
      "r390"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total Deferred Tax Liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "Intangibles"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill": {
     "auth_ref": [
      "r395",
      "r396",
      "r431",
      "r432"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill",
        "negatedLabel": "Goodwill",
        "terseLabel": "Deferred tax liabilities goodwill"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NCOMETAXESDetailsDeferredtaxassetsandliabilities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Expected employee contribution"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Employee contribution, percent"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage employer matches of the employee's percentage contribution matched.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "terseLabel": "Employer matching contribution, percent"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DepositsAssets": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment in the future.",
        "label": "Deposits Assets",
        "terseLabel": "Deposits and other"
       }
      }
     },
     "localname": "DepositsAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r121",
      "r263"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r121",
      "r197"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNotionalAmount": {
     "auth_ref": [
      "r463",
      "r464",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payments on the derivative asset.",
        "label": "Derivative Asset, Notional Amount",
        "terseLabel": "Notional amounts"
       }
      }
     },
     "localname": "DerivativeAssetNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetNumberOfInstrumentsHeld": {
     "auth_ref": [
      "r464",
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of derivative instruments of a particular derivative asset or group of derivative assets held by the entity.",
        "label": "Derivative Asset, Number of Instruments Held",
        "terseLabel": "Number of forward interest rate cap agreements"
       }
      }
     },
     "localname": "DerivativeAssetNumberOfInstrumentsHeld",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r67",
      "r70",
      "r485"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "terseLabel": "Current and long term liabilities"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeBasisSpreadOnVariableRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage points added to the reference rate to compute the variable rate on the interest rate derivative.",
        "label": "Derivative, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DerivativeBasisSpreadOnVariableRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r470"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "negatedTerseLabel": "Amount of loss recognized in income on derivative (current period ineffective portion)"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r469",
      "r471",
      "r474",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r67",
      "r70",
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Current and long term liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r143",
      "r462",
      "r465",
      "r467",
      "r468",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "DERIVATIVE INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r8",
      "r18",
      "r34",
      "r137",
      "r528"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Due from affiliates"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DueToAffiliateCurrent": {
     "auth_ref": [
      "r25",
      "r137",
      "r528",
      "r598"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of payable due to an entity that is affiliated with the reporting entity by means of direct or indirect ownership. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Due to Affiliate, Current",
        "terseLabel": "Due to affiliates"
       }
      }
     },
     "localname": "DueToAffiliateCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r92",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r166",
      "r169",
      "r174",
      "r175",
      "r176",
      "r179",
      "r180",
      "r564",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "netLabel": "Basic net (loss) income per share attributable to RadNet, inc. common stockholders (in dollars per share)",
        "terseLabel": "BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "verboseLabel": "BASIC NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "WEIGHTED AVERAGE SHARES OUTSTANDING"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r92",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r169",
      "r174",
      "r175",
      "r176",
      "r179",
      "r180",
      "r564",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "netLabel": "Diluted net (loss) income per share attributable to RadNet, Inc. common stockholders (in dollars per share)",
        "terseLabel": "DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted [Abstract]",
        "verboseLabel": "DILUTED NET (LOSS) INCOME PER SHARE ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "EarningsPerShareDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Stock options and non-vested restricted awards excluded from the computation of diluted per share amounts as their effect would be antidilutive:"
       }
      }
     },
     "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r177",
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r489"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "EFFECT OF EXCHANGE RATE CHANGES ON CASH"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued salary and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized expense weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue from External Customer [Line Items]",
        "terseLabel": "Revenue from External Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Medical equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r152",
      "r160",
      "r162",
      "r181",
      "r233",
      "r290",
      "r296",
      "r364",
      "r365",
      "r366",
      "r401",
      "r402",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r589",
      "r590",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityIssuedInBusinessCombinationFairValueDisclosure": {
     "auth_ref": [
      "r481"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of equity issued in a business combination.",
        "label": "Equity Issued in Business Combination, Fair Value Disclosure",
        "terseLabel": "Contingent consideration, fair value"
       }
      }
     },
     "localname": "EquityIssuedInBusinessCombinationFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentAggregateCost": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Aggregate Cost",
        "terseLabel": "Total net assets",
        "totalLabel": "Total net assets"
       }
      }
     },
     "localname": "EquityMethodInvestmentAggregateCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "auth_ref": [
      "r87",
      "r116",
      "r121",
      "r576"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "negatedLabel": "Distribution of earnings"
       }
      }
     },
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r3",
      "r134",
      "r231",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r3",
      "r134",
      "r231",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember": {
     "auth_ref": [
      "r3",
      "r134",
      "r231",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee or group of nonconsolidated investees. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee or Group of Investees [Member]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee or Group of Investees"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeOrGroupOfInvesteesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity interest percentage"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r94",
      "r95",
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "negatedTerseLabel": "Loss on equity method investment",
        "terseLabel": "Sale of ownership interest",
        "verboseLabel": "Gain (loss) on equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentUnderlyingEquityInNetAssets": {
     "auth_ref": [
      "r229"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the entity's ownership percentage in the investee multiplied by the investee's total equity.",
        "label": "Equity Method Investment, Underlying Equity in Net Assets",
        "terseLabel": "Cost in excess of book value of acquired joint venture interests accounted for as equity method goodwill"
       }
      }
     },
     "localname": "EquityMethodInvestmentUnderlyingEquityInNetAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r46",
      "r203",
      "r226"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Book value of RadNet joint venture interests"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r46",
      "r116",
      "r131",
      "r228",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "EQUITY INVESTMENTS AT FAIR VALUE"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Investment in Joint Ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimate of Fair Value Measurement"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EurodollarMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.",
        "label": "Eurodollar [Member]",
        "terseLabel": "Eurodollar"
       }
      }
     },
     "localname": "EurodollarMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r481",
      "r486",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r481",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets and Liabilities"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r482",
      "r534",
      "r535",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r481",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r319",
      "r320",
      "r325",
      "r326",
      "r482",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r319",
      "r320",
      "r325",
      "r326",
      "r482",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r482",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r534",
      "r535",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r509",
      "r517",
      "r525"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsLeaseCost": {
       "order": 2.0,
       "parentTag": "rdnt_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest on lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r511",
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows from financing leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r507",
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Total",
        "totalLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r507"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Current portion of finance lease liability",
        "verboseLabel": "Current portion of finance lease"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Maturities of Finance Lease Liability"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r507"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Long-term finance lease liability",
        "verboseLabel": "Finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total Lease Payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r510",
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows from financing leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "totalLabel": "Equipment, net"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAccumulatedAmortization": {
     "auth_ref": [
      "r509",
      "r517"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated amortization of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r509",
      "r517",
      "r525"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsLeaseCost": {
       "order": 1.0,
       "parentTag": "rdnt_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Depreciation of leased equipment"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "terseLabel": "Equipment at cost"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.",
        "label": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]",
        "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r522",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r521",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases - years"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unearned premium revenue under contracts issued by an insurance entity that provide protection to the holder of a financial obligation from a financial loss in the event of a default.",
        "label": "Financial Guarantee Insurance Contracts, Unearned Premium Revenue",
        "terseLabel": "Interest rate caps premium liability"
       }
      }
     },
     "localname": "FinancialGuaranteeInsuranceContractsFutureExpectedPremiumRevenueToBeRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Amortization year thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Amortization year 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "Amortization year 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Amortization year 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Amortization year 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Amortization year 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r247",
      "r249",
      "r252",
      "r256",
      "r546",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r247",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r252",
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Amortiztion total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "FOREIGN CURRENCY TRANSLATION"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Computer and office equipment, furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "auth_ref": [
      "r121",
      "r262",
      "r267"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "negatedLabel": "Loss (gain) on sale and disposal of equipment and other",
        "negatedTerseLabel": "Loss (gain) on sale and disposal of equipment and other"
       }
      }
     },
     "localname": "GainLossOnDispositionOfAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": {
     "auth_ref": [
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.",
        "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings",
        "terseLabel": "Amount of loss recognized in income on derivative (current period ineffective portion)"
       }
      }
     },
     "localname": "GainLossOnFairValueHedgesRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee": {
     "auth_ref": [
      "r94",
      "r95",
      "r121",
      "r559",
      "r582"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.",
        "label": "Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee",
        "terseLabel": "Dissolution of GSRN"
       }
      }
     },
     "localname": "GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r121",
      "r287",
      "r288"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 22.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Gain on extinguishment of debt",
        "negatedTerseLabel": "Gain on extinguishment of debt"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r236",
      "r238",
      "r552"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill acquired"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed",
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired through acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Loss on impairment",
        "verboseLabel": "Loss on impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy": {
     "auth_ref": [
      "r131",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for indefinite-lived intangible assets (that is, those intangible assets not subject to amortization). This accounting policy also may address how the entity assesses whether events and circumstances continue to support an indefinite useful life and how the entity assesses and measures impairment of such assets.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]",
        "terseLabel": "GOODWILL AND INDEFINITE LIVED INTANGIBLES"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsIndefiniteLivedPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r121",
      "r237",
      "r241",
      "r244"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillTransfers": {
     "auth_ref": [
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers into (out of) an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Transfers",
        "terseLabel": "Goodwill transferred to other assets"
       }
      }
     },
     "localname": "GoodwillTransfers",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Goodwill disposed of through sale or transfer"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HealthCareOtherMember": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided for maintenance, diagnosis and treatment of physical and mental health, classified as other.",
        "label": "Health Care, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "HealthCareOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HealthCarePatientServiceMember": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service provided to patient for maintenance, diagnosis and treatment of physical and mental health. Excludes service to resident in health care facility.",
        "label": "Health Care, Patient Service [Member]",
        "terseLabel": "Service fee revenue"
       }
      }
     },
     "localname": "HealthCarePatientServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r121",
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Write off of the reporting unit trade name"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r261",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "LONG-LIVED ASSETS"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r141",
      "r202",
      "r206",
      "r209",
      "r212",
      "r214"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "(LOSS) INCOME BEFORE INCOME TAXES"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r87",
      "r121",
      "r199",
      "r226",
      "r558",
      "r576"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Equity in earnings of joint ventures",
        "terseLabel": "Equity in earnings in these joint ventures"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.",
        "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions",
        "negatedLabel": "Equity in earnings of joint ventures, net of dividends"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r378",
      "r386",
      "r392",
      "r406",
      "r409",
      "r411",
      "r412",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r136",
      "r161",
      "r162",
      "r200",
      "r376",
      "r407",
      "r410",
      "r584"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedLabel": "Provision for income taxes",
        "totalLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense",
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r85",
      "r131",
      "r372",
      "r373",
      "r386",
      "r387",
      "r391",
      "r399",
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "verboseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Changes in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Federal tax"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationMinorityInterestIncomeExpense": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Amount",
        "negatedTerseLabel": "Noncontrolling interests in partnerships"
       }
      }
     },
     "localname": "IncomeTaxReconciliationMinorityInterestIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "terseLabel": "Other non deductible expenses"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Deferred true-ups and other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherReconcilingItems": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax exempt income, equity in earnings (loss) of an unconsolidated subsidiary, minority noncontrolling interest income (loss), tax holiday, disposition of a business, disposition of an asset, repatriation of foreign earnings, repatriation of foreign earnings jobs creation act of 2004, increase (decrease) in enacted tax rate, prior year income taxes, increase (decrease) in deferred tax asset valuation allowance, and other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount",
        "terseLabel": "Other reconciling items"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherReconcilingItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 10.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "terseLabel": "Return to provision"
       }
      }
     },
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State franchise tax, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "auth_ref": [
      "r377"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates": {
       "order": 9.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "terseLabel": "Uncertain tax provisions"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsReconciliationofthestatutoryUSfederalrateandeffectiverates"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid during the period for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1": {
     "auth_ref": [
      "r469",
      "r472"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 6.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) included in earnings related to the fair value of the hedged item in an interest rate fair value hedge, offset by the gain (loss) on the hedging instrument to the extent that the fair value hedge is determined to be effective.",
        "label": "Increase (Decrease) in Fair Value of Hedged Item in Interest Rate Fair Value Hedge",
        "negatedTerseLabel": "Non-cash change in fair value of interest rate hedge"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherCurrentAssets": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in current assets classified as other.",
        "label": "Increase (Decrease) in Other Current Assets",
        "negatedLabel": "Other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r170",
      "r171",
      "r172",
      "r176"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Add additional shares issuable upon exercise of stock options and warrants (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r246",
      "r250"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r98",
      "r286"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Equity and Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r114",
      "r118",
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid during the period for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "2016 CAPS - Interest Rate Contracts"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "2019 SWAPS - Interest Rate Contracts"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentOwnedAtFairValue": {
     "auth_ref": [
      "r597",
      "r599",
      "r600"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.",
        "label": "Investment Owned, at Fair Value",
        "terseLabel": "Investment owned, at fair value"
       }
      }
     },
     "localname": "InvestmentOwnedAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r228",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "INVESTMENT IN JOINT VENTURES"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Investment in joint ventures",
        "verboseLabel": "Total value of RadNet joint venture interests"
       }
      }
     },
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Operating lease, lease not yet commenced, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of Operating Lease Liability"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r524"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, renewal term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESNotes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r56",
      "r134",
      "r208",
      "r231",
      "r442",
      "r450",
      "r451",
      "r488"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "BRMG and NY Groups accounts payable",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r41",
      "r134",
      "r231",
      "r488",
      "r557",
      "r575"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r58",
      "r134",
      "r231",
      "r442",
      "r450",
      "r451",
      "r488"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 3.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "negatedLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "CURRENT LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r29",
      "r30",
      "r134",
      "r231",
      "r442",
      "r450",
      "r451",
      "r488"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures": {
       "order": 4.0,
       "parentTag": "us-gaap_EquityMethodInvestmentAggregateCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "negatedLabel": "Noncurrent liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "LONG-TERM LIABILITIES"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest": {
     "auth_ref": [
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage investment held by the managing member or general partner of the limited liability company (LLC) or limited partnership (LP).",
        "label": "Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest",
        "terseLabel": "Economic interest"
       }
      }
     },
     "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCredit": {
     "auth_ref": [
      "r29",
      "r555",
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Long-term Line of Credit",
        "terseLabel": "Total credit facilities outstanding"
       }
      }
     },
     "localname": "LineOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r53",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facilities available"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Credit facility, borrowings available"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r53",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "terseLabel": "Unused capacity, commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Litigation settlement"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r29",
      "r284",
      "r555",
      "r571"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt": {
       "order": 1.0,
       "parentTag": "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "totalLabel": "Total notes payable obligations"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r144",
      "r281"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r144",
      "r281"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r144",
      "r281"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermLoansPayable": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt": {
       "order": 3.0,
       "parentTag": "rdnt_LongtermDebtShorttermDebtandCapitalLeaseObligationsIncludingCurrentMaturities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Loans Payable, Noncurrent",
        "terseLabel": "Equipment notes payable at interest rates ranging from 4.4% to 5.6%, due through 2020, collateralized by medical equipment"
       }
      }
     },
     "localname": "LongTermLoansPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermNotesPayable": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.",
        "label": "Notes Payable, Noncurrent",
        "terseLabel": "Notes payable, net of current portion"
       }
      }
     },
     "localname": "LongTermNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r60",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsTermLoans",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyAccrualAtCarryingValue": {
     "auth_ref": [
      "r277"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss contingency liability.",
        "label": "Loss Contingency Accrual",
        "terseLabel": "Loss contingency accrual liability"
       }
      }
     },
     "localname": "LossContingencyAccrualAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturities of Long-term Debt and Capital Lease Obligations [Abstract]",
        "terseLabel": "Maturities of Notes Payables [Abstract]"
       }
      }
     },
     "localname": "MaturitiesOfLongtermDebtAndCapitalLeaseObligationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsAnnualNotePayableMaturities"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MediumTermNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instruments with maturities ranging from five to ten years.",
        "label": "Medium-term Notes [Member]",
        "terseLabel": "Medium-term Notes"
       }
      }
     },
     "localname": "MediumTermNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r4",
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "FACILITY ACQUISITIONS, ASSETS HELD FOR SALE AND DISPOSITIONS"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r63",
      "r134",
      "r231",
      "r488",
      "r556",
      "r574"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions paid to noncontrolling\u00a0interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r296",
      "r439",
      "r440"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedLabel": "Purchase of noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Noncontrolling interest, ownership percentage"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r117",
      "r119",
      "r122"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r80",
      "r82",
      "r88",
      "r122",
      "r134",
      "r151",
      "r155",
      "r156",
      "r157",
      "r158",
      "r161",
      "r162",
      "r173",
      "r202",
      "r206",
      "r209",
      "r212",
      "r214",
      "r231",
      "r488",
      "r560",
      "r577"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net (loss) income attributable to RadNet, Inc. common stockholders",
        "totalLabel": "NET (LOSS) INCOME ATTRIBUTABLE TO RADNET, INC. COMMON STOCKHOLDERS"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r80",
      "r82",
      "r161",
      "r162",
      "r445",
      "r460"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Standards Update and Change in Accounting Principle [Abstract]",
        "terseLabel": "New Accounting Pronouncements and Changes in Accounting Principles [Abstract]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r149",
      "r150",
      "r153",
      "r154",
      "r163",
      "r164",
      "r165",
      "r234",
      "r235",
      "r312",
      "r313",
      "r314",
      "r315",
      "r367",
      "r403",
      "r404",
      "r405",
      "r547",
      "r548",
      "r549",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]",
        "terseLabel": "RECENT ACCOUNTING STANDARDS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/RECENTACCOUNTINGSTANDARDS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "RECENT ACCOUNTING STANDARDS"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": {
     "auth_ref": [
      "r126",
      "r127",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired",
        "terseLabel": "Contributions"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Noncompete Agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "auth_ref": [
      "r297",
      "r439",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "terseLabel": "Sale to noncontrolling interests, net of taxes"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r296",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "negatedTotalLabel": "Total other expenses (income)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Current portion of notes payable"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Notes Payable, Other Payables"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsScheduleofDebt"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfBusinessesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of businesses acquired by the entity during the period.",
        "label": "Number of Businesses Acquired",
        "terseLabel": "Number of businesses acquired"
       }
      }
     },
     "localname": "NumberOfBusinessesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OffsettingAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Offsetting Assets [Line Items]",
        "terseLabel": "Offsetting Assets [Line Items]"
       }
      }
     },
     "localname": "OffsettingAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OffsettingAssetsTable": {
     "auth_ref": [
      "r68",
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about derivative and financial assets that are subject to offsetting, including enforceable master netting arrangements.",
        "label": "Offsetting Assets [Table]",
        "terseLabel": "Offsetting Assets [Table]"
       }
      }
     },
     "localname": "OffsettingAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingCostsAndExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense.",
        "label": "Operating Costs and Expenses",
        "terseLabel": "Cost of operations, excluding depreciation and amortization"
       }
      }
     },
     "localname": "OperatingCostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "OPERATING EXPENSES"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r202",
      "r206",
      "r209",
      "r212",
      "r214"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "INCOME FROM OPERATIONS"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r518",
      "r525"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsLeaseCost"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r507"
     ],
     "calculation": {
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsMaturitiesofOperatingandFinanceLease",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r507"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liability",
        "verboseLabel": "Current portion of operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r507"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liability",
        "verboseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r512",
      "r519"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r506"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use-assets",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r522",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r521",
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases - years"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalBalanceSheet"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "auth_ref": [
      "r503"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.",
        "label": "Operating Leases, Rent Expense, Net",
        "terseLabel": "Rental expense"
       }
      }
     },
     "localname": "OperatingLeasesRentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsAdditionalInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r393"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets [Abstract]",
        "terseLabel": "OTHER ASSETS"
       }
      }
     },
     "localname": "OtherAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent": {
     "auth_ref": [
      "r436",
      "r437",
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, on foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax, Portion Attributable to Parent",
        "terseLabel": "Change in cumulative foreign currency\u00a0translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r73",
      "r75"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Change in fair value of cash flow hedge, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r75",
      "r78"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Change in fair value of cash flow hedge from prior periods reclassified to earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r73",
      "r75",
      "r480"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax",
        "terseLabel": "Change in fair value of cash flow hedge, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Expenses [Abstract]",
        "terseLabel": "OTHER INCOME AND EXPENSES"
       }
      }
     },
     "localname": "OtherExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r99"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other expenses (income)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "terseLabel": "Other Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsDerivatives"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherTaxExpenseBenefit": {
     "auth_ref": [
      "r135",
      "r376",
      "r399"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other income tax expense (benefit).",
        "label": "Other Tax Expense (Benefit)",
        "terseLabel": "Other current tax"
       }
      }
     },
     "localname": "OtherTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Additional deferred finance costs on revolving loan amendment"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBuildings": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for acquisition of buildings (properties) whether for investment or use.",
        "label": "Payments to Acquire Buildings",
        "negatedLabel": "Purchase of imaging facilities"
       }
      }
     },
     "localname": "PaymentsToAcquireBuildings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireEquityMethodInvestments": {
     "auth_ref": [
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.",
        "label": "Payments to Acquire Equity Method Investments",
        "terseLabel": "Investment at cost",
        "verboseLabel": "Payments to acquire equity method investments"
       }
      }
     },
     "localname": "PaymentsToAcquireEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.",
        "label": "Payments to Acquire Interest in Joint Venture",
        "negatedLabel": "Equity contributions in existing and purchase of interest in joint ventures",
        "terseLabel": "Payments to acquire additional interest in subsidiaries"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Equity investments at fair value"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherPropertyPlantAndEquipment": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from the acquisition of or improvements to long-lived, physical assets used to produce goods and services and not intended for resale, classified as other.",
        "label": "Payments to Acquire Other Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToFundLongtermLoansToRelatedParties": {
     "auth_ref": [
      "r104",
      "r527"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with extending a long-term loan to a related party. Alternate caption: Payments for Advances to Affiliates.",
        "label": "Payments to Fund Long-term Loans to Related Parties",
        "verboseLabel": "Payments to fund loan to related parties"
       }
      }
     },
     "localname": "PaymentsToFundLongtermLoansToRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedLabel": "Distributions paid to noncontrolling interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r336",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsFairValueMeasurements"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitPlansPolicy": {
     "auth_ref": [
      "r131",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for postemployment benefits. Postemployment benefits are benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement, except for: a) benefits provided through a pension or postretirement benefit plan, b) individual deferred compensation arrangements, c) special or contractual termination benefits, and d) stock compensation plans.",
        "label": "Postemployment Benefit Plans, Policy [Policy Text Block]",
        "terseLabel": "EMPLOYEE BENEFIT PLAN"
       }
      }
     },
     "localname": "PostemploymentBenefitPlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r9",
      "r43",
      "r44"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "RECLASSIFICATION"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromContributedCapital": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received by a corporation from a shareholder during the period.",
        "label": "Proceeds from Contributed Capital",
        "terseLabel": "Contributions from noncontrolling partners"
       }
      }
     },
     "localname": "ProceedsFromContributedCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInJointVenture": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.",
        "label": "Proceeds from Divestiture of Interest in Joint Venture",
        "terseLabel": "Proceeds from the sale of equity interests in a joint venture",
        "verboseLabel": "Proceeds from sale of business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital": {
     "auth_ref": [
      "r101",
      "r116"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of distribution received from equity method investee for return of investment, classified as investing activities. Excludes distribution for return on investment, classified as operating activities.",
        "label": "Proceeds from Equity Method Investment, Distribution, Return of Capital",
        "negatedLabel": "Nulogix return of capital",
        "terseLabel": "Nulogix return of capital"
       }
      }
     },
     "localname": "ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsInvestmentinJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from debt issuance, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r108",
      "r363"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of options"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r109",
      "r140"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Proceeds from revolving credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfIntangibleAssets": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Proceeds from Sale of Intangible Assets",
        "terseLabel": "Proceeds from sale of internal use software"
       }
      }
     },
     "localname": "ProceedsFromSaleOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "terseLabel": "Proceeds from sale of equipment"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.",
        "label": "Proceeds from Sales of Business, Affiliate and Productive Assets",
        "terseLabel": "Proceeds from sale of noncontrolling interest"
       }
      }
     },
     "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r80",
      "r82",
      "r115",
      "r134",
      "r151",
      "r161",
      "r162",
      "r202",
      "r206",
      "r209",
      "r212",
      "r214",
      "r231",
      "r436",
      "r444",
      "r446",
      "r460",
      "r461",
      "r488",
      "r565"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "NET (LOSS) INCOME",
        "totalLabel": "NET (LOSS) INCOME",
        "verboseLabel": "Net (loss) income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSSINCOME",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r265",
      "r509",
      "r517"
     ],
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r65",
      "r266",
      "r517"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "rdnt_PropertyPlantAndEquipmentAndLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      },
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r20",
      "r264",
      "r506"
     ],
     "calculation": {
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Total property and equipment cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r49",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r271",
      "r604",
      "r605",
      "r606"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r48",
      "r264"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment, Net, Including and Excluding Capital Leased Asset [Abstract]",
        "terseLabel": "PROPERTY, EQUIPMENT AND RIGHT-OF-USE ASSETS"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNetIncludingAndExcludingCapitalLeasedAssetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r47",
      "r131",
      "r266",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "verboseLabel": "PROPERTY AND EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r20",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r20",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "PP&amp;E useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r131",
      "r221",
      "r223",
      "r224",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "ACCOUNTS RECEIVABLE"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsurancePolicyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coverage retained or reinsured.",
        "label": "Reinsurance Policy [Domain]",
        "terseLabel": "Reinsurance Policy [Domain]"
       }
      }
     },
     "localname": "ReinsurancePolicyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsurancePolicyTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type, risk category or other classification of reinsurance coverage.",
        "label": "Reinsurance Policy, Type [Axis]",
        "terseLabel": "Reinsurance Policy, Type [Axis]"
       }
      }
     },
     "localname": "ReinsurancePolicyTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedLabel": "Payments on term loan debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r111",
      "r140"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Payments on revolving credit facility"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.",
        "label": "Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security",
        "negatedLabel": "Principal payments on notes and leases payable"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchDevelopmentAndComputerSoftwarePolicyTextBlock": {
     "auth_ref": [
      "r50",
      "r131",
      "r258",
      "r259",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its research and development and computer software activities including the accounting treatment for costs incurred for (1) research and development activities, (2) development of computer software for internal use, (3) computer software to be sold, leased or otherwise marketed as a separate product or as part of a product or process and (4) in-process research and development acquired in a purchase business combination.",
        "label": "Research, Development, and Computer Software, Policy [Policy Text Block]",
        "terseLabel": "SOFTWARE DEVELOPMENT COSTS"
       }
      }
     },
     "localname": "ResearchDevelopmentAndComputerSoftwarePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r37",
      "r296",
      "r368",
      "r573",
      "r592",
      "r596"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r152",
      "r160",
      "r162",
      "r233",
      "r364",
      "r365",
      "r366",
      "r401",
      "r402",
      "r589",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r193",
      "r194",
      "r205",
      "r210",
      "r211",
      "r215",
      "r216",
      "r217",
      "r308",
      "r309",
      "r545"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Service fee revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r132",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r306",
      "r307",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "SOFTWARE REVENUE RECOGNITION"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue that is not accounted for under Topic 606.",
        "label": "Revenue Not from Contract with Customer",
        "terseLabel": "Provider relief funding"
       }
      }
     },
     "localname": "RevenueNotFromContractWithCustomer",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "REVENUES"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r86",
      "r134",
      "r193",
      "r194",
      "r205",
      "r210",
      "r211",
      "r215",
      "r216",
      "r217",
      "r231",
      "r488",
      "r565"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Net revenue",
        "totalLabel": "Total revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "REVENUE"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r520",
      "r525"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Financing leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r520",
      "r525"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/LEASESDetailsSupplementalCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accounts Payable and Accrued Expenses"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/ACCOUNTSPAYABLEANDACCRUEDEXPENSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r177"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r417",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative",
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsScheduleofAssetsandLiabilitiesAssumed"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "auth_ref": [
      "r417",
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "terseLabel": "Schedule of Business Acquisitions Acquired Assets and Assumed Liabilities"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSANDDISPOSITIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Effect of Derivative Instruments on Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r60",
      "r139",
      "r291",
      "r293",
      "r294",
      "r295",
      "r498",
      "r499",
      "r502",
      "r566"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Term Loans and Financing Activity"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Revolving Credit Facility, Notes Payable, and Capital Lease Obligations"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Income Tax Expense"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsSummaryofnetrevenue"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r3",
      "r134",
      "r230",
      "r231",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsKeyFinancialDataonJointVentures"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r247",
      "r251",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r243",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsScheduleofGoodwill"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Annual Principal Maturities of Notes Payable"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Schedule of RSA Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPrincipalTransactionsRevenueTextBlock": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue by reporting categories or types of financial instruments, including derivatives but excluding dividends and interests, from trading for own account by broker dealers.",
        "label": "Schedule of Principal Transactions Revenue [Table Text Block]",
        "terseLabel": "Schedule of Service Fee Revenue"
       }
      }
     },
     "localname": "ScheduleOfPrincipalTransactionsRevenueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r49",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetails",
      "http://www.radnet.com/role/PROPERTYANDEQUIPMENTDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r336",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r342",
      "r354",
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Options Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r385",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r441",
      "r442",
      "r450",
      "r451",
      "r452",
      "r453",
      "r455",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Annual Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionAxis": {
     "auth_ref": [
      "r66",
      "r142",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of securities financing transactions, including, but not limited to those measured at fair value or cost.",
        "label": "Securities Financing Transaction [Axis]",
        "terseLabel": "Securities Financing Transaction [Axis]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SecuritiesFinancingTransactionTypeDomain": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement of financing transaction securities held.",
        "label": "Securities Financing Transaction [Domain]",
        "terseLabel": "Securities Financing Transaction [Domain]"
       }
      }
     },
     "localname": "SecuritiesFinancingTransactionTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r217",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SelfInsuranceReserve": {
     "auth_ref": [
      "r61"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.",
        "label": "Self Insurance Reserve",
        "terseLabel": "Self-insurance accrual"
       }
      }
     },
     "localname": "SelfInsuranceReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "Settled Litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r121",
      "r272",
      "r274",
      "r275"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Share-based payment award, award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "terseLabel": "RSA's forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "RSA's granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value, granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "RSA's unvested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Weighted-average fair value, ending balance (in dollars per share)",
        "periodStartLabel": "Weighted-average fair value, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted-Average Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Weighted-Average Remaining Contractual Term (Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "RSA's vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value, vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r343",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "RSA's outstanding, ending balance (in shares)",
        "periodStartLabel": "RSA's outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "verboseLabel": "Shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "periodEndLabel": "Exercisable at the end (in shares)",
        "terseLabel": "Exercisable shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "periodEndLabel": "Exercisable at the end (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "terseLabel": "Options cancelled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "netLabel": "Issuance of stock upon exercise of options (in shares)",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Aggregate value outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r344",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending Balance (in dollars per share)",
        "periodStartLabel": "Beginning Balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise price Per Common Share"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Stock-based compensation (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r333",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsRSUs"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "verboseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Share-based payment award, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r362"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "periodEndLabel": "Aggregate value exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Balance at end of period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at the end"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r26",
      "r554",
      "r570"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "verboseLabel": "Convertible promissory note"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "verboseLabel": "Software in development"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsAnnualAmortizationSchedule"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": {
     "auth_ref": [
      "r135",
      "r376",
      "r407"
     ],
     "calculation": {
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of state and local current and deferred income tax expense (benefit) attributable to continuing operations.",
        "label": "State and Local Income Tax Expense (Benefit), Continuing Operations",
        "terseLabel": "State current tax"
       }
      }
     },
     "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsIncometaxexpense"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r217",
      "r243",
      "r269",
      "r273",
      "r276",
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r62",
      "r146",
      "r147",
      "r148",
      "r152",
      "r160",
      "r162",
      "r181",
      "r233",
      "r290",
      "r296",
      "r364",
      "r365",
      "r366",
      "r401",
      "r402",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r589",
      "r590",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r146",
      "r147",
      "r148",
      "r181",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r32",
      "r33",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of stock for acquisitions (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r32",
      "r33",
      "r290",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares issued under the equity compensation plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares (or other type of equity) forfeited during the period.",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited",
        "negatedLabel": "Forfeiture of restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r32",
      "r33",
      "r290",
      "r296",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r62",
      "r290",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of stock for acquisitions"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r32",
      "r33",
      "r296",
      "r335",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Shares issued under the equity compensation plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": {
     "auth_ref": [
      "r361"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, Forfeited",
        "negatedTerseLabel": "Forfeiture of restricted stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Equity Option"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsNarrative",
      "http://www.radnet.com/role/STOCKBASEDCOMPENSATIONDetailsOutstandingoptionsandwarrants"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r33",
      "r39",
      "r40",
      "r134",
      "r222",
      "r231",
      "r488"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total RadNet, Inc.'s stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r134",
      "r146",
      "r147",
      "r148",
      "r152",
      "r160",
      "r231",
      "r233",
      "r296",
      "r364",
      "r365",
      "r366",
      "r401",
      "r402",
      "r434",
      "r435",
      "r459",
      "r488",
      "r490",
      "r491",
      "r495",
      "r590",
      "r591"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTOFEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r496",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r496",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r496",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r496",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r530",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUBSEQUENTEVENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxYear2018Member": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified as tax year 2018.",
        "label": "Tax Year 2018 [Member]",
        "terseLabel": "Tax Year 2018"
       }
      }
     },
     "localname": "TaxYear2018Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/FACILITYACQUISITIONSASSETSHELDFORSALEANDDISPOSITIONSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 21.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedTerseLabel": "Non-cash change in fair value of interest rate hedge"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r371",
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized tax benefit, Balance at end of year",
        "periodStartLabel": "Unrecognized tax benefit, Balance at beginning of year",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative",
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Decrease related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r379"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest accrued"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increases related to current year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increases related to prior year tax positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedLabel": "Expiration of the statute of limitations for the assessment of taxes"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/INCOMETAXESDetailsUnrecognizedtaxbenefit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemAxis": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Axis]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Axis]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemDomain": {
     "auth_ref": [
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Domain]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Domain]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "USE OF ESTIMATES"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityExpense": {
     "auth_ref": [
      "r456"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Expense",
        "terseLabel": "BRMG and NY Groups operating expenses"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax": {
     "auth_ref": [
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the amount of pre-tax income (loss) derived by the reporting entity from the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Income or Loss before Tax",
        "terseLabel": "Management services provided to BRMG and NY Groups"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityActivityBetweenVIEAndEntityRevenues": {
     "auth_ref": [
      "r456"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income between the reporting entity and the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Measure of Activity, Revenues",
        "terseLabel": "BRMG and NY Groups revenues"
       }
      }
     },
     "localname": "VariableInterestEntityActivityBetweenVIEAndEntityRevenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "Economic interest"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r441",
      "r442",
      "r450",
      "r451",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/NATUREOFBUSINESSDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatio",
      "http://www.radnet.com/role/CREDITFACILITIESANDNOTESPAYABLEDetailsMarginSpreadBasedonLeverageRatioDebtInstrumentDetails",
      "http://www.radnet.com/role/CREDITFACILITYANDNOTESPAYABLEDetailsNarrative",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r168",
      "r176"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of common shares used in calculating diluted net income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r166",
      "r176"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average number of common shares outstanding during the period (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "auth_ref": [
      "r167"
     ],
     "calculation": {
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "terseLabel": "Add nonvested restricted stock subject only to service vesting (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsEarningsPerShare"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WorkersCompensationLiabilityCurrent": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Workers' Compensation Liability, Current",
        "terseLabel": "Workers' compensation liability, current"
       }
      }
     },
     "localname": "WorkersCompensationLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.radnet.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=SL94080555-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(m))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31137-122693"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=SL108384541-122693"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2646-109256"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1828-109256"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19347-109286"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(i)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "740"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "740"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121554379&loc=d3e9972-128506"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "740",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121554379&loc=d3e9979-128506"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569655-111683"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4616395-111683"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "d",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6228884-111685"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5708775-113959"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.15)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28567-108399"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "840",
   "URI": "http://asc.fasb.org/topic&trid=2208923"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL6224234-111729"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(1)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(2)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(f)(3)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35711157&loc=d3e42567-110969"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(g))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Subparagraph": "(b)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=SL120429264-123010"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "450",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r609": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r610": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r611": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r612": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r613": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r614": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r615": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r616": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r617": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=49176635&loc=d3e9760-107771"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>88
<FILENAME>0000790526-21-000009-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000790526-21-000009-xbrl.zip
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MBT>K9]H\TAH]5 :LT L++5BB^?XVLKAHB6@+@18LBUL?SW?BM<R]Z<VA?=
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MXIW/&WR.CUNL]%6TL/]&9B*._@%02P,$%     @ &'UP4N2 %^G6 P  1Q
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M"5I?:?9#/G.IW;;U%;NZ[ _^ E!+ P04    "  8?7!2\G[]B[((  !T0
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M@ &^!S)ET";HR,)D%4&_A)83DL 4HW:BUDHY5[]\YLV#KD'#F8M$BDB12B
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MQ5;+4$4W[F/D.U>L,,PZIIND*> T7!N#&W;D2'7AV%DQ%T1$IAT%4IO'VQ"
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MJ+;,UFTSX1RP&XZ-DQD;"J1:UUVO[&:2H\+4Y>QN84&I%2\#0^*:X,;4#Q8
MR[G,ZDZ^6M[*%4U7XS^$Y^V^K_\F)G*B+C'=7TAC9-ZUJ?[VC9%%MT1MR(+3
M2GXA54I5 ]%S4FC:K6YZ*=,%)YLN$PZ#Z]2[LBMJ0OAVWT:=VTJBT_%.@A-;
M3!BL($Q:J=_6&9ZK,WR3/FYKM;U.\'QSX(7/MOU#:GT'N82-YFN,G3>U9JWJ
M4) TQ9JN&Q77$*(_[^0MG&;FH4]*S__WP1$\$1Q;R_?>J-9)3[MK:=_CZX,4
MX9X#_H_T;F>UG?-H$VC)60H5OGVR^">Q^VO4,VGZ3P[WR*B#"\60O0+I>T3D
MX4\F]\BH^S7W8^I\E^'=R2AW*KW],6 &H)$W+!*D8IA#8^B["H-AF8K%IJ$"
M 6'=X@X MO5J"HO-O6\,2ZQ"%A1%"R6OF/V08N3]*D78[R=8 BVPW%DIP?3R
M5NA[OJ<H8%@)(9(L@U6!;RP4JO^BF'EP&%#(\C2DJRC'2NJ*/CH>N,TK7%D1
MW'8A"TPN5N;Y+L]]YGOVK&%[+4\^W!G,Z9]02P,$%     @ &'UP4N6VW7,B
M-P0 27(L !$   !R9&YT+3(P,C Q,C,Q+FAT;>R]:U>;R9(N^+U_!>.S9L[,
M6JUR7B)OWK7K+&RPB]T&O ';#5]J169&@FQ=:$E@XU\_D1)@H%P&EP72*U2]
MV^CRWI1/7)Z(S(SX]?]\[G963FDP;/=[_WPB?Q%/5O[/;[_^7ZW6?S_?>;VR
MUD\G7>J-5EX,"$>45SZU1T<K[S,-/ZZ40;^[\KX_^-@^Q59K?,Z+_O'9H'UX
M-%I10LD;7PZ>I6R%02E;8.L_N<A6U 9;'B!(%W0)P?WGX3.%A10*TTH%J 4%
M?"LDA2V*(CD=B)*/_YF?&51!&R), B'7"XM2A$HN.E=2A'K;HQ'_.OZ%O>&S
M]N?1/Y\<C4;'SYX^_?3ITR^?XZ#S2W]P^+3=Z[1[5'_NT]$ >\/2'W1QQ,/Q
M5 EI6D*UE'UR?A$^\N.WKZ*$T$_KUQ&'=''XR;!UB'A\>4;!81P???X%GZ5$
M2\B6EA>G?/[3+3[I\2DRA/!T_.W%H8/<N_Z3!IA[-/HE];OC"TMU>=F_OF =
MH2>70_17OTWJ*\-T<?AP,/KS+^,/O_&K>/!;0TK7+L_O?SGLG]XZ_O[JZ/ C
MM;\#0+LW'&$OT=7C\]<3KAYLGTZ^O#QTV/[6*/&1\NE_;[[>34?4Q=;-&[2'
M?5#2?>^1)D=<G)#IQN-<# -_<7/@GG6P=_C/)]1KO=U]PL),F'_[M4LC7*D7
M:-'_G+1/__GD1;\W8A5M[9T=\V.ER;M_/AG1Y]'3,;I/?_N/__B/7T?M48=^
MJS+3NA".7Y]./OSUZ>32L9_/?OLUMT]7AJ.S#OWS26X/CSMX]JS7[Q$_0/OS
MLWH@#28OVSE3;_R2O]]B.S%HI\G]/X]VJ/SS2;LXXUQ25LO@@943?2S&YQ)S
MR#8+_&.M/HJ0_)._"FP/N_76U'ZVWN/G.WO!/V> G8U>IL__16=/5MJ9+YWU
MN[.XUC]]K79.]_7F2?ZP?GKP*GS8_O#N://#QR];[]]U]M]O?MK?V_FXN<:?
M[3WO'GQ8/=O_DMM;7W)W7VV(UWJKL_^E+_?W-LSFEW>=@_<O/VR^6A<':ZO\
MV?JG@^[^I\WNIM[_D/1!=ZN]]=*+U^K@;/]]L@=[AY_WWV^<'7QX"_M[G<[6
MVE%WO_NRL]_=-YOO]^7!VJ;A\]76E]73_.IE.[YZR^=D?K9WG<UZO'JK^)R/
M6U\^?MG_LOYI>^_@P]:7?;GU:NO#YMKF^3GO^%ZF=[!WS,>OGVV]?_MY^_U;
M?;"W+[9?_5MO[_&Q>ZMFBY]QZ\-;L:\V/VU*_^7UWOIH<U=\?KVW^@=Y<EJP
MI34>=0N$$RUO76E9U#(6D&R$\Y/?!/_G@C#*_OKT&I[3AW>BWGSVY]&SV.]W
M"'L%.]5F?@5^E7U.KG[G90</EX#?!KBX"KADYR<=>T\M96D!X]'RWIA68&-4
M2O#%)WCRV\O5U[OK]X[U5T0OB,3+]C!AYPU?OY]?\F?#);JWH:NNHJNB*\*E
MV"*M?0M<@58D)UNHM Y1H(D8&=W]F4&[3SA8 GLG8/558$&60,Z[%B03F/0Z
MQW;:VI9+'A1_S@BY)[_5\?\1: .BT4$*XR&#%CYJ#%CXO?,Z49#?@?:<HC[;
M/<(!/6=2FU_TN\?4&XZYV>J J=HA5=R?GWT]Y V>U8]6/^$@C_]Y1\-1NW<X
M47@Y6YG0V[NAF[HO>]O=?;G]_E\?MM;>?M[<6V=\_FU8-MJ;:QN?MM_OM/?Y
MO.V]U4^;7XXZK_5.AW[?.3MXGX^C LMR9/A[L;6WSN<FL[76.=I^O_%I\\.J
M.7CUK_;^EV0VUU:_;+]Z5[;XNEM?WLKMM778^K NMP[_T!RI1%%,*T-FK(O1
MK>@SM$IPB*""LB2?_/9&_Y "3POE>#O*\2;*ZY^/VX/QP1.,'S?$:OO??Z2H
M HBB6SJ3:H$,I16=2*V@D(0&5:)@$_W&_!#$FKVV])#8@4L0@2/E('1R(5AI
M2G+I-JI5HZ]G^61PQN;Y OL:"SQ[3S5>I[QZ2@,\I-5N?S!J?[D"Z Z'/>T>
MZ_!&K]KV&=MUL_7B'& >[,T/#,JK?W7VU;H^6-LYVGS_KKVUMOYYZ_V_]<&K
M@_:6VNENKCW_>!/@S;W],P;STW[WW8?]O?QQZ]7ZYX/W&X(%A?U!_GC0W>#S
M^=ZO=LKVVL<_D)VP*E:UC+;L=%,0K0!)MJ)**'+Q)8G$'/J'\+3%&JGX;%L@
M! HV>2.<3LS5J0#\L?%7FOJRW:L!Z&MB3=RIV&V7MT-:'0YIM#O"T5A9M\OD
MJ#93K?ZP7<%<_\QAX; =._2Z/1S-%L3/6VL?OUPXZ*WN^AE?O[/UY?F'_2]'
M#. J;'XX^K"]=OBY.N:#]YOLG/DYU+_9V;Z#_/N_.@>J<QH_]-7^WK^.MEZ]
MU9OLC+=?,8!KAV?;KS9A>^TE/^<!/]>^YM_PX>"E_\*_![;V-@5?]\O6VK_/
M_L@^N*A83U-,8:*G(<IJBA,D8OX3"GO<BV%_,^@?TV!T]H9C\M%J+Z]S\'T\
MMH*]_!U(5LN(!JN)&=))IR;0UNAX0(S+V+KV\E5U^Q'Q\2*C1I%*3.Q($&.,
MSK(M2*H@16\?E5__O%GOT_O7T<&7OCE8^S?K\O[9%O,Z/H9%8O5S%:_MM9V/
M!VN'DKD;&_[-+UN[01S\]Y%(W7<]?!].MC]T/FZMO>P<?& Q^M+AY_GWI\VU
MEU6\8.O5SL?MM;?,W=CP?]F4__TEJ>W5/X*V5BKR+38.V*K,F0V]$JT$UAD#
M+$8B_[ OGQ:RS??ELX 5&%8!5@09=2MGS0$TBM+R$$-+%QL=!NTX@OZV_WYZ
M/2LVH$(#8L,P_$8RKR9RGPW'244&?F6<V'TV.CMF'(?M[G&G9AC'GQT-JEQ<
MR]O]\GG(@O7KT^O7F-S_ZTW/GV'8/QF,WXUSI\_.A6V"[-^)_"XN1./DW,6[
M=J[O2YL&*^,'HF^F>E]L_-?U7-/-DW^[^.CZU8_'XGCQ;CC"P6B-K>EO%_E2
M(2_.^_K=Y6/FKX=*U=+RZRTFWUR\O[C)TVL#=7&=DUY[,F@GX[&??-AEBW\R
MH-_.<[S/WNZN79Q^\=7%^WK^-S%@L=*J9#)9!+"$2+8@>.+8GJF[P0D3$%:+
M.1CZ2?I[=#[PMJ7%Y87.O_G!T1Q60S3\TX">@SG^\H='-"(RR0/OC;/ M)EI
M=\@I!N=("];?\8A*H869KQ%E.=8M8?[>B%Z7J;NSR[D:@1L:^A,C(&/B$0@N
M1>"PVK+=YJC81& MLY*LJ2,@P]R-@ P_,P)7;11[\+&3O_QYN7W*CW7UT+'?
MPE%_\#?-V9_.KQ^N4:_?93[\C<O>5:FO7>+I]:>_3?>#3!AE9L19\I,S[->B
M!F&T+#D:*6;@T<Y_-AU6GC5YF_EFGX\[[=0>;5(W\BURNUO#LSH'/QR,:K21
M3])H>[!+@]-VHM7/[>'76.1WPL[HZ 6/XQMF:WS5\Z,FU_KUZ3=O<3EVET\R
MKZ[VNC&G"-$4+Y1RP*,<@'PP%$IFRY;4./$APSF@#Z/1BP(H&YN[ GK3+OT$
MH$K7)&51EOBO\SXJI3R6A%YEJV&<K)3^ E"_!/0' /5W!]1/#= D4K1,IRCX
M!![0"[:\3+]2"?S:S2*(F!Z@XQSI"SQNCVX&T<.%M+;%9^VL\Q$3&"NCT2XY
M,"[F;(R/C;:V,\-R-H:VD$UD"FGK-"#KHH0LBO52N[KV0S3:T,X.RYG86$@>
MP*BB V@P)D0J!GU66@M0D>P,]+(1.F"S*P*-,:@X$! Y<"1HA#':9!N"F(4.
M-$+>8H0D' \;2;8:6OG$?S YKT26%,0X?';S:#(ND^ 7<V%UHF9T5C/A_5XU
M#]>)&G_>[?=V1_WT<?IVXTI<[Z:6V7 Y 49;7   :U44Q2?C2K$E%D9D8:!9
MS7D\<XF=-]C.&[V)M>\T!*9DV/V:A'55.SAM8Y1)QY*LIA)3*HL#T]?)S>W1
M$0WJ<0,ZJE<[I8U>ZG?O(>JY%\B$T@4Q!XY>-("ROFBGE-"('FQ0<6$@VZ$1
MMGN4UW%0%W;< V.Z%WQBL0A*&^:S&9S-J!-*](JTX$#%V\;C,R:U8U]TU.]D
M&@PGAZU1^7K9N4?)2Q^R-L(5I@YD3)04A7/6(#NJDA='B[;ZO?K#!_U.9[PZ
M:D0#&C8%);"@4F1#YY,%2]XS(AZ"]Z%43F$>#J59C8"-("P'!+I(_N'D8O(F
M2/[M44!= M2 \'B>N.[L8Q9'*+()4# BE(HI1.V(=)2ZD&E"OF->&?+LP25(
M*(*J$P8%BI6H.#1-[/4U9J-S7AQP'YH$S![;;(TJ&*+R(@(PJDRVE:$LB\W.
M@%\<;!^:.LP!MI2M"TFZ* 20=LSAR2<L 1V_C@N([4SBX=D#7=<-JI0Y5LX)
M>.A]#"HPK"$ICMJR63R@[S^*GCVJE3P5&2JK\@!*!8L"L]))FI"BFF2Q%@',
MA\H#^^G%V;9PZ$* .7DPK'>%32NE)&50QI-?&&AFD0>>'DPNNVQ#X=&3 %:;
M:'-!#5)ZC$HX6!R89IP'GAYDBC1$MGM.*(* HD:1TD1M4G)92EH8R!XT#SP]
M?*)$8U4B+4.$H,CG'#6Y8I63$)5I/#XSS -/#R41A+ 1F/Q'!*$\*J&-L9EC
M=NF#DXU':89YX"GJ$I(%;[)2(H&V-A8!#@QQT):)[>##H32K$2@B)NN55#81
M9$5,=2.*'*C4M2*Q-&#)VSQQW=FO^4'G04,H.B, Z>2+K77G4DE*.Q_-X@$Z
MFSSP3, -*N7H42BV3^"C"BFE3"Y2*&2"UXL#[DSSP#/!UEAT1D J*BN(.@53
MP$KC2&D.GO(L%CDN"'68/;8.(D7)1,.K!";&H'/(B2054B0]+1ZVL\\#SP3H
MA(!:DY2H%83D,4N3,UB+!F4V<O& ?N \\&PX5<%$(OJ@! *'"-ZC%Y2D28IX
MY.W#;:=M,C>>UC[?ZPKGLO.8#'CD:!LM8Y0+JYZKVW>RU0L#S2SRP-.#R5N0
M,FD3LD0@X6/VNJ".E++"8L/BP#3C//#T(,L^1>]$<CXYL#YZ%8*,5F,PM6Y*
M61C('C0//#U\9&'^:+U@&NDA65OW0[E$!0H"QX*B\?C,, \\/930!IM"B59J
M-H$)@ZA;OMD*LBJ5C-!XE&:8!YX>2C8EDV-Q*J$!2-F7G"UY2:!L8-_5@$W<
M\\3T9K^3.X02-&HLWF9(A4-L'45T')$Y<([\8P;TSG=^?C)DOS@<KB:^\Z2.
MYA7+O$9T/"GTP+3FET44(DS*61?)H_%@,7F?$X?Q(>MD4LY-J*:SA/(<2L_D
MU9#7Y MPR!@=(' (GXOUA<(WZTK.*93S%B_.'MP2C9%U.T\A 1!5Q.P=DV*E
M1$&?RN* .\M9D=E@FW(H20:VN-Y R2GHF)BG^1)]K+7-&H3M%&WPTEC\_27Y
MX+6(!ET2&7(Q06EV#@84.P.K=1/J-<VQ0#T^ X62PT5KI<B:0 2*CJPLN; O
MB@*$:I \S5FD/WML05HJ+NG"_X,$*03AA,Y2NPC@XP)&D3.?MIT-T)+'VX7@
M8[0&C'>(HI""8-$KJ\T" OVPT[:S055'1+!&@ZP;*[-'4AIB3@[Y?RJ)AZL#
M?<]@/M"T[10+5&>O J5"/D?/3K)X43R1=IZR9Z)/"P/-#*9MIPB3#Q1 F&)+
M+9_H,:#.12CC"F%"A8L#TVRG;:<(F99@E02O:BY$,G[.9$O**>?9?>7%,7H/
M.6T[17PP"6853"4JB91$DV872EJO#-B<&H_/[*9MIX@2%>.R!"VE(Y )/#-_
MA.P\PY1ILKVTT2C-;MIVFBC99$N0B=F#A5AR$)F5*RD9'$?C*9S3=GM.V^N+
M>87K!W(Y]T_5[9VI^K5#?X*JBZR\3UD*ESUH*R.[+X_1&$ RE-WYNEE_OFZV
MOF@FDELGG?YA^_/]KY+U=UXE>^W0O]D6JG=2'_PO&AD=\\N+"]RYC1%8RL$)
M4DHB! A!:V%=C"YYI:P\;V&S%(3O6-J;V/[,8C/TWDKKR&1F*:%N)$,E,N-
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MCOWF0G;<5-J@E$H16QG :()V&%-P E!):YJPG/C! %Y:G1N%WI3E #R!4QX
M! ?F)B61+6#B;R[ZXCU ^=D?SD9,J:AJK<V=O0ZAUO)'Z8+UIFY,4RF2=:()
M:WM_)#I8^.FY(I#(.,>2G* 8CUBKPLB(&OG?$.<_[;A#[8M]UV_Z?.Q-KG71
MDN[\F(9D_9+4 AD<:06 4B: 05>]EO 9I7;S6V-I#G&98C&EDDAGX5.T*8#4
MZ(V,69<"[!1$F.<T_?W1S4E5K9-:+>N8;=;9C;8&SSLGM'O4IDYNB.YQ!,'N
M'(+,'&,H$M'X7%3RR0.257-L$_\V&WMT&*=L;5 ^:4$2G(XAA21LR.ST3,QQ
MC+&P4LYOI=[O5\J^*#YYO\T;A6U)>:7.[L^41[.0F7XXQ\,/!64(Y(P@2R1T
MCIXNFT7Y9@)RS\VB_KI47JU;2)D^3_SM[MF02>]PHY=^P5Y^&"DY[PWEIR E
M[&,E*ZVIS:' \I5S2$5[8Z(R)CN<7]-\&;)SJ'[#>.[0L(8BN7[5$/,)$:*3
M1#I$ \$Z7\CJQ+XQ.O*&+EH]VODSG]61O6;E/!SOVGR!PZM(O-U='8WZ@QZ=
M#2=EE%_V!WM']+YV:QKTUMK#T:"=1OVR19_V^X./]ZTT=CJFU8@<+,<-/E($
MR[HB59 ::LL*;:2Y6 @=+EJNSG%Y^J_(U>C]Y$;AUET:C3J4OQXT#=8SO\)R
M<Z[XKL7QP\\4Q[_13;M?\'! XS3*MZO$3P[;+JL7AUU<]^Y-MK/GP->PJ?$
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MO2KW=/M'&<Q17>:J6T+S65X) JT'G6J%[@.GV3<QO]5:FU)6!9WV4KD1==K
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MN^3!K&12OJ8$K!VDE(%!_?,8P=M$<IWP1V%88/WYW-3WE)[* Z6H\)@RJSG
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MYH,.7^IQO@;*7!.1G.-9?21H^7_&LTC\WA"'28X*Z<G)B7D0HQ+_;VJI[R@
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MPM>4=NT)BKS='?BY QZBY(;36-0D$4D0K'<6EU*3Y311&OO;8M/^),,L(!?
M![B7R\;P^S-C4+\U!^97):>YLH>JN/$=6/(A&]6G\A,0HK[R)S#=Z$[V!,)(
MYQ@_Y*HU MLUT28J9M 4K8,&!>R-0W*L-6Z<4C$C/8]0$GR77K9VL]VV0S<#
M=GYL?:^DPRT3UPV"%T/! 1SPRCG_S0XPLG=L() H77'SB4KQ2Y!U2/^V7YDN
M\PZUX(@3$*V1V] ,K;H<#"",91%OM@1-,):"82QU,@99:<:V<W (E,WZ2)D(
MM%5CDK8BPP?@4/FQ$53,9ZX]%3+BB,Y)V. G(J<E2S0'PH&+)&" %!%$7I G
M!B^$:C,S\DZ.%5P%(\HC>2F#$"_>RCG=JK!:_^^[_ [*L4ZUE-.U,0B;X8(R
MIHO)O<QFRJ;W(-QS5H"&4R&J=DFS&A2B]Y$JU<S["J1I)@J-W_'_L_>NS7$;
MR;;H7T$X/&>D"(@F*<NV[+M/!$W)MN98(VU)LWWOIQ/H!IJ$A09Z\"#5\^MO
MY<K,JBPTFJ1D/=A2QXDSVV)WXU&/K'RL7(N7;5A?5$/'&B1;#TPI'T&4$)PS
M6WK'ZX3!!>Q>4=E[4;:4G.V27Q^GR6]H89\[-Z]8)X_U5=/D^7GI7$)W_+TL
MZ<+J !+/ZT#5W6D" )2)2X;R^$J_WRG1<])'P1<KPIVE'?B".W<]$T0@Q2X(
MO-,!=@" @Z ?(M#WUP]^.'B8+(F'& C<)PLZ%-W5J&?96XS,U^/]Z%MJBTNB
M7%\#8-EZ2A&^>=+,W$H6ARU)7A8%ZX0\3.F8QL-]$,40'E&ATS&L%A\()'0K
M33Y=3*H;GMK%30^!^7AYN!$,X(0%YEM;V:F1/1EZ-\7_R3S:/B!OQEN>5H[I
M<I=V4>\=TK%!$!&J3*R#IVB?)5KSM ?9UC"S$I\%6@3):%LJ,<PUQ]([S/>M
MCPD^D>MSJK#6IM[!S;"SCALKC?#0-X:WA9Y,X9*Z'WG#-=(7U2T)VZ642,0S
MHQ]'7&@*H.(?>3@5%]&XU,@_5#HH8IK4.VIN@ V GA-ITC66.\8TD[/KIC6^
M(C?7G/ IMK$\"4Q6KPIP7*A]VO-J'E;M&$7&=0$I3E.A<@=7Q\XNZS\*I>I3
M[#ZJP +XY.J[G#:AHL*.DR*@#9(/F**5\^6EA:;D;-6T# ]7=;:7<OCS?P_<
MBR,?3RS.B" KHCGR[!;F44-=F]%1[NC+P!^^$;,8B&$(7;9A&P[@4XGBVZGI
M/'@I!).JU>:>I;DHW-<9L*F$C-ZND =7-Z@S*14K4T0RSL!#)<^@Z-(:#RU@
M3]&$YT[WO%'JV'DS5#E#0AE'$8W$"/MAA8/,'>OBDKC*\&7?\A-<CQU<_#N[
M:Q\+N Z):1/E:RG3,,NO(Z/?Q6G!<2H0=)/^M.C.W=J7%A2.9SP_F:<VBUGR
MZ9!BC H9$;>$SLM9V8N%W[A<]%ND&V0C"(U-)O @O.EE$Z?*]2#*"[<#J)LU
M5(?YH'7WH.H:C9$;& 1![@*S@LXX2908[C8ZDQ@C1-D%.D0%=LZ!C_M&5;XN
MDE.W'-RCU666(J:^(+>Y=QNV9XD MJ3DT-=HU$6,5)7+$N)+93L?EMR20@[$
M15-=>,$ ZMI%7[66E1E,U OX!X^P_8Z  LV*<-NF=HMN!U?V7A;I@U/<"YFQ
M&R3XK.B5JPNR\E2>XM.\I]Q-EA";0X\<14 [:!.:AU7 \A!L#*$H+T"R*7L]
MB]U8#^6"%D'>N+N051GJ%D5-9PC7Y%.@E=?,=':640\;PV?,=-,RZBCOW._U
M+G9M\DN>>G8?Q @,SC><^]V^W;U;9JUSPZ$(?P,6ET_I-/%:U5B 132;^IZ>
MH?YL=:.1%]3G"<=BML:Y.[2]H% I@F7V1D$]2Z 1'^_RL6^9@ZP' QP2=J&F
MMLX!I4XYJ<J[,#73LVHZAG4SZ#DO"4%\7C!5.1)^E^2 B6'7AX9K(#>37/]5
M3J+V&NMH"$;/11EAW*Z_"CV/\)+*G3/K[GE&DZGQ[R1:D0P!LY "WYQ':01X
MC*'Y,)257KOXJ2KRLP)E)1=O#7TL("E][AKJA.KY9QC$[.%[-X?OW=\=^-XG
M2C[_7JH9\#+&MS]COK-A_A]%2% %</8*>&Q)Q?I>7LKWJ+!)V7%Y<=6"BPTA
MZ%E@\:>66,K+N6,BSX((B#>/4V09RA[A33QRO?[I).CWQ=3UB*XA(J.9^A)1
MGS;+9=%2*@N.I_B@A51-W3EDVY&EVBFWEQ;@<'891HUPCW!PC^B&3G4,2Q!9
MS.609T0"5&(Y$<H#TPIUF= Y^.9W1.G^9&L+U&R17#E(?FLNW<2T+H3/W=]I
M4J8&@7-_/07R'NE -P%KCLT%$J7'?%ZL>GR#=,=PXF; L!_$)0!<'N! .B\Y
M'>C&SA?F46./G\&D\$-Z\3QK<^9:Y$O@C"Z7*P(X<C7 )H2S-:],\#JZ];KF
MQ(^(YGV&Y^SM??#G0]L-9I^/DW[CAJWI[HA8WD#$#*1[:^E>.&Q&11(ML\KK
MPX?U18D]_"C<5M;V&5_Q/+M@F)+L263/X$_3U@@D<U\?'1PJ8@)R#%2]R)48
M[.O[YE.Y079V1B3(5.IP7Z<LXGX=?L0'#[E3;R2GELH\6WG$")3J!8?DC!((
M.PY,$I:M-943OSY^<)BZY^?E@K9/XE]RJ[=9$B ]$RG8IMURTXX.@G]._89[
MUSG+G'7QX0*Y*K?HB:&#&."T:;ZI72PC#:"\T('9<5]M&364E]VB/!M:P\+.
MTK#N"5S(.+B7:^EH^'-HU](EY<8E$VR>1GT(Q,B(E_QJ_'TZ"O(B(Z(7M'7U
M7/CID!0&HLZ/%JE>N7T&+O$LN20R@,50\:]Q91J3Z-84THU&Z"!Y9M+4="E_
MRJ"2)57KO,$.1AVK<[-$C;68K:@%38L%?"WCU##53.A0$_/ .7T:?>!:OHPZ
MU"=RI%^@J? MD2=[I_^O]@S]RL[U9_$NMWE:KNF\*"PBP,=#SO**V@RWW/9%
MGAJ11^^YRZ<43!3U1>DL+2P_I[HZ]\*4)71>&B$%@1)D\O/09A5% ,RZ:!QN
M-;(J/>PN@\0?@Y/HQQ 900?]( Q8-TCC!;H%DL*K2H!"+:-#:(ZU< K\NZI,
M6<FM#G=H:L(-QP5"U(M,B18#=)9C07?<P-(S1X*OS=I):+T]8NA1$/8D7H;)
M[_&H6&Y<GB><L6WA#M&"0\NF)CR&)4[%%)BK5MDEOW2#]N;1="':0J*7ZFT0
MY6($=11F;UL5O':^B+/L]MJJW[%F=6V?%FV//0K'[_?L\FW:9&[O2][F^;H:
MD D8!\B;*5D%.C?&INDF%.([+U\&&#WGLEG=ZRJ<(^WP;H#,&>U@!3\OBAR)
M+@ [T;SFS$"71B8&]U+C1@\W+UJ8Q,HO*'?[,=[*O4Q3U\4X?4,<F_>\*-G5
MSPR[I\ M#XM#Z8B)>SF"P4F \I>WY'_OE#R08WDB=WB*. GF,Z2RQ-^>\V;@
MZR&$#RA8\XS4*V*>D:A(R<)22.+..N2Y!N?OMV[:T10Q(^-,1M+?6XA\WHMZ
MY=X4OK.5"((WSS5DICY/FB7WW<_B%6_S;%VYS)X(.>MF]"U.82H.%])FO[B'
M*G/ UZIL+68'R>.:?) >)=[P]6RDQBWKH.3?"#Q-@OGHF[9A5PO82$,H8:HL
MHZ6L(9M?G*TE.R^4@N&J_+A(=KLO2:H0Z&(]#0P^J15O6)B\RI46!.@C.+Y-
M!8UC7,'37D?W\]6.5^=LZL$72RES&6]MUF>DX\:@<D+'7E+&&/YA\88*'ITG
MS]'GH?G4Y_ESR,_8],(=G8/F&H\Q(M[B*]9G?"R4 <$8<OBVNR>0RG;.M^[[
MC;%>%,4X0\QN=J!.95CX!G(:\<YF-#%.(8?>P&L.XY334VZGU+PN>YL8>ET4
M*_23;PP ;F+L55AK?VW@M[P?]]Y2L!1%2&URX;[)H0T_$2\6]A4$3;6@4U[G
M8>_W?]*3P#L?8*S%/\J<2# &IF0_<2%<$/'\13S"$[>O[[TNYZ]GV?QU\A*E
MP_W)^$G7Y(UUC>)FW&-68.)>Y-Y0<5X4E#-0$D:(LV[I25%"%M)%<LNC)'T[
MF">-'\[(W'"P'R05XHX3)K"\HZOQ+@M__XVOP[%'^.GX^V5^=V]%/N*#JQ6@
MI!#ASVI-]TR:!7\&\'?H!YIFH/P4E6 @* 2N92X8"0N?=[U D;GB.,YY+Q3=
MT7^[,&VH)?Y-T-?D#FK4J5+!"%+FDLI2=\J[DI@4>D^.".&ZT*?R\<+]7!07
MR9^! Z$-&N//"4M*1*I-H.[S0A@L55[G<LCJJDZ#@?7^9-@;$9-K2P\E3[6'
MN[T'N-NW>[C;-4.D'FJJ+ JM--='6X%W(Z&7.$DCOT(MF'XGW\$O99_0EJ6]
M8K;*>]LI*&./$^C8JE=Y*DC(!,AM\49$[B61_4Y;EE'1%R6GR^:MBQ,YB*N)
M-6J?W_[H!:SIF7?1^:QMLMS#!<+IA,[=B!."T7Q>DUS5I=RY1Z>66SE:WP!L
MHX>$G81,$^4S%U<WR1RMK,0EWC-"K'4!,G?_/N.DI%S@20U:0+?JI"2J'_SK
MX.4!R1:Y.%]9;8PVSV^#>XWDI9Y(=YX]^?4N>B%!XYW'N=LN^:K+%M1NV\Z:
M]BLHFQ4TFIWD54J*([%'<.8B$3S,&/:?<GDIZ\"[,=E C!%#3R*^*G _]WE'
M4F'D)H: ,7#7TL1)P#&>OH,$N0GW4OH^&2+^*FF'"J#'?[K-"8>77%UQ>$,6
M&&1IH0SUDMK D?(^;1K2BX>G>\J3Y@Y&)N@6"9ZW&G=Z<W#@D F4#!-Q-:81
M#P%Q[-H9Z+XRMG!Z_=*(::[C(JL&=UZ%9@%%ZMA%3'Q [B%!DD4]K1OE1N9_
MQ*1QT,],*B%<U_FB*X?'N]+ IM(N4E:B.I212J)[O+FZ=.81N=>UUR;7+/21
MF*$)/5M:9RW!]YS5?I5==0NW[4O2:T:RSM<.WO:U?.OIBF"&1?XE,?OX1=29
M9O[(6BJB=P$"1#^980Y3F\G"'" K%XK$]FJ"H&+K4%RQ(V;%/*,<A1 KD@DB
MZPS"12][)#0 [B-PB;J5V?+V8:HBY@[R"XD!V1TOBPJ96<2^DA?C5I\>,$SF
M^)]X ^RSIA5(N8%X(V>[(K''WN;8)E_.@*DI($]D"BZ](E<S=*1CT%/4K3W2
M@$-H9M*6LZZZ4VI VM?9()IHMS;)^),4A)\!N3X(EN3=VH3WH[\YTM/%"'?K
MYCIT@O]Q7E9^-I%)OQ3^/&@R,H)[X@Z!XPG0/VU$]PU2=/1EK4_(3C^EF7&A
M:HE,Z6E# 25C&*>7+=:0K%TRM^Z)W3QW"\8B\B! $")8-F-Z:62G6L&Z>>L,
ME7M]=Q:9;(IMJY/B(@97D]TW\"KV;ND.I5_=!FQ?$QSCLWCWVSR-UT87C]WQ
M-D<%\KGHY;S0W-+)',[AT<,?'J9H]($]BA)E?B)3$W\8B ('HH%[)T $^&:=
M:$I*?8T];F F"H+7P8T5_4.?G/+%TD@?(KE#4.HEU8'HF.7Q$J%J#AS<=T+!
M$;AK3ZAIRX]BT-_A!C%+RU9/ELN2?N3B8B0/JRTW$KS"DZOHP:%?+W*?"N3+
M^C#=AB1R4H1;*@]:9NM:%'5(YE)"A:ZX-D<0[D?GFC/\8K&_/GH K+KO' G1
MD<]=HN7CZ/#0?W&CY)M)?_8%GW#0N5P6*HH4 D!^RLWW9.5*&E_*O#).<\D%
MA;\83'$ YP:(0A_S*,K=M!DQ&>HF^@TQ\*Z"6J8-@>*"+]X!C?T(M51'M0CD
M\7Y305TY6-\0/)\^?7EW,JAD]E?KRKI@KPK>F6@Z<5F9W2FC\6*[DEBUC*1J
M?'-$EB_=@*%O&Z( 7AC&^$289,W>LH[AZX)WY\*-2#T/N6XNGXO=V!_W'_'!
M_^7]:&/O0RT=UD!">5[QDRQO] ,5>W<>VVH=?^PYK 'B"\;>TM865YT+!O@'
M:$U1+>YY6V/LW$'R$E"0T2VTS!^P%)Z:#L@"A$&UQA]DB4>8.<&NL#)Z,B"#
M#"T-M^*=(]RZP&FH3?IU/$AI<OHJ39Z^>)).#!54CL/]EID[C4&=94;Q#BGF
MTJ9R7G91P!Q.?>_N0?+\\2M<L1[F%=58%6-AE=TS-9U^"E 6W3K\P^8B&9UT
M)"6H0> ;7%/@']NO^B,J7AA%TE$?FK;IYLT*W5)F3,UC(VZ1:%'BHXYPCYR6
MRT!479'"7^8^[.E9^F%6R-S-Z"?*P^Z6T&N&'6ETW.1T8\KH%#]QL<T"2N)'
MX..B+\YH]<F2%$ G]S4O4H60"L@S'[@3C<!'GG8#/6\!Y"2W %F/5-:<&Y,Q
MDW7+?HP<EI1+U*=+?6@;HV"L3^739W8!+-WA4ZU]ER9GG3KJ)<N%<B:K>36'
ME>^S#\%U(N\(E92W2S7=%ONWLX8[=C0]0SPO4.P2LEL@RS%$+SC+C;&96"]
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M=E=#J=7ZFZJGRH0)1++/^G$#N<_J1S)HVX)V2G8:T[_1IJ=EC'7"8F(IT@)
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M@[=Z;@^SJ)>[R-.L=;^_CW[#(R*QH?[+3INM!-6/!+=[>@0!$P: <L4W,2\
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MS&T2=G15-$@N8@3I?4>E;9@\)YRR,_H'O!CB=G@B<1W."/UP_% ?#ACEDAM
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MH9C<X@<FMYIY,,C+9$O6864Y7/]*OSUY]?CT-^B[\XG+#XVN)*_$1V%"QT]
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MT&25,&^:AX:5%G&NK6(UR@#)14;EMK7J?@;.-IDVKG(D,Z3!>I^^'[BQ;=L
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M4TG4CHG(483N^&DT4 G!/-.)L0^B?H^[X6\EI66Y[ U"Q9K2=1-(K$C_U4,
MY-BD2+&0YE^>QJ;=L -<<&?@(M8$Z,5'(R7A#8'.!&?CIK%=9A5X*='NZU;N
MT/NGI-QJ>%*JZ)O Q7MZ%%*&,H"I.G*O6="@]<&:'T\F!6;_#M&JZ+3@/6@(
M;X57M"N)PK?TWIX[8PV<IPFUI;'<K5M0W91S32\;?)ZX94-HX<37SYL**I&[
M.!0[&UQ2?J.G@XMU'>8^)\^T'C*1(IWQSY.7CT[^._F5TU)/.9PC:[VH"$R
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MNM:)HF/@TB$UE)#2YT5@\8.453L?EBS# JUZ[GZ!Z:*9<":.Z 2K\C7Y4*A
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MO@29$\1&Q'TA+1! _P*^XH*FZ$'\VW^"\*OFN/$]&B@,=GOM2W7CD>&>T@C
M^ X7<D(N# K4(4##-.SY N[#4Y?,^VO@7@]02^\E1L5O%DZ) 'W#^>(7SCSX
ME.X?(!L].,<WE_@6'[B6T@"^?XE*$%DS!-,)Z.#FODBO;:96;?F6*EUHL^ N
M6E'Q2  9S%!3D2SG9/Q-4LLBR@P)_#32Q,WS#9A=9#?:IBY5JF6 %L('X8?A
MJP;"[8%KQ$/>RM<;KW+U<F#V1AW+*N=IK.@7[=N#O9;=_5G/5IOM=[=__ RN
MX6/X9#='2[-#F;TRIQ(68XV\LM_]^!^2H%=K$K1*8LT)X;$0%Q6"$24IQKG)
M0:BE^VL6CE$9'NK$92+*IP0YLU1?  6Y#9#;.+#II+/ZWVZV8Q^3K%^:)!J2
M?&3;YGX%SE5XHQ8YRJU$[IZ=/Q5R&X#<;M5:WN="[@F9IZ)L/(V@G,$;/'0>
M;2O:.)WFC WJP6CJQF!WW\^GDU@/=/%4]' 4>C ?:'.@Z*%-]# :[+:"#J;R
MUE+96A11^%!(-' CF9,P$3D'3(,C8 1)F[O?*"K-[H,P#?=2W&F!L=*89Y_,
M*6]N(M(N1%$VQI3$QQ1"N E@29]BN^*O'0R7C;GG<@P?8Q +_RQ?C6$J&0?E
M(L;!ORV""*-M&(L-HLA%)WSB3]EM$))#/N3N?)S KD7\..3^1 2074S*N]<"
M7VY7<SP6P>NO?8JBB8"<?(6(_\MXECP'15+"D/DW,IL-3T+A$P\C<1'L/P2C
M0\129JR06)?("#;%[G#QV(WH  )<6A+#=?>_+,L;!*A2[@&?3KF#B?+>O2[S
M_?#/>! ,]4U<)XU!A)S-$4-9+@_B5>:"8.Y(^@$&V6,9I(]#YL28",0PGH1S
MKK*4' I&(Z+G"P^V$M..N(CL4PJDC)^GE$.IB5OA]&"4"8DE2N9S%@+E3M)4
MA]4XUQG]/4B W"?1RQ,,0ZERB?+E$OWE+1;_K7?E@XHE-B<\UZC-JEBBBB6>
M)!Y+':J&:"P9+JP0UVK:^4L%_4[Y_.T+W5T&\SD/*3'0]>&>AM>*)W-T-]L5
M<X#SU]N!TQMV=>/40UF*F-M!S-B V>Z>>-!=$7,[B+F'W<3-NA+S"5UM?J6B
MPG#-!-J0 -' 5 ;+'.@C:_<8O>>/V9T(;&WLZ+N[3;6"[9Z1YI&E#X>[Q=]1
MICPV\,(G))P[:5DG9:NG]]4HH-IC::A;PZH=^A26CL%+1YQU?T+V)O;#YV'T
M]Z6R]Q\6\"?J/>+Z?R9AF:ZW#:0BV]:[ V6+/DE;;4L?C.J6JGD:H+6[NCG:
MK:&4)5H.E!^H:T;:;T2F)K7/++7-/>L+E,'S?'=[?=C?+4\5EHZ/I9YNFE7G
MA"FS=*.3(&NG64Q&/4T[U#0?[ JOC*6]0=OO[7:Z*-#N"5I02<.G-_';8(<6
M.EDYV,F*6N@&T_BN7!SHE%2H:<#%<?>=7!DZQ\?2 "X-1S1T%)9*8:FO6_T]
M0_;*'%WW%)RF]0E72VNDHL9/ MJNWNL]?4EJ&T%K#O5!+>/Q$_R_1EF?G]>+
M/O<S.L713ZW[RL@V]8%5V?=6$1A/;@DMT^5^EM!I(MC4#8SZVWV%XE-%\; /
MZJ)Z*O8S(?B$[.1/9<K[RVB7$R- LVOHIOF 7^,X@J2*O#@UK%@]?=1](-M+
M8>7978!]O6L\D-UU9)F\05E8^'^-,OR76MZ5UXKBH!(#LFN%#6">! FVI$CW
MW=[*GX,#J.;\JAL#4Q]VC:KFU:'A].0&]C*+[UD*ISCF&0!4=XXQ>UW='.Q9
M#: X1G%,RSAF-.CI9K>RAZ8N_'*HII'/"/;&#U.-[Q>(#^^^V)TQPDE[.$P4
MBQNP5:0<@Y:.,.MH;_)IALO#&8.IQIDSRV8<WG ?NS<NKT^]'8,[G/F6#GVD
MV8S9,+YTGK'\DH=#_PIM&*GS(?:<3-^Z,ERQHWW!2<<T@]G%[H?P^GRT,TT@
MO*/)JC'UR7R+)Q M*K,9E(4FC-A%,0>3&&:'\]SNM3L<0HG'9)0BG4V%%N,5
M8#D_".$3%L&W_*79@-<Q[@Y'),I1=Y$?W$6PG7E4F%2(_4!%=E_ZBCA(#P%O
M2%.RV6*! U'IBPXVAO&\?"HM=A45"'5P.*R^,AY2<SQJ^PE[^LSQ /3]D..G
MHK$DC>NCN:[!&#M?PM%O<.PLY80C-[L+X;R"YV9 7-I$#(-$T3$3H^D6'HZY
M!8#EPV(O:#ICQ%<?B?!\G([W+^8G.*46P3/'";1B<F3$LV4V;"V>L3C[7#8
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M19[X5^)S+9O7]Q!',  ?4DR65@W4Q"/!&V\X7_PBYFA>^TY'U\Z^R__TW4O
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M0>:A%;,=%,_=6<%V"MFM&$-)!\N0&")Y7!0J11(>LTA('=1:0IHOPI0@\A5
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ML#G*1L&/75L'I KXR$>%.%X6\D.#OK:V\R#OX&[*W6"&XD$X-,TIV8\_569
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MVM>^@%Z!)2;;8YNF50TLH7C!P: F5$JMX+;%T*KD0#LU"MMLODO55>:*^20
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M.ME]XC(%DZ<$N97T%,D)*]=VLTLPV<T=AX)<B76>])6G51RZ+<SEP=U0>J;
MD)URRG8'>P_,6Y%IS7FDR\LE_A[%@?/U?$RV+UXMP10D6_$QW0\V%C35#E8O
M'G7$>A<@]4:F;MO':71RR(H\175-HKJ^3<DRQZ.ZT^I@LD7$EQ38I8I9FSND
MS;3TKE%U;-!A9K2I47JEL334!_9QABVVQN3[*7$]LN0H:/!7XBYH4'I($<FV
M]?XSACI<&AMO]IP\FOIZ=[3GS#=E)Y0#\J]\@EO1HF2Q\-S6#8+N=O51O^K
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M>J^#" "I@_^9<#['1?$KR,(^&4OX=)#$J)6)$XE)X%N2;8C-I(7@(Z??PFZ
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M::UFE2C8-HALVW -%/?A1U_\I&_6!DA/@@0=K^G6E15R, #5FRG[?4OO5A[
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M\Q+X#Q-Q&%27WTK7"1>:*@.D5.44Z,E6 V\5"S?H(<=9KRDH_9N_?J'V&KX
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MM/GKWMJ8;6/#FS5=<J2NC.QHG: :NMH]9O/30L#HR'G.BMQ 'LK)K#HFIQS
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M=#PVE1H_E*<M0M=%<4J>:2@3V4Y<\T\U)5J/NG5B4Y0WCS>R:*J-]5[!.[V
MC7[9W.F>&D9=UN 3[LN;JJ@&:=H>\;:8Z'Z7N%&XF=H.VYKW66)*RY3HXO;"
M0A@-BO(IU]/'VFH81&P]P$J-#YZ[/M<CT*7D0;DS:1NP^D9Z]F&Y>"V5#);
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M";4]'(X44A)["!T3L90+%P<PV[W8=3<N)?34@@-'S7*.GC464RSR2-MU'UV
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MA-M^3&CF.R2R(T&H$T3, Z.,I6(K3+N.N#:/N +'2WW/=XD(N0_$!?(NR;*
M<$9!^(#T\9D+HL[N>3CP:@%^QE+3+I<Z38W/K@_>8E/K0*1BE(C"\IR>A4),
M7H0$9\$/+P7<YXL8UJV //_2%03]//R !I_*4%.7X5N5-^LL/*,B% @8$"-4
M/;7C@+"(QP3/BL74<_P47*45Q\MV=7K;Q)9W3\=W;+E>MFR,=*0^"P)0<!EL
M.QCT-"61&[G$L2.>IK''8VG0;Q!;/LU\ZQZL&C>6#:U+EG.2CTG*+O,I&W9]
M_S^_TJ[>_7>P^8/QOMKZ3K"L)%C^;.K[D'DB$2$E:2A L"1^0F(_ .G";=
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M._8=$<7"QY&RU ?3Y=[8MEW3Q^:R\$.&'CH67@,+-T(/(&4SZH1$>!XF3EA
M(COS"8]C&GH4_F<'P,)1SZ;WCCMV++RY+/R0 82.A>_/PHT  J?85>F[Q'42
MG&@8Q"3V*2<1%V'D^R+E ;*PUZ/^NF:S;E!V<UL<@O[_SO+IM96/+<&*,;Q
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M#UD;[4T0,2=1Q+RMJ44I7RZ10"E'E!"E90SWXX*[8@ON;*[ *<F4EPER,<A
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MRYUT3LF@<$E<)AJCV"X#2O.([<(JV%%LGT)LIS'KQ,I]*F0"-N[78Q4'[[P
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MH/3(\5)4ZN54ZID8JI Y41N@HE^4.FDPQ=4"SHM1;:U3JNX-;XI2KU?1WS2
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MA5^WC,0C=YJ;2YV&59Y2$:C=:T@=Y)V"$RK47 JU.^M#4"D8\5% S(R H(F
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MWD5S'E\TIVX!EF750A3D1+GX 81#&08T"KVS=C_A.OB;O[222_?8!IC>F]8
M7;C^#@3\<1NPY;IACRE%$BN:7<4"&:(]PH8*9RASD9.<\B_9;7H,=S[B->;H
M[]$WK&/;NV#;)1"3V=06C* 0J$/Y!)'1AB-"/&..J21R5V&"NQ9B#Y1I?W +
ML8Z?[X"?VS@KB6"\$LAY&1$G4B,G;,Z? R,K.F.<<[D^!S_$;F+W:L[H?!I#
M!@Q5I^%NQNB:8(HI/#"\NOT,L=WF7+L98E\IV%:&F'!.E18DH>2D0)R;W"H@
M:H2Y-)(EZ8W(P]+S'&5^>8;8C;N7=#,%'Y9DN -LTDF&=9(,2P@#R$5)&0(2
M-IL\DEMD"/Q38T5#<,DR0C:VC.GSNQAOU F&AR48[@#_=()AC01#"PL)R?($
M X^8H"97$"5DC*5(8&\MB=$$QG)[=-E7_/* \O63#(]QXNBSW?WM_2?=Q-&'
ML,A'EN'Y8C(8^<&9'?;.:K]7#U31:#R#6^0(XC#:*;R$#ZT;/K:V&^L:*7P9
MF\,Z2,_'H^.C.#E]&EWN'U1G@1Q&/Y]TNOFFNGG_Z4H'<6("M:">433>@6YF
M8+0[4-!$>88]ECIAM['%^D)V#<0?*%M_S[Y_'5M_2[9N-_YC *.$0E(J8.LD
M-;)$!22=!NX.5BAI-K9DGYL[\-%U;+V.;/T] XH=6W]#MFXA:9,TY9QCY"('
M)"T]1A8G@I1SQ!GBB!$JLS5>EW$?CRQC\44+8,R !WK#,2PB "=T"8AK!RNR
M@.J$T8V$T4K3\,0U"=G?KV528&,0C R.&AD6E&!>$I78QA9G?6KD>N0X=%E+
M#P4[=+S[-;S;2C=TE$D1P7*($@P);PG2$>P**B-V(@HI,. #CON*W\:2Z'AW
MC7GW1P&$CG>_@G?;X32OO$[:(B<Q1IQ@A@SA#F%GE*01"V/"QA9C?<T>8&[A
M/4 !V[#JO-EV".R2XF020R\-1G;D(SS^M(('D_AN/'R7TPT+1@!N&85NB.EW
MGBZT(I-VI]-Y/J,G^8@Z 74C ?7' ACLO]D1!W^\)EZ3I*A POC<-R(J9).2
MB#+#!/6>"4/R^$*R'GZ*SOVX?NTBOJBFO./@N^/@\Q4.]H(8AR-'TF(.$(%(
M,#.L0=[2@"6/22>UCI7B'2O?T_80'2O?&2OOKRICF8S&U 64E &TSX1')CON
MK) V<$^32V8=6?FQ10]6NE?GJ$%O4+-!OS>*L]+BH'ZC A*/+*JPWCWJ&I'5
M>3B^0F:MC /"DF)FK$.>T P>=$2.)8R"])Q2ZY(4=V=Z=#[*]>7B'S62M&/E
MV[%R*Q%)V:")3H@(GF>="X(T#11IYG7RCE))_<:647UR1;5@Q\D/AI-_0(^Y
MCHEOQ<2MB(/T@FJ)%9+><]#'7"+C64!9#@L>A-%>K*,^?F1QAU7\<&;/_4GT
M;WMGD_$L5@P*+X\GMDI+NE5S@X<MK+Y'1M(DC&8KXNJW,>S6*+M MJ?3P726
M15<GM&XDM/YN12%V/^S]\1I.GK-(#5*8$L1AJ_-(0H.,C@X+%G2486.+]S&]
MW%>I\V ^&'[^QL&(CI6_"2N?K["RQXD&FSRBR@ K>Q.03C8A.,>DB*4F$;>.
M/LR.F>\7DNB8^5LP\_ZJ7DXJ@2'%,%(!)\0#<+13P-%<2,RH(0RK^]B%^J$%
M)%::L .@&(3>;-R#HR@MF<?#84Y?:IHN/[9@Q+J6."R;.^X-1N/)8'9^>&(G
M\60\#''2A5*_-J\INT%D4DJ3//I8<\2)P\@JQQ"S2GJ3/*;>Y];*1G>ME1\H
M(W_7@$3'R-\BO2E/O2$B@&D8D"$X=RIC##E-$\)*VHBYU5*2W/0 "]4Q\L-D
MY!_3;KECY#M,;LK=2X(PWCB*I,+9O^=B[II.D&(B)>,X]M1DC<SIFC#R(P,0
MJQ&)*9!YSF&Z!D \,ORPWLE,>1;P]"#].I_"PJ?3[90&PX&=Q>U1@*^%>6Z,
MV T(_AH!]FJEFS*.*>A@D/7>@P#C!CGA-<+6$VL,F)J*K&-DM3-(UCM$\<69
M3AV??T,^7R(.@D/4R1.4)'&(J\215I2 M:*9Y]Y*JL/&ENA3==EUT''Y@^'R
M'Y %U3'XMV/P%A)13-F8DD6<$ %_)(PL=1Y1PQ4##2_NLL3B^P&2>XH[GHS;
M(R,+^+@ .L[L9#8"]/T%H.-ABZ0?@"T6IQ-#-]'W=GE.>>R"HL9K:U%2C.41
MWAPY2^"TI."2:6Q('LCR59+GV]D0-S 5'C;[W?VLQH[1OD464F8TRD"ELSR\
MP"C$,8O(F1#@GU+Q:)BG(;<T$)>;KG1,]J#,[B\&UQW_W5GB4*X*C!*,$@W6
M=53P1W("64<Q8EYH2:4.CL@\4E'R'\"!C]JQO^QEY"<Q#&:]9#V@S-EYY])?
MBXR@EDAZGKT !^E).:=.&MU(&OFVV4VU3%H[A[P)&O$@&0!^$U%,@0K,/>QX
M'O J<-]<,>*U\^D]&$[^49[[CI-OQ<E+NYXJ:UW&SB3I ':]C\AZ29'CEEJ-
M&59" R=+TJ<=)S]D3OY1,*'CY-MP<@LA4*R3<3DCU^<^1\#%R J "<(I8\'4
M$HQ1X&3,^VRM./EA.N';PQ!N@Q#NH=!9U]J E3DMG=3Y:JESO#('P3A">6)(
M<V]S=P2.-)PF(J!!DI#"A6BN1P+7I2%V;L&'E<W?L=Z=L=[2=.?91%/"H:@)
MF.Z6,^2<!]6/%88#]-R+ *RGS96F>\=ZCR/_OF.]NV*]EJWM")<8*\#*6&#$
M\V1OJVQ PAKC.6@]$=7&%E'R2EO[6[+>8W/%SR?^Q$X_E5G_V$ISUR?]I>HF
ML*C_V?;_.Q],XFY]+KNCP[F;#L+ 3KK!B#>51F]7QAB#_ $ED9 */B+N699+
M2:# 8O28<.)YET?_&/CYN[3ZZ?CYV_!SR[#G.'IE,0HD=_MA@*XM\"Y2&'NJ
M4E)1LHZ?[RL_?V>@T+'N-V?=%C (C%BA3$*8ISQL@%)D* =]+&745%$3C<].
M^/LQF^R^@H*5_)S%T " "'Y\>CK.ZQG[M[WY&;R,'^+$#RH ,3XK*?,/TRN_
M/K#@T^V*2W> Z:M1B)-=>&-4*G1&H;S]*R"]\&1\>A9'4YN?XL40=@2^-ISG
MXSC,QWI0'6(GQ&XBQ(ZVVWA"&4Y$4!CQ!% "+$>&C*0*.<>Q,9Y&4$5=4OVZ
M<N\W3:KO^/2'\^D2)PB2>P7ZA(0C%'"_Y(#[@T0,8YJH]AA+GG/R.Q9=,Q:]
M,[.^8]%U9-'VN&+%&?8  (CG%O  #L@:E@/E/DJ@<8D9SWC@?N?L4['^H& _
MSGH>K-#>3W.@_-Y@]',>"/!N$. ?[KP>49SC!OD W@UF (1O$SAPXPFP'9J-
MSW[)NS0=#P>AUSSE/91NWSFI9PH/#*]N$.>$\WT"Q_NB/M-?SU_!,>^.GC7G
MNKTXUDZ>W4B>[;2A0<PI/7G\NC%.(1Z31#8P#2#!8D6HM$H"-."B+^1MAAO?
ME(GND<?RH0F&-<TXZL3!MQ,'2P02O3>$688HDPYQ&1DR%#/$F&(6Y(1/-()Y
MP_M&7!8'7Q>HZ&3"^LN$[QSBZ(R%-9(.+?#C?11&XHBTIKEF60:DA8S(FQBM
M\0KKE#:V".YK:>Z!L7"S8,F:@"%U)8/N/'NV\^2H=_"LM_/_GOR^#330>[E]
MM-.K7A_V#O9[3[8/?_\2 '1O1=?5._.C<,ZJ?-I)*?K90=KYX$_LZ#B^M+-X
M,,HB*_]_YW_G@W<@E$:SZ<N8AU3XTF-A>K(]"JMOM+[9";(;";+=-NIQ) :E
ME4%8A0BHAPAD": >R9-)R@>1=!%D-X \/\:*N8FQ\H@9^PZ 2L?8Z\O8K>IG
M1T@D00([^X"X]H6Q+<(\Z."45(H ?F&TX^L'P==WB34ZOEXWOFZ'74 Z4YPB
M,I8EQ)VF>52B1%*'/*>(>)*K$F^".GXPN/C2<,Q:HX[]G:/>[OZ3ESO;ASN]
MGY[N5*]^7KZW6\&.WO;^T^K%SA^O=O_<?KZS?W3X8*LXKMZK-:VAOI5$>P%;
M,0Z[(S^)=AJ?QNKO1<RY+3LK>=J)P!N)P+V5X0J28Y>[,R7N<G6HRY'G/$&6
M"$YU"M$$#B*0]+6X//ZY8;8?X3SL\M<?C&3ZG@&?3C*MMV1JI:UIS8)@ 46F
M-.+&>Z2CH@@H0@EF0!X!&6Q1TU=*=I*IDTQK#P4[&?4P9%0+0.K(HN%!(,US
M@3\'\:0E""IKM8HL8.4"W=CBN&_89>OI'I3RK#5.O!8#]GLN'@]&HYRF-TZ]
ML\(1][U<Y]96%G%>"F*4=]QR"G+,:,>$XR)@2:(4KW=_K''5R:$;R:&5J=N,
M1Q>(BTB3[,@"585 .25$;;*:$V,LET4.$7DYS7]M;:6U<(0_;*'@;)1<BT I
M]IQ)Z1+FBHLHE0DQ,EZ$PNTZ"W5"X;L*A=8L#A#X-#F-"/:BZMGKF&)($4.#
MY9&J%$I>#=.7/=R=4'B\0H%+3CT0#]-><AFU5@30C]':)"FIJRP%U0F%>R,4
MVBW)E V:2X4(QQ%QP@/8##PBS'4D7BH5J=W8$J3/Z.5P]H,6"H\AM/8)R!1'
MX7JP]&TSD]=NF_[KVSW_@U$23": DQ2')!,W)AKIM<"*>8933+Q8CC\RBM@I
MB1LIB96)ZY9I&HC0*-# LNM=(&T\1LY:%A(H"FQ=MAQI'\#!_=$2][Y8I!/#
MG1CNO'H/7 PO 3Q)/*D0'7+8<<2MR<,T;0;PU"HIX5B)NG]>O4X*=U+XH4GA
MSHWZP*1P.TG8,,PC)\CY8!&7%N1Q!*$<#6<D.BV=PO?/C=K51]Z!A#A\]>+%
M\YV]G?VC[>>]I[N'3YX?'+YZN9,+)HN#Y=GS@[]ZN_O/#E[N;1_M'NQ?&X-F
M5]5=,-C@,)Z[8;RT_]>ZJ&_@S;YW]WQD,PNR".^=6>"^,)_D5(;92:S=<UEK
M+ 87?+X4X<(&K[4-<O5>7&N#?.%#KHNAL6X]5S]I<31MGU\ #>['+D_L9C;$
MRB#DJ 53EKM<% PV1# *V:0P2AZ07534R^@WMICI"WK3!BA?Q@%K IDZF?0
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MM'#4T@60Z9_@P2S#1W&6/8 YJ ]&>M;P(Z#="S;$G^6%[3W)KH3SWNZI/<X
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M<W]2Y[>TCCU?],JCSXN%!?5B&5&=LTFKA.22KYQ_6^AJLI W;:\B? V8Z.I
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MZ$\D6&PN\,9E V#]Z.D+]5P995*[;CMZJ>B%[+U_[4!'2!<",AH'Q''D2*M
M$762,N>3)SD+6VQ>;N"TT&I%W#0R"NPI6\?:"EH ^VQ59%7^$!!9H_'IP*^8
M4-%F;XZ=@.P#YJXHKZ 2..B>3?#%BY>Z9SCA.GO_ 0&';(LO2M(;Q]KV!+9S
MZ7/+.WG9GK]QIA_(,Z\$ET0EKK"W6$C&HPB):Y'(MU963]IK/UH&NT@G72KI
M@O>/7TM-$PV)(B\Y2!<M/=(^*:2U%]Z'P (';23P)U)S^U4R:(ZOG3T@,FDY
MOW9'?C[IU-*"<'(1@O8J:2; ;A'!Y"*$@)RR%BE-8C#8"&K<QA;]E',+1/:R
M)4:N_+QY9=B:TLZ5<:WM46B<\1TAU80$]HW%-F)%/9*2.L0MRV4"EB#+$V;*
M6*WSS&']"?][)J0KTM0W>]G_U.H;UH;RQ26U\-;;MK]^49M\NT)D&[P+PG%O
MP&1C*N6GE$+A%(2AT;JKT7WGLO]AQ'@.ZM 3[H*Q$061A_987[*/,.*&!FNB
M4X:J&[OLZR!J7=(W&>1F![.&QBYZ[\>CJK%#+\&YK3BC6GY\(.UGX\FB"<35
MU925J=>B\1NERP'O69^"HT9Q@[EC#DLL'4^18L?#793<?EJPUNRX(F*W)["O
MQY7U_^0DO]P=5>1\D*[Y2<,0YYW95]/Y!]#>TCDK"8V(*@K4S<#BRZ7R"#.:
MDI516DUREMTGZ-R?V,EQS.1>D5B#V2Z+43NKO/2G=O(69'1QUG\9!9M5,7TC
M\6N4#DKG<@;/3<". BUK+8&  3'[>,U\[.\O?@\R7CT"8MZ>+:H*'S&IKD91
M#[9? ST2BY5'#"Q-Q)7ER/"44T/!RE->Y#AX-C0_X?]8QC<+M4['N1"]A* N
MDF5#U4NI.;M,E,5*+6&Q)F/].K)OLE Z/\B/]H-DE]:3JL=L/MPX>%=4(FA;
M5 +;N9E1WM4PR).4757K4E2P7004X1?3N0/5,LC9=U<EK=]$0 E!53"2$JH\
MF+H:S$1'7,+"@PELK:\UK*DU+#8,?YWK=7\\:H5$&U!R6#WPT];S/F*ITU:0
M.V+_C]?"$BE) EGCD@6I0W,59) H.:RQ2\2&$#>VS":]7NK81> V<_)HY126
M7M6;(MX4E1"*)X!'C(."<SH8$PVF0#@F*=>1S8^RJ]Z#LE) 'D)CB4C 9;:>
M1,XSF]UI5BFML"! -NR3;1YSWG0&K+FM_4()U+(K]S@CZM^@+4(H:J)TQAX4
M\=-TTJJ;IN6W#N/9K-)=GVZF\E@5P$T83WD 0IPRGX#Q#!=.44.3B<10%[E.
M%9[/B*@K=+@'[+I#]M^_]MQJ1XA!T8)9R77@R&(BD;$V6A"KBF1V)>(SSJ<T
M^)"MB:K6(0MT6YW!0Z:O=JNL P<<;SM=L"0N#KI @A(6@LN<BI0]Y(;G0'_(
M,PV=Y,+8%%RNHODT;5W1'Q'>_8\=524@V<NS\!1=5!+9]SDJ(*#W:PG=-LE_
MSY\_^1I(T@ -H.ROA1JU3.:T&H+87/J721S:G.[W[_>#,#MIQLZT?EB7V>'E
M3ZPK1>G7_^2Z>0I?KL-^Z!@&R5>7V/XS+[?PE[#4,!'A=+'E 8/9BE/"U"NG
M5/*.O\[@N/[1R60YD>4X(C>)]BTJ4?M?[/"]/9]N_&NUP'$P0A?.Z^)67[^A
M:["MWW1*Q ]:_?[!T<YA[^B@MS(=XMGN_O;^D]WMYZTY$5\Y58&JM6OR_X6$
M+C>V?O0HAEX^GAXI[8L)^7>3#[H/"G,R\'?0J/9J??XTYH*E$GP'7?VKG0ZF
M!^D%P+6<]5E"DW#77X=C__8':^7]0:.5_SG=>WK\<?_I,?WGS1[_Y^D?>)^^
M/-G_*T^L>@;W?(O_IL_>_/W7GZ>7M#)<]^#I'CYX"M?X>/)V_REH]-]V0+/O
MX;V__GA_</02?K=_\L]?_Z3]CW_G>E;A (0Y!^A=Q@CJF$ID:23(*H!18'(E
MR])&[<0K7=RR_UC!B00BK2>&&\(-5=; CY)CFF(.]@ULNCW+_#29@Y&XOWWT
MZN5.'L[RZZO#W?V=P\-&K=>G?T$^PF?U#:O<FG(NG[_IZB)3$,$Y:[CSGF,C
MK58FB,B4"BQXS39^("_<YZ;69?A4K[*0,\*>C-_E@%*&Y6D2XW0&EA'84?W*
M\H>KYPC=?'8&/RBY# -[/!K#0_G>H+:X8"WO!AX66?=.>P5  ,RHTCME"GKH
MDINY[@I:U7' -P-8XGZ66RAE2VOQKZ9N8Z6L>EI5;IR,I\5VG/:O3TROE=F%
MFGZ9I(#-"$DFGKU+TFN!%?,,IY@XSU#D<NOL5F)ZY4"JJW>?E%M,UZ9P]WL+
MH;TW>Q]?:Y^TR^,WHP YQ+%G2)/@$9?)&J*3L%YM;#%V1=ODZHBF/9#?MO8T
M;T\&'X$R^[TGP$%@=8\&\/HIF-#O;2ZJ?P:,,@CPUAY@A&'IK+VL *J2;/*_
M_QY/WF[V#G+M;WV+FM![9R?GTX$? !-5E-10,0B\!0[,GJE4P88<H*[Z1!6Z
M'U3(80;V9>7^!+8)@VD&,-4G\(\RE7U:W;W%&WXX#[EAT/$H9N[)L9JJ;7RS
M@I_V7N[^W"_E::7K/&""\?'$PH)[/STY@D\*/)@ B<?3P71:17^67WFQD[\S
MFOMA#CJ>YNQ'X/\^W/&T^5*_-Q_.)G8ZGN=]:['R9)$>^=/_0Q-[#A=*P_EX
M,I[Z\=GY<A!!KV 96!OLIH\A\V.54OO.3F=PIS=P.%5RR;BU]>.4X*>G<.\!
M.AT'6]#81>E1[=>%+TUG64+ LD"ZPI4 PL<\<@%DP3PG&L IG$[SO(8PSWL<
M/\ .Y;9K)10V.'5S((IR2KX$U*L3J@DA0\@BTJ9U'4-.;\H+:A%(3E@HI%E'
MVO):*W(8Q1A*\599\-DPKNS([FCAQ&SZ0UQ\W'XUH0(NUPQ+JC9X.DZS3.G+
M<$Q^Y"H@ XL&G5*UJ(W#84,IDU)],3V?SN)I-5PIK["Y(0A4T$&3ZA"+:Q[$
M/DC7 +LX')_E]%C8UA(@RHYP .<YF)OO/YA5G!!')Q6=YA^?3>)LD3%;R*:0
M5JT.FF-LE>CE14X&N>EN+\>,ASEIY+@<2@'8BYC?))Z-)Z72Z&P^@7.,7S;T
M<,T4[&<L@]6^.GJMV^@<?5%\MI%KLWK4Y;RN=*R2UDH[[YR6_S[3*_R=^Q>L
M4#80?D7<=9;;2<GA;X>3EK=M DN5R/G\VDH92;/ ALVN:=&PLI;WE9F4GPEH
M]S1[HUP<Q<(F\/HG6&.(32,%^-7I>%(:O]G!$+XX'+__&<P>>."<6C=9K+R>
M ]I.U:MD3STF9EK) Q<C2/CAH/20@^M?+KS:[/7*Y1<C0VU*H*O*MQ</DQ^@
M$FI%E>1QU,-FJ$T^B7H,3;7M]7R9?O/N^WCQG?GTXCL@U>JW>K7(J3]HN>KR
MA\4J'$QK!K^'/+U=D76FQ4D\G@]KP09K/,O_B%4!+TA-D'E9LN8SKMI^5!:&
M_1GV8#I/F7RRW*LK[+*-40^.R5QA%P,+RZ_ Y&X'PH!GP*RH*:)%[/.SO*F-
M3@NY<7Z^??:.#K*2@9-Q/S=WK(J:IV6]_:I8YC@W(^KWAC8W1CFI<D1@);!1
MV2YH%$_,%\\+_1QG]GN#Z:*PHF0A_-FP6Q-E[>U46_-332U_[N[4E%)U5&RQ
M=>G3#I]_,6>6"S0-&"/\)!:=^AEVSOF'^3;+0O'>_\YML?U*D3;L_WDV_,HQ
M#^I0PD(I7Y8G=>UXEF1-WMCU.]: )KA_8TE=<[WW)^-R35 >)TW6;X+KCM_G
M*W_AW8H1,+UN*W[I_41^KCX<O\_5]N,:F]7B?4&A]>VK38-=.<W-&+)QDDT)
M.\KH;0!"H/YA?<3%;[^HO0(+H?C4"UG!JGZBU9W'BX!+Z;7LP)QV8(1-I^6V
M_4;6E+G:=89>#GC6CY&G2T[&I_W5Y0'_#L'P&\_RV14>=;&]W"8270X!C+=Z
M;7D/L^W64,"BUK\ YDR<8 ['=_D"@!9J0](/)GY^FF%TL?(J]9-'A%<P8FG"
M7;F=U<(S 2_>+2=:+M\\4S[K8EH7[3,;5S\"V9!MW^6U%GM^B:2F37^-O(Z3
M\?O\B_.J/] H'H]GE2HIPFO<))%56F2QAW"M7(P]GDPKT%5W0ZKD3O6W'YR5
MZUR@BU%[(\894C2OJY57HO,[!/3ODS%6I& SV&Y%1%[+S!6E5L6-H!]2+)"Q
M9/2!?=V8Y]6Y9?%8]<$=3]HY87D.RPBV;!! (%:*J6Y[/8VC0:&-D:V2EOO%
M/P('_/L8\$OH_;;9^S5.CN,$H/KFT\U^^55VW!8)6FCFR<D@IEX]5@)8^""K
MR/R#_.%_QB>CWI^;O2>3>>:CW=W=YD*5R?+?TT6%W],BH\:3?R]D(\C*T_)0
M=6^L!I'^.LY+RZ,_ZI_DT1Y/)\U2\QX4GFU\4)_P+EW9]L X[U5T5G@9N?;:
M:(6UB\KX9+#'G_<NW>.V!]_=]_3Q5>YQ%;7B7N"$-,4:<4$CTB9J9!*G.A)'
M$O8;6^;*SL^UP%GM>#"M8LKO2E/W9=UH0VRE?6,FQ]Y/O[[<^^WG2I9?VR)^
M]G[\">[+A<NUMZKW)$N]7B]?M%?,Y>E99N LMQM,OW*ATWI!"Q<3"(=1M'G5
M]7R;TLR\<F-EH=QRLBU]:S7]%RXKY%]Z+'U.7C3.M$MK@&LO?757N>@N>.AZ
MVPL;-W/;<BG9T79#YA/:8>84\Q(';A(SS.2QM HS0PP@H8[Y[C#Z]'3[/3!?
MR),SHO<H8,<0QSH@(ZE$#%.)K8Z.$KZQ==GQ6W5=+T&'3._5?*5IK(S]++=7
MT&H;QB[-W"7X;ZBP@)G>3QOY"X5--WZ^CSZDVA.R\%/"QJ'Z$<'2B_YD5)ZV
MR)T 1NJ@>$FS EVP86W/5K(J2X^*;0>SQES.W+74W;T4@5W/YI/IO&4--[[>
MUO<6_;.*V[="2Z4%Y55?67@XXX=F?*J= T]5+N)WM0G=>KK"E<6O?6K?5G"[
M6D&]H/'H>)S?=G5LN.UF+#9H&_P5Q#(:@=T"WP_'L?8:55N2+6C Y"T$4%\J
M#_A=YKH-EZEAE5&211YL^"E(ITIK++?AFBW(-O0<?IV=7H ):OB1'[PT(4@
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MZL/>T0X[./I#_'TT'.P]W7U_\-?+P=_PNX.C[?>@A8<7M?0_;UX)^!SO'^W
M;[W8?SH\.?AK]_W>FVWQSV__&?S]T8N]I]L?#W[[,U>(LKV/_K4V/DDE+))
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MKC/6 ^9QEW1@2BH-S\^%)$XPY147RH4@A'8=I+EG/'Z^X/'$DG+:&:2TB=4
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M2VBD70"+E"7GI>,^)+*Q993H$W['R0\_4((6'\2_9A9N"G^'P;NMYM'VYZ?
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MC$P?KJ@WVE1]A9F'7\:+H:S*!=N )PY&%_CG$S7P>(O)S)S@,\<CD'_X/OJ
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ME);%//Z^44;U)_$,P*\-[9>60XR)(HSB2J/LU]?4AS!!A<$ZP\J@U=&/YLG
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MEN-$KC[5[J*?LXO2^^ZB>G_,AHV51 D(!"M+B]U<X<[[2:6<)ZZZ77_X931
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MDZ2&)-0E&"QW1!69('FAO2I<PHNB35)JD><I((\4,F=:"2X,XTEJM50RTQH
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M^)'?J4=^)]9W2#^^L#DU=DVW.[,1JI>[\3#%1@R_)7;?[3.IB(HI((NI0[!
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M#DL?0A(IF(189!%Q16(V- IAJH+6PB9M15GZBPDMDR&).:J_S.K+H$#;LRM
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M.B'  Q$QJ/L,K/]E3TN+R+WNB)TM%K"7R\)V]C9/=M[M \39J!SX?BH*E/M
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M$?A%5Q[]U:=V_;.YX9RX&^Y?<=!&6YD7,>:RB0IGIW[*K1JQ]#^#JKWS7%8
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MP]I8IS'"AH)2R\B1XY@BSQV1(>I ,\%$4>JBU*4G=>[5^B+A&57T,C,4!J'
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M?[*^LGJ\]>D;6_^^M==<:>[_Y_12W:^F0F)M$Z+!YX:X3*.63.:WUDP8%9S
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ML+>.29YGE=;QHU$8%O=_JOEPT.NFV._#<[7M6HHE#O",<8"_QY[]QUB Y7[
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M[]?\4 ]J![F"I]MY2&GDFX*Y62JNYM :*O#V,'C[,6X$49VHH<(C+HU&W.N
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MDZ:U(_C,;<!_CI7UB%@/TI0$0X9ZA3@7M&)'C<Q.MVX>9M'HE#P7D@A!-;>
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M+3_ "X">\NCNVT3T!L7O&J+,G<'O-0'0=GP7D7OWC^M:#PP\)?#H)O)#S/D
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MB\[CWOT@_O$9[61X?6./&2^-=P0XF,YMV4-"VEF%G"2&">U(,.RN*,+KG3S
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M[ET"148GI"+3C)H0;"SBE-2RPHO4GZV2XGF1XH?X2"6]TTKO-06).DDGM4?
M]@L*0H&"4(*L959'(DW$15=<CI_MZ7LMV?T(=HI\L-5:G9.S7%F[E4MHQ/[I
M!S-9_#)?*'4OU_A^' 9EQF+8^.GAHVN=_*\*NJ:"KHWST4)C@5)GDV.YO!@P
M#P+TPY$D4.*"^Q X)S@LK1*MES699!X3%4,J>\7B2.4C"$(E<C,3N<TKD;-:
M.&9#0C%*#2+'0.2L=TC0Z'G@0!ER-S<MYD/:*FM%ME8\KYXB@PD(W;-<G&OX
MO%5GZIE-T'QC^7P1K#NH587GT^'YSU$*Q8(4R4J&M#<,<1$QLD9Y9*-@G 82
M=&Z+(2A0*(-?I%[K<\3G!4M?5"!8@> \@N"M5+>"P*DA\)K24BNI\U3GSB
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M+N %8?C75&.P5">YIAFQ6F1$&)\0XXPAL/TT89)GW*$/F"8M^&O-"FHV(->
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M4.1GKY9DX%O]J)N#->#\L?6]B--6A!I8*QH<^0B[;)G.671DLBCW0!6F'77
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M7H+EZDTUR SK00)(8L&J,9".^EK5FT1A+6RLS0M_C>H"CRI:8Y7X1V@XN(B
MV*Z&^,GW?L(.SC:K=KN=<D9!-/3W<8'JU[%YR&YW\-7#N$=K5J]YM#RM"1^]
MSM%VO'M^>*!=%MLXPV*:B4# =T3%/B?&&V6]5BDHW-B:<$9-JU%7S+(L6M$/
M).<J6K,^JE%I* 9MHM-1L0!3ZL6C=D5 [=.]+^^]*M:<9L&#T5P9F?VNVZL^
MPN^M7U'D;;K[_9\#SZCEVBJBC+3H2&/$T%B3+*<R=3S)9,PW7M--&5^JY!I*
M1CQ"+\Q:X2L4B@\G:,,3YRJ"'ZI-O?7^Y'_*=F\WU<._,(49Q;N619^H]6_N
M8S_,#&O3]P:E:,X+!.A*_H%^ =<[5>/"TP*6 >]"N=?V]0YEM74*-1K+XK6A
M4&A5-+_2OA9R^:?&Y  K&<]-)G22*NJ\MW$LLLQD5HL2><#8:A*WE@UY:GU)
M]F%>^X<'//6YD6E&/'6,".8Y46D:$YIZD3/J'0C$C=>"LI:X,@1JK"H.0+@%
MPBI+3.<&E+Q2I\5F>[?P12N6I,*GRH 1+F(M%),)S2U-%.>YS]0-I';O3NEK
M,XS"Q;<P\7<P[^ES]'6G-)C;0:)9PJRCH%/EF@@O.=%&,)*KQ'BJK<A<#/(N
MV=17V=.@)I451 /IH'I5 [A)BX_0V/>D;5S9_;7$PJ)J]S2I6QL,&2Q$6J^7
M;,:=;4>6%E+R;8R1:&%CI#:9T2#'7:MNU0X]2S43N98^95(P!8N?9SH6N?3*
M,</Y/;1#;ZR31V6C<W? P:Q,#)4D<=JBYQ>CV(4!VS>QWDJ12IUOO.:;,^HZ
M/Y&EP@U-7,RITAS W#EE8R!$JW*1**_R.QU@-);*8^H+W]\?9#)C,F:2,"^#
MM>R)U4X1"3OH4B! [L%09IOLTL'#35;+=-W=9+KN[A6Z^U6%=Y^JD"[;5#RY
M52%=!79>\A 55%5Z_Q54X\V4WG9 S6"?U6#Y,RJDJ^ZICBXJ<E&ER3W;<KKS
M+=8SKJ8[WP(TQ73O9\FNK*4;81W=\.$S+Z8[W^(UM72;6KJK%78ST\=LF9(R
M35!9ET)XJICE(LEDFL4BDS*;LY;NN>]U,],_:O+RYPRV@7]W?^S^^=?Q+OLL
M]KZ\C[]^_W;T]<N_CG?/VS_@[_.OYY_%M_U__;@<;//QZ"O[)_YZ_)5_PZ";
M[Q^+W>-W1_!^OO?E'_A[]_ON_E%[]\O'Z3*Z^X=LY_3 ..>TY(KDW,=@5C)'
M;"X4\4(Q;G.N$Q-CK(ABE+UJBD6N6['(E1CDPL(T#_];*7E9E;IL17\-.SZZ
M2Q&;"Y._E:B<L8#/4AIFN<[B-%.)S:RP\)<3:1H[Y836&.[;E,I\5M+Q_47I
M&/-$*I^GA'J!E2J<(#KVADB?4.X%90X[_UY_2#NW=)R-2@\J &_ @COS_]+!
MZ/PY\K.FN-S05BEI*T]US^89ZU!A;^11FZ<(=U,?:WKM7BRS,H)A ._[_:'/
MROBX4JLHW<KU&($Q 32ZQD*ZQLY%72-U62Z%34B<9VB)&TE4'CMB4B]2([7C
M"8;IT);2\I*J<<GSNHK5L)XGE]].+"_Q-JWZ,];!77#/A6_OT6>PQH5O199:
MI:BGPJ>"9<XF,I<Y=3[C(F9L*4JV- [VNXGU?RZ*]4QEU,94$"923X0TE"CM
M4H(16RYC.O4)VW@-Y-62_,Y%J1;BL64Q\YZGHW&=K?&5V*#K(F=O96HUM4I7
M'+G'93XP]/;TP'+E\D0)DDGAB*!Y1BPW"GYCL?(RSI(\Q29ZXE*>X$/H6(TO
M=I5\L0LDB]Q.*VSJE:XDQ(Q+G>S_^+6[=6"US57*4L(-IL ;X8FRH!S*V'E&
MN;2IPT)@K93&+9XN6M7O(;6+-?)MWZ68Z6-%JJU=^=-5L*6?;?G31X++SY>.
MXZUAL;"*Y$D*<"FM)#91C*C8>B"&Q,A$;KQF24N*RR[R.\>J/5YIU,:%WKC0
M&UNZ*:/YS-"\;E_OGAZD7B5"99XPFG(BG$F) 8K RIH^ 31/TUS?HWV]WA"Z
MA 9I4WQS&9CR@D5*$ZN%= GQ%IU>*N/$"(%G%BI/1.)4S+!7']BC6B]39ZZ[
MU^5<BC*<3U[FZW:E09>A0%D8^4??!S@(I36"P(_*RA/1"U0A6?SJXZ>MH$RF
MK_KA$_KJMU6<YLK6;MT_\A'N4:C"@WH8%C8Y+JKJK*$8*-8XZ4VVL:SI8V[<
MQLVK*P6=^K)D:A'"V2)3E0Z"+R_F<^#6>6]BB=4>L?Z+22V7J3,Z3CQ75Q4=
MG<_GT,M@8TIB+:/N]KM8T6KE/09W*-;(=_;=@4EBZ95W1#F:$Y$*#K])0=),
MI,Q2E7@%2B)8_)*V5,HNU]ZID0KN>%F"9WGV_<Z^INW_#(O!V?L.,,P0/^SO
M 2?U]H],I]*5QD5XGHD/ZDX4=?[Y(+<RIC[FQ"H>$Y')G!B72, [I6S"DSQ.
M0</A3+?HC/X;9>6R8;6D,]W"T>;]UX^]0"SNR&=#,%/S\>9.!%^0>Y^!H/M;
M,.2?0!S[J!7MPP#^:,.EM=OV]VSWW!VHQ.9IEGH"RX[6II;$9"FLL9"IR!)I
M/'4EWX/6""8_,BUW#LP>EW''!:C"B4UB9ACHL4HG"6/Y1N2!F4Y0XO:&OI1N
M>;?=[IZ&4N'#XV.##HA^*,8]IIDZ(IERBPKX3C8I0SHX]6V05\<PF*-^Y$%J
M9Y?)[.655O'JJ .SBTC=O.S3VZ12Y_(,,Y:5$EXJDWL;&\HY99KGQD_TI<MV
M07W)+E^N+6(U;L$V4PES.^F6-5U?AI*"Q4__:E2;)\RK=F-55RN>W&)LO]L>
M#JZ^Y5*AB_FJ!E]UVV/OJJ87UK7V\Z@WJ>YQZ(GM>?.#F!P&^]*T3\U9?^/W
MZ>)D18=<6/J+JW;UVI0_9]*8R(%8+$]49I1@VFD#B*MC[U*>*\/=QC4ETN1T
MB32Y4(6TFXGU82JDZ4TE^6TJI$F]R1B[_R)6=#/AMZN-=4/%+=X,-A%77[Y%
M>;#5J=4SIS<41/#_>9[%L>9<@-')!IFKU%/X&T\ZHA=?GV^=I[LL'5:>CNZO
MS-,J1<D$7KK.(KJFI%-3CNFF<DQIQCCGL3="")VF2N5QDBO.3.Y2GZ9SEF-Z
M&-<#&)^EC^&R#^*99I&<M.'Y=/=MUM[]OOT+S,[XV_>/Q=[;W>-O7W;X#OOK
M^.OYMMAE.^);<>%8YO@SS.5SO,L^LYW];;[[]N/Q[I_OQ0[[!G-PYU]A=CO[
MA_SK^=%Q*-/T:=P3S7+&8Z<SPKS)B* Z 859>2)CD9E8:YL:N_&:J[2E[UZ$
MHBG1=/\9BP\+<4LG$.:/ZUYX_BL*[5?WV;@=OM]?>XWYO<?/O^?&8T/\[@3B
M)4\SD2<QL1FU& KCB!6&$1:G$H@A3;1WF/N_F=!5 ?C;5YY>.D![<X1L-.6A
M+=LQ/(P9M%Q?O2<3)M!06CKPEGFOJSI[=[%8GKU1(K5P29ZF>99:X65L4JNY
MU-KE1FG.U7)4Q;M1M$W7RVO$UT+B:Z=NH? T%QD5*:&6"B*48,0:X4@LA6 J
M<8DV^<9K(=.6U'=.8GH>8=U/86>L@2GQO*V%.P+O(YH-Z]:O[['!MV8[L#@S
M6DM%1(KQ+#JV1/E4DB1.;2)2YEQLP7;0F\DR0>]BYL&J:(__"J;R',KC"NJ(
M"U8K?"9*8KFCC9)X*YSZIZXD"IZ(..>.8'0/*(DF)UHP06)ME)$>-$BK,+,@
M:?'TLI?CJ@*'#Z<&/JXY/B\N+!WD7:6B-9K8<FABTP#6:&+WC7 U34SQ6*8L
M5<1FS!#!G"+:"DNDS:02H*(9+4*C99XNIHD]@L(UBB:#,?GK$6R5O]G$8UQ?
MN&3^>(PJ%/)"302<V1H7^%SJ1)$F6N.AA,#7NIKK$I,Z;ADQC'LB+$V)<2PE
M*I$^31EU2M&KTTON=)AW5YY<(3?JC3-^-N4S;J5I+E(^XT&TSL6+5/8;J)D/
M:LXF@6%QJI1VGF1:@;XI$X":7*8DMEID.LV,D_'&ZWA3I8]10.->67:U;=][
M6H.5 *U%K.;;Z4=-M--SP*V:G4RYPA0K "HC<B(2JHEFN2>2&VUL'*<Q>@+!
M3DX>34%:CA(DRY*6N;+E);YXP(T!5I3H^!"GE6->QD]D6$S^QS3<>O9M*"^$
M%_"KKMWM8WA7: V/'W:'/8"OT!F^+$(!OY05*C) @LVEJ!LRQS;6?R[%F!>L
M=1(PNMH!V^T,^U4QD%6<R\HRUN6Z+2":N[.+M]2V"@;0Z8*].;3?O1M$@VYD
M.F=1/AP,>SZ"H?Q$5BMC*3<C>$??CRJ]@/@N^3:#6[+(_T(Y#W]4+-N9GV7Q
MB\BP 0#PX9O1VP53[;&"3%4\9L'TG<QQZD2>FS@6DN4ZC[5.D\2""J52ZY?C
M$/09]X^]0]4(>/[6 1,)6%*<$9JGC @?9T3E4J/%E:5);%2:8?F9I 6FV.5:
M(25-1&6) "2X+M+<F,A;D3DYZ75_P68.?/LL,L>@NHR^^%\+5.R[(YD1N0"5
M;;7;78<P,)O<MDM&'1-.LH:$L_?VQT&N+&59)DGL+-CFGAIB,2[2<)[2#/8J
ML0QTW,WX,M4 ?+=QPP&O7&UE1QBXB.*Q+.)C=;6/(.O*2BYGJSC^E=4XWH^7
MO372T!>L$!]KJAR7B352)#'5F78Y5U):)F66FJ<]C GG+'OYQ5+%ZRQPSW?W
M=PZ<,CK.%"74Q"!PE<J(33)+M!8RSU)IXS@!W!0MH#[\[TJA6Z+G1!.$ST#?
M! T.-C<H<]@?$4@H SUO<%&[;<T\-JTJ"6:WTP5IK VE/&>*9D+RQ&AF3":E
MLYD0(K'+H0N6!%F6('PV46]W(,IX]ZT[L$9S+XTD>>PE$3:W1"6))B)S#O;/
MJ8QA:U[9$DRT.+T<9UM5G*Q(TWJP.CP(^%+O;DU7! -KIULS>4M5<3/Z4@R.
M1G=$#HFWW:Z,H_KM0"&Y+\+!?UV;?(ZD6IDM[\H9#Q%'.QGHGT4O/.'Y9/;<
M@7SI[O>O!V"K>-A'1E+'!1%Q:HD!(4BXRV4"LI'Q'"L>MF"[6[&8 :E(9,^1
M@FX\#W@WXJ:&EI"6SG<..&AKQO*<*(MGCB:G1"<J)6#2.)ICS@'24D);:<RO
MDLTM%,8G'DL?@MG;0O';\_ 9'@POH9+WUN>^U[N2N!"8WW= IRZRH6F_"3I'
MJ,'YL=(X@(C>!8_7^TKK6&<BPK.B R5SZM-,D$3&F.XN'=$YYT3[V$JAI3,2
M#X!:L+<@4B\'2XX$J?EIBG8HEG>%'A>4O<K=.-+Y+MC/UQ9]7%[SZ"J[+M"3
M-$QSZ;UQL1%9+ V-\SQF+K5IFCLK#BCG&[6['GH*LTW3W;W][8BR*.@N]-6#
M%\T=VK[_SQ#V;?LG8OW2%,0]WZF8\.3XVY]?S[^]W8;K6VSWRS^@?/X%#+@C
M=]YFW^%9\+QML7O^F7^]R(3'WWY\^[[[8V<_*W;>?J7 S/'.\6>Q<_[C=)?!
MF'#L^X=\=S\[^O?Y/V>[6P<)T\""2A'NE<=@90WLYRQQ0F V1IR+7%\LM)KQ
M6#*C!3"O![)4QL@TUEK!KN2&<W&Q'NZGSW]\VO[G\_;N?K3]+_CYZ?J2M3/K
M9=[XSD>AX(68\-IBK4\STKU.])>!=>V=1:4Q2]&6#<7U "J+3NF9CCX5QP66
ML6O[L^C]L3E$Z^'/7G=XTHK^_OL-6,71B>D-.K[7/RI.HE,T2>JW_$^W?X*>
MJ: P_H\W;;Q>GO+THQ<;X:M;&7)?T1]L_+89X9D/&#6^U-CA@6TLRP_B-CH>
MM@<%.>YF@+Z#LZBH!M,?/:T[' 2WT&DW"O[H8!:!^O O>/BP9Z(W:/R ;O$&
M[@<AT"D,OBU8846(\4#1C3?@M'^&FU!$+.1V=VG"<NU!GTVY8(FRS(,6Y))8
M<A^GJ@QGH3$8A+?VMK\?CQ7,F:T\+]H%"+<^8EF1%:97@-'3[W==^!3,G[^Z
ML)?E&OC^\CCA'QWBWO_:PR;.WW?.=O=!]]A_?R TB XK.,EY%H/BFGEB.8 >
MI\8;G68RV/#QYE6- RNO_&;TT62[?A HH5?8(:H:BQ -3W-0?[2EE"KA&=..
M"JN4CYU*DER7D@R(II1D=Z.>W6['F?[17N\#<&WUQY8#HZ<L1!T"F?9R(""/
MQ>+A<P #VE#-F&I^'$A+><R%(C8V>(RC)+$Z,P2TJQ2V,(:-M$@UEVV=*:I!
MH#%AF8-&:JZV<CI5 /Z%*F&IBHV3H.\ T,1.ZS@3J4J37(!H9-D--!/,G6G*
M^!N@&"CW[\+8 @$6;1O3.0.0W^M5USY,D/[O#SNF$P!X)WA$]WI_>KADVM5W
M]DZK+[X/ @6P?41#Y,E[XSTU$7W_>F! '.262B)BQ<#<21BQB?<$V\AKHT M
M3PS8S)<=+_\K\D 'W6/0AHMJ98-HG1:D4U!445GP-Z+ 7 B:LM2:1!HIM1.:
M21B=$SRV2D@O;,(;>;8L1'7^SX'+XX0+'1.9,NQGD0-&6<4)F-86C"6EG&"(
M3)=;XDPCTVWP2')TYX&LT)0)D1J;)JEU4@DA,JF-:_!HB4EGZT HDP!C&Z*D
M!=(!NYH8,/M ,\I5QKA.-.S7ZQF.X!EX=#D:81FMGY]@48SL'P30=][VPA](
MGN%8#R,MVCX@:)8%[0C-F(FN% X4OWT(WS,=[-=2V0XXQ*_=WH_H#=HIIN=-
M8*GRP.=DV'-'IH^/[P# C>P<C$2;BOQ9+-A'.DM!_&NP?IU$QV<.DL0HJV+X
M>,1\=,1\C*E;P_4?PSXL9K\/[&B+3AC\F_I,]GNP*Z5WM-$;1RRV^W;[@$L'
M.)A)DFE.B6!>$POJ&Z'2&"NR- 4M;N.UY)M7%6P>FQO1*C#8^TZT8X#4)_S4
M\\X7/Y?0-@J-]C[TNL[[K/^NUSW^LPOHT EG0OU^@5EKSE?BY&W1+Q4KI/NM
MC]N?MMR@(?,QF1\>4&GSA+D,S".)W?F8(@H(G^B4<^\2I1(*2DARHQ("6'I8
M+GF4U=8\RH>=K%]S[H=-B& 7%G;B7_;87\M M[DX>E_3*6K^3E'LZDY1BYQF
M)./3C"?H+[5 GZBE:^Y$V29C_-Y;$"FY*=/Y^B6M9)WH2P=:@5C>#_QQB6MZ
M<W:>VDI/L!P:B--NJ?R]#+B,WYJ4R 9% /5K$)SFL.?#^7B_/"?8<@Y=\IAB
M@%D9U9_HH@@*.6B7';#ZVW@KIG6 O7^YD\XXN6XFGE40+\72'<I>+X@>>Y2[
MW<Y-0>1S2\NY$5IO-'#9P.4EN(STUOI@)+II87(!\((%DJ%7<PZ86UXTFY7T
M,+_NN6S)$MN8<3AVT4PD4733UBV85L'8IEQ6(36-R6IF;]-E"8+Z/#8,^\,3
MC SH5UN'>:#'Z"(.&D@+[$O7'B*$A"MOC@J?1]N_O!NB/1;MY7GAX$&XN>6U
MB3I27:M\A)ULZ(*/L!/Y*5K!,?@\+V,:T6,V^C#S?5BX,JK[I.;_PW%D$P)S
M=0([&1-89?I^'+;A=\H-H?*%_RU\B<JL^JMZTR>83J]L);W]RP5]#"UEO$PU
M%ZW(P-./0X9K^!TI_&*&PV;TQR2_MNC7)MD*(_[0@Y4L3F!=9J_>Y/JE%<0I
MXB; TP='9C#O H1VZ^.5O7K<ZP13X4"D"GF!G=J^2'=KA%;+BTU_>&>&_9!U
MCAGR10>#G#N#J#W9O%9YBH(G#17Y1^B+C/(Q[_3\2;<7C*1C<Q92Z4]Z'H]]
MHVXO5+H _CXN^B'B-=A:F]%6N]]M(0=AQOWHX *S[J<!:QJL!MU1E&R9C%_F
MW]?2]A%@>D7_1\F[8V;%45E0=HX]3,5D_C]#3+2WDZF[RBXL.@$]BVK>>$""
M#RH1$BW%4;9KNPAY6<%D]+^*?IC\21<8 X$-[JMA [X]E/LH4-ORZP4".V/Q
M]G_ZT<= )P@&[T<4]:9.41,T_CBBJ*68\[HH*GM3^@C&&6(&!)ZDH76+YX48
MM6[;1?]HY!'!9(A!62DO&G/6W'BQ.2&$&Z$%1F-*M@(D*/45%-)=_.QGD>%9
MCNEW.\$0-WV0UH%#>_[0]+)1&8V>;X^.[I&39[T&)Q5:I\%'9J((3;XZ0;%R
M17Y5$S@9]DZZ_1)$C /+*IM Q.?-3YNCHP.LH."</PD*VL2]=%+J)*A!O<!0
M<Q:_^G-KZT/XE;[Z;:&5*C68_@20+F@K =1>%+\AC.+FC: S;*;OA''#G'MH
M'V;EUU$(U%<8 ,T4[1;.8-BKZD+ 2["0$?S:\WD[0#*6+L'#5U.!/'X'O2#=
MVG%UJ,I2Q@-5?U5A%:]@C#C(Z_:WQ.>I5X0D'1QYB#.*.AXI!D_1!Z-*,'-M
M[HQMQ UI510"KPV'AR>#_J3T2U8F^%V81QC2:(PACOG2DTV56FW&JU+CPW+1
MX&V#;N_R&N%56*>;%FK"")5L#G,' 0< TCZKI'2U'L..&:=ZUZ,+6A'(RR 6
M:WMX84"3#-$JQ*N4Q,-V%AT95(TC#";HX6*7PGU4_&;6)ESM_UM=6&W5#@IG
MV(-WL%U:TZ8?;D"_'RCH*M.O5/GFQ94KK)H+Q8[ N,/MG8B*DN(O27P2/CKL
MA2RH=SVP^4XQ/N4%BRG_;92[;L]&M 5L.RCUKT\HD;JA--)>[]!TZER#7]X'
M^L].0>D*=_7#XHX@]<W>I[T)I$Y;D9/U:M6Y;X9!./^2G<*:W6P6/@LJW^YU
M^H/H?YOCDU?15Y!JA]'??W]HS80&'"RB)2XOX!*HSR&_XV0(].+J0C$O>L<M
MP W8G&$6TL5G/^Z.%!P<#54^7ADO5?2JNUK1Z5'ACE#[*$9T8'V[>UI^$3[>
MZG2&8XT5B>E=MW<<T9C\WUO4WEM=1?_-Q(1Z0.7^AO59)7[9[59F)R[98JCR
MPJ &#%=*>IWRN^53?C?X:R)MZOZVWZ(N:F[(=I-^P:4I SI\#T925IDK/QIQ
M3/G7F&W*/P,L(H^.!#OJ@@'ST(47RIA,5)*SJ%W\0(4#E+%+WV\MM@X+!G4V
M@2^+![[P>PE\P1#OI0A\>?QUG0V6(V&1 U9.1.''B2C\4(K"6OC!.Q"%2T\O
M]^ +>:K*H55F*59$..JV 3+[8U? ']VJ9.C;NA%6)MBU8 ?=54#TB&1%)1H:
M)T4GF!(S9/#>O#)XN>)VP[R^^,IVK)3 ^M*'7>K7$G,JM? ^M,*Q83.O41/>
MS5[--&SNVZ)!.RG*1X__+7H1'@OVS7BTP6D41&JW)(S6?"OWHJ9D_S;V\*$P
M1\]%NSVQX*L"*?U6S<BYSW6_-*5ES^,8D6LH.URGV=8LKT]P 6#_D5!+N-KL
M"OI'OJ.:"$ 6[N-[*D1Z\;D3V.$36BY]H( /;[;V_OBMM+DPE0/[YP0JM*8=
MW@IT>]G-=J5=C_0!5*9;(]]I>-;4@VO^,O1?C(Z.^ZUP2M+S1[[31Z)XT>[V
M881@0G6//5!+J&@47H#)OE$.!E7E3C5@;%7C&QSAB0MVA!FGL93G/E<50&Z-
M(7LTV$YW4+D_D0U*THO*H9>9 #2IZ@SX7S#<?K]TG0P[H 2WB[Q ,JQ -93_
MZ7:6C )G"X(_3+\HU[,2"<LUZ-ELLS_#M+_^-*)^^' K .I4=18'_;F\98MZ
MX$?>A,#X86)X<7(D-I[F+0[&-J.]0-'5BI1G&D4X(ZU(&0FY.]$([N8Y&4,R
M\E' M,T(<:Z''MW9CINZ:V<,=P&BPL*7?OHRFQ]';?V47RC<4<F7T?G$"+"N
M@-)PRI+[+"1H]"=Q)FUS.E'FS,D)C#4XQWO!;L8+,-)A>UKFUN)4\!MCV[DF
M@D>/#'-:,ERX4C)-7,3CG9Q?-(6)1OM'W7[]:K6+I7_T%$ Z%-['(R??PT2G
M<MW#FV CNS8<.<T\I# 6"Z:<'OE06?(V+'T:_! CC>5*A64E=FNOMD$5GI2+
M5V)7Z=D9]2];"*!:%=R-ST7',1.UXYE3,,T#](4 !Q#I($K'L#D*TZ@><#E^
MK [)5P+HE*)7#@G^QM&TZ@042NH,43$(=%$[R33]*N(M)'NBP!^?]E70ZXJ>
M&QZ7^7+]@%G6MPO_TT_<^>4:5Z=G>,I<HTT[EJ0U/7K)J&>V#O 6'83E"1TN
MY50T5OZ\[,.M*M_Y-H)ME<,*YHTHV(SNM$*C<()!P/WK@PKHT@85N'%0 5NF
MF()Y]W"1N -7BSNPOHS+@\EV.^V9NM/BP0=N*OB /W7HP47:?IC0@R4$OB9Z
M\\[1FP&4YPO<7 6*^+W_>S3S)'X5!O]W%X_3#WV NTE)Q"49W;3#:,G7\]:%
M/YM3TL5/2<7]G)+*)SXE?9K5(W,>%S9YM^N7=UN5*?ACW>H4E,U$WW?*,D%3
M'H?%J@Q0M=0I44\_2JPRL/0"YHY5](6:5=5@66)A/FQ]W(_>OW^_1+NP6(^Z
M.7=!TJ:V1"/C9M26H/'FV@BV<015ZW)Z0^G/>M/MG01S.RHKWJ&E_CR%WU)&
M)>,A?#'1.R8GM"%NJ>A'%<F631#"F6UU-#6),W:FZO]6)5U,-KU*O1A=N$P"
M%[\QBQK&WT%R&;W"PU1"UQ0\N TCI\D+\UMUCM$?W5*%6F?5V0B\^4.O^^NL
M#*$)_LY0%14F$8)"JMC^'>\'U1';5(!@>6J=%^WZ"?>G[3?A#W@5+&F4@;46
M!=.M#"KH9*-,G[S $HTAOJ4,N:KF<F%$HW25,-TR#6&T*%F$_CYXD0W><?3]
M76H<-#_541DLQX9C%AOX.#@QZY;>>T#OS$\? 7@@!]>OQQ[@07@H+3'&PVX=
M!?WQ2;M[YK&RQ"C]I'XV%;R2T6FOVSG,NN/CI7!F==P=^)<KN(PW['\E_@C*
MNI="8ZF'FW([".5/6A$"V#893^CQA_!J:LGPEHW71V#M5,7Y TF6AP(8#W+7
ME9_/8]?LXGWL8CYLMUOA5'1R5-H:G:;AWDX"0\ICU4G]FG#>&B1B>;#7=65'
MR7'L#@JS:5D6Q$X51ER&7Y317MBV>-@IJJ9&#?VL#OU</ *KB24,E6O-#HRK
MEZ<JRG@;/"0/?T^>&+2RAA96AA:J6(-1]$IHLY$=E9KDZ$PVZ#-5M,?QR6!R
MH#PY.09MYV?1O1!"B?=-44V[[0_A-GC'L#.2/]:#]E1T>[4H@5K\0[>*SBJ#
M!S < Z.X'H6^EE=5^MH=AK/I*I(2%<Z3LY%5\:92/B>A7-NE\EG%[IYZVR_
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M+Y7T(%1G!XJ6,56L%5&M64G+__/_MW>MSXGC2/Q?4<U67>U6,02;9W9KMXH
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MH(<R_B*/BWE HN\!3,@E\7RR1OTEOJ7\J^#>];Z7T !:#0!@W&&/NJ&_Z5I
M9^!G\=.DO'4!=41G.C-T)AX4G>"="O8T*2@AZOLAO&C*[X(.4O?L(\R??,/[
M[BAIK4PWBLH+R*EL=@5RU,%>+,P]8W^]$OG^]8/6J/PBB^%$ *# 3X%?HN"G
M<O&+!WZ;1EB51NOT34$I$5_69?\J+OM=?$>9DUA&7W'PSX'0 ?4?X'& %*(
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MEH?V#-[,9D!P:REB2#BB-5_#R^ !;'KFU%ORC^S9#SS^:!;\F&F U\!:RCE
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M9+EALM3?[B?+;G+L*D2^&E&$(R%@U5Z7J="']ILI?KYR()+.1K^(B'THG(#
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M(Y;%8)7SM6PE#O_JQ"=[R?-#$0,QKC>MIG"U._E0XTS/=N $$@(=JN5 D@S
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MRGT-\M&;@&=,6.DX2T9T^B!WJQVY]JJ><VXFLN*0*2T-25'MHR?VF:^B#:P
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MX*E](SM><"4"3,J*H7N&1,=UH,VV=MM*]XUXMBB1:I\YAW1MI%.LW:?S;OP
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M32RDIE.#@7>(BPWUT3 B.3W8/[CMW9V=[QV]V3M]LU$]SO*';>^4KDCHMJ'
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M[-)-B.<'U-HZVRFDWHXNQST3$=C!!4*-1<!;QM ]D0HQH"ED7IHY[B[KMH#
M+G5)?'9 K:VQW>*I_P5Z*65K= *BI&:(=F&)S3H2](*]%,9&YIH,:EV5P"[-
M#GY^/*VKL9WA:3:=XX9$374R,5DB@LY$QB QT$Z!9.\$C<Q$L\-#D&54=FE$
M\+,B:W/==2D[O%E7J$U>\PP9XLK]H%:&'?H]X*/T1#@'1'JGB6,.-S#)(0=E
M7(#F1^,[2SLLS1LJ9S6/FA(3A2*2)U."C$0\\YY& TE'OS,IO(0<<%5<K63.
MJNBN<6F \T9ER);DDNZ08#/Q+C'"E%$17+'LNX/1B\HD5(?+6KJHUUMAU;PV
M30)#369)4 *IH\:1$+/&+[F+,EL=VYC=3AS)/98[I-8H9Q1ZO)8)]'V=(3;P
M2*CTP>D4=61-:K W);A+1KD)^M8ZF*NEV9TOR.ML8Y0T6Z4M,;)8#05(9.29
M&*[!.O3$E6MR]6I-.KMDVSN%NDWT^#Q@FV4B!5@#*DH2&,)""BF(%;YD(JE1
MG$,Y*GEVN'4MB]P]P*VMRV>!W"Q726G@(H,FT9:94KZ4G3GTMHS+QGKG<Q9-
M3E?7);1+6>;. 6YM33X/WDJRB09*H^2!..Y+ 0>@3Z]T(ES+D#V*B]-GK3WK
M8A:Z>WA;5Y,[Q]O=#&?*F0EN-1$&(SXI528NHK^9'49^&HJ!;E*4O!&U7<I2
M=PIYF^NT8=;Z\&C_^/W!^=[?-QL(??O7M\\R+R5FVZOTMQZ\>9>BAP^IRG&+
M?D6W'C_/W1\.\8?XSV\P;X2QG2"6/;6J9%8BO=(!P]5+SOVW>=^,US"$W)_V
MM"\#1I(GEF:.NT5PQ&MT5G"MFLPHS;'-%*LE]&R[#\WOX+P%-,=^\)!=\(&'
MD#@1N10>E\)2GZTC(&(4+ELC:!-VGZ"K2]FI&DBYOY745$LUG^5LZJ=E8.<[
M_.1@"=?[HR'N?9>X_<WWP=(!ED;F5:2.1%62%D8""=9HHHS0Z.D;%GV3I/"F
M!'<I"]4"73M19+UK"--/,'XH &$8!08.'25#RVF_0K])2L),3(I'B(JW:6JR
MD)PNY9%:0*:"$BK."\R YC'-K>,R=IVTQH%GQ @Y<ZR!.*8,NO)&1I^X3KG)
M@(/5R.M2'J@%8!HHJ3J 5K&#/0TT2JTCT8AQ(A6BVZ4@2:;*@S0Q2]ID\UJ'
MR"XE>5J"J;K"=A-0S^.64XBC8>P/^K,GCS*:U DR=(E@_?[A+%\M%-QJP6/\
MDC/$TD6]?+UME+K]^UN$<;7$T3C@R\%[*V5"XY0DD9QQXDPT"&,=P/&8&E4T
M- KX;AY[5_Q+WK9W'8*<76OFQ^^C)GI6"ZTDCVBO$^[_CGH2*+?$X(K#0(0[
MK9N<NE3EXB4$D^N@\+[U?#Z55]NQE["P>#^ 2<]3\$D'1I2/OM3.<6*EBRB]
MP#A$R*)-&?>:=+Z$0+,!\JJHK36VCD9E4[G$72<,8"Z361340XYSPF5 G*:
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M=1+L=P%]F/+<.YTM6MSZ-&+E6[8@7]ELCORRM-P:O1Q.%_DZ91=-*["&*D5
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M=:6\L<^2:)IQK3'.$A>EQJ&ZJ-'3<Z:C4]SRX=\]G;L:["&!>M=]X!N%W9Y
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M2:*E=]>\7GZ2D9AL!.=>R6RKW*#9&?G!2.YYN&Q)<MMYHW?[$>"+Y),--A&
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MVP3)">!5W,R]*N()UW*_@MC$XGT[D;\F&,T^G:QPK5P>'4ON?23:*T.D"8)
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M[]'>%6;VWV$R+'Y.036?IZ( Q35X0K4I#FRIQFV,0]I<="J$S.[70NZ'__M
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M$2)9!&4RL09G3BTH.DXRE#M1-331BN8;*_VZ$6&/E'[=SMK[J__K>>8L0R!
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M+US,7 *\B:%62<8<:_238P#2,5.BJ\,V7'79$G6:\>^\^>B=R]WM/&!KKCM
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MIYT#[1O)Z?2%MI$V*/J?SR69)B%%]Z$<BV?7T\@-2I?=172K55D77"T]NTW
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MU*S?5>Z#".N5\^QV_Y?3<9K6S.QSY3AMW%6J)\"1:<,#"U%99G(N4F@?K1I
M"!O??^S2&,;P:\0RZ!GK<@_V8O+Y\VA><?^*M]TFBS))"9&)Y#EMP+BA]2_2
M(JA+,8X+6@6[)*T.LC?>@/%Y"ZDU*6L$U.0$]_?QY0SS<N.^";G'[,CK3HRV
M\X56QR!9+!"8R,DD*%8G+?8EITZ(CU=<PQ.V1FH]*PP1[,D*[.4L>O^LR):
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MR,@-JB5LKH_8 ==/7?%W*^(Z%WG=P>K[K/@KHD<E<F(E$4@ME&(A /W#2R<
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MP^\V[D O,S?((5W3$K4+HI^R[?=65#W>_7D7.S=8"]8@T[2UT58Z5NN1,&W
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M&HTMJE'*\188CT,\K4AI$".X#NKOXTOR E_ %_IY,W"911&%=C^\;C\UIR%
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M*<33SB8.=D>%/I=K63:H;R)-S7SAMCC#) >'NV>/GSO8MD+XWY(*M[-(9=!
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M0UT35:BCC83(4=+2-M3OA%;*D: ZS,IJA;-17<%M0M-[6U4757)*9E#&88'
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MC:X5<._W)"0I"R5!N!Q/E4YE'MJ^]-L_O  A';:9YM">(VIT_U*W<=ZGQLQ
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M[/Y5#C#J-P,'APPW,6LP=*A0WKLEP2&(:@X:T0!S/\('Z@?4G2DLF^IA5UJ
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M-YC).&DK"-?UYU-S&@Z1/66NOG#S7B]\9I7YPIGE6CGTWC-A2J*Q,=GKCI%
M4NJM)]<![B>5:3A2$K$&UUD92ZP-K&38LT>R&6RHU)GZC5FD7!ON=%RR>Z?C
M5:QIUJ-84?LR*6/SC=H#*\!YZO\B&32@"9(JVPBIV24]%$([2@@L$&L^B5 9
M#%@YEW'R9)K^>:C^6L5WKH JE4PQ<<I*+G9K2]<JZ,EMA]]O+P*&&H:KK1\J
M%]) _.F/<(=@KP%)M8<+O,FB!]-RN@?B7HE<PB4@9>O=SXJNH^IZ@]*<?VR7
MX/K#@F %RVIF*V2 $*A!/M7#TO/9S !=IRP?S6I'HAEG+ C$?T%W1<BY=V.U
MX+1C["\<H!;=Y9VZM:.I#_2Y6=C2P:I<2KQ8Q C*_<\ O[RUWUAPBSQHZST6
M JWJ/?!-1D8"7&'7\(VWDZIC7MJ?%QM?_$1!653;,21I@0,D(VLT8HU68J/5
MMY[O!YO)E3VV^2IJ@X9$&?^IL,)2O\4]>_74C8?_W-O.E6OXN4SE@HNN/SV!
M8$P@M1*HYI6)..HY*-S=8/J ^GZE8-1L96(=J\GR%<D"37$/X7F%C^QX%I9"
M^BU[R%T??Y?[SPFPGN9/0?5D)$<2NY%IT<:C9E:4#-$%L0N+D3,O#MZ+>O-E
M]6.4R"W-]I>W7@( -UFOJS(9Q\7>_0,OPQ;!3#M0OZ>8'7QN%?74/])C_N"R
MQK&./;],8TOW]IVH4K[K!192"12--ONDW(%V5.H%X5&SPQ04[*J8RZ*;;EG@
MI=>UKX\E6)T=9*PIQ_+SR"&DF7I@,JV2HIY.S2'KQ87"=H(YG::WPTQU4XO=
M'P7JZ2J03TN$(E@ SSU _1:R' 4JE_XK_DGZD(MP JU[!TK!X-F<1$/J)CM&
MGH\T\<2<^ZKQ7GNMP0\P'7&E'XYE:U>VYBH&]:]S90M+#,+Z@ /05"7.5B:%
ML)I:7]VR19/+PF4#$+T93LLZ[^:/&K]2A2-_Z@ 2IRW^H6%C_FF=CYI<^2?[
MB0 HG<;]0X+M3(+]LV3\'RXE^6^J_8FRB7]R%V"B?>6/^M9KN*HD2]G))[Z6
MZ_T;4/S'=87_/[9H-/LSG%8W &I)Q^%(!5-.Z&C1Z$]H;QKO;+->/_JE_R?^
M(<,]A_8!]1^3;MS)&R4_DUS/84J@Z&-4'Z;X+-V$UKA\>E8PM"7'? 1+@/UX
ME[_96J$OZNJJ##>0U0@1;MSM<&A6P/\3!R"EXZOMTPA>A$FYP^ZS%1THYB6P
MK,(#,SNK5'V=*S?@!O-/9:"]=^/1N_&\OJ&9.5S]P$WO_][:;7Z"*3W!YI.D
MKK %\-1?J#2HS-0QW'KQ3BB5CF^T'OO"5\&T#;SU8&3%)21PR$/)2\/_BL$J
M'+)B4-FY@P#N3NQXW6K ]*D;81ZC372:0EF%L_GN1NI8<UH#_G)/65@V*5A%
MWEDT [^6_?_Z ^M:<53(L"T8!\#*V1VE#"3H/YL3CVX)>'9,H0D?7U'_^@+]
MJ\=[0'_'%Y<(^S>6KOM,MG]Y\Y:V5;D:@YE4>#=1A"V'Z6HY1#D<U6Z:G4_F
M #M5+H9\^+E\.47PB?-=K\Q,\/LW"F$ODI2K9 3NH1!2LHE46PC*-5%M.H?(
MTMTX+M#^W3[P6$=NN6C$A5VMU&\LUO!BI-$,4=?K>O<>N%?$JPL_<1BQ8^;P
M,KQ8ZP&F!+@_9!ULH\6USTB8ULTK:F)R.J7&D=?N>^V1+EB<-U&-[YV+G+#3
MZ:^3ZH\P:E?3C)]QNBYY3BA;XXG,=R,:CBFE2MY8,B A)VTII3WXJ3CZA2R*
MU+-R</^L7<(FDNN\?Z.30/92]D*.Z)$]PSK/'GR<#QC:93U\0M#Z>O0U5DFK
M"B9JZ[6:#M$=^!IX6V5&/XVW#2?7J@%RDXG)S*# X1[66_)0UO.CW!27VR6?
MW>OV>V8;J.T/?NW NZ#7@4_%"43O^VFP2.1'J(-17<;&$SMFYC<Z<D>EARSV
M.70;8\['-HR?K7M,CEFQ&XW6QZH.L57<L&ICK7O &Q-=D;<1H8D)NJ$?0D9U
MO3H4:=,&R8K7[]R02%.-E ,SZ!_ 7$*-'E.JE.X^W@*[=FV-D(87P0:3<4I^
M#:)[+<+]GGQN>^E7(R%S5FW_!S/?SWU69BDB,BE4^\G6;@8]'3*;RZVZ["FD
M&/IKJQKVR)!9$,W]+,VH-C/4_]5/Y\9:OS-M>C#IR;.V-7<4BR)L=SJ^D^#:
M7+>(,%F2I35WPNL:EXY1<?0$6HAO$R&=+>L;.?^J^HFC=+C3SG[CP0."\X>\
MIA5-G<L'_\=6*F81<F"J8RKY4XP8YLQ_8N^]PYIJMT3QC0A(C721$J4C(!:*
M% D61$3$\@'2C(H(B(C2E9 @2)$B @H*2E!$E&*4JH"$$D $I'<E"2@6B.P(
MA"U)=GZ;\WOF.=^<[\R=F7O/-W?.'?]X'Q)VUG[;JN]:[UJ,IB^9>69E]/CT
MNB$J1[V&S!61)R_U]0BVR*;R .'-)!ZP.W:.NU!!:+(K1K30!X@Z&JD/G#]R
MG > Z8A 7] ^P0.H=C:_8'_!_H+]!?L+]O\*;.5\-T=6$1;A#V&OPK?"ZM!X
M(:0ZN=127:H2"U)W>TE9DB9UFTZ_J#[>^$$;===#/D-IF^>]PT+=9.GKB!A&
MNFWT6B!$KR4\YDAS;SS+8\HGO\BL&L9O>)?"$MT^VI+L]NF\=!5VFXG[#E*?
MR$\'6-B<C?8C/$?->C_ :3#/7H\H#E]RKR%2J+(6MNI/?LRHJ->?TI_MUN)4
MC(V?<K8HL[KVPSY2YU]-E^^%M2=B7/YNSNC?3]=*4<8)\]<I]_Z"_9\%ZS4Z
M,W:[JV^72=R%!T[G#9]UQ"X9/?W3O-%*W:TYY.M#:"$+MTC0P;:2S+RGHD#.
M:#(VF=>[Z/[M](>NDD!S7%'*EF0Y"\#6Z&<EVP_'!Q4B_9I!:23.UN?<5(MC
MM "5)U# TZ^P"=-][)Q)\V6]2O^CTRR6:+'?4_R@FI5ZM'KE9O7+,F]..[XG
M/PT^+!0+=; *(":=FH+7@,P#5E*X0$F3XJI]??(@.:7"WWN/V:&7)U;[>F8Q
M3'HZSA[=Y_,FW?B]VMG#@474K>%9\!KN5"IB<F^I1^$$H5W<U!#F=II)BQ\Z
ML5ZF_V3M%M]JUT[7U^\*@AY9&R;6ZF>;C^<<OS\HPXC]Z/CSQ;(:8MY'A+#-
M<'NXSQ$[\!%!C ><)R>BA4,(0N$&-,+5RG$#X:\JNG['",5^8^\ON4W8?1SO
MVF;C+_#(TNGSR;X.'6TQ'V7.L2;B"S3#&]2"A:\SI>$UO6 ;W7%QL;X\8A(E
MCC.#[FH^.!<<$;!FQCG#06-PWG"2OEG_U.N:JZ5#FKXG=M25>88BFV#GDR=Q
MC.;0A!*%NXFK+91!Z0;$"GJ!DZ;[8W;UX=X'& ^%]HY3W)2\S_@1KWS[\C!*
MY$?J.!&V1[>167P$KKC?X,S?'J+F2<S\;73 D/S?'!_DK4K4_N=N9!../A':
MU,:1BYYO"X!S0!O6UMH,^UZ),#<_JF3A+M;U>._UP;L.\W<&70O1\#+ZC@B5
MXX3Q( JRO":S81%/.$IE9EDMQ(0KE=71L,27PU'])Z#XPYXR$D6'UL3:=0;]
MR%C_5"W\60<L_)0M"7G#P@RV F3".M,;$/?@J6^F_^5)QN7KOD;W+WRJFYEI
M"_U)Q'4VVDDU&:4$_4@$EJ[\@X^'+:T0<<4AO%7$^#BPM>8)7[X40TVDV:6_
M9]A'80CD/T18%X-"?R<6^X]]_4*O58FZ4T1(/XP1P51DA7*S9BV%\%U'#:F*
MEN8S+R!I^LY'4K?2)[[/"0<]E5-J4WXDUJ> _[:_)Y.6#?S CB:D0IM2.;+4
M%D+5Q ,$+8-8[IGS#63!P7H_?VQ+8%&*]_%#13,BYZM3XASC;ZO>?#NXO.N$
M'5L$?H.1()\DC^HV4,L"FCXZ]ULH/[3Q,UJZ);FHV*II5]PN>$C%=\)E?WLC
M3@(@N?[#9XVZB?E# '_QBK?W#UB7AZ+._?$TB,/W=\J>_J&CNGS69QZ08<.<
MXT9A>< >U\4K_QKA?/AK_C:BH#+V;Z*??("'B=K_K(U/N<]PV_Y&QWTNUQM6
MD7<0:+E%5/!8-Z1C0T%#NH)UC^?H64WS8> XZ[RM:=Q<Q^F:[@356=Q/X6@=
MFXF$FBT?UCY#B#Z);8.SZ\&+0<XL/NX=HSWRK9@Q/_< (<CUN*U!OJ\ O]_Z
MYMCF-0R&PM63>W3NF'WN,%K4FJUD[\ 9<F\2O ,$X4ZRT *Y+#RHT55L_=GL
M9,&?NPVZ#:]%?O6Z6?>,2OFQ=<Y*>?%/..']%57W7],.G[N2>__AU^KUK2\(
MXJ4%CU!&@X.=#]3BC 3NCJ:*Y*VRM0 V78'D8='KS)A)5(NX6@,6M$6-DD^D
M=T_*,W2?UN>0OH42MT-!C1=QRZT/:<&H-7XA3@TW+=X6!B8"" W3,FK.YB/;
M)LI]L>+4:CS'B2SLQ)G@O2$"VWCT!,5FM,[ VUQ_HN@)-=2NHR!#*.YPN>:!
M+:3>HFF\&&X#\BM$"0:'&^9BS59?P<;5J3T8^VJF0D2K*AY7/3YU]$JY_V$[
ME>/IAVR-^G_%!OXSQU7QY4QAUD%N=&K,(A8-37E4]2UXH.R)AP<7S=N-K7W]
MQ/S5R\U#':W/:CT7K$=H.WI+N#FBI%7R@);NZV30#9.R7K9EY=M,'+C4Z*%[
M^*#M@W"1UM-5T+'.@,MF1I28!]K/"L]7S$'Z!BDX%[8+S@'R0BR*(Y#:L_>N
MW\@*W_=5,U.=^JE+-4)1YQ^+!W=:<<<_O(V>V(9WTF962R6RIQI@$;"P.4#@
M*UJB3OB!V]<K*E<+QK^.&=_UR3E=41EME*A]&!F@(W_/8<&"/\GS]8LO_OG-
M_7,K.LER%20.%E*(BI8Z,TQ?O"*8>SVDV"_[VNL-E=77"])>O&<<BU7*B#(U
MZAW^C.'(DAQ7$IWD$2NKFPT@54)SUX& 667?!\S/#'2DIP[:$[Q_NZFR/OL=
M.=!NO"#9,^[P\WH1TSQQ,K1QKBD S?&H6$F#*3O#2N[1*&?.,32>M%VF1VZ>
MGR9(A&M2/_;IK?TAWY6@WWR[(2-8K_FBT1+#N2_XOL&NOM(*?=2AZ'=OWW[8
M4%Y1F6 C(ZD:N]?:?27[%'^4X*:6O^NU_D>T/]'S'8A!<^R9\HU8/H[_E$$,
M+.,1UE)C<RU$ERKJ<^%1BLV1Q"&;JJH-:_>G.^ZEQ<P[3\]QI*B3^ZK9D>,.
M[+TX86XY+LR$<E^K&8TZ"]V7*RVI3N,6U<0]PNW*__!U^\;*RF1*AO6:Z'79
M&WIM%3F=W<N.S,+)T+N@ ^US$GZ[GZO'X"+Q&FX[H=1C]'CKB8B$4O^)T!M&
M0&:HY$VA0&N\#?[#6$ #-XA%>;52_H[0N+G>Z L3%U2G CCP?R5++![WJH+N
MJA0489N+7+X9/T^OEDS:T3?I%^_1HW_'VVNLP,IRGEM"/D4>P[*>,[T3C!C;
M81%9I@E=///^ZHLXTSZ\W G7L7'UAZN]ZP?K1E3<6'[I7UDAF3LRUV2L2[<Y
M]1%;CN'(Q+ R,>"N%%T6$^JGW;>A$*7;XD@,_XRFW'69/RN3WBSJ+,SH'W09
MUSRX;=.>L,T-3S]E>8D46*TD]!5#AEV+;S@A!!4\Q3<0I3'GNX0:LK;[CD#W
MGUF';'?_&BJ54OK8]76-N<T3]XT;R()#FMO.'.@17,3$8\!C!$@S-9KLA1;'
M70 )K2G23<@;^RE5L #H??USWS.]8%^M1.47S?P55GO\T1EZEL'1.QQ+/X2=
MU#F)DD,Z-@JOIF>UUI+6XGO1*(1D2&19V&S$)SNX)B"A3IBY?FC<GB!^8GOQ
MW>\EF1,Z^3?UMCV4Z]RK$)JE<YM>)\ ^@N]'5Y X4IZ3SAPY0B-1CK/G(93;
MSK&=0L>IR)@]>OKP>+CW[MI7*<&UKRVV1#.>E<Y></6[[EB("EZOH"I)D1[E
M\(-NM'@&P@4%#I&YY3S JQ1[@ P^RP=-CH'$%H=UX0>F38.I4M^V4T?KB5(.
M$J=J:ZJB1:G&CGJ]NN-[*1=$+-T@Y6)WN!,+!CA05HI6RB>GZ]0;AV,/,;.:
M2C$-%Y^OSR0_\9//ZGCLX'7>X:Z%O-Q8LHGPIN@<*6=U/8<*_D5=EC\T3N<!
M8VZL<%"+(4NW<XXYR/P<4]&]=L3M#3U['4G?\^7QD1LE#ZT*"S<,^YTXQ9;F
MB Y@SJ)'/M,=9NG%$QI=<U&PLD^-P&*G_:WL"+MU)],&EN7WJ8T,%_['_)X#
MG.U,[S@Z=(D.>0UM=+*7ZG6Q_;)7I^7"[VY].Q&:147E(#_ZM)_V=3/E!^JM
MIMRW3I]_=U?&2H8'T+>";5S!/!Y0_X0'7&MK1B^LCX&7BXFC8P0.U,P#\+'H
MOWX$COWN-_FP-%J,T',.Q?[VC/#W+MS(\#G\]2>IT$'<5AZPZPEFKN@5]WXA
M#^A.QBQ].?+7CX<%,+_[#>:O ROZ_&_<]?DU_E_C_S7^7^/_-?Y?X_\U_G^&
M\5_^S-!@([H?]S:\*KR6E0253CXIK</0/HA,'1O(WGY7_?C [<2MG*/[V9[6
ML%:(\LPG-+3Q<Q-&VA<K7.?QEX.HI^IQJ&1LQ5!-O1Y3MHZ2U;-PN" X4EDT
M4"UZH/AD5,-;R3)/P5<82/N6'!4\AH9TA)K)D'IAW 9;6(ECQM:B$,>.^LA<
M#EM+H5<04&]L5K\_X'3Y] Y--:7$( 52[YN%TFWKAK0K1F1_ XJ>/P$DHL0.
M"SC\VMA?X_\U_E_C_S?'[U3%M(F?TW)S\W#22GLG*?/#'OLDO?6M,4KYWH'F
M!\<;5 O^)-_;JRY^.JH9+8JS&K+<! 4UC(5D)=3M\O;W*STW-$37K$T4O/W0
M62VFLO#6YZ<?VG>L^_(E;U7QN67CM$EQ,P_TB;Y24JG6NNRA'P*9IH)!<4ZK
M52+/=<GP*9>6EJ94A#H9]S:+:4MIG[8J2A1<%;4#D!B4R=Z<8ERJ0MZ<<7ZX
MIZFGY4J/SETU+0W^J8VV'Z,N.?G\C_8 DG2X+PE^Q'CT\]19XA1QK&VRI.&K
MI5C/QSJWK=HV YNO2XZ[M.[?D>X[H7UK"G@C3%N_>(Y#Y1:U<7;N@47H=-2(
MS2'T!6@G>UN']Q0U)9EL5%4ZZ2M[(^EA^Z"'Y]$EJ8T"+CC*204!X$HU1]*$
MM0]*!8589P=X@ ]F[+2T06MW:LT,-#-9T-E[.WTHXJ9K_T$@_:BY79AD0HU:
M7=ZE1/:F/W<%_IRT<7]<YS_<'WQ]X@\H!WROER>T;P>1[Z68A0-.C%-_ZW[Y
MAQ7C^Z]J8#>D@V:4TQT@K>I9ORG,6#S%R8X0D3\B2A#UV:.Q>/]LT"<7%U52
MY\29SIRJ:*<MC-1;P^(\8'40]SK'F2T/MPWE3SE.G</(6VJ<6U(Q@=I*WP-G
M:X<75VED:ZJE/-?9#V"S@B_0Q*?K#-KX8947B,9UO[]>OM5R'+1C;:]).L[4
M9@^-+5'LKF'.5&U@;NB?%-^H=BOGRA9*-'G_GTY?O[#K3VNZTW/0)A[ >$M=
MJ8 T4DW!*EAL?WS_6)M910\41 ^+/YW4E76<J<'<,FJ5Q@,Z/$IKSN[JL.&_
MVBZ[D((/@/AAXQ5DR1ZTU+//H4837I1^'-.*;?Q9&D)-",IC^[^9G7)(.N.7
M=BOK3,+%Z2A+Y!W11_'->V!A-EL^/(A&2@C96!0^?C0S8"W'@2EJ-VU;$IZ^
M<#W@V?I#90 4J_3#,U;XL]%"Y)_O0/KE,OXSW<0_4CER)JP19L"L%WNC^QYP
MWV E*HDJ'9)$6,U1[CW9F/WY!%E3N] 1T[PJZTZZ\?>]3JU,C\\<Z0B6)IC*
MD1YF&8+.L^7TB(+ZFIZ%.7-*#55C,>5TH-?KNK,!=^O:1UG?VX]3?(FWG-]B
MR@(X_N:PR.@4:IQZK&NND0>,%LQ9\(&[L/H!15"Z-;_;T)10W)H"__Q+MT-^
M?-COTX6_^5_BHOR%87]6<VXE@&[8L?%)3$/J:+X=]Q[YK"^G.X5<(5&7*P"Y
M^<L4G"G/_"A0-RBLU*9<4%M^][)DN[H>=;/?["OU&^O&7,XX6A]UN4,#S-+]
MYI-@X18E(GC, =(F43"0;F%"VC.\$B3P#%:$N[:^W2[>4G'HF//PY!?4F!=5
M+)"/J-VN&+0N#U5&/HT9U:)7S^JR=2 TZS!T!(#?@&?CE8EC8QO2L>_OO>Y"
M%.5I>W-;W=#.:Q( Z;=_&!LG;R#0$&,%#"%QS+&L66;W+&)6B2GP .%"SD;"
M*)%YC-#4"[]C>X\;UJY<L%R".X@=HRR2 =?SPFAMRKB5T,RB[$J$@>0[PM!F
M\KPQ82DS%;H1!+\(X0%WRWE 704?FVN-MT*0;S.&-H.%$&P:I06,%,+KML-K
MR9 ]!L&8R<<\(#:?F\_"O/@:ALA91&1F"=TES]9CEUO&R6'FH<3A/R:)^#/S
M411EPZ\?ACOO?LVTN1[B%R%N8E^1/G.XOO:.C6R%Y-/+ZJ$79!UWJ><"JX<[
MZT40N?2,H\),3<Y+X*"A6$^:ORNU.3 \8-*^+=YNY!R_1TWNL/UMQM39NO+J
MW.-IGKGADJA[!9P"[7=\B_JR\S:,%<_Z$4B4K0AE\X FO ;DPL2V+JT7O*_R
M8,H\-0XM<6&Q&"LR9I9E6ZF;T) XOC7&(.OE&[55NZ\JN-0BNW<!X5/[IEB[
MJ[FULWB#D?<<_=K>_(%9CIV_&(F5\/'FWIN/-N*&7OHF1+E=FS_8]G:4_"D/
MY?&PCD279URB.21B9.;P_#.Y:YGH:%R8-WT$9X5\3JFL< Z[LK=L7>:R8%5N
MN%?*64$=&=OIW9]6/\D]X_43+4=HM,-X8X2HX3F.Y!@LL?'$&N89_#IF&V7&
M;EV.58]16/B4G^^G[<)WK/5ZV@R9>]3EYC9*VZ&S##+Y%F1E5JT3/+I&+?I_
MFN%76C*SWB$^.(F\UF_LEIR3L7&?^XD)CP-2VJK6>C_,5?Y_K)+A8Z(X\FJL
M..BV/YC3A $/I8[&.&WAG. 6AA2"N?%!PAH5]FLV^'L[1S[:]L@X-FM#G.#1
MC@P%V<6PV6ZV!<>(FT'PY@%"<!=1:.&J%YTLX&.\['1;3G!I_TW!S-W ![W4
M&IL+)=\[+QLA'4G9V R2 ZAC'9,$CESSI.7=';U&\P91/,!;5Q0ZD(->,WJH
M*=+Z2/S;I>H#<\2ZJUZ'#^P@]5[YQ^F1/U?*6^:3/YGQ "4>\-V%!PQXVI)F
M%FX*VI*FNF$)7Z9#',X+H9%&B$Z"]E"<UI?&=-&_I"_9U]G2?57!Z;LR3Y2%
MC[:KFFUYYYAVBQ:MS4];7@F-YR$B+\:=L/)B?LSWLROO=2+-L,@W#2"C-O@8
M"=P.3P=P]QF=@\E_%W_^I(SF]Z!&L+:)K(27@@III!N3V?:H5A6E^EZC6U59
M'6FEFVGAFB+4IG'U\RIMV9P\[KWZK2MI3Z)WP/W#F!=$CLQI.2@-#)W9"P;$
M6:"8G^W[JUKH,\<O+&Y\X#)3U2 M/2?5NOGV7?E9,%//913C;&D("1V#2L&@
M%K)H!5;!(SQPGE*O0.XKM=CCN>[RPJL+^A.R-2FV?+G;Z UOVH^\(=W$JR/<
MVI0'G L8ZV[!:T)>[-,<5]!KJ;E[K>^$*%:.&F[7%#CF$?[2IR:%@? >.1V2
MYOK3=8SS_5OFDQ[H2":GO^5;U&I#)<!KN#GP>BAFT@6\2AXPTKW-UKSZJ(GL
MS[1\H6X;X.>]%C.CE?4V;FW7CX<;O'65SG?\C&#;X]],J'-C,*=1D%;;K#7I
MVQ8'7RU&&ET>6536)=6W$3/%;,8A.YGNB2KY8]M:UPAD3FR/&F3),Y39$LBP
MK6$]_( #>Q=N [)D=\*Q#<M.]PMS#(2@ TLT,=<^GR=3TN\TB4Z[- ;R/_I2
M?/;NZ;!*[/N9D[N2."L<9P,MLE7><_BYI3S 3[%;">+B3@5,DE&<H_UUZ(!'
MB''G)W>LQ3C'*/=>>KO2I8:35LR[PCF=+S5N=89&A1=R9$A8IG<,@5:%?MY:
M"O8-=!2?PRM#I=Y%XTT%*1_NN2H74+8>X/NT^IMR4"MHMD"2X<;J&Y(E"8W$
M"4,FZOJT&[LK@)9%X6*=ZU_?-,QR3:L=^CC_*&#RYH'KR?.WC@PX4PDH'N!)
MDO/#5-Z/9Q2S#T)3>YE"21PCVFC==EKD]F97O2K7T.O^09OL(D/E+D^GVQ5G
M*.UW"RPYW*K&UWX9W6F$A30$7P@U="O#S1,"T*AO/DX0NC[9\0'K""ZXBL4?
M[SMO\-UZJ.#AB(?>C$QH>>=97;6F[M5AVUKY[Z?OXYM!@W9$R?#J%BIH[S"Z
MU&)ID>M;>7\/K3INLY'.]Z!I>]VO3IU]EI??C[Z/;/_:]WKL*134/(:^AMMY
MBNX@YGMXY&N-QSVG[,C;9?XW)M;TJ%_*4Y9UM.)_+AOX'[IADD$O)2;GT-]%
M]?C))<;OK1PIO6#+W^XN45G-,E!$S.X+'3R +Q4:^-M$4%OAEBG"LO@H@;:5
M!ZRW_/V7D8>_GOYZ^NOIKZ?_I$\A-5C4B[E]RJ1E'F3#PD*@8NMU_ZG4L=VP
M'5;VG"M.W99.%7#C+%?.WZ/CW@R6]KJM.MR_P?P%-C)\IDU%"O*BW?><M$FM
M9/MK[0;AK$M/_5P+/N:<*J^(-LYTN<=:"<#O<6[$@-8!_% UJP1*96Z'1=V8
MY%TORX<LC=[?1]/ETIYH:O18"'CIN!GR0RK??S.1\MS$5DL[I&[(QXIO,HBY
MB!.&7.C4:*KHQOY@HCATS+JJ+UC?6/18U<30FJ$=_:;M&W\[DVO;;JI9@WD1
M3H5C0K&0&*&U2CM/C/"[[ZF_GOUS/=.]#;4PNVGDV47:*U@-=QDJIW<+^LA1
M9RI39?P.'Q_7:0W]F;'MJ>?HKO99<< W,JD5$?.*93R@P1,V_%??C,#"! RM
M/E<,&BWU"!>"A=W8*KB#W,>5+\]N,2;G??5_&'YTZ.3%HU/'R=9[-RRH;BOA
M:UXJ\F:9(&K=>_Q[3P:F*HLQE8_OGD#53F/C,>4A&<;/F"JK')Y]F-ZOP;\A
MYR*S*NAJ X#>!P_Q / P>?082[K7S85;@O$+6!UNQ"$:*VLN$TR.OG(X?OX!
M-6C+TOZ18%+6+ ^@%1/!(W/CF@ZS<Y#&,$<ZPZ.NY[N$/KR9@TN O*U&\ R*
M7$[*!X[6SM-CS4*Z)]CL%>UZ'89VC_ BLZS>%/)DF_LN=R>/!51XX'8QWW<_
M\\MXKU+.+0)?Q78'K4E&'ZI<U ?PER80J/5D?\RXF+@-+(+HIP+;F0[)P:]^
MOH+LP33%)EA^[,KXNQ[_5P-J,W$W6SF+D^1<#&10.#L%)K'V(\M0QOF->[^>
M'UK?UHR7!@<L59+V]U9,WWY8[8+#/'[WT1"Q!_L.?._L=+D[DAZ$'6V1X>/P
M]6*IGY"_>$+C<YU(+8[\=MH5W_)'06C(-M0BZ24*>ASBSESH(G@03C/)7,%9
M,KB.!Z2</V*%_/G]?]#_E8\50D-S]>T>13!<!R?%V12[0&&5ULI?-Z7_\4WW
M#C3,3*(OS2Z",12JLJ7N3._7W/7@C?B@8K^L'YY+3CW[^DSYH3NQ34\^W8DR
M58U:J2 6W061*3R@"MV*B<.">[MC7#]UE7YN>6J3 !N?&PN^9OL DF@]V1_=
M?"NBO<?MP4>IV'7^F?5<D' -MQ7D 4VNV*@ZZ0?COMG&UPMWG7KD6W5I-JYO
M:-W0C@?6Z!!'V=\D&D0@++PF# R8%**DR+=102?2V)Y=Z?V3!@R#(ILBGQK_
MG@XHK/&Y>+;QO;OHS5]VO_MT45U<=,O[Q_4__P\6XV<ABXS,KAZA4G/,J8YA
ML+LM=0QKC96Y'*UM(4XO6ZYZ94BAJ[)E\]*/CZ8";R5MX4W@*?850J,GV7]N
MP6%$&A8>] <CFL((WRRU\?U+J=Z!O>BI^-T5^A<5 SI3U2S\T^Z) -PU XL[
M3:S["X>,[N\6M;,[GNV64_S4:0<]99_+Z)VH(D ]HX&4")NM. ;()QWB+0TS
M:%2$2Q5#6:RKT/5Y/4LA")5G.ZFPQ%^]E+5E<E#&1 PW=*91([PET-6;LS;0
M84SW2'P+P@*=".,YDUB&='A9R>=&._R$(AA9%_5=T?#USN%+QZ[6O3$14,RZ
MYSQ&6$7V1D6ARU'14]!*[@PYL.WJP@Z04&YA\'"/E_3S=1.3&BJ>N=]'3]NJ
MI_OP(V\D0#O,63,[>@T-XHDOJJ\^@^1=\VVF4.LMM/+U]O@G*V85U8]ZJ@?N
M[PK!"!%H5/)(A!7S'EH!X^>QIQ53D459!Y]E8ML<UK:7M$FJR^T_KRCWHN6F
M<2NSO0+@=WX_<%@ @X(BK,#<ZWYTDLB7T"MG[WNMB>MPZ&>DK].?4I:4!'X[
M,@((N/\'3Z=^93S^QS;.IY7C\F^N\1P9<U;'7RYD.H,:"UWTB,<QDT(,G<O>
M:GP!]!S3P9*%K! V*2+X:=K-+W(*P";7^G%N$<;7(([X8FGVZY3!6-B41"$+
M*Q&NM8MX;.#N?I1Q(_NE6CM?0>;N-%4>(/TF_S6N%GF[*3<'KQ$>1"->1Q@Y
M<8QP4))S!M$;*IE926IIMO[H UYJ^_O65G>^&!_;=C-E7NW D?)/B0 [X%!_
M!1?M$&/;=_Y4965E[*FJJNID]4O[\C8]?$+_#0#XHP3L_[/NIN.P!11+0\?F
MRM8RJ90Y)1]8J6=6C4HHF1F[YQ2:V<']JGG[]MJ(=-U)-!HAX$9TN4&BA7,8
MF ,+SX!^DVC&GBD[[Q\%%9!CWOY@/QUSQ=<G0MS"3UO@ES%&IC)\2Y67B0P#
MMA?\%ON"'(NA&W&?8GP,1,+E&O//5EMN'%*+\RL).;ZQ.^?B!_SQP9P;MYET
M2 ?1(Q:Y-80(YC K 728S:+ED!9SI:$C%^HW,MUOYKYP*.JT?ET^3QFJ2PZL
MK\]B&Q(:A<FT>^1R8I)02Z0?W7JN!9NPS:SC,A,]M:\$UAC\KJFL^2'DSNF;
M2C>9>U.Z78%Y%PRMBJ!$]C-5W(OL_;Z5L\6Z2.;IOK.C0BT.Z%:<#GVU.P]X
MEACQ7/.UZ  E2>F.FL*78[!R)#*VK=R*5%8J1V8&%O$K\CF!KOGY#+\6[I*;
MR_,]Y:"I4&D;<\*#@I_9-S/^Z=*]U)XO4S?6#6GG.UH?EOWM)& &Z/CP-Q(\
M5ZYLH68EV8(NZH2RMMEF>JK8MU7;,L*3QY 5I$G.7\Y:TK2+$TIWQD\< DA7
M_BUN0,)PB\B^Z'CT"QXP.S7E,!8V^8$'C')VTE)1[\]EQPWQ??XQO'31)E>L
M[,U1=>4):^5O#J,$5B)TB>V.[U81YSZVE/R&/0?.I=1A HJ^)E/DKWM9N2H
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MX089P)E*!?U*KLMSY(_1@LM>.AZ9#.QL U#0/J,+]CA^[ E"HQ#&:^X:MHK
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M-5DB&C-7,=1@C8/0!LP%WL6X!BXJ,T=K:++DH]W!!_QONCLN9EFH.'D'^?7
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M:&,('C048-H,K85[ LMLLSO[6NHV?@E,!E*$]JC<#19S&G>=<9J-JV'*BC+
M[MJB SX?I[:L.,U*E=LRD8XJDQ#-4CH&(DB"%Z)XA%A,%ZA<S7]1FC1(S7OU
M99-+]OZ@(SJH;#_LY\P,8W">DPI&HE5$!S ,XZIOL\I/YFW#&XO>06LO>#$C
M&G-^IV:VW//9!7GV_E2A3?>0V3U2<'/4&V']7"I\U@CS3TA$_LPF53EY+82.
M,%I(N1-979\FF&W.:LRMJ44;TU$MC)OGOFBN(3O-K-5 NWU"^#91<LDFY]RR
M;[YW7I>/!"P^-?$\!F-Y*]&SH0U0+Z*R77 O"K\2=.MJZ3J]6:XOS#[S\\3$
M$S-$7HA*$T^MAX-0F7[^N<6$@Z(,:&QW\:9-$D5A]D_L&1@^!%&M^<*@0>)/
M<[ \B&!11RL5A3_LM_-B:-NMWRC:\%@,A"N3MS;+_;HC^:VH4%^?+M"O4<T;
MS>S(NS U'2WW[3X;LC*"5V51U:40S;59.\SQP_A6^I;BJ:#@P:MUST;W$3'O
M 5XM>%"=B*C@*LUC_?4/B.Z/MURYVA%@JQG/)MX W'&P&95CBDI%@YR'Q/S)
MF^%/"OF"_K%^-%NIO^Z'*Q'RM$$4MQ_DU7CQO:J<WK (QA[&+H,Y/L.WQ_5R
M&-P8!H>[>0/X"%,WUA29@4UEDX+PBHW<]MC*CRGW)^OV7;(FYM8AFM1,;R?A
M4<K'Z80 G0-0:JG<O&%AIH5V;Q;@U<^ SML@\K,K>,.%Q->V@AL?=()K,OFX
M*K,%</^MZ; N0")S:^1@GA%L5HG.J^969&(<'TKQU[.^[C0\[.=;WTLS=ZGC
MC=/7>H4S(.^R>^N\Z)3*M\FXI!N?4M>%;J=R',*]")E%Z9\P_S/!A(X!)EA+
MN'3@S52=P"7&8H\D5U3>*Q'&>\:[W><JP1XW@G7T$06GRA0P%^.G^WC)9>W1
MP0QNSPW6OHFQ-/($$C2>73N3"?P2-N?-%JN4_)T$<O"ZS/,U=:_(1E]/MU^]
M&I/ 4_[IAZRBPQL2]V(P%S,A$ISU684_B*V@FM'B+N);BS[8RYMI$BZXA74T
M[6;!QOK2M)!_<;XG+%&XI[6\)-#H@<J<P-3E$B/6,H(+H@<E1H6H/"TD5::Q
M8(%^"]G03:XA^E+.VM@-T[9<%T3S&J8$VBTS++-GOK*!,WN\N(JVIW%BH-NF
M4FL1:S9@_'4@T&<YH?=8<J=E[:?;T1>."BM1#5M4YE+&I2RL45EAXMK,Z=HL
M T$>-#929_W:9!-UF43=LWZ2 5A.(G(*9_+V#54*=08IDG#^S'8LWZP<IT#>
MU3B2AY\/%QZ":Y\,U'H8U! :3!:V9B;I,"7N$S^^?L^/\[YQ"M<KQPAF<-KI
M\/I!X7:A%"JM/).0"U*9)H[DX\) 6=,HKXE2=</#!R+"._OJVU]-O;E=L_X%
M90YK_/3,O0&BYT1.'AZR-6H]Q]H+ZPCMR>JP\Q.RN15I@7]\M5FJ5AG+@N1M
M<>6]4UE",[?Z]HG#MZ8TOL=>D)P'X(NNAQA;DX>%EF"Y/8.3) 9R2&V+X2FA
M)YG00/=<)WB@WNYH)=IE$=AZ8JH0/R57%G -E86@PAH3%3QTP M>[L44 [%A
M)%@$38Q&IVR#QKN*?087J(XU]J0\D7*?EIJ)K0K%>C<3 \Z'YX@!@'&6*.D?
M*&C7WO]:^U:B>B@O<_HLMY<852]U#:R<]D(WB ',_=T$<I*(>5(U;#/4HL2*
M&&899F%VB58<8W5 6#0XMF/-QO0A-G29.+P9+3XHHF%]BQ0HJ3O6P755"4D3
MG3&$?;A]WL,DS$Q4X!Z#=9]'T;GY>.A:/WYL#*/GJN<6_#S,';QV"FXAS&PQ
MSP20QJ/UH*;%*(Q"':E&!"VHIR90#%05VM1\PIP^S4NDK>AG-K07#^NQAV($
M0=364<$J&'S(MN.];WY<?VCRT#X?,6#]=NP"\:>^G8#Q'Y!)^G_ ,W_/QO'_
M 1+B?X S?\OB\;OA[X:_&_YN^+OA?ZUA;2Z4D.+DDWBQPV%13,ZCD>/4JF,9
M_\I-("=D&X2[3E@)2YV$27RI'=3#]19[TCOZ[7ZDK,O)Z'Q09;V@8>TA5<F8
MUCUSM/V7EDB5SUQ8A&]MKZ0I-3++EC4CI[L_ZUM?VT90@VC19.>G PF!SE_N
MZG8D%.($*>$>S3'9A3M6D]FZ/+EPBAHE(2W$HE*0(8H%7>K:MY<+"( HW<+@
MN8<=(>6%O7M"PB+MU=],'MO7!LQYM8]]JNAZ\:Z![.*(MG?RGWUH"F52B '\
M 0H_!./XI(J#,+4BN>:!0,O&JOF"[ALS^8M;W1P^E9W)>?&R&*GVM3VV8):6
M@]*L7OP\T)ETG21IX?:,;%UO.!%C7VU7D"29%-1-5X9#!X\V[:=)K-M^-KYS
M]["2])<O3M:/.J.I9=M.CE%T?OF\']&5_"M9W9Y.[PICG+N-%"N[20KP?JTK
M(YME3C2?67MO="2OYY9]W>J^TU<Z;BSSC]NCW*D<GM_P+PN@)BT&RP,9SG6Q
M[ (JHA#473C4(#3QUT 52!K^B4(9H>(.M#$_5VC3.M%)&/!B.U@IK2A0U063
M:JYPG&]*#4XOEYB:_6=?EHG=*I@?P1"IUJ%GV0O GU\8]+;_K"Y*97!"&3F]
M3*^68G3^9BA3X"K*0&3%P#Q63(FIJ%A4F :ZM74%IPRKCSSRQ8UF.2>H="[@
M$S_V:KRZ^.[JA.C_YTU&?\NKA4'7W0QN-QXZ^#D(79@5- SB*&H!92J09?SJ
MO@OD9[AV(Y8FGL!9S\('JCX<IP],"I[#A_EX7N;,57_7B/,):\ *!A\7229>
MRNA'31Q4!W"/ P9[/EA<G,\Q7!Y#.SVFXG27<F68>/,? _Z?2D"2C*V8A]!6
M-W/GP"86*KWQ43^ZGE7V 9KLIMWE@FI37X?#FO<L$P-;&><ABY0PZ2_^QUWN
ML[K$P#_VA*VBJA@87,Z8NBX&A!-;\(PF6RFA$;(&ID*'!?Z05P4NBJ;"X!+X
M*F%DHM<3=XJ)IV8+X57]PY@+9T/JUG\XH>Q'6UM(^,&[TO#GEV+]NY9_]X_O
MO\OOZS'^"N5?"#+^>2CE?S*"K!>L/[S7+5JL?[I6_:71/]V@_-^22^6O5G[G
MAOFW+_]BB^@O-3RS-2<%!T/$[@6T>19J4'L56]["_@F[;ZU_R@XHSIXNT#0O
M[<O+"8H8R8B47Y7YR76X,NFDY9OKT1$&#-A%N!]9 F= N\8$U[_F1W4:5 8>
M;&(Y)%:U'9D^/[TOV:=Q*ZCUR6P>73[4/N!NA(9-P@FK%0NV;)X=.94NL,!
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M)$H&^[HL9,3 ];LT,:">_H>!BY.72X3]KOF_OF9/71LH &'9=.0T;.KT&%&
M8EZJH*8)!GV>)6;N$9?PK2U#MU:=,N^]KQDIH/^1[;[Q&16T><A6ODJXQ<'N
M#2X>#!EWZ^#']UR6OUB[[?HK=,FUKV_W EP&-U$,G*--FU%G8Y9&UP73P$__
MA,;L'Y&_Z_XOK_NB&L2XJ!6SY.NI_'#.M]AXR*IB_2L2W'R<_J@ ZGRN6P6Z
M..5L>1TRF'KQLL& ^0_$"\JL("XD[^36*?G'JK6-5K3%D]STU#ZN_'3@T2KB
MS5/C#Q?\"6L1_V3LHK20#5Z_J_[[5"5<$>4174",7;:($BR\7O:1)"RTG .\
MTC:U=]KYG_FZ<:EG[<><&FG:)0=ZI5<K37"Q&/9[Z.! J>N:EW#"Q]XV;H_%
MBG.?ADX?VJ-G$6<3.$)91B9 O=6DV0.@'.*@1'\RT%PC4QUZ*/; +?_3]7P[
MN_5WW1[V"9*U4U\NSBF(G2=1L'O'@1?Q'1QI@(<1]K]2I'[7_3]00[5BP!/7
MRA: ]41GJL:@N<J[.JD3CO9]L8+)8ZFJ>;&[4R[_?/DZ-+/#ML$T@J_#G0PG
MK(15#L-^W7T9P6;'"M8XKE*X<_GZM4JY<&R$,@T*AK=S;[ K2V</# HHT(Z<
MVK2VDK@]7*OU+D[2<7O6?H\+:F8CQF)@J%$,[.)S2,BREYA3_.V*^G_*<;E;
M-,W^I 4>PFC/M1%I,*^"4!R&SGA'.QI^5_U?6M6?/J0C)"*2?'SY\"%A%7%.
MB0YH[L^RC= KA3I?9K_.*I<.R3M[0R+$7'HZMHAQ@X$!:"BH,A<FE5_\DI"H
M?K=Z/+3;6R>@D3"Y<7-N_96_JJW;**LH(,-2W =V;!+46XZ;YS;9'#??T.L\
MV=1#J?Y-W_M!U97!Y=EE_V/W8/WA7BP=42K#DW&5E"<&JFD11$F"8L=@W4MD
M16ECEH5C,BML)*]!:?+5!PL#]<YEEW<O<&-0WD7GZ.AL.,_*MJW"OU)!GB@*
M$#'P^AJ7CJ:MJ9=R$=J!Y:?!<S8M8]5OV>$EOA"OFWDSCS'O7B*S:QUD5&G?
M>7@;E+([8K&5L&GVALXS<1NU=,;4E%D7YX80+?U5NJF5C B&K D].G46/X'V
M'+:U;^C^YI,5^)6CX9&R0D?A\8!HO=*2G$M76<H_2 572A\AZT3WD(,<W&QX
M4>-1OCYUV-=0L;Q+KO"&I6"D\"ESD[)OS1S[5(^4I)M+-^BDVG)E XZRA[[2
M<A(112NN%Z)H4Y&JFR &#O"5,=3V;6)W:WK0/=V('M;J[HV?]KWU4<^J<MIX
M;#=+)POP82AB".\9.!]=1%X*C59'H!+(2?Y6%EG+J[NX5.(=12+%MK1^W*TA
M52-K>^UIK>QQVZ7K09.IR]QYD=O*&)"*( %>)[2FU+7AAK="AZO3[2%2A(G3
MLWZ[!_DOB[]?OR#WQ+#LU&TU+?7-Q97IJXW7GF#D*S.']3GLD.0A;(V-*O&2
M'I1-UAL;MWU%3F3OR6B)F&/O=*:^O?;'W8H;$=&[W\TUKB&<YC*@;>!-]@(+
M#S$PYQMD>XVB1M;X1M NK*PMW5[>M1QRS TL-#-W+#KMTT_)V?<TRF#/)HOJ
MNPO/G5F?O0;8G"FP$N52YE/:NK3Y8"1%\J3'H1/^^LQ"%-?\I?3A2;=XO6?G
M;N5C>+;H2-)LM6^X>S?;[Y8?C$ZE.\*EC_IH:B4;H8T^@R\>D*KL]#)?O+PU
M]^?+H9>IS2MT[\3-ZS0<?KLTQ,JY;L<9PCXQ$+I,#'SNP&1I%!:*@?,&'0R7
MG381,[EZJ\&V%>V?<Z..7'M'673G<HQ+>A[[PEWOR9,#A78W\NX)*_>'$WV
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M' (&6(Q=@\R;G(=XTE-(4^Y !42ZO!NY"VW<.&YZ:,5TW\1/!==,L-5+P&6
MT&N;U?A=G.R985Y@Z .+(.>(CATY)DC 2\%(5?AZOSMX'V(*OG$XOJ;=BH(
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M=#[/_:J%CF24F91#%\H4.M=)3B04A&*/571/I93;VJHXQ&MJC+ 5 $,;K:1
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M9QUA[T8(.[R M_7E1+5:W5.V6I(E]:S7$R<J<)6X4R*U9%5WR[_^!7BI>[$
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M,EL[009EO;.PVF7$\QYFQI9YMIC=J_3B55#0DXZ7Q2"-U+DX2AV(:8#5X;C
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MF[>^_??BZ/*6:J#4#?Q>*?*'"Z 4!$I#\',Y>TK)U6^KPM6[JM9Q2:EMAY&
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M8=9D>V'&9N-N]ML!9?DZTV3*,V9&CQ>'PKMGBJS5 *4><*X4V6?$ ^732G6
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M:WU56>AR=65J-\BX]6T/DZ@3AW^OJ>D[AK_50E?U$9>Z[?34K?3;ZZV;J[S
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M*/$XE?\PJ=*Y\6PC-ANL5.=\+:!ADYL-U+"//&9;/F2.+RUF[#HPXC2 !).
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MB&+Y=S*;B??;5_*L#,M?\\7J;=/H)"2^3(,H@ )[ND>F(+K_+X.(<9I*FHB
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MG&6%N,\S)J8$B1 +J3;$.N<=<8(AB4,*!8E8& LNPDC8D>N TH^/D4O9ZU,
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M1A(Q#"/BEPG/(:0B]B!):. 1&C-$D(T)9S+HV!BVO60J^%,+#DK)+4^5C6;
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M@3:-$DABQD6L#"24&*4='7WZV/A R0?+L-.BD=#":7L G8%O^Q) >O[6E6C
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M:JB-U%6%3X?$8H.24YHQ&GA8TK'!XH""K&[NN+=;Y0N^F,U(7KLHB&"2)+&
M'F:Q,E&4=9)2S&$4^SRD2-DL=MRS/\#8:&8CG^4F:Q\XPQW4!7#TO3U:B^;0
M47-.;Z=[FOTQAMVPG-#P8#=RZKJNS>.K=CLGFMS_(UN^W,YY]CWC*S+;,FH>
M1"%R72QSD7]9+5>YT/9-F=CN!3PB'DI@ZO$4HL"/($X)A;$?TC24F":!55M6
MYQ*.C4(>ZR+EWTDV*T,JY"('LA2YW.MHF2=@\:855TOO#Z*5UXMP7;!\(77Y
M\66>E162JEU26;U\^2)R0!?SE7KXC[(K8.<]D_O7Q(SO/G3R>R;,=3^R;>7
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MB3RS3?:S9;W)$^A2&2M[  =J!YHH8R'U0TAYQ&$0XY2%,HP%LNJ0Y0+= 4R
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MJ5(16&@"MJJ428V3(LB:55ZDC583\$\]-?=SAX<F;@!U27D72C0H,[I!;Y]
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M^B_:AIZF"F>LR!0FE"<0,9) ]4\$@S0I<H(0D9Z-]>I0MK$Q\77C^!YDA;2
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M-[)F0IJ2U).0^RB"B <!3 E*8<12P1D)PS RRCTS'W)LO-X\;="?;/!IH6R
M9HZ9,HLO+3!U$O\N!S>7HCK@\<VNTPPT)!_P4*<-K_Z.=HZ.^HX'/&THM!_S
MM-YIQTQ<9-,RZ_:*<_72Y=4?GQ1W^M,D3@-))8<RT,VR8Q9![%,!_3AF6-FL
MD1<:V:6MHXR-?ZI$\4K$2?T7H(5M[21@ 6P[RSB#JV=BZ8R4,7\8(;&EC+SF
MC%RP7Y\7K_^N[B_I0OUEGR7:GST(,1BI5W.!V<7=#).B'Y7:E:_$U?-2% ZL
MO(I_96F2,IPB&-$X@2A-U-XT2CR( DR"U$L]:E>+X_108R."K:1@*ZJ=P=&"
MJYFAX0:MGGG@*% .(XG-P7!I/;2,-JC5<%[K?6O!X(ZN5L+-#[%\5@;X;\O%
MGZOOVI-'YF_3. U]R8(0RH037;TM@9AC'_J,)7X2($)\H];P9\89&T%4W[]:
M5E *"RII;>V$X]":6@H7 S:,K6"+50=+H16)BVV%XT\?V%IH5?'07FB_O$-T
MV$&BV#9=]S-Y^[)8?1 /@LRTIV7J24D2ZA&88LT-E E(0X8A20(92NPE@ACM
M(6P''AM9;%(P5^0G(%4*IOX[+>4'/\@;F"]6ZM]@6>E@$51D,R7MG-(GT#V3
MS-$TUT9Y :!DUQ'!ZM_@H5^,+>*S>L)ZH# LIYC;15IU *XUH,KF></%3770
M<B<\JLO]';X)Q;,++WI>]#+]N- GL-,@CKP0"0^& C&($%'T[U$?QH*$J:ZR
M%G/S6FK'QQ@;TQ=2@H:8X(]24)N,U!-P&E#WY2#US-)]XF-!NY?C-!##'N#E
MB#[; 6AERA.W#D>*[;+O\-^92[L6CVFZX;^IZ2NZC K^,<O98CU?U=7YHS#B
M42(HC(2(= X$A9@E& 8XECZ3) HBJ[Y2I@./C12+XZ9L(_@$K+>B U[)/JD3
M(6QKP1A.AIG/K0^(>S=\=P[S)J A-?BX0==Y+P5;J-S6:S$<>^#*+':('-9@
ML;R_:P<\K@S DTV3;WZRV9IKE\%BP?_,9K.IEW#LH="#$?8P1#Z1D'A>  /I
MI4&"HX12;-<?STZ L?'95GXP*SJ29]N.Y.7NWK9GGN6$F'%9GS#WS&E;T>'L
M:,_W'/RRD1_4"ISNH="A(5\W[-RVZ[.48>!F?MT0.FSUU_$Y=N27+U?3S^1G
M]F/]HRXN):(XB' "(^1K5A,!Q(K0(!(HC3U,/66TF;#:P9/'1E>5<&:<=(A3
M.]E<I'W/+%+)Y? T\J2V+>M>W=-8\^I?^^O]\*&#+.23NM0K]/0%W>R.346Y
MZT6^RJ_F_*;JAC9%)(X\C_@0H9!!Q'@,TXASF'H,\Y1P[HG$QL X.=+8EJ:6
M3X?F+5ZJXB+Y!(C-=XV+EZ5@65G,1L= 5@9AA[)#I[$WLR6<(-KS<M_6M"R$
M+!"[.==PS]HR.(N$2Q/@]&"#?NO/ZKS_43]_0P<O\VVVS%>?,C'7D<%%8/!5
M]8DB'DE"["O"B"-=;(+$D(J00R\. B$#CQ!NE/K:/LS8R..DH!:NU-.8&GB;
MG2#5,RG8@V3G2#V+0:LO]?3=P[E3SVJPXU$]?_4%48CSE9):7?1<E]2JWL50
M\HB%,8%)@&.(*$F@6O!J??LIBU,/AX);Y<BU#3:V5;XKZ[9^78=@Q%/PFID
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M5S%?"[#6U7X VT@.2$-T"P]6*\H&3BQ7V/7,,%LQ=\VQ#@U/6A&S"*)TA=Q
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M+/7;K0UD>W/'PH[+!1."Y[=*]+JB^[W\*.AJZOMI$F-EM7F>1W4BC;+:U-X
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M9'$4QF$L[=REIX8:GX?S[LOU_><;\'3U_]X\=BR NP^G&9.Y@*AGIMH6EIV
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M(HB)HCN4<B\,9! DU*A(Z 4RC&T]%WVL7BKA0=6\> )(0W205;);K/2.$V3
M!_W#WC-K''0.JW78'/876DQ 4P]P-]@<6#AA^I^+@9PT/<V)'>M?AF;KMZ'C
MHX?[@ERF^\YWYL)'=?@:72FX\>-_7'U]K/V8* VC*,$PY8F$B+($TC3 D(0I
M\B."2$3,OS/[3Q_;%T2+!PKY++CI #(#YK\$B)XY?8M!%V_XX?MC3L&7@#(0
MN=J 8\>8IY1OY<*#FX9CN5/R[O#7R8LN*[]?)(OG61&ZI?VQD104I5([LGS%
M4:&OXQB0#SD)O2A1]G"*.Q7,WQMG;&RU*9C=D+.3H_L4KF8N+0=H]4QI78#J
M7/_[! Q]5.S>'^I=:FR?T/=45>Q3EW>,]-=Y!'=YOA;\XWJ9S9]+&ZF(X6P.
ME4]E&" _QA2FGD<APIZ 1#<FYTP&RHSA-)#<*F+?=.2QL8:6N>B*LY @UTH
MN5B618$JB2\(Q3>>#C-JZ07DGLFFD!F40H-2ZFH+-BG#X?76JR&ZP\AV6[2<
M1J@;#SYLI+DM)@<1X]8/L&.R?+F:/C(Q)^JIMXNE8"3?I#$&(DV\-(2<IXFN
M!!M &BC*BC#SI>!Q%/A&9LWI(<;&3;5T9JS3 ET[O;@!I&<>J05SN-$XKW<+
M(ZB;&VR@_K7/!"U/'V3)G]>N7ML&5W:N6KHLSP3*/^_F=8/333%$G7,O$TEU
M^3NAMB=JNQ)+B$,9P$0(K/Y/0X9\NQ[*1N,:O=N#=D[>=/E=:?FL*YH:0&UF
M9KB#;[!:IX6<X)=:XK_J!(\-G-M:J"YJ&G1"R7'Y4X.!AZZ%:H[%D<*H%C?;
M,1$7V;2LP_S[8K:>K\CR[3:;J4_WE#(JB(P09%AO@'P20DITQ@>-,!:8!0@;
M;8!.CC V8Z(4$A"PD1,4@IKQS&D@VSG%"3P]\T>%S!XN#JCBK/);6LAK7L@%
M^_5Y\?KOZMZ2$M1?]IG@]','6?5GU:I7^/D+NQ2O>KCZ6#<MQS1,HD#",!8"
M(HZX=G1RF*C- 0X8H2BU*%.U>>[85JY0DMD4.=H"9'#TTDWMGE>DUMCUB<*A
MHNT%A[:7#UA:Z$#&W2)"A[_NW(X\6XE/V:O^QJX4\MFV_U[C!+7J77 EU5NN
MVT+?JANFPO>]V LX1(DB)>2G$A)*"0RC0!!".$Z(5=3L!;*,;:'NA!"\Z3[:
MJ^]"V31:9NOFY9TGR,S('PCVOKT"A1:P4 -L]2C;H98-6)C:N.T$=TQ ,2%E
MHW.MC]-.YY>"ZKCI>6=QANY_?BEN1UJA7_S(2Q,.[O^<"WZUNB79\G<R6XLI
M12((_!!#G\<A1(($D*:<PH AQ(2($NE;U4DZ/=38J+%1Y7^A19WH^LA220M>
MM;A=LPX.$#;U<+C K7>WQ@:R^PUD6E#P>RMD%R0<G$*CGXR#@]'>*>7@E-:G
M<PY.WM&QS,UA3EW(2((0$=!G(5),H: DGB(.P0.?<Q1Z) BMJMN,/CVQE!#4
M(G:*W.B<G#CJM$1+9.P+U@R2E/C>Z8CFB8C.4Q!WXU:W'RN!*,92!-#'3-?:
M1A@2G*80QTDL,$,$F24MG!EG;"M=1^J"3PLR!U?/2U$6Q].5[FZS9;X"GS(Q
M!YM++(]!3B%MQ@(.\.N9"@ZBV;?V /B8Y6RVT%THW5'#&41<\L.IH08EB3/Z
M[C/%N<LOB^N\7OR@V;PLJ'=%\Z)8S)0G'N<R3*&,I( (8PHQU29"S/TX]IF@
M=F7OV@8;&W%L A>;PJK/825NQS#/HS";$88K\'IFC<ZX=8[Z; .DC]#/H^.]
M2_QGF^:G@D!;[^D8"2K8>IFM,I'?JB?/639_?EJJSRDI:NT]J8=^7/P@V7S*
M?!F' @L8>\2#*"($DH#',$A#+GQ/$H]:M2$T'7ALW+*5&VP$!PW)P1^EW)8D
M8SP/9H33![H]D\_EP-I'?EJBY#3PTW3L8>,^+1$Y"/NTO;_#P>Y_?M5%B,E<
M#5(G2W%&A1>$,*8T@2A(8TA0I+@I\'F"$ X9B8W/=P\>/S8&^L^O8".AQ7'O
M(6P&I[X7@=$S831QZ))S=^0],D^ZNPB8@;+NC%X4N\/QDVJWGI$?WC7<4?E)
MB7=.S$]?U:7/3O8CN^*Z.U*VB:Q&3,8XP@12C@*(6$(AU6DU-(Y"$N(X)+%Y
M/O"1 <9&4EI$L)'1IGG.$? ,B.I"2/JV;7;0Z$)6QV"QH*L+X1F(L Q?&LNN
M0:=5;^\4=.2^ ;L#G99ZMR-0RW7==H3W+T(W9Y@_%V5Z/F6$:O>V(L:ZZ_3'
MM=BX/YA,4QHJ6HL\02$B,H0$QQA*S^,!4=87$U:>:9O!QT9YGW0A9J$[M%0Z
M@$*)":C5>)O4M40F0.G1V2%E-4-F^\6^<.^95_N W'H7V04[ESM)J_$'W4UV
M069_1]GI&:[2D [[K3TL9K/;Q5+WMIF2@ D>,Q^JS2?7W<RD^EO@PX@K&P\'
M<>I+HWZ)'<<?&_^=2*\YUDP1_*'U )4BEO1G.TUF#-@C^#V38 ^X.TAR,D*O
MWW2G=A'>.?')")_S*5!FC^E2T4J'0.Y7-D%Q[%$6"<A0$D/DXQBF411!XK.
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MP&RSI G_KW55E'BI-%OJX&727EI@Z-DWV[",8TY[_L!NIK.AY00T] 25HF4
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M)S2URL"Z0):QT5:SZ?U6&?VOP_98EA&E%TR8&;D-- T]<Y[-#&P;E/7JO7
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M9\A;7!^=C5^;A.BN1*>4V!BC75)L_J"& :)O;"[_^28GB^L?^C_5Q))Q(,,
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MCU@<"AJF&DV59/KKS5.($R6@BB/%B3#-%9TR.]I7L6]D4&H%:*GCV>T3SQU
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MUM;=;8#ZB]V+XUU/%OGB_7,^EF6.S"B-<,R4]N>0B .(9,@@$4K ,$A)A.*
M)H%5WO&AA_>-V4O]@%&PRLZR+X*W!US]W#X7#M]3VAX)IV)WQTP^H\C=WB,[
M*VYWS)C-HG9'KVGFAFV7^?Y3FE6=% -38>:[?)#&T5O^\4G.7L(1CQ$.&5$P
MBKG^_D=*>VAZR&$8$]/=+ M%ZA1IXJI WZ;X3A^&.8#@7>H/N]O7W'D8[#[T
M/L'U3!@[70$NP%)[4*D/5OI7^4'&@O8<A*;0M>D[..O0J5O1%*%=CZ/Q<QJ<
M/OSW_?7XY?G-;&G=7E9[K3Q-F8@3;"J?:(<DB12D*6(0<Y:@1"2,R,SZC.&
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M3F'1E81P'L(H"WE(TS@EV*K4?*V4OG'AMIXF-.TWAWV:HUA:;&FU@9!GRCH
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M!(1)Y=BTO%Y@_V)$KO)Y^1DN6FR^TKQ(N)L4P5$+K<=X,T+$T7\Y ;X=0;4
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M&K%I4>Z!8P19FB90X!3'(LQ0$#@%,/E1LV]$L5F98-/.K?($[!T<K&!@#+H
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M]93J?YFF/ QEFB%(0RP@(OJ3PDB6PBAFB305P43D%"GE9GYL:EA7$%4U\ O
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M-I4EIQ033&(6ZB5VB"!B@D&:*0D)$S+B1,8JBLXMSGC0\M@$N:4"H_E37@X
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MX^D]>^_8;/KPR-L;3!^YIX-?O%N=IZSGLUC7\]&/7Z[R_ZT^U)1F@J0)A4F
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MS[<WO\''J_LOX//UY,/UY^M'YW.M=G;M9-0;9SWKX1;.B^VTLSX*2EAQXK>
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MX>IUF4V8MXQKGY E+LH5 DU<N:W.7<E)LF#R?0<%AV.J!VWC-+FK!ZVAU=$
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MC5PT:Q'S@RB]G1+J>UC?[5][S24$KAT8XPA5G..:3XHX6N21HA48NDIIJ[A
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MF[ZZ98!R"5:7<;X"*)$4A>)5,B0Y[8(/*:I<Y9[''4K&@<WP2GYXWNT>$F\
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MB=3>& ?04!M.V*TC'MSQ=YU;CG+NIAV^"<,6_%JZ*)+<G?L8"=Q*P8C.#IT
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MWX\^_:^3=Y^/?_MP_.[X]=&'+T>O7Y_\\>'+\8??/IZ\/WY]_':OEBD]GSQ
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M)?9Q1$2(V0:&'FN5+?1QLOKAZZ5E]@=410/ ^KB8G\-B]>/CU*\W_;)DU@[
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M$1:?O]Y33:PE$BR3)*9<AY9,>.),BOBKDDHD"JI./Y&?T-4/92_M'&!(9;2
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MZ:L@'&?"8>8U,U')3JH/?TA5/RT8#IL8U9I4!N#<W-&^N=/.VMO,'4NVYNV
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ME1$A1NZ=:394Y+DW]#-$MTM M,++'@&1<3QZBU<P>3U=$H-6AK3,7JE,?"!
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MS\^F98[_]X;6<D;NYGIJ>I YD=1K^-R3X<)I>R5:CR[!:\N+2D];A+2CQ7Y
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MV&F7RX/%S'AZ]?"MD8DV.,R1(<^V7J03M[S.S(LB>08K4D/ET^Q]C=#364>
M7M"S.[\'8!#=F7C/V7>OOZ;)3:85GBP62/]GTK@CP16Y$R$R7Z>5:UT\ _)!
M2;T6"\E:,@<[N3[:@=9&<.RL<N<PYGEGLAL /+>MZ^T8XGA"I__IS;Q*811S
M"E!(:]M5F^\0$@-9% N@!>VYI"!UTJ&R"7&- -A9%F;' &Q=.@- W*N[U[X9
M3^MERNELL5R\Q^5(!ND*@&')U:EPQ@,YNK7(2CH;G1/1\= %R)ZAI]GM9V<)
M2)T[B/L+80!8>I9+ORVPW$S>C@N.P'A38PG,.DLFI^*%>4U_)"."LS(::3M)
M;FM 6S.,'=L5>U?"&0#>?IW-\E_CR624N!:>RQH:(.9H'C3S"I%9C9)#X,F%
M3B;5; CH>>I]Q\C9B<T#@,?9-&,93\=+?%N#!F<DDNG5F)R6:B N%_?VXOWZ
MG $?LK#,K*[C=-6T:*%N!&]S-L[))CE,._3M?1FA/4\K[AANG8IM +#<T$V<
M>[*VL^O/,)Y73I+?8E)$%5D@^HEM'.OL0LNB\AR%+=!1]543XGH>^78@;=>:
M>':&W!><QUG+H'M8P]O98C'RQ22=);(DLV$Z"5J'KIEFPAD)FH-RG82!MI/3
M\QR- P%K#Q$,0'L]4']>GJKF!\T]J9K[>TUM9 [6$1R<\74H'OWA=:J):[%V
M9I<^\4Z:F^]#=,^-T+L^; \ES@% ]X_9_$]ZV.GL^C-.%RL1?G=[8S-/621@
M:A7?EW5\@-**!1NS- 85=#->J %M/7<?[AB(;0NG[W#57>> =S#Y7*\,QPE?
M8;ZA+VA[?<#YV32-,];L)1TY>KWJ65FG'ANE6<PADAT;?,G*"M&P]U_3-_;<
MWJO+F%4G3!^ YKK$2;G/=[L@@<V_X"C(7*RJ 7_PM!MBD"R )</!.E&0_C"Y
M$U6UC9B>NR]TK)OV9O] E-']&BZ7L\_5^/PPFXS3[>D$QM=W&0$%C/4\"(96
M*::MSPR*$RR*[(TI $J]2!O]_)4]EQ8?0!VUS/8!Z*-7U2[$O(J'C>--%5;E
MWR8WZ1TLB>O3JV\^QWE:69FK#T=<9<&%EPPYU-V3"P/4F;GBE)31Z-)-#?+>
ME/=<9MA](.J @CUJ)-.>C>B31P90^9P4,.^28QS(3"W:%ADZFD2Z*\D]5QL-
M%KLO$N5P05O#Q@_]5D;)."+=1#I34B$;%P(+@8X8!PYH(PJ)OI.@6"/JFD'Q
M6$,8[0NH;PMRD_I2S9>3E.8W,!F);&2V1C$+JE8H"\6B(8/890UUU)K2V*SB
M;<O#F^'CV&(,K;"R;RALZ??T .HS\J^7X[*:E;:^13Q)Q#LB$:9Y<Z$SQ@5]
M=G.-^;=I@2^S>?WIMPB+^QFABU_G]6Y<&[*'A1<L957SDP4G-UTDLHTY^>PI
M@,[-NI,>CN9FP#VV&,:0!?]OL1]&7'J;DT9F(D =@)183*M>:2[FJ+Q13P=[
M]KD5FNV"8PN:#%3<?6^ +0?:'_/Q<HG3\U)&2@-WM<F?#TA6CB"OD+Y*C+A/
M2X'B/+A=K82'US0#W+$%1UIF[P!<E\M/Q,]?".KY<:3G9#Z'Z=6J!\XOMP\_
M<M<)X.0OF.?W-[4YR7E9?;HXN5E^FLU75C2Z4**J^=8FN[LQK-Y+)M 5RR,&
ME3H9MM[Z2II!^-CB,L,0_"!R<'9FP>J/WW&Q'$^O/N!\/,MBY$PTV8"LDS5K
MJEL!%E;MZ*J0BI$:5">I%&TNHAGBCS9JU)>XAZ+FX\_7'I^N_?77S^,YW-W-
MT<I'JLC,@7L&V4JF:TU-*)96[X..27/M32>M,%I;0;..&<<6W^I7T - >+7&
MJF5&>Q2GZ?;.,#M9GL)\?DO?_!TF-S@26<A8.&<JUV(PC8J!0&#1NX BV8#0
M249Y(^J:(?-80UGM"V@(J"/O\>JNQ?IR.5GML'4(>;6IUIV1SI>?</X!B+4C
M 08]\E#K-,IZ4WGN"I.NI*B54UET8AR_D,YF2#S6P%270AL )E^1_OY"R_NR
MOO'8V.L/#6\6_\!)'I$O'WT1GK86;3?M4V$ JC!!_ N!^T@?=Q..:D)>,P0>
M;SRJ=1$-$'BS*BY2\>N4FA#0J2 MJRD'3(O"F3=>,)M2!%Z2$+(3P_&'5#6#
MV;&%M=H7R*#010[:>'%)=$ ^G_X.\]7M[@4L<>1UL=R(P,#6#I5D,[ HC6>T
M4XHC[4WJNJ,0^T]I:X:T8XM#=26< >!M7?L_ALFO-T#>TQ+Q/F_P/BSPYJ9.
MO"'7"=.2W*DY7H]OKN_:HGR<_8*/D@NTB[7=A"7&2E]G%PH&O$:48^!%2DY6
M1"?0;'<9S5!\;'&D 8A\ (#_%<;3ZJ2=3]_ >+YRQ_Z!^0H7C\)IT]<PGY*S
MMACEQ,&#2TQH6:>XTY;VREA62M&@C$C@.^E'\B(JF\'UV*)0W0NL[PCF.]IM
MGR:W9*C,E^/_60GLO&R:LJS66->^&%DM-1B>62*OK7IFP" 9SF0QU@8OD?YJ
MEAW?[(7-\'1L(:'.6#X I58Y<UY.Z<7CY4B*+%5*AJ'7ABP03,Q[&UF.T9"B
M]MSP3ER0QT0T@]"QQEAV9O< H%)9L;Q]A\M/,]*;7W"Q7)7A_C6E-WP:?[[+
M388K'&%4'**M^<BEUME:S@+RR)0$U"5P54PG9U]C"IMU;S[6&$<W@AH  C>3
M%C[.[K*4MJ]T,8K)RJ(<,B]]5<*IK,=_Z%B,,C'$HCM19$T);(:_8XUD="*F
MODVN9]9P_KE*[>/LP\T\?8(%GF32[*M;I.V_,(*41-%*LY LL=/9M"[##!@A
M1!=E>AIA>\8D:XF@9E \ME!&;R(;*DPWRO^,O':2\?+A$-@D?(X*6L\362(H
M:S.J&!.+RJZ.A6*C5UXDOA<R?TY#,S >6U3CD((9)O[.IK3#8++%!#DI].)7
MX\FJYF@4 "SH%)GAM<U!UE@;9B169"";6"278[,*G;W(:(;"8PMZ'%@\ S 7
MMR_VY.IJCE>P7'6M'?$2-$1EF%*B=C^.CH&7B2&4XGFV&LH!795O:&L&PV.-
MB+0MG&$JOG42\,;2R",(QFNR)6CS("GPVI$OZIR9",9(LH2U,<W&A#1Z73,$
M'5LTHB-V#T!A77Z:S9<?<7[]RVP^G_VUNI8FA1L\1T6@S]4SBF2&:G+131UA
M28O(VL@N%-066IK!Z5BC!?LR?Q I^Z<SV@OS=?^H#1&7RUGZ<[TSSA:+&\R_
M?9Y-US^XJ*=ZB74ZLRUD3R;.M +%0A"<2<D1+-+V*9TD.NU :S,$'EM\X5#"
M&X"&>[@:>G,SS6]GTRMZ]O7;&4SI6Q<X@1HSAGDM.1QY+9/R.3$P=?/EJ!@X
M^J>S/"F3L^+"=('+%]#8#(_'&JSH2EB]:LJ5];!.*)R5WZ9I-EW,)N-<U_(?
ML_%T^3NM^(8$.=*UBKM>^&1K#=/"2>8%MTQ$Q*A=,@5#(U.MP<N:S0,\MGA$
M)ZP>@!+;9&UMKFQ>3Y=DBVZ+KQA,ABNO64EUQB&@8)''R%PI62:C@@B=&&^-
M*6P&O&,-1'0CJ $@\+L(RV:%9]/'.VLDHU:"0V)%N=HGJE;AI=JZ.T8;)'J9
MG\YX[R@.MIV^9N@[MMA#ET+J^Y;C::QDLZ3[NVIAI2:R+9-@:A85;2G@Q#5P
M*(O32J)N%M[ZV9N:8><H0P6M,GD VNK;'(1\LKQ/QQLI&;PMD52NJ'U$2VUI
M)X5CQ7 ?C#,A\4X4U/,D-</5L5W^MRR* 8!J^P7@!<*DYG4^I'Z^&B\^SQ8P
M&5F/0NB0F2B"%JF28&#)<89LDPLR1&<[F8KZ4D*; ?!?Z]J_);&]')9A#<OI
M*N:0/[:4G0M36!>37^+\RSCA&ZP>,I>0C)5D6-;*7:$SBT@'?D;G-7#ALFK6
M&V[KXYNAYBBO^O=G9VOJZG___3OVT@+_7'VT^J3^U@66_U7__NWB[)OGSR%/
M<?FW-+M>/_SRMW?O3B[^Z_S-Y=FO[\_>G)V>O/]X<GIZ_MO[CV?O?_UP_O;L
M].SUY2M<PGBR>"@@6GR[JL7X^O/DIR;5SN_Z^\/:GJ[Z[I7?X:B;=>+7)4XS
MV7W['1LG*=7BOMJII#8UKZW-XF)5N3(2B-%*TB^ACNS0&#V+4A>&Q8+@*CON
M.CD@GB=IWS/RO)0%+I=W(Z;)$UE-0(_>^Z**H9U7,JT3:L49=PRS 9&LUD9W
M<M^_E9IF@QBZ4ELMH>'I(;<_WP=@8#WLQ(>RZXOQXL^3K^/%R*)SI&T+X[8$
MIDG=,F\EB3P2>[Q7A=M.NCG]B*A^H=2"S)^M&=U3 (,"TZ90\"/]YJO9-1E\
M(Y>"CB8HL@R@,!T39Q$,,0E#=BD6'[H)]/R(J'[!U)[HG\74GG(8 *8VUR*U
M>/H4/K_#&F@89:V5$ 694EA#]JXP[VC;6<5%DCJ%TLU M*W4# 5%^PK[NUN$
M?3D_,/A<_G6_BBB+% 42 VY\[6QN6*C)'\*XH)%'58KJ&C\/Y#3K.'C4 -J1
M]X- $/DX>$GRP/5TU+263%72/HH@;0 F91VY94G@7A;-4BI!.IDLQ$[R2G]
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M]&8R^^N^54O]YB]89O/:DFH"B\6XC.^LB%KT]A&^CF1,NI !0?Z(JXU-E6=
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MCA>?9PN8C)SB!I-3M#[ .G&+,Z_JP"L;2BX(D+ 3Z_VEA/:3SS!,Y'8JY &
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M[@@DEHOSTLDB@FK2/J#;*87]S'O;QS3>B;^#<O<>L60]0."L5LWC8KDXH[U
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M?5'HFW^RBBGRS(A55\?!J/J$X^@\@JP[M#9#!F.3OL(C:.XV#S4%9@_79M_
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ME:4$OO@(.N4J3Y.Q#>X&T-9+P]Z8H!AZ.1ZHH9Y!5QFZJG!$HW,T%']0=%-
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M#Y->5P#X_,?RB@6O'1T"'B#3744LL (A,PU9*NTD75W)#QP3^N#G3Q.!-@;
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M6W*JM"]O3DDPG!OI'%C,GKP]*2'8C" P"ETB&IZ']5#L_(JIGPC&1\B((NW
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M5Z7D>#[_D7_R68<.?,QQN8CD+F^4NL6KB<Y$XRT$K)T2Z"QX;0UX:7+,BJ3
MFS26'T/TM"_0[1';6(U=0?;7*P*(R8>F2FZQJ4H.1BL#@M?EI#82FZK0SXA&
M;E.@&+")2W<@O=.^4;<':COE=871WQ<K.GM?%O/_M6'UZM)8?UR>G;U>KO[
M5=KB5-N04==Y+D%Z<GF%@> X@Y*89\PBDF?=%J;[DCSM,W9[I#958?=1RU7Z
MY5+,Y_AGOO1^C@QC=GWJN''-(-I/$.A$RT/F!L$RK4 E=&2]3(%8N.4EB\QB
MDW?7AH'.U6SXUYE.-Y[=\XIG@:&-O-84F3K#N:8$0C 68C!(+'O/VPP=>H*N
M?@.6?3"R;:O&5$8/MV?=?U'= ?J;9SO"KI?+Q?E\<3%??+E*!B\7ZUGD*4<D
MF^N-(-] 14&>K!* 225O"E,B-EG]>2C!_08CQZ#Q).KK *;OS[_FU?W#)HN(
MK&8 2O":'%1^M=N*,Z:)0692HVF?#Y+3;QAQ#,1&$'T' +H.@:[L]HZC,E-:
M\IP\ QU]!F500O#1@"HF*A>,XJJ)]S",O'Z]_V, UD U'0%NB(6>J>C(40@,
MG*H[,ZH@29P%O)?:U.=QQ"9UJ_L0.6WM:FOPC:ZF#B"XBXU"<O'2.^"Z3K75
MA>15=(%$ O-!!,M4VP?F X#5K BU%;#&$/YH%7^-$Q9W4][+0A[#FK[E@N#Y
MU^^?RJ5=)\\S(P7_UTGS^NMC7VB/__XF29"QY'&"=$F2"076U5]6T ]%)PB)
MO#HCC<U&;&JVGEFZY.8UYHX:=AS(%]>A_*=K#=UYS9F1:1=.% 91^%H6@1X0
MK0*6G>%)%:NQR;3.4;GH-Q6S#_YVFMB3*[JGR_TN\P_[,7D]8U$9Z:R&G*0
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M@1QKUJ2*^F%RIGTXF0!9^RMAM(E28Q=RW2Q>1Y(.UQQTD72O9R,!L]!U(7I
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MM'U<80<KI2- 79VM.AR*ZVB!YSIR:D-]/1U2<9LC*E[:K#ZX2\:T%NAP=>[
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M+FAT;5!+ 0(4 Q0    ( !A]<%+D@!?IU@,  $<0   6              "
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M4$L! A0#%     @ &'UP4L/)X*C^!   WAD  !0              ( !1R4
M '$T,C R,&5X:&EB:70S,C(N:'1M4$L! A0#%     @ &'UP4N6VW7,B-P0
M27(L !$              ( !=RH  ')D;G0M,C R,#$R,S$N:'1M4$L! A0#
M%     @ &'UP4LVI@18!'   ?CL! !$              ( !R&$$ ')D;G0M
M,C R,#$R,S$N>'-D4$L! A0#%     @ &'UP4CO8^[5A-   "# " !4
M         ( !^'T$ ')D;G0M,C R,#$R,S%?8V%L+GAM;%!+ 0(4 Q0    (
M !A]<%+7PIU&'[0  /V?!P 5              "  8RR! !R9&YT+3(P,C Q
M,C,Q7V1E9BYX;6Q02P$"% ,4    "  8?7!2]DG)7WP2 0 KXP$ %
M        @ '>9@4 <F1N="TR,#(P,3(S,5]G,2YJ<&=02P$"% ,4    "  8
M?7!2J=ZYY..: 0#]K!  %0              @ &,>08 <F1N="TR,#(P,3(S
M,5]L86(N>&UL4$L! A0#%     @ &'UP4@@9B]ZT^@  H38+ !4
M     ( !HA0( ')D;G0M,C R,#$R,S%?<')E+GAM;%!+!08     #0 - %P#
(  ")#PD    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
